siological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840862|NCT04580498|Paclitaxel|paclitaxel|mesh-list
1840863|NCT04580498|Carboplatin|carboplatin|mesh-list
1840864|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1840865|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840866|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
1840867|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
1840868|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
1840869|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840870|NCT04579848|Folic Acid|folic acid|mesh-list
1840871|NCT04579848|Methotrexate|methotrexate|mesh-list
1840872|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1840873|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
1840874|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1840875|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840876|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1840877|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
1840878|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840879|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840880|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
1840881|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840882|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1840883|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1840884|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
1840885|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840886|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1840887|NCT04579848|Hematinics|hematinics|mesh-ancestor
1840888|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
1840889|NCT04579848|Vitamins|vitamins|mesh-ancestor
1840890|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
1840904|NCT04580277|Tofacitinib|tofacitinib|mesh-list
1840905|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1840906|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840907|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840908|NCT04580147|Aflibercept|aflibercept|mesh-list
1840909|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1840910|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1840911|NCT04580147|Growth Substances|growth substances|mesh-ancestor
1840912|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840913|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
1840914|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840918|NCT04579614|Vaccines|vaccines|mesh-list
1840919|NCT04579614|Immunologic Factors|immunologic factors|mesh-ancestor
1840920|NCT04579614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840921|NCT04579731|Lactitol|lactitol|mesh-list
1840922|NCT04579731|Cathartics|cathartics|mesh-ancestor
1840923|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840929|NCT04579302|Bupivacaine|bupivacaine|mesh-list
1840930|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
1840931|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
1840932|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840933|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840934|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
1840935|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840936|NCT04578938|Ketamine|ketamine|mesh-list
1840937|NCT04578938|Analgesics|analgesics|mesh-ancestor
1840938|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
1840939|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840940|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840941|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1840942|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1840943|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
1840944|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
1840945|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840946|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1840947|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1840948|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840949|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840956|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1840957|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1840958|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1840959|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840960|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840961|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1840962|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840963|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840964|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
1840965|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840966|NCT04579133|Durvalumab|durvalumab|mesh-list
1840967|NCT04579133|Olaparib|olaparib|mesh-list
1840968|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840969|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840970|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1840971|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840972|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840973|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
1840974|NCT04578847|Dasatinib|dasatinib|mesh-list
1840975|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840976|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1840977|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840978|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840979|NCT04578613|Rituximab|rituximab|mesh-list
1840980|NCT04578613|Chlorambucil|chlorambucil|mesh-list
1840981|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840982|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840983|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
1840984|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840985|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840986|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1840987|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
1840988|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840989|NCT04578639|Rituximab|rituximab|mesh-list
1840990|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
1840991|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840992|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840993|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
1840994|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840995|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840999|NCT04578470|Vitamin D|vitamin d|mesh-list
1841000|NCT04578470|Vitamins|vitamins|mesh-ancestor
1841001|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
1841002|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841003|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1841019|NCT04578496|Afamelanotide|afamelanotide|mesh-list
1841020|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841021|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
1841022|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
1841023|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1841024|NCT04578691|Protective Agents|protective agents|mesh-ancestor
1841025|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841026|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841027|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1841028|NCT04578236|Tretinoin|tretinoin|mesh-list
1841029|NCT04578236|Captopril|captopril|mesh-list
1841030|NCT04578236|Isotretinoin|isotretinoin|mesh-list
1841031|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841032|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
1841033|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841034|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1841035|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
1841036|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841037|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841038|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1841043|NCT04578158|Quercetin|quercetin|mesh-list
1841044|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
1841045|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841046|NCT04578158|Protective Agents|protective agents|mesh-ancestor
1841047|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841048|NCT04577846|Cephalexin|cephalexin|mesh-list
1841049|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1841050|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841056|NCT04577885|Rifampin|rifampin|mesh-list
1841057|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1841058|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
1841059|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1841060|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841061|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
1841062|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1841063|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841064|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841065|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1841066|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1841067|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1841068|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1841069|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1841070|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1841071|NCT04577716|Listerine|listerine|mesh-list
1841072|NCT04577716|Fluorides|fluorides|mesh-list
1841073|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
1841074|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
1841075|NCT04577716|Protective Agents|protective agents|mesh-ancestor
1841076|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841077|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1841078|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841079|NCT04577755|Pomalidomide|pomalidomide|mesh-list
1841080|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
1841081|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841082|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1841083|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1841084|NCT04577755|Growth Substances|growth substances|mesh-ancestor
1841085|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
1841086|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841110|NCT04577443|Adenosine|adenosine|mesh-list
1841111|NCT04577443|Analgesics|analgesics|mesh-ancestor
1841112|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
1841113|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841114|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841115|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1841116|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
1841117|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1841118|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
1841119|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
1841120|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841121|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841122|NCT04577378|Itraconazole|itraconazole|mesh-list
1841123|NCT04577378|Tretinoin|tretinoin|mesh-list
1841124|NCT04577378|Isotretinoin|isotretinoin|mesh-list
1841125|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
1841126|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841127|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1841128|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1841129|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841130|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841131|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1841132|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
1841133|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841134|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841135|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1841136|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841137|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
1841138|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841139|NCT04577417|Methylphenidate|methylphenidate|mesh-list
1841140|NCT04577417|Amphetamine|amphetamine|mesh-list
1841141|NCT04577417|Adderall|adderall|mesh-list
1841142|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
1841143|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1841144|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1841145|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841146|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1841147|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1841148|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841149|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841150|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
1841151|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841152|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
1841153|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
1841154|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841155|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841156|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1841157|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
1841158|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841159|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
1841160|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841161|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841162|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1841163|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
1841164|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841165|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841166|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1841167|NCT04577027|Travoprost|travoprost|mesh-list
1841168|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1841169|NCT04577040|Tadalafil|tadalafil|mesh-list
1841170|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
1841171|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1841172|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1841173|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841174|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841175|NCT04577040|Urological Agents|urological agents|mesh-ancestor
1841176|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
1841177|NCT04576975|Ketamine|ketamine|mesh-list
1841178|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1841179|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841180|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841181|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841182|NCT04576975|Analgesics|analgesics|mesh-ancestor
1841183|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
1841184|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841185|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1841186|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1841187|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1841188|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841189|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841190|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841191|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1841192|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1841193|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
1841194|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
1841195|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1841196|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1841197|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
1841198|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1841199|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841200|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841201|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841202|NCT04577430|Analgesics|analgesics|mesh-ancestor
1841203|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
1841204|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841205|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1841206|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1841207|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1841208|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841209|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841210|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841211|NCT04577014|Gemcitabine|gemcitabine|mesh-list
1841212|NCT04577014|Docetaxel|docetaxel|mesh-list
1841213|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1841214|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
1841215|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841216|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841217|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
1841218|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841219|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841220|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841221|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
1841222|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841223|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
1841224|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
1841225|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
1841226|NCT04576962|Vaccines|vaccines|mesh-list
1841227|NCT04576962|Immunologic Factors|immunologic factors|mesh-ancestor
1841228|NCT04576962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841229|NCT04577404|Edaravone|edaravone|mesh-list
1841230|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1841231|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
1841232|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841233|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1841234|NCT04577404|Protective Agents|protective agents|mesh-ancestor
1841235|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841236|NCT04577001|Letrozole|letrozole|mesh-list
1841237|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841238|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1841239|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1841240|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841241|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841242|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1841243|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
1841244|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841245|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841246|NCT04576546|Inositol|inositol|mesh-list
1841247|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
1841248|NCT04576546|Vitamins|vitamins|mesh-ancestor
1841249|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
1841250|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841251|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
1841252|NCT04576364|Analgesics|analgesics|mesh-ancestor
1841253|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
1841254|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841255|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841256|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
1841257|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841258|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1841259|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
1841260|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1841261|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841262|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841263|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1841264|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
1841265|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1841282|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
1841283|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1841284|NCT04576143|Paclitaxel|paclitaxel|mesh-list
1841285|NCT04576143|Docetaxel|docetaxel|mesh-list
1841286|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
1841287|NCT04576143|Epirubicin|epirubicin|mesh-list
1841288|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1841289|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841290|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
1841291|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
1841292|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
1841293|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841294|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841295|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
1841296|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841297|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841298|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1841299|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
1841300|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1841301|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1841302|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1841303|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1841304|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841311|NCT04576390|Ondansetron|ondansetron|mesh-list
1841312|NCT04576390|Palonosetron|palonosetron|mesh-list
1841313|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
1841314|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
1841315|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841316|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841317|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1841318|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
1841319|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841320|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1841321|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
1841322|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841323|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841324|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1841325|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1841326|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841327|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1841328|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1841329|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1841330|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
1841331|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1841332|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841337|NCT04575844|Liraglutide|liraglutide|mesh-list
1841338|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1841339|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841340|NCT04575844|Incretins|incretins|mesh-ancestor
1841341|NCT04575844|Hormones|hormones|mesh-ancestor
1841342|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841343|NCT04575688|Bupivacaine|bupivacaine|mesh-list
1841344|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
1841345|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
1841346|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841347|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841348|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
1841349|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841350|NCT04575779|Cyclosporine|cyclosporine|mesh-list
1841351|NCT04575779|Cyclosporins|cyclosporins|mesh-list
1841352|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841353|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841354|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841355|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
1841356|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841357|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
1841358|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841359|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841360|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841361|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1841362|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
1841363|NCT04575675|Valsartan|valsartan|mesh-list
1841364|NCT04575675|Carvedilol|carvedilol|mesh-list
1841365|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1841366|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1841367|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1841368|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
1841369|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1841370|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1841371|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1841372|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841373|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1841374|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1841375|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841376|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1841377|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841378|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841379|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
1841380|NCT04575675|Protective Agents|protective agents|mesh-ancestor
1841381|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1841382|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841383|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1841384|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
1841385|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1841386|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1841387|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
1841388|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841389|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1841390|NCT04575675|Diuretics|diuretics|mesh-ancestor
1841391|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
1841392|NCT04575675|Hormones|hormones|mesh-ancestor
1841393|NCT04575922|Nivolumab|nivolumab|mesh-list
1841394|NCT04575922|Ipilimumab|ipilimumab|mesh-list
1841395|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1841396|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841397|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1841398|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841399|NCT04575558|Azithromycin|azithromycin|mesh-list
1841400|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
1841401|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1841402|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841403|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
1841404|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1841405|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1841406|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841407|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841408|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841409|NCT04575519|Aspirin|aspirin|mesh-list
1841410|NCT04575519|Ibuprofen|ibuprofen|mesh-list
1841411|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1841412|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841413|NCT04575519|Analgesics|analgesics|mesh-ancestor
1841414|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
1841415|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841416|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841417|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1841418|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841419|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1841420|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841421|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841422|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1841423|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1841424|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1841425|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
1841431|NCT04575194|Liraglutide|liraglutide|mesh-list
1841432|NCT04575194|Naltrexone|naltrexone|mesh-list
1841433|NCT04575194|Bupropion|bupropion|mesh-list
1841434|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1841435|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1841436|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841437|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
1841438|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841439|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1841440|NCT04575194|Incretins|incretins|mesh-ancestor
1841441|NCT04575194|Hormones|hormones|mesh-ancestor
1841442|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841443|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1841444|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
1841445|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1841446|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1841447|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1841448|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841449|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841450|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
1841451|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841452|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1841453|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1841454|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841455|NCT04575233|Ropivacaine|ropivacaine|mesh-list
1841456|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
1841457|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
1841458|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841459|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841460|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
1841461|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841462|NCT04575415|Bevacizumab|bevacizumab|mesh-list
1841463|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1841464|NCT04575415|Gefitinib|gefitinib|mesh-list
1841465|NCT04575415|Afatinib|afatinib|mesh-list
1841466|NCT04575415|Osimertinib|osimertinib|mesh-list
1841467|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1841468|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841469|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1841470|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1841471|NCT04575415|Growth Substances|growth substances|mesh-ancestor
1841472|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841473|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
1841474|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1841475|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841476|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841477|NCT04575389|Uric Acid|uric acid|mesh-list
1841478|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
1841479|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841480|NCT04575389|Protective Agents|protective agents|mesh-ancestor
1841481|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841482|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
1841483|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1841484|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841485|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1841486|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1841487|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841488|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841489|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841490|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1841491|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1841492|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
1841493|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1841494|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841495|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841496|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1841497|NCT04575038|Brequinar|brequinar|mesh-list
1841498|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841499|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841500|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841501|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841502|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
1841503|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841504|NCT04574960|Gemcitabine|gemcitabine|mesh-list
1841505|NCT04574960|Carboplatin|carboplatin|mesh-list
1841506|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841507|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1841508|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
1841509|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841510|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
1841511|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841512|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841513|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841514|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
1841515|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841521|NCT04574947|Lidocaine|lidocaine|mesh-list
1841522|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
1841523|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
1841524|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841525|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841526|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
1841527|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841528|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1841529|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1841530|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1841531|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841532|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841533|NCT04574713|Candesartan|candesartan|mesh-list
1841534|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
1841535|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1841536|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1841537|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1841538|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841539|NCT04574778|Acetaminophen|acetaminophen|mesh-list
1841540|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841541|NCT04574778|Analgesics|analgesics|mesh-ancestor
1841542|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
1841543|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841544|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841545|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
1841546|NCT04574791|Tizanidine|tizanidine|mesh-list
1841547|NCT04574791|Analgesics|analgesics|mesh-ancestor
1841548|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
1841549|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841550|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841551|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
1841552|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1841553|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1841554|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
1841555|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
1841556|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1841557|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1841558|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1841559|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841560|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841561|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841562|NCT04575064|Remdesivir|remdesivir|mesh-list
1841563|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
1841564|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841565|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
1841566|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841567|NCT04574479|Morphine|morphine|mesh-list
1841568|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1841569|NCT04574479|Narcotics|narcotics|mesh-ancestor
1841570|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841571|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841572|NCT04574479|Analgesics|analgesics|mesh-ancestor
1841573|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
1841574|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841588|NCT04573946|Vitamin D|vitamin d|mesh-list
1841589|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
1841590|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
1841591|NCT04573946|Vitamins|vitamins|mesh-list
1841592|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
1841593|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841594|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1841595|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1841599|NCT04574141|Melatonin|melatonin|mesh-list
1841600|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
1841601|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841602|NCT04574141|Protective Agents|protective agents|mesh-ancestor
1841603|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841604|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841605|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
1841606|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1841607|NCT04573855|Antibodies|antibodies|mesh-list
1841608|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
1841609|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841610|NCT04573920|Atrasentan|atrasentan|mesh-list
1841611|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841612|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1841613|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1841614|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841615|NCT04573803|Phenytoin|phenytoin|mesh-list
1841616|NCT04573803|Levetiracetam|levetiracetam|mesh-list
1841617|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
1841618|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
1841619|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1841620|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1841621|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841622|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841623|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1841624|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1841631|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1841632|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1841633|NCT04573426|Acetaminophen|acetaminophen|mesh-list
1841634|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841635|NCT04573426|Analgesics|analgesics|mesh-ancestor
1841636|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
1841637|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841638|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841639|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
1841640|NCT04573751|Verapamil|verapamil|mesh-list
1841641|NCT04573751|Epinephrine|epinephrine|mesh-list
1841642|NCT04573751|Racepinephrine|racepinephrine|mesh-list
1841643|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
1841644|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1841645|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1841646|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841647|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841648|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841649|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841650|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1841651|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1841652|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
1841653|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841654|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1841655|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
1841656|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
1841657|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
1841658|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1841659|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1841660|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1841661|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841662|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1841663|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
1841664|NCT04573673|Emodin|emodin|mesh-list
1841665|NCT04573673|Cathartics|cathartics|mesh-ancestor
1841666|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1841667|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1841668|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841669|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841670|NCT04573556|Lemborexant|lemborexant|mesh-list
1841671|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1841672|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841673|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841674|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1841675|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1841676|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841677|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841678|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
1841679|NCT04573686|Hematinics|hematinics|mesh-ancestor
1841680|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
1841681|NCT04573153|Sorbitol|sorbitol|mesh-list
1841682|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
1841683|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1841684|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1841685|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841686|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841687|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841688|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841689|NCT04573153|Cathartics|cathartics|mesh-ancestor
1841690|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1841691|NCT04573192|Lomustine|lomustine|mesh-list
1841692|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1841693|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
1841694|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841695|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841696|NCT04573049|Simendan|simendan|mesh-list
1841697|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1841698|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
1841699|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1841700|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1841701|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841702|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841703|NCT04573049|Protective Agents|protective agents|mesh-ancestor
1841704|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841705|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
1841706|NCT04572698|Growth Substances|growth substances|mesh-ancestor
1841707|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841708|NCT04572867|Diuretics|diuretics|mesh-list
1841709|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
1841710|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841711|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1841712|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1841713|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1841714|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841715|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841716|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1841717|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1841718|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1841719|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
1841720|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841721|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841722|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1841723|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1841724|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
1841725|NCT04572724|Valsartan|valsartan|mesh-list
1841726|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1841727|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1841728|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1841729|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841730|NCT04572997|Apremilast|apremilast|mesh-list
1841731|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1841732|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841733|NCT04572997|Analgesics|analgesics|mesh-ancestor
1841734|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
1841735|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841736|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841737|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1841738|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841739|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1841740|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1841741|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841891|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
1841742|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841743|NCT04572620|Rituximab|rituximab|mesh-list
1841744|NCT04572620|Abatacept|abatacept|mesh-list
1841745|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1841746|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841747|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
1841748|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841749|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1841750|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1841751|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841752|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841753|NCT04572542|Paclitaxel|paclitaxel|mesh-list
1841754|NCT04572542|Apatinib|apatinib|mesh-list
1841755|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1841756|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841757|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
1841758|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
1841759|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
1841760|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841761|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1841762|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841763|NCT04572763|Venetoclax|venetoclax|mesh-list
1841764|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841765|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1841766|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1841767|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1841768|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841769|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841770|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1841771|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841772|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841773|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
1841774|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841788|NCT04572256|Montelukast|montelukast|mesh-list
1841789|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1841790|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
1841791|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1841792|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
1841793|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841794|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841795|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1841796|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1841797|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841798|NCT04572217|Topiramate|topiramate|mesh-list
1841799|NCT04572217|Phentermine|phentermine|mesh-list
1841800|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
1841801|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1841802|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841803|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1841804|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
1841805|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1841806|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
1841807|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
1841808|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841809|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
1841810|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841811|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841812|NCT04572373|SMOFlipid|smoflipid|mesh-list
1841813|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1841814|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1841815|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1841816|NCT04571879|Lidocaine|lidocaine|mesh-list
1841817|NCT04571879|Midazolam|midazolam|mesh-list
1841818|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
1841819|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
1841820|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841821|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841822|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
1841823|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841824|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1841825|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1841826|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1841827|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841828|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841829|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1841830|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1841831|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1841832|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1841833|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1841834|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1841835|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
1841836|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
1841837|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
1841838|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841844|NCT04571437|Capecitabine|capecitabine|mesh-list
1841845|NCT04571437|Letrozole|letrozole|mesh-list
1841846|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1841847|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
1841848|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841849|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841850|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1841851|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1841852|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841853|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1841854|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
1841855|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841856|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841857|NCT04571489|Gemcitabine|gemcitabine|mesh-list
1841858|NCT04571489|Tegafur|tegafur|mesh-list
1841859|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1841860|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
1841861|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841862|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841863|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
1841864|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1841865|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1841866|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841867|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
1841868|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841869|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
1841870|NCT04571632|Ipilimumab|ipilimumab|mesh-list
1841871|NCT04571632|Avelumab|avelumab|mesh-list
1841872|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1841873|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841874|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1841875|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841876|NCT04571619|Buprenorphine|buprenorphine|mesh-list
1841877|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1841878|NCT04571619|Narcotics|narcotics|mesh-ancestor
1841879|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841880|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841881|NCT04571619|Analgesics|analgesics|mesh-ancestor
1841882|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
1841883|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841884|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1841885|NCT04571996|Acetaminophen|acetaminophen|mesh-list
1841886|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1841887|NCT04571996|Analgesics|analgesics|mesh-ancestor
1841888|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
1841889|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841890|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841892|NCT04571580|Reteplase|reteplase|mesh-list
1841893|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1841894|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1841895|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1841896|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841897|NCT04571606|Bupivacaine|bupivacaine|mesh-list
1841898|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
1841899|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
1841900|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1841901|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841902|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
1841903|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841904|NCT04571164|Rotigotine|rotigotine|mesh-list
1841905|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
1841906|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
1841907|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841908|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841909|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841910|NCT04571151|Halobetasol|halobetasol|mesh-list
1841911|NCT04571151|Calcipotriene|calcipotriene|mesh-list
1841912|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841913|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1841914|NCT04571229|Mifamurtide|mifamurtide|mesh-list
1841915|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1841916|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
1841917|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841918|NCT04570956|Tamoxifen|tamoxifen|mesh-list
1841919|NCT04570956|Afimoxifene|afimoxifene|mesh-list
1841920|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1841921|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
1841922|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841923|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841924|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1841925|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841926|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1841927|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1841928|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1841937|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
1841938|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1841939|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841940|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1841941|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841942|NCT04570631|Dexamethasone|dexamethasone|mesh-list
1841943|NCT04570631|Bortezomib|bortezomib|mesh-list
1841944|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1841945|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
1841946|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
1841947|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841948|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841949|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1841950|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
1841951|NCT04570631|Hormones|hormones|mesh-ancestor
1841952|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841953|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1841954|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841955|NCT04570592|Dexamethasone|dexamethasone|mesh-list
1841956|NCT04570592|Granisetron|granisetron|mesh-list
1841957|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1841958|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1841959|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
1841960|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
1841961|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1841962|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841963|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1841964|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
1841965|NCT04570592|Hormones|hormones|mesh-ancestor
1841966|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1841967|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1841968|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841969|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1841970|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
1841971|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841972|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841973|NCT04570475|Vitamin D|vitamin d|mesh-list
1841974|NCT04570475|Vitamins|vitamins|mesh-ancestor
1841975|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
1841976|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841977|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1841981|NCT04570683|Nivolumab|nivolumab|mesh-list
1841982|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1841983|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1841984|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1841985|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841986|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1841987|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
1841988|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1841989|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
1841990|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841991|NCT04570449|Fluoxetine|fluoxetine|mesh-list
1841992|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1841993|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1841994|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1841995|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1841996|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1841997|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
1841998|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1841999|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1842000|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
1842001|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1842002|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1842003|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1842004|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842005|NCT04570436|Diazepam|diazepam|mesh-list
1842006|NCT04570436|Gabapentin|gabapentin|mesh-list
1842007|NCT04570436|Analgesics|analgesics|mesh-ancestor
1842008|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
1842009|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842010|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842011|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
1842012|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1842013|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1842014|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842015|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1842016|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1842017|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1842018|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842019|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842020|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
1842021|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1842022|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
1842023|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
1842024|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842025|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1842026|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1842027|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1842028|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1842029|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
1842030|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
1842031|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
1842032|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
1842033|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
1842034|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1842035|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842036|NCT04570410|Gemcitabine|gemcitabine|mesh-list
1842037|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842038|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1842039|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
1842040|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842041|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
1842042|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842043|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842044|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842045|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
1842046|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842047|NCT04570397|Ravulizumab|ravulizumab|mesh-list
1842048|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1842049|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842050|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
1842051|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842052|NCT04570345|Aspirin|aspirin|mesh-list
1842053|NCT04570345|Ticagrelor|ticagrelor|mesh-list
1842054|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1842055|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1842056|NCT04570345|Analgesics|analgesics|mesh-ancestor
1842057|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
1842058|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842059|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842060|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842061|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842062|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1842063|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1842064|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842065|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1842066|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1842067|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842068|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
1842069|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1842070|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1842071|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1842072|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
1842073|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842074|NCT04570293|Lidocaine|lidocaine|mesh-list
1842075|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
1842076|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
1842077|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842078|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842079|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
1842080|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842081|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1842082|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1842083|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1842084|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1842085|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842086|NCT04570254|Vitamins|vitamins|mesh-list
1842087|NCT04570254|Vitamin E|vitamin e|mesh-list
1842088|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
1842089|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
1842090|NCT04570254|Melatonin|melatonin|mesh-list
1842091|NCT04570254|Antioxidants|antioxidants|mesh-list
1842092|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1842093|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
1842094|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842095|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842096|NCT04570254|Protective Agents|protective agents|mesh-ancestor
1842097|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842098|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1842099|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842100|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1842101|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1842102|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
1842103|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1842104|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
1842105|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842106|NCT04570254|Expectorants|expectorants|mesh-ancestor
1842107|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842108|NCT04570254|Antidotes|antidotes|mesh-ancestor
1842109|NCT04570150|Neostigmine|neostigmine|mesh-list
1842110|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1842111|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842112|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842113|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
1842114|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842115|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842116|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1842117|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
1842118|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842119|NCT04570306|Belimumab|belimumab|mesh-list
1842120|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842121|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
1842122|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842123|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
1842124|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1842125|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842126|NCT04570176|Epinephrine|epinephrine|mesh-list
1842127|NCT04570176|Racepinephrine|racepinephrine|mesh-list
1842128|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
1842129|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1842130|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1842131|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
1842132|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842133|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842134|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842135|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1842136|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1842137|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
1842138|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842139|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1842140|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842141|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
1842142|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
1842143|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1842144|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1842145|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1842146|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
1842147|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842148|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842149|NCT04570085|Caffeine|caffeine|mesh-list
1842150|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1842151|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842152|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1842153|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842154|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842155|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1842156|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1842157|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
1842158|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842159|NCT04569877|Molgramostim|molgramostim|mesh-list
1842160|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1842161|NCT04569877|Sargramostim|sargramostim|mesh-list
1842162|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842163|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
1842164|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842165|NCT04569916|Irinotecan|irinotecan|mesh-list
1842166|NCT04569916|Apatinib|apatinib|mesh-list
1842167|NCT04569916|Antibodies|antibodies|mesh-list
1842168|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
1842169|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842170|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1842171|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1842172|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842173|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842174|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842175|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1842176|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1842177|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
1842178|NCT04569890|Prednisone|prednisone|mesh-list
1842179|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
1842180|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842181|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
1842182|NCT04569890|Hormones|hormones|mesh-ancestor
1842183|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842184|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842185|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842186|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842187|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
1842188|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1842189|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1842190|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842191|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842192|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842193|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842194|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842195|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
1842196|NCT04569994|Insulin|insulin|mesh-list
1842197|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1842198|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842199|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
1842200|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
1842201|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842202|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842203|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842204|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
1842205|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
1842230|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
1842231|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1842232|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842233|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1842234|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842235|NCT04569214|PAZ320|paz320|mesh-list
1842236|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1842237|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842238|NCT04569279|Warfarin|warfarin|mesh-list
1842239|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
1842240|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
1842241|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1842242|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
1842243|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1842244|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
1842245|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842246|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842247|NCT04569045|Lidocaine|lidocaine|mesh-list
1842248|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
1842249|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
1842250|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842251|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842252|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
1842253|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842254|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1842255|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1842256|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1842257|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1842258|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842259|NCT04568863|Melatonin|melatonin|mesh-list
1842260|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
1842261|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842262|NCT04568863|Protective Agents|protective agents|mesh-ancestor
1842263|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842264|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842265|NCT04568772|Atovaquone|atovaquone|mesh-list
1842266|NCT04568772|Proguanil|proguanil|mesh-list
1842267|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
1842268|NCT04568772|Esomeprazole|esomeprazole|mesh-list
1842269|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1842270|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842271|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1842272|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842273|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842274|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842275|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
1842276|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1842277|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1842278|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
1842279|NCT04568603|Islatravir|islatravir|mesh-list
1842280|NCT04568603|Methadone|methadone|mesh-list
1842281|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1842282|NCT04568603|Narcotics|narcotics|mesh-ancestor
1842283|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842284|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842285|NCT04568603|Analgesics|analgesics|mesh-ancestor
1842286|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
1842287|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842288|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
1842289|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842290|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
1842291|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842292|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842293|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842294|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1842295|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1842296|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1842297|NCT04568876|Palmidrol|palmidrol|mesh-list
1842298|NCT04568876|Analgesics|analgesics|mesh-ancestor
1842299|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
1842300|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842301|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842302|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1842303|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1842304|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842305|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842306|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
1842307|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842308|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1842309|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1842310|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842311|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842312|NCT04568876|Hormones|hormones|mesh-ancestor
1842313|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842314|NCT04568837|Dexamethasone|dexamethasone|mesh-list
1842315|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
1842316|NCT04568837|Prednisone|prednisone|mesh-list
1842317|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1842318|NCT04568837|BB 1101|bb 1101|mesh-list
1842319|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842320|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
1842321|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
1842322|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842323|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842324|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842325|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
1842326|NCT04568837|Hormones|hormones|mesh-ancestor
1842327|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842328|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842329|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842330|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
1842331|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842332|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842333|NCT04568265|Entecavir|entecavir|mesh-list
1842334|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
1842335|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842336|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1842337|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
1842338|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842339|NCT04568304|Gemcitabine|gemcitabine|mesh-list
1842340|NCT04568304|Carboplatin|carboplatin|mesh-list
1842341|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842493|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1842342|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1842343|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
1842344|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842345|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
1842346|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842347|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842348|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842349|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
1842350|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842351|NCT04568096|Tamoxifen|tamoxifen|mesh-list
1842352|NCT04568096|Tretinoin|tretinoin|mesh-list
1842353|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1842354|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
1842355|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842356|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842357|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842358|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842359|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1842360|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1842361|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1842362|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
1842363|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
1842364|NCT04568200|Paclitaxel|paclitaxel|mesh-list
1842365|NCT04568200|Carboplatin|carboplatin|mesh-list
1842366|NCT04568200|Durvalumab|durvalumab|mesh-list
1842367|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1842368|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842369|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
1842370|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
1842371|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
1842372|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842373|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1842374|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
1842375|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842376|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
1842377|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842378|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842379|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1842380|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
1842381|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842382|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842383|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1842384|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1842385|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842386|NCT04567992|Bupivacaine|bupivacaine|mesh-list
1842387|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
1842388|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
1842389|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842390|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842391|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
1842392|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842395|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
1842396|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
1842397|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842398|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
1842399|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1842400|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842401|NCT04567290|Ticagrelor|ticagrelor|mesh-list
1842402|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1842403|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1842404|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1842405|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1842406|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
1842407|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842408|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842409|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842410|NCT04567108|Benzocaine|benzocaine|mesh-list
1842411|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
1842412|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
1842413|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842414|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842415|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
1842416|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842417|NCT04566952|Olaparib|olaparib|mesh-list
1842418|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1842419|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842420|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842421|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842422|NCT04567069|Vaccines|vaccines|mesh-list
1842423|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
1842424|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842425|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
1842426|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842427|NCT04566796|Neostigmine|neostigmine|mesh-list
1842428|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1842429|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842430|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842431|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
1842432|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842433|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842434|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1842435|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
1842436|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842437|NCT04566991|Deferoxamine|deferoxamine|mesh-list
1842438|NCT04566991|Siderophores|siderophores|mesh-ancestor
1842439|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1842440|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
1842441|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
1842442|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842443|NCT04567160|Propofol|propofol|mesh-list
1842444|NCT04567160|Sevoflurane|sevoflurane|mesh-list
1842445|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1842446|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842447|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842448|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1842449|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
1842450|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
1842451|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1842452|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1842453|NCT04566770|Vaccines|vaccines|mesh-list
1842454|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
1842455|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842462|NCT04566653|Calcium|calcium|mesh-list
1842463|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
1842464|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1842465|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842466|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
1842467|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
1842468|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842469|NCT04566718|Metformin|metformin|mesh-list
1842470|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1842471|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842472|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
1842473|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
1842474|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
1842475|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
1842476|NCT04566250|Analgesics|analgesics|mesh-ancestor
1842477|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
1842478|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842479|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842480|NCT04566380|Nivolumab|nivolumab|mesh-list
1842481|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1842482|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842483|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1842484|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842485|NCT04566211|Amoxicillin|amoxicillin|mesh-list
1842486|NCT04566211|Metronidazole|metronidazole|mesh-list
1842487|NCT04566211|Clarithromycin|clarithromycin|mesh-list
1842488|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
1842489|NCT04566211|Pantoprazole|pantoprazole|mesh-list
1842490|NCT04566211|Bismuth|bismuth|mesh-list
1842491|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1842492|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842494|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1842495|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1842496|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842497|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842498|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1842499|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1842500|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1842501|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842502|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1842503|NCT04566211|Antacids|antacids|mesh-ancestor
1842504|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
1842505|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842506|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
1842507|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1842508|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1842509|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842510|NCT04565925|Urological Agents|urological agents|mesh-ancestor
1842511|NCT04566016|Anesthetics|anesthetics|mesh-list
1842512|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842513|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842514|NCT04565600|Etoricoxib|etoricoxib|mesh-list
1842515|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1842516|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1842517|NCT04565600|Analgesics|analgesics|mesh-ancestor
1842518|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
1842519|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842520|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842521|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842522|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842523|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1842524|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1842525|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842526|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842527|NCT04565847|Albuterol|albuterol|mesh-list
1842528|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1842529|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
1842530|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842531|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842532|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1842533|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842534|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
1842535|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1842536|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1842537|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1842538|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1842539|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
1842540|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842541|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842542|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
1842543|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1842544|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842554|NCT04565301|Dexamethasone|dexamethasone|mesh-list
1842555|NCT04565301|Neostigmine|neostigmine|mesh-list
1842556|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842557|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
1842558|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
1842559|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842560|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842561|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842562|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
1842563|NCT04565301|Hormones|hormones|mesh-ancestor
1842564|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842565|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842566|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842871|NCT04563000|Ascorbic Acid|ascorbic acid|mesh-list
1842567|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1842568|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842569|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842570|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
1842571|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842572|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1842573|NCT04565431|Natalizumab|natalizumab|mesh-list
1842574|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
1842575|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842576|NCT04565184|Artesunate|artesunate|mesh-list
1842577|NCT04565184|Lumefantrine|lumefantrine|mesh-list
1842578|NCT04565184|Artemether|artemether|mesh-list
1842579|NCT04565184|Amodiaquine|amodiaquine|mesh-list
1842580|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1842581|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
1842582|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
1842583|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1842584|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1842585|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842586|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842587|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
1842588|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
1842589|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1842590|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
1842594|NCT04565171|Yimitasvir|yimitasvir|mesh-list
1842595|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
1842596|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842597|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
1842598|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
1842599|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1842600|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1842601|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
1842602|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842618|NCT04564872|Linagliptin|linagliptin|mesh-list
1842619|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1842620|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842621|NCT04564872|Incretins|incretins|mesh-ancestor
1842622|NCT04564872|Hormones|hormones|mesh-ancestor
1842623|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842624|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1842625|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
1842626|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842627|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842628|NCT04564638|Cyclosporine|cyclosporine|mesh-list
1842629|NCT04564638|Cyclosporins|cyclosporins|mesh-list
1842630|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842631|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842632|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842633|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
1842634|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842635|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
1842636|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842637|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
1842638|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842639|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1842640|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
1842641|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
1842642|NCT04564326|Fentanyl|fentanyl|mesh-list
1842643|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1842644|NCT04564326|Narcotics|narcotics|mesh-ancestor
1842645|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842646|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842647|NCT04564326|Analgesics|analgesics|mesh-ancestor
1842648|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
1842649|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842650|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1842651|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1842652|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
1842653|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
1842654|NCT04564690|Vitamin E|vitamin e|mesh-list
1842655|NCT04564690|Selenium|selenium|mesh-list
1842656|NCT04564690|Vitamins|vitamins|mesh-ancestor
1842657|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
1842658|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842659|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
1842660|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842661|NCT04564690|Protective Agents|protective agents|mesh-ancestor
1842662|NCT04564690|Trace Elements|trace elements|mesh-ancestor
1842663|NCT04564469|Furosemide|furosemide|mesh-list
1842664|NCT04564469|Diuretics|diuretics|mesh-ancestor
1842665|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
1842666|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842667|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1842668|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1842669|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842678|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
1842679|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1842680|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842681|NCT04564456|Fluticasone|fluticasone|mesh-list
1842682|NCT04564456|Xhance|xhance|mesh-list
1842683|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1842684|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1842685|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842686|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1842687|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
1842688|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842689|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842690|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1842691|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842692|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
1842693|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1842694|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1842695|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1842696|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1842697|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
1842698|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842699|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842700|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
1842701|NCT04564456|Hormones|hormones|mesh-ancestor
1842702|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842703|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
1842707|NCT04564430|Clonidine|clonidine|mesh-list
1842708|NCT04564430|Analgesics|analgesics|mesh-ancestor
1842709|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
1842710|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842711|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842712|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1842713|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
1842714|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
1842715|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1842716|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1842717|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1842718|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
1842719|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842720|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842726|NCT04564144|Meclizine|meclizine|mesh-list
1842727|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
1842728|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
1842729|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842730|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842731|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842732|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1842733|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
1842734|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
1842735|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842736|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842737|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1842738|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
1842739|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842740|NCT04564222|Micronutrients|micronutrients|mesh-list
1842741|NCT04564222|Trace Elements|trace elements|mesh-list
1842742|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842743|NCT04563936|Goserelin|goserelin|mesh-list
1842744|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842745|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842746|NCT04563975|Paclitaxel|paclitaxel|mesh-list
1842747|NCT04563975|Docetaxel|docetaxel|mesh-list
1842748|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1842749|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842750|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
1842751|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
1842752|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
1842753|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842754|NCT04563923|Avdoralimab|avdoralimab|mesh-list
1842755|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842756|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
1842757|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842758|NCT04563962|Methamphetamine|methamphetamine|mesh-list
1842759|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1842760|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842761|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
1842762|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
1842763|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842764|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
1842765|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842766|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842767|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
1842768|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1842769|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1842770|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1842771|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1842772|NCT04563871|Osimertinib|osimertinib|mesh-list
1842773|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842774|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1842775|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842776|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842777|NCT04564001|Infliximab|infliximab|mesh-list
1842778|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
1842779|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842780|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1842781|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
1842782|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1842783|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842784|NCT04563273|Vaccines|vaccines|mesh-list
1842785|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
1842786|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
1842787|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842788|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1842797|NCT04563299|Prednisolone|prednisolone|mesh-list
1842798|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1842799|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
1842800|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1842801|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
1842802|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1842803|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
1842804|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842805|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
1842806|NCT04563299|Hormones|hormones|mesh-ancestor
1842807|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842808|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842809|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842810|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842811|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
1842812|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
1842813|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842814|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842815|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1842816|NCT04563299|Protective Agents|protective agents|mesh-ancestor
1842817|NCT04563260|Palonosetron|palonosetron|mesh-list
1842818|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
1842819|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
1842820|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842821|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842822|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842823|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1842824|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1842825|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
1842826|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842827|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842828|NCT04563533|Vaccines|vaccines|mesh-list
1842829|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
1842830|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842831|NCT04563494|Dexamethasone|dexamethasone|mesh-list
1842832|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842833|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
1842834|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
1842835|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842836|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842837|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1842838|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
1842839|NCT04563494|Hormones|hormones|mesh-ancestor
1842840|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842841|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1842842|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842843|NCT04563351|Anesthetics|anesthetics|mesh-list
1842844|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
1842845|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842846|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842847|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
1842848|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842849|NCT04563507|Letrozole|letrozole|mesh-list
1842850|NCT04563507|Palbociclib|palbociclib|mesh-list
1842851|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842852|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1842853|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1842854|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842855|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842856|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1842857|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
1842858|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1842859|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842860|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1842861|NCT04563429|Vitamin A|vitamin a|mesh-list
1842862|NCT04563429|Vitamins|vitamins|mesh-ancestor
1842863|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
1842864|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842865|NCT04563247|Antibodies|antibodies|mesh-list
1842866|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
1842867|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842872|NCT04563000|Vitamins|vitamins|mesh-ancestor
1842873|NCT04563000|Micronutrients|micronutrients|mesh-ancestor
1842874|NCT04563000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842875|NCT04563000|Antioxidants|antioxidants|mesh-ancestor
1842876|NCT04563000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842877|NCT04563000|Protective Agents|protective agents|mesh-ancestor
1842878|NCT04562831|Niacinamide|niacinamide|mesh-list
1842879|NCT04562831|Niacin|niacin|mesh-list
1842880|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
1842881|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
1842882|NCT04562831|Vitamins|vitamins|mesh-ancestor
1842883|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
1842884|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842885|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1842886|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
1842887|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842888|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1842889|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
1842890|NCT04562532|Sirolimus|sirolimus|mesh-list
1842891|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1842892|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842893|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1842894|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842895|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
1842896|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1842897|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
1842898|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842899|NCT04562441|Avelumab|avelumab|mesh-list
1842900|NCT04562441|Axitinib|axitinib|mesh-list
1842901|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1842902|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1842903|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1842904|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1842905|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842906|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
1842907|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1842908|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1842909|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
1842910|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1842911|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842912|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
1842913|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1842914|NCT04562597|Expectorants|expectorants|mesh-ancestor
1842915|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842916|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1842917|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
1842918|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842919|NCT04562597|Protective Agents|protective agents|mesh-ancestor
1842920|NCT04562597|Antidotes|antidotes|mesh-ancestor
1842921|NCT04562779|Naltrexone|naltrexone|mesh-list
1842922|NCT04562779|Ketamine|ketamine|mesh-list
1842923|NCT04562779|Analgesics|analgesics|mesh-ancestor
1842924|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
1842925|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842926|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842927|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1842928|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1842929|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
1842930|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
1842931|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842932|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1842933|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1842934|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842935|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842936|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1842937|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1842938|NCT04562285|Antibodies|antibodies|mesh-list
1842939|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
1842940|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842941|NCT04562246|Antibodies|antibodies|mesh-list
1842942|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
1842943|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842944|NCT04561934|Fluorides|fluorides|mesh-list
1842945|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
1842946|NCT04561934|Protective Agents|protective agents|mesh-ancestor
1842947|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842948|NCT04561960|Fluorides|fluorides|mesh-list
1842949|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
1842950|NCT04561960|Protective Agents|protective agents|mesh-ancestor
1842951|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842952|NCT04562103|Epinephrine|epinephrine|mesh-list
1842953|NCT04562103|Ropivacaine|ropivacaine|mesh-list
1842954|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
1842955|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
1842956|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842957|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842958|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
1842959|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842960|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1842961|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1842962|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
1842963|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1842964|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842965|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1842966|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1842967|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
1842968|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1842969|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
1842970|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
1842971|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
1842972|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1842973|NCT04561635|Micronutrients|micronutrients|mesh-list
1842974|NCT04561635|Trace Elements|trace elements|mesh-list
1842975|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842976|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
1842977|NCT04561921|Nordefrin|nordefrin|mesh-list
1842978|NCT04561921|Mepivacaine|mepivacaine|mesh-list
1842979|NCT04561921|Analgesics|analgesics|mesh-ancestor
1842980|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
1842981|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1842982|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1842983|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
1842984|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1842985|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1842986|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
1842987|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1842988|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1842989|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1842990|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1842991|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
1842992|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1842993|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
1842994|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1842995|NCT04561687|Azelastine|azelastine|mesh-list
1842996|NCT04561687|Budesonide|budesonide|mesh-list
1842997|NCT04561687|Montelukast|montelukast|mesh-list
1842998|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1842999|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1843000|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
1843001|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843002|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843003|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1843004|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
1843005|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
1843006|NCT04561687|Hormones|hormones|mesh-ancestor
1843007|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843008|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1843009|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
1843010|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1843011|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1843012|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843013|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1843014|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843015|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1843016|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1843017|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1843018|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
1843019|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
1843020|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843021|NCT04561947|Mitogens|mitogens|mesh-list
1843022|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843023|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843024|NCT04561739|Aspirin|aspirin|mesh-list
1843025|NCT04561739|Sirolimus|sirolimus|mesh-list
1843026|NCT04561739|Paclitaxel|paclitaxel|mesh-list
1843027|NCT04561739|Clopidogrel|clopidogrel|mesh-list
1843028|NCT04561739|Ticagrelor|ticagrelor|mesh-list
1843029|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1843030|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843031|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
1843032|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
1843033|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843034|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843035|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1843036|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1843037|NCT04561739|Analgesics|analgesics|mesh-ancestor
1843038|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
1843039|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843040|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843041|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843042|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843043|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1843044|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843045|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1843046|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1843047|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843048|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
1843049|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1843050|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1843051|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1843052|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
1843053|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843054|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843055|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843056|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1843057|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
1843058|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843059|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
1843060|NCT04561466|Bezafibrate|bezafibrate|mesh-list
1843061|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1843062|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
1843063|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843064|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1843065|NCT04561856|Dexamethasone|dexamethasone|mesh-list
1843066|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
1843067|NCT04561856|BB 1101|bb 1101|mesh-list
1843068|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843069|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
1843070|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
1843071|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843072|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843073|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843074|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
1843075|NCT04561856|Hormones|hormones|mesh-ancestor
1843076|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843077|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843078|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843079|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
1843080|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843081|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843082|NCT04561817|Paclitaxel|paclitaxel|mesh-list
1843083|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1843084|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843085|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
1843086|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
1843087|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843088|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843089|NCT04561648|Heparin|heparin|mesh-list
1843090|NCT04561648|Calcium heparin|calcium heparin|mesh-list
1843091|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
1843092|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1843093|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843094|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843095|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
1843096|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1843097|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843098|NCT04561375|Fentanyl|fentanyl|mesh-list
1843099|NCT04561375|Sufentanil|sufentanil|mesh-list
1843100|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1843101|NCT04561375|Narcotics|narcotics|mesh-ancestor
1843102|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843103|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843104|NCT04561375|Analgesics|analgesics|mesh-ancestor
1843105|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
1843106|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843107|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1843108|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1843109|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
1843110|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
1843123|NCT04561336|Cetuximab|cetuximab|mesh-list
1843124|NCT04561336|Avelumab|avelumab|mesh-list
1843125|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1843126|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843130|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
1843131|NCT04561076|Paraproteins|paraproteins|mesh-list
1843132|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
1843133|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843137|NCT04560894|Sorafenib|sorafenib|mesh-list
1843138|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843139|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1843140|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843141|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843142|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
1843143|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
1843144|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
1843145|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843146|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1843147|NCT04560660|Midazolam|midazolam|mesh-list
1843148|NCT04560660|Ketamine|ketamine|mesh-list
1843149|NCT04560660|Analgesics|analgesics|mesh-ancestor
1843150|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
1843151|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843152|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843153|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1843154|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1843155|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
1843156|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
1843157|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843158|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1843159|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1843160|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843161|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843162|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1843163|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1843164|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1843165|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1843166|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1843167|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
1843168|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
1843177|NCT04560686|Atezolizumab|atezolizumab|mesh-list
1843178|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843179|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
1843180|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1843181|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843182|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843183|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
1843184|NCT04560465|Coagulants|coagulants|mesh-ancestor
1843185|NCT04560322|Venetoclax|venetoclax|mesh-list
1843186|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
1843187|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
1843188|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843189|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1843190|NCT04560751|Lenvatinib|lenvatinib|mesh-list
1843191|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843192|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1843193|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843194|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843195|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
1843196|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
1843197|NCT04560816|Choline|choline|mesh-list
1843198|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843199|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843200|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1843201|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1843202|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843203|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843204|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843205|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843206|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
1843207|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1843208|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
1843209|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843210|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1843211|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
1843212|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
1843213|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
1843214|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1843215|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1843216|NCT04560816|Growth Substances|growth substances|mesh-ancestor
1843217|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
1843218|NCT04560569|Antibodies|antibodies|mesh-list
1843219|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
1843220|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843221|NCT04560972|Carboplatin|carboplatin|mesh-list
1843222|NCT04560972|Etoposide|etoposide|mesh-list
1843223|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
1843224|NCT04560972|Atezolizumab|atezolizumab|mesh-list
1843225|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
1843226|NCT04560972|LB100|lb100|mesh-list
1843227|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1843228|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843229|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1843230|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1843231|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1843232|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843233|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843234|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
1843235|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843236|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
1843237|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
1843238|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
1843239|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
1843240|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843241|NCT04560556|Antibodies|antibodies|mesh-list
1843242|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
1843243|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843244|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
1843245|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1843246|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843247|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1843248|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1843249|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1843250|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1843251|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843252|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843253|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843254|NCT04560673|Analgesics|analgesics|mesh-ancestor
1843255|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
1843256|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843257|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
1843258|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1843259|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
1843260|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
1843261|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1843262|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843263|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843264|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
1843265|NCT04559880|Coagulants|coagulants|mesh-ancestor
1843266|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
1843267|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1843268|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843269|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843270|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
1843271|NCT04560010|Coagulants|coagulants|mesh-ancestor
1843272|NCT04560231|Remdesivir|remdesivir|mesh-list
1843273|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
1843274|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843275|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
1843276|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843277|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
1843278|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1843279|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1843280|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1843281|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1843282|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843283|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
1843284|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843285|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843286|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1843287|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843288|NCT04560218|Misoprostol|misoprostol|mesh-list
1843289|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1843290|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
1843291|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1843292|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843293|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1843294|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843295|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
1843296|NCT04560049|Phenol|phenol|mesh-list
1843297|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
1843298|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1843299|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843300|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
1843301|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1843302|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1843311|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
1843312|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
1843313|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
1843314|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843315|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843316|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
1843317|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843318|NCT04559841|Simvastatin|simvastatin|mesh-list
1843319|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1843320|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1843321|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
1843322|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843323|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1843324|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1843325|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843326|NCT04559425|Dexamethasone|dexamethasone|mesh-list
1843327|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
1843328|NCT04559425|BB 1101|bb 1101|mesh-list
1843329|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843330|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
1843331|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
1843332|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843333|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843334|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843335|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
1843336|NCT04559425|Hormones|hormones|mesh-ancestor
1843337|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843338|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843339|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843340|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
1843341|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843342|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843343|NCT04559607|Apatinib|apatinib|mesh-list
1843344|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843345|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1843346|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843347|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843348|NCT04559412|Etanercept|etanercept|mesh-list
1843349|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1843350|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1843351|NCT04559412|Analgesics|analgesics|mesh-ancestor
1843352|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
1843353|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843354|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843355|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843356|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843357|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843358|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843359|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
1843360|NCT04559529|Levetiracetam|levetiracetam|mesh-list
1843361|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
1843362|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
1843363|NCT04559568|Midazolam|midazolam|mesh-list
1843364|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1843365|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1843366|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843367|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843368|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1843369|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1843370|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1843371|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1843372|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
1843373|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
1843374|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
1843375|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
1843376|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843377|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843378|NCT04559308|Metformin|metformin|mesh-list
1843379|NCT04559308|Paclitaxel|paclitaxel|mesh-list
1843380|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
1843381|NCT04559308|Doxorubicin|doxorubicin|mesh-list
1843382|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1843383|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843384|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
1843385|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
1843386|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843387|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843388|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843389|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
1843390|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843391|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843392|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1843393|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
1843394|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1843395|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1843396|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1843397|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1843398|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1843399|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843400|NCT04559165|Chitosan|chitosan|mesh-list
1843401|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1843402|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1843403|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
1843404|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843405|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1843406|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
1843407|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
1843408|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
1843409|NCT04559165|Coagulants|coagulants|mesh-ancestor
1843410|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
1843411|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
1843412|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843413|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
1843414|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843415|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843416|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
1843417|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1843418|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1843419|NCT04559113|Prednisolone|prednisolone|mesh-list
1843420|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
1843421|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1843422|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
1843423|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843424|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
1843425|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
1843426|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843427|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843428|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843429|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
1843430|NCT04559113|Hormones|hormones|mesh-ancestor
1843431|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843432|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1843433|NCT04559113|Protective Agents|protective agents|mesh-ancestor
1843434|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843435|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843444|NCT04559074|Amlodipine|amlodipine|mesh-list
1843445|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1843446|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1843447|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1843448|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843449|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1843450|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843451|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
1843452|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1843477|NCT04559048|Tacrolimus|tacrolimus|mesh-list
1843478|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843479|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
1843480|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843481|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1843482|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843483|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843484|NCT04558892|Enoxaparin|enoxaparin|mesh-list
1843485|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
1843486|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1843487|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843488|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843491|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
1843492|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1843493|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843494|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
1843495|NCT04558736|Fludarabine|fludarabine|mesh-list
1843496|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
1843497|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1843498|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843499|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
1843500|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843501|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843502|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1843503|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
1843504|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843505|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843506|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1843507|NCT04558580|Rufinamide|rufinamide|mesh-list
1843508|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
1843509|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1843510|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1843511|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1843512|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843513|NCT04558463|Oseltamivir|oseltamivir|mesh-list
1843514|NCT04558463|Favipiravir|favipiravir|mesh-list
1843515|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
1843516|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843517|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843518|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843527|NCT04558268|Folic Acid|folic acid|mesh-list
1843528|NCT04558268|Prednisone|prednisone|mesh-list
1843529|NCT04558268|Progesterone|progesterone|mesh-list
1843530|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843531|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
1843532|NCT04558268|Hormones|hormones|mesh-ancestor
1843533|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843534|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843535|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843536|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843537|NCT04558268|Progestins|progestins|mesh-ancestor
1843538|NCT04558268|Hematinics|hematinics|mesh-ancestor
1843539|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
1843540|NCT04558268|Vitamins|vitamins|mesh-ancestor
1843541|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
1843572|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
1843573|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
1843574|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843575|NCT04558424|Protective Agents|protective agents|mesh-ancestor
1843576|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843577|NCT04558424|Vitamins|vitamins|mesh-ancestor
1843578|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
1843579|NCT04558281|Ropivacaine|ropivacaine|mesh-list
1843580|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
1843581|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
1843582|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843583|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843584|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
1843585|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843598|NCT04558216|Rifampin|rifampin|mesh-list
1843599|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1843600|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
1843601|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843602|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843603|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
1843604|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1843605|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843606|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843607|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1843608|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1843609|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1843610|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1843611|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1843612|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1843613|NCT04558021|Niclosamide|niclosamide|mesh-list
1843614|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
1843615|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1843616|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
1843617|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1843618|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843619|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
1843620|NCT04557878|Mitogens|mitogens|mesh-list
1843621|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843622|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843623|NCT04557735|Ravulizumab|ravulizumab|mesh-list
1843624|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1843625|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843626|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
1843627|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843628|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
1843629|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1843630|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
1843631|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843632|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
1843633|NCT04557943|Protective Agents|protective agents|mesh-ancestor
1843634|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
1843635|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1843636|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
1843637|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843638|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
1843639|NCT04557527|Protective Agents|protective agents|mesh-ancestor
1843640|NCT04557475|Aspirin|aspirin|mesh-list
1843641|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1843642|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1843643|NCT04557475|Analgesics|analgesics|mesh-ancestor
1843644|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
1843645|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843646|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843647|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843648|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843649|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1843650|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1843651|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843652|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1843653|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1843654|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843655|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
1843656|NCT04557397|Itraconazole|itraconazole|mesh-list
1843657|NCT04557397|Rifampin|rifampin|mesh-list
1843658|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
1843659|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843660|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1843661|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1843662|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843663|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843664|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1843665|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
1843666|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843667|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843668|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1843669|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1843670|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
1843671|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843672|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
1843673|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1843674|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1843675|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1843676|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1843677|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1843678|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1843679|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1843680|NCT04557384|Ramucirumab|ramucirumab|mesh-list
1843681|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843695|NCT04557163|Itraconazole|itraconazole|mesh-list
1843696|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
1843697|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843698|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1843699|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1843700|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843701|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843702|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1843703|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
1843704|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843705|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843706|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1843707|NCT04557137|Somatostatin|somatostatin|mesh-list
1843708|NCT04557137|Hormones|hormones|mesh-ancestor
1843709|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843710|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843711|NCT04557202|Tamsulosin|tamsulosin|mesh-list
1843712|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1843713|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1843714|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1843715|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
1843716|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843717|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843718|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843719|NCT04557202|Urological Agents|urological agents|mesh-ancestor
1843720|NCT04557020|Gemcitabine|gemcitabine|mesh-list
1843721|NCT04557020|Cisplatin|cisplatin|mesh-list
1843722|NCT04557020|Antibodies|antibodies|mesh-list
1843723|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
1843724|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843725|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1843726|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
1843727|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843728|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843729|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
1843730|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843731|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843732|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843733|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1843734|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1843735|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
1843736|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
1843737|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1843738|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843741|NCT04556760|Prednisolone|prednisolone|mesh-list
1843742|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843743|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
1843744|NCT04556760|Hormones|hormones|mesh-ancestor
1843745|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843746|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843747|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843748|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843749|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
1843750|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1843751|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843752|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
1843753|NCT04556617|Prednisone|prednisone|mesh-list
1843754|NCT04556617|Olaparib|olaparib|mesh-list
1843755|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
1843756|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843757|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
1843758|NCT04556617|Hormones|hormones|mesh-ancestor
1843759|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843760|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843761|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843762|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843763|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1843764|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843765|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843766|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1843767|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
1843768|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1843780|NCT04556110|Perindopril|perindopril|mesh-list
1843781|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1843782|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
1843783|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843784|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843785|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1843786|NCT04556136|Vitamin D|vitamin d|mesh-list
1843787|NCT04556136|Vitamins|vitamins|mesh-ancestor
1843788|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
1843789|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843790|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1843791|NCT04556084|Blinatumomab|blinatumomab|mesh-list
1843792|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843793|NCT04556058|Perindopril|perindopril|mesh-list
1843794|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1843795|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
1843796|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843797|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843798|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1843799|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1843800|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
1843801|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843802|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843803|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1843804|NCT04556279|Diuretics|diuretics|mesh-ancestor
1843805|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
1843806|NCT04556032|Ergothioneine|ergothioneine|mesh-list
1843807|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
1843808|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843809|NCT04556032|Protective Agents|protective agents|mesh-ancestor
1843810|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843811|NCT04556071|Bevacizumab|bevacizumab|mesh-list
1843812|NCT04556071|Niraparib|niraparib|mesh-list
1843813|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1843814|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843815|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1843816|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1843817|NCT04556071|Growth Substances|growth substances|mesh-ancestor
1843818|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843819|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
1843820|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1843821|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843822|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843823|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
1843824|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1843825|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843826|NCT04555798|Meropenem|meropenem|mesh-list
1843827|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843828|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843829|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1843830|NCT04555694|Cyclosporine|cyclosporine|mesh-list
1843831|NCT04555694|Dexamethasone|dexamethasone|mesh-list
1843832|NCT04555694|Cyclosporins|cyclosporins|mesh-list
1843833|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843834|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
1843835|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
1843836|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843837|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843838|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1843839|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
1843840|NCT04555694|Hormones|hormones|mesh-ancestor
1843841|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843842|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1843843|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843844|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843845|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843846|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1843847|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
1843848|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
1843849|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843850|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
1843851|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843852|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1843853|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1843854|NCT04555733|Lemborexant|lemborexant|mesh-list
1843855|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1843856|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843857|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843858|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1843859|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1843860|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843861|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843862|NCT04555707|Betamethasone|betamethasone|mesh-list
1843863|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
1843864|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1843865|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
1843866|NCT04555707|Apremilast|apremilast|mesh-list
1843867|NCT04555707|Calcipotriene|calcipotriene|mesh-list
1843868|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1843869|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843870|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
1843871|NCT04555707|Hormones|hormones|mesh-ancestor
1843872|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843873|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843874|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1843875|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
1843876|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1843877|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1843878|NCT04555707|Analgesics|analgesics|mesh-ancestor
1843879|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
1843880|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843881|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843882|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1843883|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1843884|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843885|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843886|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
1843893|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
1843894|NCT04555603|Avelumab|avelumab|mesh-list
1843895|NCT04555603|Axitinib|axitinib|mesh-list
1843896|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1843897|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843898|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1843899|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843900|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843901|NCT04555525|Sarecycline|sarecycline|mesh-list
1843902|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843903|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843904|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
1843905|NCT04555304|Paclitaxel|paclitaxel|mesh-list
1843906|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1843907|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1843908|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843909|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
1843910|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
1843911|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
1843912|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843913|NCT04555291|Ropivacaine|ropivacaine|mesh-list
1843914|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
1843915|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
1843916|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843917|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843918|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
1843919|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843920|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
1843921|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
1843922|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843923|NCT04555096|Protective Agents|protective agents|mesh-ancestor
1843924|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843925|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1843926|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
1843927|NCT04554979|Anticoagulants|anticoagulants|mesh-list
1843928|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843929|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
1843930|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1843931|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1843932|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843933|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843934|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843938|NCT04554654|Progesterone|progesterone|mesh-list
1843939|NCT04554654|Progestins|progestins|mesh-ancestor
1843940|NCT04554654|Hormones|hormones|mesh-ancestor
1843941|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1843942|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843943|NCT04554680|Trametinib|trametinib|mesh-list
1843944|NCT04554680|Dabrafenib|dabrafenib|mesh-list
1843945|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843946|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1843947|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843948|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843949|NCT04554615|Insulin|insulin|mesh-list
1843950|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1843951|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843952|NCT04554693|Metronidazole|metronidazole|mesh-list
1843953|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843954|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1843955|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1843956|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1843957|NCT04554862|Ketorolac|ketorolac|mesh-list
1843958|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1843959|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
1843960|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1843961|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1843962|NCT04554862|Analgesics|analgesics|mesh-ancestor
1843963|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
1843964|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1843965|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843966|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1843967|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1843968|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1843969|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843970|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843971|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
1843972|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843973|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1843974|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
1843975|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1843976|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1843977|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1843978|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
1843979|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1843980|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
1843981|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1843982|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1843983|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1843984|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
1843985|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1843986|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1843987|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843988|NCT04554485|Blinatumomab|blinatumomab|mesh-list
1843989|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843990|NCT04554433|Ethanol|ethanol|mesh-list
1843991|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1843992|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1843993|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1843994|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1843995|NCT04554459|Ponatinib|ponatinib|mesh-list
1843996|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1843997|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1843998|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1843999|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844000|NCT04554524|Paclitaxel|paclitaxel|mesh-list
1844001|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
1844002|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844003|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844004|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844005|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844006|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844007|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844008|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844009|NCT04554303|Amlodipine|amlodipine|mesh-list
1844010|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1844011|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1844012|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1844013|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844014|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1844015|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844016|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
1844017|NCT04554771|Paclitaxel|paclitaxel|mesh-list
1844018|NCT04554771|Carboplatin|carboplatin|mesh-list
1844019|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844020|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844021|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844022|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844023|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844024|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844025|NCT04553770|Trastuzumab|trastuzumab|mesh-list
1844026|NCT04553770|Anastrozole|anastrozole|mesh-list
1844027|NCT04553770|Camptothecin|camptothecin|mesh-list
1844028|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
1844029|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844030|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844031|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844032|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1844033|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1844034|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844035|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844036|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1844037|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
1844038|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844039|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844040|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844041|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1844042|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1844043|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
1844044|NCT04553705|Quinine|quinine|mesh-list
1844045|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
1844046|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1844047|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1844048|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844049|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1844050|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844051|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1844052|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844053|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1844054|NCT04553705|Analgesics|analgesics|mesh-ancestor
1844055|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
1844081|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1844082|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1844083|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844084|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
1844085|NCT04553263|Naltrexone|naltrexone|mesh-list
1844086|NCT04553263|Bupropion|bupropion|mesh-list
1844087|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1844088|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1844089|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844090|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
1844091|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844092|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1844093|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
1844094|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1844095|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1844096|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1844097|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1844098|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844099|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
1844100|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844101|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1844102|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1844103|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844104|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1844117|NCT04553380|Insulin|insulin|mesh-list
1844118|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
1844119|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1844120|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844121|NCT04553393|Decitabine|decitabine|mesh-list
1844122|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1844123|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
1844124|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844125|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844126|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844127|NCT04553510|Bevacizumab|bevacizumab|mesh-list
1844128|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844129|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844130|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1844131|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1844132|NCT04553510|Growth Substances|growth substances|mesh-ancestor
1844133|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844134|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
1844138|NCT04553458|Ethanol|ethanol|mesh-list
1844139|NCT04553458|Sorafenib|sorafenib|mesh-list
1844140|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844141|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1844142|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844143|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844144|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1844145|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844146|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844147|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844151|NCT04553536|Sufentanil|sufentanil|mesh-list
1844152|NCT04553536|Remifentanil|remifentanil|mesh-list
1844153|NCT04553536|Dsuvia|dsuvia|mesh-list
1844154|NCT04553536|Bromides|bromides|mesh-list
1844155|NCT04553536|Propofol|propofol|mesh-list
1844156|NCT04553536|Esketamine|esketamine|mesh-list
1844157|NCT04553536|Rocuronium|rocuronium|mesh-list
1844158|NCT04553536|Cisatracurium|cisatracurium|mesh-list
1844159|NCT04553536|Atracurium|atracurium|mesh-list
1844160|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1844161|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844162|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844163|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1844164|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
1844165|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
1844166|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1844167|NCT04553536|Narcotics|narcotics|mesh-ancestor
1844168|NCT04553536|Analgesics|analgesics|mesh-ancestor
1844169|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
1844170|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844171|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
1844172|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1844173|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1844174|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1844175|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
1844176|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1844177|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1844178|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1844179|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
1844180|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844181|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844182|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1844183|NCT04553328|Bupivacaine|bupivacaine|mesh-list
1844184|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
1844185|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
1844186|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844187|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844188|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
1844189|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844190|NCT04552782|Ethanol|ethanol|mesh-list
1844191|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1844192|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844193|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844194|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844195|NCT04552847|Octreotide|octreotide|mesh-list
1844196|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844197|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844198|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844199|NCT04552795|Lamivudine|lamivudine|mesh-list
1844200|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1844201|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1844202|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844203|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844204|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
1844205|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844206|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1844207|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1844208|NCT04552977|Temozolomide|temozolomide|mesh-list
1844209|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1844210|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
1844211|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844212|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844213|NCT04553003|Prednisone|prednisone|mesh-list
1844214|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
1844215|NCT04553003|Choline|choline|mesh-list
1844216|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
1844217|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
1844218|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844219|NCT04553003|Hormones|hormones|mesh-ancestor
1844220|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844221|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844222|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844223|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844224|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
1844225|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
1844226|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844227|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844228|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1844229|NCT04553003|Protective Agents|protective agents|mesh-ancestor
1844230|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
1844231|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1844232|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
1844309|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
1844233|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844234|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1844235|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
1844236|NCT04552951|Vitamin D|vitamin d|mesh-list
1844237|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
1844238|NCT04552951|Vitamins|vitamins|mesh-ancestor
1844239|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
1844240|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844241|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1844242|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1844243|NCT04552808|Yimitasvir|yimitasvir|mesh-list
1844244|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
1844245|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844246|NCT04552743|Plerixafor|plerixafor|mesh-list
1844247|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1844248|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1844249|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
1844250|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844251|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
1844252|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1844253|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844254|NCT04552444|Biapenem|biapenem|mesh-list
1844255|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844256|NCT04552613|Carboplatin|carboplatin|mesh-list
1844257|NCT04552613|Pemetrexed|pemetrexed|mesh-list
1844258|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844259|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844260|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844261|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1844262|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1844263|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1844269|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
1844270|NCT04552431|Tamsulosin|tamsulosin|mesh-list
1844271|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1844272|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844273|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1844274|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1844275|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844276|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844277|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844278|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1844279|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1844280|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1844281|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1844282|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1844283|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
1844284|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844285|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844286|NCT04552431|Urological Agents|urological agents|mesh-ancestor
1844291|NCT04552093|Floxuridine|floxuridine|mesh-list
1844292|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1844293|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
1844294|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844295|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844296|NCT04551924|Ropivacaine|ropivacaine|mesh-list
1844297|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
1844298|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
1844299|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844300|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844301|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
1844302|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844303|NCT04552067|Enoxaparin|enoxaparin|mesh-list
1844304|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
1844305|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1844306|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1844307|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844308|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
1844310|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
1844311|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844312|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844313|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
1844314|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844315|NCT04551963|Clarithromycin|clarithromycin|mesh-list
1844316|NCT04551963|Fluconazole|fluconazole|mesh-list
1844317|NCT04551963|Voriconazole|voriconazole|mesh-list
1844318|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
1844319|NCT04551963|Diltiazem|diltiazem|mesh-list
1844320|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1844321|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844322|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1844323|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844324|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844325|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1844326|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1844327|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
1844328|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1844329|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1844330|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
1844331|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844332|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844333|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1844334|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1844335|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1844336|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1844337|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1844338|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1844339|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
1844340|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844341|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1844342|NCT04551755|Doxycycline|doxycycline|mesh-list
1844343|NCT04551755|Ivermectin|ivermectin|mesh-list
1844344|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1844345|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844346|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
1844347|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1844348|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1844349|NCT04551703|Epinephrine|epinephrine|mesh-list
1844350|NCT04551703|Racepinephrine|racepinephrine|mesh-list
1844351|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
1844352|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1844353|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1844354|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
1844355|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844356|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844357|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844358|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1844359|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1844360|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
1844361|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844362|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1844363|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
1844364|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
1844365|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
1844366|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1844367|NCT04551950|Paclitaxel|paclitaxel|mesh-list
1844368|NCT04551950|Bevacizumab|bevacizumab|mesh-list
1844369|NCT04551950|Carboplatin|carboplatin|mesh-list
1844370|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844371|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844372|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844373|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844374|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844375|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844376|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844377|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1844378|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1844379|NCT04551950|Growth Substances|growth substances|mesh-ancestor
1844380|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844381|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
1844382|NCT04551677|Vaccines|vaccines|mesh-list
1844383|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
1844384|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844385|NCT04551768|Ribavirin|ribavirin|mesh-list
1844386|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
1844387|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844388|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
1844389|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844390|NCT04551781|Prednisone|prednisone|mesh-list
1844391|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844392|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
1844393|NCT04551781|Hormones|hormones|mesh-ancestor
1844394|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844395|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844396|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844397|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844412|NCT04551573|Rifapentine|rifapentine|mesh-list
1844413|NCT04551573|Rifampin|rifampin|mesh-list
1844414|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1844415|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
1844416|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1844417|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844418|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
1844419|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1844420|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844421|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844422|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1844423|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1844424|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1844425|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1844426|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1844427|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1844428|NCT04551170|Theophylline|theophylline|mesh-list
1844429|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1844430|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
1844431|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844432|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844433|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1844434|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
1844435|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1844436|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844437|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844438|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
1844439|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1844440|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1844441|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
1844442|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844464|NCT04551261|Ritonavir|ritonavir|mesh-list
1844465|NCT04551261|Tenofovir|tenofovir|mesh-list
1844466|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1844467|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1844468|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
1844469|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844470|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844471|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1844472|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1844473|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
1844474|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844475|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1844476|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1844477|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1844478|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1844479|NCT04551248|Vaccines|vaccines|mesh-list
1844480|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1844481|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
1844482|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844483|NCT04551547|Vaccines|vaccines|mesh-list
1844484|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
1844485|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844486|NCT04551040|Terazosin|terazosin|mesh-list
1844487|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1844488|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1844489|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1844490|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
1844491|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844492|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844493|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844494|NCT04551040|Urological Agents|urological agents|mesh-ancestor
1844495|NCT04550936|Isavuconazole|isavuconazole|mesh-list
1844496|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
1844497|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844498|NCT04550949|Denosumab|denosumab|mesh-list
1844499|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1844500|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844501|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
1844502|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1844503|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1844504|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844505|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
1844506|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844507|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844508|NCT04550858|Rebamipide|rebamipide|mesh-list
1844509|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1844510|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844511|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
1844512|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844513|NCT04550858|Protective Agents|protective agents|mesh-ancestor
1844514|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844515|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844516|NCT04551196|Acetaminophen|acetaminophen|mesh-list
1844517|NCT04551196|Ibuprofen|ibuprofen|mesh-list
1844518|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1844519|NCT04551196|Analgesics|analgesics|mesh-ancestor
1844520|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
1844521|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844522|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844523|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
1844524|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1844525|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844526|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1844527|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1844528|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844529|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844530|NCT04550702|Mirabegron|mirabegron|mesh-list
1844531|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1844532|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1844533|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1844534|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
1844535|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844536|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844537|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844538|NCT04550702|Urological Agents|urological agents|mesh-ancestor
1844539|NCT04550442|Azacitidine|azacitidine|mesh-list
1844540|NCT04550442|Venetoclax|venetoclax|mesh-list
1844541|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1844542|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
1844543|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844544|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844545|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844546|NCT04550351|Vaccines|vaccines|mesh-list
1844547|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
1844548|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844549|NCT04550637|Apixaban|apixaban|mesh-list
1844550|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1844551|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
1844552|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1844553|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
1844554|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844555|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844556|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
1844557|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
1844558|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1844559|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1844560|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844561|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
1844562|NCT04550338|Coagulants|coagulants|mesh-ancestor
1844568|NCT04550377|Cannabidiol|cannabidiol|mesh-list
1844569|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
1844570|NCT04550520|Glucagon|glucagon|mesh-list
1844571|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844572|NCT04550520|Hormones|hormones|mesh-ancestor
1844573|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844574|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844575|NCT04550494|Talazoparib|talazoparib|mesh-list
1844576|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1844577|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844578|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844579|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844580|NCT04550234|Allopurinol|allopurinol|mesh-list
1844581|NCT04550234|Verinurad|verinurad|mesh-list
1844582|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
1844583|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844584|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844585|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
1844586|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1844587|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1844588|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
1844589|NCT04550234|Protective Agents|protective agents|mesh-ancestor
1844590|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844591|NCT04550585|Insulin|insulin|mesh-list
1844592|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1844593|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1844594|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844595|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
1844596|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1844597|NCT04550611|Antibodies|antibodies|mesh-list
1844598|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
1844599|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1844600|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
1844601|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844618|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
1844619|NCT04550624|Lenvatinib|lenvatinib|mesh-list
1844620|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844621|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844622|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1844623|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844624|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844625|NCT04550104|Olaparib|olaparib|mesh-list
1844626|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1844627|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844628|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844629|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844630|NCT04549935|Prednisolone|prednisolone|mesh-list
1844631|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844632|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
1844633|NCT04549935|Hormones|hormones|mesh-ancestor
1844634|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844635|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844636|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844637|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844638|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
1844639|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
1844640|NCT04550078|Calcium|calcium|mesh-list
1844641|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1844642|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844643|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1844644|NCT04550078|Antacids|antacids|mesh-ancestor
1844645|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844646|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844647|NCT04550195|Famotidine|famotidine|mesh-list
1844648|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1844649|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844650|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1844651|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
1844652|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
1844653|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844654|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844655|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844656|NCT04549844|Bupivacaine|bupivacaine|mesh-list
1844657|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
1844658|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
1844659|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844660|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844661|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
1844662|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844663|NCT04549792|Ustekinumab|ustekinumab|mesh-list
1844664|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
1844665|NCT04549467|Tenofovir|tenofovir|mesh-list
1844666|NCT04549467|Lamivudine|lamivudine|mesh-list
1844667|NCT04549467|Emtricitabine|emtricitabine|mesh-list
1844668|NCT04549467|Dolutegravir|dolutegravir|mesh-list
1844669|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
1844670|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844671|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1844672|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1844673|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844674|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844675|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1844676|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1844677|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1844678|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1844679|NCT04549428|Atezolizumab|atezolizumab|mesh-list
1844680|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844692|NCT04549415|Metformin|metformin|mesh-list
1844693|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1844694|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844695|NCT04549207|Denosumab|denosumab|mesh-list
1844696|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
1844697|NCT04549207|Pamidronate|pamidronate|mesh-list
1844698|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1844699|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844700|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
1844701|NCT04549012|Oxytocin|oxytocin|mesh-list
1844702|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
1844703|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1844704|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844705|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1844706|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1844707|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844708|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
1844709|NCT04549012|Coagulants|coagulants|mesh-ancestor
1844719|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1844720|NCT04549116|Progesterone|progesterone|mesh-list
1844721|NCT04549116|Progestins|progestins|mesh-ancestor
1844722|NCT04549116|Hormones|hormones|mesh-ancestor
1844723|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844724|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844725|NCT04548700|Prednisone|prednisone|mesh-list
1844726|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
1844727|NCT04548700|Vincristine|vincristine|mesh-list
1844728|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
1844729|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1844730|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
1844731|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844732|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1844733|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1844734|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
1844735|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844736|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844737|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1844738|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844739|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
1844740|NCT04548700|Hormones|hormones|mesh-ancestor
1844741|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844742|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844743|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844744|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844745|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844746|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844747|NCT04548700|Analgesics|analgesics|mesh-ancestor
1844748|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
1844749|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844750|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1844751|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1844752|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844753|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
1844754|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844755|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
1844756|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844757|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
1844758|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1844759|NCT04548557|Antibodies|antibodies|mesh-list
1844760|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
1844761|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1844762|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
1844763|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844764|NCT04548440|Paclitaxel|paclitaxel|mesh-list
1844765|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1844766|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844767|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844768|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844769|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844770|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844771|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844772|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1844773|NCT04548518|Vaccines|vaccines|mesh-list
1844774|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
1844775|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844776|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1844777|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
1844778|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
1844779|NCT04548284|Hormones|hormones|mesh-ancestor
1844780|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844781|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844782|NCT04548271|Apatinib|apatinib|mesh-list
1844783|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844784|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1844785|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844786|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844787|NCT04548219|Mirikizumab|mirikizumab|mesh-list
1844788|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1844789|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1844790|NCT04548219|Analgesics|analgesics|mesh-ancestor
1844791|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
1844792|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844793|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844794|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844795|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1844796|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1844797|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844804|NCT04547829|Sargramostim|sargramostim|mesh-list
1844805|NCT04547829|Lenograstim|lenograstim|mesh-list
1844806|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
1844807|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844808|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1844809|NCT04547790|Psyllium|psyllium|mesh-list
1844810|NCT04547790|Cathartics|cathartics|mesh-ancestor
1844811|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844812|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1844813|NCT04547764|Calcium|calcium|mesh-list
1844814|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1844815|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844816|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844817|NCT04547907|Paclitaxel|paclitaxel|mesh-list
1844818|NCT04547907|Docetaxel|docetaxel|mesh-list
1844819|NCT04547907|Carboplatin|carboplatin|mesh-list
1844820|NCT04547907|Trastuzumab|trastuzumab|mesh-list
1844821|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1844822|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844823|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844824|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844825|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844826|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844827|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844828|NCT04547855|Temozolomide|temozolomide|mesh-list
1844829|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1844830|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
1844831|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844832|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844833|NCT04547842|Dexamethasone|dexamethasone|mesh-list
1844834|NCT04547842|Mirtazapine|mirtazapine|mesh-list
1844835|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1844836|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
1844837|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
1844838|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844839|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844840|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1844841|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
1844842|NCT04547842|Hormones|hormones|mesh-ancestor
1844843|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844844|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1844845|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844846|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
1844847|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1844848|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1844849|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
1844850|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
1844851|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844852|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844853|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1844854|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1844855|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844856|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1844857|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1844858|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1844859|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
1844860|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1844861|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1844862|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
1844863|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1844864|NCT04547621|Temozolomide|temozolomide|mesh-list
1844865|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1844866|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
1844867|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844868|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844869|NCT04547608|Propofol|propofol|mesh-list
1844870|NCT04547608|Rocuronium|rocuronium|mesh-list
1844871|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1844872|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844873|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844874|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1844875|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
1844876|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
1844877|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1844878|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1844879|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1844880|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844881|NCT04547348|Denosumab|denosumab|mesh-list
1844882|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1844883|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844884|NCT04547426|Nicotine|nicotine|mesh-list
1844885|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1844886|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
1844887|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844888|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844889|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1844890|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1844891|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
1844892|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1844893|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844894|NCT04547452|Antibodies|antibodies|mesh-list
1844895|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
1844896|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844897|NCT04547335|Voriconazole|voriconazole|mesh-list
1844898|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
1844899|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844900|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1844901|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1844902|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844903|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844904|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1844905|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
1844906|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1844907|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844908|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1844909|NCT04547439|Melatonin|melatonin|mesh-list
1844910|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
1844911|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844912|NCT04547439|Protective Agents|protective agents|mesh-ancestor
1844913|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844914|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1844915|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1844916|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
1844917|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1844918|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844919|NCT04547530|Vitamin D|vitamin d|mesh-list
1844920|NCT04547530|Vitamins|vitamins|mesh-ancestor
1844921|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
1844922|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844923|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1844924|NCT04546802|Grazoprevir|grazoprevir|mesh-list
1844925|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
1844926|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844927|NCT04547153|Docetaxel|docetaxel|mesh-list
1844928|NCT04547153|Fluorouracil|fluorouracil|mesh-list
1844929|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844930|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
1844931|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
1844932|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
1844933|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844934|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
1844935|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1844936|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1844937|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
1844938|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844939|NCT04546815|Daptomycin|daptomycin|mesh-list
1844940|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1844941|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844942|NCT04547088|Apatinib|apatinib|mesh-list
1844943|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844944|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1844945|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844946|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844947|NCT04547179|Erenumab|erenumab|mesh-list
1844948|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1844949|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844950|NCT04547179|Analgesics|analgesics|mesh-ancestor
1844951|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
1844952|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1844953|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844957|NCT04546828|Gemcitabine|gemcitabine|mesh-list
1844958|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844959|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1844960|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
1844961|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844962|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
1844963|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844964|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844965|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1844966|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
1844967|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844968|NCT04547049|Cytarabine|cytarabine|mesh-list
1844969|NCT04547049|Cyclosporine|cyclosporine|mesh-list
1844970|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
1844971|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
1844972|NCT04547049|Busulfan|busulfan|mesh-list
1844973|NCT04547049|Cyclosporins|cyclosporins|mesh-list
1844974|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1844975|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
1844976|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1844977|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
1844978|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1844979|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1844980|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1844981|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
1844982|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1844983|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1844984|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1844985|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1844986|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
1844987|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
1844988|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1844989|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1844990|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
1844991|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
1844992|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1844993|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1844994|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1844995|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
1844996|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1844997|NCT04546581|Remdesivir|remdesivir|mesh-list
1844998|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
1844999|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1845000|NCT04546581|Antibodies|antibodies|mesh-list
1845001|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
1845002|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845003|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
1845004|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845005|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
1845006|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845007|NCT04546672|Neostigmine|neostigmine|mesh-list
1845008|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1845009|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845010|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845011|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
1845012|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845013|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845014|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1845015|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
1845016|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845017|NCT04546373|Niraparib|niraparib|mesh-list
1845018|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1845019|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845020|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845021|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845022|NCT04546282|Osimertinib|osimertinib|mesh-list
1845023|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845024|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845025|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845026|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845027|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1845028|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
1845029|NCT04546334|Analgesics|analgesics|mesh-ancestor
1845030|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
1845031|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845032|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845033|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
1845034|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845035|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1845036|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
1845037|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1845038|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1845039|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845040|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1845041|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
1845042|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1845043|NCT04546256|Fluticasone|fluticasone|mesh-list
1845044|NCT04546256|Xhance|xhance|mesh-list
1845045|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1845046|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1845047|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845048|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1845049|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
1845050|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845051|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845052|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1845053|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
1845054|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
1845055|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1845056|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1845057|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1845058|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1845059|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
1845060|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845061|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845062|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
1845063|NCT04546256|Hormones|hormones|mesh-ancestor
1845064|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845065|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
1845066|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
1845067|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
1845068|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1845069|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845070|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845071|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845072|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845086|NCT04546113|Ropivacaine|ropivacaine|mesh-list
1845087|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
1845088|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
1845089|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845090|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845091|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
1845092|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845093|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1845094|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
1845095|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1845096|NCT04545970|Protective Agents|protective agents|mesh-ancestor
1845097|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845098|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
1845099|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1845100|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
1845101|NCT04545931|Coagulants|coagulants|mesh-ancestor
1845102|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1845103|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
1845104|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845105|NCT04545944|Midazolam|midazolam|mesh-list
1845106|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1845107|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1845108|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845109|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845110|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1845111|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1845112|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1845113|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845114|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
1845115|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
1845116|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
1845117|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
1845118|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845119|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845120|NCT04545879|Allicin|allicin|mesh-list
1845121|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845122|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1845123|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
1845124|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845125|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1845126|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
1845127|NCT04545879|Protective Agents|protective agents|mesh-ancestor
1845128|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845129|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1845130|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1845131|NCT04545892|Capsaicin|capsaicin|mesh-list
1845132|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
1845133|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
1845134|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
1845135|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845136|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845137|NCT04545866|Budesonide|budesonide|mesh-list
1845138|NCT04545866|Poractant alfa|poractant alfa|mesh-list
1845139|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1845140|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845141|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1845142|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
1845143|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845144|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845145|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1845146|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
1845147|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
1845148|NCT04545866|Hormones|hormones|mesh-ancestor
1845149|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845150|NCT04545736|Metformin|metformin|mesh-list
1845151|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1845152|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845153|NCT04545801|Ketamine|ketamine|mesh-list
1845154|NCT04545801|Analgesics|analgesics|mesh-ancestor
1845155|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
1845156|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845157|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845158|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1845159|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845160|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
1845161|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
1845162|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845163|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1845164|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1845165|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845166|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845167|NCT04545762|Vidarabine|vidarabine|mesh-list
1845168|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
1845169|NCT04545762|Fludarabine|fludarabine|mesh-list
1845170|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
1845171|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845172|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
1845173|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845174|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845175|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1845176|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
1845177|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845178|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845179|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1845180|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1845181|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
1845182|NCT04545762|Antiviral Agents|antiviral agents|mesh-ancestor
1845183|NCT04545762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845184|NCT04545788|Cycloserine|cycloserine|mesh-list
1845185|NCT04545788|Linezolid|linezolid|mesh-list
1845186|NCT04545788|Bedaquiline|bedaquiline|mesh-list
1845187|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1845188|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845189|NCT04545788|Renal Agents|renal agents|mesh-ancestor
1845190|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1845191|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
1845192|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1845193|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
1845194|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845195|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1845196|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845201|NCT04545463|Psyllium|psyllium|mesh-list
1845202|NCT04545463|Cathartics|cathartics|mesh-ancestor
1845203|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845211|NCT04545541|Heparin|heparin|mesh-list
1845212|NCT04545541|Calcium heparin|calcium heparin|mesh-list
1845213|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
1845214|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1845215|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1845216|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845217|NCT04545515|Ivacaftor|ivacaftor|mesh-list
1845218|NCT04545515|Elexacaftor|elexacaftor|mesh-list
1845219|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1845220|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1845221|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845222|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
1845223|NCT04545450|Testosterone|testosterone|mesh-list
1845224|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
1845225|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
1845226|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1845227|NCT04545450|Dutasteride|dutasteride|mesh-list
1845228|NCT04545450|Androgens|androgens|mesh-ancestor
1845229|NCT04545450|Hormones|hormones|mesh-ancestor
1845230|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845231|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845232|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1845233|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845234|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
1845235|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1845236|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1845237|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845238|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845239|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
1845240|NCT04545710|Osimertinib|osimertinib|mesh-list
1845241|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845242|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845243|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845244|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845245|NCT04545242|Dexamethasone|dexamethasone|mesh-list
1845246|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845247|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
1845248|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
1845249|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845250|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845251|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845252|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
1845253|NCT04545242|Hormones|hormones|mesh-ancestor
1845254|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845255|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1845256|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845276|NCT04544995|Niraparib|niraparib|mesh-list
1845277|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1845278|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845279|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845280|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845289|NCT04545099|Neostigmine|neostigmine|mesh-list
1845290|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1845291|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845292|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845293|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
1845294|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845295|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845296|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1845297|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
1845298|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845299|NCT04544943|Gentamicins|gentamicins|mesh-list
1845300|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1845301|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845302|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1845303|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845304|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845305|NCT04544969|Gemcitabine|gemcitabine|mesh-list
1845306|NCT04544969|Cisplatin|cisplatin|mesh-list
1845307|NCT04544969|Docetaxel|docetaxel|mesh-list
1845308|NCT04544969|Fluorouracil|fluorouracil|mesh-list
1845309|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845310|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1845311|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
1845312|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845313|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
1845314|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845315|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845316|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845317|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
1845318|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845319|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
1845320|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
1845321|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
1845322|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1845323|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845324|NCT04544683|Dexamethasone|dexamethasone|mesh-list
1845325|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
1845326|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1845327|NCT04544683|BB 1101|bb 1101|mesh-list
1845328|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845329|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
1845330|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
1845331|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845332|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845333|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845334|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
1845335|NCT04544683|Hormones|hormones|mesh-ancestor
1845336|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845337|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1845338|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845339|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
1845340|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845341|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845342|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
1845343|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1845344|NCT04544228|Ketamine|ketamine|mesh-list
1845345|NCT04544228|Bupivacaine|bupivacaine|mesh-list
1845346|NCT04544228|Neostigmine|neostigmine|mesh-list
1845347|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
1845348|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
1845349|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845350|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845351|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
1845352|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845353|NCT04544228|Analgesics|analgesics|mesh-ancestor
1845354|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1845355|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845356|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
1845357|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1845358|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1845359|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845360|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845361|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1845362|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845363|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
1845364|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1845365|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
1845366|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1845367|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1845368|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845369|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845370|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1845371|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1845372|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845373|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
1845374|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845375|NCT04544475|Estrogens|estrogens|mesh-list
1845376|NCT04544475|Estradiol|estradiol|mesh-list
1845377|NCT04544475|Hormones|hormones|mesh-ancestor
1845378|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845379|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845385|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
1845386|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1845387|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845388|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1845389|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845390|NCT04544202|Trametinib|trametinib|mesh-list
1845391|NCT04544202|Dabrafenib|dabrafenib|mesh-list
1845392|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845393|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845394|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845395|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845407|NCT04544059|Lenalidomide|lenalidomide|mesh-list
1845408|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
1845409|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845410|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1845411|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1845412|NCT04544059|Growth Substances|growth substances|mesh-ancestor
1845413|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
1845414|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845415|NCT04544163|Lidocaine|lidocaine|mesh-list
1845416|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
1845417|NCT04544163|Fentanyl|fentanyl|mesh-list
1845418|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
1845419|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
1845420|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845421|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845422|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
1845423|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845424|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1845425|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1845426|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1845427|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1845428|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845429|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1845430|NCT04544163|Narcotics|narcotics|mesh-ancestor
1845431|NCT04544163|Analgesics|analgesics|mesh-ancestor
1845432|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1845433|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845434|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
1845435|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
1845436|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1845437|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1845438|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
1845439|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1845440|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
1845441|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1845442|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845443|NCT04543916|Irinotecan|irinotecan|mesh-list
1845444|NCT04543916|Venetoclax|venetoclax|mesh-list
1845445|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1845446|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1845447|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845448|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845449|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845450|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
1845451|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845452|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
1845453|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845454|NCT04543890|Etoposide|etoposide|mesh-list
1845455|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845456|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1845457|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1845458|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1845459|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845460|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845461|NCT04543682|Iloprost|iloprost|mesh-list
1845462|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1845463|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
1845464|NCT04543942|Ethanol|ethanol|mesh-list
1845465|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1845466|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845467|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845468|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845469|NCT04543565|Tenofovir|tenofovir|mesh-list
1845470|NCT04543565|Pradefovir|pradefovir|mesh-list
1845471|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
1845472|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845473|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1845474|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1845475|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845476|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845477|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1845478|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1845479|NCT04543591|Ravulizumab|ravulizumab|mesh-list
1845480|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1845481|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845482|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
1845483|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845484|NCT04543370|Deflazacort|deflazacort|mesh-list
1845485|NCT04543370|Midazolam|midazolam|mesh-list
1845486|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1845487|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1845488|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845489|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845490|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1845491|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1845492|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1845493|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845494|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
1845495|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
1845496|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
1845497|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
1845498|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845499|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845500|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845501|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845502|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
1845503|NCT04543110|Durvalumab|durvalumab|mesh-list
1845504|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1845505|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845506|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
1845507|NCT04543227|Narcotics|narcotics|mesh-ancestor
1845508|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845509|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845510|NCT04543227|Analgesics|analgesics|mesh-ancestor
1845511|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
1845512|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845513|NCT04543188|Midazolam|midazolam|mesh-list
1845514|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1845515|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1845516|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845517|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845518|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1845519|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1845520|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1845521|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845522|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
1845523|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
1845524|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
1845525|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
1845526|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845527|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845528|NCT04543123|Citalopram|citalopram|mesh-list
1845529|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
1845530|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1845531|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1845532|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1845533|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845534|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845535|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
1845536|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845537|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1845538|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1845542|NCT04542980|Autoantibodies|autoantibodies|mesh-list
1845543|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
1845544|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845545|NCT04542694|Favipiravir|favipiravir|mesh-list
1845546|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
1845547|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845548|NCT04542993|Zinc|zinc|mesh-list
1845549|NCT04542993|Resveratrol|resveratrol|mesh-list
1845550|NCT04542993|Picolinic acid|picolinic acid|mesh-list
1845551|NCT04542993|Trace Elements|trace elements|mesh-ancestor
1845552|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
1845553|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845554|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
1845555|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845556|NCT04542993|Protective Agents|protective agents|mesh-ancestor
1845557|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845558|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1845559|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1845560|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
1845561|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
1845562|NCT04542837|Lenvatinib|lenvatinib|mesh-list
1845563|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845564|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845565|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845566|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845567|NCT04542629|Trace Elements|trace elements|mesh-list
1845568|NCT04542629|Rituximab|rituximab|mesh-list
1845569|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1845570|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845571|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
1845572|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845573|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845574|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
1845575|NCT04542759|Besifloxacin|besifloxacin|mesh-list
1845576|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1845577|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1845578|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1845579|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845580|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1845581|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1845582|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845583|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845584|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845585|NCT04542733|Everolimus|everolimus|mesh-list
1845586|NCT04542733|Tacrolimus|tacrolimus|mesh-list
1845587|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845588|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
1845589|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845590|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1845591|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845592|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845593|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845594|NCT04542395|Vaccines|vaccines|mesh-list
1845595|NCT04542395|Immunologic Factors|immunologic factors|mesh-ancestor
1845596|NCT04542395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845597|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1845598|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1845599|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845600|NCT04542135|Sulindac|sulindac|mesh-list
1845601|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1845602|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1845603|NCT04542135|Analgesics|analgesics|mesh-ancestor
1845604|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
1845605|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845606|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845607|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845608|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845609|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845610|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1845611|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845612|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845613|NCT04542226|Bromides|bromides|mesh-list
1845614|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
1845615|NCT04542213|Insulin|insulin|mesh-list
1845616|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1845617|NCT04542213|Linagliptin|linagliptin|mesh-list
1845618|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1845619|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845620|NCT04542213|Incretins|incretins|mesh-ancestor
1845621|NCT04542213|Hormones|hormones|mesh-ancestor
1845622|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845623|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1845624|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
1845625|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845626|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845627|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1845628|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1845629|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1845630|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
1845631|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845632|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1845633|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1845634|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845635|NCT04542369|Etoposide|etoposide|mesh-list
1845636|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845637|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1845638|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1845639|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1845640|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845641|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845642|NCT04542070|Rilpivirine|rilpivirine|mesh-list
1845643|NCT04542070|Cabotegravir|cabotegravir|mesh-list
1845644|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1845645|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1845646|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845647|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845648|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
1845649|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845650|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1845651|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1845652|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1845653|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1845654|NCT04542278|Prednisone|prednisone|mesh-list
1845655|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845656|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
1845657|NCT04542278|Hormones|hormones|mesh-ancestor
1845658|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845659|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845660|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1845661|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845662|NCT04542304|Metolazone|metolazone|mesh-list
1845663|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1845664|NCT04542304|Diuretics|diuretics|mesh-ancestor
1845665|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
1845666|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845667|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1845668|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1845669|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845670|NCT04542252|Cyclosporine|cyclosporine|mesh-list
1845671|NCT04542252|Cyclosporins|cyclosporins|mesh-list
1845672|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845673|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845674|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845675|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
1845676|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845677|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
1845678|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845679|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
1845680|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845681|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1845682|NCT04542200|Antibodies|antibodies|mesh-list
1845683|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
1845684|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845685|NCT04542434|Niclosamide|niclosamide|mesh-list
1845686|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
1845687|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1845688|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
1845689|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1845690|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845691|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
1845692|NCT04541719|Remifentanil|remifentanil|mesh-list
1845693|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1845694|NCT04541719|Narcotics|narcotics|mesh-ancestor
1845695|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845696|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845697|NCT04541719|Analgesics|analgesics|mesh-ancestor
1845698|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
1845699|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845700|NCT04541732|Anesthetics|anesthetics|mesh-list
1845701|NCT04541732|Propofol|propofol|mesh-list
1845702|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845703|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845704|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1845705|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845706|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
1845707|NCT04541823|Propofol|propofol|mesh-list
1845708|NCT04541823|Desflurane|desflurane|mesh-list
1845709|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1845710|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845711|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845712|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845713|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
1845714|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
1845715|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1845721|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1845722|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1845723|NCT04541680|Nintedanib|nintedanib|mesh-list
1845724|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845725|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845726|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845727|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845728|NCT04542005|Albuterol|albuterol|mesh-list
1845729|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1845730|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
1845731|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845732|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845733|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1845734|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
1845735|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
1845736|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1845737|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1845738|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1845739|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1845740|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
1845741|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845742|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845746|NCT04541173|Bevacizumab|bevacizumab|mesh-list
1845747|NCT04541173|Atezolizumab|atezolizumab|mesh-list
1845748|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1845749|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845750|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1845751|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1845752|NCT04541173|Growth Substances|growth substances|mesh-ancestor
1845753|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845754|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
1845755|NCT04541147|Dexamethasone|dexamethasone|mesh-list
1845756|NCT04541147|Analgesics|analgesics|mesh-list
1845757|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845758|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
1845759|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
1845760|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845761|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845762|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845763|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
1845764|NCT04541147|Hormones|hormones|mesh-ancestor
1845765|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845766|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1845767|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845768|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
1845769|NCT04541290|Tacrolimus|tacrolimus|mesh-list
1845770|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845771|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
1845772|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845773|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1845774|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845775|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845776|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
1845777|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1845778|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1845779|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845780|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
1845781|NCT04541303|Coagulants|coagulants|mesh-ancestor
1845782|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
1845783|NCT04541355|Cisplatin|cisplatin|mesh-list
1845784|NCT04541355|Antidotes|antidotes|mesh-list
1845785|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845786|NCT04541355|Protective Agents|protective agents|mesh-ancestor
1845787|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845788|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
1845789|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845790|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
1845791|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1845792|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845793|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
1845794|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
1845795|NCT04541277|Cytarabine|cytarabine|mesh-list
1845796|NCT04541277|Azacitidine|azacitidine|mesh-list
1845797|NCT04541277|Decitabine|decitabine|mesh-list
1845798|NCT04541277|Idarubicin|idarubicin|mesh-list
1845799|NCT04541277|Sargramostim|sargramostim|mesh-list
1845800|NCT04541277|Lenograstim|lenograstim|mesh-list
1845801|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1845802|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
1845803|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845804|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845805|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
1845806|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845807|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845808|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
1845809|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845810|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845811|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1845812|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1845813|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1845814|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1845815|NCT04541407|Temozolomide|temozolomide|mesh-list
1845816|NCT04541407|Osimertinib|osimertinib|mesh-list
1845817|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1845818|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
1845819|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845820|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845821|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1845822|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845823|NCT04541108|Paclitaxel|paclitaxel|mesh-list
1845824|NCT04541108|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1845825|NCT04541108|Carboplatin|carboplatin|mesh-list
1845826|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
1845827|NCT04541108|Nivolumab|nivolumab|mesh-list
1845828|NCT04541108|Fluorouracil|fluorouracil|mesh-list
1845829|NCT04541108|Ipilimumab|ipilimumab|mesh-list
1845830|NCT04541108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1845831|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845832|NCT04541108|Tubulin Modulators|tubulin modulators|mesh-ancestor
1845833|NCT04541108|Antimitotic Agents|antimitotic agents|mesh-ancestor
1845834|NCT04541108|Mitosis Modulators|mitosis modulators|mesh-ancestor
1845835|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845836|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1845837|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1845838|NCT04541108|Antimetabolites|antimetabolites|mesh-ancestor
1845839|NCT04541108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1845840|NCT04541108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845841|NCT04541108|Immunologic Factors|immunologic factors|mesh-ancestor
1845842|NCT04541108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845843|NCT04540926|Cyclosporine|cyclosporine|mesh-list
1845844|NCT04540926|Cyclosporins|cyclosporins|mesh-list
1845845|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845846|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845847|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845848|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
1845849|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845850|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
1845851|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845852|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
1845853|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845854|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1845855|NCT04541251|Paclitaxel|paclitaxel|mesh-list
1845856|NCT04541251|Carboplatin|carboplatin|mesh-list
1845857|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1845858|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845859|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
1845860|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
1845861|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
1845862|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845871|NCT04540861|Siponimod|siponimod|mesh-list
1845872|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1845873|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845874|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845875|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
1845876|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845877|NCT04540965|Famotidine|famotidine|mesh-list
1845878|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1845879|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845880|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1845881|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
1845882|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
1845883|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845884|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845885|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845886|NCT04540653|Vaccines|vaccines|mesh-list
1845887|NCT04540653|Immunologic Factors|immunologic factors|mesh-ancestor
1845888|NCT04540653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845889|NCT04540666|Propofol|propofol|mesh-list
1845890|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1845891|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845892|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845893|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1845894|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
1845895|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
1845896|NCT04540744|Tadalafil|tadalafil|mesh-list
1845897|NCT04540744|Macitentan|macitentan|mesh-list
1845898|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
1845899|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1845900|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1845901|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845902|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845903|NCT04540744|Urological Agents|urological agents|mesh-ancestor
1845904|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1845905|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1845906|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1845907|NCT04540692|Paclitaxel|paclitaxel|mesh-list
1845908|NCT04540692|Docetaxel|docetaxel|mesh-list
1845909|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
1845910|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1845911|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845912|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
1845913|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
1845914|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
1845915|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845916|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1845917|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
1845918|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845919|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845920|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1845921|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
1845922|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1845936|NCT04540627|Palivizumab|palivizumab|mesh-list
1845937|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
1845938|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1845941|NCT04540133|Dexamethasone|dexamethasone|mesh-list
1845942|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
1845943|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1845944|NCT04540133|BB 1101|bb 1101|mesh-list
1845945|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1845946|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
1845947|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
1845948|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1845949|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845950|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1845951|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
1845952|NCT04540133|Hormones|hormones|mesh-ancestor
1845953|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1845954|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1845955|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845956|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
1845957|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845958|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845959|NCT04539873|Colchicine|colchicine|mesh-list
1845960|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
1845961|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1845962|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
1845963|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
1845964|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
1845965|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845966|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845967|NCT04539977|Cisplatin|cisplatin|mesh-list
1845968|NCT04539977|Etoposide|etoposide|mesh-list
1845969|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
1845970|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1845971|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1845972|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1845973|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1845974|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1845975|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845976|NCT04540055|Anesthetics|anesthetics|mesh-list
1845977|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845978|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845979|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
1845980|NCT04540185|Vaccines|vaccines|mesh-list
1845981|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
1845982|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845983|NCT04540185|Protective Agents|protective agents|mesh-ancestor
1845984|NCT04539951|Memantine|memantine|mesh-list
1845985|NCT04539951|Aripiprazole|aripiprazole|mesh-list
1845986|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
1845987|NCT04539951|Sertraline|sertraline|mesh-list
1845988|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1845989|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
1845990|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1845991|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1845992|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1845993|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1845994|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1845995|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
1845996|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
1845997|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1845998|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1845999|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1846000|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1846001|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
1846002|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1846003|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1846004|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1846005|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1846006|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1846007|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1846008|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846009|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1846010|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1846011|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1846012|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1846013|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1846014|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1846015|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1846016|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1846017|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1846018|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846019|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1846020|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
1846021|NCT04539808|Leucovorin|leucovorin|mesh-list
1846022|NCT04539808|Folic Acid|folic acid|mesh-list
1846023|NCT04539808|Fluorouracil|fluorouracil|mesh-list
1846024|NCT04539808|Capecitabine|capecitabine|mesh-list
1846025|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
1846026|NCT04539808|Irinotecan|irinotecan|mesh-list
1846027|NCT04539808|Camptothecin|camptothecin|mesh-list
1846028|NCT04539808|Losartan|losartan|mesh-list
1846029|NCT04539808|Calcium|calcium|mesh-list
1846030|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
1846031|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846032|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846033|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1846034|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
1846035|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846036|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1846037|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846038|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846039|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
1846040|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1846041|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1846042|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846043|NCT04539808|Antidotes|antidotes|mesh-ancestor
1846044|NCT04539808|Protective Agents|protective agents|mesh-ancestor
1846045|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
1846046|NCT04539808|Vitamins|vitamins|mesh-ancestor
1846047|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
1846048|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1846049|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1846050|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1846051|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1846052|NCT04539808|Hematinics|hematinics|mesh-ancestor
1846053|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1846054|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1846055|NCT04539626|Estradiol|estradiol|mesh-list
1846056|NCT04539626|Estrogens|estrogens|mesh-list
1846057|NCT04539626|Hormones|hormones|mesh-ancestor
1846058|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846059|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846060|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1846061|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
1846062|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1846063|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1846064|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1846065|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1846074|NCT04539301|Anticoagulants|anticoagulants|mesh-list
1846075|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
1846076|NCT04539314|Bupivacaine|bupivacaine|mesh-list
1846077|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
1846078|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
1846079|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846080|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846081|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
1846082|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846083|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1846084|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1846085|NCT04539314|Analgesics|analgesics|mesh-ancestor
1846086|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1846087|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1846088|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1846089|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
1846090|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846091|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846092|NCT04539405|Sevoflurane|sevoflurane|mesh-list
1846093|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1846094|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1846095|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
1846096|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
1846097|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846098|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846099|NCT04539262|Remdesivir|remdesivir|mesh-list
1846100|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
1846101|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846102|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
1846103|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846104|NCT04539327|Rucaparib|rucaparib|mesh-list
1846105|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1846106|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846107|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846108|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846109|NCT04539223|Evolocumab|evolocumab|mesh-list
1846110|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1846111|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1846112|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
1846113|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846114|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1846115|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
1846116|NCT04539249|Pentazocine|pentazocine|mesh-list
1846117|NCT04539249|Analgesics|analgesics|mesh-ancestor
1846118|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
1846119|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846120|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846121|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
1846122|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846123|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1846124|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
1846125|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1846126|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846201|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846127|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846128|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846129|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
1846130|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1846131|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1846132|NCT04539249|Narcotics|narcotics|mesh-ancestor
1846133|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1846134|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1846135|NCT04539119|Tenofovir|tenofovir|mesh-list
1846136|NCT04539119|Entecavir|entecavir|mesh-list
1846137|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
1846138|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846139|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1846140|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1846141|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846142|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846143|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1846144|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1846145|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
1846146|NCT04539379|Analgesics|analgesics|mesh-ancestor
1846147|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
1846148|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846149|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846150|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
1846151|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846152|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1846153|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
1846154|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1846155|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846156|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846157|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846158|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
1846159|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1846160|NCT04539106|Ranibizumab|ranibizumab|mesh-list
1846161|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1846162|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1846163|NCT04539106|Growth Substances|growth substances|mesh-ancestor
1846164|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846165|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
1846166|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846167|NCT04538820|Dexamethasone|dexamethasone|mesh-list
1846168|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
1846169|NCT04538820|BB 1101|bb 1101|mesh-list
1846170|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846171|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
1846172|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
1846173|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846174|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846175|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846176|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
1846177|NCT04538820|Hormones|hormones|mesh-ancestor
1846178|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846179|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1846180|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846181|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
1846182|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846183|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846184|NCT04539054|Caffeine|caffeine|mesh-list
1846185|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1846186|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846187|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1846188|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846189|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846190|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1846191|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1846192|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
1846193|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846194|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1846195|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846196|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846197|NCT04539418|Vitamin K|vitamin k|mesh-list
1846198|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
1846199|NCT04539418|Vitamins|vitamins|mesh-ancestor
1846200|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
1846202|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1846203|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1846204|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846205|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
1846206|NCT04539418|Coagulants|coagulants|mesh-ancestor
1846207|NCT04538534|Nicardipine|nicardipine|mesh-list
1846208|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1846209|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1846210|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846211|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846212|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846213|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846214|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
1846215|NCT04538521|Niacin|niacin|mesh-list
1846216|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
1846217|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1846218|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
1846219|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846220|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1846221|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
1846222|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
1846223|NCT04538521|Vitamins|vitamins|mesh-ancestor
1846224|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
1846225|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846231|NCT04538391|Bupivacaine|bupivacaine|mesh-list
1846232|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
1846233|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
1846234|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846235|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846236|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
1846237|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846245|NCT04538365|Triclosan|triclosan|mesh-list
1846246|NCT04538365|Propranolol|propranolol|mesh-list
1846247|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1846248|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1846249|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846250|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1846251|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1846252|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
1846253|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846254|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1846255|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1846256|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1846257|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
1846258|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846259|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846260|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1846261|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1846262|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
1846263|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
1846264|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
1846265|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1846266|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1846267|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846268|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846269|NCT04538976|Urological Agents|urological agents|mesh-ancestor
1846281|NCT04537962|Listerine|listerine|mesh-list
1846282|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
1846283|NCT04537962|Fluorides|fluorides|mesh-list
1846284|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
1846285|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
1846286|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
1846287|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
1846288|NCT04537962|Protective Agents|protective agents|mesh-ancestor
1846289|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846290|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1846291|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846292|NCT04538053|Cefazolin|cefazolin|mesh-list
1846293|NCT04538053|Cephalexin|cephalexin|mesh-list
1846294|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1846295|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846296|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1846297|NCT04538092|Analgesics|analgesics|mesh-list
1846298|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846299|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
1846300|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846301|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846302|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
1846303|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1846304|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
1846305|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846306|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846307|NCT04537780|Montelukast|montelukast|mesh-list
1846308|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1846309|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
1846310|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1846311|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
1846312|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846313|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846314|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1846315|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1846316|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846317|NCT04537767|Esmolol|esmolol|mesh-list
1846318|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1846319|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1846320|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1846321|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
1846322|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846323|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846324|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846335|NCT04537689|Cyclosporine|cyclosporine|mesh-list
1846336|NCT04537689|Methotrexate|methotrexate|mesh-list
1846337|NCT04537689|Ixekizumab|ixekizumab|mesh-list
1846338|NCT04537689|Acitretin|acitretin|mesh-list
1846339|NCT04537689|Cyclosporins|cyclosporins|mesh-list
1846340|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1846341|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
1846342|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1846343|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846344|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1846345|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
1846346|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846347|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846348|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
1846349|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846350|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1846351|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846352|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
1846353|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1846354|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1846355|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
1846356|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846357|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1846358|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
1846383|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
1846384|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1846385|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1846386|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846387|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
1846388|NCT04537533|Coagulants|coagulants|mesh-ancestor
1846389|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1846390|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
1846391|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
1846392|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846396|NCT04537156|Vaccines|vaccines|mesh-list
1846397|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
1846398|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846399|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1846400|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
1846401|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
1846402|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1846403|NCT04537078|Cetrorelix|cetrorelix|mesh-list
1846404|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1846405|NCT04537078|Progesterone|progesterone|mesh-list
1846406|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
1846407|NCT04537078|Estradiol|estradiol|mesh-list
1846408|NCT04537078|Progestins|progestins|mesh-ancestor
1846409|NCT04537078|Hormones|hormones|mesh-ancestor
1846410|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846411|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846412|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1846413|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1846414|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
1846415|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1846416|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1846417|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846418|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1846419|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
1846420|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
1846421|NCT04537078|Estrogens|estrogens|mesh-ancestor
1846422|NCT04537065|Mydriatics|mydriatics|mesh-list
1846423|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
1846424|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846425|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846426|NCT04536922|Aldesleukin|aldesleukin|mesh-list
1846427|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
1846428|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
1846429|NCT04536922|Fludarabine|fludarabine|mesh-list
1846430|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846431|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
1846432|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846433|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1846434|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1846435|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
1846436|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846437|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846438|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1846439|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1846440|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1846441|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1846442|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
1846443|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846444|NCT04536961|BMS-986165|bms-986165|mesh-list
1846445|NCT04536961|Famotidine|famotidine|mesh-list
1846446|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1846447|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846448|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1846449|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
1846450|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
1846451|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846452|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846453|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846454|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
1846455|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1846456|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846457|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
1846458|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1846459|NCT04536805|Metformin|metformin|mesh-list
1846460|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1846461|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846462|NCT04536831|Vitamin D|vitamin d|mesh-list
1846463|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
1846464|NCT04536831|Vitamins|vitamins|mesh-list
1846465|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
1846466|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846467|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1846468|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846469|NCT04536558|Olanzapine|olanzapine|mesh-list
1846470|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
1846471|NCT04536558|Aprepitant|aprepitant|mesh-list
1846472|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
1846473|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
1846474|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846475|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846476|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846477|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1846478|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1846479|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846480|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1846481|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1846482|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1846483|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846484|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846485|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846486|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
1846487|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1846491|NCT04536662|Dexamethasone|dexamethasone|mesh-list
1846492|NCT04536662|Prednisone|prednisone|mesh-list
1846493|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
1846494|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846495|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
1846496|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
1846497|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846498|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846499|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846500|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
1846501|NCT04536662|Hormones|hormones|mesh-ancestor
1846502|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846503|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1846504|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846505|NCT04536675|Bromides|bromides|mesh-list
1846506|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
1846507|NCT04536363|Alprostadil|alprostadil|mesh-list
1846508|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1846509|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
1846510|NCT04536363|Urological Agents|urological agents|mesh-ancestor
1846511|NCT04536532|Entecavir|entecavir|mesh-list
1846512|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
1846513|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846514|NCT04536415|Oseltamivir|oseltamivir|mesh-list
1846515|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
1846516|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846517|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846518|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846519|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
1846520|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846521|NCT04536298|Vitamin D|vitamin d|mesh-list
1846522|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
1846523|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
1846524|NCT04536298|Vitamins|vitamins|mesh-list
1846525|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
1846526|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846527|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1846528|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846529|NCT04535973|Hormones|hormones|mesh-list
1846530|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846531|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846532|NCT04536051|Acetaminophen|acetaminophen|mesh-list
1846533|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1846534|NCT04536051|Analgesics|analgesics|mesh-ancestor
1846535|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
1846536|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846537|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846538|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
1846539|NCT04536493|Lidocaine|lidocaine|mesh-list
1846540|NCT04536493|Epinephrine|epinephrine|mesh-list
1846541|NCT04536493|Racepinephrine|racepinephrine|mesh-list
1846542|NCT04536493|Tetracaine|tetracaine|mesh-list
1846543|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
1846544|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
1846545|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
1846546|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846547|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846548|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
1846549|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846550|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1846551|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1846552|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1846553|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846554|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846555|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1846556|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1846557|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
1846558|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846559|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1846560|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1846561|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
1846562|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1846563|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
1846564|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
1846565|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
1846566|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1846567|NCT04535960|Liraglutide|liraglutide|mesh-list
1846568|NCT04535960|Empagliflozin|empagliflozin|mesh-list
1846569|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1846570|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846571|NCT04535960|Incretins|incretins|mesh-ancestor
1846572|NCT04535960|Hormones|hormones|mesh-ancestor
1846573|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846574|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1846575|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846576|NCT04536181|Prednisone|prednisone|mesh-list
1846577|NCT04536181|Prednisolone|prednisolone|mesh-list
1846578|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846579|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
1846580|NCT04536181|Hormones|hormones|mesh-ancestor
1846581|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846582|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846583|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1846584|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846585|NCT04536428|Hemostatics|hemostatics|mesh-list
1846586|NCT04536428|Coagulants|coagulants|mesh-ancestor
1846587|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1846588|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1846589|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
1846590|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
1846591|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846603|NCT04535817|Omalizumab|omalizumab|mesh-list
1846604|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1846605|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1846606|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
1846607|NCT04535804|Aspirin|aspirin|mesh-list
1846608|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1846609|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1846610|NCT04535804|Analgesics|analgesics|mesh-ancestor
1846611|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
1846612|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846613|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846614|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846615|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1846616|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1846617|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1846618|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846619|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1846620|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1846621|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846622|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
1846623|NCT04535713|Gemcitabine|gemcitabine|mesh-list
1846624|NCT04535713|Docetaxel|docetaxel|mesh-list
1846625|NCT04535713|Doxorubicin|doxorubicin|mesh-list
1846626|NCT04535713|Nivolumab|nivolumab|mesh-list
1846627|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1846628|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
1846629|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846630|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846631|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
1846632|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846633|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846634|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846635|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
1846636|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846637|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
1846638|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
1846639|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
1846640|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1846641|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1846642|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1846643|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1846644|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1846652|NCT04535518|Aspirin|aspirin|mesh-list
1846653|NCT04535518|Infliximab|infliximab|mesh-list
1846654|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
1846655|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1846656|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
1846657|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1846658|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1846659|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1846660|NCT04535518|Analgesics|analgesics|mesh-ancestor
1846661|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
1846662|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846663|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846664|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846665|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1846666|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1846667|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1846668|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846669|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1846670|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1846671|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846672|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
1846673|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
1846674|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
1846675|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846676|NCT04535700|Pioglitazone|pioglitazone|mesh-list
1846677|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1846678|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846700|NCT04535362|Nicotine|nicotine|mesh-list
1846701|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1846702|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
1846703|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846704|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846705|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1846706|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1846707|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
1846708|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846709|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846710|NCT04535271|Gemcitabine|gemcitabine|mesh-list
1846711|NCT04535271|Dacarbazine|dacarbazine|mesh-list
1846712|NCT04535271|Trabectedin|trabectedin|mesh-list
1846713|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1846714|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
1846715|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846716|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846717|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
1846718|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846719|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846720|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846721|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
1846722|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846723|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1846724|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
1846725|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1846726|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
1846727|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846733|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
1846734|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1846735|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
1846736|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846737|NCT04534725|Interferons|interferons|mesh-list
1846738|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
1846739|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846740|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
1846741|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846742|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
1846743|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846744|NCT04534491|Oxybutynin|oxybutynin|mesh-list
1846745|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
1846746|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
1846747|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846748|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846749|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1846750|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1846751|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
1846752|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846753|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846754|NCT04534491|Urological Agents|urological agents|mesh-ancestor
1846755|NCT04534478|Prednisone|prednisone|mesh-list
1846756|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846757|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
1846758|NCT04534478|Hormones|hormones|mesh-ancestor
1846759|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846760|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846761|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1846762|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846763|NCT04534465|Mannitol|mannitol|mesh-list
1846764|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1846765|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1846766|NCT04534465|Diuretics|diuretics|mesh-ancestor
1846767|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
1846768|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846769|NCT04534465|Laxatives|laxatives|mesh-ancestor
1846770|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846771|NCT04534218|Aspirin|aspirin|mesh-list
1846772|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
1846773|NCT04534218|Capecitabine|capecitabine|mesh-list
1846774|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846775|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
1846776|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846777|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1846778|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1846779|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
1846780|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846781|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846782|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1846783|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1846784|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
1846785|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1846786|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1846787|NCT04534218|Analgesics|analgesics|mesh-ancestor
1846788|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
1846789|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846790|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846791|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1846792|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1846793|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1846794|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1846795|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846796|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
1846797|NCT04534023|Idebenone|idebenone|mesh-list
1846798|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
1846799|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846800|NCT04534023|Protective Agents|protective agents|mesh-ancestor
1846801|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846802|NCT04534231|Nicotine|nicotine|mesh-list
1846803|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1846804|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
1846805|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846806|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846807|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1846808|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1846809|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
1846810|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846811|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846812|NCT04534153|Fexofenadine|fexofenadine|mesh-list
1846813|NCT04534153|Terfenadine|terfenadine|mesh-list
1846814|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1846815|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1846816|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1846817|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
1846818|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
1846819|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846820|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846821|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846822|NCT04534257|Sirolimus|sirolimus|mesh-list
1846823|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1846824|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846825|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1846826|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846827|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
1846828|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846829|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
1846830|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846831|NCT04534452|Phenylephrine|phenylephrine|mesh-list
1846832|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
1846833|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1846834|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
1846835|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
1846836|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846837|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846838|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
1846839|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1846840|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
1846841|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
1846842|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1846843|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1846844|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1846845|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
1846846|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846847|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846848|NCT04534452|Protective Agents|protective agents|mesh-ancestor
1846849|NCT04534322|Dexamethasone|dexamethasone|mesh-list
1846850|NCT04534322|Melphalan|melphalan|mesh-list
1846851|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1846852|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
1846853|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
1846854|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846855|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846856|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846857|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
1846858|NCT04534322|Hormones|hormones|mesh-ancestor
1846859|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1846860|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1846861|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846862|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1846863|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
1846864|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846865|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1846866|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1846867|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
1846868|NCT04533997|Furosemide|furosemide|mesh-list
1846869|NCT04533997|Diuretics|diuretics|mesh-ancestor
1846870|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
1846871|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846872|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1846873|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1846874|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846875|NCT04534582|Denosumab|denosumab|mesh-list
1846876|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1846877|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846878|NCT04533646|Insulin|insulin|mesh-list
1846879|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1846880|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846881|NCT04533841|Propranolol|propranolol|mesh-list
1846882|NCT04533841|Misoprostol|misoprostol|mesh-list
1846883|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1846884|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
1846885|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1846886|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846887|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1846888|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846889|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
1846890|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1846891|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1846892|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
1846893|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846894|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846895|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1846896|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1846897|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
1846898|NCT04533984|Teriparatide|teriparatide|mesh-list
1846899|NCT04533984|Calcium|calcium|mesh-list
1846900|NCT04533984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1846901|NCT04533984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846902|NCT04533984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1846903|NCT04533724|Amisulpride|amisulpride|mesh-list
1846904|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1846905|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1846906|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846907|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846908|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1846909|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1846910|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
1846911|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846912|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846913|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1846914|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
1846915|NCT04533867|Ondansetron|ondansetron|mesh-list
1846916|NCT04533867|Palonosetron|palonosetron|mesh-list
1846917|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
1846918|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
1846919|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846920|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846921|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1846922|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
1846923|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
1846924|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1846925|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
1846926|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1846927|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846928|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1846929|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1846930|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846931|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1846932|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1846933|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1846934|NCT04533685|Vaccines|vaccines|mesh-list
1846935|NCT04533685|Immunologic Factors|immunologic factors|mesh-ancestor
1846936|NCT04533685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846937|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
1846938|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1846939|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846953|NCT04533347|Tafenoquine|tafenoquine|mesh-list
1846954|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
1846955|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1846956|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1846957|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846958|NCT04533243|Fentanyl|fentanyl|mesh-list
1846959|NCT04533243|Morphine|morphine|mesh-list
1846960|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1846961|NCT04533243|Narcotics|narcotics|mesh-ancestor
1846962|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1846963|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846964|NCT04533243|Analgesics|analgesics|mesh-ancestor
1846965|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
1846966|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846967|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1846968|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1846969|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
1846970|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
1846971|NCT04533321|Afatinib|afatinib|mesh-list
1846972|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846973|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1846974|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1846975|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1846976|NCT04532931|Acetaminophen|acetaminophen|mesh-list
1846977|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
1846978|NCT04532931|Artesunate|artesunate|mesh-list
1846979|NCT04532931|Favipiravir|favipiravir|mesh-list
1846980|NCT04532931|Amodiaquine|amodiaquine|mesh-list
1846981|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
1846982|NCT04532931|Pyronaridine|pyronaridine|mesh-list
1846983|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1846984|NCT04532931|Analgesics|analgesics|mesh-ancestor
1846985|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
1846986|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1846987|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1846988|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
1846989|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
1846990|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1846991|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
1846992|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1846993|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1846994|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1846995|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
1846996|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1846997|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
1846998|NCT04532918|Cyclosporine|cyclosporine|mesh-list
1846999|NCT04532918|Rifampin|rifampin|mesh-list
1847000|NCT04532918|Allopurinol|allopurinol|mesh-list
1847001|NCT04532918|Verinurad|verinurad|mesh-list
1847002|NCT04532918|Cyclosporins|cyclosporins|mesh-list
1847003|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847004|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847005|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847006|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
1847007|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847008|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
1847009|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847010|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
1847011|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847012|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1847013|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1847014|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
1847015|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847016|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
1847017|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1847018|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1847019|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1847020|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1847021|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1847022|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1847023|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1847024|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
1847025|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
1847026|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1847027|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
1847028|NCT04532918|Protective Agents|protective agents|mesh-ancestor
1847029|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
1847030|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1847031|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1847032|NCT04532775|Prednisolone|prednisolone|mesh-list
1847033|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
1847034|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
1847035|NCT04532775|Bupivacaine|bupivacaine|mesh-list
1847036|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1847037|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
1847038|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
1847039|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
1847040|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847041|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847042|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
1847043|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847044|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847045|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
1847046|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
1847047|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847048|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
1847049|NCT04532775|Hormones|hormones|mesh-ancestor
1847050|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847051|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1847052|NCT04532775|Protective Agents|protective agents|mesh-ancestor
1847053|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847054|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847055|NCT04532775|Analgesics|analgesics|mesh-ancestor
1847056|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1847057|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
1847058|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1847059|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1847060|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847061|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1847062|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
1847063|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1847085|NCT04532671|Ether|ether|mesh-list
1847086|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1847087|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
1847088|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
1847089|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847090|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847091|NCT04532684|Pregabalin|pregabalin|mesh-list
1847092|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1847093|NCT04532684|Analgesics|analgesics|mesh-ancestor
1847094|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
1847095|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847096|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847097|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
1847098|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1847099|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1847100|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847101|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1847102|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1847103|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1847104|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847105|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1847106|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1847107|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1847108|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847109|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
1847110|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
1847111|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
1847112|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
1847113|NCT04532736|Methotrexate|methotrexate|mesh-list
1847114|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1847115|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
1847116|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1847117|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847118|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1847119|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
1847120|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847121|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847122|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
1847123|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847124|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1847125|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847126|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
1847127|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847128|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1847129|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847130|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
1847131|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
1847132|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847133|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847134|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
1847135|NCT04532736|Hormones|hormones|mesh-ancestor
1847136|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847137|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1847138|NCT04532736|Protective Agents|protective agents|mesh-ancestor
1847139|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1847140|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1847141|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1847142|NCT04532606|Anesthetics|anesthetics|mesh-list
1847143|NCT04532606|Propofol|propofol|mesh-list
1847144|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847145|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847146|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1847147|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1847148|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
1847162|NCT04532372|Leflunomide|leflunomide|mesh-list
1847163|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847164|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847165|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847166|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
1847167|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847168|NCT04532554|Hormones|hormones|mesh-list
1847169|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847170|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847171|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
1847172|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1847173|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847174|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
1847175|NCT04532060|Nystatin|nystatin|mesh-list
1847176|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1847177|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
1847178|NCT04532060|Ionophores|ionophores|mesh-ancestor
1847179|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1847180|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847181|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
1847182|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1847183|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847184|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
1847185|NCT04532164|Clotrimazole|clotrimazole|mesh-list
1847186|NCT04532164|Miconazole|miconazole|mesh-list
1847187|NCT04532164|Butenafine|butenafine|mesh-list
1847188|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847189|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1847190|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1847191|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1847192|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847193|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847194|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1847195|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
1847196|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847197|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847198|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1847199|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1847200|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1847201|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1847202|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847203|NCT04532333|Heparin|heparin|mesh-list
1847204|NCT04532333|Bivalirudin|bivalirudin|mesh-list
1847205|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
1847206|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1847207|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1847208|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847209|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
1847210|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1847211|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847212|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847213|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1847214|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847215|NCT04531943|Progesterone|progesterone|mesh-list
1847216|NCT04531943|Estrogens|estrogens|mesh-list
1847217|NCT04531943|Progestins|progestins|mesh-ancestor
1847218|NCT04531943|Hormones|hormones|mesh-ancestor
1847219|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847220|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847221|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
1847222|NCT04531865|Rituximab|rituximab|mesh-list
1847223|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1847224|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847225|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
1847226|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847227|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847228|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1847229|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1847230|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
1847231|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847232|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847233|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847234|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847235|NCT04531800|Mitogens|mitogens|mesh-list
1847236|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
1847237|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847238|NCT04531813|Butenafine|butenafine|mesh-list
1847239|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
1847240|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847241|NCT04531748|Toremifene|toremifene|mesh-list
1847242|NCT04531748|Melatonin|melatonin|mesh-list
1847243|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
1847244|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847245|NCT04531748|Protective Agents|protective agents|mesh-ancestor
1847246|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847247|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847248|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847249|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847250|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1847251|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1847252|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
1847253|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847254|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1847255|NCT04531527|Butenafine|butenafine|mesh-list
1847256|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
1847257|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847258|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
1847259|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1847260|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847261|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847262|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847263|NCT04531371|Analgesics|analgesics|mesh-ancestor
1847264|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
1847265|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847266|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1847267|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1847268|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1847269|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
1847270|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847271|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847272|NCT04531540|Butenafine|butenafine|mesh-list
1847273|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
1847274|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847275|NCT04531423|Golimumab|golimumab|mesh-list
1847276|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1847277|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847278|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847279|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
1847280|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847281|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
1847282|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1847283|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1847284|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847285|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1847286|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847287|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847288|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847289|NCT04531267|Calcium|calcium|mesh-list
1847290|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1847291|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847292|NCT04531475|Lansoprazole|lansoprazole|mesh-list
1847293|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
1847294|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1847295|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847296|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1847297|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847298|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847334|NCT04531228|Lenvatinib|lenvatinib|mesh-list
1847335|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847336|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1847337|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847338|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847339|NCT04531332|Linezolid|linezolid|mesh-list
1847340|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847341|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847342|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1847343|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847344|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847345|NCT04530877|Infliximab|infliximab|mesh-list
1847346|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
1847347|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847348|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847349|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
1847350|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1847351|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
1847352|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847353|NCT04531163|Expectorants|expectorants|mesh-ancestor
1847354|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
1847355|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1847356|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
1847357|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847358|NCT04531163|Protective Agents|protective agents|mesh-ancestor
1847359|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847360|NCT04531163|Antidotes|antidotes|mesh-ancestor
1847361|NCT04531072|Ritonavir|ritonavir|mesh-list
1847362|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1847363|NCT04531072|Lumefantrine|lumefantrine|mesh-list
1847364|NCT04531072|Artemether|artemether|mesh-list
1847365|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1847366|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1847367|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1847368|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847369|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847370|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847371|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1847372|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1847373|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
1847374|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847375|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1847376|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1847377|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
1847378|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1847379|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1847380|NCT04530864|Dexamethasone|dexamethasone|mesh-list
1847381|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
1847382|NCT04530864|BB 1101|bb 1101|mesh-list
1847383|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847384|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
1847385|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
1847386|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847387|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847388|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847389|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
1847390|NCT04530864|Hormones|hormones|mesh-ancestor
1847391|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847392|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847393|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847394|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847395|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847396|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847397|NCT04531098|Vaccines|vaccines|mesh-list
1847398|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
1847399|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847403|NCT04531059|Metronidazole|metronidazole|mesh-list
1847404|NCT04531059|Minocycline|minocycline|mesh-list
1847405|NCT04531059|Tetracycline|tetracycline|mesh-list
1847406|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
1847407|NCT04531059|Esomeprazole|esomeprazole|mesh-list
1847408|NCT04531059|Bismuth|bismuth|mesh-list
1847409|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847410|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847411|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847412|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1847413|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1847414|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1847415|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847416|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1847417|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847418|NCT04531059|Antacids|antacids|mesh-ancestor
1847419|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1847420|NCT04531059|Diuretics|diuretics|mesh-ancestor
1847421|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
1847422|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847423|NCT04531059|Expectorants|expectorants|mesh-ancestor
1847424|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
1847425|NCT04530903|Clonidine|clonidine|mesh-list
1847426|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
1847427|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
1847428|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
1847429|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847430|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847431|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
1847432|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847433|NCT04530903|Analgesics|analgesics|mesh-ancestor
1847434|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1847435|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
1847436|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
1847437|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1847438|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1847439|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1847440|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
1847441|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847442|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847450|NCT04530474|Ivermectin|ivermectin|mesh-list
1847451|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1847452|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847453|NCT04530500|Androgens|androgens|mesh-list
1847454|NCT04530500|Hormones|hormones|mesh-ancestor
1847455|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847456|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847457|NCT04530578|Heparin|heparin|mesh-list
1847458|NCT04530578|Calcium heparin|calcium heparin|mesh-list
1847459|NCT04530578|Enoxaparin|enoxaparin|mesh-list
1847460|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1847461|NCT04530578|Tinzaparin|tinzaparin|mesh-list
1847462|NCT04530578|Dalteparin|dalteparin|mesh-list
1847463|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
1847464|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1847465|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1847466|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847493|NCT04530422|Azithromycin|azithromycin|mesh-list
1847494|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
1847495|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
1847496|NCT04530422|Oseltamivir|oseltamivir|mesh-list
1847497|NCT04530422|Ledipasvir|ledipasvir|mesh-list
1847498|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847499|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847500|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
1847501|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1847502|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1847503|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847504|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847505|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847506|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
1847507|NCT04530617|Camostat|camostat|mesh-list
1847508|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847509|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847510|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847511|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1847512|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1847513|NCT04530656|Vaccines|vaccines|mesh-list
1847514|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
1847515|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847516|NCT04530487|Cyclosporine|cyclosporine|mesh-list
1847517|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
1847518|NCT04530487|Fludarabine|fludarabine|mesh-list
1847519|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
1847520|NCT04530487|Etoposide|etoposide|mesh-list
1847521|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
1847522|NCT04530487|Melphalan|melphalan|mesh-list
1847523|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
1847524|NCT04530487|Thiotepa|thiotepa|mesh-list
1847525|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
1847526|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1847527|NCT04530487|Tacrolimus|tacrolimus|mesh-list
1847528|NCT04530487|Cyclosporins|cyclosporins|mesh-list
1847529|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
1847530|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1847531|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
1847532|NCT04530487|Antibodies|antibodies|mesh-list
1847533|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
1847534|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1847535|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1847536|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847537|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1847538|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
1847539|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847540|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847541|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
1847542|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847543|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1847544|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1847545|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1847546|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847547|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1847548|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
1847549|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847550|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
1847551|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847552|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1847553|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1847554|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
1847555|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847556|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1847557|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
1847558|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1847559|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
1847560|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
1847561|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
1847562|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
1847567|NCT04530058|Metformin|metformin|mesh-list
1847568|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1847569|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847570|NCT04529954|Valproic Acid|valproic acid|mesh-list
1847571|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
1847572|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847573|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847574|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
1847575|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847576|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847577|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
1847578|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1847579|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847580|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1847581|NCT04530045|Piperacillin|piperacillin|mesh-list
1847582|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847583|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847584|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1847585|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1847586|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847587|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
1847588|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847589|NCT04530006|Amantadine|amantadine|mesh-list
1847590|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1847591|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1847592|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
1847593|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847594|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
1847595|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847596|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847597|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847598|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847599|NCT04530006|Analgesics|analgesics|mesh-ancestor
1847600|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
1847601|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847602|NCT04530188|Propofol|propofol|mesh-list
1847603|NCT04530188|Sevoflurane|sevoflurane|mesh-list
1847604|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1847605|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847606|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847607|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1847608|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
1847609|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
1847610|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1847611|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1847612|NCT04530227|Paclitaxel|paclitaxel|mesh-list
1847613|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1847614|NCT04530227|Pemetrexed|pemetrexed|mesh-list
1847615|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1847616|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847617|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
1847618|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
1847619|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
1847620|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847621|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847622|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1847623|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1847629|NCT04529811|Rifaximin|rifaximin|mesh-list
1847630|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847631|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847632|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847636|NCT04529785|Ethanol|ethanol|mesh-list
1847637|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1847638|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847639|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847640|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847641|NCT04529668|Vitamin D|vitamin d|mesh-list
1847642|NCT04529668|Vitamins|vitamins|mesh-ancestor
1847643|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
1847644|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847645|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1847649|NCT04529525|Ivermectin|ivermectin|mesh-list
1847650|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1847651|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847652|NCT04529512|Dexamethasone|dexamethasone|mesh-list
1847653|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847654|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
1847655|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
1847656|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847657|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847658|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847659|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
1847660|NCT04529512|Hormones|hormones|mesh-ancestor
1847661|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847662|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847663|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847667|NCT04529356|Acetaminophen|acetaminophen|mesh-list
1847668|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847669|NCT04529356|Analgesics|analgesics|mesh-ancestor
1847670|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
1847671|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847672|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847673|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
1847674|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1847675|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847676|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1847680|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
1847681|NCT04529135|Remifentanil|remifentanil|mesh-list
1847682|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1847683|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847684|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847685|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847686|NCT04529135|Analgesics|analgesics|mesh-ancestor
1847687|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
1847688|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847689|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1847690|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1847691|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1847692|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
1847693|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847694|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847695|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1847696|NCT04529135|Narcotics|narcotics|mesh-ancestor
1847697|NCT04529187|Midazolam|midazolam|mesh-list
1847698|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
1847699|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1847700|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847701|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847702|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847703|NCT04529187|Analgesics|analgesics|mesh-ancestor
1847704|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
1847705|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847706|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1847707|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1847708|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1847709|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
1847710|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847711|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847712|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1847713|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1847714|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1847715|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1847716|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1847717|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
1847718|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
1847719|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
1847720|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
1847721|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
1847722|NCT04529005|Giapreza|giapreza|mesh-list
1847723|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
1847724|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1847725|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1847726|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847727|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847728|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847729|NCT04529278|Liraglutide|liraglutide|mesh-list
1847730|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1847731|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847732|NCT04529278|Incretins|incretins|mesh-ancestor
1847733|NCT04529278|Hormones|hormones|mesh-ancestor
1847734|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847735|NCT04529226|Haloperidol|haloperidol|mesh-list
1847736|NCT04529226|Pimozide|pimozide|mesh-list
1847737|NCT04529226|Olanzapine|olanzapine|mesh-list
1847738|NCT04529226|Risperidone|risperidone|mesh-list
1847739|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
1847740|NCT04529226|Clozapine|clozapine|mesh-list
1847741|NCT04529226|Amisulpride|amisulpride|mesh-list
1847742|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1847743|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
1847744|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847745|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847746|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847747|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1847748|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1847749|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847750|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1847751|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1847752|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
1847753|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
1847754|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
1847755|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847756|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847757|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1847758|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1847759|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1847760|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1847761|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
1847762|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
1847763|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1847764|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
1847765|NCT04528628|Norepinephrine|norepinephrine|mesh-list
1847766|NCT04528628|Serotonin|serotonin|mesh-list
1847767|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1847768|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
1847769|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1847770|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1847771|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
1847772|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847773|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847774|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847775|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
1847776|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
1847777|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847778|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1847779|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1847780|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
1847781|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1847782|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1847783|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
1847784|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847785|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
1847786|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1847787|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1847788|NCT04528797|Prednisolone|prednisolone|mesh-list
1847789|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
1847790|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1847791|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
1847792|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847793|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
1847794|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
1847795|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847796|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847797|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847798|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
1847799|NCT04528797|Hormones|hormones|mesh-ancestor
1847800|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847801|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1847802|NCT04528797|Protective Agents|protective agents|mesh-ancestor
1847803|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847804|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847805|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
1847806|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1847807|NCT04528888|Heparin|heparin|mesh-list
1847808|NCT04528888|Enoxaparin|enoxaparin|mesh-list
1847809|NCT04528888|Calcium heparin|calcium heparin|mesh-list
1847810|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847811|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
1847812|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
1847813|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847814|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847815|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847816|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
1847817|NCT04528888|Hormones|hormones|mesh-ancestor
1847818|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847819|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1847820|NCT04528888|Protective Agents|protective agents|mesh-ancestor
1847821|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847822|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847823|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
1847824|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1847825|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1847826|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847835|NCT04528927|Azithromycin|azithromycin|mesh-list
1847836|NCT04528927|Doxycycline|doxycycline|mesh-list
1847837|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847838|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847839|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
1847840|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1847841|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1847842|NCT04528563|Ketorolac|ketorolac|mesh-list
1847843|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1847844|NCT04528563|Morphine|morphine|mesh-list
1847845|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1847846|NCT04528563|Narcotics|narcotics|mesh-ancestor
1847847|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847848|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847849|NCT04528563|Analgesics|analgesics|mesh-ancestor
1847850|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
1847851|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847852|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1847853|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847854|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847855|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847856|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1847857|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847858|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847859|NCT04528277|Isoniazid|isoniazid|mesh-list
1847860|NCT04528277|Rifapentine|rifapentine|mesh-list
1847861|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
1847862|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1847863|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847864|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1847865|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1847866|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
1847867|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847868|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1847869|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1847870|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
1847871|NCT04528212|Glimepiride|glimepiride|mesh-list
1847872|NCT04528212|Curcumin|curcumin|mesh-list
1847873|NCT04528212|Fenofibrate|fenofibrate|mesh-list
1847874|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1847875|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1847876|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847877|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847878|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
1847879|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1847880|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847881|NCT04528212|Analgesics|analgesics|mesh-ancestor
1847882|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
1847883|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847884|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847885|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847886|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847887|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847888|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847889|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1847890|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
1847891|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1847892|NCT04528290|Ozanimod|ozanimod|mesh-list
1847893|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1847894|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847895|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1847896|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
1847897|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847900|NCT04528173|Ketorolac|ketorolac|mesh-list
1847901|NCT04528173|Fentanyl|fentanyl|mesh-list
1847902|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
1847903|NCT04528173|Morphine|morphine|mesh-list
1847904|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1847905|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847906|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847907|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847908|NCT04528173|Analgesics|analgesics|mesh-ancestor
1847909|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
1847910|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847911|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1847912|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1847913|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1847914|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
1847915|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847916|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847917|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1847918|NCT04528173|Narcotics|narcotics|mesh-ancestor
1847919|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1847920|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1847921|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
1847922|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
1847923|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1847924|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847925|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847926|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1847927|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847928|NCT04528329|Dexamethasone|dexamethasone|mesh-list
1847929|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
1847930|NCT04528329|BB 1101|bb 1101|mesh-list
1847931|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847932|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
1847933|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
1847934|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847935|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847936|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847937|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
1847938|NCT04528329|Hormones|hormones|mesh-ancestor
1847939|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1847940|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1847941|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1847942|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
1847943|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1847944|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847945|NCT04528095|Clozapine|clozapine|mesh-list
1847946|NCT04528095|Amisulpride|amisulpride|mesh-list
1847947|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1847948|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
1847949|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1847950|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847951|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847952|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1847953|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1847954|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847955|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1847956|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
1847957|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
1847958|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1847959|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
1847960|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1847961|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
1847971|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
1847972|NCT04528056|Ambrisentan|ambrisentan|mesh-list
1847973|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1847974|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1847975|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1847976|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1847977|NCT04528056|Analgesics|analgesics|mesh-ancestor
1847978|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
1847979|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1847980|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847981|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1847982|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1847983|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1847984|NCT04528004|Niacinamide|niacinamide|mesh-list
1847985|NCT04528004|Niacin|niacin|mesh-list
1847986|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
1847987|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
1847988|NCT04528004|Vitamins|vitamins|mesh-ancestor
1847989|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
1847990|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847991|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1847992|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
1847993|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1847994|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1847995|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
1847996|NCT04527757|Anesthetics|anesthetics|mesh-list
1847997|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1847998|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1847999|NCT04527770|Dexamethasone|dexamethasone|mesh-list
1848000|NCT04527770|Midazolam|midazolam|mesh-list
1848001|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1848002|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
1848003|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
1848004|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848005|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848006|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1848007|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
1848008|NCT04527770|Hormones|hormones|mesh-ancestor
1848009|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1848010|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1848011|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848012|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1848013|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1848014|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1848015|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1848016|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1848017|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1848018|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1848019|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
1848020|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
1848021|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
1848022|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
1848023|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1848024|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848025|NCT04527562|Colchicine|colchicine|mesh-list
1848026|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
1848027|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1848028|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
1848029|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
1848030|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
1848031|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848032|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848033|NCT04527393|Morphine|morphine|mesh-list
1848034|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1848035|NCT04527393|Narcotics|narcotics|mesh-ancestor
1848036|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1848037|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848038|NCT04527393|Analgesics|analgesics|mesh-ancestor
1848039|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
1848040|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848041|NCT04527679|Lenvatinib|lenvatinib|mesh-list
1848042|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848043|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1848044|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848045|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848046|NCT04527900|Paclitaxel|paclitaxel|mesh-list
1848047|NCT04527900|Carboplatin|carboplatin|mesh-list
1848048|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1848049|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848050|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
1848051|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
1848052|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
1848053|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848067|NCT04527432|Antibodies|antibodies|mesh-list
1848068|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
1848069|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848088|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
1848089|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1848090|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848091|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
1848092|NCT04527666|Anticoagulants|anticoagulants|mesh-list
1848093|NCT04527211|Ivermectin|ivermectin|mesh-list
1848094|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1848095|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848096|NCT05140811|Azacitidine|azacitidine|mesh-list
1848097|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1848098|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
1848099|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848100|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848101|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848102|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1848103|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1848104|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848113|NCT05140655|Fulvestrant|fulvestrant|mesh-list
1848114|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1848115|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848116|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1848117|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1848118|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
1848119|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1848120|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848121|NCT05140525|Macitentan|macitentan|mesh-list
1848122|NCT05140525|Riociguat|riociguat|mesh-list
1848123|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1848124|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1848125|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848126|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1848127|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
1848128|NCT05140512|Goserelin|goserelin|mesh-list
1848129|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1848130|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848131|NCT05140499|Bupivacaine|bupivacaine|mesh-list
1848132|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
1848133|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
1848134|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1848135|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848136|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
1848137|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848138|NCT05140278|Artesunate|artesunate|mesh-list
1848139|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
1848140|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1848141|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1848142|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848143|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848144|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
1848145|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
1848146|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1848147|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
1848161|NCT05140096|Fluconazole|fluconazole|mesh-list
1848162|NCT05140096|Isavuconazole|isavuconazole|mesh-list
1848163|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
1848164|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
1848165|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848166|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1848167|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1848168|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848169|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848170|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1848171|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
1848172|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1848173|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848174|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1848175|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1848176|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848177|NCT05139966|Fluorides|fluorides|mesh-list
1848178|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
1848179|NCT05139966|Protective Agents|protective agents|mesh-ancestor
1848180|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848181|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
1848182|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1848183|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848184|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1848185|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848226|NCT05139667|Tacrolimus|tacrolimus|mesh-list
1848227|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1848228|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
1848229|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848230|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1848231|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848232|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848233|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
1848234|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
1848235|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848236|NCT05139472|Empagliflozin|empagliflozin|mesh-list
1848237|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1848238|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848239|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1848240|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848241|NCT05139420|Topiramate|topiramate|mesh-list
1848242|NCT05139420|Phentermine|phentermine|mesh-list
1848243|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
1848244|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1848245|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848246|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1848247|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
1848248|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1848249|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
1848250|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
1848251|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848252|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
1848253|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1848254|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848263|NCT05139238|Labetalol|labetalol|mesh-list
1848264|NCT05139238|Nifedipine|nifedipine|mesh-list
1848265|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1848266|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1848267|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848268|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1848269|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848270|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
1848271|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
1848272|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1848273|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1848274|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1848275|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
1848276|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1848277|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1848278|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
1848279|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
1848280|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848281|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1848282|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1848302|NCT05139095|Apatinib|apatinib|mesh-list
1848303|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848304|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1848305|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848306|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848307|NCT05139043|Dexamethasone|dexamethasone|mesh-list
1848308|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
1848309|NCT05139043|Ichthammol|ichthammol|mesh-list
1848310|NCT05139043|BB 1101|bb 1101|mesh-list
1848311|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1848312|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
1848313|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
1848314|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848315|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848316|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1848317|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
1848318|NCT05139043|Hormones|hormones|mesh-ancestor
1848319|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1848320|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1848321|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848322|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
1848323|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848324|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848325|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
1848326|NCT05139030|Bupivacaine|bupivacaine|mesh-list
1848327|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
1848328|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
1848329|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1848330|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848331|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
1848332|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848351|NCT05139004|Fludarabine|fludarabine|mesh-list
1848352|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
1848353|NCT05139004|Melphalan|melphalan|mesh-list
1848354|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
1848355|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1848356|NCT05139004|Basiliximab|basiliximab|mesh-list
1848357|NCT05139004|Mitogens|mitogens|mesh-list
1848358|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1848359|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848360|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1848361|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
1848362|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848363|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1848364|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
1848365|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848366|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1848367|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
1848368|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1848369|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
1848370|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
1848371|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
1848372|NCT05138978|Listerine|listerine|mesh-list
1848373|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
1848374|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
1848375|NCT05138978|Protective Agents|protective agents|mesh-ancestor
1848376|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848377|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1848378|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848379|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1848380|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1848381|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1848382|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1848383|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1848384|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848385|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848386|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1848387|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1848388|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848389|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
1848390|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1848391|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
1848392|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1848393|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848394|NCT05138822|Renal Agents|renal agents|mesh-ancestor
1848395|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1848396|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1848397|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1848398|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848399|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
1848400|NCT05138614|Narcotics|narcotics|mesh-ancestor
1848401|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1848402|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848403|NCT05138614|Analgesics|analgesics|mesh-ancestor
1848404|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
1848405|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848411|NCT05138549|Beta Carotene|beta carotene|mesh-list
1848412|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848413|NCT05138549|Provitamins|provitamins|mesh-ancestor
1848414|NCT05138549|Vitamins|vitamins|mesh-ancestor
1848415|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
1848416|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
1848417|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1848418|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1848419|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848420|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
1848421|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
1848422|NCT05136326|Capecitabine|capecitabine|mesh-list
1848423|NCT05136326|Temozolomide|temozolomide|mesh-list
1848424|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1848425|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
1848426|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848427|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848428|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1848429|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
1848430|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1848431|NCT05126121|Amoxicillin|amoxicillin|mesh-list
1848432|NCT05126121|Clarithromycin|clarithromycin|mesh-list
1848433|NCT05126121|Levofloxacin|levofloxacin|mesh-list
1848434|NCT05126121|Ofloxacin|ofloxacin|mesh-list
1848435|NCT05126121|Tetracycline|tetracycline|mesh-list
1848436|NCT05126121|Tinidazole|tinidazole|mesh-list
1848437|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1848438|NCT05126121|Furazolidone|furazolidone|mesh-list
1848439|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848440|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
1848441|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1848442|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848443|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848444|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1848445|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1848446|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1848447|NCT05126121|Renal Agents|renal agents|mesh-ancestor
1848448|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1848449|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1848450|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848451|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1848452|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
1848453|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1848454|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1848455|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1848456|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1848457|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1848461|NCT05108688|Sumatriptan|sumatriptan|mesh-list
1848462|NCT05108688|Mirtazapine|mirtazapine|mesh-list
1848463|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1848464|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1848465|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1848466|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
1848467|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1848468|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848469|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848470|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
1848471|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1848472|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1848473|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
1848474|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
1848475|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1848476|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1848477|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1848478|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1848479|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1848480|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1848481|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
1848482|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1848483|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1848484|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1848489|NCT05082285|Vaccines|vaccines|mesh-list
1848490|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
1848491|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848492|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
1848493|NCT05080790|Interleukin-2|interleukin-2|mesh-list
1848494|NCT05080790|Dinutuximab|dinutuximab|mesh-list
1848495|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1848496|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1848497|NCT05080790|Analgesics|analgesics|mesh-ancestor
1848498|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
1848499|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1848500|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848501|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1848502|NCT05067439|Efavirenz|efavirenz|mesh-list
1848503|NCT05067439|Caffeine|caffeine|mesh-list
1848504|NCT05067439|Omeprazole|omeprazole|mesh-list
1848505|NCT05067439|Abrocitinib|abrocitinib|mesh-list
1848506|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1848507|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1848508|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1848509|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848510|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848511|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1848512|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848513|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1848514|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1848515|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1848516|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
1848517|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1848518|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1848519|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1848520|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
1848521|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1848522|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1848523|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1848524|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1848525|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1848526|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1848527|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1848528|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1848686|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
1848687|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
1848688|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1848737|NCT04918017|Esomeprazole|esomeprazole|mesh-list
1848738|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
1848739|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1848740|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1848741|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1848742|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1848790|NCT04886154|Vaccines|vaccines|mesh-list
1848791|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
1848792|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849093|NCT04590248|Adavosertib|adavosertib|mesh-list
1849094|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849095|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849096|NCT04583969|Remdesivir|remdesivir|mesh-list
1849097|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
1849098|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849099|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
1849100|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1849194|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
1849195|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1849196|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
1849197|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849198|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
1849199|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
1849200|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849201|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849205|NCT04502693|Vaccines|vaccines|mesh-list
1849206|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
1849207|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849222|NCT04459871|Thrombin|thrombin|mesh-list
1849223|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
1849224|NCT04459871|Coagulants|coagulants|mesh-ancestor
1849230|NCT04455139|Melphalan|melphalan|mesh-list
1849231|NCT04455139|Topotecan|topotecan|mesh-list
1849232|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1849233|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
1849234|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849235|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849236|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1849237|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1849238|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
1849239|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849240|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1849241|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1849242|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849243|NCT04447183|Iodine|iodine|mesh-list
1849244|NCT04447183|Hormones|hormones|mesh-list
1849245|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1849246|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849247|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1849248|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1849249|NCT04447183|Trace Elements|trace elements|mesh-ancestor
1849250|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
1849251|NCT04417088|Carboplatin|carboplatin|mesh-list
1849252|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849264|NCT04380545|Interferons|interferons|mesh-list
1849265|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
1849266|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
1849267|NCT04380545|Fluorouracil|fluorouracil|mesh-list
1849268|NCT04380545|Nivolumab|nivolumab|mesh-list
1849269|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
1849270|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849271|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1849272|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849273|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1849274|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
1849275|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849276|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849277|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1849278|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
1849279|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1849309|NCT04318548|Vaccines|vaccines|mesh-list
1849310|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
1849311|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849312|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
1849313|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1849314|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
1849315|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1849316|NCT04312594|Expectorants|expectorants|mesh-ancestor
1849317|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
1849318|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1849319|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
1849320|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849321|NCT04312594|Protective Agents|protective agents|mesh-ancestor
1849322|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849323|NCT04312594|Antidotes|antidotes|mesh-ancestor
1849362|NCT04291508|Acetaminophen|acetaminophen|mesh-list
1849363|NCT04291508|Ascorbic Acid|ascorbic acid|mesh-list
1849364|NCT04291508|Vitamins|vitamins|mesh-ancestor
1849365|NCT04291508|Micronutrients|micronutrients|mesh-ancestor
1849366|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849367|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1849368|NCT04291508|Analgesics|analgesics|mesh-ancestor
1849369|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
1849370|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1849371|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
1849372|NCT04291508|Antioxidants|antioxidants|mesh-ancestor
1849373|NCT04291508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849374|NCT04291508|Protective Agents|protective agents|mesh-ancestor
1849375|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
1849376|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849377|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1849378|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849379|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849380|NCT04265755|Erenumab|erenumab|mesh-list
1849381|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1849382|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849383|NCT04265755|Analgesics|analgesics|mesh-ancestor
1849384|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
1849385|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1849386|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849391|NCT04246541|Acetaminophen|acetaminophen|mesh-list
1849392|NCT04246541|Ketorolac|ketorolac|mesh-list
1849393|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1849394|NCT04246541|Oxycodone|oxycodone|mesh-list
1849395|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1849396|NCT04246541|Analgesics|analgesics|mesh-ancestor
1849397|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
1849398|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1849399|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849400|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
1849401|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1849402|NCT04246541|Narcotics|narcotics|mesh-ancestor
1849403|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1849404|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1849405|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1849406|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1849407|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1849408|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849409|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849410|NCT04238416|Lactulose|lactulose|mesh-list
1849411|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1849484|NCT04201496|Empagliflozin|empagliflozin|mesh-list
1849485|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1849486|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849487|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1849488|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849536|NCT04129216|Tamoxifen|tamoxifen|mesh-list
1849537|NCT04129216|Letrozole|letrozole|mesh-list
1849538|NCT04129216|Exemestane|exemestane|mesh-list
1849539|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849540|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849541|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1849542|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1849543|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849544|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1849545|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
1849546|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1849547|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849548|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1849549|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1849550|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1849551|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1849560|NCT04106414|Nivolumab|nivolumab|mesh-list
1849561|NCT04106414|Linrodostat|linrodostat|mesh-list
1849562|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849563|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849564|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1849565|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849566|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849567|NCT04102618|Trastuzumab|trastuzumab|mesh-list
1849568|NCT04102618|Letrozole|letrozole|mesh-list
1849569|NCT04102618|Atezolizumab|atezolizumab|mesh-list
1849570|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849571|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849572|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1849573|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1849574|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849575|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849576|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1849577|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
1849578|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1849579|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849590|NCT04069819|Cilostazol|cilostazol|mesh-list
1849591|NCT04069819|Citalopram|citalopram|mesh-list
1849592|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1849593|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1849594|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1849595|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849596|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1849597|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
1849598|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849599|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1849600|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
1849601|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1849602|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
1849603|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1849604|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1849605|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1849606|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
1849607|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1849608|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1849609|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1849610|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
1849611|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1849612|NCT04069819|Protective Agents|protective agents|mesh-ancestor
1849613|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1849614|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1849615|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849619|NCT04052880|Dexamethasone|dexamethasone|mesh-list
1849620|NCT04052880|Lenalidomide|lenalidomide|mesh-list
1849621|NCT04052880|Bortezomib|bortezomib|mesh-list
1849622|NCT04052880|Daratumumab|daratumumab|mesh-list
1849623|NCT04052880|Ixazomib|ixazomib|mesh-list
1849624|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1849625|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
1849626|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
1849627|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1849628|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849629|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1849630|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
1849631|NCT04052880|Hormones|hormones|mesh-ancestor
1849632|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1849633|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1849634|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849635|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
1849636|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1849637|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1849638|NCT04052880|Growth Substances|growth substances|mesh-ancestor
1849639|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
1849640|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
1849641|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849642|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849646|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1849647|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1849648|NCT04002297|Rituximab|rituximab|mesh-list
1849649|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1849650|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
1849651|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849652|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849653|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
1849654|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849655|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1849656|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1849657|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
1849658|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849659|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1849660|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849664|NCT03993379|Ipilimumab|ipilimumab|mesh-list
1849665|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849666|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849667|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1849668|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849669|NCT03955198|Durvalumab|durvalumab|mesh-list
1849670|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849671|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849678|NCT03921866|Palbociclib|palbociclib|mesh-list
1849679|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849680|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1849681|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849682|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849819|NCT03772158|Cetirizine|cetirizine|mesh-list
1849820|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1849821|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1849822|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1849823|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
1849824|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
1849825|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1849826|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849827|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849846|NCT03724890|Avelumab|avelumab|mesh-list
1849847|NCT03724890|Peposertib|peposertib|mesh-list
1849848|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849849|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849850|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1849851|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849852|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849853|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
1849854|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1849855|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
1849856|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849857|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
1849858|NCT03723590|Protective Agents|protective agents|mesh-ancestor
1849859|NCT03697512|Rituximab|rituximab|mesh-list
1849860|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849861|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849862|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
1849863|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849864|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1849865|NCT03617718|Glycine|glycine|mesh-list
1849866|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
1849867|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1849868|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849869|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849870|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
1849871|NCT03613727|Vitamins|vitamins|mesh-ancestor
1849872|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
1849873|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849874|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
1849875|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849876|NCT03613727|Protective Agents|protective agents|mesh-ancestor
1849948|NCT03558854|Aspirin|aspirin|mesh-list
1849949|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1849950|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1849951|NCT03558854|Analgesics|analgesics|mesh-ancestor
1849952|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
1849953|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1849954|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849955|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1849956|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1849957|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1849958|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1849959|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849960|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1849961|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1849962|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849963|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
1849964|NCT03495960|Rituximab|rituximab|mesh-list
1849965|NCT03495960|Methotrexate|methotrexate|mesh-list
1849966|NCT03495960|Lenalidomide|lenalidomide|mesh-list
1849967|NCT03495960|Temozolomide|temozolomide|mesh-list
1849968|NCT03495960|Procarbazine|procarbazine|mesh-list
1849969|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849970|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1849971|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
1849972|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1849973|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1849974|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1849975|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
1849976|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1849977|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1849978|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
1849979|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1849980|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
1849981|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1849982|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1849983|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1849984|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1849985|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1849986|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1849987|NCT03495960|Growth Substances|growth substances|mesh-ancestor
1849988|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
1849989|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1849990|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
1849991|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
1849992|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1849993|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850016|NCT03444753|Nivolumab|nivolumab|mesh-list
1850017|NCT03444753|Ipilimumab|ipilimumab|mesh-list
1850018|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850019|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850020|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1850021|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850027|NCT03430895|Durvalumab|durvalumab|mesh-list
1850028|NCT03430895|Tremelimumab|tremelimumab|mesh-list
1850029|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850030|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850035|NCT03409458|Avelumab|avelumab|mesh-list
1850036|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850037|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850038|NCT03402841|Olaparib|olaparib|mesh-list
1850039|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850040|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850041|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850042|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850046|NCT03388138|Ketotifen|ketotifen|mesh-list
1850047|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
1850048|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
1850049|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1850050|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
1850051|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
1850052|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1850053|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850054|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850055|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1850056|NCT03379727|Midostaurin|midostaurin|mesh-list
1850057|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850058|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850059|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850060|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850061|NCT03366272|Gemcitabine|gemcitabine|mesh-list
1850062|NCT03366272|Rituximab|rituximab|mesh-list
1850063|NCT03366272|Nivolumab|nivolumab|mesh-list
1850064|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
1850065|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850066|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850067|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
1850068|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850069|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850070|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850071|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
1850072|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850073|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
1850074|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850075|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850076|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850228|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
1850077|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1850078|NCT03243058|Aldesleukin|aldesleukin|mesh-list
1850079|NCT03243058|Interleukin-2|interleukin-2|mesh-list
1850080|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850081|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1850082|NCT03243058|Analgesics|analgesics|mesh-ancestor
1850083|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
1850084|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850085|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850086|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1850087|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1850088|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
1850089|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850090|NCT03230838|Meropenem|meropenem|mesh-list
1850091|NCT03230838|Tazobactam|tazobactam|mesh-list
1850092|NCT03230838|Ceftolozane|ceftolozane|mesh-list
1850093|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
1850094|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1850095|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850096|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1850097|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850098|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850099|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1850100|NCT03230838|Renal Agents|renal agents|mesh-ancestor
1850111|NCT03143985|Pomalidomide|pomalidomide|mesh-list
1850112|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
1850113|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850114|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850115|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850116|NCT03143985|Growth Substances|growth substances|mesh-ancestor
1850117|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850118|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850134|NCT03113955|Epirubicin|epirubicin|mesh-list
1850135|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1850136|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850137|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1850138|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1850139|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850140|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850141|NCT03034096|Propofol|propofol|mesh-list
1850142|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1850143|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1850144|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850145|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1850146|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
1850147|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
1850148|NCT03029234|Dexamethasone|dexamethasone|mesh-list
1850149|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1850150|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
1850151|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
1850152|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850456|NCT01959139|Vitamins|vitamins|mesh-ancestor
1850153|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850154|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1850155|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
1850156|NCT03029234|Hormones|hormones|mesh-ancestor
1850157|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1850158|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1850159|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850160|NCT03016338|Niraparib|niraparib|mesh-list
1850161|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850162|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850163|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850164|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850165|NCT02995694|Estradiol|estradiol|mesh-list
1850166|NCT02995694|Estrogens|estrogens|mesh-ancestor
1850167|NCT02995694|Hormones|hormones|mesh-ancestor
1850168|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1850169|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850170|NCT02983045|Paclitaxel|paclitaxel|mesh-list
1850171|NCT02983045|Cisplatin|cisplatin|mesh-list
1850172|NCT02983045|Carboplatin|carboplatin|mesh-list
1850173|NCT02983045|Nivolumab|nivolumab|mesh-list
1850174|NCT02983045|Pemetrexed|pemetrexed|mesh-list
1850175|NCT02983045|Ipilimumab|ipilimumab|mesh-list
1850176|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1850177|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850178|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
1850179|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
1850180|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
1850181|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850182|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850183|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1850184|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850185|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1850186|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1850204|NCT02937818|Carboplatin|carboplatin|mesh-list
1850205|NCT02937818|Durvalumab|durvalumab|mesh-list
1850206|NCT02937818|Olaparib|olaparib|mesh-list
1850207|NCT02937818|Tremelimumab|tremelimumab|mesh-list
1850208|NCT02937818|Adavosertib|adavosertib|mesh-list
1850209|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850210|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850211|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850212|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850213|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850214|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
1850215|NCT02926833|Fludarabine|fludarabine|mesh-list
1850216|NCT02926833|Atezolizumab|atezolizumab|mesh-list
1850217|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850218|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
1850219|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850220|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850221|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850222|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
1850223|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850224|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850225|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1850226|NCT02720445|Nicotine|nicotine|mesh-list
1850227|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1850229|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850230|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850231|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1850232|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1850233|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
1850234|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1850235|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850236|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
1850237|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1850238|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
1850239|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850240|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
1850241|NCT02698865|Protective Agents|protective agents|mesh-ancestor
1850242|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
1850243|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1850244|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850245|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1850246|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850259|NCT02611037|Gemcitabine|gemcitabine|mesh-list
1850260|NCT02611037|Methotrexate|methotrexate|mesh-list
1850261|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850262|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850263|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
1850264|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850265|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
1850266|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850267|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850268|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850269|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
1850270|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850271|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1850272|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
1850273|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1850274|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
1850275|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1850276|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850277|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1850278|NCT02599714|Fulvestrant|fulvestrant|mesh-list
1850279|NCT02599714|Palbociclib|palbociclib|mesh-list
1850280|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1850281|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850282|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1850283|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1850284|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
1850285|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1850286|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850287|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850288|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850289|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850322|NCT02535325|Cisplatin|cisplatin|mesh-list
1850323|NCT02535325|Pemetrexed|pemetrexed|mesh-list
1850324|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850325|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850326|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850327|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1850328|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1850329|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
1850330|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850331|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850332|NCT02486718|Gemcitabine|gemcitabine|mesh-list
1850333|NCT02486718|Docetaxel|docetaxel|mesh-list
1850334|NCT02486718|Pemetrexed|pemetrexed|mesh-list
1850335|NCT02486718|Atezolizumab|atezolizumab|mesh-list
1850336|NCT02486718|Vinorelbine|vinorelbine|mesh-list
1850337|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850338|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850339|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
1850340|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850341|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
1850342|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850343|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850344|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850345|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
1850346|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850347|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
1850348|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
1850349|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
1850350|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1850351|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1850352|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1850355|NCT02454933|Durvalumab|durvalumab|mesh-list
1850356|NCT02454933|Osimertinib|osimertinib|mesh-list
1850357|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850358|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850359|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850360|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850361|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850370|NCT02282020|Olaparib|olaparib|mesh-list
1850371|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850372|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850373|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850374|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850375|NCT02257567|Rituximab|rituximab|mesh-list
1850376|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
1850377|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1850378|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1850379|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
1850380|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850381|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850382|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
1850383|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850384|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850385|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850386|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
1850387|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850421|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
1850422|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850423|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
1850424|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850425|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850426|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1850427|NCT02129647|Axitinib|axitinib|mesh-list
1850428|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850429|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850430|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850431|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850438|NCT01959139|Leucovorin|leucovorin|mesh-list
1850439|NCT01959139|Fluorouracil|fluorouracil|mesh-list
1850440|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
1850441|NCT01959139|Irinotecan|irinotecan|mesh-list
1850442|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
1850443|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850444|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
1850445|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850446|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850447|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850448|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850449|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
1850450|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1850451|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1850452|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850453|NCT01959139|Antidotes|antidotes|mesh-ancestor
1850454|NCT01959139|Protective Agents|protective agents|mesh-ancestor
1850455|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
1850457|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
1850461|NCT01921140|Olaparib|olaparib|mesh-list
1850462|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850463|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850464|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850465|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850466|NCT01874353|Olaparib|olaparib|mesh-list
1850467|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850468|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850469|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850470|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850471|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
1850472|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1850473|NCT01870193|Glycine|glycine|mesh-list
1850474|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
1850475|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850476|NCT01870193|Expectorants|expectorants|mesh-ancestor
1850477|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
1850478|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1850479|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
1850480|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850481|NCT01870193|Protective Agents|protective agents|mesh-ancestor
1850482|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850483|NCT01870193|Antidotes|antidotes|mesh-ancestor
1850484|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
1850485|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1850517|NCT01805284|Linezolid|linezolid|mesh-list
1850518|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1850519|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850520|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1850521|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850522|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850523|NCT01695941|Rituximab|rituximab|mesh-list
1850524|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1850525|NCT01695941|Bortezomib|bortezomib|mesh-list
1850526|NCT01695941|Antibodies|antibodies|mesh-list
1850527|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
1850528|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1850529|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
1850530|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850531|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850532|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850533|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1850534|NCT01638533|Romidepsin|romidepsin|mesh-list
1850535|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850536|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1850537|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850538|NCT01522976|Lenalidomide|lenalidomide|mesh-list
1850539|NCT01522976|Azacitidine|azacitidine|mesh-list
1850540|NCT01522976|Vorinostat|vorinostat|mesh-list
1850541|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
1850542|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850543|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850544|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850545|NCT01522976|Growth Substances|growth substances|mesh-ancestor
1850546|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850547|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850548|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850549|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
1850550|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850551|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850552|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1850553|NCT01366144|Paclitaxel|paclitaxel|mesh-list
1850554|NCT01366144|Carboplatin|carboplatin|mesh-list
1850555|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1850556|NCT01366144|Veliparib|veliparib|mesh-list
1850557|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1850558|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850559|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
1850560|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
1850561|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
1850562|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850563|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850564|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850565|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
1850566|NCT01286272|Bortezomib|bortezomib|mesh-list
1850567|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1850568|NCT01286272|Ofatumumab|ofatumumab|mesh-list
1850569|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1850570|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1850571|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850572|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850573|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
1850574|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850575|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1850576|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
1850577|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
1850578|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850579|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
1850580|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850581|NCT01145495|Rituximab|rituximab|mesh-list
1850582|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1850583|NCT01145495|Lenalidomide|lenalidomide|mesh-list
1850584|NCT01145495|Antibodies|antibodies|mesh-list
1850585|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
1850586|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1850587|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
1850588|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850589|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850590|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850591|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850592|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850593|NCT01145495|Growth Substances|growth substances|mesh-ancestor
1850594|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850595|NCT01139970|Temozolomide|temozolomide|mesh-list
1850596|NCT01139970|Veliparib|veliparib|mesh-list
1850597|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850598|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
1850599|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850600|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850601|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850602|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850603|NCT01134601|Capecitabine|capecitabine|mesh-list
1850604|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850605|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
1850606|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850607|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850608|NCT00977574|Sirolimus|sirolimus|mesh-list
1850609|NCT00977574|Paclitaxel|paclitaxel|mesh-list
1850610|NCT00977574|Epothilones|epothilones|mesh-list
1850611|NCT00977574|Epothilone B|epothilone b|mesh-list
1850612|NCT00977574|Bevacizumab|bevacizumab|mesh-list
1850613|NCT00977574|Carboplatin|carboplatin|mesh-list
1850614|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1850615|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1850616|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
1850617|NCT00977574|Antibodies|antibodies|mesh-list
1850618|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
1850619|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1850620|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
1850621|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1850622|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850623|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
1850624|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
1850625|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
1850626|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850627|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850628|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850629|NCT00977574|Growth Substances|growth substances|mesh-ancestor
1850630|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850631|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850632|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
1850633|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1850634|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850635|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1850636|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
1850637|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850646|NCT00731731|Temozolomide|temozolomide|mesh-list
1850647|NCT00731731|Vorinostat|vorinostat|mesh-list
1850648|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850649|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
1850650|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850651|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850652|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1850653|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850688|NCT00588991|Carboplatin|carboplatin|mesh-list
1850689|NCT00588991|Topotecan|topotecan|mesh-list
1850690|NCT00588991|Veliparib|veliparib|mesh-list
1850691|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850692|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1850693|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1850694|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850695|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850696|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1850697|NCT00336063|Azacitidine|azacitidine|mesh-list
1850698|NCT00336063|Vorinostat|vorinostat|mesh-list
1850699|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850700|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
1850701|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850702|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850703|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850704|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1850705|NCT00268385|Temozolomide|temozolomide|mesh-list
1850706|NCT00268385|Vorinostat|vorinostat|mesh-list
1850707|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850708|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
1850709|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850710|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850711|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1850712|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850713|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1850714|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1850715|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
1850716|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1850717|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850718|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850719|NCT00095784|Decitabine|decitabine|mesh-list
1850720|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850721|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
1850722|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850723|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850724|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850725|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
1850726|NCT00070499|Dasatinib|dasatinib|mesh-list
1850727|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850728|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850729|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850730|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850731|NCT04515134|Ubiquinone|ubiquinone|mesh-list
1850732|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
1850733|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
1850734|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850735|NCT04515134|Vitamins|vitamins|mesh-ancestor
1850736|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1850737|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1850738|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850739|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
1850740|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
1850741|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1850742|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1850743|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850744|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850745|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850746|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850747|NCT04489433|Trametinib|trametinib|mesh-list
1850748|NCT04489433|Dabrafenib|dabrafenib|mesh-list
1850749|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850750|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850751|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850752|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850753|NCT04488237|Vitamin D|vitamin d|mesh-list
1850754|NCT04488237|Vitamins|vitamins|mesh-ancestor
1850755|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
1850756|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850757|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1850758|NCT04484363|Azacitidine|azacitidine|mesh-list
1850759|NCT04484363|Pevonedistat|pevonedistat|mesh-list
1850760|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850761|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
1850762|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850763|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850764|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850765|NCT04482361|Antibodies|antibodies|mesh-list
1850766|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
1850767|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850768|NCT04477382|Tretinoin|tretinoin|mesh-list
1850769|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850770|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
1850771|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
1850772|NCT04455776|Propofol|propofol|mesh-list
1850773|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1850774|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1850775|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850776|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1850777|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
1850778|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
1850779|NCT04446793|Bevacizumab|bevacizumab|mesh-list
1850780|NCT04446793|Onvansertib|onvansertib|mesh-list
1850781|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1850782|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850783|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850784|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850785|NCT04446793|Growth Substances|growth substances|mesh-ancestor
1850786|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850787|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850788|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1850789|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850790|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850791|NCT04445415|Antibodies|antibodies|mesh-list
1850792|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
1850793|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850794|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1850795|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
1850796|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850797|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
1850804|NCT04407572|Vitamin D|vitamin d|mesh-list
1850805|NCT04407572|Vitamins|vitamins|mesh-list
1850806|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
1850807|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
1850808|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
1850809|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850810|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1850811|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
1850812|NCT04407572|Hematinics|hematinics|mesh-ancestor
1850813|NCT04405284|Disinfectants|disinfectants|mesh-list
1850814|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850815|NCT04397302|Valsartan|valsartan|mesh-list
1850816|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1850817|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1850818|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1850819|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850820|NCT04396587|Sufentanil|sufentanil|mesh-list
1850821|NCT04396587|Oxycodone|oxycodone|mesh-list
1850822|NCT04396587|Hydromorphone|hydromorphone|mesh-list
1850823|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1850824|NCT04396587|Narcotics|narcotics|mesh-ancestor
1850825|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1850826|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850827|NCT04396587|Analgesics|analgesics|mesh-ancestor
1850828|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
1850829|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850830|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1850831|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1850832|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
1850833|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
1850834|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1850835|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1850836|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
1850837|NCT04389294|Antibodies|antibodies|mesh-list
1850838|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
1850839|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850840|NCT04381091|Idebenone|idebenone|mesh-list
1850841|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
1850842|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850843|NCT04381091|Protective Agents|protective agents|mesh-ancestor
1850844|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850845|NCT04377295|Ranibizumab|ranibizumab|mesh-list
1850846|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850847|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850848|NCT04377295|Growth Substances|growth substances|mesh-ancestor
1850849|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850850|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850851|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850852|NCT04374123|Antibodies|antibodies|mesh-list
1850853|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
1850854|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
1850855|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850856|NCT04367688|Tenofovir|tenofovir|mesh-list
1850857|NCT04367688|Emtricitabine|emtricitabine|mesh-list
1850858|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
1850859|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850860|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1850861|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1850862|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850863|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850864|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1850865|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1850866|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
1850867|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1850868|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
1850869|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850870|NCT04365725|Remdesivir|remdesivir|mesh-list
1850871|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
1850872|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850873|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
1850874|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850875|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
1850876|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1850877|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
1850878|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850879|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850880|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1850881|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
1850882|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1850883|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
1850884|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850885|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1850886|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1850887|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
1850888|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
1850889|NCT04358588|Protective Agents|protective agents|mesh-ancestor
1850890|NCT04356950|Thrombin|thrombin|mesh-list
1850891|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
1850892|NCT04356950|Coagulants|coagulants|mesh-ancestor
1850893|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1850894|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1850895|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1850896|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1850897|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850898|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
1850899|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1850900|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850901|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
1850902|NCT04350021|Capecitabine|capecitabine|mesh-list
1850903|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850904|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
1850905|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850906|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1850907|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1850908|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
1850909|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850910|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850911|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1850912|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1850913|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
1850914|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1850915|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
1850916|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850917|NCT04334837|Copper|copper|mesh-list
1850918|NCT04334837|Trace Elements|trace elements|mesh-ancestor
1850919|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
1850920|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850921|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
1850922|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1850923|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850924|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850925|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850926|NCT04321733|Amoxicillin|amoxicillin|mesh-list
1850927|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
1850928|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
1850929|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1850930|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1850931|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850932|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1850933|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850934|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850935|NCT04319341|Autoantibodies|autoantibodies|mesh-list
1850936|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
1850937|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850938|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
1850939|NCT04318405|Hematinics|hematinics|mesh-ancestor
1850940|NCT04314336|Coal Tar|coal tar|mesh-list
1850941|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
1850942|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
1850943|NCT04312555|Alprostadil|alprostadil|mesh-list
1850944|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1850945|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
1850946|NCT04312555|Urological Agents|urological agents|mesh-ancestor
1850947|NCT04310631|Ranibizumab|ranibizumab|mesh-list
1850948|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1850949|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1850950|NCT04310631|Growth Substances|growth substances|mesh-ancestor
1850951|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850952|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
1850953|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850954|NCT04302012|Mydriatics|mydriatics|mesh-list
1850955|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
1850956|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850957|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850958|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1850959|NCT04296253|Mitogens|mitogens|mesh-list
1850960|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
1850961|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850962|NCT04294550|Naloxegol|naloxegol|mesh-list
1850963|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1850964|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850965|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
1850966|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850967|NCT04288713|Eculizumab|eculizumab|mesh-list
1850968|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1850969|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1850970|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
1850971|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850972|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1850973|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1850974|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850975|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
1850976|NCT04267601|Anagliptin|anagliptin|mesh-list
1850977|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1850978|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
1850979|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1850980|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1850981|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1850982|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850983|NCT04264884|Daratumumab|daratumumab|mesh-list
1850984|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1850985|NCT04261231|Anesthetics|anesthetics|mesh-list
1850986|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1850987|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850988|NCT04260139|Metronidazole|metronidazole|mesh-list
1850989|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1850990|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1850991|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1850992|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1850993|NCT04256265|Risdiplam|risdiplam|mesh-list
1850994|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1850995|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1850996|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1850997|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1850998|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
1850999|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851000|NCT04240509|Tenofovir|tenofovir|mesh-list
1851001|NCT04240509|Emtricitabine|emtricitabine|mesh-list
1851002|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
1851003|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851004|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1851005|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1851006|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851007|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851008|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1851009|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1851010|NCT04238741|Anesthetics|anesthetics|mesh-list
1851011|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851012|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851013|NCT04233047|Fostemsavir|fostemsavir|mesh-list
1851014|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1851015|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1851016|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
1851017|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851018|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1851019|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1851020|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851021|NCT04230707|Melatonin|melatonin|mesh-list
1851022|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
1851023|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851024|NCT04230707|Protective Agents|protective agents|mesh-ancestor
1851025|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851026|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851027|NCT04221568|Fentanyl|fentanyl|mesh-list
1851028|NCT04221568|Bupivacaine|bupivacaine|mesh-list
1851029|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
1851030|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
1851031|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
1851032|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851033|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851034|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
1851035|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851036|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1851037|NCT04221568|Narcotics|narcotics|mesh-ancestor
1851038|NCT04221568|Analgesics|analgesics|mesh-ancestor
1851039|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1851040|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1851041|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
1851042|NCT04220203|Capecitabine|capecitabine|mesh-list
1851043|NCT04220203|Trastuzumab|trastuzumab|mesh-list
1851044|NCT04220203|Tucatinib|tucatinib|mesh-list
1851045|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1851046|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
1851047|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851048|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851049|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851050|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1851051|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851052|NCT04204928|Pralsetinib|pralsetinib|mesh-list
1851053|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851054|NCT04195009|Anesthetics|anesthetics|mesh-list
1851055|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851056|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851057|NCT04187248|Asparaginase|asparaginase|mesh-list
1851058|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851059|NCT04179266|Ketamine|ketamine|mesh-list
1851060|NCT04179266|Analgesics|analgesics|mesh-ancestor
1851061|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
1851062|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851063|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851064|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1851065|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1851066|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
1851067|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
1851068|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851069|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1851070|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1851071|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851072|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851073|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1851074|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851075|NCT04163224|Imidacloprid|imidacloprid|mesh-list
1851076|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
1851077|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851078|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851079|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851080|NCT04152941|Olaparib|olaparib|mesh-list
1851081|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1851082|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851083|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851084|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851085|NCT04138641|Cangrelor|cangrelor|mesh-list
1851086|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1851087|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1851088|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1851089|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1851090|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
1851091|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851092|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851093|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851094|NCT04135092|Aldesleukin|aldesleukin|mesh-list
1851095|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
1851096|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
1851097|NCT04135092|Fludarabine|fludarabine|mesh-list
1851098|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1851099|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
1851100|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851101|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1851102|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1851103|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
1851104|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851105|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851106|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1851107|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851108|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1851109|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1851110|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
1851111|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851112|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
1851113|NCT04132882|Antidotes|antidotes|mesh-ancestor
1851114|NCT04132882|Protective Agents|protective agents|mesh-ancestor
1851115|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851116|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
1851117|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851118|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
1851119|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1851120|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851121|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
1851122|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
1851123|NCT04130776|Kallikreins|kallikreins|mesh-list
1851124|NCT04130776|Coagulants|coagulants|mesh-ancestor
1851125|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
1851126|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
1851127|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1851128|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851129|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
1851130|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1851131|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
1851132|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
1851133|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851134|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851135|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1851136|NCT04124562|Analgesics|analgesics|mesh-ancestor
1851137|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
1851138|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851139|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
1851140|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1851141|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
1851142|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851143|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
1851144|NCT04124133|Protective Agents|protective agents|mesh-ancestor
1851145|NCT04114500|Estradiol|estradiol|mesh-list
1851146|NCT04114500|Progesterone|progesterone|mesh-list
1851147|NCT04114500|Estrogens|estrogens|mesh-ancestor
1851148|NCT04114500|Hormones|hormones|mesh-ancestor
1851149|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851150|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851151|NCT04114500|Progestins|progestins|mesh-ancestor
1851152|NCT04112277|Morphine|morphine|mesh-list
1851153|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1851154|NCT04112277|Narcotics|narcotics|mesh-ancestor
1851155|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851156|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851157|NCT04112277|Analgesics|analgesics|mesh-ancestor
1851158|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
1851159|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851160|NCT04102319|Hepcidins|hepcidins|mesh-list
1851161|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851162|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
1851163|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1851164|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
1851165|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
1851166|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851167|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851168|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1851169|NCT04095494|Analgesics|analgesics|mesh-ancestor
1851170|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
1851171|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851172|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1851173|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1851174|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851175|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1851176|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1851177|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1851178|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851179|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851180|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1851181|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1851182|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1851183|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
1851184|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851185|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851186|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1851187|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1851188|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
1851189|NCT04059991|Vaccines|vaccines|mesh-list
1851190|NCT04059991|Immunologic Factors|immunologic factors|mesh-ancestor
1851191|NCT04059991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851192|NCT04049084|Adenosine|adenosine|mesh-list
1851193|NCT04049084|Analgesics|analgesics|mesh-ancestor
1851194|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
1851195|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851196|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851197|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1851198|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
1851199|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1851200|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
1851201|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
1851202|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851203|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851204|NCT04045171|Tacrolimus|tacrolimus|mesh-list
1851205|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1851206|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
1851207|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851208|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1851209|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851210|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851211|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
1851212|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
1851213|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
1851214|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851215|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851216|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
1851217|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851218|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
1851219|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1851220|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851221|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851222|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1851223|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
1851224|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1851225|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851226|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851227|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1851228|NCT03994419|Anesthetics|anesthetics|mesh-list
1851229|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851230|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851231|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
1851232|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851233|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851234|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
1851235|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851236|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851237|NCT03979625|Heparin|heparin|mesh-list
1851238|NCT03979625|Antibodies|antibodies|mesh-list
1851239|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
1851240|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851241|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
1851242|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1851243|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1851244|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851245|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
1851246|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
1851247|NCT03974464|Coagulants|coagulants|mesh-ancestor
1851248|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1851249|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1851250|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
1851251|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851252|NCT03970265|Meropenem|meropenem|mesh-list
1851253|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1851254|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851255|NCT03967483|Indomethacin|indomethacin|mesh-list
1851256|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1851257|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1851258|NCT03967483|Analgesics|analgesics|mesh-ancestor
1851259|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
1851260|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851261|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851262|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1851263|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1851264|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
1851265|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
1851266|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1851267|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1851268|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851269|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851273|NCT03947099|Ketamine|ketamine|mesh-list
1851274|NCT03947099|Analgesics|analgesics|mesh-ancestor
1851275|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
1851276|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851277|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851278|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1851279|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1851280|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
1851281|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
1851282|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851283|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1851284|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1851285|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851286|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851287|NCT03930017|Vaccines|vaccines|mesh-list
1851288|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
1851289|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851290|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1851291|NCT03920566|Dalteparin|dalteparin|mesh-list
1851292|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
1851293|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1851294|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1851295|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851296|NCT03914170|Cetuximab|cetuximab|mesh-list
1851297|NCT03914170|Folfirinox|folfirinox|mesh-list
1851298|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851299|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851300|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
1851301|NCT03912298|Narcotics|narcotics|mesh-ancestor
1851302|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851303|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851304|NCT03912298|Analgesics|analgesics|mesh-ancestor
1851305|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
1851306|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851307|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
1851308|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1851309|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
1851310|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851311|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851312|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1851313|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
1851314|NCT03907605|Hormones|hormones|mesh-list
1851315|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851316|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851317|NCT03903406|Dexamethasone|dexamethasone|mesh-list
1851318|NCT03903406|Lenalidomide|lenalidomide|mesh-list
1851319|NCT03903406|Ixazomib|ixazomib|mesh-list
1851320|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1851321|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
1851322|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
1851323|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851324|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851325|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1851326|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
1851327|NCT03903406|Hormones|hormones|mesh-ancestor
1851328|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851329|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1851330|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851331|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
1851332|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1851333|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1851334|NCT03903406|Growth Substances|growth substances|mesh-ancestor
1851335|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
1851336|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
1851337|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851338|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851339|NCT03897192|Bevacizumab|bevacizumab|mesh-list
1851340|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851341|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851342|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1851343|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1851344|NCT03897192|Growth Substances|growth substances|mesh-ancestor
1851345|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851346|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
1851347|NCT03896815|INCB054329|incb054329|mesh-list
1851348|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851349|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
1851350|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851351|NCT03881917|Cystatins|cystatins|mesh-list
1851352|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1851353|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
1851354|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851355|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851356|NCT03851965|Plasminogen|plasminogen|mesh-list
1851357|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1851358|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1851359|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851360|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1851361|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851362|NCT03833323|Treprostinil|treprostinil|mesh-list
1851363|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1851364|NCT03829579|Esketamine|esketamine|mesh-list
1851365|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
1851366|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1851367|NCT03828162|Anticoagulants|anticoagulants|mesh-list
1851368|NCT03819413|Antibodies|antibodies|mesh-list
1851369|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
1851370|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
1851371|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851372|NCT03819452|Vitamin D|vitamin d|mesh-list
1851373|NCT03819452|Vitamins|vitamins|mesh-ancestor
1851374|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
1851375|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851376|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1851377|NCT03815422|Anesthetics|anesthetics|mesh-list
1851378|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851379|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851380|NCT03811366|Prednisone|prednisone|mesh-list
1851381|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1851382|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
1851383|NCT03811366|Hormones|hormones|mesh-ancestor
1851384|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851385|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851386|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1851387|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851388|NCT03806543|Vancomycin|vancomycin|mesh-list
1851389|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1851390|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851391|NCT03804099|Aflibercept|aflibercept|mesh-list
1851392|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1851393|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1851394|NCT03804099|Growth Substances|growth substances|mesh-ancestor
1851395|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851396|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
1851397|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851398|NCT03797547|Aflibercept|aflibercept|mesh-list
1851399|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1851400|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1851401|NCT03797547|Growth Substances|growth substances|mesh-ancestor
1851402|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851403|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
1851404|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851405|NCT03793400|Bevacizumab|bevacizumab|mesh-list
1851406|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851407|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851408|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1851409|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1851410|NCT03793400|Growth Substances|growth substances|mesh-ancestor
1851411|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851412|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
1851413|NCT03792334|Anesthetics|anesthetics|mesh-list
1851414|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851415|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851416|NCT03789968|Tenofovir|tenofovir|mesh-list
1851417|NCT03789968|Emtricitabine|emtricitabine|mesh-list
1851418|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1851419|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
1851420|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851421|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1851422|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1851423|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851424|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851425|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1851426|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1851427|NCT03778424|Rufinamide|rufinamide|mesh-list
1851428|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
1851429|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1851430|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1851431|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1851432|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851433|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1851434|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1851435|NCT03767712|Antibodies|antibodies|mesh-list
1851436|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
1851437|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
1851438|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851439|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
1851440|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
1851441|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851442|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
1851443|NCT03760562|Hormones|hormones|mesh-ancestor
1851444|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851445|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851446|NCT03751397|Cystatins|cystatins|mesh-list
1851447|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1851448|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
1851449|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851450|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851451|NCT03748095|Tazobactam|tazobactam|mesh-list
1851452|NCT03748095|Piperacillin|piperacillin|mesh-list
1851453|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1851454|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851455|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1851456|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851457|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851458|NCT03744546|Tilavonemab|tilavonemab|mesh-list
1851459|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
1851460|NCT03738683|Tazobactam|tazobactam|mesh-list
1851461|NCT03738683|Piperacillin|piperacillin|mesh-list
1851462|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1851463|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1851464|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851465|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1851466|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851467|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851468|NCT03738553|Trastuzumab|trastuzumab|mesh-list
1851469|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851470|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851484|NCT05142319|Vaccines|vaccines|mesh-list
1851485|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
1851486|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851516|NCT05142228|Erenumab|erenumab|mesh-list
1851517|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1851518|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851519|NCT05142228|Analgesics|analgesics|mesh-ancestor
1851520|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
1851521|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851522|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851523|NCT05142189|Docetaxel|docetaxel|mesh-list
1851524|NCT05142189|Cemiplimab|cemiplimab|mesh-list
1851525|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851526|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
1851527|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
1851528|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
1851529|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851530|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851553|NCT05142085|Mineral Oil|mineral oil|mesh-list
1851554|NCT05142085|Emollients|emollients|mesh-ancestor
1851555|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
1851556|NCT05142072|Vitamin D|vitamin d|mesh-list
1851557|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
1851558|NCT05142072|Vitamins|vitamins|mesh-ancestor
1851559|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
1851560|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851561|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1851562|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1851563|NCT05141968|Vitamin D|vitamin d|mesh-list
1851564|NCT05141968|Vitamins|vitamins|mesh-ancestor
1851565|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
1851566|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851567|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1851570|NCT05141877|Anesthetics|anesthetics|mesh-list
1851571|NCT05141877|Propofol|propofol|mesh-list
1851572|NCT05141877|Sevoflurane|sevoflurane|mesh-list
1851573|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851574|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851575|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1851576|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1851577|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
1851578|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1851579|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1851580|NCT05141864|Lidocaine|lidocaine|mesh-list
1851581|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
1851582|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
1851583|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851584|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851585|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
1851586|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851587|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1851588|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1851589|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1851590|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1851591|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851617|NCT05141682|Azacitidine|azacitidine|mesh-list
1851618|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1851619|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
1851620|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851621|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851622|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851629|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
1851630|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1851631|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851632|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1851633|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851634|NCT05141474|Aldesleukin|aldesleukin|mesh-list
1851635|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
1851636|NCT05141474|Fludarabine|fludarabine|mesh-list
1851637|NCT05141474|Interleukin-2|interleukin-2|mesh-list
1851638|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1851639|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
1851640|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851641|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1851642|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1851643|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
1851644|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851645|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851646|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1851647|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1851648|NCT05141474|Analgesics|analgesics|mesh-ancestor
1851649|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
1851650|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851651|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1851652|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1851653|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
1851654|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851671|NCT05141344|Melatonin|melatonin|mesh-list
1851672|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
1851673|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851674|NCT05141344|Protective Agents|protective agents|mesh-ancestor
1851675|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851676|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851715|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
1851716|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1851717|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1851718|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1851719|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1851720|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851721|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
1851722|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1851723|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851724|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1851725|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851726|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1851727|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
1851728|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851729|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1851730|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1851731|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851732|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851733|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1851734|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1851735|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
1851736|NCT05140941|Velpatasvir|velpatasvir|mesh-list
1851737|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
1851738|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851739|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
1851740|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
1851741|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
1851742|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851743|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851744|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
1851745|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851750|NCT05114460|Naloxone|naloxone|mesh-list
1851751|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1851752|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851753|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
1851754|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851755|NCT05111574|Nivolumab|nivolumab|mesh-list
1851756|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851757|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851758|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1851759|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851760|NCT05111314|Edetic Acid|edetic acid|mesh-list
1851761|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1851762|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
1851763|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
1851764|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851765|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
1851766|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1851767|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1851772|NCT05089175|Aspirin|aspirin|mesh-list
1851773|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1851774|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1851775|NCT05089175|Analgesics|analgesics|mesh-ancestor
1851776|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
1851777|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851778|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851779|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1851780|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1851781|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1851782|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1851783|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851784|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1851785|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1851786|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851787|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
1851796|NCT05075993|Paclitaxel|paclitaxel|mesh-list
1851797|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1851798|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
1851799|NCT05075993|Bevacizumab|bevacizumab|mesh-list
1851800|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1851801|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851802|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
1851803|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
1851804|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
1851805|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851806|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1851807|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
1851808|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851809|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1851810|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1851811|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
1851812|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1851813|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851814|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1851815|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1851816|NCT05075993|Growth Substances|growth substances|mesh-ancestor
1851817|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
1851818|NCT05066997|Dexamethasone|dexamethasone|mesh-list
1851819|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
1851820|NCT05066997|BB 1101|bb 1101|mesh-list
1851821|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1851822|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
1851823|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
1851824|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851825|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851826|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1851827|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
1851828|NCT05066997|Hormones|hormones|mesh-ancestor
1851829|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851830|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1851831|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851832|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
1851833|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851834|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851835|NCT05064449|Itraconazole|itraconazole|mesh-list
1851836|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
1851837|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
1851838|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1851839|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1851840|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1851841|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1851842|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851843|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1851844|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
1851845|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1851846|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851847|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1851848|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1851849|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1851850|NCT05064449|Analgesics|analgesics|mesh-ancestor
1851851|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
1851852|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851853|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1851854|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1851855|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1851856|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1851857|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851858|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851883|NCT05053334|Omalizumab|omalizumab|mesh-list
1851884|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1851885|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1851886|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
1851892|NCT05046639|Lidocaine|lidocaine|mesh-list
1851893|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
1851894|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
1851895|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851896|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851897|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
1851898|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851899|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1851900|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1851901|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1851902|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1851903|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851904|NCT05045066|Vitamin D|vitamin d|mesh-list
1851905|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
1851906|NCT05045066|Vitamins|vitamins|mesh-ancestor
1851907|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
1851908|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851909|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1851910|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1851935|NCT05033639|Melatonin|melatonin|mesh-list
1851936|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
1851937|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851938|NCT05033639|Protective Agents|protective agents|mesh-ancestor
1851939|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851940|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1851989|NCT04970355|Erenumab|erenumab|mesh-list
1851990|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1851991|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1851992|NCT04970355|Analgesics|analgesics|mesh-ancestor
1851993|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
1851994|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1851995|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1851996|NCT04963283|Nivolumab|nivolumab|mesh-list
1851997|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1851998|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1851999|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1852000|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852192|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
1852089|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1852090|NCT04931615|Thrombin|thrombin|mesh-list
1852091|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
1852092|NCT04931615|Coagulants|coagulants|mesh-ancestor
1852112|NCT04912921|Palmidrol|palmidrol|mesh-list
1852113|NCT04912921|Analgesics|analgesics|mesh-ancestor
1852114|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
1852115|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852116|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852117|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1852118|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1852119|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852120|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1852121|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
1852122|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1852123|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1852124|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1852125|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1852126|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852127|NCT04912921|Hormones|hormones|mesh-ancestor
1852128|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852193|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1852194|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852195|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1852196|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852214|NCT04870138|Azithromycin|azithromycin|mesh-list
1852215|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
1852216|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
1852217|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1852218|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1852219|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1852220|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1852221|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852222|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852223|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852224|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1852225|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1852260|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
1852261|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1852262|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852263|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1852264|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852265|NCT04789616|Maraviroc|maraviroc|mesh-list
1852266|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1852267|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1852268|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852269|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1852270|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1852271|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
1852272|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1852273|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1852407|NCT04729296|Golimumab|golimumab|mesh-list
1852408|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1852409|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852410|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1852411|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
1852412|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852421|NCT04686786|PF-06372865|pf-06372865|mesh-list
1852422|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
1852423|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
1852424|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1852425|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852426|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852479|NCT04649060|Dexamethasone|dexamethasone|mesh-list
1852480|NCT04649060|Melphalan|melphalan|mesh-list
1852481|NCT04649060|Daratumumab|daratumumab|mesh-list
1852482|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852483|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
1852484|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
1852485|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852486|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852487|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1852488|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
1852489|NCT04649060|Hormones|hormones|mesh-ancestor
1852490|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852491|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1852492|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852493|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1852494|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
1852495|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852496|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1852497|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1852498|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
1852499|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1852500|NCT04642352|Bupivacaine|bupivacaine|mesh-list
1852501|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
1852502|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
1852503|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1852504|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852505|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
1852506|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852507|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852508|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
1852509|NCT04642352|Hormones|hormones|mesh-ancestor
1852510|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852511|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1852512|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
1852513|NCT04641273|Pregabalin|pregabalin|mesh-list
1852514|NCT04641273|Analgesics|analgesics|mesh-ancestor
1852515|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
1852516|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852517|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852518|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
1852519|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1852520|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1852521|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852522|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1852523|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1852524|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1852525|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1852526|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1852544|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
1852545|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1852546|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1852584|NCT04628338|Interferons|interferons|mesh-list
1852585|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
1852586|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852587|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
1852588|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1852601|NCT04566328|Dexamethasone|dexamethasone|mesh-list
1852602|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
1852603|NCT04566328|Lenalidomide|lenalidomide|mesh-list
1852604|NCT04566328|Bortezomib|bortezomib|mesh-list
1852605|NCT04566328|Daratumumab|daratumumab|mesh-list
1852606|NCT04566328|Ichthammol|ichthammol|mesh-list
1852607|NCT04566328|BB 1101|bb 1101|mesh-list
1852608|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1852609|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852610|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
1852611|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
1852612|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852613|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852614|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1852615|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
1852616|NCT04566328|Hormones|hormones|mesh-ancestor
1852617|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852618|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1852619|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852620|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
1852621|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852622|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852623|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
1852624|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1852625|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1852626|NCT04566328|Growth Substances|growth substances|mesh-ancestor
1852627|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
1852628|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
1852645|NCT04558190|Ubiquinone|ubiquinone|mesh-list
1852646|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1852647|NCT04558190|Albuterol|albuterol|mesh-list
1852648|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1852649|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
1852650|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852651|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852652|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1852653|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
1852654|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
1852655|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1852656|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1852657|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1852658|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1852659|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
1852660|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1852661|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852662|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1852663|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1852664|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1852665|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
1852678|NCT04551365|Chitosan|chitosan|mesh-list
1852679|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1852680|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1852681|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
1852682|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852683|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1852684|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
1852685|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
1852686|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
1852687|NCT04551365|Coagulants|coagulants|mesh-ancestor
1852694|NCT04551300|Sevelamer|sevelamer|mesh-list
1852695|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
1852696|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
1852697|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852705|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
1852706|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1852707|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1852708|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852709|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1852729|NCT04535089|Lidocaine|lidocaine|mesh-list
1852730|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
1852731|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
1852732|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
1852733|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1852734|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852735|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
1852736|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852737|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1852738|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1852739|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1852740|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1852741|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852742|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1852743|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1852744|NCT04535089|Analgesics|analgesics|mesh-ancestor
1852745|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1852746|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1852747|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1852748|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
1852749|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1852754|NCT04529538|Vaccines|vaccines|mesh-list
1852755|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
1852756|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852762|NCT04476420|Betamethasone|betamethasone|mesh-list
1852763|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
1852764|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1852765|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
1852766|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1852767|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852768|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
1852769|NCT04476420|Hormones|hormones|mesh-ancestor
1852770|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852771|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852772|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1852773|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
1852774|NCT04469075|Clindamycin|clindamycin|mesh-list
1852775|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
1852776|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
1852777|NCT04469075|Triamcinolone|triamcinolone|mesh-list
1852778|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1852779|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1852780|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1852781|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852782|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
1852783|NCT04469075|Hormones|hormones|mesh-ancestor
1852784|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852785|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852786|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1852787|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
1852788|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852789|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852790|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1852791|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1852792|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1852793|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1852794|NCT04466475|Melphalan|melphalan|mesh-list
1852795|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
1852796|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1852797|NCT04466475|Daratumumab|daratumumab|mesh-list
1852798|NCT04466475|Antibodies|antibodies|mesh-list
1852799|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
1852800|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1852801|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
1852802|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852803|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852804|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1852805|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
1852806|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852807|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1852808|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1852809|NCT04464980|Naltrexone|naltrexone|mesh-list
1852810|NCT04464980|Buprenorphine|buprenorphine|mesh-list
1852811|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1852812|NCT04464980|Narcotics|narcotics|mesh-ancestor
1852813|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1852814|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852815|NCT04464980|Analgesics|analgesics|mesh-ancestor
1852816|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
1852817|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852818|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1852819|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1852820|NCT04462471|Vemurafenib|vemurafenib|mesh-list
1852821|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852822|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1852823|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852824|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852830|NCT04446117|Prednisone|prednisone|mesh-list
1852831|NCT04446117|Atezolizumab|atezolizumab|mesh-list
1852832|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
1852833|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852834|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
1852835|NCT04446117|Hormones|hormones|mesh-ancestor
1852836|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852837|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852838|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1852839|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852840|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1852841|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852842|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852843|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
1852844|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1852845|NCT04444869|Cisplatin|cisplatin|mesh-list
1852846|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852847|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
1852848|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1852849|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1852850|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
1852851|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1852856|NCT04410653|Afatinib|afatinib|mesh-list
1852857|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852858|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1852859|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852860|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852865|NCT04392505|Durvalumab|durvalumab|mesh-list
1852866|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1852867|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852904|NCT04374630|Paclitaxel|paclitaxel|mesh-list
1852905|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1852906|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852907|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
1852908|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
1852909|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
1852910|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852931|NCT04340193|Nivolumab|nivolumab|mesh-list
1852932|NCT04340193|Ipilimumab|ipilimumab|mesh-list
1852933|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1852934|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852935|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1852936|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852942|NCT04329325|Dexamethasone|dexamethasone|mesh-list
1852943|NCT04329325|Methotrexate|methotrexate|mesh-list
1852944|NCT04329325|Dasatinib|dasatinib|mesh-list
1852945|NCT04329325|Blinatumomab|blinatumomab|mesh-list
1852946|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1852947|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
1852948|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
1852949|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852950|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852951|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1852952|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
1852953|NCT04329325|Hormones|hormones|mesh-ancestor
1852954|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1852955|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1852956|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852957|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1852958|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
1852959|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1852960|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1852961|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
1852962|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852963|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
1852964|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852965|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1852966|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1852967|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
1852968|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1852969|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1852970|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1852971|NCT04308694|Methadone|methadone|mesh-list
1852972|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1852973|NCT04308694|Narcotics|narcotics|mesh-ancestor
1852974|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1852975|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1852976|NCT04308694|Analgesics|analgesics|mesh-ancestor
1852977|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
1852978|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1852979|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
1852980|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
1852981|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
1852982|NCT04305054|Lenvatinib|lenvatinib|mesh-list
1852983|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1852984|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852985|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1852986|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852987|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1852988|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
1852989|NCT04305041|Lenvatinib|lenvatinib|mesh-list
1852990|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1852991|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1852992|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1852993|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1852994|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853035|NCT04290624|Listerine|listerine|mesh-list
1853036|NCT04290624|Fluorides|fluorides|mesh-list
1853037|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
1853038|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
1853039|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
1853040|NCT04290624|Protective Agents|protective agents|mesh-ancestor
1853041|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853042|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1853043|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853068|NCT04265950|Vaccines|vaccines|mesh-list
1853069|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
1853070|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853071|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1853072|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
1853073|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1853074|NCT04223765|Fludarabine|fludarabine|mesh-list
1853075|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1853076|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
1853077|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853078|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1853079|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1853080|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
1853081|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853082|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853083|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1853084|NCT04218851|Posaconazole|posaconazole|mesh-list
1853085|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
1853086|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853087|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1853088|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1853089|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1853090|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1853091|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1853092|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853093|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853094|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1853095|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
1853096|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1853097|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853120|NCT04216524|Cytarabine|cytarabine|mesh-list
1853121|NCT04216524|Dexamethasone|dexamethasone|mesh-list
1853122|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
1853123|NCT04216524|Prednisone|prednisone|mesh-list
1853124|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
1853125|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1853126|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1853127|NCT04216524|Prednisolone|prednisolone|mesh-list
1853128|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
1853129|NCT04216524|Cortisone|cortisone|mesh-list
1853130|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
1853131|NCT04216524|Rituximab|rituximab|mesh-list
1853132|NCT04216524|Doxorubicin|doxorubicin|mesh-list
1853133|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1853134|NCT04216524|Methotrexate|methotrexate|mesh-list
1853135|NCT04216524|Vincristine|vincristine|mesh-list
1853136|NCT04216524|Daunorubicin|daunorubicin|mesh-list
1853137|NCT04216524|Venetoclax|venetoclax|mesh-list
1853138|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
1853139|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1853140|NCT04216524|Antibodies|antibodies|mesh-list
1853141|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
1853142|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1853143|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1853144|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
1853145|NCT04216524|BB 1101|bb 1101|mesh-list
1853146|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1853147|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
1853148|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853149|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1853150|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1853151|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
1853152|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853153|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853154|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1853155|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1853156|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
1853157|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
1853158|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853159|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1853160|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
1853161|NCT04216524|Hormones|hormones|mesh-ancestor
1853162|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1853163|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1853164|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
1853165|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853166|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1853167|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1853168|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1853169|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1853170|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
1853171|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1853172|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1853173|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
1853174|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
1853175|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1853176|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1853177|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
1853178|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853179|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1853180|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
1853181|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
1853182|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
1853183|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1853184|NCT04216524|Protective Agents|protective agents|mesh-ancestor
1853201|NCT04209114|Nivolumab|nivolumab|mesh-list
1853202|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853203|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853204|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1853205|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853219|NCT04187196|Propofol|propofol|mesh-list
1853220|NCT04187196|Methohexital|methohexital|mesh-list
1853221|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1853222|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1853223|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853224|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1853225|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
1853226|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
1853245|NCT04176705|Triamcinolone|triamcinolone|mesh-list
1853246|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1853247|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1853248|NCT04176705|Lidocaine|lidocaine|mesh-list
1853249|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1853250|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
1853251|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
1853252|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1853253|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853254|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
1853255|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853256|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1853257|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1853258|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1853259|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1853260|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853261|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1853262|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
1853263|NCT04176705|Hormones|hormones|mesh-ancestor
1853264|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1853265|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1853266|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
1853267|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853268|NCT04175613|Apremilast|apremilast|mesh-list
1853269|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1853270|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1853271|NCT04175613|Analgesics|analgesics|mesh-ancestor
1853272|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
1853273|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853274|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853275|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1853276|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1853277|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1853278|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1853279|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853280|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853281|NCT04174196|Lenalidomide|lenalidomide|mesh-list
1853282|NCT04174196|Cc-486|cc-486|mesh-list
1853283|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
1853284|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853285|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1853286|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1853287|NCT04174196|Growth Substances|growth substances|mesh-ancestor
1853288|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
1853289|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853290|NCT04171141|Bevacizumab|bevacizumab|mesh-list
1853291|NCT04171141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853292|NCT04171141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853293|NCT04171141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1853294|NCT04171141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1853295|NCT04171141|Growth Substances|growth substances|mesh-ancestor
1853296|NCT04171141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853297|NCT04171141|Growth Inhibitors|growth inhibitors|mesh-ancestor
1853320|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
1853321|NCT04109885|Promethazine|promethazine|mesh-list
1853322|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
1853323|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1853324|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1853325|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1853326|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853327|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
1853328|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
1853329|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
1853330|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853331|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
1853332|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
1853333|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1853334|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1853335|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
1853336|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
1853337|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1853416|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853338|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853339|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1853340|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
1853341|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
1853342|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1853343|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1853344|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1853345|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1853346|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
1853401|NCT04089553|Durvalumab|durvalumab|mesh-list
1853402|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853403|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853409|NCT04078737|Aspirin|aspirin|mesh-list
1853410|NCT04078737|Clopidogrel|clopidogrel|mesh-list
1853411|NCT04078737|Ticagrelor|ticagrelor|mesh-list
1853412|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1853413|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1853414|NCT04078737|Analgesics|analgesics|mesh-ancestor
1853415|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
1853417|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853418|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1853419|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1853420|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1853421|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1853422|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853423|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1853424|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1853425|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853426|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
1853427|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1853428|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1853429|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1853430|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
1853431|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1853436|NCT04058197|Deferoxamine|deferoxamine|mesh-list
1853437|NCT04058197|Siderophores|siderophores|mesh-ancestor
1853438|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1853439|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
1853440|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
1853441|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853464|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1853465|NCT03999411|Nicotine|nicotine|mesh-list
1853466|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
1853467|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853468|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1853469|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
1853470|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853471|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853472|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1853473|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1853474|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
1853475|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1853476|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853521|NCT03958981|Castor Oil|castor oil|mesh-list
1853522|NCT03958981|Cathartics|cathartics|mesh-ancestor
1853523|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1853532|NCT03946800|Durvalumab|durvalumab|mesh-list
1853533|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853534|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853535|NCT03937635|Dexamethasone|dexamethasone|mesh-list
1853536|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
1853537|NCT03937635|Lenalidomide|lenalidomide|mesh-list
1853538|NCT03937635|Daratumumab|daratumumab|mesh-list
1853539|NCT03937635|Ichthammol|ichthammol|mesh-list
1853540|NCT03937635|BB 1101|bb 1101|mesh-list
1853541|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1853542|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
1853543|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
1853544|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853545|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853546|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1853547|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
1853548|NCT03937635|Hormones|hormones|mesh-ancestor
1853549|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1853550|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1853551|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853552|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
1853553|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1853554|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1853555|NCT03937635|Growth Substances|growth substances|mesh-ancestor
1853556|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
1853557|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
1853558|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853559|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853560|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
1853657|NCT03908437|Buprenorphine|buprenorphine|mesh-list
1853658|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1853659|NCT03908437|Naloxone|naloxone|mesh-list
1853660|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1853661|NCT03908437|Narcotics|narcotics|mesh-ancestor
1853662|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1853663|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853664|NCT03908437|Analgesics|analgesics|mesh-ancestor
1853665|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
1853666|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1853667|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1853668|NCT03907969|AZD7648|azd7648|mesh-list
1853669|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1853670|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853671|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853704|NCT03892369|Ethanol|ethanol|mesh-list
1853705|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1853706|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853707|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1853708|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853709|NCT03878589|Oxytocin|oxytocin|mesh-list
1853710|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
1853711|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1853712|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853741|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
1853742|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853743|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853764|NCT03809429|Cetrorelix|cetrorelix|mesh-list
1853765|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1853766|NCT03809429|Hormones|hormones|mesh-ancestor
1853767|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1853768|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853769|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1853770|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
1853771|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1853772|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
1853773|NCT03803605|Vorinostat|vorinostat|mesh-list
1853774|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853775|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1853776|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853777|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853793|NCT03774394|Clopidogrel|clopidogrel|mesh-list
1853794|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1853795|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1853796|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1853797|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1853798|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
1853799|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1853800|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853801|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853802|NCT03770728|Metformin|metformin|mesh-list
1853803|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
1853804|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1853805|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853806|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1853807|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
1853808|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853817|NCT03737110|Rilonacept|rilonacept|mesh-list
1853818|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1853834|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
1853835|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1853836|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853840|NCT03687957|Temozolomide|temozolomide|mesh-list
1853841|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1853842|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
1853843|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853844|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853866|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
1853867|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853868|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853869|NCT03635489|Paclitaxel|paclitaxel|mesh-list
1853870|NCT03635489|Bevacizumab|bevacizumab|mesh-list
1853871|NCT03635489|Carboplatin|carboplatin|mesh-list
1853872|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1853873|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853874|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
1853875|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
1853876|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
1853877|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853878|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853879|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1853880|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1853881|NCT03635489|Growth Substances|growth substances|mesh-ancestor
1853882|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853883|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
1853950|NCT03542669|Doxorubicin|doxorubicin|mesh-list
1853951|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1853952|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853953|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1853954|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1853955|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853956|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853957|NCT03524235|Rituximab|rituximab|mesh-list
1853958|NCT03524235|Fludarabine|fludarabine|mesh-list
1853959|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1853960|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853961|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853962|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
1853963|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1853964|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1853965|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853966|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1853967|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
1853975|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
1853976|NCT03514901|Nivolumab|nivolumab|mesh-list
1853977|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1853978|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1853979|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1853980|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853987|NCT03471624|Tenofovir|tenofovir|mesh-list
1853988|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
1853989|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853990|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1853991|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1853992|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1853993|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1853994|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1853995|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1853996|NCT03462966|Rifaximin|rifaximin|mesh-list
1853997|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1853998|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1853999|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854000|NCT03462251|Paclitaxel|paclitaxel|mesh-list
1854001|NCT03462251|Bevacizumab|bevacizumab|mesh-list
1854002|NCT03462251|Capecitabine|capecitabine|mesh-list
1854003|NCT03462251|Fulvestrant|fulvestrant|mesh-list
1854004|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1854005|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1854006|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854007|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
1854008|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
1854009|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
1854010|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854011|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854012|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854013|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854014|NCT03462251|Growth Substances|growth substances|mesh-ancestor
1854015|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854016|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854017|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1854018|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
1854019|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1854020|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1854021|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1854022|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
1854023|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854024|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1854025|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854046|NCT03369197|Anesthetics|anesthetics|mesh-list
1854047|NCT03369197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1854048|NCT03369197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854049|NCT03338647|Doxorubicin|doxorubicin|mesh-list
1854050|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1854051|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854052|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1854053|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1854054|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854055|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854056|NCT03332095|Tenofovir|tenofovir|mesh-list
1854057|NCT03332095|Lamivudine|lamivudine|mesh-list
1854058|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1854059|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
1854060|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854061|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1854062|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1854063|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854064|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854065|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1854066|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
1854067|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854068|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854079|NCT03295396|TIC10 compound|tic10 compound|mesh-list
1854080|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854091|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
1854092|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1854093|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854130|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
1854131|NCT03220477|Guadecitabine|guadecitabine|mesh-list
1854132|NCT03220477|Mocetinostat|mocetinostat|mesh-list
1854133|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854134|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854135|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1854136|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854137|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854184|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
1854185|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854186|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854187|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1854188|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1854189|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
1854190|NCT03051516|Vaccines|vaccines|mesh-list
1854191|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
1854192|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854193|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1854194|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
1854195|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1854196|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
1854197|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854198|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854199|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854207|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1854208|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
1854209|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854210|NCT02894398|Letrozole|letrozole|mesh-list
1854211|NCT02894398|Fulvestrant|fulvestrant|mesh-list
1854212|NCT02894398|Palbociclib|palbociclib|mesh-list
1854213|NCT02894398|Anastrozole|anastrozole|mesh-list
1854214|NCT02894398|Exemestane|exemestane|mesh-list
1854215|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854216|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1854217|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1854218|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854219|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854220|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1854221|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
1854222|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854223|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854224|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1854225|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1854226|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1854227|NCT02852057|Timolol|timolol|mesh-list
1854228|NCT02852057|Dorzolamide|dorzolamide|mesh-list
1854229|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1854230|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1854231|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
1854232|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1854233|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854234|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854235|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1854236|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1854237|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854238|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1854245|NCT02734537|Cisplatin|cisplatin|mesh-list
1854246|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854247|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1854248|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1854249|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
1854250|NCT02710734|Doxorubicin|doxorubicin|mesh-list
1854251|NCT02710734|Methotrexate|methotrexate|mesh-list
1854252|NCT02710734|Mitomycins|mitomycins|mesh-list
1854253|NCT02710734|Mitomycin|mitomycin|mesh-list
1854254|NCT02710734|Vinblastine|vinblastine|mesh-list
1854255|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854256|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1854257|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1854258|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1854259|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854260|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854261|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1854262|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
1854263|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1854264|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854265|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1854266|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
1854267|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
1854268|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1854269|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854270|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
1854271|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1854272|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1854273|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
1854274|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1854275|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
1854276|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
1854277|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
1854278|NCT02611024|Irinotecan|irinotecan|mesh-list
1854279|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1854280|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1854281|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854282|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854283|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854317|NCT02564796|Iron|iron|mesh-list
1854318|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
1854319|NCT02564796|Trace Elements|trace elements|mesh-ancestor
1854320|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
1854321|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854322|NCT02564796|Hematinics|hematinics|mesh-ancestor
1854323|NCT02562716|Gemcitabine|gemcitabine|mesh-list
1854324|NCT02562716|Paclitaxel|paclitaxel|mesh-list
1854325|NCT02562716|Camptothecin|camptothecin|mesh-list
1854326|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1854327|NCT02562716|Fluorouracil|fluorouracil|mesh-list
1854328|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
1854329|NCT02562716|Irinotecan|irinotecan|mesh-list
1854330|NCT02562716|Pancrelipase|pancrelipase|mesh-list
1854331|NCT02562716|Pancreatin|pancreatin|mesh-list
1854332|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1854333|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854334|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
1854335|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
1854336|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
1854337|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854338|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1854339|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
1854340|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
1854341|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854342|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854343|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854344|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
1854345|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854346|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1854347|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1854348|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854349|NCT02558010|Morphine|morphine|mesh-list
1854350|NCT02558010|Methadone|methadone|mesh-list
1854351|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1854352|NCT02558010|Narcotics|narcotics|mesh-ancestor
1854353|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1854354|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854355|NCT02558010|Analgesics|analgesics|mesh-ancestor
1854356|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
1854357|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854358|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
1854359|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
1854360|NCT02525692|TIC10 compound|tic10 compound|mesh-list
1854361|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854373|NCT02502006|Celecoxib|celecoxib|mesh-list
1854374|NCT02502006|Naproxen|naproxen|mesh-list
1854375|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1854376|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1854377|NCT02502006|Analgesics|analgesics|mesh-ancestor
1854378|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
1854379|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854380|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854381|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854382|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1854383|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1854384|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1854385|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854386|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854387|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
1854388|NCT02481245|Bezafibrate|bezafibrate|mesh-list
1854389|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1854390|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
1854391|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854392|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1854393|NCT02477384|Propranolol|propranolol|mesh-list
1854394|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1854395|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1854396|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
1854397|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1854398|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854399|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854400|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1854401|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1854402|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
1854471|NCT02442349|Osimertinib|osimertinib|mesh-list
1854472|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854473|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1854474|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854475|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854476|NCT02427724|Lidocaine|lidocaine|mesh-list
1854477|NCT02427724|Tetracaine|tetracaine|mesh-list
1854478|NCT02427724|Prilocaine|prilocaine|mesh-list
1854479|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
1854480|NCT02427724|Anesthetics|anesthetics|mesh-list
1854481|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1854482|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854483|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
1854484|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854485|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1854486|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1854487|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1854488|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1854489|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854494|NCT02393794|Nivolumab|nivolumab|mesh-list
1854495|NCT02393794|Romidepsin|romidepsin|mesh-list
1854496|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1854497|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854498|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854499|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1854500|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854501|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1854502|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854503|NCT02343042|Clarithromycin|clarithromycin|mesh-list
1854504|NCT02343042|Dexamethasone|dexamethasone|mesh-list
1854505|NCT02343042|Lenalidomide|lenalidomide|mesh-list
1854506|NCT02343042|Bortezomib|bortezomib|mesh-list
1854507|NCT02343042|Daratumumab|daratumumab|mesh-list
1854508|NCT02343042|Pomalidomide|pomalidomide|mesh-list
1854509|NCT02343042|Ixazomib|ixazomib|mesh-list
1854510|NCT02343042|Elotuzumab|elotuzumab|mesh-list
1854511|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854512|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
1854513|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
1854514|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854515|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854516|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854517|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
1854518|NCT02343042|Hormones|hormones|mesh-ancestor
1854519|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854520|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1854521|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854522|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
1854523|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854524|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854525|NCT02343042|Growth Substances|growth substances|mesh-ancestor
1854526|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854527|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1854528|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854529|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1854530|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854531|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854532|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1854533|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1854534|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
1854551|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
1854552|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1854553|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854554|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854555|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1854556|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854557|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854609|NCT02163733|Osimertinib|osimertinib|mesh-list
1854610|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854611|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1854612|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854613|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854650|NCT02094261|Osimertinib|osimertinib|mesh-list
1854651|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854652|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1854653|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854654|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854655|NCT02047513|Gemcitabine|gemcitabine|mesh-list
1854656|NCT02047513|Paclitaxel|paclitaxel|mesh-list
1854657|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1854658|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1854659|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854660|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
1854661|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
1854662|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
1854663|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854664|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1854665|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
1854666|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
1854667|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854668|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854669|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854670|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
1854671|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854672|NCT02043847|Melphalan|melphalan|mesh-list
1854673|NCT02043847|Lenograstim|lenograstim|mesh-list
1854674|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1854675|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
1854676|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854677|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1854678|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
1854679|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854680|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854681|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1854682|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854683|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
1854684|NCT01976286|Salicylates|salicylates|mesh-list
1854685|NCT01976286|Glycolic acid|glycolic acid|mesh-list
1854686|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854687|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
1854688|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
1854689|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
1854690|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1854691|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1854692|NCT01976286|Analgesics|analgesics|mesh-ancestor
1854693|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
1854694|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854695|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854696|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854697|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1854698|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1854699|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854700|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854724|NCT01775644|Bevacizumab|bevacizumab|mesh-list
1854725|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854726|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854727|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854728|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854729|NCT01775644|Growth Substances|growth substances|mesh-ancestor
1854730|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854731|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854732|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
1854733|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1854734|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1854735|NCT01496976|Prednisolone|prednisolone|mesh-list
1854736|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
1854737|NCT01496976|Lenalidomide|lenalidomide|mesh-list
1854738|NCT01496976|Ofatumumab|ofatumumab|mesh-list
1854739|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1854740|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
1854741|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
1854742|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854743|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854744|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854745|NCT01496976|Growth Substances|growth substances|mesh-ancestor
1854746|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854747|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854748|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854749|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
1854750|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
1854751|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854752|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854753|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
1854754|NCT01496976|Hormones|hormones|mesh-ancestor
1854755|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854756|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1854757|NCT01496976|Protective Agents|protective agents|mesh-ancestor
1854758|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1854759|NCT01472081|Nivolumab|nivolumab|mesh-list
1854760|NCT01472081|Ipilimumab|ipilimumab|mesh-list
1854761|NCT01472081|Sunitinib|sunitinib|mesh-list
1854762|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854763|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854764|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1854765|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854766|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854767|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854768|NCT01472081|Growth Substances|growth substances|mesh-ancestor
1854769|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854770|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854771|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1854772|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854773|NCT01367002|Paclitaxel|paclitaxel|mesh-list
1854774|NCT01367002|Carboplatin|carboplatin|mesh-list
1854775|NCT01367002|Trastuzumab|trastuzumab|mesh-list
1854776|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1854777|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854778|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
1854779|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
1854780|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
1854781|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854782|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1854783|NCT01309672|Prednisone|prednisone|mesh-list
1854784|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
1854785|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854786|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
1854787|NCT01309672|Hormones|hormones|mesh-ancestor
1854788|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854789|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854790|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1854791|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854792|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1854793|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854794|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854795|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
1854796|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1854797|NCT01131169|Vidarabine|vidarabine|mesh-list
1854798|NCT01131169|Fludarabine|fludarabine|mesh-list
1854799|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
1854800|NCT01131169|Melphalan|melphalan|mesh-list
1854801|NCT01131169|Busulfan|busulfan|mesh-list
1854802|NCT01131169|Lenograstim|lenograstim|mesh-list
1854803|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854804|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1854805|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
1854806|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854807|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854808|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
1854809|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854810|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
1854811|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854812|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1854813|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
1854814|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1854815|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1854816|NCT00882505|Vitamin D|vitamin d|mesh-list
1854817|NCT00882505|Vitamins|vitamins|mesh-ancestor
1854818|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
1854819|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854820|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1854821|NCT00871013|Thalidomide|thalidomide|mesh-list
1854822|NCT00871013|Dexamethasone|dexamethasone|mesh-list
1854823|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
1854824|NCT00871013|Melphalan|melphalan|mesh-list
1854825|NCT00871013|Doxorubicin|doxorubicin|mesh-list
1854826|NCT00871013|Etoposide|etoposide|mesh-list
1854827|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1854828|NCT00871013|Bortezomib|bortezomib|mesh-list
1854829|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854830|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
1854831|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854832|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1854833|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1854834|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
1854835|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854836|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854837|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1854838|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854839|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
1854840|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
1854841|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854842|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854843|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
1854844|NCT00871013|Hormones|hormones|mesh-ancestor
1854845|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854846|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1854847|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1854848|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1854849|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1854850|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1854851|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1854852|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
1854853|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1854854|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854855|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854856|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854857|NCT00871013|Growth Substances|growth substances|mesh-ancestor
1854858|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854859|NCT00774345|Lenalidomide|lenalidomide|mesh-list
1854860|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
1854861|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854862|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1854863|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1854864|NCT00774345|Growth Substances|growth substances|mesh-ancestor
1854865|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
1854866|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854867|NCT00735657|Iodine|iodine|mesh-list
1854868|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1854869|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1854870|NCT00735657|Trace Elements|trace elements|mesh-ancestor
1854871|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
1854872|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854940|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
1854941|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
1854942|NCT00258427|Busulfan|busulfan|mesh-list
1854943|NCT00258427|Fludarabine|fludarabine|mesh-list
1854944|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
1854945|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1854946|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1854947|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
1854948|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854949|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1854950|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1854951|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
1854952|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1854953|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1854954|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1854955|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1854956|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
1854957|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854958|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
1854959|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
1854960|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854961|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1854962|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
1854963|NCT00258427|Hormones|hormones|mesh-ancestor
1854964|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854965|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1854966|NCT00258427|Protective Agents|protective agents|mesh-ancestor
1854967|NCT00250341|Beclomethasone|beclomethasone|mesh-list
1854968|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1854969|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1854970|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
1854971|NCT00250341|Hormones|hormones|mesh-ancestor
1854972|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1854973|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854974|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1854975|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
1854976|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1854977|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
1854978|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854979|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
1854987|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
1854988|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1854989|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1854990|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1854991|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1854992|NCT03723538|Analgesics|analgesics|mesh-ancestor
1854993|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
1854994|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1854995|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1854996|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1854997|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1854998|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
1854999|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1855000|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855010|NCT00000102|Nifedipine|nifedipine|mesh-list
1855011|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1855012|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855013|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855014|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855015|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855016|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
1855017|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
1855018|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855019|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
1855020|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1855021|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1855022|NCT00000134|Ganciclovir|ganciclovir|mesh-list
1855023|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1855024|NCT00000134|Foscarnet|foscarnet|mesh-list
1855025|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
1855026|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855027|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855028|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855029|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855030|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1855031|NCT00000136|Ganciclovir|ganciclovir|mesh-list
1855032|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1855033|NCT00000136|Foscarnet|foscarnet|mesh-list
1855034|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
1855035|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855036|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855037|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855038|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855039|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1855040|NCT00000142|Cidofovir|cidofovir|mesh-list
1855041|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
1855042|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855043|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855044|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855045|NCT00000143|Ganciclovir|ganciclovir|mesh-list
1855046|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1855047|NCT00000143|Cidofovir|cidofovir|mesh-list
1855048|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
1855049|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855050|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855051|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855052|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855053|NCT00000371|Cycloserine|cycloserine|mesh-list
1855054|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1855055|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855056|NCT00000371|Renal Agents|renal agents|mesh-ancestor
1855057|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1855058|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
1855059|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1855060|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
1855061|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855062|NCT00000378|Sertraline|sertraline|mesh-list
1855063|NCT00000378|Nortriptyline|nortriptyline|mesh-list
1855064|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
1855065|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1855066|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1855067|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1855068|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855069|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855070|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1855071|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
1855072|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855073|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1855074|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1855075|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
1855076|NCT00000479|Aspirin|aspirin|mesh-list
1855077|NCT00000479|Vitamin E|vitamin e|mesh-list
1855078|NCT00000479|Vitamins|vitamins|mesh-ancestor
1855079|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
1855080|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855081|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1855082|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855083|NCT00000479|Analgesics|analgesics|mesh-ancestor
1855084|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
1855085|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855086|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855087|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855088|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1855089|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1855090|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855091|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1855092|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1855093|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855094|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
1855095|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
1855096|NCT00000479|Protective Agents|protective agents|mesh-ancestor
1855097|NCT00000575|Nedocromil|nedocromil|mesh-list
1855098|NCT00000575|Budesonide|budesonide|mesh-list
1855099|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855100|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1855101|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
1855102|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855103|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855104|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1855105|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
1855106|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
1855107|NCT00000575|Hormones|hormones|mesh-ancestor
1855108|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855109|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1855110|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
1855111|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1855112|NCT00000620|Insulin|insulin|mesh-list
1855113|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1855114|NCT00000620|Metformin|metformin|mesh-list
1855115|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
1855116|NCT00000620|Pioglitazone|pioglitazone|mesh-list
1855117|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
1855118|NCT00000620|Glimepiride|glimepiride|mesh-list
1855119|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
1855120|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
1855121|NCT00000620|Acarbose|acarbose|mesh-list
1855122|NCT00000620|Repaglinide|repaglinide|mesh-list
1855123|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1855124|NCT00000620|Metoprolol|metoprolol|mesh-list
1855125|NCT00000620|Felodipine|felodipine|mesh-list
1855126|NCT00000620|Amlodipine|amlodipine|mesh-list
1855127|NCT00000620|Valsartan|valsartan|mesh-list
1855128|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1855129|NCT00000620|Carvedilol|carvedilol|mesh-list
1855130|NCT00000620|Candesartan|candesartan|mesh-list
1855131|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
1855132|NCT00000620|Lisinopril|lisinopril|mesh-list
1855133|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
1855134|NCT00000620|Diltiazem|diltiazem|mesh-list
1855135|NCT00000620|Benazepril|benazepril|mesh-list
1855136|NCT00000620|Hydralazine|hydralazine|mesh-list
1855137|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
1855138|NCT00000620|Reserpine|reserpine|mesh-list
1855139|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
1855140|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
1855141|NCT00000620|Triamterene|triamterene|mesh-list
1855142|NCT00000620|Furosemide|furosemide|mesh-list
1855143|NCT00000620|Simvastatin|simvastatin|mesh-list
1855144|NCT00000620|Fenofibrate|fenofibrate|mesh-list
1855145|NCT00000620|Terazosin|terazosin|mesh-list
1855146|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855147|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1855148|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855149|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855150|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855151|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
1855152|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1855153|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1855154|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
1855155|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1855156|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1855157|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855158|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1855159|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1855160|NCT00000620|Diuretics|diuretics|mesh-ancestor
1855161|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
1855162|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1855163|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1855164|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855165|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
1855166|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
1855167|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
1855168|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855169|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1855170|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1855171|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1855172|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
1855173|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1855174|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1855175|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
1855176|NCT00000620|Protective Agents|protective agents|mesh-ancestor
1855177|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1855178|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1855179|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1855180|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
1855181|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1855182|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1855183|NCT00000620|Urological Agents|urological agents|mesh-ancestor
1855184|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1855185|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1855186|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1855187|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1855188|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1855189|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1855190|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1855191|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1855192|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1855193|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
1855194|NCT00001151|Calcitriol|calcitriol|mesh-list
1855195|NCT00001151|Vitamins|vitamins|mesh-ancestor
1855196|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
1855197|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855198|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1855199|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855200|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1855201|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855202|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855203|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1855204|NCT00001213|Cysteamine|cysteamine|mesh-list
1855205|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1855206|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855207|NCT00001262|Copper|copper|mesh-list
1855208|NCT00001262|Trace Elements|trace elements|mesh-ancestor
1855209|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
1855210|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855211|NCT00001304|Vitamin D|vitamin d|mesh-list
1855212|NCT00001304|Calcitriol|calcitriol|mesh-list
1855213|NCT00001304|Calcium|calcium|mesh-list
1855214|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
1855215|NCT00001304|Hormones|hormones|mesh-list
1855216|NCT00001304|Vitamins|vitamins|mesh-ancestor
1855217|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
1855218|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855219|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855220|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1855221|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855222|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1855223|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855224|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855225|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1855226|NCT00001566|Indinavir|indinavir|mesh-list
1855227|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1855228|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1855229|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
1855230|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855231|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855232|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1855233|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1855234|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
1855235|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855236|NCT00001575|Edetic Acid|edetic acid|mesh-list
1855237|NCT00001575|Calcium|calcium|mesh-list
1855238|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
1855239|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855240|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855241|NCT00001575|Antidotes|antidotes|mesh-ancestor
1855242|NCT00001575|Protective Agents|protective agents|mesh-ancestor
1855243|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
1855244|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
1855245|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855246|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1855247|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
1855248|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1855249|NCT00001586|Vidarabine|vidarabine|mesh-list
1855250|NCT00001586|Rituximab|rituximab|mesh-list
1855251|NCT00001586|Fludarabine|fludarabine|mesh-list
1855252|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
1855253|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1855254|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855255|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
1855256|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855257|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855258|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855259|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
1855260|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855261|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855262|NCT00001586|Antiviral Agents|antiviral agents|mesh-ancestor
1855263|NCT00001586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855264|NCT00001596|Pirfenidone|pirfenidone|mesh-list
1855265|NCT00001596|Analgesics|analgesics|mesh-ancestor
1855266|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
1855267|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855268|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855269|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1855270|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855271|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855272|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855273|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855274|NCT00001656|Olanzapine|olanzapine|mesh-list
1855275|NCT00001656|Clozapine|clozapine|mesh-list
1855276|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
1855277|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
1855278|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855279|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855280|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1855281|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1855282|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1855283|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1855284|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1855285|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1855286|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1855287|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855288|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855289|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1855290|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
1855291|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1855292|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
1855293|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
1855294|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
1855295|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1855296|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
1855297|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855298|NCT00001723|Orlistat|orlistat|mesh-list
1855299|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855300|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855301|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1855302|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1855303|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
1855304|NCT00001832|Fludarabine|fludarabine|mesh-list
1855305|NCT00001832|Interleukin-2|interleukin-2|mesh-list
1855306|NCT00001832|Sargramostim|sargramostim|mesh-list
1855307|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855308|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
1855309|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855310|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855311|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855312|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
1855313|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855314|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855315|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855316|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855317|NCT00001832|Analgesics|analgesics|mesh-ancestor
1855318|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
1855319|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855320|NCT00001849|Edetic Acid|edetic acid|mesh-list
1855321|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
1855322|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855323|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855324|NCT00001849|Antidotes|antidotes|mesh-ancestor
1855325|NCT00001849|Protective Agents|protective agents|mesh-ancestor
1855326|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
1855327|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
1855328|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1855329|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
1855330|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1855331|NCT00001880|Cyclosporine|cyclosporine|mesh-list
1855332|NCT00001880|Methotrexate|methotrexate|mesh-list
1855333|NCT00001880|Cyclosporins|cyclosporins|mesh-list
1855334|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1855335|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
1855336|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855337|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855338|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855339|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
1855340|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855341|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855342|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
1855343|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855344|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1855345|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855346|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
1855347|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855348|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855349|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
1855350|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855351|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1855352|NCT00001941|Daclizumab|daclizumab|mesh-list
1855353|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855354|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
1855355|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855356|NCT00001959|Pirfenidone|pirfenidone|mesh-list
1855357|NCT00001959|Analgesics|analgesics|mesh-ancestor
1855358|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
1855359|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855360|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855361|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1855362|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855363|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855364|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855365|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855366|NCT00001962|Daclizumab|daclizumab|mesh-list
1855367|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855368|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
1855369|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855370|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
1855371|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1855372|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855373|NCT00002525|Leucovorin|leucovorin|mesh-list
1855374|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
1855375|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
1855376|NCT00002525|Fluorouracil|fluorouracil|mesh-list
1855377|NCT00002525|Calcium|calcium|mesh-list
1855378|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
1855379|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855380|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855381|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
1855382|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855383|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855384|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855385|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855386|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
1855387|NCT00002525|Antidotes|antidotes|mesh-ancestor
1855388|NCT00002525|Protective Agents|protective agents|mesh-ancestor
1855389|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
1855390|NCT00002525|Vitamins|vitamins|mesh-ancestor
1855391|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
1855392|NCT00002558|Paclitaxel|paclitaxel|mesh-list
1855393|NCT00002558|Etoposide|etoposide|mesh-list
1855394|NCT00002558|Carboplatin|carboplatin|mesh-list
1855395|NCT00002558|Ifosfamide|ifosfamide|mesh-list
1855396|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855397|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855398|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855399|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855400|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855401|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855402|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855403|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855404|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855405|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855406|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
1855407|NCT00002597|Leuprolide|leuprolide|mesh-list
1855408|NCT00002597|Goserelin|goserelin|mesh-list
1855409|NCT00002597|Flutamide|flutamide|mesh-list
1855410|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1855411|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
1855412|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855413|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855414|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855415|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855416|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
1855417|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
1855418|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855419|NCT00002601|Doxorubicin|doxorubicin|mesh-list
1855420|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855421|NCT00002601|Melphalan|melphalan|mesh-list
1855422|NCT00002601|Ifosfamide|ifosfamide|mesh-list
1855423|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855424|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855425|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855426|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855427|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855428|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855429|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
1855430|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855431|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855432|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
1855433|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855434|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855435|NCT00002651|Goserelin|goserelin|mesh-list
1855436|NCT00002651|Bicalutamide|bicalutamide|mesh-list
1855437|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855438|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855439|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
1855440|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
1855441|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855442|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855443|NCT00002766|Cytarabine|cytarabine|mesh-list
1855444|NCT00002766|Dactinomycin|dactinomycin|mesh-list
1855445|NCT00002766|Prednisone|prednisone|mesh-list
1855446|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
1855447|NCT00002766|Carmustine|carmustine|mesh-list
1855448|NCT00002766|Doxorubicin|doxorubicin|mesh-list
1855449|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855450|NCT00002766|Methotrexate|methotrexate|mesh-list
1855451|NCT00002766|Etoposide|etoposide|mesh-list
1855452|NCT00002766|Vincristine|vincristine|mesh-list
1855453|NCT00002766|Daunorubicin|daunorubicin|mesh-list
1855454|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
1855455|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
1855456|NCT00002766|Pegaspargase|pegaspargase|mesh-list
1855457|NCT00002766|Sargramostim|sargramostim|mesh-list
1855458|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855459|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
1855460|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855461|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855462|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855463|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
1855464|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855465|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855466|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855467|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855468|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855469|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855470|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855471|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855472|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
1855473|NCT00002766|Hormones|hormones|mesh-ancestor
1855474|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855475|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855476|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1855477|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
1855478|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855479|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855480|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
1855481|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
1855482|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1855483|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855484|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855485|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
1855486|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855487|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855488|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855489|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855490|NCT00002766|Analgesics|analgesics|mesh-ancestor
1855491|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
1855492|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855493|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1855494|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1855495|NCT00002842|Leucovorin|leucovorin|mesh-list
1855496|NCT00002842|Fluorouracil|fluorouracil|mesh-list
1855497|NCT00002842|Floxuridine|floxuridine|mesh-list
1855498|NCT00002842|Calcium|calcium|mesh-list
1855499|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
1855500|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855501|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855502|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
1855503|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855504|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855505|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855506|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855507|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
1855508|NCT00002842|Antidotes|antidotes|mesh-ancestor
1855509|NCT00002842|Protective Agents|protective agents|mesh-ancestor
1855510|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
1855511|NCT00002842|Vitamins|vitamins|mesh-ancestor
1855512|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
1855513|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
1855514|NCT00002850|Ofloxacin|ofloxacin|mesh-list
1855515|NCT00002850|Trimethoprim|trimethoprim|mesh-list
1855516|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
1855517|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1855518|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855519|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855520|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855521|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855522|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855523|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855524|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1855525|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1855526|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1855527|NCT00002850|Renal Agents|renal agents|mesh-ancestor
1855528|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
1855529|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1855530|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1855531|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1855532|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1855533|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1855534|NCT00002874|Bicalutamide|bicalutamide|mesh-list
1855535|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
1855536|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
1855537|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855538|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855539|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855540|NCT00002931|Paclitaxel|paclitaxel|mesh-list
1855541|NCT00002931|Etoposide|etoposide|mesh-list
1855542|NCT00002931|Carboplatin|carboplatin|mesh-list
1855543|NCT00002931|Ifosfamide|ifosfamide|mesh-list
1855544|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855545|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855546|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855547|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855548|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855549|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855550|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855551|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855552|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855553|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855554|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
1855555|NCT00003042|Tamoxifen|tamoxifen|mesh-list
1855556|NCT00003042|Paclitaxel|paclitaxel|mesh-list
1855557|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
1855558|NCT00003042|Doxorubicin|doxorubicin|mesh-list
1855559|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855560|NCT00003042|Melphalan|melphalan|mesh-list
1855561|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855562|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855563|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855564|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855565|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855566|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855567|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855568|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
1855569|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855570|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855571|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855572|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
1855573|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855574|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855575|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855576|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855577|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855578|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1855579|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
1855580|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855581|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855582|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1855583|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1855584|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1855585|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
1855586|NCT00003138|Lenograstim|lenograstim|mesh-list
1855587|NCT00003138|Sargramostim|sargramostim|mesh-list
1855588|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1855589|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
1855590|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855591|NCT00003138|Hematinics|hematinics|mesh-ancestor
1855592|NCT00003199|Tamoxifen|tamoxifen|mesh-list
1855593|NCT00003199|Aldesleukin|aldesleukin|mesh-list
1855594|NCT00003199|Melphalan|melphalan|mesh-list
1855595|NCT00003199|Busulfan|busulfan|mesh-list
1855596|NCT00003199|Thiotepa|thiotepa|mesh-list
1855597|NCT00003199|Interleukin-2|interleukin-2|mesh-list
1855598|NCT00003199|Sargramostim|sargramostim|mesh-list
1855599|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855600|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855601|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
1855602|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855603|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855604|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855605|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
1855606|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855607|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855608|NCT00003199|Analgesics|analgesics|mesh-ancestor
1855609|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
1855610|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855611|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1855612|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
1855613|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855614|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855615|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1855616|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1855617|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1855618|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1855619|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1855620|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
1855621|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855622|NCT00003222|Aldesleukin|aldesleukin|mesh-list
1855623|NCT00003222|Interleukin-2|interleukin-2|mesh-list
1855624|NCT00003222|Sargramostim|sargramostim|mesh-list
1855625|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
1855626|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855627|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855628|NCT00003222|Analgesics|analgesics|mesh-ancestor
1855629|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
1855630|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855631|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855632|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
1855633|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1855634|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1855635|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
1855636|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855637|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1855638|NCT00003224|Vaccines|vaccines|mesh-list
1855639|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
1855640|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
1855641|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855642|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1855643|NCT00003270|Cyclosporine|cyclosporine|mesh-list
1855644|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
1855645|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
1855646|NCT00003270|Busulfan|busulfan|mesh-list
1855647|NCT00003270|Cyclosporins|cyclosporins|mesh-list
1855648|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1855649|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855650|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
1855651|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855652|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855653|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855654|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
1855655|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855656|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855657|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855658|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855659|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
1855660|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855661|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
1855662|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1855663|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855664|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
1855665|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
1855666|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855667|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1855668|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
1855669|NCT00003270|Hormones|hormones|mesh-ancestor
1855670|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855671|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1855672|NCT00003270|Protective Agents|protective agents|mesh-ancestor
1855673|NCT00003298|Leucovorin|leucovorin|mesh-list
1855674|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
1855675|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
1855676|NCT00003298|Paclitaxel|paclitaxel|mesh-list
1855677|NCT00003298|Cisplatin|cisplatin|mesh-list
1855678|NCT00003298|Fluorouracil|fluorouracil|mesh-list
1855679|NCT00003298|Calcium|calcium|mesh-list
1855680|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
1855681|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855682|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855683|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855684|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855685|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855686|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855687|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855688|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855689|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
1855690|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855691|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855692|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
1855693|NCT00003298|Antidotes|antidotes|mesh-ancestor
1855694|NCT00003298|Protective Agents|protective agents|mesh-ancestor
1855695|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
1855696|NCT00003298|Vitamins|vitamins|mesh-ancestor
1855697|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
1855698|NCT00003377|Paclitaxel|paclitaxel|mesh-list
1855699|NCT00003377|Cisplatin|cisplatin|mesh-list
1855700|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855701|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855702|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855703|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855704|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855705|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855706|NCT00003389|Prednisone|prednisone|mesh-list
1855707|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
1855708|NCT00003389|Dacarbazine|dacarbazine|mesh-list
1855709|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
1855710|NCT00003389|Doxorubicin|doxorubicin|mesh-list
1855711|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855712|NCT00003389|Etoposide|etoposide|mesh-list
1855713|NCT00003389|Vincristine|vincristine|mesh-list
1855714|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
1855715|NCT00003389|Bleomycin|bleomycin|mesh-list
1855716|NCT00003389|Vinblastine|vinblastine|mesh-list
1855717|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
1855718|NCT00003389|Imidazole|imidazole|mesh-list
1855719|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855720|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
1855721|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855722|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855723|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855724|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
1855725|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855726|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855727|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855728|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855729|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855730|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855731|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855732|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855733|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
1855734|NCT00003389|Hormones|hormones|mesh-ancestor
1855735|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855736|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855737|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855738|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855739|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855740|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855741|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
1855742|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
1855743|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
1855744|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855745|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
1855746|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855747|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855748|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855749|NCT00003631|Cytarabine|cytarabine|mesh-list
1855750|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
1855751|NCT00003631|Melphalan|melphalan|mesh-list
1855752|NCT00003631|Ifosfamide|ifosfamide|mesh-list
1855753|NCT00003631|Carmustine|carmustine|mesh-list
1855754|NCT00003631|Carboplatin|carboplatin|mesh-list
1855755|NCT00003631|Etoposide|etoposide|mesh-list
1855756|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855757|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
1855758|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855759|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855760|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855761|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
1855762|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855763|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855764|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855765|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855766|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855767|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855768|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855769|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855770|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
1855771|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
1855772|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855773|NCT00003641|Interferons|interferons|mesh-list
1855774|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
1855775|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
1855776|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855777|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
1855778|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855779|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
1855780|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855781|NCT00003644|Paclitaxel|paclitaxel|mesh-list
1855782|NCT00003644|Carboplatin|carboplatin|mesh-list
1855783|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855784|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855785|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855786|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855787|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855788|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855789|NCT00003645|Leuprolide|leuprolide|mesh-list
1855790|NCT00003645|Goserelin|goserelin|mesh-list
1855791|NCT00003645|Flutamide|flutamide|mesh-list
1855792|NCT00003645|Bicalutamide|bicalutamide|mesh-list
1855793|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1855794|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
1855795|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855796|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855797|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855798|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855799|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
1855800|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
1855801|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855802|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
1855803|NCT00003659|Rituximab|rituximab|mesh-list
1855804|NCT00003659|Fludarabine|fludarabine|mesh-list
1855805|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
1855806|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855807|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
1855808|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855809|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855810|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855811|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
1855812|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855813|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855814|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855815|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1855816|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855817|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
1855818|NCT00003702|Dactinomycin|dactinomycin|mesh-list
1855819|NCT00003702|Cactinomycin|cactinomycin|mesh-list
1855820|NCT00003702|Methotrexate|methotrexate|mesh-list
1855821|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1855822|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
1855823|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855824|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855825|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855826|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
1855827|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855828|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855829|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
1855830|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855831|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1855832|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855833|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
1855834|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855835|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855836|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1855837|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855838|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855839|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1855840|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
1855841|NCT00003782|Docetaxel|docetaxel|mesh-list
1855842|NCT00003782|Doxorubicin|doxorubicin|mesh-list
1855843|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855844|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
1855845|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855846|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855847|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855848|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
1855849|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855850|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855851|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855852|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855853|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855854|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855855|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855856|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855857|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855858|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855859|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
1855860|NCT00003816|Melphalan|melphalan|mesh-list
1855861|NCT00003816|Busulfan|busulfan|mesh-list
1855862|NCT00003816|Thiotepa|thiotepa|mesh-list
1855863|NCT00003816|Carboplatin|carboplatin|mesh-list
1855864|NCT00003816|Fludarabine|fludarabine|mesh-list
1855865|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
1855866|NCT00003816|Etoposide|etoposide|mesh-list
1855867|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1855868|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855869|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
1855870|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855871|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855872|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855873|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
1855874|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855875|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855876|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855877|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855878|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
1855879|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855880|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855881|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855882|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855883|NCT00003820|Rituximab|rituximab|mesh-list
1855884|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1855885|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855886|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
1855887|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855888|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855889|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
1855890|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855891|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1855892|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1855893|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855894|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1855895|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855896|NCT00003875|Aldesleukin|aldesleukin|mesh-list
1855897|NCT00003875|Etoposide|etoposide|mesh-list
1855898|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
1855899|NCT00003875|Busulfan|busulfan|mesh-list
1855900|NCT00003875|Interleukin-2|interleukin-2|mesh-list
1855901|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855902|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855903|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855904|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855905|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855906|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855907|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
1855908|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855909|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
1855910|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855911|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855912|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855913|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1855914|NCT00003875|Analgesics|analgesics|mesh-ancestor
1855915|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
1855916|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1855917|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1855918|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1855919|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
1855920|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1855921|NCT00003896|Paclitaxel|paclitaxel|mesh-list
1855922|NCT00003896|Doxorubicin|doxorubicin|mesh-list
1855923|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855924|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1855925|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855926|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
1855927|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
1855928|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
1855929|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855930|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855931|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855932|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855933|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855934|NCT00003907|Cisplatin|cisplatin|mesh-list
1855935|NCT00003907|Doxorubicin|doxorubicin|mesh-list
1855936|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855937|NCT00003907|Mitomycins|mitomycins|mesh-list
1855938|NCT00003907|Mitomycin|mitomycin|mesh-list
1855939|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855940|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855941|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855942|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855943|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855944|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855945|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
1855946|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855947|NCT00003910|Prednisone|prednisone|mesh-list
1855948|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
1855949|NCT00003910|Methotrexate|methotrexate|mesh-list
1855950|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855951|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
1855952|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855953|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855954|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855955|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
1855956|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855957|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855958|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855959|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855960|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
1855961|NCT00003910|Hormones|hormones|mesh-ancestor
1855962|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855963|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1855964|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1855965|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
1855966|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1855967|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1855968|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
1855969|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
1855970|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855971|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1855972|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1855973|NCT00004031|Prednisone|prednisone|mesh-list
1855974|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
1855975|NCT00004031|Carmustine|carmustine|mesh-list
1855976|NCT00004031|Rituximab|rituximab|mesh-list
1855977|NCT00004031|Doxorubicin|doxorubicin|mesh-list
1855978|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1855979|NCT00004031|Etoposide|etoposide|mesh-list
1855980|NCT00004031|Vincristine|vincristine|mesh-list
1855981|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1855982|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
1855983|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1855984|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1855985|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1855986|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
1855987|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1855988|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1855989|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1855990|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1855991|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1855992|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1855993|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1855994|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1855995|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1855996|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
1855997|NCT00004031|Hormones|hormones|mesh-ancestor
1855998|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1855999|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856000|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856001|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856002|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856003|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856004|NCT00004054|Paclitaxel|paclitaxel|mesh-list
1856005|NCT00004054|Etoposide|etoposide|mesh-list
1856006|NCT00004054|Bicalutamide|bicalutamide|mesh-list
1856007|NCT00004054|Flutamide|flutamide|mesh-list
1856008|NCT00004054|Estramustine|estramustine|mesh-list
1856009|NCT00004054|Warfarin|warfarin|mesh-list
1856010|NCT00004054|Hormones|hormones|mesh-list
1856011|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1856012|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856013|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856014|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856015|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856016|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856017|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856018|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856019|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856020|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856021|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856022|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856023|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
1856024|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
1856025|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
1856026|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856027|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856028|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
1856029|NCT00004088|Pamidronate|pamidronate|mesh-list
1856030|NCT00004088|Interferons|interferons|mesh-list
1856031|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
1856032|NCT00004088|Thalidomide|thalidomide|mesh-list
1856033|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
1856034|NCT00004088|Melphalan|melphalan|mesh-list
1856035|NCT00004088|Busulfan|busulfan|mesh-list
1856036|NCT00004088|Lenograstim|lenograstim|mesh-list
1856037|NCT00004088|Sargramostim|sargramostim|mesh-list
1856038|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856039|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
1856040|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856041|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856042|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856043|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
1856044|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856045|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856046|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856047|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
1856048|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856049|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1856050|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
1856051|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1856052|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1856053|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1856054|NCT00004088|Growth Substances|growth substances|mesh-ancestor
1856055|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
1856056|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1856057|NCT00004092|Paclitaxel|paclitaxel|mesh-list
1856058|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
1856059|NCT00004092|Carboplatin|carboplatin|mesh-list
1856060|NCT00004092|Doxorubicin|doxorubicin|mesh-list
1856061|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856062|NCT00004092|Thiotepa|thiotepa|mesh-list
1856063|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856064|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856065|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856066|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856067|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856068|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856069|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856070|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
1856071|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856072|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856073|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856074|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
1856075|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856076|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856077|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856078|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856079|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856080|NCT00004124|Prednisone|prednisone|mesh-list
1856081|NCT00004124|Goserelin|goserelin|mesh-list
1856082|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
1856083|NCT00004124|Bicalutamide|bicalutamide|mesh-list
1856084|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1856085|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
1856086|NCT00004124|Hormones|hormones|mesh-ancestor
1856087|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856088|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856089|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856090|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856091|NCT00004124|Analgesics|analgesics|mesh-ancestor
1856092|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
1856093|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856094|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856095|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856096|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856097|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856098|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
1856099|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
1856100|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
1856178|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856101|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1856102|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856103|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
1856104|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856105|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1856106|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1856107|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856108|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1856109|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856110|NCT00004228|Leucovorin|leucovorin|mesh-list
1856111|NCT00004228|Cytarabine|cytarabine|mesh-list
1856112|NCT00004228|Dexamethasone|dexamethasone|mesh-list
1856113|NCT00004228|Prednisone|prednisone|mesh-list
1856114|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
1856115|NCT00004228|Doxorubicin|doxorubicin|mesh-list
1856116|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856117|NCT00004228|Methotrexate|methotrexate|mesh-list
1856118|NCT00004228|Vincristine|vincristine|mesh-list
1856119|NCT00004228|Daunorubicin|daunorubicin|mesh-list
1856120|NCT00004228|Asparaginase|asparaginase|mesh-list
1856121|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
1856122|NCT00004228|Thioguanine|thioguanine|mesh-list
1856123|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
1856124|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856125|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
1856126|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856127|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856128|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856129|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
1856130|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856131|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856132|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856133|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1856134|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
1856135|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
1856136|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856137|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1856138|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
1856139|NCT00004228|Hormones|hormones|mesh-ancestor
1856140|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856141|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856142|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856143|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856144|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856145|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856146|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1856147|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
1856148|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1856149|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856150|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
1856151|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
1856152|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1856153|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1856154|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
1856155|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856156|NCT00004228|Antidotes|antidotes|mesh-ancestor
1856157|NCT00004228|Protective Agents|protective agents|mesh-ancestor
1856158|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
1856159|NCT00004228|Vitamins|vitamins|mesh-ancestor
1856160|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
1856161|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856162|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856163|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856164|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856165|NCT00004259|Carmustine|carmustine|mesh-list
1856166|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856167|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
1856168|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856169|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856170|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
1856171|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856172|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1856173|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
1856174|NCT00004547|Paclitaxel|paclitaxel|mesh-list
1856175|NCT00004547|Cisplatin|cisplatin|mesh-list
1856176|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856177|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856179|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856180|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856181|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856182|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1856183|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1856184|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1856185|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1856186|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
1856187|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
1856188|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1856189|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856190|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856191|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
1856192|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
1856193|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856194|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
1856195|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856196|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856197|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856198|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
1856199|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856200|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856201|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856202|NCT00004635|Thalidomide|thalidomide|mesh-list
1856203|NCT00004635|Leuprolide|leuprolide|mesh-list
1856204|NCT00004635|Goserelin|goserelin|mesh-list
1856205|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856206|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
1856207|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856208|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
1856209|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1856210|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856211|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1856212|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1856213|NCT00004635|Growth Substances|growth substances|mesh-ancestor
1856214|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
1856215|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856216|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1856217|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
1856218|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1856219|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856220|NCT00004859|Thalidomide|thalidomide|mesh-list
1856221|NCT00004859|Paclitaxel|paclitaxel|mesh-list
1856222|NCT00004859|Carboplatin|carboplatin|mesh-list
1856223|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856224|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856225|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856226|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856227|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856228|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856229|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856230|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
1856231|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856232|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
1856233|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1856234|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856235|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1856236|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1856237|NCT00004859|Growth Substances|growth substances|mesh-ancestor
1856238|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
1856239|NCT00004888|Docetaxel|docetaxel|mesh-list
1856240|NCT00004888|Doxorubicin|doxorubicin|mesh-list
1856241|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856242|NCT00004888|Trastuzumab|trastuzumab|mesh-list
1856243|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856244|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856245|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856246|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856247|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856248|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856249|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856250|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856251|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856252|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1856253|NCT00004978|Aldesleukin|aldesleukin|mesh-list
1856254|NCT00004978|Interleukin-2|interleukin-2|mesh-list
1856255|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856256|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1856257|NCT00004978|Analgesics|analgesics|mesh-ancestor
1856258|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
1856259|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856260|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856261|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856262|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856263|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
1856264|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856265|NCT00005044|Bicalutamide|bicalutamide|mesh-list
1856266|NCT00005044|Flutamide|flutamide|mesh-list
1856267|NCT00005044|Hormones|hormones|mesh-list
1856268|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1856269|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856270|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856271|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
1856272|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
1856273|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856274|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856275|NCT00005047|Doxorubicin|doxorubicin|mesh-list
1856276|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856277|NCT00005047|Methotrexate|methotrexate|mesh-list
1856278|NCT00005047|Vinblastine|vinblastine|mesh-list
1856279|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856280|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856281|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856282|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856283|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856284|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856285|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1856286|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
1856287|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1856288|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856289|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856290|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
1856291|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
1856292|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1856293|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856294|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
1856295|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856296|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1856297|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856298|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856299|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856300|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856301|NCT00005669|Metformin|metformin|mesh-list
1856302|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1856303|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856304|NCT00005803|Cytarabine|cytarabine|mesh-list
1856305|NCT00005803|Cyclosporine|cyclosporine|mesh-list
1856306|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
1856307|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
1856308|NCT00005803|Melphalan|melphalan|mesh-list
1856309|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
1856310|NCT00005803|Carmustine|carmustine|mesh-list
1856311|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1856312|NCT00005803|Fludarabine|fludarabine|mesh-list
1856313|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
1856314|NCT00005803|Etoposide|etoposide|mesh-list
1856315|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
1856316|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
1856317|NCT00005803|Cyclosporins|cyclosporins|mesh-list
1856318|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856319|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
1856320|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856321|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856322|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856323|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
1856324|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856325|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856326|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856327|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856328|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
1856329|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856330|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856331|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856332|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856333|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
1856334|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856335|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
1856336|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
1856337|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1856338|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856339|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1856340|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
1856341|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1856342|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
1856343|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856344|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856345|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856346|NCT00005901|Pamidronate|pamidronate|mesh-list
1856347|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1856348|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856349|NCT00005906|Octreotide|octreotide|mesh-list
1856350|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1856351|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856352|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856353|NCT00005908|Tamoxifen|tamoxifen|mesh-list
1856354|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
1856355|NCT00005908|Docetaxel|docetaxel|mesh-list
1856356|NCT00005908|Doxorubicin|doxorubicin|mesh-list
1856357|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856358|NCT00005908|Capecitabine|capecitabine|mesh-list
1856359|NCT00005908|Anastrozole|anastrozole|mesh-list
1856360|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856361|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
1856362|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856363|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856364|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856365|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
1856366|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856367|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856368|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856369|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856370|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856371|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856372|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856373|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856374|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856375|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856376|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856377|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
1856378|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1856379|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
1856380|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856381|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856382|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1856383|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1856384|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1856385|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1856386|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1856387|NCT00005937|Cyclosporine|cyclosporine|mesh-list
1856388|NCT00005937|Cyclosporins|cyclosporins|mesh-list
1856389|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1856390|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856391|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856392|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856393|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
1856394|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856395|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
1856396|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856397|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
1856398|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856399|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1856400|NCT00006011|Paclitaxel|paclitaxel|mesh-list
1856401|NCT00006011|Doxorubicin|doxorubicin|mesh-list
1856402|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856403|NCT00006011|Lenograstim|lenograstim|mesh-list
1856404|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856405|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856406|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856407|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856408|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856409|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856410|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856411|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856412|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856413|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856414|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1856415|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
1856416|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856417|NCT00006046|Antibodies|antibodies|mesh-list
1856418|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1856419|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
1856420|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856421|NCT00006099|Antibodies|antibodies|mesh-list
1856422|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1856423|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
1856424|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856425|NCT00006101|Eflornithine|eflornithine|mesh-list
1856426|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856427|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1856428|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1856429|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1856430|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856431|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1856432|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856433|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856434|NCT00006110|Paclitaxel|paclitaxel|mesh-list
1856435|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
1856436|NCT00006110|Doxorubicin|doxorubicin|mesh-list
1856437|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856438|NCT00006110|Trastuzumab|trastuzumab|mesh-list
1856439|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856440|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856441|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856442|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856443|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856444|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856445|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856446|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
1856447|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856448|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856449|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856450|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
1856451|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856452|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856453|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856454|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856455|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856456|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1856457|NCT00006164|Ribavirin|ribavirin|mesh-list
1856458|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1856459|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
1856460|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
1856461|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856462|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
1856463|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856464|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
1856465|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856466|NCT00006170|Bupropion|bupropion|mesh-list
1856467|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1856468|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
1856469|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1856470|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1856471|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1856472|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1856473|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856474|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
1856475|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1856476|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856477|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1856478|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1856479|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856480|NCT00006178|Sirolimus|sirolimus|mesh-list
1856481|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
1856482|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1856483|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856484|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856485|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856486|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
1856487|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856488|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
1856489|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856490|NCT00006184|Cyclosporine|cyclosporine|mesh-list
1856491|NCT00006184|Prednisone|prednisone|mesh-list
1856492|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
1856493|NCT00006184|Doxorubicin|doxorubicin|mesh-list
1856494|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856495|NCT00006184|Methotrexate|methotrexate|mesh-list
1856496|NCT00006184|Fludarabine|fludarabine|mesh-list
1856497|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
1856498|NCT00006184|Etoposide|etoposide|mesh-list
1856499|NCT00006184|Vincristine|vincristine|mesh-list
1856500|NCT00006184|Bortezomib|bortezomib|mesh-list
1856501|NCT00006184|Molgramostim|molgramostim|mesh-list
1856502|NCT00006184|Cyclosporins|cyclosporins|mesh-list
1856503|NCT00006184|Lenograstim|lenograstim|mesh-list
1856504|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
1856505|NCT00006184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1856506|NCT00006184|Antibodies|antibodies|mesh-list
1856507|NCT00006184|Sargramostim|sargramostim|mesh-list
1856508|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
1856509|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856510|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
1856511|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856512|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856513|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856514|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
1856515|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856516|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856517|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856518|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856519|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856520|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856521|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856522|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1856523|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
1856524|NCT00006184|Hormones|hormones|mesh-ancestor
1856525|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856526|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856527|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1856528|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
1856529|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1856530|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856531|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
1856532|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
1856533|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1856534|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1856535|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856536|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1856537|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856538|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856539|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856540|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
1856541|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856542|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1856543|NCT00006227|Paclitaxel|paclitaxel|mesh-list
1856544|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856545|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856546|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856547|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856548|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856549|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856550|NCT00006237|Interferons|interferons|mesh-list
1856551|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
1856552|NCT00006237|Aldesleukin|aldesleukin|mesh-list
1856553|NCT00006237|Interleukin-2|interleukin-2|mesh-list
1856554|NCT00006237|Dacarbazine|dacarbazine|mesh-list
1856555|NCT00006237|Vinblastine|vinblastine|mesh-list
1856556|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856557|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
1856558|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856559|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
1856560|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856561|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1856562|NCT00006237|Analgesics|analgesics|mesh-ancestor
1856563|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
1856564|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856565|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856566|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856567|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856568|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
1856569|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856570|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856571|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856572|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856573|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856574|NCT00006244|Interferons|interferons|mesh-list
1856575|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
1856576|NCT00006244|Aldesleukin|aldesleukin|mesh-list
1856577|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
1856578|NCT00006244|Melphalan|melphalan|mesh-list
1856579|NCT00006244|Interleukin-2|interleukin-2|mesh-list
1856580|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856581|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
1856582|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856583|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856584|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
1856585|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856586|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856587|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856588|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
1856589|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856590|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1856591|NCT00006244|Analgesics|analgesics|mesh-ancestor
1856592|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
1856593|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856594|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856595|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856596|NCT00006289|Neurotropin|neurotropin|mesh-list
1856597|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1856598|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
1856599|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856600|NCT00006289|Analgesics|analgesics|mesh-ancestor
1856601|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
1856602|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856603|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
1856604|NCT00006305|Biguanides|biguanides|mesh-list
1856605|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
1856606|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
1856607|NCT00006305|Calcium|calcium|mesh-list
1856608|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1856609|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1856610|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1856611|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1856612|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856613|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1856614|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1856615|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
1856616|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1856617|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856618|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
1856619|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856620|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1856621|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
1856622|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856623|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1856624|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
1856625|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856626|NCT00006392|Vitamins|vitamins|mesh-list
1856627|NCT00006392|Vitamin E|vitamin e|mesh-list
1856628|NCT00006392|Tocopherols|tocopherols|mesh-list
1856629|NCT00006392|Tocotrienols|tocotrienols|mesh-list
1856630|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
1856631|NCT00006392|Selenium|selenium|mesh-list
1856632|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
1856633|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856634|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
1856635|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856636|NCT00006392|Protective Agents|protective agents|mesh-ancestor
1856637|NCT00006392|Trace Elements|trace elements|mesh-ancestor
1856638|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
1856639|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856640|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
1856641|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856642|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856643|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1856644|NCT00006489|Naltrexone|naltrexone|mesh-list
1856645|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1856646|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1856647|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856648|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
1856649|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856650|NCT00006604|Ritonavir|ritonavir|mesh-list
1856651|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1856652|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1856653|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
1856654|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856655|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856656|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856657|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856658|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
1856659|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856660|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1856661|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1856662|NCT00006721|Prednisone|prednisone|mesh-list
1856663|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
1856664|NCT00006721|Rituximab|rituximab|mesh-list
1856665|NCT00006721|Doxorubicin|doxorubicin|mesh-list
1856666|NCT00006721|Vincristine|vincristine|mesh-list
1856667|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856668|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
1856669|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856670|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856671|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856672|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
1856673|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856674|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856675|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856676|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1856677|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856678|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856679|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856680|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856681|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1856682|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
1856683|NCT00006721|Hormones|hormones|mesh-ancestor
1856684|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856685|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856686|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856687|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856688|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856689|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856690|NCT00006903|Fulvestrant|fulvestrant|mesh-list
1856691|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856692|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856693|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1856694|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1856695|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
1856696|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1856697|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856698|NCT00007020|Cholic Acids|cholic acids|mesh-list
1856699|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1856700|NCT00007345|Romidepsin|romidepsin|mesh-list
1856701|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856702|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856703|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
1856704|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856705|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
1856706|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856707|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856708|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856709|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
1856710|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856711|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856712|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856713|NCT00008138|Paclitaxel|paclitaxel|mesh-list
1856714|NCT00008138|Carboplatin|carboplatin|mesh-list
1856715|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856716|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856717|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856718|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856719|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856720|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856721|NCT00008385|Selenium|selenium|mesh-list
1856722|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
1856723|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856724|NCT00008385|Protective Agents|protective agents|mesh-ancestor
1856725|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856726|NCT00008385|Trace Elements|trace elements|mesh-ancestor
1856727|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
1856728|NCT00009737|Leucovorin|leucovorin|mesh-list
1856729|NCT00009737|Fluorouracil|fluorouracil|mesh-list
1856730|NCT00009737|Capecitabine|capecitabine|mesh-list
1856731|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
1856732|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856733|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856734|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856735|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856736|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
1856737|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856738|NCT00009737|Antidotes|antidotes|mesh-ancestor
1856739|NCT00009737|Protective Agents|protective agents|mesh-ancestor
1856740|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
1856741|NCT00009737|Vitamins|vitamins|mesh-ancestor
1856742|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
1856743|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
1856744|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1856745|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856746|NCT00010257|Paclitaxel|paclitaxel|mesh-list
1856747|NCT00010257|Carboplatin|carboplatin|mesh-list
1856748|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856749|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856750|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856751|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856752|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856753|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856754|NCT00010439|Alendronate|alendronate|mesh-list
1856755|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1856756|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856757|NCT00011986|Gemcitabine|gemcitabine|mesh-list
1856758|NCT00011986|Paclitaxel|paclitaxel|mesh-list
1856759|NCT00011986|Carboplatin|carboplatin|mesh-list
1856760|NCT00011986|Doxorubicin|doxorubicin|mesh-list
1856761|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856762|NCT00011986|Topotecan|topotecan|mesh-list
1856763|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856764|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856765|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856766|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856767|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856768|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856769|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856770|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
1856771|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
1856772|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856773|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856774|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856775|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
1856776|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856777|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856778|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856779|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856780|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1856781|NCT00012012|Amifostine|amifostine|mesh-list
1856782|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1856783|NCT00012012|Protective Agents|protective agents|mesh-ancestor
1856784|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856785|NCT00012298|Rituximab|rituximab|mesh-list
1856786|NCT00012298|Oprelvekin|oprelvekin|mesh-list
1856787|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1856788|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1856789|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856790|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
1856791|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856792|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856793|NCT00013611|Aldesleukin|aldesleukin|mesh-list
1856794|NCT00013611|Interleukin-2|interleukin-2|mesh-list
1856795|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856796|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1856797|NCT00013611|Analgesics|analgesics|mesh-ancestor
1856798|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
1856799|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856800|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856801|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856802|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856803|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
1856804|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856805|NCT00014222|Paclitaxel|paclitaxel|mesh-list
1856806|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
1856807|NCT00014222|Doxorubicin|doxorubicin|mesh-list
1856808|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1856809|NCT00014222|Fluorouracil|fluorouracil|mesh-list
1856810|NCT00014222|Epirubicin|epirubicin|mesh-list
1856811|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
1856812|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856813|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856814|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856815|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856816|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856817|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856818|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856819|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
1856820|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856821|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856822|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856823|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
1856824|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856825|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856826|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856827|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856828|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856829|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
1856830|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856831|NCT00014222|Hematinics|hematinics|mesh-ancestor
1856832|NCT00014495|Cytarabine|cytarabine|mesh-list
1856833|NCT00014495|Bismuth|bismuth|mesh-list
1856834|NCT00014495|Antibodies|antibodies|mesh-list
1856835|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1856836|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
1856837|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856838|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1856839|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
1856840|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856841|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856842|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
1856843|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856844|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856845|NCT00014495|Antacids|antacids|mesh-ancestor
1856846|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1856847|NCT00014911|Sirolimus|sirolimus|mesh-list
1856848|NCT00014911|Pentamidine|pentamidine|mesh-list
1856849|NCT00014911|Trimethoprim|trimethoprim|mesh-list
1856850|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
1856851|NCT00014911|Ganciclovir|ganciclovir|mesh-list
1856852|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1856853|NCT00014911|Tacrolimus|tacrolimus|mesh-list
1856854|NCT00014911|Daclizumab|daclizumab|mesh-list
1856855|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856856|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
1856857|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856858|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1856859|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856860|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856861|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1856862|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856863|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856864|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856865|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
1856866|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1856867|NCT00014911|Renal Agents|renal agents|mesh-ancestor
1856868|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
1856869|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1856870|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1857174|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
1856871|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1856872|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1856873|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1856874|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1856875|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
1856876|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1856877|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1856878|NCT00015457|Amlodipine|amlodipine|mesh-list
1856879|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
1856880|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1856881|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1856882|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856883|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
1856884|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1856885|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856886|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1856887|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1856888|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1856889|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
1856890|NCT00015847|Interferons|interferons|mesh-list
1856891|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
1856892|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
1856893|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856894|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
1856895|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856896|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
1856897|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856898|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1856899|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856900|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856901|NCT00016718|Emtricitabine|emtricitabine|mesh-list
1856902|NCT00016718|Efavirenz|efavirenz|mesh-list
1856903|NCT00016718|Didanosine|didanosine|mesh-list
1856904|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
1856905|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856906|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1856907|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1856908|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856909|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856910|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856911|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856912|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1856913|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1856914|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1856915|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1856916|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1856917|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1856918|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
1856919|NCT00016913|Paclitaxel|paclitaxel|mesh-list
1856920|NCT00016913|Carboplatin|carboplatin|mesh-list
1856921|NCT00016913|Leuprolide|leuprolide|mesh-list
1856922|NCT00016913|Goserelin|goserelin|mesh-list
1856923|NCT00016913|Estramustine|estramustine|mesh-list
1856924|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1856925|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856926|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856927|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856928|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856929|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856930|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1856931|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
1856932|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1856933|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856934|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1856935|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856936|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
1856937|NCT00017563|Docetaxel|docetaxel|mesh-list
1856938|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
1856939|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856940|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856941|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856942|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856943|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856944|NCT00017563|Analgesics|analgesics|mesh-ancestor
1856945|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
1856946|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1856947|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856948|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856949|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856950|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856951|NCT00018031|Ribavirin|ribavirin|mesh-list
1856952|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1856953|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
1856954|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
1856955|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856956|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
1856957|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856958|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
1856959|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856960|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1856961|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1856962|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856963|NCT00019682|Aldesleukin|aldesleukin|mesh-list
1856964|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856965|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1856966|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1856967|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
1856968|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1856969|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
1856970|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856971|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1856972|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856973|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856974|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
1856975|NCT00021255|Carboplatin|carboplatin|mesh-list
1856976|NCT00021255|Docetaxel|docetaxel|mesh-list
1856977|NCT00021255|Doxorubicin|doxorubicin|mesh-list
1856978|NCT00021255|Trastuzumab|trastuzumab|mesh-list
1856979|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1856980|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
1856981|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1856982|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1856983|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1856984|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
1856985|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1856986|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856987|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1856988|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
1856989|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
1856990|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
1856991|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1856992|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1856993|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1856994|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1856995|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1856996|NCT00021541|Tipifarnib|tipifarnib|mesh-list
1856997|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1856998|NCT00022490|Cytarabine|cytarabine|mesh-list
1856999|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
1857000|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857001|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
1857002|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857003|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857004|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
1857005|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857006|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857007|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
1857008|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857009|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1857010|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857011|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
1857012|NCT00022516|Methotrexate|methotrexate|mesh-list
1857013|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857014|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
1857015|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857016|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857017|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857018|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
1857019|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857020|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857021|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857022|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1857023|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
1857024|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1857025|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857026|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
1857027|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857028|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857029|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1857030|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1857031|NCT00022633|Gemcitabine|gemcitabine|mesh-list
1857032|NCT00022633|Paclitaxel|paclitaxel|mesh-list
1857033|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857034|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857035|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857036|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857037|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857038|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857039|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857040|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
1857041|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
1857042|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857043|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857044|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857045|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
1857046|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857047|NCT00022659|Bevacizumab|bevacizumab|mesh-list
1857048|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1857049|NCT00022659|Antibodies|antibodies|mesh-list
1857050|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
1857051|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1857052|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857053|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1857054|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1857055|NCT00022659|Growth Substances|growth substances|mesh-ancestor
1857056|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857057|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
1857058|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
1857059|NCT00022672|Trastuzumab|trastuzumab|mesh-list
1857060|NCT00022672|Anastrozole|anastrozole|mesh-list
1857061|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857062|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857063|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857064|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1857065|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1857066|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857067|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857068|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1857069|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857070|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857071|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857072|NCT00022698|Capecitabine|capecitabine|mesh-list
1857073|NCT00022698|Irinotecan|irinotecan|mesh-list
1857074|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857075|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
1857076|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857077|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857078|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1857079|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857080|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857081|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
1857082|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1857083|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1857084|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857085|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1857086|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1857087|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
1857088|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857089|NCT00023309|Lamivudine|lamivudine|mesh-list
1857090|NCT00023309|Adefovir|adefovir|mesh-list
1857091|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1857092|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1857093|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1857094|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857095|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857096|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
1857097|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857098|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1857099|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1857100|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1857101|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
1857102|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857103|NCT00023452|Isoniazid|isoniazid|mesh-list
1857104|NCT00023452|Rifapentine|rifapentine|mesh-list
1857105|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
1857106|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1857107|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857108|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1857109|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1857110|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
1857111|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857112|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1857113|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1857114|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
1857115|NCT00023673|Paclitaxel|paclitaxel|mesh-list
1857116|NCT00023673|Carboplatin|carboplatin|mesh-list
1857117|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857118|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857119|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857120|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857121|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857122|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857123|NCT00023712|Bortezomib|bortezomib|mesh-list
1857124|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857125|NCT00023764|Bortezomib|bortezomib|mesh-list
1857126|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857127|NCT00024102|Doxorubicin|doxorubicin|mesh-list
1857128|NCT00024102|Capecitabine|capecitabine|mesh-list
1857129|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857130|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857131|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857132|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857133|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857134|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857135|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857136|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
1857137|NCT00024167|Ketoconazole|ketoconazole|mesh-list
1857138|NCT00024167|Dexamethasone|dexamethasone|mesh-list
1857139|NCT00024167|Prednisone|prednisone|mesh-list
1857140|NCT00024167|Estramustine|estramustine|mesh-list
1857141|NCT00024167|Docetaxel|docetaxel|mesh-list
1857142|NCT00024167|Doxorubicin|doxorubicin|mesh-list
1857143|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1857144|NCT00024167|Vinblastine|vinblastine|mesh-list
1857145|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857146|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
1857147|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
1857148|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857149|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857150|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1857151|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
1857152|NCT00024167|Hormones|hormones|mesh-ancestor
1857153|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857154|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857155|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857156|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857157|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857158|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857159|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857160|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857161|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857162|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857163|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857164|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
1857165|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857166|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1857167|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1857168|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1857169|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857170|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1857171|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857172|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857173|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
1857175|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857176|NCT00025155|Epothilones|epothilones|mesh-list
1857177|NCT00025155|Epothilone B|epothilone b|mesh-list
1857178|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857179|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857180|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857181|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857182|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857183|NCT00025233|Bevacizumab|bevacizumab|mesh-list
1857184|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1857185|NCT00025233|Antibodies|antibodies|mesh-list
1857186|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
1857187|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1857188|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857189|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1857190|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1857191|NCT00025233|Growth Substances|growth substances|mesh-ancestor
1857192|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857193|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
1857194|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
1857195|NCT00025259|Cytarabine|cytarabine|mesh-list
1857196|NCT00025259|Dexamethasone|dexamethasone|mesh-list
1857197|NCT00025259|Prednisone|prednisone|mesh-list
1857198|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
1857199|NCT00025259|Cortisone|cortisone|mesh-list
1857200|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
1857201|NCT00025259|Cisplatin|cisplatin|mesh-list
1857202|NCT00025259|Doxorubicin|doxorubicin|mesh-list
1857203|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1857204|NCT00025259|Etoposide|etoposide|mesh-list
1857205|NCT00025259|Vincristine|vincristine|mesh-list
1857206|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
1857207|NCT00025259|Bleomycin|bleomycin|mesh-list
1857208|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
1857209|NCT00025259|Lenograstim|lenograstim|mesh-list
1857210|NCT00025259|BB 1101|bb 1101|mesh-list
1857211|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857212|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
1857213|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857214|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857215|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857216|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
1857217|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857218|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857219|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857220|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857221|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
1857222|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
1857223|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857224|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1857225|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
1857226|NCT00025259|Hormones|hormones|mesh-ancestor
1857227|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857228|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857229|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857230|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857231|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857232|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857233|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857234|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1857235|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857236|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
1857237|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
1857238|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857239|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857240|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857241|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857242|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
1857243|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
1857244|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857245|NCT00025506|Thalidomide|thalidomide|mesh-list
1857246|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857247|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
1857248|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857249|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
1857250|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1857251|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857252|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1857253|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1857254|NCT00025506|Growth Substances|growth substances|mesh-ancestor
1857255|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
1857256|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857257|NCT00025662|Interleukin-2|interleukin-2|mesh-list
1857258|NCT00025662|Immunotoxins|immunotoxins|mesh-list
1857259|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857260|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1857261|NCT00025662|Analgesics|analgesics|mesh-ancestor
1857262|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
1857263|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857264|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857265|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
1857266|NCT00026208|Prednisone|prednisone|mesh-list
1857267|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
1857268|NCT00026208|Doxorubicin|doxorubicin|mesh-list
1857269|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1857270|NCT00026208|Etoposide|etoposide|mesh-list
1857271|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
1857272|NCT00026208|Vincristine|vincristine|mesh-list
1857273|NCT00026208|Bleomycin|bleomycin|mesh-list
1857274|NCT00026208|Vinblastine|vinblastine|mesh-list
1857275|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857276|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
1857277|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857278|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857279|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857280|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
1857281|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857282|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857283|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857284|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857285|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857286|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857287|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857288|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857289|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
1857290|NCT00026208|Hormones|hormones|mesh-ancestor
1857291|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857292|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857293|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857294|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857295|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857296|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857297|NCT00026221|Interferons|interferons|mesh-list
1857298|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
1857299|NCT00026221|Bevacizumab|bevacizumab|mesh-list
1857300|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857301|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857302|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1857303|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1857304|NCT00026221|Growth Substances|growth substances|mesh-ancestor
1857305|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857306|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
1857307|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
1857308|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857309|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
1857310|NCT00026312|Vitamin A|vitamin a|mesh-list
1857311|NCT00026312|Aldesleukin|aldesleukin|mesh-list
1857312|NCT00026312|Interleukin-2|interleukin-2|mesh-list
1857313|NCT00026312|Tretinoin|tretinoin|mesh-list
1857314|NCT00026312|Dinutuximab|dinutuximab|mesh-list
1857315|NCT00026312|Isotretinoin|isotretinoin|mesh-list
1857316|NCT00026312|Sargramostim|sargramostim|mesh-list
1857317|NCT00026312|Vitamins|vitamins|mesh-ancestor
1857318|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
1857319|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857320|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857321|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1857322|NCT00026312|Analgesics|analgesics|mesh-ancestor
1857323|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
1857324|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857325|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
1857326|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1857327|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1857328|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
1857329|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857330|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
1857331|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857332|NCT00026494|Temozolomide|temozolomide|mesh-list
1857333|NCT00026494|Vinorelbine|vinorelbine|mesh-list
1857334|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857335|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
1857336|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857337|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857338|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857339|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857340|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857341|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857342|NCT00027027|Pertuzumab|pertuzumab|mesh-list
1857343|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857344|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857345|NCT00027378|Fluoxetine|fluoxetine|mesh-list
1857346|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1857347|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1857348|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1857349|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857350|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1857351|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
1857352|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857353|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1857354|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
1857355|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1857356|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1857357|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1857358|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857359|NCT00027560|Cyclosporine|cyclosporine|mesh-list
1857360|NCT00027560|Fludarabine|fludarabine|mesh-list
1857361|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
1857362|NCT00027560|Melphalan|melphalan|mesh-list
1857363|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
1857364|NCT00027560|Cyclosporins|cyclosporins|mesh-list
1857365|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857366|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857367|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
1857368|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857369|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857370|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
1857371|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857372|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857373|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
1857374|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857375|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857376|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857377|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1857378|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857379|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
1857380|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857381|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857382|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
1857383|NCT00027846|Carboplatin|carboplatin|mesh-list
1857384|NCT00027846|Etoposide|etoposide|mesh-list
1857385|NCT00027846|Vincristine|vincristine|mesh-list
1857386|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
1857387|NCT00027846|Lenograstim|lenograstim|mesh-list
1857388|NCT00027846|Sargramostim|sargramostim|mesh-list
1857389|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857390|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
1857391|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857392|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857393|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857394|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
1857395|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857396|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857397|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857398|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857399|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857400|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857401|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857402|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1857403|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857404|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857405|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857406|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
1857407|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857408|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
1857409|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857410|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1857411|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857412|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857413|NCT00028093|Ribavirin|ribavirin|mesh-list
1857414|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1857415|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
1857416|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
1857417|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857418|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
1857419|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857420|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
1857421|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857422|NCT00028262|Cysteamine|cysteamine|mesh-list
1857423|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1857424|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857425|NCT00028769|Paclitaxel|paclitaxel|mesh-list
1857426|NCT00028769|Etoposide|etoposide|mesh-list
1857427|NCT00028769|Leuprolide|leuprolide|mesh-list
1857428|NCT00028769|Goserelin|goserelin|mesh-list
1857429|NCT00028769|Bicalutamide|bicalutamide|mesh-list
1857430|NCT00028769|Flutamide|flutamide|mesh-list
1857431|NCT00028769|Estramustine|estramustine|mesh-list
1857432|NCT00028769|Nilutamide|nilutamide|mesh-list
1857433|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857434|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857435|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857436|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857437|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857438|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857439|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857440|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857441|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857442|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1857443|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
1857444|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1857445|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857446|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857447|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
1857448|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857449|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857450|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857451|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
1857452|NCT00029107|Rituximab|rituximab|mesh-list
1857453|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857454|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857455|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
1857456|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857457|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857458|NCT00029536|Progesterone|progesterone|mesh-list
1857459|NCT00029536|Progestins|progestins|mesh-ancestor
1857460|NCT00029536|Hormones|hormones|mesh-ancestor
1857461|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857462|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857463|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1857464|NCT00030147|Estradiol|estradiol|mesh-list
1857465|NCT00030147|Estrogens|estrogens|mesh-ancestor
1857466|NCT00030147|Hormones|hormones|mesh-ancestor
1857467|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857468|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857469|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1857470|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857471|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1857472|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1857473|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1857474|NCT00030264|Methotrexate|methotrexate|mesh-list
1857475|NCT00030264|Vinblastine|vinblastine|mesh-list
1857476|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1857477|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
1857478|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1857479|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857480|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857481|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
1857482|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857483|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857484|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857485|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857486|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1857487|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857488|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
1857489|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857490|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1857491|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857492|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857493|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857494|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857495|NCT00030901|Selenium|selenium|mesh-list
1857496|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
1857497|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857498|NCT00030901|Protective Agents|protective agents|mesh-ancestor
1857499|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857500|NCT00030901|Trace Elements|trace elements|mesh-ancestor
1857501|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
1857502|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
1857503|NCT00030992|Promethazine|promethazine|mesh-list
1857504|NCT00030992|Ranitidine|ranitidine|mesh-list
1857505|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1857506|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1857507|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1857508|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1857509|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857510|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
1857511|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
1857512|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
1857513|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857514|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
1857515|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
1857516|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1857517|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1857518|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
1857519|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
1857520|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1857521|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857522|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1857523|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
1857524|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857525|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1857526|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1857527|NCT00031447|Acyclovir|acyclovir|mesh-list
1857528|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
1857529|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857530|NCT00031460|Acyclovir|acyclovir|mesh-list
1857531|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
1857532|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857533|NCT00031486|Valacyclovir|valacyclovir|mesh-list
1857534|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
1857535|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857536|NCT00031551|Etanercept|etanercept|mesh-list
1857537|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1857538|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1857539|NCT00031551|Analgesics|analgesics|mesh-ancestor
1857540|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
1857541|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857542|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857543|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857544|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857545|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1857546|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857547|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
1857548|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
1857549|NCT00031590|Lomustine|lomustine|mesh-list
1857550|NCT00031590|Etoposide|etoposide|mesh-list
1857551|NCT00031590|Vincristine|vincristine|mesh-list
1857552|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857553|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
1857554|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857555|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857556|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857557|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
1857558|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857559|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857560|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857561|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857562|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857563|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857564|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857565|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857566|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857567|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857568|NCT00031694|Paclitaxel|paclitaxel|mesh-list
1857569|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
1857570|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857571|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857572|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857573|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857574|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857575|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857576|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1857577|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
1857578|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857579|NCT00032487|Metformin|metformin|mesh-list
1857580|NCT00032487|Glimepiride|glimepiride|mesh-list
1857581|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
1857582|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1857583|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857584|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1857585|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857586|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
1857587|NCT00032591|Thrombin|thrombin|mesh-list
1857588|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
1857589|NCT00032591|Coagulants|coagulants|mesh-ancestor
1857616|NCT00033371|Eflornithine|eflornithine|mesh-list
1857617|NCT00033371|Celecoxib|celecoxib|mesh-list
1857618|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1857619|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1857620|NCT00033371|Analgesics|analgesics|mesh-ancestor
1857621|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
1857622|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857623|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857624|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857625|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857626|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1857627|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1857628|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857629|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857630|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857631|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1857632|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1857633|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1857634|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857635|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1857636|NCT00033514|Trastuzumab|trastuzumab|mesh-list
1857637|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1857638|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857639|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857640|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1857641|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857642|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857643|NCT00033540|Gemcitabine|gemcitabine|mesh-list
1857644|NCT00033540|Capecitabine|capecitabine|mesh-list
1857645|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857646|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
1857647|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857648|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857649|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
1857650|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857651|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857652|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857653|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
1857654|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857655|NCT00033657|Paclitaxel|paclitaxel|mesh-list
1857656|NCT00033657|Camptothecin|camptothecin|mesh-list
1857657|NCT00033657|Cisplatin|cisplatin|mesh-list
1857658|NCT00033657|Irinotecan|irinotecan|mesh-list
1857659|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857660|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857661|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857662|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857663|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857664|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857665|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1857666|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857667|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857668|NCT00033917|Indomethacin|indomethacin|mesh-list
1857669|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1857670|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1857671|NCT00033917|Analgesics|analgesics|mesh-ancestor
1857672|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
1857673|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857674|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857675|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857676|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857677|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
1857678|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
1857679|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1857680|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1857681|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857682|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857683|NCT00035555|Cyclosporine|cyclosporine|mesh-list
1857684|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
1857685|NCT00035555|Abatacept|abatacept|mesh-list
1857686|NCT00035555|Cyclosporins|cyclosporins|mesh-list
1857687|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857688|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857689|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857690|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
1857691|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857692|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
1857693|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857694|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857695|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857696|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1857697|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857698|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857699|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1857700|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
1857701|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1857702|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1857703|NCT00035815|Mitogens|mitogens|mesh-list
1857704|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857705|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857706|NCT00035932|Ritonavir|ritonavir|mesh-list
1857707|NCT00035932|Lopinavir|lopinavir|mesh-list
1857708|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1857709|NCT00035932|Saquinavir|saquinavir|mesh-list
1857710|NCT00035932|Tenofovir|tenofovir|mesh-list
1857711|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1857712|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1857713|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
1857714|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857789|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857715|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857716|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1857717|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1857718|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
1857719|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857720|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1857721|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1857722|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1857723|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1857724|NCT00036270|Tamoxifen|tamoxifen|mesh-list
1857725|NCT00036270|Exemestane|exemestane|mesh-list
1857726|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1857727|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857728|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857729|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857730|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857731|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857732|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1857733|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1857734|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1857735|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1857736|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1857737|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857738|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857739|NCT00036569|Interferons|interferons|mesh-list
1857740|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
1857741|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857742|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
1857743|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857744|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
1857745|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857746|NCT00036738|Cyclosporine|cyclosporine|mesh-list
1857747|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
1857748|NCT00036738|Fludarabine|fludarabine|mesh-list
1857749|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
1857750|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
1857751|NCT00036738|Dasatinib|dasatinib|mesh-list
1857752|NCT00036738|Cyclosporins|cyclosporins|mesh-list
1857753|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857754|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857755|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
1857756|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857757|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857758|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
1857759|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857760|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857761|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
1857762|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857763|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857764|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857765|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1857766|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857767|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1857768|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
1857769|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1857770|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1857771|NCT00038103|Celecoxib|celecoxib|mesh-list
1857772|NCT00038103|Exemestane|exemestane|mesh-list
1857773|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1857774|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1857775|NCT00038103|Analgesics|analgesics|mesh-ancestor
1857776|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
1857777|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857778|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857779|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857780|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857781|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1857782|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1857783|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857784|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857785|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857786|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1857787|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1857788|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1857790|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857791|NCT00038467|Tamoxifen|tamoxifen|mesh-list
1857792|NCT00038467|Exemestane|exemestane|mesh-list
1857793|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1857794|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
1857795|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857796|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857797|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857798|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857799|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1857800|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1857801|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1857802|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1857803|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1857804|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857805|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857806|NCT00038610|Cytarabine|cytarabine|mesh-list
1857807|NCT00038610|Dexamethasone|dexamethasone|mesh-list
1857808|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
1857809|NCT00038610|Doxorubicin|doxorubicin|mesh-list
1857810|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1857811|NCT00038610|Methotrexate|methotrexate|mesh-list
1857812|NCT00038610|Vincristine|vincristine|mesh-list
1857813|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
1857814|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857815|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
1857816|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857817|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857818|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857819|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
1857820|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857821|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857822|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857823|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857824|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
1857825|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
1857826|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857827|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1857828|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
1857829|NCT00038610|Hormones|hormones|mesh-ancestor
1857830|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857831|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857832|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857833|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857834|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857835|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857836|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1857837|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
1857838|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1857839|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857840|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
1857841|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857842|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1857843|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1857844|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
1857845|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857846|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857847|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857848|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857849|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857850|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1857851|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
1857852|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857853|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1857854|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857855|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857859|NCT00038857|Vidarabine|vidarabine|mesh-list
1857860|NCT00038857|Fludarabine|fludarabine|mesh-list
1857861|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
1857862|NCT00038857|Melphalan|melphalan|mesh-list
1857863|NCT00038857|Thiotepa|thiotepa|mesh-list
1857864|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
1857865|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1857866|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857867|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857868|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
1857869|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857870|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857871|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
1857872|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857873|NCT00038857|Antiviral Agents|antiviral agents|mesh-ancestor
1857874|NCT00038857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857875|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857876|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
1857877|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857878|NCT00038948|Cyclosporine|cyclosporine|mesh-list
1857879|NCT00038948|Sirolimus|sirolimus|mesh-list
1857880|NCT00038948|Tacrolimus|tacrolimus|mesh-list
1857881|NCT00038948|Cyclosporins|cyclosporins|mesh-list
1857882|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857883|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
1857884|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857885|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1857886|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857887|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857888|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
1857889|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857890|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857891|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857892|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1857893|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857894|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857895|NCT00039130|Leucovorin|leucovorin|mesh-list
1857896|NCT00039130|Cytarabine|cytarabine|mesh-list
1857897|NCT00039130|Dexamethasone|dexamethasone|mesh-list
1857898|NCT00039130|Prednisone|prednisone|mesh-list
1857899|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
1857900|NCT00039130|Ifosfamide|ifosfamide|mesh-list
1857901|NCT00039130|Rituximab|rituximab|mesh-list
1857902|NCT00039130|Doxorubicin|doxorubicin|mesh-list
1857903|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1857904|NCT00039130|Methotrexate|methotrexate|mesh-list
1857905|NCT00039130|Etoposide|etoposide|mesh-list
1857906|NCT00039130|Vincristine|vincristine|mesh-list
1857907|NCT00039130|Allopurinol|allopurinol|mesh-list
1857908|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
1857909|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857910|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
1857911|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857912|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857913|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857914|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
1857915|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857916|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857917|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857918|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857919|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
1857920|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
1857921|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1857922|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1857923|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
1857924|NCT00039130|Hormones|hormones|mesh-ancestor
1857925|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857926|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857927|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857928|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857929|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857930|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857931|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857932|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1857933|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
1857934|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1857935|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1857936|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
1857937|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
1857938|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1857939|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1857940|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857941|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
1857942|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1857943|NCT00039130|Antidotes|antidotes|mesh-ancestor
1857944|NCT00039130|Protective Agents|protective agents|mesh-ancestor
1857945|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
1857946|NCT00039130|Vitamins|vitamins|mesh-ancestor
1857947|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
1857948|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857949|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857950|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857951|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
1857952|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1857953|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
1857954|NCT00039195|Prednisone|prednisone|mesh-list
1857955|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
1857956|NCT00039195|Ifosfamide|ifosfamide|mesh-list
1857957|NCT00039195|Rituximab|rituximab|mesh-list
1857958|NCT00039195|Carboplatin|carboplatin|mesh-list
1857959|NCT00039195|Doxorubicin|doxorubicin|mesh-list
1857960|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1857961|NCT00039195|Etoposide|etoposide|mesh-list
1857962|NCT00039195|Vincristine|vincristine|mesh-list
1857963|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857964|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
1857965|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857966|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1857967|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1857968|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
1857969|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1857970|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1857971|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1857972|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1857973|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1857974|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1857975|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1857976|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1857977|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1857978|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
1857979|NCT00039195|Hormones|hormones|mesh-ancestor
1857980|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1857981|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1857982|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1857983|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
1857984|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
1857985|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
1857986|NCT00039377|Leucovorin|leucovorin|mesh-list
1857987|NCT00039377|Cytarabine|cytarabine|mesh-list
1857988|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
1857989|NCT00039377|Methotrexate|methotrexate|mesh-list
1857990|NCT00039377|Etoposide|etoposide|mesh-list
1857991|NCT00039377|Vincristine|vincristine|mesh-list
1857992|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
1857993|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
1857994|NCT00039377|Tacrolimus|tacrolimus|mesh-list
1857995|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
1857996|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1857997|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
1857998|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1857999|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858000|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858001|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
1858002|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858003|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858004|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858005|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1858006|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
1858007|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1858008|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858009|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
1858010|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858011|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858012|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1858013|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1858014|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858015|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858016|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858017|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
1858018|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858019|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858020|NCT00039377|Antidotes|antidotes|mesh-ancestor
1858021|NCT00039377|Protective Agents|protective agents|mesh-ancestor
1858022|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
1858023|NCT00039377|Vitamins|vitamins|mesh-ancestor
1858024|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
1858025|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858026|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858027|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858028|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858029|NCT00039871|Ribavirin|ribavirin|mesh-list
1858030|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1858031|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
1858032|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
1858033|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858034|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
1858035|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858036|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
1858037|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858038|NCT00040365|Amifostine|amifostine|mesh-list
1858039|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1858040|NCT00040365|Protective Agents|protective agents|mesh-ancestor
1858041|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858042|NCT00040664|Ritonavir|ritonavir|mesh-list
1858043|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
1858044|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1858045|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1858046|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
1858047|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858048|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858049|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1858050|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1858051|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
1858052|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858053|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1858054|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1858055|NCT00040846|Cyclosporine|cyclosporine|mesh-list
1858056|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
1858057|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1858058|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
1858059|NCT00040846|Fludarabine|fludarabine|mesh-list
1858060|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
1858061|NCT00040846|Antibodies|antibodies|mesh-list
1858062|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
1858063|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1858064|NCT00040846|Cyclosporins|cyclosporins|mesh-list
1858065|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
1858066|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858067|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858068|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858069|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
1858070|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858071|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858072|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858073|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
1858074|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858075|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858076|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858077|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858078|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858079|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1858080|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
1858081|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858082|NCT00040937|Thalidomide|thalidomide|mesh-list
1858083|NCT00040937|Dexamethasone|dexamethasone|mesh-list
1858084|NCT00040937|Prednisone|prednisone|mesh-list
1858085|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
1858086|NCT00040937|Melphalan|melphalan|mesh-list
1858087|NCT00040937|Sargramostim|sargramostim|mesh-list
1858088|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858089|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
1858090|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858091|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858092|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858093|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
1858094|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858095|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858096|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858097|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858098|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
1858099|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
1858100|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858101|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1858102|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
1858103|NCT00040937|Hormones|hormones|mesh-ancestor
1858104|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858105|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1858106|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
1858107|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858108|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858109|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1858110|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1858111|NCT00040937|Growth Substances|growth substances|mesh-ancestor
1858112|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
1858113|NCT00041067|Docetaxel|docetaxel|mesh-list
1858114|NCT00041067|Trastuzumab|trastuzumab|mesh-list
1858115|NCT00041067|Vinorelbine|vinorelbine|mesh-list
1858116|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858117|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858118|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858119|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858120|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858121|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858122|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858123|NCT00041080|Tamoxifen|tamoxifen|mesh-list
1858124|NCT00041080|Thalidomide|thalidomide|mesh-list
1858125|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1858126|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
1858127|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858128|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858129|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1858130|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858131|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1858132|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1858133|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1858134|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858135|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
1858136|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
1858137|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858138|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858139|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1858140|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1858141|NCT00041080|Growth Substances|growth substances|mesh-ancestor
1858142|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
1858143|NCT00041119|Paclitaxel|paclitaxel|mesh-list
1858144|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
1858145|NCT00041119|Doxorubicin|doxorubicin|mesh-list
1858146|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1858147|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858148|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858149|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858150|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858151|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858152|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858153|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858154|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
1858155|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858156|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858157|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858158|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
1858159|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858160|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858161|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858162|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858163|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858164|NCT00041132|Leucovorin|leucovorin|mesh-list
1858165|NCT00041132|Cytarabine|cytarabine|mesh-list
1858166|NCT00041132|Dexamethasone|dexamethasone|mesh-list
1858167|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
1858168|NCT00041132|Rituximab|rituximab|mesh-list
1858169|NCT00041132|Doxorubicin|doxorubicin|mesh-list
1858170|NCT00041132|Methotrexate|methotrexate|mesh-list
1858171|NCT00041132|Vincristine|vincristine|mesh-list
1858172|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
1858173|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858174|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
1858175|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858176|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858177|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858178|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
1858179|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858180|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858181|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858182|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858183|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
1858184|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
1858185|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858186|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1858187|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
1858188|NCT00041132|Hormones|hormones|mesh-ancestor
1858189|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858190|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1858191|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858192|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858193|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858194|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858195|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858196|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1858197|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
1858198|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1858199|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858200|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
1858201|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858202|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1858203|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1858204|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
1858205|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858206|NCT00041132|Antidotes|antidotes|mesh-ancestor
1858207|NCT00041132|Protective Agents|protective agents|mesh-ancestor
1858208|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
1858209|NCT00041132|Vitamins|vitamins|mesh-ancestor
1858210|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
1858211|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858212|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858213|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858214|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858215|NCT00041470|Paclitaxel|paclitaxel|mesh-list
1858216|NCT00041470|Vinorelbine|vinorelbine|mesh-list
1858217|NCT00041470|Trastuzumab|trastuzumab|mesh-list
1858218|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858219|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858220|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858221|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858222|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858223|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858224|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858225|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
1858226|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1858227|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1858228|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858229|NCT00041938|Aspirin|aspirin|mesh-list
1858230|NCT00041938|Warfarin|warfarin|mesh-list
1858231|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1858232|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1858233|NCT00041938|Analgesics|analgesics|mesh-ancestor
1858234|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
1858235|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858236|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858237|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858238|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858239|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1858240|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1858241|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858242|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1858243|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1858244|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858245|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
1858246|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
1858247|NCT00042224|Clozapine|clozapine|mesh-list
1858248|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1858249|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
1858250|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858251|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858252|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858253|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1858254|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1858255|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1858256|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1858257|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
1858258|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
1858259|NCT00042432|Cinacalcet|cinacalcet|mesh-list
1858260|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1858261|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858262|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1858263|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
1858264|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858265|NCT00042939|Docetaxel|docetaxel|mesh-list
1858266|NCT00042939|Irinotecan|irinotecan|mesh-list
1858267|NCT00042939|Cetuximab|cetuximab|mesh-list
1858268|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858269|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858270|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858271|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858272|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858273|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1858274|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858275|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858276|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858277|NCT00042991|Gefitinib|gefitinib|mesh-list
1858278|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858279|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858280|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858281|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858282|NCT00043186|Denosumab|denosumab|mesh-list
1858283|NCT00043186|Alendronate|alendronate|mesh-list
1858284|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1858285|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858286|NCT00043550|Sertraline|sertraline|mesh-list
1858287|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1858288|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
1858289|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1858290|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1858291|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1858292|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1858293|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858294|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858295|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
1858296|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858297|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1858298|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1858299|NCT00043979|Cyclosporine|cyclosporine|mesh-list
1858300|NCT00043979|Sirolimus|sirolimus|mesh-list
1858301|NCT00043979|Prednisone|prednisone|mesh-list
1858302|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
1858303|NCT00043979|Melphalan|melphalan|mesh-list
1858304|NCT00043979|Doxorubicin|doxorubicin|mesh-list
1858305|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1858306|NCT00043979|Fludarabine|fludarabine|mesh-list
1858307|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
1858308|NCT00043979|Etoposide|etoposide|mesh-list
1858309|NCT00043979|Vincristine|vincristine|mesh-list
1858310|NCT00043979|Tacrolimus|tacrolimus|mesh-list
1858311|NCT00043979|Cyclosporins|cyclosporins|mesh-list
1858312|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1858313|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858314|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
1858315|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858316|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858317|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858318|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
1858319|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858320|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858321|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858322|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858323|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858324|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858325|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858326|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858327|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
1858328|NCT00043979|Hormones|hormones|mesh-ancestor
1858329|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858330|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1858331|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858332|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
1858333|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858334|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858335|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858336|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858337|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858338|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
1858339|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858340|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858341|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858342|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1858343|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1858344|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1858345|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1858346|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1858347|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858348|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1858349|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1858350|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1858351|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1858352|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
1858353|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858354|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858355|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1858356|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1858357|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
1858358|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1858359|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1858360|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
1858361|NCT00044044|Haloperidol|haloperidol|mesh-list
1858362|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
1858363|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1858364|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
1858365|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
1858366|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858367|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858368|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1858369|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1858370|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1858371|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1858372|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1858373|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1858374|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
1858375|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858376|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858377|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1858378|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1858379|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1858380|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1858381|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
1858382|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1858383|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1858384|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
1858385|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1858386|NCT00044083|Tolcapone|tolcapone|mesh-list
1858387|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1858388|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1858389|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1858390|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858391|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858392|NCT00044213|Vitamins|vitamins|mesh-list
1858393|NCT00044213|Edetic Acid|edetic acid|mesh-list
1858394|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
1858395|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
1858396|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858397|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
1858398|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1858399|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
1858400|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
1858626|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
1858401|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858402|NCT00044213|Antidotes|antidotes|mesh-ancestor
1858403|NCT00044213|Protective Agents|protective agents|mesh-ancestor
1858404|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1858405|NCT00044512|Sorafenib|sorafenib|mesh-list
1858406|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858407|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858408|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858409|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858410|NCT00044655|Olanzapine|olanzapine|mesh-list
1858411|NCT00044655|Risperidone|risperidone|mesh-list
1858412|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1858413|NCT00044655|Aripiprazole|aripiprazole|mesh-list
1858414|NCT00044655|Ziprasidone|ziprasidone|mesh-list
1858415|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1858416|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
1858417|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858418|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858419|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858420|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1858421|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1858422|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1858423|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1858424|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1858425|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
1858426|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
1858427|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
1858428|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858429|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1858430|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1858431|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1858432|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1858433|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
1858434|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
1858435|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1858436|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1858437|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1858438|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1858439|NCT00045032|Trastuzumab|trastuzumab|mesh-list
1858440|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858441|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858442|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1858443|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858444|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858445|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858446|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858447|NCT00045162|Irinotecan|irinotecan|mesh-list
1858448|NCT00045162|Etoposide|etoposide|mesh-list
1858449|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858450|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1858451|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858452|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858453|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858454|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858455|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858456|NCT00045305|Cyclosporine|cyclosporine|mesh-list
1858457|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
1858458|NCT00045305|Methotrexate|methotrexate|mesh-list
1858459|NCT00045305|Pentostatin|pentostatin|mesh-list
1858460|NCT00045305|Methoxsalen|methoxsalen|mesh-list
1858461|NCT00045305|Cyclosporins|cyclosporins|mesh-list
1858462|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1858463|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
1858464|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1858465|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858466|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858467|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
1858468|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858469|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858470|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858471|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858472|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1858473|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858474|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
1858475|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858476|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1858477|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
1858478|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858479|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858480|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858481|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1858482|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
1858483|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858484|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1858485|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1858486|NCT00045435|Cyclosporine|cyclosporine|mesh-list
1858487|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
1858488|NCT00045435|Fludarabine|fludarabine|mesh-list
1858489|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
1858490|NCT00045435|Cyclosporins|cyclosporins|mesh-list
1858491|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858492|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858493|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
1858494|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858495|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858496|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
1858497|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858498|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858499|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
1858500|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858501|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858502|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858503|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858504|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858505|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1858506|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
1858507|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858508|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1858509|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858510|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858511|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858512|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858513|NCT00045630|Gemcitabine|gemcitabine|mesh-list
1858514|NCT00045630|Paclitaxel|paclitaxel|mesh-list
1858515|NCT00045630|Carboplatin|carboplatin|mesh-list
1858516|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858517|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858518|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858519|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858520|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858521|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858522|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858523|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
1858524|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
1858525|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858526|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858527|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858528|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
1858529|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858530|NCT00045708|Epothilones|epothilones|mesh-list
1858531|NCT00045708|Epothilone B|epothilone b|mesh-list
1858532|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
1858533|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858534|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858535|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858536|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858537|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858538|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
1858539|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858540|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858541|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858542|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858543|NCT00045942|Itraconazole|itraconazole|mesh-list
1858544|NCT00045942|Midostaurin|midostaurin|mesh-list
1858545|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
1858546|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858547|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1858548|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1858549|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858550|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858551|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1858552|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
1858553|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858554|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858555|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1858556|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858557|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858558|NCT00046228|Reteplase|reteplase|mesh-list
1858559|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1858560|NCT00046228|Abciximab|abciximab|mesh-list
1858561|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
1858562|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1858563|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1858564|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1858565|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858566|NCT00046475|Midodrine|midodrine|mesh-list
1858567|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
1858568|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
1858569|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858570|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858571|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1858572|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1858573|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1858574|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1858575|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
1858576|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858577|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858578|NCT00046566|Caseins|caseins|mesh-list
1858579|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
1858580|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
1858581|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858582|NCT00046839|Celecoxib|celecoxib|mesh-list
1858583|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
1858584|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1858585|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1858586|NCT00046839|Analgesics|analgesics|mesh-ancestor
1858587|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
1858588|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858589|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858590|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858591|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858592|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1858593|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858594|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858595|NCT00046930|Cytarabine|cytarabine|mesh-list
1858596|NCT00046930|Daunorubicin|daunorubicin|mesh-list
1858597|NCT00046930|Molgramostim|molgramostim|mesh-list
1858598|NCT00046930|Lenograstim|lenograstim|mesh-list
1858599|NCT00046930|Sargramostim|sargramostim|mesh-list
1858600|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1858601|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
1858602|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858603|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858604|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
1858605|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858606|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858607|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
1858608|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858609|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858610|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858611|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858612|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858613|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858614|NCT00047008|Cisplatin|cisplatin|mesh-list
1858615|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858616|NCT00047060|Cyclosporine|cyclosporine|mesh-list
1858617|NCT00047060|Fludarabine|fludarabine|mesh-list
1858618|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
1858619|NCT00047060|Cyclosporins|cyclosporins|mesh-list
1858620|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858621|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858622|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858623|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
1858624|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858625|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858627|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858628|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858629|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858630|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858631|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858632|NCT00047320|Carboplatin|carboplatin|mesh-list
1858633|NCT00047320|Etoposide|etoposide|mesh-list
1858634|NCT00047320|Ifosfamide|ifosfamide|mesh-list
1858635|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
1858636|NCT00047320|Thiotepa|thiotepa|mesh-list
1858637|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858638|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858639|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858640|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858641|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858642|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858643|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858644|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
1858645|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858646|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858647|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
1858648|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858649|NCT00047697|Donepezil|donepezil|mesh-list
1858650|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1858651|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858652|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858653|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
1858654|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858655|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858656|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
1858657|NCT00047879|Interferons|interferons|mesh-list
1858658|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
1858659|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
1858660|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1858661|NCT00047879|Thalidomide|thalidomide|mesh-list
1858662|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858663|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
1858664|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858665|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
1858666|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858667|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858668|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
1858669|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858670|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1858671|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1858672|NCT00047879|Growth Substances|growth substances|mesh-ancestor
1858673|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
1858674|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
1858675|NCT00048035|Hematinics|hematinics|mesh-ancestor
1858676|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
1858677|NCT00048048|Hematinics|hematinics|mesh-ancestor
1858678|NCT00048061|Vitamin D|vitamin d|mesh-list
1858679|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
1858680|NCT00048061|Calcium|calcium|mesh-list
1858681|NCT00048061|Vitamins|vitamins|mesh-ancestor
1858682|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
1858683|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858684|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1858685|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1858686|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
1858687|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1858688|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858689|NCT00048165|Cyclosporine|cyclosporine|mesh-list
1858690|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
1858691|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
1858692|NCT00048165|Cyclosporins|cyclosporins|mesh-list
1858693|NCT00048165|Daclizumab|daclizumab|mesh-list
1858694|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858695|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858696|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858697|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
1858698|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858699|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
1858700|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858701|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858702|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858703|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858704|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858705|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858706|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1858707|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
1858708|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858709|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858710|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
1858711|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
1858712|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1858713|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1858714|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
1858715|NCT00048165|Hormones|hormones|mesh-ancestor
1858716|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858717|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1858718|NCT00048165|Protective Agents|protective agents|mesh-ancestor
1858719|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
1858720|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1858721|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
1858722|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858723|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858724|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
1858725|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858726|NCT00048542|Adalimumab|adalimumab|mesh-list
1858727|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858728|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858729|NCT00048568|Methotrexate|methotrexate|mesh-list
1858730|NCT00048568|Abatacept|abatacept|mesh-list
1858731|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1858732|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
1858733|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1858734|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858735|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858736|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
1858737|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858738|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858739|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
1858740|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858741|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1858742|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858743|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
1858744|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858745|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1858746|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1858747|NCT00048581|Abatacept|abatacept|mesh-list
1858748|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1858749|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858750|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858751|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858752|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
1858753|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858754|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858755|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1858756|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
1858757|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858758|NCT00048737|Vidarabine|vidarabine|mesh-list
1858759|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
1858760|NCT00048737|Rituximab|rituximab|mesh-list
1858761|NCT00048737|Fludarabine|fludarabine|mesh-list
1858762|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
1858763|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858764|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
1858765|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858766|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858767|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858768|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
1858769|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858770|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858771|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858772|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858773|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858774|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
1858775|NCT00048737|Antiviral Agents|antiviral agents|mesh-ancestor
1858776|NCT00048737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858777|NCT00048815|Citalopram|citalopram|mesh-list
1858778|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1858779|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1858780|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1858781|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858782|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858783|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
1858784|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858785|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1858786|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
1858787|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1858788|NCT00048893|Metronidazole|metronidazole|mesh-list
1858789|NCT00048893|Paclitaxel|paclitaxel|mesh-list
1858790|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
1858791|NCT00048893|Doxorubicin|doxorubicin|mesh-list
1858792|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1858793|NCT00048893|Fludarabine|fludarabine|mesh-list
1858794|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
1858795|NCT00048893|Vaccines|vaccines|mesh-list
1858796|NCT00048893|Sargramostim|sargramostim|mesh-list
1858797|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
1858798|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858799|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858800|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858801|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858802|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858803|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858804|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858805|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858806|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858807|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858808|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
1858809|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858810|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858811|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858812|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858813|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858814|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858815|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
1858816|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858817|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858818|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1858819|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1858820|NCT00048932|Abatacept|abatacept|mesh-list
1858821|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1858822|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858823|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858824|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858825|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
1858826|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858827|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858828|NCT00049036|Prednisone|prednisone|mesh-list
1858829|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
1858830|NCT00049036|Rituximab|rituximab|mesh-list
1858831|NCT00049036|Doxorubicin|doxorubicin|mesh-list
1858832|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1858833|NCT00049036|Etoposide|etoposide|mesh-list
1858834|NCT00049036|Vincristine|vincristine|mesh-list
1858835|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
1858836|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858837|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
1858838|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858839|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858840|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858841|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
1858842|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858843|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858844|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858845|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858846|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858847|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858848|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858849|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858850|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858851|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
1858852|NCT00049036|Hormones|hormones|mesh-ancestor
1858853|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858854|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1858855|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858856|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858857|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858858|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858859|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
1858860|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858861|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858862|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858863|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858864|NCT00049257|Paclitaxel|paclitaxel|mesh-list
1858865|NCT00049257|Carboplatin|carboplatin|mesh-list
1858866|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858867|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858868|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858869|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858870|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858871|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858872|NCT00049322|Bevacizumab|bevacizumab|mesh-list
1858873|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858874|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858875|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1858876|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1858877|NCT00049322|Growth Substances|growth substances|mesh-ancestor
1858878|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858879|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
1858880|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
1858881|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
1858882|NCT00049504|Fludarabine|fludarabine|mesh-list
1858883|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
1858884|NCT00049504|Tacrolimus|tacrolimus|mesh-list
1858885|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858886|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
1858887|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858888|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858889|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858890|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
1858891|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858892|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858893|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858894|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858895|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
1858896|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1858897|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858898|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858899|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1858900|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
1858901|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858902|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858903|NCT00049517|Cytarabine|cytarabine|mesh-list
1858904|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
1858905|NCT00049517|Busulfan|busulfan|mesh-list
1858906|NCT00049517|Daunorubicin|daunorubicin|mesh-list
1858907|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
1858908|NCT00049517|Sargramostim|sargramostim|mesh-list
1858909|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858910|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
1858911|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858912|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1858913|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1858914|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
1858915|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858916|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858917|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1858918|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858919|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
1858920|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
1858921|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858922|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1858923|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1858924|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1858925|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858926|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1858927|NCT00049530|Interferons|interferons|mesh-list
1858928|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
1858929|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
1858930|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1858931|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858932|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
1858933|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858934|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
1858935|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858936|NCT00049543|Gefitinib|gefitinib|mesh-list
1858937|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858938|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1858939|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858940|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858941|NCT00049673|Thalidomide|thalidomide|mesh-list
1858942|NCT00049673|Prednisone|prednisone|mesh-list
1858943|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1858944|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
1858945|NCT00049673|Hormones|hormones|mesh-ancestor
1858946|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858947|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858948|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1858949|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858950|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1858951|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
1858952|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
1858953|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1858954|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858955|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1858956|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1858957|NCT00049673|Growth Substances|growth substances|mesh-ancestor
1858958|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
1858959|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1858960|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
1858961|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858962|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
1858963|NCT00050011|Letrozole|letrozole|mesh-list
1858964|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858965|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1858966|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1858967|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1858968|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858969|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1858970|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
1858971|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1858972|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858973|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1858974|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1858975|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
1858976|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1858977|NCT00050167|Paclitaxel|paclitaxel|mesh-list
1858978|NCT00050167|Docetaxel|docetaxel|mesh-list
1858979|NCT00050167|Capecitabine|capecitabine|mesh-list
1858980|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1858981|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1858982|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
1858983|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
1858984|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
1858985|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858986|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1858987|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
1858988|NCT00050622|Methylphenidate|methylphenidate|mesh-list
1858989|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1858990|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1858991|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1858992|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1858993|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1858994|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1858995|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
1858996|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1858997|NCT00050778|Interferons|interferons|mesh-list
1858998|NCT00050778|Interferon-beta|interferon-beta|mesh-list
1858999|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
1859000|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
1859001|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859002|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
1859003|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859004|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859005|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
1859006|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859007|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1859008|NCT00050960|Paclitaxel|paclitaxel|mesh-list
1859009|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1859010|NCT00050960|Carboplatin|carboplatin|mesh-list
1859011|NCT00050960|Bexarotene|bexarotene|mesh-list
1859012|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859013|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859014|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859015|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859016|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859017|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859018|NCT00050986|Temozolomide|temozolomide|mesh-list
1859019|NCT00050986|Tipifarnib|tipifarnib|mesh-list
1859020|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859021|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
1859022|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859023|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859024|NCT00051168|Travoprost|travoprost|mesh-list
1859025|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1859026|NCT00051311|Cyclosporine|cyclosporine|mesh-list
1859027|NCT00051311|Prednisone|prednisone|mesh-list
1859028|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
1859029|NCT00051311|Doxorubicin|doxorubicin|mesh-list
1859030|NCT00051311|Methotrexate|methotrexate|mesh-list
1859031|NCT00051311|Fludarabine|fludarabine|mesh-list
1859032|NCT00051311|Etoposide|etoposide|mesh-list
1859033|NCT00051311|Vincristine|vincristine|mesh-list
1859034|NCT00051311|Cyclosporins|cyclosporins|mesh-list
1859035|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859036|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
1859037|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859038|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859039|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859040|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
1859041|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859042|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859043|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859044|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859045|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859046|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859047|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859048|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859049|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
1859050|NCT00051311|Hormones|hormones|mesh-ancestor
1859051|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859052|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859053|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1859054|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
1859055|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1859056|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859057|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
1859058|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859059|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1859060|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1859061|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859062|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859063|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859064|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859065|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
1859066|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859067|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859068|NCT00051558|Alendronate|alendronate|mesh-list
1859069|NCT00051558|Teriparatide|teriparatide|mesh-list
1859070|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1859071|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859072|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1859073|NCT00051636|Vitamin D|vitamin d|mesh-list
1859074|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
1859075|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
1859076|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
1859077|NCT00051636|Calcium|calcium|mesh-list
1859078|NCT00051636|Vitamins|vitamins|mesh-ancestor
1859079|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
1859080|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859081|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1859082|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1859083|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1859084|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1859161|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859085|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859086|NCT00052078|Sertraline|sertraline|mesh-list
1859087|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
1859088|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859089|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1859090|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1859091|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1859092|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859093|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859094|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
1859095|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859096|NCT00052429|Fluorouracil|fluorouracil|mesh-list
1859097|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859098|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
1859099|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859100|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859101|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859102|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
1859103|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859104|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1859105|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859106|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1859107|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859108|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859109|NCT00052715|Poly ICLC|poly iclc|mesh-list
1859110|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
1859111|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
1859112|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859113|NCT00052910|Leucovorin|leucovorin|mesh-list
1859114|NCT00052910|Fluorouracil|fluorouracil|mesh-list
1859115|NCT00052910|Epirubicin|epirubicin|mesh-list
1859116|NCT00052910|Calcium|calcium|mesh-list
1859117|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
1859118|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859119|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1859120|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859121|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
1859122|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859123|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859124|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859125|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
1859126|NCT00052910|Antidotes|antidotes|mesh-ancestor
1859127|NCT00052910|Protective Agents|protective agents|mesh-ancestor
1859128|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
1859129|NCT00052910|Vitamins|vitamins|mesh-ancestor
1859130|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
1859131|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859132|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859133|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859134|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859135|NCT00053014|Cyclosporine|cyclosporine|mesh-list
1859136|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
1859137|NCT00053014|Fludarabine|fludarabine|mesh-list
1859138|NCT00053014|Cyclosporins|cyclosporins|mesh-list
1859139|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859140|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859141|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859142|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
1859143|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859144|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859145|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
1859146|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859147|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859148|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859149|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859150|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859151|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1859152|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
1859153|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1859154|NCT00053352|Etoposide|etoposide|mesh-list
1859155|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
1859156|NCT00053352|Bleomycin|bleomycin|mesh-list
1859157|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859158|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859159|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859160|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859162|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859163|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859164|NCT00053365|Irofulven|irofulven|mesh-list
1859165|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859166|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
1859167|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859168|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859169|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
1859170|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1859171|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1859172|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859173|NCT00053482|Vaccines|vaccines|mesh-list
1859174|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
1859175|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859176|NCT00053677|Naltrexone|naltrexone|mesh-list
1859177|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1859178|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1859179|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859180|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
1859181|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859182|NCT00053703|Olanzapine|olanzapine|mesh-list
1859183|NCT00053703|Risperidone|risperidone|mesh-list
1859184|NCT00053703|Molindone|molindone|mesh-list
1859185|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1859186|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
1859187|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859188|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859189|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859190|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1859191|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1859192|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1859193|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859194|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1859195|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
1859196|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
1859197|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
1859198|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859199|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1859200|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1859201|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1859202|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1859203|NCT00053846|Buspirone|buspirone|mesh-list
1859204|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1859205|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1859206|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1859207|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859208|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859209|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1859210|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
1859211|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859212|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859213|NCT00053898|Tamoxifen|tamoxifen|mesh-list
1859214|NCT00053898|Anastrozole|anastrozole|mesh-list
1859215|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859216|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1859217|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
1859218|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859219|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859220|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859221|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859222|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1859223|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1859224|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1859225|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1859226|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1859227|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859228|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
1859229|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
1859230|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
1859231|NCT00053989|Fludarabine|fludarabine|mesh-list
1859232|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
1859233|NCT00053989|Tacrolimus|tacrolimus|mesh-list
1859234|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1859235|NCT00053989|Sargramostim|sargramostim|mesh-list
1859236|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859237|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
1859238|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859239|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859240|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859241|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
1859242|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859243|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859244|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859245|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859246|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
1859247|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859248|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859249|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859250|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1859251|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
1859252|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1859253|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859254|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859255|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
1859256|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
1859257|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859258|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1859259|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
1859260|NCT00053989|Hormones|hormones|mesh-ancestor
1859261|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859262|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1859263|NCT00053989|Protective Agents|protective agents|mesh-ancestor
1859264|NCT00054028|Suramin|suramin|mesh-list
1859265|NCT00054028|Paclitaxel|paclitaxel|mesh-list
1859266|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859267|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859268|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859269|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859270|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859271|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859272|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
1859273|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
1859274|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1859275|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859276|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1859277|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1859278|NCT00054132|Bevacizumab|bevacizumab|mesh-list
1859279|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1859280|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1859281|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
1859282|NCT00054132|Antibodies|antibodies|mesh-list
1859283|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
1859284|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1859285|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
1859286|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859287|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1859288|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1859289|NCT00054132|Growth Substances|growth substances|mesh-ancestor
1859290|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859291|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
1859292|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
1859293|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1859294|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859295|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859296|NCT00054275|Docetaxel|docetaxel|mesh-list
1859297|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1859298|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859299|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859300|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859301|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859302|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859303|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1859304|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859305|NCT00054327|Cytarabine|cytarabine|mesh-list
1859306|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
1859307|NCT00054327|Busulfan|busulfan|mesh-list
1859308|NCT00054327|Etoposide|etoposide|mesh-list
1859309|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
1859310|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859311|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
1859312|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859313|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859314|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859315|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
1859316|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859317|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859318|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859319|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859320|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859321|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859322|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859323|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859324|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
1859325|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
1859326|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859327|NCT00054353|Cyclosporine|cyclosporine|mesh-list
1859328|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
1859329|NCT00054353|Fludarabine|fludarabine|mesh-list
1859330|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
1859331|NCT00054353|Melphalan|melphalan|mesh-list
1859332|NCT00054353|Cyclosporins|cyclosporins|mesh-list
1859333|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859334|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859335|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
1859336|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859337|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859338|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
1859339|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859340|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859341|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
1859342|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859343|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859344|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859345|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859346|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859347|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1859348|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
1859349|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1859350|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859351|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
1859352|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859353|NCT00054639|Rituximab|rituximab|mesh-list
1859354|NCT00054639|Oblimersen|oblimersen|mesh-list
1859355|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859356|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859357|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
1859358|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859359|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859360|NCT00054665|Prednisone|prednisone|mesh-list
1859361|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
1859362|NCT00054665|Doxorubicin|doxorubicin|mesh-list
1859363|NCT00054665|Etoposide|etoposide|mesh-list
1859364|NCT00054665|Vincristine|vincristine|mesh-list
1859365|NCT00054665|Bortezomib|bortezomib|mesh-list
1859366|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859367|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
1859368|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859369|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859370|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859371|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
1859372|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859373|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859374|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859375|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859376|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859377|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859378|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859379|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859380|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
1859381|NCT00054665|Hormones|hormones|mesh-ancestor
1859382|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859383|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859384|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859385|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859386|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859387|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859388|NCT00054691|Gefitinib|gefitinib|mesh-list
1859389|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859390|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1859391|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859392|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859393|NCT00054704|Riluzole|riluzole|mesh-list
1859394|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
1859395|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1859396|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1859397|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859398|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859399|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859400|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1859401|NCT00054704|Protective Agents|protective agents|mesh-ancestor
1859402|NCT00054717|Ritonavir|ritonavir|mesh-list
1859403|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
1859404|NCT00054717|Tipranavir|tipranavir|mesh-list
1859405|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
1859406|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1859407|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859408|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859409|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1859410|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1859411|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
1859412|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859413|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1859414|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1859415|NCT00054756|Hormones|hormones|mesh-list
1859416|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
1859417|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859418|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859419|NCT00055237|Bevacizumab|bevacizumab|mesh-list
1859420|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859421|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859422|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1859423|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1859424|NCT00055237|Growth Substances|growth substances|mesh-ancestor
1859425|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859426|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
1859427|NCT00055497|Adalimumab|adalimumab|mesh-list
1859428|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859429|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859430|NCT00055601|Gemcitabine|gemcitabine|mesh-list
1859431|NCT00055601|Paclitaxel|paclitaxel|mesh-list
1859432|NCT00055601|Fluorouracil|fluorouracil|mesh-list
1859433|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859434|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859435|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859436|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859437|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859438|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859439|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859440|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
1859441|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
1859442|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859443|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859444|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859445|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
1859446|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859447|NCT00055692|Bevacizumab|bevacizumab|mesh-list
1859448|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1859449|NCT00055692|Antibodies|antibodies|mesh-list
1859450|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
1859451|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1859452|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859453|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1859454|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1859455|NCT00055692|Growth Substances|growth substances|mesh-ancestor
1859456|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859457|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
1859458|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
1859459|NCT00056160|Dexamethasone|dexamethasone|mesh-list
1859460|NCT00056160|Lenalidomide|lenalidomide|mesh-list
1859461|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859462|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
1859463|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
1859464|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859465|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859466|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1859467|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
1859468|NCT00056160|Hormones|hormones|mesh-ancestor
1859469|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859470|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859471|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859472|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
1859473|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1859474|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1859475|NCT00056160|Growth Substances|growth substances|mesh-ancestor
1859476|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
1859477|NCT00056407|Dutasteride|dutasteride|mesh-list
1859478|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1859479|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1859480|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859481|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859482|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
1859483|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859484|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859485|NCT00056472|Olanzapine|olanzapine|mesh-list
1859486|NCT00056472|Sertraline|sertraline|mesh-list
1859487|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
1859488|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
1859489|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859490|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859491|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1859492|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1859493|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1859494|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1859495|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859496|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1859497|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1859498|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1859499|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859500|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859501|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
1859502|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
1859503|NCT00056498|Risperidone|risperidone|mesh-list
1859504|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1859505|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
1859506|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859507|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859508|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859509|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1859510|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1859511|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1859512|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859513|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1859514|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
1859515|NCT00056550|Antithrombins|antithrombins|mesh-list
1859516|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
1859517|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1859518|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
1859519|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859520|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859521|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
1859522|NCT00056862|Ribavirin|ribavirin|mesh-list
1859523|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1859524|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
1859525|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
1859526|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859527|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
1859528|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859529|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
1859530|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859531|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
1859532|NCT00057330|Vaccines|vaccines|mesh-list
1859533|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
1859534|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
1859535|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859536|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1859537|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859538|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859539|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
1859540|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859541|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
1859542|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1859543|NCT00057330|Protective Agents|protective agents|mesh-ancestor
1859544|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
1859545|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859546|NCT00057681|Valproic Acid|valproic acid|mesh-list
1859547|NCT00057681|Risperidone|risperidone|mesh-list
1859548|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
1859549|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1859550|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
1859551|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859552|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859553|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859554|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1859555|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1859556|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1859557|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1859558|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1859559|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
1859560|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
1859561|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859562|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
1859563|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
1859564|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
1859565|NCT00057785|Fluorouracil|fluorouracil|mesh-list
1859566|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859567|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
1859568|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859569|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859570|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859571|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
1859572|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859573|NCT00057811|Leucovorin|leucovorin|mesh-list
1859574|NCT00057811|Cytarabine|cytarabine|mesh-list
1859575|NCT00057811|Prednisone|prednisone|mesh-list
1859576|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
1859577|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1859578|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1859579|NCT00057811|Prednisolone|prednisolone|mesh-list
1859580|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
1859581|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
1859582|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1859583|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1859584|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1859585|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
1859586|NCT00057811|Rituximab|rituximab|mesh-list
1859587|NCT00057811|Doxorubicin|doxorubicin|mesh-list
1859588|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1859589|NCT00057811|Methotrexate|methotrexate|mesh-list
1859590|NCT00057811|Etoposide|etoposide|mesh-list
1859591|NCT00057811|Vincristine|vincristine|mesh-list
1859592|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
1859593|NCT00057811|Rasburicase|rasburicase|mesh-list
1859594|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1859595|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
1859596|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
1859597|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859598|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
1859599|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859600|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859601|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859602|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
1859603|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859604|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859605|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859606|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859607|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859608|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859609|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859610|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859611|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859612|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
1859613|NCT00057811|Hormones|hormones|mesh-ancestor
1859614|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859615|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859616|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1859617|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
1859618|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1859619|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859620|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
1859621|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859622|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1859623|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1859624|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859625|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
1859626|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859627|NCT00057811|Antidotes|antidotes|mesh-ancestor
1859628|NCT00057811|Protective Agents|protective agents|mesh-ancestor
1859629|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
1859630|NCT00057811|Vitamins|vitamins|mesh-ancestor
1859631|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
1859632|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859633|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859634|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859635|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
1859636|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
1859637|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859638|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1859639|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1859640|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
1859641|NCT00057837|Cisplatin|cisplatin|mesh-list
1859642|NCT00057837|Irinotecan|irinotecan|mesh-list
1859643|NCT00057837|Etoposide|etoposide|mesh-list
1859644|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
1859645|NCT00057837|Topotecan|topotecan|mesh-list
1859646|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
1859647|NCT00057837|Camptothecin|camptothecin|mesh-list
1859648|NCT00057837|Lenograstim|lenograstim|mesh-list
1859649|NCT00057837|Sargramostim|sargramostim|mesh-list
1859650|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859651|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1859652|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859653|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859654|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859655|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859656|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859657|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1859658|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
1859659|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859660|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
1859661|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859662|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859663|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859664|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859665|NCT00057863|Paclitaxel|paclitaxel|mesh-list
1859666|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
1859667|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859668|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859669|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859670|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859671|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859672|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859673|NCT00057876|Gemcitabine|gemcitabine|mesh-list
1859674|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859675|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
1859676|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859677|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859678|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
1859679|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859680|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859681|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859682|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
1859683|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859684|NCT00057941|Gefitinib|gefitinib|mesh-list
1859685|NCT00057941|Fulvestrant|fulvestrant|mesh-list
1859686|NCT00057941|Anastrozole|anastrozole|mesh-list
1859687|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859688|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1859689|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859690|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859691|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859692|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1859693|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1859694|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
1859695|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859773|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
1859696|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859697|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1859698|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1859699|NCT00057954|Cyclosporine|cyclosporine|mesh-list
1859700|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
1859701|NCT00057954|Methotrexate|methotrexate|mesh-list
1859702|NCT00057954|Pentostatin|pentostatin|mesh-list
1859703|NCT00057954|Cyclosporins|cyclosporins|mesh-list
1859704|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1859705|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
1859706|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1859707|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859708|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859709|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
1859710|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859711|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859712|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859713|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859714|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1859715|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859716|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
1859717|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859718|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1859719|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
1859720|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859721|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859722|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859723|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1859724|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
1859725|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1859726|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1859727|NCT00058019|Epothilones|epothilones|mesh-list
1859728|NCT00058019|Epothilone B|epothilone b|mesh-list
1859729|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859730|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859731|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859732|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859733|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859734|NCT00058123|Poly ICLC|poly iclc|mesh-list
1859735|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
1859736|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
1859737|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859738|NCT00058240|Alvocidib|alvocidib|mesh-list
1859739|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859740|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
1859741|NCT00058240|Growth Substances|growth substances|mesh-ancestor
1859742|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859743|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1859744|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859745|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859746|NCT00058370|Vincristine|vincristine|mesh-list
1859747|NCT00058370|Lomustine|lomustine|mesh-list
1859748|NCT00058370|Antibodies|antibodies|mesh-list
1859749|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1859750|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
1859751|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859752|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859753|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859754|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859755|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859756|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859757|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859758|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859759|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
1859760|NCT00058422|Prednisone|prednisone|mesh-list
1859761|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
1859762|NCT00058422|Rituximab|rituximab|mesh-list
1859763|NCT00058422|Doxorubicin|doxorubicin|mesh-list
1859764|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1859765|NCT00058422|Vincristine|vincristine|mesh-list
1859766|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
1859767|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1859768|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859769|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
1859770|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859771|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859772|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859774|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859775|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859776|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859777|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859778|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859779|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859780|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859781|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859782|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859783|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
1859784|NCT00058422|Hormones|hormones|mesh-ancestor
1859785|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859786|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859787|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859788|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859789|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859790|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859791|NCT00058422|Hematinics|hematinics|mesh-ancestor
1859792|NCT00058539|Pertuzumab|pertuzumab|mesh-list
1859793|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859794|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859795|NCT00058552|Pertuzumab|pertuzumab|mesh-list
1859796|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859797|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859798|NCT00058825|Cyclosporine|cyclosporine|mesh-list
1859799|NCT00058825|Fludarabine|fludarabine|mesh-list
1859800|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
1859801|NCT00058825|Tacrolimus|tacrolimus|mesh-list
1859802|NCT00058825|Cyclosporins|cyclosporins|mesh-list
1859803|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859804|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859805|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859806|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
1859807|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859808|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859809|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859810|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
1859811|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859812|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859813|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859814|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859815|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1859816|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1859817|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1859818|NCT00059215|Clopidogrel|clopidogrel|mesh-list
1859819|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1859820|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1859821|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1859822|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1859823|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1859824|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
1859825|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859826|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859827|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859828|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1859829|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1859830|NCT00059228|Estradiol|estradiol|mesh-list
1859831|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1859832|NCT00059228|Estrogens|estrogens|mesh-ancestor
1859833|NCT00059228|Hormones|hormones|mesh-ancestor
1859834|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859835|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859836|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1859837|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
1859838|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1859839|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1859840|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
1859841|NCT00059332|Analgesics|analgesics|mesh-ancestor
1859842|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
1859843|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859844|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859845|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
1859846|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1859847|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1859848|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
1859849|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1859850|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1859851|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859852|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1859853|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
1859854|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1859855|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
1859856|NCT00059475|Interleukin-2|interleukin-2|mesh-list
1859857|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859858|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1859859|NCT00059475|Analgesics|analgesics|mesh-ancestor
1859860|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
1859861|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859862|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859863|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1859864|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
1859865|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859866|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
1859867|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859868|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
1859869|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1859870|NCT00059475|Protective Agents|protective agents|mesh-ancestor
1859871|NCT00059787|Paclitaxel|paclitaxel|mesh-list
1859872|NCT00059787|Carboplatin|carboplatin|mesh-list
1859873|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1859874|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859875|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859876|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859877|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859878|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859879|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859880|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1859881|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859882|NCT00059839|Prednisone|prednisone|mesh-list
1859883|NCT00059839|Doxorubicin|doxorubicin|mesh-list
1859884|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1859885|NCT00059839|Methotrexate|methotrexate|mesh-list
1859886|NCT00059839|Vincristine|vincristine|mesh-list
1859887|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
1859888|NCT00059839|Vinblastine|vinblastine|mesh-list
1859889|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859890|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859891|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859892|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859893|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859894|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859895|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859896|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
1859897|NCT00059839|Hormones|hormones|mesh-ancestor
1859898|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859899|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859900|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859901|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1859902|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
1859903|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1859904|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859905|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
1859906|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859907|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1859908|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859909|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
1859910|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859911|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1859912|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859913|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859914|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859915|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859916|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1859917|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1859918|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859919|NCT00060346|Prednisone|prednisone|mesh-list
1859920|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
1859921|NCT00060346|Rituximab|rituximab|mesh-list
1859922|NCT00060346|Doxorubicin|doxorubicin|mesh-list
1859923|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1859924|NCT00060346|Vincristine|vincristine|mesh-list
1859925|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859926|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
1859927|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859928|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859929|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1859930|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
1859931|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859932|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859933|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1859934|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1859935|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859936|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1859937|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1859938|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859939|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1859940|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
1859941|NCT00060346|Hormones|hormones|mesh-ancestor
1859942|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1859943|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1859944|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1859945|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
1859946|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
1859947|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
1859948|NCT00060424|Cyclosporine|cyclosporine|mesh-list
1859949|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
1859950|NCT00060424|Fludarabine|fludarabine|mesh-list
1859951|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
1859952|NCT00060424|Cyclosporins|cyclosporins|mesh-list
1859953|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859954|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1859955|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
1859956|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859957|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1859958|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
1859959|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859960|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1859961|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
1859962|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859963|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
1859964|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1859965|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1859966|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1859967|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1859968|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
1859969|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1859970|NCT00060528|Metronidazole|metronidazole|mesh-list
1859971|NCT00060528|Molgramostim|molgramostim|mesh-list
1859972|NCT00060528|Sargramostim|sargramostim|mesh-list
1859973|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
1859974|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859975|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1859976|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1859977|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1859978|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1859979|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1859980|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
1859981|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1859982|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
1859983|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1859984|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1859985|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1859986|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
1859987|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1859988|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
1859989|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1859990|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1859991|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1859992|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
1859993|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
1859994|NCT00060840|Protective Agents|protective agents|mesh-ancestor
1859995|NCT00060944|Dexamethasone|dexamethasone|mesh-list
1859996|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
1859997|NCT00060944|Trabectedin|trabectedin|mesh-list
1859998|NCT00060944|BB 1101|bb 1101|mesh-list
1859999|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860000|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
1860001|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
1860002|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860003|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860004|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1860005|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
1860006|NCT00060944|Hormones|hormones|mesh-ancestor
1860007|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860008|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860009|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860010|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
1860011|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860012|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860013|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860014|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
1860015|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
1860016|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860017|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860018|NCT00061373|Aspirin|aspirin|mesh-list
1860019|NCT00061373|Tinzaparin|tinzaparin|mesh-list
1860020|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1860021|NCT00061373|Dalteparin|dalteparin|mesh-list
1860022|NCT00061373|Eptifibatide|eptifibatide|mesh-list
1860023|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1860024|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1860025|NCT00061373|Analgesics|analgesics|mesh-ancestor
1860026|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
1860027|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860028|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860029|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860030|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860031|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1860032|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1860033|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860034|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1860035|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1860036|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860037|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
1860038|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
1860039|NCT00061633|Vancomycin|vancomycin|mesh-list
1860040|NCT00061633|Penicillins|penicillins|mesh-list
1860041|NCT00061633|Telavancin|telavancin|mesh-list
1860042|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860043|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860044|NCT00061893|Celecoxib|celecoxib|mesh-list
1860045|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
1860046|NCT00061893|Ifosfamide|ifosfamide|mesh-list
1860047|NCT00061893|Doxorubicin|doxorubicin|mesh-list
1860048|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1860049|NCT00061893|Etoposide|etoposide|mesh-list
1860050|NCT00061893|Vincristine|vincristine|mesh-list
1860051|NCT00061893|Vinblastine|vinblastine|mesh-list
1860052|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860053|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
1860054|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860055|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860056|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860057|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
1860058|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860059|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860060|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1860061|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860062|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860063|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860064|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860065|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860066|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860067|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860068|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860069|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1860070|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1860071|NCT00061893|Analgesics|analgesics|mesh-ancestor
1860072|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
1860073|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860074|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860075|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1860076|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1860077|NCT00061932|Irinotecan|irinotecan|mesh-list
1860078|NCT00061932|Bortezomib|bortezomib|mesh-list
1860079|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1860080|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860081|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860082|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860083|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860084|NCT00061945|Leucovorin|leucovorin|mesh-list
1860085|NCT00061945|Cytarabine|cytarabine|mesh-list
1860086|NCT00061945|Acyclovir|acyclovir|mesh-list
1860087|NCT00061945|Trimethoprim|trimethoprim|mesh-list
1860088|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
1860089|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1860090|NCT00061945|Dexamethasone|dexamethasone|mesh-list
1860091|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
1860092|NCT00061945|Methotrexate|methotrexate|mesh-list
1860093|NCT00061945|Vincristine|vincristine|mesh-list
1860094|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
1860095|NCT00061945|Daunorubicin|daunorubicin|mesh-list
1860096|NCT00061945|Asparaginase|asparaginase|mesh-list
1860097|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
1860098|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
1860099|NCT00061945|Allopurinol|allopurinol|mesh-list
1860100|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
1860101|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860102|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
1860103|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860104|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860105|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860106|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
1860107|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860108|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860109|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1860110|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860111|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
1860112|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
1860113|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860114|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1860115|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
1860116|NCT00061945|Hormones|hormones|mesh-ancestor
1860117|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860118|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860119|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1860120|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
1860121|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1860122|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860123|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
1860124|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
1860125|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860126|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1860127|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1860128|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
1860129|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860130|NCT00061945|Antidotes|antidotes|mesh-ancestor
1860131|NCT00061945|Protective Agents|protective agents|mesh-ancestor
1860132|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
1860133|NCT00061945|Vitamins|vitamins|mesh-ancestor
1860134|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
1860135|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860136|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860137|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860138|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860139|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1860140|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860141|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860142|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860143|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860144|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
1860145|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1860146|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
1860147|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1860148|NCT00061945|Renal Agents|renal agents|mesh-ancestor
1860149|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
1860150|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1860151|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1860152|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1860153|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1860154|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1860155|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860156|NCT00062010|Interferons|interferons|mesh-list
1860157|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
1860158|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
1860159|NCT00062010|Paclitaxel|paclitaxel|mesh-list
1860160|NCT00062010|Tretinoin|tretinoin|mesh-list
1860161|NCT00062010|Isotretinoin|isotretinoin|mesh-list
1860162|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860163|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860164|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860165|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860166|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860167|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860168|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
1860169|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860170|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
1860171|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860172|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
1860173|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
1860174|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
1860175|NCT00062374|Alovudine|alovudine|mesh-list
1860176|NCT00062374|Cisplatin|cisplatin|mesh-list
1860177|NCT00062374|Irinotecan|irinotecan|mesh-list
1860178|NCT00062374|Camptothecin|camptothecin|mesh-list
1860179|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1860180|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860181|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1860182|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860183|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860184|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860185|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1860186|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860187|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
1860188|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
1860189|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860190|NCT00062439|Docetaxel|docetaxel|mesh-list
1860191|NCT00062439|Etoposide|etoposide|mesh-list
1860192|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860193|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860194|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860195|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860196|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860197|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860198|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860199|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860200|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860201|NCT00062647|Vancomycin|vancomycin|mesh-list
1860202|NCT00062647|Cloxacillin|cloxacillin|mesh-list
1860203|NCT00062647|Telavancin|telavancin|mesh-list
1860204|NCT00062647|Oxacillin|oxacillin|mesh-list
1860205|NCT00062647|Nafcillin|nafcillin|mesh-list
1860206|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860207|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860208|NCT00062738|Paroxetine|paroxetine|mesh-list
1860209|NCT00062738|Nortriptyline|nortriptyline|mesh-list
1860210|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1860211|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1860212|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1860213|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860214|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1860215|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
1860216|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860217|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1860218|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
1860219|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1860220|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1860221|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1860222|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860223|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1860224|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1860225|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
1860226|NCT00062764|Pioglitazone|pioglitazone|mesh-list
1860227|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1860228|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860229|NCT00063154|Pertuzumab|pertuzumab|mesh-list
1860230|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860231|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860232|NCT00063232|Metformin|metformin|mesh-list
1860233|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1860234|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860235|NCT00063258|Paclitaxel|paclitaxel|mesh-list
1860236|NCT00063258|Carboplatin|carboplatin|mesh-list
1860237|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1860238|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860239|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860240|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860241|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860242|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860243|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860244|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1860245|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860246|NCT00063362|Lamotrigine|lamotrigine|mesh-list
1860247|NCT00063362|Valproic Acid|valproic acid|mesh-list
1860248|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
1860249|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
1860250|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1860251|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860252|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860253|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
1860254|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1860255|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1860256|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860257|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
1860258|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1860259|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1860260|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1860261|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1860262|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1860263|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
1860264|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1860265|NCT00063570|Gemcitabine|gemcitabine|mesh-list
1860266|NCT00063570|Pemetrexed|pemetrexed|mesh-list
1860267|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860268|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
1860269|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860270|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860271|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
1860272|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860273|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860274|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860275|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
1860276|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860277|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1860278|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1860279|NCT00063622|Vitamin E|vitamin e|mesh-list
1860280|NCT00063622|Pioglitazone|pioglitazone|mesh-list
1860281|NCT00063622|Vitamins|vitamins|mesh-ancestor
1860282|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
1860283|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860284|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1860285|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
1860286|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860287|NCT00063622|Protective Agents|protective agents|mesh-ancestor
1860288|NCT00063635|Vitamin E|vitamin e|mesh-list
1860289|NCT00063635|Metformin|metformin|mesh-list
1860290|NCT00063635|Vitamins|vitamins|mesh-ancestor
1860291|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
1860292|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860293|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1860294|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
1860295|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860296|NCT00063635|Protective Agents|protective agents|mesh-ancestor
1860297|NCT00063934|Docetaxel|docetaxel|mesh-list
1860298|NCT00063934|Doxorubicin|doxorubicin|mesh-list
1860299|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1860300|NCT00063934|Oblimersen|oblimersen|mesh-list
1860301|NCT00063934|Lenograstim|lenograstim|mesh-list
1860302|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860303|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860304|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860305|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860306|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860307|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860308|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860309|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860310|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860311|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1860312|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
1860313|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860314|NCT00063999|Paclitaxel|paclitaxel|mesh-list
1860315|NCT00063999|Cisplatin|cisplatin|mesh-list
1860316|NCT00063999|Carboplatin|carboplatin|mesh-list
1860317|NCT00063999|Doxorubicin|doxorubicin|mesh-list
1860318|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1860319|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1860320|NCT00063999|Lenograstim|lenograstim|mesh-list
1860321|NCT00063999|Sargramostim|sargramostim|mesh-list
1860322|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860323|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860324|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860325|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860326|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860327|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860328|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860329|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860330|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860331|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860332|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1860333|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
1860334|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860335|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1860336|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
1860337|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1860338|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1860339|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1860340|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
1860341|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1860342|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860343|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1860344|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1860345|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1860346|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860347|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860348|NCT00064038|Dexamethasone|dexamethasone|mesh-list
1860349|NCT00064038|Lenalidomide|lenalidomide|mesh-list
1860350|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860351|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
1860352|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
1860353|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860354|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860355|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1860356|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
1860357|NCT00064038|Hormones|hormones|mesh-ancestor
1860358|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860359|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860360|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860361|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
1860362|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1860363|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1860364|NCT00064038|Growth Substances|growth substances|mesh-ancestor
1860365|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
1860366|NCT00064077|Gemcitabine|gemcitabine|mesh-list
1860367|NCT00064077|Paclitaxel|paclitaxel|mesh-list
1860368|NCT00064077|Vinorelbine|vinorelbine|mesh-list
1860369|NCT00064077|Cisplatin|cisplatin|mesh-list
1860370|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1860371|NCT00064077|Topotecan|topotecan|mesh-list
1860372|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860373|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860374|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860375|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860376|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860377|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860378|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860379|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
1860380|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
1860381|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860382|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860383|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860384|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
1860385|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860386|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1860463|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1860387|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860388|NCT00064259|Fluorouracil|fluorouracil|mesh-list
1860389|NCT00064259|Oblimersen|oblimersen|mesh-list
1860390|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860391|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
1860392|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860393|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860394|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860395|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
1860396|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860397|NCT00064337|Thalidomide|thalidomide|mesh-list
1860398|NCT00064337|Dexamethasone|dexamethasone|mesh-list
1860399|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
1860400|NCT00064337|Melphalan|melphalan|mesh-list
1860401|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860402|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
1860403|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860404|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860405|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860406|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
1860407|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860408|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860409|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1860410|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860411|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
1860412|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
1860413|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860414|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1860415|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
1860416|NCT00064337|Hormones|hormones|mesh-ancestor
1860417|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860418|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860419|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
1860420|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860421|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860422|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1860423|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1860424|NCT00064337|Growth Substances|growth substances|mesh-ancestor
1860425|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
1860426|NCT00064350|Sorafenib|sorafenib|mesh-list
1860427|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860428|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1860429|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860430|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860431|NCT00064701|Cyclosporine|cyclosporine|mesh-list
1860432|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
1860433|NCT00064701|Tacrolimus|tacrolimus|mesh-list
1860434|NCT00064701|Cyclosporins|cyclosporins|mesh-list
1860435|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860436|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
1860437|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860438|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1860439|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860440|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860441|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
1860442|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860443|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
1860444|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860445|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860446|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860447|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1860448|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
1860449|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860450|NCT00064792|Simvastatin|simvastatin|mesh-list
1860451|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1860452|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1860453|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
1860454|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860455|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1860456|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1860457|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860458|NCT00064844|Nicotine|nicotine|mesh-list
1860459|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1860460|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
1860461|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860462|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860464|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1860465|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
1860466|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1860467|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860468|NCT00064987|Hormones|hormones|mesh-list
1860469|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1860470|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860471|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860472|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
1860473|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1860474|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860475|NCT00065156|Lenalidomide|lenalidomide|mesh-list
1860476|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
1860477|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860478|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1860479|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1860480|NCT00065156|Growth Substances|growth substances|mesh-ancestor
1860481|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
1860482|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860483|NCT00065182|Docetaxel|docetaxel|mesh-list
1860484|NCT00065182|Topotecan|topotecan|mesh-list
1860485|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860486|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860487|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860488|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860489|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860490|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1860491|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860492|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860493|NCT00065260|Cyclosporine|cyclosporine|mesh-list
1860494|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
1860495|NCT00065260|Cyclosporins|cyclosporins|mesh-list
1860496|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
1860497|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1860498|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860499|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860500|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860501|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
1860502|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860503|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
1860504|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860505|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
1860506|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860507|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1860508|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860509|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860510|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
1860511|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860512|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860513|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860514|NCT00065468|Interferons|interferons|mesh-list
1860515|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
1860516|NCT00065468|Sirolimus|sirolimus|mesh-list
1860517|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860518|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
1860519|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860520|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
1860521|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860522|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860523|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860524|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
1860525|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860526|NCT00065507|Entecavir|entecavir|mesh-list
1860527|NCT00065507|Adefovir|adefovir|mesh-list
1860528|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
1860529|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860530|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1860531|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1860532|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860533|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860534|NCT00065611|Dexamethasone|dexamethasone|mesh-list
1860535|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860536|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
1860537|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
1860538|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860539|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860540|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1860541|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
1860542|NCT00065611|Hormones|hormones|mesh-ancestor
1860543|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860544|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860545|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860546|NCT00065806|Atorvastatin|atorvastatin|mesh-list
1860547|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1860548|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1860549|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
1860550|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860551|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1860552|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1860553|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860554|NCT00066066|Amoxicillin|amoxicillin|mesh-list
1860555|NCT00066066|Metronidazole|metronidazole|mesh-list
1860556|NCT00066066|Doxycycline|doxycycline|mesh-list
1860557|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1860558|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860559|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1860560|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1860561|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
1860562|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
1860563|NCT00066170|Modafinil|modafinil|mesh-list
1860564|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1860565|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860566|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1860567|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1860568|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1860569|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860570|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1860571|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1860572|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
1860573|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
1860574|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1860575|NCT00066222|Etoposide|etoposide|mesh-list
1860576|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860577|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860578|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860579|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860580|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860581|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860582|NCT00066365|Molgramostim|molgramostim|mesh-list
1860583|NCT00066365|Sargramostim|sargramostim|mesh-list
1860584|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
1860585|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860586|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860587|NCT00066469|Prednisone|prednisone|mesh-list
1860588|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
1860589|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1860590|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1860591|NCT00066469|Prednisolone|prednisolone|mesh-list
1860592|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
1860593|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
1860594|NCT00066469|Rituximab|rituximab|mesh-list
1860595|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1860596|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
1860597|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860598|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
1860599|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860600|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860601|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860602|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
1860603|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860604|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860605|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1860606|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860607|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860608|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
1860609|NCT00066469|Hormones|hormones|mesh-ancestor
1860610|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860611|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860612|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
1860613|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
1860614|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860615|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1860616|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1860617|NCT00066469|Protective Agents|protective agents|mesh-ancestor
1860618|NCT00066573|Anastrozole|anastrozole|mesh-list
1860619|NCT00066573|Exemestane|exemestane|mesh-list
1860620|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860621|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860622|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1860623|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1860624|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860625|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860626|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1860627|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
1860628|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860629|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860630|NCT00066677|Docetaxel|docetaxel|mesh-list
1860631|NCT00066677|Bevacizumab|bevacizumab|mesh-list
1860632|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860633|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860634|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860635|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860636|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860637|NCT00066677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860638|NCT00066677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1860639|NCT00066677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1860640|NCT00066677|Growth Substances|growth substances|mesh-ancestor
1860641|NCT00066677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860642|NCT00066677|Growth Inhibitors|growth inhibitors|mesh-ancestor
1860643|NCT00066690|Tamoxifen|tamoxifen|mesh-list
1860644|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1860645|NCT00066690|Exemestane|exemestane|mesh-list
1860646|NCT00066690|Tryptophan|tryptophan|mesh-list
1860647|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860648|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860649|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860650|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1860651|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
1860652|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860653|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860654|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1860655|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1860656|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1860657|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1860658|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1860659|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860660|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
1860661|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1860662|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
1860663|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1860664|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1860665|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1860666|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
1860667|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1860668|NCT00066703|Tamoxifen|tamoxifen|mesh-list
1860669|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1860670|NCT00066703|Exemestane|exemestane|mesh-list
1860671|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1860672|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
1860673|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860674|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860675|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860676|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860677|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1860678|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1860679|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1860680|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1860681|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1860682|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860683|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860684|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
1860685|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1860686|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
1860687|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1860688|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1860689|NCT00066742|Etoposide|etoposide|mesh-list
1860690|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
1860691|NCT00066742|Tirapazamine|tirapazamine|mesh-list
1860692|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860693|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860694|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860695|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860696|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860697|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860698|NCT00066781|Gemcitabine|gemcitabine|mesh-list
1860699|NCT00066781|Irinotecan|irinotecan|mesh-list
1860700|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860701|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
1860702|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860703|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860704|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
1860705|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860706|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860707|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860708|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
1860709|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860710|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1860711|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860712|NCT00066937|Benztropine|benztropine|mesh-list
1860713|NCT00066937|Nortriptyline|nortriptyline|mesh-list
1860714|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1860715|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
1860716|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1860717|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1860718|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1860719|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1860720|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860721|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
1860722|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1860723|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860724|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1860725|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1860726|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
1860727|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
1860728|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860729|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1860730|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1860731|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
1860732|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1860733|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
1860734|NCT00066963|Fluorides|fluorides|mesh-list
1860735|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
1860736|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
1860737|NCT00066963|Protective Agents|protective agents|mesh-ancestor
1860738|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860739|NCT00067002|Vidarabine|vidarabine|mesh-list
1860740|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
1860741|NCT00067002|Melphalan|melphalan|mesh-list
1860742|NCT00067002|Thiotepa|thiotepa|mesh-list
1860743|NCT00067002|Rituximab|rituximab|mesh-list
1860744|NCT00067002|Fludarabine|fludarabine|mesh-list
1860745|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
1860746|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860747|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
1860748|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860749|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860750|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860751|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
1860752|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860753|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860754|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1860755|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860756|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860757|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
1860758|NCT00067002|Antiviral Agents|antiviral agents|mesh-ancestor
1860759|NCT00067002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860760|NCT00067028|Cytarabine|cytarabine|mesh-list
1860761|NCT00067028|Clofarabine|clofarabine|mesh-list
1860762|NCT00067028|Idarubicin|idarubicin|mesh-list
1860763|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860764|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
1860765|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860766|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860767|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
1860768|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860769|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860770|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
1860771|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860772|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860773|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860774|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860775|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860776|NCT00067808|Decitabine|decitabine|mesh-list
1860777|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860778|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
1860779|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860780|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860781|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860782|NCT00067990|Losartan|losartan|mesh-list
1860783|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1860784|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1860785|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1860786|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1860787|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860788|NCT00068250|Rituximab|rituximab|mesh-list
1860789|NCT00068250|Methotrexate|methotrexate|mesh-list
1860790|NCT00068250|Temozolomide|temozolomide|mesh-list
1860791|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860792|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860793|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
1860794|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860795|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860796|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1860797|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
1860798|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1860799|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860800|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
1860801|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860802|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
1860803|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860804|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1860805|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860806|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1860807|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860808|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
1860809|NCT00068341|Carboplatin|carboplatin|mesh-list
1860810|NCT00068341|Docetaxel|docetaxel|mesh-list
1860811|NCT00068341|Trastuzumab|trastuzumab|mesh-list
1860812|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860813|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
1860814|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
1860815|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
1860816|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860817|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860818|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1860819|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860820|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1860821|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860822|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860823|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
1860824|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860825|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1860826|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860827|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860828|NCT00068393|Gemcitabine|gemcitabine|mesh-list
1860829|NCT00068393|Doxorubicin|doxorubicin|mesh-list
1860830|NCT00068393|Lenograstim|lenograstim|mesh-list
1860831|NCT00068393|Sargramostim|sargramostim|mesh-list
1860832|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860833|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
1860834|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860835|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860836|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
1860837|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860838|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860839|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860840|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
1860841|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860842|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1860843|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1860844|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860845|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1860846|NCT00068406|Cisplatin|cisplatin|mesh-list
1860847|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860848|NCT00068419|Tamoxifen|tamoxifen|mesh-list
1860849|NCT00068419|Sulindac|sulindac|mesh-list
1860850|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860851|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1860852|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
1860853|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1860854|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860855|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860856|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860857|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1860858|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1860859|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1860860|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1860861|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1860862|NCT00068419|Analgesics|analgesics|mesh-ancestor
1860863|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
1860864|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860865|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860866|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860867|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1860868|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860869|NCT00068445|Lamotrigine|lamotrigine|mesh-list
1860870|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
1860871|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1860872|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1860873|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860874|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1860875|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860876|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1860877|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1860878|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1860879|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1860880|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1860881|NCT00068575|Interferons|interferons|mesh-list
1860882|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
1860883|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
1860884|NCT00068575|Cisplatin|cisplatin|mesh-list
1860885|NCT00068575|Fluorouracil|fluorouracil|mesh-list
1860886|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860887|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
1860888|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860889|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860890|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860891|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
1860892|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860893|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
1860894|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1860895|NCT00068588|Capecitabine|capecitabine|mesh-list
1860896|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860897|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
1860898|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860899|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860900|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
1860901|NCT00068601|Goserelin|goserelin|mesh-list
1860902|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860903|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
1860904|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860905|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860906|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1860907|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
1860908|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860909|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860910|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1860911|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1860912|NCT00068692|Leucovorin|leucovorin|mesh-list
1860913|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
1860914|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
1860915|NCT00068692|Fluorouracil|fluorouracil|mesh-list
1860916|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
1860917|NCT00068692|Irinotecan|irinotecan|mesh-list
1860918|NCT00068692|Camptothecin|camptothecin|mesh-list
1860919|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
1860920|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860921|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
1860922|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860923|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860924|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860925|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860926|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
1860927|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1860928|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1860929|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860930|NCT00068692|Antidotes|antidotes|mesh-ancestor
1860931|NCT00068692|Protective Agents|protective agents|mesh-ancestor
1860932|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
1860933|NCT00068692|Vitamins|vitamins|mesh-ancestor
1860934|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
1860935|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1860936|NCT00068770|Celecoxib|celecoxib|mesh-list
1860937|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1860938|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1860939|NCT00068770|Analgesics|analgesics|mesh-ancestor
1860940|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
1860941|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1860942|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860943|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1860944|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1860945|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1860946|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1860947|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1860948|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860949|NCT00069095|Leucovorin|leucovorin|mesh-list
1860950|NCT00069095|Bevacizumab|bevacizumab|mesh-list
1860951|NCT00069095|Fluorouracil|fluorouracil|mesh-list
1860952|NCT00069095|Capecitabine|capecitabine|mesh-list
1860953|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
1860954|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1860955|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860956|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1860957|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1860958|NCT00069095|Growth Substances|growth substances|mesh-ancestor
1860959|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860960|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
1860961|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
1860962|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860963|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860964|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860965|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
1860966|NCT00069095|Antidotes|antidotes|mesh-ancestor
1860967|NCT00069095|Protective Agents|protective agents|mesh-ancestor
1860968|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
1860969|NCT00069095|Vitamins|vitamins|mesh-ancestor
1860970|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
1860971|NCT00069108|Leucovorin|leucovorin|mesh-list
1860972|NCT00069108|Capecitabine|capecitabine|mesh-list
1860973|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
1860974|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860975|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
1860976|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860977|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860978|NCT00069108|Antidotes|antidotes|mesh-ancestor
1860979|NCT00069108|Protective Agents|protective agents|mesh-ancestor
1860980|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860981|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
1860982|NCT00069108|Vitamins|vitamins|mesh-ancestor
1860983|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
1860984|NCT00069121|Leucovorin|leucovorin|mesh-list
1860985|NCT00069121|Fluorouracil|fluorouracil|mesh-list
1860986|NCT00069121|Capecitabine|capecitabine|mesh-list
1860987|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
1860988|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
1860989|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1860990|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1860991|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1860992|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1860993|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
1860994|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1860995|NCT00069121|Antidotes|antidotes|mesh-ancestor
1860996|NCT00069121|Protective Agents|protective agents|mesh-ancestor
1860997|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
1860998|NCT00069121|Vitamins|vitamins|mesh-ancestor
1860999|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
1861000|NCT00069160|Docetaxel|docetaxel|mesh-list
1861001|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
1861002|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861003|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861004|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861005|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861006|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861007|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1861008|NCT00069238|Prednisone|prednisone|mesh-list
1861009|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
1861010|NCT00069238|Doxorubicin|doxorubicin|mesh-list
1861011|NCT00069238|Etoposide|etoposide|mesh-list
1861012|NCT00069238|Vincristine|vincristine|mesh-list
1861013|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
1861014|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861015|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
1861016|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861017|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861018|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861019|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
1861020|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861021|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861022|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861023|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861024|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861025|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861026|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861027|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861028|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
1861029|NCT00069238|Hormones|hormones|mesh-ancestor
1861030|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861031|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1861032|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861033|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861034|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861035|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861036|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861037|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1861038|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861039|NCT00069784|Insulin|insulin|mesh-list
1861040|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1861041|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
1861042|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1861043|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861044|NCT00069823|Esomeprazole|esomeprazole|mesh-list
1861045|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
1861046|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1861047|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1861048|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861049|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861050|NCT00069953|Paclitaxel|paclitaxel|mesh-list
1861051|NCT00069953|Fluorouracil|fluorouracil|mesh-list
1861052|NCT00069953|Lenograstim|lenograstim|mesh-list
1861053|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861054|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861055|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861056|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861057|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861058|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861059|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
1861060|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861061|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861062|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
1861063|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861064|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1861095|NCT00070070|Sargramostim|sargramostim|mesh-list
1861096|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
1861097|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
1861098|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861099|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1861100|NCT00070109|Trabectedin|trabectedin|mesh-list
1861101|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861102|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
1861103|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861104|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861105|NCT00070135|Methotrexate|methotrexate|mesh-list
1861106|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
1861107|NCT00070135|Fludarabine|fludarabine|mesh-list
1861108|NCT00070135|Busulfan|busulfan|mesh-list
1861109|NCT00070135|Tacrolimus|tacrolimus|mesh-list
1861110|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1861111|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1861112|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
1861113|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1861114|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861115|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861116|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
1861117|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861118|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861119|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
1861120|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861121|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1861122|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861123|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
1861124|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861125|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861126|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1861127|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
1861128|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861129|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861130|NCT00070291|Cyclosporine|cyclosporine|mesh-list
1861131|NCT00070291|Cyclosporins|cyclosporins|mesh-list
1861132|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861133|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861134|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861135|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
1861136|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861137|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
1861138|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861139|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
1861140|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861141|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1861142|NCT00070317|Methylene Blue|methylene blue|mesh-list
1861143|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
1861144|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861145|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861146|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1861168|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
1861169|NCT00070707|Albuterol|albuterol|mesh-list
1861170|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1861171|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
1861172|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861173|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861174|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1861175|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
1861176|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
1861177|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1861178|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1861179|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1861180|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1861181|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
1861182|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1861183|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861184|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861185|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
1861186|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1861187|NCT00070941|Citalopram|citalopram|mesh-list
1861188|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1861189|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1861190|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1861191|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861192|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1861193|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
1861194|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861195|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1861196|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
1861197|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1861198|NCT00071006|Axitinib|axitinib|mesh-list
1861199|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861200|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861201|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861202|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861203|NCT00071396|Rituximab|rituximab|mesh-list
1861204|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
1861205|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861206|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861207|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
1861208|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861209|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861210|NCT00071487|Belimumab|belimumab|mesh-list
1861211|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861212|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
1861213|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861214|NCT00071721|Valproic Acid|valproic acid|mesh-list
1861215|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
1861216|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861217|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861218|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
1861219|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1861220|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861221|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
1861222|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1861223|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1861224|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1861225|NCT00071760|Ritonavir|ritonavir|mesh-list
1861226|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
1861227|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1861228|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1861229|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
1861230|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861231|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861232|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1861233|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1861234|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
1861235|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861236|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1861237|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1861238|NCT00071799|Cytarabine|cytarabine|mesh-list
1861239|NCT00071799|Azacitidine|azacitidine|mesh-list
1861240|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861241|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
1861242|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861243|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861244|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
1861245|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861246|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861247|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
1861248|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861249|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861250|NCT00071812|Belimumab|belimumab|mesh-list
1861251|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861252|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
1861253|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861254|NCT00071890|Aldesleukin|aldesleukin|mesh-list
1861255|NCT00071890|Interleukin-2|interleukin-2|mesh-list
1861256|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861257|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1861258|NCT00071890|Analgesics|analgesics|mesh-ancestor
1861259|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
1861260|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861261|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861262|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1861263|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1861264|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
1861265|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861266|NCT00071981|Molgramostim|molgramostim|mesh-list
1861267|NCT00071981|Vaccines|vaccines|mesh-list
1861268|NCT00071981|Sargramostim|sargramostim|mesh-list
1861269|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
1861270|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
1861271|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861272|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861273|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1861274|NCT00072176|Sirolimus|sirolimus|mesh-list
1861275|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861276|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861277|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861278|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861279|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
1861280|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861281|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
1861282|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861283|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
1861284|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861285|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861286|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861287|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861288|NCT00072280|Dactinomycin|dactinomycin|mesh-list
1861289|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
1861290|NCT00072280|Ifosfamide|ifosfamide|mesh-list
1861291|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
1861292|NCT00072280|Etoposide|etoposide|mesh-list
1861293|NCT00072280|Vincristine|vincristine|mesh-list
1861294|NCT00072280|Lenograstim|lenograstim|mesh-list
1861295|NCT00072280|Sargramostim|sargramostim|mesh-list
1861296|NCT00072280|Mesna|mesna|mesh-list
1861297|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861298|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
1861299|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861300|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861301|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861302|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
1861303|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861304|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861305|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861306|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861307|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861308|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861309|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861310|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1861311|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861312|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861313|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861314|NCT00072280|Protective Agents|protective agents|mesh-ancestor
1861315|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861316|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861317|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861318|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1861319|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861320|NCT00072384|Carboplatin|carboplatin|mesh-list
1861321|NCT00072384|Etoposide|etoposide|mesh-list
1861322|NCT00072384|Vincristine|vincristine|mesh-list
1861323|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
1861324|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861325|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861326|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861327|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861328|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861329|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861330|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861331|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861332|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861333|NCT00072449|Rituximab|rituximab|mesh-list
1861334|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861335|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861336|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
1861337|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861338|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861339|NCT00072475|Vatalanib|vatalanib|mesh-list
1861340|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861341|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861342|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861343|NCT00072514|Gemcitabine|gemcitabine|mesh-list
1861344|NCT00072514|Dexamethasone|dexamethasone|mesh-list
1861345|NCT00072514|Rituximab|rituximab|mesh-list
1861346|NCT00072514|Carboplatin|carboplatin|mesh-list
1861347|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861348|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
1861349|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
1861350|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861351|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861352|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1861353|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
1861354|NCT00072514|Hormones|hormones|mesh-ancestor
1861355|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861356|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1861357|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861358|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861359|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
1861360|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861361|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861362|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
1861363|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861364|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
1861365|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861366|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861367|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861368|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
1861369|NCT00072566|Bevacizumab|bevacizumab|mesh-list
1861370|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1861371|NCT00072566|Antibodies|antibodies|mesh-list
1861372|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
1861373|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1861374|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
1861375|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
1861376|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861377|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
1861378|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861379|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861380|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861381|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
1861382|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861383|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861384|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861385|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1861386|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1861387|NCT00072566|Growth Substances|growth substances|mesh-ancestor
1861388|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
1861389|NCT00073008|Lapatinib|lapatinib|mesh-list
1861390|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861391|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861392|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861393|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861394|NCT00073021|Mesalamine|mesalamine|mesh-list
1861395|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1861396|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1861397|NCT00073021|Analgesics|analgesics|mesh-ancestor
1861398|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
1861399|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861400|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861401|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861402|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861403|NCT00073073|Vitamin D|vitamin d|mesh-list
1861404|NCT00073073|Exemestane|exemestane|mesh-list
1861405|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
1861406|NCT00073073|Calcium|calcium|mesh-list
1861407|NCT00073073|Vitamins|vitamins|mesh-ancestor
1861408|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
1861409|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861410|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1861411|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1861412|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861413|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1861414|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1861415|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861416|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861417|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1861418|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
1861419|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861420|NCT00073073|Antacids|antacids|mesh-ancestor
1861421|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1861422|NCT00073307|Sorafenib|sorafenib|mesh-list
1861423|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861424|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861425|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861426|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861427|NCT00073528|Letrozole|letrozole|mesh-list
1861428|NCT00073528|Lapatinib|lapatinib|mesh-list
1861429|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861430|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1861431|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1861432|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861433|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861434|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1861435|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
1861436|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861437|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861438|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861439|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1861440|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861441|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861442|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861443|NCT00073918|Iodine|iodine|mesh-list
1861444|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
1861445|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
1861446|NCT00073918|Etoposide|etoposide|mesh-list
1861447|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
1861448|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
1861449|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1861450|NCT00073918|Antibodies|antibodies|mesh-list
1861451|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
1861452|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1861453|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861454|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
1861455|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861456|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861457|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861458|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
1861459|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861460|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861461|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861462|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861463|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861464|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861465|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861466|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1861467|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861468|NCT00073918|Trace Elements|trace elements|mesh-ancestor
1861469|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
1861470|NCT00073957|Cytarabine|cytarabine|mesh-list
1861471|NCT00073957|Rituximab|rituximab|mesh-list
1861472|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861473|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861474|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
1861475|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861476|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861477|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861478|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
1861479|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861480|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
1861481|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861482|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861483|NCT00073983|Gemcitabine|gemcitabine|mesh-list
1861484|NCT00073983|Docetaxel|docetaxel|mesh-list
1861485|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861486|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
1861487|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861488|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861489|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
1861490|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861491|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861492|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861493|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
1861494|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861495|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861496|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861497|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861498|NCT00074035|Pentostatin|pentostatin|mesh-list
1861499|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861500|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1861501|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861502|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861503|NCT00074165|Cytarabine|cytarabine|mesh-list
1861504|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
1861505|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
1861506|NCT00074165|Rituximab|rituximab|mesh-list
1861507|NCT00074165|Carboplatin|carboplatin|mesh-list
1861508|NCT00074165|Etoposide|etoposide|mesh-list
1861509|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
1861510|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861511|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
1861512|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861513|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861514|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861515|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
1861516|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861517|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861518|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861519|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861520|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861521|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861522|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861523|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861524|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861525|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
1861526|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
1861527|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861528|NCT00074165|Antidotes|antidotes|mesh-ancestor
1861529|NCT00074165|Protective Agents|protective agents|mesh-ancestor
1861530|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
1861531|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
1861532|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861533|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
1861534|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
1861535|NCT00074269|Cyclosporine|cyclosporine|mesh-list
1861536|NCT00074269|Methotrexate|methotrexate|mesh-list
1861537|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
1861538|NCT00074269|Fludarabine|fludarabine|mesh-list
1861539|NCT00074269|Melphalan|melphalan|mesh-list
1861540|NCT00074269|Cyclosporins|cyclosporins|mesh-list
1861541|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1861542|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1861543|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
1861544|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1861545|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861546|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861547|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
1861548|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861549|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861550|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
1861551|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861552|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1861553|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861554|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
1861555|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861556|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861557|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
1861558|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861559|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1861560|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861561|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
1861562|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861563|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
1861564|NCT00074282|Rituximab|rituximab|mesh-list
1861565|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
1861566|NCT00074282|Pentostatin|pentostatin|mesh-list
1861567|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861568|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
1861569|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861570|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861571|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861572|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
1861573|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861574|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861575|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861576|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861577|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1861578|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861579|NCT00074308|Bevacizumab|bevacizumab|mesh-list
1861580|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1861581|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
1861582|NCT00074308|Antibodies|antibodies|mesh-list
1861583|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
1861584|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1861585|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861586|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1861587|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1861588|NCT00074308|Growth Substances|growth substances|mesh-ancestor
1861589|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861590|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
1861591|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
1861592|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861593|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861594|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861595|NCT00074412|Nevirapine|nevirapine|mesh-list
1861596|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1861597|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861598|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861599|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861600|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
1861601|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861602|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1861603|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1861604|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1861605|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1861606|NCT00074490|Prednisone|prednisone|mesh-list
1861607|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
1861608|NCT00074490|Rituximab|rituximab|mesh-list
1861609|NCT00074490|Doxorubicin|doxorubicin|mesh-list
1861610|NCT00074490|Fludarabine|fludarabine|mesh-list
1861611|NCT00074490|Etoposide|etoposide|mesh-list
1861612|NCT00074490|Vincristine|vincristine|mesh-list
1861613|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861614|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
1861615|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861616|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861617|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861618|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
1861619|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861620|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861621|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861622|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861623|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861624|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861625|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861626|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861627|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861628|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
1861629|NCT00074490|Hormones|hormones|mesh-ancestor
1861630|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861631|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1861632|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861633|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861634|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861635|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861636|NCT00074581|Ritonavir|ritonavir|mesh-list
1861637|NCT00074581|Lopinavir|lopinavir|mesh-list
1861638|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1861639|NCT00074581|Tenofovir|tenofovir|mesh-list
1861640|NCT00074581|Lamivudine|lamivudine|mesh-list
1861641|NCT00074581|Zidovudine|zidovudine|mesh-list
1861642|NCT00074581|Emtricitabine|emtricitabine|mesh-list
1861643|NCT00074581|Nevirapine|nevirapine|mesh-list
1861644|NCT00074581|Stavudine|stavudine|mesh-list
1861645|NCT00074581|Didanosine|didanosine|mesh-list
1861646|NCT00074581|Efavirenz|efavirenz|mesh-list
1861647|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1861648|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1861649|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
1861650|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861651|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861652|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1861653|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1861654|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
1861655|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861656|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1861657|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1861658|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1861659|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861660|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
1861661|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1861662|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1861663|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1861664|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1861665|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1861666|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
1861667|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
1861668|NCT00074711|Calcium|calcium|mesh-list
1861669|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1861670|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861671|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1861672|NCT00074711|Antacids|antacids|mesh-ancestor
1861673|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861674|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1861675|NCT00074802|Paroxetine|paroxetine|mesh-list
1861676|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1861677|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1861678|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1861832|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
1861679|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861680|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1861681|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
1861682|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861683|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1861684|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
1861685|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1861686|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1861687|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1861688|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861689|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
1861690|NCT00074815|Citalopram|citalopram|mesh-list
1861691|NCT00074815|Fluoxetine|fluoxetine|mesh-list
1861692|NCT00074815|Paroxetine|paroxetine|mesh-list
1861693|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1861694|NCT00074815|Sertraline|sertraline|mesh-list
1861695|NCT00074815|Clomipramine|clomipramine|mesh-list
1861696|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1861697|NCT00074815|Serotonin|serotonin|mesh-list
1861698|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1861699|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1861700|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861701|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1861702|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
1861703|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861704|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1861705|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
1861706|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1861707|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1861708|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1861709|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861710|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1861711|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1861712|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1861713|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1861714|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1861715|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1861716|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1861717|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1861718|NCT00075023|Thalidomide|thalidomide|mesh-list
1861719|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861720|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
1861721|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861722|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
1861723|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861724|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861725|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1861726|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1861727|NCT00075023|Growth Substances|growth substances|mesh-ancestor
1861728|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
1861729|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861730|NCT00075218|Sunitinib|sunitinib|mesh-list
1861731|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861732|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1861733|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1861734|NCT00075218|Growth Substances|growth substances|mesh-ancestor
1861735|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861736|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
1861737|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861738|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861739|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861740|NCT00075270|Paclitaxel|paclitaxel|mesh-list
1861741|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1861742|NCT00075270|Lapatinib|lapatinib|mesh-list
1861743|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861744|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861745|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861746|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861747|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861748|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861749|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861750|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861751|NCT00075335|Plerixafor|plerixafor|mesh-list
1861752|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1861753|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1861754|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
1861755|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861756|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
1861757|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861758|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861759|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861760|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861761|NCT00075478|Cyclosporine|cyclosporine|mesh-list
1861762|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
1861763|NCT00075478|Fludarabine|fludarabine|mesh-list
1861764|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
1861765|NCT00075478|Cyclosporins|cyclosporins|mesh-list
1861766|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861767|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861768|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
1861769|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861770|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861771|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
1861772|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861773|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861774|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
1861775|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861776|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
1861777|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861778|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1861779|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861780|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1861781|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
1861782|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861783|NCT00075504|Gemcitabine|gemcitabine|mesh-list
1861784|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861785|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
1861786|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861787|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861788|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
1861789|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861790|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861791|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861792|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
1861793|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861794|NCT00075582|Dactinomycin|dactinomycin|mesh-list
1861795|NCT00075582|Cactinomycin|cactinomycin|mesh-list
1861796|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
1861797|NCT00075582|Vincristine|vincristine|mesh-list
1861798|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861799|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
1861800|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861801|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861802|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861803|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
1861804|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861805|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861806|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861807|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861808|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861809|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861810|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861811|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861812|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861813|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861814|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1861815|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861816|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861817|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
1861818|NCT00075725|Leucovorin|leucovorin|mesh-list
1861819|NCT00075725|Folic Acid|folic acid|mesh-list
1861820|NCT00075725|Cytarabine|cytarabine|mesh-list
1861821|NCT00075725|Dexamethasone|dexamethasone|mesh-list
1861822|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
1861823|NCT00075725|Prednisone|prednisone|mesh-list
1861824|NCT00075725|Cortisone|cortisone|mesh-list
1861825|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
1861826|NCT00075725|Doxorubicin|doxorubicin|mesh-list
1861827|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1861828|NCT00075725|Methotrexate|methotrexate|mesh-list
1861829|NCT00075725|Vincristine|vincristine|mesh-list
1861830|NCT00075725|Daunorubicin|daunorubicin|mesh-list
1861831|NCT00075725|Asparaginase|asparaginase|mesh-list
1861833|NCT00075725|Pegaspargase|pegaspargase|mesh-list
1861834|NCT00075725|Thioguanine|thioguanine|mesh-list
1861835|NCT00075725|BB 1101|bb 1101|mesh-list
1861836|NCT00075725|Calcium|calcium|mesh-list
1861837|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
1861838|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
1861839|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861840|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
1861841|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861842|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861843|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1861844|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
1861845|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861846|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861847|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1861848|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861849|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
1861850|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
1861851|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861852|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1861853|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
1861854|NCT00075725|Hormones|hormones|mesh-ancestor
1861855|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861856|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1861857|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
1861858|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861859|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861860|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1861861|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1861862|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1861863|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1861864|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1861865|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
1861866|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1861867|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1861868|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
1861869|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
1861870|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1861871|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861872|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
1861873|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861874|NCT00075725|Antidotes|antidotes|mesh-ancestor
1861875|NCT00075725|Protective Agents|protective agents|mesh-ancestor
1861876|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
1861877|NCT00075725|Vitamins|vitamins|mesh-ancestor
1861878|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
1861879|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1861880|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861881|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861882|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861883|NCT00075725|Hematinics|hematinics|mesh-ancestor
1861884|NCT00075764|Fulvestrant|fulvestrant|mesh-list
1861885|NCT00075764|Anastrozole|anastrozole|mesh-list
1861886|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1861887|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861888|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1861889|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1861890|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
1861891|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861892|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861893|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1861894|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1861895|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861896|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861897|NCT00075803|Fluconazole|fluconazole|mesh-list
1861898|NCT00075803|Voriconazole|voriconazole|mesh-list
1861899|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
1861900|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861901|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1861902|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1861903|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861904|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861905|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1861906|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
1861907|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861908|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861909|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1861910|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1861911|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1861912|NCT00075829|Thalidomide|thalidomide|mesh-list
1861913|NCT00075829|Dexamethasone|dexamethasone|mesh-list
1861914|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861915|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
1861916|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
1861917|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861918|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861919|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1861920|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
1861921|NCT00075829|Hormones|hormones|mesh-ancestor
1861922|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1861923|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1861924|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861925|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861926|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
1861927|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
1861928|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861929|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861930|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1861931|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1861932|NCT00075829|Growth Substances|growth substances|mesh-ancestor
1861933|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
1861934|NCT00075881|Bortezomib|bortezomib|mesh-list
1861935|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861936|NCT00075946|Rituximab|rituximab|mesh-list
1861937|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1861938|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861939|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
1861940|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861941|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861942|NCT00076011|Mitogens|mitogens|mesh-list
1861943|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
1861944|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861945|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861946|NCT00076011|Growth Substances|growth substances|mesh-ancestor
1861947|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861948|NCT00076024|Docetaxel|docetaxel|mesh-list
1861949|NCT00076024|Axitinib|axitinib|mesh-list
1861950|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861951|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
1861952|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
1861953|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
1861954|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861955|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1861956|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861957|NCT00076102|Pirfenidone|pirfenidone|mesh-list
1861958|NCT00076102|Analgesics|analgesics|mesh-ancestor
1861959|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
1861960|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1861961|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861962|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1861963|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1861964|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1861965|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1861966|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861967|NCT00076336|Lamivudine|lamivudine|mesh-list
1861968|NCT00076336|Telbivudine|telbivudine|mesh-list
1861969|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1861970|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1861971|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861972|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861973|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
1861974|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861975|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1861976|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1861977|NCT00076570|Sirolimus|sirolimus|mesh-list
1861978|NCT00076570|Tacrolimus|tacrolimus|mesh-list
1861979|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1861980|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
1861981|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1861982|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1861983|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1861984|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861985|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1861986|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1861987|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1861988|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1861989|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
1861990|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
1861991|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1861992|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
1861993|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1861994|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1861995|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1861996|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1861997|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1861998|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
1861999|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862000|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862001|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1862002|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862003|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
1862004|NCT00076752|Promethazine|promethazine|mesh-list
1862005|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
1862006|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
1862007|NCT00076752|Rituximab|rituximab|mesh-list
1862008|NCT00076752|Fludarabine|fludarabine|mesh-list
1862009|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
1862010|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862011|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
1862012|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862013|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862014|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1862015|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
1862016|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862017|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862018|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1862019|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862020|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862021|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
1862022|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862023|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
1862024|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
1862025|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862026|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862027|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
1862028|NCT00076752|Hormones|hormones|mesh-ancestor
1862029|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862030|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1862031|NCT00076752|Protective Agents|protective agents|mesh-ancestor
1862032|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1862033|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1862034|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1862035|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
1862036|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
1862037|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
1862038|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1862039|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
1862040|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
1862041|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862042|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1862043|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
1862044|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
1862045|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1862046|NCT00077064|Captopril|captopril|mesh-list
1862047|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1862048|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
1862049|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862050|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862051|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1862052|NCT00077207|Carboplatin|carboplatin|mesh-list
1862053|NCT00077207|Vincristine|vincristine|mesh-list
1862054|NCT00077207|Temozolomide|temozolomide|mesh-list
1862055|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862056|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1862057|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862058|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862059|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862060|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862061|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1862062|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
1862063|NCT00077376|Carboplatin|carboplatin|mesh-list
1862064|NCT00077376|Trastuzumab|trastuzumab|mesh-list
1862065|NCT00077376|Epothilone B|epothilone b|mesh-list
1862066|NCT00077376|Epothilones|epothilones|mesh-list
1862067|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862068|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862069|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862070|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862071|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862072|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862073|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
1862074|NCT00077610|Hematinics|hematinics|mesh-ancestor
1862075|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
1862076|NCT00077623|Hematinics|hematinics|mesh-ancestor
1862077|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1862078|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
1862079|NCT00077636|Ribavirin|ribavirin|mesh-list
1862080|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
1862081|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862082|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
1862083|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862084|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
1862085|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862086|NCT00077649|Ribavirin|ribavirin|mesh-list
1862087|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1862088|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
1862089|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
1862090|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
1862091|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
1862092|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862093|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
1862094|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862095|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
1862096|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862097|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862098|NCT00077675|Vancomycin|vancomycin|mesh-list
1862099|NCT00077675|Penicillins|penicillins|mesh-list
1862100|NCT00077675|Telavancin|telavancin|mesh-list
1862101|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862102|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862103|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
1862104|NCT00077766|Hematinics|hematinics|mesh-ancestor
1862105|NCT00077857|Docetaxel|docetaxel|mesh-list
1862106|NCT00077857|Capecitabine|capecitabine|mesh-list
1862107|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862108|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862109|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862110|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862111|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862112|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862113|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
1862114|NCT00077974|Sunitinib|sunitinib|mesh-list
1862115|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862116|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862117|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862118|NCT00077974|Growth Substances|growth substances|mesh-ancestor
1862119|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862120|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862121|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1862122|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862123|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862124|NCT00078286|Sertraline|sertraline|mesh-list
1862125|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
1862126|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1862127|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1862128|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1862129|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1862130|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862131|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862132|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
1862133|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862134|NCT00078312|Modafinil|modafinil|mesh-list
1862135|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1862136|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862137|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1862138|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1862139|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1862140|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862141|NCT00078325|Modafinil|modafinil|mesh-list
1862142|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1862143|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862144|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1862145|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1862146|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1862147|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862148|NCT00078338|Interferons|interferons|mesh-list
1862149|NCT00078338|Interferon-beta|interferon-beta|mesh-list
1862150|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
1862151|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
1862152|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
1862153|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862154|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
1862155|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862156|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
1862157|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862158|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1862159|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862160|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862161|NCT00078377|Modafinil|modafinil|mesh-list
1862162|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1862163|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862164|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1862165|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1862166|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1862167|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862168|NCT00078403|Ribavirin|ribavirin|mesh-list
1862169|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1862170|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
1862171|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862172|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
1862173|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862174|NCT00078559|Acetaminophen|acetaminophen|mesh-list
1862175|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
1862176|NCT00078559|Promethazine|promethazine|mesh-list
1862177|NCT00078559|Sirolimus|sirolimus|mesh-list
1862178|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1862179|NCT00078559|Nystatin|nystatin|mesh-list
1862180|NCT00078559|Clotrimazole|clotrimazole|mesh-list
1862181|NCT00078559|Miconazole|miconazole|mesh-list
1862182|NCT00078559|Pentamidine|pentamidine|mesh-list
1862183|NCT00078559|Trimethoprim|trimethoprim|mesh-list
1862184|NCT00078559|Valganciclovir|valganciclovir|mesh-list
1862185|NCT00078559|Acyclovir|acyclovir|mesh-list
1862186|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
1862187|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
1862188|NCT00078559|Tacrolimus|tacrolimus|mesh-list
1862189|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862190|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
1862191|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862192|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1862193|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862194|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862195|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1862196|NCT00078559|Analgesics|analgesics|mesh-ancestor
1862197|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
1862198|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862199|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
1862200|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862201|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862202|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862203|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862204|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
1862205|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862206|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
1862207|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
1862208|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862209|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
1862210|NCT00078559|Hormones|hormones|mesh-ancestor
1862211|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862212|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1862213|NCT00078559|Protective Agents|protective agents|mesh-ancestor
1862214|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862215|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1862216|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1862217|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1862218|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
1862219|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
1862220|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1862221|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
1862222|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
1862223|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862224|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1862225|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
1862226|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
1862227|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1862228|NCT00078559|Renal Agents|renal agents|mesh-ancestor
1862229|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
1862230|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1862231|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1862232|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1862233|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1862234|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1862235|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1862236|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
1862237|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1862238|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1862239|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1862240|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
1862241|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1862242|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1862243|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1862244|NCT00078559|Ionophores|ionophores|mesh-ancestor
1862245|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1862246|NCT00078715|Yohimbine|yohimbine|mesh-list
1862247|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
1862248|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
1862249|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862250|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862251|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1862252|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1862253|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1862254|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
1862255|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862256|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862257|NCT00078715|Urological Agents|urological agents|mesh-ancestor
1862258|NCT00078754|Valproic Acid|valproic acid|mesh-list
1862259|NCT00078754|Fluoxetine|fluoxetine|mesh-list
1862260|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1862261|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1862262|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1862263|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862264|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862265|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
1862266|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862267|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1862268|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
1862269|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1862270|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1862271|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1862272|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862273|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
1862274|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
1862275|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
1862276|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1862277|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1862278|NCT00078767|Sertraline|sertraline|mesh-list
1862279|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
1862280|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1862281|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1862282|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1862283|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1862284|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862285|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1862286|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
1862287|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862300|NCT00078819|Etanercept|etanercept|mesh-list
1862301|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1862302|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1862303|NCT00078819|Analgesics|analgesics|mesh-ancestor
1862304|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
1862305|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862306|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862307|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862308|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862309|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862310|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862311|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
1862312|NCT00078897|Selenium|selenium|mesh-list
1862313|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
1862314|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862315|NCT00078897|Protective Agents|protective agents|mesh-ancestor
1862316|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862317|NCT00078897|Trace Elements|trace elements|mesh-ancestor
1862318|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
1862319|NCT00078949|Gemcitabine|gemcitabine|mesh-list
1862320|NCT00078949|Cytarabine|cytarabine|mesh-list
1862321|NCT00078949|Dexamethasone|dexamethasone|mesh-list
1862322|NCT00078949|Rituximab|rituximab|mesh-list
1862323|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862324|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862325|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
1862326|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
1862327|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862328|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862329|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862330|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
1862331|NCT00078949|Hormones|hormones|mesh-ancestor
1862332|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862333|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1862334|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862335|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
1862336|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862337|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862338|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
1862339|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862340|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
1862341|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862342|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862343|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862344|NCT00079001|Vitamin D|vitamin d|mesh-list
1862345|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
1862346|NCT00079001|Calcium|calcium|mesh-list
1862347|NCT00079001|Androgens|androgens|mesh-list
1862348|NCT00079001|Vitamins|vitamins|mesh-ancestor
1862349|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
1862350|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862351|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1862352|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1862353|NCT00079001|Hormones|hormones|mesh-ancestor
1862354|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862355|NCT00079040|Bevacizumab|bevacizumab|mesh-list
1862356|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1862357|NCT00079040|Etoposide|etoposide|mesh-list
1862358|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
1862359|NCT00079040|Antibodies|antibodies|mesh-list
1862360|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
1862361|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1862362|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862363|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862364|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862365|NCT00079040|Growth Substances|growth substances|mesh-ancestor
1862366|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862367|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862368|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
1862369|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1862370|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862371|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862372|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862373|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862374|NCT00079183|Sirolimus|sirolimus|mesh-list
1862375|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862376|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862377|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862378|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862379|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
1862380|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862381|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
1862382|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862383|NCT00079274|Leucovorin|leucovorin|mesh-list
1862384|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1862385|NCT00079274|Cetuximab|cetuximab|mesh-list
1862386|NCT00079274|Fluorouracil|fluorouracil|mesh-list
1862387|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
1862388|NCT00079274|Irinotecan|irinotecan|mesh-list
1862389|NCT00079274|Antibodies|antibodies|mesh-list
1862390|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
1862391|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1862392|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
1862393|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
1862394|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862395|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862396|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
1862397|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862398|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862399|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862400|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1862401|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862402|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862403|NCT00079274|Antidotes|antidotes|mesh-ancestor
1862404|NCT00079274|Protective Agents|protective agents|mesh-ancestor
1862405|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
1862406|NCT00079274|Vitamins|vitamins|mesh-ancestor
1862407|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
1862408|NCT00079326|Trastuzumab|trastuzumab|mesh-list
1862409|NCT00079326|Epothilone B|epothilone b|mesh-list
1862410|NCT00079326|Epothilones|epothilones|mesh-list
1862411|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862412|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862413|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862414|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862415|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862416|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862417|NCT00079339|Tipifarnib|tipifarnib|mesh-list
1862418|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862419|NCT00079417|Iodine|iodine|mesh-list
1862420|NCT00079417|Carboplatin|carboplatin|mesh-list
1862421|NCT00079417|Vincristine|vincristine|mesh-list
1862422|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862423|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1862424|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862425|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862426|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862427|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862428|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1862429|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862430|NCT00079417|Trace Elements|trace elements|mesh-ancestor
1862431|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
1862432|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862433|NCT00079677|Modafinil|modafinil|mesh-list
1862434|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1862435|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862436|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1862437|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1862438|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1862439|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862440|NCT00079937|Fluticasone|fluticasone|mesh-list
1862441|NCT00079937|Omalizumab|omalizumab|mesh-list
1862442|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862595|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1862443|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1862444|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
1862445|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862446|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862447|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1862448|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
1862449|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
1862450|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1862451|NCT00080119|Isoniazid|isoniazid|mesh-list
1862452|NCT00080119|Trimethoprim|trimethoprim|mesh-list
1862453|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
1862454|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
1862455|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862456|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862457|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1862458|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1862459|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
1862460|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862461|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1862462|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1862463|NCT00080119|Renal Agents|renal agents|mesh-ancestor
1862464|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
1862465|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1862466|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1862467|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1862468|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862469|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1862470|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1862471|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1862472|NCT00080223|Pirfenidone|pirfenidone|mesh-list
1862473|NCT00080223|Analgesics|analgesics|mesh-ancestor
1862474|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
1862475|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862476|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862477|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1862478|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1862479|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862480|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862481|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862482|NCT00080288|Modafinil|modafinil|mesh-list
1862483|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1862484|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862485|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1862486|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1862487|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1862488|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862489|NCT00080301|Capecitabine|capecitabine|mesh-list
1862490|NCT00080301|Epothilones|epothilones|mesh-list
1862491|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862492|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
1862493|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862494|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862495|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862496|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862497|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862498|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
1862499|NCT00080483|Testosterone|testosterone|mesh-list
1862500|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
1862501|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
1862502|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1862503|NCT00080483|Androgens|androgens|mesh-ancestor
1862504|NCT00080483|Hormones|hormones|mesh-ancestor
1862505|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862506|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862507|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1862508|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862509|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
1862510|NCT00080899|Fenretinide|fenretinide|mesh-list
1862511|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862512|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1862513|NCT00080899|Protective Agents|protective agents|mesh-ancestor
1862514|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862515|NCT00080938|Temozolomide|temozolomide|mesh-list
1862516|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1862517|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
1862518|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862519|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862520|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
1862521|NCT00081159|Doxorubicin|doxorubicin|mesh-list
1862522|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1862523|NCT00081159|Leuprolide|leuprolide|mesh-list
1862524|NCT00081159|Goserelin|goserelin|mesh-list
1862525|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862526|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862527|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862528|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862529|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862530|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862531|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1862532|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862533|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1862534|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
1862535|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1862536|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1862537|NCT00081263|Celecoxib|celecoxib|mesh-list
1862538|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
1862539|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1862540|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1862541|NCT00081263|Analgesics|analgesics|mesh-ancestor
1862542|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
1862543|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862544|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862545|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862546|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862547|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1862548|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1862549|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862550|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862551|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1862552|NCT00081289|Leucovorin|leucovorin|mesh-list
1862553|NCT00081289|Folic Acid|folic acid|mesh-list
1862554|NCT00081289|Fluorouracil|fluorouracil|mesh-list
1862555|NCT00081289|Capecitabine|capecitabine|mesh-list
1862556|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
1862557|NCT00081289|Irinotecan|irinotecan|mesh-list
1862558|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
1862559|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
1862560|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862561|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862562|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862563|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862564|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
1862565|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862566|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1862567|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862568|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862569|NCT00081289|Antidotes|antidotes|mesh-ancestor
1862570|NCT00081289|Protective Agents|protective agents|mesh-ancestor
1862571|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
1862572|NCT00081289|Vitamins|vitamins|mesh-ancestor
1862573|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
1862574|NCT00081289|Hematinics|hematinics|mesh-ancestor
1862575|NCT00081328|Metformin|metformin|mesh-list
1862576|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
1862577|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1862578|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862579|NCT00081458|Teduglutide|teduglutide|mesh-list
1862580|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862581|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1862582|NCT00081458|Protective Agents|protective agents|mesh-ancestor
1862583|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862584|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
1862585|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1862586|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862587|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
1862588|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1862589|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1862590|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1862591|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862592|NCT00081770|Ribavirin|ribavirin|mesh-list
1862593|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1862594|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
1862596|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
1862597|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862598|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
1862599|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862600|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
1862601|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862602|NCT00081861|Bevacizumab|bevacizumab|mesh-list
1862603|NCT00081861|Rituximab|rituximab|mesh-list
1862604|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862605|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862606|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862607|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862608|NCT00081861|Growth Substances|growth substances|mesh-ancestor
1862609|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862610|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862611|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
1862612|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862613|NCT00081939|Thalidomide|thalidomide|mesh-list
1862614|NCT00081939|Bortezomib|bortezomib|mesh-list
1862615|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862616|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862617|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
1862618|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862619|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
1862620|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862621|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862622|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862623|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862624|NCT00081939|Growth Substances|growth substances|mesh-ancestor
1862625|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862626|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
1862627|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862628|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1862629|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862630|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862631|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
1862632|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862633|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862634|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862635|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862636|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862637|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862638|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862639|NCT00082329|Plerixafor|plerixafor|mesh-list
1862640|NCT00082329|Lenograstim|lenograstim|mesh-list
1862641|NCT00082329|Sargramostim|sargramostim|mesh-list
1862642|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1862643|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
1862644|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862645|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1862646|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1862647|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
1862648|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862649|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1862650|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1862651|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1862652|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862653|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
1862654|NCT00082381|Exenatide|exenatide|mesh-list
1862655|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1862656|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862657|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1862658|NCT00082381|Incretins|incretins|mesh-ancestor
1862659|NCT00082381|Hormones|hormones|mesh-ancestor
1862660|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862661|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
1862662|NCT00082407|Exenatide|exenatide|mesh-list
1862663|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
1862664|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1862665|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862666|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1862667|NCT00082407|Incretins|incretins|mesh-ancestor
1862668|NCT00082407|Hormones|hormones|mesh-ancestor
1862669|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862670|NCT00082433|Capecitabine|capecitabine|mesh-list
1862671|NCT00082433|Epothilones|epothilones|mesh-list
1862672|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862673|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
1862674|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862675|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862676|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862677|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862678|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862679|NCT00082628|Hormones|hormones|mesh-list
1862680|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862681|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862682|NCT00082758|Interleukin-2|interleukin-2|mesh-list
1862683|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
1862684|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862685|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1862686|NCT00082758|Analgesics|analgesics|mesh-ancestor
1862687|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
1862688|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862689|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862690|NCT00082810|Fulvestrant|fulvestrant|mesh-list
1862691|NCT00082810|Tipifarnib|tipifarnib|mesh-list
1862692|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1862693|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862694|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1862695|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1862696|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
1862697|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862698|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862699|NCT00082888|Tipifarnib|tipifarnib|mesh-list
1862700|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862701|NCT00083122|Cisplatin|cisplatin|mesh-list
1862702|NCT00083122|Alvocidib|alvocidib|mesh-list
1862703|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862704|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862705|NCT00083122|Growth Substances|growth substances|mesh-ancestor
1862706|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862707|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1862708|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862709|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862710|NCT00083174|Exemestane|exemestane|mesh-list
1862711|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862712|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1862713|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1862714|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862715|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862716|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1862717|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
1862718|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862719|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862720|NCT00083226|Doxorubicin|doxorubicin|mesh-list
1862721|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1862722|NCT00083226|Bortezomib|bortezomib|mesh-list
1862723|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862724|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862725|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862726|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862727|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862728|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862729|NCT00083382|Pamidronate|pamidronate|mesh-list
1862730|NCT00083382|Thalidomide|thalidomide|mesh-list
1862731|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862732|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
1862733|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862734|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
1862735|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862736|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862737|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862738|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862739|NCT00083382|Growth Substances|growth substances|mesh-ancestor
1862740|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862741|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862742|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1862743|NCT00083551|Interferons|interferons|mesh-list
1862744|NCT00083551|Cytarabine|cytarabine|mesh-list
1862745|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
1862746|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
1862747|NCT00083551|Thalidomide|thalidomide|mesh-list
1862748|NCT00083551|Dexamethasone|dexamethasone|mesh-list
1862749|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
1862750|NCT00083551|Melphalan|melphalan|mesh-list
1862751|NCT00083551|Carmustine|carmustine|mesh-list
1862752|NCT00083551|Cisplatin|cisplatin|mesh-list
1862753|NCT00083551|Doxorubicin|doxorubicin|mesh-list
1862754|NCT00083551|Etoposide|etoposide|mesh-list
1862755|NCT00083551|Vincristine|vincristine|mesh-list
1862756|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862757|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
1862758|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862759|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862760|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1862761|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
1862762|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862763|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862764|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1862765|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862766|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
1862767|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
1862768|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862769|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862770|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
1862771|NCT00083551|Hormones|hormones|mesh-ancestor
1862772|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862773|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1862774|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862775|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862776|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862777|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862778|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1862779|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
1862780|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862781|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862782|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
1862783|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862784|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862785|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862786|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
1862787|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862788|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862789|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862790|NCT00083551|Growth Substances|growth substances|mesh-ancestor
1862791|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862792|NCT00083616|Panitumumab|panitumumab|mesh-list
1862793|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862794|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862795|NCT00083720|Cetuximab|cetuximab|mesh-list
1862796|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862797|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862798|NCT00083759|Natalizumab|natalizumab|mesh-list
1862799|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
1862800|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862801|NCT00083889|Interferons|interferons|mesh-list
1862802|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
1862803|NCT00083889|Sunitinib|sunitinib|mesh-list
1862804|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862805|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
1862806|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862807|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
1862808|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862809|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1862810|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1862811|NCT00083889|Growth Substances|growth substances|mesh-ancestor
1862812|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1862813|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1862814|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862815|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862816|NCT00084136|Tenofovir|tenofovir|mesh-list
1862817|NCT00084136|Lamivudine|lamivudine|mesh-list
1862818|NCT00084136|Zidovudine|zidovudine|mesh-list
1862819|NCT00084136|Emtricitabine|emtricitabine|mesh-list
1862820|NCT00084136|Efavirenz|efavirenz|mesh-list
1862821|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1862822|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1862823|NCT00084136|Didanosine|didanosine|mesh-list
1862824|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1862825|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
1862826|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862827|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1862828|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1862829|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862830|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862831|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1862832|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1862833|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
1862834|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1862835|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1862836|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1862837|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1862838|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1862839|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1862840|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1862841|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1862842|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
1862843|NCT00084149|Ritonavir|ritonavir|mesh-list
1862844|NCT00084149|Lopinavir|lopinavir|mesh-list
1862845|NCT00084149|Lamivudine|lamivudine|mesh-list
1862846|NCT00084149|Zidovudine|zidovudine|mesh-list
1862847|NCT00084149|Abacavir|abacavir|mesh-list
1862848|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1862849|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1862850|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
1862851|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862852|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862853|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1862854|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1862855|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
1862856|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862857|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1862858|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1862859|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1862860|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1862861|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
1862862|NCT00084266|Vancomycin|vancomycin|mesh-list
1862863|NCT00084266|Linezolid|linezolid|mesh-list
1862864|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862865|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862866|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1862867|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862868|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862869|NCT00084318|Docetaxel|docetaxel|mesh-list
1862870|NCT00084318|Cetuximab|cetuximab|mesh-list
1862871|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862872|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862873|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862874|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862875|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862876|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1862877|NCT00084409|Iloprost|iloprost|mesh-list
1862878|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1862879|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
1862880|NCT00084617|Capecitabine|capecitabine|mesh-list
1862881|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
1862882|NCT00084617|Irinotecan|irinotecan|mesh-list
1862883|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862884|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
1862885|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862886|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862887|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1862888|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862889|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862890|NCT00084682|Romidepsin|romidepsin|mesh-list
1862891|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862892|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862893|NCT00084747|Bortezomib|bortezomib|mesh-list
1862894|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862895|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
1862896|NCT00084838|Leucovorin|leucovorin|mesh-list
1862897|NCT00084838|Cytarabine|cytarabine|mesh-list
1862898|NCT00084838|Dactinomycin|dactinomycin|mesh-list
1862899|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
1862900|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1862901|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1862902|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1862903|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
1862904|NCT00084838|Temozolomide|temozolomide|mesh-list
1862905|NCT00084838|Cisplatin|cisplatin|mesh-list
1862906|NCT00084838|Doxorubicin|doxorubicin|mesh-list
1862907|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1862908|NCT00084838|Methotrexate|methotrexate|mesh-list
1862909|NCT00084838|Etoposide|etoposide|mesh-list
1862910|NCT00084838|Vincristine|vincristine|mesh-list
1862911|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
1862912|NCT00084838|Razoxane|razoxane|mesh-list
1862913|NCT00084838|Lenograstim|lenograstim|mesh-list
1862914|NCT00084838|Calcium|calcium|mesh-list
1862915|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
1862916|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862917|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
1862918|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862919|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862920|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1862921|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
1862922|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862923|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862924|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1862925|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1862926|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862927|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862928|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862929|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1862930|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1862931|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1862932|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
1862933|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1862934|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1862935|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
1862936|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
1862937|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1862938|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1862939|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1862940|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1862941|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
1862942|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1862943|NCT00084838|Antidotes|antidotes|mesh-ancestor
1862944|NCT00084838|Protective Agents|protective agents|mesh-ancestor
1862945|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
1862946|NCT00084838|Vitamins|vitamins|mesh-ancestor
1862947|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
1862948|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
1862949|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
1862950|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
1862951|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862952|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1862953|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1862954|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1862955|NCT00084864|Calcitriol|calcitriol|mesh-list
1862956|NCT00084864|Dexamethasone|dexamethasone|mesh-list
1862957|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1862958|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
1862959|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
1862960|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1862961|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862962|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1862963|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
1862964|NCT00084864|Hormones|hormones|mesh-ancestor
1862965|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1862966|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1862967|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862968|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1862969|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1862970|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1862971|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862972|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1862973|NCT00084864|Vitamins|vitamins|mesh-ancestor
1862974|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
1862975|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1862976|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
1862977|NCT00085098|Cisplatin|cisplatin|mesh-list
1862978|NCT00085098|Carboplatin|carboplatin|mesh-list
1862979|NCT00085098|Etoposide|etoposide|mesh-list
1862980|NCT00085098|Lenograstim|lenograstim|mesh-list
1862981|NCT00085098|Sargramostim|sargramostim|mesh-list
1862982|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1862983|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
1862984|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1862985|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1862986|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1862987|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
1862988|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1862989|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1862990|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1862991|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1862992|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1862993|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1862994|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1862995|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1863011|NCT00085254|Temozolomide|temozolomide|mesh-list
1863012|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863013|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
1863014|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863015|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863016|NCT00085293|Decitabine|decitabine|mesh-list
1863017|NCT00085293|Azacitidine|azacitidine|mesh-list
1863018|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1863019|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863020|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
1863021|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863022|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863023|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863024|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1863025|NCT00085410|Bortezomib|bortezomib|mesh-list
1863026|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863027|NCT00085423|Aldesleukin|aldesleukin|mesh-list
1863028|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
1863029|NCT00085423|Fludarabine|fludarabine|mesh-list
1863030|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
1863031|NCT00085423|Interleukin-2|interleukin-2|mesh-list
1863032|NCT00085423|Molgramostim|molgramostim|mesh-list
1863033|NCT00085423|Sargramostim|sargramostim|mesh-list
1863034|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863035|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
1863036|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863037|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863038|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863039|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
1863040|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863041|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863042|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1863043|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863044|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
1863045|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1863046|NCT00085423|Analgesics|analgesics|mesh-ancestor
1863047|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
1863048|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1863049|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1863050|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1863051|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
1863052|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863053|NCT00085436|Interferons|interferons|mesh-list
1863054|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
1863055|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
1863056|NCT00085436|Aldesleukin|aldesleukin|mesh-list
1863057|NCT00085436|Vaccines|vaccines|mesh-list
1863058|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
1863136|NCT00086138|Sertraline|sertraline|mesh-list
1863059|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863060|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863061|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
1863062|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863063|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1863064|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1863065|NCT00085540|Romidepsin|romidepsin|mesh-list
1863066|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863067|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863068|NCT00085566|Everolimus|everolimus|mesh-list
1863069|NCT00085566|Gefitinib|gefitinib|mesh-list
1863070|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863071|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863072|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
1863073|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863074|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863075|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863076|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863077|NCT00085644|Adalimumab|adalimumab|mesh-list
1863078|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1863079|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863080|NCT00085709|Cytarabine|cytarabine|mesh-list
1863081|NCT00085709|Daunorubicin|daunorubicin|mesh-list
1863082|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
1863083|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863084|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
1863085|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863086|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863087|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
1863088|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863089|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863090|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
1863091|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863092|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863093|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1863094|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1863095|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863096|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863097|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
1863098|NCT00085735|Lomustine|lomustine|mesh-list
1863099|NCT00085735|Cisplatin|cisplatin|mesh-list
1863100|NCT00085735|Vincristine|vincristine|mesh-list
1863101|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863102|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
1863103|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863104|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863105|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863106|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
1863107|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863108|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863109|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1863110|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1863111|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863112|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863113|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863114|NCT00085839|Paclitaxel|paclitaxel|mesh-list
1863115|NCT00085839|Carboplatin|carboplatin|mesh-list
1863116|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1863117|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1863118|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863119|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863120|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863121|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863122|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863123|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863124|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863125|NCT00085917|Interferons|interferons|mesh-list
1863126|NCT00085917|Ribavirin|ribavirin|mesh-list
1863127|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
1863128|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1863129|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863130|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
1863131|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863132|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
1863133|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863134|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
1863135|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863137|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
1863138|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863139|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1863140|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863141|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863142|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863143|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863144|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
1863145|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863146|NCT00086190|Paroxetine|paroxetine|mesh-list
1863147|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1863148|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1863149|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863150|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863151|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863152|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863153|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
1863154|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863155|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1863156|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
1863157|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863158|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1863159|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1863160|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863161|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1863162|NCT00086281|Zolpidem|zolpidem|mesh-list
1863163|NCT00086281|Modafinil|modafinil|mesh-list
1863164|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1863165|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863166|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1863167|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1863168|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1863169|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863170|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1863171|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1863172|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863173|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1863174|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
1863175|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
1863176|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863177|NCT00086307|Pramipexole|pramipexole|mesh-list
1863178|NCT00086307|Citalopram|citalopram|mesh-list
1863179|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1863180|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863181|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863182|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863183|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863184|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
1863185|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863186|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1863187|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
1863188|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863189|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1863190|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1863191|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
1863192|NCT00086307|Protective Agents|protective agents|mesh-ancestor
1863193|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
1863194|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
1863195|NCT00086346|Cyclosporine|cyclosporine|mesh-list
1863196|NCT00086346|Sirolimus|sirolimus|mesh-list
1863197|NCT00086346|Tacrolimus|tacrolimus|mesh-list
1863198|NCT00086346|Cyclosporins|cyclosporins|mesh-list
1863199|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863200|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
1863201|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863202|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1863203|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863204|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863205|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
1863206|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863207|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
1863208|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863209|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1863210|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863211|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863212|NCT00086385|Bupropion|bupropion|mesh-list
1863213|NCT00086385|Nicotine|nicotine|mesh-list
1863214|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1863215|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
1863216|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1863217|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863218|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1863219|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1863220|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
1863221|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863222|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863223|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1863224|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
1863225|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863226|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1863227|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863228|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863229|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
1863230|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1863231|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1863232|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863233|NCT00086411|Bupropion|bupropion|mesh-list
1863234|NCT00086411|Nicotine|nicotine|mesh-list
1863235|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1863236|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
1863237|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1863238|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863239|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1863240|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1863241|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
1863242|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863243|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863244|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1863245|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
1863246|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863247|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1863248|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863249|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863250|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
1863251|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1863252|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1863253|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863254|NCT00086502|Metformin|metformin|mesh-list
1863255|NCT00086502|Pioglitazone|pioglitazone|mesh-list
1863256|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1863257|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1863258|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863259|NCT00086502|Incretins|incretins|mesh-ancestor
1863260|NCT00086502|Hormones|hormones|mesh-ancestor
1863261|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863262|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1863263|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
1863264|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863265|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863266|NCT00086515|Metformin|metformin|mesh-list
1863267|NCT00086515|Pioglitazone|pioglitazone|mesh-list
1863268|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1863269|NCT00086515|Glipizide|glipizide|mesh-list
1863270|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1863271|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863272|NCT00086515|Incretins|incretins|mesh-ancestor
1863273|NCT00086515|Hormones|hormones|mesh-ancestor
1863274|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863275|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1863276|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
1863277|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863278|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863279|NCT00086580|Vidarabine|vidarabine|mesh-list
1863280|NCT00086580|Fludarabine|fludarabine|mesh-list
1863281|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
1863282|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
1863283|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863284|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863285|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
1863286|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863287|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863288|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
1863289|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863290|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
1863291|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863292|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863293|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
1863294|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863295|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1863296|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
1863297|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
1863298|NCT00086957|Docetaxel|docetaxel|mesh-list
1863299|NCT00086957|Trastuzumab|trastuzumab|mesh-list
1863300|NCT00086957|Gefitinib|gefitinib|mesh-list
1863301|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863302|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863303|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863304|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863305|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863306|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863307|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863308|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863309|NCT00086996|Fluorouracil|fluorouracil|mesh-list
1863310|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
1863311|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
1863312|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863313|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863314|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863315|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863316|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
1863317|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863318|NCT00087126|Topotecan|topotecan|mesh-list
1863319|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1863320|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1863321|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863322|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863323|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863324|NCT00087139|Epothilones|epothilones|mesh-list
1863325|NCT00087139|Epothilone B|epothilone b|mesh-list
1863326|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863327|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863328|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863329|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863330|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863331|NCT00087152|Capecitabine|capecitabine|mesh-list
1863332|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
1863333|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863334|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
1863335|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863336|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863337|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863338|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863339|NCT00087490|Vancomycin|vancomycin|mesh-list
1863340|NCT00087490|Linezolid|linezolid|mesh-list
1863341|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1863342|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863343|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1863344|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863345|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863346|NCT00087516|Metformin|metformin|mesh-list
1863347|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1863348|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1863349|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863350|NCT00087516|Incretins|incretins|mesh-ancestor
1863351|NCT00087516|Hormones|hormones|mesh-ancestor
1863352|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863353|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1863354|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
1863355|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863356|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863357|NCT00087529|Rituximab|rituximab|mesh-list
1863358|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863359|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863360|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
1863361|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863362|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863363|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
1863364|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1863365|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1863366|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1863367|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
1863368|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
1863369|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863370|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863371|NCT00087568|Ribavirin|ribavirin|mesh-list
1863372|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1863373|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
1863374|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863375|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
1863376|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863377|NCT00087594|Ribavirin|ribavirin|mesh-list
1863378|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1863379|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
1863380|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863381|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
1863382|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863383|NCT00087607|Ribavirin|ribavirin|mesh-list
1863384|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1863385|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1863386|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
1863387|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863388|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
1863389|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863390|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1863391|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
1863392|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863393|NCT00087646|Ribavirin|ribavirin|mesh-list
1863394|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1863395|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
1863396|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
1863397|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863398|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
1863399|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863400|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
1863401|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863402|NCT00087672|Lenalidomide|lenalidomide|mesh-list
1863403|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
1863404|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863405|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1863406|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1863407|NCT00087672|Growth Substances|growth substances|mesh-ancestor
1863408|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
1863409|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863410|NCT00087685|Everolimus|everolimus|mesh-list
1863411|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863412|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863413|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
1863414|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863415|NCT00087698|Pemetrexed|pemetrexed|mesh-list
1863416|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863417|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863418|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863419|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1863420|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1863421|NCT00088153|Progesterone|progesterone|mesh-list
1863422|NCT00088153|Estrogens|estrogens|mesh-list
1863423|NCT00088153|Progestins|progestins|mesh-ancestor
1863424|NCT00088153|Hormones|hormones|mesh-ancestor
1863425|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863426|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863427|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
1863428|NCT00088166|Hormones|hormones|mesh-ancestor
1863429|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863430|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863431|NCT00088218|Cytarabine|cytarabine|mesh-list
1863432|NCT00088218|Clofarabine|clofarabine|mesh-list
1863433|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863434|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
1863435|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863436|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863437|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
1863438|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863439|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863440|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
1863441|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863442|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1863443|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1863444|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863445|NCT00088413|Molgramostim|molgramostim|mesh-list
1863446|NCT00088413|Sargramostim|sargramostim|mesh-list
1863447|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
1863448|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863449|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863450|NCT00088452|Lamotrigine|lamotrigine|mesh-list
1863451|NCT00088452|Valproic Acid|valproic acid|mesh-list
1863452|NCT00088452|Ethosuximide|ethosuximide|mesh-list
1863453|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
1863454|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1863455|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863456|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863457|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1863458|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863459|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1863460|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1863461|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863462|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863463|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1863464|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863465|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
1863466|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863467|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
1863468|NCT00088465|Olanzapine|olanzapine|mesh-list
1863469|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
1863470|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
1863471|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1863472|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863473|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1863474|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1863475|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1863476|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863477|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863478|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1863479|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863480|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863481|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863482|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863483|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
1863484|NCT00088530|Gemcitabine|gemcitabine|mesh-list
1863485|NCT00088530|Prednisone|prednisone|mesh-list
1863486|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
1863487|NCT00088530|Rituximab|rituximab|mesh-list
1863488|NCT00088530|Etoposide|etoposide|mesh-list
1863489|NCT00088530|Vincristine|vincristine|mesh-list
1863490|NCT00088530|Vinorelbine|vinorelbine|mesh-list
1863491|NCT00088530|Pixantrone|pixantrone|mesh-list
1863492|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863493|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
1863494|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863495|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863496|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863497|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
1863498|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863499|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863500|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1863501|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863502|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863503|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
1863504|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
1863505|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863506|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863507|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1863508|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
1863509|NCT00088530|Hormones|hormones|mesh-ancestor
1863510|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863511|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1863512|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1863513|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1863514|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1863515|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863516|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863517|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863518|NCT00088595|Pasireotide|pasireotide|mesh-list
1863519|NCT00088595|Hormones|hormones|mesh-ancestor
1863520|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863521|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863522|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1863523|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1863524|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1863525|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863526|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863527|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863528|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1863529|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1863530|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1863531|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
1863532|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863533|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863534|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1863535|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1863536|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
1863537|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1863538|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1863539|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
1863540|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1863541|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1863542|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1863543|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863544|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863545|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863546|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1863547|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1863548|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1863549|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
1863550|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863551|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863552|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1863553|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1863554|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
1863555|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1863556|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1863557|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
1863558|NCT00088699|Ketamine|ketamine|mesh-list
1863559|NCT00088699|Analgesics|analgesics|mesh-ancestor
1863560|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
1863561|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1863562|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863563|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1863564|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1863565|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
1863566|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
1863567|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1863568|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1863569|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1863570|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863571|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863572|NCT00088881|Prednisone|prednisone|mesh-list
1863573|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
1863574|NCT00088881|Rituximab|rituximab|mesh-list
1863575|NCT00088881|Doxorubicin|doxorubicin|mesh-list
1863576|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1863577|NCT00088881|Vincristine|vincristine|mesh-list
1863578|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863579|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
1863580|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863581|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863582|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863583|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
1863584|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863585|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863586|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1863587|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863588|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863589|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1863590|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1863591|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863592|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1863593|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
1863594|NCT00088881|Hormones|hormones|mesh-ancestor
1863595|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863596|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1863597|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1863598|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863599|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863600|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863601|NCT00088907|Docetaxel|docetaxel|mesh-list
1863602|NCT00088907|Gefitinib|gefitinib|mesh-list
1863603|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863604|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863605|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863606|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863607|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863608|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863609|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863610|NCT00088985|Trastuzumab|trastuzumab|mesh-list
1863611|NCT00088985|Vinorelbine|vinorelbine|mesh-list
1863612|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863613|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863614|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1863615|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863616|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863617|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863618|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863619|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
1863620|NCT00089011|Fludarabine|fludarabine|mesh-list
1863621|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
1863622|NCT00089011|Tacrolimus|tacrolimus|mesh-list
1863623|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863624|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863625|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
1863626|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863627|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863628|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
1863629|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863630|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1863631|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863632|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863633|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1863634|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
1863635|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1863636|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863637|NCT00089024|Leucovorin|leucovorin|mesh-list
1863638|NCT00089024|Gemcitabine|gemcitabine|mesh-list
1863639|NCT00089024|Fluorouracil|fluorouracil|mesh-list
1863640|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
1863641|NCT00089024|Calcium|calcium|mesh-list
1863642|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
1863643|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863644|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
1863645|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863646|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863647|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
1863648|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863649|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863650|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863651|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
1863652|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863653|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1863654|NCT00089024|Antidotes|antidotes|mesh-ancestor
1863655|NCT00089024|Protective Agents|protective agents|mesh-ancestor
1863656|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
1863657|NCT00089024|Vitamins|vitamins|mesh-ancestor
1863658|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
1863659|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1863660|NCT00089076|Ipilimumab|ipilimumab|mesh-list
1863661|NCT00089076|Antibodies|antibodies|mesh-list
1863662|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
1863663|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1863664|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
1863665|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863666|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863667|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1863668|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863669|NCT00089102|Gemcitabine|gemcitabine|mesh-list
1863670|NCT00089102|Irinotecan|irinotecan|mesh-list
1863671|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863672|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
1863673|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863674|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863675|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
1863676|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863677|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863678|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863679|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
1863680|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863681|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1863682|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1863683|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
1863684|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863685|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863686|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1863687|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
1863688|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1863689|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863690|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863691|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863692|NCT00089284|Rituximab|rituximab|mesh-list
1863693|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
1863694|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863695|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863696|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
1863697|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863698|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863699|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1863700|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
1863701|NCT00089297|Paclitaxel|paclitaxel|mesh-list
1863702|NCT00089297|Carboplatin|carboplatin|mesh-list
1863703|NCT00089297|Cetuximab|cetuximab|mesh-list
1863704|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1863705|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863706|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863707|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863708|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863709|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863710|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863711|NCT00089479|Capecitabine|capecitabine|mesh-list
1863712|NCT00089479|Docetaxel|docetaxel|mesh-list
1863713|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863714|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
1863715|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863716|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863717|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863718|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863719|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863720|NCT00089505|Ritonavir|ritonavir|mesh-list
1863721|NCT00089505|Lopinavir|lopinavir|mesh-list
1863722|NCT00089505|Tenofovir|tenofovir|mesh-list
1863723|NCT00089505|Emtricitabine|emtricitabine|mesh-list
1863724|NCT00089505|Nevirapine|nevirapine|mesh-list
1863725|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1863726|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1863727|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1863728|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
1863729|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863730|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863731|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1863732|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1863733|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
1863734|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863735|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1863736|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1863887|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
1863737|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1863738|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1863739|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1863740|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1863741|NCT00089544|Thalidomide|thalidomide|mesh-list
1863742|NCT00089544|Doxorubicin|doxorubicin|mesh-list
1863743|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1863744|NCT00089544|Ifosfamide|ifosfamide|mesh-list
1863745|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
1863746|NCT00089544|Dacarbazine|dacarbazine|mesh-list
1863747|NCT00089544|Imidazole|imidazole|mesh-list
1863748|NCT00089544|Lenograstim|lenograstim|mesh-list
1863749|NCT00089544|Sargramostim|sargramostim|mesh-list
1863750|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1863751|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863752|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1863753|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1863754|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863755|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863756|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1863757|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
1863758|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863759|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863760|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
1863761|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863762|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
1863763|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1863764|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863765|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1863766|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1863767|NCT00089544|Growth Substances|growth substances|mesh-ancestor
1863768|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
1863769|NCT00089583|Ritonavir|ritonavir|mesh-list
1863770|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
1863771|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1863772|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1863773|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
1863774|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863775|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863776|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1863777|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1863778|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
1863779|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863780|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1863781|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1863782|NCT00089609|Thalidomide|thalidomide|mesh-list
1863783|NCT00089609|Prednisone|prednisone|mesh-list
1863784|NCT00089609|Bevacizumab|bevacizumab|mesh-list
1863785|NCT00089609|Docetaxel|docetaxel|mesh-list
1863786|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863787|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863788|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1863789|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1863790|NCT00089609|Growth Substances|growth substances|mesh-ancestor
1863791|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863792|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
1863793|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863794|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863795|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863796|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863797|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1863798|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
1863799|NCT00089609|Hormones|hormones|mesh-ancestor
1863800|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863801|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1863802|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863803|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
1863804|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
1863805|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1863806|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863807|NCT00089635|Panitumumab|panitumumab|mesh-list
1863808|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863809|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863810|NCT00089648|Sunitinib|sunitinib|mesh-list
1863811|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863812|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1863813|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1863814|NCT00089648|Growth Substances|growth substances|mesh-ancestor
1863815|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863816|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
1863817|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863818|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863819|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863820|NCT00089661|Denosumab|denosumab|mesh-list
1863821|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1863822|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863823|NCT00089674|Denosumab|denosumab|mesh-list
1863824|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1863825|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863826|NCT00089778|Aldesleukin|aldesleukin|mesh-list
1863827|NCT00089778|Interleukin-2|interleukin-2|mesh-list
1863828|NCT00089778|Mitogens|mitogens|mesh-list
1863829|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863830|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1863831|NCT00089778|Analgesics|analgesics|mesh-ancestor
1863832|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
1863833|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1863834|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863835|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863836|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863837|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1863838|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1863839|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
1863840|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863841|NCT00089791|Denosumab|denosumab|mesh-list
1863842|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1863843|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863844|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
1863845|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
1863846|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
1863847|NCT00089843|Testosterone|testosterone|mesh-list
1863848|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
1863849|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
1863850|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1863851|NCT00089843|Androgens|androgens|mesh-ancestor
1863852|NCT00089843|Hormones|hormones|mesh-ancestor
1863853|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863854|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863855|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1863856|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863857|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
1863858|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1863859|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863860|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863861|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1863862|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1863863|NCT00089895|Eptifibatide|eptifibatide|mesh-list
1863864|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1863865|NCT00089999|Lapatinib|lapatinib|mesh-list
1863866|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863867|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863868|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863869|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863870|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
1863871|NCT00090051|Rituximab|rituximab|mesh-list
1863872|NCT00090051|Fludarabine|fludarabine|mesh-list
1863873|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
1863874|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1863875|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
1863876|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863877|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1863878|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1863879|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
1863880|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863881|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863882|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1863883|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1863884|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1863885|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
1863886|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
1863888|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863889|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1863890|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
1863891|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863892|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863893|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1863894|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1863895|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1863896|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
1863897|NCT00090103|Tamsulosin|tamsulosin|mesh-list
1863898|NCT00090103|Dutasteride|dutasteride|mesh-list
1863899|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1863900|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1863901|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1863902|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
1863903|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863904|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863905|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863906|NCT00090103|Urological Agents|urological agents|mesh-ancestor
1863907|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1863908|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1863909|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863910|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
1863911|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863912|NCT00090142|Montelukast|montelukast|mesh-list
1863913|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1863914|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
1863915|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1863916|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
1863917|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1863918|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863919|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1863920|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1863921|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863922|NCT00090259|Losartan|losartan|mesh-list
1863923|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1863924|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1863925|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1863926|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1863927|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863928|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
1863929|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
1863930|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863931|NCT00090402|Protective Agents|protective agents|mesh-ancestor
1863932|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863933|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
1863934|NCT00090402|Vitamins|vitamins|mesh-ancestor
1863935|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
1863936|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
1863937|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863938|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863939|NCT00090545|Sorafenib|sorafenib|mesh-list
1863940|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863941|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1863942|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863943|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863944|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1863945|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1863946|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1863947|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
1863948|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1863949|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863950|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863951|NCT00090584|Urological Agents|urological agents|mesh-ancestor
1863952|NCT00090610|Carboplatin|carboplatin|mesh-list
1863953|NCT00090610|Docetaxel|docetaxel|mesh-list
1863954|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863955|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
1863956|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
1863957|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
1863958|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863959|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
1863960|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
1863961|NCT00090753|Hematinics|hematinics|mesh-ancestor
1863962|NCT00090766|Valganciclovir|valganciclovir|mesh-list
1863963|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
1863964|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863965|NCT00090779|Ritonavir|ritonavir|mesh-list
1863966|NCT00090779|Lopinavir|lopinavir|mesh-list
1863967|NCT00090779|Tenofovir|tenofovir|mesh-list
1863968|NCT00090779|Emtricitabine|emtricitabine|mesh-list
1863969|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1863970|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1863971|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1863972|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
1863973|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863974|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863975|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1863976|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1863977|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
1863978|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1863979|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1863980|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1863981|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1863982|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1863983|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1863984|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
1863985|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1863986|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
1863987|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1863988|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1863989|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1863990|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1863991|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863992|NCT00090857|Letrozole|letrozole|mesh-list
1863993|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1863994|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1863995|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1863996|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1863997|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1863998|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1863999|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
1864000|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864001|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864002|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
1864003|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864004|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864005|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864006|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864007|NCT00091026|Gemcitabine|gemcitabine|mesh-list
1864008|NCT00091026|Bevacizumab|bevacizumab|mesh-list
1864009|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1864010|NCT00091026|Cetuximab|cetuximab|mesh-list
1864011|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1864012|NCT00091026|Antibodies|antibodies|mesh-list
1864013|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
1864014|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1864015|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864016|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864017|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864018|NCT00091026|Growth Substances|growth substances|mesh-ancestor
1864019|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864020|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864021|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
1864022|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864023|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
1864024|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864025|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
1864026|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864027|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864028|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864029|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864030|NCT00091260|Dexamethasone|dexamethasone|mesh-list
1864031|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
1864032|NCT00091260|Lenalidomide|lenalidomide|mesh-list
1864033|NCT00091260|BB 1101|bb 1101|mesh-list
1864034|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864035|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
1864036|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
1864037|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864038|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864039|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864040|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
1864041|NCT00091260|Hormones|hormones|mesh-ancestor
1864042|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864043|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864044|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864045|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
1864046|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864047|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864048|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
1864049|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864050|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864051|NCT00091260|Growth Substances|growth substances|mesh-ancestor
1864052|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864053|NCT00091273|Sargramostim|sargramostim|mesh-list
1864054|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
1864055|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
1864056|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864057|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1864058|NCT00091442|Docetaxel|docetaxel|mesh-list
1864059|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1864060|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864061|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864062|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864063|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864064|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864065|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864066|NCT00091507|Insulin|insulin|mesh-list
1864067|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864068|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864069|NCT00091572|Temozolomide|temozolomide|mesh-list
1864070|NCT00091572|Dacarbazine|dacarbazine|mesh-list
1864071|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1864072|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
1864073|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864074|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864075|NCT00091793|Denosumab|denosumab|mesh-list
1864076|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1864077|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864078|NCT00091819|Vancomycin|vancomycin|mesh-list
1864079|NCT00091819|Telavancin|telavancin|mesh-list
1864080|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864081|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864082|NCT00091832|Denosumab|denosumab|mesh-list
1864083|NCT00091832|Diphosphonates|diphosphonates|mesh-list
1864084|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1864085|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864086|NCT00091949|Pioglitazone|pioglitazone|mesh-list
1864087|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864088|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864089|NCT00092118|Montelukast|montelukast|mesh-list
1864090|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1864091|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
1864092|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1864093|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
1864094|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864095|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864096|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1864097|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1864098|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864099|NCT00092131|Montelukast|montelukast|mesh-list
1864100|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1864101|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
1864102|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1864103|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
1864104|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864105|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864106|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1864107|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1864108|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864109|NCT00092417|Vaccines|vaccines|mesh-list
1864110|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
1864111|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864112|NCT00092534|Vaccines|vaccines|mesh-list
1864113|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
1864114|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864115|NCT00092677|Simvastatin|simvastatin|mesh-list
1864116|NCT00092677|Ezetimibe|ezetimibe|mesh-list
1864117|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1864118|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1864119|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
1864120|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864121|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1864122|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1864123|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864124|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
1864125|NCT00093015|Hematinics|hematinics|mesh-ancestor
1864126|NCT00093041|Zalutumumab|zalutumumab|mesh-list
1864127|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864128|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864129|NCT00093145|Paclitaxel|paclitaxel|mesh-list
1864130|NCT00093145|Carboplatin|carboplatin|mesh-list
1864131|NCT00093145|Trastuzumab|trastuzumab|mesh-list
1864132|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1864133|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864134|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864135|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864136|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864137|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864138|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864139|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864140|NCT00093379|Capecitabine|capecitabine|mesh-list
1864141|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
1864142|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864143|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
1864144|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864145|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864146|NCT00093470|Tipifarnib|tipifarnib|mesh-list
1864147|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864148|NCT00093496|Gemcitabine|gemcitabine|mesh-list
1864149|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864150|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
1864151|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864152|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864153|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
1864154|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864155|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864156|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864157|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
1864158|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864159|NCT00093756|Paclitaxel|paclitaxel|mesh-list
1864160|NCT00093756|Carboplatin|carboplatin|mesh-list
1864161|NCT00093756|Bortezomib|bortezomib|mesh-list
1864162|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864163|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864164|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864165|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864166|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864167|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864168|NCT00093782|Sirolimus|sirolimus|mesh-list
1864169|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864170|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864171|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864172|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864173|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
1864174|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864175|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
1864176|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864177|NCT00093795|Gemcitabine|gemcitabine|mesh-list
1864178|NCT00093795|Paclitaxel|paclitaxel|mesh-list
1864179|NCT00093795|Docetaxel|docetaxel|mesh-list
1864180|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
1864181|NCT00093795|Doxorubicin|doxorubicin|mesh-list
1864182|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864183|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864184|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864185|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864186|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864335|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864187|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864188|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864189|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
1864190|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864191|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864192|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1864193|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
1864194|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1864195|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864196|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
1864197|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
1864198|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864199|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864200|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864201|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1864202|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1864203|NCT00093808|Capecitabine|capecitabine|mesh-list
1864204|NCT00093808|Trastuzumab|trastuzumab|mesh-list
1864205|NCT00093808|Vinorelbine|vinorelbine|mesh-list
1864206|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864207|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
1864208|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864209|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864210|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864211|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864212|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864213|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864214|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864215|NCT00094055|Axitinib|axitinib|mesh-list
1864216|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864217|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864218|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864219|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864220|NCT00094094|Axitinib|axitinib|mesh-list
1864221|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864222|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864223|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864224|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864225|NCT00094107|Axitinib|axitinib|mesh-list
1864226|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864227|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864228|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864229|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864230|NCT00094172|Atorvastatin|atorvastatin|mesh-list
1864231|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1864232|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1864233|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
1864234|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864235|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1864236|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1864237|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864238|NCT00094302|Spironolactone|spironolactone|mesh-list
1864239|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1864240|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
1864241|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864242|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864243|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1864244|NCT00094302|Diuretics|diuretics|mesh-ancestor
1864245|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
1864246|NCT00094328|Anastrozole|anastrozole|mesh-list
1864247|NCT00094328|Bicalutamide|bicalutamide|mesh-list
1864248|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864249|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864250|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1864251|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1864252|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864253|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864254|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1864255|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
1864256|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864257|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864258|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
1864259|NCT00094445|Curcumin|curcumin|mesh-list
1864260|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1864261|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1864262|NCT00094445|Analgesics|analgesics|mesh-ancestor
1864263|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
1864264|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864265|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864266|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864267|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864268|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864269|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864270|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864271|NCT00094458|Azathioprine|azathioprine|mesh-list
1864272|NCT00094458|Infliximab|infliximab|mesh-list
1864273|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864274|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864275|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864276|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
1864277|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864278|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864279|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864280|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864281|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
1864282|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864283|NCT00094497|Doxorubicin|doxorubicin|mesh-list
1864284|NCT00094497|Etoposide|etoposide|mesh-list
1864285|NCT00094497|Mitotane|mitotane|mesh-list
1864286|NCT00094497|Streptozocin|streptozocin|mesh-list
1864287|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864288|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864289|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1864290|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1864291|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864292|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864293|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864294|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864295|NCT00094653|Ipilimumab|ipilimumab|mesh-list
1864296|NCT00094653|Vaccines|vaccines|mesh-list
1864297|NCT00094653|Antibodies|antibodies|mesh-list
1864298|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1864299|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
1864300|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864301|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864302|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864303|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1864304|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864305|NCT00094757|Pioglitazone|pioglitazone|mesh-list
1864306|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1864307|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864308|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864309|NCT00094757|Incretins|incretins|mesh-ancestor
1864310|NCT00094757|Hormones|hormones|mesh-ancestor
1864311|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864312|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1864313|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
1864314|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864315|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864316|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1864317|NCT00094770|Glipizide|glipizide|mesh-list
1864318|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864319|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864320|NCT00094770|Incretins|incretins|mesh-ancestor
1864321|NCT00094770|Hormones|hormones|mesh-ancestor
1864322|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864323|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1864324|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
1864325|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864326|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864327|NCT00094835|Paclitaxel|paclitaxel|mesh-list
1864328|NCT00094835|Carboplatin|carboplatin|mesh-list
1864329|NCT00094835|Panitumumab|panitumumab|mesh-list
1864330|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
1864331|NCT00094835|Imetelstat|imetelstat|mesh-list
1864332|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864333|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864334|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864336|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864337|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864338|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864339|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864340|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864341|NCT00094861|Paclitaxel|paclitaxel|mesh-list
1864342|NCT00094861|Carboplatin|carboplatin|mesh-list
1864343|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864344|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864345|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864346|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864347|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864348|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864349|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
1864350|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1864351|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
1864352|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864353|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864354|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1864355|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
1864356|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1864357|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
1864358|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864359|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1864360|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1864361|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
1864362|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
1864363|NCT00094887|Protective Agents|protective agents|mesh-ancestor
1864364|NCT00094900|Rilonacept|rilonacept|mesh-list
1864365|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864366|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1864367|NCT00095056|Glipizide|glipizide|mesh-list
1864368|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864369|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864370|NCT00095056|Incretins|incretins|mesh-ancestor
1864371|NCT00095056|Hormones|hormones|mesh-ancestor
1864372|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864373|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1864374|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
1864375|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864376|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864377|NCT00095121|Lamivudine|lamivudine|mesh-list
1864378|NCT00095121|Adefovir|adefovir|mesh-list
1864379|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1864380|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1864381|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864382|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864383|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864384|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
1864385|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864386|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1864387|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1864388|NCT00095147|Methotrexate|methotrexate|mesh-list
1864389|NCT00095147|Abatacept|abatacept|mesh-list
1864390|NCT00095147|Infliximab|infliximab|mesh-list
1864391|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1864392|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
1864393|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1864394|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864395|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864396|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
1864397|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864398|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864399|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864400|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864401|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1864402|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864403|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
1864404|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864405|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864406|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864407|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1864408|NCT00095173|Abatacept|abatacept|mesh-list
1864409|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1864485|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864410|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864411|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864412|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864413|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
1864414|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864415|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864416|NCT00095199|Docetaxel|docetaxel|mesh-list
1864417|NCT00095199|Pemetrexed|pemetrexed|mesh-list
1864418|NCT00095199|Cetuximab|cetuximab|mesh-list
1864419|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864420|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864421|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864422|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864423|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864424|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864425|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1864426|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864427|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864428|NCT00095212|Testosterone|testosterone|mesh-list
1864429|NCT00095212|Androgens|androgens|mesh-ancestor
1864430|NCT00095212|Hormones|hormones|mesh-ancestor
1864431|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864432|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864433|NCT00095238|Irbesartan|irbesartan|mesh-list
1864434|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1864435|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1864436|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1864437|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864438|NCT00095498|Denosumab|denosumab|mesh-list
1864439|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1864440|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864441|NCT00095563|Lapatinib|lapatinib|mesh-list
1864442|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864443|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864444|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864445|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864446|NCT00095836|Gefitinib|gefitinib|mesh-list
1864447|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864448|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864449|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864450|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864451|NCT00095875|Carboplatin|carboplatin|mesh-list
1864452|NCT00095875|Docetaxel|docetaxel|mesh-list
1864453|NCT00095875|Fluorouracil|fluorouracil|mesh-list
1864454|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864455|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864456|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864457|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864458|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864459|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
1864460|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864461|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864462|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
1864463|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864464|NCT00095940|Lapatinib|lapatinib|mesh-list
1864465|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864466|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864467|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864468|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864469|NCT00095979|Epothilones|epothilones|mesh-list
1864470|NCT00095979|Epothilone B|epothilone b|mesh-list
1864471|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864472|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864473|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864474|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864475|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864476|NCT00096018|Thalidomide|thalidomide|mesh-list
1864477|NCT00096018|Fludarabine|fludarabine|mesh-list
1864478|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
1864479|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864480|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864481|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
1864482|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864483|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864484|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
1864486|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
1864487|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864488|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864489|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864490|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864491|NCT00096018|Growth Substances|growth substances|mesh-ancestor
1864492|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864493|NCT00096031|Cetuximab|cetuximab|mesh-list
1864494|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864495|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864496|NCT00096044|Rituximab|rituximab|mesh-list
1864497|NCT00096044|Lenalidomide|lenalidomide|mesh-list
1864498|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864499|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864500|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
1864501|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864502|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864503|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864504|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864505|NCT00096044|Growth Substances|growth substances|mesh-ancestor
1864506|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864507|NCT00096122|Cytarabine|cytarabine|mesh-list
1864508|NCT00096122|Idarubicin|idarubicin|mesh-list
1864509|NCT00096122|Tipifarnib|tipifarnib|mesh-list
1864510|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864511|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
1864512|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864513|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864514|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
1864515|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864516|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864517|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
1864518|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864519|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864520|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1864521|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1864522|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864523|NCT00096135|Leucovorin|leucovorin|mesh-list
1864524|NCT00096135|Cytarabine|cytarabine|mesh-list
1864525|NCT00096135|Dexamethasone|dexamethasone|mesh-list
1864526|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
1864527|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1864528|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1864529|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1864530|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
1864531|NCT00096135|Methotrexate|methotrexate|mesh-list
1864532|NCT00096135|Etoposide|etoposide|mesh-list
1864533|NCT00096135|Vincristine|vincristine|mesh-list
1864534|NCT00096135|Daunorubicin|daunorubicin|mesh-list
1864535|NCT00096135|Asparaginase|asparaginase|mesh-list
1864536|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
1864537|NCT00096135|Pegaspargase|pegaspargase|mesh-list
1864538|NCT00096135|Lenograstim|lenograstim|mesh-list
1864539|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
1864540|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864541|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
1864542|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864543|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864544|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1864545|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
1864546|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864547|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864548|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1864549|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864550|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
1864551|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
1864552|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864553|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864554|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
1864555|NCT00096135|Hormones|hormones|mesh-ancestor
1864556|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864557|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864558|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1864559|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
1864560|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1864561|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864562|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
1864563|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864564|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864565|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1864566|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864567|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864568|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1864569|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1864570|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1864571|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
1864572|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864573|NCT00096135|Antidotes|antidotes|mesh-ancestor
1864574|NCT00096135|Protective Agents|protective agents|mesh-ancestor
1864575|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
1864576|NCT00096135|Vitamins|vitamins|mesh-ancestor
1864577|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
1864578|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864579|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864580|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864581|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864582|NCT00096161|Cyclosporine|cyclosporine|mesh-list
1864583|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
1864584|NCT00096161|Vidarabine|vidarabine|mesh-list
1864585|NCT00096161|Pentostatin|pentostatin|mesh-list
1864586|NCT00096161|Cyclosporins|cyclosporins|mesh-list
1864587|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864588|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864589|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864590|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
1864591|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864592|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
1864593|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864594|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864595|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864596|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1864597|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1864598|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864599|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1864600|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
1864601|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864602|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1864603|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
1864604|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
1864605|NCT00096174|Cisplatin|cisplatin|mesh-list
1864606|NCT00096174|Cetuximab|cetuximab|mesh-list
1864607|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864608|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864609|NCT00096200|Paclitaxel|paclitaxel|mesh-list
1864610|NCT00096200|Carboplatin|carboplatin|mesh-list
1864611|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1864612|NCT00096200|Sorafenib|sorafenib|mesh-list
1864613|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864614|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864615|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864616|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864617|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864618|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864619|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864620|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864621|NCT00096226|Paclitaxel|paclitaxel|mesh-list
1864622|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1864623|NCT00096226|Carboplatin|carboplatin|mesh-list
1864624|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864625|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864626|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
1864627|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
1864628|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
1864629|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864630|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1864631|NCT00096265|Temozolomide|temozolomide|mesh-list
1864632|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864633|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864634|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864635|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864636|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1864637|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
1864638|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
1864639|NCT00096278|Leucovorin|leucovorin|mesh-list
1864640|NCT00096278|Folic Acid|folic acid|mesh-list
1864641|NCT00096278|Bevacizumab|bevacizumab|mesh-list
1864642|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1864643|NCT00096278|Fluorouracil|fluorouracil|mesh-list
1864644|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
1864645|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
1864646|NCT00096278|Antibodies|antibodies|mesh-list
1864647|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
1864648|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1864649|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
1864650|NCT00096278|Calcium|calcium|mesh-list
1864651|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
1864652|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864653|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864654|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864655|NCT00096278|Growth Substances|growth substances|mesh-ancestor
1864656|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864657|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864658|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
1864659|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1864660|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1864661|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
1864662|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864663|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864664|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864665|NCT00096278|Antidotes|antidotes|mesh-ancestor
1864666|NCT00096278|Protective Agents|protective agents|mesh-ancestor
1864667|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
1864668|NCT00096278|Vitamins|vitamins|mesh-ancestor
1864669|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
1864670|NCT00096278|Hematinics|hematinics|mesh-ancestor
1864671|NCT00096356|Vitamins|vitamins|mesh-list
1864672|NCT00096356|Vitamin E|vitamin e|mesh-list
1864673|NCT00096356|Tocopherols|tocopherols|mesh-list
1864674|NCT00096356|Tocotrienols|tocotrienols|mesh-list
1864675|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
1864676|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
1864677|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864678|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
1864679|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864680|NCT00096356|Protective Agents|protective agents|mesh-ancestor
1864681|NCT00096382|Aldesleukin|aldesleukin|mesh-list
1864682|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
1864683|NCT00096382|Fludarabine|fludarabine|mesh-list
1864684|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
1864685|NCT00096382|Interleukin-2|interleukin-2|mesh-list
1864686|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864687|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
1864688|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864689|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864690|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1864691|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
1864692|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864693|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864694|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1864695|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864696|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
1864697|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1864698|NCT00096382|Analgesics|analgesics|mesh-ancestor
1864699|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
1864700|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864701|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1864702|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1864703|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
1864704|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864705|NCT00096447|Lapatinib|lapatinib|mesh-list
1864706|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864707|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864708|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864709|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864710|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
1864711|NCT00096460|Carmustine|carmustine|mesh-list
1864712|NCT00096460|Rituximab|rituximab|mesh-list
1864713|NCT00096460|Methotrexate|methotrexate|mesh-list
1864714|NCT00096460|Fludarabine|fludarabine|mesh-list
1864715|NCT00096460|Etoposide|etoposide|mesh-list
1864716|NCT00096460|Tacrolimus|tacrolimus|mesh-list
1864717|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864718|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
1864719|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864720|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864721|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1864722|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
1864723|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864724|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864725|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1864726|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864727|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1864728|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
1864729|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1864730|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864731|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
1864732|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864733|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864734|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1864735|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864736|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1864737|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1864738|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1864739|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1864740|NCT00096486|Everolimus|everolimus|mesh-list
1864741|NCT00096486|Gefitinib|gefitinib|mesh-list
1864742|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864743|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864744|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
1864745|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864746|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864747|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864748|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864749|NCT00096538|Valganciclovir|valganciclovir|mesh-list
1864750|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
1864751|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864752|NCT00096785|Entecavir|entecavir|mesh-list
1864753|NCT00096785|Adefovir|adefovir|mesh-list
1864754|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
1864755|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864756|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1864757|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864758|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864759|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864760|NCT00096941|Pertuzumab|pertuzumab|mesh-list
1864761|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864762|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864763|NCT00096954|Omalizumab|omalizumab|mesh-list
1864764|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1864765|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1864766|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
1864767|NCT00096993|Gemcitabine|gemcitabine|mesh-list
1864768|NCT00096993|Pertuzumab|pertuzumab|mesh-list
1864769|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864770|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
1864771|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864772|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864773|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
1864774|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864775|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864776|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864777|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
1864778|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864779|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1864780|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
1864781|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864782|NCT00097448|Prednisone|prednisone|mesh-list
1864783|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
1864784|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1864785|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1864786|NCT00097448|Prednisolone|prednisolone|mesh-list
1864787|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
1864788|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1864789|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
1864790|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864791|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
1864792|NCT00097448|Hormones|hormones|mesh-ancestor
1864793|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864794|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864795|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864796|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864797|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
1864798|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
1864799|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864800|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864801|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1864802|NCT00097448|Protective Agents|protective agents|mesh-ancestor
1864803|NCT00097500|Metformin|metformin|mesh-list
1864804|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
1864805|NCT00097500|Exenatide|exenatide|mesh-list
1864806|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864807|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864808|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1864809|NCT00097500|Incretins|incretins|mesh-ancestor
1864810|NCT00097500|Hormones|hormones|mesh-ancestor
1864811|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864812|NCT00097591|Clopidogrel|clopidogrel|mesh-list
1864813|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1864814|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1864815|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1864816|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1864817|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1864818|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
1864819|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1864820|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864821|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864822|NCT00097669|Folic Acid|folic acid|mesh-list
1864823|NCT00097669|Hematinics|hematinics|mesh-ancestor
1864824|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
1864825|NCT00097669|Vitamins|vitamins|mesh-ancestor
1864826|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
1864827|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864828|NCT00097695|Icatibant|icatibant|mesh-list
1864829|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1864830|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1864831|NCT00097695|Analgesics|analgesics|mesh-ancestor
1864832|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
1864833|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864834|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864835|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864836|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864837|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1864838|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1864839|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864840|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1864841|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864842|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
1864843|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
1864844|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1864845|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1864846|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864847|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1864848|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
1864849|NCT00097773|Tobramycin|tobramycin|mesh-list
1864850|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864851|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864852|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1864853|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1864854|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864855|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864856|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864857|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1864858|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1864859|NCT00097786|Nateglinide|nateglinide|mesh-list
1864860|NCT00097786|Valsartan|valsartan|mesh-list
1864861|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1864862|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1864863|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1864864|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864865|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1864866|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864867|NCT00097981|Thalidomide|thalidomide|mesh-list
1864868|NCT00097981|Dexamethasone|dexamethasone|mesh-list
1864869|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864870|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
1864871|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
1864872|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864873|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864874|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864875|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
1864876|NCT00097981|Hormones|hormones|mesh-ancestor
1864877|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864878|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864879|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864880|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864881|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
1864882|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
1864883|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864884|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864885|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864886|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864887|NCT00097981|Growth Substances|growth substances|mesh-ancestor
1864888|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864889|NCT00098020|Isotretinoin|isotretinoin|mesh-list
1864890|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864891|NCT00098059|Famciclovir|famciclovir|mesh-list
1864892|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
1864893|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864894|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864895|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864896|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864897|NCT00098254|Sorafenib|sorafenib|mesh-list
1864898|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864899|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864900|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864901|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864902|NCT00098293|Lamivudine|lamivudine|mesh-list
1864903|NCT00098293|Zidovudine|zidovudine|mesh-list
1864904|NCT00098293|Efavirenz|efavirenz|mesh-list
1864905|NCT00098293|Maraviroc|maraviroc|mesh-list
1864906|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1864907|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1864908|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864909|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864910|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
1864911|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864912|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1864913|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1864914|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
1864915|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1864916|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1864917|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1864918|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1864919|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1864920|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1864921|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1864922|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1864923|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1864924|NCT00098306|Maraviroc|maraviroc|mesh-list
1864925|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1864926|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1864927|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864928|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1864929|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1864930|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
1864931|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864932|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1864933|NCT00098371|Alvocidib|alvocidib|mesh-list
1864934|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864935|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864936|NCT00098371|Growth Substances|growth substances|mesh-ancestor
1864937|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864938|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1864939|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864940|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864941|NCT00098475|Thalidomide|thalidomide|mesh-list
1864942|NCT00098475|Dexamethasone|dexamethasone|mesh-list
1864943|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
1864944|NCT00098475|Lenalidomide|lenalidomide|mesh-list
1864945|NCT00098475|Ichthammol|ichthammol|mesh-list
1864946|NCT00098475|BB 1101|bb 1101|mesh-list
1864947|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1864948|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
1864949|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
1864950|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1864951|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864952|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1864953|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
1864954|NCT00098475|Hormones|hormones|mesh-ancestor
1864955|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1864956|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1864957|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864958|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
1864959|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1864960|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864961|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
1864962|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1864963|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1864964|NCT00098475|Growth Substances|growth substances|mesh-ancestor
1864965|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
1864966|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864967|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
1864968|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1864969|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864970|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
1864971|NCT00098670|Rituximab|rituximab|mesh-list
1864972|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1864973|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
1864974|NCT00098670|Fludarabine|fludarabine|mesh-list
1864975|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
1864976|NCT00098670|Antibodies|antibodies|mesh-list
1864977|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
1864978|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1864979|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
1864980|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1864981|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1864982|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1864983|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1864984|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
1864985|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864986|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1864987|NCT00098722|Maraviroc|maraviroc|mesh-list
1864988|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1864989|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1864990|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1864991|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1864992|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1864993|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
1864994|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1864995|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1864996|NCT00098748|Maraviroc|maraviroc|mesh-list
1864997|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1864998|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1864999|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865000|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865001|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865002|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
1865003|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865004|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1865005|NCT00098774|Leucovorin|leucovorin|mesh-list
1865006|NCT00098774|Cytarabine|cytarabine|mesh-list
1865007|NCT00098774|Rituximab|rituximab|mesh-list
1865008|NCT00098774|Methotrexate|methotrexate|mesh-list
1865009|NCT00098774|Etoposide|etoposide|mesh-list
1865010|NCT00098774|Temozolomide|temozolomide|mesh-list
1865011|NCT00098774|Calcium|calcium|mesh-list
1865012|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
1865013|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865014|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865015|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
1865016|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865017|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865018|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1865019|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1865020|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
1865021|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1865022|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865023|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
1865024|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865025|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
1865026|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865027|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1865028|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865029|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865030|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865031|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865032|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865033|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
1865034|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865035|NCT00098774|Antidotes|antidotes|mesh-ancestor
1865036|NCT00098774|Protective Agents|protective agents|mesh-ancestor
1865037|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
1865038|NCT00098774|Vitamins|vitamins|mesh-ancestor
1865039|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
1865040|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865041|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
1865042|NCT00098787|Leucovorin|leucovorin|mesh-list
1865043|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
1865044|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
1865045|NCT00098787|Bevacizumab|bevacizumab|mesh-list
1865046|NCT00098787|Fluorouracil|fluorouracil|mesh-list
1865047|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
1865048|NCT00098787|Irinotecan|irinotecan|mesh-list
1865049|NCT00098787|Camptothecin|camptothecin|mesh-list
1865050|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
1865051|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865052|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865053|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1865054|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1865055|NCT00098787|Growth Substances|growth substances|mesh-ancestor
1865056|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865057|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
1865058|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
1865059|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865060|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865061|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865062|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
1865063|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1865064|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865065|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865066|NCT00098787|Antidotes|antidotes|mesh-ancestor
1865067|NCT00098787|Protective Agents|protective agents|mesh-ancestor
1865068|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
1865069|NCT00098787|Vitamins|vitamins|mesh-ancestor
1865070|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
1865071|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865072|NCT00098813|Romidepsin|romidepsin|mesh-list
1865073|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865074|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865075|NCT00098839|Leucovorin|leucovorin|mesh-list
1865076|NCT00098839|Cytarabine|cytarabine|mesh-list
1865077|NCT00098839|Prednisone|prednisone|mesh-list
1865078|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
1865079|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1865080|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1865081|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1865082|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
1865083|NCT00098839|Doxorubicin|doxorubicin|mesh-list
1865084|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1865085|NCT00098839|Methotrexate|methotrexate|mesh-list
1865086|NCT00098839|Etoposide|etoposide|mesh-list
1865087|NCT00098839|Vincristine|vincristine|mesh-list
1865088|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
1865089|NCT00098839|Asparaginase|asparaginase|mesh-list
1865090|NCT00098839|Pegaspargase|pegaspargase|mesh-list
1865091|NCT00098839|Epratuzumab|epratuzumab|mesh-list
1865092|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
1865093|NCT00098839|Razoxane|razoxane|mesh-list
1865094|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
1865095|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865096|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
1865097|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865098|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865099|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865100|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
1865101|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865102|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865103|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1865104|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865105|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865106|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865107|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865108|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865109|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
1865110|NCT00098839|Hormones|hormones|mesh-ancestor
1865111|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865112|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865113|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1865114|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
1865115|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1865116|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865117|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
1865118|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
1865119|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1865120|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865121|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865122|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
1865123|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865124|NCT00098839|Antidotes|antidotes|mesh-ancestor
1865125|NCT00098839|Protective Agents|protective agents|mesh-ancestor
1865126|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
1865127|NCT00098839|Vitamins|vitamins|mesh-ancestor
1865128|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
1865129|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
1865130|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
1865131|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
1865132|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865133|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1865134|NCT00098865|Thalidomide|thalidomide|mesh-list
1865135|NCT00098865|Temozolomide|temozolomide|mesh-list
1865136|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865137|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
1865138|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865139|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865140|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865141|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
1865142|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865143|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
1865144|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1865145|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865146|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1865147|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1865148|NCT00098865|Growth Substances|growth substances|mesh-ancestor
1865149|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
1865150|NCT00098956|Topotecan|topotecan|mesh-list
1865151|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
1865152|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1865153|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865154|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865155|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865156|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865157|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865158|NCT00099021|Pioglitazone|pioglitazone|mesh-list
1865159|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1865160|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865161|NCT00099047|Celecoxib|celecoxib|mesh-list
1865162|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1865163|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1865164|NCT00099047|Analgesics|analgesics|mesh-ancestor
1865165|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
1865166|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1865167|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865168|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865169|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865170|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1865171|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1865172|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865173|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865174|NCT00099268|Levodopa|levodopa|mesh-list
1865175|NCT00099268|Carbidopa|carbidopa|mesh-list
1865176|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1865177|NCT00099268|Entacapone|entacapone|mesh-list
1865178|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1865179|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1865180|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
1865181|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865182|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865183|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865184|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1865185|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865186|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1865187|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
1865188|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
1865189|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1865190|NCT00099359|Lamivudine|lamivudine|mesh-list
1865191|NCT00099359|Zidovudine|zidovudine|mesh-list
1865192|NCT00099359|Nevirapine|nevirapine|mesh-list
1865193|NCT00099359|Nelfinavir|nelfinavir|mesh-list
1865194|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1865195|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865196|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865197|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865198|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
1865199|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865200|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865201|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865202|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
1865203|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1865204|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1865205|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1865206|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1865207|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
1865208|NCT00099437|Fulvestrant|fulvestrant|mesh-list
1865209|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865210|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865211|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1865212|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1865213|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
1865214|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865215|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865216|NCT00099632|Ritonavir|ritonavir|mesh-list
1865217|NCT00099632|Lopinavir|lopinavir|mesh-list
1865218|NCT00099632|Tenofovir|tenofovir|mesh-list
1865219|NCT00099632|Lamivudine|lamivudine|mesh-list
1865220|NCT00099632|Zidovudine|zidovudine|mesh-list
1865221|NCT00099632|Emtricitabine|emtricitabine|mesh-list
1865222|NCT00099632|Nevirapine|nevirapine|mesh-list
1865223|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1865224|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1865225|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1865226|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1865227|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
1865228|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865229|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865230|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865231|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865232|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
1865233|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865234|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1865235|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1865236|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1865237|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865238|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
1865239|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1865240|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1865241|NCT00099983|Risperidone|risperidone|mesh-list
1865242|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1865243|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
1865244|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865245|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865246|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865247|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1865248|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1865249|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1865250|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1865251|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1865252|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
1865253|NCT00100048|Tenofovir|tenofovir|mesh-list
1865254|NCT00100048|Lamivudine|lamivudine|mesh-list
1865255|NCT00100048|Efavirenz|efavirenz|mesh-list
1865256|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
1865257|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
1865258|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865259|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1865260|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865261|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865262|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865263|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865264|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865265|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1865266|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1865267|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1865268|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1865269|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1865270|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1865271|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1865272|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1865273|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
1865274|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1865275|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1865276|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
1865277|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865278|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865279|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865280|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
1865281|NCT00100178|Daclizumab|daclizumab|mesh-list
1865282|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865283|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865284|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1865285|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
1865286|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1865287|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865288|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865289|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865290|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865291|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
1865292|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865293|NCT00100659|Interferons|interferons|mesh-list
1865294|NCT00100659|Ribavirin|ribavirin|mesh-list
1865295|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865296|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
1865297|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865298|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
1865299|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865300|NCT00100698|Hormones|hormones|mesh-list
1865301|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865302|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865303|NCT00100789|Gemcitabine|gemcitabine|mesh-list
1865304|NCT00100789|Paclitaxel|paclitaxel|mesh-list
1865305|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865306|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865307|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
1865308|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
1865309|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
1865310|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865311|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865312|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
1865313|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
1865314|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865315|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865316|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865317|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
1865318|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865319|NCT00100802|Temozolomide|temozolomide|mesh-list
1865320|NCT00100802|Lomustine|lomustine|mesh-list
1865321|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865322|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
1865323|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865324|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865325|NCT00100815|Gemcitabine|gemcitabine|mesh-list
1865326|NCT00100815|Bevacizumab|bevacizumab|mesh-list
1865327|NCT00100815|Capecitabine|capecitabine|mesh-list
1865328|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865329|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865330|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1865331|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1865332|NCT00100815|Growth Substances|growth substances|mesh-ancestor
1865333|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865334|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
1865335|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865336|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
1865337|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865338|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
1865339|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865340|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865341|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865342|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
1865343|NCT00100841|Leucovorin|leucovorin|mesh-list
1865344|NCT00100841|Bevacizumab|bevacizumab|mesh-list
1865345|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1865346|NCT00100841|Cetuximab|cetuximab|mesh-list
1865347|NCT00100841|Fluorouracil|fluorouracil|mesh-list
1865348|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
1865349|NCT00100841|Antibodies|antibodies|mesh-list
1865350|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
1865351|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1865352|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
1865353|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865354|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1865355|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1865356|NCT00100841|Growth Substances|growth substances|mesh-ancestor
1865357|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865358|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
1865359|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
1865360|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
1865361|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865362|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865363|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865364|NCT00100841|Antidotes|antidotes|mesh-ancestor
1865365|NCT00100841|Protective Agents|protective agents|mesh-ancestor
1865366|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
1865367|NCT00100841|Vitamins|vitamins|mesh-ancestor
1865368|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
1865369|NCT00101010|Prednisone|prednisone|mesh-list
1865370|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
1865371|NCT00101010|Rituximab|rituximab|mesh-list
1865372|NCT00101010|Doxorubicin|doxorubicin|mesh-list
1865373|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1865374|NCT00101010|Vincristine|vincristine|mesh-list
1865375|NCT00101010|Lenograstim|lenograstim|mesh-list
1865376|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865377|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
1865378|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865379|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865380|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865381|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
1865382|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865383|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865384|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1865385|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865386|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865387|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865388|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865389|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865390|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865391|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
1865392|NCT00101010|Hormones|hormones|mesh-ancestor
1865393|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865394|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865395|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1865396|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865397|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
1865398|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
1865399|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
1865400|NCT00101036|Lapatinib|lapatinib|mesh-list
1865401|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865402|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865403|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865404|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865405|NCT00101101|Aldesleukin|aldesleukin|mesh-list
1865406|NCT00101101|Dexamethasone|dexamethasone|mesh-list
1865407|NCT00101101|Prednisone|prednisone|mesh-list
1865408|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
1865409|NCT00101101|Doxorubicin|doxorubicin|mesh-list
1865410|NCT00101101|Vincristine|vincristine|mesh-list
1865411|NCT00101101|Interleukin-2|interleukin-2|mesh-list
1865412|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865413|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
1865414|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865415|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865416|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865417|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
1865418|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865419|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865420|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1865421|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865422|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
1865423|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
1865424|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1865425|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1865426|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
1865427|NCT00101101|Hormones|hormones|mesh-ancestor
1865428|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865429|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865430|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865431|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865432|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865433|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865434|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865435|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
1865436|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
1865437|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
1865438|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1865439|NCT00101101|Analgesics|analgesics|mesh-ancestor
1865440|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
1865441|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865442|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865443|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
1865444|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865445|NCT00101166|Vaccines|vaccines|mesh-list
1865446|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
1865447|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865448|NCT00101192|Cetuximab|cetuximab|mesh-list
1865449|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865450|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865451|NCT00101283|Gemcitabine|gemcitabine|mesh-list
1865452|NCT00101283|Carboplatin|carboplatin|mesh-list
1865453|NCT00101283|Pemetrexed|pemetrexed|mesh-list
1865454|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865455|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865456|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
1865457|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865458|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
1865459|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865460|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865461|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865462|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
1865463|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865464|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1865465|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865466|NCT00101361|Oxandrolone|oxandrolone|mesh-list
1865467|NCT00101361|Androgens|androgens|mesh-ancestor
1865468|NCT00101361|Hormones|hormones|mesh-ancestor
1865469|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865470|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865471|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
1865472|NCT00101400|Sorafenib|sorafenib|mesh-list
1865473|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865474|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865475|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865476|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865477|NCT00101413|Sorafenib|sorafenib|mesh-list
1865478|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865479|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865480|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865481|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865482|NCT00101439|Ezetimibe|ezetimibe|mesh-list
1865483|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1865484|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1865485|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
1865486|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865487|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1865488|NCT00101452|Citalopram|citalopram|mesh-list
1865489|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1865490|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1865491|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1865492|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865493|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865494|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
1865495|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865496|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1865497|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
1865498|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1865499|NCT00101582|Cisplatin|cisplatin|mesh-list
1865500|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865501|NCT00101647|Dasatinib|dasatinib|mesh-list
1865502|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865503|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865504|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865505|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865506|NCT00101660|Dasatinib|dasatinib|mesh-list
1865507|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865508|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865509|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865510|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865511|NCT00101686|Bevacizumab|bevacizumab|mesh-list
1865512|NCT00101686|Capecitabine|capecitabine|mesh-list
1865513|NCT00101686|Irinotecan|irinotecan|mesh-list
1865514|NCT00101686|Fluorouracil|fluorouracil|mesh-list
1865515|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865516|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865517|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1865518|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1865519|NCT00101686|Growth Substances|growth substances|mesh-ancestor
1865520|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865521|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
1865522|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865523|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
1865524|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865525|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1865526|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865527|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865528|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865529|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
1865530|NCT00101816|Dasatinib|dasatinib|mesh-list
1865531|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865532|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865533|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865534|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865535|NCT00101907|Gemcitabine|gemcitabine|mesh-list
1865536|NCT00101907|Panitumumab|panitumumab|mesh-list
1865537|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
1865538|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865539|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865540|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
1865541|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865542|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
1865543|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865544|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865545|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865546|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
1865547|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865548|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865549|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865550|NCT00102063|Aripiprazole|aripiprazole|mesh-list
1865551|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
1865552|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1865553|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1865554|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1865555|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1865632|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
1865556|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865557|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
1865558|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
1865559|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865560|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865561|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1865562|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1865563|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
1865564|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1865565|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1865566|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1865567|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1865568|NCT00102440|Allopurinol|allopurinol|mesh-list
1865569|NCT00102440|Febuxostat|febuxostat|mesh-list
1865570|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
1865571|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865572|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865573|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
1865574|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865575|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1865576|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
1865577|NCT00102440|Protective Agents|protective agents|mesh-ancestor
1865578|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865579|NCT00102518|Aripiprazole|aripiprazole|mesh-list
1865580|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
1865581|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1865582|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1865583|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1865584|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1865585|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865586|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
1865587|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
1865588|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865589|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865590|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1865591|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1865592|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
1865593|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1865594|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1865595|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1865596|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1865597|NCT00102531|Cisplatin|cisplatin|mesh-list
1865598|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865599|NCT00102687|Azacitidine|azacitidine|mesh-list
1865600|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865601|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
1865602|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865603|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865604|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865605|NCT00102804|Pemetrexed|pemetrexed|mesh-list
1865606|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865607|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865608|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865609|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1865610|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865611|NCT00102960|Ritonavir|ritonavir|mesh-list
1865612|NCT00102960|Lopinavir|lopinavir|mesh-list
1865613|NCT00102960|Lamivudine|lamivudine|mesh-list
1865614|NCT00102960|Zidovudine|zidovudine|mesh-list
1865615|NCT00102960|Nevirapine|nevirapine|mesh-list
1865616|NCT00102960|Abacavir|abacavir|mesh-list
1865617|NCT00102960|Didanosine|didanosine|mesh-list
1865618|NCT00102960|Efavirenz|efavirenz|mesh-list
1865619|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1865620|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1865621|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
1865622|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865623|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865624|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865625|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865626|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
1865627|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865628|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1865629|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1865630|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1865631|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865633|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1865634|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1865635|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1865636|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1865637|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1865638|NCT00103116|Vaccines|vaccines|mesh-list
1865639|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
1865640|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865641|NCT00103142|Sargramostim|sargramostim|mesh-list
1865642|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
1865643|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865644|NCT00103194|Lapatinib|lapatinib|mesh-list
1865645|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865646|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865647|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865648|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865649|NCT00103207|Cetuximab|cetuximab|mesh-list
1865650|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865651|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865652|NCT00103259|Irinotecan|irinotecan|mesh-list
1865653|NCT00103259|Bortezomib|bortezomib|mesh-list
1865654|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1865655|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865656|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865657|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865658|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865659|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
1865660|NCT00103285|Leucovorin|leucovorin|mesh-list
1865661|NCT00103285|Folic Acid|folic acid|mesh-list
1865662|NCT00103285|Cytarabine|cytarabine|mesh-list
1865663|NCT00103285|Dexamethasone|dexamethasone|mesh-list
1865664|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
1865665|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
1865666|NCT00103285|Doxorubicin|doxorubicin|mesh-list
1865667|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1865668|NCT00103285|Methotrexate|methotrexate|mesh-list
1865669|NCT00103285|Vincristine|vincristine|mesh-list
1865670|NCT00103285|Asparaginase|asparaginase|mesh-list
1865671|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
1865672|NCT00103285|Pegaspargase|pegaspargase|mesh-list
1865673|NCT00103285|Thioguanine|thioguanine|mesh-list
1865674|NCT00103285|BB 1101|bb 1101|mesh-list
1865675|NCT00103285|Calcium|calcium|mesh-list
1865676|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
1865677|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
1865678|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865679|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
1865680|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865681|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865682|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865683|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
1865684|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865685|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865686|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1865687|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865688|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
1865689|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
1865690|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1865691|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1865692|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
1865693|NCT00103285|Hormones|hormones|mesh-ancestor
1865694|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865695|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865696|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
1865697|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865698|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865699|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865700|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865701|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1865702|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1865703|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1865704|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
1865705|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1865706|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865707|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
1865708|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
1865709|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1865862|NCT00104572|Calcium|calcium|mesh-list
1865710|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865711|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
1865712|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865713|NCT00103285|Antidotes|antidotes|mesh-ancestor
1865714|NCT00103285|Protective Agents|protective agents|mesh-ancestor
1865715|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
1865716|NCT00103285|Vitamins|vitamins|mesh-ancestor
1865717|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
1865718|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865719|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
1865720|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
1865721|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
1865722|NCT00103285|Hematinics|hematinics|mesh-ancestor
1865723|NCT00103376|Bortezomib|bortezomib|mesh-list
1865724|NCT00103376|Androgens|androgens|mesh-list
1865725|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
1865726|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865727|NCT00103376|Hormones|hormones|mesh-ancestor
1865728|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865729|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865730|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
1865731|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
1865732|NCT00103402|Alfuzosin|alfuzosin|mesh-list
1865733|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1865734|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1865735|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1865736|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
1865737|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1865738|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865739|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865740|NCT00103402|Urological Agents|urological agents|mesh-ancestor
1865741|NCT00103506|Doxorubicin|doxorubicin|mesh-list
1865742|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1865743|NCT00103506|Bortezomib|bortezomib|mesh-list
1865744|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865745|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865746|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865747|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865748|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865749|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865750|NCT00103610|Plerixafor|plerixafor|mesh-list
1865751|NCT00103610|Sargramostim|sargramostim|mesh-list
1865752|NCT00103610|Lenograstim|lenograstim|mesh-list
1865753|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
1865754|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865755|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1865756|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865757|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865758|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
1865759|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865760|NCT00103662|Plerixafor|plerixafor|mesh-list
1865761|NCT00103662|Sargramostim|sargramostim|mesh-list
1865762|NCT00103662|Lenograstim|lenograstim|mesh-list
1865763|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
1865764|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865765|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1865766|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865767|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865768|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
1865769|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865770|NCT00103740|Vitamin D|vitamin d|mesh-list
1865771|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
1865772|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
1865773|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
1865774|NCT00103740|Calcium|calcium|mesh-list
1865775|NCT00103740|Vitamins|vitamins|mesh-ancestor
1865776|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
1865777|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865778|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1865779|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1865780|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1865781|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1865782|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865783|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
1865784|NCT00103844|Dasatinib|dasatinib|mesh-list
1865785|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865786|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1865787|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865863|NCT00104572|Testosterone|testosterone|mesh-list
1865788|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865789|NCT00103857|Metformin|metformin|mesh-list
1865790|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1865791|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1865792|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865793|NCT00103857|Incretins|incretins|mesh-ancestor
1865794|NCT00103857|Hormones|hormones|mesh-ancestor
1865795|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865796|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1865797|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
1865798|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865799|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865800|NCT00104052|Ribavirin|ribavirin|mesh-list
1865801|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1865802|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
1865803|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
1865804|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865805|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
1865806|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865807|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
1865808|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865809|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
1865810|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1865811|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865812|NCT00104247|Verapamil|verapamil|mesh-list
1865813|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1865814|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1865815|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1865816|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865817|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1865818|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865819|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
1865820|NCT00104299|Prednisone|prednisone|mesh-list
1865821|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
1865822|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
1865823|NCT00104299|Rituximab|rituximab|mesh-list
1865824|NCT00104299|Azathioprine|azathioprine|mesh-list
1865825|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
1865826|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865827|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
1865828|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865829|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865830|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865831|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
1865832|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865833|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865834|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1865835|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1865836|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865837|NCT00104299|Hormones|hormones|mesh-ancestor
1865838|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865839|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865840|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
1865841|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
1865842|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1865843|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1865844|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1865845|NCT00104299|Protective Agents|protective agents|mesh-ancestor
1865846|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
1865847|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865848|NCT00104416|Lamotrigine|lamotrigine|mesh-list
1865849|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
1865850|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1865851|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1865852|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865853|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1865854|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865855|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1865856|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1865857|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1865858|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1865859|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1865860|NCT00104572|Vitamin D|vitamin d|mesh-list
1865861|NCT00104572|Anastrozole|anastrozole|mesh-list
1865864|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1865865|NCT00104572|Vitamins|vitamins|mesh-ancestor
1865866|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
1865867|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865868|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1865869|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1865870|NCT00104572|Androgens|androgens|mesh-ancestor
1865871|NCT00104572|Hormones|hormones|mesh-ancestor
1865872|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865873|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1865874|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865875|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1865876|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865877|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865878|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1865879|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
1865880|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
1865881|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865882|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
1865883|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1865884|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1865885|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865886|NCT00104637|Urological Agents|urological agents|mesh-ancestor
1865887|NCT00104650|Denosumab|denosumab|mesh-list
1865888|NCT00104650|Diphosphonates|diphosphonates|mesh-list
1865889|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1865890|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865891|NCT00104676|Paclitaxel|paclitaxel|mesh-list
1865892|NCT00104676|Etoposide|etoposide|mesh-list
1865893|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
1865894|NCT00104676|Ifosfamide|ifosfamide|mesh-list
1865895|NCT00104676|Bleomycin|bleomycin|mesh-list
1865896|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1865897|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865898|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
1865899|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
1865900|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
1865901|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865902|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1865903|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1865904|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865905|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1865906|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
1865907|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865908|NCT00104858|Cyclosporine|cyclosporine|mesh-list
1865909|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
1865910|NCT00104858|Rituximab|rituximab|mesh-list
1865911|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1865912|NCT00104858|Fludarabine|fludarabine|mesh-list
1865913|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
1865914|NCT00104858|Antibodies|antibodies|mesh-list
1865915|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
1865916|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1865917|NCT00104858|Cyclosporins|cyclosporins|mesh-list
1865918|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
1865919|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865920|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865921|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1865922|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865923|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
1865924|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865925|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865926|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865927|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
1865928|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865929|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
1865930|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1865931|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865932|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1865933|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
1865934|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1865935|NCT00104871|Bortezomib|bortezomib|mesh-list
1865936|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865937|NCT00104884|Romidepsin|romidepsin|mesh-list
1865938|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865939|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865940|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
1865941|NCT00105001|Sirolimus|sirolimus|mesh-list
1865942|NCT00105001|Fludarabine|fludarabine|mesh-list
1865943|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
1865944|NCT00105001|Tacrolimus|tacrolimus|mesh-list
1865945|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1865946|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1865947|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
1865948|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865949|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865950|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
1865951|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865952|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1865953|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865954|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1865955|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1865956|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
1865957|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1865958|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865959|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
1865960|NCT00105027|Triamcinolone|triamcinolone|mesh-list
1865961|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1865962|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1865963|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1865964|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1865965|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
1865966|NCT00105027|Hormones|hormones|mesh-ancestor
1865967|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1865968|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865969|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1865970|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
1865971|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865972|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865973|NCT00105066|Metformin|metformin|mesh-list
1865974|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1865975|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1865976|NCT00105079|Ritonavir|ritonavir|mesh-list
1865977|NCT00105079|Lopinavir|lopinavir|mesh-list
1865978|NCT00105079|Saquinavir|saquinavir|mesh-list
1865979|NCT00105079|Tenofovir|tenofovir|mesh-list
1865980|NCT00105079|Emtricitabine|emtricitabine|mesh-list
1865981|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1865982|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1865983|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1865984|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
1865985|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1865986|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1865987|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865988|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865989|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
1865990|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1865991|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1865992|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1865993|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1865994|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1865995|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
1865996|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1865997|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1865998|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
1865999|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866000|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1866001|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1866002|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866003|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866004|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
1866005|NCT00105183|Antibodies|antibodies|mesh-list
1866006|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
1866007|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1866008|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1866009|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
1866010|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1866011|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
1866012|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866013|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866014|NCT00105196|Aripiprazole|aripiprazole|mesh-list
1866015|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
1866016|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1866017|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1866018|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1866019|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1866020|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866021|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
1866022|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
1866023|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866024|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866025|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1866026|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1866027|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
1866028|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1866029|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1866030|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1866031|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1866032|NCT00105235|Cyclosporine|cyclosporine|mesh-list
1866033|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
1866034|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
1866035|NCT00105235|Tacrolimus|tacrolimus|mesh-list
1866036|NCT00105235|Cyclosporins|cyclosporins|mesh-list
1866037|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866038|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
1866039|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866040|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1866041|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866042|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866043|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
1866044|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866045|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
1866046|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866047|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866048|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866049|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1866050|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
1866051|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866052|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866053|NCT00105443|Sorafenib|sorafenib|mesh-list
1866054|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866055|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866056|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866057|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866058|NCT00105469|Tobramycin|tobramycin|mesh-list
1866059|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866060|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866061|NCT00105482|Naltrexone|naltrexone|mesh-list
1866062|NCT00105482|Nicotine|nicotine|mesh-list
1866063|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1866064|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
1866065|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866066|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866067|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1866068|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1866069|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
1866070|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866071|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866072|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1866073|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1866074|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
1866075|NCT00105534|Azithromycin|azithromycin|mesh-list
1866076|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866077|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866078|NCT00105586|Citalopram|citalopram|mesh-list
1866079|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1866080|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1866081|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1866082|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866083|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866084|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
1866085|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866086|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1866087|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
1866088|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1866089|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1866090|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1866091|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1866092|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1866093|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866094|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866095|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866096|NCT00105989|Analgesics|analgesics|mesh-ancestor
1866097|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
1866098|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866099|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
1866100|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1866101|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
1866102|NCT00106002|Pemetrexed|pemetrexed|mesh-list
1866103|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866104|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866105|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866106|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1866107|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866108|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
1866109|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1866110|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1866111|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866112|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1866113|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866114|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1866115|NCT00106106|Acamprosate|acamprosate|mesh-list
1866116|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1866117|NCT00106184|Rituximab|rituximab|mesh-list
1866118|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866119|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866120|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
1866121|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866122|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866123|NCT00106353|Sirolimus|sirolimus|mesh-list
1866124|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866125|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866126|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866127|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866128|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
1866129|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866130|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
1866131|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866132|NCT00106392|Tacrolimus|tacrolimus|mesh-list
1866133|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866134|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
1866135|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866136|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1866137|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866138|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866139|NCT00106431|Romidepsin|romidepsin|mesh-list
1866140|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866141|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866142|NCT00106535|Methotrexate|methotrexate|mesh-list
1866143|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1866144|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
1866145|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1866146|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866147|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866148|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
1866149|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866150|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866151|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
1866152|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866153|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1866154|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866155|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
1866156|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866157|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866158|NCT00106626|Pemetrexed|pemetrexed|mesh-list
1866159|NCT00106626|Vorinostat|vorinostat|mesh-list
1866160|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866161|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866162|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866163|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1866238|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
1866164|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866165|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1866166|NCT00106639|Tacrolimus|tacrolimus|mesh-list
1866167|NCT00106639|Tofacitinib|tofacitinib|mesh-list
1866168|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866169|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
1866170|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866171|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1866172|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866173|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866174|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866175|NCT00106704|Pioglitazone|pioglitazone|mesh-list
1866176|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1866177|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1866178|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866179|NCT00106704|Incretins|incretins|mesh-ancestor
1866180|NCT00106704|Hormones|hormones|mesh-ancestor
1866181|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866182|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1866183|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
1866184|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866185|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866186|NCT00107120|Citalopram|citalopram|mesh-list
1866187|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1866188|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1866189|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1866190|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866191|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866192|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
1866193|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866194|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1866195|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
1866196|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1866197|NCT00107198|Prednisone|prednisone|mesh-list
1866198|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
1866199|NCT00107198|Doxorubicin|doxorubicin|mesh-list
1866200|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1866201|NCT00107198|Vincristine|vincristine|mesh-list
1866202|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866203|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
1866204|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866205|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866206|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866207|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
1866208|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866209|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866210|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1866211|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866212|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1866213|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866214|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866215|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866216|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
1866217|NCT00107198|Hormones|hormones|mesh-ancestor
1866218|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866219|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866220|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866221|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866222|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866223|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866224|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
1866225|NCT00107276|Capecitabine|capecitabine|mesh-list
1866226|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866227|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
1866228|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866229|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866230|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866231|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
1866232|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866233|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866234|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1866235|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866236|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
1866237|NCT00107380|Prednisone|prednisone|mesh-list
1866239|NCT00107380|Rituximab|rituximab|mesh-list
1866240|NCT00107380|Doxorubicin|doxorubicin|mesh-list
1866241|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1866242|NCT00107380|Vincristine|vincristine|mesh-list
1866243|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
1866244|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866245|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
1866246|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866247|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866248|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866249|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
1866250|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866251|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866252|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1866253|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866254|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866255|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1866256|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866257|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866258|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866259|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
1866260|NCT00107380|Hormones|hormones|mesh-ancestor
1866261|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866262|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866263|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866264|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866265|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866266|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866267|NCT00107536|Lapatinib|lapatinib|mesh-list
1866268|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866269|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866270|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866271|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866272|NCT00107653|Ribavirin|ribavirin|mesh-list
1866273|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1866274|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
1866275|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
1866276|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866277|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
1866278|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866279|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
1866280|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866281|NCT00107744|Caseins|caseins|mesh-list
1866282|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
1866283|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
1866284|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866285|NCT00107783|Nitisinone|nitisinone|mesh-list
1866286|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866287|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866288|NCT00107900|Edoxaban|edoxaban|mesh-list
1866289|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1866290|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
1866291|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1866292|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
1866293|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866294|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866295|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
1866296|NCT00107952|Vancomycin|vancomycin|mesh-list
1866297|NCT00107952|Telavancin|telavancin|mesh-list
1866298|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866299|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866300|NCT00107978|Vancomycin|vancomycin|mesh-list
1866301|NCT00107978|Telavancin|telavancin|mesh-list
1866302|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866303|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866304|NCT00107991|Etanercept|etanercept|mesh-list
1866305|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1866306|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1866307|NCT00107991|Analgesics|analgesics|mesh-ancestor
1866308|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
1866309|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866310|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866311|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866312|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866313|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866314|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866315|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
1866316|NCT00108069|Tamoxifen|tamoxifen|mesh-list
1866317|NCT00108069|Bortezomib|bortezomib|mesh-list
1866318|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866319|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1866320|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
1866321|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866322|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866323|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866324|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1866325|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1866326|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1866327|NCT00108082|Atenolol|atenolol|mesh-list
1866328|NCT00108082|Carvedilol|carvedilol|mesh-list
1866329|NCT00108082|Lisinopril|lisinopril|mesh-list
1866330|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1866331|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1866332|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
1866333|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866334|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866335|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866336|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1866337|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
1866338|NCT00108082|Protective Agents|protective agents|mesh-ancestor
1866339|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1866340|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1866341|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1866342|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
1866343|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1866344|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1866345|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1866346|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
1866347|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866348|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1866349|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1866350|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
1866351|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
1866352|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866353|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1866354|NCT00108160|Mupirocin|mupirocin|mesh-list
1866355|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866356|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866357|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1866358|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866359|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866360|NCT00108355|Octreotide|octreotide|mesh-list
1866361|NCT00108355|Midodrine|midodrine|mesh-list
1866362|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866363|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866364|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866365|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
1866366|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
1866367|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866368|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866369|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1866370|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1866371|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1866372|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1866373|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
1866374|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866375|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866376|NCT00108485|Niacin|niacin|mesh-list
1866377|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1866378|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
1866379|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866380|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1866381|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
1866382|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
1866383|NCT00108485|Vitamins|vitamins|mesh-ancestor
1866384|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
1866385|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866386|NCT00108524|Orlistat|orlistat|mesh-list
1866387|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866388|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866389|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1866390|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1866391|NCT00108550|Gabapentin|gabapentin|mesh-list
1866392|NCT00108550|Analgesics|analgesics|mesh-ancestor
1866393|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
1866394|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866395|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866396|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
1866397|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1866398|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1866399|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1866400|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1866401|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1866402|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1866403|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866404|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866405|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
1866406|NCT00108732|Metronidazole|metronidazole|mesh-list
1866407|NCT00108732|Goserelin|goserelin|mesh-list
1866408|NCT00108732|Bicalutamide|bicalutamide|mesh-list
1866409|NCT00108732|Vaccines|vaccines|mesh-list
1866410|NCT00108732|Sargramostim|sargramostim|mesh-list
1866411|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
1866412|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866413|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866414|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866415|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
1866416|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
1866417|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866418|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866419|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866420|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1866421|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1866422|NCT00108745|Paclitaxel|paclitaxel|mesh-list
1866423|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1866424|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
1866425|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866426|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866427|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866428|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866429|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866430|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866431|NCT00108953|Doxorubicin|doxorubicin|mesh-list
1866432|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1866433|NCT00108953|Sorafenib|sorafenib|mesh-list
1866434|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866435|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866436|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1866437|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866438|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866439|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866440|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866441|NCT00109005|Lenalidomide|lenalidomide|mesh-list
1866442|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
1866443|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866444|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1866445|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1866446|NCT00109005|Growth Substances|growth substances|mesh-ancestor
1866447|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
1866448|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866449|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
1866450|NCT00109031|Etoposide|etoposide|mesh-list
1866451|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866452|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
1866453|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866454|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866455|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866456|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
1866457|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866458|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866459|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1866460|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866461|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1866462|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866463|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866464|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1866465|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
1866466|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866467|NCT00109473|Prednisone|prednisone|mesh-list
1866468|NCT00109473|Hormones|hormones|mesh-list
1866469|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866470|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
1866471|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866472|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866473|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866474|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866475|NCT00109590|Ritonavir|ritonavir|mesh-list
1866476|NCT00109590|Lopinavir|lopinavir|mesh-list
1866477|NCT00109590|Zidovudine|zidovudine|mesh-list
1866478|NCT00109590|Nevirapine|nevirapine|mesh-list
1866479|NCT00109590|Didanosine|didanosine|mesh-list
1866480|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1866481|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1866482|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
1866483|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866484|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866485|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1866486|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1866487|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
1866488|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866489|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1866490|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1866491|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
1866492|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1866493|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866494|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1866495|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1866496|NCT00109733|Hormones|hormones|mesh-list
1866497|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866498|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866499|NCT00109772|Lenalidomide|lenalidomide|mesh-list
1866500|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
1866501|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866502|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1866503|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1866504|NCT00109772|Growth Substances|growth substances|mesh-ancestor
1866505|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
1866506|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866507|NCT00109837|Leucovorin|leucovorin|mesh-list
1866508|NCT00109837|Cytarabine|cytarabine|mesh-list
1866509|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1866510|NCT00109837|Dexamethasone|dexamethasone|mesh-list
1866511|NCT00109837|Prednisone|prednisone|mesh-list
1866512|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
1866513|NCT00109837|Doxorubicin|doxorubicin|mesh-list
1866514|NCT00109837|Methotrexate|methotrexate|mesh-list
1866515|NCT00109837|Vincristine|vincristine|mesh-list
1866516|NCT00109837|Daunorubicin|daunorubicin|mesh-list
1866517|NCT00109837|Asparaginase|asparaginase|mesh-list
1866518|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
1866519|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
1866520|NCT00109837|Thioguanine|thioguanine|mesh-list
1866521|NCT00109837|Allopurinol|allopurinol|mesh-list
1866522|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866523|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
1866524|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866525|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866526|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866527|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
1866528|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866529|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866530|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1866531|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866532|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
1866533|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
1866534|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866535|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866536|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
1866537|NCT00109837|Hormones|hormones|mesh-ancestor
1866538|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866539|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866540|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866541|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1866542|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866543|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866544|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1866545|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
1866546|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1866547|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866548|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
1866549|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
1866550|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1866551|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866552|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
1866553|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866554|NCT00109837|Antidotes|antidotes|mesh-ancestor
1866555|NCT00109837|Protective Agents|protective agents|mesh-ancestor
1866556|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
1866557|NCT00109837|Vitamins|vitamins|mesh-ancestor
1866558|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
1866559|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866560|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866561|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866562|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866563|NCT00109837|Analgesics|analgesics|mesh-ancestor
1866564|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
1866565|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
1866566|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1866567|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
1866568|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1866569|NCT00109837|Renal Agents|renal agents|mesh-ancestor
1866570|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866571|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
1866572|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1866573|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1866574|NCT00109850|Irinotecan|irinotecan|mesh-list
1866575|NCT00109850|Cetuximab|cetuximab|mesh-list
1866576|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866577|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1866578|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866579|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866580|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866581|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866582|NCT00109928|Gemcitabine|gemcitabine|mesh-list
1866583|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
1866584|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1866585|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1866586|NCT00109928|Prednisolone|prednisolone|mesh-list
1866587|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
1866588|NCT00109928|Etoposide|etoposide|mesh-list
1866589|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1866590|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
1866591|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866592|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866593|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
1866594|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866595|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
1866596|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866597|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866598|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866599|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
1866600|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866601|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866602|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1866603|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866604|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866605|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
1866606|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
1866607|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866608|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866609|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
1866610|NCT00109928|Hormones|hormones|mesh-ancestor
1866611|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866612|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1866613|NCT00109928|Protective Agents|protective agents|mesh-ancestor
1866614|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866615|NCT00109967|Sirolimus|sirolimus|mesh-list
1866616|NCT00109967|Rituximab|rituximab|mesh-list
1866617|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866618|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866619|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
1866620|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866621|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866622|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866623|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866624|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866625|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
1866626|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866627|NCT00110019|Paclitaxel|paclitaxel|mesh-list
1866628|NCT00110019|Carboplatin|carboplatin|mesh-list
1866629|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1866630|NCT00110019|Sorafenib|sorafenib|mesh-list
1866631|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866632|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866633|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866634|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866635|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866636|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866637|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866638|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866639|NCT00110084|Gemcitabine|gemcitabine|mesh-list
1866640|NCT00110084|Paclitaxel|paclitaxel|mesh-list
1866641|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1866642|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866643|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866644|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866645|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866646|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866647|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866648|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866649|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
1866650|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
1866651|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866652|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866653|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866654|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
1866655|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866656|NCT00110149|Rituximab|rituximab|mesh-list
1866657|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866658|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866659|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
1866660|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866661|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866662|NCT00110214|Prednisone|prednisone|mesh-list
1866663|NCT00110214|Bevacizumab|bevacizumab|mesh-list
1866664|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1866665|NCT00110214|Docetaxel|docetaxel|mesh-list
1866666|NCT00110214|Antibodies|antibodies|mesh-list
1866667|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
1866668|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1866669|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866670|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1866671|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1866672|NCT00110214|Growth Substances|growth substances|mesh-ancestor
1866673|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866674|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
1866675|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
1866676|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866677|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866678|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866679|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866680|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866681|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
1866682|NCT00110214|Hormones|hormones|mesh-ancestor
1866683|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866684|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866685|NCT00110266|Deferasirox|deferasirox|mesh-list
1866686|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1866687|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
1866688|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
1866689|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866690|NCT00110305|Efavirenz|efavirenz|mesh-list
1866691|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1866692|NCT00110305|Rilpivirine|rilpivirine|mesh-list
1866693|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866694|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866996|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
1866695|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866696|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
1866697|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866698|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1866699|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1866700|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1866701|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1866702|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1866703|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1866704|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1866705|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1866706|NCT00110357|Irinotecan|irinotecan|mesh-list
1866707|NCT00110357|Cetuximab|cetuximab|mesh-list
1866708|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1866709|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866710|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866711|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866712|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866713|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866714|NCT00110396|Interferons|interferons|mesh-list
1866715|NCT00110396|Interferon-beta|interferon-beta|mesh-list
1866716|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
1866717|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866718|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
1866719|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866720|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
1866721|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866722|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1866723|NCT00110461|Aripiprazole|aripiprazole|mesh-list
1866724|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
1866725|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1866726|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1866727|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1866728|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1866729|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866730|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
1866731|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
1866732|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1866733|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866734|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1866735|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1866736|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
1866737|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1866738|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1866739|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1866740|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1866741|NCT00110513|Antithrombins|antithrombins|mesh-list
1866742|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
1866743|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1866744|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
1866745|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866746|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866747|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
1866748|NCT00110617|Deferasirox|deferasirox|mesh-list
1866749|NCT00110617|Deferoxamine|deferoxamine|mesh-list
1866750|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1866751|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
1866752|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
1866753|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866754|NCT00110617|Siderophores|siderophores|mesh-ancestor
1866755|NCT00110812|Aldesleukin|aldesleukin|mesh-list
1866756|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866757|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1866758|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1866759|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
1866760|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866761|NCT00110890|Cinacalcet|cinacalcet|mesh-list
1866762|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1866763|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866764|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1866765|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
1866766|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866767|NCT00110994|Sorafenib|sorafenib|mesh-list
1866768|NCT00110994|Dacarbazine|dacarbazine|mesh-list
1866769|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866770|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866771|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866772|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866773|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866774|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
1866775|NCT00111007|Paclitaxel|paclitaxel|mesh-list
1866776|NCT00111007|Carboplatin|carboplatin|mesh-list
1866777|NCT00111007|Sorafenib|sorafenib|mesh-list
1866778|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866779|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866780|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866781|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866782|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866783|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866784|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866785|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866786|NCT00111241|Letrozole|letrozole|mesh-list
1866787|NCT00111241|Anastrozole|anastrozole|mesh-list
1866788|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1866789|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866790|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1866791|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866792|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866793|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1866794|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
1866795|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866796|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866797|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866798|NCT00111657|Rasburicase|rasburicase|mesh-list
1866799|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
1866800|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866801|NCT00111761|Leucovorin|leucovorin|mesh-list
1866802|NCT00111761|Fluorouracil|fluorouracil|mesh-list
1866803|NCT00111761|Irinotecan|irinotecan|mesh-list
1866804|NCT00111761|Panitumumab|panitumumab|mesh-list
1866805|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
1866806|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866807|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866808|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866809|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866810|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
1866811|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866812|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1866813|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1866814|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866815|NCT00111761|Antidotes|antidotes|mesh-ancestor
1866816|NCT00111761|Protective Agents|protective agents|mesh-ancestor
1866817|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
1866818|NCT00111761|Vitamins|vitamins|mesh-ancestor
1866819|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
1866820|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866821|NCT00111813|Bortezomib|bortezomib|mesh-list
1866822|NCT00111813|Vorinostat|vorinostat|mesh-list
1866823|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866824|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1866825|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866826|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866827|NCT00111839|Pemetrexed|pemetrexed|mesh-list
1866828|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866829|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866830|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866831|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1866832|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866833|NCT00111917|Infliximab|infliximab|mesh-list
1866834|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
1866835|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866836|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866837|NCT00112047|Tenofovir|tenofovir|mesh-list
1866838|NCT00112047|Lamivudine|lamivudine|mesh-list
1866839|NCT00112047|Zidovudine|zidovudine|mesh-list
1866840|NCT00112047|Emtricitabine|emtricitabine|mesh-list
1866841|NCT00112047|Efavirenz|efavirenz|mesh-list
1866842|NCT00112047|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1866843|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1866844|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
1866845|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867074|NCT00113230|Bevacizumab|bevacizumab|mesh-list
1866846|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1866847|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1866848|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866849|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866850|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1866851|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1866852|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
1866853|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1866854|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1866855|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1866856|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1866857|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1866858|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1866859|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
1866860|NCT00112151|Testosterone|testosterone|mesh-list
1866861|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
1866862|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
1866863|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1866864|NCT00112151|Androgens|androgens|mesh-ancestor
1866865|NCT00112151|Hormones|hormones|mesh-ancestor
1866866|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1866867|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866868|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1866869|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866870|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
1866871|NCT00112294|Paclitaxel|paclitaxel|mesh-list
1866872|NCT00112294|Docetaxel|docetaxel|mesh-list
1866873|NCT00112294|Carboplatin|carboplatin|mesh-list
1866874|NCT00112294|Cetuximab|cetuximab|mesh-list
1866875|NCT00112294|Taxane|taxane|mesh-list
1866876|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866877|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866878|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866879|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866880|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866881|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866882|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866883|NCT00112385|Etanercept|etanercept|mesh-list
1866884|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1866885|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1866886|NCT00112385|Analgesics|analgesics|mesh-ancestor
1866887|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
1866888|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866889|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866890|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866891|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866892|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866893|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866894|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
1866895|NCT00112437|Vitamin D|vitamin d|mesh-list
1866896|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
1866897|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
1866898|NCT00112437|Calcium|calcium|mesh-list
1866899|NCT00112437|Vitamins|vitamins|mesh-ancestor
1866900|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
1866901|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866902|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1866903|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1866904|NCT00112437|Antacids|antacids|mesh-ancestor
1866905|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866906|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1866907|NCT00112463|Romidepsin|romidepsin|mesh-list
1866908|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866909|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866910|NCT00112489|Paclitaxel|paclitaxel|mesh-list
1866911|NCT00112489|Carboplatin|carboplatin|mesh-list
1866912|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1866913|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866914|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
1866915|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
1866916|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
1866917|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866918|NCT00112502|Thalidomide|thalidomide|mesh-list
1866919|NCT00112502|Celecoxib|celecoxib|mesh-list
1866920|NCT00112502|Temozolomide|temozolomide|mesh-list
1866921|NCT00112502|Isotretinoin|isotretinoin|mesh-list
1867075|NCT00113230|Capecitabine|capecitabine|mesh-list
1866922|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1866923|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
1866924|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866925|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866926|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1866927|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1866928|NCT00112502|Analgesics|analgesics|mesh-ancestor
1866929|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
1866930|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1866931|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866932|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1866933|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866934|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1866935|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1866936|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866937|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866938|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
1866939|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
1866940|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866941|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866942|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1866943|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1866944|NCT00112502|Growth Substances|growth substances|mesh-ancestor
1866945|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
1866946|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
1866947|NCT00112580|Ipilimumab|ipilimumab|mesh-list
1866948|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1866949|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866950|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1866951|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866952|NCT00112593|Cyclosporine|cyclosporine|mesh-list
1866953|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
1866954|NCT00112593|Fludarabine|fludarabine|mesh-list
1866955|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
1866956|NCT00112593|Cyclosporins|cyclosporins|mesh-list
1866957|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866958|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1866959|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
1866960|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866961|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866962|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
1866963|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866964|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866965|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
1866966|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866967|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
1866968|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1866969|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1866970|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866971|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1866972|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
1866973|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866974|NCT00112671|Sorafenib|sorafenib|mesh-list
1866975|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866976|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866977|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866978|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866979|NCT00112723|Alvocidib|alvocidib|mesh-list
1866980|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866981|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
1866982|NCT00112723|Growth Substances|growth substances|mesh-ancestor
1866983|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1866984|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866985|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866986|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866987|NCT00112736|Sirolimus|sirolimus|mesh-list
1866988|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1866989|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1866990|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1866991|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1866992|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1866993|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1866994|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1866995|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1866997|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1866998|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
1866999|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867000|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
1867001|NCT00112827|Melphalan|melphalan|mesh-list
1867002|NCT00112827|Lenalidomide|lenalidomide|mesh-list
1867003|NCT00112827|Lenograstim|lenograstim|mesh-list
1867004|NCT00112827|Sargramostim|sargramostim|mesh-list
1867005|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867006|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
1867007|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867008|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867009|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867010|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
1867011|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867012|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867013|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1867014|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1867015|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867016|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867017|NCT00112827|Growth Substances|growth substances|mesh-ancestor
1867018|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867027|NCT00112905|Sorafenib|sorafenib|mesh-list
1867028|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867029|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867030|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867031|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867032|NCT00112918|Leucovorin|leucovorin|mesh-list
1867033|NCT00112918|Bevacizumab|bevacizumab|mesh-list
1867034|NCT00112918|Fluorouracil|fluorouracil|mesh-list
1867035|NCT00112918|Capecitabine|capecitabine|mesh-list
1867036|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
1867037|NCT00112918|Calcium|calcium|mesh-list
1867038|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
1867039|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867040|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867041|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867042|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867043|NCT00112918|Growth Substances|growth substances|mesh-ancestor
1867044|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867045|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867046|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1867047|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
1867048|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867049|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867050|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867051|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
1867052|NCT00112918|Antidotes|antidotes|mesh-ancestor
1867053|NCT00112918|Protective Agents|protective agents|mesh-ancestor
1867054|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
1867055|NCT00112918|Vitamins|vitamins|mesh-ancestor
1867056|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
1867057|NCT00112957|Vaccines|vaccines|mesh-list
1867058|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
1867059|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867060|NCT00113087|Enalapril|enalapril|mesh-list
1867061|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1867062|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
1867063|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867064|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867065|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1867066|NCT00113217|Bevacizumab|bevacizumab|mesh-list
1867067|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867068|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867069|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867070|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867071|NCT00113217|Growth Substances|growth substances|mesh-ancestor
1867072|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867073|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867076|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867077|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867078|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867079|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867080|NCT00113230|Growth Substances|growth substances|mesh-ancestor
1867081|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867082|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867083|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867084|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
1867085|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867086|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
1867087|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
1867088|NCT00113269|Tacrolimus|tacrolimus|mesh-list
1867089|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
1867090|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1867091|NCT00113269|Basiliximab|basiliximab|mesh-list
1867092|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867093|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
1867094|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867095|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1867096|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867097|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867098|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867099|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867100|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1867101|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
1867102|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1867103|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867104|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867105|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1867106|NCT00113295|Paroxetine|paroxetine|mesh-list
1867107|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867108|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867109|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1867110|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1867111|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1867112|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867113|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1867114|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1867115|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1867116|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867117|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867118|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
1867119|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1867120|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1867121|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1867122|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867123|NCT00113321|Decitabine|decitabine|mesh-list
1867124|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867125|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
1867126|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867127|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867128|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867129|NCT00113360|Everolimus|everolimus|mesh-list
1867130|NCT00113360|Octreotide|octreotide|mesh-list
1867131|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867132|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867133|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
1867134|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867135|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1867136|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867137|NCT00113373|Lapatinib|lapatinib|mesh-list
1867138|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867139|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867140|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867141|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867142|NCT00113490|Palivizumab|palivizumab|mesh-list
1867143|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
1867144|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867145|NCT00113516|Paclitaxel|paclitaxel|mesh-list
1867146|NCT00113516|Carboplatin|carboplatin|mesh-list
1867147|NCT00113516|Sunitinib|sunitinib|mesh-list
1867148|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1867149|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867150|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
1867151|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
1867152|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
1867153|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867154|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867155|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867156|NCT00113516|Growth Substances|growth substances|mesh-ancestor
1867157|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867158|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867159|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867160|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867161|NCT00113529|Sunitinib|sunitinib|mesh-list
1867162|NCT00113529|Gefitinib|gefitinib|mesh-list
1867163|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867164|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867165|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867166|NCT00113529|Growth Substances|growth substances|mesh-ancestor
1867167|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867168|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867169|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867170|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867171|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867172|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
1867173|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1867174|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1867175|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867176|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
1867177|NCT00113568|Coagulants|coagulants|mesh-ancestor
1867178|NCT00113607|Dexamethasone|dexamethasone|mesh-list
1867179|NCT00113607|Trabectedin|trabectedin|mesh-list
1867180|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867181|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
1867182|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
1867183|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867184|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867185|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1867186|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
1867187|NCT00113607|Hormones|hormones|mesh-ancestor
1867188|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867189|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867190|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867191|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867192|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
1867193|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867194|NCT00113763|Panitumumab|panitumumab|mesh-list
1867195|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867196|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867197|NCT00113841|Curcumin|curcumin|mesh-list
1867198|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1867199|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1867200|NCT00113841|Analgesics|analgesics|mesh-ancestor
1867201|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
1867202|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867203|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867204|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867205|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867206|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867207|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867208|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867209|NCT00114101|Lenalidomide|lenalidomide|mesh-list
1867210|NCT00114101|Melphalan|melphalan|mesh-list
1867211|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
1867212|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1867213|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
1867214|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867215|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867216|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867217|NCT00114101|Growth Substances|growth substances|mesh-ancestor
1867218|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867219|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867220|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867221|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
1867222|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867223|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1867224|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867225|NCT00114114|Goserelin|goserelin|mesh-list
1867226|NCT00114114|Testosterone|testosterone|mesh-list
1867227|NCT00114114|Androgens|androgens|mesh-ancestor
1867228|NCT00114114|Hormones|hormones|mesh-ancestor
1867229|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867230|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867231|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867232|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867233|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1867234|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1867235|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1867236|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1867237|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867238|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867239|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867240|NCT00114127|Analgesics|analgesics|mesh-ancestor
1867241|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
1867242|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867243|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867244|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867245|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
1867246|NCT00114140|Temozolomide|temozolomide|mesh-list
1867247|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867248|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
1867249|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867250|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867251|NCT00114166|Topotecan|topotecan|mesh-list
1867252|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1867253|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1867254|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867255|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867256|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867257|NCT00114218|Gemcitabine|gemcitabine|mesh-list
1867258|NCT00114218|Docetaxel|docetaxel|mesh-list
1867259|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867260|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
1867261|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867262|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867263|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
1867264|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867265|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867266|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867267|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
1867268|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867269|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
1867270|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
1867271|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
1867272|NCT00114231|Capecitabine|capecitabine|mesh-list
1867273|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
1867274|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867275|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
1867276|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867277|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867278|NCT00114244|Gemcitabine|gemcitabine|mesh-list
1867279|NCT00114244|Sorafenib|sorafenib|mesh-list
1867280|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867281|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
1867282|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867283|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867284|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
1867285|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867286|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867287|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867288|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
1867289|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867290|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867291|NCT00114504|Simvastatin|simvastatin|mesh-list
1867292|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1867293|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1867294|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
1867295|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867296|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1867297|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1867298|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867299|NCT00114517|Estradiol|estradiol|mesh-list
1867300|NCT00114517|Estrogens|estrogens|mesh-list
1867301|NCT00114517|Hormones|hormones|mesh-ancestor
1867302|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867303|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867304|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
1867305|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867306|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
1867307|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867308|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867309|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867310|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
1867311|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867312|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867313|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1867314|NCT00114738|Rituximab|rituximab|mesh-list
1867315|NCT00114738|Bortezomib|bortezomib|mesh-list
1867316|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867317|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867318|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
1867319|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867320|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867321|NCT00114777|Cyclosporine|cyclosporine|mesh-list
1867322|NCT00114777|Abatacept|abatacept|mesh-list
1867323|NCT00114777|Cyclosporins|cyclosporins|mesh-list
1867324|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867325|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867326|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867327|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
1867328|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867329|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
1867330|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867331|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867332|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867333|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1867334|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1867335|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867336|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
1867337|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
1867338|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867339|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867340|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867341|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867342|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1867343|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1867344|NCT00114972|Paclitaxel|paclitaxel|mesh-list
1867345|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1867346|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1867347|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867348|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
1867349|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
1867350|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
1867351|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867352|NCT00115037|Naltrexone|naltrexone|mesh-list
1867353|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1867354|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1867355|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867356|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
1867357|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867358|NCT00115063|Orlistat|orlistat|mesh-list
1867359|NCT00115063|Sibutramine|sibutramine|mesh-list
1867360|NCT00115063|Diethylpropion|diethylpropion|mesh-list
1867361|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867362|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867363|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1867364|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1867365|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867366|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867367|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
1867368|NCT00115297|Montelukast|montelukast|mesh-list
1867369|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1867370|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
1867371|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1867372|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
1867373|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867374|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867375|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1867376|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1867377|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867378|NCT00115336|Ibuprofen|ibuprofen|mesh-list
1867379|NCT00115336|Ketorolac|ketorolac|mesh-list
1867380|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1867381|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1867382|NCT00115336|Analgesics|analgesics|mesh-ancestor
1867383|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
1867384|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867385|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867386|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867387|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867388|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1867389|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867390|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867391|NCT00115349|Deferiprone|deferiprone|mesh-list
1867392|NCT00115349|Deferoxamine|deferoxamine|mesh-list
1867393|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1867394|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
1867395|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
1867396|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867397|NCT00115349|Siderophores|siderophores|mesh-ancestor
1867398|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
1867399|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867400|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867401|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867402|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867403|NCT00115765|Bevacizumab|bevacizumab|mesh-list
1867404|NCT00115765|Panitumumab|panitumumab|mesh-list
1867405|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
1867406|NCT00115765|Irinotecan|irinotecan|mesh-list
1867407|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867408|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867409|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867410|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867411|NCT00115765|Growth Substances|growth substances|mesh-ancestor
1867412|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867413|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867414|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1867415|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1867416|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867417|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867418|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
1867419|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1867420|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
1867421|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1867422|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
1867423|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867424|NCT00115804|Fluoxetine|fluoxetine|mesh-list
1867425|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1867426|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1867427|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1867428|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867429|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867430|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
1867431|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867432|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1867433|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867434|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867435|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1867436|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1867437|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867458|NCT00116207|Niacinamide|niacinamide|mesh-list
1867459|NCT00116207|Allopurinol|allopurinol|mesh-list
1867460|NCT00116207|Antioxidants|antioxidants|mesh-list
1867461|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
1867462|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867463|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867464|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
1867465|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867466|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1867467|NCT00116207|Protective Agents|protective agents|mesh-ancestor
1867468|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867469|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
1867470|NCT00116207|Vitamins|vitamins|mesh-ancestor
1867471|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
1867472|NCT00116272|Etanercept|etanercept|mesh-list
1867473|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1867474|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1867475|NCT00116272|Analgesics|analgesics|mesh-ancestor
1867476|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
1867477|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867478|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867479|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867480|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867481|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1867482|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867483|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
1867484|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1867485|NCT00116649|Imiquimod|imiquimod|mesh-list
1867486|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1867487|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
1867488|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867489|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867490|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
1867491|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1867492|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1867493|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1867494|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867495|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867496|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867497|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
1867498|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867499|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1867500|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1867501|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
1867502|NCT00116831|Glipizide|glipizide|mesh-list
1867503|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1867504|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867505|NCT00116844|Valacyclovir|valacyclovir|mesh-list
1867506|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
1867507|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867508|NCT00116857|Sertraline|sertraline|mesh-list
1867509|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867510|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867511|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1867512|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1867513|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1867514|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867515|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867516|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
1867517|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867518|NCT00117156|Rituximab|rituximab|mesh-list
1867519|NCT00117156|Fludarabine|fludarabine|mesh-list
1867520|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867521|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867522|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
1867523|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867524|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867525|NCT00117338|Montelukast|montelukast|mesh-list
1867526|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1867527|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
1867528|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1867529|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
1867530|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867531|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867532|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1867533|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1867534|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867535|NCT00117507|Deferasirox|deferasirox|mesh-list
1867536|NCT00117507|Chelating Agents|chelating agents|mesh-list
1867537|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1867538|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
1867539|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867540|NCT00117572|Docetaxel|docetaxel|mesh-list
1867541|NCT00117572|Fluorouracil|fluorouracil|mesh-list
1867542|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
1867543|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867544|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
1867545|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
1867546|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
1867547|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867548|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
1867549|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867550|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867551|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
1867552|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867553|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
1867554|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867555|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867556|NCT00117598|Sirolimus|sirolimus|mesh-list
1867557|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1867558|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867559|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867560|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867561|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
1867562|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867563|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
1867564|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867565|NCT00117637|Interferons|interferons|mesh-list
1867566|NCT00117637|Sorafenib|sorafenib|mesh-list
1867567|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867568|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
1867569|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867570|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867571|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867572|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867573|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1867574|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1867575|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1867576|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867577|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867578|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867579|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
1867580|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867581|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1867582|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1867583|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
1867584|NCT00117715|Caffeine|caffeine|mesh-list
1867585|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1867586|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867587|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1867588|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867589|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867590|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1867591|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1867592|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
1867593|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867594|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
1867595|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
1867596|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1867597|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1867598|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
1867599|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867600|NCT00117962|Carboplatin|carboplatin|mesh-list
1867601|NCT00117962|Pemetrexed|pemetrexed|mesh-list
1867602|NCT00117962|Cetuximab|cetuximab|mesh-list
1867603|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867604|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867605|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867606|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1867607|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867608|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867609|NCT00118040|Genistein|genistein|mesh-list
1867610|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1867611|NCT00118040|Protective Agents|protective agents|mesh-ancestor
1867612|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867613|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867614|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867615|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867616|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867617|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
1867618|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1867619|NCT00118040|Estrogens|estrogens|mesh-ancestor
1867620|NCT00118040|Hormones|hormones|mesh-ancestor
1867621|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867622|NCT00118131|Docetaxel|docetaxel|mesh-list
1867623|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867624|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
1867625|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
1867626|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
1867627|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867628|NCT00118144|Bortezomib|bortezomib|mesh-list
1867629|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867630|NCT00118157|Tamoxifen|tamoxifen|mesh-list
1867631|NCT00118157|Lapatinib|lapatinib|mesh-list
1867632|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867633|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1867634|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
1867635|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867636|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867637|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867638|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867639|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1867640|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1867641|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1867642|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1867643|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867644|NCT00118209|Prednisone|prednisone|mesh-list
1867645|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
1867646|NCT00118209|Rituximab|rituximab|mesh-list
1867647|NCT00118209|Doxorubicin|doxorubicin|mesh-list
1867648|NCT00118209|Etoposide|etoposide|mesh-list
1867649|NCT00118209|Vincristine|vincristine|mesh-list
1867650|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867651|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
1867652|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867653|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867654|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867655|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
1867656|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867657|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867658|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1867659|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867660|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867661|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1867662|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1867663|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867664|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867665|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
1867666|NCT00118209|Hormones|hormones|mesh-ancestor
1867667|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867668|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867669|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1867670|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
1867671|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
1867672|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
1867673|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
1867674|NCT00118274|Vaccines|vaccines|mesh-list
1867675|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
1867676|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
1867677|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867678|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867679|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867680|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867681|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
1867682|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867683|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867684|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1867685|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1867686|NCT00118287|Etanercept|etanercept|mesh-list
1867687|NCT00118287|Azacitidine|azacitidine|mesh-list
1867688|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867689|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
1867690|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867691|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867692|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867693|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1867694|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1867695|NCT00118287|Analgesics|analgesics|mesh-ancestor
1867696|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
1867697|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867698|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867699|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867700|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867701|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1867702|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867703|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
1867704|NCT00118352|Cyclosporine|cyclosporine|mesh-list
1867705|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
1867706|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1867707|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
1867708|NCT00118352|Fludarabine|fludarabine|mesh-list
1867709|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
1867710|NCT00118352|Antibodies|antibodies|mesh-list
1867711|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
1867712|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1867713|NCT00118352|Cyclosporins|cyclosporins|mesh-list
1867714|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
1867715|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867716|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867717|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867718|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
1867719|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867720|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867721|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867722|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
1867723|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867724|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867725|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867726|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1867727|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867728|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1867729|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
1867730|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1867731|NCT00118365|Eflornithine|eflornithine|mesh-list
1867732|NCT00118365|Sulindac|sulindac|mesh-list
1867733|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867734|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1867735|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1867736|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1867737|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867738|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1867739|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867740|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867741|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1867742|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1867743|NCT00118365|Analgesics|analgesics|mesh-ancestor
1867744|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
1867745|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867746|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867747|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867748|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867749|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1867750|NCT00118378|Modafinil|modafinil|mesh-list
1867751|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1867752|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867753|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1867754|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1867755|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1867756|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867757|NCT00118404|Fluoxetine|fluoxetine|mesh-list
1867758|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1867759|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1867760|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1867761|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867762|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867763|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
1867764|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867765|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1867766|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867767|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867768|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1867769|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1867770|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867771|NCT00118417|Clonazepam|clonazepam|mesh-list
1867772|NCT00118417|Sertraline|sertraline|mesh-list
1867773|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
1867774|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867775|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1867776|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1867777|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1867778|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867779|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867780|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
1867781|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867782|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
1867783|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
1867784|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
1867785|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
1867786|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1867787|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
1867788|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867789|NCT00118716|Fluticasone|fluticasone|mesh-list
1867790|NCT00118716|Xhance|xhance|mesh-list
1867791|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1867792|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867793|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1867794|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
1867795|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867796|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867797|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1867798|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
1867799|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867800|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1867801|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1867802|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1867803|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1867804|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
1867805|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1867806|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867807|NCT00118742|Cyclosporine|cyclosporine|mesh-list
1867808|NCT00118742|Sirolimus|sirolimus|mesh-list
1867809|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
1867810|NCT00118742|Tacrolimus|tacrolimus|mesh-list
1867811|NCT00118742|Cyclosporins|cyclosporins|mesh-list
1867812|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867813|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
1867814|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867815|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1867816|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867817|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867818|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
1867819|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867820|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867821|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867822|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867823|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867824|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1867825|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
1867826|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1867827|NCT00118755|Bevacizumab|bevacizumab|mesh-list
1867828|NCT00118755|Capecitabine|capecitabine|mesh-list
1867829|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
1867830|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867831|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867832|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867833|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867834|NCT00118755|Growth Substances|growth substances|mesh-ancestor
1867835|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867836|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867837|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867838|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
1867839|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867840|NCT00118898|Ritonavir|ritonavir|mesh-list
1867841|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1867842|NCT00118898|Tenofovir|tenofovir|mesh-list
1867843|NCT00118898|Lamivudine|lamivudine|mesh-list
1867844|NCT00118898|Emtricitabine|emtricitabine|mesh-list
1867845|NCT00118898|Abacavir|abacavir|mesh-list
1867846|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1867847|NCT00118898|Efavirenz|efavirenz|mesh-list
1867848|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
1867849|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1867850|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1867851|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
1867852|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867853|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867854|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1867855|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1867856|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
1867857|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867858|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1867859|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1867860|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1867861|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867862|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1867863|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1867864|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1867865|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1867866|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1867867|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
1867868|NCT00119015|Fluticasone|fluticasone|mesh-list
1867869|NCT00119015|Xhance|xhance|mesh-list
1867870|NCT00119015|Montelukast|montelukast|mesh-list
1867871|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867872|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1867873|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
1867874|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867875|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867876|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1867877|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
1867878|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867879|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1867880|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1867881|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
1867882|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867883|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1867884|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1867885|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867886|NCT00119106|Tenofovir|tenofovir|mesh-list
1867887|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
1867888|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867889|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1867890|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867891|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867892|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867893|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1867894|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1867895|NCT00119158|Fluticasone|fluticasone|mesh-list
1867896|NCT00119158|Xhance|xhance|mesh-list
1867897|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
1867898|NCT00119158|Tacrolimus|tacrolimus|mesh-list
1867899|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867900|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1867901|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
1867902|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1867903|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867904|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1867905|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
1867906|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867907|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1867908|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1867909|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1867910|NCT00119158|Analgesics|analgesics|mesh-ancestor
1867911|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
1867912|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867913|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867914|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
1867915|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1867916|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867917|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867918|NCT00119262|Tamoxifen|tamoxifen|mesh-list
1867919|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
1867920|NCT00119262|Bevacizumab|bevacizumab|mesh-list
1867921|NCT00119262|Doxorubicin|doxorubicin|mesh-list
1867922|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1867923|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1867924|NCT00119262|Antibodies|antibodies|mesh-list
1867925|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
1867926|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1867927|NCT00119262|Lenograstim|lenograstim|mesh-list
1867928|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1867929|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867930|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867931|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867932|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
1867933|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867934|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867935|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1867936|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
1867937|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1867938|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1867939|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1867940|NCT00119262|Growth Substances|growth substances|mesh-ancestor
1867941|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
1867942|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867943|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1867944|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1867945|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867946|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1867947|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1867948|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
1867949|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867950|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867951|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1867952|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1867953|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1867954|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1867955|NCT00119379|Tenofovir|tenofovir|mesh-list
1867956|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
1867957|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867958|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1867959|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1867960|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867961|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867962|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1867963|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1867964|NCT00119392|Cyclosporine|cyclosporine|mesh-list
1867965|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
1867966|NCT00119392|Rituximab|rituximab|mesh-list
1867967|NCT00119392|Fludarabine|fludarabine|mesh-list
1867968|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
1867969|NCT00119392|Cyclosporins|cyclosporins|mesh-list
1867970|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1867971|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1867972|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867973|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
1867974|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867975|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1867976|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1867977|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
1867978|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1867979|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1867980|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1867981|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
1867982|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1867983|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
1867984|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1867985|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1867986|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1867987|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
1867988|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1867989|NCT00119678|Prednisone|prednisone|mesh-list
1867990|NCT00119678|Abatacept|abatacept|mesh-list
1867991|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1867992|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
1867993|NCT00119678|Hormones|hormones|mesh-ancestor
1867994|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1867995|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1867996|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1867997|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1867998|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1867999|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868000|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868001|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
1868002|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868003|NCT00120042|Misoprostol|misoprostol|mesh-list
1868004|NCT00120042|Oxytocin|oxytocin|mesh-list
1868005|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
1868006|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868007|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868008|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1868009|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
1868010|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1868011|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1868012|NCT00120250|Eszopiclone|eszopiclone|mesh-list
1868013|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1868014|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1868015|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868016|NCT00120289|Niacin|niacin|mesh-list
1868017|NCT00120289|Simvastatin|simvastatin|mesh-list
1868018|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1868019|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1868020|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
1868021|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868022|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1868023|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1868024|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868025|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
1868026|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
1868027|NCT00120289|Vitamins|vitamins|mesh-ancestor
1868028|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
1868029|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868030|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
1868031|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1868032|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1868033|NCT00120523|Analgesics|analgesics|mesh-ancestor
1868034|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
1868035|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868036|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868037|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868038|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868039|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868040|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868041|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
1868042|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1868043|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868044|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868045|NCT00120874|Memantine|memantine|mesh-list
1868046|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1868047|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1868048|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
1868049|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868200|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
1868050|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868051|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868052|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1868053|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1868054|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
1868055|NCT00121134|Bevacizumab|bevacizumab|mesh-list
1868056|NCT00121134|Capecitabine|capecitabine|mesh-list
1868057|NCT00121134|Methotrexate|methotrexate|mesh-list
1868058|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868059|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
1868060|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868061|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868062|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1868063|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
1868064|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868065|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868066|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1868067|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868068|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868069|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868070|NCT00121134|Growth Substances|growth substances|mesh-ancestor
1868071|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868072|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868073|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
1868074|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1868075|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
1868076|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868077|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868078|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868079|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1868080|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868081|NCT00121186|Methotrexate|methotrexate|mesh-list
1868082|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
1868083|NCT00121186|Fludarabine|fludarabine|mesh-list
1868084|NCT00121186|Melphalan|melphalan|mesh-list
1868085|NCT00121186|Tacrolimus|tacrolimus|mesh-list
1868086|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1868087|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
1868088|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868089|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868090|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868091|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
1868092|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868093|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868094|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868095|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868096|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1868097|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868098|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
1868099|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868100|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868101|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1868102|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1868103|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
1868104|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1868105|NCT00121199|Prednisone|prednisone|mesh-list
1868106|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
1868107|NCT00121199|Bevacizumab|bevacizumab|mesh-list
1868108|NCT00121199|Rituximab|rituximab|mesh-list
1868109|NCT00121199|Doxorubicin|doxorubicin|mesh-list
1868110|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1868111|NCT00121199|Vincristine|vincristine|mesh-list
1868112|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1868113|NCT00121199|Antibodies|antibodies|mesh-list
1868114|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
1868115|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1868116|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868117|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
1868118|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868119|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868120|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1868121|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
1868122|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868123|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868124|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1868125|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868126|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868127|NCT00121199|Growth Substances|growth substances|mesh-ancestor
1868128|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868129|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1868130|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1868131|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1868132|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868133|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868134|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
1868135|NCT00121199|Hormones|hormones|mesh-ancestor
1868136|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868137|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1868138|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1868139|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
1868140|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
1868141|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
1868142|NCT00121225|Vorinostat|vorinostat|mesh-list
1868143|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868144|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1868145|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868146|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868147|NCT00121251|Gemcitabine|gemcitabine|mesh-list
1868148|NCT00121251|Capecitabine|capecitabine|mesh-list
1868149|NCT00121251|Sorafenib|sorafenib|mesh-list
1868150|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868151|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
1868152|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868153|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868154|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
1868155|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868156|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868157|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868158|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
1868159|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868160|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868161|NCT00121641|Metformin|metformin|mesh-list
1868162|NCT00121641|Saxagliptin|saxagliptin|mesh-list
1868163|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1868164|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868165|NCT00121641|Incretins|incretins|mesh-ancestor
1868166|NCT00121641|Hormones|hormones|mesh-ancestor
1868167|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868168|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1868169|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
1868170|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868171|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868172|NCT00121667|Metformin|metformin|mesh-list
1868173|NCT00121667|Pioglitazone|pioglitazone|mesh-list
1868174|NCT00121667|Saxagliptin|saxagliptin|mesh-list
1868175|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1868176|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868177|NCT00121667|Incretins|incretins|mesh-ancestor
1868178|NCT00121667|Hormones|hormones|mesh-ancestor
1868179|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868180|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1868181|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
1868182|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868183|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868184|NCT00121719|Lenvatinib|lenvatinib|mesh-list
1868185|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868186|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868187|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868188|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868189|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
1868190|NCT00121810|Sirolimus|sirolimus|mesh-list
1868191|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1868192|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1868193|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868194|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1868195|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
1868196|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1868197|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868198|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868199|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868201|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868202|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
1868203|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868204|NCT00121836|Bevacizumab|bevacizumab|mesh-list
1868205|NCT00121836|Capecitabine|capecitabine|mesh-list
1868206|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868207|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868208|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868209|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868210|NCT00121836|Growth Substances|growth substances|mesh-ancestor
1868211|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868212|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868213|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868214|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
1868215|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868216|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
1868217|NCT00121992|Docetaxel|docetaxel|mesh-list
1868218|NCT00121992|Doxorubicin|doxorubicin|mesh-list
1868219|NCT00121992|Fluorouracil|fluorouracil|mesh-list
1868220|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868221|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
1868222|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868223|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868224|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1868225|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
1868226|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868227|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868228|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1868229|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
1868230|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
1868231|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
1868232|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1868233|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1868234|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1868235|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868236|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
1868237|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868238|NCT00122278|Dexamethasone|dexamethasone|mesh-list
1868239|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868240|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
1868241|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
1868242|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868243|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868244|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1868245|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
1868246|NCT00122278|Hormones|hormones|mesh-ancestor
1868247|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868248|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1868249|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868250|NCT00122317|Eculizumab|eculizumab|mesh-list
1868251|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1868252|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868253|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
1868254|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868255|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1868256|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1868257|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868258|NCT00122382|Methotrexate|methotrexate|mesh-list
1868259|NCT00122382|Abatacept|abatacept|mesh-list
1868260|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1868261|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
1868262|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868263|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868264|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868265|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
1868266|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868267|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868268|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868269|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868270|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1868271|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868272|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
1868273|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868274|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868275|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1868276|NCT00122447|Aspirin|aspirin|mesh-list
1868277|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
1868278|NCT00122447|Olmesartan|olmesartan|mesh-list
1868279|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1868280|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1868281|NCT00122447|Analgesics|analgesics|mesh-ancestor
1868282|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
1868283|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868284|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868285|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868286|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868287|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1868288|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1868289|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868290|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1868291|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1868292|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868293|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
1868294|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1868295|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1868296|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1868297|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
1868298|NCT00122447|Protective Agents|protective agents|mesh-ancestor
1868299|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
1868300|NCT00122447|Vitamins|vitamins|mesh-ancestor
1868301|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
1868302|NCT00122460|Cisplatin|cisplatin|mesh-list
1868303|NCT00122460|Carboplatin|carboplatin|mesh-list
1868304|NCT00122460|Fluorouracil|fluorouracil|mesh-list
1868305|NCT00122460|Cetuximab|cetuximab|mesh-list
1868306|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868307|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
1868308|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868309|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868310|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868311|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
1868312|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868313|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868314|NCT00122681|Vaccines|vaccines|mesh-list
1868315|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
1868316|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868317|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
1868318|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868319|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
1868320|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868321|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868322|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868323|NCT00123110|Metformin|metformin|mesh-list
1868324|NCT00123110|Leuprolide|leuprolide|mesh-list
1868325|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1868326|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868327|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1868328|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
1868329|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868330|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1868331|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868332|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
1868333|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1868334|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1868335|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868336|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
1868337|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868338|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
1868339|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868340|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
1868341|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1868342|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1868343|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868344|NCT00123162|Urological Agents|urological agents|mesh-ancestor
1868345|NCT00123474|Dasatinib|dasatinib|mesh-list
1868346|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868347|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868348|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868349|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868350|NCT00123487|Dasatinib|dasatinib|mesh-list
1868351|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868352|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868353|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868354|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868355|NCT00123604|Metoprolol|metoprolol|mesh-list
1868356|NCT00123604|Carvedilol|carvedilol|mesh-list
1868357|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1868358|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1868359|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
1868360|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
1868361|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868362|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868363|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1868364|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1868365|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1868366|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
1868367|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868368|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868369|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
1868370|NCT00123604|Protective Agents|protective agents|mesh-ancestor
1868371|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1868372|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868373|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1868374|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
1868375|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1868376|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1868377|NCT00123630|Omalizumab|omalizumab|mesh-list
1868378|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1868379|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1868380|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
1868381|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
1868382|NCT00123643|Glyburide|glyburide|mesh-list
1868383|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1868384|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868385|NCT00123955|Spironolactone|spironolactone|mesh-list
1868386|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1868387|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
1868388|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868389|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868390|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1868391|NCT00123955|Diuretics|diuretics|mesh-ancestor
1868392|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
1868393|NCT00124020|Vancomycin|vancomycin|mesh-list
1868394|NCT00124020|Telavancin|telavancin|mesh-list
1868395|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1868396|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868397|NCT00124072|Folic Acid|folic acid|mesh-list
1868398|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
1868399|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
1868400|NCT00124072|Simvastatin|simvastatin|mesh-list
1868401|NCT00124072|Vitamins|vitamins|mesh-ancestor
1868402|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
1868403|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868404|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1868405|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1868406|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
1868407|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868408|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1868409|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1868410|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868411|NCT00124072|Hematinics|hematinics|mesh-ancestor
1868412|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
1868413|NCT00124176|Albuterol|albuterol|mesh-list
1868414|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1868415|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
1868416|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868417|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868418|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1868419|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
1868420|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
1868421|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868422|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1868423|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1868424|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1868425|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
1868426|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868427|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868428|NCT00124449|Abatacept|abatacept|mesh-list
1868429|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1868430|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868431|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868432|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868433|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
1868434|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868435|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868436|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1868437|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
1868438|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1868439|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
1868440|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868441|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868442|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1868443|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1868444|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868445|NCT00124579|Thalidomide|thalidomide|mesh-list
1868446|NCT00124579|Dexamethasone|dexamethasone|mesh-list
1868447|NCT00124579|Bortezomib|bortezomib|mesh-list
1868448|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868449|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
1868450|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
1868451|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868452|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868453|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1868454|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
1868455|NCT00124579|Hormones|hormones|mesh-ancestor
1868456|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868457|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1868458|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868459|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868460|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
1868461|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
1868462|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1868463|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868464|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868465|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868466|NCT00124579|Growth Substances|growth substances|mesh-ancestor
1868467|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868468|NCT00124618|Cetuximab|cetuximab|mesh-list
1868469|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868470|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868471|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1868472|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868473|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868474|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868475|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868476|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
1868477|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1868478|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1868479|NCT00124709|Analgesics|analgesics|mesh-ancestor
1868480|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
1868481|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868482|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868483|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868484|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868485|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868486|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868487|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
1868488|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1868489|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868490|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868491|NCT00124735|Rocuronium|rocuronium|mesh-list
1868492|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1868493|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1868494|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1868495|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868496|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868497|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
1868498|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868499|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868500|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868501|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868502|NCT00124943|Paclitaxel|paclitaxel|mesh-list
1868503|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1868504|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1868505|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868506|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
1868507|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
1868508|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
1868509|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868510|NCT00124982|Abatacept|abatacept|mesh-list
1868511|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
1868512|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1868513|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868514|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868515|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868516|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
1868517|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868518|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
1868519|NCT00125034|Cetuximab|cetuximab|mesh-list
1868520|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868521|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868522|NCT00125138|Metylperon|metylperon|mesh-list
1868523|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1868524|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1868525|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1868526|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868527|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1868528|NCT00125164|Mecasermin|mecasermin|mesh-list
1868529|NCT00125164|Growth Substances|growth substances|mesh-ancestor
1868530|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868531|NCT00125190|Mecasermin|mecasermin|mesh-list
1868532|NCT00125190|Growth Substances|growth substances|mesh-ancestor
1868533|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868534|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1868535|NCT00125359|Bexarotene|bexarotene|mesh-list
1868536|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868537|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868538|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868539|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868540|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1868541|NCT00125372|Bexarotene|bexarotene|mesh-list
1868542|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868543|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868544|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868545|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868546|NCT00125515|Naltrexone|naltrexone|mesh-list
1868547|NCT00125515|Memantine|memantine|mesh-list
1868548|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1868549|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1868550|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868551|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
1868552|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868553|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1868554|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1868555|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
1868556|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868557|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868558|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1868559|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1868560|NCT00125528|Cycloserine|cycloserine|mesh-list
1868561|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1868562|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868563|NCT00125528|Renal Agents|renal agents|mesh-ancestor
1868564|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1868565|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
1868566|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1868567|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
1868568|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868569|NCT00125593|Simvastatin|simvastatin|mesh-list
1868570|NCT00125593|Ezetimibe|ezetimibe|mesh-list
1868571|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1868572|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1868573|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
1868574|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868575|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1868576|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1868577|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868578|NCT00125853|Atenolol|atenolol|mesh-list
1868579|NCT00125853|Nebivolol|nebivolol|mesh-list
1868580|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1868581|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1868582|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
1868583|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
1868584|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868585|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868586|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1868587|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1868588|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1868589|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
1868590|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868591|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868592|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
1868593|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1868594|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1868595|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1868596|NCT00125931|Pentazocine|pentazocine|mesh-list
1868597|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1868598|NCT00125931|Narcotics|narcotics|mesh-ancestor
1868599|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1868600|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868601|NCT00125931|Analgesics|analgesics|mesh-ancestor
1868602|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
1868603|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868604|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1868605|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1868606|NCT00125957|Bupropion|bupropion|mesh-list
1868607|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1868608|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
1868609|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1868610|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1868611|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1868612|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868613|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868614|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
1868615|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868616|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868617|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1868618|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1868619|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868620|NCT00126191|Leucovorin|leucovorin|mesh-list
1868621|NCT00126191|Cytarabine|cytarabine|mesh-list
1868622|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
1868623|NCT00126191|Ifosfamide|ifosfamide|mesh-list
1868624|NCT00126191|Rituximab|rituximab|mesh-list
1868625|NCT00126191|Doxorubicin|doxorubicin|mesh-list
1868626|NCT00126191|Methotrexate|methotrexate|mesh-list
1868627|NCT00126191|Etoposide|etoposide|mesh-list
1868628|NCT00126191|Vincristine|vincristine|mesh-list
1868629|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868630|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
1868631|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868632|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868633|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1868634|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
1868635|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868636|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868637|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1868638|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868639|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1868640|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1868641|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1868642|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868643|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1868644|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
1868645|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1868646|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868647|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
1868648|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868649|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1868650|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868651|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1868652|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
1868653|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868654|NCT00126191|Antidotes|antidotes|mesh-ancestor
1868655|NCT00126191|Protective Agents|protective agents|mesh-ancestor
1868656|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
1868657|NCT00126191|Vitamins|vitamins|mesh-ancestor
1868658|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
1868659|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
1868660|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
1868661|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
1868662|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
1868663|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868664|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868665|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868666|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1868667|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
1868668|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868669|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868670|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868671|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1868672|NCT00126490|Aldesleukin|aldesleukin|mesh-list
1868673|NCT00126490|Bevacizumab|bevacizumab|mesh-list
1868674|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1868675|NCT00126490|Interleukin-2|interleukin-2|mesh-list
1868676|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
1868677|NCT00126490|Antibodies|antibodies|mesh-list
1868678|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
1868679|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1868680|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
1868681|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868682|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868683|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868684|NCT00126490|Growth Substances|growth substances|mesh-ancestor
1868685|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868686|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868687|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
1868688|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1868689|NCT00126490|Analgesics|analgesics|mesh-ancestor
1868690|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
1868691|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868692|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1868693|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1868694|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
1868695|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868696|NCT00126503|Bevacizumab|bevacizumab|mesh-list
1868697|NCT00126503|Sorafenib|sorafenib|mesh-list
1868698|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868699|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868700|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868701|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868702|NCT00126503|Growth Substances|growth substances|mesh-ancestor
1868703|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868704|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868705|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868706|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868707|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868708|NCT00126555|Gefitinib|gefitinib|mesh-list
1868709|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868710|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868711|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868712|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868713|NCT00126568|Sorafenib|sorafenib|mesh-list
1868714|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868715|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868716|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868717|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868718|NCT00126581|Paclitaxel|paclitaxel|mesh-list
1868719|NCT00126581|Carboplatin|carboplatin|mesh-list
1868720|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1868721|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1868722|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1868723|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868724|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
1868725|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
1868726|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
1868727|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868728|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868729|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868730|NCT00126594|Interferons|interferons|mesh-list
1868731|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
1868732|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
1868733|NCT00126594|Sorafenib|sorafenib|mesh-list
1868734|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868735|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
1868736|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868737|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1868738|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868739|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868740|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
1868741|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868742|NCT00127036|Bevacizumab|bevacizumab|mesh-list
1868743|NCT00127036|Capecitabine|capecitabine|mesh-list
1868744|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
1868745|NCT00127036|Irinotecan|irinotecan|mesh-list
1868746|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868747|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868748|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1868749|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1868750|NCT00127036|Growth Substances|growth substances|mesh-ancestor
1868751|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868752|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
1868753|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868754|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
1868755|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868756|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1868757|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1868758|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868759|NCT00127101|Vorinostat|vorinostat|mesh-list
1868760|NCT00127101|Bexarotene|bexarotene|mesh-list
1868761|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868762|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1868763|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868764|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868765|NCT00127166|Fluticasone|fluticasone|mesh-list
1868766|NCT00127166|Xhance|xhance|mesh-list
1868767|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1868768|NCT00127166|Montelukast|montelukast|mesh-list
1868769|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868770|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1868771|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
1868772|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868773|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868774|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1868775|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
1868776|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
1868777|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1868778|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1868779|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1868780|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1868781|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
1868782|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868783|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868784|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1868785|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
1868786|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868787|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1868788|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1868789|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1868790|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1868791|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868792|NCT00127192|Incretins|incretins|mesh-ancestor
1868793|NCT00127192|Hormones|hormones|mesh-ancestor
1868794|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868795|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1868796|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
1868797|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868798|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868799|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
1868800|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
1868801|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
1868802|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1868803|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868804|NCT00127218|Niacin|niacin|mesh-list
1868805|NCT00127218|Atorvastatin|atorvastatin|mesh-list
1868806|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1868807|NCT00127218|Simvastatin|simvastatin|mesh-list
1868808|NCT00127218|Pravastatin|pravastatin|mesh-list
1868809|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1868810|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1868811|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
1868812|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868813|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1868814|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1868815|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868816|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
1868817|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
1868818|NCT00127218|Vitamins|vitamins|mesh-ancestor
1868819|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
1868820|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868821|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
1868822|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1868823|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868824|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868825|NCT00127712|Amiodarone|amiodarone|mesh-list
1868826|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1868827|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
1868828|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1868829|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868830|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868831|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1868832|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1868833|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1868834|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868835|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1868836|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1868837|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1868838|NCT00127803|Vaccines|vaccines|mesh-list
1868839|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
1868840|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868841|NCT00127842|Etanercept|etanercept|mesh-list
1868842|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1868843|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1868844|NCT00127842|Analgesics|analgesics|mesh-ancestor
1868845|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
1868846|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868847|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868848|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868849|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1868850|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1868851|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1868852|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
1868853|NCT00127855|Vaccines|vaccines|mesh-list
1868854|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1868855|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
1868856|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868857|NCT00127933|Capecitabine|capecitabine|mesh-list
1868858|NCT00127933|Docetaxel|docetaxel|mesh-list
1868859|NCT00127933|Trastuzumab|trastuzumab|mesh-list
1868860|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1868861|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
1868862|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868863|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868864|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
1868865|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
1868866|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
1868867|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1868868|NCT00128102|Vorinostat|vorinostat|mesh-list
1868869|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868870|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1868871|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868872|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868873|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
1868874|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1868875|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1868876|NCT00128180|Prednisolone|prednisolone|mesh-list
1868877|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
1868878|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1868879|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
1868880|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1868881|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
1868882|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
1868883|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868884|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868885|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1868886|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
1868887|NCT00128180|Hormones|hormones|mesh-ancestor
1868888|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1868889|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1868890|NCT00128180|Protective Agents|protective agents|mesh-ancestor
1868891|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1868892|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868893|NCT00128206|Rifampin|rifampin|mesh-list
1868894|NCT00128206|Isoniazid|isoniazid|mesh-list
1868895|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1868896|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
1868897|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1868898|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868899|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
1868900|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868901|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868902|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868903|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1868904|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1868905|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1868906|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1868907|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1868908|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1868909|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1868910|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1868911|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
1868912|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1868913|NCT00128401|Cycloserine|cycloserine|mesh-list
1868914|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1868915|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868916|NCT00128401|Renal Agents|renal agents|mesh-ancestor
1868917|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1868918|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
1868919|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1868920|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
1868921|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868922|NCT00128661|Vaccines|vaccines|mesh-list
1868923|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
1868924|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868925|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1868926|NCT00128830|Etravirine|etravirine|mesh-list
1868927|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
1868928|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
1868929|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
1868930|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1868931|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868932|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868933|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
1868934|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1868935|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1868936|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1868937|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1868938|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1868939|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1868940|NCT00128921|Bortezomib|bortezomib|mesh-list
1868941|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1868942|NCT00129116|Vaccines|vaccines|mesh-list
1868943|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
1868944|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868945|NCT00129129|Vaccines|vaccines|mesh-list
1868946|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
1868947|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868948|NCT00129220|Haloperidol|haloperidol|mesh-list
1868949|NCT00129220|Olanzapine|olanzapine|mesh-list
1868950|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
1868951|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
1868952|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
1868953|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868954|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868955|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1868956|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1868957|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1868958|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1868959|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1868960|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1868961|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1868962|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868963|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868964|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868965|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
1868966|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1868967|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
1868968|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1868969|NCT00129246|Naltrexone|naltrexone|mesh-list
1868970|NCT00129246|Bupropion|bupropion|mesh-list
1868971|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1868972|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1868973|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868974|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
1868975|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1868976|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1868977|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
1868978|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1868979|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1868980|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1868981|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868982|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1868983|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
1868984|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1868985|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1868986|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1868987|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1868988|NCT00129259|Iron|iron|mesh-list
1868989|NCT00129259|Trace Elements|trace elements|mesh-ancestor
1868990|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
1868991|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1868992|NCT00129272|Bupropion|bupropion|mesh-list
1868993|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1868994|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
1868995|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1868996|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1868997|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1868998|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1868999|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869000|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
1869001|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869002|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869003|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1869004|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1869005|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869006|NCT00129285|Modafinil|modafinil|mesh-list
1869007|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1869008|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869009|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1869010|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1869011|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1869012|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869013|NCT00129311|Selegiline|selegiline|mesh-list
1869014|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
1869015|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869016|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1869017|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1869018|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1869019|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869020|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869021|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1869022|NCT00129311|Protective Agents|protective agents|mesh-ancestor
1869023|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869024|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
1869025|NCT00129376|Docetaxel|docetaxel|mesh-list
1869026|NCT00129376|Doxorubicin|doxorubicin|mesh-list
1869027|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869028|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
1869029|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869030|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869031|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869032|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
1869033|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869034|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869035|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869036|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869037|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869038|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869039|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869040|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1869041|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1869042|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869043|NCT00129389|Paclitaxel|paclitaxel|mesh-list
1869044|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
1869045|NCT00129389|Doxorubicin|doxorubicin|mesh-list
1869046|NCT00129389|Fluorouracil|fluorouracil|mesh-list
1869047|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1869048|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869049|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869050|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869051|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869052|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869053|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869054|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
1869055|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869056|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869057|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869058|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
1869059|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869060|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869061|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1869062|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1869063|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869064|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
1869065|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869066|NCT00129402|Simvastatin|simvastatin|mesh-list
1869067|NCT00129402|Ezetimibe|ezetimibe|mesh-list
1869068|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1869069|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1869070|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
1869071|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869072|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1869073|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1869074|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869075|NCT00129467|Methylphenidate|methylphenidate|mesh-list
1869076|NCT00129467|Serotonin|serotonin|mesh-list
1869077|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1869078|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1869079|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869080|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1869081|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1869082|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1869083|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869084|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
1869085|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869086|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1869087|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
1869088|NCT00129545|Warfarin|warfarin|mesh-list
1869089|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
1869090|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
1869091|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1869092|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869093|NCT00129727|Paclitaxel|paclitaxel|mesh-list
1869094|NCT00129727|Bevacizumab|bevacizumab|mesh-list
1869095|NCT00129727|Carboplatin|carboplatin|mesh-list
1869096|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1869097|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869098|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869099|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869100|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869101|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869102|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869401|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1869103|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869104|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869105|NCT00129727|Growth Substances|growth substances|mesh-ancestor
1869106|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869107|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869108|NCT00129766|Palivizumab|palivizumab|mesh-list
1869109|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
1869110|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869111|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
1869112|NCT00129935|Docetaxel|docetaxel|mesh-list
1869113|NCT00129935|Capecitabine|capecitabine|mesh-list
1869114|NCT00129935|Epirubicin|epirubicin|mesh-list
1869115|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869116|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
1869117|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869118|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869119|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869120|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
1869121|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869122|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869123|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869124|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869125|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869126|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869127|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869128|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
1869129|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869130|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1869131|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1869132|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869133|NCT00129961|Cyclosporine|cyclosporine|mesh-list
1869134|NCT00129961|Sirolimus|sirolimus|mesh-list
1869135|NCT00129961|Tacrolimus|tacrolimus|mesh-list
1869136|NCT00129961|Cyclosporins|cyclosporins|mesh-list
1869137|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869138|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
1869139|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869140|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1869141|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869142|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869143|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
1869144|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869145|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
1869146|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869147|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1869148|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869149|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869150|NCT00130039|Cilostazol|cilostazol|mesh-list
1869151|NCT00130039|Clopidogrel|clopidogrel|mesh-list
1869152|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1869153|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1869154|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1869155|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1869156|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
1869157|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869158|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869159|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869160|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1869161|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
1869162|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869163|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1869164|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
1869165|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1869166|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1869167|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
1869168|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1869169|NCT00130039|Protective Agents|protective agents|mesh-ancestor
1869170|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1869171|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1869172|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869173|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
1869174|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
1869175|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1869176|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869177|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869178|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1869179|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
1869180|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
1869181|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1869182|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
1869183|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869184|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1869185|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1869186|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1869187|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869188|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869189|NCT00130247|Rifampin|rifampin|mesh-list
1869190|NCT00130247|Isoniazid|isoniazid|mesh-list
1869191|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
1869192|NCT00130247|Ethambutol|ethambutol|mesh-list
1869193|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1869194|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
1869195|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1869196|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869197|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
1869198|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869199|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869200|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869201|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1869202|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1869203|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1869204|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1869205|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1869206|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1869207|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1869208|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1869209|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
1869210|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1869211|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
1869212|NCT00130286|Hormones|hormones|mesh-list
1869213|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869214|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869215|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869216|NCT00130442|Dacarbazine|dacarbazine|mesh-list
1869217|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869218|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
1869219|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869220|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869221|NCT00130520|Bevacizumab|bevacizumab|mesh-list
1869222|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1869223|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869224|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869225|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869226|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869227|NCT00130520|Growth Substances|growth substances|mesh-ancestor
1869228|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869229|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869230|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869231|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869232|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869233|NCT00130533|Capecitabine|capecitabine|mesh-list
1869234|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869235|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
1869236|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869237|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869238|NCT00130637|Daclizumab|daclizumab|mesh-list
1869239|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869240|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
1869241|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869242|NCT00130689|Cetuximab|cetuximab|mesh-list
1869243|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869244|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869245|NCT00130728|Bevacizumab|bevacizumab|mesh-list
1869246|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1869247|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869248|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869249|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869250|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869251|NCT00130728|Growth Substances|growth substances|mesh-ancestor
1869252|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869253|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869254|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869255|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869256|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869257|NCT00130780|Bevacizumab|bevacizumab|mesh-list
1869258|NCT00130780|Docetaxel|docetaxel|mesh-list
1869259|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869260|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869261|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869262|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869263|NCT00130780|Growth Substances|growth substances|mesh-ancestor
1869264|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869265|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869266|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869267|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869268|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869269|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869270|NCT00130793|Vaccines|vaccines|mesh-list
1869271|NCT00130793|Immunoglobulins|immunoglobulins|mesh-list
1869272|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
1869273|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869274|NCT00130832|Vaccines|vaccines|mesh-list
1869275|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
1869276|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869277|NCT00130923|Risperidone|risperidone|mesh-list
1869278|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1869279|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
1869280|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869281|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869282|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869283|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1869284|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1869285|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1869286|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869287|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1869288|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
1869289|NCT00131248|Metoclopramide|metoclopramide|mesh-list
1869290|NCT00131248|Ranitidine|ranitidine|mesh-list
1869291|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1869292|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
1869293|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
1869294|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869295|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869296|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1869297|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1869298|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1869299|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
1869300|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869301|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869302|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1869303|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1869304|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
1869305|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
1869306|NCT00131352|Hylan|hylan|mesh-list
1869307|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
1869308|NCT00131352|Protective Agents|protective agents|mesh-ancestor
1869309|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869310|NCT00131378|Hormones|hormones|mesh-list
1869311|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869312|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869313|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1869314|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1869315|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1869316|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1869317|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869318|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869319|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869320|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1869321|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
1869322|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869323|NCT00131469|Teriparatide|teriparatide|mesh-list
1869324|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1869325|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869326|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1869327|NCT00131664|Metformin|metformin|mesh-list
1869328|NCT00131664|Glimepiride|glimepiride|mesh-list
1869329|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
1869330|NCT00131664|Maleic acid|maleic acid|mesh-list
1869331|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869332|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869333|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869334|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869335|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1869336|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869337|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
1869338|NCT00131677|Tenofovir|tenofovir|mesh-list
1869339|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
1869340|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869341|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1869342|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869343|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869344|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869345|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1869346|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1869347|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
1869348|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1869349|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
1869350|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869351|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869352|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1869353|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1869354|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1869355|NCT00131911|Sorafenib|sorafenib|mesh-list
1869356|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869357|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869358|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869359|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869360|NCT00131937|Sorafenib|sorafenib|mesh-list
1869361|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869362|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869363|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869364|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869365|NCT00132002|Vorinostat|vorinostat|mesh-list
1869366|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869367|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1869368|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869369|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869370|NCT00132028|Vorinostat|vorinostat|mesh-list
1869371|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869372|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1869373|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869374|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869375|NCT00132301|Prednisone|prednisone|mesh-list
1869376|NCT00132301|Docetaxel|docetaxel|mesh-list
1869377|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869378|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869379|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869380|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869381|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869382|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869383|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
1869384|NCT00132301|Hormones|hormones|mesh-ancestor
1869385|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869386|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869387|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869388|NCT00132314|Risperidone|risperidone|mesh-list
1869389|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
1869390|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1869391|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
1869392|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869393|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869394|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869395|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1869396|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1869397|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869398|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1869399|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
1869400|NCT00132496|Rabeprazole|rabeprazole|mesh-list
1869402|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1869403|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1869404|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869405|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869406|NCT00132678|Risperidone|risperidone|mesh-list
1869407|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1869408|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
1869409|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869410|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869411|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869412|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1869413|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1869414|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1869415|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869416|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1869417|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
1869418|NCT00132691|Cyclosporine|cyclosporine|mesh-list
1869419|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
1869420|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1869421|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
1869422|NCT00132691|Chlorambucil|chlorambucil|mesh-list
1869423|NCT00132691|Methotrexate|methotrexate|mesh-list
1869424|NCT00132691|Azathioprine|azathioprine|mesh-list
1869425|NCT00132691|Infliximab|infliximab|mesh-list
1869426|NCT00132691|Tacrolimus|tacrolimus|mesh-list
1869427|NCT00132691|Cyclosporins|cyclosporins|mesh-list
1869428|NCT00132691|Daclizumab|daclizumab|mesh-list
1869429|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1869430|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
1869431|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
1869432|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869433|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869434|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869435|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869436|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869437|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869438|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1869439|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
1869440|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869441|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869442|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
1869443|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
1869444|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869445|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1869446|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869447|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1869448|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
1869449|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869450|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869451|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1869452|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
1869453|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1869454|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1869455|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869456|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
1869457|NCT00132691|Hormones|hormones|mesh-ancestor
1869458|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869459|NCT00132730|MK 0873|mk 0873|mesh-list
1869460|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1869461|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1869462|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869463|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869464|NCT00132769|MK 0873|mk 0873|mesh-list
1869465|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1869466|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1869467|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869468|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869469|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
1869470|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1869471|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869472|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
1869473|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1869474|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1869475|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
1869476|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
1869477|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1869478|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869479|NCT00133575|Vaccines|vaccines|mesh-list
1869480|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
1869481|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869482|NCT00133705|Mifepristone|mifepristone|mesh-list
1869483|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1869484|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
1869485|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869486|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869487|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1869488|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1869489|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1869490|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
1869491|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1869492|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1869493|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
1869494|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869495|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
1869496|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1869497|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1869498|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
1869499|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869500|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869501|NCT00133978|Selenium|selenium|mesh-list
1869502|NCT00133978|Antioxidants|antioxidants|mesh-list
1869503|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869504|NCT00133978|Protective Agents|protective agents|mesh-ancestor
1869505|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869506|NCT00133978|Trace Elements|trace elements|mesh-ancestor
1869507|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
1869508|NCT00133991|Leucovorin|leucovorin|mesh-list
1869509|NCT00133991|Cytarabine|cytarabine|mesh-list
1869510|NCT00133991|Prednisone|prednisone|mesh-list
1869511|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
1869512|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
1869513|NCT00133991|Rituximab|rituximab|mesh-list
1869514|NCT00133991|Methotrexate|methotrexate|mesh-list
1869515|NCT00133991|Vincristine|vincristine|mesh-list
1869516|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869517|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
1869518|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869519|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869520|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869521|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
1869522|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869523|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869524|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869525|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869526|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869527|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
1869528|NCT00133991|Hormones|hormones|mesh-ancestor
1869529|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869530|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869531|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1869532|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
1869533|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869534|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869535|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
1869536|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
1869537|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869538|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1869539|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869540|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
1869541|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869542|NCT00133991|Antidotes|antidotes|mesh-ancestor
1869543|NCT00133991|Protective Agents|protective agents|mesh-ancestor
1869544|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
1869545|NCT00133991|Vitamins|vitamins|mesh-ancestor
1869546|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
1869547|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1869548|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869549|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869550|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869551|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
1869552|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
1869553|NCT00134004|Fludarabine|fludarabine|mesh-list
1869554|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
1869555|NCT00134004|Tacrolimus|tacrolimus|mesh-list
1869556|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869557|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
1869558|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869559|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869560|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869561|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
1869562|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869563|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869564|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869565|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869566|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
1869567|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1869568|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869569|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869570|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1869571|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
1869572|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1869573|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869574|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
1869575|NCT00134017|Busulfan|busulfan|mesh-list
1869576|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869577|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
1869578|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869579|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869580|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869581|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
1869582|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869583|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869584|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869585|NCT00134043|Vorinostat|vorinostat|mesh-list
1869586|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869587|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1869588|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869589|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869590|NCT00134056|Prednisone|prednisone|mesh-list
1869591|NCT00134056|Docetaxel|docetaxel|mesh-list
1869592|NCT00134056|Atrasentan|atrasentan|mesh-list
1869593|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869594|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869595|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869596|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869597|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869598|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869599|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
1869600|NCT00134056|Hormones|hormones|mesh-ancestor
1869601|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869602|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869603|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869604|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1869605|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1869606|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
1869607|NCT00134082|Rituximab|rituximab|mesh-list
1869608|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869609|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
1869610|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869611|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869612|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869613|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
1869614|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869615|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869616|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869617|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869618|NCT00134563|Teriflunomide|teriflunomide|mesh-list
1869619|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1869620|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1869621|NCT00134563|Analgesics|analgesics|mesh-ancestor
1869622|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
1869623|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869624|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869625|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869626|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869627|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869628|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
1869629|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1869630|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
1869631|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869632|NCT00134901|Memantine|memantine|mesh-list
1869633|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1869634|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1869635|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
1869636|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869637|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869638|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869639|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1869640|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1869641|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
1869642|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869643|NCT00135226|Aspirin|aspirin|mesh-list
1869644|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1869645|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1869646|NCT00135226|Analgesics|analgesics|mesh-ancestor
1869647|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
1869648|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869649|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869650|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869651|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869652|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1869653|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1869654|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869655|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1869656|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1869657|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869658|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
1869659|NCT00135330|Exenatide|exenatide|mesh-list
1869660|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
1869661|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869662|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869663|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1869664|NCT00135330|Incretins|incretins|mesh-ancestor
1869665|NCT00135330|Hormones|hormones|mesh-ancestor
1869666|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869667|NCT00135356|Ritonavir|ritonavir|mesh-list
1869668|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1869669|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
1869670|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1869671|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
1869672|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1869673|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869674|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869675|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1869676|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1869677|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
1869678|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869679|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1869680|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1869681|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869682|NCT00135512|Bupropion|bupropion|mesh-list
1869683|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1869684|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
1869685|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869686|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1869687|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1869688|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1869689|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869690|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
1869691|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869692|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869693|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1869694|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1869695|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869696|NCT00135694|Prednisone|prednisone|mesh-list
1869697|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1869698|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869699|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
1869700|NCT00135694|Hormones|hormones|mesh-ancestor
1869779|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1869701|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869702|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869703|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869704|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869705|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869706|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869707|NCT00135707|Vitamins|vitamins|mesh-list
1869708|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
1869709|NCT00135707|Vitamin E|vitamin e|mesh-list
1869710|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
1869711|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
1869712|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869713|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
1869714|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869715|NCT00135707|Protective Agents|protective agents|mesh-ancestor
1869716|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1869717|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
1869718|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869719|NCT00136084|Cytarabine|cytarabine|mesh-list
1869720|NCT00136084|Dexamethasone|dexamethasone|mesh-list
1869721|NCT00136084|Prednisone|prednisone|mesh-list
1869722|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
1869723|NCT00136084|Methotrexate|methotrexate|mesh-list
1869724|NCT00136084|Etoposide|etoposide|mesh-list
1869725|NCT00136084|Vincristine|vincristine|mesh-list
1869726|NCT00136084|Daunorubicin|daunorubicin|mesh-list
1869727|NCT00136084|Asparaginase|asparaginase|mesh-list
1869728|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
1869729|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
1869730|NCT00136084|Cladribine|cladribine|mesh-list
1869731|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
1869732|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869733|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
1869734|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869735|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869736|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869737|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
1869738|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869739|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869740|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869741|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869742|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
1869743|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
1869744|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869745|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1869746|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
1869747|NCT00136084|Hormones|hormones|mesh-ancestor
1869748|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869749|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869750|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1869751|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
1869752|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869753|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869754|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
1869755|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
1869756|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869757|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1869758|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869759|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1869760|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1869761|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1869762|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
1869763|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869764|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869765|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869766|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869767|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869768|NCT00136084|Analgesics|analgesics|mesh-ancestor
1869769|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
1869770|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869771|NCT00136318|Ribavirin|ribavirin|mesh-list
1869772|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1869773|NCT00136318|Citalopram|citalopram|mesh-list
1869774|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
1869775|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869776|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
1869777|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869778|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1869780|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1869781|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869782|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
1869783|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869784|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1869785|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
1869786|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869787|NCT00136695|Anastrozole|anastrozole|mesh-list
1869788|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869789|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869790|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1869791|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1869792|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869793|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869794|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1869795|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
1869796|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869797|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869798|NCT00136760|Bupropion|bupropion|mesh-list
1869799|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1869800|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
1869801|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869802|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1869803|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1869804|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1869805|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869806|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
1869807|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869808|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869809|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1869810|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1869811|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869812|NCT00136916|Insulin|insulin|mesh-list
1869813|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1869814|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869815|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869816|NCT00136955|Irinotecan|irinotecan|mesh-list
1869817|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1869818|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1869819|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869820|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869821|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869822|NCT00137046|Insulin|insulin|mesh-list
1869823|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1869824|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869825|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869826|NCT00137111|Cytarabine|cytarabine|mesh-list
1869827|NCT00137111|Dexamethasone|dexamethasone|mesh-list
1869828|NCT00137111|Prednisone|prednisone|mesh-list
1869829|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
1869830|NCT00137111|Doxorubicin|doxorubicin|mesh-list
1869831|NCT00137111|Methotrexate|methotrexate|mesh-list
1869832|NCT00137111|Etoposide|etoposide|mesh-list
1869833|NCT00137111|Vincristine|vincristine|mesh-list
1869834|NCT00137111|Daunorubicin|daunorubicin|mesh-list
1869835|NCT00137111|Asparaginase|asparaginase|mesh-list
1869836|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
1869837|NCT00137111|Pegaspargase|pegaspargase|mesh-list
1869838|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1869839|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
1869840|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869841|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869842|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1869843|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
1869844|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869845|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869846|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1869847|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869848|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
1869849|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
1869850|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869851|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1869852|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
1869853|NCT00137111|Hormones|hormones|mesh-ancestor
1869854|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869930|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
1869855|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869856|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1869857|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1869858|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1869859|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869860|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1869861|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
1869862|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1869863|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1869864|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
1869865|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
1869866|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1869867|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1869868|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1869869|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
1869870|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869871|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869872|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869873|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869874|NCT00137423|Sunitinib|sunitinib|mesh-list
1869875|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869876|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869877|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869878|NCT00137423|Growth Substances|growth substances|mesh-ancestor
1869879|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869880|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869881|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869882|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869883|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869884|NCT00137436|Prednisone|prednisone|mesh-list
1869885|NCT00137436|Docetaxel|docetaxel|mesh-list
1869886|NCT00137436|Sunitinib|sunitinib|mesh-list
1869887|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869888|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
1869889|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
1869890|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
1869891|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869892|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869893|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
1869894|NCT00137436|Hormones|hormones|mesh-ancestor
1869895|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869896|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869897|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869898|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869899|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869900|NCT00137436|Growth Substances|growth substances|mesh-ancestor
1869901|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869902|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869903|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869904|NCT00137449|Sunitinib|sunitinib|mesh-list
1869905|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869906|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1869907|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1869908|NCT00137449|Growth Substances|growth substances|mesh-ancestor
1869909|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869910|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
1869911|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869912|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869913|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869914|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1869915|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869916|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1869917|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869918|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869919|NCT00137969|Acetaminophen|acetaminophen|mesh-list
1869920|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
1869921|NCT00137969|Promethazine|promethazine|mesh-list
1869922|NCT00137969|Prednisone|prednisone|mesh-list
1869923|NCT00137969|Rituximab|rituximab|mesh-list
1869924|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869925|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869926|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
1869927|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869928|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1869929|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1869931|NCT00137969|Hormones|hormones|mesh-ancestor
1869932|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869933|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869934|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1869935|NCT00137969|Analgesics|analgesics|mesh-ancestor
1869936|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
1869937|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1869938|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
1869939|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1869940|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1869941|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1869942|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
1869943|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
1869944|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
1869945|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
1869946|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1869947|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1869948|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
1869949|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
1869950|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869951|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869952|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1869953|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
1869954|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
1869955|NCT00138125|Trastuzumab|trastuzumab|mesh-list
1869956|NCT00138125|Fulvestrant|fulvestrant|mesh-list
1869957|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1869958|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869959|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1869960|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1869961|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1869962|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
1869963|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1869964|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869965|NCT00138203|Vorinostat|vorinostat|mesh-list
1869966|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1869967|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1869968|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869969|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869970|NCT00138424|Cidofovir|cidofovir|mesh-list
1869971|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
1869972|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1869973|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1869974|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869975|NCT00138671|Insulin|insulin|mesh-list
1869976|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1869977|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869978|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869979|NCT00139477|Metformin|metformin|mesh-list
1869980|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869981|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869982|NCT00139659|Insulin|insulin|mesh-list
1869983|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1869984|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1869985|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869986|NCT00139737|Ziprasidone|ziprasidone|mesh-list
1869987|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1869988|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
1869989|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1869990|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1869991|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1869992|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1869993|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1869994|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1869995|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1869996|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1869997|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
1869998|NCT00139776|Celecoxib|celecoxib|mesh-list
1869999|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870000|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870001|NCT00139776|Analgesics|analgesics|mesh-ancestor
1870002|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
1870003|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870004|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870005|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870006|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870007|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1870008|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1870009|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870010|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870011|NCT00140140|Paclitaxel|paclitaxel|mesh-list
1870012|NCT00140140|Vinorelbine|vinorelbine|mesh-list
1870013|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1870014|NCT00140140|Trastuzumab|trastuzumab|mesh-list
1870015|NCT00140140|Sargramostim|sargramostim|mesh-list
1870016|NCT00140140|Lenograstim|lenograstim|mesh-list
1870017|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870018|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870019|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870020|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870021|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870022|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870023|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870024|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
1870025|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870026|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1870027|NCT00140426|Risperidone|risperidone|mesh-list
1870028|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1870029|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
1870030|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870031|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870032|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870033|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870034|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870035|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870036|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870037|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1870038|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
1870039|NCT00140556|Bevacizumab|bevacizumab|mesh-list
1870040|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1870041|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870042|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870043|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1870044|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1870045|NCT00140556|Growth Substances|growth substances|mesh-ancestor
1870046|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870047|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
1870048|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1870049|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870050|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870051|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1870052|NCT00140855|Ipilimumab|ipilimumab|mesh-list
1870053|NCT00140855|Antibodies|antibodies|mesh-list
1870054|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
1870055|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1870056|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
1870057|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870058|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870059|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1870060|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870061|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
1870062|NCT00141037|Trimethoprim|trimethoprim|mesh-list
1870063|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
1870064|NCT00141037|Valganciclovir|valganciclovir|mesh-list
1870065|NCT00141037|Ganciclovir|ganciclovir|mesh-list
1870066|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1870067|NCT00141037|Prednisone|prednisone|mesh-list
1870068|NCT00141037|Tacrolimus|tacrolimus|mesh-list
1870069|NCT00141037|Daclizumab|daclizumab|mesh-list
1870070|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870071|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
1870072|NCT00141037|Hormones|hormones|mesh-ancestor
1870073|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870074|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870075|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870076|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870077|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870078|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
1870079|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1870080|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870081|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870082|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1870083|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1870084|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
1870085|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1870086|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870087|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1870088|NCT00141037|Renal Agents|renal agents|mesh-ancestor
1870089|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
1870090|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1870091|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1870092|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1870093|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1870094|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1870095|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870096|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
1870097|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1870098|NCT00141102|Celecoxib|celecoxib|mesh-list
1870099|NCT00141102|Diclofenac|diclofenac|mesh-list
1870100|NCT00141102|Omeprazole|omeprazole|mesh-list
1870101|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870102|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870103|NCT00141102|Analgesics|analgesics|mesh-ancestor
1870104|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
1870105|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870106|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870107|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870108|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870109|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1870110|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1870111|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870112|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870113|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1870114|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870115|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1870116|NCT00141115|Levetiracetam|levetiracetam|mesh-list
1870117|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
1870118|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
1870119|NCT00141219|Pregabalin|pregabalin|mesh-list
1870120|NCT00141219|Analgesics|analgesics|mesh-ancestor
1870121|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
1870122|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870123|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870124|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
1870125|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1870126|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1870127|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870128|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1870129|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1870130|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870131|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870132|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870133|NCT00141271|Ziprasidone|ziprasidone|mesh-list
1870134|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1870135|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
1870136|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870137|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870138|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870139|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870140|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870141|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870142|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870143|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1870144|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
1870145|NCT00141297|Palbociclib|palbociclib|mesh-list
1870146|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870147|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1870148|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870149|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870150|NCT00141453|Olmesartan|olmesartan|mesh-list
1870151|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1870152|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870153|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1870154|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1870155|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870156|NCT00141518|Levodopa|levodopa|mesh-list
1870157|NCT00141518|Carbidopa|carbidopa|mesh-list
1870158|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1870159|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1870160|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1870161|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
1870162|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870163|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870164|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870165|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1870166|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870167|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1870168|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
1870169|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
1870170|NCT00141726|Etanercept|etanercept|mesh-list
1870171|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870172|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870173|NCT00141726|Analgesics|analgesics|mesh-ancestor
1870174|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
1870175|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870176|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870177|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870178|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870179|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870180|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870181|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
1870182|NCT00141739|Etanercept|etanercept|mesh-list
1870183|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870184|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870185|NCT00141739|Analgesics|analgesics|mesh-ancestor
1870186|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
1870187|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870188|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870189|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870190|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870191|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870192|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870193|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
1870194|NCT00141778|Ramipril|ramipril|mesh-list
1870195|NCT00141778|Spironolactone|spironolactone|mesh-list
1870196|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1870197|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1870198|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1870199|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
1870200|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
1870201|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870202|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870203|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1870204|NCT00141778|Diuretics|diuretics|mesh-ancestor
1870205|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
1870206|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
1870207|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870208|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870209|NCT00141778|Hormones|hormones|mesh-ancestor
1870210|NCT00141817|Pantoprazole|pantoprazole|mesh-list
1870211|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1870212|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870213|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1870214|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870215|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870216|NCT00141921|Etanercept|etanercept|mesh-list
1870217|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870218|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870219|NCT00141921|Analgesics|analgesics|mesh-ancestor
1870220|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
1870221|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870222|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870223|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870224|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870225|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870226|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870227|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
1870228|NCT00142116|Thalidomide|thalidomide|mesh-list
1870229|NCT00142116|Rituximab|rituximab|mesh-list
1870230|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870231|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870232|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
1870233|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870234|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870235|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870236|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
1870237|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1870238|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870239|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1870240|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1870241|NCT00142116|Growth Substances|growth substances|mesh-ancestor
1870242|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
1870243|NCT00142168|Rituximab|rituximab|mesh-list
1870244|NCT00142168|Lenalidomide|lenalidomide|mesh-list
1870245|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870246|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870247|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
1870248|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870249|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870250|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1870251|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1870252|NCT00142168|Growth Substances|growth substances|mesh-ancestor
1870253|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
1870254|NCT00142298|Telbivudine|telbivudine|mesh-list
1870255|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
1870256|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870257|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1870258|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870259|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870260|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1870261|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
1870262|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
1870263|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870264|NCT00142454|Imiquimod|imiquimod|mesh-list
1870265|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1870266|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
1870267|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870268|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870269|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
1870270|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
1870271|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870272|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
1870273|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1870274|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1870275|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870276|NCT00142506|Urological Agents|urological agents|mesh-ancestor
1870277|NCT00142818|Naltrexone|naltrexone|mesh-list
1870278|NCT00142818|Modafinil|modafinil|mesh-list
1870279|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1870280|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1870281|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870282|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
1870283|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870284|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1870285|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1870286|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1870287|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1870288|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870289|NCT00142909|Lofexidine|lofexidine|mesh-list
1870290|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870291|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1870292|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870293|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
1870294|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870295|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1870296|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1870297|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1870298|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
1870299|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870300|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870301|NCT00143247|Insulin|insulin|mesh-list
1870302|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1870303|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870304|NCT00143312|Voriconazole|voriconazole|mesh-list
1870305|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
1870306|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870307|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1870308|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870309|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870310|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870311|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1870312|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
1870313|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870314|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870315|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1870316|NCT00143390|Anastrozole|anastrozole|mesh-list
1870317|NCT00143390|Exemestane|exemestane|mesh-list
1870318|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870319|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870320|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1870321|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1870322|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870323|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870324|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1870325|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
1870326|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870327|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870328|NCT00143403|Leucovorin|leucovorin|mesh-list
1870329|NCT00143403|Folic Acid|folic acid|mesh-list
1870330|NCT00143403|Irinotecan|irinotecan|mesh-list
1870331|NCT00143403|Fluorouracil|fluorouracil|mesh-list
1870332|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
1870333|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1870334|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1870335|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870336|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870337|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870338|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
1870339|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1870340|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870341|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
1870342|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870343|NCT00143403|Antidotes|antidotes|mesh-ancestor
1870344|NCT00143403|Protective Agents|protective agents|mesh-ancestor
1870345|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
1870346|NCT00143403|Vitamins|vitamins|mesh-ancestor
1870347|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
1870348|NCT00143403|Hematinics|hematinics|mesh-ancestor
1870349|NCT00143455|Cisplatin|cisplatin|mesh-list
1870350|NCT00143455|Irinotecan|irinotecan|mesh-list
1870351|NCT00143455|Etoposide|etoposide|mesh-list
1870352|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870353|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1870354|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1870355|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870356|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870357|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870358|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1870359|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1870360|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
1870361|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870362|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
1870363|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870364|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870365|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870366|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870367|NCT00144170|Ritonavir|ritonavir|mesh-list
1870368|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
1870369|NCT00144170|Tipranavir|tipranavir|mesh-list
1870370|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
1870371|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1870372|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870373|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870374|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1870375|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1870376|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
1870377|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870378|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1870379|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870380|NCT00144300|Pramipexole|pramipexole|mesh-list
1870381|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
1870382|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870383|NCT00144300|Protective Agents|protective agents|mesh-ancestor
1870384|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870385|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1870386|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1870387|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
1870388|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
1870389|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870390|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
1870391|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1870392|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
1870393|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870394|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870395|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1870396|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
1870397|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
1870398|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1870399|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
1870400|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870401|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870402|NCT00144391|Testosterone|testosterone|mesh-list
1870403|NCT00144391|Androgens|androgens|mesh-ancestor
1870404|NCT00144391|Hormones|hormones|mesh-ancestor
1870405|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870406|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870407|NCT00144963|Dexamethasone|dexamethasone|mesh-list
1870408|NCT00144963|Vincristine|vincristine|mesh-list
1870409|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870410|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
1870411|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
1870412|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870413|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870414|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870415|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
1870416|NCT00144963|Hormones|hormones|mesh-ancestor
1870417|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870418|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870419|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870420|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870421|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870422|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870423|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870424|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870425|NCT00145041|Vincristine|vincristine|mesh-list
1870426|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870427|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870428|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870429|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870430|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870431|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870432|NCT00145249|Fluconazole|fluconazole|mesh-list
1870433|NCT00145249|Amphotericin B|amphotericin b|mesh-list
1870434|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1870435|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
1870436|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870437|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1870438|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870439|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870440|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870441|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1870442|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
1870443|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870444|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870445|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1870446|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1870447|NCT00145249|Amebicides|amebicides|mesh-ancestor
1870448|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1870449|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1870450|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1870451|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
1870452|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1870453|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870454|NCT00145418|Docetaxel|docetaxel|mesh-list
1870455|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
1870456|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870457|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870458|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870459|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870460|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870461|NCT00145470|Asenapine|asenapine|mesh-list
1870462|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870463|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870464|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870465|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870466|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870467|NCT00145496|Olanzapine|olanzapine|mesh-list
1870468|NCT00145496|Asenapine|asenapine|mesh-list
1870469|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
1870470|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
1870471|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870472|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870473|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870474|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870475|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870476|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870477|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870478|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1870479|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1870480|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1870481|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870482|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870483|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
1870484|NCT00145509|Asenapine|asenapine|mesh-list
1870485|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870486|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870487|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870488|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870489|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870490|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1870491|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1870492|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1870493|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
1870494|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870495|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1870496|NCT00145587|Antibodies|antibodies|mesh-list
1870497|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
1870498|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870499|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
1870500|NCT00145626|Melphalan|melphalan|mesh-list
1870501|NCT00145626|Thiotepa|thiotepa|mesh-list
1870502|NCT00145626|Fludarabine|fludarabine|mesh-list
1870503|NCT00145626|Antibodies|antibodies|mesh-list
1870504|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870505|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
1870506|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870507|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870508|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1870509|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
1870510|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870511|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870512|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1870513|NCT00145795|Ritonavir|ritonavir|mesh-list
1870514|NCT00145795|Lopinavir|lopinavir|mesh-list
1870515|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1870516|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1870517|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
1870518|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870519|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870520|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1870521|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1870522|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
1870523|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870524|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1870525|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870526|NCT00145977|Vitamin D|vitamin d|mesh-list
1870527|NCT00145977|Alendronate|alendronate|mesh-list
1870528|NCT00145977|Calcium|calcium|mesh-list
1870529|NCT00145977|Vitamins|vitamins|mesh-ancestor
1870530|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
1870531|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870532|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1870533|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1870534|NCT00146328|Tipranavir|tipranavir|mesh-list
1870535|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1870536|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1870537|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
1870538|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870539|NCT00146640|Prednisone|prednisone|mesh-list
1870540|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870541|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
1870542|NCT00146640|Hormones|hormones|mesh-ancestor
1870543|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870544|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870545|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870546|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870547|NCT00147199|Treprostinil|treprostinil|mesh-list
1870548|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870549|NCT00147212|Trabectedin|trabectedin|mesh-list
1870550|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1870551|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
1870552|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870553|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870554|NCT00147225|Carboplatin|carboplatin|mesh-list
1870555|NCT00147225|Doxorubicin|doxorubicin|mesh-list
1870556|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1870557|NCT00147225|Ifosfamide|ifosfamide|mesh-list
1870558|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870559|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1870560|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1870561|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1870562|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870563|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870564|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1870565|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
1870566|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1870567|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1870568|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1870569|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870570|NCT00147498|Tofacitinib|tofacitinib|mesh-list
1870571|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1870572|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870573|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870574|NCT00147537|Paclitaxel|paclitaxel|mesh-list
1870575|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1870576|NCT00147537|Carboplatin|carboplatin|mesh-list
1870577|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1870578|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1870579|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870580|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870581|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870582|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870583|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870584|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870585|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1870586|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870587|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
1870588|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870589|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
1870590|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1870591|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1870592|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870593|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1870594|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1870595|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
1870596|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870597|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1870598|NCT00147966|Rituximab|rituximab|mesh-list
1870599|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870600|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870601|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
1870602|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870603|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870604|NCT00148109|Cetuximab|cetuximab|mesh-list
1870605|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870606|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870607|NCT00148122|Docetaxel|docetaxel|mesh-list
1870608|NCT00148122|Capecitabine|capecitabine|mesh-list
1870609|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870610|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870611|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870612|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870613|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870614|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1870615|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
1870616|NCT00148317|Dexamethasone|dexamethasone|mesh-list
1870617|NCT00148317|Doxorubicin|doxorubicin|mesh-list
1870618|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1870619|NCT00148317|Bortezomib|bortezomib|mesh-list
1870620|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870621|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
1870622|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
1870623|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870624|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870625|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870626|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
1870627|NCT00148317|Hormones|hormones|mesh-ancestor
1870628|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870629|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870630|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870631|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1870632|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1870633|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1870634|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870635|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870636|NCT00148668|Carboplatin|carboplatin|mesh-list
1870637|NCT00148668|Docetaxel|docetaxel|mesh-list
1870638|NCT00148668|Trastuzumab|trastuzumab|mesh-list
1870639|NCT00148668|Vinorelbine|vinorelbine|mesh-list
1870640|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870641|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870642|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870643|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870644|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870645|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870646|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870647|NCT00148798|Cisplatin|cisplatin|mesh-list
1870648|NCT00148798|Cetuximab|cetuximab|mesh-list
1870649|NCT00148798|Vinorelbine|vinorelbine|mesh-list
1870650|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870651|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870652|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870653|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870654|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870655|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870656|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870657|NCT00148941|Vaccines|vaccines|mesh-list
1870658|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
1870659|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870660|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
1870661|NCT00149214|Docetaxel|docetaxel|mesh-list
1870662|NCT00149214|Doxorubicin|doxorubicin|mesh-list
1870663|NCT00149214|Pemetrexed|pemetrexed|mesh-list
1870664|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870665|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
1870666|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870667|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870668|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1870669|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
1870670|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870671|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870672|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1870673|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
1870674|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
1870675|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
1870676|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1870677|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1870678|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1870679|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870680|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1870681|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1870682|NCT00149227|Valsartan|valsartan|mesh-list
1870683|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
1870684|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1870685|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1870686|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870687|NCT00149630|Disulfiram|disulfiram|mesh-list
1870688|NCT00149630|Methadone|methadone|mesh-list
1870689|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1870690|NCT00149630|Narcotics|narcotics|mesh-ancestor
1870691|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870692|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870693|NCT00149630|Analgesics|analgesics|mesh-ancestor
1870694|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
1870695|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870696|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
1870697|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
1870698|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1870699|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1870700|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870701|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870702|NCT00149643|Fluoxetine|fluoxetine|mesh-list
1870703|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1870704|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1870705|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1870706|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870707|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870708|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
1870709|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870710|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1870711|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
1870712|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870713|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1870714|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870715|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870716|NCT00149734|Ondansetron|ondansetron|mesh-list
1870717|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
1870718|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
1870719|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870720|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870721|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870722|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
1870723|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
1870724|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1870725|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
1870726|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870727|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870728|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870729|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870730|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870731|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870732|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1870733|NCT00149799|Citalopram|citalopram|mesh-list
1870734|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1870735|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1870736|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1870737|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870738|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870739|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
1870740|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870741|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1870742|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
1870743|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870744|NCT00149825|Dexetimide|dexetimide|mesh-list
1870745|NCT00149825|Citalopram|citalopram|mesh-list
1870746|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1870747|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1870748|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1870749|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870750|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870751|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
1870752|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870753|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1870754|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
1870755|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870756|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1870757|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1870758|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
1870759|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
1870760|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870761|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1870762|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1870763|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
1870764|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
1870765|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870766|NCT00149890|Cyclosporine|cyclosporine|mesh-list
1870767|NCT00149890|Cyclosporins|cyclosporins|mesh-list
1870768|NCT00149890|Basiliximab|basiliximab|mesh-list
1870769|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870770|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870771|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870772|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
1870773|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870774|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
1870775|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870776|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
1870777|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870778|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1870779|NCT00149994|Cyclosporine|cyclosporine|mesh-list
1870780|NCT00149994|Prednisone|prednisone|mesh-list
1870781|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
1870782|NCT00149994|Tacrolimus|tacrolimus|mesh-list
1870783|NCT00149994|Cyclosporins|cyclosporins|mesh-list
1870784|NCT00149994|Basiliximab|basiliximab|mesh-list
1870785|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870786|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
1870787|NCT00149994|Hormones|hormones|mesh-ancestor
1870788|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870789|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870790|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870791|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870792|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870793|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
1870794|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1870795|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870796|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870797|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
1870798|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870799|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
1870800|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870801|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
1870802|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
1870803|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870804|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870805|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1870806|NCT00149994|Protective Agents|protective agents|mesh-ancestor
1870807|NCT00150176|Asenapine|asenapine|mesh-list
1870808|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1870809|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1870810|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1870811|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870812|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1870813|NCT00150345|Voriconazole|voriconazole|mesh-list
1870814|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
1870815|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870816|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1870817|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1870818|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870819|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870820|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1870821|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
1870822|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870823|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870824|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1870825|NCT00150462|Dexamethasone|dexamethasone|mesh-list
1870826|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870827|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
1870828|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
1870829|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870830|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870831|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1870832|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
1870833|NCT00150462|Hormones|hormones|mesh-ancestor
1870834|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870835|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870836|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870837|NCT00150592|Guanfacine|guanfacine|mesh-list
1870838|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870839|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1870840|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1870841|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1870842|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
1870843|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870844|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870845|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870846|NCT00150618|Guanfacine|guanfacine|mesh-list
1870847|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870848|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1870849|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1870850|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1870851|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
1870852|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870853|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870854|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870855|NCT00150800|Brivaracetam|brivaracetam|mesh-list
1870856|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
1870857|NCT00150813|Levetiracetam|levetiracetam|mesh-list
1870858|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
1870859|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
1870860|NCT00150969|Vitamin K|vitamin k|mesh-list
1870861|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
1870862|NCT00150969|Vitamins|vitamins|mesh-ancestor
1870863|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
1870864|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870865|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1870866|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1870867|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870868|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
1870869|NCT00150969|Coagulants|coagulants|mesh-ancestor
1870870|NCT00151281|Thalidomide|thalidomide|mesh-list
1870871|NCT00151281|Prednisone|prednisone|mesh-list
1870872|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
1870873|NCT00151281|Rituximab|rituximab|mesh-list
1870874|NCT00151281|Etoposide|etoposide|mesh-list
1870875|NCT00151281|Procarbazine|procarbazine|mesh-list
1870876|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1870877|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
1870878|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870879|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870880|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1870881|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
1870882|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870883|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870884|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1870885|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870886|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870887|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
1870888|NCT00151281|Hormones|hormones|mesh-ancestor
1870889|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1870890|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1870891|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1870892|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1870893|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1870894|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870895|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
1870896|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1870897|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1870898|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1870899|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1870900|NCT00151281|Growth Substances|growth substances|mesh-ancestor
1870901|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
1870902|NCT00151320|Rituximab|rituximab|mesh-list
1870903|NCT00151320|Bortezomib|bortezomib|mesh-list
1870904|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1870905|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1870906|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
1870907|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870908|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870909|NCT00151411|Metformin|metformin|mesh-list
1870910|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1870911|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870912|NCT00151476|Celecoxib|celecoxib|mesh-list
1870913|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870914|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870915|NCT00151476|Analgesics|analgesics|mesh-ancestor
1870916|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
1870917|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870918|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870919|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870920|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870921|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1870922|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1870923|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870924|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870925|NCT00151775|Olmesartan|olmesartan|mesh-list
1870926|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1870927|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870928|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1870929|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1870930|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870931|NCT00151814|Olmesartan|olmesartan|mesh-list
1870932|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1870933|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870934|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1870935|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1870936|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870937|NCT00151892|Mesalamine|mesalamine|mesh-list
1870938|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1870939|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1870940|NCT00151892|Analgesics|analgesics|mesh-ancestor
1870941|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
1870942|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870943|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870944|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1870945|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1870946|NCT00151996|Guanfacine|guanfacine|mesh-list
1870947|NCT00151996|Methylphenidate|methylphenidate|mesh-list
1870948|NCT00151996|Amphetamine|amphetamine|mesh-list
1870949|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1870950|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870951|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1870952|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1870953|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1870954|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870955|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
1870956|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870957|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
1870958|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
1870959|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1870960|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
1870961|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1870962|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870963|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1870964|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1870965|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1870966|NCT00152009|Guanfacine|guanfacine|mesh-list
1870967|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1870968|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1870969|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1870970|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1870971|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
1870972|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870973|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870974|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870975|NCT00152464|Levocetirizine|levocetirizine|mesh-list
1870976|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1870977|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1870978|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
1870979|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
1870980|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1870981|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870982|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1870983|NCT00152516|Levetiracetam|levetiracetam|mesh-list
1870984|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
1870985|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
1870986|NCT00152971|Enoxaparin|enoxaparin|mesh-list
1870987|NCT00152971|Dabigatran|dabigatran|mesh-list
1870988|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
1870989|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1870990|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1870991|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1870992|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
1870993|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1870994|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
1870995|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1870996|NCT00153062|Telmisartan|telmisartan|mesh-list
1870997|NCT00153062|Clopidogrel|clopidogrel|mesh-list
1870998|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
1870999|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1871000|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1871001|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1871002|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1871003|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
1871004|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871005|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871006|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871007|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1871008|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1871009|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1871010|NCT00153101|Telmisartan|telmisartan|mesh-list
1871011|NCT00153101|Ramipril|ramipril|mesh-list
1871012|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1871013|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1871014|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1871015|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871016|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1871017|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871018|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871019|NCT00153166|Pioglitazone|pioglitazone|mesh-list
1871020|NCT00153166|Atorvastatin|atorvastatin|mesh-list
1871021|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1871022|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1871023|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
1871024|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871025|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1871026|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1871027|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871028|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1871029|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871030|NCT00153179|Acipimox|acipimox|mesh-list
1871031|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1871032|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
1871033|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871034|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1871035|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1871036|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871037|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1871038|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871039|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871040|NCT00153816|Vitamin D|vitamin d|mesh-list
1871041|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
1871042|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
1871043|NCT00153816|Calcium|calcium|mesh-list
1871044|NCT00153816|Vitamins|vitamins|mesh-ancestor
1871045|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
1871046|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871047|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1871048|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1871049|NCT00153816|Antacids|antacids|mesh-ancestor
1871050|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871051|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871052|NCT00153842|Bexarotene|bexarotene|mesh-list
1871053|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871054|NCT00153920|Bortezomib|bortezomib|mesh-list
1871055|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871056|NCT00153985|Fludarabine|fludarabine|mesh-list
1871057|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
1871058|NCT00153985|Busulfan|busulfan|mesh-list
1871059|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871060|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871061|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871062|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
1871063|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871064|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871065|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
1871066|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1871067|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1871068|NCT00154102|Leucovorin|leucovorin|mesh-list
1871069|NCT00154102|Folic Acid|folic acid|mesh-list
1871070|NCT00154102|Fluorouracil|fluorouracil|mesh-list
1871071|NCT00154102|Irinotecan|irinotecan|mesh-list
1871072|NCT00154102|Cetuximab|cetuximab|mesh-list
1871073|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
1871074|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
1871075|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871076|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1871077|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871078|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871079|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
1871080|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871081|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1871082|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1871083|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871084|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871085|NCT00154102|Antidotes|antidotes|mesh-ancestor
1871086|NCT00154102|Protective Agents|protective agents|mesh-ancestor
1871087|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
1871088|NCT00154102|Vitamins|vitamins|mesh-ancestor
1871089|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
1871090|NCT00154102|Hematinics|hematinics|mesh-ancestor
1871091|NCT00154284|Cyclosporine|cyclosporine|mesh-list
1871092|NCT00154284|Prednisone|prednisone|mesh-list
1871093|NCT00154284|Everolimus|everolimus|mesh-list
1871094|NCT00154284|Cyclosporins|cyclosporins|mesh-list
1871095|NCT00154284|Basiliximab|basiliximab|mesh-list
1871096|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871097|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
1871098|NCT00154284|Hormones|hormones|mesh-ancestor
1871099|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871100|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871101|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871102|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871103|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871104|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871105|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871106|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
1871107|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
1871108|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871109|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871110|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871111|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1871112|NCT00154297|Everolimus|everolimus|mesh-list
1871113|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871114|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871115|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
1871116|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871117|NCT00154310|Cyclosporine|cyclosporine|mesh-list
1871118|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
1871119|NCT00154310|Everolimus|everolimus|mesh-list
1871120|NCT00154310|Cyclosporins|cyclosporins|mesh-list
1871121|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871122|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871123|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871124|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
1871125|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871126|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
1871127|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871128|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871129|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871130|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1871131|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871132|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1871360|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
1871133|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1871134|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
1871135|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1871136|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
1871137|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
1871138|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871139|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1871140|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871141|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871142|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
1871143|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1871144|NCT00156013|Clofarabine|clofarabine|mesh-list
1871145|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1871146|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
1871147|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871148|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871149|NCT00156065|Haloperidol|haloperidol|mesh-list
1871150|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
1871151|NCT00156065|Asenapine|asenapine|mesh-list
1871152|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
1871153|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
1871154|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871155|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871156|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871157|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1871158|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1871159|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871160|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871161|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1871162|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
1871163|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871164|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871165|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1871166|NCT00156247|Acitretin|acitretin|mesh-list
1871167|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
1871168|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871169|NCT00156533|Zolpidem|zolpidem|mesh-list
1871170|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1871171|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1871172|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871173|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871174|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1871175|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
1871176|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
1871177|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871178|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871179|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1871180|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
1871181|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871182|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1871183|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1871184|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871185|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871186|NCT00156819|Fluticasone|fluticasone|mesh-list
1871187|NCT00156819|Xhance|xhance|mesh-list
1871188|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1871189|NCT00156819|Montelukast|montelukast|mesh-list
1871190|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871191|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1871192|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
1871193|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871194|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871195|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1871196|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
1871197|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871198|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1871199|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1871200|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1871201|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1871202|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
1871203|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871204|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871205|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1871206|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
1871207|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871208|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1871209|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1871210|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
1871211|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1871212|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1871213|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1871214|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871215|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871216|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871217|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871218|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871219|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1871220|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871221|NCT00156923|Naltrexone|naltrexone|mesh-list
1871222|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1871223|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1871224|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871225|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
1871226|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871227|NCT00156936|Naltrexone|naltrexone|mesh-list
1871228|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1871229|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1871230|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871231|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
1871232|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871233|NCT00157014|Cyclosporine|cyclosporine|mesh-list
1871234|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
1871235|NCT00157014|Prednisone|prednisone|mesh-list
1871236|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
1871237|NCT00157014|Tacrolimus|tacrolimus|mesh-list
1871238|NCT00157014|Cyclosporins|cyclosporins|mesh-list
1871239|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871240|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
1871241|NCT00157014|Hormones|hormones|mesh-ancestor
1871242|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871243|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871244|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871245|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871246|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871247|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
1871248|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1871249|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871250|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871251|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
1871252|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871253|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871254|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871255|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1871256|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1871257|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
1871258|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1871259|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
1871260|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
1871261|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871262|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871263|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1871264|NCT00157014|Protective Agents|protective agents|mesh-ancestor
1871265|NCT00157157|Factor VIII|factor viii|mesh-list
1871266|NCT00157157|Coagulants|coagulants|mesh-ancestor
1871267|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
1871268|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871269|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
1871270|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871271|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871272|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1871273|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
1871274|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871275|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871276|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1871277|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
1871278|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871279|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
1871280|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871281|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871282|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1871283|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
1871284|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871285|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871286|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1871287|NCT00157248|Dabigatran|dabigatran|mesh-list
1871288|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
1871289|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1871290|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871291|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871292|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871293|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
1871294|NCT00157573|Sargramostim|sargramostim|mesh-list
1871295|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
1871296|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871297|NCT00158184|Oxycodone|oxycodone|mesh-list
1871298|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1871299|NCT00158184|Narcotics|narcotics|mesh-ancestor
1871300|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871301|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871302|NCT00158184|Analgesics|analgesics|mesh-ancestor
1871303|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
1871304|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871305|NCT00158223|Pimozide|pimozide|mesh-list
1871306|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1871307|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1871308|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871309|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871310|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871311|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1871312|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
1871313|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871314|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871315|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1871316|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1871317|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
1871318|NCT00158262|Propranolol|propranolol|mesh-list
1871319|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1871320|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1871321|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
1871322|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871323|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871324|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871325|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1871326|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1871327|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
1871328|NCT00158379|Paclitaxel|paclitaxel|mesh-list
1871329|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1871330|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871331|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
1871332|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
1871333|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
1871334|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871335|NCT00158743|Digoxin|digoxin|mesh-list
1871336|NCT00158743|Antibodies|antibodies|mesh-list
1871337|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
1871338|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
1871339|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871340|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1871341|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1871342|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871343|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871344|NCT00158743|Protective Agents|protective agents|mesh-ancestor
1871345|NCT00158756|Vaccines|vaccines|mesh-list
1871346|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
1871347|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871348|NCT00158860|Valacyclovir|valacyclovir|mesh-list
1871349|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
1871350|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871351|NCT00159263|Budesonide|budesonide|mesh-list
1871352|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
1871353|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871354|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1871355|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
1871356|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871357|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871358|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1871359|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
1871361|NCT00159263|Hormones|hormones|mesh-ancestor
1871362|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871363|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1871364|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1871365|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1871366|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
1871367|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871368|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871369|NCT00159419|Alendronate|alendronate|mesh-list
1871370|NCT00159419|Pamidronate|pamidronate|mesh-list
1871371|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1871372|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871373|NCT00159432|Bevacizumab|bevacizumab|mesh-list
1871374|NCT00159432|Capecitabine|capecitabine|mesh-list
1871375|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
1871376|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871377|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871378|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1871379|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1871380|NCT00159432|Growth Substances|growth substances|mesh-ancestor
1871381|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871382|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
1871383|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1871384|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
1871385|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871386|NCT00159783|Olanzapine|olanzapine|mesh-list
1871387|NCT00159783|Asenapine|asenapine|mesh-list
1871388|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
1871389|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
1871390|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871391|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871392|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871393|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1871394|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1871395|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871396|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871397|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1871398|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1871399|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871400|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871401|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871402|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
1871403|NCT00159822|Voriconazole|voriconazole|mesh-list
1871404|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
1871405|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871406|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1871407|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1871408|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871409|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871410|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1871411|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
1871412|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871413|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871414|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1871415|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
1871416|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871417|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
1871418|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1871419|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1871420|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871421|NCT00159861|Urological Agents|urological agents|mesh-ancestor
1871422|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
1871423|NCT00159874|Citric Acid|citric acid|mesh-list
1871424|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
1871425|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
1871426|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1871427|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
1871428|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
1871429|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871430|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
1871431|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1871432|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1871433|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871434|NCT00159874|Urological Agents|urological agents|mesh-ancestor
1871435|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
1871436|NCT00159913|Citric Acid|citric acid|mesh-list
1871437|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
1871438|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
1871439|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1871440|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
1871441|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
1871442|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871443|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
1871444|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1871445|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1871446|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871447|NCT00159913|Urological Agents|urological agents|mesh-ancestor
1871448|NCT00159965|Sertraline|sertraline|mesh-list
1871449|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
1871450|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871451|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1871452|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1871453|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871454|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871455|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871456|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
1871457|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871458|NCT00160199|Progesterone|progesterone|mesh-list
1871459|NCT00160199|Progestins|progestins|mesh-ancestor
1871460|NCT00160199|Hormones|hormones|mesh-ancestor
1871461|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871462|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871463|NCT00160251|Ribavirin|ribavirin|mesh-list
1871464|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1871465|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
1871466|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871467|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
1871468|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871469|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
1871470|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871471|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
1871472|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871473|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871474|NCT00160615|Levetiracetam|levetiracetam|mesh-list
1871475|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
1871476|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
1871477|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
1871478|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871479|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
1871480|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871481|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871482|NCT00160654|Levetiracetam|levetiracetam|mesh-list
1871483|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
1871484|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
1871485|NCT00160667|Brivaracetam|brivaracetam|mesh-list
1871486|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
1871487|NCT00160680|Levocetirizine|levocetirizine|mesh-list
1871488|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1871489|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1871490|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
1871491|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
1871492|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871493|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871494|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871495|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
1871496|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871497|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
1871498|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871499|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871500|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
1871501|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871502|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
1871503|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871504|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871505|NCT00161213|Gemcitabine|gemcitabine|mesh-list
1871506|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
1871507|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1871508|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
1871509|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871510|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871511|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
1871512|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871513|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871514|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871515|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
1871516|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871517|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1871518|NCT00161473|Prazosin|prazosin|mesh-list
1871519|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1871520|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1871521|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1871522|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1871523|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
1871524|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871525|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871526|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871527|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
1871528|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1871529|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871530|NCT00162097|Efavirenz|efavirenz|mesh-list
1871531|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1871532|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1871533|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1871534|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871535|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871536|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
1871537|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871538|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1871539|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1871540|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1871541|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1871542|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1871543|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1871544|NCT00162123|Ipilimumab|ipilimumab|mesh-list
1871545|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871546|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871547|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1871548|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871549|NCT00162266|Abatacept|abatacept|mesh-list
1871550|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1871551|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871552|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871553|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871554|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
1871555|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871556|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871557|NCT00162981|Clobazam|clobazam|mesh-list
1871558|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
1871559|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1871560|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1871561|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871562|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871563|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871564|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1871565|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
1871566|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
1871567|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871568|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871569|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1871570|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1871571|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1871572|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
1871573|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871574|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871575|NCT00163020|Progestins|progestins|mesh-ancestor
1871576|NCT00163020|Hormones|hormones|mesh-ancestor
1871577|NCT00163293|Ciclesonide|ciclesonide|mesh-list
1871578|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
1871579|NCT00163293|Hormones|hormones|mesh-ancestor
1871580|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871581|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871582|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1871583|NCT00163657|Cyclosporine|cyclosporine|mesh-list
1871584|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
1871585|NCT00163657|Tacrolimus|tacrolimus|mesh-list
1871586|NCT00163657|Cyclosporins|cyclosporins|mesh-list
1871587|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871588|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
1871589|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871590|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1871591|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871592|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871593|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
1871594|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871595|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871596|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871597|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1871598|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871599|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1871600|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
1871601|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1871602|NCT00165646|Rabeprazole|rabeprazole|mesh-list
1871603|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1871604|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871605|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1871606|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871607|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871608|NCT00165672|Rabeprazole|rabeprazole|mesh-list
1871609|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1871610|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871611|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1871612|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871613|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871614|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
1871615|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
1871616|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1871617|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871618|NCT00165698|Vitamins|vitamins|mesh-ancestor
1871619|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
1871620|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
1871621|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
1871622|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1871623|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1871624|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1871625|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871626|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871627|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871628|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871629|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871630|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1871631|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871632|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1871633|NCT00165841|Rabeprazole|rabeprazole|mesh-list
1871634|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1871635|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871636|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1871637|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871638|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871639|NCT00166036|Atorvastatin|atorvastatin|mesh-list
1871640|NCT00166036|Pravastatin|pravastatin|mesh-list
1871641|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1871642|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1871643|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
1871644|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871645|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1871646|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1871647|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871648|NCT00166114|Citalopram|citalopram|mesh-list
1871649|NCT00166114|Desipramine|desipramine|mesh-list
1871650|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1871651|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1871652|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871653|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871654|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871655|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
1871656|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871732|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1871657|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1871658|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
1871659|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871660|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1871661|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871662|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1871663|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
1871664|NCT00166166|Fluconazole|fluconazole|mesh-list
1871665|NCT00166166|Nitroprusside|nitroprusside|mesh-list
1871666|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
1871667|NCT00166166|Acetylcholine|acetylcholine|mesh-list
1871668|NCT00166166|Bradykinin|bradykinin|mesh-list
1871669|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
1871670|NCT00166166|Kininogens|kininogens|mesh-list
1871671|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
1871672|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871673|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1871674|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1871675|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871676|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871677|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1871678|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
1871679|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871680|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871681|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1871682|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1871683|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1871684|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
1871685|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1871686|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1871687|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871688|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871689|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1871690|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871691|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1871692|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871693|NCT00166296|Citalopram|citalopram|mesh-list
1871694|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1871695|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1871696|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871697|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871698|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871699|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
1871700|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871701|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1871702|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
1871703|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871704|NCT00166439|Cytarabine|cytarabine|mesh-list
1871705|NCT00166439|Dexamethasone|dexamethasone|mesh-list
1871706|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
1871707|NCT00166439|Rituximab|rituximab|mesh-list
1871708|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871709|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
1871710|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
1871711|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871712|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871713|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871714|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
1871715|NCT00166439|Hormones|hormones|mesh-ancestor
1871716|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871717|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871718|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871719|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871720|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
1871721|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871722|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1871723|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
1871724|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871725|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
1871726|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871727|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871728|NCT00166504|Atorvastatin|atorvastatin|mesh-list
1871729|NCT00166504|Simvastatin|simvastatin|mesh-list
1871730|NCT00166504|Ezetimibe|ezetimibe|mesh-list
1871731|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1871733|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
1871734|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871735|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1871736|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1871737|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871738|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
1871739|NCT00166712|Sirolimus|sirolimus|mesh-list
1871740|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
1871741|NCT00166712|Tacrolimus|tacrolimus|mesh-list
1871742|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871743|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
1871744|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871745|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1871746|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871747|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871748|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1871749|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871750|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1871751|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
1871752|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1871753|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1871754|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
1871755|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871756|NCT00167102|Alefacept|alefacept|mesh-list
1871757|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
1871758|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
1871759|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871760|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
1871761|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871762|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
1871763|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871764|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871765|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1871766|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
1871767|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871768|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871769|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1871770|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
1871771|NCT00167206|Fludarabine|fludarabine|mesh-list
1871772|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871773|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
1871774|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871775|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871776|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1871777|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
1871778|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871779|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871780|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1871781|NCT00167245|Topiramate|topiramate|mesh-list
1871782|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
1871783|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1871784|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871785|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
1871786|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871787|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
1871788|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871789|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871790|NCT00167934|Valproic Acid|valproic acid|mesh-list
1871791|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
1871792|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871793|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871794|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
1871795|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871796|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871797|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
1871798|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1871799|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1871800|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1871801|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
1871802|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1871803|NCT00168038|Antibodies|antibodies|mesh-list
1871804|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
1871805|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871806|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
1871807|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1871808|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
1871809|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871810|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1871811|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871812|NCT00168103|Complement C1s|complement c1s|mesh-list
1871813|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1871814|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1871815|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
1871816|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871817|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1871818|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871819|NCT00168298|Dexamethasone|dexamethasone|mesh-list
1871820|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
1871821|NCT00168298|BB 1101|bb 1101|mesh-list
1871822|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871823|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
1871824|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
1871825|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871826|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871827|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871828|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
1871829|NCT00168298|Hormones|hormones|mesh-ancestor
1871830|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871831|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871832|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871833|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871834|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871835|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871836|NCT00168324|Dexamethasone|dexamethasone|mesh-list
1871837|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
1871838|NCT00168324|BB 1101|bb 1101|mesh-list
1871839|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871840|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
1871841|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
1871842|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871843|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871844|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871845|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
1871846|NCT00168324|Hormones|hormones|mesh-ancestor
1871847|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871848|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871849|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871850|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871851|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871852|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871853|NCT00168337|Dexamethasone|dexamethasone|mesh-list
1871854|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871855|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
1871856|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
1871857|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871858|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871859|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871860|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
1871861|NCT00168337|Hormones|hormones|mesh-ancestor
1871862|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871863|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871864|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871865|NCT00168389|Dexamethasone|dexamethasone|mesh-list
1871866|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1871867|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
1871868|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
1871869|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871870|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871871|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1871872|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
1871873|NCT00168389|Hormones|hormones|mesh-ancestor
1871874|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871875|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871876|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871877|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
1871878|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1871879|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1871880|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1871881|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871882|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871883|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871884|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871885|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871886|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1871887|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871888|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
1871889|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1871890|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1871891|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1871892|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871893|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871894|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871895|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871896|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871897|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1871898|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871899|NCT00168805|Enoxaparin|enoxaparin|mesh-list
1871900|NCT00168805|Dabigatran|dabigatran|mesh-list
1871901|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
1871902|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1871903|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1871904|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871905|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
1871906|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1871907|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871908|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871909|NCT00168818|Enoxaparin|enoxaparin|mesh-list
1871910|NCT00168818|Dabigatran|dabigatran|mesh-list
1871911|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
1871912|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1871913|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1871914|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871915|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
1871916|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1871917|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
1871918|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871919|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
1871920|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1871921|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
1871922|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871923|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871924|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1871925|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
1871926|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
1871927|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1871928|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871929|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871930|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871931|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
1871932|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1871933|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
1871934|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1871935|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871936|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1871937|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
1871938|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
1871939|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1871940|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
1871941|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1871942|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871943|NCT00169104|Trastuzumab|trastuzumab|mesh-list
1871944|NCT00169104|Vinorelbine|vinorelbine|mesh-list
1871945|NCT00169104|Lenograstim|lenograstim|mesh-list
1871946|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871947|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871948|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1871949|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
1871950|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871951|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1871952|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
1871953|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
1871954|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
1871955|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871956|NCT00170157|Ipilimumab|ipilimumab|mesh-list
1871957|NCT00170157|Leuprolide|leuprolide|mesh-list
1871958|NCT00170157|Goserelin|goserelin|mesh-list
1871959|NCT00170157|Bicalutamide|bicalutamide|mesh-list
1871960|NCT00170157|Flutamide|flutamide|mesh-list
1871961|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1871962|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871963|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1871964|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871965|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1871966|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
1871967|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1871968|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871969|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1871970|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
1871971|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
1871972|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1871973|NCT00170625|Topotecan|topotecan|mesh-list
1871974|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1871975|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1871976|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871977|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871978|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871979|NCT00170846|Everolimus|everolimus|mesh-list
1871980|NCT00170846|Azathioprine|azathioprine|mesh-list
1871981|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1871982|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1871983|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1871984|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
1871985|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1871986|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1871987|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871988|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
1871989|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1871990|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1871991|NCT00170950|Amlodipine|amlodipine|mesh-list
1871992|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1871993|NCT00170950|Benazepril|benazepril|mesh-list
1871994|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1871995|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1871996|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1871997|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1871998|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1871999|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872000|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
1872001|NCT00170950|Diuretics|diuretics|mesh-ancestor
1872002|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
1872003|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1872004|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1872005|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
1872006|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872007|NCT00171054|Amlodipine|amlodipine|mesh-list
1872008|NCT00171054|Valsartan|valsartan|mesh-list
1872009|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1872010|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1872011|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1872012|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872013|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872014|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1872015|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872016|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
1872017|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1872018|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1872019|NCT00171054|Diuretics|diuretics|mesh-ancestor
1872020|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
1872021|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1872022|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
1872023|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872024|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1872025|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872026|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872027|NCT00171210|Deferasirox|deferasirox|mesh-list
1872028|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1872029|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
1872030|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
1872031|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872032|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
1872033|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872034|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1872035|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872036|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872037|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
1872038|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872039|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1872040|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872041|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872042|NCT00171301|Deferasirox|deferasirox|mesh-list
1872043|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1872044|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
1872045|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
1872046|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872047|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
1872048|NCT00171314|Letrozole|letrozole|mesh-list
1872049|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872050|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1872051|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1872052|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872053|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872054|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1872055|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
1872056|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872057|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872058|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1872059|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
1872060|NCT00171340|Letrozole|letrozole|mesh-list
1872061|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872062|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1872063|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1872064|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872065|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872066|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1872067|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
1872068|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872069|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872070|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1872071|NCT00171704|Tamoxifen|tamoxifen|mesh-list
1872072|NCT00171704|Letrozole|letrozole|mesh-list
1872073|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872074|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1872075|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1872076|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872077|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872078|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1872079|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
1872080|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872081|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872082|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1872083|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1872084|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1872085|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1872086|NCT00171730|Pasireotide|pasireotide|mesh-list
1872087|NCT00171730|Hormones|hormones|mesh-ancestor
1872088|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872089|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872090|NCT00171834|Epothilones|epothilones|mesh-list
1872091|NCT00171834|Epothilone B|epothilone b|mesh-list
1872092|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872093|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872094|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872095|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872096|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872097|NCT00171873|Octreotide|octreotide|mesh-list
1872098|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872099|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1872100|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872101|NCT00171925|Vitamin D|vitamin d|mesh-list
1872102|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
1872103|NCT00171925|Calcium|calcium|mesh-list
1872104|NCT00171925|Vitamins|vitamins|mesh-ancestor
1872105|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
1872106|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872107|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1872108|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1872109|NCT00171951|Pasireotide|pasireotide|mesh-list
1872110|NCT00171951|Hormones|hormones|mesh-ancestor
1872111|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872112|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872113|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
1872114|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1872115|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872116|NCT00172185|Teduglutide|teduglutide|mesh-list
1872117|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872118|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1872119|NCT00172185|Protective Agents|protective agents|mesh-ancestor
1872120|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872121|NCT00174265|Olanzapine|olanzapine|mesh-list
1872122|NCT00174265|Asenapine|asenapine|mesh-list
1872123|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
1872124|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
1872125|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872126|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872127|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872128|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1872129|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872130|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872131|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872132|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872133|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872134|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872135|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872136|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872137|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
1872138|NCT00174382|Donepezil|donepezil|mesh-list
1872139|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1872140|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872141|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872142|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
1872143|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872144|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872145|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
1872146|NCT00174447|Ziprasidone|ziprasidone|mesh-list
1872147|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1872148|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
1872149|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872150|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872151|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872152|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1872153|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872154|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872155|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872156|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1872157|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
1872158|NCT00174785|Dronedarone|dronedarone|mesh-list
1872159|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1872160|NCT00174915|Allopurinol|allopurinol|mesh-list
1872161|NCT00174915|Febuxostat|febuxostat|mesh-list
1872162|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
1872163|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872164|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872165|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
1872166|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872167|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1872168|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
1872169|NCT00174915|Protective Agents|protective agents|mesh-ancestor
1872170|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872171|NCT00174941|Febuxostat|febuxostat|mesh-list
1872172|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
1872173|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872174|NCT00174967|Febuxostat|febuxostat|mesh-list
1872175|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
1872176|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872177|NCT00175019|Allopurinol|allopurinol|mesh-list
1872178|NCT00175019|Febuxostat|febuxostat|mesh-list
1872179|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
1872180|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872181|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872182|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
1872183|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872184|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1872185|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
1872186|NCT00175019|Protective Agents|protective agents|mesh-ancestor
1872187|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872188|NCT00175825|Brivaracetam|brivaracetam|mesh-list
1872189|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
1872190|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
1872191|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872192|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
1872193|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872194|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872195|NCT00175916|Brivaracetam|brivaracetam|mesh-list
1872196|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
1872197|NCT00176202|Valproic Acid|valproic acid|mesh-list
1872198|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
1872199|NCT00176202|Risperidone|risperidone|mesh-list
1872200|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
1872201|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1872202|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
1872203|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872204|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872205|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872206|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872207|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872208|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872209|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1872210|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
1872211|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872212|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
1872213|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
1872214|NCT00176228|Lamotrigine|lamotrigine|mesh-list
1872215|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
1872216|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1872217|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872218|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872219|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1872220|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872221|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1872222|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872223|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872224|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872225|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1872226|NCT00176254|Paclitaxel|paclitaxel|mesh-list
1872227|NCT00176254|Carboplatin|carboplatin|mesh-list
1872228|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1872229|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872230|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872231|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872232|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872233|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872234|NCT00176306|Levofloxacin|levofloxacin|mesh-list
1872235|NCT00176306|Ofloxacin|ofloxacin|mesh-list
1872236|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1872237|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872238|NCT00176306|Renal Agents|renal agents|mesh-ancestor
1872239|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1872240|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1872241|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1872242|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872243|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872244|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872245|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1872246|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1872247|NCT00176423|Galantamine|galantamine|mesh-list
1872248|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1872249|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872250|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872251|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
1872252|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872253|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872254|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1872255|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
1872256|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872257|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
1872258|NCT00176462|Leucovorin|leucovorin|mesh-list
1872259|NCT00176462|Cytarabine|cytarabine|mesh-list
1872260|NCT00176462|Dexamethasone|dexamethasone|mesh-list
1872261|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
1872262|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
1872263|NCT00176462|Methotrexate|methotrexate|mesh-list
1872264|NCT00176462|Vincristine|vincristine|mesh-list
1872265|NCT00176462|Asparaginase|asparaginase|mesh-list
1872266|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
1872267|NCT00176462|Thioguanine|thioguanine|mesh-list
1872268|NCT00176462|Daunorubicin|daunorubicin|mesh-list
1872269|NCT00176462|Aminopterin|aminopterin|mesh-list
1872270|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872271|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
1872272|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872273|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872274|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872275|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
1872276|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872277|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872278|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872279|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1872280|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
1872281|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
1872282|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872283|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872284|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
1872285|NCT00176462|Hormones|hormones|mesh-ancestor
1872286|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872287|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1872288|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1872289|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
1872290|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1872291|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1872292|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
1872293|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
1872294|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872295|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1872296|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1872297|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
1872298|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872299|NCT00176462|Antidotes|antidotes|mesh-ancestor
1872300|NCT00176462|Protective Agents|protective agents|mesh-ancestor
1872301|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
1872302|NCT00176462|Vitamins|vitamins|mesh-ancestor
1872303|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
1872304|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1872305|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872306|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872307|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872308|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1872309|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1872310|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1872311|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
1872312|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
1872313|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
1872314|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1872315|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
1872316|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872317|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872318|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872319|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
1872320|NCT00176605|Etoposide|etoposide|mesh-list
1872321|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872322|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
1872323|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872324|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872325|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872326|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
1872327|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872328|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872329|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872330|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1872331|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1872332|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1872333|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872334|NCT00176644|Estradiol|estradiol|mesh-list
1872335|NCT00176644|Estrogens|estrogens|mesh-ancestor
1872336|NCT00176644|Hormones|hormones|mesh-ancestor
1872337|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872338|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872339|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
1872340|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
1872341|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
1872342|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872343|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872344|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1872345|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1872346|NCT00176800|Growth Substances|growth substances|mesh-ancestor
1872347|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872348|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
1872349|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872350|NCT00176826|Busulfan|busulfan|mesh-list
1872351|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
1872352|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872353|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872354|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
1872355|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872356|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872357|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872358|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872359|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
1872360|NCT00176839|Melphalan|melphalan|mesh-list
1872361|NCT00176839|Busulfan|busulfan|mesh-list
1872362|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1872363|NCT00176839|Lenograstim|lenograstim|mesh-list
1872364|NCT00176839|Sargramostim|sargramostim|mesh-list
1872365|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872366|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
1872367|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872368|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872369|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872370|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
1872371|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872372|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872373|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872374|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1872375|NCT00176852|Vidarabine|vidarabine|mesh-list
1872376|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
1872377|NCT00176852|Busulfan|busulfan|mesh-list
1872378|NCT00176852|Fludarabine|fludarabine|mesh-list
1872379|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
1872380|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
1872381|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1872382|NCT00176852|Sargramostim|sargramostim|mesh-list
1872383|NCT00176852|Lenograstim|lenograstim|mesh-list
1872384|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872385|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
1872386|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872387|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872388|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872389|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
1872390|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872391|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872392|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872393|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1872394|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
1872395|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
1872396|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872397|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1872398|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1872399|NCT00176865|Cyclosporine|cyclosporine|mesh-list
1872400|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
1872401|NCT00176865|Fludarabine|fludarabine|mesh-list
1872402|NCT00176865|Melphalan|melphalan|mesh-list
1872403|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
1872404|NCT00176865|Cyclosporins|cyclosporins|mesh-list
1872405|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1872406|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
1872407|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1872408|NCT00176865|Antibodies|antibodies|mesh-list
1872409|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
1872410|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1872411|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872412|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872413|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872414|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
1872415|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872416|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872417|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
1872418|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872419|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
1872420|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872421|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1872422|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1872423|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1872424|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
1872425|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1872426|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872427|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
1872428|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872429|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1872430|NCT00176878|Fludarabine|fludarabine|mesh-list
1872431|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
1872432|NCT00176878|Busulfan|busulfan|mesh-list
1872433|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1872434|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872435|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1872436|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
1872437|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872438|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872439|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
1872440|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872441|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
1872442|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872443|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872444|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
1872445|NCT00176904|Busulfan|busulfan|mesh-list
1872446|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1872447|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872448|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
1872449|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872450|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872451|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872452|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
1872453|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872454|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872455|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872456|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
1872457|NCT00176917|Busulfan|busulfan|mesh-list
1872458|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
1872459|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872460|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
1872461|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872462|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872463|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872464|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
1872465|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872466|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872467|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872468|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
1872469|NCT00176930|Busulfan|busulfan|mesh-list
1872470|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872471|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
1872472|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872473|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872474|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872475|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
1872476|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872477|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872478|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872479|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
1872480|NCT00177047|Melphalan|melphalan|mesh-list
1872481|NCT00177047|Sargramostim|sargramostim|mesh-list
1872482|NCT00177047|Lenograstim|lenograstim|mesh-list
1872483|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872484|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
1872485|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872486|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872487|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872488|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
1872788|NCT00180674|Warfarin|warfarin|mesh-list
1872489|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872490|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872491|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872492|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1872493|NCT00177164|Olanzapine|olanzapine|mesh-list
1872494|NCT00177164|Risperidone|risperidone|mesh-list
1872495|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1872496|NCT00177164|Aripiprazole|aripiprazole|mesh-list
1872497|NCT00177164|Ziprasidone|ziprasidone|mesh-list
1872498|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
1872499|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1872500|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
1872501|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872502|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872503|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872504|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872505|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872506|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872507|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1872508|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
1872509|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
1872510|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
1872511|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872512|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872513|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872514|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872515|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872516|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872517|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
1872518|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1872519|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1872520|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1872521|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1872522|NCT00177216|Zolpidem|zolpidem|mesh-list
1872523|NCT00177216|Citalopram|citalopram|mesh-list
1872524|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872525|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872526|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872527|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872528|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872529|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
1872530|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872531|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1872532|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872533|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872534|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1872535|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1872536|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872537|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1872538|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
1872539|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
1872540|NCT00177255|Docetaxel|docetaxel|mesh-list
1872541|NCT00177255|Capecitabine|capecitabine|mesh-list
1872542|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872543|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872544|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872545|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872546|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872547|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1872548|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
1872549|NCT00177294|Citalopram|citalopram|mesh-list
1872550|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872551|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872552|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872553|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872554|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872555|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
1872556|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872557|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1872558|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872559|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872560|NCT00177307|Bevacizumab|bevacizumab|mesh-list
1872561|NCT00177307|Capecitabine|capecitabine|mesh-list
1872562|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
1872563|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1872564|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872565|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1872566|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1872567|NCT00177307|Growth Substances|growth substances|mesh-ancestor
1872568|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872569|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
1872570|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1872571|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
1872572|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872573|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1872574|NCT00177671|Donepezil|donepezil|mesh-list
1872575|NCT00177671|Citalopram|citalopram|mesh-list
1872576|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1872577|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872578|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872579|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872580|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872581|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872582|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
1872583|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872584|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1872585|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872586|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872587|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872588|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
1872589|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1872590|NCT00177671|Analgesics|analgesics|mesh-ancestor
1872591|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
1872592|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
1872593|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1872594|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872595|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
1872596|NCT00178178|Bupivacaine|bupivacaine|mesh-list
1872597|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
1872598|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
1872599|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872600|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872601|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
1872602|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872603|NCT00178256|Paclitaxel|paclitaxel|mesh-list
1872604|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1872605|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872606|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872607|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872608|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872609|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872610|NCT00178464|Aspirin|aspirin|mesh-list
1872611|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1872612|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1872613|NCT00178464|Analgesics|analgesics|mesh-ancestor
1872614|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
1872615|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872616|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872617|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1872618|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872619|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1872620|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1872621|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872622|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1872623|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1872624|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872625|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
1872626|NCT00178503|Methylphenidate|methylphenidate|mesh-list
1872627|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1872628|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872629|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1872630|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872631|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872632|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872633|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
1872634|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872635|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
1872636|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1872637|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1872638|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1872639|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872640|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872641|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
1872642|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872643|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872644|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1872645|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872646|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
1872647|NCT00178841|Bexarotene|bexarotene|mesh-list
1872648|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1872649|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872650|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872651|NCT00178919|Trimethaphan|trimethaphan|mesh-list
1872652|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
1872653|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872654|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1872655|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1872656|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1872657|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
1872658|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872659|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872660|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1872661|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1872662|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
1872663|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872664|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
1872665|NCT00179010|Adenosine|adenosine|mesh-list
1872666|NCT00179010|Analgesics|analgesics|mesh-ancestor
1872667|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
1872668|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872669|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872670|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1872671|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
1872672|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1872673|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
1872674|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
1872675|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872676|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872677|NCT00179309|Docetaxel|docetaxel|mesh-list
1872678|NCT00179309|Sargramostim|sargramostim|mesh-list
1872679|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872680|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872681|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872682|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872683|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872684|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
1872685|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872686|NCT00179413|Interferons|interferons|mesh-list
1872687|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
1872688|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
1872689|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1872690|NCT00179413|Colchicine|colchicine|mesh-list
1872691|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872692|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
1872693|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872694|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
1872695|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872696|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
1872697|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872698|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872699|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872700|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872701|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872702|NCT00179478|Interferons|interferons|mesh-list
1872703|NCT00179478|Interferon-beta|interferon-beta|mesh-list
1872704|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
1872705|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872706|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
1872707|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872708|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
1872709|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872710|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1872711|NCT00179517|Anastrozole|anastrozole|mesh-list
1872789|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
1872712|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1872713|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872714|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1872715|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1872716|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872717|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872718|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1872719|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
1872720|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872721|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872722|NCT00179621|Lenalidomide|lenalidomide|mesh-list
1872723|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
1872724|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872725|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1872726|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1872727|NCT00179621|Growth Substances|growth substances|mesh-ancestor
1872728|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
1872729|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872730|NCT00179647|Dexamethasone|dexamethasone|mesh-list
1872731|NCT00179647|Lenalidomide|lenalidomide|mesh-list
1872732|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1872733|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
1872734|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
1872735|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872736|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872737|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872738|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
1872739|NCT00179647|Hormones|hormones|mesh-ancestor
1872740|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872741|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1872742|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872743|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
1872744|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1872745|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1872746|NCT00179647|Growth Substances|growth substances|mesh-ancestor
1872747|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
1872748|NCT00179660|Lenalidomide|lenalidomide|mesh-list
1872749|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
1872750|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872751|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1872752|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1872753|NCT00179660|Growth Substances|growth substances|mesh-ancestor
1872754|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
1872755|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872756|NCT00179673|Lenalidomide|lenalidomide|mesh-list
1872757|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
1872758|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872759|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1872760|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1872761|NCT00179673|Growth Substances|growth substances|mesh-ancestor
1872762|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
1872763|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872764|NCT00179959|Mupirocin|mupirocin|mesh-list
1872765|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
1872766|NCT00179959|Eusol|eusol|mesh-list
1872767|NCT00179959|Petrolatum|petrolatum|mesh-list
1872768|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1872769|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872770|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1872771|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872772|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872773|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
1872774|NCT00179959|Emollients|emollients|mesh-ancestor
1872775|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
1872776|NCT00180479|Paclitaxel|paclitaxel|mesh-list
1872777|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1872778|NCT00180479|Everolimus|everolimus|mesh-list
1872779|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1872780|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872781|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872782|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872783|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872784|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872785|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872786|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
1872787|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872790|NCT00180687|Bupivacaine|bupivacaine|mesh-list
1872791|NCT00180687|Coal Tar|coal tar|mesh-list
1872792|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
1872793|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
1872794|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872795|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872796|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
1872797|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872798|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
1872799|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
1872800|NCT00180713|Simvastatin|simvastatin|mesh-list
1872801|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1872802|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1872803|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
1872804|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872805|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1872806|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1872807|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872808|NCT00181155|Allopurinol|allopurinol|mesh-list
1872809|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
1872810|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872811|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872812|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
1872813|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872814|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1872815|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
1872816|NCT00181155|Protective Agents|protective agents|mesh-ancestor
1872817|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872818|NCT00181714|Methylphenidate|methylphenidate|mesh-list
1872819|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1872820|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872821|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1872822|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872823|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872824|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872825|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
1872826|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872827|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1872828|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1872829|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872830|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872831|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872832|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
1872833|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872834|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872835|NCT00181844|Lamotrigine|lamotrigine|mesh-list
1872836|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
1872837|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1872838|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872839|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872840|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1872841|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872842|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1872843|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872844|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872845|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872846|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1872847|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1872848|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872849|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872850|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1872851|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872852|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872853|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872854|NCT00182000|Cycloserine|cycloserine|mesh-list
1872855|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1872856|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872857|NCT00182000|Renal Agents|renal agents|mesh-ancestor
1872858|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1872859|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
1872860|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1872861|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
1872862|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872863|NCT00182078|Sertraline|sertraline|mesh-list
1872864|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872865|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872866|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872867|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872868|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872869|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872870|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872871|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
1872872|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872873|NCT00182091|Hormones|hormones|mesh-list
1872874|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1872875|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872876|NCT00182689|Sorafenib|sorafenib|mesh-list
1872877|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872878|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1872879|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872880|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872881|NCT00182754|Octreotide|octreotide|mesh-list
1872882|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1872883|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1872884|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872885|NCT00182767|Doxorubicin|doxorubicin|mesh-list
1872886|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1872887|NCT00182767|Epothilone B|epothilone b|mesh-list
1872888|NCT00182767|Epothilones|epothilones|mesh-list
1872889|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1872890|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872891|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1872892|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1872893|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872894|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872895|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
1872896|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
1872897|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
1872898|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
1872899|NCT00182793|Melphalan|melphalan|mesh-list
1872900|NCT00182793|Thiotepa|thiotepa|mesh-list
1872901|NCT00182793|Carboplatin|carboplatin|mesh-list
1872902|NCT00182793|Trastuzumab|trastuzumab|mesh-list
1872903|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872904|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
1872905|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872906|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1872907|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1872908|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
1872909|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872910|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872911|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1872912|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1872913|NCT00183092|Quinacrine|quinacrine|mesh-list
1872914|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
1872915|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1872916|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
1872917|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1872918|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872919|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
1872920|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1872921|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
1872922|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872923|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872924|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872925|NCT00183196|Naltrexone|naltrexone|mesh-list
1872926|NCT00183196|Gabapentin|gabapentin|mesh-list
1872927|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1872928|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1872929|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872930|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
1872931|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872932|NCT00183196|Analgesics|analgesics|mesh-ancestor
1872933|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
1872934|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1872935|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1872936|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1872937|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872938|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1872939|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1872940|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872941|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872942|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
1872943|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
1872944|NCT00183248|Sirolimus|sirolimus|mesh-list
1872945|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
1872946|NCT00183248|Tacrolimus|tacrolimus|mesh-list
1872947|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1872948|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
1872949|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872950|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1872951|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872952|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872953|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1872954|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1872955|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1872956|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
1872957|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1872958|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1872959|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
1872960|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1872961|NCT00183274|Norepinephrine|norepinephrine|mesh-list
1872962|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1872963|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
1872964|NCT00183274|Serotonin|serotonin|mesh-list
1872965|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872966|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872967|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872968|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872969|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872970|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1872971|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872972|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872973|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1872974|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1872975|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
1872976|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
1872977|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
1872978|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1872979|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1872980|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1872981|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
1872982|NCT00183339|Fluoxetine|fluoxetine|mesh-list
1872983|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1872984|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1872985|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1872986|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1872987|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1872988|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
1872989|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1872990|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1872991|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
1872992|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1872993|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1872994|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1872995|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1872996|NCT00183391|Methylphenidate|methylphenidate|mesh-list
1872997|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1872998|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1872999|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873000|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1873001|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873002|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873003|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873004|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
1873005|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873006|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1873007|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
1873008|NCT00183430|Prazosin|prazosin|mesh-list
1873009|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1873010|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1873011|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1873012|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1873013|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
1873014|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873015|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873016|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873017|NCT00183443|Valproic Acid|valproic acid|mesh-list
1873018|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1873019|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
1873020|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873021|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1873022|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873023|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873024|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873025|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873026|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873027|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
1873028|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
1873029|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
1873030|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873031|NCT00183469|Lamotrigine|lamotrigine|mesh-list
1873032|NCT00183469|Valproic Acid|valproic acid|mesh-list
1873033|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
1873034|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1873035|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873036|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873037|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1873038|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873039|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1873040|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873041|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873042|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873043|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1873044|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873045|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
1873046|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873047|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
1873048|NCT00183625|Olanzapine|olanzapine|mesh-list
1873049|NCT00183625|Risperidone|risperidone|mesh-list
1873050|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1873051|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
1873052|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873053|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873054|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873055|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1873056|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873057|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873058|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873059|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1873060|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
1873061|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
1873062|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
1873063|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873064|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873065|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1873066|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873067|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873068|NCT00183677|Citalopram|citalopram|mesh-list
1873069|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1873070|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873071|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873072|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873073|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873074|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
1873075|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873076|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1873077|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
1873078|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873079|NCT00183729|Memantine|memantine|mesh-list
1873080|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1873081|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1873082|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
1873083|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873084|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873085|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873086|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1873087|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1873088|NCT00183794|Gemcitabine|gemcitabine|mesh-list
1873089|NCT00183794|Docetaxel|docetaxel|mesh-list
1873090|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873091|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
1873092|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873093|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873094|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
1873095|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873096|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873097|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873098|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
1873099|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873100|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873101|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873102|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873103|NCT00183872|Docetaxel|docetaxel|mesh-list
1873104|NCT00183872|Irinotecan|irinotecan|mesh-list
1873105|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873106|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873107|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873108|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873109|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873110|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1873111|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1873112|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873113|NCT00184002|Prednisone|prednisone|mesh-list
1873114|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
1873115|NCT00184002|Doxorubicin|doxorubicin|mesh-list
1873116|NCT00184002|Vincristine|vincristine|mesh-list
1873117|NCT00184002|Rituximab|rituximab|mesh-list
1873118|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873119|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
1873120|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873121|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873122|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873123|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
1873124|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873125|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873126|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1873127|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873128|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1873129|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1873130|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873131|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1873132|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
1873133|NCT00184002|Hormones|hormones|mesh-ancestor
1873134|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873135|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1873136|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1873137|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873138|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873139|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873140|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1873141|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
1873142|NCT00184028|Docetaxel|docetaxel|mesh-list
1873143|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873144|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873145|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873146|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873147|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873148|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
1873149|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
1873150|NCT00184054|Vitamins|vitamins|mesh-ancestor
1873151|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
1873152|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873153|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
1873154|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873155|NCT00184054|Protective Agents|protective agents|mesh-ancestor
1873156|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873157|NCT00184093|Gemcitabine|gemcitabine|mesh-list
1873158|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873159|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
1873160|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873161|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873162|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
1873163|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873164|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873165|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873166|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
1873167|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873168|NCT00184600|Insulin|insulin|mesh-list
1873169|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1873170|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
1873171|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
1873172|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1873173|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
1873174|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
1873175|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1873176|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873177|NCT00185211|Interferons|interferons|mesh-list
1873178|NCT00185211|Interferon-beta|interferon-beta|mesh-list
1873179|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
1873180|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873181|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
1873182|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873183|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
1873184|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873185|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1873186|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
1873187|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1873188|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
1873189|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873190|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873191|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1873192|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1873193|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1873194|NCT00185588|Gemcitabine|gemcitabine|mesh-list
1873195|NCT00185588|Vatalanib|vatalanib|mesh-list
1873196|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873197|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
1873198|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873199|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873200|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
1873201|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873202|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873203|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873204|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
1873205|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873206|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1873207|NCT00185614|Cyclosporine|cyclosporine|mesh-list
1873208|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
1873209|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
1873210|NCT00185614|Melphalan|melphalan|mesh-list
1873211|NCT00185614|Cyclosporins|cyclosporins|mesh-list
1873212|NCT00185614|Lenograstim|lenograstim|mesh-list
1873213|NCT00185614|Sargramostim|sargramostim|mesh-list
1873214|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873215|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
1873216|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873217|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873218|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873219|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
1873220|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873221|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873222|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1873223|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1873224|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873225|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
1873226|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873227|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
1873228|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1873229|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873230|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1873231|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
1873232|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1873233|NCT00185640|Cyclosporine|cyclosporine|mesh-list
1873234|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
1873235|NCT00185640|Lenograstim|lenograstim|mesh-list
1873236|NCT00185640|Cyclosporins|cyclosporins|mesh-list
1873237|NCT00185640|Sargramostim|sargramostim|mesh-list
1873238|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
1873239|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1873240|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1873241|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
1873242|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873243|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873244|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873245|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873246|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
1873247|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873248|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
1873249|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873250|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1873251|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873252|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873253|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1873254|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
1873255|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1873256|NCT00185692|Acetaminophen|acetaminophen|mesh-list
1873257|NCT00185692|Cyclosporine|cyclosporine|mesh-list
1873258|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
1873259|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
1873260|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1873261|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1873262|NCT00185692|Prednisolone|prednisolone|mesh-list
1873263|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
1873264|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
1873265|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1873266|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1873267|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1873268|NCT00185692|Cyclosporins|cyclosporins|mesh-list
1873269|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1873270|NCT00185692|Lenograstim|lenograstim|mesh-list
1873271|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1873272|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
1873273|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873274|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873275|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873276|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
1873277|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873278|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
1873279|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873280|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
1873281|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873282|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1873283|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1873284|NCT00185692|Analgesics|analgesics|mesh-ancestor
1873285|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
1873286|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873287|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
1873288|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873289|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873290|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1873291|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
1873292|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1873293|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1873294|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
1873295|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
1873296|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873297|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
1873298|NCT00185692|Hormones|hormones|mesh-ancestor
1873299|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873300|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1873301|NCT00185692|Protective Agents|protective agents|mesh-ancestor
1873302|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1873303|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1873304|NCT00185731|Atorvastatin|atorvastatin|mesh-list
1873305|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1873306|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1873307|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
1873308|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873309|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1873310|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1873311|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873312|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
1873313|NCT00185900|Nifedipine|nifedipine|mesh-list
1873314|NCT00185900|Analgesics|analgesics|mesh-ancestor
1873315|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
1873619|NCT00187135|Analgesics|analgesics|mesh-ancestor
1873316|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873317|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873318|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
1873319|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873320|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1873321|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
1873322|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1873323|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873324|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873325|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1873326|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
1873327|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873328|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
1873329|NCT00186017|Olanzapine|olanzapine|mesh-list
1873330|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
1873331|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
1873332|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873333|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873334|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873335|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1873336|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873337|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873338|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873339|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1873340|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873341|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873342|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873343|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873344|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
1873345|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1873346|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
1873347|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873348|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1873349|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873350|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873351|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873352|NCT00186056|Mifepristone|mifepristone|mesh-list
1873353|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1873354|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
1873355|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873356|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873357|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1873358|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1873359|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1873360|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
1873361|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1873362|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1873363|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
1873364|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873365|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
1873366|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1873367|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1873368|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
1873369|NCT00186069|Analgesics|analgesics|mesh-ancestor
1873370|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
1873371|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873372|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873373|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
1873374|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873375|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1873376|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
1873377|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1873378|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873379|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873380|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1873381|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
1873382|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873383|NCT00186121|Anastrozole|anastrozole|mesh-list
1873384|NCT00186121|Goserelin|goserelin|mesh-list
1873385|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1873386|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873387|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1874221|NCT00193375|Bevacizumab|bevacizumab|mesh-list
1873388|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1873389|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873390|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873391|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1873392|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
1873393|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873394|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873395|NCT00186186|Valproic Acid|valproic acid|mesh-list
1873396|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
1873397|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873398|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873399|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
1873400|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873401|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873402|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
1873403|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873404|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873405|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873406|NCT00186446|Bupropion|bupropion|mesh-list
1873407|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1873408|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
1873409|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873410|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1873411|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873412|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873413|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873414|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
1873415|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873416|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873417|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1873418|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1873419|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873420|NCT00186498|Memantine|memantine|mesh-list
1873421|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1873422|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1873423|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
1873424|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873425|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873426|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873427|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1873428|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1873429|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
1873430|NCT00186537|Fenofibrate|fenofibrate|mesh-list
1873431|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1873432|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873433|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1873434|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
1873435|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873436|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1873437|NCT00186628|Acetaminophen|acetaminophen|mesh-list
1873438|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
1873439|NCT00186628|Promethazine|promethazine|mesh-list
1873440|NCT00186628|Cyclosporine|cyclosporine|mesh-list
1873441|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
1873442|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
1873443|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1873444|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1873445|NCT00186628|Prednisolone|prednisolone|mesh-list
1873446|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
1873447|NCT00186628|Rituximab|rituximab|mesh-list
1873448|NCT00186628|Granisetron|granisetron|mesh-list
1873449|NCT00186628|Lenograstim|lenograstim|mesh-list
1873450|NCT00186628|Cyclosporins|cyclosporins|mesh-list
1873451|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
1873452|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1873453|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1873454|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
1873455|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1873456|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873457|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
1873458|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873459|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873460|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1873461|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873462|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873463|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873464|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
1873465|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873466|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
1873467|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1873468|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1873469|NCT00186628|Analgesics|analgesics|mesh-ancestor
1873470|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
1873471|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873472|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
1873473|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1873474|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
1873475|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
1873476|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873477|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
1873478|NCT00186628|Hormones|hormones|mesh-ancestor
1873479|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873480|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1873481|NCT00186628|Protective Agents|protective agents|mesh-ancestor
1873482|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1873483|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1873484|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1873485|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873486|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
1873487|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
1873488|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1873489|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
1873490|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
1873491|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873492|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1873493|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
1873494|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1873495|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
1873496|NCT00186875|Cytarabine|cytarabine|mesh-list
1873497|NCT00186875|Dexamethasone|dexamethasone|mesh-list
1873498|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
1873499|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
1873500|NCT00186875|Methotrexate|methotrexate|mesh-list
1873501|NCT00186875|Etoposide|etoposide|mesh-list
1873502|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
1873503|NCT00186875|Vincristine|vincristine|mesh-list
1873504|NCT00186875|Asparaginase|asparaginase|mesh-list
1873505|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
1873506|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
1873507|NCT00186875|Vinblastine|vinblastine|mesh-list
1873508|NCT00186875|Pegaspargase|pegaspargase|mesh-list
1873509|NCT00186875|Teniposide|teniposide|mesh-list
1873510|NCT00186875|BB 1101|bb 1101|mesh-list
1873511|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873512|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
1873513|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873514|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873515|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873516|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
1873517|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873518|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873519|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1873520|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1873521|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
1873522|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
1873523|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873524|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873525|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
1873526|NCT00186875|Hormones|hormones|mesh-ancestor
1873527|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873528|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1873529|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
1873530|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873531|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1873532|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
1873533|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873534|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873535|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
1873536|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
1873537|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873538|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1873539|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1873540|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1873541|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1873542|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
1873543|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873544|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873545|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873546|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873547|NCT00186875|Analgesics|analgesics|mesh-ancestor
1873548|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
1873574|NCT00186901|Vitamin D|vitamin d|mesh-list
1873575|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
1873576|NCT00186901|Calcium|calcium|mesh-list
1873577|NCT00186901|Vitamins|vitamins|mesh-ancestor
1873578|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
1873579|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873580|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1873581|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1873582|NCT00186901|Antacids|antacids|mesh-ancestor
1873583|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873584|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873585|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
1873586|NCT00187096|Fludarabine|fludarabine|mesh-list
1873587|NCT00187096|Etoposide|etoposide|mesh-list
1873588|NCT00187096|Interleukin-2|interleukin-2|mesh-list
1873589|NCT00187096|Clofarabine|clofarabine|mesh-list
1873590|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873591|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
1873592|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873593|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873594|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873595|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
1873596|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873597|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873598|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1873599|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873600|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
1873601|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1873602|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1873603|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1873604|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873605|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1873606|NCT00187096|Analgesics|analgesics|mesh-ancestor
1873607|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
1873608|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873609|NCT00187135|Fentanyl|fentanyl|mesh-list
1873610|NCT00187135|Propofol|propofol|mesh-list
1873611|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1873612|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873613|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873614|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1873615|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
1873616|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
1873617|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1873618|NCT00187135|Narcotics|narcotics|mesh-ancestor
1873620|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
1873621|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873622|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1873623|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1873624|NCT00187486|Temozolomide|temozolomide|mesh-list
1873625|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873626|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1873627|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873628|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873629|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873630|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
1873631|NCT00187655|Cefotaxime|cefotaxime|mesh-list
1873632|NCT00187655|Cefoxitin|cefoxitin|mesh-list
1873633|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1873634|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873635|NCT00187681|Metformin|metformin|mesh-list
1873636|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1873637|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873638|NCT00187720|Metformin|metformin|mesh-list
1873639|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1873640|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873641|NCT00187889|Eplerenone|eplerenone|mesh-list
1873642|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1873643|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
1873644|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873645|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873646|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1873647|NCT00187889|Diuretics|diuretics|mesh-ancestor
1873648|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
1873649|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1873650|NCT00189098|Trimethoprim|trimethoprim|mesh-list
1873651|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1873652|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
1873653|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1873654|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873655|NCT00189098|Renal Agents|renal agents|mesh-ancestor
1873656|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
1873657|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1873658|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1873659|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873660|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873661|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873662|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1873663|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1873664|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1873665|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1873666|NCT00189137|Gemcitabine|gemcitabine|mesh-list
1873667|NCT00189137|Docetaxel|docetaxel|mesh-list
1873668|NCT00189137|Doxorubicin|doxorubicin|mesh-list
1873669|NCT00189137|Ifosfamide|ifosfamide|mesh-list
1873670|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873671|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
1873672|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873673|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873674|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
1873675|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873676|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873677|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873678|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
1873679|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873680|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873681|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873682|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873683|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873684|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1873685|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1873686|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873687|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
1873688|NCT00189202|Sirolimus|sirolimus|mesh-list
1873689|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1873690|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873691|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873692|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873693|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
1873694|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873695|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
1873696|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873697|NCT00189228|Omalizumab|omalizumab|mesh-list
1873698|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1873699|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1873700|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
1873701|NCT00189306|Imiquimod|imiquimod|mesh-list
1873702|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1873703|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
1873704|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873705|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873706|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
1873707|NCT00189436|Budesonide|budesonide|mesh-list
1873708|NCT00189436|Albuterol|albuterol|mesh-list
1873709|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1873710|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1873711|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
1873712|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873713|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873714|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1873715|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
1873716|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
1873717|NCT00189436|Hormones|hormones|mesh-ancestor
1873718|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873719|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
1873720|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873721|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1873722|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1873723|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1873724|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
1873725|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873726|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873727|NCT00189462|Montelukast|montelukast|mesh-list
1873728|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1873729|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
1873730|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1873731|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
1873732|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873733|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873734|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1873735|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1873736|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873737|NCT00189475|Montelukast|montelukast|mesh-list
1873738|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1873739|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
1873740|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1873741|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
1873742|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873743|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873744|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1873745|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1873746|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873747|NCT00189488|Methotrexate|methotrexate|mesh-list
1873748|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1873749|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
1873750|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873751|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873752|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873753|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
1873754|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873755|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873756|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
1873757|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873758|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873759|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873760|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
1873761|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873762|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1873763|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
1873764|NCT00190671|Pemetrexed|pemetrexed|mesh-list
1873765|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873766|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
1873767|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873768|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1873769|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1873770|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
1873771|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873772|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873773|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1873774|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873775|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873776|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1873777|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1873778|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1873779|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873780|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873781|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873782|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
1873783|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873784|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873785|NCT00190749|Olanzapine|olanzapine|mesh-list
1873786|NCT00190749|Risperidone|risperidone|mesh-list
1873787|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1873788|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
1873789|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873790|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873791|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873792|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1873793|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1873794|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1873795|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1873796|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1873797|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
1873798|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
1873799|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
1873800|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1873801|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1873802|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1873803|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873804|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873805|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1873806|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1873807|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873808|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873809|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873810|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
1873811|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873812|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873813|NCT00190983|Pemetrexed|pemetrexed|mesh-list
1873814|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873815|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873816|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873817|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873818|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1873819|NCT00191100|Gemcitabine|gemcitabine|mesh-list
1873820|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873821|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873822|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
1873823|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873824|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
1873825|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873826|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873827|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873828|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
1873829|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873830|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1873831|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1873832|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
1873833|NCT00191113|Estradiol|estradiol|mesh-list
1873834|NCT00191113|Hormones|hormones|mesh-ancestor
1873835|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1873836|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873837|NCT00191113|Estrogens|estrogens|mesh-ancestor
1873838|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1873839|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
1873840|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1873841|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1873842|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1873843|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1873844|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1873845|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1873846|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1873847|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873848|NCT00191139|Gemcitabine|gemcitabine|mesh-list
1873849|NCT00191139|Cisplatin|cisplatin|mesh-list
1873850|NCT00191139|Docetaxel|docetaxel|mesh-list
1873851|NCT00191139|Etoposide|etoposide|mesh-list
1873852|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
1873853|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873854|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873855|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
1873856|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873857|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
1873858|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873859|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873860|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873861|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
1873862|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873863|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873864|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873865|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873866|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1873867|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1873868|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1873869|NCT00191152|Gemcitabine|gemcitabine|mesh-list
1873870|NCT00191152|Capecitabine|capecitabine|mesh-list
1873871|NCT00191152|Docetaxel|docetaxel|mesh-list
1873872|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873873|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
1873874|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873875|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873876|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
1873877|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873878|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873879|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873880|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
1873881|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873882|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873883|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873884|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873885|NCT00191191|Pemetrexed|pemetrexed|mesh-list
1873886|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873887|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873888|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873889|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873890|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1873891|NCT00191269|Gemcitabine|gemcitabine|mesh-list
1873892|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873893|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
1873894|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873895|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873896|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
1873897|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873898|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873899|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873900|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
1873901|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873902|NCT00191282|Insulin|insulin|mesh-list
1873903|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1873904|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
1873905|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
1873906|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
1873907|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
1873908|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
1873909|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1873910|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873911|NCT00191308|Pemetrexed|pemetrexed|mesh-list
1873912|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873913|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873914|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873915|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1873916|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1873917|NCT00191334|Gemcitabine|gemcitabine|mesh-list
1873918|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873919|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873920|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
1873921|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873922|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
1873923|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873924|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873925|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873926|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
1873927|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873928|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1873929|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1873930|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1873931|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1873932|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873933|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
1873934|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1873935|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873936|NCT00191451|Gemcitabine|gemcitabine|mesh-list
1873937|NCT00191451|Carboplatin|carboplatin|mesh-list
1873938|NCT00191451|Trastuzumab|trastuzumab|mesh-list
1873939|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873940|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873941|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
1873942|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873943|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
1873944|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873945|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873946|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873947|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
1873948|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873949|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1873950|NCT00191477|Gemcitabine|gemcitabine|mesh-list
1873951|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873952|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
1873953|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873954|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873955|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
1873956|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873957|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873958|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873959|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
1873960|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873961|NCT00191646|Gemcitabine|gemcitabine|mesh-list
1873962|NCT00191646|Paclitaxel|paclitaxel|mesh-list
1873963|NCT00191646|Carboplatin|carboplatin|mesh-list
1873964|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1873965|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873966|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
1873967|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
1873968|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
1873969|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873970|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873971|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
1873972|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
1873973|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873974|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873975|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873976|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
1873977|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873978|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
1873979|NCT00191724|Enoxaparin|enoxaparin|mesh-list
1873980|NCT00191724|Protein C|protein c|mesh-list
1873981|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
1873982|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1873983|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1873984|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873985|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873986|NCT00191789|Gemcitabine|gemcitabine|mesh-list
1873987|NCT00191789|Doxorubicin|doxorubicin|mesh-list
1873988|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1873989|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1873990|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
1873991|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1873992|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
1873993|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1873994|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1873995|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1873996|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
1873997|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1873998|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1873999|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874000|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874001|NCT00191815|Gemcitabine|gemcitabine|mesh-list
1874002|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874003|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874004|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
1874005|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874006|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
1874007|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874008|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874009|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874010|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
1874011|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874012|NCT00191854|Gemcitabine|gemcitabine|mesh-list
1874013|NCT00191854|Paclitaxel|paclitaxel|mesh-list
1874014|NCT00191854|Carboplatin|carboplatin|mesh-list
1874015|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874016|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874017|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874018|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874019|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874020|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874021|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874022|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
1874023|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
1874024|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874025|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874026|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874027|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
1874028|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874029|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1874030|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1874031|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1874032|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1874033|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874034|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
1874035|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874036|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874037|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1874038|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1874039|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1874040|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1874041|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874042|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
1874043|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874044|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874045|NCT00191984|Irinotecan|irinotecan|mesh-list
1874046|NCT00191984|Pemetrexed|pemetrexed|mesh-list
1874047|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1874048|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874049|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874050|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874051|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874052|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874053|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874054|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1874055|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1874056|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1874057|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1874058|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874059|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
1874060|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874061|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874062|NCT00192036|Gemcitabine|gemcitabine|mesh-list
1874063|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874064|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874065|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
1874066|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874067|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
1874068|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874069|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874070|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874071|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
1874072|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874073|NCT00192075|Leucovorin|leucovorin|mesh-list
1874074|NCT00192075|Folic Acid|folic acid|mesh-list
1874075|NCT00192075|Gemcitabine|gemcitabine|mesh-list
1874076|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
1874077|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
1874078|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874079|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
1874080|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874081|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874082|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
1874083|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874084|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874085|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874086|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
1874087|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874088|NCT00192075|Antidotes|antidotes|mesh-ancestor
1874089|NCT00192075|Protective Agents|protective agents|mesh-ancestor
1874090|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
1874091|NCT00192075|Vitamins|vitamins|mesh-ancestor
1874092|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
1874093|NCT00192075|Hematinics|hematinics|mesh-ancestor
1874094|NCT00192647|Ribavirin|ribavirin|mesh-list
1874095|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1874096|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
1874097|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
1874098|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874099|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
1874100|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874101|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874102|NCT00193037|Docetaxel|docetaxel|mesh-list
1874103|NCT00193037|Doxorubicin|doxorubicin|mesh-list
1874104|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1874105|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874106|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874107|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874108|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874109|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874110|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1874111|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874112|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874113|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874114|NCT00193050|Gemcitabine|gemcitabine|mesh-list
1874115|NCT00193050|Docetaxel|docetaxel|mesh-list
1874116|NCT00193050|Epirubicin|epirubicin|mesh-list
1874117|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874118|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
1874119|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874120|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874121|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
1874122|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874123|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874124|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874125|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
1874126|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874127|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874128|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874129|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874130|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1874131|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874132|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874133|NCT00193063|Gemcitabine|gemcitabine|mesh-list
1874134|NCT00193063|Trastuzumab|trastuzumab|mesh-list
1874135|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874136|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
1874137|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874138|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874139|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
1874140|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874141|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874142|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874143|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
1874144|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874145|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874146|NCT00193128|Docetaxel|docetaxel|mesh-list
1874147|NCT00193128|Capecitabine|capecitabine|mesh-list
1874148|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
1874149|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874150|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874151|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874152|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874153|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874154|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874155|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
1874156|NCT00193180|Docetaxel|docetaxel|mesh-list
1874157|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
1874158|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874159|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874160|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874161|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874162|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874163|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1874164|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874165|NCT00193206|Gemcitabine|gemcitabine|mesh-list
1874166|NCT00193206|Paclitaxel|paclitaxel|mesh-list
1874167|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1874168|NCT00193206|Epirubicin|epirubicin|mesh-list
1874169|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874170|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874171|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874172|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874173|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874174|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874175|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874176|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
1874177|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
1874178|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874179|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874180|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874181|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
1874182|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874183|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1874184|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874185|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874208|NCT00193258|Bevacizumab|bevacizumab|mesh-list
1874209|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1874210|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
1874211|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874212|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874213|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1874214|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1874215|NCT00193258|Growth Substances|growth substances|mesh-ancestor
1874216|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874217|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
1874218|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1874219|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874220|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874222|NCT00193375|Carboplatin|carboplatin|mesh-list
1874223|NCT00193375|Irinotecan|irinotecan|mesh-list
1874224|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874225|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874226|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1874227|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1874228|NCT00193375|Growth Substances|growth substances|mesh-ancestor
1874229|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874230|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
1874231|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1874232|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874233|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874234|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874235|NCT00193414|Gemcitabine|gemcitabine|mesh-list
1874236|NCT00193414|Pemetrexed|pemetrexed|mesh-list
1874237|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874238|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
1874239|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874240|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874241|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
1874242|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874243|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874244|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874245|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
1874246|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874247|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874248|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874249|NCT00193427|Gemcitabine|gemcitabine|mesh-list
1874250|NCT00193427|Carboplatin|carboplatin|mesh-list
1874251|NCT00193427|Docetaxel|docetaxel|mesh-list
1874252|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874253|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874254|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
1874255|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874256|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
1874257|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874258|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874259|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874260|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
1874261|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874262|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874263|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874264|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874265|NCT00193453|Gemcitabine|gemcitabine|mesh-list
1874266|NCT00193453|Docetaxel|docetaxel|mesh-list
1874267|NCT00193453|Cetuximab|cetuximab|mesh-list
1874268|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874269|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
1874270|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874271|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874272|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
1874273|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874274|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874275|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874276|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
1874277|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874278|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874279|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874280|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874281|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874282|NCT00193479|Prednisone|prednisone|mesh-list
1874283|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
1874284|NCT00193479|Rituximab|rituximab|mesh-list
1874285|NCT00193479|Vincristine|vincristine|mesh-list
1874286|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
1874287|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874288|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
1874289|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874290|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874291|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1874292|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
1874293|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874294|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874295|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1874296|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874297|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874298|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
1874299|NCT00193479|Hormones|hormones|mesh-ancestor
1874300|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874301|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1874302|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874303|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874304|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874305|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874306|NCT00193479|Analgesics|analgesics|mesh-ancestor
1874307|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
1874308|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874309|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874310|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874311|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874312|NCT00193492|Bevacizumab|bevacizumab|mesh-list
1874313|NCT00193492|Rituximab|rituximab|mesh-list
1874314|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874315|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874316|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1874317|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1874318|NCT00193492|Growth Substances|growth substances|mesh-ancestor
1874319|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874320|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
1874321|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
1874322|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874323|NCT00193596|Gemcitabine|gemcitabine|mesh-list
1874324|NCT00193596|Paclitaxel|paclitaxel|mesh-list
1874325|NCT00193596|Etoposide|etoposide|mesh-list
1874326|NCT00193596|Carboplatin|carboplatin|mesh-list
1874327|NCT00193596|Irinotecan|irinotecan|mesh-list
1874328|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874329|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874330|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874331|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874332|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874333|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874334|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874335|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
1874336|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
1874337|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874338|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874339|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874340|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
1874341|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874342|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1874343|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874344|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874345|NCT00193609|Capecitabine|capecitabine|mesh-list
1874346|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
1874347|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874348|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
1874349|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874350|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874351|NCT00194012|Aripiprazole|aripiprazole|mesh-list
1874352|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
1874353|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874354|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1874355|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1874356|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1874357|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874358|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
1874359|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
1874360|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874361|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874362|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1874363|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1874364|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
1874365|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1874366|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1874367|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1874368|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1874369|NCT00194025|Valproic Acid|valproic acid|mesh-list
1874370|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
1874371|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874372|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874373|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
1874374|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874375|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874376|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
1874377|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1874378|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1874379|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874380|NCT00194077|Aripiprazole|aripiprazole|mesh-list
1874381|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
1874382|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874383|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1874384|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1874385|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1874386|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874387|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
1874388|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
1874389|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874390|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874391|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1874392|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1874393|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
1874394|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1874395|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1874396|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1874397|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1874398|NCT00194116|Valproic Acid|valproic acid|mesh-list
1874399|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
1874400|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874401|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874402|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
1874403|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874404|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874405|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
1874406|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1874407|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1874408|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874409|NCT00194129|Valproic Acid|valproic acid|mesh-list
1874410|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
1874411|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
1874412|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874413|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874414|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874415|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
1874416|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1874417|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1874418|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874419|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
1874420|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
1874421|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874422|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
1874423|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
1874424|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
1874425|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1874426|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874427|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874428|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874429|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874430|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874431|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874432|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1874433|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1874434|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
1874435|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1874436|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1874437|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1874438|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874439|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
1874440|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874441|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874442|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1874443|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874444|NCT00194675|Testosterone|testosterone|mesh-list
1874445|NCT00194675|Dutasteride|dutasteride|mesh-list
1874446|NCT00194675|Androgens|androgens|mesh-ancestor
1874447|NCT00194675|Hormones|hormones|mesh-ancestor
1874448|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874449|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874450|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1874451|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1874452|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874453|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874454|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
1874455|NCT00194779|Tamoxifen|tamoxifen|mesh-list
1874456|NCT00194779|Vinorelbine|vinorelbine|mesh-list
1874457|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
1874458|NCT00194779|Doxorubicin|doxorubicin|mesh-list
1874459|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1874460|NCT00194779|Capecitabine|capecitabine|mesh-list
1874461|NCT00194779|Methotrexate|methotrexate|mesh-list
1874462|NCT00194779|Trastuzumab|trastuzumab|mesh-list
1874463|NCT00194779|Letrozole|letrozole|mesh-list
1874464|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874465|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874466|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874467|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874468|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874469|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874470|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874471|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
1874472|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874473|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874474|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1874475|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
1874476|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1874477|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1874478|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1874479|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1874480|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874481|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874482|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
1874483|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1874484|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
1874485|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1874486|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874487|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874488|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874489|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874490|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1874491|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1874492|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1874493|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
1874494|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874495|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1874496|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1874497|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1874498|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1874499|NCT00194792|Paclitaxel|paclitaxel|mesh-list
1874500|NCT00194792|Vinorelbine|vinorelbine|mesh-list
1874501|NCT00194792|Capecitabine|capecitabine|mesh-list
1874502|NCT00194792|Methotrexate|methotrexate|mesh-list
1874503|NCT00194792|Exemestane|exemestane|mesh-list
1874504|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1874505|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874506|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874507|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874508|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874509|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874510|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874511|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874512|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
1874513|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1874514|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
1874515|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1874516|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874517|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874518|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874519|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874520|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874521|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
1874522|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874523|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874524|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1874525|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1874526|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1874527|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
1874528|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874529|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
1874530|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1874531|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
1874532|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1874533|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1874534|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
1874535|NCT00194896|Glyburide|glyburide|mesh-list
1874536|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1874537|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874538|NCT00194987|Prednisone|prednisone|mesh-list
1874539|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
1874540|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1874541|NCT00194987|Antibodies|antibodies|mesh-list
1874542|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
1874543|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1874544|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874545|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
1874546|NCT00194987|Hormones|hormones|mesh-ancestor
1874547|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874548|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874549|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1874550|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874551|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
1874552|NCT00195039|Antibodies|antibodies|mesh-list
1874553|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1874554|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
1874555|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874556|NCT00195273|Cyclosporine|cyclosporine|mesh-list
1874557|NCT00195273|Sirolimus|sirolimus|mesh-list
1874558|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
1874559|NCT00195273|Cyclosporins|cyclosporins|mesh-list
1874560|NCT00195273|Daclizumab|daclizumab|mesh-list
1874561|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874562|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874563|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874564|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
1874565|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874566|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
1874567|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874568|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874569|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874570|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1874571|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1874572|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874573|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1874574|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
1874575|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1874576|NCT00195338|Etanercept|etanercept|mesh-list
1874577|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1874578|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1874579|NCT00195338|Analgesics|analgesics|mesh-ancestor
1874580|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
1874581|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874582|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874583|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874584|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874585|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1874586|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874587|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
1874588|NCT00195351|Metronidazole|metronidazole|mesh-list
1874589|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
1874590|NCT00195351|Tigecycline|tigecycline|mesh-list
1874591|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874592|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1874593|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1874594|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1874595|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1874596|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874597|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874598|NCT00195403|Etanercept|etanercept|mesh-list
1874599|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1874600|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1874601|NCT00195403|Analgesics|analgesics|mesh-ancestor
1874602|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
1874603|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874604|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874605|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874606|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874607|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1874608|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874609|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
1874610|NCT00195429|Sirolimus|sirolimus|mesh-list
1874611|NCT00195429|Prednisone|prednisone|mesh-list
1874612|NCT00195429|Tacrolimus|tacrolimus|mesh-list
1874613|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874614|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
1874615|NCT00195429|Hormones|hormones|mesh-ancestor
1874616|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874617|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874618|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1874619|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874620|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874621|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
1874622|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1874623|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874624|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874625|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1874626|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874627|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1874628|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
1874629|NCT00195442|Factor VIII|factor viii|mesh-list
1874630|NCT00195442|Coagulants|coagulants|mesh-ancestor
1874631|NCT00195494|Etanercept|etanercept|mesh-list
1874632|NCT00195494|Methotrexate|methotrexate|mesh-list
1874633|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1874634|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
1874635|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1874636|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874637|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874638|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
1874639|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874640|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874641|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874642|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874643|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874644|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874645|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
1874646|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874647|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874648|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1874649|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1874650|NCT00195494|Analgesics|analgesics|mesh-ancestor
1874651|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
1874652|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874653|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874654|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1874655|NCT00195507|Etanercept|etanercept|mesh-list
1874656|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1874657|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1874658|NCT00195507|Analgesics|analgesics|mesh-ancestor
1874659|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
1874660|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874661|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874662|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874663|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874664|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1874665|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874666|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
1874667|NCT00195624|Cyclosporine|cyclosporine|mesh-list
1874668|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
1874669|NCT00195624|Cyclosporins|cyclosporins|mesh-list
1874670|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874671|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874672|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874673|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
1874674|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874675|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
1874676|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874677|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874678|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874679|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1874680|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874681|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874682|NCT00195650|Adalimumab|adalimumab|mesh-list
1874683|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874684|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874685|NCT00195663|Adalimumab|adalimumab|mesh-list
1874686|NCT00195663|Methotrexate|methotrexate|mesh-list
1874687|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1874688|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
1874689|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1874690|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874691|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874692|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
1874693|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874694|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874695|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874696|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874697|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874698|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874699|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
1874700|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874701|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874702|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874703|NCT00195676|Adalimumab|adalimumab|mesh-list
1874704|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874705|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874706|NCT00195702|Adalimumab|adalimumab|mesh-list
1874707|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874708|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874709|NCT00195715|Adalimumab|adalimumab|mesh-list
1874710|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874711|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874712|NCT00195819|Adalimumab|adalimumab|mesh-list
1874713|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874714|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874715|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
1874716|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1874717|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
1874718|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1874719|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874720|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1874721|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1874722|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1874723|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
1874724|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1874725|NCT00196326|Estradiol|estradiol|mesh-list
1874726|NCT00196326|Estrogens|estrogens|mesh-ancestor
1874727|NCT00196326|Hormones|hormones|mesh-ancestor
1874728|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874729|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874730|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1874731|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
1874732|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1874733|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1874734|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1874735|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1874736|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1874737|NCT00196976|Edetic Acid|edetic acid|mesh-list
1874738|NCT00196976|Vaccines|vaccines|mesh-list
1874739|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
1874740|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
1874741|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874742|NCT00196976|Antidotes|antidotes|mesh-ancestor
1874743|NCT00196976|Protective Agents|protective agents|mesh-ancestor
1874744|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
1874745|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
1874746|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874747|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1874748|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
1874749|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1874750|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1874751|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
1874752|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874753|NCT00197106|Fluticasone|fluticasone|mesh-list
1874754|NCT00197106|Xhance|xhance|mesh-list
1874755|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1874756|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874757|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1874758|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
1874759|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874760|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874761|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1874762|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
1874763|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
1874764|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1874765|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1874766|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1874767|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1874768|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
1874769|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874770|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874771|NCT00197145|Aplaviroc|aplaviroc|mesh-list
1874772|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1874773|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1874774|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874775|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1874776|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1874777|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
1874778|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874779|NCT00197184|Vaccines|vaccines|mesh-list
1874780|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
1874781|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874782|NCT00198029|Hylan|hylan|mesh-list
1874783|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
1874784|NCT00198029|Protective Agents|protective agents|mesh-ancestor
1874785|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874786|NCT00198081|Celecoxib|celecoxib|mesh-list
1874787|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
1874788|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1874789|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1874790|NCT00198081|Analgesics|analgesics|mesh-ancestor
1874791|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
1874792|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874793|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874794|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874795|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874796|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1874797|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874798|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874799|NCT00198107|Cycloserine|cycloserine|mesh-list
1874800|NCT00198107|Aripiprazole|aripiprazole|mesh-list
1874801|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
1874802|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874803|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1874804|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1874805|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1874806|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874807|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
1874808|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
1874809|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874810|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874811|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1874812|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1874813|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
1874814|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1874815|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1874816|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1874817|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1874818|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1874819|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874820|NCT00198107|Renal Agents|renal agents|mesh-ancestor
1874821|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1874822|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
1874823|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1874824|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
1874825|NCT00198133|Pemetrexed|pemetrexed|mesh-list
1874826|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874827|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874828|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874905|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1874829|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1874830|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1874831|NCT00198822|Vitamin A|vitamin a|mesh-list
1874832|NCT00198822|Beta Carotene|beta carotene|mesh-list
1874833|NCT00198822|Carotenoids|carotenoids|mesh-list
1874834|NCT00198822|Vitamins|vitamins|mesh-ancestor
1874835|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
1874836|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874837|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
1874838|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874839|NCT00198822|Protective Agents|protective agents|mesh-ancestor
1874840|NCT00198822|Provitamins|provitamins|mesh-ancestor
1874841|NCT00199381|Istradefylline|istradefylline|mesh-list
1874842|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
1874843|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1874844|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1874845|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
1874846|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874847|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874848|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874849|NCT00199797|Leucovorin|leucovorin|mesh-list
1874850|NCT00199797|Fluorouracil|fluorouracil|mesh-list
1874851|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
1874852|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
1874853|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874854|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874855|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874856|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874857|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
1874858|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874859|NCT00199797|Antidotes|antidotes|mesh-ancestor
1874860|NCT00199797|Protective Agents|protective agents|mesh-ancestor
1874861|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
1874862|NCT00199797|Vitamins|vitamins|mesh-ancestor
1874863|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
1874864|NCT00200161|Temozolomide|temozolomide|mesh-list
1874865|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1874866|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
1874867|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874868|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874869|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1874870|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1874871|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1874872|NCT00200356|Ozagrel|ozagrel|mesh-list
1874873|NCT00200356|Edaravone|edaravone|mesh-list
1874874|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1874875|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
1874876|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874877|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1874878|NCT00200356|Protective Agents|protective agents|mesh-ancestor
1874879|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874880|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874881|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1874882|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1874883|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
1874884|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
1874885|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874886|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1874887|NCT00200902|Citalopram|citalopram|mesh-list
1874888|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1874889|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1874890|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1874891|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1874892|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874893|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874894|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
1874895|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874896|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1874897|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
1874898|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1874899|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874900|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1874901|NCT00200902|Analgesics|analgesics|mesh-ancestor
1874902|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
1874903|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
1874904|NCT00200967|Beclomethasone|beclomethasone|mesh-list
1874906|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1874907|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
1874908|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874909|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874910|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1874911|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
1874912|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1874913|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1874914|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1874915|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
1874916|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1874917|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874918|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874919|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
1874920|NCT00200967|Hormones|hormones|mesh-ancestor
1874921|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874922|NCT00201123|Interferons|interferons|mesh-list
1874923|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
1874924|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874925|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
1874926|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874927|NCT00201448|Vaccines|vaccines|mesh-list
1874928|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
1874929|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874930|NCT00201643|Dexamethasone|dexamethasone|mesh-list
1874931|NCT00201643|Betamethasone|betamethasone|mesh-list
1874932|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874933|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
1874934|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
1874935|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874936|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874937|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1874938|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
1874939|NCT00201643|Hormones|hormones|mesh-ancestor
1874940|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874941|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1874942|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874943|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1874944|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
1874945|NCT00201734|Paclitaxel|paclitaxel|mesh-list
1874946|NCT00201734|Carboplatin|carboplatin|mesh-list
1874947|NCT00201734|Capecitabine|capecitabine|mesh-list
1874948|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1874949|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874950|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874951|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874952|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874953|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874954|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874955|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
1874956|NCT00201760|Gemcitabine|gemcitabine|mesh-list
1874957|NCT00201760|Trastuzumab|trastuzumab|mesh-list
1874958|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874959|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874960|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
1874961|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874962|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
1874963|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1874964|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874965|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1874966|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
1874967|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874968|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1874969|NCT00201773|Celecoxib|celecoxib|mesh-list
1874970|NCT00201773|Exemestane|exemestane|mesh-list
1874971|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1874972|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1874973|NCT00201773|Analgesics|analgesics|mesh-ancestor
1874974|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
1874975|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1874976|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1874977|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1874978|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1874979|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1874980|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1874981|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1874982|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874983|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874984|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1874985|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1874986|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1874987|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
1874988|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1874989|NCT00201825|Docetaxel|docetaxel|mesh-list
1874990|NCT00201825|Capecitabine|capecitabine|mesh-list
1874991|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1874992|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
1874993|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
1874994|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
1874995|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1874996|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1874997|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
1874998|NCT00201838|Gemcitabine|gemcitabine|mesh-list
1874999|NCT00201838|Etanercept|etanercept|mesh-list
1875000|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875001|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
1875002|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875003|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875004|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
1875005|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875006|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875007|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875008|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
1875009|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875010|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1875011|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1875012|NCT00201838|Analgesics|analgesics|mesh-ancestor
1875013|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
1875014|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875015|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875016|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875017|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875018|NCT00201851|Tamoxifen|tamoxifen|mesh-list
1875019|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1875020|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
1875021|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875022|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875023|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875024|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875025|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1875026|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1875027|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1875028|NCT00201864|Fulvestrant|fulvestrant|mesh-list
1875029|NCT00201864|Exemestane|exemestane|mesh-list
1875030|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875031|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875032|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1875033|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1875034|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
1875035|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875036|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875037|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1875038|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1875039|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875040|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875041|NCT00201877|Rituximab|rituximab|mesh-list
1875042|NCT00201877|Bortezomib|bortezomib|mesh-list
1875043|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875044|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875045|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
1875046|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875047|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875048|NCT00202449|Prazosin|prazosin|mesh-list
1875049|NCT00202449|Paroxetine|paroxetine|mesh-list
1875050|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1875051|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875052|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875053|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875054|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875055|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
1875056|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875057|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1875058|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875059|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875060|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1875061|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1875062|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875063|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1875064|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1875065|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1875066|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1875067|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
1875068|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
1875069|NCT00202644|Anagrelide|anagrelide|mesh-list
1875070|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875071|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
1875072|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875073|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875074|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1875075|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1875076|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1875077|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1875078|NCT00202722|Remifentanil|remifentanil|mesh-list
1875079|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1875080|NCT00202722|Narcotics|narcotics|mesh-ancestor
1875081|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875082|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875083|NCT00202722|Analgesics|analgesics|mesh-ancestor
1875084|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
1875085|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875086|NCT00202839|Ribavirin|ribavirin|mesh-list
1875087|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1875088|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
1875089|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
1875090|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875091|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
1875092|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875093|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
1875094|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875095|NCT00202878|Simvastatin|simvastatin|mesh-list
1875096|NCT00202878|Ezetimibe|ezetimibe|mesh-list
1875097|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1875098|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1875099|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1875100|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
1875101|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875102|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1875103|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1875104|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875105|NCT00202930|Rituximab|rituximab|mesh-list
1875106|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875107|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875108|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
1875109|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875110|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875111|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
1875112|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
1875113|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1875114|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
1875115|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875116|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875117|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875118|NCT00203047|Prednisone|prednisone|mesh-list
1875119|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
1875120|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
1875121|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875122|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
1875123|NCT00203047|Hormones|hormones|mesh-ancestor
1875124|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875125|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875126|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875127|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875128|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1875129|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
1875130|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875131|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875132|NCT00203216|Levetiracetam|levetiracetam|mesh-list
1875133|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
1875134|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
1875135|NCT00203229|Lamotrigine|lamotrigine|mesh-list
1875136|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
1875137|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1875138|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875139|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875140|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1875141|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875142|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875143|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875144|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875145|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875146|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1875147|NCT00203242|Valproic Acid|valproic acid|mesh-list
1875148|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
1875149|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875150|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875151|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
1875152|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875153|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875154|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
1875155|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875156|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875157|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875158|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
1875159|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1875160|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
1875161|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
1875162|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875163|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875164|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875165|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1875166|NCT00203268|Analgesics|analgesics|mesh-ancestor
1875167|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
1875168|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875169|NCT00203294|Triamcinolone|triamcinolone|mesh-list
1875170|NCT00203294|Lidocaine|lidocaine|mesh-list
1875171|NCT00203294|Bupivacaine|bupivacaine|mesh-list
1875172|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
1875173|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
1875174|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875175|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875176|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
1875177|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875178|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1875179|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1875180|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1875181|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875182|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875183|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875184|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
1875185|NCT00203294|Hormones|hormones|mesh-ancestor
1875186|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875187|NCT00203307|Olanzapine|olanzapine|mesh-list
1875188|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
1875189|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
1875190|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875191|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875192|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875193|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875194|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875195|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875196|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875197|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1875198|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875199|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875200|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875201|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875202|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
1875203|NCT00203411|Bevacizumab|bevacizumab|mesh-list
1875204|NCT00203411|Capecitabine|capecitabine|mesh-list
1875205|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875206|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875207|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1875208|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1875209|NCT00203411|Growth Substances|growth substances|mesh-ancestor
1875210|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875211|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
1875212|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875213|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
1875214|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875215|NCT00203424|Bevacizumab|bevacizumab|mesh-list
1875216|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1875217|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875218|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875219|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1875220|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1875221|NCT00203424|Growth Substances|growth substances|mesh-ancestor
1875222|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875223|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
1875224|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1875225|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875226|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875227|NCT00203476|Niacin|niacin|mesh-list
1875228|NCT00203476|Ezetimibe|ezetimibe|mesh-list
1875229|NCT00203476|Colestipol|colestipol|mesh-list
1875230|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1875231|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1875232|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
1875233|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875234|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1875235|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
1875236|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
1875237|NCT00203476|Vitamins|vitamins|mesh-ancestor
1875238|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
1875239|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875240|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
1875241|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
1875242|NCT00203502|Bevacizumab|bevacizumab|mesh-list
1875243|NCT00203502|Docetaxel|docetaxel|mesh-list
1875244|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875245|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
1875246|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875247|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875248|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1875249|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
1875250|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875251|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875252|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1875253|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875254|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1875255|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1875256|NCT00203502|Growth Substances|growth substances|mesh-ancestor
1875257|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
1875258|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875259|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875260|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875261|NCT00203931|Pemetrexed|pemetrexed|mesh-list
1875262|NCT00203931|Cetuximab|cetuximab|mesh-list
1875263|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875264|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875265|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875266|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1875267|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1875268|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875269|NCT00203996|Pioglitazone|pioglitazone|mesh-list
1875270|NCT00203996|Leuprolide|leuprolide|mesh-list
1875271|NCT00203996|Estrogens|estrogens|mesh-list
1875272|NCT00203996|Progestins|progestins|mesh-list
1875273|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1875274|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875275|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1875276|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
1875277|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1875278|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875279|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875280|NCT00203996|Hormones|hormones|mesh-ancestor
1875281|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875282|NCT00204373|Lansoprazole|lansoprazole|mesh-list
1875283|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
1875284|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1875285|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875286|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1875287|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875288|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875297|NCT00205374|Cidofovir|cidofovir|mesh-list
1875298|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
1875299|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875300|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875301|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875302|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
1875303|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1875304|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1875305|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
1875306|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1875307|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875308|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1875309|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1875310|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1875311|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1875312|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875313|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875314|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875315|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875316|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875317|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875318|NCT00205699|Olanzapine|olanzapine|mesh-list
1875319|NCT00205699|Risperidone|risperidone|mesh-list
1875320|NCT00205699|Aripiprazole|aripiprazole|mesh-list
1875321|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1875322|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
1875323|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875324|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875325|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875326|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875327|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875328|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875329|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875330|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1875331|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
1875332|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
1875333|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
1875334|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875335|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875336|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1875337|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875338|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875339|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875340|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
1875341|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1875342|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1875343|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1875344|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1875345|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
1875346|NCT00205712|Ketamine|ketamine|mesh-list
1875347|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1875348|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875349|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875350|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1875351|NCT00205712|Analgesics|analgesics|mesh-ancestor
1875352|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
1875353|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875354|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1875355|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1875356|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1875357|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
1875358|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875359|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875360|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1875361|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1875362|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
1875363|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
1875364|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1875365|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1875366|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
1875367|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1875368|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1875369|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
1875370|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875371|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875372|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1875373|NCT00205803|Vaccines|vaccines|mesh-list
1875374|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1875375|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
1875376|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875377|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
1875378|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1875379|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875380|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1875381|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
1875382|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1875383|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875384|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875385|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875386|NCT00206102|Risperidone|risperidone|mesh-list
1875387|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1875388|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1875389|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
1875390|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875391|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875392|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875393|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875394|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875395|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875396|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875397|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1875398|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
1875399|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875400|NCT00206323|Topiramate|topiramate|mesh-list
1875401|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
1875402|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1875403|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875404|NCT00206336|Topiramate|topiramate|mesh-list
1875405|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
1875406|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1875407|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875408|NCT00206427|Lapatinib|lapatinib|mesh-list
1875409|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875410|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1875411|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875412|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875413|NCT00206440|Esomeprazole|esomeprazole|mesh-list
1875414|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1875415|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875416|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1875417|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875418|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875419|NCT00206518|Docetaxel|docetaxel|mesh-list
1875420|NCT00206518|Doxorubicin|doxorubicin|mesh-list
1875421|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1875422|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
1875423|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875424|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875425|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875426|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875427|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875428|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1875429|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875430|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875431|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875432|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875433|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
1875434|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875435|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875436|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1875437|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
1875438|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1875439|NCT00206726|Fludarabine|fludarabine|mesh-list
1875440|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
1875441|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875442|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875443|NCT00207090|Rifampin|rifampin|mesh-list
1875444|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1875445|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
1875446|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1875447|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875448|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
1875449|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1875450|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875451|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875452|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1875453|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1875454|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1875455|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1875456|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1875457|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1875458|NCT00207142|Ritonavir|ritonavir|mesh-list
1875459|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1875460|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1875461|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1875462|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
1875463|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875464|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875465|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1875466|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1875467|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
1875468|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875469|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1875470|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1875471|NCT00207714|Golimumab|golimumab|mesh-list
1875472|NCT00207714|Infliximab|infliximab|mesh-list
1875473|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
1875474|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875475|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875476|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1875477|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875478|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875479|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
1875480|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875481|NCT00207727|Ustekinumab|ustekinumab|mesh-list
1875482|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
1875483|NCT00207740|Golimumab|golimumab|mesh-list
1875484|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1875485|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875486|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875487|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
1875488|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875489|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
1875490|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1875491|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1875492|NCT00208026|Analgesics|analgesics|mesh-ancestor
1875493|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
1875494|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875495|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875496|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875497|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875498|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
1875499|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875500|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
1875501|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1875502|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875503|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875504|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
1875505|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1875506|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875507|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875508|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
1875509|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875510|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875511|NCT00208767|Valsartan|valsartan|mesh-list
1875512|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1875513|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1875514|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1875515|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875516|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
1875517|NCT00208975|Rituximab|rituximab|mesh-list
1875518|NCT00208975|Fludarabine|fludarabine|mesh-list
1875519|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
1875520|NCT00208975|Sargramostim|sargramostim|mesh-list
1875521|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875522|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
1875523|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875524|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875525|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1875526|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
1875527|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875528|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875529|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1875530|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875531|NCT00208975|Analgesics|analgesics|mesh-ancestor
1875532|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
1875533|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875534|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875535|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875536|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875537|NCT00209092|Docetaxel|docetaxel|mesh-list
1875538|NCT00209092|Capecitabine|capecitabine|mesh-list
1875539|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875540|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875541|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875542|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875543|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875544|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875545|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
1875546|NCT00209170|Citalopram|citalopram|mesh-list
1875547|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1875548|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875549|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875550|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875551|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875552|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
1875553|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875554|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1875555|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875556|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875557|NCT00209560|Fospropofol|fospropofol|mesh-list
1875558|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1875559|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875560|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875561|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
1875562|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875563|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1875564|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875565|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875566|NCT00210184|Leucovorin|leucovorin|mesh-list
1875567|NCT00210184|Fluorouracil|fluorouracil|mesh-list
1875568|NCT00210184|Irinotecan|irinotecan|mesh-list
1875569|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
1875570|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875571|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875572|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875573|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875574|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
1875575|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875576|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1875577|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875578|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875579|NCT00210184|Antidotes|antidotes|mesh-ancestor
1875580|NCT00210184|Protective Agents|protective agents|mesh-ancestor
1875581|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
1875582|NCT00210184|Vitamins|vitamins|mesh-ancestor
1875583|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
1875584|NCT00210353|Rituximab|rituximab|mesh-list
1875585|NCT00210353|Chlorambucil|chlorambucil|mesh-list
1875586|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875587|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875588|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
1875589|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875590|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875591|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1875592|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
1875593|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875594|NCT00210470|Zinc|zinc|mesh-list
1875595|NCT00210470|Indomethacin|indomethacin|mesh-list
1875596|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
1875597|NCT00210470|Omeprazole|omeprazole|mesh-list
1875598|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875599|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
1875600|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875601|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875602|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1875603|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
1875604|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875605|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875606|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1875607|NCT00210470|Trace Elements|trace elements|mesh-ancestor
1875608|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
1875609|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1875610|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875611|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1875612|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875613|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1875614|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1875615|NCT00210470|Analgesics|analgesics|mesh-ancestor
1875616|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
1875617|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875618|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875619|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
1875620|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
1875621|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1875622|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1875623|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
1875624|NCT00210626|Hematinics|hematinics|mesh-ancestor
1875625|NCT00211081|Spironolactone|spironolactone|mesh-list
1875626|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1875627|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
1875628|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875629|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875630|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1875631|NCT00211081|Diuretics|diuretics|mesh-ancestor
1875632|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
1875633|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1875634|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1875635|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
1875636|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875637|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875638|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875639|NCT00211185|Prednisone|prednisone|mesh-list
1875640|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
1875641|NCT00211185|Doxorubicin|doxorubicin|mesh-list
1875642|NCT00211185|Vincristine|vincristine|mesh-list
1875643|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
1875644|NCT00211185|Sargramostim|sargramostim|mesh-list
1875645|NCT00211185|Lenograstim|lenograstim|mesh-list
1875646|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875647|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
1875648|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875649|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875650|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1875651|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
1875652|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875653|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875654|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1875655|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1875656|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875657|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875658|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875659|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875660|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
1875661|NCT00211185|Hormones|hormones|mesh-ancestor
1875662|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875663|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875664|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1875665|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875666|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875667|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875668|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1875669|NCT00211510|Insulin|insulin|mesh-list
1875670|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1875671|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875672|NCT00211536|Insulin|insulin|mesh-list
1875673|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1875674|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1875675|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875676|NCT00211692|Interferons|interferons|mesh-list
1875677|NCT00211692|Ribavirin|ribavirin|mesh-list
1875678|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
1875679|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
1875680|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875681|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
1875682|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875683|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
1875684|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875685|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
1875686|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875687|NCT00211757|Valproic Acid|valproic acid|mesh-list
1875688|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
1875689|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875690|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875691|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
1875692|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875693|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875694|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
1875695|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875696|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875697|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875698|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1875699|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1875700|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875701|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875702|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875703|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875704|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875705|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1875706|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875707|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875708|NCT00211887|Interferons|interferons|mesh-list
1875709|NCT00211887|Interferon-beta|interferon-beta|mesh-list
1875710|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
1875711|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
1875712|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
1875713|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875714|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
1875715|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875716|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
1875717|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875718|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1875719|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875720|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1875721|NCT00212134|Dipivefrin|dipivefrin|mesh-list
1875722|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1875723|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
1875724|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875725|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875726|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875727|NCT00212758|Hormones|hormones|mesh-list
1875878|NCT00215943|Dexamethasone|dexamethasone|mesh-list
1875728|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875729|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875730|NCT00213135|Cladribine|cladribine|mesh-list
1875731|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875732|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875733|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
1875734|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875735|NCT00213148|Anastrozole|anastrozole|mesh-list
1875736|NCT00213148|Citric Acid|citric acid|mesh-list
1875737|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
1875738|NCT00213148|Clomiphene|clomiphene|mesh-list
1875739|NCT00213148|Enclomiphene|enclomiphene|mesh-list
1875740|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
1875741|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
1875742|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1875743|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
1875744|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
1875745|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875746|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875747|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875748|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1875749|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1875750|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875751|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1875752|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
1875753|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875754|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875755|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1875756|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
1875757|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1875758|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1875759|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1875760|NCT00213239|Remifentanil|remifentanil|mesh-list
1875761|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1875762|NCT00213239|Narcotics|narcotics|mesh-ancestor
1875763|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875764|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875765|NCT00213239|Analgesics|analgesics|mesh-ancestor
1875766|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
1875767|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875768|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
1875769|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1875770|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875771|NCT00214019|Fluticasone|fluticasone|mesh-list
1875772|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1875773|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1875774|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875775|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1875776|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
1875777|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875778|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875779|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1875780|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
1875781|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
1875782|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1875783|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1875784|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1875785|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1875786|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
1875787|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875788|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875789|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
1875790|NCT00214019|Hormones|hormones|mesh-ancestor
1875791|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875792|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
1875793|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1875794|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875795|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875796|NCT00214461|Vaccines|vaccines|mesh-list
1875797|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
1875798|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875799|NCT00214890|Tenofovir|tenofovir|mesh-list
1875800|NCT00214890|Abacavir|abacavir|mesh-list
1875801|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
1875802|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875803|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1875804|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1875805|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875806|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875807|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1875808|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1875809|NCT00215137|Citalopram|citalopram|mesh-list
1875810|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1875811|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875812|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875813|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875814|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875815|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
1875816|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875817|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1875818|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875819|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875820|NCT00215150|Ziprasidone|ziprasidone|mesh-list
1875821|NCT00215150|Sertraline|sertraline|mesh-list
1875822|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875823|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875824|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1875825|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1875826|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875827|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875828|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875829|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
1875830|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875831|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1875832|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875833|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875834|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875835|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1875836|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
1875837|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1875838|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
1875839|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1875840|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
1875841|NCT00215644|Capecitabine|capecitabine|mesh-list
1875842|NCT00215644|Epirubicin|epirubicin|mesh-list
1875843|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875844|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875845|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
1875846|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875847|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1875848|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875849|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875850|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875851|NCT00215787|Lansoprazole|lansoprazole|mesh-list
1875852|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
1875853|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1875854|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875855|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1875856|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875857|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875858|NCT00215930|Gemcitabine|gemcitabine|mesh-list
1875859|NCT00215930|Carboplatin|carboplatin|mesh-list
1875860|NCT00215930|Docetaxel|docetaxel|mesh-list
1875861|NCT00215930|Vinorelbine|vinorelbine|mesh-list
1875862|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875863|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875864|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
1875865|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875866|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
1875867|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875868|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875869|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875870|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
1875871|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875872|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875873|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875874|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875875|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1875876|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
1875877|NCT00215943|Thalidomide|thalidomide|mesh-list
1875879|NCT00215943|Doxorubicin|doxorubicin|mesh-list
1875880|NCT00215943|Vincristine|vincristine|mesh-list
1875881|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1875882|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875883|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
1875884|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
1875885|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875886|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875887|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1875888|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
1875889|NCT00215943|Hormones|hormones|mesh-ancestor
1875890|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1875891|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1875892|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875893|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1875894|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875895|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875896|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875897|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875898|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1875899|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875900|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875901|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875902|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1875903|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
1875904|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
1875905|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1875906|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1875907|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1875908|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1875909|NCT00215943|Growth Substances|growth substances|mesh-ancestor
1875910|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
1875911|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1875912|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
1875913|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1875914|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1875915|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875916|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1875917|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875918|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1875919|NCT00216086|Capecitabine|capecitabine|mesh-list
1875920|NCT00216086|Irinotecan|irinotecan|mesh-list
1875921|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1875922|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
1875923|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875924|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875925|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1875926|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875927|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875928|NCT00216099|Folic Acid|folic acid|mesh-list
1875929|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
1875930|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
1875931|NCT00216099|Pemetrexed|pemetrexed|mesh-list
1875932|NCT00216099|Vitamins|vitamins|mesh-ancestor
1875933|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
1875934|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875935|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875936|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875937|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875938|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1875939|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1875940|NCT00216099|Hematinics|hematinics|mesh-ancestor
1875941|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
1875942|NCT00216125|Docetaxel|docetaxel|mesh-list
1875943|NCT00216125|Etoposide|etoposide|mesh-list
1875944|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875945|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
1875946|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
1875947|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
1875948|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875949|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1875950|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1875951|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1875952|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875953|NCT00216203|Pemetrexed|pemetrexed|mesh-list
1875954|NCT00216203|Cetuximab|cetuximab|mesh-list
1875955|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1875956|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1875957|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875958|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1875959|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1875960|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1875961|NCT00216476|Risperidone|risperidone|mesh-list
1875962|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1875963|NCT00216476|Aripiprazole|aripiprazole|mesh-list
1875964|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1875965|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
1875966|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875967|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875968|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875969|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875970|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875971|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875972|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875973|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1875974|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
1875975|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
1875976|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
1875977|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1875978|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1875979|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1875980|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1875981|NCT00216671|Risperidone|risperidone|mesh-list
1875982|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1875983|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
1875984|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1875985|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1875986|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875987|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1875988|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1875989|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1875990|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1875991|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1875992|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
1875993|NCT00216736|Dexamethasone|dexamethasone|mesh-list
1875994|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1875995|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
1875996|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
1875997|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1875998|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1875999|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876000|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
1876001|NCT00216736|Hormones|hormones|mesh-ancestor
1876002|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876003|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876004|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876005|NCT00217022|Budesonide|budesonide|mesh-list
1876006|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876007|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1876008|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
1876009|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876010|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876011|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1876012|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
1876013|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
1876014|NCT00217022|Hormones|hormones|mesh-ancestor
1876015|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876016|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
1876017|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876018|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
1876019|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1876020|NCT00217399|Sorafenib|sorafenib|mesh-list
1876021|NCT00217399|Anastrozole|anastrozole|mesh-list
1876022|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876023|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1876024|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876025|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876026|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876027|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1876028|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1876029|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1876030|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
1876031|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876032|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876033|NCT00217425|Prednisone|prednisone|mesh-list
1876034|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
1876035|NCT00217425|Bevacizumab|bevacizumab|mesh-list
1876036|NCT00217425|Doxorubicin|doxorubicin|mesh-list
1876037|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1876038|NCT00217425|Vincristine|vincristine|mesh-list
1876039|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876040|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
1876041|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876042|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1876043|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1876044|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
1876045|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876046|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876047|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1876048|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876049|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876050|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876051|NCT00217425|Growth Substances|growth substances|mesh-ancestor
1876052|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876053|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1876054|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1876055|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1876056|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876057|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876058|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
1876059|NCT00217425|Hormones|hormones|mesh-ancestor
1876060|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876061|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876062|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1876063|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876064|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876065|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876066|NCT00217438|Melphalan|melphalan|mesh-list
1876067|NCT00217438|Amifostine|amifostine|mesh-list
1876068|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1876069|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
1876070|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876071|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876072|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1876073|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876074|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
1876075|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876076|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1876077|NCT00217438|Protective Agents|protective agents|mesh-ancestor
1876078|NCT00217464|Fulvestrant|fulvestrant|mesh-list
1876079|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876080|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876081|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1876082|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1876083|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
1876084|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876085|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876086|NCT00217581|Bevacizumab|bevacizumab|mesh-list
1876087|NCT00217581|Docetaxel|docetaxel|mesh-list
1876088|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
1876089|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876090|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876091|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876092|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876093|NCT00217581|Growth Substances|growth substances|mesh-ancestor
1876094|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876095|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876096|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876097|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876098|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876099|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876100|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
1876101|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876102|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876103|NCT00217620|Sorafenib|sorafenib|mesh-list
1876104|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876105|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1876106|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876107|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876108|NCT00217672|Bevacizumab|bevacizumab|mesh-list
1876109|NCT00217672|Docetaxel|docetaxel|mesh-list
1876110|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876111|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876112|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876113|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876114|NCT00217672|Growth Substances|growth substances|mesh-ancestor
1876115|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876116|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876117|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876118|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876119|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876120|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876121|NCT00217971|Dronabinol|dronabinol|mesh-list
1876122|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
1876123|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876124|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876125|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1876126|NCT00217971|Analgesics|analgesics|mesh-ancestor
1876127|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
1876128|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876129|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1876130|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1876131|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876132|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876133|NCT00217971|Hormones|hormones|mesh-ancestor
1876134|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876135|NCT00218023|Naltrexone|naltrexone|mesh-list
1876136|NCT00218023|Levodopa|levodopa|mesh-list
1876137|NCT00218023|Carbidopa|carbidopa|mesh-list
1876138|NCT00218023|Modafinil|modafinil|mesh-list
1876139|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1876140|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1876141|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876142|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
1876143|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876144|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1876145|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1876146|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
1876147|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876148|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876149|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1876150|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876151|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1876152|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1876153|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1876154|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1876155|NCT00218062|Modafinil|modafinil|mesh-list
1876156|NCT00218062|Amphetamine|amphetamine|mesh-list
1876157|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
1876158|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1876159|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876160|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1876161|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1876162|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1876163|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876164|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
1876165|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
1876166|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876167|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
1876168|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876169|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
1876170|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1876171|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876172|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876173|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1876174|NCT00218257|Progesterone|progesterone|mesh-list
1876175|NCT00218257|Progestins|progestins|mesh-ancestor
1876176|NCT00218257|Hormones|hormones|mesh-ancestor
1876177|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876178|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876179|NCT00218296|Lobeline|lobeline|mesh-list
1876180|NCT00218296|Nicotine|nicotine|mesh-list
1876181|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1876182|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
1876183|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876184|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876185|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1876186|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1876187|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
1876188|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876189|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876190|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
1876191|NCT00218387|Modafinil|modafinil|mesh-list
1876192|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1876193|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876194|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1876195|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1876196|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1876197|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876198|NCT00218426|Naltrexone|naltrexone|mesh-list
1876199|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1876200|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1876201|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876202|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
1876203|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876204|NCT00218439|Paroxetine|paroxetine|mesh-list
1876205|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1876206|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876207|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876208|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876209|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876210|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
1876211|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876212|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1876213|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876214|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876215|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1876216|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1876217|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876218|NCT00218465|Glycine|glycine|mesh-list
1876219|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
1876220|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876221|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876222|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876223|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
1876224|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1876225|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
1876226|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876227|NCT00218491|Expectorants|expectorants|mesh-ancestor
1876228|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
1876229|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1876230|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
1876231|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876232|NCT00218491|Protective Agents|protective agents|mesh-ancestor
1876233|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876234|NCT00218491|Antidotes|antidotes|mesh-ancestor
1876235|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1876236|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1876237|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876238|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876239|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876240|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
1876241|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876242|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876243|NCT00219141|Losartan|losartan|mesh-list
1876244|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1876245|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1876246|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1876247|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1876321|NCT00220701|Dexetimide|dexetimide|mesh-list
1876248|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876249|NCT00219284|Levodopa|levodopa|mesh-list
1876250|NCT00219284|Carbidopa|carbidopa|mesh-list
1876251|NCT00219284|Entacapone|entacapone|mesh-list
1876252|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1876253|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1876254|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1876255|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
1876256|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876257|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876258|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876259|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1876260|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876261|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1876262|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1876263|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
1876264|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
1876265|NCT00219349|Citalopram|citalopram|mesh-list
1876266|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1876267|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876268|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876269|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876270|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876271|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
1876272|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876273|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1876274|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876275|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876276|NCT00219544|Pregabalin|pregabalin|mesh-list
1876277|NCT00219544|Analgesics|analgesics|mesh-ancestor
1876278|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
1876279|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876280|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876281|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
1876282|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1876283|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876284|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876285|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1876286|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1876287|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876288|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876289|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876290|NCT00219557|Gemcitabine|gemcitabine|mesh-list
1876291|NCT00219557|Axitinib|axitinib|mesh-list
1876292|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876293|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
1876294|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876295|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876296|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
1876297|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876298|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876299|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876300|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
1876301|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876302|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1876303|NCT00220636|Aripiprazole|aripiprazole|mesh-list
1876304|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876305|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876306|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1876307|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876308|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876309|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876310|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
1876311|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
1876312|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876313|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876314|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1876315|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1876316|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
1876317|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1876318|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1876319|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1876320|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1876322|NCT00220701|Citalopram|citalopram|mesh-list
1876323|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1876324|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876325|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876326|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876327|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876328|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
1876329|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876330|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1876331|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876332|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876333|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1876334|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1876335|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
1876336|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
1876337|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876338|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1876339|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1876340|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
1876341|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
1876342|NCT00220727|Antibodies|antibodies|mesh-list
1876343|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
1876344|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1876345|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1876346|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
1876347|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
1876348|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876349|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
1876350|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1876351|NCT00220740|Antibodies|antibodies|mesh-list
1876352|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
1876353|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1876354|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
1876355|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
1876356|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876357|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
1876358|NCT00220779|Antibodies|antibodies|mesh-list
1876359|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
1876360|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1876361|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1876362|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
1876363|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
1876364|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876365|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
1876366|NCT00220805|Antibodies|antibodies|mesh-list
1876367|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
1876368|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1876369|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1876370|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
1876371|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
1876372|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876373|NCT00220961|Pioglitazone|pioglitazone|mesh-list
1876374|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1876375|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876376|NCT00221104|Pravastatin|pravastatin|mesh-list
1876377|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1876378|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1876379|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
1876380|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876381|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1876382|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1876383|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876384|NCT00221195|Thrombin|thrombin|mesh-list
1876385|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
1876386|NCT00221195|Coagulants|coagulants|mesh-ancestor
1876387|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
1876388|NCT00221299|Hormones|hormones|mesh-list
1876389|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
1876390|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876391|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876392|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1876393|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876394|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876395|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1876396|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1876397|NCT00221338|Gabapentin|gabapentin|mesh-list
1876398|NCT00221338|Analgesics|analgesics|mesh-ancestor
1876399|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
1876400|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876401|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876402|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
1876403|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1876404|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876405|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876406|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876407|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1876408|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1876409|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876410|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876411|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
1876412|NCT00221403|Valproic Acid|valproic acid|mesh-list
1876413|NCT00221403|Risperidone|risperidone|mesh-list
1876414|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1876415|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1876416|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
1876417|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876418|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876419|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876420|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1876421|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876422|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876423|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876424|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1876425|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
1876426|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
1876427|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876428|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
1876429|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
1876430|NCT00222105|Thalidomide|thalidomide|mesh-list
1876431|NCT00222105|Dexamethasone|dexamethasone|mesh-list
1876432|NCT00222105|Doxorubicin|doxorubicin|mesh-list
1876433|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1876434|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876435|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
1876436|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
1876437|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876438|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876439|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876440|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
1876441|NCT00222105|Hormones|hormones|mesh-ancestor
1876442|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876443|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876444|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876445|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1876446|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1876447|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1876448|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876449|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876450|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876451|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
1876452|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
1876453|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1876454|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876455|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876456|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876457|NCT00222105|Growth Substances|growth substances|mesh-ancestor
1876458|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876459|NCT00222131|Esomeprazole|esomeprazole|mesh-list
1876460|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1876461|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876462|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1876463|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876464|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876465|NCT00222729|Bevacizumab|bevacizumab|mesh-list
1876466|NCT00222729|Pemetrexed|pemetrexed|mesh-list
1876467|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876468|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876469|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876470|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876471|NCT00222729|Growth Substances|growth substances|mesh-ancestor
1876472|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876473|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876474|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876475|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876476|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1876477|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1876478|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1876479|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
1876480|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876481|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1876482|NCT00223080|Antacids|antacids|mesh-ancestor
1876483|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876484|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876485|NCT00223236|Choline|choline|mesh-list
1876486|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1876487|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
1876488|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1876489|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
1876490|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876491|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876492|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1876493|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
1876494|NCT00223262|Lamotrigine|lamotrigine|mesh-list
1876495|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
1876496|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1876497|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876498|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876499|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1876500|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876501|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1876502|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876503|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876504|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876505|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1876506|NCT00223496|Aripiprazole|aripiprazole|mesh-list
1876507|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876508|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876509|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1876510|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876511|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876512|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876513|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
1876514|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
1876515|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876516|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876517|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1876518|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1876519|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
1876520|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1876521|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1876522|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1876523|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1876524|NCT00223665|Leuprolide|leuprolide|mesh-list
1876525|NCT00223665|Flutamide|flutamide|mesh-list
1876526|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1876527|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
1876528|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1876529|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876530|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876531|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876532|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
1876533|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
1876534|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876535|NCT00223678|Sirolimus|sirolimus|mesh-list
1876536|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1876537|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876538|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1876539|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876540|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
1876541|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876542|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
1876543|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876544|NCT00223704|Icatibant|icatibant|mesh-list
1876545|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
1876546|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1876547|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1876548|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876549|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
1876550|NCT00223704|Coagulants|coagulants|mesh-ancestor
1876551|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1876552|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1876553|NCT00223704|Analgesics|analgesics|mesh-ancestor
1876554|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
1876555|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876556|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876557|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876558|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1876559|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1876560|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1876561|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1876562|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876563|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
1876564|NCT00223821|Oxybutynin|oxybutynin|mesh-list
1876565|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
1876566|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
1876567|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876568|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876569|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1876570|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1876571|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
1876572|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876573|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876574|NCT00223821|Urological Agents|urological agents|mesh-ancestor
1876575|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
1876576|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
1876577|NCT00223977|Hematinics|hematinics|mesh-ancestor
1876578|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
1876579|NCT00224003|Hematinics|hematinics|mesh-ancestor
1876580|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
1876581|NCT00224016|Oxybutynin|oxybutynin|mesh-list
1876582|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
1876583|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
1876584|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876585|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876586|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1876587|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1876588|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
1876589|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876590|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876591|NCT00224016|Urological Agents|urological agents|mesh-ancestor
1876592|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1876593|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876594|NCT00224016|Renal Agents|renal agents|mesh-ancestor
1876595|NCT00224029|Oxybutynin|oxybutynin|mesh-list
1876596|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
1876597|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
1876598|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876599|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876600|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1876601|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1876602|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
1876603|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876604|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876605|NCT00224029|Urological Agents|urological agents|mesh-ancestor
1876606|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
1876607|NCT00224042|Hematinics|hematinics|mesh-ancestor
1876608|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
1876609|NCT00224055|Hematinics|hematinics|mesh-ancestor
1876610|NCT00224107|Silodosin|silodosin|mesh-list
1876611|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1876612|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1876613|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1876614|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
1876615|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876616|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876617|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876618|NCT00224107|Urological Agents|urological agents|mesh-ancestor
1876619|NCT00224120|Silodosin|silodosin|mesh-list
1876620|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1876621|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1876622|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1876623|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
1876624|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876625|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876626|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876627|NCT00224120|Urological Agents|urological agents|mesh-ancestor
1876628|NCT00224133|Silodosin|silodosin|mesh-list
1876629|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1876630|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1876631|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1876632|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
1876633|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876634|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876635|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876636|NCT00224133|Urological Agents|urological agents|mesh-ancestor
1876637|NCT00224289|Latanoprost|latanoprost|mesh-list
1876638|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1876639|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1876640|NCT00224484|Vaccines|vaccines|mesh-list
1876641|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
1876642|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876643|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1876644|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1876645|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1876646|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876647|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
1876648|NCT00224874|Etanercept|etanercept|mesh-list
1876649|NCT00224874|Pentostatin|pentostatin|mesh-list
1876650|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
1876651|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1876652|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876653|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1876654|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
1876655|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1876656|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876657|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876658|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876659|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1876660|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1876661|NCT00224874|Analgesics|analgesics|mesh-ancestor
1876662|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
1876663|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876664|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876665|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876666|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1876667|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876668|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876669|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
1876670|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1876671|NCT00224952|Carbamazepine|carbamazepine|mesh-list
1876672|NCT00224952|Valproic Acid|valproic acid|mesh-list
1876673|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
1876674|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876675|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876676|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
1876677|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876678|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876679|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
1876680|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876681|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876682|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876683|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1876684|NCT00224952|Analgesics|analgesics|mesh-ancestor
1876685|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
1876686|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876687|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1876688|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876689|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1876690|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1876691|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1876692|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1876693|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1876694|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1876695|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
1876696|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876697|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876698|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1876699|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
1876700|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876701|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1876702|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1876703|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876704|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
1876705|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876706|NCT00225212|Rituximab|rituximab|mesh-list
1876707|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876708|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876709|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
1876710|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876711|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1876712|NCT00225251|Bupropion|bupropion|mesh-list
1876713|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1876714|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876715|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876716|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1876717|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876718|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876719|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876720|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
1876721|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876722|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876723|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1876724|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1876725|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876726|NCT00225277|Pioglitazone|pioglitazone|mesh-list
1876727|NCT00225277|Glimepiride|glimepiride|mesh-list
1876728|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1876729|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876730|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1876731|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876732|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
1876733|NCT00225420|Docetaxel|docetaxel|mesh-list
1876734|NCT00225420|Leuprolide|leuprolide|mesh-list
1876735|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876736|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876737|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876738|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876739|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876740|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1876741|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
1876742|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1876743|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876744|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876745|NCT00225498|Olanzapine|olanzapine|mesh-list
1876746|NCT00225498|Risperidone|risperidone|mesh-list
1876747|NCT00225498|Ziprasidone|ziprasidone|mesh-list
1876748|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1876749|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
1876750|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876751|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876752|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876753|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1876754|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876755|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876756|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876757|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1876758|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
1876759|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
1876760|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
1876761|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876762|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876763|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1876764|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1876765|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1876766|NCT00225732|Ibuprofen|ibuprofen|mesh-list
1876767|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1876768|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1876769|NCT00225732|Analgesics|analgesics|mesh-ancestor
1876770|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
1876771|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876772|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876773|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876774|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1876775|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1876776|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876777|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876778|NCT00225758|Lapatinib|lapatinib|mesh-list
1876779|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876780|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1876781|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876782|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876783|NCT00225784|Gemcitabine|gemcitabine|mesh-list
1876784|NCT00225784|Cetuximab|cetuximab|mesh-list
1876785|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876786|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
1876787|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876788|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876789|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
1876790|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876791|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876792|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876793|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
1876794|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876795|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876796|NCT00226239|Docetaxel|docetaxel|mesh-list
1876797|NCT00226239|Cetuximab|cetuximab|mesh-list
1876798|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876799|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876800|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876801|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876802|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876803|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876804|NCT00226577|Gemcitabine|gemcitabine|mesh-list
1876805|NCT00226577|Pemetrexed|pemetrexed|mesh-list
1876806|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876807|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
1876808|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876809|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876810|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
1876811|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876812|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876813|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876814|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
1876815|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876816|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1876817|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1876818|NCT00226590|Gemcitabine|gemcitabine|mesh-list
1876819|NCT00226590|Paclitaxel|paclitaxel|mesh-list
1876820|NCT00226590|Carboplatin|carboplatin|mesh-list
1876821|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1876822|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876823|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876824|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876825|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876826|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876827|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876828|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
1876829|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
1876830|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876831|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876832|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876833|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
1876834|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876835|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
1876836|NCT00226655|Hormones|hormones|mesh-ancestor
1876837|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876838|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876839|NCT00226811|Sunitinib|sunitinib|mesh-list
1876840|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876841|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876842|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876843|NCT00226811|Growth Substances|growth substances|mesh-ancestor
1876844|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876845|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876846|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1876847|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876925|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1876848|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876849|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
1876850|NCT00226941|Promethazine|promethazine|mesh-list
1876851|NCT00226941|Capecitabine|capecitabine|mesh-list
1876852|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
1876853|NCT00226941|Cetuximab|cetuximab|mesh-list
1876854|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876855|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
1876856|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876857|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876858|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876859|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1876860|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1876861|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876862|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876863|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
1876864|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
1876865|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
1876866|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876867|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
1876868|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
1876869|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876870|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1876871|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
1876872|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
1876873|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876874|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1876875|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
1876876|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
1876877|NCT00227019|Vitamins|vitamins|mesh-list
1876878|NCT00227019|Folic Acid|folic acid|mesh-list
1876879|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
1876880|NCT00227019|Hydroxocobalamin|hydroxocobalamin|mesh-list
1876881|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
1876882|NCT00227019|Dexamethasone|dexamethasone|mesh-list
1876883|NCT00227019|Bevacizumab|bevacizumab|mesh-list
1876884|NCT00227019|Pemetrexed|pemetrexed|mesh-list
1876885|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876886|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876887|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876888|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876889|NCT00227019|Growth Substances|growth substances|mesh-ancestor
1876890|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876891|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876892|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
1876893|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876894|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
1876895|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
1876896|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1876897|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1876898|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
1876899|NCT00227019|Hormones|hormones|mesh-ancestor
1876900|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876901|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876902|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876903|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876904|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1876905|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1876906|NCT00227019|Hematinics|hematinics|mesh-ancestor
1876907|NCT00227266|Valproic Acid|valproic acid|mesh-list
1876908|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
1876909|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876910|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876911|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
1876912|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1876913|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876914|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
1876915|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876916|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876917|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876918|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1876919|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
1876920|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1876921|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1876922|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1876923|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1876924|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876926|NCT00227370|Valganciclovir|valganciclovir|mesh-list
1876927|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
1876928|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876929|NCT00227539|Pemetrexed|pemetrexed|mesh-list
1876930|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1876931|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876932|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876933|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876934|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1876935|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1876936|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1876937|NCT00227591|Prednisone|prednisone|mesh-list
1876938|NCT00227591|Lenalidomide|lenalidomide|mesh-list
1876939|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1876940|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
1876941|NCT00227591|Hormones|hormones|mesh-ancestor
1876942|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1876943|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876944|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1876945|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876946|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
1876947|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876948|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876949|NCT00227591|Growth Substances|growth substances|mesh-ancestor
1876950|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876951|NCT00227617|Leucovorin|leucovorin|mesh-list
1876952|NCT00227617|Bevacizumab|bevacizumab|mesh-list
1876953|NCT00227617|Fluorouracil|fluorouracil|mesh-list
1876954|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
1876955|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1876956|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876957|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1876958|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1876959|NCT00227617|Growth Substances|growth substances|mesh-ancestor
1876960|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876961|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
1876962|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
1876963|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876964|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876965|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876966|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
1876967|NCT00227617|Antidotes|antidotes|mesh-ancestor
1876968|NCT00227617|Protective Agents|protective agents|mesh-ancestor
1876969|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
1876970|NCT00227617|Vitamins|vitamins|mesh-ancestor
1876971|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
1876972|NCT00227721|Gemcitabine|gemcitabine|mesh-list
1876973|NCT00227721|Docetaxel|docetaxel|mesh-list
1876974|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1876975|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
1876976|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876977|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876978|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
1876979|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1876980|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876981|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1876982|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
1876983|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1876984|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
1876985|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
1876986|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
1876987|NCT00227760|Cediranib|cediranib|mesh-list
1876988|NCT00227760|Maleic acid|maleic acid|mesh-list
1876989|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876990|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876991|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1876992|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1876993|NCT00227994|Donepezil|donepezil|mesh-list
1876994|NCT00227994|Galantamine|galantamine|mesh-list
1876995|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1876996|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1876997|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1876998|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
1876999|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877000|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877001|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
1877002|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1877003|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
1877004|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877005|NCT00228423|Clopidogrel|clopidogrel|mesh-list
1877006|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1877007|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1877008|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1877009|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1877010|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
1877011|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877012|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877013|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877014|NCT00228553|Modafinil|modafinil|mesh-list
1877015|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1877016|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877017|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1877018|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1877019|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1877020|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877021|NCT00228566|Modafinil|modafinil|mesh-list
1877022|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1877023|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877024|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1877025|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1877026|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1877027|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877028|NCT00228813|Sargramostim|sargramostim|mesh-list
1877029|NCT00228813|Lenograstim|lenograstim|mesh-list
1877030|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
1877031|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877032|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1877033|NCT00228943|Tryptophan|tryptophan|mesh-list
1877034|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1877035|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
1877036|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877037|NCT00229619|Rituximab|rituximab|mesh-list
1877038|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877039|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877040|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
1877041|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877042|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877043|NCT00229658|Pramlintide|pramlintide|mesh-list
1877044|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1877045|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877046|NCT00229723|Gefitinib|gefitinib|mesh-list
1877047|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877048|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877049|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877050|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877051|NCT00229970|Montelukast|montelukast|mesh-list
1877052|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1877053|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
1877054|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1877055|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
1877056|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877057|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877058|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1877059|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1877060|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877061|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1877062|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877063|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877064|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877065|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877066|NCT00230178|Allopurinol|allopurinol|mesh-list
1877067|NCT00230178|Rasburicase|rasburicase|mesh-list
1877068|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
1877069|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877070|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877071|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
1877072|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877073|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1877074|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
1877075|NCT00230178|Protective Agents|protective agents|mesh-ancestor
1877076|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877077|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
1877078|NCT00230282|Fludarabine|fludarabine|mesh-list
1877079|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
1877080|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877081|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
1877082|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877083|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877084|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1877085|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
1877086|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877087|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877088|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1877089|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877090|NCT00230737|Melatonin|melatonin|mesh-list
1877091|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
1877092|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877093|NCT00230737|Protective Agents|protective agents|mesh-ancestor
1877094|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877095|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877096|NCT00230971|Metronidazole|metronidazole|mesh-list
1877097|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
1877098|NCT00230971|Tigecycline|tigecycline|mesh-list
1877099|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877100|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1877101|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1877102|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1877103|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1877104|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877105|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877106|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
1877107|NCT00231153|Povidone|povidone|mesh-list
1877108|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
1877109|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
1877110|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1877111|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877112|NCT00231309|Sargramostim|sargramostim|mesh-list
1877113|NCT00231309|Lenograstim|lenograstim|mesh-list
1877114|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
1877115|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877116|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1877117|NCT00231465|Docetaxel|docetaxel|mesh-list
1877118|NCT00231465|Gefitinib|gefitinib|mesh-list
1877119|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877120|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
1877121|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
1877122|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
1877123|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877124|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877125|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877126|NCT00231478|Granisetron|granisetron|mesh-list
1877127|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
1877128|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
1877129|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877130|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877131|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877132|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1877133|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
1877134|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877135|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877136|NCT00231777|Ondansetron|ondansetron|mesh-list
1877137|NCT00231777|Aprepitant|aprepitant|mesh-list
1877138|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
1877139|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
1877140|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877141|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877142|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877143|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
1877144|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
1877145|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1877146|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
1877147|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877148|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877149|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1877150|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877151|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877152|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877153|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1877154|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1877155|NCT00231842|Ifosfamide|ifosfamide|mesh-list
1877156|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877157|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1877158|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
1877159|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877160|NCT00231868|Paclitaxel|paclitaxel|mesh-list
1877161|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1877162|NCT00231868|Carboplatin|carboplatin|mesh-list
1877163|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1877164|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877165|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
1877166|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
1877167|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
1877168|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877169|NCT00231894|Pioglitazone|pioglitazone|mesh-list
1877170|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1877171|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877172|NCT00232141|Pregabalin|pregabalin|mesh-list
1877173|NCT00232141|Analgesics|analgesics|mesh-ancestor
1877174|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
1877175|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877176|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877177|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
1877178|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1877179|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877180|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877181|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1877182|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1877183|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877184|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877185|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877186|NCT00232180|Eplerenone|eplerenone|mesh-list
1877187|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1877188|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
1877189|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877190|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877191|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1877192|NCT00232180|Diuretics|diuretics|mesh-ancestor
1877193|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
1877194|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1877195|NCT00232479|Carboplatin|carboplatin|mesh-list
1877196|NCT00232479|Docetaxel|docetaxel|mesh-list
1877197|NCT00232479|Trastuzumab|trastuzumab|mesh-list
1877198|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877199|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
1877200|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
1877201|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
1877202|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877203|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877204|NCT00232505|Carboplatin|carboplatin|mesh-list
1877205|NCT00232505|Cetuximab|cetuximab|mesh-list
1877206|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877207|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877208|NCT00232583|Metformin|metformin|mesh-list
1877209|NCT00232583|Pioglitazone|pioglitazone|mesh-list
1877210|NCT00232583|Glyburide|glyburide|mesh-list
1877211|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1877212|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877213|NCT00232596|Ezogabine|ezogabine|mesh-list
1877214|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
1877215|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877216|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877217|NCT00232739|Sirolimus|sirolimus|mesh-list
1877218|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1877219|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877220|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1877221|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877222|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
1877223|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877224|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
1877225|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877226|NCT00233064|Palivizumab|palivizumab|mesh-list
1877227|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
1877228|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877229|NCT00233103|Sertraline|sertraline|mesh-list
1877230|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
1877231|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877232|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1877233|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1877234|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877235|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877236|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877237|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
1877238|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877239|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1877240|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
1877241|NCT00233363|Rebamipide|rebamipide|mesh-list
1877242|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1877243|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877244|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
1877245|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877246|NCT00233363|Protective Agents|protective agents|mesh-ancestor
1877247|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877248|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877249|NCT00233389|Rebamipide|rebamipide|mesh-list
1877250|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1877251|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877252|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
1877253|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877254|NCT00233389|Protective Agents|protective agents|mesh-ancestor
1877255|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877256|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877257|NCT00233454|Midostaurin|midostaurin|mesh-list
1877258|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877259|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877260|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877261|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877262|NCT00233480|Atorvastatin|atorvastatin|mesh-list
1877263|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1877264|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1877265|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
1877266|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877267|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1877268|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1877269|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877270|NCT00233948|Nelfinavir|nelfinavir|mesh-list
1877271|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1877272|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1877273|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
1877274|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877275|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877276|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1877277|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1877278|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
1877279|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877280|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
1877281|NCT00233987|Melphalan|melphalan|mesh-list
1877282|NCT00233987|Carmustine|carmustine|mesh-list
1877283|NCT00233987|Etoposide|etoposide|mesh-list
1877284|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877285|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
1877286|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877287|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877288|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1877289|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
1877290|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877291|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877292|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1877293|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1877294|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1877295|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1877296|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877297|NCT00234039|Gemcitabine|gemcitabine|mesh-list
1877298|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1877299|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
1877300|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877301|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877302|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
1877303|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877304|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877305|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877306|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
1877307|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877308|NCT00234052|Bevacizumab|bevacizumab|mesh-list
1877309|NCT00234052|Carboplatin|carboplatin|mesh-list
1877310|NCT00234052|Pemetrexed|pemetrexed|mesh-list
1877311|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877312|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877313|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1877314|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1877315|NCT00234052|Growth Substances|growth substances|mesh-ancestor
1877316|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877317|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
1877318|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877319|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877320|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1877321|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1877322|NCT00234065|Aspirin|aspirin|mesh-list
1877323|NCT00234065|Cilostazol|cilostazol|mesh-list
1877324|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1877325|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1877326|NCT00234065|Analgesics|analgesics|mesh-ancestor
1877327|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
1877328|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877329|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877330|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877331|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877332|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1877333|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1877334|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877335|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1877336|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1877337|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877338|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
1877339|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1877340|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
1877341|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1877342|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
1877343|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
1877344|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1877345|NCT00234065|Protective Agents|protective agents|mesh-ancestor
1877346|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1877347|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1877348|NCT00234078|Rebamipide|rebamipide|mesh-list
1877349|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1877350|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877351|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
1877352|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877353|NCT00234078|Protective Agents|protective agents|mesh-ancestor
1877354|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877355|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877356|NCT00234104|Tolvaptan|tolvaptan|mesh-list
1877357|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1877358|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877359|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
1877360|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877361|NCT00234494|Gemcitabine|gemcitabine|mesh-list
1877362|NCT00234494|Bevacizumab|bevacizumab|mesh-list
1877363|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877364|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877365|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1877366|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1877367|NCT00234494|Growth Substances|growth substances|mesh-ancestor
1877368|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877369|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
1877370|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1877371|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
1877372|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877373|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
1877374|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877375|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877376|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877377|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
1877378|NCT00234832|Sibutramine|sibutramine|mesh-list
1877379|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
1877380|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877381|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
1877382|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1877383|NCT00234884|Adalimumab|adalimumab|mesh-list
1877384|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877385|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877386|NCT00235391|Deferasirox|deferasirox|mesh-list
1877387|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1877388|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
1877389|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
1877390|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877391|NCT00235443|Lacosamide|lacosamide|mesh-list
1877392|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
1877393|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1877394|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1877395|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877396|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877397|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
1877398|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
1877399|NCT00235573|Vitamins|vitamins|mesh-ancestor
1877400|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
1877401|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877402|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
1877403|NCT00235573|Hematinics|hematinics|mesh-ancestor
1877404|NCT00235716|Vitamins|vitamins|mesh-list
1877405|NCT00235716|Vitamin E|vitamin e|mesh-list
1877406|NCT00235716|Tocopherols|tocopherols|mesh-list
1877407|NCT00235716|Tocotrienols|tocotrienols|mesh-list
1877408|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
1877409|NCT00235716|Memantine|memantine|mesh-list
1877410|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
1877411|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877412|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
1877413|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877414|NCT00235716|Protective Agents|protective agents|mesh-ancestor
1877415|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1877416|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1877417|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
1877418|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877419|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1877420|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1877421|NCT00235755|Ezogabine|ezogabine|mesh-list
1877422|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
1877423|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877424|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877425|NCT00235833|Adalimumab|adalimumab|mesh-list
1877426|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877427|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877428|NCT00235872|Adalimumab|adalimumab|mesh-list
1877429|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877430|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877431|NCT00235989|Interferons|interferons|mesh-list
1877432|NCT00235989|Interferon-beta|interferon-beta|mesh-list
1877433|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
1877434|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877435|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
1877436|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877437|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
1877438|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877439|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1877440|NCT00236080|Modafinil|modafinil|mesh-list
1877441|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1877442|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877443|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1877444|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1877445|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1877446|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877447|NCT00236184|Rabeprazole|rabeprazole|mesh-list
1877448|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1877449|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877450|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1877451|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877452|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877453|NCT00236197|Rabeprazole|rabeprazole|mesh-list
1877454|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1877455|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877456|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1877457|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877458|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877459|NCT00236899|Gemcitabine|gemcitabine|mesh-list
1877460|NCT00236899|Paclitaxel|paclitaxel|mesh-list
1877461|NCT00236899|Docetaxel|docetaxel|mesh-list
1877462|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1877463|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877464|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
1877465|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
1877466|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
1877467|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877468|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1877469|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
1877470|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
1877471|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877472|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877473|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877474|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
1877475|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877476|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
1877477|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1877478|NCT00236938|Hematinics|hematinics|mesh-ancestor
1877479|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
1877480|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1877481|NCT00236951|Hematinics|hematinics|mesh-ancestor
1877482|NCT00236977|Iron|iron|mesh-list
1877483|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1877484|NCT00236977|Trace Elements|trace elements|mesh-ancestor
1877485|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
1877486|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877487|NCT00236977|Hematinics|hematinics|mesh-ancestor
1877488|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
1877489|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1877490|NCT00237042|Estradiol|estradiol|mesh-list
1877491|NCT00237042|Estrogens|estrogens|mesh-ancestor
1877492|NCT00237042|Hormones|hormones|mesh-ancestor
1877493|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877494|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877495|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1877496|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
1877497|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1877498|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1877499|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1877500|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1877501|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1877502|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
1877503|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877504|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877505|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877506|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877507|NCT00237458|Lacosamide|lacosamide|mesh-list
1877508|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
1877509|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1877510|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1877511|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877512|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877513|NCT00237666|Ziprasidone|ziprasidone|mesh-list
1877514|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1877515|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
1877516|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877517|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877518|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877519|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1877520|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877521|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877522|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877523|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1877524|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
1877525|NCT00237718|Vitamin E|vitamin e|mesh-list
1877526|NCT00237718|Tocopherols|tocopherols|mesh-list
1877527|NCT00237718|Tocotrienols|tocotrienols|mesh-list
1877528|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
1877529|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
1877530|NCT00237718|Vitamins|vitamins|mesh-ancestor
1877531|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
1877532|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877533|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
1877534|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877535|NCT00237718|Protective Agents|protective agents|mesh-ancestor
1877536|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
1877537|NCT00238108|Melatonin|melatonin|mesh-list
1877538|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
1877539|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877540|NCT00238108|Protective Agents|protective agents|mesh-ancestor
1877541|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877542|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877543|NCT00238121|Sorafenib|sorafenib|mesh-list
1877544|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877545|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877546|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877547|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877548|NCT00238238|Rituximab|rituximab|mesh-list
1877549|NCT00238238|Lenalidomide|lenalidomide|mesh-list
1877550|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877551|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877552|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
1877553|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877554|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877555|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1877556|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1877557|NCT00238238|Growth Substances|growth substances|mesh-ancestor
1877558|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
1877559|NCT00238303|Vorinostat|vorinostat|mesh-list
1877560|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877561|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1877562|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877563|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877564|NCT00238355|Voriconazole|voriconazole|mesh-list
1877565|NCT00238355|Caspofungin|caspofungin|mesh-list
1877566|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
1877567|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877568|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1877569|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1877570|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877571|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877572|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1877573|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
1877574|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877575|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877576|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1877593|NCT00238433|Melphalan|melphalan|mesh-list
1877594|NCT00238433|Busulfan|busulfan|mesh-list
1877595|NCT00238433|Thiotepa|thiotepa|mesh-list
1877596|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
1877597|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877598|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1877599|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
1877600|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877601|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877602|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1877603|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877604|NCT00238615|Carboplatin|carboplatin|mesh-list
1877605|NCT00238615|Docetaxel|docetaxel|mesh-list
1877606|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877607|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
1877608|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
1877609|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
1877610|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877611|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
1877612|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1877613|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877614|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1877615|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
1877616|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1877617|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877618|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877619|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877620|NCT00239356|Aripiprazole|aripiprazole|mesh-list
1877621|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
1877622|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877623|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1877624|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877625|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877626|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877627|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
1877628|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
1877629|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877630|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877631|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1877632|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1877633|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
1877634|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1877635|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1877636|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1877637|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1877638|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
1877639|NCT00239590|Testosterone|testosterone|mesh-list
1877640|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
1877641|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
1877642|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1877643|NCT00239590|Androgens|androgens|mesh-ancestor
1877644|NCT00239590|Hormones|hormones|mesh-ancestor
1877645|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877646|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877647|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1877648|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877649|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
1877650|NCT00239642|Iron|iron|mesh-list
1877651|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1877652|NCT00239642|Trace Elements|trace elements|mesh-ancestor
1877653|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
1877654|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877655|NCT00239642|Hematinics|hematinics|mesh-ancestor
1877656|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1877657|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1877658|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1877659|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
1877660|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877661|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1877662|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1877663|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877664|NCT00240071|Tamoxifen|tamoxifen|mesh-list
1877665|NCT00240071|Bevacizumab|bevacizumab|mesh-list
1877666|NCT00240071|Letrozole|letrozole|mesh-list
1877667|NCT00240071|Exemestane|exemestane|mesh-list
1877668|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877669|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877670|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1877671|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1877672|NCT00240071|Growth Substances|growth substances|mesh-ancestor
1877673|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877674|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
1877675|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1877676|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1877677|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877678|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877679|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1877680|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
1877681|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877682|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1877683|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1877684|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1877685|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1877686|NCT00240097|Carboplatin|carboplatin|mesh-list
1877687|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
1877688|NCT00240097|Irinotecan|irinotecan|mesh-list
1877689|NCT00240097|Etoposide|etoposide|mesh-list
1877690|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877691|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1877692|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1877693|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877694|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877695|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1877696|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1877697|NCT00240110|Valproic Acid|valproic acid|mesh-list
1877698|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
1877699|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
1877700|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877701|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877702|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877703|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
1877704|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877705|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877706|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877707|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
1877708|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
1877709|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877710|NCT00240162|Vatalanib|vatalanib|mesh-list
1877711|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877712|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877713|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877714|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1877715|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1877716|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1877717|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
1877718|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877719|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1877720|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1877721|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877722|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
1877723|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1877724|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
1877725|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877726|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877727|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1877728|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
1877729|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1877730|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
1877731|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877732|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877733|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1877734|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
1877735|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
1877736|NCT00240487|Protective Agents|protective agents|mesh-ancestor
1877737|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
1877738|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1877739|NCT00240526|Antibodies|antibodies|mesh-list
1877740|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
1877741|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877742|NCT00240981|Testosterone|testosterone|mesh-list
1877743|NCT00240981|Androgens|androgens|mesh-ancestor
1877744|NCT00240981|Hormones|hormones|mesh-ancestor
1877745|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877746|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877747|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
1877748|NCT00240994|Sirolimus|sirolimus|mesh-list
1877749|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
1877750|NCT00240994|Tacrolimus|tacrolimus|mesh-list
1877751|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877752|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
1877753|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877754|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1877755|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877756|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877757|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1877758|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877759|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1877760|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
1877761|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1877762|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877763|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
1877764|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877765|NCT00241176|Aripiprazole|aripiprazole|mesh-list
1877766|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
1877767|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877768|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1877769|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877770|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877771|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877772|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
1877773|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
1877774|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877775|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877776|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1877777|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1877778|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
1877779|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1877780|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1877781|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1877782|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1877783|NCT00241358|Plerixafor|plerixafor|mesh-list
1877784|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1877785|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1877786|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
1877787|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877788|NCT00241631|Fluticasone|fluticasone|mesh-list
1877789|NCT00241631|Xhance|xhance|mesh-list
1877790|NCT00241631|Theophylline|theophylline|mesh-list
1877791|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877792|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1877793|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
1877794|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877795|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877796|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1877797|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
1877798|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
1877799|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1877800|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1877801|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877802|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877803|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
1877804|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1877805|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1877806|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
1877807|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877808|NCT00241644|Vaccines|vaccines|mesh-list
1877809|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
1877810|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877811|NCT00241839|Allopurinol|allopurinol|mesh-list
1877812|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
1877813|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
1877814|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877815|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877816|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
1877817|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877818|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1877819|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
1877820|NCT00241839|Protective Agents|protective agents|mesh-ancestor
1877821|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877822|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1877823|NCT00241839|Diuretics|diuretics|mesh-ancestor
1877824|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
1877825|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1877826|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877827|NCT00241904|Propranolol|propranolol|mesh-list
1877828|NCT00241904|Metoprolol|metoprolol|mesh-list
1877829|NCT00241904|Atenolol|atenolol|mesh-list
1877830|NCT00241904|Lisinopril|lisinopril|mesh-list
1877831|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1877832|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1877907|NCT00242632|Memantine|memantine|mesh-list
1877833|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1877834|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1877835|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
1877836|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877837|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877838|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877839|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1877840|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1877841|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
1877842|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
1877843|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
1877844|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877845|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1877846|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
1877847|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877848|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1877849|NCT00241904|Protective Agents|protective agents|mesh-ancestor
1877850|NCT00242216|Ritonavir|ritonavir|mesh-list
1877851|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1877852|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
1877853|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1877854|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1877855|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
1877856|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877857|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877858|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1877859|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1877860|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
1877861|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1877862|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1877863|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1877864|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
1877865|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1877866|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877867|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877868|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1877869|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1877870|NCT00242502|Bevacizumab|bevacizumab|mesh-list
1877871|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1877872|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877873|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877874|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1877875|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1877876|NCT00242502|Growth Substances|growth substances|mesh-ancestor
1877877|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877878|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
1877879|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877880|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877881|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877882|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
1877883|NCT00242567|Androgens|androgens|mesh-list
1877884|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1877885|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877886|NCT00242567|Hormones|hormones|mesh-ancestor
1877887|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877888|NCT00242580|Triamcinolone|triamcinolone|mesh-list
1877889|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1877890|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1877891|NCT00242580|Verteporfin|verteporfin|mesh-list
1877892|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1877893|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877894|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
1877895|NCT00242580|Hormones|hormones|mesh-ancestor
1877896|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877897|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877898|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877899|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
1877900|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877901|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877902|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1877903|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
1877904|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
1877905|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1877906|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877908|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1877909|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1877910|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
1877911|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1877912|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877913|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877914|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1877915|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1877916|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
1877917|NCT00242710|Estrogens|estrogens|mesh-list
1877918|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1877919|NCT00242710|Hormones|hormones|mesh-ancestor
1877920|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877921|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877922|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1877923|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1877924|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
1877925|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1877926|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
1877927|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
1877928|NCT00243022|Vitamins|vitamins|mesh-ancestor
1877929|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
1877930|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877931|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
1877932|NCT00243022|Hematinics|hematinics|mesh-ancestor
1877933|NCT00243061|Cediranib|cediranib|mesh-list
1877934|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877935|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877936|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877937|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877938|NCT00243074|Cediranib|cediranib|mesh-list
1877939|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877940|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877941|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877942|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877943|NCT00243152|Lamotrigine|lamotrigine|mesh-list
1877944|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
1877945|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1877946|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1877947|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877948|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1877949|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877950|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1877951|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1877952|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1877953|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1877954|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1877955|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
1877956|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877957|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877958|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877959|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877960|NCT00243347|Cediranib|cediranib|mesh-list
1877961|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877962|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1877963|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877964|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877965|NCT00243386|Factor VIII|factor viii|mesh-list
1877966|NCT00243386|Coagulants|coagulants|mesh-ancestor
1877967|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
1877968|NCT00243412|Rituximab|rituximab|mesh-list
1877969|NCT00243412|Methotrexate|methotrexate|mesh-list
1877970|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877971|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1877972|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
1877973|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1877974|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1877975|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1877976|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
1877977|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1877978|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1877979|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
1877980|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1877981|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
1877982|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1877983|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1877984|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1877985|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1877986|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1877987|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
1877988|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
1877989|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1877990|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1877991|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
1877992|NCT00243412|Hormones|hormones|mesh-ancestor
1877993|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1877994|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1877995|NCT00243412|Protective Agents|protective agents|mesh-ancestor
1877996|NCT00243503|Trastuzumab|trastuzumab|mesh-list
1877997|NCT00243503|Sunitinib|sunitinib|mesh-list
1877998|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1877999|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878000|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1878001|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1878002|NCT00243503|Growth Substances|growth substances|mesh-ancestor
1878003|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878004|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
1878005|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878006|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878007|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878008|NCT00243659|Factor VIII|factor viii|mesh-list
1878009|NCT00243659|Coagulants|coagulants|mesh-ancestor
1878010|NCT00243932|Ubiquinone|ubiquinone|mesh-list
1878011|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
1878012|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
1878013|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878014|NCT00243932|Vitamins|vitamins|mesh-ancestor
1878015|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1878016|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
1878017|NCT00244374|Vaccines|vaccines|mesh-list
1878018|NCT00244374|Immunologic Factors|immunologic factors|mesh-ancestor
1878019|NCT00244374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878020|NCT00244621|Candesartan|candesartan|mesh-list
1878021|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
1878022|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878023|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1878024|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1878025|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878026|NCT00244712|Tenofovir|tenofovir|mesh-list
1878027|NCT00244712|Lamivudine|lamivudine|mesh-list
1878028|NCT00244712|Emtricitabine|emtricitabine|mesh-list
1878029|NCT00244712|Abacavir|abacavir|mesh-list
1878030|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
1878031|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878032|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1878033|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1878034|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878035|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878036|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1878037|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1878038|NCT00244725|Warfarin|warfarin|mesh-list
1878039|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
1878040|NCT00244855|Dexamethasone|dexamethasone|mesh-list
1878041|NCT00244855|Rituximab|rituximab|mesh-list
1878042|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878043|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
1878044|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
1878045|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878046|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878047|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878048|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
1878049|NCT00244855|Hormones|hormones|mesh-ancestor
1878050|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878051|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1878052|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878053|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878054|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
1878055|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878056|NCT00244881|Cediranib|cediranib|mesh-list
1878057|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878058|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878059|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878060|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878061|NCT00244933|Gemcitabine|gemcitabine|mesh-list
1878062|NCT00244933|Genistein|genistein|mesh-list
1878063|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878064|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
1878065|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878066|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878067|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
1878068|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878069|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878070|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878071|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
1878072|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878073|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1878074|NCT00244933|Protective Agents|protective agents|mesh-ancestor
1878075|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878076|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
1878077|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1878078|NCT00244933|Estrogens|estrogens|mesh-ancestor
1878079|NCT00244933|Hormones|hormones|mesh-ancestor
1878080|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878081|NCT00244985|Rituximab|rituximab|mesh-list
1878082|NCT00244985|Doxorubicin|doxorubicin|mesh-list
1878083|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1878084|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878085|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878086|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
1878087|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878088|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878089|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1878090|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1878091|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1878092|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878093|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878094|NCT00245011|Ifosfamide|ifosfamide|mesh-list
1878095|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
1878096|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878097|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878098|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
1878099|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878100|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878101|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1878102|NCT00245011|Analgesics|analgesics|mesh-ancestor
1878103|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
1878104|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878105|NCT00245037|Cyclosporine|cyclosporine|mesh-list
1878106|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
1878107|NCT00245037|Methotrexate|methotrexate|mesh-list
1878108|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
1878109|NCT00245037|Fludarabine|fludarabine|mesh-list
1878110|NCT00245037|Busulfan|busulfan|mesh-list
1878111|NCT00245037|Phenytoin|phenytoin|mesh-list
1878112|NCT00245037|Cyclosporins|cyclosporins|mesh-list
1878113|NCT00245037|Sargramostim|sargramostim|mesh-list
1878114|NCT00245037|Lenograstim|lenograstim|mesh-list
1878115|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1878116|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
1878117|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1878118|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878119|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878120|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
1878121|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878122|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878123|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
1878124|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878125|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1878126|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878127|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
1878128|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878129|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1878130|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
1878131|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878132|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1878133|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1878134|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1878135|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
1878136|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1878137|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
1878138|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878139|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1878140|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1878141|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
1878142|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1878143|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1878144|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878145|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1878146|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1878147|NCT00245050|Pyridoxine|pyridoxine|mesh-list
1878148|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
1878149|NCT00245050|Doxorubicin|doxorubicin|mesh-list
1878150|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1878151|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1878152|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878153|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1878154|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1878155|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878156|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878157|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
1878158|NCT00245050|Vitamins|vitamins|mesh-ancestor
1878159|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
1878160|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878161|NCT00245063|Cediranib|cediranib|mesh-list
1878162|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878163|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878164|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878165|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878166|NCT00245102|Sorafenib|sorafenib|mesh-list
1878167|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878168|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878169|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878170|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878171|NCT00245557|Sertraline|sertraline|mesh-list
1878172|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878173|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878174|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1878175|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878176|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878177|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878178|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878179|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
1878180|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878181|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1878182|NCT00245570|Montelukast|montelukast|mesh-list
1878183|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1878184|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
1878185|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878186|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878187|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1878188|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
1878189|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1878190|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1878191|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1878192|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
1878193|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878194|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878195|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1878196|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
1878197|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878198|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1878199|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1878200|NCT00245583|Topiramate|topiramate|mesh-list
1878201|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
1878202|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1878203|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878204|NCT00245635|Fluoxetine|fluoxetine|mesh-list
1878205|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1878206|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878207|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878208|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878209|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878210|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
1878211|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878212|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1878213|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878214|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878215|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1878216|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1878217|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878218|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
1878219|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878220|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
1878221|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878222|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878223|NCT00245856|Dalteparin|dalteparin|mesh-list
1878224|NCT00245856|Tinzaparin|tinzaparin|mesh-list
1878225|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1878226|NCT00245856|Warfarin|warfarin|mesh-list
1878227|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
1878228|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1878229|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1878230|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878243|NCT00246012|Dacarbazine|dacarbazine|mesh-list
1878244|NCT00246012|Intetumumab|intetumumab|mesh-list
1878245|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878246|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
1878247|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878248|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878249|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878250|NCT00246025|Dabigatran|dabigatran|mesh-list
1878251|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
1878252|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1878253|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
1878254|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878255|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878256|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
1878257|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
1878258|NCT00246129|Daclizumab|daclizumab|mesh-list
1878259|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878260|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878261|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878262|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
1878263|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878264|NCT00246259|Risperidone|risperidone|mesh-list
1878265|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
1878266|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1878267|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
1878268|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878269|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878270|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878271|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878272|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878273|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878274|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1878275|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
1878276|NCT00246324|Interferons|interferons|mesh-list
1878277|NCT00246324|Interferon-beta|interferon-beta|mesh-list
1878278|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
1878279|NCT00246324|Doxycycline|doxycycline|mesh-list
1878280|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878281|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
1878282|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878283|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1878284|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
1878285|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1878286|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1878287|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
1878288|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878289|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1878290|NCT00246337|Rizatriptan|rizatriptan|mesh-list
1878291|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1878292|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
1878293|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878294|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878295|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878296|NCT00246376|Niacin|niacin|mesh-list
1878297|NCT00246376|Fenofibrate|fenofibrate|mesh-list
1878298|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1878299|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
1878300|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878301|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1878302|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
1878303|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
1878304|NCT00246376|Vitamins|vitamins|mesh-ancestor
1878305|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
1878306|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878307|NCT00246441|Paroxetine|paroxetine|mesh-list
1878308|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1878309|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878310|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878311|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878312|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878313|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
1878314|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878315|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1878316|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878317|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878318|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1878319|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1878320|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878321|NCT00246519|Atenolol|atenolol|mesh-list
1878322|NCT00246519|Metoprolol|metoprolol|mesh-list
1878323|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1878324|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
1878325|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878326|NCT00246519|Diuretics|diuretics|mesh-ancestor
1878327|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
1878328|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878329|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1878330|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878331|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878332|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1878333|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
1878334|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
1878335|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878336|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1878337|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1878338|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1878339|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
1878340|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878341|NCT00246571|Sunitinib|sunitinib|mesh-list
1878342|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878343|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1878344|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1878345|NCT00246571|Growth Substances|growth substances|mesh-ancestor
1878346|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878347|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
1878348|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878349|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878350|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878351|NCT00246740|Doxycycline|doxycycline|mesh-list
1878352|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1878353|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878354|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
1878355|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1878356|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1878357|NCT00246753|Lapatinib|lapatinib|mesh-list
1878358|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878359|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878360|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878361|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878362|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
1878363|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
1878364|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1878365|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878366|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878367|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1878368|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878369|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1878370|NCT00247416|Gemcitabine|gemcitabine|mesh-list
1878371|NCT00247416|Dexamethasone|dexamethasone|mesh-list
1878372|NCT00247416|Carboplatin|carboplatin|mesh-list
1878373|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878374|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
1878375|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
1878376|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878377|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878378|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878379|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
1878380|NCT00247416|Hormones|hormones|mesh-ancestor
1878381|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878382|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1878383|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878384|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878385|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
1878386|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878387|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
1878388|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878389|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878390|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878391|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
1878392|NCT00247624|Eszopiclone|eszopiclone|mesh-list
1878393|NCT00247624|Fluoxetine|fluoxetine|mesh-list
1878394|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1878395|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878396|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878397|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878398|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878399|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
1878400|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878401|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1878402|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878403|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878404|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1878405|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1878406|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878407|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1878408|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878409|NCT00247676|Sunitinib|sunitinib|mesh-list
1878410|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878411|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1878412|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1878413|NCT00247676|Growth Substances|growth substances|mesh-ancestor
1878414|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878415|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
1878416|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878417|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878418|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878419|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
1878420|NCT00247962|Etanercept|etanercept|mesh-list
1878421|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1878422|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1878423|NCT00247962|Analgesics|analgesics|mesh-ancestor
1878424|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
1878425|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878426|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878427|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878428|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878429|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878430|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878431|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
1878432|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878433|NCT00248170|Letrozole|letrozole|mesh-list
1878434|NCT00248170|Anastrozole|anastrozole|mesh-list
1878435|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878436|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1878437|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1878438|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878439|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878440|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1878441|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
1878442|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878443|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878444|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1878454|NCT00248495|Pemetrexed|pemetrexed|mesh-list
1878455|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878456|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878457|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878458|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1878459|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1878460|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
1878461|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1878462|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1878463|NCT00248534|Prednisolone|prednisolone|mesh-list
1878464|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
1878465|NCT00248534|Rituximab|rituximab|mesh-list
1878466|NCT00248534|Temozolomide|temozolomide|mesh-list
1878467|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1878468|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
1878469|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878470|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878471|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
1878472|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878473|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878474|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878475|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
1878476|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878477|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878478|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
1878479|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
1878480|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878481|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878482|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
1878483|NCT00248534|Hormones|hormones|mesh-ancestor
1878484|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878485|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1878486|NCT00248534|Protective Agents|protective agents|mesh-ancestor
1878487|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1878488|NCT00248547|Dexamethasone|dexamethasone|mesh-list
1878489|NCT00248547|Ondansetron|ondansetron|mesh-list
1878490|NCT00248547|Aprepitant|aprepitant|mesh-list
1878491|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878492|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
1878493|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
1878494|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878495|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878496|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878497|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
1878498|NCT00248547|Hormones|hormones|mesh-ancestor
1878499|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878500|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1878501|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878502|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
1878503|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
1878504|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1878505|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
1878506|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878507|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878508|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1878509|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878510|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878511|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878512|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1878513|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1878514|NCT00248560|Gemcitabine|gemcitabine|mesh-list
1878515|NCT00248560|Docetaxel|docetaxel|mesh-list
1878516|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878517|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
1878518|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878519|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878520|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
1878521|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878522|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878523|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878524|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
1878525|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878526|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
1878527|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
1878528|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
1878529|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1878530|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1878531|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878532|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878533|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878534|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878535|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878536|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1878537|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878538|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878539|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
1878540|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1878541|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
1878542|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878543|NCT00248625|Expectorants|expectorants|mesh-ancestor
1878544|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
1878545|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1878546|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
1878547|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878548|NCT00248625|Protective Agents|protective agents|mesh-ancestor
1878549|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878550|NCT00248625|Antidotes|antidotes|mesh-ancestor
1878551|NCT00248651|Amitriptyline|amitriptyline|mesh-list
1878552|NCT00248651|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1878553|NCT00248651|Citalopram|citalopram|mesh-list
1878554|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1878555|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878556|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878557|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878558|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878559|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
1878560|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878561|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1878562|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878563|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878564|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878565|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1878566|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1878567|NCT00248651|Analgesics|analgesics|mesh-ancestor
1878568|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
1878569|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1878570|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
1878571|NCT00248651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1878572|NCT00248651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878573|NCT00248651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878574|NCT00248807|Enalaprilat|enalaprilat|mesh-list
1878575|NCT00248807|Enalapril|enalapril|mesh-list
1878576|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1878577|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
1878578|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878579|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878580|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878581|NCT00248833|Vaccines|vaccines|mesh-list
1878582|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
1878583|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878584|NCT00249002|Paclitaxel|paclitaxel|mesh-list
1878585|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1878586|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1878587|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878588|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
1878589|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
1878590|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
1878591|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878592|NCT00249249|Atorvastatin|atorvastatin|mesh-list
1878593|NCT00249249|Pitavastatin|pitavastatin|mesh-list
1878594|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1878595|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1878596|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
1878597|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878598|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1878599|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1878600|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878601|NCT00249288|Folic Acid|folic acid|mesh-list
1878602|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
1878603|NCT00249288|Hematinics|hematinics|mesh-ancestor
1878604|NCT00249288|Vitamins|vitamins|mesh-ancestor
1878605|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
1878606|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878607|NCT00249379|Acamprosate|acamprosate|mesh-list
1878608|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1878609|NCT00249444|Mirtazapine|mirtazapine|mesh-list
1878610|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878611|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878612|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1878613|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
1878614|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
1878615|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878616|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878617|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878618|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1878619|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878620|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878621|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1878622|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1878623|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1878624|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
1878625|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1878626|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1878627|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
1878628|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1878629|NCT00249769|Vaccines|vaccines|mesh-list
1878630|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
1878631|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878632|NCT00249795|Irbesartan|irbesartan|mesh-list
1878633|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878634|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1878635|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1878636|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878637|NCT00249808|Antibodies|antibodies|mesh-list
1878638|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1878639|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
1878640|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878641|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1878642|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1878643|NCT00249834|Hormones|hormones|mesh-ancestor
1878644|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878645|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878646|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1878647|NCT00249873|Clopidogrel|clopidogrel|mesh-list
1878648|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1878649|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1878650|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1878651|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1878652|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
1878653|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878803|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878654|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878655|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878656|NCT00250432|Caspofungin|caspofungin|mesh-list
1878657|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
1878658|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878659|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878660|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878661|NCT00250458|Rizatriptan|rizatriptan|mesh-list
1878662|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1878663|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
1878664|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878665|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878666|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878667|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
1878668|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1878669|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
1878670|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878671|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878672|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1878673|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
1878674|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1878675|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1878676|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1878677|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
1878678|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878679|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878680|NCT00250705|Aripiprazole|aripiprazole|mesh-list
1878681|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878682|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878683|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1878684|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878685|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878686|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878687|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
1878688|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
1878689|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878690|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878691|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1878692|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1878693|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
1878694|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1878695|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1878696|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1878697|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1878698|NCT00250835|Celecoxib|celecoxib|mesh-list
1878699|NCT00250835|Capecitabine|capecitabine|mesh-list
1878700|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
1878701|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878702|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
1878703|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878704|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878705|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1878706|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1878707|NCT00250835|Analgesics|analgesics|mesh-ancestor
1878708|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
1878709|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878710|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878711|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878712|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878713|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1878714|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1878715|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878716|NCT00250926|Dexamethasone|dexamethasone|mesh-list
1878717|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
1878718|NCT00250926|Rituximab|rituximab|mesh-list
1878719|NCT00250926|Bortezomib|bortezomib|mesh-list
1878720|NCT00250926|BB 1101|bb 1101|mesh-list
1878721|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1878722|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
1878723|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
1878724|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1878725|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878726|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878727|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
1878728|NCT00250926|Hormones|hormones|mesh-ancestor
1878729|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1878730|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1878731|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878732|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
1878733|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878734|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878735|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878736|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
1878737|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878738|NCT00251004|Cyclosporine|cyclosporine|mesh-list
1878739|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
1878740|NCT00251004|Everolimus|everolimus|mesh-list
1878741|NCT00251004|Cyclosporins|cyclosporins|mesh-list
1878742|NCT00251004|Basiliximab|basiliximab|mesh-list
1878743|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878744|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878745|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878746|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
1878747|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878748|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
1878749|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1878750|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
1878751|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878752|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1878753|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878754|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1878755|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1878756|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
1878757|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1878758|NCT00251225|Docetaxel|docetaxel|mesh-list
1878759|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
1878760|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878761|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
1878762|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
1878763|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
1878764|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878765|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878766|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878767|NCT00251303|Riluzole|riluzole|mesh-list
1878768|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
1878769|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1878770|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1878771|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878772|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878773|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878774|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1878775|NCT00251303|Protective Agents|protective agents|mesh-ancestor
1878776|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
1878777|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878778|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878779|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878780|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878781|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
1878782|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878783|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878784|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878785|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1878786|NCT00251589|Vorinostat|vorinostat|mesh-list
1878787|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878788|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878789|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878790|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878791|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1878792|NCT00251641|Methotrexate|methotrexate|mesh-list
1878793|NCT00251641|Infliximab|infliximab|mesh-list
1878794|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1878795|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
1878796|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1878797|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878798|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878799|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
1878800|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878801|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878802|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
1878804|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1878805|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878806|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
1878807|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878808|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1878809|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878810|NCT00251693|Lansoprazole|lansoprazole|mesh-list
1878811|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
1878812|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1878813|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878814|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1878815|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878816|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878817|NCT00251719|Lansoprazole|lansoprazole|mesh-list
1878818|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
1878819|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1878820|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878821|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1878822|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878823|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878824|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
1878825|NCT00251745|Lansoprazole|lansoprazole|mesh-list
1878826|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1878827|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878828|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1878829|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878830|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878831|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
1878832|NCT00251758|Lansoprazole|lansoprazole|mesh-list
1878833|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1878834|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878835|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1878836|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878837|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878838|NCT00251927|Esomeprazole|esomeprazole|mesh-list
1878839|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1878840|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878841|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1878842|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878843|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878844|NCT00251979|Esomeprazole|esomeprazole|mesh-list
1878845|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1878846|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1878847|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1878848|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878849|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878850|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1878851|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
1878852|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878853|NCT00252239|Plasminogen|plasminogen|mesh-list
1878854|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1878855|NCT00252239|Tenecteplase|tenecteplase|mesh-list
1878856|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1878857|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1878858|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878859|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
1878860|NCT00252499|Fenofibrate|fenofibrate|mesh-list
1878861|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1878862|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878863|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1878864|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
1878865|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878866|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1878867|NCT00252564|Leucovorin|leucovorin|mesh-list
1878868|NCT00252564|Bevacizumab|bevacizumab|mesh-list
1878869|NCT00252564|Cetuximab|cetuximab|mesh-list
1878870|NCT00252564|Fluorouracil|fluorouracil|mesh-list
1878871|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
1878872|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1878873|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878874|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1878875|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1878876|NCT00252564|Growth Substances|growth substances|mesh-ancestor
1878877|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878878|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
1878879|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
1878880|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878881|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1878882|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878883|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
1878884|NCT00252564|Antidotes|antidotes|mesh-ancestor
1878885|NCT00252564|Protective Agents|protective agents|mesh-ancestor
1878886|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
1878887|NCT00252564|Vitamins|vitamins|mesh-ancestor
1878888|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
1878889|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
1878890|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878891|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878892|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878893|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878894|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
1878895|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878896|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878897|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878898|NCT00252694|Candesartan|candesartan|mesh-list
1878899|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878900|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1878901|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1878902|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878903|NCT00252720|Candesartan|candesartan|mesh-list
1878904|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878905|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1878906|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1878907|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878908|NCT00252733|Candesartan|candesartan|mesh-list
1878909|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
1878910|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1878911|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1878912|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1878913|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878914|NCT00252967|Atorvastatin|atorvastatin|mesh-list
1878915|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1878916|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1878917|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
1878918|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878919|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1878920|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1878921|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878922|NCT00253370|Cisplatin|cisplatin|mesh-list
1878923|NCT00253370|Docetaxel|docetaxel|mesh-list
1878924|NCT00253370|Sorafenib|sorafenib|mesh-list
1878925|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878926|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
1878927|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
1878928|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
1878929|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878930|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1878931|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878932|NCT00253435|Carboplatin|carboplatin|mesh-list
1878933|NCT00253435|Etoposide|etoposide|mesh-list
1878934|NCT00253435|Melphalan|melphalan|mesh-list
1878935|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878936|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1878937|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1878938|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1878939|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878940|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878941|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
1878942|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878943|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878944|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
1878945|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1878946|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878947|NCT00253513|Fludarabine|fludarabine|mesh-list
1878948|NCT00253513|Treosulfan|treosulfan|mesh-list
1878949|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878950|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878951|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878952|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
1878953|NCT00253630|Vorinostat|vorinostat|mesh-list
1878954|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878955|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1878956|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1878957|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878958|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
1878959|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
1878960|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878961|NCT00253643|Protective Agents|protective agents|mesh-ancestor
1878962|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878963|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1878964|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1878965|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1878966|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1878967|NCT00253747|Methylphenidate|methylphenidate|mesh-list
1878968|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1878969|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878970|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1878971|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878972|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878973|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878974|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
1878975|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878976|NCT00253890|Trazodone|trazodone|mesh-list
1878977|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1878978|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1878979|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1878980|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878981|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1878982|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1878983|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1878984|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1878985|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1878986|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1878987|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
1878988|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1878989|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
1878990|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
1878991|NCT00254163|Rituximab|rituximab|mesh-list
1878992|NCT00254163|Fludarabine|fludarabine|mesh-list
1878993|NCT00254163|Pentostatin|pentostatin|mesh-list
1878994|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1878995|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
1878996|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1878997|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1878998|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1878999|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
1879000|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879001|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879002|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879003|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879004|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1879005|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879006|NCT00254293|Abatacept|abatacept|mesh-list
1879007|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1879008|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1879009|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879010|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879011|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879012|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
1879013|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879014|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879015|NCT00254397|Leuprolide|leuprolide|mesh-list
1879016|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1879017|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
1879018|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1879019|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879020|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879021|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879022|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
1879023|NCT00254410|Rituximab|rituximab|mesh-list
1879024|NCT00254410|Fludarabine|fludarabine|mesh-list
1879025|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
1879026|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879027|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
1879028|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879029|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879030|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879031|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
1879032|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879033|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879034|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879035|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879036|NCT00254410|Analgesics|analgesics|mesh-ancestor
1879037|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
1879038|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879039|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879040|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879041|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879042|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1879043|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1879044|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1879045|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879046|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879047|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
1879048|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879049|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879050|NCT00254488|Valproic Acid|valproic acid|mesh-list
1879051|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879052|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879053|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879054|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
1879055|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879056|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879057|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879058|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
1879059|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
1879060|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879061|NCT00254540|Sunitinib|sunitinib|mesh-list
1879062|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879063|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1879064|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1879065|NCT00254540|Growth Substances|growth substances|mesh-ancestor
1879066|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879067|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
1879068|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1879069|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879070|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879071|NCT00254566|Azithromycin|azithromycin|mesh-list
1879072|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
1879073|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1879074|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1879075|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879076|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879077|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879078|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879079|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879080|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879081|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1879082|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
1879083|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1879084|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879085|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1879086|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1879087|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1879088|NCT00254592|Paclitaxel|paclitaxel|mesh-list
1879089|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1879090|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
1879091|NCT00254592|Bevacizumab|bevacizumab|mesh-list
1879092|NCT00254592|Carboplatin|carboplatin|mesh-list
1879093|NCT00254592|Doxorubicin|doxorubicin|mesh-list
1879094|NCT00254592|Trastuzumab|trastuzumab|mesh-list
1879095|NCT00254592|Sargramostim|sargramostim|mesh-list
1879096|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1879097|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879098|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
1879099|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
1879100|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
1879101|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879102|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879103|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
1879104|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879105|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879106|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879107|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
1879108|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879109|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879110|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1879111|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1879112|NCT00254592|Growth Substances|growth substances|mesh-ancestor
1879113|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
1879114|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1879115|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879116|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879117|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879118|NCT00254982|Infliximab|infliximab|mesh-list
1879119|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879120|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879121|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879122|NCT00255008|Ribavirin|ribavirin|mesh-list
1879123|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1879124|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
1879125|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
1879126|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879127|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
1879128|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879129|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
1879130|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879131|NCT00255034|Ribavirin|ribavirin|mesh-list
1879132|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1879133|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
1879134|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
1879135|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879136|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
1879137|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879138|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
1879139|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879140|NCT00255086|Memantine|memantine|mesh-list
1879141|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1879142|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1879143|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
1879144|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879145|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879146|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879147|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1879148|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1879149|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
1879150|NCT00255151|Lansoprazole|lansoprazole|mesh-list
1879151|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1879152|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879153|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1879154|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879155|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879156|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
1879157|NCT00255164|Lansoprazole|lansoprazole|mesh-list
1879158|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1879159|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879160|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1879161|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879162|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879163|NCT00255177|Mifepristone|mifepristone|mesh-list
1879164|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1879165|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
1879166|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1879167|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879168|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1879169|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1879170|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1879171|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
1879172|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1879173|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1879174|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
1879474|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
1879175|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879176|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
1879177|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1879178|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1879179|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
1879180|NCT00255190|Lansoprazole|lansoprazole|mesh-list
1879181|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1879182|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879183|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1879184|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879185|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879186|NCT00255346|Dasatinib|dasatinib|mesh-list
1879187|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879188|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1879189|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879190|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879191|NCT00255684|Cyclosporine|cyclosporine|mesh-list
1879192|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
1879193|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
1879194|NCT00255684|Fludarabine|fludarabine|mesh-list
1879195|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
1879196|NCT00255684|Cyclosporins|cyclosporins|mesh-list
1879197|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879198|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
1879199|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879200|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879201|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879202|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
1879203|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879204|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879205|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879206|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879207|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
1879208|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879209|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
1879210|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879211|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879212|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1879213|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1879214|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1879215|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
1879216|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1879217|NCT00255723|Carboplatin|carboplatin|mesh-list
1879218|NCT00255723|Etoposide|etoposide|mesh-list
1879219|NCT00255723|Ifosfamide|ifosfamide|mesh-list
1879220|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879221|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1879222|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879223|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879224|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879225|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879226|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879227|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
1879228|NCT00255801|Doxorubicin|doxorubicin|mesh-list
1879229|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1879230|NCT00255801|Bexarotene|bexarotene|mesh-list
1879231|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1879232|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879233|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879234|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879235|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879236|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879237|NCT00255840|Ritonavir|ritonavir|mesh-list
1879238|NCT00255840|Lopinavir|lopinavir|mesh-list
1879239|NCT00255840|Lamivudine|lamivudine|mesh-list
1879240|NCT00255840|Nevirapine|nevirapine|mesh-list
1879241|NCT00255840|Stavudine|stavudine|mesh-list
1879242|NCT00255840|Efavirenz|efavirenz|mesh-list
1879243|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1879244|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1879245|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
1879246|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879247|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879248|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1879249|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1879250|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
1879251|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879252|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1879253|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1879254|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1879255|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1879256|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1879257|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1879258|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1879259|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1879260|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1879261|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
1879262|NCT00256204|Rasagiline|rasagiline|mesh-list
1879263|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1879264|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879265|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879266|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1879267|NCT00256204|Protective Agents|protective agents|mesh-ancestor
1879268|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879269|NCT00256217|Anastrozole|anastrozole|mesh-list
1879270|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879271|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879272|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1879273|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1879274|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879275|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879276|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1879277|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
1879278|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879279|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879280|NCT00256243|Paclitaxel|paclitaxel|mesh-list
1879281|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
1879282|NCT00256243|Carboplatin|carboplatin|mesh-list
1879283|NCT00256243|Doxorubicin|doxorubicin|mesh-list
1879284|NCT00256243|Trastuzumab|trastuzumab|mesh-list
1879285|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1879286|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879287|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
1879288|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
1879289|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
1879290|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879291|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879292|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
1879293|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879294|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879295|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879296|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
1879297|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879298|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1879299|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879300|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879301|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879302|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879303|NCT00256282|Docetaxel|docetaxel|mesh-list
1879304|NCT00256282|Vinorelbine|vinorelbine|mesh-list
1879305|NCT00256282|Sargramostim|sargramostim|mesh-list
1879306|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879307|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
1879308|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
1879309|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
1879310|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879311|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1879312|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
1879313|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879314|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
1879315|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879316|NCT00256451|Ethanol|ethanol|mesh-list
1879317|NCT00256451|Naltrexone|naltrexone|mesh-list
1879318|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1879319|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879320|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879321|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879322|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1879323|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1879324|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
1879623|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
1879325|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879326|NCT00256698|Fulvestrant|fulvestrant|mesh-list
1879327|NCT00256698|Anastrozole|anastrozole|mesh-list
1879328|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879329|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879330|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1879331|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1879332|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
1879333|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879334|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879335|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1879336|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1879337|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879338|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879339|NCT00256750|Cyclosporine|cyclosporine|mesh-list
1879340|NCT00256750|Abatacept|abatacept|mesh-list
1879341|NCT00256750|Cyclosporins|cyclosporins|mesh-list
1879342|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879343|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879344|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879345|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
1879346|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879347|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
1879348|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879349|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879350|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879351|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1879352|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1879353|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879354|NCT00256776|Thalidomide|thalidomide|mesh-list
1879355|NCT00256776|Dexamethasone|dexamethasone|mesh-list
1879356|NCT00256776|Bortezomib|bortezomib|mesh-list
1879357|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1879358|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
1879359|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
1879360|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879361|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879362|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879363|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
1879364|NCT00256776|Hormones|hormones|mesh-ancestor
1879365|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879366|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879367|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879368|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879369|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
1879370|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
1879371|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1879372|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879373|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1879374|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1879375|NCT00256776|Growth Substances|growth substances|mesh-ancestor
1879376|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
1879377|NCT00256854|Ropinirole|ropinirole|mesh-list
1879378|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1879379|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1879380|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
1879381|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
1879382|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879383|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879384|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879385|NCT00256997|Risperidone|risperidone|mesh-list
1879386|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
1879387|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1879388|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
1879389|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879390|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879391|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879392|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879393|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879394|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879395|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1879396|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
1879397|NCT00257010|Almotriptan|almotriptan|mesh-list
1879398|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1879399|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
1879400|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879401|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879402|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879403|NCT00257166|Ziprasidone|ziprasidone|mesh-list
1879404|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1879405|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
1879406|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879407|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879408|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879409|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1879410|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879411|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879412|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879413|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1879414|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
1879415|NCT00257192|Ziprasidone|ziprasidone|mesh-list
1879416|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1879417|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
1879418|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879419|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879420|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879421|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1879422|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879423|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879424|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879425|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1879426|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
1879427|NCT00257309|Tenecteplase|tenecteplase|mesh-list
1879428|NCT00257309|Clopidogrel|clopidogrel|mesh-list
1879429|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1879430|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1879431|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1879432|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1879433|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
1879434|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879435|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879436|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879437|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1879438|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1879439|NCT00257556|Menotropins|menotropins|mesh-list
1879440|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1879441|NCT00257556|Hormones|hormones|mesh-ancestor
1879442|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879443|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879444|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1879445|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
1879446|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1879447|NCT00257608|Bevacizumab|bevacizumab|mesh-list
1879448|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1879449|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879450|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879451|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1879452|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1879453|NCT00257608|Growth Substances|growth substances|mesh-ancestor
1879454|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879455|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
1879456|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1879457|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879458|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879459|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
1879460|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1879461|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1879462|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1879463|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879464|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879465|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
1879466|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879467|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879468|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1879469|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879470|NCT00257686|Pravastatin|pravastatin|mesh-list
1879471|NCT00257686|Pitavastatin|pitavastatin|mesh-list
1879472|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1879473|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1879475|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879476|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1879477|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1879478|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879479|NCT00257725|Methylphenidate|methylphenidate|mesh-list
1879480|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1879481|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879482|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1879483|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1879484|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879485|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879486|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
1879487|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879488|NCT00257894|Baclofen|baclofen|mesh-list
1879489|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879490|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1879491|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1879492|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879493|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1879494|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
1879495|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
1879496|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879497|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879498|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
1879499|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879500|NCT00257920|Vitamins|vitamins|mesh-ancestor
1879501|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
1879502|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1879503|NCT00257933|Prednisolone|prednisolone|mesh-list
1879504|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1879505|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
1879506|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1879507|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
1879508|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1879509|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
1879510|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1879511|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
1879512|NCT00257933|Hormones|hormones|mesh-ancestor
1879513|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879514|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879515|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879516|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879517|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
1879518|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
1879519|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879520|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879521|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1879522|NCT00257933|Protective Agents|protective agents|mesh-ancestor
1879523|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1879524|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1879525|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1879526|NCT00258128|Analgesics|analgesics|mesh-ancestor
1879527|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
1879528|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879529|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879530|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1879531|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879532|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
1879533|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879534|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
1879535|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879536|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879537|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879538|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
1879539|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879540|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879541|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879542|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
1879543|NCT00258206|Rituximab|rituximab|mesh-list
1879544|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879545|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
1879546|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879547|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879548|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879549|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
1879550|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879551|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879552|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879553|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879554|NCT00258310|Capecitabine|capecitabine|mesh-list
1879555|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879556|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
1879557|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879558|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879559|NCT00258349|Trastuzumab|trastuzumab|mesh-list
1879560|NCT00258349|Vorinostat|vorinostat|mesh-list
1879561|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879562|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879563|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1879564|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879565|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879566|NCT00258362|Carboplatin|carboplatin|mesh-list
1879567|NCT00258362|Docetaxel|docetaxel|mesh-list
1879568|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879569|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
1879570|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
1879571|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
1879572|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879573|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
1879574|NCT00258440|Hematinics|hematinics|mesh-ancestor
1879575|NCT00258817|Vaccines|vaccines|mesh-list
1879576|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
1879577|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879578|NCT00258830|Vaccines|vaccines|mesh-list
1879579|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
1879580|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879581|NCT00258856|Vaccines|vaccines|mesh-list
1879582|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
1879583|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879584|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
1879585|NCT00258960|Doxorubicin|doxorubicin|mesh-list
1879586|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1879587|NCT00258960|Trastuzumab|trastuzumab|mesh-list
1879588|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879589|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
1879590|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879591|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879592|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879593|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
1879594|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879595|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879596|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1879597|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1879598|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1879599|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1879600|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879601|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879602|NCT00259012|Pantoprazole|pantoprazole|mesh-list
1879603|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1879604|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879605|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1879606|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879607|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879608|NCT00259090|Fulvestrant|fulvestrant|mesh-list
1879609|NCT00259090|Anastrozole|anastrozole|mesh-list
1879610|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879611|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879612|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1879613|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1879614|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
1879615|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879616|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879617|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1879618|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1879619|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879620|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879621|NCT00259272|Olanzapine|olanzapine|mesh-list
1879622|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
1879624|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879625|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879626|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879627|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1879628|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879629|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879630|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879631|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1879632|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1879633|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879634|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879635|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879636|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
1879637|NCT00259285|Pemetrexed|pemetrexed|mesh-list
1879638|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879639|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879640|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879641|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1879642|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1879643|NCT00259298|Teriparatide|teriparatide|mesh-list
1879644|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1879645|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879646|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1879647|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
1879648|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
1879649|NCT00259610|Etanercept|etanercept|mesh-list
1879650|NCT00259610|Methotrexate|methotrexate|mesh-list
1879651|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1879652|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
1879653|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1879654|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879655|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879656|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
1879657|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879658|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879659|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879660|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879661|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1879662|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879663|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
1879664|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879665|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1879666|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
1879667|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1879668|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1879669|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879670|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1879671|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1879672|NCT00259610|Analgesics|analgesics|mesh-ancestor
1879673|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
1879674|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879675|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1879676|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879677|NCT00259649|Eletriptan|eletriptan|mesh-list
1879678|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1879679|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
1879680|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879681|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879682|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879683|NCT00259740|Denosumab|denosumab|mesh-list
1879684|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1879685|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879686|NCT00259857|Alendronate|alendronate|mesh-list
1879687|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1879688|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879689|NCT00260065|Decitabine|decitabine|mesh-list
1879690|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879691|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
1879692|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879693|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879694|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879695|NCT00260208|Cyclosporine|cyclosporine|mesh-list
1879696|NCT00260208|Tacrolimus|tacrolimus|mesh-list
1879697|NCT00260208|Cyclosporins|cyclosporins|mesh-list
1879698|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879699|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
1879700|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879701|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1879702|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879703|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879704|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
1879705|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879706|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879707|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879708|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1879709|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1879710|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1879711|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879712|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879713|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
1879714|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879715|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879716|NCT00260689|Cyclosporine|cyclosporine|mesh-list
1879717|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
1879718|NCT00260689|Cyclosporins|cyclosporins|mesh-list
1879719|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1879720|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
1879721|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879722|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879723|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879724|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
1879725|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879726|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
1879727|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879728|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879729|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879730|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1879731|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879732|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879733|NCT00260832|Cytarabine|cytarabine|mesh-list
1879734|NCT00260832|Decitabine|decitabine|mesh-list
1879735|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879736|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
1879737|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879738|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879739|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
1879740|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879741|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879742|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
1879743|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879744|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879745|NCT00260962|Olanzapine|olanzapine|mesh-list
1879746|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
1879747|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
1879748|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879749|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879750|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879751|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1879752|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879753|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879754|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879755|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1879756|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1879757|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879758|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879759|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879760|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
1879761|NCT00261443|Valproic Acid|valproic acid|mesh-list
1879762|NCT00261443|Aripiprazole|aripiprazole|mesh-list
1879763|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
1879764|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
1879765|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879766|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1879767|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879768|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879769|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879770|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
1879771|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
1879772|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879773|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879774|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1879775|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1879776|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
1879777|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1879778|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1879779|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1879780|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1879781|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879782|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
1879783|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
1879784|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
1879785|NCT00261495|Oxycodone|oxycodone|mesh-list
1879786|NCT00261495|Hydromorphone|hydromorphone|mesh-list
1879787|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1879788|NCT00261495|Narcotics|narcotics|mesh-ancestor
1879789|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879790|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879791|NCT00261495|Analgesics|analgesics|mesh-ancestor
1879792|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
1879793|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879797|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
1879798|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1879799|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879800|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879801|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1879802|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1879803|NCT00261950|Cinacalcet|cinacalcet|mesh-list
1879804|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1879805|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879806|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1879807|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
1879808|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879809|NCT00262002|Vaccines|vaccines|mesh-list
1879810|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
1879811|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879812|NCT00262028|Vaccines|vaccines|mesh-list
1879813|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
1879814|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879815|NCT00262041|Vaccines|vaccines|mesh-list
1879816|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
1879817|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879818|NCT00262067|Bevacizumab|bevacizumab|mesh-list
1879819|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1879820|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879821|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1879822|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1879823|NCT00262067|Growth Substances|growth substances|mesh-ancestor
1879824|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879825|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
1879826|NCT00262080|Ecallantide|ecallantide|mesh-list
1879827|NCT00262080|Analgesics|analgesics|mesh-ancestor
1879828|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
1879829|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879830|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879831|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1879832|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1879833|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1879834|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879835|NCT00262223|Sertraline|sertraline|mesh-list
1879836|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
1879837|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879838|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1879839|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1879840|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1879841|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879842|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879843|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
1879844|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879845|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1879846|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1880153|NCT00264550|Golimumab|golimumab|mesh-list
1879847|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879848|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
1879849|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879850|NCT00262522|Ritonavir|ritonavir|mesh-list
1879851|NCT00262522|Lopinavir|lopinavir|mesh-list
1879852|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1879853|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1879854|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1879855|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
1879856|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879857|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879858|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1879859|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1879860|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
1879861|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879862|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1879863|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1879864|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1879865|NCT00262600|Warfarin|warfarin|mesh-list
1879866|NCT00262600|Dabigatran|dabigatran|mesh-list
1879867|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
1879868|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
1879869|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1879870|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
1879871|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879872|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879873|NCT00262639|Gabapentin|gabapentin|mesh-list
1879874|NCT00262639|Flumazenil|flumazenil|mesh-list
1879875|NCT00262639|Analgesics|analgesics|mesh-ancestor
1879876|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
1879877|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879878|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879879|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
1879880|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1879881|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1879882|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1879883|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1879884|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1879885|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1879886|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1879887|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879888|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
1879889|NCT00262639|Antidotes|antidotes|mesh-ancestor
1879890|NCT00262639|Protective Agents|protective agents|mesh-ancestor
1879891|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
1879892|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
1879893|NCT00262730|Temozolomide|temozolomide|mesh-list
1879894|NCT00262730|Poly ICLC|poly iclc|mesh-list
1879895|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1879896|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
1879897|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879898|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879899|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
1879900|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
1879901|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879902|NCT00262821|Tirapazamine|tirapazamine|mesh-list
1879903|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879904|NCT00262834|Vorinostat|vorinostat|mesh-list
1879905|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879906|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1879907|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879908|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879909|NCT00262847|Paclitaxel|paclitaxel|mesh-list
1879910|NCT00262847|Bevacizumab|bevacizumab|mesh-list
1879911|NCT00262847|Carboplatin|carboplatin|mesh-list
1879912|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1879913|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1879914|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
1879915|NCT00262847|Antibodies|antibodies|mesh-list
1879916|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
1879917|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1879918|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
1879919|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1879920|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879921|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
1879922|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
1879923|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
1879924|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879925|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1879926|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1879927|NCT00262847|Growth Substances|growth substances|mesh-ancestor
1879928|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879929|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
1879930|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
1879931|NCT00262860|Gemcitabine|gemcitabine|mesh-list
1879932|NCT00262860|Bortezomib|bortezomib|mesh-list
1879933|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879934|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
1879935|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879936|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879937|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
1879938|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1879939|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879940|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879941|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
1879942|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879943|NCT00262873|Bortezomib|bortezomib|mesh-list
1879944|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879945|NCT00262925|Leucovorin|leucovorin|mesh-list
1879946|NCT00262925|Dexamethasone|dexamethasone|mesh-list
1879947|NCT00262925|Methotrexate|methotrexate|mesh-list
1879948|NCT00262925|Vincristine|vincristine|mesh-list
1879949|NCT00262925|Asparaginase|asparaginase|mesh-list
1879950|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
1879951|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
1879952|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1879953|NCT00262925|Antibodies|antibodies|mesh-list
1879954|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
1879955|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1879956|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
1879957|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
1879958|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1879959|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1879960|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
1879961|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
1879962|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1879963|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1879964|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
1879965|NCT00262925|Hormones|hormones|mesh-ancestor
1879966|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1879967|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1879968|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879969|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1879970|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
1879971|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1879972|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1879973|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
1879974|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879975|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
1879976|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1879977|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1879978|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1879979|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1879980|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1879981|NCT00262925|Antidotes|antidotes|mesh-ancestor
1879982|NCT00262925|Protective Agents|protective agents|mesh-ancestor
1879983|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
1879984|NCT00262925|Vitamins|vitamins|mesh-ancestor
1879985|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
1879986|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1879987|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
1879988|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
1879989|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
1879990|NCT00262951|Interferons|interferons|mesh-list
1879991|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
1879992|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
1879993|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
1879994|NCT00262951|Cisplatin|cisplatin|mesh-list
1879995|NCT00262951|Fluorouracil|fluorouracil|mesh-list
1879996|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1879997|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
1879998|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1879999|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880000|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880001|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
1880002|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880003|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
1880004|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880005|NCT00262964|Niacin|niacin|mesh-list
1880006|NCT00262964|Fenofibrate|fenofibrate|mesh-list
1880007|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1880008|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
1880009|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880010|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1880011|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
1880012|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
1880013|NCT00262964|Vitamins|vitamins|mesh-ancestor
1880014|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
1880015|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880016|NCT00263211|Aspirin|aspirin|mesh-list
1880017|NCT00263211|Clopidogrel|clopidogrel|mesh-list
1880018|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1880019|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1880020|NCT00263211|Analgesics|analgesics|mesh-ancestor
1880021|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
1880022|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880023|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880024|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880025|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880026|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1880027|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1880028|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880029|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1880030|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1880031|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880032|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
1880033|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1880034|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1880035|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1880036|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
1880037|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880038|NCT00263328|Tacrolimus|tacrolimus|mesh-list
1880039|NCT00263328|Tofacitinib|tofacitinib|mesh-list
1880040|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880041|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
1880042|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880043|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1880044|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880045|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880046|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880047|NCT00263575|Fentanyl|fentanyl|mesh-list
1880048|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1880049|NCT00263575|Narcotics|narcotics|mesh-ancestor
1880050|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880051|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880052|NCT00263575|Analgesics|analgesics|mesh-ancestor
1880053|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
1880054|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880055|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1880056|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1880057|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
1880058|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
1880059|NCT00263588|Lapatinib|lapatinib|mesh-list
1880060|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880061|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880062|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880063|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880064|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
1880065|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1880066|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880067|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880068|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1880069|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1880070|NCT00264004|Cediranib|cediranib|mesh-list
1880071|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880072|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880073|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880074|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880075|NCT00264147|Diclofenac|diclofenac|mesh-list
1880076|NCT00264147|Etoricoxib|etoricoxib|mesh-list
1880077|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1880078|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1880079|NCT00264147|Analgesics|analgesics|mesh-ancestor
1880080|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
1880081|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880082|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880083|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880084|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880085|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1880086|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880087|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880088|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1880089|NCT00264238|Memantine|memantine|mesh-list
1880090|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1880091|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1880092|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
1880093|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880094|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880095|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880096|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1880097|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1880098|NCT00264290|Valganciclovir|valganciclovir|mesh-list
1880099|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
1880100|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880101|NCT00264303|Levocetirizine|levocetirizine|mesh-list
1880102|NCT00264303|Desloratadine|desloratadine|mesh-list
1880103|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1880104|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1880105|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
1880106|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
1880107|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880108|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880109|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880110|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1880111|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
1880112|NCT00264381|Dalteparin|dalteparin|mesh-list
1880113|NCT00264381|Tinzaparin|tinzaparin|mesh-list
1880114|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1880115|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
1880116|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1880117|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1880118|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880119|NCT00264498|Gemcitabine|gemcitabine|mesh-list
1880120|NCT00264498|Carboplatin|carboplatin|mesh-list
1880121|NCT00264498|Gefitinib|gefitinib|mesh-list
1880122|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880123|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880124|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
1880125|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880126|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
1880127|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880128|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880129|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880130|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
1880131|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880132|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880133|NCT00264537|Golimumab|golimumab|mesh-list
1880134|NCT00264537|Methotrexate|methotrexate|mesh-list
1880135|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1880136|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1880137|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
1880138|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1880139|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880140|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880141|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
1880142|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880143|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880144|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880145|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880146|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880147|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880148|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
1880149|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880150|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880151|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1880152|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880154|NCT00264550|Methotrexate|methotrexate|mesh-list
1880155|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1880156|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1880157|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
1880158|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1880159|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880160|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880161|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
1880162|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880163|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880164|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880165|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880166|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880167|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880168|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
1880169|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880170|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880171|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1880172|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880173|NCT00264641|Insulin|insulin|mesh-list
1880174|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1880175|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1880176|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880177|NCT00264797|Methylphenidate|methylphenidate|mesh-list
1880178|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1880179|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880180|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1880181|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1880182|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880183|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880184|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
1880185|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880186|NCT00264849|Omalizumab|omalizumab|mesh-list
1880187|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1880188|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1880189|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
1880190|NCT00264875|Pregabalin|pregabalin|mesh-list
1880191|NCT00264875|Analgesics|analgesics|mesh-ancestor
1880192|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
1880193|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880194|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880195|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
1880196|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1880197|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880198|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880199|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1880200|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1880201|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880202|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880203|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880204|NCT00265083|Golimumab|golimumab|mesh-list
1880205|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1880206|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1880207|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880208|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880209|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
1880210|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880211|NCT00265096|Golimumab|golimumab|mesh-list
1880212|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1880213|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1880214|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880215|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880216|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
1880217|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880218|NCT00265109|Levetiracetam|levetiracetam|mesh-list
1880219|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
1880220|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
1880221|NCT00265122|Ustekinumab|ustekinumab|mesh-list
1880222|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880223|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
1880224|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1880225|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880226|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
1880227|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1880228|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880229|NCT00265239|Edaravone|edaravone|mesh-list
1880230|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1880231|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
1880232|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880233|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1880234|NCT00265239|Protective Agents|protective agents|mesh-ancestor
1880235|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880236|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1880237|NCT00265317|Sunitinib|sunitinib|mesh-list
1880238|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880239|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880240|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880241|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880242|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880243|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880244|NCT00265317|Growth Substances|growth substances|mesh-ancestor
1880245|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880246|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880247|NCT00265330|Ziprasidone|ziprasidone|mesh-list
1880248|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1880249|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
1880250|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880251|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880252|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880253|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1880254|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880255|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880256|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880257|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1880258|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
1880259|NCT00265343|Olanzapine|olanzapine|mesh-list
1880260|NCT00265343|Asenapine|asenapine|mesh-list
1880261|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
1880262|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
1880263|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880264|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880265|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1880266|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1880267|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880268|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880269|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880270|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1880271|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1880272|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880273|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880274|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880275|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
1880276|NCT00265382|Ziprasidone|ziprasidone|mesh-list
1880277|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1880278|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
1880279|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880280|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880281|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880282|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1880283|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880284|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880285|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880286|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1880287|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
1880288|NCT00265395|Interferons|interferons|mesh-list
1880289|NCT00265395|Ribavirin|ribavirin|mesh-list
1880290|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
1880291|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
1880292|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1880293|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880294|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
1880295|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880296|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
1880297|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880298|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
1880299|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880300|NCT00265616|Pentobarbital|pentobarbital|mesh-list
1880301|NCT00265616|Thiopental|thiopental|mesh-list
1880302|NCT00265616|Propofol|propofol|mesh-list
1880303|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1880304|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880305|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880306|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1880307|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
1880308|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
1880309|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
1880310|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
1880311|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
1880312|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880313|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880314|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1880315|NCT00265759|Letrozole|letrozole|mesh-list
1880316|NCT00265759|Anastrozole|anastrozole|mesh-list
1880317|NCT00265759|Exemestane|exemestane|mesh-list
1880318|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880319|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1880320|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1880321|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880322|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880323|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1880324|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
1880325|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1880326|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880327|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1880328|NCT00265785|Pemetrexed|pemetrexed|mesh-list
1880329|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880330|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880331|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880332|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880333|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880334|NCT00265798|Sorafenib|sorafenib|mesh-list
1880335|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880336|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880337|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880338|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880339|NCT00265850|Leucovorin|leucovorin|mesh-list
1880340|NCT00265850|Folic Acid|folic acid|mesh-list
1880341|NCT00265850|Bevacizumab|bevacizumab|mesh-list
1880342|NCT00265850|Cetuximab|cetuximab|mesh-list
1880343|NCT00265850|Fluorouracil|fluorouracil|mesh-list
1880344|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
1880345|NCT00265850|Irinotecan|irinotecan|mesh-list
1880346|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
1880347|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880348|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880349|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880350|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880351|NCT00265850|Growth Substances|growth substances|mesh-ancestor
1880352|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880353|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880354|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
1880355|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880356|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880357|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880358|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
1880359|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1880360|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880361|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880362|NCT00265850|Antidotes|antidotes|mesh-ancestor
1880363|NCT00265850|Protective Agents|protective agents|mesh-ancestor
1880364|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
1880365|NCT00265850|Vitamins|vitamins|mesh-ancestor
1880366|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
1880367|NCT00265850|Hematinics|hematinics|mesh-ancestor
1880368|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
1880369|NCT00265889|Melphalan|melphalan|mesh-list
1880370|NCT00265889|Busulfan|busulfan|mesh-list
1880371|NCT00265889|Etoposide|etoposide|mesh-list
1880372|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880373|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
1880374|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880375|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880376|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1880377|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
1880378|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880379|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880380|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1880381|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1880382|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1880383|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880384|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880385|NCT00265941|Cetuximab|cetuximab|mesh-list
1880386|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880387|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880388|NCT00266032|Drospirenone|drospirenone|mesh-list
1880389|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1880390|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
1880391|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1880392|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880393|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1880394|NCT00266032|Diuretics|diuretics|mesh-ancestor
1880395|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
1880396|NCT00266110|Trastuzumab|trastuzumab|mesh-list
1880397|NCT00266110|Vinorelbine|vinorelbine|mesh-list
1880398|NCT00266110|Sargramostim|sargramostim|mesh-list
1880399|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880400|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880401|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1880402|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
1880403|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
1880404|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
1880405|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880406|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
1880407|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880408|NCT00266227|Rituximab|rituximab|mesh-list
1880409|NCT00266227|Methotrexate|methotrexate|mesh-list
1880410|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880411|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880412|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
1880413|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880414|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880415|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1880416|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
1880417|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1880418|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880419|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
1880420|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880421|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880422|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880423|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880424|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880425|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880426|NCT00266279|Capecitabine|capecitabine|mesh-list
1880427|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
1880428|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880429|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
1880430|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880431|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880432|NCT00266409|Alprazolam|alprazolam|mesh-list
1880433|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1880434|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880435|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880436|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1880437|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880438|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880439|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
1880440|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
1880441|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880442|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880443|NCT00266630|Carbamazepine|carbamazepine|mesh-list
1880444|NCT00266630|Valproic Acid|valproic acid|mesh-list
1880445|NCT00266630|Olanzapine|olanzapine|mesh-list
1880446|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
1880447|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
1880448|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880449|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880450|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1880451|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1880452|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880453|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880454|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880455|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1880456|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1880457|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880458|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880459|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880460|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
1880461|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880462|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
1880463|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
1880464|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
1880465|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1880466|NCT00266630|Analgesics|analgesics|mesh-ancestor
1880467|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
1880468|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1880469|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1880470|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1880471|NCT00266656|Hormones|hormones|mesh-list
1880472|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1880473|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880474|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
1880475|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880476|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880477|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
1880478|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
1880479|NCT00266708|Diphosphonates|diphosphonates|mesh-list
1880480|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1880481|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880482|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880483|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1880484|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880485|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1880486|NCT00266799|Doxorubicin|doxorubicin|mesh-list
1880487|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1880488|NCT00266799|Capecitabine|capecitabine|mesh-list
1880489|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1880490|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880491|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1880492|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880493|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880494|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880495|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880496|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
1880497|NCT00266812|Temozolomide|temozolomide|mesh-list
1880498|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1880499|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
1880500|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880501|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880502|NCT00266851|Azithromycin|azithromycin|mesh-list
1880503|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1880504|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880505|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
1880506|NCT00266864|Testosterone|testosterone|mesh-list
1880507|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
1880508|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
1880509|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1880510|NCT00266864|Androgens|androgens|mesh-ancestor
1880511|NCT00266864|Hormones|hormones|mesh-ancestor
1880512|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1880513|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880514|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1880515|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880516|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
1880517|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
1880518|NCT00267007|Hematinics|hematinics|mesh-ancestor
1880519|NCT00267020|Gemcitabine|gemcitabine|mesh-list
1880520|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880521|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
1880522|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880523|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880524|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
1880525|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880526|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880527|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880528|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
1880529|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880530|NCT00267046|Doxorubicin|doxorubicin|mesh-list
1880531|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1880532|NCT00267046|Vincristine|vincristine|mesh-list
1880533|NCT00267046|Ifosfamide|ifosfamide|mesh-list
1880534|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880535|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1880536|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1880537|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880538|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880539|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880540|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1880541|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
1880542|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
1880543|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
1880544|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1880545|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
1880546|NCT00267059|Lenalidomide|lenalidomide|mesh-list
1880547|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
1880548|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880549|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880550|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880551|NCT00267059|Growth Substances|growth substances|mesh-ancestor
1880552|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880553|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880554|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
1880555|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880556|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880557|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880558|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880559|NCT00267111|Tetracaine|tetracaine|mesh-list
1880560|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
1880561|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
1880562|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880563|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880564|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
1880565|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880566|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
1880567|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1880568|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880569|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1880570|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
1880571|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1880572|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880573|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880574|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880575|NCT00267189|Cyclosporine|cyclosporine|mesh-list
1880576|NCT00267189|Everolimus|everolimus|mesh-list
1880577|NCT00267189|Azathioprine|azathioprine|mesh-list
1880578|NCT00267189|Tacrolimus|tacrolimus|mesh-list
1880579|NCT00267189|Cyclosporins|cyclosporins|mesh-list
1880580|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1880581|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880582|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880583|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
1880584|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880585|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880586|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880587|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880588|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
1880589|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880590|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880591|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
1880592|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880593|NCT00267202|Omalizumab|omalizumab|mesh-list
1880594|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
1880595|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880596|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1880597|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1880598|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
1880599|NCT00267293|Acetaminophen|acetaminophen|mesh-list
1880600|NCT00267293|Ibuprofen|ibuprofen|mesh-list
1880601|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1880602|NCT00267293|Analgesics|analgesics|mesh-ancestor
1880603|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
1880604|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880605|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880606|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
1880607|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1880608|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880609|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880610|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1880611|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880612|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880613|NCT00267488|Topotecan|topotecan|mesh-list
1880614|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1880615|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880616|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880617|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880618|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880619|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
1880620|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1880621|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880622|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880623|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1880624|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1880625|NCT00267670|Protective Agents|protective agents|mesh-ancestor
1880626|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880627|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
1880628|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1880629|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
1880630|NCT00267696|Gemcitabine|gemcitabine|mesh-list
1880631|NCT00267696|Bevacizumab|bevacizumab|mesh-list
1880632|NCT00267696|Carboplatin|carboplatin|mesh-list
1880633|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880634|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880635|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880636|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880637|NCT00267696|Growth Substances|growth substances|mesh-ancestor
1880638|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880639|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880640|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880641|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
1880642|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880643|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
1880644|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880645|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880646|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880647|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
1880648|NCT00267748|Sunitinib|sunitinib|mesh-list
1880649|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880650|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880651|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880652|NCT00267748|Growth Substances|growth substances|mesh-ancestor
1880653|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880654|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880655|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880656|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880657|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880658|NCT00267865|Leucovorin|leucovorin|mesh-list
1880659|NCT00267865|Rituximab|rituximab|mesh-list
1880660|NCT00267865|Methotrexate|methotrexate|mesh-list
1880661|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880662|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880663|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
1880664|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880665|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880666|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1880667|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
1880668|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1880669|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880670|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
1880671|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880672|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880673|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880674|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880675|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880676|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880677|NCT00267865|Antidotes|antidotes|mesh-ancestor
1880678|NCT00267865|Protective Agents|protective agents|mesh-ancestor
1880679|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
1880680|NCT00267865|Vitamins|vitamins|mesh-ancestor
1880681|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
1880682|NCT00267956|Ustekinumab|ustekinumab|mesh-list
1880683|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880684|NCT00267969|Ustekinumab|ustekinumab|mesh-list
1880685|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880686|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
1880687|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880688|NCT00268242|Gemcitabine|gemcitabine|mesh-list
1880689|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
1880690|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1880691|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
1880692|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880693|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880694|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
1880695|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880696|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880697|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880698|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
1880699|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880700|NCT00268242|Analgesics|analgesics|mesh-ancestor
1880701|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
1880702|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880703|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1880704|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880705|NCT00268346|Gefitinib|gefitinib|mesh-list
1880706|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880707|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880708|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880709|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880710|NCT00268437|Carboplatin|carboplatin|mesh-list
1880711|NCT00268437|Pemetrexed|pemetrexed|mesh-list
1880712|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880713|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880714|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880715|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880716|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880717|NCT00268762|Argatroban|argatroban|mesh-list
1880718|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
1880719|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1880720|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
1880721|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880722|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880723|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
1880724|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1880725|NCT00268905|Carboplatin|carboplatin|mesh-list
1880726|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880727|NCT00268983|Iodine|iodine|mesh-list
1880728|NCT00268983|Rituximab|rituximab|mesh-list
1880729|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
1880730|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1880731|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880732|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880733|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
1880734|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880735|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880736|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1880737|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880738|NCT00268983|Trace Elements|trace elements|mesh-ancestor
1880739|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
1880740|NCT00269087|Fluticasone|fluticasone|mesh-list
1880741|NCT00269087|Xhance|xhance|mesh-list
1880742|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1880743|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880744|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1880745|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
1880746|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880747|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880748|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1880749|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
1880750|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880751|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1880752|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1880753|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1880754|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1880755|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
1880756|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880757|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880758|NCT00269113|Rituximab|rituximab|mesh-list
1880759|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880760|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880761|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
1880762|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880763|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880764|NCT00269152|Carboplatin|carboplatin|mesh-list
1880765|NCT00269152|Pemetrexed|pemetrexed|mesh-list
1880766|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880767|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880768|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880769|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1880770|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880771|NCT00269399|Vancomycin|vancomycin|mesh-list
1880772|NCT00269399|Rifaximin|rifaximin|mesh-list
1880773|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1880774|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880775|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1880776|NCT00269919|Risperidone|risperidone|mesh-list
1880777|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1880778|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
1880779|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880780|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880781|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880782|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1880783|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1880784|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880785|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880786|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1880787|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
1880788|NCT00270205|Vaccines|vaccines|mesh-list
1880789|NCT00270205|Immunologic Factors|immunologic factors|mesh-ancestor
1880790|NCT00270205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880791|NCT00270231|Naltrexone|naltrexone|mesh-list
1880792|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1880793|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1880794|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880795|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
1880796|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880797|NCT00270257|Buprenorphine|buprenorphine|mesh-list
1880798|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1880799|NCT00270257|Naloxone|naloxone|mesh-list
1880800|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1880801|NCT00270257|Narcotics|narcotics|mesh-ancestor
1880802|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880803|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880804|NCT00270257|Analgesics|analgesics|mesh-ancestor
1880805|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
1880806|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880807|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1880808|NCT00270296|Ritonavir|ritonavir|mesh-list
1880809|NCT00270296|Lopinavir|lopinavir|mesh-list
1880810|NCT00270296|Lamivudine|lamivudine|mesh-list
1880811|NCT00270296|Zidovudine|zidovudine|mesh-list
1880812|NCT00270296|Nevirapine|nevirapine|mesh-list
1880813|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1880814|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1880815|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1880816|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
1880817|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880818|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880819|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1880820|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1880821|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
1880822|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880823|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1880824|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1880825|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1880826|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880827|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
1880828|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1880829|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1880830|NCT00270634|Tacrolimus|tacrolimus|mesh-list
1880831|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880832|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
1880833|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880834|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1880835|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880913|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
1880836|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880837|NCT00270790|Carboplatin|carboplatin|mesh-list
1880838|NCT00270790|Amifostine|amifostine|mesh-list
1880839|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880840|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1880841|NCT00270790|Protective Agents|protective agents|mesh-ancestor
1880842|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880843|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
1880844|NCT00270894|Docetaxel|docetaxel|mesh-list
1880845|NCT00270894|Trastuzumab|trastuzumab|mesh-list
1880846|NCT00270894|Epirubicin|epirubicin|mesh-list
1880847|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1880848|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
1880849|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880850|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880851|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1880852|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
1880853|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880854|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880855|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1880856|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
1880857|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
1880858|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
1880859|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880860|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1880861|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1880862|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1880863|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880864|NCT00271024|Naltrexone|naltrexone|mesh-list
1880865|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1880866|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1880867|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880868|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
1880869|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880870|NCT00271219|Buprenorphine|buprenorphine|mesh-list
1880871|NCT00271219|Methadone|methadone|mesh-list
1880872|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1880873|NCT00271219|Narcotics|narcotics|mesh-ancestor
1880874|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1880875|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880876|NCT00271219|Analgesics|analgesics|mesh-ancestor
1880877|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
1880878|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880879|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1880880|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
1880881|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
1880882|NCT00271505|Bevacizumab|bevacizumab|mesh-list
1880883|NCT00271505|Carboplatin|carboplatin|mesh-list
1880884|NCT00271505|Docetaxel|docetaxel|mesh-list
1880885|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880886|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880887|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880888|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880889|NCT00271505|Growth Substances|growth substances|mesh-ancestor
1880890|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880891|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880892|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
1880893|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
1880894|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
1880895|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880896|NCT00271570|Infliximab|infliximab|mesh-list
1880897|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
1880898|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1880899|NCT00271570|Antibodies|antibodies|mesh-list
1880900|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
1880901|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1880902|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
1880903|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880904|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
1880905|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1880906|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880907|NCT00271596|Citalopram|citalopram|mesh-list
1880908|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1880909|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1880910|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880911|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880912|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1880914|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880915|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1880916|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
1880917|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1880918|NCT00271609|Bevacizumab|bevacizumab|mesh-list
1880919|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1880920|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880921|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1880922|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1880923|NCT00271609|Growth Substances|growth substances|mesh-ancestor
1880924|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880925|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
1880926|NCT00271817|Niacin|niacin|mesh-list
1880927|NCT00271817|Niacinamide|niacinamide|mesh-list
1880928|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
1880929|NCT00271817|Simvastatin|simvastatin|mesh-list
1880930|NCT00271817|Ezetimibe|ezetimibe|mesh-list
1880931|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1880932|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1880933|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1880934|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
1880935|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880936|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1880937|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1880938|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880939|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
1880940|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
1880941|NCT00271817|Vitamins|vitamins|mesh-ancestor
1880942|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
1880943|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880944|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1880945|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1880946|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1880947|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880948|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880949|NCT00272311|Aspirin|aspirin|mesh-list
1880950|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1880951|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1880952|NCT00272311|Analgesics|analgesics|mesh-ancestor
1880953|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
1880954|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880955|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880956|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880957|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880958|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1880959|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1880960|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880961|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1880962|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1880963|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880964|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
1880965|NCT00272337|Aspirin|aspirin|mesh-list
1880966|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1880967|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1880968|NCT00272337|Analgesics|analgesics|mesh-ancestor
1880969|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
1880970|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1880971|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1880972|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1880973|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1880974|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1880975|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1880976|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880977|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1880978|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1880979|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1880980|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
1880981|NCT00272779|Emtricitabine|emtricitabine|mesh-list
1880982|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1880983|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
1880984|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1880985|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1880986|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1880987|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881137|NCT00274924|Lenograstim|lenograstim|mesh-list
1880988|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880989|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1880990|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1880991|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1880992|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1880993|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
1880994|NCT00272792|Verapamil|verapamil|mesh-list
1880995|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1880996|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1880997|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1880998|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1880999|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881000|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881001|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
1881002|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
1881003|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1881004|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1881005|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881006|NCT00272987|Paclitaxel|paclitaxel|mesh-list
1881007|NCT00272987|Trastuzumab|trastuzumab|mesh-list
1881008|NCT00272987|Lapatinib|lapatinib|mesh-list
1881009|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1881010|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881011|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881012|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881013|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881014|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881015|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881016|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881017|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881018|NCT00273052|Metoprolol|metoprolol|mesh-list
1881019|NCT00273052|Carvedilol|carvedilol|mesh-list
1881020|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1881021|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1881022|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
1881023|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
1881024|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881025|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881026|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1881027|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1881028|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1881029|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
1881030|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881031|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881032|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
1881033|NCT00273052|Protective Agents|protective agents|mesh-ancestor
1881034|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1881035|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881036|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881037|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
1881038|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1881039|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1881040|NCT00273754|Caffeine|caffeine|mesh-list
1881041|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1881042|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881043|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1881044|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881045|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881046|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1881047|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1881048|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
1881049|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881050|NCT00273910|Imiquimod|imiquimod|mesh-list
1881051|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1881052|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
1881053|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881054|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881055|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
1881056|NCT00274261|Nonoxynol|nonoxynol|mesh-list
1881057|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1881058|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1881059|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881060|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1881061|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
1881062|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1881063|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1881064|NCT00274287|Sargramostim|sargramostim|mesh-list
1881065|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
1881066|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881067|NCT00274456|Paclitaxel|paclitaxel|mesh-list
1881068|NCT00274456|Docetaxel|docetaxel|mesh-list
1881069|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1881070|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1881071|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881072|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881073|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881074|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881075|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881076|NCT00274469|Fulvestrant|fulvestrant|mesh-list
1881077|NCT00274469|Anastrozole|anastrozole|mesh-list
1881078|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881079|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881080|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1881081|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1881082|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
1881083|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881084|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881085|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1881086|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1881087|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881088|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881089|NCT00274651|Belinostat|belinostat|mesh-list
1881090|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881091|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1881092|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881093|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881094|NCT00274742|Blinatumomab|blinatumomab|mesh-list
1881095|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1881096|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881097|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
1881098|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881099|NCT00274768|Capecitabine|capecitabine|mesh-list
1881100|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881101|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
1881102|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881103|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881104|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
1881105|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
1881106|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881107|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881108|NCT00274846|Aldesleukin|aldesleukin|mesh-list
1881109|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
1881110|NCT00274846|Fludarabine|fludarabine|mesh-list
1881111|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
1881112|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881113|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
1881114|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881115|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881116|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881117|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
1881118|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881119|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881120|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881121|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881122|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
1881123|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1881124|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1881125|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
1881126|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881127|NCT00274924|Prednisone|prednisone|mesh-list
1881128|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
1881129|NCT00274924|Ifosfamide|ifosfamide|mesh-list
1881130|NCT00274924|Rituximab|rituximab|mesh-list
1881131|NCT00274924|Carboplatin|carboplatin|mesh-list
1881132|NCT00274924|Doxorubicin|doxorubicin|mesh-list
1881133|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1881134|NCT00274924|Etoposide|etoposide|mesh-list
1881135|NCT00274924|Vincristine|vincristine|mesh-list
1881136|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
1881138|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881139|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
1881140|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881141|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881142|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881143|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
1881144|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881145|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881146|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881147|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881148|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881149|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1881150|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1881151|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881152|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881153|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
1881154|NCT00274924|Hormones|hormones|mesh-ancestor
1881155|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881156|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881157|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1881158|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1881159|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881160|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881161|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881162|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
1881163|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
1881164|NCT00274937|Fluorouracil|fluorouracil|mesh-list
1881165|NCT00274937|Amifostine|amifostine|mesh-list
1881166|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881167|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
1881168|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881169|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881170|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881171|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
1881172|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881173|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1881174|NCT00274937|Protective Agents|protective agents|mesh-ancestor
1881175|NCT00275002|Temozolomide|temozolomide|mesh-list
1881176|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
1881177|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881178|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
1881179|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881180|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881181|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881182|NCT00275028|Cediranib|cediranib|mesh-list
1881183|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881184|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881185|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881186|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881187|NCT00275262|Leuprolide|leuprolide|mesh-list
1881188|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1881189|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
1881190|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1881191|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881192|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881193|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881194|NCT00275275|Pramipexole|pramipexole|mesh-list
1881195|NCT00275275|Ropinirole|ropinirole|mesh-list
1881196|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
1881197|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881198|NCT00275275|Protective Agents|protective agents|mesh-ancestor
1881199|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881200|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1881201|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1881202|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
1881203|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
1881204|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881205|NCT00275301|Olanzapine|olanzapine|mesh-list
1881206|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
1881207|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
1881208|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881209|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881210|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1881211|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1881212|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1881213|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881214|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1881215|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1881216|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1881217|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881218|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881219|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881220|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
1881221|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
1881222|NCT00275509|Dexamethasone|dexamethasone|mesh-list
1881223|NCT00275509|Prednisone|prednisone|mesh-list
1881224|NCT00275509|Tacrolimus|tacrolimus|mesh-list
1881225|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
1881226|NCT00275509|Daclizumab|daclizumab|mesh-list
1881227|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881228|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
1881229|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
1881230|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881231|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881232|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1881233|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
1881234|NCT00275509|Hormones|hormones|mesh-ancestor
1881235|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881236|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881237|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881238|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881239|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
1881240|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1881241|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881242|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881243|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881244|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1881245|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
1881246|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881247|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881248|NCT00275561|Fluticasone|fluticasone|mesh-list
1881249|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881250|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1881251|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
1881252|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881253|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881254|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1881255|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
1881256|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
1881257|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1881258|NCT00275821|Ranibizumab|ranibizumab|mesh-list
1881259|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881260|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881261|NCT00275821|Growth Substances|growth substances|mesh-ancestor
1881262|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881263|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881264|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881265|NCT00275834|Zonisamide|zonisamide|mesh-list
1881266|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
1881267|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1881268|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881269|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881270|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881271|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881272|NCT00276016|Phenylephrine|phenylephrine|mesh-list
1881273|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
1881274|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
1881275|NCT00276016|Ephedrine|ephedrine|mesh-list
1881276|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1881277|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
1881278|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
1881279|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881280|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881281|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
1881282|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1881283|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
1881284|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
1881285|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1881286|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1881287|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1881288|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
1881289|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881290|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881291|NCT00276016|Protective Agents|protective agents|mesh-ancestor
1881292|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1881293|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1881294|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1881295|NCT00276094|Tamoxifen|tamoxifen|mesh-list
1881296|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1881297|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
1881298|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881299|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881300|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881301|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881302|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1881303|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1881304|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1881305|NCT00276250|Abatacept|abatacept|mesh-list
1881306|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1881307|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881308|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881309|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881310|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
1881311|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881312|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881313|NCT00276380|Aspirin|aspirin|mesh-list
1881314|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1881315|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1881316|NCT00276380|Analgesics|analgesics|mesh-ancestor
1881317|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
1881318|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881319|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881320|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881321|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881322|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1881323|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1881324|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881325|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1881326|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1881327|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881328|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
1881329|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
1881330|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1881331|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881332|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881333|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
1881334|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881335|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881336|NCT00276458|Atorvastatin|atorvastatin|mesh-list
1881337|NCT00276458|Ezetimibe|ezetimibe|mesh-list
1881338|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1881339|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1881340|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
1881341|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881342|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1881343|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1881344|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881345|NCT00276484|Atorvastatin|atorvastatin|mesh-list
1881346|NCT00276484|Ezetimibe|ezetimibe|mesh-list
1881347|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1881348|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1881349|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
1881350|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881351|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1881352|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1881353|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881354|NCT00276549|Gemcitabine|gemcitabine|mesh-list
1881355|NCT00276549|Docetaxel|docetaxel|mesh-list
1881356|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881357|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
1881358|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881359|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881360|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
1881361|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881362|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881363|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881364|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
1881365|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881366|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881367|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881368|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881369|NCT00276614|Bortezomib|bortezomib|mesh-list
1881370|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881371|NCT00276744|Gemcitabine|gemcitabine|mesh-list
1881372|NCT00276744|Sirolimus|sirolimus|mesh-list
1881373|NCT00276744|Capecitabine|capecitabine|mesh-list
1881374|NCT00276744|Docetaxel|docetaxel|mesh-list
1881375|NCT00276744|Irinotecan|irinotecan|mesh-list
1881376|NCT00276744|Cetuximab|cetuximab|mesh-list
1881377|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1881378|NCT00276744|Mitomycins|mitomycins|mesh-list
1881379|NCT00276744|Mitomycin|mitomycin|mesh-list
1881380|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881381|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
1881382|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881383|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881384|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
1881385|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881386|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881387|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881388|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
1881389|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881390|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881391|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881392|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881393|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1881394|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1881395|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881396|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881397|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881398|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881399|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
1881400|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
1881401|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1881402|NCT00276861|Gemcitabine|gemcitabine|mesh-list
1881403|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
1881404|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881405|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
1881406|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881407|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881408|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
1881409|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881410|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881411|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881412|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
1881413|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881414|NCT00277212|Lamotrigine|lamotrigine|mesh-list
1881415|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
1881416|NCT00277212|Aripiprazole|aripiprazole|mesh-list
1881417|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
1881418|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1881419|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1881420|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1881421|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881422|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881423|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
1881424|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
1881425|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881426|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881427|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1881428|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1881429|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
1881430|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1881431|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1881432|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1881433|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1881434|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1881435|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881436|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881437|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1881438|NCT00277355|Minocycline|minocycline|mesh-list
1881439|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881440|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881441|NCT00277394|Heparin|heparin|mesh-list
1881442|NCT00277394|Tinzaparin|tinzaparin|mesh-list
1881443|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
1881444|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1881445|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1881446|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881447|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
1881448|NCT00278109|Doxorubicin|doxorubicin|mesh-list
1881449|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881450|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
1881451|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881452|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881453|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881454|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
1881455|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881456|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881457|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881458|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881459|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1881460|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1881461|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881462|NCT00278148|Paclitaxel|paclitaxel|mesh-list
1881463|NCT00278148|Carboplatin|carboplatin|mesh-list
1881464|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1881465|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1881466|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881467|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881468|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881469|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881470|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881471|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881472|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881473|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
1881474|NCT00278161|Rituximab|rituximab|mesh-list
1881475|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881476|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
1881477|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881478|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881479|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881480|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
1881481|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881482|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881483|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881484|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881490|NCT00278395|Vorinostat|vorinostat|mesh-list
1881491|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881492|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1881493|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881494|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881495|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
1881496|NCT00278512|Fludarabine|fludarabine|mesh-list
1881497|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
1881498|NCT00278512|Tacrolimus|tacrolimus|mesh-list
1881499|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
1881500|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881501|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
1881502|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881503|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881504|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881505|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
1881506|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881507|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881508|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881509|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1881510|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881511|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881512|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
1881513|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1881514|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1881515|NCT00278564|Prednisolone|prednisolone|mesh-list
1881516|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
1881517|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
1881518|NCT00278564|Rituximab|rituximab|mesh-list
1881519|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1881520|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
1881521|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881522|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
1881523|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881524|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881525|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881526|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
1881527|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881528|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881529|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881530|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881531|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881532|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
1881533|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
1881534|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881535|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1881536|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
1881537|NCT00278564|Hormones|hormones|mesh-ancestor
1881538|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881539|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1881540|NCT00278564|Protective Agents|protective agents|mesh-ancestor
1881541|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881542|NCT00278863|Capecitabine|capecitabine|mesh-list
1881543|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881544|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
1881545|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881546|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881547|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
1881548|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881549|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881550|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881551|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881552|NCT00278889|Leucovorin|leucovorin|mesh-list
1881553|NCT00278889|Bevacizumab|bevacizumab|mesh-list
1881554|NCT00278889|Fluorouracil|fluorouracil|mesh-list
1881555|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
1881556|NCT00278889|Cediranib|cediranib|mesh-list
1881557|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881558|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881559|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881560|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881561|NCT00278889|Growth Substances|growth substances|mesh-ancestor
1881562|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881563|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881564|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
1881565|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881566|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881567|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881568|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
1881569|NCT00278889|Antidotes|antidotes|mesh-ancestor
1881570|NCT00278889|Protective Agents|protective agents|mesh-ancestor
1881571|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
1881572|NCT00278889|Vitamins|vitamins|mesh-ancestor
1881573|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
1881574|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881575|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881576|NCT00278915|Fulvestrant|fulvestrant|mesh-list
1881577|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881578|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881579|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1881580|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1881581|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
1881582|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881583|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881584|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
1881585|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1881586|NCT00278954|Antibodies|antibodies|mesh-list
1881587|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
1881588|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1881589|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
1881590|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881591|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
1881592|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
1881593|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
1881594|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
1881595|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
1881596|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1881597|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881598|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
1881599|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881600|NCT00279305|Rituximab|rituximab|mesh-list
1881601|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881602|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881603|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
1881604|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881605|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881606|NCT00279708|Atorvastatin|atorvastatin|mesh-list
1881607|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1881608|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1881609|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
1881610|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881611|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1881612|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1881613|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881614|NCT00279812|Selenium|selenium|mesh-list
1881615|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
1881616|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881617|NCT00279812|Protective Agents|protective agents|mesh-ancestor
1881618|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881619|NCT00279812|Trace Elements|trace elements|mesh-ancestor
1881620|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
1881621|NCT00279916|Triamcinolone|triamcinolone|mesh-list
1881622|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1881623|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1881624|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1881625|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881626|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
1881627|NCT00279916|Hormones|hormones|mesh-ancestor
1881628|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881629|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881630|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881631|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
1881632|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881633|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881634|NCT00280059|Pregabalin|pregabalin|mesh-list
1881635|NCT00280059|Lamotrigine|lamotrigine|mesh-list
1881636|NCT00280059|Analgesics|analgesics|mesh-ancestor
1881637|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
1881638|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881639|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881640|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
1881641|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1881642|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881643|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881644|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881645|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1881646|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1881647|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881648|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1881649|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1881650|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1881651|NCT00280150|Paclitaxel|paclitaxel|mesh-list
1881652|NCT00280150|Bevacizumab|bevacizumab|mesh-list
1881653|NCT00280150|Carboplatin|carboplatin|mesh-list
1881654|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1881655|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1881656|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881657|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881658|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881659|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881660|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881661|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881662|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881663|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881664|NCT00280150|Growth Substances|growth substances|mesh-ancestor
1881665|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881666|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881667|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881668|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881669|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
1881670|NCT00280241|Rituximab|rituximab|mesh-list
1881671|NCT00280241|Fludarabine|fludarabine|mesh-list
1881672|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881673|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
1881674|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881675|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881676|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881677|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
1881678|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881679|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881680|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881681|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881682|NCT00280293|Lamotrigine|lamotrigine|mesh-list
1881683|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
1881684|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1881685|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881686|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881687|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881688|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881689|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1881690|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1881691|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881692|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1881693|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1881694|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
1881695|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
1881696|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1881697|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1881698|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1881699|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881700|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881701|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
1881702|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881703|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881704|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1881705|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881706|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1881707|NCT00280397|Lenvatinib|lenvatinib|mesh-list
1881708|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881709|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881710|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881711|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881712|NCT00280566|Ziprasidone|ziprasidone|mesh-list
1881713|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1881714|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
1881715|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881716|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881717|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881718|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1881719|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1881720|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881721|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1881722|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1881723|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
1881724|NCT00280735|Carboplatin|carboplatin|mesh-list
1881725|NCT00280735|Docetaxel|docetaxel|mesh-list
1881726|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881727|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881728|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881729|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881730|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881731|NCT00280748|Pemetrexed|pemetrexed|mesh-list
1881732|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881733|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881734|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881735|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1881736|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1881737|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1881738|NCT00281021|Digoxin|digoxin|mesh-list
1881739|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881740|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881741|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881742|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881743|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1881744|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1881745|NCT00281021|Protective Agents|protective agents|mesh-ancestor
1881746|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881747|NCT00281320|Asenapine|asenapine|mesh-list
1881748|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1881749|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1881750|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881751|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881752|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1881753|NCT00281528|Paclitaxel|paclitaxel|mesh-list
1881754|NCT00281528|Bevacizumab|bevacizumab|mesh-list
1881755|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1881756|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1881757|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881758|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881759|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881760|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881761|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881762|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881763|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881764|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881765|NCT00281528|Growth Substances|growth substances|mesh-ancestor
1881766|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881767|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881768|NCT00281580|Amlodipine|amlodipine|mesh-list
1881769|NCT00281580|Telmisartan|telmisartan|mesh-list
1881770|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1881771|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1881772|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1881773|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881774|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1881775|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881776|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
1881777|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1881778|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1881789|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1881790|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
1881791|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881792|NCT00281697|Bevacizumab|bevacizumab|mesh-list
1881793|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881794|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881795|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881796|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881797|NCT00281697|Growth Substances|growth substances|mesh-ancestor
1881798|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881799|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881800|NCT00281827|Gemcitabine|gemcitabine|mesh-list
1881801|NCT00281827|Thalidomide|thalidomide|mesh-list
1881802|NCT00281827|Carboplatin|carboplatin|mesh-list
1881803|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881804|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881805|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
1881806|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881807|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
1881808|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881809|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881810|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881811|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
1881812|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881813|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
1881814|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881815|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881816|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881817|NCT00281827|Growth Substances|growth substances|mesh-ancestor
1881818|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881819|NCT00281840|Bevacizumab|bevacizumab|mesh-list
1881820|NCT00281840|Docetaxel|docetaxel|mesh-list
1881821|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881822|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881823|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1881824|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1881825|NCT00281840|Growth Substances|growth substances|mesh-ancestor
1881826|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881827|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
1881828|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881829|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881830|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881831|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881832|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
1881833|NCT00281918|Rituximab|rituximab|mesh-list
1881834|NCT00281918|Fludarabine|fludarabine|mesh-list
1881835|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
1881836|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881837|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
1881838|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881839|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881840|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881841|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
1881842|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881843|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881844|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881845|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881846|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881847|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
1881848|NCT00281957|Sirolimus|sirolimus|mesh-list
1881849|NCT00281957|Sorafenib|sorafenib|mesh-list
1881850|NCT00281957|Tipifarnib|tipifarnib|mesh-list
1881851|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881852|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881853|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881854|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881855|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881856|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881857|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881858|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
1881859|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881860|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
1881861|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881862|NCT00282048|Axitinib|axitinib|mesh-list
1881863|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881864|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1881865|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881866|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881867|NCT00282087|Gemcitabine|gemcitabine|mesh-list
1881868|NCT00282087|Docetaxel|docetaxel|mesh-list
1881869|NCT00282087|Doxorubicin|doxorubicin|mesh-list
1881870|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881871|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
1881872|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881873|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881874|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
1881875|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881876|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881877|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881878|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
1881879|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881880|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
1881881|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
1881882|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
1881883|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881884|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1881885|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1881886|NCT00282243|Tacrolimus|tacrolimus|mesh-list
1881887|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881888|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
1881889|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881890|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1881891|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881892|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881893|NCT00282256|Tacrolimus|tacrolimus|mesh-list
1881894|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881895|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
1881896|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881897|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1881898|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881899|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881900|NCT00282282|Sirolimus|sirolimus|mesh-list
1881901|NCT00282282|Fludarabine|fludarabine|mesh-list
1881902|NCT00282282|Busulfan|busulfan|mesh-list
1881903|NCT00282282|Tacrolimus|tacrolimus|mesh-list
1881904|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881905|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881906|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881907|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
1881908|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881909|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1881910|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881911|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881912|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881913|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881914|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
1881915|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
1881916|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881917|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1881918|NCT00282308|Rituximab|rituximab|mesh-list
1881919|NCT00282308|Methotrexate|methotrexate|mesh-list
1881920|NCT00282308|Vaccines|vaccines|mesh-list
1881921|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1881922|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
1881923|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
1881924|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881925|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881926|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881927|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881928|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1881929|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
1881930|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1881931|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1881932|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
1881933|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881934|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
1881935|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881936|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1881937|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881938|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1881939|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1881940|NCT00282347|Acetaminophen|acetaminophen|mesh-list
1881941|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
1881942|NCT00282347|Promethazine|promethazine|mesh-list
1881943|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
1881944|NCT00282347|Prednisone|prednisone|mesh-list
1881945|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
1881946|NCT00282347|Rituximab|rituximab|mesh-list
1881947|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1881948|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1881949|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
1881950|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881951|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881952|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1881953|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
1881954|NCT00282347|Hormones|hormones|mesh-ancestor
1881955|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1881956|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1881957|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1881958|NCT00282347|Analgesics|analgesics|mesh-ancestor
1881959|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
1881960|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1881961|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
1881962|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1881963|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1881964|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
1881965|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1881966|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1881967|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1881968|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881969|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
1881970|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
1881971|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1881972|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1881973|NCT00282347|Protective Agents|protective agents|mesh-ancestor
1881974|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1881975|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1881976|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1881977|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
1881978|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
1881979|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1881980|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
1881981|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
1881982|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1881983|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1881984|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
1881985|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
1881986|NCT00282412|Cyclosporine|cyclosporine|mesh-list
1881987|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
1881988|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
1881989|NCT00282412|Fludarabine|fludarabine|mesh-list
1881990|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
1881991|NCT00282412|Cyclosporins|cyclosporins|mesh-list
1881992|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1881993|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
1881994|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1881995|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1881996|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1881997|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
1881998|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1881999|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882000|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1882001|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882002|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
1882003|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882004|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
1882005|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1882006|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882007|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1882008|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
1882009|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1882010|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882011|NCT00282464|Ziprasidone|ziprasidone|mesh-list
1882012|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1882013|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
1882014|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882015|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882016|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882017|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1882018|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1882019|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1882020|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882021|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1882022|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
1882023|NCT00282568|Tacrolimus|tacrolimus|mesh-list
1882024|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882025|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
1882026|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882027|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1882028|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882029|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882030|NCT00282828|Clonazepam|clonazepam|mesh-list
1882031|NCT00282828|Sertraline|sertraline|mesh-list
1882032|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1882033|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
1882034|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882035|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1882036|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1882037|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882038|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882039|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882040|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
1882041|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882042|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1882043|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1882044|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
1882045|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
1882046|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
1882047|NCT00282867|Insulin|insulin|mesh-list
1882048|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882049|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882050|NCT00282919|Azithromycin|azithromycin|mesh-list
1882051|NCT00282919|Chloroquine|chloroquine|mesh-list
1882052|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1882053|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882054|NCT00282919|Amebicides|amebicides|mesh-ancestor
1882055|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1882056|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1882057|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
1882058|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882059|NCT00282971|Insulin|insulin|mesh-list
1882060|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882061|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882062|NCT00282984|Varenicline|varenicline|mesh-list
1882063|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1882064|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1882065|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
1882066|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882067|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882068|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882069|NCT00283049|Insulin|insulin|mesh-list
1882070|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1882071|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
1882072|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
1882073|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882074|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882075|NCT00283062|Docetaxel|docetaxel|mesh-list
1882076|NCT00283062|Leuprolide|leuprolide|mesh-list
1882077|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882078|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882079|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882080|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882081|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882082|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1882083|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
1882084|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1882085|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882086|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882087|NCT00283244|Gemcitabine|gemcitabine|mesh-list
1882088|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1882089|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882090|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
1882091|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882092|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882093|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
1882094|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882095|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882096|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882097|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
1882098|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882099|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1882100|NCT00283387|Betaine|betaine|mesh-list
1882101|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882102|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
1882103|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1882104|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
1882105|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882106|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1882107|NCT00283504|Omalizumab|omalizumab|mesh-list
1882108|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1882109|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1882110|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
1882111|NCT00283595|Hormones|hormones|mesh-list
1882112|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882113|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882114|NCT00283686|Telmisartan|telmisartan|mesh-list
1882115|NCT00283686|Lisinopril|lisinopril|mesh-list
1882116|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1882117|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1882118|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1882119|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1882120|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882121|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882122|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882123|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1882124|NCT00283686|Protective Agents|protective agents|mesh-ancestor
1882125|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882126|NCT00283712|Infliximab|infliximab|mesh-list
1882127|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
1882128|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882129|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882130|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
1882131|NCT00283803|Hormones|hormones|mesh-list
1882132|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1882133|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
1882134|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882135|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882136|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882137|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882138|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1882139|NCT00283803|Protective Agents|protective agents|mesh-ancestor
1882140|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1882141|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882142|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882143|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1882144|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1882145|NCT00283803|Analgesics|analgesics|mesh-ancestor
1882146|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
1882147|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882148|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882149|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882150|NCT00283816|Metformin|metformin|mesh-list
1882151|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
1882152|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
1882153|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1882154|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882155|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882156|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1882157|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1882158|NCT00284050|Ranibizumab|ranibizumab|mesh-list
1882159|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882160|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882161|NCT00284050|Growth Substances|growth substances|mesh-ancestor
1882162|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882163|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882164|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882165|NCT00284089|Ranibizumab|ranibizumab|mesh-list
1882166|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882167|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882168|NCT00284089|Growth Substances|growth substances|mesh-ancestor
1882169|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882170|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882171|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882172|NCT00284141|Aflibercept|aflibercept|mesh-list
1882173|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882174|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882175|NCT00284141|Growth Substances|growth substances|mesh-ancestor
1882176|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882177|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882178|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882179|NCT00284180|Trastuzumab|trastuzumab|mesh-list
1882180|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882181|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882182|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
1882183|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1882184|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1882185|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1882186|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882187|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882188|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
1882189|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882190|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882191|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1882192|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882193|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1882194|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1882195|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1882196|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882197|NCT00284856|Fluticasone|fluticasone|mesh-list
1882198|NCT00284856|Montelukast|montelukast|mesh-list
1882199|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882200|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1882201|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
1882202|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882203|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882204|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1882205|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
1882206|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
1882207|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1882208|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1882209|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882210|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882211|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1882212|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1882213|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882214|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
1882215|NCT00284934|Prednisone|prednisone|mesh-list
1882216|NCT00284934|Tacrolimus|tacrolimus|mesh-list
1882217|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882218|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
1882219|NCT00284934|Hormones|hormones|mesh-ancestor
1882220|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882221|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882222|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882223|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882224|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882225|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
1882226|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1882227|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882228|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882229|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882230|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1882231|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
1882232|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1882233|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882234|NCT00285012|Varenicline|varenicline|mesh-list
1882235|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1882236|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1882237|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
1882238|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882239|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882240|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882241|NCT00285467|Vitamin D|vitamin d|mesh-list
1882242|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
1882243|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
1882244|NCT00285467|Vitamins|vitamins|mesh-ancestor
1882245|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
1882246|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882247|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1882248|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1882249|NCT00285584|Bupropion|bupropion|mesh-list
1882250|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1882251|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
1882252|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882253|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1882254|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1882255|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882256|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882257|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
1882258|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882259|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882260|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1882261|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1882262|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882263|NCT00285779|Etanercept|etanercept|mesh-list
1882264|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1882265|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1882266|NCT00285779|Analgesics|analgesics|mesh-ancestor
1882267|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
1882268|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882269|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882270|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882271|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882272|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882273|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882274|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
1882275|NCT00285818|Mifepristone|mifepristone|mesh-list
1882276|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1882277|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
1882278|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1882279|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882280|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1882281|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1882282|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1882283|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
1882284|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1882285|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1882286|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882287|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882288|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
1882289|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1882290|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1882291|NCT00285857|Lovastatin|lovastatin|mesh-list
1882292|NCT00285857|L 647318|l 647318|mesh-list
1882293|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
1882294|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1882295|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
1882296|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882297|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1882298|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1882299|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1882300|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882301|NCT00286091|Denosumab|denosumab|mesh-list
1882302|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1882303|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882304|NCT00286156|Sirolimus|sirolimus|mesh-list
1882305|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1882306|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882307|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882308|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882309|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
1882310|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882311|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
1882312|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882313|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
1882314|NCT00286182|Hematinics|hematinics|mesh-ancestor
1882315|NCT00286221|Fentanyl|fentanyl|mesh-list
1882316|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1882317|NCT00286221|Narcotics|narcotics|mesh-ancestor
1882318|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1882319|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882320|NCT00286221|Analgesics|analgesics|mesh-ancestor
1882321|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
1882322|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882323|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1882324|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1882325|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
1882326|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
1882327|NCT00286234|Niacin|niacin|mesh-list
1882328|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
1882329|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1882330|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
1882331|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882332|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1882333|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
1882334|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
1882335|NCT00286234|Vitamins|vitamins|mesh-ancestor
1882336|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
1882337|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882338|NCT00286325|Rituximab|rituximab|mesh-list
1882339|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882340|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882341|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
1882342|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882343|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882344|NCT00286429|Insulin|insulin|mesh-list
1882345|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1882346|NCT00286429|Alogliptin|alogliptin|mesh-list
1882347|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882348|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882349|NCT00286429|Incretins|incretins|mesh-ancestor
1882350|NCT00286429|Hormones|hormones|mesh-ancestor
1882351|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882352|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1882353|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882354|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882355|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882356|NCT00286442|Metformin|metformin|mesh-list
1882357|NCT00286442|Alogliptin|alogliptin|mesh-list
1882358|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882359|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882360|NCT00286442|Incretins|incretins|mesh-ancestor
1882361|NCT00286442|Hormones|hormones|mesh-ancestor
1882362|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882363|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1882364|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882365|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882366|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882367|NCT00286455|Alogliptin|alogliptin|mesh-list
1882368|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882369|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882370|NCT00286455|Incretins|incretins|mesh-ancestor
1882371|NCT00286455|Hormones|hormones|mesh-ancestor
1882372|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882373|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1882374|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882375|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882376|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882377|NCT00286468|Alogliptin|alogliptin|mesh-list
1882378|NCT00286468|Glyburide|glyburide|mesh-list
1882379|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882380|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882381|NCT00286468|Incretins|incretins|mesh-ancestor
1882382|NCT00286468|Hormones|hormones|mesh-ancestor
1882383|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882384|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1882385|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882386|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882387|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882388|NCT00286494|Pioglitazone|pioglitazone|mesh-list
1882389|NCT00286494|Alogliptin|alogliptin|mesh-list
1882390|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882391|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882392|NCT00286494|Incretins|incretins|mesh-ancestor
1882393|NCT00286494|Hormones|hormones|mesh-ancestor
1882394|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882395|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1882396|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882397|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882398|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882399|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1882400|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1882401|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1882402|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882403|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882404|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
1882405|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882406|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882407|NCT00287053|Valproic Acid|valproic acid|mesh-list
1882408|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
1882409|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882410|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882411|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
1882412|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882413|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882414|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
1882415|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1882416|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1882417|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882418|NCT00287222|Bevacizumab|bevacizumab|mesh-list
1882419|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1882420|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882421|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882422|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882423|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882424|NCT00287222|Growth Substances|growth substances|mesh-ancestor
1882425|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882426|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882427|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1882428|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882429|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882430|NCT00287287|Lenalidomide|lenalidomide|mesh-list
1882431|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
1882432|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882433|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882434|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882435|NCT00287287|Growth Substances|growth substances|mesh-ancestor
1882436|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882437|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882438|NCT00287339|Esomeprazole|esomeprazole|mesh-list
1882439|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1882440|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882441|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1882442|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882443|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882444|NCT00287586|Testosterone|testosterone|mesh-list
1882445|NCT00287586|Androgens|androgens|mesh-ancestor
1882446|NCT00287586|Hormones|hormones|mesh-ancestor
1882447|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882448|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882449|NCT00287690|Genistein|genistein|mesh-list
1882450|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1882451|NCT00287690|Protective Agents|protective agents|mesh-ancestor
1882452|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882453|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882454|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1882455|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882456|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882457|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
1882458|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1882459|NCT00287690|Estrogens|estrogens|mesh-ancestor
1882460|NCT00287690|Hormones|hormones|mesh-ancestor
1882461|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882462|NCT00287716|Pirfenidone|pirfenidone|mesh-list
1882463|NCT00287716|Analgesics|analgesics|mesh-ancestor
1882464|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
1882465|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882466|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882467|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1882468|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1882469|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882470|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882471|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882472|NCT00287729|Pirfenidone|pirfenidone|mesh-list
1882473|NCT00287729|Analgesics|analgesics|mesh-ancestor
1882474|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
1882475|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882476|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882477|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1882478|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1882479|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882480|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882481|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882482|NCT00287872|Thalidomide|thalidomide|mesh-list
1882483|NCT00287872|Bortezomib|bortezomib|mesh-list
1882484|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882485|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882486|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
1882487|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882488|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
1882489|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1882490|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882491|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882492|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882493|NCT00287872|Growth Substances|growth substances|mesh-ancestor
1882494|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882495|NCT00287989|Paclitaxel|paclitaxel|mesh-list
1882496|NCT00287989|Carboplatin|carboplatin|mesh-list
1882497|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1882498|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1882499|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882500|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882501|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882502|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882503|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882504|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1882505|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882506|NCT00288015|Bevacizumab|bevacizumab|mesh-list
1882507|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882508|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882509|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882510|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882511|NCT00288015|Growth Substances|growth substances|mesh-ancestor
1882512|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882513|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882514|NCT00288054|Docetaxel|docetaxel|mesh-list
1882515|NCT00288054|Cetuximab|cetuximab|mesh-list
1882516|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882517|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882518|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882519|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882520|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882521|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882522|NCT00288067|Rituximab|rituximab|mesh-list
1882523|NCT00288067|Fenretinide|fenretinide|mesh-list
1882524|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882525|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882526|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
1882527|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882528|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882529|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1882530|NCT00288067|Protective Agents|protective agents|mesh-ancestor
1882531|NCT00288080|Dexamethasone|dexamethasone|mesh-list
1882532|NCT00288080|Prednisone|prednisone|mesh-list
1882533|NCT00288080|Docetaxel|docetaxel|mesh-list
1882534|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
1882535|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882536|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
1882537|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
1882538|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882539|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882540|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882541|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
1882542|NCT00288080|Hormones|hormones|mesh-ancestor
1882543|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882544|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882545|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882546|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882547|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882548|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882549|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882550|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882551|NCT00288366|Aripiprazole|aripiprazole|mesh-list
1882552|NCT00288366|Ziprasidone|ziprasidone|mesh-list
1882553|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
1882554|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882555|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1882556|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1882557|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1882558|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882559|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
1882560|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
1882561|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882562|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882563|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1882564|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1882565|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
1882566|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1882567|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1882568|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1882569|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1882570|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
1882571|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1882572|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1882573|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1882574|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882575|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882576|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
1882577|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882578|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882579|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1882580|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882581|NCT00288574|Fluoxetine|fluoxetine|mesh-list
1882582|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1882583|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1882584|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882585|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882586|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882587|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
1882588|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882589|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1882590|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
1882591|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882592|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1882593|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1882594|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882595|NCT00288587|Diuretics|diuretics|mesh-list
1882596|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
1882597|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
1882598|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882599|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882600|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882601|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1882602|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
1882603|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1882604|NCT00288600|Antibodies|antibodies|mesh-list
1882605|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
1882606|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1882607|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
1882608|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882609|NCT00288626|Cytarabine|cytarabine|mesh-list
1882610|NCT00288626|Prednisone|prednisone|mesh-list
1882611|NCT00288626|Etoposide|etoposide|mesh-list
1882612|NCT00288626|Melphalan|melphalan|mesh-list
1882613|NCT00288626|Carmustine|carmustine|mesh-list
1882614|NCT00288626|Sargramostim|sargramostim|mesh-list
1882615|NCT00288626|Lenograstim|lenograstim|mesh-list
1882616|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882617|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
1882618|NCT00288626|Hormones|hormones|mesh-ancestor
1882619|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882620|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882621|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882622|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882623|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1882624|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1882625|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1882626|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882627|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882628|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882629|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
1882630|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
1882631|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882632|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882633|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
1882634|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1882635|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
1882636|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1882637|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1882638|NCT00288639|Pregabalin|pregabalin|mesh-list
1882639|NCT00288639|Analgesics|analgesics|mesh-ancestor
1882640|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
1882641|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882642|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882643|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
1882644|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1882645|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1882646|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882647|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1882648|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1882649|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1882650|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1882651|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1882652|NCT00288704|Rilonacept|rilonacept|mesh-list
1882653|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882654|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1882655|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882656|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882657|NCT00289211|Complement C1s|complement c1s|mesh-list
1882658|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1882659|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1882660|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
1882661|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882662|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1882663|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882664|NCT00289536|Factor VIII|factor viii|mesh-list
1882665|NCT00289536|Coagulants|coagulants|mesh-ancestor
1882666|NCT00289653|Nicotine|nicotine|mesh-list
1882667|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1882668|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
1882669|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882670|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882671|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1882672|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1882673|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
1882674|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1882675|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882676|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1882677|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
1882678|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882679|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1882680|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1882681|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882682|NCT00289848|Incretins|incretins|mesh-ancestor
1882683|NCT00289848|Hormones|hormones|mesh-ancestor
1882684|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882685|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1882686|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
1882687|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882688|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882689|NCT00289874|Montelukast|montelukast|mesh-list
1882690|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1882691|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
1882692|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1882693|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882694|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882695|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882696|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1882697|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1882698|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882699|NCT00289887|Losartan|losartan|mesh-list
1882700|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1882701|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1882702|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1882703|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1882704|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882705|NCT00289900|Atorvastatin|atorvastatin|mesh-list
1882706|NCT00289900|Simvastatin|simvastatin|mesh-list
1882707|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1882708|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1882709|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
1882710|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882711|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1882712|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1882713|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882714|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1882715|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1882716|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882717|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882718|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
1882719|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882720|NCT00289991|Itraconazole|itraconazole|mesh-list
1882721|NCT00289991|Voriconazole|voriconazole|mesh-list
1882722|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
1882723|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882724|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1882725|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1882726|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882727|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882728|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1882729|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882730|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882731|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882732|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1882733|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
1882734|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1882735|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
1882736|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1882737|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882738|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1882739|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
1882740|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
1882741|NCT00290290|Povidone|povidone|mesh-list
1882742|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1882743|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882744|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
1882745|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
1882746|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
1882747|NCT00290329|Vaccines|vaccines|mesh-list
1882748|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
1882749|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882750|NCT00290342|Edetic Acid|edetic acid|mesh-list
1882751|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
1882752|NCT00290342|Antidotes|antidotes|mesh-ancestor
1882753|NCT00290342|Protective Agents|protective agents|mesh-ancestor
1882754|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882755|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
1882756|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
1882757|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882758|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1882759|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
1882760|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1882761|NCT00290433|Cytarabine|cytarabine|mesh-list
1882762|NCT00290433|Dexamethasone|dexamethasone|mesh-list
1882763|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
1882764|NCT00290433|Doxorubicin|doxorubicin|mesh-list
1882765|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1882766|NCT00290433|Methotrexate|methotrexate|mesh-list
1882767|NCT00290433|Vincristine|vincristine|mesh-list
1882768|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882769|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
1882770|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882771|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882772|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1882773|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
1882774|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882775|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882776|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1882777|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882778|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
1882779|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
1882780|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882781|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882782|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
1882783|NCT00290433|Hormones|hormones|mesh-ancestor
1882784|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882785|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882786|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882787|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1882788|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1882789|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882790|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1882791|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
1882792|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1882793|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882794|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
1882795|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
1882796|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1882797|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1882798|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
1882799|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882800|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1882801|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882802|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882803|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882804|NCT00290472|Sirolimus|sirolimus|mesh-list
1882805|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1882806|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882807|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882808|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882809|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
1882810|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882811|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
1882812|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882813|NCT00290498|Cytarabine|cytarabine|mesh-list
1882814|NCT00290498|Dexamethasone|dexamethasone|mesh-list
1882815|NCT00290498|Prednisone|prednisone|mesh-list
1882816|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
1882817|NCT00290498|Rituximab|rituximab|mesh-list
1882818|NCT00290498|Doxorubicin|doxorubicin|mesh-list
1882819|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1882820|NCT00290498|Methotrexate|methotrexate|mesh-list
1882821|NCT00290498|Vincristine|vincristine|mesh-list
1882822|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882823|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
1882824|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882825|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1882826|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1882827|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
1882828|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882829|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882830|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1882831|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882832|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
1882833|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
1882834|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882835|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882836|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
1882837|NCT00290498|Hormones|hormones|mesh-ancestor
1882838|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882839|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882840|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882841|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882842|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1882843|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1882844|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882845|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1882846|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
1882847|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1882848|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882849|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
1882850|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
1882851|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1882852|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1882853|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
1882854|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882855|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1882856|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882857|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882858|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882859|NCT00290537|Paclitaxel|paclitaxel|mesh-list
1882860|NCT00290537|Carboplatin|carboplatin|mesh-list
1882861|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1882862|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882863|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882864|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882865|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882866|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882867|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
1882868|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1882869|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1882870|NCT00290589|Prednisolone|prednisolone|mesh-list
1882871|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
1882872|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1882873|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
1882874|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1882875|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
1882876|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
1882877|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1882878|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882879|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1882880|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
1882881|NCT00290589|Hormones|hormones|mesh-ancestor
1882882|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882883|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1882884|NCT00290589|Protective Agents|protective agents|mesh-ancestor
1882885|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882886|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882887|NCT00290615|Bevacizumab|bevacizumab|mesh-list
1882888|NCT00290615|Cetuximab|cetuximab|mesh-list
1882889|NCT00290615|Capecitabine|capecitabine|mesh-list
1882890|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
1882891|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1882892|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882893|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882894|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882895|NCT00290615|Growth Substances|growth substances|mesh-ancestor
1882896|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882897|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882898|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882899|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
1882900|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882901|NCT00290654|Tamoxifen|tamoxifen|mesh-list
1882902|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1882903|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882904|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882905|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882906|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882907|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882908|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1882909|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1882910|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1882911|NCT00290693|Docetaxel|docetaxel|mesh-list
1882912|NCT00290693|Capecitabine|capecitabine|mesh-list
1882913|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882914|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
1882915|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
1882916|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
1882917|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882918|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882919|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
1882920|NCT00290706|Gemcitabine|gemcitabine|mesh-list
1882921|NCT00290706|Bortezomib|bortezomib|mesh-list
1882922|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1882923|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
1882924|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882925|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882926|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
1882927|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1882928|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882929|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1882930|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
1882931|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882932|NCT00290732|Doxorubicin|doxorubicin|mesh-list
1882933|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1882934|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1882935|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882936|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1882937|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1882938|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882939|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882940|NCT00290745|Tamoxifen|tamoxifen|mesh-list
1882941|NCT00290745|Letrozole|letrozole|mesh-list
1882942|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882943|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882944|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1882945|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1882946|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882947|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1882948|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882949|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882950|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882951|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1882952|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1882953|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1882954|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1882968|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
1882969|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
1882970|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882971|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1882972|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882973|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882974|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
1882975|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1882976|NCT00290810|Bevacizumab|bevacizumab|mesh-list
1882977|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1882978|NCT00290810|Antibodies|antibodies|mesh-list
1882979|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
1882980|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1882981|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882982|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1882983|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1882984|NCT00290810|Growth Substances|growth substances|mesh-ancestor
1882985|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882986|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
1882987|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
1882988|NCT00291135|Letrozole|letrozole|mesh-list
1882989|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1882990|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1882991|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1882992|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1882993|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1882994|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1882995|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
1882996|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1882997|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1882998|NCT00291226|Glycine|glycine|mesh-list
1882999|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
1883000|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883001|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883002|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883003|NCT00291330|Warfarin|warfarin|mesh-list
1883004|NCT00291330|Dabigatran|dabigatran|mesh-list
1883005|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
1883006|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
1883007|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1883008|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
1883009|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883010|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883011|NCT00291577|Docetaxel|docetaxel|mesh-list
1883012|NCT00291577|Sunitinib|sunitinib|mesh-list
1883013|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883014|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
1883015|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
1883016|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
1883017|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883018|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1883019|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1883020|NCT00291577|Growth Substances|growth substances|mesh-ancestor
1883021|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883022|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
1883023|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1883024|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883025|NCT00291642|Cetirizine|cetirizine|mesh-list
1883026|NCT00291642|Levocetirizine|levocetirizine|mesh-list
1883027|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1883028|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1883029|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1883030|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
1883031|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
1883032|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883033|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883034|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883035|NCT00291655|Levetiracetam|levetiracetam|mesh-list
1883036|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
1883037|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
1883038|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
1883039|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883040|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
1883041|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883042|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883043|NCT00291694|Celecoxib|celecoxib|mesh-list
1883044|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883045|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883046|NCT00291694|Analgesics|analgesics|mesh-ancestor
1883047|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
1883048|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883049|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883050|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883051|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883052|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1883053|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1883054|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883055|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883056|NCT00292162|Metoprolol|metoprolol|mesh-list
1883057|NCT00292162|Carvedilol|carvedilol|mesh-list
1883058|NCT00292162|Ramipril|ramipril|mesh-list
1883059|NCT00292162|Enalapril|enalapril|mesh-list
1883060|NCT00292162|Lisinopril|lisinopril|mesh-list
1883061|NCT00292162|Bisoprolol|bisoprolol|mesh-list
1883062|NCT00292162|Perindopril|perindopril|mesh-list
1883063|NCT00292162|Captopril|captopril|mesh-list
1883064|NCT00292162|Spironolactone|spironolactone|mesh-list
1883065|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1883066|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1883067|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1883068|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1883069|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1883070|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
1883071|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
1883072|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883073|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883074|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1883075|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1883076|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
1883077|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883078|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883079|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883080|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883081|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1883082|NCT00292162|Diuretics|diuretics|mesh-ancestor
1883083|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
1883084|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
1883085|NCT00292162|Protective Agents|protective agents|mesh-ancestor
1883086|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1883237|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
1883087|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883088|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1883089|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
1883090|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1883091|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1883092|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
1883093|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883094|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1883095|NCT00292188|Pregabalin|pregabalin|mesh-list
1883096|NCT00292188|Analgesics|analgesics|mesh-ancestor
1883097|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
1883098|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883099|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883100|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
1883101|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1883102|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883103|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883104|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1883105|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1883106|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1883107|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1883108|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1883109|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
1883110|NCT00292227|Rotigotine|rotigotine|mesh-list
1883111|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1883112|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883113|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1883114|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1883115|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883116|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883117|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883118|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883119|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
1883120|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
1883121|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883122|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1883123|NCT00292370|Paroxetine|paroxetine|mesh-list
1883124|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
1883125|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1883126|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1883127|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1883128|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1883129|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883130|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1883131|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1883132|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883133|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883134|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883135|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
1883136|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1883137|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1883138|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883139|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883140|NCT00292461|Lamotrigine|lamotrigine|mesh-list
1883141|NCT00292461|Zonisamide|zonisamide|mesh-list
1883142|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
1883143|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1883144|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883145|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883146|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1883147|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883148|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1883149|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1883150|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1883151|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1883152|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1883153|NCT00292591|Vitamin D|vitamin d|mesh-list
1883154|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
1883155|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
1883156|NCT00292591|Vitamins|vitamins|mesh-list
1883157|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
1883158|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883159|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1883238|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
1883160|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1883161|NCT00292942|Artesunate|artesunate|mesh-list
1883162|NCT00292942|Mannitol|mannitol|mesh-list
1883163|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
1883164|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1883165|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1883166|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883167|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883168|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
1883169|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
1883170|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1883171|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
1883172|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1883173|NCT00292942|Diuretics|diuretics|mesh-ancestor
1883174|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
1883175|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883176|NCT00292981|Complement C1s|complement c1s|mesh-list
1883177|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1883178|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1883179|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
1883180|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883181|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1883182|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883183|NCT00293020|Fentanyl|fentanyl|mesh-list
1883184|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1883185|NCT00293020|Narcotics|narcotics|mesh-ancestor
1883186|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1883187|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883188|NCT00293020|Analgesics|analgesics|mesh-ancestor
1883189|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
1883190|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883191|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1883192|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1883193|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
1883194|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
1883195|NCT00293033|Fentanyl|fentanyl|mesh-list
1883196|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1883197|NCT00293033|Narcotics|narcotics|mesh-ancestor
1883198|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1883199|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883200|NCT00293033|Analgesics|analgesics|mesh-ancestor
1883201|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
1883202|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883203|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1883204|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1883205|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
1883206|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
1883207|NCT00293059|Dienogest|dienogest|mesh-list
1883208|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1883209|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1883210|NCT00293059|Estradiol|estradiol|mesh-list
1883211|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1883212|NCT00293059|Estrogens|estrogens|mesh-ancestor
1883213|NCT00293059|Hormones|hormones|mesh-ancestor
1883214|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883215|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883216|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1883217|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
1883218|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1883219|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1883220|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1883221|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1883222|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1883223|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883224|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883225|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883226|NCT00293202|Etanercept|etanercept|mesh-list
1883227|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883228|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883229|NCT00293202|Analgesics|analgesics|mesh-ancestor
1883230|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
1883231|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883232|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883233|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883234|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883235|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883236|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883239|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1883240|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1883241|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
1883242|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883243|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1883244|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1883245|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883246|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883247|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
1883248|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1883249|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1883250|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
1883251|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883252|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1883253|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1883254|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883255|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883256|NCT00293293|Taxane|taxane|mesh-list
1883257|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883258|NCT00293384|Dexamethasone|dexamethasone|mesh-list
1883259|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
1883260|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
1883261|NCT00293384|Aprepitant|aprepitant|mesh-list
1883262|NCT00293384|Granisetron|granisetron|mesh-list
1883263|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1883264|NCT00293384|BB 1101|bb 1101|mesh-list
1883265|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883266|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
1883267|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883268|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883269|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1883270|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
1883271|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883272|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883273|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1883274|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883275|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
1883276|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
1883277|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883278|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883279|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
1883280|NCT00293384|Hormones|hormones|mesh-ancestor
1883281|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883282|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883283|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
1883284|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883285|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1883286|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883287|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1883288|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
1883289|NCT00293397|Doxorubicin|doxorubicin|mesh-list
1883290|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1883291|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1883292|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883293|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1883294|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1883295|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883296|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883297|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
1883298|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1883299|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
1883300|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883301|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1883302|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883303|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
1883304|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883305|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
1883306|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1883307|NCT00293423|Protective Agents|protective agents|mesh-ancestor
1883308|NCT00293462|Sargramostim|sargramostim|mesh-list
1883309|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
1883310|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883311|NCT00293540|Tamoxifen|tamoxifen|mesh-list
1883312|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1883313|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883314|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883315|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883316|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883317|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883318|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1883319|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1883320|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1883321|NCT00293579|Pemetrexed|pemetrexed|mesh-list
1883322|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883323|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883324|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883325|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1883326|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883327|NCT00293709|Etanercept|etanercept|mesh-list
1883328|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883329|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883330|NCT00293709|Analgesics|analgesics|mesh-ancestor
1883331|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
1883332|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883333|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883334|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883335|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883336|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883337|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883338|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
1883339|NCT00293722|Etanercept|etanercept|mesh-list
1883340|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883341|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883342|NCT00293722|Analgesics|analgesics|mesh-ancestor
1883343|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
1883344|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883345|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883346|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883347|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883348|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883349|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883350|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
1883351|NCT00293813|Denosumab|denosumab|mesh-list
1883352|NCT00293813|Alendronate|alendronate|mesh-list
1883353|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1883354|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883355|NCT00294398|Fluticasone|fluticasone|mesh-list
1883356|NCT00294398|Xhance|xhance|mesh-list
1883357|NCT00294398|Budesonide|budesonide|mesh-list
1883358|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883359|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1883360|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
1883361|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883362|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883363|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1883364|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
1883365|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883366|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1883367|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
1883368|NCT00294398|Hormones|hormones|mesh-ancestor
1883369|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883370|NCT00294515|Valganciclovir|valganciclovir|mesh-list
1883371|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
1883372|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883373|NCT00294554|Memantine|memantine|mesh-list
1883374|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1883375|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1883376|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
1883377|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883378|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883379|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883380|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1883381|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1883382|NCT00294632|Rituximab|rituximab|mesh-list
1883383|NCT00294632|Lenalidomide|lenalidomide|mesh-list
1883384|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883385|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883386|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
1883387|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883388|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883389|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1883390|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1883391|NCT00294632|Growth Substances|growth substances|mesh-ancestor
1883392|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
1883393|NCT00294658|Prednisone|prednisone|mesh-list
1883394|NCT00294658|Prednisolone|prednisolone|mesh-list
1883395|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883396|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
1883397|NCT00294658|Hormones|hormones|mesh-ancestor
1883398|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883399|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883400|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883401|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883402|NCT00294671|Diflunisal|diflunisal|mesh-list
1883403|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883404|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883405|NCT00294671|Analgesics|analgesics|mesh-ancestor
1883406|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
1883407|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883408|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883409|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883410|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883411|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1883412|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883413|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883414|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
1883415|NCT00294684|Prednisolone|prednisolone|mesh-list
1883416|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883417|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
1883418|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
1883419|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883420|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883421|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883422|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
1883423|NCT00294684|Hormones|hormones|mesh-ancestor
1883424|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883425|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1883426|NCT00294684|Protective Agents|protective agents|mesh-ancestor
1883427|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883428|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883429|NCT00294723|Liraglutide|liraglutide|mesh-list
1883430|NCT00294723|Glimepiride|glimepiride|mesh-list
1883431|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1883432|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883433|NCT00294723|Incretins|incretins|mesh-ancestor
1883434|NCT00294723|Hormones|hormones|mesh-ancestor
1883435|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883436|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1883437|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883438|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
1883439|NCT00294762|Paclitaxel|paclitaxel|mesh-list
1883440|NCT00294762|Carboplatin|carboplatin|mesh-list
1883441|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1883442|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1883443|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883444|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
1883445|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
1883446|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
1883447|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883448|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1883449|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883450|NCT00295022|Montelukast|montelukast|mesh-list
1883451|NCT00295022|Levocetirizine|levocetirizine|mesh-list
1883452|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1883453|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
1883454|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1883455|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883456|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883457|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883458|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1883459|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1883460|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883461|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1883462|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1883463|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
1883464|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
1883465|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883466|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
1883467|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1883468|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
1883469|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883470|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883471|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1883472|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1883473|NCT00295503|Bevacizumab|bevacizumab|mesh-list
1883474|NCT00295503|Pemetrexed|pemetrexed|mesh-list
1883475|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883476|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883477|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1883478|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1883479|NCT00295503|Growth Substances|growth substances|mesh-ancestor
1883480|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883481|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
1883482|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883483|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883484|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1883485|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883486|NCT00295620|Anastrozole|anastrozole|mesh-list
1883487|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883488|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883489|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1883490|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1883491|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883492|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883493|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1883494|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883495|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883496|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883497|NCT00295633|Metformin|metformin|mesh-list
1883498|NCT00295633|Pioglitazone|pioglitazone|mesh-list
1883499|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
1883500|NCT00295633|Saxagliptin|saxagliptin|mesh-list
1883501|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1883502|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883503|NCT00295633|Incretins|incretins|mesh-ancestor
1883504|NCT00295633|Hormones|hormones|mesh-ancestor
1883505|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883506|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1883507|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
1883508|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883509|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883510|NCT00295750|Leuprolide|leuprolide|mesh-list
1883511|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1883512|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
1883513|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1883514|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883515|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883516|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883517|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
1883518|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1883519|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883520|NCT00295932|Prednisone|prednisone|mesh-list
1883521|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
1883522|NCT00295932|Rituximab|rituximab|mesh-list
1883523|NCT00295932|Bortezomib|bortezomib|mesh-list
1883524|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883525|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
1883526|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883527|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883528|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1883529|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
1883530|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883531|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883532|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1883533|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883534|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883535|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
1883536|NCT00295932|Hormones|hormones|mesh-ancestor
1883537|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883538|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883539|NCT00296036|Pyridoxine|pyridoxine|mesh-list
1883540|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
1883541|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
1883542|NCT00296036|Vitamins|vitamins|mesh-ancestor
1883543|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
1883544|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883545|NCT00296192|Rotigotine|rotigotine|mesh-list
1883546|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
1883547|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
1883548|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883549|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883550|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883551|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
1883552|NCT00296244|Prednisone|prednisone|mesh-list
1883553|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
1883554|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1883555|NCT00296244|Tacrolimus|tacrolimus|mesh-list
1883556|NCT00296244|Basiliximab|basiliximab|mesh-list
1883557|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883558|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
1883559|NCT00296244|Hormones|hormones|mesh-ancestor
1883560|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883561|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883562|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883563|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883564|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883565|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
1883566|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1883567|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883568|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883569|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
1883570|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
1883571|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883572|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883573|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1883574|NCT00296244|Protective Agents|protective agents|mesh-ancestor
1883575|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1883576|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1883577|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
1883578|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1883579|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883580|NCT00296296|Cyclosporine|cyclosporine|mesh-list
1883581|NCT00296296|Tacrolimus|tacrolimus|mesh-list
1883582|NCT00296296|Cyclosporins|cyclosporins|mesh-list
1883583|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883584|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
1883585|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883586|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1883587|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883588|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883589|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
1883590|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883591|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883592|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883593|NCT00296322|Mitomycins|mitomycins|mesh-list
1883594|NCT00296322|Mitomycin|mitomycin|mesh-list
1883595|NCT00296322|Doxifluridine|doxifluridine|mesh-list
1883596|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883597|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1883598|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
1883599|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883600|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883601|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883602|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1883603|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
1883604|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883605|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
1883606|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883607|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
1883608|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1883609|NCT00296335|Mitomycins|mitomycins|mesh-list
1883610|NCT00296335|Mitomycin|mitomycin|mesh-list
1883611|NCT00296335|Doxifluridine|doxifluridine|mesh-list
1883612|NCT00296335|Floxuridine|floxuridine|mesh-list
1883613|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883614|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1883615|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
1883616|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883617|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883618|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883619|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1883620|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
1883621|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883622|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
1883623|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883624|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
1883625|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1883626|NCT00296374|Atorvastatin|atorvastatin|mesh-list
1883627|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1883628|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1883629|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1883630|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
1883631|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883632|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1883633|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1883634|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883635|NCT00296400|Atorvastatin|atorvastatin|mesh-list
1883636|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1883637|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1883638|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1883639|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
1883640|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883641|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1883642|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1883643|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883644|NCT00296491|Fluticasone|fluticasone|mesh-list
1883645|NCT00296491|Xhance|xhance|mesh-list
1883646|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1883647|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1883648|NCT00296491|Montelukast|montelukast|mesh-list
1883649|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883650|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1883651|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
1883652|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883653|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883654|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1883655|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
1883656|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883657|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1883658|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1883659|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1883660|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1883661|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
1883662|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883663|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883664|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1883665|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883666|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883667|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1883668|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1883669|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
1883670|NCT00296491|Hormones|hormones|mesh-ancestor
1883671|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
1883672|NCT00296504|Ritonavir|ritonavir|mesh-list
1883673|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
1883674|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1883675|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1883676|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
1883677|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883678|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883679|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1883680|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1883681|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
1883682|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883683|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1883684|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883685|NCT00296517|Bupropion|bupropion|mesh-list
1883686|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1883687|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
1883688|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1883689|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1883690|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1883691|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883692|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883693|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
1883694|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883695|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883696|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1883697|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883698|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883699|NCT00296647|Bupropion|bupropion|mesh-list
1883700|NCT00296647|Nicotine|nicotine|mesh-list
1883701|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1883702|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
1883703|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883704|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883705|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1883706|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1883707|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
1883708|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883709|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883710|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1883711|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
1883712|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1883713|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1883714|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1883715|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883716|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
1883717|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1883718|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883719|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883720|NCT00296725|Fluoxetine|fluoxetine|mesh-list
1883721|NCT00296725|Imipramine|imipramine|mesh-list
1883722|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1883723|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1883724|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883725|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883726|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883727|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
1883728|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883729|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1883730|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
1883731|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1883732|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1883733|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883734|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883735|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1883736|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1883737|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
1883738|NCT00296816|Bevacizumab|bevacizumab|mesh-list
1883739|NCT00296816|Docetaxel|docetaxel|mesh-list
1883740|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
1883741|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883742|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883743|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1883744|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1883745|NCT00296816|Growth Substances|growth substances|mesh-ancestor
1883746|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883747|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
1883748|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
1883749|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
1883750|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
1883751|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883752|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
1883753|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883754|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883755|NCT00297037|Analgesics|analgesics|mesh-ancestor
1883756|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
1883757|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883758|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883759|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883760|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883761|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883762|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883763|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
1883764|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1883765|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883766|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883767|NCT00297232|Natalizumab|natalizumab|mesh-list
1883768|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
1883769|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883770|NCT00297479|Nicotine|nicotine|mesh-list
1883771|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1883772|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
1883773|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883774|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883775|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1883776|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1883777|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
1883778|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883779|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883780|NCT00297492|Nicotine|nicotine|mesh-list
1883781|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1883782|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
1883783|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883784|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883785|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1883786|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1883787|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
1883788|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883789|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883790|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
1883791|NCT00297596|Trastuzumab|trastuzumab|mesh-list
1883792|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883793|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883794|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
1883795|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883796|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
1883797|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883798|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883799|NCT00297778|Pramipexole|pramipexole|mesh-list
1883800|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
1883801|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883802|NCT00297778|Protective Agents|protective agents|mesh-ancestor
1883803|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883804|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1883805|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1883806|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
1883807|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
1883808|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883809|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
1883810|NCT00297830|Alendronate|alendronate|mesh-list
1883811|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1883812|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883813|NCT00297882|Artesunate|artesunate|mesh-list
1883814|NCT00297882|Lumefantrine|lumefantrine|mesh-list
1883815|NCT00297882|Artemether|artemether|mesh-list
1883816|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1883817|NCT00297882|Amodiaquine|amodiaquine|mesh-list
1883818|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
1883819|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1883820|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1883821|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883822|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883823|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
1883824|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
1883825|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1883826|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
1883827|NCT00298038|Rifaximin|rifaximin|mesh-list
1883828|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1883829|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883830|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883831|NCT00298155|Ketoconazole|ketoconazole|mesh-list
1883832|NCT00298155|Goserelin|goserelin|mesh-list
1883833|NCT00298155|Bicalutamide|bicalutamide|mesh-list
1883834|NCT00298155|Dutasteride|dutasteride|mesh-list
1883835|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1883836|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883837|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
1883838|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883839|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1883840|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883841|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883842|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883843|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1883844|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
1883845|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883846|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883847|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1883848|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
1883849|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1883850|NCT00298233|Oseltamivir|oseltamivir|mesh-list
1883851|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
1883852|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883853|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883854|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883855|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
1883856|NCT00298272|Adalimumab|adalimumab|mesh-list
1883857|NCT00298272|Etanercept|etanercept|mesh-list
1883858|NCT00298272|Rituximab|rituximab|mesh-list
1883859|NCT00298272|Methotrexate|methotrexate|mesh-list
1883860|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883861|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883862|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
1883863|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883864|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883865|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1883866|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
1883867|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1883868|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1883869|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
1883870|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883871|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883872|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883873|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1883874|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883875|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883876|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883877|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
1883878|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
1883879|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883880|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883881|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
1883882|NCT00298272|Hormones|hormones|mesh-ancestor
1883883|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883884|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1883885|NCT00298272|Protective Agents|protective agents|mesh-ancestor
1883886|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1883887|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1883888|NCT00298272|Analgesics|analgesics|mesh-ancestor
1883889|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
1883890|NCT00298363|Tenofovir|tenofovir|mesh-list
1883891|NCT00298363|Emtricitabine|emtricitabine|mesh-list
1883892|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1883893|NCT00298363|Entecavir|entecavir|mesh-list
1883894|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
1883895|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883896|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1883897|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883898|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883899|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883900|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1883901|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1883902|NCT00298610|Artesunate|artesunate|mesh-list
1883903|NCT00298610|Atovaquone|atovaquone|mesh-list
1883904|NCT00298610|Proguanil|proguanil|mesh-list
1883905|NCT00298610|Quinidine|quinidine|mesh-list
1883906|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
1883907|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
1883908|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1883909|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1883910|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1883911|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883912|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
1883913|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
1883914|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1883915|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
1883916|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883917|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883918|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
1883919|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1883920|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1883921|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
1883922|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1883923|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883924|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1883925|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1883926|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1883927|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
1883928|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1883929|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1883930|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1883931|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1883932|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1883933|NCT00298766|Bortezomib|bortezomib|mesh-list
1883934|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883935|NCT00298831|Rocuronium|rocuronium|mesh-list
1883936|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1883937|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1883938|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1883939|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883940|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883941|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
1883942|NCT00299104|Rituximab|rituximab|mesh-list
1883943|NCT00299104|Methotrexate|methotrexate|mesh-list
1883944|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883945|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883946|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
1883947|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883948|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883949|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1883950|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
1883951|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1883952|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1883953|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
1883954|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883955|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883956|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883957|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1883958|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883959|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883960|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883961|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
1883962|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
1883963|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883964|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883965|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
1883966|NCT00299104|Hormones|hormones|mesh-ancestor
1883967|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883968|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1883969|NCT00299104|Protective Agents|protective agents|mesh-ancestor
1883970|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
1883971|NCT00299130|Rituximab|rituximab|mesh-list
1883972|NCT00299130|Methotrexate|methotrexate|mesh-list
1883973|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1883974|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1883975|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
1883976|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1883977|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1883978|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1883979|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
1883980|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1883981|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1883982|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
1883983|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1883984|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
1883985|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1883986|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1883987|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1883988|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1883989|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1883990|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
1883991|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
1883992|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1883993|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1883994|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
1883995|NCT00299130|Hormones|hormones|mesh-ancestor
1883996|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1883997|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1883998|NCT00299130|Protective Agents|protective agents|mesh-ancestor
1883999|NCT00299156|Clofarabine|clofarabine|mesh-list
1884000|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884001|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
1884002|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884003|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884004|NCT00299182|Cytarabine|cytarabine|mesh-list
1884005|NCT00299182|Dexamethasone|dexamethasone|mesh-list
1884006|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
1884007|NCT00299182|Rituximab|rituximab|mesh-list
1884008|NCT00299182|Doxorubicin|doxorubicin|mesh-list
1884009|NCT00299182|Methotrexate|methotrexate|mesh-list
1884010|NCT00299182|Vincristine|vincristine|mesh-list
1884011|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884012|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
1884013|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884014|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884015|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884016|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
1884017|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884018|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884019|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884020|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884021|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
1884022|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
1884023|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884024|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884025|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
1884026|NCT00299182|Hormones|hormones|mesh-ancestor
1884027|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884028|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1884029|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884030|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884031|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884032|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884033|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884034|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1884035|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
1884036|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1884037|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884038|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
1884039|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884040|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1884041|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1884042|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
1884043|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884044|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884045|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
1884046|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
1884047|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
1884048|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
1884049|NCT00299221|Tacrolimus|tacrolimus|mesh-list
1884050|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884051|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
1884052|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884053|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1884054|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884055|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884056|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884057|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884058|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1884059|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
1884060|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1884061|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884062|NCT00299494|Rituximab|rituximab|mesh-list
1884063|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1884064|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884065|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884066|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
1884067|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884068|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884069|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884070|NCT00299546|Golimumab|golimumab|mesh-list
1884071|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1884072|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1884073|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884074|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884075|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
1884076|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884077|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
1884078|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884079|NCT00299702|Aripiprazole|aripiprazole|mesh-list
1884080|NCT00299702|Risperidone|risperidone|mesh-list
1884081|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
1884082|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884083|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1884084|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1884085|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884086|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884087|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
1884088|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
1884089|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884090|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884091|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1884092|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1884093|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
1884094|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1884095|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1884096|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1884097|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1884098|NCT00299741|Sunitinib|sunitinib|mesh-list
1884099|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884100|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1884101|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1884102|NCT00299741|Growth Substances|growth substances|mesh-ancestor
1884103|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884104|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
1884105|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884106|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884107|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884108|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
1884109|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1884110|NCT00299988|Antibodies|antibodies|mesh-list
1884111|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
1884112|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1884113|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
1884114|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884115|NCT00300053|Lenograstim|lenograstim|mesh-list
1884116|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1884117|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
1884118|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884119|NCT00300274|Cyclosporine|cyclosporine|mesh-list
1884120|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
1884121|NCT00300274|Everolimus|everolimus|mesh-list
1884122|NCT00300274|Cyclosporins|cyclosporins|mesh-list
1884123|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884124|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884125|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884126|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
1884127|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884128|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
1884129|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884130|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884131|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884132|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1884133|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884134|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884135|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1884136|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
1884137|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1884138|NCT00300365|Aspirin|aspirin|mesh-list
1884139|NCT00300365|Niacin|niacin|mesh-list
1884140|NCT00300365|Pioglitazone|pioglitazone|mesh-list
1884364|NCT00301834|Cyclosporins|cyclosporins|mesh-list
1884141|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1884142|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1884143|NCT00300365|Analgesics|analgesics|mesh-ancestor
1884144|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
1884145|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884146|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884147|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884148|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884149|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1884150|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1884151|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884152|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1884153|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1884154|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884155|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
1884156|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1884157|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1884158|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
1884159|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1884160|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
1884161|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
1884162|NCT00300365|Vitamins|vitamins|mesh-ancestor
1884163|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
1884164|NCT00300391|Haloperidol|haloperidol|mesh-list
1884165|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
1884166|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
1884167|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
1884168|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884169|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884170|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884171|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1884172|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1884173|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884174|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884175|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1884176|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
1884177|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884178|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884179|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1884180|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
1884181|NCT00300430|Atorvastatin|atorvastatin|mesh-list
1884182|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1884183|NCT00300430|Simvastatin|simvastatin|mesh-list
1884184|NCT00300430|Fenofibrate|fenofibrate|mesh-list
1884185|NCT00300430|Calcium|calcium|mesh-list
1884186|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1884187|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884188|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1884189|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1884190|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1884191|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
1884192|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884193|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1884194|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1884195|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884196|NCT00300456|Simvastatin|simvastatin|mesh-list
1884197|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1884198|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1884199|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
1884200|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884201|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1884202|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1884203|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884204|NCT00300469|Atorvastatin|atorvastatin|mesh-list
1884205|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1884206|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1884207|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
1884208|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884209|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1884210|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1884211|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884212|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1884213|NCT00300482|Calcium|calcium|mesh-list
1884214|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1884215|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884216|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1884217|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1884218|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
1884219|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884220|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1884221|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1884222|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884223|NCT00300495|Amiodarone|amiodarone|mesh-list
1884224|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1884225|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
1884226|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1884227|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884228|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884229|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1884230|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1884231|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1884232|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884233|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1884234|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1884235|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1884236|NCT00300677|Voriconazole|voriconazole|mesh-list
1884237|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
1884238|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884239|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1884240|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1884241|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884242|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884243|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1884244|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
1884245|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884246|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884247|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1884248|NCT00300742|Topiramate|topiramate|mesh-list
1884249|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
1884250|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1884251|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884252|NCT00300755|Pantoprazole|pantoprazole|mesh-list
1884253|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1884254|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884255|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1884256|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884257|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884258|NCT00300885|Paclitaxel|paclitaxel|mesh-list
1884259|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1884260|NCT00300885|Carboplatin|carboplatin|mesh-list
1884261|NCT00300885|Sorafenib|sorafenib|mesh-list
1884262|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884263|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884264|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
1884265|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
1884266|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
1884267|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884268|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884269|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884270|NCT00301028|Paclitaxel|paclitaxel|mesh-list
1884271|NCT00301028|Carboplatin|carboplatin|mesh-list
1884272|NCT00301028|Cetuximab|cetuximab|mesh-list
1884273|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884274|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884275|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
1884276|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
1884277|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
1884278|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884279|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884280|NCT00301067|Calcitriol|calcitriol|mesh-list
1884281|NCT00301067|Temozolomide|temozolomide|mesh-list
1884282|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884283|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
1884284|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884285|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884286|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1884287|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884288|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1884289|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884290|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1884291|NCT00301067|Vitamins|vitamins|mesh-ancestor
1884292|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
1884293|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1884294|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
1884295|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884296|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
1884297|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1884298|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1884299|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884300|NCT00301262|Urological Agents|urological agents|mesh-ancestor
1884301|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
1884302|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1884303|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884304|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884305|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1884306|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1884307|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1884308|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884309|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884310|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884311|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884312|NCT00301756|Belinostat|belinostat|mesh-list
1884313|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884314|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1884315|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884316|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884317|NCT00301808|Docetaxel|docetaxel|mesh-list
1884318|NCT00301808|Pemetrexed|pemetrexed|mesh-list
1884319|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884320|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
1884321|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
1884322|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
1884323|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884324|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884325|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1884326|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1884327|NCT00301821|Prednisone|prednisone|mesh-list
1884328|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
1884329|NCT00301821|Rituximab|rituximab|mesh-list
1884330|NCT00301821|Doxorubicin|doxorubicin|mesh-list
1884331|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1884332|NCT00301821|Vincristine|vincristine|mesh-list
1884333|NCT00301821|Epratuzumab|epratuzumab|mesh-list
1884334|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884335|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
1884336|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884337|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884338|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884339|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
1884340|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884341|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884342|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884343|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884344|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884345|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884346|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884347|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884348|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884349|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
1884350|NCT00301821|Hormones|hormones|mesh-ancestor
1884351|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884352|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1884353|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884354|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
1884355|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
1884356|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
1884357|NCT00301834|Cyclosporine|cyclosporine|mesh-list
1884358|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
1884359|NCT00301834|Methotrexate|methotrexate|mesh-list
1884360|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
1884361|NCT00301834|Fludarabine|fludarabine|mesh-list
1884362|NCT00301834|Busulfan|busulfan|mesh-list
1884363|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
1884365|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1884366|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
1884367|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1884368|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884369|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884370|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
1884371|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884372|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884373|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884374|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884375|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1884376|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884377|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
1884378|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884379|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1884380|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
1884381|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884382|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1884383|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884384|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
1884385|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
1884386|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884387|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884388|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
1884389|NCT00301834|Hormones|hormones|mesh-ancestor
1884390|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884391|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1884392|NCT00301834|Protective Agents|protective agents|mesh-ancestor
1884393|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
1884394|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884395|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884396|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884397|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
1884398|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1884399|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884400|NCT00301964|Bevacizumab|bevacizumab|mesh-list
1884401|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1884402|NCT00301964|Antibodies|antibodies|mesh-list
1884403|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
1884404|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1884405|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884406|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1884407|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1884408|NCT00301964|Growth Substances|growth substances|mesh-ancestor
1884409|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884410|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
1884411|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
1884412|NCT00302003|Cytarabine|cytarabine|mesh-list
1884413|NCT00302003|Dexamethasone|dexamethasone|mesh-list
1884414|NCT00302003|Prednisone|prednisone|mesh-list
1884415|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
1884416|NCT00302003|Ifosfamide|ifosfamide|mesh-list
1884417|NCT00302003|Doxorubicin|doxorubicin|mesh-list
1884418|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1884419|NCT00302003|Etoposide|etoposide|mesh-list
1884420|NCT00302003|Vincristine|vincristine|mesh-list
1884421|NCT00302003|Vinorelbine|vinorelbine|mesh-list
1884422|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
1884423|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884424|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
1884425|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884426|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884427|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884428|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
1884429|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884430|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884431|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884432|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884433|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
1884434|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
1884435|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884436|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884437|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
1884438|NCT00302003|Hormones|hormones|mesh-ancestor
1884439|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884440|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1884441|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884442|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884443|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884444|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884445|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884446|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884447|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
1884448|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
1884449|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884450|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
1884451|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
1884452|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
1884453|NCT00302068|Sertraline|sertraline|mesh-list
1884454|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
1884455|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884456|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1884457|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1884458|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884459|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884460|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884461|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
1884462|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884463|NCT00302081|Ribavirin|ribavirin|mesh-list
1884464|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1884465|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
1884466|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
1884467|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884468|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
1884469|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884470|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
1884471|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884472|NCT00302107|Mirtazapine|mirtazapine|mesh-list
1884473|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
1884474|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884475|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1884476|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
1884477|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
1884478|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884479|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884480|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884481|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1884482|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1884483|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884484|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1884485|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1884486|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1884487|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
1884488|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1884489|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1884490|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
1884491|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1884492|NCT00302133|Naltrexone|naltrexone|mesh-list
1884493|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1884494|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1884495|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884496|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
1884497|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884498|NCT00302159|Temozolomide|temozolomide|mesh-list
1884499|NCT00302159|Valproic Acid|valproic acid|mesh-list
1884500|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884501|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
1884502|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884503|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884504|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
1884505|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884506|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
1884507|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884508|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884509|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
1884510|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1884511|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884512|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884513|NCT00302211|Bosentan|bosentan|mesh-list
1884514|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
1884515|NCT00302211|Iloprost|iloprost|mesh-list
1884516|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
1884517|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1884518|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1884519|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884520|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884521|NCT00302211|Urological Agents|urological agents|mesh-ancestor
1884522|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1884523|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1884524|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1884525|NCT00302458|Methylphenidate|methylphenidate|mesh-list
1884526|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1884527|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884528|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1884529|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1884530|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884531|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884532|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
1884533|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884534|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1884535|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1884536|NCT00302731|Hormones|hormones|mesh-list
1884537|NCT00302731|Estradiol|estradiol|mesh-list
1884538|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1884539|NCT00302731|Progesterone|progesterone|mesh-list
1884540|NCT00302731|Estrogens|estrogens|mesh-list
1884541|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884542|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884543|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1884544|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
1884545|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1884546|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1884547|NCT00302731|Progestins|progestins|mesh-ancestor
1884548|NCT00302848|Drospirenone|drospirenone|mesh-list
1884549|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
1884550|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
1884551|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
1884552|NCT00302848|Progestins|progestins|mesh-list
1884553|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1884554|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884555|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1884556|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1884557|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1884558|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1884559|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
1884560|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884561|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1884562|NCT00302848|Diuretics|diuretics|mesh-ancestor
1884563|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
1884564|NCT00302848|Hormones|hormones|mesh-ancestor
1884565|NCT00302952|Lovastatin|lovastatin|mesh-list
1884566|NCT00302952|L 647318|l 647318|mesh-list
1884567|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
1884568|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1884569|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1884570|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
1884571|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884572|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1884573|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1884574|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884575|NCT00303108|Carboplatin|carboplatin|mesh-list
1884576|NCT00303108|Doxorubicin|doxorubicin|mesh-list
1884577|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1884578|NCT00303108|Trastuzumab|trastuzumab|mesh-list
1884579|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884580|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884581|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884582|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884583|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884584|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884585|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884586|NCT00303316|Vaccines|vaccines|mesh-list
1884587|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
1884588|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884589|NCT00303329|Deferasirox|deferasirox|mesh-list
1884590|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1884591|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
1884592|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
1884593|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884594|NCT00303446|Dutasteride|dutasteride|mesh-list
1884595|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1884596|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1884597|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884598|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884599|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
1884600|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884601|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884602|NCT00303459|Bosentan|bosentan|mesh-list
1884603|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1884604|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1884605|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884606|NCT00303485|Vitamin D|vitamin d|mesh-list
1884607|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
1884608|NCT00303485|Calcium|calcium|mesh-list
1884609|NCT00303485|Vitamins|vitamins|mesh-ancestor
1884610|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
1884611|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884612|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1884613|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1884614|NCT00303602|Olanzapine|olanzapine|mesh-list
1884615|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
1884616|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
1884617|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884618|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884619|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884620|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1884621|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1884622|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884623|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884624|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1884625|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1884626|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884627|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884628|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884629|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
1884630|NCT00303628|Leucovorin|leucovorin|mesh-list
1884631|NCT00303628|Bevacizumab|bevacizumab|mesh-list
1884632|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1884633|NCT00303628|Fluorouracil|fluorouracil|mesh-list
1884634|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
1884635|NCT00303628|Antibodies|antibodies|mesh-list
1884636|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
1884637|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1884638|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
1884639|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884640|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1884641|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1884642|NCT00303628|Growth Substances|growth substances|mesh-ancestor
1884643|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884644|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
1884645|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
1884646|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
1884647|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884648|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884649|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884650|NCT00303628|Antidotes|antidotes|mesh-ancestor
1884651|NCT00303628|Protective Agents|protective agents|mesh-ancestor
1884652|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
1884653|NCT00303628|Vitamins|vitamins|mesh-ancestor
1884654|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
1884655|NCT00303667|Vidarabine|vidarabine|mesh-list
1884656|NCT00303667|Aldesleukin|aldesleukin|mesh-list
1884657|NCT00303667|Cyclosporine|cyclosporine|mesh-list
1884658|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
1884659|NCT00303667|Fludarabine|fludarabine|mesh-list
1884660|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
1884661|NCT00303667|Interleukin-2|interleukin-2|mesh-list
1884662|NCT00303667|Cyclosporins|cyclosporins|mesh-list
1884663|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
1884664|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884665|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
1884666|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884667|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884668|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884669|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
1884670|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884671|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884672|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884673|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884674|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
1884675|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
1884676|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884677|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884678|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
1884679|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884680|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1884681|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1884682|NCT00303667|Analgesics|analgesics|mesh-ancestor
1884683|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
1884684|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884685|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1884686|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1884687|NCT00303719|Cyclosporine|cyclosporine|mesh-list
1884688|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
1884689|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
1884690|NCT00303719|Fludarabine|fludarabine|mesh-list
1884691|NCT00303719|Cyclosporins|cyclosporins|mesh-list
1884692|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1884693|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884694|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
1884695|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884696|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884697|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884698|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
1884699|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884700|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884701|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884702|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884703|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
1884704|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884705|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884706|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1884707|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884708|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1884709|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
1884710|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1884711|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
1884712|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
1884713|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884714|NCT00303823|Protective Agents|protective agents|mesh-ancestor
1884715|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884716|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1884717|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1884718|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884719|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1884720|NCT00303862|Cediranib|cediranib|mesh-list
1884721|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884722|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884723|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884724|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884725|NCT00303953|Belinostat|belinostat|mesh-list
1884726|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884727|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1884728|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884729|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884730|NCT00303966|Sorafenib|sorafenib|mesh-list
1884731|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884732|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884733|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884734|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884735|NCT00304031|Temozolomide|temozolomide|mesh-list
1884736|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884737|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
1884738|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884739|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884740|NCT00304070|Doxorubicin|doxorubicin|mesh-list
1884741|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1884742|NCT00304070|Etoposide|etoposide|mesh-list
1884743|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
1884744|NCT00304070|Mitotane|mitotane|mesh-list
1884745|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884746|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884747|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884748|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884749|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884750|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884751|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884752|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1884753|NCT00304083|Doxorubicin|doxorubicin|mesh-list
1884754|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1884755|NCT00304083|Etoposide|etoposide|mesh-list
1884756|NCT00304083|Ifosfamide|ifosfamide|mesh-list
1884757|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884758|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884759|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884760|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884761|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884762|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884763|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1884764|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884765|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
1884766|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1884767|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1884768|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1884769|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884770|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884771|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
1884772|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884773|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884774|NCT00304187|Erythromycin|erythromycin|mesh-list
1884775|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
1884776|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1884777|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
1884778|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1884779|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884780|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884781|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1884782|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884783|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884784|NCT00304278|Cisplatin|cisplatin|mesh-list
1884785|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1884786|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884787|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884788|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884789|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884790|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
1884791|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1884792|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884793|NCT00304707|Bupropion|bupropion|mesh-list
1884794|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1884795|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
1884796|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1884797|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1884798|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1884799|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1884800|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884801|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
1884802|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884803|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884804|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1884805|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1884806|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884807|NCT00304746|Testosterone|testosterone|mesh-list
1884808|NCT00304746|Androgens|androgens|mesh-ancestor
1884809|NCT00304746|Hormones|hormones|mesh-ancestor
1884810|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884811|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884812|NCT00304954|Sirolimus|sirolimus|mesh-list
1884813|NCT00304954|Infliximab|infliximab|mesh-list
1884814|NCT00304954|Daclizumab|daclizumab|mesh-list
1884815|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1884816|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884817|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884818|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884819|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
1884820|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884821|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
1884822|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884823|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884824|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1884825|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884826|NCT00305058|Morphine|morphine|mesh-list
1884827|NCT00305058|Hydromorphone|hydromorphone|mesh-list
1884828|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1884829|NCT00305058|Narcotics|narcotics|mesh-ancestor
1884830|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884831|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884832|NCT00305058|Analgesics|analgesics|mesh-ancestor
1884833|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
1884834|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884835|NCT00305084|Doxorubicin|doxorubicin|mesh-list
1884836|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884837|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884838|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1884839|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884840|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884841|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884842|NCT00305110|Hydromorphone|hydromorphone|mesh-list
1884843|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1884844|NCT00305110|Narcotics|narcotics|mesh-ancestor
1884845|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1884846|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884847|NCT00305110|Analgesics|analgesics|mesh-ancestor
1884848|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
1884849|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884850|NCT00305162|Clopidogrel|clopidogrel|mesh-list
1884851|NCT00305162|Cangrelor|cangrelor|mesh-list
1884852|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1884853|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1884854|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1884855|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1884856|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
1884857|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884858|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884859|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884860|NCT00305344|Vaccines|vaccines|mesh-list
1884861|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
1884862|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884863|NCT00305448|Fulvestrant|fulvestrant|mesh-list
1884864|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1884865|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884866|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1884867|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1884868|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
1884869|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884870|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884871|NCT00305578|Memantine|memantine|mesh-list
1884872|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1884873|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1884874|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
1884875|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1884876|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884877|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884878|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1884879|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1884880|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1884881|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1884882|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884883|NCT00305604|Incretins|incretins|mesh-ancestor
1884884|NCT00305604|Hormones|hormones|mesh-ancestor
1884885|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884886|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1884887|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
1884888|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884889|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884890|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
1884891|NCT00305682|Sirolimus|sirolimus|mesh-list
1884892|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
1884893|NCT00305682|Fludarabine|fludarabine|mesh-list
1884894|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1884895|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884896|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
1884897|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884898|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884899|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884900|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
1884901|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884902|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884903|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884904|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1884905|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1884906|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
1884907|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1884908|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884909|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884910|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
1884911|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
1884912|NCT00305695|Imidazole|imidazole|mesh-list
1884913|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1884914|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884915|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884916|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884917|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
1884918|NCT00305760|Cetuximab|cetuximab|mesh-list
1884919|NCT00305760|Vaccines|vaccines|mesh-list
1884920|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
1884921|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884922|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884923|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1884924|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884925|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
1884926|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884927|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884928|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1884929|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1884930|NCT00305773|Vorinostat|vorinostat|mesh-list
1884931|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884932|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1884933|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884934|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884935|NCT00305864|Temozolomide|temozolomide|mesh-list
1884936|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
1884937|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1884938|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
1884939|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884940|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884941|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1884942|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884943|NCT00305877|Gemcitabine|gemcitabine|mesh-list
1884944|NCT00305877|Bevacizumab|bevacizumab|mesh-list
1884945|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1884946|NCT00305877|Cetuximab|cetuximab|mesh-list
1884947|NCT00305877|Capecitabine|capecitabine|mesh-list
1884948|NCT00305877|Antibodies|antibodies|mesh-list
1884949|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
1884950|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1884951|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884952|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1884953|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1884954|NCT00305877|Growth Substances|growth substances|mesh-ancestor
1884955|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884956|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
1884957|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
1884958|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1884959|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
1884960|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884961|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
1884962|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884963|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884964|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1884965|NCT00305942|Carboplatin|carboplatin|mesh-list
1884966|NCT00305942|Topotecan|topotecan|mesh-list
1884967|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884968|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1884969|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1884970|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884971|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884972|NCT00306163|Fluticasone|fluticasone|mesh-list
1884973|NCT00306163|Ciclesonide|ciclesonide|mesh-list
1884974|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1884975|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1884976|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
1884977|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1884978|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884979|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1884980|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
1884981|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
1884982|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1884983|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
1884984|NCT00306163|Hormones|hormones|mesh-ancestor
1884985|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1884986|NCT00306189|Denosumab|denosumab|mesh-list
1884987|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1884988|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1884989|NCT00306202|Dasatinib|dasatinib|mesh-list
1884990|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1884991|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1884992|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1884993|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1884994|NCT00306293|Valacyclovir|valacyclovir|mesh-list
1884995|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
1884996|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1884997|NCT00306384|Alogliptin|alogliptin|mesh-list
1884998|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1884999|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885000|NCT00306384|Incretins|incretins|mesh-ancestor
1885001|NCT00306384|Hormones|hormones|mesh-ancestor
1885002|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885003|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1885004|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
1885005|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885006|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885007|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1885008|NCT00306488|Antioxidants|antioxidants|mesh-list
1885009|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1885010|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885011|NCT00306488|Protective Agents|protective agents|mesh-ancestor
1885012|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885013|NCT00306527|Vaccines|vaccines|mesh-list
1885014|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
1885015|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885016|NCT00306592|Natalizumab|natalizumab|mesh-list
1885017|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
1885018|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885019|NCT00306670|Prednisone|prednisone|mesh-list
1885020|NCT00306670|Rituximab|rituximab|mesh-list
1885021|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1885022|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885023|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
1885024|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885025|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885026|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885027|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
1885028|NCT00306670|Hormones|hormones|mesh-ancestor
1885029|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885030|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1885031|NCT00306787|Valacyclovir|valacyclovir|mesh-list
1885032|NCT00306787|Famciclovir|famciclovir|mesh-list
1885033|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
1885034|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885035|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1885036|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885037|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885038|NCT00306852|Mitomycins|mitomycins|mesh-list
1885039|NCT00306852|Mitomycin|mitomycin|mesh-list
1885040|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1885041|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885042|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
1885043|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885044|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1885045|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885046|NCT00306891|Cediranib|cediranib|mesh-list
1885047|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885048|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1885049|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885050|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885051|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1885052|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
1885053|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885054|NCT00307047|Paclitaxel|paclitaxel|mesh-list
1885055|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1885056|NCT00307047|Everolimus|everolimus|mesh-list
1885057|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1885058|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885059|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885060|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885061|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885062|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885063|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885064|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
1885065|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885066|NCT00307086|Bortezomib|bortezomib|mesh-list
1885067|NCT00307086|Melphalan|melphalan|mesh-list
1885068|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885069|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1885070|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
1885071|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885072|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1885073|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885074|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
1885075|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885076|NCT00307125|Rituximab|rituximab|mesh-list
1885077|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1885078|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885079|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
1885080|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885081|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885082|NCT00307151|Ritonavir|ritonavir|mesh-list
1885083|NCT00307151|Lopinavir|lopinavir|mesh-list
1885084|NCT00307151|Lamivudine|lamivudine|mesh-list
1885085|NCT00307151|Zidovudine|zidovudine|mesh-list
1885086|NCT00307151|Nevirapine|nevirapine|mesh-list
1885087|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1885088|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1885089|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
1885090|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885091|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885092|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1885093|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1885094|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
1885095|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885096|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1885097|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1885098|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1885099|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1885100|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
1885101|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1885102|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1885103|NCT00307294|Thalidomide|thalidomide|mesh-list
1885104|NCT00307294|Doxorubicin|doxorubicin|mesh-list
1885105|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1885106|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885107|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1885108|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1885109|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885110|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885111|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885112|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
1885113|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885114|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
1885115|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885116|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885117|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1885118|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1885119|NCT00307294|Growth Substances|growth substances|mesh-ancestor
1885120|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
1885121|NCT00307437|Ustekinumab|ustekinumab|mesh-list
1885122|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
1885123|NCT00307489|Tenofovir|tenofovir|mesh-list
1885124|NCT00307489|Emtricitabine|emtricitabine|mesh-list
1885125|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
1885126|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885127|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1885128|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1885129|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885130|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885131|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1885132|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1885133|NCT00307684|Methylphenidate|methylphenidate|mesh-list
1885134|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1885135|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885136|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1885137|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1885138|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885139|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885140|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
1885141|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885142|NCT00307736|Bevacizumab|bevacizumab|mesh-list
1885143|NCT00307736|Fluorouracil|fluorouracil|mesh-list
1885144|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1885145|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1885146|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885147|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1885148|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1885149|NCT00307736|Growth Substances|growth substances|mesh-ancestor
1885150|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885151|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
1885152|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
1885153|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885154|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1885155|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885156|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
1885157|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1885158|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885159|NCT00307801|Dienogest|dienogest|mesh-list
1885160|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1885161|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1885162|NCT00307801|Estradiol|estradiol|mesh-list
1885163|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1885164|NCT00307801|Estrogens|estrogens|mesh-ancestor
1885165|NCT00307801|Hormones|hormones|mesh-ancestor
1885166|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885167|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885168|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1885169|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
1885170|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1885171|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1885172|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1885173|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1885174|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1885175|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
1885176|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1885177|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885178|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
1885179|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885180|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
1885181|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885182|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885183|NCT00308074|Aripiprazole|aripiprazole|mesh-list
1885184|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
1885185|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1885186|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1885187|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1885188|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885189|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885190|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
1885191|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
1885192|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885193|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885194|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1885195|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1885196|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
1885197|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1885198|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1885199|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1885200|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1885201|NCT00308087|Rituximab|rituximab|mesh-list
1885202|NCT00308087|Molgramostim|molgramostim|mesh-list
1885203|NCT00308087|Sargramostim|sargramostim|mesh-list
1885204|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1885205|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885206|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
1885207|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885208|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885209|NCT00308139|Exenatide|exenatide|mesh-list
1885210|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885211|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885212|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1885213|NCT00308139|Incretins|incretins|mesh-ancestor
1885214|NCT00308139|Hormones|hormones|mesh-ancestor
1885215|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885216|NCT00308308|Insulin|insulin|mesh-list
1885217|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885218|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885240|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
1885241|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885242|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
1885243|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885244|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885245|NCT00308620|Chloroquine|chloroquine|mesh-list
1885246|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
1885247|NCT00308620|Amebicides|amebicides|mesh-ancestor
1885248|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1885249|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1885250|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885251|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
1885252|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885253|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1885254|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885255|NCT00308620|Analgesics|analgesics|mesh-ancestor
1885256|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
1885257|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885258|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885259|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885260|NCT00308620|Filaricides|filaricides|mesh-ancestor
1885261|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
1885262|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
1885263|NCT00308711|Misoprostol|misoprostol|mesh-list
1885264|NCT00308711|Dinoprostone|dinoprostone|mesh-list
1885265|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1885266|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
1885267|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1885268|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885269|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1885270|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1885271|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
1885272|NCT00308737|Insulin|insulin|mesh-list
1885273|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885274|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885275|NCT00308750|Carboplatin|carboplatin|mesh-list
1885276|NCT00308750|Docetaxel|docetaxel|mesh-list
1885277|NCT00308750|Pemetrexed|pemetrexed|mesh-list
1885278|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885279|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885280|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885281|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885282|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885283|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885284|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1885285|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1885286|NCT00309166|Vaccines|vaccines|mesh-list
1885287|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
1885288|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885289|NCT00309244|Insulin|insulin|mesh-list
1885290|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1885291|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
1885292|NCT00309244|Protamines|protamines|mesh-list
1885293|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885294|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885295|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
1885296|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885297|NCT00309244|Coagulants|coagulants|mesh-ancestor
1885298|NCT00309465|Insulin|insulin|mesh-list
1885299|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1885300|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
1885301|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885302|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885303|NCT00309608|Glimepiride|glimepiride|mesh-list
1885304|NCT00309608|Linagliptin|linagliptin|mesh-list
1885305|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1885306|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885307|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885308|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885309|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
1885310|NCT00309608|Incretins|incretins|mesh-ancestor
1885311|NCT00309608|Hormones|hormones|mesh-ancestor
1885312|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885313|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1885314|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
1885315|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885316|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885317|NCT00309738|Simvastatin|simvastatin|mesh-list
1885318|NCT00309738|Pitavastatin|pitavastatin|mesh-list
1885319|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1885320|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1885321|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
1885322|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885323|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1885324|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1885325|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885326|NCT00309751|Atorvastatin|atorvastatin|mesh-list
1885327|NCT00309751|Pitavastatin|pitavastatin|mesh-list
1885328|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1885329|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1885330|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
1885331|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885332|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1885333|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1885334|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885335|NCT00309777|Simvastatin|simvastatin|mesh-list
1885336|NCT00309777|Pitavastatin|pitavastatin|mesh-list
1885337|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1885338|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1885339|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
1885340|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885341|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1885342|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1885343|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885344|NCT00309842|Cyclosporine|cyclosporine|mesh-list
1885345|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
1885346|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
1885347|NCT00309842|Fludarabine|fludarabine|mesh-list
1885348|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
1885349|NCT00309842|Cyclosporins|cyclosporins|mesh-list
1885350|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885351|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
1885352|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885353|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885354|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1885355|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
1885356|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885357|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885358|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1885359|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1885360|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
1885361|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885362|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
1885363|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885364|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
1885365|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1885366|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1885367|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1885368|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
1885369|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885370|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
1885371|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1885372|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1885373|NCT00309907|Prednisolone|prednisolone|mesh-list
1885374|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
1885375|NCT00309907|Etanercept|etanercept|mesh-list
1885376|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1885377|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
1885378|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885379|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
1885380|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
1885381|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885382|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885383|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1885384|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
1885385|NCT00309907|Hormones|hormones|mesh-ancestor
1885386|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885387|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1885388|NCT00309907|Protective Agents|protective agents|mesh-ancestor
1885389|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1885390|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885391|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1885392|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885393|NCT00309907|Analgesics|analgesics|mesh-ancestor
1885394|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
1885395|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885396|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885397|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
1885398|NCT00309946|Cediranib|cediranib|mesh-list
1885399|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885400|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885401|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885402|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1885403|NCT00309959|Paclitaxel|paclitaxel|mesh-list
1885404|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1885405|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1885406|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885407|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885408|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885409|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885410|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885411|NCT00309985|Docetaxel|docetaxel|mesh-list
1885412|NCT00309985|Androgens|androgens|mesh-list
1885413|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885414|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885415|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885416|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885417|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885418|NCT00309985|Hormones|hormones|mesh-ancestor
1885419|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885420|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885421|NCT00310037|Bortezomib|bortezomib|mesh-list
1885422|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885423|NCT00310050|Pemetrexed|pemetrexed|mesh-list
1885424|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885425|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885426|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885427|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1885428|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1885429|NCT00310076|Thalidomide|thalidomide|mesh-list
1885430|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885431|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
1885432|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885433|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
1885434|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885435|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885436|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1885437|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1885438|NCT00310076|Growth Substances|growth substances|mesh-ancestor
1885439|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
1885440|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885458|NCT00310375|Ezogabine|ezogabine|mesh-list
1885459|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
1885460|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885461|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885466|NCT00310401|Albuterol|albuterol|mesh-list
1885467|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1885468|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
1885469|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885470|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885471|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1885472|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
1885473|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
1885474|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1885475|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1885476|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1885477|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1885478|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
1885479|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885480|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885481|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
1885482|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1885483|NCT00310791|Hormones|hormones|mesh-list
1885484|NCT00310791|Estradiol|estradiol|mesh-list
1885485|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1885486|NCT00310791|Estrogens|estrogens|mesh-list
1885487|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
1885488|NCT00310791|Progestins|progestins|mesh-list
1885489|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885490|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885491|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1885492|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
1885493|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1885494|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1885495|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1885496|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1885497|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1885498|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1885499|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
1885500|NCT00310804|Vaccines|vaccines|mesh-list
1885501|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
1885502|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885503|NCT00310817|Vaccines|vaccines|mesh-list
1885504|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
1885505|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885506|NCT00310856|Vaccines|vaccines|mesh-list
1885507|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
1885508|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885509|NCT00311155|Amlodipine|amlodipine|mesh-list
1885510|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1885511|NCT00311155|Olmesartan|olmesartan|mesh-list
1885512|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1885513|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1885514|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1885515|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885516|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885517|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1885518|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885519|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
1885520|NCT00311155|Diuretics|diuretics|mesh-ancestor
1885521|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
1885522|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1885523|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1885524|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1885525|NCT00311246|Adalimumab|adalimumab|mesh-list
1885526|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885527|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885528|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
1885529|NCT00311311|Sirolimus|sirolimus|mesh-list
1885530|NCT00311311|Prednisone|prednisone|mesh-list
1885531|NCT00311311|Tacrolimus|tacrolimus|mesh-list
1885532|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885533|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
1885534|NCT00311311|Hormones|hormones|mesh-ancestor
1885535|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885536|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885537|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1885538|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885539|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885540|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
1885541|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1885542|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885543|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885544|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1885545|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1885546|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
1885547|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885548|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885549|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
1885550|NCT00311363|Gabapentin|gabapentin|mesh-list
1885551|NCT00311363|Analgesics|analgesics|mesh-ancestor
1885552|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
1885553|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885554|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885555|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
1885556|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1885557|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1885558|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885559|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1885560|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1885561|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1885562|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885563|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885564|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
1885565|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
1885566|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1885567|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1885568|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1885569|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885570|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885571|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
1885572|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885573|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885574|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1885575|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885576|NCT00311402|Aspirin|aspirin|mesh-list
1885577|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
1885578|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1885579|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885580|NCT00311402|Analgesics|analgesics|mesh-ancestor
1885581|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
1885582|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885583|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885584|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885585|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885586|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1885587|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1885588|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885589|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1885590|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1885591|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885592|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
1885593|NCT00311584|Irinotecan|irinotecan|mesh-list
1885594|NCT00311584|Temozolomide|temozolomide|mesh-list
1885595|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1885596|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1885597|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885598|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885599|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885600|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1885601|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
1885602|NCT00311623|Sirolimus|sirolimus|mesh-list
1885603|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885604|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885605|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1885606|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885607|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
1885608|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885609|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
1885610|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885611|NCT00312195|Buprenorphine|buprenorphine|mesh-list
1885612|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885613|NCT00312195|Narcotics|narcotics|mesh-ancestor
1885614|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885615|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885616|NCT00312195|Analgesics|analgesics|mesh-ancestor
1885617|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
1885618|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885619|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885620|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
1885621|NCT00312208|Docetaxel|docetaxel|mesh-list
1885622|NCT00312208|Doxorubicin|doxorubicin|mesh-list
1885623|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1885624|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885625|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
1885626|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885627|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885628|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1885629|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
1885630|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885631|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885632|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1885633|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885634|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885635|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885636|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1885637|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1885638|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1885639|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885640|NCT00312221|Oxycodone|oxycodone|mesh-list
1885641|NCT00312221|Buprenorphine|buprenorphine|mesh-list
1885642|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885643|NCT00312221|Narcotics|narcotics|mesh-ancestor
1885644|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885645|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885646|NCT00312221|Analgesics|analgesics|mesh-ancestor
1885647|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
1885648|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885649|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885650|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
1885651|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1885652|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885653|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885654|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1885655|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1885656|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885657|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885658|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885659|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1885660|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
1885661|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1885662|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885663|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1885664|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1885665|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1885666|NCT00312377|Docetaxel|docetaxel|mesh-list
1885667|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885668|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885669|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885670|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885671|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885672|NCT00312494|Ziprasidone|ziprasidone|mesh-list
1885673|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1885674|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
1885675|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885676|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885677|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885678|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1885679|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1885680|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885681|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1885682|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1885683|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
1885684|NCT00312572|Buprenorphine|buprenorphine|mesh-list
1885685|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885686|NCT00312572|Narcotics|narcotics|mesh-ancestor
1885687|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885688|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885689|NCT00312572|Analgesics|analgesics|mesh-ancestor
1885690|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
1885691|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885692|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885693|NCT00312728|Bevacizumab|bevacizumab|mesh-list
1885694|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1885695|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885696|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1885697|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1885698|NCT00312728|Growth Substances|growth substances|mesh-ancestor
1885699|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885700|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
1885701|NCT00312845|Rituximab|rituximab|mesh-list
1885702|NCT00312845|Bortezomib|bortezomib|mesh-list
1885703|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1885704|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885705|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
1885706|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885707|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885708|NCT00312858|Vaccines|vaccines|mesh-list
1885709|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1885710|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
1885711|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885712|NCT00312923|Policosanol|policosanol|mesh-list
1885713|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1885714|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1885715|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
1885716|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885717|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1885718|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1885719|NCT00313014|Oxycodone|oxycodone|mesh-list
1885720|NCT00313014|Buprenorphine|buprenorphine|mesh-list
1885721|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885722|NCT00313014|Narcotics|narcotics|mesh-ancestor
1885723|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885724|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885725|NCT00313014|Analgesics|analgesics|mesh-ancestor
1885726|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
1885727|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885728|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885729|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
1885730|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1885731|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885732|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885733|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1885734|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1885735|NCT00313170|Fulvestrant|fulvestrant|mesh-list
1885736|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1885737|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885738|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1885739|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1885740|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
1885741|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885742|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885743|NCT00313300|Apixaban|apixaban|mesh-list
1885744|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1885745|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
1885746|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1885747|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
1885748|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885749|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885750|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
1885751|NCT00313313|Metformin|metformin|mesh-list
1885752|NCT00313313|Saxagliptin|saxagliptin|mesh-list
1885753|NCT00313313|Glyburide|glyburide|mesh-list
1885754|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885755|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885756|NCT00313313|Incretins|incretins|mesh-ancestor
1885757|NCT00313313|Hormones|hormones|mesh-ancestor
1885758|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885759|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1885760|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
1885761|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885762|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885763|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1885764|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885765|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1885766|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885767|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885768|NCT00313586|Azacitidine|azacitidine|mesh-list
1885769|NCT00313586|Entinostat|entinostat|mesh-list
1885770|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1885771|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1885772|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
1885773|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885774|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885775|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885776|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
1885777|NCT00313612|Topotecan|topotecan|mesh-list
1885778|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885779|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1885780|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1885781|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885782|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885783|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
1885784|NCT00313716|Hematinics|hematinics|mesh-ancestor
1885785|NCT00313729|Temozolomide|temozolomide|mesh-list
1885786|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1885787|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
1885788|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885789|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885790|NCT00313781|Prednisone|prednisone|mesh-list
1885791|NCT00313781|Docetaxel|docetaxel|mesh-list
1885792|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885793|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
1885794|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
1885795|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
1885796|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885797|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885798|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
1885799|NCT00313781|Hormones|hormones|mesh-ancestor
1885800|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885801|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885802|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1885803|NCT00313820|Pregabalin|pregabalin|mesh-list
1885804|NCT00313820|Analgesics|analgesics|mesh-ancestor
1885805|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
1885806|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885807|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885808|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
1885809|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1885810|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885811|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885812|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1885813|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1885814|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1885815|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885816|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1885817|NCT00313846|Buprenorphine|buprenorphine|mesh-list
1885818|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885819|NCT00313846|Narcotics|narcotics|mesh-ancestor
1885820|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885821|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885822|NCT00313846|Analgesics|analgesics|mesh-ancestor
1885823|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
1885824|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885825|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885826|NCT00314106|Aldesleukin|aldesleukin|mesh-list
1885827|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
1885828|NCT00314106|Fludarabine|fludarabine|mesh-list
1885829|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1885830|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
1885831|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885832|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885833|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1885834|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
1885835|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885836|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885837|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1885838|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1885839|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1885840|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
1885841|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885842|NCT00314249|Milnacipran|milnacipran|mesh-list
1885843|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
1885844|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1885845|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1885846|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885847|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885848|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885849|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885850|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885851|NCT00314249|Analgesics|analgesics|mesh-ancestor
1885852|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
1885853|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885854|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
1885855|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1885856|NCT00314262|Celecoxib|celecoxib|mesh-list
1885857|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1885858|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1885859|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1885860|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1885861|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885862|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1885863|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885864|NCT00314262|Analgesics|analgesics|mesh-ancestor
1885865|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
1885866|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885867|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885868|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885869|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885946|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
1885870|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1885871|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1885872|NCT00314340|Acetaminophen|acetaminophen|mesh-list
1885873|NCT00314340|Morphine|morphine|mesh-list
1885874|NCT00314340|Hydrocodone|hydrocodone|mesh-list
1885875|NCT00314340|Phenobarbital|phenobarbital|mesh-list
1885876|NCT00314340|Amphetamine|amphetamine|mesh-list
1885877|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885878|NCT00314340|Narcotics|narcotics|mesh-ancestor
1885879|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885880|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885881|NCT00314340|Analgesics|analgesics|mesh-ancestor
1885882|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
1885883|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885884|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885885|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
1885886|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
1885887|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
1885888|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1885889|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
1885890|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
1885891|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
1885892|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885893|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885894|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
1885895|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1885896|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1885897|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1885898|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1885899|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
1885900|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1885901|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1885902|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1885903|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
1885904|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
1885905|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1885906|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1885907|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1885908|NCT00314574|Omalizumab|omalizumab|mesh-list
1885909|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1885910|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1885911|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
1885912|NCT00314808|Dronabinol|dronabinol|mesh-list
1885913|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
1885914|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885915|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1885916|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885917|NCT00314808|Analgesics|analgesics|mesh-ancestor
1885918|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
1885919|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885920|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1885921|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1885922|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885923|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885924|NCT00314808|Hormones|hormones|mesh-ancestor
1885925|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1885926|NCT00314951|Vancomycin|vancomycin|mesh-list
1885927|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
1885928|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1885929|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1885930|NCT00315055|Vaccines|vaccines|mesh-list
1885931|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
1885932|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885933|NCT00315146|Pioglitazone|pioglitazone|mesh-list
1885934|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1885935|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885936|NCT00315302|Atropine|atropine|mesh-list
1885937|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1885938|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1885939|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1885940|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
1885941|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885942|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885943|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1885944|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
1885945|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
1885947|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1885948|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1885949|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
1885950|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885951|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885952|NCT00315328|Atropine|atropine|mesh-list
1885953|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1885954|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1885955|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1885956|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
1885957|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885958|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885959|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1885960|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
1885961|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
1885962|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
1885963|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1885964|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1885965|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
1885966|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1885967|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1885968|NCT00315341|Buprenorphine|buprenorphine|mesh-list
1885969|NCT00315341|Methadone|methadone|mesh-list
1885970|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1885971|NCT00315341|Naloxone|naloxone|mesh-list
1885972|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885973|NCT00315341|Narcotics|narcotics|mesh-ancestor
1885974|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885975|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885976|NCT00315341|Analgesics|analgesics|mesh-ancestor
1885977|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
1885978|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885979|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885980|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
1885981|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
1885982|NCT00315445|Acetaminophen|acetaminophen|mesh-list
1885983|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1885984|NCT00315445|Oxycodone|oxycodone|mesh-list
1885985|NCT00315445|Buprenorphine|buprenorphine|mesh-list
1885986|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1885987|NCT00315445|Analgesics|analgesics|mesh-ancestor
1885988|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
1885989|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1885990|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1885991|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
1885992|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1885993|NCT00315445|Narcotics|narcotics|mesh-ancestor
1885994|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1885995|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1885996|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1885997|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1885998|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1885999|NCT00315458|Buprenorphine|buprenorphine|mesh-list
1886000|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1886001|NCT00315458|Narcotics|narcotics|mesh-ancestor
1886002|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886003|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886004|NCT00315458|Analgesics|analgesics|mesh-ancestor
1886005|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
1886006|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886007|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1886008|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
1886009|NCT00315705|Etoposide|etoposide|mesh-list
1886010|NCT00315705|Clofarabine|clofarabine|mesh-list
1886011|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886012|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
1886013|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886014|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1886015|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1886016|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
1886017|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886018|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886019|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1886020|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1886021|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1886022|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1886023|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886024|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886025|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
1886026|NCT00316004|Dextrans|dextrans|mesh-list
1886027|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
1886028|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
1886029|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
1886030|NCT00316017|Dextrans|dextrans|mesh-list
1886031|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
1886032|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
1886033|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
1886034|NCT00316082|Metformin|metformin|mesh-list
1886035|NCT00316082|Saxagliptin|saxagliptin|mesh-list
1886036|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1886037|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886038|NCT00316082|Incretins|incretins|mesh-ancestor
1886039|NCT00316082|Hormones|hormones|mesh-ancestor
1886040|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1886041|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1886042|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
1886043|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886044|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886045|NCT00316173|Carboplatin|carboplatin|mesh-list
1886046|NCT00316173|Topotecan|topotecan|mesh-list
1886047|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886048|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1886049|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1886050|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886051|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886052|NCT00316186|Carboplatin|carboplatin|mesh-list
1886053|NCT00316186|Topotecan|topotecan|mesh-list
1886054|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886055|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1886056|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1886057|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886058|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886059|NCT00316199|Gemcitabine|gemcitabine|mesh-list
1886060|NCT00316199|Paclitaxel|paclitaxel|mesh-list
1886061|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1886062|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886063|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886064|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886065|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886066|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886067|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886068|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
1886069|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
1886070|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886071|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886072|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886073|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
1886074|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886075|NCT00316225|Pemetrexed|pemetrexed|mesh-list
1886076|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886077|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886078|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886079|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1886080|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1886081|NCT00316264|Palivizumab|palivizumab|mesh-list
1886082|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
1886083|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886084|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
1886085|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1886086|NCT00316277|Narcotics|narcotics|mesh-ancestor
1886087|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886088|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886089|NCT00316277|Analgesics|analgesics|mesh-ancestor
1886090|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
1886091|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886092|NCT00316719|Lamivudine|lamivudine|mesh-list
1886093|NCT00316719|Adefovir|adefovir|mesh-list
1886094|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1886095|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1886096|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1886097|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886098|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886099|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
1886100|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886101|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1886102|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1886103|NCT00316862|Irinotecan|irinotecan|mesh-list
1886104|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886105|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1886106|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1886107|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886108|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886109|NCT00316888|Cisplatin|cisplatin|mesh-list
1886110|NCT00316888|Fluorouracil|fluorouracil|mesh-list
1886111|NCT00316888|Cetuximab|cetuximab|mesh-list
1886112|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886113|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
1886114|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886115|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886116|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886117|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
1886118|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886119|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886120|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
1886121|NCT00316914|Calcium|calcium|mesh-list
1886122|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1886123|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886124|NCT00316914|Analgesics|analgesics|mesh-ancestor
1886125|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
1886126|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886127|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
1886128|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886129|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1886130|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
1886131|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1886132|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886133|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886134|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
1886135|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1886136|NCT00317044|Esomeprazole|esomeprazole|mesh-list
1886137|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1886138|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886139|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1886140|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886141|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886142|NCT00317473|Vaccines|vaccines|mesh-list
1886143|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
1886144|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886145|NCT00317642|Cytarabine|cytarabine|mesh-list
1886146|NCT00317642|Clofarabine|clofarabine|mesh-list
1886147|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886148|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
1886149|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886150|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886151|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
1886152|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886153|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886154|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
1886155|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886156|NCT00317720|Trastuzumab|trastuzumab|mesh-list
1886157|NCT00317720|Everolimus|everolimus|mesh-list
1886158|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886159|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886160|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886161|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
1886162|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886163|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
1886164|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1886165|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
1886166|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886167|NCT00318136|Paclitaxel|paclitaxel|mesh-list
1886168|NCT00318136|Bevacizumab|bevacizumab|mesh-list
1886169|NCT00318136|Carboplatin|carboplatin|mesh-list
1886170|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1886171|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886172|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886173|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886174|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886175|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886176|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886177|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886178|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886179|NCT00318136|Growth Substances|growth substances|mesh-ancestor
1886180|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886181|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886182|NCT00318149|Vaccines|vaccines|mesh-list
1886183|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
1886184|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886185|NCT00318292|Epinephrine|epinephrine|mesh-list
1886186|NCT00318292|Bupivacaine|bupivacaine|mesh-list
1886187|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
1886188|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
1886189|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886190|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886191|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
1886192|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886193|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1886194|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1886195|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
1886196|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886197|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886198|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1886199|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1886200|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
1886201|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1886202|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
1886203|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
1886204|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
1886205|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1886206|NCT00318370|Farletuzumab|farletuzumab|mesh-list
1886207|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886208|NCT00318409|Bupropion|bupropion|mesh-list
1886209|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1886210|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
1886211|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886212|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1886213|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1886214|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886215|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886216|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
1886217|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886218|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886219|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1886220|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1886221|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886222|NCT00318461|Metformin|metformin|mesh-list
1886223|NCT00318461|Liraglutide|liraglutide|mesh-list
1886224|NCT00318461|Glimepiride|glimepiride|mesh-list
1886225|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1886226|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886227|NCT00318461|Incretins|incretins|mesh-ancestor
1886228|NCT00318461|Hormones|hormones|mesh-ancestor
1886229|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1886230|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1886231|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886232|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
1886233|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
1886234|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1886235|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1886236|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1886237|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886238|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1886239|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
1886240|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1886241|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886242|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886243|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
1886244|NCT00318643|Mitomycins|mitomycins|mesh-list
1886245|NCT00318643|Mitomycin|mitomycin|mesh-list
1886246|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1886247|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886248|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
1886249|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886326|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
1886250|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1886251|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886252|NCT00318656|Metformin|metformin|mesh-list
1886253|NCT00318656|Glimepiride|glimepiride|mesh-list
1886254|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
1886255|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1886256|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886257|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1886258|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886259|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
1886260|NCT00318708|Fluticasone|fluticasone|mesh-list
1886261|NCT00318708|Xhance|xhance|mesh-list
1886262|NCT00318708|Clarithromycin|clarithromycin|mesh-list
1886263|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1886264|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1886265|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
1886266|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886267|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886268|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1886269|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
1886270|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
1886271|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1886272|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1886273|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886274|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1886275|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886276|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886277|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1886278|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1886279|NCT00318812|Iron|iron|mesh-list
1886280|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1886281|NCT00318812|Trace Elements|trace elements|mesh-ancestor
1886282|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
1886283|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886284|NCT00318812|Hematinics|hematinics|mesh-ancestor
1886285|NCT00318929|Valproic Acid|valproic acid|mesh-list
1886286|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
1886287|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886288|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886289|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
1886290|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886291|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886292|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
1886293|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1886294|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886295|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886296|NCT00319020|Bosentan|bosentan|mesh-list
1886297|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1886298|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1886299|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886300|NCT00319046|Miglustat|miglustat|mesh-list
1886301|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886302|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886303|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1886304|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1886305|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
1886306|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886307|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1886308|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1886309|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886310|NCT00319111|Bosentan|bosentan|mesh-list
1886311|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1886312|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1886313|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886314|NCT00319449|Atorvastatin|atorvastatin|mesh-list
1886315|NCT00319449|Ezetimibe|ezetimibe|mesh-list
1886316|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1886317|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1886318|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
1886319|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886320|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1886321|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1886322|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886323|NCT00319501|Diazepam|diazepam|mesh-list
1886324|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1886325|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
1886327|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
1886328|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886329|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886330|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886331|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1886332|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886333|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1886334|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1886335|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1886336|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1886337|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886338|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1886339|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
1886340|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
1886341|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
1886342|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
1886343|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886344|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886345|NCT00319592|Vaccines|vaccines|mesh-list
1886346|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
1886347|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886348|NCT00319696|Bosentan|bosentan|mesh-list
1886349|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1886350|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1886351|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886352|NCT00319956|Azithromycin|azithromycin|mesh-list
1886353|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1886354|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886355|NCT00319982|Diltiazem|diltiazem|mesh-list
1886356|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1886357|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1886358|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886359|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886360|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1886361|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886362|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
1886363|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
1886364|NCT00320190|Dasatinib|dasatinib|mesh-list
1886365|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886366|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1886367|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886368|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886369|NCT00320216|Ustekinumab|ustekinumab|mesh-list
1886370|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
1886371|NCT00320255|Apixaban|apixaban|mesh-list
1886372|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1886373|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
1886374|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1886375|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
1886376|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886377|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886378|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
1886379|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
1886380|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1886381|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1886382|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1886383|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886384|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886385|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
1886386|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886387|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886388|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1886389|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886390|NCT00320385|Trastuzumab|trastuzumab|mesh-list
1886391|NCT00320385|Lapatinib|lapatinib|mesh-list
1886392|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886393|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886394|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1886395|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886396|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886397|NCT00320398|PENTA|penta|mesh-list
1886398|NCT00320398|Fondaparinux|fondaparinux|mesh-list
1886399|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1886400|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
1886401|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1886402|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
1886403|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886404|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886405|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
1886406|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1886407|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1886408|NCT00320411|Lapatinib|lapatinib|mesh-list
1886409|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886410|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1886411|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886412|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886413|NCT00320424|PENTA|penta|mesh-list
1886414|NCT00320424|Fondaparinux|fondaparinux|mesh-list
1886415|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1886416|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
1886417|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1886418|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
1886419|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886420|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886421|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
1886422|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1886423|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1886424|NCT00320489|Olanzapine|olanzapine|mesh-list
1886425|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
1886426|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
1886427|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886428|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886429|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886430|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1886431|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1886432|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886433|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886434|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1886435|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1886436|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886437|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886438|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886439|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
1886440|NCT00320515|Pemetrexed|pemetrexed|mesh-list
1886441|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886442|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886443|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886444|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1886445|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1886446|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1886447|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1886448|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1886449|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886450|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886451|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
1886452|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886453|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886454|NCT00320541|Gemcitabine|gemcitabine|mesh-list
1886455|NCT00320541|Paclitaxel|paclitaxel|mesh-list
1886456|NCT00320541|Bevacizumab|bevacizumab|mesh-list
1886457|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1886458|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886459|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886460|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886461|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886462|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886463|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886464|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886465|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886466|NCT00320541|Growth Substances|growth substances|mesh-ancestor
1886467|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886468|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886469|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886470|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
1886471|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
1886472|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886473|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886474|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886475|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
1886476|NCT00320671|Risperidone|risperidone|mesh-list
1886477|NCT00320671|Aripiprazole|aripiprazole|mesh-list
1886478|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1886479|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
1886480|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886481|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886482|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886483|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1886484|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1886485|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886486|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886487|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1886488|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
1886489|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
1886490|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
1886491|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1886492|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1886493|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1886494|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1886495|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
1886496|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1886497|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886498|NCT00320749|Gemcitabine|gemcitabine|mesh-list
1886499|NCT00320749|Capecitabine|capecitabine|mesh-list
1886500|NCT00320749|Docetaxel|docetaxel|mesh-list
1886501|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886502|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
1886503|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886504|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886505|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
1886506|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886507|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886508|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886509|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
1886510|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886511|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886512|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886513|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886514|NCT00320788|Aflibercept|aflibercept|mesh-list
1886515|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886516|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886517|NCT00320788|Growth Substances|growth substances|mesh-ancestor
1886518|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886519|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886520|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886521|NCT00320801|Buprenorphine|buprenorphine|mesh-list
1886522|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1886523|NCT00320801|Narcotics|narcotics|mesh-ancestor
1886524|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886525|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886526|NCT00320801|Analgesics|analgesics|mesh-ancestor
1886527|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
1886528|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886529|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1886530|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
1886531|NCT00321464|Denosumab|denosumab|mesh-list
1886532|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1886533|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886534|NCT00321555|Immunotoxins|immunotoxins|mesh-list
1886535|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
1886536|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886537|NCT00321594|Belinostat|belinostat|mesh-list
1886538|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886539|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1886540|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886541|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886542|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
1886543|NCT00321620|Denosumab|denosumab|mesh-list
1886544|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1886545|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886546|NCT00321646|Bevacizumab|bevacizumab|mesh-list
1886547|NCT00321646|Docetaxel|docetaxel|mesh-list
1886548|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886549|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886550|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886551|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886552|NCT00321646|Growth Substances|growth substances|mesh-ancestor
1886553|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886554|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886555|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886556|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886557|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886558|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886559|NCT00321672|Capsaicin|capsaicin|mesh-list
1886560|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
1886561|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
1886562|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
1886563|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886564|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886565|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
1886566|NCT00321685|Leucovorin|leucovorin|mesh-list
1886567|NCT00321685|Folic Acid|folic acid|mesh-list
1886568|NCT00321685|Bevacizumab|bevacizumab|mesh-list
1886569|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1886570|NCT00321685|Fluorouracil|fluorouracil|mesh-list
1886571|NCT00321685|Capecitabine|capecitabine|mesh-list
1886572|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
1886573|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
1886574|NCT00321685|Antibodies|antibodies|mesh-list
1886575|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
1886576|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1886577|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
1886578|NCT00321685|Calcium|calcium|mesh-list
1886579|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
1886580|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886581|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886582|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886583|NCT00321685|Growth Substances|growth substances|mesh-ancestor
1886584|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886585|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886586|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
1886587|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1886588|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1886589|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
1886590|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886591|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886592|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886593|NCT00321685|Antidotes|antidotes|mesh-ancestor
1886594|NCT00321685|Protective Agents|protective agents|mesh-ancestor
1886595|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
1886596|NCT00321685|Vitamins|vitamins|mesh-ancestor
1886597|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
1886598|NCT00321685|Hematinics|hematinics|mesh-ancestor
1886599|NCT00321698|Docetaxel|docetaxel|mesh-list
1886600|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886601|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886602|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886603|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886604|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886605|NCT00321711|Azacitidine|azacitidine|mesh-list
1886606|NCT00321711|Decitabine|decitabine|mesh-list
1886607|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886608|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
1886609|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886610|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886611|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886612|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
1886613|NCT00321737|Lansoprazole|lansoprazole|mesh-list
1886614|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1886615|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886616|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1886617|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886618|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886619|NCT00321828|Leucovorin|leucovorin|mesh-list
1886620|NCT00321828|Bevacizumab|bevacizumab|mesh-list
1886621|NCT00321828|Fluorouracil|fluorouracil|mesh-list
1886622|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
1886623|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
1886624|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886625|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886626|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886627|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886628|NCT00321828|Growth Substances|growth substances|mesh-ancestor
1886629|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886630|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886631|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
1886632|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886633|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886634|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886635|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
1886636|NCT00321828|Antidotes|antidotes|mesh-ancestor
1886637|NCT00321828|Protective Agents|protective agents|mesh-ancestor
1886638|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
1886639|NCT00321828|Vitamins|vitamins|mesh-ancestor
1886640|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
1886641|NCT00321854|Pramipexole|pramipexole|mesh-list
1886642|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
1886643|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886644|NCT00321854|Protective Agents|protective agents|mesh-ancestor
1886645|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886646|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1886647|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1886648|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
1886649|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
1886650|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886651|NCT00321893|Budesonide|budesonide|mesh-list
1886652|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1886653|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1886654|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
1886655|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886656|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886657|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1886658|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
1886659|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
1886660|NCT00321893|Hormones|hormones|mesh-ancestor
1886661|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1886662|NCT00321906|Sirolimus|sirolimus|mesh-list
1886663|NCT00321906|Azathioprine|azathioprine|mesh-list
1886664|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1886665|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886666|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1886667|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886668|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
1886669|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886670|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
1886671|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886672|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
1886673|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886674|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886675|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1886676|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
1886677|NCT00321919|Hematinics|hematinics|mesh-ancestor
1886678|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
1886679|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
1886680|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
1886681|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
1886682|NCT00321932|Calcium|calcium|mesh-list
1886683|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1886684|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886685|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1886686|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886687|NCT00321932|Vitamins|vitamins|mesh-ancestor
1886688|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
1886689|NCT00321932|Antacids|antacids|mesh-ancestor
1886690|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886691|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
1886692|NCT00321984|Lansoprazole|lansoprazole|mesh-list
1886693|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1886694|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886695|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1886696|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886697|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886698|NCT00322049|Vaccines|vaccines|mesh-list
1886699|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
1886700|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886701|NCT00322101|Cyclosporine|cyclosporine|mesh-list
1886702|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
1886703|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
1886704|NCT00322101|Busulfan|busulfan|mesh-list
1886705|NCT00322101|Methotrexate|methotrexate|mesh-list
1886706|NCT00322101|Fludarabine|fludarabine|mesh-list
1886707|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
1886708|NCT00322101|Tacrolimus|tacrolimus|mesh-list
1886709|NCT00322101|Cyclosporins|cyclosporins|mesh-list
1886710|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886711|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
1886712|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886713|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1886714|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1886715|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
1886716|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886717|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886718|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1886719|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1886720|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
1886721|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1886722|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886723|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
1886724|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
1886725|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886726|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1886727|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1886728|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1886729|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
1886730|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886731|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1886732|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1886733|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
1886734|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1886735|NCT00322153|Memantine|memantine|mesh-list
1886736|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1886737|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1886738|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
1886739|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886740|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886741|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886742|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1886743|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1886744|NCT00322309|Mirtazapine|mirtazapine|mesh-list
1886745|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
1886746|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886747|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1886748|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
1886749|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
1886750|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886751|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886752|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886753|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1886754|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1886755|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1886756|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1886757|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1886758|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1886759|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
1886760|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1886761|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1886762|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
1886763|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1886764|NCT00322335|PENTA|penta|mesh-list
1886765|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
1886766|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1886767|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1886768|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886769|NCT00322348|Goserelin|goserelin|mesh-list
1886770|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1886771|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886772|NCT00322374|Epirubicin|epirubicin|mesh-list
1886773|NCT00322374|Epothilones|epothilones|mesh-list
1886774|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1886775|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886776|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1886777|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1886778|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886779|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886780|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886781|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886782|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886783|NCT00322387|Plerixafor|plerixafor|mesh-list
1886784|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1886785|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1886786|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
1886787|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886788|NCT00322439|Etanercept|etanercept|mesh-list
1886789|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1886790|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1886791|NCT00322439|Analgesics|analgesics|mesh-ancestor
1886792|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
1886793|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886794|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886795|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1886796|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1886797|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1886798|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886799|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
1886800|NCT00322452|Paclitaxel|paclitaxel|mesh-list
1886801|NCT00322452|Carboplatin|carboplatin|mesh-list
1886802|NCT00322452|Gefitinib|gefitinib|mesh-list
1886803|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1886804|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886805|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886806|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886807|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886808|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886809|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1886810|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886811|NCT00322465|Azithromycin|azithromycin|mesh-list
1886812|NCT00322465|Doxycycline|doxycycline|mesh-list
1886813|NCT00322465|Tinidazole|tinidazole|mesh-list
1886814|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1886815|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886816|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
1886817|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1886818|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1886819|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
1886820|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886821|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1886822|NCT00322491|Plerixafor|plerixafor|mesh-list
1886823|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1886824|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1886825|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
1886826|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886827|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
1886828|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1886829|NCT00322556|Antibodies|antibodies|mesh-list
1886830|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
1886831|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886832|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1886833|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1886834|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1886835|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886836|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886837|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886838|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886839|NCT00322621|Analgesics|analgesics|mesh-ancestor
1886840|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
1886841|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1886842|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
1886843|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1886844|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
1886845|NCT00322842|Plerixafor|plerixafor|mesh-list
1886846|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1886847|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1886848|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
1886849|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886850|NCT00322868|Pioglitazone|pioglitazone|mesh-list
1886851|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1886852|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886853|NCT00322881|Paclitaxel|paclitaxel|mesh-list
1886854|NCT00322881|Carboplatin|carboplatin|mesh-list
1886855|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1886856|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886857|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
1886858|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
1886859|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
1886860|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886861|NCT00323037|Carvedilol|carvedilol|mesh-list
1886862|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1886863|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1886864|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
1886865|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1886866|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886867|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886868|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1886869|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
1886870|NCT00323037|Protective Agents|protective agents|mesh-ancestor
1886871|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1886872|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1886873|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1886874|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
1886875|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1886876|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1886877|NCT00323063|Gemcitabine|gemcitabine|mesh-list
1886878|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
1886879|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886880|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
1886881|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886882|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886883|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
1886884|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886885|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886886|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886887|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
1886888|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886889|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1886890|NCT00323115|Temozolomide|temozolomide|mesh-list
1886891|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1886892|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
1886893|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886894|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886895|NCT00323297|Bosentan|bosentan|mesh-list
1886896|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
1886897|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886898|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
1886899|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1886900|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1886901|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886902|NCT00323297|Urological Agents|urological agents|mesh-ancestor
1886903|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1886904|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1886905|NCT00323362|Gemcitabine|gemcitabine|mesh-list
1886906|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
1886907|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886908|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
1886909|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886910|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886911|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
1886912|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886913|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886914|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886915|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
1886916|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886917|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1886918|NCT00323479|Anastrozole|anastrozole|mesh-list
1886919|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1886920|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886921|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1886922|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1886923|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886924|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886925|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1886926|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
1886927|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1886928|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886929|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1886930|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1886931|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1886932|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886933|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886934|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
1886935|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886936|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1886937|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1886938|NCT00323557|Molgramostim|molgramostim|mesh-list
1886939|NCT00323557|Sargramostim|sargramostim|mesh-list
1886940|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1886941|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
1886942|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886943|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886944|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
1886945|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
1886946|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
1886947|NCT00323622|Amodiaquine|amodiaquine|mesh-list
1886948|NCT00323622|Vaccines|vaccines|mesh-list
1886949|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
1886950|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886951|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
1886952|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1886953|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1886954|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886955|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1886956|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886957|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886958|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1886959|NCT00323622|Renal Agents|renal agents|mesh-ancestor
1886960|NCT00323739|Bevacizumab|bevacizumab|mesh-list
1886961|NCT00323739|Everolimus|everolimus|mesh-list
1886962|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886963|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886964|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886965|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886966|NCT00323739|Growth Substances|growth substances|mesh-ancestor
1886967|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886968|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886969|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886970|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
1886971|NCT00323869|Gemcitabine|gemcitabine|mesh-list
1886972|NCT00323869|Bevacizumab|bevacizumab|mesh-list
1886973|NCT00323869|Carboplatin|carboplatin|mesh-list
1886974|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886975|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886976|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1886977|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1886978|NCT00323869|Growth Substances|growth substances|mesh-ancestor
1886979|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1886980|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
1886981|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1886982|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
1886983|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886984|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
1886985|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1886986|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1886987|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1886988|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
1886989|NCT00323882|Ipilimumab|ipilimumab|mesh-list
1886990|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1886991|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1886992|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1886993|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1886994|NCT00324038|Acetaminophen|acetaminophen|mesh-list
1886995|NCT00324038|Buprenorphine|buprenorphine|mesh-list
1886996|NCT00324038|Codeine|codeine|mesh-list
1886997|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1886998|NCT00324038|Analgesics|analgesics|mesh-ancestor
1886999|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
1887000|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887001|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887002|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
1887003|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1887004|NCT00324038|Narcotics|narcotics|mesh-ancestor
1887005|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887006|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1887007|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
1887008|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
1887009|NCT00324155|Ipilimumab|ipilimumab|mesh-list
1887010|NCT00324155|Dacarbazine|dacarbazine|mesh-list
1887011|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887012|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887013|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1887014|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887015|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1887016|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
1887017|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1887018|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887019|NCT00324259|Estradiol|estradiol|mesh-list
1887020|NCT00324259|Estrogens|estrogens|mesh-ancestor
1887021|NCT00324259|Hormones|hormones|mesh-ancestor
1887022|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887023|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887024|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1887025|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
1887026|NCT00324272|Coagulants|coagulants|mesh-ancestor
1887027|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1887028|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1887029|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887030|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1887031|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1887032|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
1887033|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887034|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887035|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1887036|NCT00324415|Fluorouracil|fluorouracil|mesh-list
1887037|NCT00324415|Cetuximab|cetuximab|mesh-list
1887038|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887039|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
1887040|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887041|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1887042|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887043|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
1887044|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887045|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887046|NCT00324649|Lamivudine|lamivudine|mesh-list
1887047|NCT00324649|Zidovudine|zidovudine|mesh-list
1887048|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1887049|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1887050|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1887051|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887052|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887053|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
1887054|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887055|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1887056|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1887057|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
1887058|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
1887059|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887060|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887061|NCT00324740|Vorinostat|vorinostat|mesh-list
1887062|NCT00324740|Isotretinoin|isotretinoin|mesh-list
1887063|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887064|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1887065|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887066|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887067|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
1887068|NCT00324805|Gemcitabine|gemcitabine|mesh-list
1887069|NCT00324805|Bevacizumab|bevacizumab|mesh-list
1887070|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1887071|NCT00324805|Cisplatin|cisplatin|mesh-list
1887072|NCT00324805|Docetaxel|docetaxel|mesh-list
1887073|NCT00324805|Pemetrexed|pemetrexed|mesh-list
1887074|NCT00324805|Vinorelbine|vinorelbine|mesh-list
1887075|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
1887076|NCT00324805|Antibodies|antibodies|mesh-list
1887077|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
1887078|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1887079|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
1887080|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887081|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887082|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887083|NCT00324805|Growth Substances|growth substances|mesh-ancestor
1887084|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887085|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887086|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
1887087|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1887088|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
1887089|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887090|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
1887091|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887092|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887093|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887094|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887095|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887096|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887097|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1887098|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1887099|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1887100|NCT00324870|Bevacizumab|bevacizumab|mesh-list
1887101|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1887102|NCT00324870|Vorinostat|vorinostat|mesh-list
1887103|NCT00324870|Antibodies|antibodies|mesh-list
1887104|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
1887105|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1887106|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887107|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887108|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887109|NCT00324870|Growth Substances|growth substances|mesh-ancestor
1887110|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887111|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887112|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
1887113|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1887114|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887115|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887116|NCT00324896|Eszopiclone|eszopiclone|mesh-list
1887117|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1887118|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887119|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887120|NCT00324961|Adefovir|adefovir|mesh-list
1887121|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1887122|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
1887123|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887124|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1887125|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1887126|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887127|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887128|NCT00324987|Bevacizumab|bevacizumab|mesh-list
1887129|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1887130|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
1887131|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
1887132|NCT00324987|Antibodies|antibodies|mesh-list
1887133|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
1887134|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1887135|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
1887136|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887137|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887138|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887139|NCT00324987|Growth Substances|growth substances|mesh-ancestor
1887140|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887141|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887142|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
1887143|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887144|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887145|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887146|NCT00325078|Infliximab|infliximab|mesh-list
1887147|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
1887148|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1887149|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887150|NCT00325143|Edetic Acid|edetic acid|mesh-list
1887151|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
1887152|NCT00325143|Antidotes|antidotes|mesh-ancestor
1887153|NCT00325143|Protective Agents|protective agents|mesh-ancestor
1887154|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887155|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
1887156|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
1887157|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887158|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1887159|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
1887160|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1887161|NCT00325234|Gemcitabine|gemcitabine|mesh-list
1887162|NCT00325234|Carboplatin|carboplatin|mesh-list
1887163|NCT00325234|Pemetrexed|pemetrexed|mesh-list
1887164|NCT00325234|Vinorelbine|vinorelbine|mesh-list
1887165|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887166|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1887167|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
1887168|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887169|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
1887170|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887171|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887172|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887173|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
1887174|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887175|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1887176|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1887177|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1887178|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887179|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887180|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887181|NCT00325403|Treprostinil|treprostinil|mesh-list
1887182|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1887183|NCT00325416|Melphalan|melphalan|mesh-list
1887184|NCT00325416|Topotecan|topotecan|mesh-list
1887185|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1887186|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
1887187|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887188|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887189|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1887190|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887191|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
1887192|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887193|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1887194|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1887195|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887196|NCT00325442|Treprostinil|treprostinil|mesh-list
1887197|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1887198|NCT00325468|Denosumab|denosumab|mesh-list
1887199|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1887200|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887201|NCT00325780|Pitavastatin|pitavastatin|mesh-list
1887202|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1887203|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1887204|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1887205|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
1887206|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887207|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887208|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1887209|NCT00325819|Acetaminophen|acetaminophen|mesh-list
1887210|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1887211|NCT00325819|Analgesics|analgesics|mesh-ancestor
1887212|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
1887213|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887214|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887215|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
1887216|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1887217|NCT00325897|Azithromycin|azithromycin|mesh-list
1887218|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887219|NCT00326170|Azacitidine|azacitidine|mesh-list
1887220|NCT00326170|Tretinoin|tretinoin|mesh-list
1887221|NCT00326170|Valproic Acid|valproic acid|mesh-list
1887222|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1887223|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
1887224|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887225|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887226|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887227|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
1887228|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
1887229|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
1887230|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
1887231|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887232|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887233|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
1887234|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1887235|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887236|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887237|NCT00326209|Mesalamine|mesalamine|mesh-list
1887238|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1887239|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1887240|NCT00326209|Analgesics|analgesics|mesh-ancestor
1887241|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
1887242|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887243|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887244|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1887245|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887246|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
1887247|NCT00326417|Fludarabine|fludarabine|mesh-list
1887248|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887249|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
1887250|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887251|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887252|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1887253|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
1887254|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887255|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887256|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1887257|NCT00326495|Cetuximab|cetuximab|mesh-list
1887258|NCT00326495|Sorafenib|sorafenib|mesh-list
1887259|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887260|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887261|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887262|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887263|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887264|NCT00326599|Gemcitabine|gemcitabine|mesh-list
1887265|NCT00326599|Carboplatin|carboplatin|mesh-list
1887266|NCT00326599|Cediranib|cediranib|mesh-list
1887267|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887268|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1887269|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
1887270|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887271|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
1887272|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887273|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887274|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887275|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
1887276|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887277|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887278|NCT00326612|Midazolam|midazolam|mesh-list
1887279|NCT00326612|Diazepam|diazepam|mesh-list
1887280|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1887281|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1887282|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887283|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887284|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1887285|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1887286|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887287|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1887288|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
1887289|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
1887290|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
1887291|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
1887292|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887293|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887294|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
1887295|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
1887296|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
1887297|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887298|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1887299|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1887300|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1887301|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
1887302|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
1887303|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1887304|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
1887305|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887306|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887307|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887308|NCT00326716|Ritonavir|ritonavir|mesh-list
1887309|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1887310|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1887311|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1887312|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1887313|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
1887314|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887541|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
1887315|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887316|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1887317|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1887318|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
1887319|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887320|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1887321|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1887322|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1887323|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1887324|NCT00326781|Nicotine|nicotine|mesh-list
1887325|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1887326|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
1887327|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887328|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887329|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1887330|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1887331|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
1887332|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887333|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887334|NCT00326872|Cediranib|cediranib|mesh-list
1887335|NCT00326872|Maleic acid|maleic acid|mesh-list
1887336|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887337|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887338|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887339|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887340|NCT00326885|Catumaxomab|catumaxomab|mesh-list
1887341|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1887342|NCT00326898|Sorafenib|sorafenib|mesh-list
1887343|NCT00326898|Sunitinib|sunitinib|mesh-list
1887344|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887345|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887346|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887347|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887348|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887349|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887350|NCT00326898|Growth Substances|growth substances|mesh-ancestor
1887351|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887352|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887353|NCT00326911|Gemcitabine|gemcitabine|mesh-list
1887354|NCT00326911|Bevacizumab|bevacizumab|mesh-list
1887355|NCT00326911|Cetuximab|cetuximab|mesh-list
1887356|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887357|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887358|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887359|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887360|NCT00326911|Growth Substances|growth substances|mesh-ancestor
1887361|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887362|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887363|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1887364|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
1887365|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887366|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
1887367|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887368|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887369|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887370|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
1887371|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
1887372|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1887373|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1887374|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887375|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1887376|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1887377|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
1887378|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887379|NCT00327015|Metformin|metformin|mesh-list
1887380|NCT00327015|Pioglitazone|pioglitazone|mesh-list
1887381|NCT00327015|Saxagliptin|saxagliptin|mesh-list
1887382|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887383|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887384|NCT00327015|Incretins|incretins|mesh-ancestor
1887385|NCT00327015|Hormones|hormones|mesh-ancestor
1887386|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887387|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1887388|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
1887389|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887390|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887391|NCT00327171|Aflibercept|aflibercept|mesh-list
1887392|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887393|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887394|NCT00327171|Growth Substances|growth substances|mesh-ancestor
1887395|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887396|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887397|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887398|NCT00327340|Docetaxel|docetaxel|mesh-list
1887399|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
1887400|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887401|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887402|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887403|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887404|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887405|NCT00327340|Analgesics|analgesics|mesh-ancestor
1887406|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
1887407|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887408|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887409|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1887410|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1887411|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887412|NCT00327392|Fospropofol|fospropofol|mesh-list
1887413|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1887414|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887415|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887416|NCT00327444|Aflibercept|aflibercept|mesh-list
1887417|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887418|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887419|NCT00327444|Growth Substances|growth substances|mesh-ancestor
1887420|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887421|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887422|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887423|NCT00327717|Zonisamide|zonisamide|mesh-list
1887424|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
1887425|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1887426|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1887427|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887428|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1887429|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887430|NCT00328094|Insulin|insulin|mesh-list
1887431|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1887432|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887433|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887434|NCT00328172|Metformin|metformin|mesh-list
1887435|NCT00328172|Linagliptin|linagliptin|mesh-list
1887436|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887437|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887438|NCT00328172|Incretins|incretins|mesh-ancestor
1887439|NCT00328172|Hormones|hormones|mesh-ancestor
1887440|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887441|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1887442|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
1887443|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887444|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887445|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
1887446|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887447|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887448|NCT00328562|Gefitinib|gefitinib|mesh-list
1887449|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887450|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887451|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887452|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887453|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
1887454|NCT00328614|Goserelin|goserelin|mesh-list
1887455|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
1887456|NCT00328614|Bicalutamide|bicalutamide|mesh-list
1887457|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
1887458|NCT00328614|Androgens|androgens|mesh-list
1887459|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1887460|NCT00328614|Ethylene|ethylene|mesh-list
1887461|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1887462|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887463|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
1887464|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
1887542|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1887465|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887466|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887467|NCT00328614|Hormones|hormones|mesh-ancestor
1887468|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
1887469|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887470|NCT00328614|Protective Agents|protective agents|mesh-ancestor
1887471|NCT00328614|Vitamins|vitamins|mesh-ancestor
1887472|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
1887473|NCT00328614|Estrogens|estrogens|mesh-ancestor
1887474|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
1887475|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
1887476|NCT00328614|Growth Substances|growth substances|mesh-ancestor
1887477|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1887478|NCT00328614|Analgesics|analgesics|mesh-ancestor
1887479|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
1887480|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887481|NCT00328627|Pioglitazone|pioglitazone|mesh-list
1887482|NCT00328627|Alogliptin|alogliptin|mesh-list
1887483|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887484|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887485|NCT00328627|Incretins|incretins|mesh-ancestor
1887486|NCT00328627|Hormones|hormones|mesh-ancestor
1887487|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887488|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1887489|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
1887490|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887491|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887492|NCT00328770|Sirolimus|sirolimus|mesh-list
1887493|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1887494|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887495|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1887496|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887497|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
1887498|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887499|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
1887500|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887501|NCT00328861|Aldesleukin|aldesleukin|mesh-list
1887502|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
1887503|NCT00328861|Fludarabine|fludarabine|mesh-list
1887504|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887505|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
1887506|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887507|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887508|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1887509|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
1887510|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887511|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887512|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1887513|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1887514|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1887515|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
1887516|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887517|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1887518|NCT00328926|Hormones|hormones|mesh-list
1887519|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1887520|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887521|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887522|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1887523|NCT00329030|Rituximab|rituximab|mesh-list
1887524|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
1887525|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887526|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887527|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
1887528|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887529|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887530|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1887531|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1887532|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1887533|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
1887534|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887535|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1887536|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1887537|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887538|NCT00329238|Warfarin|warfarin|mesh-list
1887539|NCT00329238|Dabigatran|dabigatran|mesh-list
1887540|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
1887543|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
1887544|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887545|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887546|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
1887547|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887548|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
1887549|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887550|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887551|NCT00329407|Topiramate|topiramate|mesh-list
1887552|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
1887553|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887554|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887555|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
1887556|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887557|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
1887558|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887559|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887560|NCT00329433|Heparin|heparin|mesh-list
1887561|NCT00329433|Desirudin|desirudin|mesh-list
1887562|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
1887563|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1887564|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1887565|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887566|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
1887567|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887568|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
1887569|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887570|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887571|NCT00329602|Ropinirole|ropinirole|mesh-list
1887572|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1887573|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1887574|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
1887575|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
1887576|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887577|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887578|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887579|NCT00329641|Paclitaxel|paclitaxel|mesh-list
1887580|NCT00329641|Carboplatin|carboplatin|mesh-list
1887581|NCT00329641|Sorafenib|sorafenib|mesh-list
1887582|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1887583|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887584|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887585|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887586|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887587|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887588|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887589|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887590|NCT00329719|Sirolimus|sirolimus|mesh-list
1887591|NCT00329719|Sorafenib|sorafenib|mesh-list
1887592|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887593|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887594|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887595|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887596|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1887597|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887598|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1887599|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
1887600|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887601|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
1887602|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887603|NCT00329797|Vitamin D|vitamin d|mesh-list
1887604|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
1887605|NCT00329797|Calcium|calcium|mesh-list
1887606|NCT00329797|Vitamins|vitamins|mesh-ancestor
1887607|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
1887608|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887609|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1887610|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1887611|NCT00329849|Vaccines|vaccines|mesh-list
1887612|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
1887613|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887614|NCT00329901|Vaccines|vaccines|mesh-list
1887615|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
1887616|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887617|NCT00330161|Vorinostat|vorinostat|mesh-list
1887618|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887619|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1887620|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887621|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887622|NCT00330174|Acamprosate|acamprosate|mesh-list
1887623|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1887624|NCT00330187|Bupropion|bupropion|mesh-list
1887625|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1887626|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
1887627|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887628|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1887629|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1887630|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1887631|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887632|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
1887633|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887634|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887635|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1887636|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1887637|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887638|NCT00330343|Naloxone|naloxone|mesh-list
1887639|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1887640|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887641|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
1887642|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887643|NCT00330421|Sorafenib|sorafenib|mesh-list
1887644|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887645|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887646|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887647|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887648|NCT00330460|Denosumab|denosumab|mesh-list
1887649|NCT00330460|Alendronate|alendronate|mesh-list
1887650|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1887651|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887652|NCT00330551|Risperidone|risperidone|mesh-list
1887653|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1887654|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
1887655|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887656|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887657|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887658|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1887659|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1887660|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887661|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887662|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1887663|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
1887664|NCT00330564|Sunitinib|sunitinib|mesh-list
1887665|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887666|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887667|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887668|NCT00330564|Growth Substances|growth substances|mesh-ancestor
1887669|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887670|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887671|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887672|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887673|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887674|NCT00330668|Mecasermin|mecasermin|mesh-list
1887675|NCT00330668|Growth Substances|growth substances|mesh-ancestor
1887676|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887677|NCT00330681|Edaravone|edaravone|mesh-list
1887678|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1887679|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
1887680|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887681|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1887682|NCT00330681|Protective Agents|protective agents|mesh-ancestor
1887683|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887684|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1887685|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1887686|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1887687|NCT00330733|Analgesics|analgesics|mesh-ancestor
1887688|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
1887689|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887690|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887691|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1887692|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887693|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
1887694|NCT00330759|Denosumab|denosumab|mesh-list
1887695|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1887696|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887697|NCT00330863|Olanzapine|olanzapine|mesh-list
1887698|NCT00330863|Risperidone|risperidone|mesh-list
1887699|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1887700|NCT00330863|Aripiprazole|aripiprazole|mesh-list
1887701|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1887702|NCT00330863|Ziprasidone|ziprasidone|mesh-list
1887703|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1887704|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
1887705|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887706|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887707|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887708|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1887709|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1887710|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887711|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887712|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1887713|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
1887714|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
1887715|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
1887716|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887717|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1887718|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1887719|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1887720|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1887721|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
1887722|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
1887723|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1887724|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1887725|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1887726|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1887727|NCT00330876|Pitavastatin|pitavastatin|mesh-list
1887728|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1887729|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1887730|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1887731|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
1887732|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887733|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887734|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1887735|NCT00330915|Pemetrexed|pemetrexed|mesh-list
1887736|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887737|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887738|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887739|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1887740|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1887741|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1887742|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1887743|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1887744|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1887745|NCT00331006|Rituximab|rituximab|mesh-list
1887746|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887747|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887748|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
1887749|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887750|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887751|NCT00331136|Artesunate|artesunate|mesh-list
1887752|NCT00331136|Pyronaridine|pyronaridine|mesh-list
1887753|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
1887754|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1887755|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1887756|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887757|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887758|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
1887759|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
1887760|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1887761|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
1887762|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
1887763|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1887764|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
1887765|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887766|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887767|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887768|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887769|NCT00331344|Prednisone|prednisone|mesh-list
1887770|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
1887771|NCT00331344|Epothilone B|epothilone b|mesh-list
1887772|NCT00331344|Epothilones|epothilones|mesh-list
1887773|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1887774|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
1887775|NCT00331344|Hormones|hormones|mesh-ancestor
1887776|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887777|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887778|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1887779|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887780|NCT00331344|Analgesics|analgesics|mesh-ancestor
1887781|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
1887782|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887783|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1887784|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1887785|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887786|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887787|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887788|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887789|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887790|NCT00331409|Everolimus|everolimus|mesh-list
1887791|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
1887792|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887793|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887794|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
1887795|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887796|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887797|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887798|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887799|NCT00331422|Paclitaxel|paclitaxel|mesh-list
1887800|NCT00331422|Carboplatin|carboplatin|mesh-list
1887801|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1887802|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887803|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887804|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887805|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887806|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887807|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
1887808|NCT00331552|Doxorubicin|doxorubicin|mesh-list
1887809|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1887810|NCT00331552|Trastuzumab|trastuzumab|mesh-list
1887811|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1887812|NCT00331552|Antibodies|antibodies|mesh-list
1887813|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
1887814|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1887815|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887816|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
1887817|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887818|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887819|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1887820|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
1887821|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887822|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887823|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1887824|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1887825|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1887826|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1887827|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887828|NCT00331630|Paclitaxel|paclitaxel|mesh-list
1887829|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1887830|NCT00331630|Lapatinib|lapatinib|mesh-list
1887831|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1887832|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887833|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887834|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887835|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887836|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887837|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887838|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887839|NCT00331682|Docetaxel|docetaxel|mesh-list
1887840|NCT00331682|Alvocidib|alvocidib|mesh-list
1887841|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887842|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
1887843|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
1887844|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
1887845|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887846|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887847|NCT00331682|Growth Substances|growth substances|mesh-ancestor
1887848|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887849|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1887850|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887851|NCT00331760|Cisplatin|cisplatin|mesh-list
1887852|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887853|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1887854|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1887855|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1887856|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1887857|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887858|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887859|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887860|NCT00331799|Analgesics|analgesics|mesh-ancestor
1887861|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
1887862|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887863|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
1887864|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887865|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
1887866|NCT00331864|Ranibizumab|ranibizumab|mesh-list
1887867|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1887868|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1887869|NCT00331864|Growth Substances|growth substances|mesh-ancestor
1887870|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887871|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
1887872|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887873|NCT00332163|Irinotecan|irinotecan|mesh-list
1887874|NCT00332163|Panitumumab|panitumumab|mesh-list
1887875|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1887876|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1887877|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887878|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887879|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1887880|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1887881|NCT00332189|Verapamil|verapamil|mesh-list
1887882|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1887883|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1887884|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1887885|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887886|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1887887|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887888|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
1887889|NCT00332241|Aripiprazole|aripiprazole|mesh-list
1887890|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
1887891|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887892|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1887893|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1887894|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1887895|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887896|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
1887897|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
1887898|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887899|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887900|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1887901|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1887902|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
1887903|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1887904|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1887905|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1887906|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1887907|NCT00332332|Etanercept|etanercept|mesh-list
1887908|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1887909|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1887910|NCT00332332|Analgesics|analgesics|mesh-ancestor
1887911|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
1887912|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887913|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887914|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1887915|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887916|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1887917|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887918|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
1887919|NCT00332462|Cyclosporine|cyclosporine|mesh-list
1887920|NCT00332462|Cyclosporins|cyclosporins|mesh-list
1887921|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887922|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887923|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1887924|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
1887925|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887926|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
1887927|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887928|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
1887929|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1887930|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1887931|NCT00332488|Insulin|insulin|mesh-list
1887932|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1887933|NCT00332488|Metformin|metformin|mesh-list
1887934|NCT00332488|Secretagogues|secretagogues|mesh-list
1887935|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1887936|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887937|NCT00332579|Naltrexone|naltrexone|mesh-list
1887938|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1887939|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1887940|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887941|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
1887942|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887943|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
1887944|NCT00332605|Naltrexone|naltrexone|mesh-list
1887945|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1887946|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1887947|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1887948|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887949|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
1887950|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887951|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
1887952|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1887953|NCT00332605|Expectorants|expectorants|mesh-ancestor
1887954|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
1887955|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1887956|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
1887957|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887958|NCT00332605|Protective Agents|protective agents|mesh-ancestor
1887959|NCT00332605|Antidotes|antidotes|mesh-ancestor
1887960|NCT00332644|Bupropion|bupropion|mesh-list
1887961|NCT00332644|Nicotine|nicotine|mesh-list
1887962|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1887963|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
1887964|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887965|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887966|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1887967|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1887968|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
1887969|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1887970|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1887971|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1887972|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
1887973|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1887974|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1887975|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1887976|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1887977|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
1887978|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1887979|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1887980|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887981|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
1887982|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1887983|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1887984|NCT00332696|Prednisolone|prednisolone|mesh-list
1887985|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
1887986|NCT00332696|Octreotide|octreotide|mesh-list
1887987|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1887988|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
1887989|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1887990|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
1887991|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
1887992|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1887993|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1887994|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1887995|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
1887996|NCT00332696|Hormones|hormones|mesh-ancestor
1888223|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1887997|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1887998|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1887999|NCT00332696|Protective Agents|protective agents|mesh-ancestor
1888000|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1888001|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888002|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
1888003|NCT00332709|Letrozole|letrozole|mesh-list
1888004|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888005|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1888006|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1888007|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888008|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888009|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1888010|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
1888011|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888012|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888013|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1888014|NCT00332839|Cyclosporine|cyclosporine|mesh-list
1888015|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
1888016|NCT00332839|Everolimus|everolimus|mesh-list
1888017|NCT00332839|Tacrolimus|tacrolimus|mesh-list
1888018|NCT00332839|Cyclosporins|cyclosporins|mesh-list
1888019|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888020|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
1888021|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888022|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1888023|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888024|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888025|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
1888026|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888027|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
1888028|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888029|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888030|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888031|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1888032|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
1888033|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888034|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1888035|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1888036|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888037|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888038|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
1888039|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888040|NCT00333177|Risperidone|risperidone|mesh-list
1888041|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1888042|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
1888043|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888044|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888045|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888046|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1888047|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888048|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888049|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888050|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1888051|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
1888052|NCT00333359|Gabapentin|gabapentin|mesh-list
1888053|NCT00333359|Analgesics|analgesics|mesh-ancestor
1888054|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
1888055|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888056|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888057|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
1888058|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1888059|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888060|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888061|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888062|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1888063|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1888064|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888065|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888066|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
1888067|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
1888068|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888069|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888070|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1888071|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
1888072|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888073|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888074|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888075|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888076|NCT00333775|Bevacizumab|bevacizumab|mesh-list
1888077|NCT00333775|Docetaxel|docetaxel|mesh-list
1888078|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888079|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888080|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1888081|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1888082|NCT00333775|Growth Substances|growth substances|mesh-ancestor
1888083|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888084|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
1888085|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888086|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888087|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888088|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888089|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
1888090|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888091|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
1888092|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888093|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888094|NCT00333814|Dexamethasone|dexamethasone|mesh-list
1888095|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
1888096|NCT00333814|BB 1101|bb 1101|mesh-list
1888097|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888098|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
1888099|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
1888100|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888101|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888102|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888103|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
1888104|NCT00333814|Hormones|hormones|mesh-ancestor
1888105|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888106|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1888107|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888108|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
1888109|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888110|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888111|NCT00333840|Interferons|interferons|mesh-list
1888112|NCT00333840|Cytarabine|cytarabine|mesh-list
1888113|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
1888114|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
1888115|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
1888116|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888117|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
1888118|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888119|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888120|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
1888121|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888122|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888123|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
1888124|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888125|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1888126|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888127|NCT00333866|Pregabalin|pregabalin|mesh-list
1888128|NCT00333866|Analgesics|analgesics|mesh-ancestor
1888129|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
1888130|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888131|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888132|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
1888133|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1888134|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888135|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888136|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1888137|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1888138|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888139|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888140|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888141|NCT00334074|Cytarabine|cytarabine|mesh-list
1888142|NCT00334074|Clofarabine|clofarabine|mesh-list
1888143|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888144|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
1888145|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888146|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888147|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
1888148|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888149|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888150|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
1888151|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888152|NCT00334295|Fulvestrant|fulvestrant|mesh-list
1888153|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1888154|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888155|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1888156|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1888157|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
1888158|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888159|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888160|NCT00334542|Simvastatin|simvastatin|mesh-list
1888161|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1888162|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1888163|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
1888164|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888165|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1888166|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1888167|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888168|NCT00334633|Metronidazole|metronidazole|mesh-list
1888169|NCT00334633|Tinidazole|tinidazole|mesh-list
1888170|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888171|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888172|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1888173|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1888174|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
1888175|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888176|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1888177|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
1888178|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
1888179|NCT00334737|Hematinics|hematinics|mesh-ancestor
1888180|NCT00334802|Gemcitabine|gemcitabine|mesh-list
1888181|NCT00334802|Paclitaxel|paclitaxel|mesh-list
1888182|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888183|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888184|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888185|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888186|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888187|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888188|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888189|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
1888190|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
1888191|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888192|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888193|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888194|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
1888195|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888196|NCT00334815|Bevacizumab|bevacizumab|mesh-list
1888197|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1888198|NCT00334815|Cisplatin|cisplatin|mesh-list
1888199|NCT00334815|Docetaxel|docetaxel|mesh-list
1888200|NCT00334815|Etoposide|etoposide|mesh-list
1888201|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
1888202|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
1888203|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
1888204|NCT00334815|Antibodies|antibodies|mesh-list
1888205|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
1888206|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1888207|NCT00334815|Lenograstim|lenograstim|mesh-list
1888208|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
1888209|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888210|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1888211|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1888212|NCT00334815|Growth Substances|growth substances|mesh-ancestor
1888213|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888214|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
1888215|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
1888216|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888217|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888218|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888219|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888220|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888221|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888222|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888224|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1888225|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
1888226|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
1888227|NCT00334958|Rufinamide|rufinamide|mesh-list
1888228|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
1888229|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1888230|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1888231|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888232|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888233|NCT00335140|Leucovorin|leucovorin|mesh-list
1888234|NCT00335140|Cytarabine|cytarabine|mesh-list
1888235|NCT00335140|Dexamethasone|dexamethasone|mesh-list
1888236|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
1888237|NCT00335140|Rituximab|rituximab|mesh-list
1888238|NCT00335140|Methotrexate|methotrexate|mesh-list
1888239|NCT00335140|Vincristine|vincristine|mesh-list
1888240|NCT00335140|Procarbazine|procarbazine|mesh-list
1888241|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1888242|NCT00335140|BB 1101|bb 1101|mesh-list
1888243|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
1888244|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888245|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
1888246|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
1888247|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888248|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888249|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888250|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
1888251|NCT00335140|Hormones|hormones|mesh-ancestor
1888252|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888253|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1888254|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888255|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
1888256|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888257|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888258|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888259|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
1888260|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888261|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1888262|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
1888263|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1888264|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888265|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
1888266|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
1888267|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1888268|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888269|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1888270|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
1888271|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888272|NCT00335140|Antidotes|antidotes|mesh-ancestor
1888273|NCT00335140|Protective Agents|protective agents|mesh-ancestor
1888274|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
1888275|NCT00335140|Vitamins|vitamins|mesh-ancestor
1888276|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
1888277|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888278|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888279|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888280|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888281|NCT00335153|Levodopa|levodopa|mesh-list
1888282|NCT00335153|Carbidopa|carbidopa|mesh-list
1888283|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1888284|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1888285|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1888286|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
1888287|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888288|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888289|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888290|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1888291|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888292|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1888293|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
1888294|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
1888295|NCT00335283|Lansoprazole|lansoprazole|mesh-list
1888296|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
1888297|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1888298|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888299|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1888300|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888529|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
1888301|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888302|NCT00335322|Ritonavir|ritonavir|mesh-list
1888303|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1888304|NCT00335322|Tenofovir|tenofovir|mesh-list
1888305|NCT00335322|Zidovudine|zidovudine|mesh-list
1888306|NCT00335322|Emtricitabine|emtricitabine|mesh-list
1888307|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1888308|NCT00335322|Abacavir|abacavir|mesh-list
1888309|NCT00335322|Efavirenz|efavirenz|mesh-list
1888310|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1888311|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1888312|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
1888313|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888314|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888315|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1888316|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1888317|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
1888318|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888319|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1888320|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1888321|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1888322|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1888323|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
1888324|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1888325|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1888326|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1888327|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1888328|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1888329|NCT00335452|Clopidogrel|clopidogrel|mesh-list
1888330|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1888331|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1888332|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1888333|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1888334|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
1888335|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888336|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888337|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888338|NCT00335478|Daptomycin|daptomycin|mesh-list
1888339|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888340|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888341|NCT00335504|Sulindac|sulindac|mesh-list
1888342|NCT00335504|Atorvastatin|atorvastatin|mesh-list
1888343|NCT00335504|Calcium|calcium|mesh-list
1888344|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1888345|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888346|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1888347|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1888348|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
1888349|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888350|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1888351|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1888352|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888353|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1888354|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1888355|NCT00335504|Analgesics|analgesics|mesh-ancestor
1888356|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
1888357|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888358|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888359|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888360|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888361|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1888362|NCT00335556|Dactinomycin|dactinomycin|mesh-list
1888363|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
1888364|NCT00335556|Carboplatin|carboplatin|mesh-list
1888365|NCT00335556|Doxorubicin|doxorubicin|mesh-list
1888366|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1888367|NCT00335556|Irinotecan|irinotecan|mesh-list
1888368|NCT00335556|Etoposide|etoposide|mesh-list
1888369|NCT00335556|Vincristine|vincristine|mesh-list
1888370|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888371|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
1888372|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888373|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888374|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1888375|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
1888376|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888377|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888378|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1888379|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888380|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888381|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888382|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888383|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1888384|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888385|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888386|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888387|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888388|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888389|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888390|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1888391|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1888392|NCT00335725|Hormones|hormones|mesh-list
1888393|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1888394|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888395|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888396|NCT00335738|Carboplatin|carboplatin|mesh-list
1888397|NCT00335738|Etoposide|etoposide|mesh-list
1888398|NCT00335738|Vincristine|vincristine|mesh-list
1888399|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
1888400|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888401|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888402|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888403|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888404|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888405|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888406|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888407|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888408|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888409|NCT00335764|Sirolimus|sirolimus|mesh-list
1888410|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1888411|NCT00335764|Sorafenib|sorafenib|mesh-list
1888412|NCT00335764|Tipifarnib|tipifarnib|mesh-list
1888413|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888414|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1888415|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888416|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888417|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888418|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888419|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888420|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
1888421|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888422|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
1888423|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888424|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
1888425|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1888426|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
1888427|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
1888428|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888429|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888430|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888431|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1888432|NCT00335777|Analgesics|analgesics|mesh-ancestor
1888433|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
1888434|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888435|NCT00335829|Bevacizumab|bevacizumab|mesh-list
1888436|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888437|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888438|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1888439|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1888440|NCT00335829|Growth Substances|growth substances|mesh-ancestor
1888441|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888442|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
1888443|NCT00335959|Capecitabine|capecitabine|mesh-list
1888444|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
1888445|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888446|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
1888447|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888448|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888449|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
1888450|NCT00335972|Remifentanil|remifentanil|mesh-list
1888451|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1888452|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888453|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888454|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1888455|NCT00335972|Analgesics|analgesics|mesh-ancestor
1888456|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
1888457|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888458|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1888459|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1888460|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1888461|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
1888462|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888463|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888464|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1888465|NCT00335972|Narcotics|narcotics|mesh-ancestor
1888466|NCT00336024|Leucovorin|leucovorin|mesh-list
1888467|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
1888468|NCT00336024|Thiotepa|thiotepa|mesh-list
1888469|NCT00336024|Carboplatin|carboplatin|mesh-list
1888470|NCT00336024|Methotrexate|methotrexate|mesh-list
1888471|NCT00336024|Etoposide|etoposide|mesh-list
1888472|NCT00336024|Vincristine|vincristine|mesh-list
1888473|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
1888474|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
1888475|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888476|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
1888477|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888478|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888479|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1888480|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
1888481|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888482|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888483|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1888484|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1888485|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
1888486|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1888487|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888488|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
1888489|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
1888490|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888491|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1888492|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1888493|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888494|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888495|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888496|NCT00336024|Antidotes|antidotes|mesh-ancestor
1888497|NCT00336024|Protective Agents|protective agents|mesh-ancestor
1888498|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
1888499|NCT00336024|Vitamins|vitamins|mesh-ancestor
1888500|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
1888501|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888502|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888503|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888504|NCT00336232|Vitamin K|vitamin k|mesh-list
1888505|NCT00336232|Vitamins|vitamins|mesh-ancestor
1888506|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
1888507|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888508|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1888509|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1888510|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888511|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
1888512|NCT00336232|Coagulants|coagulants|mesh-ancestor
1888513|NCT00336323|Bevacizumab|bevacizumab|mesh-list
1888514|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888515|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888516|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1888517|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1888518|NCT00336323|Growth Substances|growth substances|mesh-ancestor
1888519|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888520|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
1888521|NCT00336479|Interferons|interferons|mesh-list
1888522|NCT00336479|Ribavirin|ribavirin|mesh-list
1888523|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
1888524|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
1888525|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1888526|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888527|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
1888528|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888530|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888531|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
1888532|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888533|NCT00336492|Infliximab|infliximab|mesh-list
1888534|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
1888535|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888536|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888537|NCT00336505|Clarithromycin|clarithromycin|mesh-list
1888538|NCT00336505|Cethromycin|cethromycin|mesh-list
1888539|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888540|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888541|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1888542|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888543|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888544|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1888545|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1888546|NCT00336544|Clarithromycin|clarithromycin|mesh-list
1888547|NCT00336544|Cethromycin|cethromycin|mesh-list
1888548|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888549|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888550|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1888551|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888552|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888553|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1888554|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1888555|NCT00336583|Cytarabine|cytarabine|mesh-list
1888556|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
1888557|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
1888558|NCT00336583|Etoposide|etoposide|mesh-list
1888559|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888560|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888561|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888562|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888563|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888564|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888565|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888566|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
1888567|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
1888568|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888569|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888570|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
1888571|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888572|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888573|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
1888574|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
1888575|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888576|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888577|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
1888578|NCT00336583|Hormones|hormones|mesh-ancestor
1888579|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888580|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1888581|NCT00336583|Protective Agents|protective agents|mesh-ancestor
1888582|NCT00336700|Gemcitabine|gemcitabine|mesh-list
1888583|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1888584|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888585|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
1888586|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888587|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888588|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
1888589|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888590|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888591|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888592|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
1888593|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888594|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1888595|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
1888596|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888597|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888598|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1888599|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
1888600|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888601|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888602|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888603|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888604|NCT00336856|Irinotecan|irinotecan|mesh-list
1888605|NCT00336856|Cetuximab|cetuximab|mesh-list
1888606|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1888607|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888608|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888609|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888610|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888611|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888612|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
1888613|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888614|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888615|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1888616|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
1888617|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1888618|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888619|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888620|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888621|NCT00337103|Capecitabine|capecitabine|mesh-list
1888622|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888623|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
1888624|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888625|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888626|NCT00337168|Cytarabine|cytarabine|mesh-list
1888627|NCT00337168|Clofarabine|clofarabine|mesh-list
1888628|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888629|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
1888630|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888631|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888632|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
1888633|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888634|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888635|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
1888636|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888637|NCT00337194|Gemcitabine|gemcitabine|mesh-list
1888638|NCT00337194|Doxorubicin|doxorubicin|mesh-list
1888639|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1888640|NCT00337194|Vinorelbine|vinorelbine|mesh-list
1888641|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1888642|NCT00337194|Antibodies|antibodies|mesh-list
1888643|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1888644|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
1888645|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888646|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888647|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
1888648|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888649|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888650|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
1888651|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888652|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888653|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888654|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888655|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888656|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888657|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888658|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888659|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888660|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888661|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888662|NCT00337207|Bevacizumab|bevacizumab|mesh-list
1888663|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888664|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888665|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1888666|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1888667|NCT00337207|Growth Substances|growth substances|mesh-ancestor
1888668|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888669|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
1888670|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1888671|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1888672|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888673|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1888674|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1888675|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888676|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888677|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
1888678|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888679|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
1888680|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1888681|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888682|NCT00337428|Vaccines|vaccines|mesh-list
1888683|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
1888684|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888685|NCT00337467|Ritonavir|ritonavir|mesh-list
1888686|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1888687|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1888688|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1888689|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
1888690|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888691|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888692|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1888693|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1888694|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
1888695|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888696|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1888697|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1888698|NCT00337571|Aripiprazole|aripiprazole|mesh-list
1888699|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
1888700|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888701|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1888702|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888703|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888704|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888705|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
1888706|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
1888707|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888708|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888709|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1888710|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1888711|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
1888712|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1888713|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1888714|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1888715|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1888716|NCT00337610|Metformin|metformin|mesh-list
1888717|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1888718|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1888719|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888720|NCT00337610|Incretins|incretins|mesh-ancestor
1888721|NCT00337610|Hormones|hormones|mesh-ancestor
1888722|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888723|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1888724|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
1888725|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888726|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888727|NCT00337662|Olanzapine|olanzapine|mesh-list
1888728|NCT00337662|Risperidone|risperidone|mesh-list
1888729|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1888730|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
1888731|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888732|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888733|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888734|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1888735|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888736|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888737|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888738|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1888739|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
1888740|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
1888741|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
1888742|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888743|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888744|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1888745|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1888746|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888747|NCT00337675|Montelukast|montelukast|mesh-list
1888748|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1888749|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
1888750|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1888751|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
1888829|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888752|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888753|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888754|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1888755|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1888756|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888757|NCT00337727|Dexamethasone|dexamethasone|mesh-list
1888758|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
1888759|NCT00337727|Ondansetron|ondansetron|mesh-list
1888760|NCT00337727|Aprepitant|aprepitant|mesh-list
1888761|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
1888762|NCT00337727|BB 1101|bb 1101|mesh-list
1888763|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888764|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
1888765|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
1888766|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888767|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888768|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888769|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
1888770|NCT00337727|Hormones|hormones|mesh-ancestor
1888771|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888772|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1888773|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888774|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
1888775|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888776|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888777|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
1888778|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
1888779|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1888780|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
1888781|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888782|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1888783|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888784|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888785|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888786|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1888787|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1888788|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
1888789|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
1888790|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1888791|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
1888792|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888793|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888794|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888795|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
1888796|NCT00337935|Hematinics|hematinics|mesh-ancestor
1888797|NCT00337987|Prednisone|prednisone|mesh-list
1888798|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
1888799|NCT00337987|Vincristine|vincristine|mesh-list
1888800|NCT00337987|Doxorubicin|doxorubicin|mesh-list
1888801|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1888802|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
1888803|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888804|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
1888805|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888806|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888807|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1888808|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
1888809|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888810|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888811|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1888812|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888813|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
1888814|NCT00337987|Hormones|hormones|mesh-ancestor
1888815|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888816|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1888817|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1888818|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
1888819|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
1888820|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
1888821|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1888822|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1888823|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1888824|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888825|NCT00338039|Gemcitabine|gemcitabine|mesh-list
1888826|NCT00338039|Capecitabine|capecitabine|mesh-list
1888827|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
1888828|NCT00338039|Cetuximab|cetuximab|mesh-list
1888830|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
1888831|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888832|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888833|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
1888834|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1888835|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888836|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1888837|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
1888838|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888839|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888840|NCT00338104|Insulin|insulin|mesh-list
1888841|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1888842|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
1888843|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1888844|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888845|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
1888846|NCT00338286|Hematinics|hematinics|mesh-ancestor
1888847|NCT00338598|Glycine|glycine|mesh-list
1888848|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
1888849|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888850|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888851|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888852|NCT00338728|Letrozole|letrozole|mesh-list
1888853|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
1888854|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888855|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1888856|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1888857|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888858|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888859|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1888860|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
1888861|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1888862|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888863|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1888864|NCT00338884|Sunitinib|sunitinib|mesh-list
1888865|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888866|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1888867|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1888868|NCT00338884|Growth Substances|growth substances|mesh-ancestor
1888869|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888870|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
1888871|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1888872|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888873|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888874|NCT00338949|Olanzapine|olanzapine|mesh-list
1888875|NCT00338949|Risperidone|risperidone|mesh-list
1888876|NCT00338949|Ziprasidone|ziprasidone|mesh-list
1888877|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1888878|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
1888879|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888880|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888881|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888882|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1888883|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888884|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888885|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888886|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1888887|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
1888888|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
1888889|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
1888890|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888891|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888892|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1888893|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1888894|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888895|NCT00338962|Naltrexone|naltrexone|mesh-list
1888896|NCT00338962|Paroxetine|paroxetine|mesh-list
1888897|NCT00338962|Desipramine|desipramine|mesh-list
1888898|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1888899|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1888900|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888901|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
1888902|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888903|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1888904|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1888905|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888906|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888907|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888908|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
1888909|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1888910|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
1888911|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888912|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1888913|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1888914|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888915|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1888916|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1888917|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
1888918|NCT00338988|Capecitabine|capecitabine|mesh-list
1888919|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
1888920|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1888921|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
1888922|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888923|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888924|NCT00339079|Fluoxetine|fluoxetine|mesh-list
1888925|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1888926|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1888927|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888928|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888929|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888930|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
1888931|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888932|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1888933|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
1888934|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888935|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1888936|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1888937|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888938|NCT00339144|Dasatinib|dasatinib|mesh-list
1888939|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888940|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1888941|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1888942|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888943|NCT00339183|Panitumumab|panitumumab|mesh-list
1888944|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1888945|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888946|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1888947|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1888948|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1888949|NCT00339833|Analgesics|analgesics|mesh-ancestor
1888950|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
1888951|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888952|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888953|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1888954|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1888955|NCT00340379|Haloperidol|haloperidol|mesh-list
1888956|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
1888957|NCT00340379|Ziprasidone|ziprasidone|mesh-list
1888958|NCT00340379|Sertraline|sertraline|mesh-list
1888959|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
1888960|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1888961|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1888962|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1888963|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1888964|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888965|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888966|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
1888967|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888968|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
1888969|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
1888970|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1888971|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1888972|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1888973|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1888974|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1888975|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1888976|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
1888977|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1888978|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1888979|NCT00340678|Losartan|losartan|mesh-list
1888980|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1888981|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1888982|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1888983|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1888984|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888985|NCT00340704|Tamsulosin|tamsulosin|mesh-list
1888986|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1888987|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1888988|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1888989|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
1888990|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1888991|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1888992|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1888993|NCT00340704|Urological Agents|urological agents|mesh-ancestor
1888994|NCT00340834|Interferons|interferons|mesh-list
1888995|NCT00340834|Interferon-beta|interferon-beta|mesh-list
1888996|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
1888997|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1888998|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1888999|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
1889000|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889001|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1889002|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889003|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889004|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
1889005|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889006|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1889007|NCT00342355|Ritonavir|ritonavir|mesh-list
1889008|NCT00342355|Lopinavir|lopinavir|mesh-list
1889009|NCT00342355|Lamivudine|lamivudine|mesh-list
1889010|NCT00342355|Zidovudine|zidovudine|mesh-list
1889011|NCT00342355|Stavudine|stavudine|mesh-list
1889012|NCT00342355|Didanosine|didanosine|mesh-list
1889013|NCT00342355|Efavirenz|efavirenz|mesh-list
1889014|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1889015|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1889016|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
1889017|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889018|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889019|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1889020|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1889021|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
1889022|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889023|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1889024|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1889025|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1889026|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889027|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
1889028|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1889029|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1889030|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1889031|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1889032|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1889033|NCT00342563|Mecamylamine|mecamylamine|mesh-list
1889034|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1889035|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1889036|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
1889037|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889038|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889039|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1889040|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1889041|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
1889042|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889043|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889044|NCT00342628|Vaccines|vaccines|mesh-list
1889045|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
1889046|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889047|NCT00343044|Bevacizumab|bevacizumab|mesh-list
1889048|NCT00343044|Topotecan|topotecan|mesh-list
1889049|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889050|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889051|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1889127|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
1889052|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1889053|NCT00343044|Growth Substances|growth substances|mesh-ancestor
1889054|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889055|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
1889056|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1889057|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889058|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889059|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889060|NCT00343083|Paclitaxel|paclitaxel|mesh-list
1889061|NCT00343083|Carboplatin|carboplatin|mesh-list
1889062|NCT00343083|Cetuximab|cetuximab|mesh-list
1889063|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1889064|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889065|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
1889066|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
1889067|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
1889068|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889069|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889070|NCT00343252|Teriparatide|teriparatide|mesh-list
1889071|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
1889072|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
1889073|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1889074|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889075|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1889076|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1889077|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1889078|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889079|NCT00343291|Paclitaxel|paclitaxel|mesh-list
1889080|NCT00343291|Bevacizumab|bevacizumab|mesh-list
1889081|NCT00343291|Carboplatin|carboplatin|mesh-list
1889082|NCT00343291|Cetuximab|cetuximab|mesh-list
1889083|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1889084|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889085|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
1889086|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
1889087|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
1889088|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889089|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889090|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1889091|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1889092|NCT00343291|Growth Substances|growth substances|mesh-ancestor
1889093|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889094|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
1889095|NCT00343382|Pilocarpine|pilocarpine|mesh-list
1889096|NCT00343382|Miotics|miotics|mesh-ancestor
1889097|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
1889098|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889099|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889100|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1889101|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1889102|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
1889103|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889104|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889105|NCT00343460|Dexamethasone|dexamethasone|mesh-list
1889106|NCT00343460|Palonosetron|palonosetron|mesh-list
1889107|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889108|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
1889109|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
1889110|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889111|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889112|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1889113|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
1889114|NCT00343460|Hormones|hormones|mesh-ancestor
1889115|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889116|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1889117|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889118|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1889119|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1889120|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
1889121|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889122|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889123|NCT00343512|Docetaxel|docetaxel|mesh-list
1889124|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889125|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
1889126|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
1889128|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889129|NCT00343785|Cyclosporine|cyclosporine|mesh-list
1889130|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
1889131|NCT00343785|Methotrexate|methotrexate|mesh-list
1889132|NCT00343785|Cyclosporins|cyclosporins|mesh-list
1889133|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
1889134|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1889135|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
1889136|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889137|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
1889138|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889139|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889140|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1889141|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
1889142|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889143|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889144|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1889145|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1889146|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
1889147|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1889148|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1889149|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
1889150|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
1889151|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889152|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1889153|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889154|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
1889155|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889156|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1889157|NCT00343863|Dexamethasone|dexamethasone|mesh-list
1889158|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
1889159|NCT00343863|Doxorubicin|doxorubicin|mesh-list
1889160|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1889161|NCT00343863|Ondansetron|ondansetron|mesh-list
1889162|NCT00343863|Palonosetron|palonosetron|mesh-list
1889163|NCT00343863|Antiemetics|antiemetics|mesh-list
1889164|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889165|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
1889166|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889167|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889168|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1889169|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
1889170|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889171|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889172|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1889173|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889174|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
1889175|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889176|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1889177|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
1889178|NCT00343863|Hormones|hormones|mesh-ancestor
1889179|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889180|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1889181|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1889182|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889183|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889184|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889185|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
1889186|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
1889187|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1889188|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
1889189|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889190|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1889191|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889192|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889193|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889194|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1889195|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1889196|NCT00343889|Vaccines|vaccines|mesh-list
1889197|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
1889198|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889199|NCT00344032|Vaccines|vaccines|mesh-list
1889200|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
1889201|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889202|NCT00344175|Simvastatin|simvastatin|mesh-list
1889203|NCT00344175|Pitavastatin|pitavastatin|mesh-list
1889204|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1889205|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1889206|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
1889207|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889208|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1889209|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1889210|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889211|NCT00344305|Vaccines|vaccines|mesh-list
1889212|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
1889213|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889214|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1889215|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
1889216|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889217|NCT00344370|Atorvastatin|atorvastatin|mesh-list
1889218|NCT00344370|Pitavastatin|pitavastatin|mesh-list
1889219|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1889220|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1889221|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
1889222|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889223|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1889224|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1889225|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889226|NCT00344461|Tenofovir|tenofovir|mesh-list
1889227|NCT00344461|Nevirapine|nevirapine|mesh-list
1889228|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
1889229|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889230|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1889231|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889232|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889233|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889234|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1889235|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1889236|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1889237|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1889238|NCT00344682|Memantine|memantine|mesh-list
1889239|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1889240|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1889241|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
1889242|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889243|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889244|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889245|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1889246|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1889247|NCT00344773|Gefitinib|gefitinib|mesh-list
1889248|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889249|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1889250|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889251|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889252|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1889253|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889254|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
1889255|NCT00344968|Hormones|hormones|mesh-ancestor
1889256|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889257|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889258|NCT00345033|Aripiprazole|aripiprazole|mesh-list
1889259|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
1889260|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889261|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1889262|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889263|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889264|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889265|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
1889266|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
1889267|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889268|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889269|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1889270|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1889271|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
1889272|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1889273|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1889274|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1889275|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1889276|NCT00345046|Prednisolone|prednisolone|mesh-list
1889277|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1889278|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
1889279|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1889280|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
1889281|NCT00345046|Prednisone|prednisone|mesh-list
1889282|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1889283|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
1889284|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889285|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
1889286|NCT00345046|Hormones|hormones|mesh-ancestor
1889287|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889288|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889289|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1889290|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889291|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
1889292|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
1889293|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889294|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1889295|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1889296|NCT00345046|Protective Agents|protective agents|mesh-ancestor
1889303|NCT00345371|Topiramate|topiramate|mesh-list
1889304|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
1889305|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1889306|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889307|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
1889308|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1889309|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889310|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889311|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1889312|NCT00345384|Analgesics|analgesics|mesh-ancestor
1889313|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
1889314|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889315|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1889316|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1889317|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1889318|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
1889319|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889320|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889321|NCT00345540|Carboplatin|carboplatin|mesh-list
1889322|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889323|NCT00345579|PENTA|penta|mesh-list
1889324|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
1889325|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1889326|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1889327|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889328|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1889329|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889330|NCT00345683|Vaccines|vaccines|mesh-list
1889331|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
1889332|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889333|NCT00345839|Cinacalcet|cinacalcet|mesh-list
1889334|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1889335|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889336|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1889337|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
1889338|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889339|NCT00345865|Cytarabine|cytarabine|mesh-list
1889340|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
1889341|NCT00345865|Carmustine|carmustine|mesh-list
1889342|NCT00345865|Etoposide|etoposide|mesh-list
1889343|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889344|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
1889345|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889346|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889347|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1889348|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
1889349|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889350|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889351|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1889352|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1889353|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889354|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889355|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889356|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1889357|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
1889358|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
1889359|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889360|NCT00345878|Vaccines|vaccines|mesh-list
1889361|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
1889362|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889363|NCT00345969|Testosterone|testosterone|mesh-list
1889364|NCT00345969|Androgens|androgens|mesh-ancestor
1889365|NCT00345969|Hormones|hormones|mesh-ancestor
1889366|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889367|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889368|NCT00346034|Pregabalin|pregabalin|mesh-list
1889369|NCT00346034|Analgesics|analgesics|mesh-ancestor
1889370|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
1889371|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889372|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889373|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
1889374|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1889375|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1889376|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889377|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1889378|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1889379|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889380|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889381|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889382|NCT00346151|Sirolimus|sirolimus|mesh-list
1889383|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
1889384|NCT00346151|Abatacept|abatacept|mesh-list
1889385|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
1889386|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1889387|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
1889388|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
1889389|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889390|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889391|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1889392|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889393|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
1889394|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889395|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
1889396|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889397|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889398|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
1889399|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
1889400|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889401|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1889402|NCT00346151|Hormones|hormones|mesh-ancestor
1889403|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889404|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1889405|NCT00346151|Protective Agents|protective agents|mesh-ancestor
1889406|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1889407|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889408|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889409|NCT00346164|Doxorubicin|doxorubicin|mesh-list
1889410|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1889411|NCT00346164|Ifosfamide|ifosfamide|mesh-list
1889412|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1889413|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889414|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889415|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889416|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889417|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889418|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1889419|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
1889420|NCT00346216|Ibuprofen|ibuprofen|mesh-list
1889421|NCT00346216|Celecoxib|celecoxib|mesh-list
1889422|NCT00346216|Naproxen|naproxen|mesh-list
1889423|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1889424|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1889425|NCT00346216|Analgesics|analgesics|mesh-ancestor
1889426|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
1889427|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889428|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889429|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889430|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889431|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1889432|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889433|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889434|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1889435|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
1889436|NCT00346268|Parecoxib|parecoxib|mesh-list
1889437|NCT00346268|Morphine|morphine|mesh-list
1889438|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1889439|NCT00346268|Narcotics|narcotics|mesh-ancestor
1889440|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889441|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889442|NCT00346268|Analgesics|analgesics|mesh-ancestor
1889443|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
1889444|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889445|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1889446|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1889447|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889448|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889449|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1889450|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1889451|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889452|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889453|NCT00346775|Beclomethasone|beclomethasone|mesh-list
1889454|NCT00346775|Flunisolide|flunisolide|mesh-list
1889455|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889456|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
1889457|NCT00346775|Hormones|hormones|mesh-ancestor
1889458|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889459|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889460|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1889461|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
1889462|NCT00347009|Adefovir|adefovir|mesh-list
1889463|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1889464|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
1889465|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889466|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1889467|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889468|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889469|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889470|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
1889471|NCT00347360|Carvedilol|carvedilol|mesh-list
1889472|NCT00347360|Lisinopril|lisinopril|mesh-list
1889473|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1889474|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1889475|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
1889476|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889477|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889478|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889479|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1889480|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
1889481|NCT00347360|Protective Agents|protective agents|mesh-ancestor
1889482|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1889483|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1889484|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1889485|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
1889486|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1889487|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1889488|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1889489|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
1889490|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889491|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1889492|NCT00347438|Capecitabine|capecitabine|mesh-list
1889493|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1889494|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
1889495|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889496|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889497|NCT00347776|Azithromycin|azithromycin|mesh-list
1889498|NCT00347776|Tetracycline|tetracycline|mesh-list
1889499|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889500|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889501|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1889502|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889503|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889504|NCT00347919|Lapatinib|lapatinib|mesh-list
1889505|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889506|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1889507|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889508|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889509|NCT00347932|Besifloxacin|besifloxacin|mesh-list
1889510|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889511|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889512|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889513|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889514|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889515|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889516|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889517|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
1889518|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1889519|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889520|NCT00348283|Adalimumab|adalimumab|mesh-list
1889521|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889522|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889523|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
1889524|NCT00348309|Donepezil|donepezil|mesh-list
1889525|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1889526|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889527|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889528|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
1889529|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889530|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889531|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
1889532|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1889533|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
1889534|NCT00348348|Besifloxacin|besifloxacin|mesh-list
1889535|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889536|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889537|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889538|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889539|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889540|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889541|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889542|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
1889543|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1889544|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889545|NCT00348595|Lenalidomide|lenalidomide|mesh-list
1889546|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
1889547|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889548|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1889549|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1889550|NCT00348595|Growth Substances|growth substances|mesh-ancestor
1889551|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
1889552|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889553|NCT00348686|Felodipine|felodipine|mesh-list
1889554|NCT00348686|Candesartan|candesartan|mesh-list
1889555|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
1889556|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1889557|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1889558|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1889559|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889560|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1889561|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1889562|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1889563|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1889564|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889565|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
1889566|NCT00348790|Vatalanib|vatalanib|mesh-list
1889567|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1889568|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889569|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889570|NCT00348816|Prednisone|prednisone|mesh-list
1889571|NCT00348816|Docetaxel|docetaxel|mesh-list
1889572|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889573|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
1889574|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
1889575|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
1889576|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889577|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889578|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
1889579|NCT00348816|Hormones|hormones|mesh-ancestor
1889580|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889581|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889582|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1889583|NCT00348881|Vaccines|vaccines|mesh-list
1889584|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
1889585|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889586|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
1889587|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
1889588|NCT00348933|Betaine|betaine|mesh-list
1889589|NCT00348933|Vitamins|vitamins|mesh-ancestor
1889590|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
1889591|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889592|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
1889593|NCT00348933|Hematinics|hematinics|mesh-ancestor
1889594|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1889595|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
1889596|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1889597|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
1889598|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889599|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1889600|NCT00348946|Androgens|androgens|mesh-list
1889601|NCT00348946|Oxandrolone|oxandrolone|mesh-list
1889602|NCT00348946|Hormones|hormones|mesh-ancestor
1889603|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889604|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889605|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
1889606|NCT00349336|Bevacizumab|bevacizumab|mesh-list
1889607|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889608|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889609|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1889610|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1889611|NCT00349336|Growth Substances|growth substances|mesh-ancestor
1889612|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889613|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
1889614|NCT00349349|Ofatumumab|ofatumumab|mesh-list
1889615|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889616|NCT00349388|Mesalamine|mesalamine|mesh-list
1889617|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1889618|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1889619|NCT00349388|Analgesics|analgesics|mesh-ancestor
1889620|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
1889621|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889622|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889623|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889624|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889625|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
1889626|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889627|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889628|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
1889629|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889630|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
1889631|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889632|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889633|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
1889634|NCT00349778|Melphalan|melphalan|mesh-list
1889635|NCT00349778|Carmustine|carmustine|mesh-list
1889636|NCT00349778|Etoposide|etoposide|mesh-list
1889637|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
1889638|NCT00349778|Lenograstim|lenograstim|mesh-list
1889639|NCT00349778|Sargramostim|sargramostim|mesh-list
1889640|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889641|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
1889642|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889643|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889644|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1889645|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
1889646|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889647|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889648|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1889649|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1889650|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889651|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889652|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889653|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1889654|NCT00349921|Adenosine|adenosine|mesh-list
1889655|NCT00349921|Clonidine|clonidine|mesh-list
1889656|NCT00349921|Analgesics|analgesics|mesh-ancestor
1889657|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
1889658|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889659|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889660|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1889661|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
1889662|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
1889663|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1889664|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1889665|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1889666|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
1889667|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889668|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889669|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1889670|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
1889671|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1889672|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
1889673|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
1889674|NCT00349973|Dipyridamole|dipyridamole|mesh-list
1889675|NCT00349973|Olanzapine|olanzapine|mesh-list
1889676|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
1889677|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
1889678|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889679|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889680|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1889681|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1889682|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889683|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889684|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889685|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1889686|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1889687|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1889688|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889689|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889690|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
1889691|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1889692|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889693|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1889694|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
1889695|NCT00350025|Paclitaxel|paclitaxel|mesh-list
1889696|NCT00350025|Cetuximab|cetuximab|mesh-list
1889697|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1889698|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889699|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
1889700|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
1889701|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
1889702|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889703|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889704|NCT00350142|Gemcitabine|gemcitabine|mesh-list
1889705|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1889706|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
1889707|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889708|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889709|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
1889710|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889711|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889712|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889713|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
1889714|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889715|NCT00350207|Bromides|bromides|mesh-list
1889716|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
1889717|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1889718|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1889719|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
1889720|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889721|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889722|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1889723|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
1889724|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
1889725|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1889726|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
1889727|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889728|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889729|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1889730|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1889731|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1889732|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
1889733|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
1889734|NCT00350272|Tenofovir|tenofovir|mesh-list
1889735|NCT00350272|Lamivudine|lamivudine|mesh-list
1889736|NCT00350272|Efavirenz|efavirenz|mesh-list
1889737|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
1889738|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
1889739|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889740|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1889741|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889742|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889743|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889744|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1889745|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1889746|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1889747|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1889748|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1889749|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1889750|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1889751|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1889752|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
1889753|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889754|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889755|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1889756|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1889757|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889758|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889759|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889760|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889761|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889762|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
1889763|NCT00350519|Hematinics|hematinics|mesh-ancestor
1889764|NCT00350532|Clonidine|clonidine|mesh-list
1889765|NCT00350532|Analgesics|analgesics|mesh-ancestor
1889766|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
1889767|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889768|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889769|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1889770|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
1889771|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
1889772|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1889773|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1889774|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1889775|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
1889776|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889777|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889778|NCT00350545|Cyclosporine|cyclosporine|mesh-list
1889779|NCT00350545|Prednisone|prednisone|mesh-list
1889780|NCT00350545|Rituximab|rituximab|mesh-list
1889781|NCT00350545|Tacrolimus|tacrolimus|mesh-list
1889782|NCT00350545|Cyclosporins|cyclosporins|mesh-list
1889783|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889784|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889785|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
1889786|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889787|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889788|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1889789|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
1889790|NCT00350545|Hormones|hormones|mesh-ancestor
1889791|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889792|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1889793|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889794|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1889795|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889796|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889797|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
1889798|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889799|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
1889800|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
1889801|NCT00350636|Oxybutynin|oxybutynin|mesh-list
1889802|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
1889803|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
1889804|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889805|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889806|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1889807|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1889808|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
1889809|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889810|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889811|NCT00350636|Urological Agents|urological agents|mesh-ancestor
1889812|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1889813|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889814|NCT00350636|Renal Agents|renal agents|mesh-ancestor
1889815|NCT00350727|Lapatinib|lapatinib|mesh-list
1889816|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889817|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1889818|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889819|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889820|NCT00350779|Metformin|metformin|mesh-list
1889821|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1889822|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
1889823|NCT00350779|Glipizide|glipizide|mesh-list
1889824|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1889825|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889826|NCT00350779|Incretins|incretins|mesh-ancestor
1889827|NCT00350779|Hormones|hormones|mesh-ancestor
1889828|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889829|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1889830|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
1889831|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889832|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889833|NCT00350792|Carboplatin|carboplatin|mesh-list
1889834|NCT00350792|Pemetrexed|pemetrexed|mesh-list
1889835|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889836|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889837|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889838|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1889839|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889840|NCT00350870|Disulfiram|disulfiram|mesh-list
1889841|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1889842|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1889843|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889844|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889845|NCT00351000|Ziprasidone|ziprasidone|mesh-list
1889846|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1889847|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
1889848|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889849|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889850|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889851|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1889852|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889853|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889854|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889855|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1889856|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
1889857|NCT00351039|Bevacizumab|bevacizumab|mesh-list
1889858|NCT00351039|Pemetrexed|pemetrexed|mesh-list
1889859|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1889860|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1889861|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889862|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1889863|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1889864|NCT00351039|Growth Substances|growth substances|mesh-ancestor
1889865|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889866|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
1889867|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889868|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889869|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1889870|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889871|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1889872|NCT00351273|Azithromycin|azithromycin|mesh-list
1889873|NCT00351273|Doxycycline|doxycycline|mesh-list
1889874|NCT00351273|Rifampin|rifampin|mesh-list
1889875|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889876|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889877|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
1889878|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1889879|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1889880|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1889881|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
1889882|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
1889883|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1889884|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889885|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889886|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1889887|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1889888|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1889889|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1889890|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1889891|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1889892|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
1889893|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1889894|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889895|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889896|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1889897|NCT00351299|Analgesics|analgesics|mesh-ancestor
1889898|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
1889899|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889900|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1889901|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1889902|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1889903|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
1889904|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889905|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889906|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
1889907|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1889908|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889909|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1889910|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
1889911|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1889912|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1889913|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889914|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889915|NCT00351416|Letrozole|letrozole|mesh-list
1889916|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1889917|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
1889918|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889919|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1889920|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889921|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889922|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1889923|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
1889924|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889925|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889926|NCT00351611|Pregabalin|pregabalin|mesh-list
1889927|NCT00351611|Analgesics|analgesics|mesh-ancestor
1889928|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
1889929|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1889930|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889931|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
1889932|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1889933|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1889934|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889935|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1889936|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1889937|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889938|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889939|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889940|NCT00351819|Testosterone|testosterone|mesh-list
1889941|NCT00351819|Androgens|androgens|mesh-ancestor
1889942|NCT00351819|Hormones|hormones|mesh-ancestor
1889943|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1889944|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889945|NCT00351936|Aripiprazole|aripiprazole|mesh-list
1889946|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
1889947|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1889948|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1889949|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1889950|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1889951|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889952|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
1889953|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
1889954|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1889955|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889956|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1889957|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1889958|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
1889959|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1889960|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1889961|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1889962|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1889963|NCT00352001|Lenalidomide|lenalidomide|mesh-list
1889964|NCT00352001|Azacitidine|azacitidine|mesh-list
1889965|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
1889966|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889967|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1889968|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1889969|NCT00352001|Growth Substances|growth substances|mesh-ancestor
1889970|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
1889971|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889972|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1889973|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
1889974|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889975|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889976|NCT00352027|Prednisone|prednisone|mesh-list
1889977|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
1889978|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
1889979|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
1889980|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1889981|NCT00352027|Doxorubicin|doxorubicin|mesh-list
1889982|NCT00352027|Etoposide|etoposide|mesh-list
1889983|NCT00352027|Vincristine|vincristine|mesh-list
1889984|NCT00352027|Bleomycin|bleomycin|mesh-list
1889985|NCT00352027|Vinblastine|vinblastine|mesh-list
1889986|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1889987|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
1889988|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1889989|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1889990|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1889991|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
1889992|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1889993|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1889994|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1889995|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1889996|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1889997|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1889998|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1889999|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890000|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
1890001|NCT00352027|Hormones|hormones|mesh-ancestor
1890002|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890003|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1890004|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1890005|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
1890006|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
1890007|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
1890008|NCT00352053|Tenofovir|tenofovir|mesh-list
1890009|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
1890010|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890011|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1890012|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1890013|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890014|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890015|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1890016|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1890017|NCT00352105|Fluorouracil|fluorouracil|mesh-list
1890018|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890019|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
1890020|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890021|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890022|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890023|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
1890024|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890025|NCT00352365|Lenalidomide|lenalidomide|mesh-list
1890026|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
1890104|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
1890027|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890028|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890029|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890030|NCT00352365|Growth Substances|growth substances|mesh-ancestor
1890031|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890032|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890033|NCT00352417|Atreleuton|atreleuton|mesh-list
1890034|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1890035|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890036|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890056|NCT00352612|Clindamycin|clindamycin|mesh-list
1890057|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
1890058|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
1890059|NCT00352612|Cephalexin|cephalexin|mesh-list
1890060|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890061|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890062|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1890063|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890064|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890065|NCT00352664|Donepezil|donepezil|mesh-list
1890066|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1890067|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890068|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890069|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
1890070|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890071|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890072|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
1890073|NCT00352690|Paclitaxel|paclitaxel|mesh-list
1890074|NCT00352690|Carboplatin|carboplatin|mesh-list
1890075|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
1890076|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1890077|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890078|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
1890079|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
1890080|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
1890081|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890082|NCT00352755|Leucovorin|leucovorin|mesh-list
1890083|NCT00352755|Fluorouracil|fluorouracil|mesh-list
1890084|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
1890085|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
1890086|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890087|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890088|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890089|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890090|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
1890091|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890092|NCT00352755|Antidotes|antidotes|mesh-ancestor
1890093|NCT00352755|Protective Agents|protective agents|mesh-ancestor
1890094|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
1890095|NCT00352755|Vitamins|vitamins|mesh-ancestor
1890096|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
1890097|NCT00352781|Nicotine|nicotine|mesh-list
1890098|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1890099|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
1890100|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890101|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890102|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1890103|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1890105|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890106|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890107|NCT00352794|Prednisone|prednisone|mesh-list
1890108|NCT00352794|Lenalidomide|lenalidomide|mesh-list
1890109|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890110|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
1890111|NCT00352794|Hormones|hormones|mesh-ancestor
1890112|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890113|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890114|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1890115|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890116|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
1890117|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890118|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890119|NCT00352794|Growth Substances|growth substances|mesh-ancestor
1890120|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890121|NCT00352846|Vitamin D|vitamin d|mesh-list
1890122|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
1890123|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
1890124|NCT00352846|Calcium|calcium|mesh-list
1890125|NCT00352846|Vitamins|vitamins|mesh-ancestor
1890126|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
1890127|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890128|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1890129|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1890130|NCT00352846|Antacids|antacids|mesh-ancestor
1890131|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890132|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1890133|NCT00352885|Citalopram|citalopram|mesh-list
1890134|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1890135|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1890136|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1890137|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890138|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890139|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
1890140|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890141|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1890142|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
1890143|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890144|NCT00352911|Mifepristone|mifepristone|mesh-list
1890145|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1890146|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
1890147|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1890148|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890149|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1890150|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1890151|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1890152|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
1890153|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1890154|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1890155|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
1890156|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890157|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
1890158|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1890159|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1890160|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
1890161|NCT00352976|Sirolimus|sirolimus|mesh-list
1890162|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
1890163|NCT00352976|Fludarabine|fludarabine|mesh-list
1890164|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890165|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
1890166|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890167|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890168|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1890169|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
1890170|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890171|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890172|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1890173|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1890174|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1890175|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
1890176|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890177|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890178|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890179|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
1890180|NCT00353119|Etanercept|etanercept|mesh-list
1890181|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1890182|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1890183|NCT00353119|Analgesics|analgesics|mesh-ancestor
1890184|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
1890185|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890186|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890187|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890188|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890189|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1890190|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890191|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
1890192|NCT00353262|Capecitabine|capecitabine|mesh-list
1890193|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
1890194|NCT00353262|Bevacizumab|bevacizumab|mesh-list
1890195|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890196|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
1890197|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890198|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890199|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890200|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890201|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890202|NCT00353262|Growth Substances|growth substances|mesh-ancestor
1890203|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890204|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890205|NCT00353301|Sirolimus|sirolimus|mesh-list
1890206|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1890207|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890208|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1890209|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890210|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890211|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890212|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890213|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1890214|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
1890215|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890216|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
1890217|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890218|NCT00353418|Ribavirin|ribavirin|mesh-list
1890219|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1890220|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
1890221|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890222|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
1890223|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890224|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
1890225|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1890226|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890227|NCT00353496|Lanreotide|lanreotide|mesh-list
1890228|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890229|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
1890230|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1890231|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1890232|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
1890233|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890234|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1890235|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
1890236|NCT00353652|Spironolactone|spironolactone|mesh-list
1890237|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1890238|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
1890239|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890240|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890241|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1890242|NCT00353652|Diuretics|diuretics|mesh-ancestor
1890243|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
1890244|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1890245|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1890246|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1890247|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890248|NCT00353704|Pregabalin|pregabalin|mesh-list
1890249|NCT00353704|Morphine|morphine|mesh-list
1890250|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1890251|NCT00353704|Narcotics|narcotics|mesh-ancestor
1890252|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1890253|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890254|NCT00353704|Analgesics|analgesics|mesh-ancestor
1890255|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
1890256|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890257|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
1890258|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1890259|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1890260|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890261|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1890262|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1890263|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1890264|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890265|NCT00353834|Insulin|insulin|mesh-list
1890266|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1890267|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
1890268|NCT00353834|Exenatide|exenatide|mesh-list
1890269|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1890270|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890271|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1890272|NCT00353834|Incretins|incretins|mesh-ancestor
1890273|NCT00353834|Hormones|hormones|mesh-ancestor
1890274|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890275|NCT00353873|Fluticasone|fluticasone|mesh-list
1890276|NCT00353873|Xhance|xhance|mesh-list
1890277|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1890278|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890279|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1890280|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
1890281|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890282|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890283|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1890284|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
1890285|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
1890286|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1890287|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1890288|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1890289|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1890290|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
1890291|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890292|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890293|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
1890294|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
1890295|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890296|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890297|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
1890298|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890299|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890300|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1890301|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1890302|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1890303|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
1890304|NCT00353977|Vaccines|vaccines|mesh-list
1890305|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
1890306|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890307|NCT00354029|Ketamine|ketamine|mesh-list
1890308|NCT00354029|Analgesics|analgesics|mesh-ancestor
1890309|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
1890310|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890311|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890312|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1890313|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1890314|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
1890315|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
1890316|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1890317|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1890318|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1890319|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890320|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890321|NCT00354107|Cytarabine|cytarabine|mesh-list
1890322|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
1890323|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1890324|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1890325|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1890326|NCT00354107|Carboplatin|carboplatin|mesh-list
1890327|NCT00354107|Methotrexate|methotrexate|mesh-list
1890328|NCT00354107|Etoposide|etoposide|mesh-list
1890329|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
1890330|NCT00354107|Ifosfamide|ifosfamide|mesh-list
1890331|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1890332|NCT00354107|Antibodies|antibodies|mesh-list
1890333|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1890334|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
1890335|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890336|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890337|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1890338|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
1890339|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1890340|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890341|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
1890342|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890343|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
1890344|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890345|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1890346|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890347|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890348|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1890349|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1890350|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1890351|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1890352|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
1890353|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890354|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890355|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1890356|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
1890357|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890358|NCT00354172|Cyclosporine|cyclosporine|mesh-list
1890359|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
1890360|NCT00354172|Aldesleukin|aldesleukin|mesh-list
1890361|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
1890362|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1890363|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1890364|NCT00354172|Prednisolone|prednisolone|mesh-list
1890365|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
1890366|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
1890367|NCT00354172|Fludarabine|fludarabine|mesh-list
1890368|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
1890369|NCT00354172|Interleukin-2|interleukin-2|mesh-list
1890370|NCT00354172|Cyclosporins|cyclosporins|mesh-list
1890371|NCT00354172|Lenograstim|lenograstim|mesh-list
1890372|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1890373|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
1890374|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890375|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
1890376|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890377|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890378|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1890379|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
1890380|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890381|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890382|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1890383|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890384|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
1890385|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1890386|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890387|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
1890388|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890389|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
1890390|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1890391|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1890392|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1890393|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
1890394|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890395|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890396|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
1890397|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
1890398|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890399|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1890400|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
1890401|NCT00354172|Hormones|hormones|mesh-ancestor
1890402|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890403|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1890404|NCT00354172|Protective Agents|protective agents|mesh-ancestor
1890405|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1890406|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1890407|NCT00354172|Analgesics|analgesics|mesh-ancestor
1890408|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
1890409|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1890410|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1890411|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
1890412|NCT00354224|Capecitabine|capecitabine|mesh-list
1890413|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
1890414|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890415|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
1890416|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890417|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890418|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
1890419|NCT00354341|Hematinics|hematinics|mesh-ancestor
1890420|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1890421|NCT00354432|Caseins|caseins|mesh-list
1890422|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1890423|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1890424|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1890425|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890426|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890427|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890428|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1890429|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
1890430|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890431|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
1890432|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
1890433|NCT00354601|Docetaxel|docetaxel|mesh-list
1890434|NCT00354601|Capecitabine|capecitabine|mesh-list
1890435|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890436|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
1890437|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
1890438|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
1890439|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890440|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890441|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
1890442|NCT00354640|Anastrozole|anastrozole|mesh-list
1890443|NCT00354640|Simvastatin|simvastatin|mesh-list
1890444|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1890445|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1890446|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
1890447|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890448|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1890449|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1890450|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890451|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1890452|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890453|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1890454|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1890455|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1890456|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
1890457|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890458|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890459|NCT00354679|Bevacizumab|bevacizumab|mesh-list
1890460|NCT00354679|Irinotecan|irinotecan|mesh-list
1890461|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890462|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890463|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890464|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890465|NCT00354679|Growth Substances|growth substances|mesh-ancestor
1890466|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890467|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890468|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1890469|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1890470|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890471|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890472|NCT00354744|Dactinomycin|dactinomycin|mesh-list
1890473|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
1890474|NCT00354744|Ifosfamide|ifosfamide|mesh-list
1890475|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
1890476|NCT00354744|Doxorubicin|doxorubicin|mesh-list
1890477|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1890478|NCT00354744|Irinotecan|irinotecan|mesh-list
1890479|NCT00354744|Etoposide|etoposide|mesh-list
1890480|NCT00354744|Vincristine|vincristine|mesh-list
1890481|NCT00354744|Camptothecin|camptothecin|mesh-list
1890482|NCT00354744|Lenograstim|lenograstim|mesh-list
1890483|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890484|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
1890485|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890486|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890487|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1890488|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
1890489|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890490|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890491|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1890492|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1890493|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1890494|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1890495|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890496|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1890497|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1890498|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1890499|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
1890500|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
1890501|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
1890502|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890503|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890504|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1890505|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1890506|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
1890507|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1890508|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
1890509|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890510|NCT00354770|Expectorants|expectorants|mesh-ancestor
1890511|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
1890512|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1890513|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
1890514|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890515|NCT00354770|Protective Agents|protective agents|mesh-ancestor
1890516|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890517|NCT00354770|Antidotes|antidotes|mesh-ancestor
1890543|NCT00354887|Capecitabine|capecitabine|mesh-list
1890544|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
1890545|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890546|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
1890547|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890548|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890549|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
1890550|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
1890551|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890552|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1890553|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890554|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890555|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
1890556|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1890557|NCT00354978|Leucovorin|leucovorin|mesh-list
1890558|NCT00354978|Bevacizumab|bevacizumab|mesh-list
1890559|NCT00354978|Fluorouracil|fluorouracil|mesh-list
1890560|NCT00354978|Irinotecan|irinotecan|mesh-list
1890561|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890562|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890563|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890564|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890565|NCT00354978|Growth Substances|growth substances|mesh-ancestor
1890566|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890567|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890568|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
1890569|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890570|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890571|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890572|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
1890573|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1890574|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1890575|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890576|NCT00354978|Antidotes|antidotes|mesh-ancestor
1890577|NCT00354978|Protective Agents|protective agents|mesh-ancestor
1890578|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
1890579|NCT00354978|Vitamins|vitamins|mesh-ancestor
1890580|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
1890581|NCT00355030|Leuprolide|leuprolide|mesh-list
1890582|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1890583|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
1890584|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1890585|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890586|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1890587|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890588|NCT00355082|Lamotrigine|lamotrigine|mesh-list
1890589|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
1890590|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1890591|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1890592|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890593|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1890594|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890595|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1890596|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1890597|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1890598|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890599|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1890600|NCT00355121|Vaccines|vaccines|mesh-list
1890601|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
1890602|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890603|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1890604|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1890605|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890606|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890607|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
1890608|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890609|NCT00355199|Rituximab|rituximab|mesh-list
1890610|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890611|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890612|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
1890613|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890614|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890615|NCT00355342|Fluticasone|fluticasone|mesh-list
1890616|NCT00355342|Xhance|xhance|mesh-list
1890617|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1890618|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890619|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1890620|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
1890621|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890622|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890623|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1890624|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
1890625|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
1890626|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1890627|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1890628|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1890629|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1890630|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
1890631|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890632|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890633|NCT00355368|Rocuronium|rocuronium|mesh-list
1890634|NCT00355368|Succinylcholine|succinylcholine|mesh-list
1890635|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1890636|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1890637|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1890638|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890639|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890640|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1890641|NCT00355394|Metoclopramide|metoclopramide|mesh-list
1890642|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
1890643|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
1890644|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890645|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890646|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1890647|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1890648|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1890649|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
1890650|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890651|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890652|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
1890653|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890654|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1890655|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1890656|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1890657|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
1890658|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890659|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1890660|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1890661|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890662|NCT00355784|Hormones|hormones|mesh-list
1890663|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890664|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890665|NCT00356031|Bevacizumab|bevacizumab|mesh-list
1890666|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890667|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890668|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890669|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890670|NCT00356031|Growth Substances|growth substances|mesh-ancestor
1890671|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890672|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890673|NCT00356122|Bevacizumab|bevacizumab|mesh-list
1890674|NCT00356122|Docetaxel|docetaxel|mesh-list
1890675|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
1890676|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1890677|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890678|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890679|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890680|NCT00356122|Growth Substances|growth substances|mesh-ancestor
1890681|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890682|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890683|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
1890684|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
1890685|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
1890686|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890687|NCT00356135|Clopidogrel|clopidogrel|mesh-list
1890688|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1890689|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1890690|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1890691|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1890692|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1890693|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
1890694|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890695|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890696|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890697|NCT00356148|Ampicillin|ampicillin|mesh-list
1890698|NCT00356148|Sulbactam|sulbactam|mesh-list
1890699|NCT00356148|Sultamicillin|sultamicillin|mesh-list
1890700|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890701|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890702|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1890703|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890854|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
1890704|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890705|NCT00356200|Fluphenazine|fluphenazine|mesh-list
1890706|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
1890707|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
1890708|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1890709|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1890710|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1890711|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890712|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890713|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1890714|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
1890715|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890716|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890717|NCT00356265|Phenylephrine|phenylephrine|mesh-list
1890718|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
1890719|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1890720|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
1890721|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
1890722|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890723|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890724|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
1890725|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1890726|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
1890727|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
1890728|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1890729|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1890730|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1890731|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
1890732|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890733|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890734|NCT00356265|Protective Agents|protective agents|mesh-ancestor
1890735|NCT00356278|Cycloserine|cycloserine|mesh-list
1890736|NCT00356278|Alprazolam|alprazolam|mesh-list
1890737|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1890738|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890739|NCT00356278|Renal Agents|renal agents|mesh-ancestor
1890740|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1890741|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
1890742|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890743|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
1890744|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890745|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1890746|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1890747|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890748|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1890749|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1890750|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1890751|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
1890752|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
1890753|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890754|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
1890755|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890756|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
1890757|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890758|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890759|NCT00356525|Gemcitabine|gemcitabine|mesh-list
1890760|NCT00356525|Carboplatin|carboplatin|mesh-list
1890761|NCT00356525|Pemetrexed|pemetrexed|mesh-list
1890762|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890763|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1890764|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
1890765|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890766|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
1890767|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890768|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890769|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890770|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
1890771|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890772|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1890773|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1890774|NCT00356590|Etanercept|etanercept|mesh-list
1890775|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1890776|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1890777|NCT00356590|Analgesics|analgesics|mesh-ancestor
1890778|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
1890779|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890780|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890781|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890782|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890783|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1890784|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890785|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
1890786|NCT00356603|Sumatriptan|sumatriptan|mesh-list
1890787|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1890788|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1890789|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1890790|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
1890791|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890792|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890793|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890794|NCT00356759|Warfarin|warfarin|mesh-list
1890795|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
1890796|NCT00356811|Paclitaxel|paclitaxel|mesh-list
1890797|NCT00356811|Lapatinib|lapatinib|mesh-list
1890798|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1890799|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890800|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
1890801|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
1890802|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
1890803|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890804|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1890805|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890806|NCT00356889|Bevacizumab|bevacizumab|mesh-list
1890807|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1890808|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1890809|NCT00356889|Antibodies|antibodies|mesh-list
1890810|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
1890811|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1890812|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890813|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890814|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890815|NCT00356889|Growth Substances|growth substances|mesh-ancestor
1890816|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890817|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890818|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
1890819|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1890820|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890821|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890822|NCT00356915|Itraconazole|itraconazole|mesh-list
1890823|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
1890824|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
1890825|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890826|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1890827|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1890828|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890829|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890830|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1890831|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
1890832|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890833|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890834|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1890835|NCT00356993|Nicotine|nicotine|mesh-list
1890836|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1890837|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
1890838|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890839|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890840|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1890841|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1890842|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
1890843|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890844|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890845|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1890846|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1890847|NCT00357006|Estradiol|estradiol|mesh-list
1890848|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1890849|NCT00357006|Estrogens|estrogens|mesh-ancestor
1890850|NCT00357006|Hormones|hormones|mesh-ancestor
1890851|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890852|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890853|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1890855|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1890856|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1890857|NCT00357032|Belinostat|belinostat|mesh-list
1890858|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890859|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1890860|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890861|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890862|NCT00357097|Ropinirole|ropinirole|mesh-list
1890863|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1890864|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1890865|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
1890866|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
1890867|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1890868|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890869|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890870|NCT00357110|Fulvestrant|fulvestrant|mesh-list
1890871|NCT00357110|Anastrozole|anastrozole|mesh-list
1890872|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1890873|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890874|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1890875|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1890876|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
1890877|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1890878|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890879|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1890880|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1890881|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890882|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890883|NCT00357162|Belinostat|belinostat|mesh-list
1890884|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890885|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1890886|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890887|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890888|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
1890889|NCT00357331|Diuretics|diuretics|mesh-ancestor
1890890|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
1890891|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890892|NCT00357331|Expectorants|expectorants|mesh-ancestor
1890893|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
1890894|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
1890895|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1890896|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890897|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1890898|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890899|NCT00357396|Melphalan|melphalan|mesh-list
1890900|NCT00357396|Busulfan|busulfan|mesh-list
1890901|NCT00357396|Thiotepa|thiotepa|mesh-list
1890902|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1890903|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
1890904|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890905|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890906|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1890907|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890908|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
1890909|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890910|NCT00357500|Thalidomide|thalidomide|mesh-list
1890911|NCT00357500|Celecoxib|celecoxib|mesh-list
1890912|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
1890913|NCT00357500|Etoposide|etoposide|mesh-list
1890914|NCT00357500|Fenofibrate|fenofibrate|mesh-list
1890915|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890916|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
1890917|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890918|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890919|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1890920|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
1890921|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890922|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890923|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1890924|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1890925|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1890926|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1890927|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890928|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1890929|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1890930|NCT00357500|Analgesics|analgesics|mesh-ancestor
1890931|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
1890932|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890933|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890934|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1890935|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1890936|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
1890937|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1890938|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890939|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890940|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890941|NCT00357500|Growth Substances|growth substances|mesh-ancestor
1890942|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890943|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1890944|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
1890945|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1890946|NCT00357552|Ritonavir|ritonavir|mesh-list
1890947|NCT00357552|Lopinavir|lopinavir|mesh-list
1890948|NCT00357552|Tenofovir|tenofovir|mesh-list
1890949|NCT00357552|Emtricitabine|emtricitabine|mesh-list
1890950|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1890951|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1890952|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1890953|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
1890954|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890955|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890956|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1890957|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1890958|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
1890959|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890960|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1890961|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1890962|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1890963|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1890964|NCT00357656|Factor VIII|factor viii|mesh-list
1890965|NCT00357656|Coagulants|coagulants|mesh-ancestor
1890966|NCT00357734|Gefitinib|gefitinib|mesh-list
1890967|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890968|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1890969|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1890970|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1890971|NCT00357760|Aflibercept|aflibercept|mesh-list
1890972|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
1890973|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1890974|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1890975|NCT00357760|Growth Substances|growth substances|mesh-ancestor
1890976|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890977|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
1890978|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1890979|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
1890980|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1890981|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1890982|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1890983|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
1890984|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
1890985|NCT00357903|Etanercept|etanercept|mesh-list
1890986|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1890987|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1890988|NCT00357903|Analgesics|analgesics|mesh-ancestor
1890989|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
1890990|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1890991|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1890992|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1890993|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1890994|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1890995|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1890996|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
1890997|NCT00357968|Clopidogrel|clopidogrel|mesh-list
1890998|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1890999|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1891000|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1891001|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1891002|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1891003|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
1891155|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1891004|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891005|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891006|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891007|NCT00357994|Levodopa|levodopa|mesh-list
1891008|NCT00357994|Carbidopa|carbidopa|mesh-list
1891009|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1891010|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1891011|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1891012|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
1891013|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891014|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891015|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891016|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1891017|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891018|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1891019|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
1891020|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
1891021|NCT00358150|Eliglustat|eliglustat|mesh-list
1891022|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891023|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891024|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
1891025|NCT00358215|Hematinics|hematinics|mesh-ancestor
1891026|NCT00358436|Bromides|bromides|mesh-list
1891027|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
1891028|NCT00358462|Azithromycin|azithromycin|mesh-list
1891029|NCT00358462|Doxycycline|doxycycline|mesh-list
1891030|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1891031|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891032|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
1891033|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1891034|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1891035|NCT00358501|Defibrotide|defibrotide|mesh-list
1891036|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1891037|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1891038|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891039|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1891040|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
1891041|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891042|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891043|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1891044|NCT00358579|Vasopressins|vasopressins|mesh-list
1891045|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
1891046|NCT00358579|Epinephrine|epinephrine|mesh-list
1891047|NCT00358579|Racepinephrine|racepinephrine|mesh-list
1891048|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
1891049|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891050|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1891051|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1891052|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891053|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891054|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891055|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1891056|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1891057|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
1891058|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891059|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1891060|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
1891061|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
1891062|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
1891063|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1891064|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
1891065|NCT00358579|Coagulants|coagulants|mesh-ancestor
1891066|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1891067|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
1891068|NCT00358644|Decitabine|decitabine|mesh-list
1891069|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891070|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
1891071|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891072|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891073|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891074|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
1891075|NCT00358657|Sirolimus|sirolimus|mesh-list
1891076|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
1891077|NCT00358657|Fludarabine|fludarabine|mesh-list
1891078|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
1891079|NCT00358657|Tacrolimus|tacrolimus|mesh-list
1891080|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891081|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
1891082|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891083|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891084|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891085|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
1891086|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891087|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891088|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1891089|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891090|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
1891091|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1891092|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891093|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1891094|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1891095|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
1891096|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1891097|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891098|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
1891099|NCT00358670|Infliximab|infliximab|mesh-list
1891100|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891101|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1891102|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891103|NCT00358735|Enoxaparin|enoxaparin|mesh-list
1891104|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
1891105|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1891106|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1891107|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891108|NCT00358826|Atreleuton|atreleuton|mesh-list
1891109|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1891110|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891111|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891112|NCT00358917|Ritonavir|ritonavir|mesh-list
1891113|NCT00358917|Lopinavir|lopinavir|mesh-list
1891114|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1891115|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1891116|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1891117|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
1891118|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891119|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891120|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1891121|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1891122|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
1891123|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891124|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1891125|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1891126|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1891127|NCT00359021|Etravirine|etravirine|mesh-list
1891128|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1891129|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1891130|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891131|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891132|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
1891133|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891134|NCT00359073|Montelukast|montelukast|mesh-list
1891135|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1891136|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
1891137|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1891138|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
1891139|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891140|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891141|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1891142|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1891143|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891144|NCT00359138|Cetirizine|cetirizine|mesh-list
1891145|NCT00359138|Loratadine|loratadine|mesh-list
1891146|NCT00359138|Levocetirizine|levocetirizine|mesh-list
1891147|NCT00359138|Desloratadine|desloratadine|mesh-list
1891148|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1891149|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1891150|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
1891151|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
1891152|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891153|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891154|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891156|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1891157|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
1891158|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
1891159|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891160|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
1891161|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891162|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891163|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1891164|NCT00359281|Niacin|niacin|mesh-list
1891165|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
1891166|NCT00359281|Atorvastatin|atorvastatin|mesh-list
1891167|NCT00359281|Simvastatin|simvastatin|mesh-list
1891168|NCT00359281|Ezetimibe|ezetimibe|mesh-list
1891169|NCT00359281|Fenofibrate|fenofibrate|mesh-list
1891170|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1891171|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1891172|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
1891173|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891174|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1891175|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1891176|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891177|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
1891178|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
1891179|NCT00359281|Vitamins|vitamins|mesh-ancestor
1891180|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
1891181|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891182|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
1891183|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
1891184|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1891185|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1891186|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891187|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1891188|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1891189|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1891190|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891191|NCT00359632|Linezolid|linezolid|mesh-list
1891192|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1891193|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891194|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1891195|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891196|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891197|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
1891198|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
1891199|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1891200|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1891201|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891202|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891203|NCT00359736|Urological Agents|urological agents|mesh-ancestor
1891204|NCT00359762|Exenatide|exenatide|mesh-list
1891205|NCT00359762|Glimepiride|glimepiride|mesh-list
1891206|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1891207|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891208|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1891209|NCT00359762|Incretins|incretins|mesh-ancestor
1891210|NCT00359762|Hormones|hormones|mesh-ancestor
1891211|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891212|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1891213|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891214|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
1891215|NCT00359788|Albuterol|albuterol|mesh-list
1891216|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
1891217|NCT00359788|Ipratropium|ipratropium|mesh-list
1891218|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1891219|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
1891220|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891221|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891222|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1891223|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
1891224|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
1891225|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1891226|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
1891227|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891228|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891229|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
1891230|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1891231|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1891232|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1891233|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1891234|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891235|NCT00359801|Insulin|insulin|mesh-list
1891236|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1891237|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1891238|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891239|NCT00360126|Lamotrigine|lamotrigine|mesh-list
1891240|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
1891241|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1891242|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891243|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891244|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1891245|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891246|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1891247|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1891248|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1891249|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1891250|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1891251|NCT00360230|Vaccines|vaccines|mesh-list
1891252|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
1891253|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891254|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1891255|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1891256|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891257|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891258|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891259|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891260|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891261|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891262|NCT00360282|Rizatriptan|rizatriptan|mesh-list
1891263|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1891264|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
1891265|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891266|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891267|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891268|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
1891269|NCT00360334|Exenatide|exenatide|mesh-list
1891270|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1891271|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891272|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1891273|NCT00360334|Incretins|incretins|mesh-ancestor
1891274|NCT00360334|Hormones|hormones|mesh-ancestor
1891275|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891276|NCT00360360|Paclitaxel|paclitaxel|mesh-list
1891277|NCT00360360|Bevacizumab|bevacizumab|mesh-list
1891278|NCT00360360|Carboplatin|carboplatin|mesh-list
1891279|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1891280|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1891281|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891282|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
1891283|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
1891284|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
1891285|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891286|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891287|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891288|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891289|NCT00360360|Growth Substances|growth substances|mesh-ancestor
1891290|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891291|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891292|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1891293|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891294|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1891295|NCT00360399|Citalopram|citalopram|mesh-list
1891296|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1891297|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891298|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891299|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891300|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891301|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
1891302|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891303|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1891304|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
1891305|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1891306|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891307|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1891308|NCT00360399|Analgesics|analgesics|mesh-ancestor
1891309|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
1891310|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
1891311|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1891312|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
1891313|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
1891314|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1891315|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
1891316|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1891317|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891318|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1891319|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1891320|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1891321|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1891322|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1891323|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1891324|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891325|NCT00360568|Levodopa|levodopa|mesh-list
1891326|NCT00360568|Carbidopa|carbidopa|mesh-list
1891327|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1891328|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1891329|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1891330|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
1891331|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891332|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891333|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891334|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1891335|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891336|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1891337|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
1891338|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
1891339|NCT00360672|Lenalidomide|lenalidomide|mesh-list
1891340|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
1891341|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891342|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891343|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891344|NCT00360672|Growth Substances|growth substances|mesh-ancestor
1891345|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891346|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891347|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
1891348|NCT00360685|Methotrexate|methotrexate|mesh-list
1891349|NCT00360685|Tacrolimus|tacrolimus|mesh-list
1891350|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1891351|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
1891352|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1891353|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891354|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891355|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
1891356|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891357|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891358|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891359|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891360|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1891361|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891362|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
1891363|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891364|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1891365|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1891366|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1891367|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1891368|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
1891369|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1891370|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891371|NCT00360698|Insulin|insulin|mesh-list
1891372|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1891373|NCT00360698|Metformin|metformin|mesh-list
1891374|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
1891375|NCT00360698|Glimepiride|glimepiride|mesh-list
1891376|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
1891377|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1891378|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891379|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1891380|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891381|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
1891382|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1891383|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1891384|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891385|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891386|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891387|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891388|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891389|NCT00360724|Analgesics|analgesics|mesh-ancestor
1891390|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
1891391|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891392|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
1891393|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1891394|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
1891395|NCT00360828|Irinotecan|irinotecan|mesh-list
1891396|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1891397|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1891398|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891399|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891400|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891401|NCT00360971|Cisplatin|cisplatin|mesh-list
1891402|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891403|NCT00361140|Vidarabine|vidarabine|mesh-list
1891404|NCT00361140|Fludarabine|fludarabine|mesh-list
1891405|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
1891406|NCT00361140|Busulfan|busulfan|mesh-list
1891407|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891408|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891409|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
1891410|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891411|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891412|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
1891413|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891414|NCT00361140|Antiviral Agents|antiviral agents|mesh-ancestor
1891415|NCT00361140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891416|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
1891417|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891418|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1891419|NCT00361218|Citalopram|citalopram|mesh-list
1891420|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1891421|NCT00361218|Serotonin|serotonin|mesh-list
1891422|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891423|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891424|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891425|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891426|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
1891427|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891428|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1891429|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
1891430|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1891431|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1891432|NCT00361231|Gemcitabine|gemcitabine|mesh-list
1891433|NCT00361231|Bevacizumab|bevacizumab|mesh-list
1891434|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
1891435|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891436|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891437|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891438|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891439|NCT00361231|Growth Substances|growth substances|mesh-ancestor
1891440|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891441|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891442|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891443|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
1891444|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891445|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
1891446|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891447|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891448|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891449|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
1891450|NCT00361257|Minocycline|minocycline|mesh-list
1891451|NCT00361257|Tetracycline|tetracycline|mesh-list
1891452|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1891453|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891454|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1891455|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891456|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891457|NCT00361270|Complement Factor H|complement factor h|mesh-list
1891458|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1891459|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891460|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
1891461|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891462|NCT00361283|Atorvastatin|atorvastatin|mesh-list
1891463|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1891464|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1891465|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
1891466|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891467|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1891468|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1891469|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891470|NCT00361335|Golimumab|golimumab|mesh-list
1891471|NCT00361335|Methotrexate|methotrexate|mesh-list
1891472|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1891473|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
1891474|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1891475|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891476|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891477|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
1891478|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891479|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891480|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891481|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891482|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1891483|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891484|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
1891485|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891486|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1891487|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1891488|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891489|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
1891490|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891491|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891492|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1891493|NCT00361504|Oxycodone|oxycodone|mesh-list
1891494|NCT00361504|Tapentadol|tapentadol|mesh-list
1891495|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1891496|NCT00361504|Narcotics|narcotics|mesh-ancestor
1891497|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1891498|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891499|NCT00361504|Analgesics|analgesics|mesh-ancestor
1891500|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
1891501|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891502|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1891503|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891504|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891505|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891506|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891507|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891508|NCT00361569|Estrogens|estrogens|mesh-list
1891509|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1891510|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
1891511|NCT00361569|Hormones|hormones|mesh-ancestor
1891512|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891513|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891514|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
1891515|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1891516|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891517|NCT00361634|Etanercept|etanercept|mesh-list
1891518|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1891519|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1891520|NCT00361634|Analgesics|analgesics|mesh-ancestor
1891521|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
1891522|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891523|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891524|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891525|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891526|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1891527|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891528|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
1891529|NCT00361842|Irinotecan|irinotecan|mesh-list
1891530|NCT00361842|Floxuridine|floxuridine|mesh-list
1891531|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1891532|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1891533|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891534|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891535|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891536|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1891537|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
1891538|NCT00361972|Lansoprazole|lansoprazole|mesh-list
1891539|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
1891540|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1891541|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1891542|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1891543|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891544|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891545|NCT00362115|Olmesartan|olmesartan|mesh-list
1891546|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1891547|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1891548|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1891549|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1891550|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891551|NCT00362180|Mipomersen|mipomersen|mesh-list
1891552|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1891553|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1891554|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
1891555|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891556|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1891557|NCT00362232|Enoxaparin|enoxaparin|mesh-list
1891558|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
1891559|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
1891560|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1891561|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
1891562|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1891563|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
1891564|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891565|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891566|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
1891567|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1891568|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1891569|NCT00362297|Valacyclovir|valacyclovir|mesh-list
1891570|NCT00362297|Acyclovir|acyclovir|mesh-list
1891571|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
1891572|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891573|NCT00362414|Mitogens|mitogens|mesh-list
1891574|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
1891575|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891576|NCT00362440|Metformin|metformin|mesh-list
1891577|NCT00362440|Pioglitazone|pioglitazone|mesh-list
1891578|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1891579|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891580|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
1891581|NCT00362466|Dasatinib|dasatinib|mesh-list
1891582|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891583|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1891584|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891585|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891586|NCT00362609|Pantoprazole|pantoprazole|mesh-list
1891587|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1891588|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1891589|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1891590|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891591|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891592|NCT00362817|Carboplatin|carboplatin|mesh-list
1891593|NCT00362817|Temozolomide|temozolomide|mesh-list
1891594|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891595|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891596|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
1891597|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891598|NCT00362882|Docetaxel|docetaxel|mesh-list
1891599|NCT00362882|Bortezomib|bortezomib|mesh-list
1891600|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891601|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
1891602|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
1891603|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
1891604|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891618|NCT00363051|Everolimus|everolimus|mesh-list
1891619|NCT00363051|Octreotide|octreotide|mesh-list
1891620|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891621|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891622|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
1891623|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891624|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1891625|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1891626|NCT00363077|Vaccines|vaccines|mesh-list
1891627|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
1891628|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891629|NCT00363129|Vitamin E|vitamin e|mesh-list
1891630|NCT00363129|Vitamins|vitamins|mesh-ancestor
1891631|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
1891632|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891633|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
1891634|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891635|NCT00363129|Protective Agents|protective agents|mesh-ancestor
1891636|NCT00363142|Ritonavir|ritonavir|mesh-list
1891637|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
1891638|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1891639|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1891640|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
1891641|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891642|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891643|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1891644|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1891645|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
1891646|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891647|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1891648|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1891649|NCT00363168|Ranibizumab|ranibizumab|mesh-list
1891650|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891651|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891652|NCT00363168|Growth Substances|growth substances|mesh-ancestor
1891653|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891654|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891655|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891656|NCT00363298|Caffeine|caffeine|mesh-list
1891657|NCT00363298|Amphetamine|amphetamine|mesh-list
1891658|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
1891659|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1891660|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891661|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1891662|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891663|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891664|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1891665|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1891666|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
1891667|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891668|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
1891669|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
1891670|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891671|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
1891672|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891673|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1891674|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891675|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891676|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1891677|NCT00363311|Dutasteride|dutasteride|mesh-list
1891678|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1891679|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1891680|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891681|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891682|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
1891683|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891684|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891685|NCT00363415|Carboplatin|carboplatin|mesh-list
1891686|NCT00363415|Etoposide|etoposide|mesh-list
1891687|NCT00363415|Pemetrexed|pemetrexed|mesh-list
1891688|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891689|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1891690|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1891691|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1891692|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891693|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891694|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1891695|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1891696|NCT00363467|Busulfan|busulfan|mesh-list
1891697|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
1891698|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891699|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
1891700|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891701|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891702|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891703|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891704|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1891705|NCT00363480|Fluticasone|fluticasone|mesh-list
1891706|NCT00363480|Albuterol|albuterol|mesh-list
1891707|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1891708|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891709|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1891710|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
1891711|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891712|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891713|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1891714|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
1891715|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891716|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1891717|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1891718|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1891719|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1891720|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891721|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891722|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891723|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
1891724|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1891725|NCT00363545|Vaccines|vaccines|mesh-list
1891726|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
1891727|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891728|NCT00363649|Interferons|interferons|mesh-list
1891729|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
1891730|NCT00363649|Sargramostim|sargramostim|mesh-list
1891731|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891732|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
1891733|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891734|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
1891735|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891736|NCT00363779|Cyclosporine|cyclosporine|mesh-list
1891737|NCT00363779|Cyclosporins|cyclosporins|mesh-list
1891738|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891739|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891740|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891741|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
1891742|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891743|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
1891744|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891745|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
1891746|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891747|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1891748|NCT00363883|Vorinostat|vorinostat|mesh-list
1891749|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891750|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1891751|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891752|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891753|NCT00363896|Bromides|bromides|mesh-list
1891754|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
1891755|NCT00364013|Panitumumab|panitumumab|mesh-list
1891756|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891757|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891758|NCT00364156|Nicotine|nicotine|mesh-list
1891759|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1891760|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
1891761|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891762|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891763|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1891764|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1891765|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
1891766|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891767|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891768|NCT00364286|Dasatinib|dasatinib|mesh-list
1891769|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891770|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1891771|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891772|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891773|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1891774|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891775|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1891776|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891777|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891778|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1891779|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1891780|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891781|NCT00364377|Incretins|incretins|mesh-ancestor
1891782|NCT00364377|Hormones|hormones|mesh-ancestor
1891783|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891784|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1891785|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
1891786|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891787|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891788|NCT00364533|Oxycodone|oxycodone|mesh-list
1891789|NCT00364533|Tapentadol|tapentadol|mesh-list
1891790|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1891791|NCT00364533|Narcotics|narcotics|mesh-ancestor
1891792|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1891793|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891794|NCT00364533|Analgesics|analgesics|mesh-ancestor
1891795|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
1891796|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891797|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1891798|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1891799|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1891800|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891801|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
1891802|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891803|NCT00364611|Bevacizumab|bevacizumab|mesh-list
1891804|NCT00364611|Trastuzumab|trastuzumab|mesh-list
1891805|NCT00364611|Docetaxel|docetaxel|mesh-list
1891806|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891807|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891808|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891809|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891810|NCT00364611|Growth Substances|growth substances|mesh-ancestor
1891811|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891812|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891813|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
1891814|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
1891815|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
1891816|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891817|NCT00364793|Emtricitabine|emtricitabine|mesh-list
1891818|NCT00364793|Efavirenz|efavirenz|mesh-list
1891819|NCT00364793|Didanosine|didanosine|mesh-list
1891820|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
1891821|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1891822|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1891823|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1891824|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891825|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891826|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1891827|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1891828|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1891829|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1891830|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1891831|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1891832|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1891833|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1891834|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
1891835|NCT00364819|Rituximab|rituximab|mesh-list
1891836|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891837|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891838|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
1891839|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891840|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891841|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
1891842|NCT00364832|Hematinics|hematinics|mesh-ancestor
1891843|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
1891844|NCT00364845|Hematinics|hematinics|mesh-ancestor
1891845|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1891846|NCT00364923|Aminopterin|aminopterin|mesh-list
1891847|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1891848|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891849|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891850|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891851|NCT00365053|Belinostat|belinostat|mesh-list
1891852|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891853|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1891854|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891855|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891856|NCT00365105|Vitamin D|vitamin d|mesh-list
1891857|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
1891858|NCT00365105|Calcium|calcium|mesh-list
1891859|NCT00365105|Vitamins|vitamins|mesh-ancestor
1891860|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
1891861|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891862|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1891863|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1891864|NCT00365144|Bevacizumab|bevacizumab|mesh-list
1891865|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1891866|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891867|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891868|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891869|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891870|NCT00365144|Growth Substances|growth substances|mesh-ancestor
1891871|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891872|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891873|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1891874|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891875|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891876|NCT00365209|Curcumin|curcumin|mesh-list
1891877|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1891878|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1891879|NCT00365209|Analgesics|analgesics|mesh-ancestor
1891880|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
1891881|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891882|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891883|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891884|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891885|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891886|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891887|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891888|NCT00365261|Eszopiclone|eszopiclone|mesh-list
1891889|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1891890|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1891891|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891892|NCT00365274|Prednisone|prednisone|mesh-list
1891893|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
1891894|NCT00365274|Doxorubicin|doxorubicin|mesh-list
1891895|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1891896|NCT00365274|Vincristine|vincristine|mesh-list
1891897|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1891898|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891899|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
1891900|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891901|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891902|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891903|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
1891904|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891905|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891906|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1891982|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
1891907|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1891908|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1891909|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1891910|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891911|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1891912|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
1891913|NCT00365274|Hormones|hormones|mesh-ancestor
1891914|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1891915|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1891916|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1891917|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
1891918|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
1891919|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
1891920|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891921|NCT00365300|Pantoprazole|pantoprazole|mesh-list
1891922|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1891923|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1891924|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1891925|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891926|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891927|NCT00365352|Gabapentin|gabapentin|mesh-list
1891928|NCT00365352|Analgesics|analgesics|mesh-ancestor
1891929|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
1891930|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1891931|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891932|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
1891933|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1891934|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1891935|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1891936|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1891937|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1891938|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1891939|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1891940|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891941|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
1891942|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
1891943|NCT00365365|Bevacizumab|bevacizumab|mesh-list
1891944|NCT00365365|Carboplatin|carboplatin|mesh-list
1891945|NCT00365365|Docetaxel|docetaxel|mesh-list
1891946|NCT00365365|Doxorubicin|doxorubicin|mesh-list
1891947|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1891948|NCT00365365|Trastuzumab|trastuzumab|mesh-list
1891949|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891950|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
1891951|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891952|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891953|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891954|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
1891955|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891956|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891957|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1891958|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1891959|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891960|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891961|NCT00365365|Growth Substances|growth substances|mesh-ancestor
1891962|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891963|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
1891964|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
1891965|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
1891966|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1891967|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1891968|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1891969|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891970|NCT00365391|Bevacizumab|bevacizumab|mesh-list
1891971|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1891972|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1891973|NCT00365391|Antibodies|antibodies|mesh-list
1891974|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
1891975|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1891976|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891977|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1891978|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1891979|NCT00365391|Growth Substances|growth substances|mesh-ancestor
1891980|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891981|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
1891983|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1891984|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1891985|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891986|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
1891987|NCT00365417|Bevacizumab|bevacizumab|mesh-list
1891988|NCT00365417|Docetaxel|docetaxel|mesh-list
1891989|NCT00365417|Doxorubicin|doxorubicin|mesh-list
1891990|NCT00365417|Capecitabine|capecitabine|mesh-list
1891991|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1891992|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
1891993|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1891994|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1891995|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1891996|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
1891997|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1891998|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1891999|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1892000|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892001|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892002|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892003|NCT00365417|Growth Substances|growth substances|mesh-ancestor
1892004|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892005|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
1892006|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
1892007|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
1892008|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892009|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1892010|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1892011|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892012|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892013|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
1892014|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
1892015|NCT00365456|Hormones|hormones|mesh-list
1892016|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
1892017|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892018|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892019|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1892020|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892021|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892022|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1892023|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1892024|NCT00365508|Nicotine|nicotine|mesh-list
1892025|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1892026|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
1892027|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892028|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892029|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1892030|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1892031|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
1892032|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892033|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892034|NCT00365547|Bevacizumab|bevacizumab|mesh-list
1892035|NCT00365547|Topotecan|topotecan|mesh-list
1892036|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892037|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892038|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892039|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892040|NCT00365547|Growth Substances|growth substances|mesh-ancestor
1892041|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892042|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892043|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1892044|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1892045|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892046|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892047|NCT00365599|Tamoxifen|tamoxifen|mesh-list
1892048|NCT00365599|Vorinostat|vorinostat|mesh-list
1892049|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892050|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1892051|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
1892052|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892053|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892054|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1892055|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892056|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1892057|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1892058|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1892059|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1892060|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892061|NCT00365716|Vaccines|vaccines|mesh-list
1892062|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
1892063|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892064|NCT00365794|Testosterone|testosterone|mesh-list
1892065|NCT00365794|Androgens|androgens|mesh-ancestor
1892066|NCT00365794|Hormones|hormones|mesh-ancestor
1892067|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892068|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892069|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
1892070|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892071|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892072|NCT00365859|Aripiprazole|aripiprazole|mesh-list
1892073|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
1892074|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892075|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1892076|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1892077|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1892078|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892079|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
1892080|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
1892081|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892082|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892083|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1892084|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1892085|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
1892086|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1892087|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1892088|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1892089|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1892090|NCT00365976|Eszopiclone|eszopiclone|mesh-list
1892091|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1892092|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1892093|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892094|NCT00366106|Dexamethasone|dexamethasone|mesh-list
1892095|NCT00366106|Doxorubicin|doxorubicin|mesh-list
1892096|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1892097|NCT00366106|Bortezomib|bortezomib|mesh-list
1892098|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1892099|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
1892100|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
1892101|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892102|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892103|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1892104|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
1892105|NCT00366106|Hormones|hormones|mesh-ancestor
1892106|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892107|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1892108|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892109|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892110|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1892111|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1892112|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892113|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892114|NCT00366249|Ertapenem|ertapenem|mesh-list
1892115|NCT00366249|Tigecycline|tigecycline|mesh-list
1892116|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1892117|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892118|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1892119|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892120|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892121|NCT00366301|Metformin|metformin|mesh-list
1892122|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
1892123|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1892124|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892125|NCT00366340|Vaccines|vaccines|mesh-list
1892126|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1892127|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
1892128|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892129|NCT00366444|Diclofenac|diclofenac|mesh-list
1892206|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892130|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1892131|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1892132|NCT00366444|Analgesics|analgesics|mesh-ancestor
1892133|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
1892134|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892135|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892136|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1892137|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892138|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1892139|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892140|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892141|NCT00366457|Gemcitabine|gemcitabine|mesh-list
1892142|NCT00366457|Bevacizumab|bevacizumab|mesh-list
1892143|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1892144|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892145|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892146|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892147|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892148|NCT00366457|Growth Substances|growth substances|mesh-ancestor
1892149|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892150|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892151|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892152|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
1892153|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892154|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
1892155|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892156|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892157|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892158|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
1892159|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892160|NCT00366535|Neurotropin|neurotropin|mesh-list
1892161|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1892162|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
1892163|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892164|NCT00366535|Analgesics|analgesics|mesh-ancestor
1892165|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
1892166|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892167|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
1892168|NCT00366548|Vaccines|vaccines|mesh-list
1892169|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1892170|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
1892171|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892172|NCT00366626|Naltrexone|naltrexone|mesh-list
1892173|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1892174|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1892175|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892176|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
1892177|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892178|NCT00366678|Vaccines|vaccines|mesh-list
1892179|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1892180|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
1892181|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892182|NCT00366899|Vaccines|vaccines|mesh-list
1892183|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1892184|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
1892185|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892186|NCT00367016|Omalizumab|omalizumab|mesh-list
1892187|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1892188|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1892189|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
1892190|NCT00367055|Metformin|metformin|mesh-list
1892191|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
1892192|NCT00367055|Gliclazide|gliclazide|mesh-list
1892193|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1892194|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892195|NCT00367133|Triamcinolone|triamcinolone|mesh-list
1892196|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1892197|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1892198|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1892199|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1892200|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
1892201|NCT00367133|Hormones|hormones|mesh-ancestor
1892202|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892203|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892204|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892205|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
1892207|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892208|NCT00367237|Methotrexate|methotrexate|mesh-list
1892209|NCT00367237|Infliximab|infliximab|mesh-list
1892210|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1892211|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
1892212|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1892213|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892214|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892215|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
1892216|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892217|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892218|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
1892219|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892220|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1892221|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892222|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
1892223|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892224|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892225|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1892226|NCT00367341|Citalopram|citalopram|mesh-list
1892227|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1892228|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1892229|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892230|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892231|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892232|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
1892233|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892234|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1892235|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
1892236|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892237|NCT00367432|Levetiracetam|levetiracetam|mesh-list
1892238|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
1892239|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
1892240|NCT00367458|Atorvastatin|atorvastatin|mesh-list
1892241|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1892242|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1892243|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
1892244|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892245|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1892246|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1892247|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892248|NCT00367484|Interferons|interferons|mesh-list
1892249|NCT00367484|Interferon-beta|interferon-beta|mesh-list
1892250|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
1892251|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892252|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
1892253|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892254|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
1892255|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892256|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1892257|NCT00367601|Bevacizumab|bevacizumab|mesh-list
1892258|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1892259|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892260|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892261|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892262|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892263|NCT00367601|Growth Substances|growth substances|mesh-ancestor
1892264|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892265|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892266|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892267|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892268|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892269|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
1892270|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892271|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
1892272|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1892273|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892274|NCT00367770|Bosentan|bosentan|mesh-list
1892275|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1892276|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1892277|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892278|NCT00367835|Guanfacine|guanfacine|mesh-list
1892279|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1892280|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1892281|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1892282|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1892283|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
1892284|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892285|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892286|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892287|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
1892288|NCT00367991|Hematinics|hematinics|mesh-ancestor
1892289|NCT00368069|Levetiracetam|levetiracetam|mesh-list
1892290|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
1892291|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
1892292|NCT00368251|Brivaracetam|brivaracetam|mesh-list
1892293|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
1892294|NCT00368277|Amlodipine|amlodipine|mesh-list
1892295|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1892296|NCT00368277|Ramipril|ramipril|mesh-list
1892297|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1892298|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1892299|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892300|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892301|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1892302|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892303|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
1892304|NCT00368277|Diuretics|diuretics|mesh-ancestor
1892305|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
1892306|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1892307|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1892308|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
1892309|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892310|NCT00368290|Modafinil|modafinil|mesh-list
1892311|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1892312|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892313|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1892314|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1892315|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1892316|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892317|NCT00368355|Cytarabine|cytarabine|mesh-list
1892318|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
1892319|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
1892320|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892321|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
1892322|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892323|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892324|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1892325|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
1892326|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892327|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892328|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1892329|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892330|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
1892331|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
1892332|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892333|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892334|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1892335|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1892336|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
1892337|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892338|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892339|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1892340|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1892341|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1892342|NCT00368537|Ampicillin|ampicillin|mesh-list
1892343|NCT00368537|Tigecycline|tigecycline|mesh-list
1892344|NCT00368537|Sulbactam|sulbactam|mesh-list
1892345|NCT00368537|Sultamicillin|sultamicillin|mesh-list
1892346|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1892347|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892348|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1892349|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892350|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892351|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1892352|NCT00368550|Sertraline|sertraline|mesh-list
1892353|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
1892354|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892428|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892355|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1892356|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1892357|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892358|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892359|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892360|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
1892361|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892362|NCT00368641|Icodextrin|icodextrin|mesh-list
1892363|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
1892364|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1892365|NCT00368745|Pregabalin|pregabalin|mesh-list
1892366|NCT00368745|Analgesics|analgesics|mesh-ancestor
1892367|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
1892368|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892369|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892370|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
1892371|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1892372|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892373|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892374|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1892375|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1892376|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1892377|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1892378|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892379|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1892380|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1892381|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1892382|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892383|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892384|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
1892385|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892386|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892387|NCT00368875|Paclitaxel|paclitaxel|mesh-list
1892388|NCT00368875|Bevacizumab|bevacizumab|mesh-list
1892389|NCT00368875|Vorinostat|vorinostat|mesh-list
1892390|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1892391|NCT00368875|Antibodies|antibodies|mesh-list
1892392|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
1892393|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1892394|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1892395|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892396|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
1892397|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
1892398|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
1892399|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892400|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892401|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892402|NCT00368875|Growth Substances|growth substances|mesh-ancestor
1892403|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892404|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892405|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
1892406|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1892407|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892408|NCT00368927|Sulindac|sulindac|mesh-list
1892409|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1892410|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1892411|NCT00368927|Analgesics|analgesics|mesh-ancestor
1892412|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
1892413|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892414|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892415|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1892416|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892417|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892418|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1892419|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892420|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892421|NCT00368966|Vaccines|vaccines|mesh-list
1892422|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1892423|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
1892424|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892425|NCT00368979|Dutasteride|dutasteride|mesh-list
1892426|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1892427|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1892429|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892430|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
1892431|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892432|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892433|NCT00368992|Paclitaxel|paclitaxel|mesh-list
1892434|NCT00368992|Bevacizumab|bevacizumab|mesh-list
1892435|NCT00368992|Cetuximab|cetuximab|mesh-list
1892436|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1892437|NCT00368992|Antibodies|antibodies|mesh-list
1892438|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
1892439|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1892440|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1892441|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892442|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
1892443|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
1892444|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
1892445|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892446|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892447|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892448|NCT00368992|Growth Substances|growth substances|mesh-ancestor
1892449|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892450|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892451|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
1892452|NCT00369122|Bevacizumab|bevacizumab|mesh-list
1892453|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1892454|NCT00369122|Cisplatin|cisplatin|mesh-list
1892455|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
1892456|NCT00369122|Antibodies|antibodies|mesh-list
1892457|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
1892458|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1892459|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
1892460|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892461|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892462|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892463|NCT00369122|Growth Substances|growth substances|mesh-ancestor
1892464|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892465|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892466|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
1892467|NCT00369161|Everolimus|everolimus|mesh-list
1892468|NCT00369161|Tacrolimus|tacrolimus|mesh-list
1892469|NCT00369161|Basiliximab|basiliximab|mesh-list
1892470|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892471|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
1892472|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892473|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1892474|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892475|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892476|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892477|NCT00369226|Methotrexate|methotrexate|mesh-list
1892478|NCT00369226|Bortezomib|bortezomib|mesh-list
1892479|NCT00369226|Tacrolimus|tacrolimus|mesh-list
1892480|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1892481|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
1892482|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1892483|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892484|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892485|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
1892486|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892487|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892488|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
1892489|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892490|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1892491|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892492|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
1892493|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892494|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892495|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1892496|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
1892497|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892498|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892499|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1892500|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
1892501|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1892502|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892503|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892504|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892525|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1892526|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1892527|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1892528|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892529|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892530|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892531|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892532|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
1892533|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892534|NCT00369382|Cyclosporine|cyclosporine|mesh-list
1892535|NCT00369382|Sirolimus|sirolimus|mesh-list
1892536|NCT00369382|Tacrolimus|tacrolimus|mesh-list
1892537|NCT00369382|Cyclosporins|cyclosporins|mesh-list
1892538|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892539|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
1892540|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892541|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1892542|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892543|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892544|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
1892545|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892546|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
1892547|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892548|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1892549|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892550|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892551|NCT00369486|Triamcinolone|triamcinolone|mesh-list
1892552|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1892553|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1892554|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1892555|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1892556|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
1892557|NCT00369486|Hormones|hormones|mesh-ancestor
1892558|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892559|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892560|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892561|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
1892562|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892563|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892564|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1892565|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892566|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892567|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892568|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892569|NCT00369577|Loxapine|loxapine|mesh-list
1892570|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1892571|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1892572|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1892573|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892574|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892575|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1892576|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
1892577|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892578|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892579|NCT00369590|Aflibercept|aflibercept|mesh-list
1892580|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
1892581|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892582|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892583|NCT00369590|Growth Substances|growth substances|mesh-ancestor
1892584|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892585|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892586|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892587|NCT00369629|Gemcitabine|gemcitabine|mesh-list
1892588|NCT00369629|Pemetrexed|pemetrexed|mesh-list
1892589|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892590|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
1892591|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892592|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892593|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
1892594|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892595|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892596|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892597|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
1892598|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892599|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1892600|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892601|NCT00369655|Aflibercept|aflibercept|mesh-list
1892602|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
1892603|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892604|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892605|NCT00369655|Growth Substances|growth substances|mesh-ancestor
1892606|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892607|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892608|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892609|NCT00369681|Rituximab|rituximab|mesh-list
1892610|NCT00369681|Doxorubicin|doxorubicin|mesh-list
1892611|NCT00369681|Dacarbazine|dacarbazine|mesh-list
1892612|NCT00369681|Bleomycin|bleomycin|mesh-list
1892613|NCT00369681|Vinblastine|vinblastine|mesh-list
1892614|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892615|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892616|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
1892617|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892618|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892619|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892620|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1892621|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1892622|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892623|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892624|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1892625|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
1892626|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1892627|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
1892628|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
1892629|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
1892630|NCT00369707|Rituximab|rituximab|mesh-list
1892631|NCT00369707|Bortezomib|bortezomib|mesh-list
1892632|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892633|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892634|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
1892635|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892636|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892637|NCT00369746|Citalopram|citalopram|mesh-list
1892638|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1892639|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1892640|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892641|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892642|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892643|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
1892644|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892645|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1892646|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
1892647|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892648|NCT00369785|Donepezil|donepezil|mesh-list
1892649|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1892650|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892651|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892652|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
1892653|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892654|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892655|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
1892656|NCT00369915|Scopolamine|scopolamine|mesh-list
1892657|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1892658|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1892659|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
1892660|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
1892661|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892662|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892663|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1892664|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
1892665|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1892666|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
1892667|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892668|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892669|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1892670|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
1892671|NCT00369941|Tenofovir|tenofovir|mesh-list
1892672|NCT00369941|Emtricitabine|emtricitabine|mesh-list
1892673|NCT00369941|Efavirenz|efavirenz|mesh-list
1892674|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
1892675|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1892676|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
1892677|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892678|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1892679|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892680|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892681|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892682|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1892683|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1892684|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1892685|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1892686|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1892687|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1892688|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1892689|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1892690|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1892691|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1892692|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
1892693|NCT00369967|NuvaRing|nuvaring|mesh-list
1892694|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1892695|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892696|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1892697|NCT00370032|Alosetron|alosetron|mesh-list
1892698|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1892699|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1892700|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
1892701|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892702|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892703|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892704|NCT00370071|Interferons|interferons|mesh-list
1892705|NCT00370071|Interferon-beta|interferon-beta|mesh-list
1892706|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
1892707|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892708|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
1892709|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892710|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
1892711|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892712|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1892713|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1892714|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892715|NCT00370292|Pemetrexed|pemetrexed|mesh-list
1892716|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892717|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892718|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892719|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1892720|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892721|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1892722|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
1892723|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892724|NCT00370552|Paclitaxel|paclitaxel|mesh-list
1892725|NCT00370552|Epothilones|epothilones|mesh-list
1892726|NCT00370552|Bevacizumab|bevacizumab|mesh-list
1892727|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1892728|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892729|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
1892730|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
1892731|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
1892732|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892733|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892734|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892735|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892736|NCT00370552|Growth Substances|growth substances|mesh-ancestor
1892737|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892738|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892739|NCT00370682|Vaccines|vaccines|mesh-list
1892740|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
1892741|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892742|NCT00370838|Clonidine|clonidine|mesh-list
1892743|NCT00370838|Levetiracetam|levetiracetam|mesh-list
1892744|NCT00370838|Analgesics|analgesics|mesh-ancestor
1892745|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
1892746|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892747|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892748|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1892749|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
1892750|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
1892751|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1892752|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1892753|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1892754|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
1892755|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892756|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892757|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
1892758|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
1892759|NCT00371150|Entecavir|entecavir|mesh-list
1892760|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
1892761|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892762|NCT00371176|Cycloserine|cycloserine|mesh-list
1892763|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1892764|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892765|NCT00371176|Renal Agents|renal agents|mesh-ancestor
1892766|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1892767|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
1892768|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1892769|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
1892770|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892771|NCT00371254|Dasatinib|dasatinib|mesh-list
1892772|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892773|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892774|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892775|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892776|NCT00371345|Dasatinib|dasatinib|mesh-list
1892777|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892778|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892779|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892780|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892781|NCT00371566|Lapatinib|lapatinib|mesh-list
1892782|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892783|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892784|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892785|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892786|NCT00371683|Enoxaparin|enoxaparin|mesh-list
1892787|NCT00371683|Apixaban|apixaban|mesh-list
1892788|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
1892789|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1892790|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1892791|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892792|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1892793|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
1892794|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1892795|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
1892796|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892797|NCT00371761|Interferons|interferons|mesh-list
1892798|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
1892799|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
1892800|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1892801|NCT00371761|Adefovir|adefovir|mesh-list
1892802|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1892803|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892804|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
1892805|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892806|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
1892807|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892808|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1892809|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892810|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892811|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892812|NCT00371826|Cyclosporine|cyclosporine|mesh-list
1892813|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
1892814|NCT00371826|Prednisone|prednisone|mesh-list
1892815|NCT00371826|Everolimus|everolimus|mesh-list
1892816|NCT00371826|Cyclosporins|cyclosporins|mesh-list
1892817|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1892818|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1892819|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
1892820|NCT00371826|Hormones|hormones|mesh-ancestor
1892821|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892822|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892823|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1892824|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892825|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892826|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892827|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892828|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
1892829|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
1892830|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892831|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
1892832|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892833|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892834|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1892835|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
1892836|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1892837|NCT00372060|Pioglitazone|pioglitazone|mesh-list
1892838|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1892839|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1892840|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892841|NCT00372060|Incretins|incretins|mesh-ancestor
1892842|NCT00372060|Hormones|hormones|mesh-ancestor
1892843|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892844|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1892845|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
1892846|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892847|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892856|NCT00372385|Interferons|interferons|mesh-list
1892857|NCT00372385|Ribavirin|ribavirin|mesh-list
1892858|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
1892859|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
1892860|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1892861|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892862|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
1892863|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892864|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
1892865|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892866|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
1892867|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892868|NCT00372424|Docetaxel|docetaxel|mesh-list
1892869|NCT00372424|Trastuzumab|trastuzumab|mesh-list
1892870|NCT00372424|Sunitinib|sunitinib|mesh-list
1892871|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892872|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
1892873|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
1892874|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
1892875|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892876|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892877|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892878|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892879|NCT00372424|Growth Substances|growth substances|mesh-ancestor
1892880|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892881|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892882|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892883|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892884|NCT00372528|Pregabalin|pregabalin|mesh-list
1892885|NCT00372528|Analgesics|analgesics|mesh-ancestor
1892886|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
1892887|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892888|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892889|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
1892890|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1892891|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892892|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892893|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1892894|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1892895|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1892896|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1892897|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1892898|NCT00372567|Sunitinib|sunitinib|mesh-list
1892899|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
1892900|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892901|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892902|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892903|NCT00372567|Growth Substances|growth substances|mesh-ancestor
1892904|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892905|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892906|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892907|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892908|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892909|NCT00372593|Cytarabine|cytarabine|mesh-list
1892910|NCT00372593|Etoposide|etoposide|mesh-list
1892911|NCT00372593|Daunorubicin|daunorubicin|mesh-list
1892912|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
1892913|NCT00372593|Asparaginase|asparaginase|mesh-list
1892914|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
1892915|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1892916|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892917|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1892918|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1892919|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892920|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892921|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892922|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
1892923|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
1892924|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892925|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892926|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
1892927|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892928|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1892929|NCT00372593|Analgesics|analgesics|mesh-ancestor
1892930|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
1892931|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892932|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892933|NCT00372619|Cytarabine|cytarabine|mesh-list
1892934|NCT00372619|Methotrexate|methotrexate|mesh-list
1892935|NCT00372619|Clofarabine|clofarabine|mesh-list
1892936|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1892937|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
1892938|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1892939|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892940|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1892941|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
1892942|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892943|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892944|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
1892945|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892946|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1892947|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1892948|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
1892949|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892950|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1892951|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
1892952|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1892953|NCT00372697|Octreotide|octreotide|mesh-list
1892954|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1892955|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1892956|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892957|NCT00372775|Sunitinib|sunitinib|mesh-list
1892958|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892959|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1892960|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1892961|NCT00372775|Growth Substances|growth substances|mesh-ancestor
1892962|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892963|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
1892964|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1892965|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892966|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892967|NCT00372905|Rituximab|rituximab|mesh-list
1892968|NCT00372905|Bortezomib|bortezomib|mesh-list
1892969|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1892970|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1892971|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892972|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
1892973|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892974|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1892975|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
1892976|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1892977|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1892978|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1892979|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1892980|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892981|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
1892982|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1892983|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892984|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1892985|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1892986|NCT00372996|Fulvestrant|fulvestrant|mesh-list
1892987|NCT00372996|Exemestane|exemestane|mesh-list
1892988|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1892989|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1892990|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1892991|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1892992|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
1892993|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1892994|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1892995|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1892996|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1892997|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1892998|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1892999|NCT00373113|Capecitabine|capecitabine|mesh-list
1893000|NCT00373113|Sunitinib|sunitinib|mesh-list
1893001|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893002|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
1893003|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893004|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893005|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893006|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893007|NCT00373113|Growth Substances|growth substances|mesh-ancestor
1893008|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893009|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893010|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893011|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893012|NCT00373256|Paclitaxel|paclitaxel|mesh-list
1893013|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1893014|NCT00373256|Bevacizumab|bevacizumab|mesh-list
1893015|NCT00373256|Sunitinib|sunitinib|mesh-list
1893016|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1893017|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893018|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
1893019|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
1893020|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
1893021|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893022|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1893023|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893024|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893025|NCT00373256|Growth Substances|growth substances|mesh-ancestor
1893026|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893027|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893028|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893029|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893030|NCT00373295|Baclofen|baclofen|mesh-list
1893031|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1893032|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893033|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1893034|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893035|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1893036|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
1893037|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
1893038|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893039|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893040|NCT00373334|Nizatidine|nizatidine|mesh-list
1893041|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1893042|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1893043|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1893044|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
1893045|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
1893046|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893047|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893048|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893049|NCT00373360|Treprostinil|treprostinil|mesh-list
1893050|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1893051|NCT00373386|Hormones|hormones|mesh-list
1893052|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893053|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893054|NCT00373399|Dronabinol|dronabinol|mesh-list
1893055|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
1893056|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893057|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1893058|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893059|NCT00373399|Analgesics|analgesics|mesh-ancestor
1893060|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
1893061|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893062|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1893063|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1893064|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893065|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893066|NCT00373399|Hormones|hormones|mesh-ancestor
1893067|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893068|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1893069|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893070|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893071|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893072|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893073|NCT00373490|Vorinostat|vorinostat|mesh-list
1893074|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893075|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1893076|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893077|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893078|NCT00373529|Clofarabine|clofarabine|mesh-list
1893079|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893080|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
1893081|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893082|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893083|NCT00373685|Celecoxib|celecoxib|mesh-list
1893084|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1893085|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893086|NCT00373685|Analgesics|analgesics|mesh-ancestor
1893087|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
1893088|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893089|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893090|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893091|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893092|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1893093|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1893094|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893095|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893096|NCT00373880|Cocaine|cocaine|mesh-list
1893097|NCT00373880|Aripiprazole|aripiprazole|mesh-list
1893098|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
1893099|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1893100|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1893101|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1893102|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893103|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893104|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
1893105|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
1893106|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893107|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893108|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1893109|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1893110|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
1893111|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1893112|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1893113|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1893114|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1893115|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
1893116|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
1893117|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
1893118|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893119|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1893120|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1893121|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1893122|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893123|NCT00373958|Vaccines|vaccines|mesh-list
1893124|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1893125|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
1893126|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893127|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
1893128|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1893129|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
1893130|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893131|NCT00374088|Expectorants|expectorants|mesh-ancestor
1893132|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
1893133|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1893134|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
1893135|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893136|NCT00374088|Protective Agents|protective agents|mesh-ancestor
1893137|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893138|NCT00374088|Antidotes|antidotes|mesh-ancestor
1893139|NCT00374140|Everolimus|everolimus|mesh-list
1893140|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893141|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893142|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
1893143|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893144|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
1893145|NCT00374231|Prednisone|prednisone|mesh-list
1893146|NCT00374231|Tacrolimus|tacrolimus|mesh-list
1893147|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893148|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
1893149|NCT00374231|Hormones|hormones|mesh-ancestor
1893150|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893151|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893152|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1893153|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893154|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893155|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
1893156|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1893157|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893158|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893159|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893160|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1893161|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
1893162|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893163|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893164|NCT00374244|Pimozide|pimozide|mesh-list
1893165|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1893166|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1893167|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893168|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893169|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1893170|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1893171|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
1893172|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893173|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893174|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1893175|NCT00374322|Lapatinib|lapatinib|mesh-list
1893176|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893177|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893178|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893253|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893179|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893180|NCT00374556|Eszopiclone|eszopiclone|mesh-list
1893181|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1893182|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893183|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893184|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
1893185|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893186|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893187|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1893188|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
1893189|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893190|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893191|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893192|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893193|NCT00374868|Pemetrexed|pemetrexed|mesh-list
1893194|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893195|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893196|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893197|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1893198|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1893199|NCT00374907|Metformin|metformin|mesh-list
1893200|NCT00374907|Saxagliptin|saxagliptin|mesh-list
1893201|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1893202|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893203|NCT00374907|Incretins|incretins|mesh-ancestor
1893204|NCT00374907|Hormones|hormones|mesh-ancestor
1893205|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893206|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1893207|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
1893208|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893209|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893210|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
1893211|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1893212|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893213|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1893214|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893215|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893216|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
1893217|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1893218|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893219|NCT00375492|Exenatide|exenatide|mesh-list
1893220|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1893221|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893222|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1893223|NCT00375492|Incretins|incretins|mesh-ancestor
1893224|NCT00375492|Hormones|hormones|mesh-ancestor
1893225|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893226|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
1893227|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1893228|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893229|NCT00375518|Atorvastatin|atorvastatin|mesh-list
1893230|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1893231|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1893232|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
1893233|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893234|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1893235|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1893236|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893237|NCT00375609|Enoxaparin|enoxaparin|mesh-list
1893238|NCT00375609|Betrixaban|betrixaban|mesh-list
1893239|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
1893240|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1893241|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1893242|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893243|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1893244|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
1893245|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1893246|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
1893247|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893248|NCT00375674|Sunitinib|sunitinib|mesh-list
1893249|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893250|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893251|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893252|NCT00375674|Growth Substances|growth substances|mesh-ancestor
1893254|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893255|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893256|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893257|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893258|NCT00375713|Cetirizine|cetirizine|mesh-list
1893259|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
1893260|NCT00375713|Levocetirizine|levocetirizine|mesh-list
1893261|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893262|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1893263|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1893264|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1893265|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
1893266|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
1893267|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893268|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893269|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893270|NCT00375752|Letrozole|letrozole|mesh-list
1893271|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893272|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1893273|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1893274|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893275|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893276|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1893277|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
1893278|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893279|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893280|NCT00375830|Diphosphonates|diphosphonates|mesh-list
1893281|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
1893282|NCT00375830|Listerine|listerine|mesh-list
1893283|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
1893284|NCT00375830|Fluorides|fluorides|mesh-list
1893285|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
1893286|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1893287|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
1893288|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
1893289|NCT00375830|Protective Agents|protective agents|mesh-ancestor
1893290|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893291|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1893292|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893293|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1893294|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893295|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
1893296|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
1893297|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1893298|NCT00375934|Diclofenac|diclofenac|mesh-list
1893299|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1893300|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893301|NCT00375934|Analgesics|analgesics|mesh-ancestor
1893302|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
1893303|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893304|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893305|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893306|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893307|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1893308|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893309|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893310|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1893311|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1893312|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1893313|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893314|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893315|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893316|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893317|NCT00375973|Analgesics|analgesics|mesh-ancestor
1893318|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
1893319|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893320|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
1893321|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1893322|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
1893323|NCT00375999|Docetaxel|docetaxel|mesh-list
1893324|NCT00375999|Epirubicin|epirubicin|mesh-list
1893325|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893326|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
1893327|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
1893328|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
1893329|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893330|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893331|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1893332|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1893333|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893334|NCT00376220|Riluzole|riluzole|mesh-list
1893335|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
1893336|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1893337|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1893338|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893339|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893340|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893341|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1893342|NCT00376220|Protective Agents|protective agents|mesh-ancestor
1893343|NCT00376246|Ezetimibe|ezetimibe|mesh-list
1893344|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1893345|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1893346|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
1893347|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893348|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1893349|NCT00376259|Adefovir|adefovir|mesh-list
1893350|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1893351|NCT00376259|Telbivudine|telbivudine|mesh-list
1893352|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
1893353|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893354|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1893355|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1893356|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893357|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893358|NCT00376675|Methylphenidate|methylphenidate|mesh-list
1893359|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1893360|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893361|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1893362|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1893363|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893364|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893365|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
1893366|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893367|NCT00376688|Sirolimus|sirolimus|mesh-list
1893368|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893369|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893370|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893371|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893372|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
1893373|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893374|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
1893375|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893376|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
1893377|NCT00376805|Fludarabine|fludarabine|mesh-list
1893378|NCT00376805|Interleukin-2|interleukin-2|mesh-list
1893379|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893380|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
1893381|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893382|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893383|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893384|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
1893385|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893386|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893387|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1893388|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893389|NCT00376805|Analgesics|analgesics|mesh-ancestor
1893390|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
1893391|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893392|NCT00376948|Gemcitabine|gemcitabine|mesh-list
1893393|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1893394|NCT00376948|Genistein|genistein|mesh-list
1893395|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893396|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
1893397|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893398|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893399|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
1893400|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893401|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893402|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893403|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
1893404|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893405|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893406|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1893407|NCT00376948|Protective Agents|protective agents|mesh-ancestor
1893408|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
1893409|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1893410|NCT00376948|Estrogens|estrogens|mesh-ancestor
1893411|NCT00376948|Hormones|hormones|mesh-ancestor
1893412|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893413|NCT00376961|Prednisone|prednisone|mesh-list
1893414|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
1893415|NCT00376961|Rituximab|rituximab|mesh-list
1893416|NCT00376961|Doxorubicin|doxorubicin|mesh-list
1893417|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1893418|NCT00376961|Vincristine|vincristine|mesh-list
1893419|NCT00376961|Bortezomib|bortezomib|mesh-list
1893420|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893421|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
1893422|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893423|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893424|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893425|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
1893426|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893427|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893428|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1893429|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1893430|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893431|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1893432|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1893433|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893434|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893435|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
1893436|NCT00376961|Hormones|hormones|mesh-ancestor
1893437|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893438|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1893439|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1893440|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
1893441|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
1893442|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
1893443|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
1893444|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
1893445|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1893446|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893447|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893448|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1893449|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893450|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1893451|NCT00377260|Amoxicillin|amoxicillin|mesh-list
1893452|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
1893453|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
1893454|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1893455|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893456|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893457|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1893458|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893459|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893460|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1893461|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
1893462|NCT00377312|Hormones|hormones|mesh-list
1893463|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
1893464|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893465|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893466|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1893467|NCT00377364|Acetaminophen|acetaminophen|mesh-list
1893468|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893469|NCT00377364|Analgesics|analgesics|mesh-ancestor
1893470|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
1893471|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893472|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893473|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
1893474|NCT00377403|Acetaminophen|acetaminophen|mesh-list
1893475|NCT00377403|Amoxicillin|amoxicillin|mesh-list
1893476|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
1893477|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
1893478|NCT00377403|Ephedrine|ephedrine|mesh-list
1893479|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
1893480|NCT00377403|Guaifenesin|guaifenesin|mesh-list
1893481|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
1893482|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893483|NCT00377403|Analgesics|analgesics|mesh-ancestor
1893484|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
1893485|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893486|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893487|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
1893488|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893489|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893490|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
1893491|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
1893492|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1893493|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1893494|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893495|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893496|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1893497|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
1893498|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1893499|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
1893500|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1893501|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1893502|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
1893503|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
1893504|NCT00377403|Expectorants|expectorants|mesh-ancestor
1893505|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1893506|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1893507|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
1893508|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1893509|NCT00377429|Catumaxomab|catumaxomab|mesh-list
1893510|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1893511|NCT00377520|Pemetrexed|pemetrexed|mesh-list
1893512|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893513|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893514|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893515|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1893516|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1893517|NCT00377572|Omalizumab|omalizumab|mesh-list
1893518|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1893519|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1893520|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1893521|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
1893522|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
1893523|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893524|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
1893525|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
1893526|NCT00377637|Azathioprine|azathioprine|mesh-list
1893527|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893528|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
1893529|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893530|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893531|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893532|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
1893533|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893534|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893535|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1893536|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893537|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1893538|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
1893539|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893540|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893541|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893542|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
1893543|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893544|NCT00377676|Bromocriptine|bromocriptine|mesh-list
1893545|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1893546|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1893547|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
1893548|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893549|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893550|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
1893551|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
1893552|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893553|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893554|NCT00377741|Valganciclovir|valganciclovir|mesh-list
1893555|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
1893556|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893557|NCT00377819|Denosumab|denosumab|mesh-list
1893558|NCT00377819|Alendronate|alendronate|mesh-list
1893559|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1893560|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893561|NCT00377832|Acetaminophen|acetaminophen|mesh-list
1893562|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1893563|NCT00377832|Analgesics|analgesics|mesh-ancestor
1893564|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
1893565|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893566|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893567|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
1893568|NCT00377858|Insulin|insulin|mesh-list
1893569|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1893570|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
1893571|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
1893572|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1893573|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893574|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
1893575|NCT00377962|Everolimus|everolimus|mesh-list
1893576|NCT00377962|Azathioprine|azathioprine|mesh-list
1893577|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1893578|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893579|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893580|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
1893581|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893582|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893583|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893584|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
1893585|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893586|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893587|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893588|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1893589|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
1893590|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893591|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893592|NCT00378014|Everolimus|everolimus|mesh-list
1893593|NCT00378014|Basiliximab|basiliximab|mesh-list
1893594|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893595|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893596|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
1893597|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893598|NCT00378079|Methadone|methadone|mesh-list
1893599|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1893600|NCT00378079|Narcotics|narcotics|mesh-ancestor
1893601|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893602|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893603|NCT00378079|Analgesics|analgesics|mesh-ancestor
1893604|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
1893605|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893606|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
1893607|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
1893608|NCT00378105|Dexamethasone|dexamethasone|mesh-list
1893609|NCT00378105|Lenalidomide|lenalidomide|mesh-list
1893610|NCT00378105|Bortezomib|bortezomib|mesh-list
1893611|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893612|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
1893613|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
1893614|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893615|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893616|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1893617|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
1893618|NCT00378105|Hormones|hormones|mesh-ancestor
1893619|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893620|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1893621|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893622|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
1893623|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893624|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893625|NCT00378105|Growth Substances|growth substances|mesh-ancestor
1893626|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893627|NCT00378209|Dexamethasone|dexamethasone|mesh-list
1893628|NCT00378209|Lenalidomide|lenalidomide|mesh-list
1893629|NCT00378209|Bortezomib|bortezomib|mesh-list
1893630|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893631|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
1893632|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
1893633|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893634|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893635|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1893636|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
1893637|NCT00378209|Hormones|hormones|mesh-ancestor
1893638|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893639|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1893640|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893641|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
1893642|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893643|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893644|NCT00378209|Growth Substances|growth substances|mesh-ancestor
1893645|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893646|NCT00378326|Tacrolimus|tacrolimus|mesh-list
1893647|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893648|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
1893649|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893650|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1893651|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893652|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893653|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
1893654|NCT00378352|Hematinics|hematinics|mesh-ancestor
1893655|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
1893656|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893657|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
1893658|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1893659|NCT00378482|Tremelimumab|tremelimumab|mesh-list
1893660|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893661|NCT00378534|Cyclosporine|cyclosporine|mesh-list
1893662|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
1893663|NCT00378534|Fludarabine|fludarabine|mesh-list
1893664|NCT00378534|Cyclosporins|cyclosporins|mesh-list
1893665|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893666|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
1893667|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893668|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893669|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893670|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
1893671|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893672|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893673|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1893674|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893675|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
1893676|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893677|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
1893678|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1893679|NCT00378573|Gemcitabine|gemcitabine|mesh-list
1893680|NCT00378573|Bevacizumab|bevacizumab|mesh-list
1893681|NCT00378573|Docetaxel|docetaxel|mesh-list
1893682|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1893683|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893684|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893685|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893686|NCT00378573|Growth Substances|growth substances|mesh-ancestor
1893687|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893688|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893689|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893690|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
1893691|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893692|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
1893693|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893694|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893695|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893696|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
1893697|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
1893698|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
1893699|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
1893700|NCT00378599|Interferons|interferons|mesh-list
1893701|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
1893702|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
1893703|NCT00378599|Ribavirin|ribavirin|mesh-list
1893704|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1893705|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893706|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
1893707|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893708|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
1893709|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893710|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
1893711|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893712|NCT00378703|Sirolimus|sirolimus|mesh-list
1893713|NCT00378703|Bevacizumab|bevacizumab|mesh-list
1893714|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1893715|NCT00378703|Sorafenib|sorafenib|mesh-list
1893716|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
1893717|NCT00378703|Antibodies|antibodies|mesh-list
1893718|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
1893719|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1893720|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
1893721|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893722|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893723|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893724|NCT00378703|Growth Substances|growth substances|mesh-ancestor
1893725|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893726|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893727|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
1893728|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893729|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893730|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893731|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893732|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893733|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893734|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
1893735|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893736|NCT00379145|Trabectedin|trabectedin|mesh-list
1893737|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893738|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
1893739|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893740|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893741|NCT00379197|Naltrexone|naltrexone|mesh-list
1893742|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1893743|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1893744|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893745|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
1893746|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893747|NCT00379288|Fluticasone|fluticasone|mesh-list
1893748|NCT00379288|Xhance|xhance|mesh-list
1893749|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
1893750|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1893751|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1893752|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893753|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1893754|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
1893755|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893756|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893757|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1893758|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
1893759|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
1893760|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1893761|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1893762|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1893763|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1893764|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
1893765|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893766|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893767|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
1893768|NCT00379288|Hormones|hormones|mesh-ancestor
1893769|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893770|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
1893771|NCT00379340|Dactinomycin|dactinomycin|mesh-list
1893772|NCT00379340|Cactinomycin|cactinomycin|mesh-list
1893773|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
1893774|NCT00379340|Doxorubicin|doxorubicin|mesh-list
1893775|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1893776|NCT00379340|Etoposide|etoposide|mesh-list
1893777|NCT00379340|Vincristine|vincristine|mesh-list
1893778|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
1893779|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893780|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
1893781|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893782|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893783|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893784|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
1893860|NCT00379769|Metformin|metformin|mesh-list
1893785|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893786|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893787|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1893788|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893789|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1893790|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1893791|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893792|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1893793|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
1893794|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
1893795|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
1893796|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893797|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893798|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1893799|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1893800|NCT00379353|Thalidomide|thalidomide|mesh-list
1893801|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893802|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
1893803|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893804|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
1893805|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893806|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893807|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893808|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893809|NCT00379353|Growth Substances|growth substances|mesh-ancestor
1893810|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893811|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893812|NCT00379574|Prednisolone|prednisolone|mesh-list
1893813|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
1893814|NCT00379574|Doxorubicin|doxorubicin|mesh-list
1893815|NCT00379574|Vincristine|vincristine|mesh-list
1893816|NCT00379574|Bortezomib|bortezomib|mesh-list
1893817|NCT00379574|Lenograstim|lenograstim|mesh-list
1893818|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893819|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
1893820|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893821|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893822|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1893823|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
1893824|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893825|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893826|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1893827|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893828|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1893829|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1893830|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893831|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1893832|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
1893833|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
1893834|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
1893835|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1893836|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
1893837|NCT00379574|Hormones|hormones|mesh-ancestor
1893838|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893839|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1893840|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1893841|NCT00379587|Rituximab|rituximab|mesh-list
1893842|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1893843|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893844|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
1893845|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893846|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893847|NCT00379639|Gemcitabine|gemcitabine|mesh-list
1893848|NCT00379639|Romidepsin|romidepsin|mesh-list
1893849|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893850|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
1893851|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893852|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893853|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
1893854|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893855|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893856|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893857|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
1893858|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893859|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1893861|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
1893862|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1893863|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893864|NCT00379795|Ranibizumab|ranibizumab|mesh-list
1893865|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1893866|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1893867|NCT00379795|Growth Substances|growth substances|mesh-ancestor
1893868|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893869|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1893870|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893871|NCT00379808|Montelukast|montelukast|mesh-list
1893872|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1893873|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
1893874|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1893875|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
1893876|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893877|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893878|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1893879|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1893880|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893881|NCT00379821|Azithromycin|azithromycin|mesh-list
1893882|NCT00379821|Artesunate|artesunate|mesh-list
1893883|NCT00379821|Chloroquine|chloroquine|mesh-list
1893884|NCT00379821|Atovaquone|atovaquone|mesh-list
1893885|NCT00379821|Proguanil|proguanil|mesh-list
1893886|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
1893887|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1893888|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893889|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
1893890|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1893891|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1893892|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893893|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
1893894|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
1893895|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1893896|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
1893897|NCT00379821|Amebicides|amebicides|mesh-ancestor
1893898|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1893899|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893900|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893901|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
1893902|NCT00379834|Timolol|timolol|mesh-list
1893903|NCT00379834|Dorzolamide|dorzolamide|mesh-list
1893904|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1893905|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1893906|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
1893907|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893908|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893909|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893910|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1893911|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1893912|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1893913|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893914|NCT00379899|Vitamin D|vitamin d|mesh-list
1893915|NCT00379899|Cinacalcet|cinacalcet|mesh-list
1893916|NCT00379899|Vitamins|vitamins|mesh-ancestor
1893917|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
1893918|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893919|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1893920|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1893921|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1893922|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
1893923|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1893924|NCT00379912|Azacitidine|azacitidine|mesh-list
1893925|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
1893926|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893927|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
1893928|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893929|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893930|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893931|NCT00379912|Hematinics|hematinics|mesh-ancestor
1893932|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1893933|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893934|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1893935|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893936|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893937|NCT00380068|Ambrisentan|ambrisentan|mesh-list
1893938|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1893939|NCT00380081|Zolpidem|zolpidem|mesh-list
1893940|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1893941|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1893942|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893943|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893944|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1893945|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
1893946|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
1893947|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893948|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893949|NCT00380250|Lubiprostone|lubiprostone|mesh-list
1893950|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1893951|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893952|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893953|NCT00380393|Vaccines|vaccines|mesh-list
1893954|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
1893955|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893956|NCT00380588|Gemcitabine|gemcitabine|mesh-list
1893957|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893958|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1893959|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
1893960|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893961|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
1893962|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1893963|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893964|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1893965|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
1893966|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893967|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1893968|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1893969|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1893970|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893971|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893972|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
1893973|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1893974|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893975|NCT00380718|Pemetrexed|pemetrexed|mesh-list
1893976|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1893977|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1893978|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893979|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1893980|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1893981|NCT00380874|Pregabalin|pregabalin|mesh-list
1893982|NCT00380874|Analgesics|analgesics|mesh-ancestor
1893983|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
1893984|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1893985|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893986|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
1893987|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1893988|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1893989|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1893990|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1893991|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1893992|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1893993|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893994|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1893995|NCT00380978|Narcotics|narcotics|mesh-list
1893996|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1893997|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1893998|NCT00380978|Analgesics|analgesics|mesh-ancestor
1893999|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
1894000|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894001|NCT00381004|Vidarabine|vidarabine|mesh-list
1894002|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
1894003|NCT00381004|Rituximab|rituximab|mesh-list
1894004|NCT00381004|Fludarabine|fludarabine|mesh-list
1894005|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
1894006|NCT00381004|Sargramostim|sargramostim|mesh-list
1894007|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894008|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
1894009|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894010|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894011|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1894012|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
1894013|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894014|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894015|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1894016|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894017|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894018|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
1894019|NCT00381004|Antiviral Agents|antiviral agents|mesh-ancestor
1894020|NCT00381004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894021|NCT00381043|Acamprosate|acamprosate|mesh-list
1894022|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1894023|NCT00381095|Pregabalin|pregabalin|mesh-list
1894024|NCT00381095|Analgesics|analgesics|mesh-ancestor
1894025|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
1894026|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894027|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894028|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
1894029|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1894030|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1894031|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894032|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1894033|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1894034|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1894035|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894036|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894037|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
1894038|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1894039|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894040|NCT00381303|Ritonavir|ritonavir|mesh-list
1894041|NCT00381303|Darunavir|darunavir|mesh-list
1894042|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1894043|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1894044|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
1894045|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894046|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894047|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1894048|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1894049|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
1894050|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894051|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1894052|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1894061|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
1894062|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
1894063|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894064|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
1894065|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894066|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894067|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894068|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894069|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894070|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894071|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894072|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894073|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894074|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894075|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894076|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894077|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894078|NCT00381550|Fludarabine|fludarabine|mesh-list
1894079|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
1894080|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894081|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894082|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
1894083|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894084|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894085|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
1894086|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894087|NCT00381615|Vaccines|vaccines|mesh-list
1894088|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
1894089|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894090|NCT00381641|Sunitinib|sunitinib|mesh-list
1894091|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894092|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1894093|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1894094|NCT00381641|Growth Substances|growth substances|mesh-ancestor
1894095|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894096|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
1894097|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1894098|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894099|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894100|NCT00381680|Leucovorin|leucovorin|mesh-list
1894101|NCT00381680|Cytarabine|cytarabine|mesh-list
1894102|NCT00381680|Dexamethasone|dexamethasone|mesh-list
1894103|NCT00381680|Prednisone|prednisone|mesh-list
1894104|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
1894105|NCT00381680|Doxorubicin|doxorubicin|mesh-list
1894106|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1894107|NCT00381680|Methotrexate|methotrexate|mesh-list
1894108|NCT00381680|Etoposide|etoposide|mesh-list
1894109|NCT00381680|Vincristine|vincristine|mesh-list
1894110|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
1894111|NCT00381680|Asparaginase|asparaginase|mesh-list
1894112|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
1894113|NCT00381680|Pegaspargase|pegaspargase|mesh-list
1894114|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
1894115|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894116|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
1894117|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894118|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894119|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1894120|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
1894121|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894122|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894123|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1894124|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894125|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
1894126|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
1894127|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894128|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1894129|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
1894130|NCT00381680|Hormones|hormones|mesh-ancestor
1894131|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894132|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1894133|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1894134|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1894135|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1894136|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894137|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1894138|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
1894139|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1894140|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894141|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
1894142|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894143|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1894144|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1894145|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1894146|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
1894147|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894148|NCT00381680|Antidotes|antidotes|mesh-ancestor
1894149|NCT00381680|Protective Agents|protective agents|mesh-ancestor
1894150|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
1894151|NCT00381680|Vitamins|vitamins|mesh-ancestor
1894152|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
1894153|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
1894154|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
1894155|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
1894156|NCT00381693|Azacitidine|azacitidine|mesh-list
1894157|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894158|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
1894159|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894160|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894161|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894162|NCT00381706|Leucovorin|leucovorin|mesh-list
1894163|NCT00381706|Cisplatin|cisplatin|mesh-list
1894164|NCT00381706|Fluorouracil|fluorouracil|mesh-list
1894165|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
1894166|NCT00381706|Irinotecan|irinotecan|mesh-list
1894167|NCT00381706|Cetuximab|cetuximab|mesh-list
1894168|NCT00381706|Epirubicin|epirubicin|mesh-list
1894169|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894170|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
1894171|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894172|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894173|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894174|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
1894175|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894176|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1894177|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1894178|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894179|NCT00381706|Antidotes|antidotes|mesh-ancestor
1894180|NCT00381706|Protective Agents|protective agents|mesh-ancestor
1894181|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
1894182|NCT00381706|Vitamins|vitamins|mesh-ancestor
1894183|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
1894184|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894185|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1894186|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1894187|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
1894188|NCT00381797|Bevacizumab|bevacizumab|mesh-list
1894189|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1894190|NCT00381797|Irinotecan|irinotecan|mesh-list
1894191|NCT00381797|Camptothecin|camptothecin|mesh-list
1894192|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
1894193|NCT00381797|Antibodies|antibodies|mesh-list
1894194|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
1894195|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1894196|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
1894197|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1894198|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894199|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1894200|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1894201|NCT00381797|Growth Substances|growth substances|mesh-ancestor
1894202|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894203|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
1894204|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
1894205|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1894206|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1894207|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894208|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894209|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1894210|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1894211|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
1894212|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
1894213|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894214|NCT00381810|Acetaminophen|acetaminophen|mesh-list
1894215|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
1894216|NCT00381810|Promethazine|promethazine|mesh-list
1894217|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
1894218|NCT00381810|Rituximab|rituximab|mesh-list
1894219|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894220|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894221|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
1894222|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894223|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894224|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1894225|NCT00381810|Analgesics|analgesics|mesh-ancestor
1894226|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
1894227|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894228|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
1894229|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894230|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
1894231|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
1894232|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1894233|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
1894234|NCT00381810|Hormones|hormones|mesh-ancestor
1894235|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894236|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1894237|NCT00381810|Protective Agents|protective agents|mesh-ancestor
1894238|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1894239|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1894240|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894241|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
1894242|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
1894243|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1894244|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
1894245|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
1894246|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894247|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894248|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894249|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
1894250|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894251|NCT00381862|Leucovorin|leucovorin|mesh-list
1894252|NCT00381862|Dexamethasone|dexamethasone|mesh-list
1894253|NCT00381862|Fluorouracil|fluorouracil|mesh-list
1894254|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
1894255|NCT00381862|Irinotecan|irinotecan|mesh-list
1894256|NCT00381862|Camptothecin|camptothecin|mesh-list
1894257|NCT00381862|Aprepitant|aprepitant|mesh-list
1894258|NCT00381862|Palonosetron|palonosetron|mesh-list
1894259|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
1894260|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894261|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
1894262|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
1894263|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894264|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894265|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1894266|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
1894267|NCT00381862|Hormones|hormones|mesh-ancestor
1894268|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894269|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1894270|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894271|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
1894272|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894273|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894274|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894275|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
1894276|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1894277|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1894278|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894279|NCT00381862|Antidotes|antidotes|mesh-ancestor
1894280|NCT00381862|Protective Agents|protective agents|mesh-ancestor
1894281|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
1894282|NCT00381862|Vitamins|vitamins|mesh-ancestor
1894283|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
1894284|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1894285|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894286|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1894287|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1894288|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
1894289|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1894290|NCT00381888|PENTA|penta|mesh-list
1894291|NCT00381888|Fondaparinux|fondaparinux|mesh-list
1894292|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1894293|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
1894294|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1894295|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
1894296|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894297|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894298|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
1894299|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1894300|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1894301|NCT00381940|Bortezomib|bortezomib|mesh-list
1894302|NCT00381940|Vinorelbine|vinorelbine|mesh-list
1894303|NCT00381940|Ifosfamide|ifosfamide|mesh-list
1894304|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894305|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1894306|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
1894307|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
1894308|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
1894309|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894310|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1894311|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
1894312|NCT00382031|Zalutumumab|zalutumumab|mesh-list
1894313|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1894314|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894315|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894316|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
1894317|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894318|NCT00382070|Letrozole|letrozole|mesh-list
1894319|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894320|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1894321|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1894322|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894323|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894324|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1894325|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
1894326|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894327|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894328|NCT00382109|Sirolimus|sirolimus|mesh-list
1894329|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
1894330|NCT00382109|Thiotepa|thiotepa|mesh-list
1894331|NCT00382109|Methotrexate|methotrexate|mesh-list
1894332|NCT00382109|Tacrolimus|tacrolimus|mesh-list
1894333|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894334|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
1894335|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894336|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894337|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1894338|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
1894339|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894340|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894341|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1894342|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1894343|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
1894344|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1894345|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894346|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
1894347|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894348|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894349|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1894350|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1894351|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1894352|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1894353|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894354|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1894355|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
1894356|NCT00382148|Omalizumab|omalizumab|mesh-list
1894357|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894358|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894359|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894360|NCT00382265|Tamsulosin|tamsulosin|mesh-list
1894361|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1894362|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1894363|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1894364|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894365|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894366|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894367|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894368|NCT00382265|Urological Agents|urological agents|mesh-ancestor
1894369|NCT00382590|Cytarabine|cytarabine|mesh-list
1894370|NCT00382590|Azacitidine|azacitidine|mesh-list
1894371|NCT00382590|Valproic Acid|valproic acid|mesh-list
1894372|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894373|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
1894374|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894375|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894376|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
1894377|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894378|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894379|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
1894380|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894381|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894382|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
1894383|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
1894384|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894385|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
1894386|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1894387|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894388|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894389|NCT00382720|Docetaxel|docetaxel|mesh-list
1894390|NCT00382720|Capecitabine|capecitabine|mesh-list
1894391|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
1894392|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894393|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
1894394|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
1894395|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
1894396|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894397|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894398|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
1894399|NCT00382733|Topotecan|topotecan|mesh-list
1894400|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1894401|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1894402|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894403|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894404|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894405|NCT00382824|Ubiquinone|ubiquinone|mesh-list
1894406|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
1894407|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
1894408|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894409|NCT00382824|Vitamins|vitamins|mesh-ancestor
1894410|NCT00382993|Naproxen|naproxen|mesh-list
1894411|NCT00382993|Sumatriptan|sumatriptan|mesh-list
1894412|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1894413|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1894414|NCT00382993|Analgesics|analgesics|mesh-ancestor
1894415|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
1894416|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894417|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894418|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894419|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894420|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
1894421|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1894422|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894423|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894424|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1894425|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1894426|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1894427|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
1894428|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894429|NCT00383019|Latanoprost|latanoprost|mesh-list
1894430|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1894431|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1894432|NCT00383149|Cetuximab|cetuximab|mesh-list
1894433|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894434|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894435|NCT00383162|Naproxen|naproxen|mesh-list
1894436|NCT00383162|Sumatriptan|sumatriptan|mesh-list
1894437|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1894438|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1894439|NCT00383162|Analgesics|analgesics|mesh-ancestor
1894440|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
1894441|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894442|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894443|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894444|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894445|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
1894446|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1894447|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894448|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894449|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1894450|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1894451|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1894452|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
1894453|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894454|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
1894455|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
1894456|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894457|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
1894458|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894459|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894460|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894461|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894462|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894463|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894464|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894465|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894466|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894467|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894468|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894469|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894470|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894471|NCT00383266|Carboplatin|carboplatin|mesh-list
1894472|NCT00383266|Pemetrexed|pemetrexed|mesh-list
1894473|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894474|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894475|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894476|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1894477|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1894478|NCT00383331|Gemcitabine|gemcitabine|mesh-list
1894479|NCT00383331|Pemetrexed|pemetrexed|mesh-list
1894480|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894481|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
1894482|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894483|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894484|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
1894485|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894486|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894487|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894488|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
1894489|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894490|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1894491|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1894492|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
1894493|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
1894494|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894495|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
1894496|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894497|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894498|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894499|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894500|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894501|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894502|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894503|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894504|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894505|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894506|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894507|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894508|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894509|NCT00383448|Cyclosporine|cyclosporine|mesh-list
1894510|NCT00383448|Melphalan|melphalan|mesh-list
1894511|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
1894512|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
1894513|NCT00383448|Clofarabine|clofarabine|mesh-list
1894514|NCT00383448|Cyclosporins|cyclosporins|mesh-list
1894515|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894516|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894517|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894518|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
1894519|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894520|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
1894521|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894522|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894523|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894524|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1894525|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1894526|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
1894527|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894528|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1894529|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894530|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
1894531|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1894532|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894533|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
1894534|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
1894535|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
1894536|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894537|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
1894538|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894539|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894540|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894541|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894542|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894543|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894544|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894545|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894546|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894621|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894547|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894548|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894549|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894550|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894551|NCT00383565|Romidepsin|romidepsin|mesh-list
1894552|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1894553|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894554|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
1894555|NCT00383643|Zolpidem|zolpidem|mesh-list
1894556|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1894557|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1894558|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894559|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894560|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1894561|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
1894562|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
1894563|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894564|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894565|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1894566|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1894567|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
1894568|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
1894571|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
1894572|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
1894573|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894574|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
1894575|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894576|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894577|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894578|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894579|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894580|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894581|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894582|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894583|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894584|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894585|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894586|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894587|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894588|NCT00383747|Nicotine|nicotine|mesh-list
1894589|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1894590|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
1894591|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894592|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894593|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1894594|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1894595|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
1894596|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894597|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894598|NCT00383786|Vofopitant|vofopitant|mesh-list
1894599|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
1894600|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
1894601|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894602|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894603|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1894604|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1894605|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894606|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894607|NCT00383942|Misoprostol|misoprostol|mesh-list
1894608|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1894609|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
1894610|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1894611|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894612|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1894613|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1894614|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
1894615|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1894616|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1894617|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1894618|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1894619|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1894620|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894622|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894623|NCT00384033|Analgesics|analgesics|mesh-ancestor
1894624|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
1894625|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894626|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
1894627|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894628|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
1894629|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1894630|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
1894631|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894632|NCT00384085|Insulin|insulin|mesh-list
1894633|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1894634|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
1894635|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
1894636|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1894637|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894638|NCT00384176|Leucovorin|leucovorin|mesh-list
1894639|NCT00384176|Bevacizumab|bevacizumab|mesh-list
1894640|NCT00384176|Fluorouracil|fluorouracil|mesh-list
1894641|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
1894642|NCT00384176|Cediranib|cediranib|mesh-list
1894643|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1894644|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894645|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1894646|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1894647|NCT00384176|Growth Substances|growth substances|mesh-ancestor
1894648|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894649|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
1894650|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
1894651|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894652|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894653|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894654|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
1894655|NCT00384176|Antidotes|antidotes|mesh-ancestor
1894656|NCT00384176|Protective Agents|protective agents|mesh-ancestor
1894657|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
1894658|NCT00384176|Vitamins|vitamins|mesh-ancestor
1894659|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
1894660|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1894661|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894662|NCT00384189|Ciclesonide|ciclesonide|mesh-list
1894663|NCT00384189|Albuterol|albuterol|mesh-list
1894664|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894665|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
1894666|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894667|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894668|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894669|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894670|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
1894671|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1894672|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894673|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894674|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894675|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894676|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894677|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894678|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
1894679|NCT00384189|Hormones|hormones|mesh-ancestor
1894680|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894681|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1894682|NCT00384332|Olanzapine|olanzapine|mesh-list
1894683|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
1894684|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
1894685|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894686|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894687|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1894688|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1894689|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1894690|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894691|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894692|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1894693|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1894694|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1894695|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894696|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894697|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
1894698|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1894699|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
1894700|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894701|NCT00384449|Ranibizumab|ranibizumab|mesh-list
1894702|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1894703|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1894704|NCT00384449|Growth Substances|growth substances|mesh-ancestor
1894705|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894706|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
1894707|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894708|NCT00384670|Vaccines|vaccines|mesh-list
1894709|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
1894710|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894711|NCT00384774|Lasmiditan|lasmiditan|mesh-list
1894712|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1894713|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
1894714|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894715|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894716|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894717|NCT00384839|Azacitidine|azacitidine|mesh-list
1894718|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894719|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
1894720|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894721|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894722|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894723|NCT00384865|Aspirin|aspirin|mesh-list
1894724|NCT00384865|Simvastatin|simvastatin|mesh-list
1894725|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1894726|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1894727|NCT00384865|Analgesics|analgesics|mesh-ancestor
1894728|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
1894729|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894730|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894731|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894732|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894733|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1894734|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1894735|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894736|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1894737|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1894738|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894739|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
1894740|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1894741|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1894742|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
1894743|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1894744|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1894745|NCT00384930|Tadalafil|tadalafil|mesh-list
1894746|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
1894747|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1894748|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1894749|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894750|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894751|NCT00384930|Urological Agents|urological agents|mesh-ancestor
1894752|NCT00384956|Azacitidine|azacitidine|mesh-list
1894753|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894754|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
1894755|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894756|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894757|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894758|NCT00385008|Naproxen|naproxen|mesh-list
1894759|NCT00385008|Sumatriptan|sumatriptan|mesh-list
1894760|NCT00385008|Eletriptan|eletriptan|mesh-list
1894761|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1894762|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1894763|NCT00385008|Analgesics|analgesics|mesh-ancestor
1894764|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
1894765|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894766|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894767|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894768|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894769|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
1894770|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1894771|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894993|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
1894772|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894773|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1894774|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1894775|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1894776|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
1894777|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894778|NCT00385138|Clopidogrel|clopidogrel|mesh-list
1894779|NCT00385138|Cangrelor|cangrelor|mesh-list
1894780|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1894781|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1894782|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1894783|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1894784|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
1894785|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894786|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894787|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894788|NCT00385203|Cediranib|cediranib|mesh-list
1894789|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894790|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1894791|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894792|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894793|NCT00385216|Nicotine|nicotine|mesh-list
1894794|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1894795|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
1894796|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894797|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894798|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1894799|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1894800|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
1894801|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894802|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894803|NCT00385268|Acamprosate|acamprosate|mesh-list
1894804|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1894805|NCT00385515|Meclocycline|meclocycline|mesh-list
1894806|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1894807|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894808|NCT00385541|Morphine|morphine|mesh-list
1894809|NCT00385541|Hydromorphone|hydromorphone|mesh-list
1894810|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1894811|NCT00385541|Narcotics|narcotics|mesh-ancestor
1894812|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894813|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894814|NCT00385541|Analgesics|analgesics|mesh-ancestor
1894815|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
1894816|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894817|NCT00385580|Dasatinib|dasatinib|mesh-list
1894818|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894819|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1894820|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894821|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894822|NCT00385593|Budesonide|budesonide|mesh-list
1894823|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
1894824|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1894825|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894826|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1894827|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
1894828|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894829|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894830|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1894831|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894832|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
1894833|NCT00385593|Hormones|hormones|mesh-ancestor
1894834|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894835|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1894836|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1894837|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1894838|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
1894839|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894840|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894841|NCT00385671|Pregabalin|pregabalin|mesh-list
1894842|NCT00385671|Gabapentin|gabapentin|mesh-list
1894843|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1894844|NCT00385671|Analgesics|analgesics|mesh-ancestor
1894845|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
1894994|NCT00386152|Hematinics|hematinics|mesh-ancestor
1894846|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894847|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894848|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
1894849|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1894850|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1894851|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894852|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1894853|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1894854|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1894855|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894856|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894857|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1894858|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1894859|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894860|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
1894861|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1894862|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1894863|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
1894864|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
1894865|NCT00385684|Acetaminophen|acetaminophen|mesh-list
1894866|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1894867|NCT00385684|Hydrocodone|hydrocodone|mesh-list
1894868|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1894869|NCT00385684|Narcotics|narcotics|mesh-ancestor
1894870|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894871|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894872|NCT00385684|Analgesics|analgesics|mesh-ancestor
1894873|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
1894874|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894875|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
1894876|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
1894877|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1894878|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
1894879|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1894880|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894881|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894882|NCT00385736|Adalimumab|adalimumab|mesh-list
1894883|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894884|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894885|NCT00385762|Paroxetine|paroxetine|mesh-list
1894886|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1894887|NCT00385762|Serotonin|serotonin|mesh-list
1894888|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1894889|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1894890|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894891|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894892|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
1894893|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894894|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1894895|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
1894896|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894897|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1894898|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1894899|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894900|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1894901|NCT00385788|Gemcitabine|gemcitabine|mesh-list
1894902|NCT00385788|Vidarabine|vidarabine|mesh-list
1894903|NCT00385788|Methotrexate|methotrexate|mesh-list
1894904|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
1894905|NCT00385788|Fludarabine|fludarabine|mesh-list
1894906|NCT00385788|Melphalan|melphalan|mesh-list
1894907|NCT00385788|Tacrolimus|tacrolimus|mesh-list
1894908|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
1894909|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1894910|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1894911|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
1894912|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894913|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894914|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
1894915|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1894916|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894917|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1894918|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
1894919|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894995|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
1894920|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1894921|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
1894922|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1894923|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
1894924|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1894925|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1894926|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1894927|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1894928|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1894929|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
1894930|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1894931|NCT00385801|Risperidone|risperidone|mesh-list
1894932|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1894933|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
1894934|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894935|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894936|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894937|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1894938|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1894939|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894940|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1894941|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1894942|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
1894943|NCT00385827|Prednisone|prednisone|mesh-list
1894944|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
1894945|NCT00385827|Siltuximab|siltuximab|mesh-list
1894946|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1894947|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
1894948|NCT00385827|Hormones|hormones|mesh-ancestor
1894949|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894950|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894951|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1894952|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894953|NCT00385827|Analgesics|analgesics|mesh-ancestor
1894954|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
1894955|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1894956|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1894957|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1894958|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894959|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894960|NCT00385944|Clopidogrel|clopidogrel|mesh-list
1894961|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1894962|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1894963|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1894964|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1894965|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1894966|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
1894967|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1894968|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894969|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894970|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1894971|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1894972|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1894973|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894974|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894975|NCT00386009|Tadalafil|tadalafil|mesh-list
1894976|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
1894977|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1894978|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1894979|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1894980|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1894981|NCT00386009|Urological Agents|urological agents|mesh-ancestor
1894982|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1894983|NCT00386022|Estrogens|estrogens|mesh-list
1894984|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
1894985|NCT00386022|Hormones|hormones|mesh-ancestor
1894986|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1894987|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894988|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
1894989|NCT00386100|Metformin|metformin|mesh-list
1894990|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1894991|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1894992|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
1894996|NCT00386243|Analgesics|analgesics|mesh-list
1894997|NCT00386243|Narcotics|narcotics|mesh-ancestor
1894998|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1894999|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895000|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
1895001|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895002|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
1895003|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1895004|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1895005|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895006|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
1895007|NCT00386308|Coagulants|coagulants|mesh-ancestor
1895008|NCT00386334|Eszopiclone|eszopiclone|mesh-list
1895009|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1895010|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895011|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895012|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
1895013|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1895014|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1895015|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895016|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1895017|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895018|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1895019|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
1895020|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895021|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
1895022|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1895023|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895024|NCT00386607|Valsartan|valsartan|mesh-list
1895025|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1895026|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1895027|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1895028|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1895029|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895030|NCT00386607|Diuretics|diuretics|mesh-ancestor
1895031|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
1895032|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895033|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1895034|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1895035|NCT00387010|Fentanyl|fentanyl|mesh-list
1895036|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1895037|NCT00387010|Narcotics|narcotics|mesh-ancestor
1895038|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895039|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895040|NCT00387010|Analgesics|analgesics|mesh-ancestor
1895041|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
1895042|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895043|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1895044|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1895045|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
1895046|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
1895047|NCT00387023|Rituximab|rituximab|mesh-list
1895048|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895049|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895050|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
1895051|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895052|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895053|NCT00387036|Fluticasone|fluticasone|mesh-list
1895054|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1895055|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1895056|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
1895057|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895058|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895059|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1895060|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
1895061|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
1895062|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1895063|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
1895064|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1895065|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
1895066|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895067|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895068|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1895069|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
1895070|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
1895071|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1895072|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
1895073|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895074|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895075|NCT00387127|Lapatinib|lapatinib|mesh-list
1895076|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895077|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895078|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895079|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895080|NCT00387335|Sunitinib|sunitinib|mesh-list
1895081|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895082|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895083|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895084|NCT00387335|Growth Substances|growth substances|mesh-ancestor
1895085|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895086|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895087|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895088|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895089|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895090|NCT00387348|Dexetimide|dexetimide|mesh-list
1895091|NCT00387348|Citalopram|citalopram|mesh-list
1895092|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1895093|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1895094|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1895095|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895096|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895097|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
1895098|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895099|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1895100|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
1895101|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895102|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1895103|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1895104|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
1895105|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
1895106|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895107|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1895108|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1895109|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
1895110|NCT00387426|Sunitinib|sunitinib|mesh-list
1895111|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895112|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895113|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895114|NCT00387426|Growth Substances|growth substances|mesh-ancestor
1895115|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895116|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895117|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895118|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895119|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895120|NCT00387465|Azacitidine|azacitidine|mesh-list
1895121|NCT00387465|Entinostat|entinostat|mesh-list
1895122|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1895123|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895124|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
1895125|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895126|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895127|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895128|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1895129|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
1895130|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895131|NCT00387647|Azacitidine|azacitidine|mesh-list
1895132|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895133|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
1895134|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895135|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895136|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895137|NCT00387660|Carboplatin|carboplatin|mesh-list
1895138|NCT00387660|Irinotecan|irinotecan|mesh-list
1895139|NCT00387660|Camptothecin|camptothecin|mesh-list
1895140|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895141|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1895142|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1895143|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895144|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895145|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895146|NCT00387751|Bevacizumab|bevacizumab|mesh-list
1895147|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1895148|NCT00387751|Sorafenib|sorafenib|mesh-list
1895149|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
1895150|NCT00387751|Antibodies|antibodies|mesh-list
1895151|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
1895152|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1895153|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
1895154|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895155|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895156|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895157|NCT00387751|Growth Substances|growth substances|mesh-ancestor
1895158|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895159|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895160|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
1895161|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895162|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895163|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895164|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
1895165|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895166|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1895167|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
1895168|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1895169|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1895170|NCT00387829|Estradiol|estradiol|mesh-list
1895171|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1895172|NCT00387829|Estrogens|estrogens|mesh-ancestor
1895173|NCT00387829|Hormones|hormones|mesh-ancestor
1895174|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895175|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895176|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1895177|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
1895178|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1895179|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1895180|NCT00387881|Naproxen|naproxen|mesh-list
1895181|NCT00387881|Sumatriptan|sumatriptan|mesh-list
1895182|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1895183|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1895184|NCT00387881|Analgesics|analgesics|mesh-ancestor
1895185|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
1895186|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895187|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895188|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1895189|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895190|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
1895191|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1895192|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895193|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895194|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1895195|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1895196|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1895197|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
1895198|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895199|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1895200|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895201|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895202|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895203|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895204|NCT00387959|Cyclosporine|cyclosporine|mesh-list
1895205|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
1895206|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
1895207|NCT00387959|Rituximab|rituximab|mesh-list
1895208|NCT00387959|Fludarabine|fludarabine|mesh-list
1895209|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
1895210|NCT00387959|Cyclosporins|cyclosporins|mesh-list
1895211|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895212|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
1895213|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895214|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895215|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1895216|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
1895217|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895218|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895219|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1895220|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895221|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895222|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
1895223|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895224|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
1895225|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895226|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
1895227|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1895228|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1895229|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1895230|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
1895231|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1895232|NCT00388037|Sunitinib|sunitinib|mesh-list
1895233|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895234|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895235|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895236|NCT00388037|Growth Substances|growth substances|mesh-ancestor
1895237|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895238|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895239|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895240|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895241|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895242|NCT00388154|Gemcitabine|gemcitabine|mesh-list
1895243|NCT00388154|Cisplatin|cisplatin|mesh-list
1895244|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895245|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895246|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
1895247|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895248|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
1895249|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895250|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895251|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895252|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
1895253|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895254|NCT00388349|Gemcitabine|gemcitabine|mesh-list
1895255|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
1895256|NCT00388349|Carmustine|carmustine|mesh-list
1895257|NCT00388349|Etoposide|etoposide|mesh-list
1895258|NCT00388349|Vinorelbine|vinorelbine|mesh-list
1895259|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895260|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
1895261|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895262|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895263|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1895264|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
1895265|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895266|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895267|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1895268|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895269|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
1895270|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
1895271|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895272|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895273|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895274|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1895275|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1895276|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895277|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895278|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895279|NCT00388362|Sirolimus|sirolimus|mesh-list
1895280|NCT00388362|Prednisone|prednisone|mesh-list
1895281|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1895282|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
1895283|NCT00388362|Hormones|hormones|mesh-ancestor
1895284|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895285|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895286|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1895287|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895288|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1895289|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895290|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1895291|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
1895292|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895293|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
1895294|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1895295|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1895296|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1895297|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1895298|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895299|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895300|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895301|NCT00388414|Analgesics|analgesics|mesh-ancestor
1895302|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
1895303|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895304|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
1895305|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895306|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
1895307|NCT00388505|Tobramycin|tobramycin|mesh-list
1895308|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1895309|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895310|NCT00388583|Vaccines|vaccines|mesh-list
1895311|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
1895312|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895313|NCT00388674|Entecavir|entecavir|mesh-list
1895314|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
1895315|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895316|NCT00388804|Leuprolide|leuprolide|mesh-list
1895317|NCT00388804|Goserelin|goserelin|mesh-list
1895318|NCT00388804|Flutamide|flutamide|mesh-list
1895319|NCT00388804|Bicalutamide|bicalutamide|mesh-list
1895320|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1895321|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
1895322|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1895323|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895324|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1895325|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895326|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
1895327|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
1895328|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895329|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1895330|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
1895331|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895332|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1895333|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895334|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895335|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895336|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1895337|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
1895338|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895339|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1895340|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895341|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895342|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895343|NCT00389168|Atenolol|atenolol|mesh-list
1895344|NCT00389168|Irbesartan|irbesartan|mesh-list
1895345|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1895346|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1895347|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
1895348|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
1895349|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895350|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895351|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1895352|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1895353|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1895354|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
1895355|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895356|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895357|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1895358|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1895359|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1895360|NCT00389207|Nevirapine|nevirapine|mesh-list
1895361|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1895362|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1895363|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
1895364|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895365|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895366|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1895367|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1895368|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
1895369|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895370|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1895371|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1895372|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1895373|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1895374|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
1895375|NCT00389324|Antibodies|antibodies|mesh-list
1895376|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
1895377|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1895378|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1895379|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
1895380|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
1895381|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895382|NCT00389441|Axitinib|axitinib|mesh-list
1895383|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895384|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895385|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895386|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895387|NCT00389493|Risperidone|risperidone|mesh-list
1895388|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1895389|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
1895390|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895391|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895392|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895393|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1895394|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895395|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895396|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895397|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1895398|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
1895399|NCT00389519|Ramipril|ramipril|mesh-list
1895400|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1895401|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
1895402|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895403|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895404|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1895405|NCT00389532|Vaccines|vaccines|mesh-list
1895406|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
1895407|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895408|NCT00389805|Pemetrexed|pemetrexed|mesh-list
1895409|NCT00389805|Bortezomib|bortezomib|mesh-list
1895410|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895411|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895412|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895413|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1895414|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1895415|NCT00389818|Prednisone|prednisone|mesh-list
1895416|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
1895417|NCT00389818|Rituximab|rituximab|mesh-list
1895418|NCT00389818|Doxorubicin|doxorubicin|mesh-list
1895419|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1895420|NCT00389818|Vincristine|vincristine|mesh-list
1895421|NCT00389818|Sargramostim|sargramostim|mesh-list
1895422|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895423|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
1895424|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895425|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895426|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1895427|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
1895428|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895429|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895430|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1895431|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895432|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1895433|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1895434|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1895435|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895436|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1895437|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
1895438|NCT00389818|Hormones|hormones|mesh-ancestor
1895439|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895440|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1895441|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895442|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895443|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895444|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895445|NCT00389831|Rotigotine|rotigotine|mesh-list
1895446|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
1895447|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
1895448|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895449|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895450|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895451|NCT00389857|Vaccines|vaccines|mesh-list
1895452|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
1895453|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895454|NCT00389974|Sunitinib|sunitinib|mesh-list
1895455|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895456|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895457|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895458|NCT00389974|Growth Substances|growth substances|mesh-ancestor
1895459|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895460|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895461|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895462|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895463|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895464|NCT00390013|Gabapentin|gabapentin|mesh-list
1895465|NCT00390013|Analgesics|analgesics|mesh-ancestor
1895466|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
1895467|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895468|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895469|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
1895470|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1895471|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895472|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895473|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895474|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1895475|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1895476|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895477|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895478|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
1895479|NCT00390182|Gemcitabine|gemcitabine|mesh-list
1895480|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895481|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
1895482|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895483|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895484|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
1895485|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895486|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895487|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895488|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
1895489|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895490|NCT00390221|Daclizumab|daclizumab|mesh-list
1895491|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895492|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
1895493|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895494|NCT00390234|Aflibercept|aflibercept|mesh-list
1895495|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
1895496|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895497|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895498|NCT00390234|Growth Substances|growth substances|mesh-ancestor
1895499|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895500|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895501|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895502|NCT00390325|Sorafenib|sorafenib|mesh-list
1895503|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895504|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895505|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895506|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895507|NCT00390364|Everolimus|everolimus|mesh-list
1895508|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895509|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895510|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
1895511|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895512|NCT00390416|Leucovorin|leucovorin|mesh-list
1895513|NCT00390416|Bevacizumab|bevacizumab|mesh-list
1895514|NCT00390416|Docetaxel|docetaxel|mesh-list
1895515|NCT00390416|Fluorouracil|fluorouracil|mesh-list
1895516|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895517|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895518|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895519|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895520|NCT00390416|Growth Substances|growth substances|mesh-ancestor
1895521|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895522|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895523|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895524|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895525|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895526|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895527|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
1895528|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895529|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895530|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
1895531|NCT00390416|Antidotes|antidotes|mesh-ancestor
1895532|NCT00390416|Protective Agents|protective agents|mesh-ancestor
1895533|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
1895534|NCT00390416|Vitamins|vitamins|mesh-ancestor
1895535|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
1895536|NCT00390429|Docetaxel|docetaxel|mesh-list
1895537|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1895538|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895539|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895540|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895541|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895542|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895543|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895544|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895545|NCT00390455|Lapatinib|lapatinib|mesh-list
1895546|NCT00390455|Fulvestrant|fulvestrant|mesh-list
1895547|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895548|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895549|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895550|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895551|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1895552|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1895553|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1895554|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
1895555|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895556|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895557|NCT00390546|Propranolol|propranolol|mesh-list
1895558|NCT00390546|Digoxin|digoxin|mesh-list
1895559|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1895560|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1895561|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
1895562|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895563|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895564|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895565|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1895566|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1895567|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
1895568|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1895569|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895570|NCT00390546|Protective Agents|protective agents|mesh-ancestor
1895571|NCT00390559|Nicotine|nicotine|mesh-list
1895572|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1895573|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
1895574|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895575|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895576|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1895577|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1895578|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
1895579|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895580|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895581|NCT00390611|Paclitaxel|paclitaxel|mesh-list
1895582|NCT00390611|Carboplatin|carboplatin|mesh-list
1895583|NCT00390611|Sorafenib|sorafenib|mesh-list
1895584|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895585|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895586|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895587|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895588|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895589|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895590|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895591|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895592|NCT00390689|Pramipexole|pramipexole|mesh-list
1895593|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
1895594|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895595|NCT00390689|Protective Agents|protective agents|mesh-ancestor
1895596|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895597|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1895598|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1895599|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
1895600|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
1895601|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895602|NCT00390780|Clotrimazole|clotrimazole|mesh-list
1895603|NCT00390780|Miconazole|miconazole|mesh-list
1895604|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1895605|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895606|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
1895607|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1895608|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1895609|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895610|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895611|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1895612|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
1895613|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895614|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895615|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1895616|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1895617|NCT00390806|Topotecan|topotecan|mesh-list
1895618|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1895619|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1895620|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895621|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895622|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895623|NCT00390858|Deferasirox|deferasirox|mesh-list
1895624|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1895625|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
1895626|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
1895627|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895628|NCT00390884|Vaccines|vaccines|mesh-list
1895629|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
1895630|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895631|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1895632|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
1895633|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895634|NCT00391027|Insulin|insulin|mesh-list
1895635|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1895636|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
1895637|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1895638|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895639|NCT00391053|Vaccines|vaccines|mesh-list
1895640|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
1895641|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895642|NCT00391079|Nabiximols|nabiximols|mesh-list
1895643|NCT00391079|Analgesics|analgesics|mesh-ancestor
1895644|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
1895645|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895646|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895647|NCT00391092|Bevacizumab|bevacizumab|mesh-list
1895648|NCT00391092|Trastuzumab|trastuzumab|mesh-list
1895649|NCT00391092|Docetaxel|docetaxel|mesh-list
1895650|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895651|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895652|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895653|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895654|NCT00391092|Growth Substances|growth substances|mesh-ancestor
1895655|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895656|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895657|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895658|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895659|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895660|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895661|NCT00391118|Paclitaxel|paclitaxel|mesh-list
1895662|NCT00391118|Carboplatin|carboplatin|mesh-list
1895663|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895664|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895665|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895666|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895667|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895668|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895669|NCT00391222|Olanzapine|olanzapine|mesh-list
1895670|NCT00391222|Risperidone|risperidone|mesh-list
1895671|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1895672|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
1895673|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895674|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895675|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895676|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1895677|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895678|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895679|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895680|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1895681|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
1895682|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
1895683|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
1895684|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895685|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1895686|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1895687|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1895688|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1895689|NCT00391274|Docetaxel|docetaxel|mesh-list
1895690|NCT00391274|Pemetrexed|pemetrexed|mesh-list
1895691|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895692|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895693|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895694|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895695|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895696|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895697|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1895698|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1895699|NCT00391391|Vaccines|vaccines|mesh-list
1895700|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
1895701|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895702|NCT00391443|Bosentan|bosentan|mesh-list
1895703|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1895704|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1895705|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895706|NCT00391586|Gemcitabine|gemcitabine|mesh-list
1895707|NCT00391586|Paclitaxel|paclitaxel|mesh-list
1895708|NCT00391586|Etoposide|etoposide|mesh-list
1895709|NCT00391586|Vinorelbine|vinorelbine|mesh-list
1895710|NCT00391586|Docetaxel|docetaxel|mesh-list
1895711|NCT00391586|Irinotecan|irinotecan|mesh-list
1895712|NCT00391586|Pemetrexed|pemetrexed|mesh-list
1895713|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1895714|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895715|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895716|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895717|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895718|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895719|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895720|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1895721|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
1895722|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
1895723|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895724|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895725|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1895726|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
1895727|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895728|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1895729|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1895730|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1895731|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1895732|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1895733|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895734|NCT00391716|Gabapentin|gabapentin|mesh-list
1895735|NCT00391716|Analgesics|analgesics|mesh-ancestor
1895736|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
1895737|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895738|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895739|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
1895740|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1895741|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895742|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895743|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895744|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1895745|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1895746|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895747|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895748|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
1895749|NCT00391768|Oseltamivir|oseltamivir|mesh-list
1895750|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
1895751|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895752|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895753|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895754|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1895755|NCT00391807|Norethindrone|norethindrone|mesh-list
1895756|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
1895757|NCT00391807|Estradiol|estradiol|mesh-list
1895758|NCT00391807|Estrogens|estrogens|mesh-ancestor
1895759|NCT00391807|Hormones|hormones|mesh-ancestor
1895760|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895761|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895762|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1895763|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
1895764|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1895765|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1895766|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1895767|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1895768|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1895769|NCT00391846|Metoprolol|metoprolol|mesh-list
1895770|NCT00391846|Valsartan|valsartan|mesh-list
1895771|NCT00391846|Carvedilol|carvedilol|mesh-list
1895772|NCT00391846|Candesartan|candesartan|mesh-list
1895773|NCT00391846|Ramipril|ramipril|mesh-list
1895774|NCT00391846|Enalapril|enalapril|mesh-list
1895775|NCT00391846|Lisinopril|lisinopril|mesh-list
1895776|NCT00391846|Eplerenone|eplerenone|mesh-list
1895777|NCT00391846|Bisoprolol|bisoprolol|mesh-list
1895778|NCT00391846|Captopril|captopril|mesh-list
1895779|NCT00391846|Trandolapril|trandolapril|mesh-list
1895780|NCT00391846|Spironolactone|spironolactone|mesh-list
1895781|NCT00391846|Diuretics|diuretics|mesh-list
1895782|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1895783|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1895784|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1895785|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895786|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1895787|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
1895788|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
1895789|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895790|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895791|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1895792|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1895793|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1895794|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
1895795|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895796|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1895797|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
1895798|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895799|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1895800|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
1895801|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
1895802|NCT00391846|Protective Agents|protective agents|mesh-ancestor
1895803|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1895804|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1895805|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1895806|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
1895807|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1895808|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1895809|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1895810|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
1895811|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895812|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1895813|NCT00391872|Clopidogrel|clopidogrel|mesh-list
1895814|NCT00391872|Ticagrelor|ticagrelor|mesh-list
1895815|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1895816|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1895817|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1895818|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1895819|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
1895820|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895821|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895974|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
1895822|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895823|NCT00391898|Levodopa|levodopa|mesh-list
1895824|NCT00391898|Carbidopa|carbidopa|mesh-list
1895825|NCT00391898|Entacapone|entacapone|mesh-list
1895826|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1895827|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1895828|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
1895829|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895830|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895831|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895832|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1895833|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895834|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1895835|NCT00391976|Tobramycin|tobramycin|mesh-list
1895836|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1895837|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895838|NCT00391989|Dasatinib|dasatinib|mesh-list
1895839|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895840|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895841|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895842|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895843|NCT00392041|Eszopiclone|eszopiclone|mesh-list
1895844|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1895845|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895846|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895847|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1895848|NCT00392171|Temozolomide|temozolomide|mesh-list
1895849|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1895850|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
1895851|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895852|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895853|NCT00392197|Aripiprazole|aripiprazole|mesh-list
1895854|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
1895855|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1895856|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1895857|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1895858|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1895859|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895860|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
1895861|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
1895862|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895863|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895864|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1895865|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1895866|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
1895867|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1895868|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1895869|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1895870|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1895871|NCT00392223|Azithromycin|azithromycin|mesh-list
1895872|NCT00392223|Minocycline|minocycline|mesh-list
1895873|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1895874|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1895875|NCT00392288|Ciclesonide|ciclesonide|mesh-list
1895876|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
1895877|NCT00392288|Hormones|hormones|mesh-ancestor
1895878|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1895879|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895880|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1895907|NCT00392379|Nicotine|nicotine|mesh-list
1895908|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1895909|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
1895910|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895911|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895912|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1895913|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1895914|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
1895915|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1895916|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895917|NCT00392392|Paclitaxel|paclitaxel|mesh-list
1895918|NCT00392392|Bevacizumab|bevacizumab|mesh-list
1895919|NCT00392392|Trastuzumab|trastuzumab|mesh-list
1895920|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895921|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895922|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895923|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895924|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895925|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895926|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895927|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895928|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895929|NCT00392392|Growth Substances|growth substances|mesh-ancestor
1895930|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895931|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895932|NCT00392444|Sunitinib|sunitinib|mesh-list
1895933|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895934|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895935|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895936|NCT00392444|Growth Substances|growth substances|mesh-ancestor
1895937|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895938|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895939|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895940|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895941|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895942|NCT00392496|Sunitinib|sunitinib|mesh-list
1895943|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895944|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895945|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895946|NCT00392496|Growth Substances|growth substances|mesh-ancestor
1895947|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895948|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895949|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895950|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895951|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895952|NCT00392665|Sulindac|sulindac|mesh-list
1895953|NCT00392665|Bevacizumab|bevacizumab|mesh-list
1895954|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1895955|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895956|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895957|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895958|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895959|NCT00392665|Growth Substances|growth substances|mesh-ancestor
1895960|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895961|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
1895962|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1895963|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895964|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895965|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1895966|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1895967|NCT00392665|Analgesics|analgesics|mesh-ancestor
1895968|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
1895969|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895970|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1895971|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895972|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1895973|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1895975|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1895976|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1895977|NCT00392678|Analgesics|analgesics|mesh-ancestor
1895978|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
1895979|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1895980|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1895981|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1895982|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1895983|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1895984|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1895985|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895986|NCT00392704|Paclitaxel|paclitaxel|mesh-list
1895987|NCT00392704|Bevacizumab|bevacizumab|mesh-list
1895988|NCT00392704|Fluorouracil|fluorouracil|mesh-list
1895989|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1895990|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1895991|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1895992|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
1895993|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
1895994|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
1895995|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1895996|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1895997|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1895998|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1895999|NCT00392704|Growth Substances|growth substances|mesh-ancestor
1896000|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896001|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896002|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
1896003|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896004|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896005|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
1896006|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896007|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896008|NCT00392769|Cetuximab|cetuximab|mesh-list
1896009|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896010|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896011|NCT00392782|Fludarabine|fludarabine|mesh-list
1896012|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
1896013|NCT00392782|Thiotepa|thiotepa|mesh-list
1896014|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1896015|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896016|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896017|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
1896018|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896019|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896020|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
1896021|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896022|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1896023|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
1896024|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1896025|NCT00392821|Everolimus|everolimus|mesh-list
1896026|NCT00392821|Sorafenib|sorafenib|mesh-list
1896027|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896028|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896029|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
1896030|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896031|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896032|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896033|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896034|NCT00392834|Leucovorin|leucovorin|mesh-list
1896035|NCT00392834|Cytarabine|cytarabine|mesh-list
1896036|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
1896037|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1896038|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1896039|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1896040|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
1896041|NCT00392834|Ifosfamide|ifosfamide|mesh-list
1896042|NCT00392834|Rituximab|rituximab|mesh-list
1896043|NCT00392834|Doxorubicin|doxorubicin|mesh-list
1896044|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1896045|NCT00392834|Methotrexate|methotrexate|mesh-list
1896046|NCT00392834|Etoposide|etoposide|mesh-list
1896047|NCT00392834|Vincristine|vincristine|mesh-list
1896048|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
1896049|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896050|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
1896051|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896052|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896053|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1896054|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
1896055|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896056|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896057|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1896058|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896059|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1896060|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1896061|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896062|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896063|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1896064|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
1896065|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1896066|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896067|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
1896068|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896069|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1896070|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1896071|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1896072|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
1896073|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896074|NCT00392834|Antidotes|antidotes|mesh-ancestor
1896075|NCT00392834|Protective Agents|protective agents|mesh-ancestor
1896076|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
1896077|NCT00392834|Vitamins|vitamins|mesh-ancestor
1896078|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
1896079|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896080|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896081|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896082|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1896083|NCT00392925|Pramlintide|pramlintide|mesh-list
1896084|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
1896085|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896086|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896087|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
1896088|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1896089|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
1896090|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896091|NCT00392951|Sirolimus|sirolimus|mesh-list
1896092|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1896093|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896094|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1896095|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896096|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
1896097|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896098|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
1896099|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896100|NCT00392990|Cytarabine|cytarabine|mesh-list
1896101|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
1896102|NCT00392990|Ifosfamide|ifosfamide|mesh-list
1896103|NCT00392990|Rituximab|rituximab|mesh-list
1896104|NCT00392990|Doxorubicin|doxorubicin|mesh-list
1896105|NCT00392990|Methotrexate|methotrexate|mesh-list
1896106|NCT00392990|Etoposide|etoposide|mesh-list
1896107|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
1896108|NCT00392990|Vincristine|vincristine|mesh-list
1896109|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1896110|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
1896111|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896112|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
1896113|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896114|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896115|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1896116|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
1896117|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896118|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896119|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1896120|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896121|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1896122|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1896123|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896124|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896125|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1896126|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
1896127|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1896128|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896129|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
1896130|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896131|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1896132|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1896133|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1896134|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
1896135|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896136|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896137|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896138|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896139|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
1896140|NCT00393029|Aldesleukin|aldesleukin|mesh-list
1896141|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
1896142|NCT00393029|Fludarabine|fludarabine|mesh-list
1896143|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
1896144|NCT00393029|Interleukin-2|interleukin-2|mesh-list
1896145|NCT00393029|Lenograstim|lenograstim|mesh-list
1896146|NCT00393029|Sargramostim|sargramostim|mesh-list
1896147|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896148|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
1896149|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896150|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896151|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1896152|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
1896153|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896154|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896155|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1896156|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896157|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
1896158|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1896159|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1896160|NCT00393029|Analgesics|analgesics|mesh-ancestor
1896161|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
1896162|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896163|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896164|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896165|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
1896166|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896167|NCT00393042|Amphetamine|amphetamine|mesh-list
1896168|NCT00393042|Adderall|adderall|mesh-list
1896169|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1896170|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1896171|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896172|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
1896173|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
1896174|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896175|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
1896176|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896177|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896178|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896179|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1896180|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1896181|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1896182|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1896183|NCT00393068|Paclitaxel|paclitaxel|mesh-list
1896184|NCT00393068|Bevacizumab|bevacizumab|mesh-list
1896185|NCT00393068|Carboplatin|carboplatin|mesh-list
1896186|NCT00393068|Fluorouracil|fluorouracil|mesh-list
1896187|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1896188|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1896189|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896190|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896191|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896192|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896193|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896194|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896195|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896196|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896197|NCT00393068|Growth Substances|growth substances|mesh-ancestor
1896198|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896199|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896200|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
1896201|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896202|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896203|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
1896204|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896205|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896206|NCT00393094|Bevacizumab|bevacizumab|mesh-list
1896207|NCT00393094|Irinotecan|irinotecan|mesh-list
1896208|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896209|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896210|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896211|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896212|NCT00393094|Growth Substances|growth substances|mesh-ancestor
1896213|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896214|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896215|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1896216|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896217|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896218|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896219|NCT00393367|Prednisone|prednisone|mesh-list
1896220|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
1896221|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1896222|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1896223|NCT00393367|Prednisolone|prednisolone|mesh-list
1896224|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
1896225|NCT00393367|Budesonide|budesonide|mesh-list
1896226|NCT00393367|Bromides|bromides|mesh-list
1896227|NCT00393367|Albuterol|albuterol|mesh-list
1896228|NCT00393367|Ipratropium|ipratropium|mesh-list
1896229|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1896230|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
1896231|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1896232|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
1896233|NCT00393367|Hormones|hormones|mesh-ancestor
1896234|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896235|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896236|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1896237|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896238|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
1896239|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
1896240|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896241|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1896242|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1896243|NCT00393367|Protective Agents|protective agents|mesh-ancestor
1896244|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1896245|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1896246|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
1896247|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
1896248|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
1896249|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1896250|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1896251|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1896252|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1896253|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896254|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896255|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896256|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1896257|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
1896258|NCT00393380|Teriparatide|teriparatide|mesh-list
1896259|NCT00393380|Hormones|hormones|mesh-list
1896260|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
1896261|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896262|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896263|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1896264|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1896265|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
1896266|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1896267|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
1896268|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896269|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896270|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1896271|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
1896272|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1896273|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1896274|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1896275|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896276|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896277|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896278|NCT00393484|Lamivudine|lamivudine|mesh-list
1896279|NCT00393484|Entecavir|entecavir|mesh-list
1896280|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1896281|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1896282|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896283|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896284|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
1896285|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896286|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896287|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896288|NCT00393705|Insulin|insulin|mesh-list
1896289|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1896290|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
1896291|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896292|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896293|NCT00393718|Liraglutide|liraglutide|mesh-list
1896294|NCT00393718|Glyburide|glyburide|mesh-list
1896295|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896296|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896297|NCT00393718|Incretins|incretins|mesh-ancestor
1896298|NCT00393718|Hormones|hormones|mesh-ancestor
1896299|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896300|NCT00393796|Sunitinib|sunitinib|mesh-list
1896301|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896302|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896303|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896304|NCT00393796|Growth Substances|growth substances|mesh-ancestor
1896305|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896306|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896307|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896308|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896309|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896310|NCT00393848|Ketoconazole|ketoconazole|mesh-list
1896311|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
1896312|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896313|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1896314|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1896315|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896316|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896317|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1896318|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
1896319|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896320|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896321|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1896322|NCT00393861|Bevacizumab|bevacizumab|mesh-list
1896323|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
1896324|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896325|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896326|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896327|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896328|NCT00393861|Growth Substances|growth substances|mesh-ancestor
1896329|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896330|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896331|NCT00393874|Prazosin|prazosin|mesh-list
1896332|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1896333|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1896334|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1896335|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1896336|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896337|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896338|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896339|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896340|NCT00393939|Docetaxel|docetaxel|mesh-list
1896341|NCT00393939|Sunitinib|sunitinib|mesh-list
1896342|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896343|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896344|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896345|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896346|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896347|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896348|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896349|NCT00393939|Growth Substances|growth substances|mesh-ancestor
1896350|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896351|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896352|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896353|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896354|NCT00393978|Topiramate|topiramate|mesh-list
1896355|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1896356|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
1896357|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896358|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1896359|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896360|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896361|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896362|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
1896363|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896364|NCT00394082|Paclitaxel|paclitaxel|mesh-list
1896365|NCT00394082|Bevacizumab|bevacizumab|mesh-list
1896366|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1896367|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1896368|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896369|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896370|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896371|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896372|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896373|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896374|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896375|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896376|NCT00394082|Growth Substances|growth substances|mesh-ancestor
1896377|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896378|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896379|NCT00394095|Topiramate|topiramate|mesh-list
1896380|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
1896381|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896382|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896383|NCT00394251|Paclitaxel|paclitaxel|mesh-list
1896384|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
1896385|NCT00394251|Bevacizumab|bevacizumab|mesh-list
1896386|NCT00394251|Doxorubicin|doxorubicin|mesh-list
1896387|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1896388|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1896389|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1896390|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896391|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896392|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896393|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896394|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896395|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896396|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
1896397|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896398|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896399|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1896400|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
1896401|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1896402|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896403|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896404|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896405|NCT00394251|Growth Substances|growth substances|mesh-ancestor
1896406|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896407|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1896408|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1896409|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896410|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896411|NCT00394277|Ribavirin|ribavirin|mesh-list
1896412|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1896413|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
1896414|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
1896415|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896416|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
1896417|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896418|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
1896419|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896420|NCT00394329|Beclomethasone|beclomethasone|mesh-list
1896421|NCT00394329|Albuterol|albuterol|mesh-list
1896422|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1896423|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
1896424|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896425|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896426|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1896427|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
1896428|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
1896429|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1896430|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1896431|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1896432|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1896433|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896434|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896435|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896436|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1896437|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
1896438|NCT00394329|Hormones|hormones|mesh-ancestor
1896439|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896440|NCT00394355|Fluticasone|fluticasone|mesh-list
1896441|NCT00394355|Xhance|xhance|mesh-list
1896442|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
1896443|NCT00394355|Montelukast|montelukast|mesh-list
1896444|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1896445|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1896446|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
1896447|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896448|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896449|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1896450|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
1896451|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896452|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1896453|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1896454|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
1896455|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896456|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1896457|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1896458|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896459|NCT00394433|Bevacizumab|bevacizumab|mesh-list
1896460|NCT00394433|Cisplatin|cisplatin|mesh-list
1896461|NCT00394433|Docetaxel|docetaxel|mesh-list
1896462|NCT00394433|Irinotecan|irinotecan|mesh-list
1896463|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896464|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896465|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896466|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896467|NCT00394433|Growth Substances|growth substances|mesh-ancestor
1896468|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896469|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896470|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896471|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896472|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896473|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896474|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1896475|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896476|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896477|NCT00394472|Lesogaberan|lesogaberan|mesh-list
1896478|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1896479|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1896480|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
1896481|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
1896482|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896483|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896484|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896485|NCT00394524|Insulin|insulin|mesh-list
1896486|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896487|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896488|NCT00394589|Infliximab|infliximab|mesh-list
1896489|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896490|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1896491|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896492|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1896493|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1896494|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
1896495|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1896496|NCT00394771|Estradiol|estradiol|mesh-list
1896497|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1896498|NCT00394771|Estrogens|estrogens|mesh-ancestor
1896499|NCT00394771|Hormones|hormones|mesh-ancestor
1896500|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896501|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896502|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1896503|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
1896504|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1896505|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1896506|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1896507|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1896508|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1896509|NCT00394836|Ofatumumab|ofatumumab|mesh-list
1896510|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1896511|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896512|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
1896513|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896514|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
1896515|NCT00394901|Pregabalin|pregabalin|mesh-list
1896516|NCT00394901|Analgesics|analgesics|mesh-ancestor
1896517|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
1896518|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896519|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896520|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
1896521|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1896522|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1896523|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896524|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1896525|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1896526|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896527|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896528|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896529|NCT00394914|Pleconaril|pleconaril|mesh-list
1896530|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
1896531|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896532|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
1896533|NCT00394953|Hematinics|hematinics|mesh-ancestor
1896534|NCT00395018|Entecavir|entecavir|mesh-list
1896535|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
1896536|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896537|NCT00395044|Gabapentin|gabapentin|mesh-list
1896538|NCT00395044|Analgesics|analgesics|mesh-ancestor
1896539|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
1896540|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896541|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896542|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
1896543|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1896544|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896545|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896546|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896547|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1896548|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1896549|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896550|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896551|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
1896552|NCT00395057|Ranibizumab|ranibizumab|mesh-list
1896553|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896554|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896555|NCT00395057|Growth Substances|growth substances|mesh-ancestor
1896556|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896557|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896558|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896559|NCT00395161|Selenium|selenium|mesh-list
1896560|NCT00395161|Metoclopramide|metoclopramide|mesh-list
1896561|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
1896562|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896563|NCT00395161|Protective Agents|protective agents|mesh-ancestor
1896564|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896565|NCT00395161|Trace Elements|trace elements|mesh-ancestor
1896566|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
1896567|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
1896568|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
1896569|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896570|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1896571|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1896572|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1896573|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
1896574|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896575|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
1896576|NCT00395226|Astringents|astringents|mesh-ancestor
1896577|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896578|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896579|NCT00395304|Fluticasone|fluticasone|mesh-list
1896580|NCT00395304|Xhance|xhance|mesh-list
1896581|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1896582|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1896583|NCT00395304|Montelukast|montelukast|mesh-list
1896584|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1896585|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1896586|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
1896587|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896588|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896589|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1896590|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
1896591|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896592|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1896593|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1896594|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1896595|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1896596|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896597|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896598|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896599|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1896600|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
1896601|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896602|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1896603|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1896604|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
1896605|NCT00395304|Hormones|hormones|mesh-ancestor
1896606|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
1896607|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1896608|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896609|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896610|NCT00395343|Incretins|incretins|mesh-ancestor
1896611|NCT00395343|Hormones|hormones|mesh-ancestor
1896612|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896613|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1896614|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
1896615|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896616|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896617|NCT00395486|Atorvastatin|atorvastatin|mesh-list
1896618|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1896619|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1896620|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1896621|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
1896622|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896623|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1896624|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1896625|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896626|NCT00395512|Pioglitazone|pioglitazone|mesh-list
1896627|NCT00395512|Alogliptin|alogliptin|mesh-list
1896628|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896629|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896630|NCT00395512|Incretins|incretins|mesh-ancestor
1896631|NCT00395512|Hormones|hormones|mesh-ancestor
1896632|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896633|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1896634|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
1896635|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896636|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896637|NCT00395629|Deferasirox|deferasirox|mesh-list
1896638|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1896639|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
1896640|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
1896641|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896642|NCT00395694|Lamotrigine|lamotrigine|mesh-list
1896643|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
1896644|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1896645|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1896646|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896647|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1896648|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896649|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1896650|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896651|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896652|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896653|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1896654|NCT00395746|Liraglutide|liraglutide|mesh-list
1896655|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896656|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896657|NCT00395746|Incretins|incretins|mesh-ancestor
1896658|NCT00395746|Hormones|hormones|mesh-ancestor
1896659|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896660|NCT00395850|Disulfiram|disulfiram|mesh-list
1896661|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1896662|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1896663|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896664|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896665|NCT00395876|Tenecteplase|tenecteplase|mesh-list
1896666|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1896667|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1896668|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896669|NCT00395967|Plerixafor|plerixafor|mesh-list
1896670|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896671|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896672|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
1896673|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896674|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
1896675|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1896676|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896677|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896678|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1896679|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1896680|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1896681|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
1896682|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896683|NCT00396032|Tenecteplase|tenecteplase|mesh-list
1896684|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1896685|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1896686|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896687|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
1896688|NCT00396084|Levofloxacin|levofloxacin|mesh-list
1896689|NCT00396084|Ofloxacin|ofloxacin|mesh-list
1896690|NCT00396084|Isoniazid|isoniazid|mesh-list
1896691|NCT00396084|Linezolid|linezolid|mesh-list
1896692|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
1896693|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1896694|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896695|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1896696|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896697|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896698|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896699|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896700|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1896701|NCT00396084|Renal Agents|renal agents|mesh-ancestor
1896702|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1896703|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1896704|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
1896705|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1896706|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1896707|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
1896708|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1896709|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1896710|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1896711|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1896712|NCT00396201|Plerixafor|plerixafor|mesh-list
1896713|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896714|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896715|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
1896716|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896717|NCT00396253|Tenecteplase|tenecteplase|mesh-list
1896718|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1896719|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1896720|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896721|NCT00396266|Plerixafor|plerixafor|mesh-list
1896722|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896723|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896724|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
1896725|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896726|NCT00396279|Vitamin D|vitamin d|mesh-list
1896727|NCT00396279|Denosumab|denosumab|mesh-list
1896728|NCT00396279|Calcium|calcium|mesh-list
1896729|NCT00396279|Vitamins|vitamins|mesh-ancestor
1896730|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
1896731|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896732|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1896733|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1896734|NCT00396318|Tenecteplase|tenecteplase|mesh-list
1896735|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1896736|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1896737|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896738|NCT00396331|Plerixafor|plerixafor|mesh-list
1896739|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896740|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896741|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
1896742|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896743|NCT00396383|Plerixafor|plerixafor|mesh-list
1896744|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1896745|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1896746|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
1896747|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896748|NCT00396409|Omalizumab|omalizumab|mesh-list
1896749|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1896750|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1896751|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
1896752|NCT00396565|Olanzapine|olanzapine|mesh-list
1896753|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1896754|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
1896755|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
1896756|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896757|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896758|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1896759|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1896760|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896761|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896762|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896763|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1896764|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1896765|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1896766|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896767|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896768|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
1896769|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1896770|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1896771|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1896772|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1896773|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
1896774|NCT00396591|Aflibercept|aflibercept|mesh-list
1896775|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896776|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896777|NCT00396591|Growth Substances|growth substances|mesh-ancestor
1896778|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896779|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896780|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896781|NCT00396656|Atenolol|atenolol|mesh-list
1896782|NCT00396656|Valsartan|valsartan|mesh-list
1896783|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1896784|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1896785|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1896786|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1896787|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896788|NCT00396656|Diuretics|diuretics|mesh-ancestor
1896789|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
1896790|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896791|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1896792|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1896793|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1896794|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
1896795|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
1896796|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1896797|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1896798|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1896799|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1896800|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
1896801|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896802|NCT00396812|Rituximab|rituximab|mesh-list
1896803|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896804|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896805|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
1896806|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896807|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896808|NCT00396877|Clopidogrel|clopidogrel|mesh-list
1896809|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1897490|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896810|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1896811|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1896812|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1896813|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
1896814|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896815|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896816|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896817|NCT00397020|Valproic Acid|valproic acid|mesh-list
1896818|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1896819|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
1896820|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896821|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1896822|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896823|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896824|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896825|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
1896826|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896827|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896828|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
1896829|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896830|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
1896831|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1896832|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1896833|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1896834|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896835|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896836|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1896837|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1896838|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1896839|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
1896840|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896841|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896842|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1896843|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1896844|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
1896845|NCT00397189|Melatonin|melatonin|mesh-list
1896846|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
1896847|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896848|NCT00397189|Protective Agents|protective agents|mesh-ancestor
1896849|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896850|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1896851|NCT00397254|Rizatriptan|rizatriptan|mesh-list
1896852|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1896853|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
1896854|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1896855|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896856|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896857|NCT00397488|Sunitinib|sunitinib|mesh-list
1896858|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896859|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896860|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896861|NCT00397488|Growth Substances|growth substances|mesh-ancestor
1896862|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896863|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896864|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896865|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896866|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896867|NCT00397631|Pioglitazone|pioglitazone|mesh-list
1896868|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1896869|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1896870|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896871|NCT00397631|Incretins|incretins|mesh-ancestor
1896872|NCT00397631|Hormones|hormones|mesh-ancestor
1896873|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1896874|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1896875|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
1896876|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896877|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896878|NCT00397813|Cyclosporine|cyclosporine|mesh-list
1896879|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
1896880|NCT00397813|Fludarabine|fludarabine|mesh-list
1896881|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
1896882|NCT00397813|Cyclosporins|cyclosporins|mesh-list
1896883|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896884|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896885|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
1896886|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896887|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896888|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
1896889|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896890|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896891|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
1896892|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896893|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
1896894|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1896895|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1896896|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1896897|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1896898|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
1896899|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1896900|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
1896901|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1896902|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896903|NCT00397878|Saracatinib|saracatinib|mesh-list
1896904|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896905|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896906|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896907|NCT00397904|Irinotecan|irinotecan|mesh-list
1896908|NCT00397904|Cetuximab|cetuximab|mesh-list
1896909|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896910|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1896911|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1896912|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896913|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896914|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896915|NCT00397943|Vaccines|vaccines|mesh-list
1896916|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
1896917|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896918|NCT00397982|Sirolimus|sirolimus|mesh-list
1896919|NCT00397982|Bevacizumab|bevacizumab|mesh-list
1896920|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1896921|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
1896922|NCT00397982|Antibodies|antibodies|mesh-list
1896923|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
1896924|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1896925|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
1896926|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896927|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896928|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896929|NCT00397982|Growth Substances|growth substances|mesh-ancestor
1896930|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896931|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896932|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
1896933|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1896934|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896935|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1896936|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
1896937|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896938|NCT00398047|Mitogens|mitogens|mesh-list
1896939|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896940|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896941|NCT00398086|Gemcitabine|gemcitabine|mesh-list
1896942|NCT00398086|Paclitaxel|paclitaxel|mesh-list
1896943|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1896944|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1896945|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896946|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
1896947|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
1896948|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
1896949|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896950|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896951|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
1896952|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
1896953|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1896954|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896955|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1896956|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
1896957|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896958|NCT00398112|Sunitinib|sunitinib|mesh-list
1896959|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896960|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896961|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896962|NCT00398112|Growth Substances|growth substances|mesh-ancestor
1896963|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896964|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896965|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1896966|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896967|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896968|NCT00398138|Sargramostim|sargramostim|mesh-list
1896969|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
1896970|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
1896971|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896972|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1896973|NCT00398216|Edoxaban|edoxaban|mesh-list
1896974|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
1896975|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
1896976|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1896977|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
1896978|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1896979|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896980|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
1896981|NCT00398320|Bevacizumab|bevacizumab|mesh-list
1896982|NCT00398320|Capecitabine|capecitabine|mesh-list
1896983|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
1896984|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1896985|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1896986|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1896987|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1896988|NCT00398320|Growth Substances|growth substances|mesh-ancestor
1896989|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1896990|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
1896991|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896992|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
1896993|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1896994|NCT00398398|Capecitabine|capecitabine|mesh-list
1896995|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
1896996|NCT00398398|Cetuximab|cetuximab|mesh-list
1896997|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1896998|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
1896999|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897000|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897001|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897002|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
1897003|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897004|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897005|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1897006|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1897007|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897008|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897009|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897010|NCT00398476|Fluticasone|fluticasone|mesh-list
1897011|NCT00398476|Xhance|xhance|mesh-list
1897012|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897013|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1897014|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
1897015|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897016|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897017|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1897018|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
1897019|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
1897020|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1897021|NCT00398567|Trastuzumab|trastuzumab|mesh-list
1897022|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897023|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897024|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1897025|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1897026|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897027|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897028|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897029|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897030|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897031|NCT00398632|Analgesics|analgesics|mesh-ancestor
1897032|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
1897033|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897034|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
1897035|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897036|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
1897037|NCT00398866|Triamcinolone|triamcinolone|mesh-list
1897038|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1897039|NCT00398866|Bupivacaine|bupivacaine|mesh-list
1897040|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
1897041|NCT00398866|Hylan|hylan|mesh-list
1897042|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
1897043|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
1897044|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897045|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897046|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
1897047|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897048|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897049|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
1897050|NCT00398866|Hormones|hormones|mesh-ancestor
1897051|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1897052|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897053|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
1897054|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1897055|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
1897056|NCT00398866|Protective Agents|protective agents|mesh-ancestor
1897057|NCT00398918|Zonisamide|zonisamide|mesh-list
1897058|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
1897059|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1897060|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897061|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897062|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1897063|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897064|NCT00398983|Decitabine|decitabine|mesh-list
1897065|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897066|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
1897067|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897068|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897069|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897070|NCT00399035|Leucovorin|leucovorin|mesh-list
1897071|NCT00399035|Fluorouracil|fluorouracil|mesh-list
1897072|NCT00399035|Capecitabine|capecitabine|mesh-list
1897073|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
1897074|NCT00399035|Cediranib|cediranib|mesh-list
1897075|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
1897076|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
1897077|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897078|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897079|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897080|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897081|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
1897082|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897083|NCT00399035|Antidotes|antidotes|mesh-ancestor
1897084|NCT00399035|Protective Agents|protective agents|mesh-ancestor
1897085|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
1897086|NCT00399035|Vitamins|vitamins|mesh-ancestor
1897087|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
1897088|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1897089|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897090|NCT00399360|Metformin|metformin|mesh-list
1897091|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1897092|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897093|NCT00399490|Tanezumab|tanezumab|mesh-list
1897094|NCT00399490|Analgesics|analgesics|mesh-ancestor
1897095|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
1897096|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897097|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897098|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
1897099|NCT00399529|Trastuzumab|trastuzumab|mesh-list
1897100|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897101|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
1897102|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897103|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897104|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1897105|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
1897106|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897107|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897108|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1897109|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897110|NCT00399542|Lubiprostone|lubiprostone|mesh-list
1897111|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1897112|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897113|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897114|NCT00399568|Acetaminophen|acetaminophen|mesh-list
1897115|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1897116|NCT00399568|Analgesics|analgesics|mesh-ancestor
1897117|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
1897118|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897119|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897120|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
1897121|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1897122|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1897123|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897124|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897125|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897126|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
1897127|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897128|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897129|NCT00399893|Octreotide|octreotide|mesh-list
1897130|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897131|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1897132|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897133|NCT00400153|Ipratropium|ipratropium|mesh-list
1897134|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1897135|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
1897136|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897137|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897138|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1897139|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
1897140|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1897141|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
1897142|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897143|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897144|NCT00400179|Cisplatin|cisplatin|mesh-list
1897145|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897146|NCT00400205|Docetaxel|docetaxel|mesh-list
1897147|NCT00400205|Fluorouracil|fluorouracil|mesh-list
1897148|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897149|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
1897150|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
1897151|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
1897152|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897153|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
1897154|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897155|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897156|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
1897157|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897158|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
1897159|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1897160|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897161|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1897162|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
1897163|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897164|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897165|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897166|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897167|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
1897168|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1897169|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1897170|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
1897171|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897172|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1897173|NCT00400517|Thalidomide|thalidomide|mesh-list
1897174|NCT00400517|Sargramostim|sargramostim|mesh-list
1897175|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897176|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
1897177|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897178|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
1897179|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897180|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897181|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1897182|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1897183|NCT00400517|Growth Substances|growth substances|mesh-ancestor
1897184|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
1897185|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897186|NCT00400569|Sunitinib|sunitinib|mesh-list
1897187|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897188|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1897189|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1897190|NCT00400569|Growth Substances|growth substances|mesh-ancestor
1897191|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897192|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
1897193|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1897194|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897195|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897196|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
1897197|NCT00400686|Hematinics|hematinics|mesh-ancestor
1897198|NCT00400764|Rituximab|rituximab|mesh-list
1897199|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897200|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897201|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
1897202|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897203|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897204|NCT00400803|Gemcitabine|gemcitabine|mesh-list
1897205|NCT00400803|Bevacizumab|bevacizumab|mesh-list
1897206|NCT00400803|Carboplatin|carboplatin|mesh-list
1897207|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897208|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897209|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1897210|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1897211|NCT00400803|Growth Substances|growth substances|mesh-ancestor
1897212|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897213|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
1897214|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897215|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
1897216|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897217|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
1897218|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897219|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897220|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897221|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
1897222|NCT00400946|Leucovorin|leucovorin|mesh-list
1897223|NCT00400946|Cytarabine|cytarabine|mesh-list
1897224|NCT00400946|Dexamethasone|dexamethasone|mesh-list
1897225|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
1897226|NCT00400946|Prednisolone|prednisolone|mesh-list
1897227|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
1897228|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1897229|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1897230|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1897231|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
1897232|NCT00400946|Doxorubicin|doxorubicin|mesh-list
1897233|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1897234|NCT00400946|Methotrexate|methotrexate|mesh-list
1897235|NCT00400946|Etoposide|etoposide|mesh-list
1897236|NCT00400946|Vincristine|vincristine|mesh-list
1897237|NCT00400946|Asparaginase|asparaginase|mesh-list
1897238|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
1897239|NCT00400946|Pegaspargase|pegaspargase|mesh-list
1897240|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
1897241|NCT00400946|Razoxane|razoxane|mesh-list
1897242|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
1897243|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897244|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
1897245|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897246|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897247|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1897248|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
1897249|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897250|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897251|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1897252|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897253|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
1897254|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
1897255|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897256|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897257|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
1897258|NCT00400946|Hormones|hormones|mesh-ancestor
1897259|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1897260|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1897261|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1897262|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1897263|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1897264|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897265|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1897266|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
1897267|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1897268|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897269|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
1897270|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
1897271|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1897272|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1897273|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1897274|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
1897275|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897276|NCT00400946|Antidotes|antidotes|mesh-ancestor
1897277|NCT00400946|Protective Agents|protective agents|mesh-ancestor
1897278|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
1897279|NCT00400946|Vitamins|vitamins|mesh-ancestor
1897280|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
1897281|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
1897282|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
1897283|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
1897284|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1897285|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1897286|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
1897287|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1897288|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1897289|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897290|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
1897291|NCT00401193|Coagulants|coagulants|mesh-ancestor
1897292|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1897293|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1897294|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897295|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897296|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897297|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897298|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897299|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
1897300|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897301|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1897302|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1897303|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897304|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897305|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897306|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897307|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897308|NCT00401258|Analgesics|analgesics|mesh-ancestor
1897309|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
1897310|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897311|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
1897312|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897313|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
1897314|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
1897315|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1897316|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897317|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
1897318|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897319|NCT00401401|Zalutumumab|zalutumumab|mesh-list
1897320|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897321|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897322|NCT00401414|Warfarin|warfarin|mesh-list
1897323|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
1897324|NCT00401531|Vaccines|vaccines|mesh-list
1897325|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1897326|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
1897327|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897328|NCT00401544|Dextrans|dextrans|mesh-list
1897329|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
1897330|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
1897331|NCT00401544|Hematinics|hematinics|mesh-ancestor
1897332|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
1897333|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
1897334|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
1897335|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1897336|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1897337|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897338|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897339|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897340|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897341|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897342|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1897343|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
1897344|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897345|NCT00401752|Esomeprazole|esomeprazole|mesh-list
1897346|NCT00401752|Ranitidine|ranitidine|mesh-list
1897347|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1897348|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1897349|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897350|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1897351|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897352|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897353|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1897354|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
1897355|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
1897356|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897357|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897358|NCT00401778|Everolimus|everolimus|mesh-list
1897359|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897360|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897361|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
1897362|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897363|NCT00401817|Bevacizumab|bevacizumab|mesh-list
1897364|NCT00401817|Rituximab|rituximab|mesh-list
1897365|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897366|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897367|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1897368|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1897369|NCT00401817|Growth Substances|growth substances|mesh-ancestor
1897370|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897371|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
1897372|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
1897373|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897374|NCT00401830|Lacosamide|lacosamide|mesh-list
1897375|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
1897376|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1897377|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1897378|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897379|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897380|NCT00401843|Dexamethasone|dexamethasone|mesh-list
1897381|NCT00401843|Bortezomib|bortezomib|mesh-list
1897382|NCT00401843|Siltuximab|siltuximab|mesh-list
1897383|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897384|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
1897385|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
1897386|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897387|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897388|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897389|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
1897390|NCT00401843|Hormones|hormones|mesh-ancestor
1897391|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1897392|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1897393|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897394|NCT00401882|Metoprolol|metoprolol|mesh-list
1897395|NCT00401882|Epinephrine|epinephrine|mesh-list
1897396|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1897397|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1897398|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
1897399|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897400|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897401|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897402|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1897403|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1897404|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
1897405|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897406|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1897407|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
1897408|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
1897409|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
1897410|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1897411|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1897412|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1897413|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
1897491|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897414|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1897415|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1897416|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1897417|NCT00401960|Daptomycin|daptomycin|mesh-list
1897418|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897419|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897420|NCT00401973|Metformin|metformin|mesh-list
1897421|NCT00401973|Amantadine|amantadine|mesh-list
1897422|NCT00401973|Zonisamide|zonisamide|mesh-list
1897423|NCT00401973|Olanzapine|olanzapine|mesh-list
1897424|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1897425|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897426|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
1897427|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
1897428|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897429|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897430|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1897431|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1897432|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897433|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897434|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1897435|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897436|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897437|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897438|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897439|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
1897440|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1897441|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1897442|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
1897443|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897444|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
1897445|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1897446|NCT00401973|Analgesics|analgesics|mesh-ancestor
1897447|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
1897448|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
1897449|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1897450|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1897451|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1897452|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897453|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897454|NCT00402051|Carboplatin|carboplatin|mesh-list
1897455|NCT00402051|Pemetrexed|pemetrexed|mesh-list
1897456|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897457|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897458|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897459|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1897460|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1897461|NCT00402103|Amlodipine|amlodipine|mesh-list
1897462|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1897463|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1897464|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1897465|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897466|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897467|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1897468|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897469|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
1897470|NCT00402103|Diuretics|diuretics|mesh-ancestor
1897471|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
1897472|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1897473|NCT00402116|Temozolomide|temozolomide|mesh-list
1897474|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1897475|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
1897476|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897477|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897478|NCT00402168|Cyclosporine|cyclosporine|mesh-list
1897479|NCT00402168|Abatacept|abatacept|mesh-list
1897480|NCT00402168|Tacrolimus|tacrolimus|mesh-list
1897481|NCT00402168|Cyclosporins|cyclosporins|mesh-list
1897482|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897483|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
1897484|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897485|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1897486|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897487|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897488|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
1897489|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897492|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1897493|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897494|NCT00402194|Losartan|losartan|mesh-list
1897495|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1897496|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1897497|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1897498|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1897499|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897500|NCT00402233|Pramipexole|pramipexole|mesh-list
1897501|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
1897502|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897503|NCT00402233|Protective Agents|protective agents|mesh-ancestor
1897504|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897505|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1897506|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1897507|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
1897508|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
1897509|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897510|NCT00402285|Lycopene|lycopene|mesh-list
1897511|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897512|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
1897513|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897514|NCT00402285|Protective Agents|protective agents|mesh-ancestor
1897515|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897516|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1897517|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1897518|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897519|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
1897520|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
1897521|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897522|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897523|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
1897524|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897525|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897526|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1897527|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897528|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897529|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
1897530|NCT00402324|Valproic Acid|valproic acid|mesh-list
1897531|NCT00402324|Olanzapine|olanzapine|mesh-list
1897532|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
1897533|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
1897534|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897535|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897536|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897537|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1897538|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1897539|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897540|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897541|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1897542|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897543|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897544|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897545|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897546|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
1897547|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
1897548|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897549|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
1897550|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
1897551|NCT00402337|Linaclotide|linaclotide|mesh-list
1897552|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1897553|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
1897554|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897555|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897556|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
1897557|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1897558|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
1897559|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1897560|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
1897561|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897562|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897563|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
1897564|NCT00402688|Levofloxacin|levofloxacin|mesh-list
1897565|NCT00402688|Ofloxacin|ofloxacin|mesh-list
1897566|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1897567|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897568|NCT00402688|Renal Agents|renal agents|mesh-ancestor
1897569|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897570|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1897571|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1897572|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897573|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897574|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897575|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1897576|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1897577|NCT00402714|Pentostatin|pentostatin|mesh-list
1897578|NCT00402714|Methoxsalen|methoxsalen|mesh-list
1897579|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897580|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1897581|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897582|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897583|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1897584|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
1897585|NCT00402727|Amoxicillin|amoxicillin|mesh-list
1897586|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
1897587|NCT00402727|Tazobactam|tazobactam|mesh-list
1897588|NCT00402727|Piperacillin|piperacillin|mesh-list
1897589|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
1897590|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
1897591|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1897592|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1897593|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897594|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897595|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1897596|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1897597|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897598|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897599|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897600|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1897601|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
1897602|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1897603|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897604|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1897605|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1897606|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1897607|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1897608|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1897609|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897610|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1897611|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897612|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897613|NCT00402896|Mitogens|mitogens|mesh-list
1897614|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
1897615|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
1897616|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897617|NCT00402896|Growth Substances|growth substances|mesh-ancestor
1897618|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897619|NCT00402987|Celecoxib|celecoxib|mesh-list
1897620|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1897621|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1897622|NCT00402987|Analgesics|analgesics|mesh-ancestor
1897623|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
1897624|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897625|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897626|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897627|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897628|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1897629|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1897630|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897631|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897632|NCT00403117|Naltrexone|naltrexone|mesh-list
1897633|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1897634|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1897635|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897636|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
1897637|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897638|NCT00403130|Gemcitabine|gemcitabine|mesh-list
1897639|NCT00403130|Paclitaxel|paclitaxel|mesh-list
1897640|NCT00403130|Bevacizumab|bevacizumab|mesh-list
1897641|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1897642|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897643|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
1897644|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
1897645|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
1897646|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897647|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897648|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1897649|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1897650|NCT00403130|Growth Substances|growth substances|mesh-ancestor
1897651|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897652|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
1897653|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897654|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
1897655|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
1897656|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897657|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897658|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897659|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
1897660|NCT00403234|Buprenorphine|buprenorphine|mesh-list
1897661|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1897662|NCT00403234|Narcotics|narcotics|mesh-ancestor
1897663|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897664|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897665|NCT00403234|Analgesics|analgesics|mesh-ancestor
1897666|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
1897667|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897668|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1897669|NCT00403260|Artesunate|artesunate|mesh-list
1897670|NCT00403260|Mefloquine|mefloquine|mesh-list
1897671|NCT00403260|Pyronaridine|pyronaridine|mesh-list
1897672|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
1897673|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1897674|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1897675|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897676|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897677|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
1897678|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
1897679|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1897680|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
1897681|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
1897682|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1897683|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1897684|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1897685|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897686|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897687|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
1897688|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897689|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897690|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1897691|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897692|NCT00403403|Bevacizumab|bevacizumab|mesh-list
1897693|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897694|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897695|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1897696|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1897697|NCT00403403|Growth Substances|growth substances|mesh-ancestor
1897698|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897699|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
1897700|NCT00403455|Paroxetine|paroxetine|mesh-list
1897701|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1897702|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897703|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897704|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897705|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897706|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
1897707|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897708|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1897709|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
1897710|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897711|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1897712|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1897713|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897714|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1897715|NCT00403481|Olmesartan|olmesartan|mesh-list
1897716|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1897717|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1897718|NCT00403481|Diuretics|diuretics|mesh-ancestor
1897719|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
1897720|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897721|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1897722|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897723|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897724|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1897725|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1897726|NCT00403494|Verapamil|verapamil|mesh-list
1897727|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1897728|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1897729|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897730|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897731|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1897732|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897733|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
1897734|NCT00403546|Ziprasidone|ziprasidone|mesh-list
1897735|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1897736|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
1897737|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897738|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897739|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897740|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1897741|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1897742|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897743|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897744|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1897745|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
1897746|NCT00403585|Adefovir|adefovir|mesh-list
1897747|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1897748|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
1897749|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897750|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1897751|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1897752|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897753|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897754|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1897755|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1897756|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
1897757|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897758|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897759|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1897760|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
1897761|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1897762|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1897763|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1897764|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
1897765|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897766|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897767|NCT00403767|Warfarin|warfarin|mesh-list
1897768|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
1897769|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
1897770|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1897771|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
1897772|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1897773|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
1897774|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897775|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897776|NCT00404066|Dexamethasone|dexamethasone|mesh-list
1897777|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
1897778|NCT00404066|Docetaxel|docetaxel|mesh-list
1897779|NCT00404066|Doxorubicin|doxorubicin|mesh-list
1897780|NCT00404066|Trastuzumab|trastuzumab|mesh-list
1897781|NCT00404066|Lapatinib|lapatinib|mesh-list
1897782|NCT00404066|Lenograstim|lenograstim|mesh-list
1897783|NCT00404066|Sargramostim|sargramostim|mesh-list
1897784|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897785|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
1897786|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897787|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897788|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1897789|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
1897865|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
1897790|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897791|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897792|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1897793|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897794|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
1897795|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
1897796|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897797|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897798|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
1897799|NCT00404066|Hormones|hormones|mesh-ancestor
1897800|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1897801|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1897802|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
1897803|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
1897804|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
1897805|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1897806|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1897807|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1897808|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897809|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1897810|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1897811|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1897812|NCT00404092|Caspofungin|caspofungin|mesh-list
1897813|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
1897814|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897815|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897816|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897817|NCT00404235|Paclitaxel|paclitaxel|mesh-list
1897818|NCT00404235|Carboplatin|carboplatin|mesh-list
1897819|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1897820|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1897821|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897822|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
1897823|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
1897824|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
1897825|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897826|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
1897827|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1897828|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
1897829|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897830|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897831|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
1897832|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897833|NCT00404495|Irinotecan|irinotecan|mesh-list
1897834|NCT00404495|Temozolomide|temozolomide|mesh-list
1897835|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1897836|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1897837|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897838|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897839|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897840|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1897841|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
1897842|NCT00404547|Ciclesonide|ciclesonide|mesh-list
1897843|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
1897844|NCT00404547|Hormones|hormones|mesh-ancestor
1897845|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1897846|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897847|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1897848|NCT00404651|Vaccines|vaccines|mesh-list
1897849|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
1897850|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897851|NCT00404755|Citalopram|citalopram|mesh-list
1897852|NCT00404755|Bupropion|bupropion|mesh-list
1897853|NCT00404755|Imipramine|imipramine|mesh-list
1897854|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1897855|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1897856|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1897857|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897858|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1897859|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
1897860|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897861|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1897862|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
1897863|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1897864|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1897866|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1897867|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1897868|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897869|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1897870|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1897871|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
1897872|NCT00404820|Vitamin D|vitamin d|mesh-list
1897873|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
1897874|NCT00404820|Alendronate|alendronate|mesh-list
1897875|NCT00404820|Calcium|calcium|mesh-list
1897876|NCT00404820|Vitamins|vitamins|mesh-ancestor
1897877|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
1897878|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897879|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1897880|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1897881|NCT00405067|Ezetimibe|ezetimibe|mesh-list
1897882|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1897883|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1897884|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
1897885|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897886|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1897887|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
1897888|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
1897889|NCT00405275|Etanercept|etanercept|mesh-list
1897890|NCT00405275|Methotrexate|methotrexate|mesh-list
1897891|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1897892|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
1897893|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1897894|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897895|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1897896|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
1897897|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897898|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897899|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
1897900|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897901|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1897902|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1897903|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
1897904|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1897905|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1897906|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
1897907|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1897908|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1897909|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897910|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1897911|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1897912|NCT00405275|Analgesics|analgesics|mesh-ancestor
1897913|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
1897914|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897915|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897916|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1897917|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
1897918|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1897919|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1897920|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1897921|NCT00405288|Pramoxine|pramoxine|mesh-list
1897922|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897923|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
1897924|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
1897925|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897926|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897927|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
1897928|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897929|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
1897930|NCT00405353|Testosterone|testosterone|mesh-list
1897931|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
1897932|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
1897933|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1897934|NCT00405353|Androgens|androgens|mesh-ancestor
1897935|NCT00405353|Hormones|hormones|mesh-ancestor
1897936|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1897937|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897938|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1897939|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897940|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
1897941|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
1897942|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1897943|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897944|NCT00405522|Remifentanil|remifentanil|mesh-list
1897945|NCT00405522|Propofol|propofol|mesh-list
1897946|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1897947|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1897948|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897949|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1897950|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
1897951|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
1897952|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1897953|NCT00405522|Narcotics|narcotics|mesh-ancestor
1897954|NCT00405522|Analgesics|analgesics|mesh-ancestor
1897955|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
1897956|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1897957|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1897958|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
1897959|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897960|NCT00405587|Vemurafenib|vemurafenib|mesh-list
1897961|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897962|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1897963|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897964|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897965|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1897966|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
1897967|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1897968|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
1897969|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1897970|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1897971|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1897972|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
1897973|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897974|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897975|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897976|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897977|NCT00405704|Trimethoprim|trimethoprim|mesh-list
1897978|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1897979|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
1897980|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1897981|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1897982|NCT00405704|Renal Agents|renal agents|mesh-ancestor
1897983|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
1897984|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1897985|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1897986|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1897987|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1897988|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1897989|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1897990|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1897991|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1897992|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1897993|NCT00405756|Aspirin|aspirin|mesh-list
1897994|NCT00405756|Prednisone|prednisone|mesh-list
1897995|NCT00405756|Lenalidomide|lenalidomide|mesh-list
1897996|NCT00405756|Melphalan|melphalan|mesh-list
1897997|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1897998|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
1897999|NCT00405756|Hormones|hormones|mesh-ancestor
1898000|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898001|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898002|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1898003|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898004|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1898005|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1898006|NCT00405756|Analgesics|analgesics|mesh-ancestor
1898007|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
1898008|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898009|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898010|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1898011|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1898012|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898013|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1898014|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1898015|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898016|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
1898017|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
1898018|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898019|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898020|NCT00405756|Growth Substances|growth substances|mesh-ancestor
1898021|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898022|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898023|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
1898024|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1898025|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898026|NCT00405821|Acyclovir|acyclovir|mesh-list
1898027|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
1898028|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898029|NCT00405938|Bevacizumab|bevacizumab|mesh-list
1898030|NCT00405938|Fulvestrant|fulvestrant|mesh-list
1898031|NCT00405938|Anastrozole|anastrozole|mesh-list
1898032|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898033|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898034|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898035|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898036|NCT00405938|Growth Substances|growth substances|mesh-ancestor
1898037|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898038|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898039|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1898040|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1898041|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1898042|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
1898043|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898044|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1898045|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1898046|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898047|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898048|NCT00405964|Desloratadine|desloratadine|mesh-list
1898049|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1898050|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
1898051|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898052|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898053|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898054|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1898055|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1898056|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
1898057|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
1898058|NCT00406029|Levodopa|levodopa|mesh-list
1898059|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1898060|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1898061|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
1898062|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898063|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898064|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898065|NCT00406276|Docetaxel|docetaxel|mesh-list
1898066|NCT00406276|Everolimus|everolimus|mesh-list
1898067|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898068|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898069|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898070|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898071|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898072|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898073|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
1898074|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898075|NCT00406315|Ziprasidone|ziprasidone|mesh-list
1898076|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1898077|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
1898078|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898079|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898080|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898081|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1898082|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1898083|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1898084|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898085|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1898086|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
1898087|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1898088|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1898089|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898090|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898091|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898092|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
1898093|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898094|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898095|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1898096|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1898097|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898098|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898099|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1898100|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898101|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898102|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
1898103|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898104|NCT00406393|Sirolimus|sirolimus|mesh-list
1898105|NCT00406393|Methotrexate|methotrexate|mesh-list
1898106|NCT00406393|Tacrolimus|tacrolimus|mesh-list
1898107|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1898108|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
1898109|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1898110|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898111|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898112|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
1898113|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898114|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898115|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
1898116|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898117|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898118|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898119|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
1898120|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898121|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898122|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1898123|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1898124|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898125|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1898126|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
1898127|NCT00406419|Methotrexate|methotrexate|mesh-list
1898128|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
1898129|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1898130|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
1898131|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1898132|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898133|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898134|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
1898135|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898136|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898137|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
1898138|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898139|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898140|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898141|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
1898142|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898143|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898144|NCT00406640|Citalopram|citalopram|mesh-list
1898145|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1898146|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1898147|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898148|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898149|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898150|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898151|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
1898152|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898153|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1898154|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898155|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898156|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1898157|NCT00406653|Abatacept|abatacept|mesh-list
1898158|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1898159|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898160|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898161|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898162|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
1898163|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898164|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898165|NCT00406692|Zonisamide|zonisamide|mesh-list
1898166|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
1898167|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1898168|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898169|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898170|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898171|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898172|NCT00406783|Desloratadine|desloratadine|mesh-list
1898173|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1898174|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
1898175|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898176|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898177|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898178|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1898179|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1898180|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
1898181|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
1898182|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1898183|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1898184|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898185|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898186|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898187|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898188|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898189|NCT00406848|Analgesics|analgesics|mesh-ancestor
1898190|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
1898191|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898192|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898193|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898194|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
1898195|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1898196|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1898197|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1898198|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898199|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898200|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1898201|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898202|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898203|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
1898204|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898205|NCT00407355|Ranibizumab|ranibizumab|mesh-list
1898206|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898207|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898208|NCT00407355|Growth Substances|growth substances|mesh-ancestor
1898209|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898210|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898211|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898212|NCT00407381|Ranibizumab|ranibizumab|mesh-list
1898213|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898214|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898215|NCT00407381|Growth Substances|growth substances|mesh-ancestor
1898216|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898217|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898218|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898219|NCT00407485|Aflibercept|aflibercept|mesh-list
1898220|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898221|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898222|NCT00407485|Growth Substances|growth substances|mesh-ancestor
1898223|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898224|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898225|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898226|NCT00407511|Pregabalin|pregabalin|mesh-list
1898227|NCT00407511|Analgesics|analgesics|mesh-ancestor
1898228|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
1898229|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898230|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898231|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
1898232|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1898233|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898234|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898235|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898236|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1898237|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1898238|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1898239|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898240|NCT00407537|Amlodipine|amlodipine|mesh-list
1898241|NCT00407537|Atorvastatin|atorvastatin|mesh-list
1898242|NCT00407537|Calcium|calcium|mesh-list
1898243|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898244|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898245|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1898246|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1898247|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
1898248|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898249|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1898250|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1898251|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898252|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1898253|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1898254|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898255|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
1898256|NCT00407550|Gemcitabine|gemcitabine|mesh-list
1898257|NCT00407550|Pemetrexed|pemetrexed|mesh-list
1898258|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898259|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
1898260|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898261|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898262|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
1898263|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898264|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898265|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898266|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
1898267|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898268|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898269|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898270|NCT00407563|Paclitaxel|paclitaxel|mesh-list
1898271|NCT00407563|Bevacizumab|bevacizumab|mesh-list
1898272|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1898273|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898274|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898275|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898276|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898277|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898278|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898279|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898280|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898281|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898282|NCT00407563|Growth Substances|growth substances|mesh-ancestor
1898283|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898284|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898285|NCT00407654|Aflibercept|aflibercept|mesh-list
1898286|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
1898287|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898288|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898289|NCT00407654|Growth Substances|growth substances|mesh-ancestor
1898290|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898291|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898292|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898293|NCT00407745|Pregabalin|pregabalin|mesh-list
1898294|NCT00407745|Analgesics|analgesics|mesh-ancestor
1898295|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
1898296|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898297|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898298|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
1898299|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1898300|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898301|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898302|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898303|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1898304|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1898305|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1898306|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898307|NCT00407797|Pregabalin|pregabalin|mesh-list
1898308|NCT00407797|Analgesics|analgesics|mesh-ancestor
1898309|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
1898310|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898311|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898312|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
1898313|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1898314|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898315|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898316|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898317|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1898318|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1898319|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1898320|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898321|NCT00407888|Paclitaxel|paclitaxel|mesh-list
1898322|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1898323|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
1898324|NCT00407888|Doxorubicin|doxorubicin|mesh-list
1898325|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1898326|NCT00407888|Trastuzumab|trastuzumab|mesh-list
1898327|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898328|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898329|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898330|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898331|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898332|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898333|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898334|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
1898335|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898336|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898337|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898338|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
1898339|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1898340|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1898341|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898342|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898343|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898344|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898345|NCT00407966|Cytarabine|cytarabine|mesh-list
1898346|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
1898347|NCT00407966|Alvocidib|alvocidib|mesh-list
1898348|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898349|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
1898350|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898351|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898352|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
1898353|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898354|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898355|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
1898356|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898357|NCT00407966|Analgesics|analgesics|mesh-ancestor
1898358|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
1898359|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898360|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898361|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898362|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898363|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898364|NCT00407966|Growth Substances|growth substances|mesh-ancestor
1898365|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898366|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
1898367|NCT00408005|Leucovorin|leucovorin|mesh-list
1898368|NCT00408005|Folic Acid|folic acid|mesh-list
1898369|NCT00408005|Cytarabine|cytarabine|mesh-list
1898370|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
1898371|NCT00408005|Dexamethasone|dexamethasone|mesh-list
1898372|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
1898373|NCT00408005|Prednisone|prednisone|mesh-list
1898374|NCT00408005|Cortisone|cortisone|mesh-list
1898375|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
1898376|NCT00408005|Doxorubicin|doxorubicin|mesh-list
1898377|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1898378|NCT00408005|Methotrexate|methotrexate|mesh-list
1898379|NCT00408005|Vincristine|vincristine|mesh-list
1898380|NCT00408005|Daunorubicin|daunorubicin|mesh-list
1898381|NCT00408005|Asparaginase|asparaginase|mesh-list
1898382|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
1898383|NCT00408005|Pegaspargase|pegaspargase|mesh-list
1898384|NCT00408005|Thioguanine|thioguanine|mesh-list
1898385|NCT00408005|BB 1101|bb 1101|mesh-list
1898386|NCT00408005|Calcium|calcium|mesh-list
1898387|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
1898388|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
1898389|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898390|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
1898391|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898392|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898393|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898394|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
1898395|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898396|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898397|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1898398|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898399|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
1898400|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
1898401|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898402|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1898403|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
1898404|NCT00408005|Hormones|hormones|mesh-ancestor
1898405|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898406|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1898407|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
1898408|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898409|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1898410|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898411|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898412|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898413|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1898414|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1898415|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
1898416|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1898417|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898418|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
1898419|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
1898420|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898421|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898422|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
1898423|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898424|NCT00408005|Antidotes|antidotes|mesh-ancestor
1898425|NCT00408005|Protective Agents|protective agents|mesh-ancestor
1898426|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
1898427|NCT00408005|Vitamins|vitamins|mesh-ancestor
1898428|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
1898429|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898430|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898431|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898432|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898433|NCT00408005|Hematinics|hematinics|mesh-ancestor
1898434|NCT00408070|Paclitaxel|paclitaxel|mesh-list
1898435|NCT00408070|Bevacizumab|bevacizumab|mesh-list
1898436|NCT00408070|Carboplatin|carboplatin|mesh-list
1898437|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898438|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898439|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898440|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898441|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898442|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898443|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898444|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898445|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898446|NCT00408070|Growth Substances|growth substances|mesh-ancestor
1898447|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898448|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898449|NCT00408200|Sotalol|sotalol|mesh-list
1898450|NCT00408200|Flecainide|flecainide|mesh-list
1898451|NCT00408200|Propafenone|propafenone|mesh-list
1898452|NCT00408200|Dofetilide|dofetilide|mesh-list
1898453|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1898454|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1898455|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
1898456|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898457|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898458|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898459|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1898460|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
1898461|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
1898462|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898463|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1898464|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1898465|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898466|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1898467|NCT00408317|Pancrelipase|pancrelipase|mesh-list
1898468|NCT00408317|Pancreatin|pancreatin|mesh-list
1898469|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1898470|NCT00408408|Gemcitabine|gemcitabine|mesh-list
1898471|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
1898472|NCT00408408|Bevacizumab|bevacizumab|mesh-list
1898473|NCT00408408|Docetaxel|docetaxel|mesh-list
1898474|NCT00408408|Doxorubicin|doxorubicin|mesh-list
1898475|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1898476|NCT00408408|Capecitabine|capecitabine|mesh-list
1898477|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898478|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
1898479|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898480|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898481|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898482|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
1898483|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898484|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898485|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1898486|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898487|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898488|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898489|NCT00408408|Growth Substances|growth substances|mesh-ancestor
1898490|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898491|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898492|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
1898493|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
1898494|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898495|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898496|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898497|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898498|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898499|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1898500|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898501|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898502|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1898503|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1898504|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898505|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898506|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898507|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898508|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898509|NCT00408421|Analgesics|analgesics|mesh-ancestor
1898510|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
1898511|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898512|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898513|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898514|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
1898515|NCT00408434|Efatutazone|efatutazone|mesh-list
1898516|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898517|NCT00408460|Paclitaxel|paclitaxel|mesh-list
1898518|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
1898519|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898520|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898521|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898522|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898523|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898524|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898525|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898526|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898527|NCT00408499|Cetuximab|cetuximab|mesh-list
1898528|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1898529|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898530|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898531|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898532|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898533|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898534|NCT00408564|Gemcitabine|gemcitabine|mesh-list
1898535|NCT00408564|Capecitabine|capecitabine|mesh-list
1898536|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
1898537|NCT00408564|Cetuximab|cetuximab|mesh-list
1898538|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898539|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
1898540|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898541|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898542|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
1898543|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898544|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898545|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898546|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
1898547|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898548|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898549|NCT00408629|Adalimumab|adalimumab|mesh-list
1898550|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898551|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898552|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
1898553|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898554|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898555|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898556|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898557|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
1898558|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1898559|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1898560|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898561|NCT00408694|Bevacizumab|bevacizumab|mesh-list
1898562|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1898563|NCT00408694|Cisplatin|cisplatin|mesh-list
1898564|NCT00408694|Fluorouracil|fluorouracil|mesh-list
1898565|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
1898566|NCT00408694|Antibodies|antibodies|mesh-list
1898567|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
1898568|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1898569|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
1898570|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898571|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898572|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898573|NCT00408694|Growth Substances|growth substances|mesh-ancestor
1898574|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898575|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898576|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
1898577|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
1898578|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898579|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898580|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898581|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1898582|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1898583|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898584|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898585|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898586|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898587|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898588|NCT00408876|Analgesics|analgesics|mesh-ancestor
1898589|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
1898590|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898591|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898592|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898593|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
1898594|NCT00408928|Bortezomib|bortezomib|mesh-list
1898595|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898596|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1898597|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1898598|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898599|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898600|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898601|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898602|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898603|NCT00408993|Analgesics|analgesics|mesh-ancestor
1898604|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
1898605|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898606|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898607|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898608|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
1898609|NCT00409006|Pemetrexed|pemetrexed|mesh-list
1898610|NCT00409006|Gefitinib|gefitinib|mesh-list
1898611|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898612|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898613|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898614|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898615|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898616|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898617|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
1898618|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898619|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
1898620|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898621|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898622|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898623|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
1898624|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898625|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898626|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1898627|NCT00409292|Everolimus|everolimus|mesh-list
1898628|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898629|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898630|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
1898631|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898632|NCT00409565|Bevacizumab|bevacizumab|mesh-list
1898633|NCT00409565|Cetuximab|cetuximab|mesh-list
1898634|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898635|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898636|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898637|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898638|NCT00409565|Growth Substances|growth substances|mesh-ancestor
1898639|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898640|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898641|NCT00409578|Valsartan|valsartan|mesh-list
1898642|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1898643|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1898644|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1898645|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898646|NCT00409617|Adalimumab|adalimumab|mesh-list
1898647|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898648|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898649|NCT00409682|Adalimumab|adalimumab|mesh-list
1898650|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898651|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898652|NCT00409708|Methylphenidate|methylphenidate|mesh-list
1898653|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1898654|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898655|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1898656|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1898657|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1898658|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898659|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
1898660|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898661|NCT00409747|Minocycline|minocycline|mesh-list
1898662|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1898663|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898664|NCT00409773|Atorvastatin|atorvastatin|mesh-list
1898665|NCT00409773|Simvastatin|simvastatin|mesh-list
1898666|NCT00409773|Ezetimibe|ezetimibe|mesh-list
1898667|NCT00409773|Calcium|calcium|mesh-list
1898668|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1898669|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898670|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1898671|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1898672|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
1898673|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898674|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1898675|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1898676|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898677|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1898678|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1898679|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1898680|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
1898681|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898682|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898683|NCT00409825|Progestins|progestins|mesh-ancestor
1898684|NCT00409825|Hormones|hormones|mesh-ancestor
1898685|NCT00409838|Methotrexate|methotrexate|mesh-list
1898686|NCT00409838|Abatacept|abatacept|mesh-list
1898687|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1898688|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
1898689|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1898690|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898691|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898692|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
1898693|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898694|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898695|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
1898696|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898697|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898698|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898699|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
1898700|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898701|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898702|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1898703|NCT00410046|Etanercept|etanercept|mesh-list
1898704|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1898705|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1898706|NCT00410046|Analgesics|analgesics|mesh-ancestor
1898707|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
1898708|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898709|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898710|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898711|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898712|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1898713|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898714|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
1898715|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1898716|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898717|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898718|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898719|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898720|NCT00410072|Tenofovir|tenofovir|mesh-list
1898721|NCT00410072|Entecavir|entecavir|mesh-list
1898722|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
1898723|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898724|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1898725|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898726|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898727|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898728|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1898729|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1898730|NCT00410124|Everolimus|everolimus|mesh-list
1898731|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898732|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898733|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
1898734|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898735|NCT00410150|Albuterol|albuterol|mesh-list
1898736|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1898737|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
1898738|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898739|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898740|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1898741|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
1898742|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
1898743|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1898744|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1898745|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1898746|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1898747|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
1898748|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898749|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898750|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
1898751|NCT00410163|Fludarabine|fludarabine|mesh-list
1898752|NCT00410163|Ofatumumab|ofatumumab|mesh-list
1898753|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1898754|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898755|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
1898756|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898757|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898758|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898759|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
1898760|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898761|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898762|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1898763|NCT00410202|Tenofovir|tenofovir|mesh-list
1898764|NCT00410202|Lamivudine|lamivudine|mesh-list
1898765|NCT00410202|Entecavir|entecavir|mesh-list
1898766|NCT00410202|Adefovir|adefovir|mesh-list
1898767|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
1898768|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898769|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1898770|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898771|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898772|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898773|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1898774|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1898775|NCT00410384|Belimumab|belimumab|mesh-list
1898776|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898777|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
1898778|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898779|NCT00410410|Abatacept|abatacept|mesh-list
1898780|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1898781|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898782|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898783|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898784|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
1898785|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898786|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898787|NCT00410423|Cytarabine|cytarabine|mesh-list
1898788|NCT00410423|Etoposide|etoposide|mesh-list
1898789|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
1898790|NCT00410423|Bortezomib|bortezomib|mesh-list
1898791|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898792|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898793|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898794|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898795|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898796|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898797|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898798|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
1898799|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
1898800|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898801|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898802|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
1898803|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898804|NCT00410423|Analgesics|analgesics|mesh-ancestor
1898805|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
1898806|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898807|NCT00410488|Dexamethasone|dexamethasone|mesh-list
1898808|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
1898809|NCT00410488|Doxorubicin|doxorubicin|mesh-list
1898810|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1898811|NCT00410488|Vincristine|vincristine|mesh-list
1898812|NCT00410488|Ifosfamide|ifosfamide|mesh-list
1898813|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
1898814|NCT00410488|Palonosetron|palonosetron|mesh-list
1898815|NCT00410488|BB 1101|bb 1101|mesh-list
1898816|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898817|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
1898818|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
1898819|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898820|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898821|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1898822|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
1898823|NCT00410488|Hormones|hormones|mesh-ancestor
1898824|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898825|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1898826|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898827|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
1898828|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898829|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898830|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1898831|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898832|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898833|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1898834|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
1898835|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
1898836|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
1898837|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1898838|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
1898839|NCT00410488|Protective Agents|protective agents|mesh-ancestor
1898840|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1898841|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1898842|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
1898843|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898844|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1898845|NCT00410514|Mirabegron|mirabegron|mesh-list
1898846|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1898847|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1898848|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1898849|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
1898850|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898851|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898852|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898853|NCT00410514|Urological Agents|urological agents|mesh-ancestor
1898854|NCT00410605|Dexamethasone|dexamethasone|mesh-list
1898855|NCT00410605|Bevacizumab|bevacizumab|mesh-list
1898856|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1898857|NCT00410605|Lenalidomide|lenalidomide|mesh-list
1898858|NCT00410605|Antibodies|antibodies|mesh-list
1898859|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
1898860|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1898861|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898862|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898863|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898864|NCT00410605|Growth Substances|growth substances|mesh-ancestor
1898865|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898866|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898867|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
1898868|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1898869|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
1898870|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
1898871|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1898872|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1898873|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
1898874|NCT00410605|Hormones|hormones|mesh-ancestor
1898875|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898876|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1898877|NCT00410813|Dasatinib|dasatinib|mesh-list
1898878|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898879|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898880|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898881|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898882|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1898883|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898884|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898885|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898886|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898887|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
1898888|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1898889|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898890|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1898891|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1898892|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1898893|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1898894|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898895|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898896|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898897|NCT00410904|Pemetrexed|pemetrexed|mesh-list
1898898|NCT00410904|Cediranib|cediranib|mesh-list
1898899|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898900|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898901|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898902|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1898903|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1898904|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898905|NCT00411086|Rituximab|rituximab|mesh-list
1898906|NCT00411086|Molgramostim|molgramostim|mesh-list
1898907|NCT00411086|Sargramostim|sargramostim|mesh-list
1898908|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898909|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898910|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
1898911|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898912|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1898913|NCT00411151|Sunitinib|sunitinib|mesh-list
1898914|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898915|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1898916|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1898917|NCT00411151|Growth Substances|growth substances|mesh-ancestor
1898918|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898919|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
1898920|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898921|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898922|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898923|NCT00411398|Memantine|memantine|mesh-list
1898924|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1898925|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1898926|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
1898927|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1898928|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898929|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898930|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1898931|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1898932|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1898933|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1898934|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898935|NCT00411411|Incretins|incretins|mesh-ancestor
1898936|NCT00411411|Hormones|hormones|mesh-ancestor
1898937|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898938|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1898939|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
1898940|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898941|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898942|NCT00411450|Panitumumab|panitumumab|mesh-list
1898943|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1898944|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898945|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1898946|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
1898947|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1898948|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1898949|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1898950|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1898951|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898952|NCT00411554|Inositol|inositol|mesh-list
1898953|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1898954|NCT00411554|Voglibose|voglibose|mesh-list
1898955|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1898956|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898957|NCT00411554|Incretins|incretins|mesh-ancestor
1898958|NCT00411554|Hormones|hormones|mesh-ancestor
1898959|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1898960|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1898961|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
1898962|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898963|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898964|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1898965|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
1898966|NCT00411554|Vitamins|vitamins|mesh-ancestor
1898967|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
1898968|NCT00411619|Everolimus|everolimus|mesh-list
1898969|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898970|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1898971|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
1898972|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898973|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1898974|NCT00411632|Bexarotene|bexarotene|mesh-list
1898975|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898976|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898977|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898978|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898979|NCT00411645|Maribavir|maribavir|mesh-list
1898980|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
1898981|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1898982|NCT00411671|Sorafenib|sorafenib|mesh-list
1898983|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898984|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1898985|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1898986|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898987|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
1898988|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1898989|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
1898990|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1898991|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1898992|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1898993|NCT00411762|Capecitabine|capecitabine|mesh-list
1898994|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1898995|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
1898996|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1898997|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1898998|NCT00411788|Sirolimus|sirolimus|mesh-list
1898999|NCT00411788|Trastuzumab|trastuzumab|mesh-list
1899000|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899001|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899002|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1899003|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899004|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1899005|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
1899006|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899007|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
1899008|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899009|NCT00412061|Everolimus|everolimus|mesh-list
1899010|NCT00412061|Octreotide|octreotide|mesh-list
1899011|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899012|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899013|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
1899014|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899015|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899016|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1899017|NCT00412074|Vitamin D|vitamin d|mesh-list
1899018|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
1899019|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
1899020|NCT00412074|Vitamins|vitamins|mesh-list
1899021|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
1899022|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899023|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1899024|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899025|NCT00412087|Vitamin D|vitamin d|mesh-list
1899026|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
1899027|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
1899028|NCT00412087|Vitamins|vitamins|mesh-list
1899029|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
1899030|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899031|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1899032|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899033|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
1899034|NCT00412113|Amlodipine|amlodipine|mesh-list
1899035|NCT00412113|Atorvastatin|atorvastatin|mesh-list
1899036|NCT00412113|Calcium|calcium|mesh-list
1899037|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899038|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899039|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1899040|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1899041|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1899042|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
1899043|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899044|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1899045|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1899046|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899047|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899048|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899049|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899050|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899051|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1899052|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899053|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899054|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899055|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899056|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
1899057|NCT00412243|Clofarabine|clofarabine|mesh-list
1899058|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899059|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
1899060|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899061|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1899062|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1899063|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
1899064|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899065|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899066|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1899067|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899068|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
1899069|NCT00412360|Cyclosporine|cyclosporine|mesh-list
1899070|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
1899071|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
1899072|NCT00412360|Fludarabine|fludarabine|mesh-list
1899073|NCT00412360|Cyclosporins|cyclosporins|mesh-list
1899074|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899075|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
1899076|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899077|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1899078|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1899079|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
1899080|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899081|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899082|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1899083|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899084|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
1899085|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899086|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
1899087|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1899088|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1899089|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1899090|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
1899091|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1899092|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1899093|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1899094|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1899095|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899096|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899097|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899098|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1899099|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1899100|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
1899101|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899102|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899103|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1899104|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1899105|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
1899106|NCT00412425|Palonosetron|palonosetron|mesh-list
1899107|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
1899108|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
1899109|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899110|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899111|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899112|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1899113|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1899114|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
1899115|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899116|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899117|NCT00412451|Plasminogen|plasminogen|mesh-list
1899118|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1899119|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1899120|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899121|NCT00412464|PENTA|penta|mesh-list
1899122|NCT00412464|Fondaparinux|fondaparinux|mesh-list
1899123|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1899124|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
1899125|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1899126|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
1899127|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899128|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899129|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
1899130|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1899131|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1899132|NCT00412529|Entecavir|entecavir|mesh-list
1899133|NCT00412529|Telbivudine|telbivudine|mesh-list
1899134|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
1899135|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899136|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899137|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899138|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899139|NCT00412542|Thalidomide|thalidomide|mesh-list
1899140|NCT00412542|Irinotecan|irinotecan|mesh-list
1899141|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1899142|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1899143|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899144|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899145|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899146|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899147|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
1899148|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899149|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
1899150|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1899151|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899152|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899153|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899154|NCT00412542|Growth Substances|growth substances|mesh-ancestor
1899155|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899156|NCT00412737|Oseltamivir|oseltamivir|mesh-list
1899157|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
1899158|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899159|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899160|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899161|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1899162|NCT00412750|Telbivudine|telbivudine|mesh-list
1899163|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
1899164|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899165|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899166|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899167|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899168|NCT00412841|Atorvastatin|atorvastatin|mesh-list
1899169|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1899170|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1899171|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
1899172|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899173|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1899174|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1899175|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899176|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1899177|NCT00412867|Plasminogen|plasminogen|mesh-list
1899178|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1899179|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1899180|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899181|NCT00412893|Voriconazole|voriconazole|mesh-list
1899182|NCT00412893|Isavuconazole|isavuconazole|mesh-list
1899183|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
1899184|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899185|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1899186|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1899187|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899188|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899189|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1899190|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
1899191|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899192|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899193|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1899194|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1899195|NCT00412932|Olmesartan|olmesartan|mesh-list
1899196|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1899197|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899198|NCT00412932|Diuretics|diuretics|mesh-ancestor
1899199|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
1899200|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899201|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1899202|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899203|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899204|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1899205|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1899206|NCT00412958|Plasminogen|plasminogen|mesh-list
1899207|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
1899208|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1899209|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1899210|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899211|NCT00412984|Warfarin|warfarin|mesh-list
1899212|NCT00412984|Apixaban|apixaban|mesh-list
1899213|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
1899214|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1899215|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
1899216|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1899217|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
1899218|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899219|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899220|NCT00413010|Pregabalin|pregabalin|mesh-list
1899221|NCT00413010|Analgesics|analgesics|mesh-ancestor
1899222|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
1899223|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899224|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899225|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
1899226|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899227|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899228|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899229|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899230|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1899231|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1899232|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899233|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899234|NCT00413036|Lenalidomide|lenalidomide|mesh-list
1899235|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
1899236|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899237|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899238|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899239|NCT00413036|Growth Substances|growth substances|mesh-ancestor
1899240|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899241|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899242|NCT00413049|Amlodipine|amlodipine|mesh-list
1899243|NCT00413049|Valsartan|valsartan|mesh-list
1899244|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899245|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899246|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899247|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899248|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899249|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899250|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899251|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1899252|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1899253|NCT00413153|Ritonavir|ritonavir|mesh-list
1899254|NCT00413153|Lopinavir|lopinavir|mesh-list
1899255|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1899256|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1899257|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1899258|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
1899259|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899260|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899261|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1899262|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1899263|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
1899264|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899265|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1899266|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1899267|NCT00413166|Idarubicin|idarubicin|mesh-list
1899268|NCT00413166|Tretinoin|tretinoin|mesh-list
1899269|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
1899270|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
1899271|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1899272|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899273|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1899274|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1899275|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899276|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899277|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
1899278|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
1899279|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899280|NCT00413218|Voriconazole|voriconazole|mesh-list
1899281|NCT00413218|Caspofungin|caspofungin|mesh-list
1899282|NCT00413218|Isavuconazole|isavuconazole|mesh-list
1899283|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
1899284|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899285|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1899286|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1899287|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899361|NCT00413777|Tolvaptan|tolvaptan|mesh-list
1899288|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899289|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1899290|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
1899291|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899292|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899293|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1899294|NCT00413244|Testosterone|testosterone|mesh-list
1899295|NCT00413244|Androgens|androgens|mesh-ancestor
1899296|NCT00413244|Hormones|hormones|mesh-ancestor
1899297|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899298|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899299|NCT00413283|Gemcitabine|gemcitabine|mesh-list
1899300|NCT00413283|Carboplatin|carboplatin|mesh-list
1899301|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899302|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899303|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
1899304|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899305|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
1899306|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899307|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899308|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899309|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
1899310|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899311|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
1899312|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1899313|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899314|NCT00413374|Enoxaparin|enoxaparin|mesh-list
1899315|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
1899316|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1899317|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1899318|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899319|NCT00413400|Etanercept|etanercept|mesh-list
1899320|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1899321|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1899322|NCT00413400|Analgesics|analgesics|mesh-ancestor
1899323|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
1899324|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899325|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899326|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1899327|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1899328|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899329|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899330|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
1899331|NCT00413413|Amlodipine|amlodipine|mesh-list
1899332|NCT00413413|Valsartan|valsartan|mesh-list
1899333|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899334|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899335|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899336|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899337|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899338|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899339|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899340|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1899341|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1899342|NCT00413478|Azacitidine|azacitidine|mesh-list
1899343|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899344|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
1899345|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899346|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899347|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899348|NCT00413634|Anagrelide|anagrelide|mesh-list
1899349|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1899350|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1899351|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899352|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1899353|NCT00413660|Tofacitinib|tofacitinib|mesh-list
1899354|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899355|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899356|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899362|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1899363|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899364|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
1899365|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899366|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
1899367|NCT00413894|Hematinics|hematinics|mesh-ancestor
1899368|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
1899369|NCT00413920|Prednisone|prednisone|mesh-list
1899370|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1899371|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
1899372|NCT00413920|Hormones|hormones|mesh-ancestor
1899373|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899374|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899375|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1899376|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899377|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1899378|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1899379|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
1899380|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1899381|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899382|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899383|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899384|NCT00413959|Dexamethasone|dexamethasone|mesh-list
1899385|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
1899386|NCT00413959|Rituximab|rituximab|mesh-list
1899387|NCT00413959|Bortezomib|bortezomib|mesh-list
1899388|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899389|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
1899390|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899391|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1899392|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1899393|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
1899394|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899395|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899396|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1899397|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1899398|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
1899399|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
1899400|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899401|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899402|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
1899403|NCT00413959|Hormones|hormones|mesh-ancestor
1899404|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899405|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1899406|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899407|NCT00413972|Simvastatin|simvastatin|mesh-list
1899408|NCT00413972|Ezetimibe|ezetimibe|mesh-list
1899409|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1899410|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1899411|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
1899412|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899413|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1899414|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1899415|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899416|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
1899417|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
1899418|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1899419|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899420|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1899421|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1899422|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899423|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899424|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899425|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1899426|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1899427|NCT00414050|Vaccines|vaccines|mesh-list
1899428|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
1899429|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899430|NCT00414076|Letrozole|letrozole|mesh-list
1899431|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899432|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1899433|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1899434|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899435|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899436|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1899437|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
1899438|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899439|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899440|NCT00414167|Bupropion|bupropion|mesh-list
1899441|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1899442|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
1899443|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899444|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1899445|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1899446|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899447|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899448|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
1899449|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899450|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899451|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1899452|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1899453|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899454|NCT00414206|Mecamylamine|mecamylamine|mesh-list
1899455|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899456|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1899457|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
1899458|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899459|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899460|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1899461|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1899462|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
1899463|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899464|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899465|NCT00414271|Docetaxel|docetaxel|mesh-list
1899466|NCT00414271|Capecitabine|capecitabine|mesh-list
1899467|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899468|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
1899469|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
1899470|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
1899471|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899472|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899473|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
1899474|NCT00414310|Decitabine|decitabine|mesh-list
1899475|NCT00414310|Valproic Acid|valproic acid|mesh-list
1899476|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899477|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
1899478|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899479|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899480|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899481|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
1899482|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
1899483|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899484|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899485|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
1899486|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1899487|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899488|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899489|NCT00414388|Sorafenib|sorafenib|mesh-list
1899490|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899491|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899492|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899493|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899494|NCT00414440|Everolimus|everolimus|mesh-list
1899495|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899496|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899497|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
1899498|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899499|NCT00414466|Gabapentin|gabapentin|mesh-list
1899500|NCT00414466|Analgesics|analgesics|mesh-ancestor
1899501|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
1899502|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899503|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899504|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
1899505|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1899506|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1899507|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899508|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899509|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1899510|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1899511|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899512|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899513|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
1899514|NCT00414518|Ritonavir|ritonavir|mesh-list
1899515|NCT00414518|Lopinavir|lopinavir|mesh-list
1899516|NCT00414518|Tenofovir|tenofovir|mesh-list
1899517|NCT00414518|Emtricitabine|emtricitabine|mesh-list
1899518|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1899519|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1899520|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
1899521|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899522|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899523|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1899524|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1899525|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
1899526|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899527|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1899528|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1899529|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1899530|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899531|NCT00414661|Tofacitinib|tofacitinib|mesh-list
1899532|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899533|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899534|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899535|NCT00414765|Aldesleukin|aldesleukin|mesh-list
1899536|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899537|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1899538|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1899539|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
1899540|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899541|NCT00414908|Pancrelipase|pancrelipase|mesh-list
1899542|NCT00414908|Pancreatin|pancreatin|mesh-list
1899543|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899544|NCT00414973|Teriparatide|teriparatide|mesh-list
1899545|NCT00414973|Calcitonin|calcitonin|mesh-list
1899546|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
1899547|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1899548|NCT00414973|Katacalcin|katacalcin|mesh-list
1899549|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899550|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899551|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1899552|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899553|NCT00415168|Pemetrexed|pemetrexed|mesh-list
1899554|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899555|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899556|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899557|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1899558|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899559|NCT00415194|Pemetrexed|pemetrexed|mesh-list
1899560|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899561|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899562|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899563|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1899564|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899565|NCT00415506|Rituximab|rituximab|mesh-list
1899566|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899567|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899568|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
1899569|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899570|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1899571|NCT00415519|Edaravone|edaravone|mesh-list
1899572|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1899573|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
1899574|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899575|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1899576|NCT00415519|Protective Agents|protective agents|mesh-ancestor
1899577|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899578|NCT00415597|Naltrexone|naltrexone|mesh-list
1899579|NCT00415597|Morphine|morphine|mesh-list
1899580|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1899581|NCT00415597|Narcotics|narcotics|mesh-ancestor
1899582|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899583|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899584|NCT00415597|Analgesics|analgesics|mesh-ancestor
1899585|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
1899586|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899587|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1899588|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1899589|NCT00415610|Nicardipine|nicardipine|mesh-list
1899590|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899591|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899592|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899593|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899594|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899595|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899596|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899597|NCT00415623|Amlodipine|amlodipine|mesh-list
1899598|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899599|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899600|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899601|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899602|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899603|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899604|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899605|NCT00415636|Pemetrexed|pemetrexed|mesh-list
1899606|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899607|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899608|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899609|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1899610|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899611|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1899612|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
1899613|NCT00415857|Vaccines|vaccines|mesh-list
1899614|NCT00415857|Sargramostim|sargramostim|mesh-list
1899615|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
1899616|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899617|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899618|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899619|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899620|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899621|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
1899622|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899623|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
1899624|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899625|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899626|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899627|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899628|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1899629|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1899630|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899631|NCT00416494|Bevacizumab|bevacizumab|mesh-list
1899632|NCT00416494|Capecitabine|capecitabine|mesh-list
1899633|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
1899634|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899635|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899636|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899637|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899638|NCT00416494|Growth Substances|growth substances|mesh-ancestor
1899639|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899640|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899641|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899642|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
1899643|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899644|NCT00416520|Sevelamer|sevelamer|mesh-list
1899645|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
1899646|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
1899647|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899648|NCT00416598|Cytarabine|cytarabine|mesh-list
1899649|NCT00416598|Etoposide|etoposide|mesh-list
1899650|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
1899651|NCT00416598|Daunorubicin|daunorubicin|mesh-list
1899652|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
1899653|NCT00416598|Busulfan|busulfan|mesh-list
1899654|NCT00416598|Decitabine|decitabine|mesh-list
1899655|NCT00416598|Lenograstim|lenograstim|mesh-list
1899656|NCT00416598|Sargramostim|sargramostim|mesh-list
1899657|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1899658|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899659|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1899660|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1899661|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899662|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899663|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1899664|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
1899665|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899666|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899667|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
1899668|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
1899669|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899670|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899671|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
1899672|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1899673|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1899674|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1899675|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
1899676|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
1899677|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
1899678|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
1899679|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
1899680|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
1899681|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
1899682|NCT00416624|Hematinics|hematinics|mesh-ancestor
1899683|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
1899684|NCT00416715|Vitamin D|vitamin d|mesh-list
1899685|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
1899686|NCT00416715|Letrozole|letrozole|mesh-list
1899687|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
1899688|NCT00416715|Citric Acid|citric acid|mesh-list
1899689|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
1899690|NCT00416715|Calcium|calcium|mesh-list
1899691|NCT00416715|Vitamins|vitamins|mesh-ancestor
1899692|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
1899693|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899694|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899695|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1899696|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
1899697|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1899698|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
1899699|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
1899700|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899701|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899702|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1899703|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1899704|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899705|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1899706|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
1899707|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899708|NCT00416715|Antacids|antacids|mesh-ancestor
1899709|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899710|NCT00416793|Carboplatin|carboplatin|mesh-list
1899711|NCT00416793|Bortezomib|bortezomib|mesh-list
1899712|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899713|NCT00416884|Fludarabine|fludarabine|mesh-list
1899714|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
1899715|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899716|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899717|NCT00417079|Prednisone|prednisone|mesh-list
1899718|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
1899719|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1899720|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
1899721|NCT00417079|Hormones|hormones|mesh-ancestor
1899722|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899723|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899724|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1899725|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899726|NCT00417079|Analgesics|analgesics|mesh-ancestor
1899727|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
1899728|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899729|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1899730|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1899731|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899732|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899733|NCT00417170|Amlodipine|amlodipine|mesh-list
1899734|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1899735|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899736|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899737|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899738|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899739|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899740|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
1899741|NCT00417274|Quinacrine|quinacrine|mesh-list
1899742|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
1899743|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1899744|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
1899745|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1899746|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899747|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
1899748|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1899749|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
1899750|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899751|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899752|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899753|NCT00417417|Rilonacept|rilonacept|mesh-list
1899754|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1899755|NCT00417482|Risperidone|risperidone|mesh-list
1899756|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1899757|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
1899758|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899759|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899760|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899761|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1899762|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1899763|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899764|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899765|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1899766|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
1899767|NCT00417885|Sunitinib|sunitinib|mesh-list
1899768|NCT00417885|Exemestane|exemestane|mesh-list
1899769|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899770|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899771|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899772|NCT00417885|Growth Substances|growth substances|mesh-ancestor
1899773|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899774|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899775|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1899776|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899777|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899778|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1899779|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1899780|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1899781|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
1899782|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899783|NCT00417976|Gemcitabine|gemcitabine|mesh-list
1899784|NCT00417976|Bevacizumab|bevacizumab|mesh-list
1899785|NCT00417976|Fluorouracil|fluorouracil|mesh-list
1899786|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899787|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899788|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899789|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899790|NCT00417976|Growth Substances|growth substances|mesh-ancestor
1899791|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899792|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899793|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899794|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
1899795|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899796|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
1899797|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899798|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899799|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899800|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
1899801|NCT00418028|Capecitabine|capecitabine|mesh-list
1899802|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899803|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
1899804|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899805|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899806|NCT00418093|Gemcitabine|gemcitabine|mesh-list
1899807|NCT00418093|Bevacizumab|bevacizumab|mesh-list
1899808|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
1899809|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899810|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899811|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899812|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899813|NCT00418093|Growth Substances|growth substances|mesh-ancestor
1899814|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899815|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899816|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899817|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
1899818|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899819|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
1899820|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899821|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899822|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899823|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
1899824|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1899825|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1899826|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1899827|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899828|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899829|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
1899830|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899831|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899832|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
1899833|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899834|NCT00418457|Anesthetics|anesthetics|mesh-list
1899835|NCT00418457|Propofol|propofol|mesh-list
1899836|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899837|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899838|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1899839|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1899840|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
1899841|NCT00418522|Insulin|insulin|mesh-list
1899842|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1899843|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
1899844|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1899845|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899846|NCT00418574|Abagovomab|abagovomab|mesh-list
1899847|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899848|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899849|NCT00418691|Methylphenidate|methylphenidate|mesh-list
1899850|NCT00418691|Modafinil|modafinil|mesh-list
1899851|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1899852|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899853|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1899854|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1899855|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899856|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899857|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
1899858|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899859|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1899860|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1899861|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1899862|NCT00418717|Etanercept|etanercept|mesh-list
1899863|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1899864|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1899865|NCT00418717|Analgesics|analgesics|mesh-ancestor
1899866|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
1899867|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899868|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899869|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1899870|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1899871|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1899872|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899873|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
1899874|NCT00418834|Atorvastatin|atorvastatin|mesh-list
1899875|NCT00418834|Ezetimibe|ezetimibe|mesh-list
1899876|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1899877|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1899878|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
1899879|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899880|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1899881|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1899882|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899883|NCT00418886|Pemetrexed|pemetrexed|mesh-list
1899884|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899885|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899886|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899887|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1899888|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1899889|NCT00418938|Leucovorin|leucovorin|mesh-list
1899890|NCT00418938|Bevacizumab|bevacizumab|mesh-list
1899891|NCT00418938|Panitumumab|panitumumab|mesh-list
1899892|NCT00418938|Fluorouracil|fluorouracil|mesh-list
1899893|NCT00418938|Irinotecan|irinotecan|mesh-list
1899894|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1899895|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899896|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1899897|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1899898|NCT00418938|Growth Substances|growth substances|mesh-ancestor
1899899|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899900|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
1899901|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
1899902|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899903|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1899904|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899905|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
1899906|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1899907|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1899908|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899909|NCT00418938|Antidotes|antidotes|mesh-ancestor
1899910|NCT00418938|Protective Agents|protective agents|mesh-ancestor
1899911|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
1899912|NCT00418938|Vitamins|vitamins|mesh-ancestor
1899913|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
1899914|NCT00418951|Voriconazole|voriconazole|mesh-list
1899915|NCT00418951|Amphotericin B|amphotericin b|mesh-list
1899916|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1899917|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
1899918|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899919|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1899920|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1899921|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899922|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899923|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1899924|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
1899925|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1899926|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899927|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1899928|NCT00418951|Amebicides|amebicides|mesh-ancestor
1899929|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1899930|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1899931|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1899932|NCT00419003|Lamotrigine|lamotrigine|mesh-list
1899933|NCT00419003|Ketamine|ketamine|mesh-list
1899934|NCT00419003|Riluzole|riluzole|mesh-list
1899935|NCT00419003|Analgesics|analgesics|mesh-ancestor
1899936|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
1899937|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1899938|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899939|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1899940|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1899941|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
1899942|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
1899943|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1899944|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1899945|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1899946|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899947|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899948|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
1899949|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1899950|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899951|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899952|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1899953|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1899954|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1899955|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1899956|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1899957|NCT00419003|Protective Agents|protective agents|mesh-ancestor
1899958|NCT00419094|Levetiracetam|levetiracetam|mesh-list
1899959|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
1899960|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
1899961|NCT00419159|Everolimus|everolimus|mesh-list
1899962|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1899963|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1899964|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
1899965|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899966|NCT00419263|Peramivir|peramivir|mesh-list
1899967|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
1899968|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1899969|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1899970|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899971|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
1899972|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1899973|NCT00419341|Antibodies|antibodies|mesh-list
1899974|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
1899975|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899976|NCT00419393|Levetiracetam|levetiracetam|mesh-list
1899977|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
1899978|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
1899979|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
1899980|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1899981|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1899982|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
1899983|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1899984|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899985|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899986|NCT00419562|Insulin|insulin|mesh-list
1899987|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1899988|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899989|NCT00419666|Calcitriol|calcitriol|mesh-list
1899990|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1899991|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1899992|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1899993|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1899994|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1899995|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1899996|NCT00419666|Vitamins|vitamins|mesh-ancestor
1899997|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
1899998|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1899999|NCT00419744|Budesonide|budesonide|mesh-list
1900000|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
1900001|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1900002|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900003|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1900004|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
1900005|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900006|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900007|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1900008|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
1900009|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
1900010|NCT00419744|Hormones|hormones|mesh-ancestor
1900011|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900012|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1900013|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1900014|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1900015|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
1900016|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900017|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900018|NCT00419757|Budesonide|budesonide|mesh-list
1900019|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
1900020|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1900021|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900022|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1900023|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
1900024|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900025|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900026|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1900027|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
1900028|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
1900029|NCT00419757|Hormones|hormones|mesh-ancestor
1900030|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900031|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1900032|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1900033|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1900034|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
1900035|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900258|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
1900036|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900037|NCT00419770|Amphotericin B|amphotericin b|mesh-list
1900038|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1900039|NCT00419770|Deferasirox|deferasirox|mesh-list
1900040|NCT00419770|Amebicides|amebicides|mesh-ancestor
1900041|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1900042|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1900043|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900044|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1900045|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
1900046|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1900047|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
1900048|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
1900049|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900050|NCT00419926|Cyclosporine|cyclosporine|mesh-list
1900051|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
1900052|NCT00419926|Prednisone|prednisone|mesh-list
1900053|NCT00419926|Cyclosporins|cyclosporins|mesh-list
1900054|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900055|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
1900056|NCT00419926|Hormones|hormones|mesh-ancestor
1900057|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900058|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900059|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900060|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900061|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900062|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900063|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900064|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
1900065|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
1900066|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900067|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900068|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900069|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1900070|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1900071|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1900072|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
1900073|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1900074|NCT00419952|Budesonide|budesonide|mesh-list
1900075|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
1900076|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1900077|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900078|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1900079|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
1900080|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900081|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900082|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1900083|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
1900084|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
1900085|NCT00419952|Hormones|hormones|mesh-ancestor
1900086|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900087|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1900088|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1900089|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1900090|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
1900091|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900092|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900093|NCT00420004|Citalopram|citalopram|mesh-list
1900094|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1900095|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1900096|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900097|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900098|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900099|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
1900100|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900101|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1900102|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
1900103|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900104|NCT00420017|Amiodarone|amiodarone|mesh-list
1900105|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1900106|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
1900107|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1900108|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900109|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900110|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1900111|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1900112|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1900113|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900114|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1900115|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1900116|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1900117|NCT00420056|Palbociclib|palbociclib|mesh-list
1900118|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900119|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900120|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900121|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900122|NCT00420095|Insulin|insulin|mesh-list
1900123|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1900124|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
1900125|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1900126|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900127|NCT00420199|Abatacept|abatacept|mesh-list
1900128|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1900129|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900130|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900131|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900132|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
1900133|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900134|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900135|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1900136|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900137|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900138|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
1900139|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900140|NCT00420238|Etanercept|etanercept|mesh-list
1900141|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1900142|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1900143|NCT00420238|Analgesics|analgesics|mesh-ancestor
1900144|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
1900145|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900146|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900147|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900148|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900149|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900150|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900151|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
1900152|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1900153|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900154|NCT00420303|Etanercept|etanercept|mesh-list
1900155|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1900156|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1900157|NCT00420303|Analgesics|analgesics|mesh-ancestor
1900158|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
1900159|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900160|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900161|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900162|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900163|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900164|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900165|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
1900166|NCT00420316|Vaccines|vaccines|mesh-list
1900167|NCT00420316|Immunologic Factors|immunologic factors|mesh-ancestor
1900168|NCT00420316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900169|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1900170|NCT00420342|Drospirenone|drospirenone|mesh-list
1900171|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1900172|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1900173|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
1900174|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1900175|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1900176|NCT00420342|Estradiol|estradiol|mesh-list
1900177|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1900178|NCT00420342|Estrogens|estrogens|mesh-ancestor
1900179|NCT00420342|Hormones|hormones|mesh-ancestor
1900180|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900181|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900182|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1900183|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
1900259|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1900184|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1900185|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1900186|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1900187|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1900188|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1900189|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1900190|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900191|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900192|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1900193|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
1900194|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1900195|NCT00420342|Diuretics|diuretics|mesh-ancestor
1900196|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
1900197|NCT00420407|Vasopressins|vasopressins|mesh-list
1900198|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
1900199|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
1900200|NCT00420407|Coagulants|coagulants|mesh-ancestor
1900201|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1900202|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1900203|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
1900204|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900205|NCT00420459|Aripiprazole|aripiprazole|mesh-list
1900206|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
1900207|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900208|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1900209|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1900210|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1900211|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900212|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
1900213|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
1900214|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900215|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900216|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1900217|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1900218|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
1900219|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1900220|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1900221|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1900222|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1900223|NCT00420511|Metformin|metformin|mesh-list
1900224|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1900225|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1900226|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900227|NCT00420511|Incretins|incretins|mesh-ancestor
1900228|NCT00420511|Hormones|hormones|mesh-ancestor
1900229|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900230|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1900231|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
1900232|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900233|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900234|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1900235|NCT00420628|Tobramycin|tobramycin|mesh-list
1900236|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1900237|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900238|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1900239|NCT00420641|Paroxetine|paroxetine|mesh-list
1900240|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1900241|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1900242|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900243|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900244|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900245|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
1900246|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900247|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1900248|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
1900249|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900250|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1900251|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1900252|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900253|NCT00420771|Gabapentin|gabapentin|mesh-list
1900254|NCT00420771|Analgesics|analgesics|mesh-ancestor
1900255|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
1900256|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900257|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900260|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1900261|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1900262|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900263|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1900264|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1900265|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900266|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900267|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
1900268|NCT00420784|Interferons|interferons|mesh-list
1900269|NCT00420784|Ribavirin|ribavirin|mesh-list
1900270|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
1900271|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
1900272|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1900273|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900274|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
1900275|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900276|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
1900277|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900278|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
1900279|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900280|NCT00420849|Dexamethasone|dexamethasone|mesh-list
1900281|NCT00420849|Lenalidomide|lenalidomide|mesh-list
1900282|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900283|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
1900284|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
1900285|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900286|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900287|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900288|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
1900289|NCT00420849|Hormones|hormones|mesh-ancestor
1900290|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900291|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900292|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900293|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
1900294|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1900295|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1900296|NCT00420849|Growth Substances|growth substances|mesh-ancestor
1900297|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
1900298|NCT00420927|Adalimumab|adalimumab|mesh-list
1900299|NCT00420927|Methotrexate|methotrexate|mesh-list
1900300|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1900301|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
1900302|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1900303|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900304|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900305|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
1900306|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900307|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900308|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900309|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900310|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1900311|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900312|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
1900313|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900314|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1900315|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900316|NCT00420992|Naltrexone|naltrexone|mesh-list
1900317|NCT00420992|Morphine|morphine|mesh-list
1900318|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1900319|NCT00420992|Narcotics|narcotics|mesh-ancestor
1900320|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1900321|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900322|NCT00420992|Analgesics|analgesics|mesh-ancestor
1900323|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
1900324|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900325|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1900326|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1900327|NCT00421148|Bromides|bromides|mesh-list
1900328|NCT00421148|Rocuronium|rocuronium|mesh-list
1900329|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
1900330|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1900331|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1900332|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1900333|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900334|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900335|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
1900336|NCT00421174|Etanercept|etanercept|mesh-list
1900337|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900338|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
1900339|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
1900340|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900341|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900342|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900343|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
1900344|NCT00421174|Hormones|hormones|mesh-ancestor
1900345|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900346|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1900347|NCT00421174|Protective Agents|protective agents|mesh-ancestor
1900348|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1900349|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1900350|NCT00421174|Analgesics|analgesics|mesh-ancestor
1900351|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
1900352|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900353|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900354|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
1900355|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
1900356|NCT00421343|Alendronate|alendronate|mesh-list
1900357|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
1900358|NCT00421343|Calcium|calcium|mesh-list
1900359|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1900360|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900361|NCT00421343|Vitamins|vitamins|mesh-ancestor
1900362|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
1900363|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1900364|NCT00421343|Antacids|antacids|mesh-ancestor
1900365|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900366|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900367|NCT00421603|Topiramate|topiramate|mesh-list
1900368|NCT00421603|Adderall|adderall|mesh-list
1900369|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
1900370|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1900371|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900372|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1900373|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
1900374|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1900375|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900376|NCT00421733|Vitamins|vitamins|mesh-ancestor
1900377|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
1900378|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1900379|NCT00421889|Paclitaxel|paclitaxel|mesh-list
1900380|NCT00421889|Carboplatin|carboplatin|mesh-list
1900381|NCT00421889|Belinostat|belinostat|mesh-list
1900382|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1900383|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900384|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
1900385|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
1900386|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
1900387|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900388|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1900389|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900390|NCT00421928|Oxycodone|oxycodone|mesh-list
1900391|NCT00421928|Tapentadol|tapentadol|mesh-list
1900392|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1900393|NCT00421928|Narcotics|narcotics|mesh-ancestor
1900394|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1900395|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900396|NCT00421928|Analgesics|analgesics|mesh-ancestor
1900397|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
1900398|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900399|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1900400|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1900401|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900402|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900403|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
1900404|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900405|NCT00421993|Adapalene|adapalene|mesh-list
1900406|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1900407|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1900408|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900409|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1900410|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1900411|NCT00421993|Analgesics|analgesics|mesh-ancestor
1900412|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
1900413|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900414|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900415|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900416|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900417|NCT00422032|Clofarabine|clofarabine|mesh-list
1900418|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900419|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
1900420|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900421|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900422|NCT00422058|Liraglutide|liraglutide|mesh-list
1900423|NCT00422058|Orlistat|orlistat|mesh-list
1900424|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1900425|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900426|NCT00422058|Incretins|incretins|mesh-ancestor
1900427|NCT00422058|Hormones|hormones|mesh-ancestor
1900428|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900429|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900430|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900431|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1900432|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1900433|NCT00422084|Artesunate|artesunate|mesh-list
1900434|NCT00422084|Lumefantrine|lumefantrine|mesh-list
1900435|NCT00422084|Artemether|artemether|mesh-list
1900436|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1900437|NCT00422084|Pyronaridine|pyronaridine|mesh-list
1900438|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
1900439|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1900440|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1900441|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900442|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900443|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
1900444|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
1900445|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1900446|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
1900447|NCT00422097|Epothilones|epothilones|mesh-list
1900448|NCT00422097|Famotidine|famotidine|mesh-list
1900449|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
1900450|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
1900451|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
1900452|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900453|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900454|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1900455|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900456|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1900457|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
1900458|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
1900459|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900460|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900461|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1900462|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1900463|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1900464|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900465|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900466|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900467|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900468|NCT00422162|Analgesics|analgesics|mesh-ancestor
1900469|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
1900470|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900471|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
1900472|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900473|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
1900474|NCT00422201|Mifepristone|mifepristone|mesh-list
1900475|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1900476|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
1900477|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1900478|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900479|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1900480|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1900481|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1900482|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
1900483|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1900484|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1900485|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
1900486|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900487|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
1900488|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1900489|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1900490|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
1900491|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
1900492|NCT00422227|Etanercept|etanercept|mesh-list
1900493|NCT00422227|Methotrexate|methotrexate|mesh-list
1900494|NCT00422227|Leflunomide|leflunomide|mesh-list
1900495|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1900496|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
1900497|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1900498|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900499|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900500|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
1900501|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900502|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900503|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900504|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900505|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1900506|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900507|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
1900508|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900509|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1900510|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
1900511|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1900512|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1900513|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900514|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1900515|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1900516|NCT00422227|Analgesics|analgesics|mesh-ancestor
1900517|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
1900518|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900519|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900520|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900521|NCT00422292|Vaccines|vaccines|mesh-list
1900522|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
1900523|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900524|NCT00422383|Rituximab|rituximab|mesh-list
1900525|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1900526|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900527|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
1900528|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900529|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900530|NCT00422422|Brivaracetam|brivaracetam|mesh-list
1900531|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
1900532|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
1900533|NCT00422513|Hematinics|hematinics|mesh-ancestor
1900534|NCT00422591|Cytarabine|cytarabine|mesh-list
1900535|NCT00422591|Idarubicin|idarubicin|mesh-list
1900536|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900537|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
1900538|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900539|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900540|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
1900541|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900542|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900543|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
1900544|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900545|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1900546|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1900547|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1900548|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900549|NCT00422734|Tadalafil|tadalafil|mesh-list
1900550|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
1900551|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1900552|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1900553|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900554|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900555|NCT00422734|Urological Agents|urological agents|mesh-ancestor
1900556|NCT00422799|Rituximab|rituximab|mesh-list
1900557|NCT00422799|Bortezomib|bortezomib|mesh-list
1900558|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1900559|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900560|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
1900561|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900562|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900563|NCT00422903|Letrozole|letrozole|mesh-list
1900564|NCT00422903|Lapatinib|lapatinib|mesh-list
1900565|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900566|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1900567|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1900568|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900569|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900570|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1900571|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
1900572|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900573|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900574|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900575|NCT00423085|Rivastigmine|rivastigmine|mesh-list
1900576|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1900577|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900578|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900579|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
1900580|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900581|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900582|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1900583|NCT00423085|Protective Agents|protective agents|mesh-ancestor
1900584|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
1900585|NCT00423098|Prednisone|prednisone|mesh-list
1900586|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
1900587|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1900588|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1900589|NCT00423098|Prednisolone|prednisolone|mesh-list
1900590|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
1900591|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1900592|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
1900593|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900594|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
1900595|NCT00423098|Hormones|hormones|mesh-ancestor
1900596|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900597|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900598|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900599|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900600|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1900601|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1900602|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
1900603|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1900604|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900605|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900606|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900607|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
1900608|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
1900609|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900610|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900611|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1900612|NCT00423098|Protective Agents|protective agents|mesh-ancestor
1900613|NCT00423150|Temozolomide|temozolomide|mesh-list
1900614|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1900615|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
1900616|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900617|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900618|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1900619|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1900620|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900621|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
1900622|NCT00423189|Ranibizumab|ranibizumab|mesh-list
1900623|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1900624|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1900625|NCT00423189|Growth Substances|growth substances|mesh-ancestor
1900626|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900627|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
1900628|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900629|NCT00423267|Fluconazole|fluconazole|mesh-list
1900630|NCT00423267|Posaconazole|posaconazole|mesh-list
1900631|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
1900632|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900633|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1900634|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1900635|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900636|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900637|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1900638|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
1900639|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900640|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900641|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1900642|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1900643|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1900644|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1900645|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1900646|NCT00423293|Fluorouracil|fluorouracil|mesh-list
1900647|NCT00423293|Mitomycins|mitomycins|mesh-list
1900648|NCT00423293|Mitomycin|mitomycin|mesh-list
1900649|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
1900650|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900651|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900652|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900653|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900654|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
1900655|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900656|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1900657|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
1900658|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1900659|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900660|NCT00423319|Enoxaparin|enoxaparin|mesh-list
1900661|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
1900662|NCT00423319|Apixaban|apixaban|mesh-list
1900663|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
1900664|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1900665|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1900666|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900667|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1900668|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
1900669|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1900670|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
1900671|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900672|NCT00423332|Cediranib|cediranib|mesh-list
1900673|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900674|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900675|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900676|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900677|NCT00423358|Vitamin D|vitamin d|mesh-list
1900678|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
1900679|NCT00423358|Vitamins|vitamins|mesh-ancestor
1900680|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
1900681|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900682|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1900683|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1900684|NCT00423449|Gemcitabine|gemcitabine|mesh-list
1900685|NCT00423449|Vorinostat|vorinostat|mesh-list
1900686|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900687|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
1900688|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900689|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900690|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
1900691|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900692|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900693|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900694|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
1900695|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900696|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1900697|NCT00423488|Simvastatin|simvastatin|mesh-list
1900698|NCT00423488|Ezetimibe|ezetimibe|mesh-list
1900699|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1900700|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1900701|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
1900702|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900703|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1900704|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1900705|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900706|NCT00423579|Simvastatin|simvastatin|mesh-list
1900707|NCT00423579|Ezetimibe|ezetimibe|mesh-list
1900708|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1900709|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1900710|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1900711|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
1900712|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900713|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1900714|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1900715|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900716|NCT00423592|Ambrisentan|ambrisentan|mesh-list
1900717|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1900718|NCT00423657|Vancomycin|vancomycin|mesh-list
1900719|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1900720|NCT00423657|Aztreonam|aztreonam|mesh-list
1900721|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1900722|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900723|NCT00423670|Ribavirin|ribavirin|mesh-list
1900724|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1900725|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
1900726|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900727|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
1900728|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900729|NCT00423683|PENTA|penta|mesh-list
1900730|NCT00423683|Fondaparinux|fondaparinux|mesh-list
1900731|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1900732|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
1900733|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1900734|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
1900735|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900736|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900737|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
1900738|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1900739|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1900740|NCT00423735|Dasatinib|dasatinib|mesh-list
1900741|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900742|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900743|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900744|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900745|NCT00423800|Interferons|interferons|mesh-list
1900746|NCT00423800|Ribavirin|ribavirin|mesh-list
1900747|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
1900748|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
1900749|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1900750|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900751|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
1900752|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900753|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
1900754|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900755|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
1900756|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900757|NCT00423852|Paclitaxel|paclitaxel|mesh-list
1900758|NCT00423852|Carboplatin|carboplatin|mesh-list
1900759|NCT00423852|Ifosfamide|ifosfamide|mesh-list
1900760|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1900761|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900762|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
1900763|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
1900764|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
1900765|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900766|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1900767|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
1900768|NCT00423878|Olanzapine|olanzapine|mesh-list
1900769|NCT00423878|Risperidone|risperidone|mesh-list
1900770|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1900771|NCT00423878|Aripiprazole|aripiprazole|mesh-list
1900772|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1900773|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
1900774|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900775|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900776|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900777|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1900778|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1900779|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1900780|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900781|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1900782|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
1900783|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
1900784|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
1900785|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900786|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900787|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1900788|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1900789|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900790|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
1900791|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
1900792|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1900793|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1900794|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1900795|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1900796|NCT00423891|Entecavir|entecavir|mesh-list
1900797|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
1900798|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900799|NCT00423917|Bevacizumab|bevacizumab|mesh-list
1900800|NCT00423917|Fulvestrant|fulvestrant|mesh-list
1900801|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1900802|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900803|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1900804|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1900805|NCT00423917|Growth Substances|growth substances|mesh-ancestor
1900806|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900807|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
1900808|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900809|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1900810|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1900811|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
1900812|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900813|NCT00423930|Bevacizumab|bevacizumab|mesh-list
1900814|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1900815|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900816|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1900817|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1900818|NCT00423930|Growth Substances|growth substances|mesh-ancestor
1900819|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900820|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
1900821|NCT00423943|Modafinil|modafinil|mesh-list
1900822|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1900823|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900824|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1900825|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1900826|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1900827|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900828|NCT00424008|Fluticasone|fluticasone|mesh-list
1900829|NCT00424008|Xhance|xhance|mesh-list
1900830|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
1900831|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
1900832|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1900833|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1900834|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900835|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1900836|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
1900837|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900838|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900839|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1900840|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
1900841|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900842|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1900843|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1900844|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1900845|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1900846|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
1900847|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1900848|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900849|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
1900850|NCT00424008|Hormones|hormones|mesh-ancestor
1900851|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900852|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
1900853|NCT00424021|Ambrisentan|ambrisentan|mesh-list
1900854|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1900855|NCT00424047|Dexamethasone|dexamethasone|mesh-list
1900856|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
1900857|NCT00424047|Lenalidomide|lenalidomide|mesh-list
1900858|NCT00424047|BB 1101|bb 1101|mesh-list
1900859|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900860|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
1900861|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
1900862|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900863|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900864|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900865|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
1900866|NCT00424047|Hormones|hormones|mesh-ancestor
1900867|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900868|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900869|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900870|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
1900871|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900872|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900873|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
1900874|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1900875|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1900876|NCT00424047|Growth Substances|growth substances|mesh-ancestor
1900877|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
1900878|NCT00424190|Vancomycin|vancomycin|mesh-list
1900879|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1900880|NCT00424190|Aztreonam|aztreonam|mesh-list
1900881|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1900882|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1900883|NCT00424255|Lapatinib|lapatinib|mesh-list
1900884|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900885|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900886|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900887|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900888|NCT00424294|Celecoxib|celecoxib|mesh-list
1900889|NCT00424294|Methotrexate|methotrexate|mesh-list
1900890|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1900891|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
1900892|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1900893|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900894|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900895|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
1900896|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900897|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900898|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900899|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900900|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1900901|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900902|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
1900903|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900904|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1900905|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1900906|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1900907|NCT00424294|Analgesics|analgesics|mesh-ancestor
1900908|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
1900909|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900910|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900911|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1900912|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1900913|NCT00424372|Pregabalin|pregabalin|mesh-list
1900914|NCT00424372|Analgesics|analgesics|mesh-ancestor
1900915|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
1900916|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900917|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900918|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
1900919|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1900920|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1900921|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900922|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1900923|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1900924|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1900925|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1900926|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1900927|NCT00424385|Sorafenib|sorafenib|mesh-list
1900928|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
1900929|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900930|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900931|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900932|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900933|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
1900934|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1900935|NCT00424463|Edaravone|edaravone|mesh-list
1900936|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1900937|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
1900938|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900939|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1900940|NCT00424463|Protective Agents|protective agents|mesh-ancestor
1900941|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900942|NCT00424476|Belimumab|belimumab|mesh-list
1900943|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900944|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
1900945|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900946|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
1900947|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1900948|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1900949|NCT00424489|Prednisolone|prednisolone|mesh-list
1900950|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
1900951|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
1900952|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1900953|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
1900954|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900955|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
1900956|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900957|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900958|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1900959|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
1900960|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900961|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900962|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1900963|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1900964|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
1900965|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
1900966|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1900967|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1900968|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
1900969|NCT00424489|Hormones|hormones|mesh-ancestor
1900970|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1900971|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1900972|NCT00424489|Protective Agents|protective agents|mesh-ancestor
1900973|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1900974|NCT00424502|Rituximab|rituximab|mesh-list
1900975|NCT00424502|Methotrexate|methotrexate|mesh-list
1900976|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1900977|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900978|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
1900979|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1900980|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1900981|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1900982|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
1900983|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1900984|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1900985|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
1900986|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900987|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
1900988|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900989|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1900990|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1900991|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1900992|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
1900993|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1900994|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1900995|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1900996|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1900997|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
1900998|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
1900999|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1901000|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
1901001|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901002|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901003|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1901004|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
1901005|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
1901006|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1901007|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
1901008|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901009|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901010|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1901011|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1901012|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1901013|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
1901014|NCT00424554|Temozolomide|temozolomide|mesh-list
1901015|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901016|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
1901017|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901018|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901019|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1901020|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1901021|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1901022|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901023|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901024|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901025|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901026|NCT00424593|Analgesics|analgesics|mesh-ancestor
1901027|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
1901028|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901029|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
1901030|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1901031|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
1901032|NCT00424619|Vitamin D|vitamin d|mesh-list
1901033|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
1901034|NCT00424619|Vitamins|vitamins|mesh-list
1901035|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
1901036|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901037|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1901038|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1901039|NCT00424749|Prednisone|prednisone|mesh-list
1901040|NCT00424749|Rituximab|rituximab|mesh-list
1901041|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901042|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901043|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
1901044|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901045|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901046|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901047|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
1901048|NCT00424749|Hormones|hormones|mesh-ancestor
1901049|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901050|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901051|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
1901052|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1901053|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901054|NCT00424775|Vorinostat|vorinostat|mesh-list
1901055|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901056|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1901057|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901058|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901059|NCT00424827|Gemcitabine|gemcitabine|mesh-list
1901060|NCT00424827|Fluorouracil|fluorouracil|mesh-list
1901061|NCT00424827|Cetuximab|cetuximab|mesh-list
1901062|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1901063|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
1901064|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901065|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901066|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
1901067|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901068|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901069|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901070|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
1901071|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901072|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901073|NCT00424840|Bevacizumab|bevacizumab|mesh-list
1901074|NCT00424840|Carboplatin|carboplatin|mesh-list
1901075|NCT00424840|Bortezomib|bortezomib|mesh-list
1901076|NCT00424840|Docetaxel|docetaxel|mesh-list
1901077|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901078|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901079|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1901080|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1901081|NCT00424840|Growth Substances|growth substances|mesh-ancestor
1901082|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901083|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
1901084|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901085|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901086|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901087|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901088|NCT00425100|Fesoterodine|fesoterodine|mesh-list
1901089|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1901090|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1901091|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
1901092|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901093|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901094|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901095|NCT00425100|Urological Agents|urological agents|mesh-ancestor
1901096|NCT00425113|Metronidazole|metronidazole|mesh-list
1901097|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901098|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901099|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1901100|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1901101|NCT00425308|Cyclosporine|cyclosporine|mesh-list
1901102|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
1901103|NCT00425308|Everolimus|everolimus|mesh-list
1901104|NCT00425308|Cyclosporins|cyclosporins|mesh-list
1901105|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901106|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901107|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901108|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
1901109|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901110|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
1901111|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901112|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
1901113|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901114|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1901115|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901116|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901117|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1901118|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
1901119|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901120|NCT00425373|Amlodipine|amlodipine|mesh-list
1901121|NCT00425373|Valsartan|valsartan|mesh-list
1901122|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1901123|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1901124|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901125|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901126|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1901127|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901128|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
1901129|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1901130|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1901131|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1901132|NCT00425386|Sunitinib|sunitinib|mesh-list
1901133|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901134|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901135|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901136|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901137|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1901138|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1901139|NCT00425386|Growth Substances|growth substances|mesh-ancestor
1901140|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901141|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
1901142|NCT00425477|Bexarotene|bexarotene|mesh-list
1901143|NCT00425477|Sargramostim|sargramostim|mesh-list
1901144|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
1901145|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901146|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901147|NCT00425503|Bortezomib|bortezomib|mesh-list
1901148|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901149|NCT00425555|Panobinostat|panobinostat|mesh-list
1901150|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901151|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1901152|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901153|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901154|NCT00425607|Lonafarnib|lonafarnib|mesh-list
1901155|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901156|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901157|NCT00425672|Interleukin-2|interleukin-2|mesh-list
1901158|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
1901159|NCT00425672|Immunotoxins|immunotoxins|mesh-list
1901160|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901161|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1901162|NCT00425672|Analgesics|analgesics|mesh-ancestor
1901163|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
1901164|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901319|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
1901165|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901166|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
1901167|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
1901168|NCT00425698|Hematinics|hematinics|mesh-ancestor
1901169|NCT00425750|Docetaxel|docetaxel|mesh-list
1901170|NCT00425750|Bortezomib|bortezomib|mesh-list
1901171|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901172|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901173|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901174|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901175|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901176|NCT00425802|Cyclosporine|cyclosporine|mesh-list
1901177|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
1901178|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
1901179|NCT00425802|Rituximab|rituximab|mesh-list
1901180|NCT00425802|Fludarabine|fludarabine|mesh-list
1901181|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
1901182|NCT00425802|Cyclosporins|cyclosporins|mesh-list
1901183|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1901184|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901185|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
1901186|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901187|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901188|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901189|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
1901190|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901191|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901192|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901193|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901194|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1901195|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
1901196|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901197|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
1901198|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901199|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
1901200|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1901201|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901202|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1901203|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
1901204|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901205|NCT00425854|Afatinib|afatinib|mesh-list
1901206|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901207|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901208|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901209|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901210|NCT00425945|Pycnogenols|pycnogenols|mesh-list
1901211|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1901212|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
1901213|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901214|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
1901215|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901216|NCT00425945|Protective Agents|protective agents|mesh-ancestor
1901217|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1901218|NCT00426127|Docetaxel|docetaxel|mesh-list
1901219|NCT00426127|Doxorubicin|doxorubicin|mesh-list
1901220|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1901221|NCT00426127|Enoxaparin|enoxaparin|mesh-list
1901222|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901223|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901224|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901225|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901226|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901227|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901228|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1901229|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1901230|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901231|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
1901232|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1901233|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1901234|NCT00426153|Octreotide|octreotide|mesh-list
1901235|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1901236|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901237|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901238|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
1901239|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
1901240|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901241|NCT00426283|Fluticasone|fluticasone|mesh-list
1901242|NCT00426283|Xhance|xhance|mesh-list
1901243|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901244|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1901245|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
1901246|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901247|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901248|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1901249|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
1901250|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
1901251|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1901252|NCT00426361|Vaccines|vaccines|mesh-list
1901253|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
1901254|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901255|NCT00426517|Sirolimus|sirolimus|mesh-list
1901256|NCT00426517|Busulfan|busulfan|mesh-list
1901257|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
1901258|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901259|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901260|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901261|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901262|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
1901263|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901264|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
1901265|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901266|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
1901267|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901268|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901269|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901270|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901271|NCT00426556|Paclitaxel|paclitaxel|mesh-list
1901272|NCT00426556|Trastuzumab|trastuzumab|mesh-list
1901273|NCT00426556|Everolimus|everolimus|mesh-list
1901274|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1901275|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901276|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901277|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901278|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901279|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901280|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901281|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901282|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
1901283|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901284|NCT00426660|Maraviroc|maraviroc|mesh-list
1901285|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1901286|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1901287|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901288|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1901289|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1901290|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
1901291|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901292|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1901293|NCT00426751|Abciximab|abciximab|mesh-list
1901294|NCT00426751|Eptifibatide|eptifibatide|mesh-list
1901295|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
1901296|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1901297|NCT00426764|Romidepsin|romidepsin|mesh-list
1901298|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901299|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901300|NCT00426842|Midodrine|midodrine|mesh-list
1901301|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
1901302|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
1901303|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901304|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901305|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1901306|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1901307|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1901308|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1901309|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
1901310|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901311|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901312|NCT00426855|Bortezomib|bortezomib|mesh-list
1901313|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1901314|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901315|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901316|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
1901317|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901318|NCT00427037|Vitamin D|vitamin d|mesh-list
1901320|NCT00427037|Vitamins|vitamins|mesh-ancestor
1901321|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
1901322|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901323|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1901324|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1901325|NCT00427297|Ritonavir|ritonavir|mesh-list
1901326|NCT00427297|Lopinavir|lopinavir|mesh-list
1901327|NCT00427297|Tenofovir|tenofovir|mesh-list
1901328|NCT00427297|Lamivudine|lamivudine|mesh-list
1901329|NCT00427297|Zidovudine|zidovudine|mesh-list
1901330|NCT00427297|Nevirapine|nevirapine|mesh-list
1901331|NCT00427297|Abacavir|abacavir|mesh-list
1901332|NCT00427297|Stavudine|stavudine|mesh-list
1901333|NCT00427297|Didanosine|didanosine|mesh-list
1901334|NCT00427297|Efavirenz|efavirenz|mesh-list
1901335|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
1901336|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1901337|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1901338|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
1901339|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901340|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901341|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1901342|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1901343|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
1901344|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901345|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1901346|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1901347|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1901348|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1901349|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
1901350|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1901351|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1901352|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1901353|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1901354|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1901355|NCT00427336|Vidarabine|vidarabine|mesh-list
1901356|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
1901357|NCT00427336|Fludarabine|fludarabine|mesh-list
1901358|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
1901359|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
1901360|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1901361|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901362|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
1901363|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901364|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901365|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901366|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
1901367|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901368|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901369|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901370|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1901371|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
1901372|NCT00427336|Antiviral Agents|antiviral agents|mesh-ancestor
1901373|NCT00427336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901374|NCT00427349|Octreotide|octreotide|mesh-list
1901375|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
1901376|NCT00427349|Imetelstat|imetelstat|mesh-list
1901377|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1901378|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901379|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901380|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901381|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901382|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901383|NCT00427557|Vidarabine|vidarabine|mesh-list
1901384|NCT00427557|Rituximab|rituximab|mesh-list
1901385|NCT00427557|Fludarabine|fludarabine|mesh-list
1901386|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
1901387|NCT00427557|Melphalan|melphalan|mesh-list
1901388|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901389|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901390|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
1901391|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901392|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901393|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1901394|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
1901395|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901396|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901397|NCT00427557|Antiviral Agents|antiviral agents|mesh-ancestor
1901398|NCT00427557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901399|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901400|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
1901401|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901402|NCT00427635|Esomeprazole|esomeprazole|mesh-list
1901403|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1901404|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1901405|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1901406|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901407|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901408|NCT00427648|Lidocaine|lidocaine|mesh-list
1901409|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
1901410|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
1901411|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1901412|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901413|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
1901414|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901415|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1901416|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1901417|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1901418|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901419|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901420|NCT00427661|Cyclosporine|cyclosporine|mesh-list
1901421|NCT00427661|Fludarabine|fludarabine|mesh-list
1901422|NCT00427661|Busulfan|busulfan|mesh-list
1901423|NCT00427661|Cyclosporins|cyclosporins|mesh-list
1901424|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901425|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901426|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901427|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
1901428|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901429|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901430|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
1901431|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901432|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
1901433|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901434|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1901435|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
1901436|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901437|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901438|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1901439|NCT00427700|Clomiphene|clomiphene|mesh-list
1901440|NCT00427700|Enclomiphene|enclomiphene|mesh-list
1901441|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
1901442|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1901443|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
1901444|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901445|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901446|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1901447|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
1901448|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1901449|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1901450|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1901451|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1901452|NCT00427765|Melphalan|melphalan|mesh-list
1901453|NCT00427765|Busulfan|busulfan|mesh-list
1901454|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901455|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
1901456|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901457|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901458|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901459|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901460|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
1901461|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901462|NCT00427791|Rituximab|rituximab|mesh-list
1901463|NCT00427791|Etoposide|etoposide|mesh-list
1901464|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901465|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901466|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
1901467|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901468|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901469|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1901470|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1901471|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1901472|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901473|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901474|NCT00427804|Calcitriol|calcitriol|mesh-list
1901475|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1901476|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901477|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1901478|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901479|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901480|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1901481|NCT00427804|Vitamins|vitamins|mesh-ancestor
1901482|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
1901483|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1901484|NCT00427895|Vaccines|vaccines|mesh-list
1901485|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1901486|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
1901487|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901488|NCT00427921|Adalimumab|adalimumab|mesh-list
1901489|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901490|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901491|NCT00427934|Maraviroc|maraviroc|mesh-list
1901492|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1901493|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1901494|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901495|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1901496|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1901497|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
1901498|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901499|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1901500|NCT00427960|Atorvastatin|atorvastatin|mesh-list
1901501|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1901502|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1901503|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1901504|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
1901505|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901506|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1901507|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1901508|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901509|NCT00427973|Cediranib|cediranib|mesh-list
1901510|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901511|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901512|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901513|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901514|NCT00427999|Pioglitazone|pioglitazone|mesh-list
1901515|NCT00427999|Dexamethasone|dexamethasone|mesh-list
1901516|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
1901517|NCT00427999|Etoricoxib|etoricoxib|mesh-list
1901518|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
1901519|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901520|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
1901521|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
1901522|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901523|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901524|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1901525|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
1901526|NCT00427999|Hormones|hormones|mesh-ancestor
1901527|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901528|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901529|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901530|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1901531|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901532|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901533|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901534|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1901535|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1901536|NCT00427999|Analgesics|analgesics|mesh-ancestor
1901537|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
1901538|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901539|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1901540|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1901541|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
1901542|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1901543|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901544|NCT00428220|Sunitinib|sunitinib|mesh-list
1901545|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901546|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1901547|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1901548|NCT00428220|Growth Substances|growth substances|mesh-ancestor
1901549|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901550|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
1901551|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901552|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901553|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901554|NCT00428298|Valacyclovir|valacyclovir|mesh-list
1901555|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
1901556|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901557|NCT00428389|Rivastigmine|rivastigmine|mesh-list
1901558|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1901559|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901560|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901561|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
1901562|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901563|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901564|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1901565|NCT00428389|Protective Agents|protective agents|mesh-ancestor
1901566|NCT00428441|Warfarin|warfarin|mesh-list
1901567|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
1901568|NCT00428584|Interferons|interferons|mesh-list
1901569|NCT00428584|Interferon-beta|interferon-beta|mesh-list
1901570|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
1901571|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901572|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
1901573|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901574|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
1901575|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901576|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1901577|NCT00428597|Sunitinib|sunitinib|mesh-list
1901578|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901579|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1901580|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1901581|NCT00428597|Growth Substances|growth substances|mesh-ancestor
1901582|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901583|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
1901584|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901585|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901586|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901587|NCT00428792|Methylphenidate|methylphenidate|mesh-list
1901588|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1901589|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901590|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1901591|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1901592|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901593|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901594|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
1901595|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901596|NCT00428844|Vancomycin|vancomycin|mesh-list
1901597|NCT00428844|Daptomycin|daptomycin|mesh-list
1901598|NCT00428844|Teicoplanin|teicoplanin|mesh-list
1901599|NCT00428844|Floxacillin|floxacillin|mesh-list
1901600|NCT00428844|Oxacillin|oxacillin|mesh-list
1901601|NCT00428844|Nafcillin|nafcillin|mesh-list
1901602|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901603|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901604|NCT00428922|Bevacizumab|bevacizumab|mesh-list
1901605|NCT00428922|Trastuzumab|trastuzumab|mesh-list
1901606|NCT00428922|Docetaxel|docetaxel|mesh-list
1901607|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901608|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901609|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1901610|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1901611|NCT00428922|Growth Substances|growth substances|mesh-ancestor
1901612|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901613|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
1901614|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901615|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901616|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901617|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901618|NCT00428948|Tolvaptan|tolvaptan|mesh-list
1901619|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1901620|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901621|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
1901622|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901623|NCT00429104|Trastuzumab|trastuzumab|mesh-list
1901624|NCT00429104|Sargramostim|sargramostim|mesh-list
1901625|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901626|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901627|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
1901628|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901629|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
1901630|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
1901631|NCT00429143|Tacrolimus|tacrolimus|mesh-list
1901632|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901633|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
1901634|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901635|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901636|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901637|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
1901638|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901639|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901640|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901641|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1901642|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901643|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901644|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1901645|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
1901646|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901647|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901648|NCT00429169|Bupropion|bupropion|mesh-list
1901649|NCT00429169|Paroxetine|paroxetine|mesh-list
1901650|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1901651|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
1901652|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1901653|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1901654|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1901655|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901656|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901657|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
1901658|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901659|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901660|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1901661|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1901662|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901663|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1901664|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
1901665|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
1901666|NCT00429182|Thiotepa|thiotepa|mesh-list
1901667|NCT00429182|Carboplatin|carboplatin|mesh-list
1901668|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901669|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
1901670|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901671|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901672|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901673|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
1901674|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901675|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901676|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901677|NCT00429273|Guanfacine|guanfacine|mesh-list
1901678|NCT00429273|Methylphenidate|methylphenidate|mesh-list
1901679|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1901680|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1901681|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901682|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1901683|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1901684|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901685|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901686|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
1901687|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901688|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1901689|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1901690|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1901691|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1901692|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
1901693|NCT00429299|Paclitaxel|paclitaxel|mesh-list
1901694|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
1901695|NCT00429299|Fluorouracil|fluorouracil|mesh-list
1901696|NCT00429299|Trastuzumab|trastuzumab|mesh-list
1901697|NCT00429299|Lapatinib|lapatinib|mesh-list
1901698|NCT00429299|Epirubicin|epirubicin|mesh-list
1901699|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1901700|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901701|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901702|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901703|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901704|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901705|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901706|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
1901707|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901708|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901709|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901710|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
1901711|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901712|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
1901713|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1901714|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901715|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901716|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901717|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901718|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1901719|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1901720|NCT00429364|Losartan|losartan|mesh-list
1901721|NCT00429364|Atenolol|atenolol|mesh-list
1901722|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1901723|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1901724|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1901725|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1901726|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901727|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
1901728|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
1901729|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901730|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901731|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1901732|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1901733|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1901734|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
1901735|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901736|NCT00429403|Goserelin|goserelin|mesh-list
1901737|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901738|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901739|NCT00429416|Cytarabine|cytarabine|mesh-list
1901740|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
1901741|NCT00429416|Fludarabine|fludarabine|mesh-list
1901742|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
1901743|NCT00429416|Molgramostim|molgramostim|mesh-list
1901744|NCT00429416|Tacrolimus|tacrolimus|mesh-list
1901745|NCT00429416|Sargramostim|sargramostim|mesh-list
1901746|NCT00429416|Mesna|mesna|mesh-list
1901747|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901748|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
1901749|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901750|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901751|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901752|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
1901753|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901754|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901755|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901756|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1901757|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
1901758|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
1901759|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901760|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1901761|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901762|NCT00429416|Protective Agents|protective agents|mesh-ancestor
1901763|NCT00429494|Leuprolide|leuprolide|mesh-list
1901764|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1901765|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
1901766|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1901767|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901768|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901769|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901770|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
1901771|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1901772|NCT00429507|Analgesics|analgesics|mesh-ancestor
1901773|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
1901774|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901775|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901776|NCT00429572|Fludarabine|fludarabine|mesh-list
1901777|NCT00429572|Melphalan|melphalan|mesh-list
1901778|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901779|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901780|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901781|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
1901782|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901783|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1901784|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
1901785|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1901786|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
1901787|NCT00429702|Promethazine|promethazine|mesh-list
1901788|NCT00429702|Dexamethasone|dexamethasone|mesh-list
1901789|NCT00429702|Lorazepam|lorazepam|mesh-list
1901790|NCT00429702|Ondansetron|ondansetron|mesh-list
1901791|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901792|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
1901793|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
1901794|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901795|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901796|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1901797|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
1901798|NCT00429702|Hormones|hormones|mesh-ancestor
1901799|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901800|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901801|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901802|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901803|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
1901804|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
1901805|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1901806|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
1901807|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901808|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1901809|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1901810|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1901811|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1901812|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1901813|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1901814|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1901815|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
1901816|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
1901817|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
1901818|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1901819|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
1901820|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
1901821|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1901822|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
1901823|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
1901824|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
1901825|NCT00429793|Sirolimus|sirolimus|mesh-list
1901826|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901827|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901828|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901829|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901830|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
1901831|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901832|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
1901833|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901834|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
1901835|NCT00429923|Difluprednate|difluprednate|mesh-list
1901836|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
1901837|NCT00429923|Hormones|hormones|mesh-ancestor
1901838|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901839|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901840|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901841|NCT00429949|Dasatinib|dasatinib|mesh-list
1901842|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901843|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901844|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901845|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901846|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
1901847|NCT00430092|Difluprednate|difluprednate|mesh-list
1901848|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
1901849|NCT00430092|Hormones|hormones|mesh-ancestor
1901850|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901851|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901852|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901853|NCT00430183|Docetaxel|docetaxel|mesh-list
1901854|NCT00430183|Leuprolide|leuprolide|mesh-list
1901855|NCT00430183|Goserelin|goserelin|mesh-list
1901856|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901857|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
1901858|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
1901859|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
1901860|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901861|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1901862|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
1901863|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1901864|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901865|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901866|NCT00430248|Allopurinol|allopurinol|mesh-list
1901867|NCT00430248|Febuxostat|febuxostat|mesh-list
1901868|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
1901869|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901870|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901871|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
1901872|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901873|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1901874|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
1901875|NCT00430248|Protective Agents|protective agents|mesh-ancestor
1901876|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901877|NCT00430352|Rituximab|rituximab|mesh-list
1901878|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1901879|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901880|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
1901881|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901882|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901883|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1901884|NCT00430508|Olmesartan|olmesartan|mesh-list
1901885|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1901886|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1901887|NCT00430508|Diuretics|diuretics|mesh-ancestor
1901888|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
1901889|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901890|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1901891|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901892|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901893|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1901894|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1901895|NCT00430521|Vaccines|vaccines|mesh-list
1901896|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
1901897|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901898|NCT00430573|Cycloserine|cycloserine|mesh-list
1901899|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1901900|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901901|NCT00430573|Renal Agents|renal agents|mesh-ancestor
1901902|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1901903|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
1901904|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901905|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
1901906|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901907|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1901908|NCT00430638|Olmesartan|olmesartan|mesh-list
1901909|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1901910|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1901911|NCT00430638|Diuretics|diuretics|mesh-ancestor
1901912|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
1901913|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901914|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1901915|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901916|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901917|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1901918|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1901919|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
1901920|NCT00430677|Prednisone|prednisone|mesh-list
1901921|NCT00430677|Prednisolone|prednisolone|mesh-list
1901922|NCT00430677|Abatacept|abatacept|mesh-list
1901923|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1901924|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
1901925|NCT00430677|Hormones|hormones|mesh-ancestor
1901926|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1901927|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901928|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1901929|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901930|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1901931|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1901932|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
1901933|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901934|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901935|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901936|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901937|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1901938|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1901939|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
1901940|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1901941|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
1901942|NCT00430716|Citric Acid|citric acid|mesh-list
1901943|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
1901944|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
1901945|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1901946|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
1901947|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
1901948|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901949|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
1901950|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1901951|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1901952|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901953|NCT00430716|Urological Agents|urological agents|mesh-ancestor
1901954|NCT00430781|Lapatinib|lapatinib|mesh-list
1901955|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1901956|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1901957|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1901958|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901959|NCT00430937|Vancomycin|vancomycin|mesh-list
1901960|NCT00430937|Daptomycin|daptomycin|mesh-list
1901961|NCT00430937|Teicoplanin|teicoplanin|mesh-list
1901962|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1901963|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1901964|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1901965|NCT00430950|Olmesartan|olmesartan|mesh-list
1901966|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1901967|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1901968|NCT00430950|Diuretics|diuretics|mesh-ancestor
1901969|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
1901970|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901971|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1901972|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1901973|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901974|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1901975|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1901976|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
1901977|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1901978|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
1901979|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
1901980|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1901981|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901982|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1901983|NCT00430989|Analgesics|analgesics|mesh-ancestor
1901984|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
1901985|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901986|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
1901987|NCT00431041|Oxybutynin|oxybutynin|mesh-list
1901988|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1901989|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1901990|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
1901991|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1901992|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1901993|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1901994|NCT00431041|Urological Agents|urological agents|mesh-ancestor
1901995|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
1901996|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
1901997|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1901998|NCT00431067|Afatinib|afatinib|mesh-list
1901999|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902000|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902001|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902077|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902002|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902003|NCT00431132|Estradiol|estradiol|mesh-list
1902004|NCT00431132|Estrogens|estrogens|mesh-ancestor
1902005|NCT00431132|Hormones|hormones|mesh-ancestor
1902006|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902007|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902008|NCT00431184|Pentazocine|pentazocine|mesh-list
1902009|NCT00431184|Lorazepam|lorazepam|mesh-list
1902010|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
1902011|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
1902012|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
1902013|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902014|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902015|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1902016|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1902017|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902018|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1902019|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1902020|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902021|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
1902022|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
1902023|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902024|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902025|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1902026|NCT00431184|Narcotics|narcotics|mesh-ancestor
1902027|NCT00431184|Analgesics|analgesics|mesh-ancestor
1902028|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
1902029|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1902030|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1902031|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
1902032|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1902033|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1902034|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902035|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1902036|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
1902037|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902038|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1902039|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1902040|NCT00431496|Cinacalcet|cinacalcet|mesh-list
1902041|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1902042|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902043|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1902044|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
1902045|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902046|NCT00431626|Dutasteride|dutasteride|mesh-list
1902047|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1902048|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1902049|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902050|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902051|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
1902052|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902053|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902054|NCT00431847|Anesthetics|anesthetics|mesh-list
1902055|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902056|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902057|NCT00431964|Azithromycin|azithromycin|mesh-list
1902058|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1902059|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902060|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
1902061|NCT00432172|Carboplatin|carboplatin|mesh-list
1902062|NCT00432172|Docetaxel|docetaxel|mesh-list
1902063|NCT00432172|Epirubicin|epirubicin|mesh-list
1902064|NCT00432172|Exemestane|exemestane|mesh-list
1902065|NCT00432172|Goserelin|goserelin|mesh-list
1902066|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902067|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
1902068|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902069|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902070|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1902071|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
1902072|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902073|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902074|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1902075|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902076|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902078|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1902079|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1902080|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902081|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902082|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1902083|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1902084|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1902085|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
1902086|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902087|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1902088|NCT00432276|Metformin|metformin|mesh-list
1902089|NCT00432276|Pioglitazone|pioglitazone|mesh-list
1902090|NCT00432276|Alogliptin|alogliptin|mesh-list
1902091|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1902092|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902093|NCT00432276|Incretins|incretins|mesh-ancestor
1902094|NCT00432276|Hormones|hormones|mesh-ancestor
1902095|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902096|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1902097|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
1902098|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902099|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902100|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
1902101|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1902102|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1902103|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1902104|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902105|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902106|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
1902107|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902108|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902109|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1902110|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902111|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
1902112|NCT00432458|Thalidomide|thalidomide|mesh-list
1902113|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902114|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
1902115|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902116|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
1902117|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1902118|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902119|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902120|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902121|NCT00432458|Growth Substances|growth substances|mesh-ancestor
1902122|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902123|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902124|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1902125|NCT00432562|Vinorelbine|vinorelbine|mesh-list
1902126|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902127|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902128|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902129|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902130|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902131|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902132|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1902133|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1902134|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902135|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902136|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1902137|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902138|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902139|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
1902140|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902141|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
1902142|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1902143|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902144|NCT00432991|Ephedrine|ephedrine|mesh-list
1902145|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1902146|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902147|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
1902148|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
1902149|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902150|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1902151|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
1902152|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902153|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902154|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
1902155|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1902156|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
1902157|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1902158|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902159|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1902160|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1902161|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1902162|NCT00433017|Ranibizumab|ranibizumab|mesh-list
1902163|NCT00433017|Verteporfin|verteporfin|mesh-list
1902164|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902165|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902166|NCT00433017|Growth Substances|growth substances|mesh-ancestor
1902167|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902168|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902169|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902170|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1902171|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
1902172|NCT00433160|Teriparatide|teriparatide|mesh-list
1902173|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1902174|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902175|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1902176|NCT00433199|Testosterone|testosterone|mesh-list
1902177|NCT00433199|Androgens|androgens|mesh-ancestor
1902178|NCT00433199|Hormones|hormones|mesh-ancestor
1902179|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902180|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902181|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1902182|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1902183|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1902184|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902185|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902186|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902187|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902188|NCT00433290|Analgesics|analgesics|mesh-ancestor
1902189|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
1902190|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902191|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
1902192|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902193|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
1902194|NCT00433329|Bosentan|bosentan|mesh-list
1902195|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
1902196|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
1902197|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1902198|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1902199|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902200|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902201|NCT00433329|Urological Agents|urological agents|mesh-ancestor
1902202|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1902203|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1902204|NCT00433381|Bevacizumab|bevacizumab|mesh-list
1902205|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1902206|NCT00433381|Irinotecan|irinotecan|mesh-list
1902207|NCT00433381|Temozolomide|temozolomide|mesh-list
1902208|NCT00433381|Camptothecin|camptothecin|mesh-list
1902209|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
1902210|NCT00433381|Antibodies|antibodies|mesh-list
1902211|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
1902212|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1902213|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
1902214|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902215|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902216|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902217|NCT00433381|Growth Substances|growth substances|mesh-ancestor
1902218|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902219|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902220|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
1902221|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1902222|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902223|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902224|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902225|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1902226|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
1902227|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902228|NCT00433446|Siltuximab|siltuximab|mesh-list
1902229|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902230|NCT00433511|Paclitaxel|paclitaxel|mesh-list
1902231|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
1902232|NCT00433511|Bevacizumab|bevacizumab|mesh-list
1902233|NCT00433511|Doxorubicin|doxorubicin|mesh-list
1902234|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1902235|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1902236|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1902237|NCT00433511|Antibodies|antibodies|mesh-list
1902238|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
1902239|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1902240|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
1902241|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
1902242|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902243|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902244|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902245|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902246|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902247|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902248|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902249|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
1902250|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902251|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902252|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1902253|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
1902254|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1902255|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902256|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902257|NCT00433511|Growth Substances|growth substances|mesh-ancestor
1902258|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902259|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1902260|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1902261|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902262|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902263|NCT00433537|Dexamethasone|dexamethasone|mesh-list
1902264|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
1902265|NCT00433537|Rituximab|rituximab|mesh-list
1902266|NCT00433537|Doxorubicin|doxorubicin|mesh-list
1902267|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1902268|NCT00433537|Vincristine|vincristine|mesh-list
1902269|NCT00433537|Bortezomib|bortezomib|mesh-list
1902270|NCT00433537|Lenograstim|lenograstim|mesh-list
1902271|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902272|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
1902273|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902274|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902275|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1902276|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
1902277|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902278|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902279|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1902280|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1902281|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
1902282|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
1902283|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902284|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1902285|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
1902286|NCT00433537|Hormones|hormones|mesh-ancestor
1902287|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902288|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1902289|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902290|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1902291|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1902292|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902293|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902294|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1902295|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902296|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902297|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902298|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902299|NCT00433550|Capecitabine|capecitabine|mesh-list
1902300|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
1902301|NCT00433550|Irinotecan|irinotecan|mesh-list
1902302|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902303|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
1902304|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902305|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902306|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1902307|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902308|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902309|NCT00433745|Vaccines|vaccines|mesh-list
1902310|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
1902311|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902312|NCT00433836|Valsartan|valsartan|mesh-list
1902313|NCT00433836|Enalapril|enalapril|mesh-list
1902314|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1902315|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1902316|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1902317|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902318|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1902319|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
1902320|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902321|NCT00433914|Vaccines|vaccines|mesh-list
1902322|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
1902323|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902324|NCT00433966|Paclitaxel|paclitaxel|mesh-list
1902325|NCT00433966|Heparin|heparin|mesh-list
1902326|NCT00433966|Calcium heparin|calcium heparin|mesh-list
1902327|NCT00433966|Bivalirudin|bivalirudin|mesh-list
1902328|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902329|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902330|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902331|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902332|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902333|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902334|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
1902335|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1902336|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1902337|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
1902338|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1902339|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
1902340|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902341|NCT00434109|Sunitinib|sunitinib|mesh-list
1902342|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902343|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902344|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902345|NCT00434109|Growth Substances|growth substances|mesh-ancestor
1902346|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902347|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902348|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902349|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902350|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902351|NCT00434148|Pasireotide|pasireotide|mesh-list
1902352|NCT00434148|Hormones|hormones|mesh-ancestor
1902353|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902354|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902355|NCT00434213|Methylphenidate|methylphenidate|mesh-list
1902356|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1902357|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902358|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1902359|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1902360|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902361|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902362|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
1902363|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902364|NCT00434226|Paclitaxel|paclitaxel|mesh-list
1902365|NCT00434226|Bevacizumab|bevacizumab|mesh-list
1902366|NCT00434226|Carboplatin|carboplatin|mesh-list
1902367|NCT00434226|Sunitinib|sunitinib|mesh-list
1902368|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902369|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902370|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902371|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902372|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902373|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902374|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902375|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902376|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902377|NCT00434226|Growth Substances|growth substances|mesh-ancestor
1902454|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1902378|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902379|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902380|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902381|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902382|NCT00434252|Paclitaxel|paclitaxel|mesh-list
1902383|NCT00434252|Bevacizumab|bevacizumab|mesh-list
1902384|NCT00434252|Carboplatin|carboplatin|mesh-list
1902385|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902386|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902387|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902388|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902389|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902390|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902391|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902392|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902393|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902394|NCT00434252|Growth Substances|growth substances|mesh-ancestor
1902395|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902396|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902397|NCT00434304|Ropinirole|ropinirole|mesh-list
1902398|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1902399|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1902400|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
1902401|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
1902402|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902403|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902404|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902405|NCT00434356|Paclitaxel|paclitaxel|mesh-list
1902406|NCT00434356|Bevacizumab|bevacizumab|mesh-list
1902407|NCT00434356|Sunitinib|sunitinib|mesh-list
1902408|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902409|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902410|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902411|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902412|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902413|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902414|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902415|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902416|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902417|NCT00434356|Growth Substances|growth substances|mesh-ancestor
1902418|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902419|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902420|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902421|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902422|NCT00434434|Omalizumab|omalizumab|mesh-list
1902423|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1902424|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1902425|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1902426|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
1902427|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
1902428|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902429|NCT00434577|Vaccines|vaccines|mesh-list
1902430|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
1902431|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902432|NCT00434642|Gemcitabine|gemcitabine|mesh-list
1902433|NCT00434642|Bevacizumab|bevacizumab|mesh-list
1902434|NCT00434642|Carboplatin|carboplatin|mesh-list
1902435|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902436|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902437|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902438|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902439|NCT00434642|Growth Substances|growth substances|mesh-ancestor
1902440|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902441|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902442|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902443|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
1902444|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902445|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
1902446|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902447|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902448|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902449|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
1902450|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1902451|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
1902452|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902453|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1902455|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902456|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902457|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
1902458|NCT00434954|Exenatide|exenatide|mesh-list
1902459|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1902460|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902461|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1902462|NCT00434954|Incretins|incretins|mesh-ancestor
1902463|NCT00434954|Hormones|hormones|mesh-ancestor
1902464|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902465|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1902466|NCT00434967|Candesartan|candesartan|mesh-list
1902467|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
1902468|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1902469|NCT00434967|Diuretics|diuretics|mesh-ancestor
1902470|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
1902471|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902472|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1902473|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902474|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902475|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1902476|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1902477|NCT00434993|Albuterol|albuterol|mesh-list
1902478|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1902479|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
1902480|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902481|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902482|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1902483|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
1902484|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
1902485|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1902486|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1902487|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1902488|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1902489|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
1902490|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902491|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902492|NCT00435019|Insulin|insulin|mesh-list
1902493|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1902494|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
1902495|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
1902496|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
1902497|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
1902498|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
1902499|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1902500|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902501|NCT00435045|Atorvastatin|atorvastatin|mesh-list
1902502|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1902503|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1902504|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
1902505|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902506|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1902507|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1902508|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902509|NCT00435162|Valsartan|valsartan|mesh-list
1902510|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1902511|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1902512|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1902513|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902514|NCT00435370|Tropisetron|tropisetron|mesh-list
1902515|NCT00435370|Risperidone|risperidone|mesh-list
1902516|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1902517|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
1902518|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902519|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902520|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902521|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1902522|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1902523|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902524|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902525|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1902526|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
1902527|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
1902528|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
1902833|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902529|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902530|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1902531|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1902532|NCT00435409|Capecitabine|capecitabine|mesh-list
1902533|NCT00435409|Sunitinib|sunitinib|mesh-list
1902534|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902535|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
1902536|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902537|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902538|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902539|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902540|NCT00435409|Growth Substances|growth substances|mesh-ancestor
1902541|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902542|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902543|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902544|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902545|NCT00435461|Fluticasone|fluticasone|mesh-list
1902546|NCT00435461|Xhance|xhance|mesh-list
1902547|NCT00435461|Fexofenadine|fexofenadine|mesh-list
1902548|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1902549|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1902550|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
1902551|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902552|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902553|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1902554|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
1902555|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
1902556|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1902557|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1902558|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1902559|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
1902560|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
1902561|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902562|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902563|NCT00435487|Heparin|heparin|mesh-list
1902564|NCT00435487|Calcium heparin|calcium heparin|mesh-list
1902565|NCT00435487|Dalteparin|dalteparin|mesh-list
1902566|NCT00435487|Tinzaparin|tinzaparin|mesh-list
1902567|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1902568|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
1902569|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1902570|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1902571|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902572|NCT00435539|Plasminogen|plasminogen|mesh-list
1902573|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
1902574|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1902575|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1902576|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902577|NCT00435591|Conivaptan|conivaptan|mesh-list
1902578|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1902579|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902580|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
1902581|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902582|NCT00435812|Vaccines|vaccines|mesh-list
1902583|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
1902584|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902585|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1902586|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
1902587|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902588|NCT00435929|Ritonavir|ritonavir|mesh-list
1902589|NCT00435929|Saquinavir|saquinavir|mesh-list
1902590|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1902591|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1902592|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
1902593|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902594|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902595|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1902596|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1902597|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
1902598|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902599|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1902600|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1902601|NCT00435994|Epinephrine|epinephrine|mesh-list
1902602|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1902603|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1902604|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
1902605|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902606|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902607|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902608|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1902609|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1902610|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
1902611|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902612|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1902613|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
1902614|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
1902615|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
1902616|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1902617|NCT00436007|Vaccines|vaccines|mesh-list
1902618|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
1902619|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902620|NCT00436046|Interferons|interferons|mesh-list
1902621|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902622|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
1902623|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902624|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1902625|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
1902626|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902627|NCT00436215|Bevacizumab|bevacizumab|mesh-list
1902628|NCT00436215|Sorafenib|sorafenib|mesh-list
1902629|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902630|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902631|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902632|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902633|NCT00436215|Growth Substances|growth substances|mesh-ancestor
1902634|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902635|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902636|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902637|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902638|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902639|NCT00436280|Gemcitabine|gemcitabine|mesh-list
1902640|NCT00436280|Rituximab|rituximab|mesh-list
1902641|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
1902642|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902643|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902644|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
1902645|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902646|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902647|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902648|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
1902649|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902650|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
1902651|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902652|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902653|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902654|NCT00436332|Bevacizumab|bevacizumab|mesh-list
1902655|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1902656|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902657|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902658|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902659|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902660|NCT00436332|Growth Substances|growth substances|mesh-ancestor
1902661|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902662|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902663|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902664|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902665|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902666|NCT00436345|Remifentanil|remifentanil|mesh-list
1902667|NCT00436345|Propofol|propofol|mesh-list
1902668|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1902669|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902670|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902671|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1902672|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
1902673|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
1902674|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1902675|NCT00436345|Narcotics|narcotics|mesh-ancestor
1902676|NCT00436345|Analgesics|analgesics|mesh-ancestor
1902677|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
1902678|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902679|NCT00436436|Temozolomide|temozolomide|mesh-list
1902680|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
1902681|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1902682|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
1902683|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902684|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902685|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902686|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
1902687|NCT00436475|Vitamin D|vitamin d|mesh-list
1902688|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
1902689|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
1902690|NCT00436475|Vitamins|vitamins|mesh-list
1902691|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
1902692|NCT00436475|Calcium|calcium|mesh-list
1902693|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
1902694|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902695|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1902696|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1902697|NCT00436475|Antacids|antacids|mesh-ancestor
1902698|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902699|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1902700|NCT00436501|Docetaxel|docetaxel|mesh-list
1902701|NCT00436501|Aflibercept|aflibercept|mesh-list
1902702|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
1902703|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902704|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902705|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902706|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902707|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902708|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902709|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902710|NCT00436501|Growth Substances|growth substances|mesh-ancestor
1902711|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902712|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902713|NCT00436553|Ranibizumab|ranibizumab|mesh-list
1902714|NCT00436553|Verteporfin|verteporfin|mesh-list
1902715|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902716|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902717|NCT00436553|Growth Substances|growth substances|mesh-ancestor
1902718|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902719|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902720|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902721|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1902722|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
1902723|NCT00436566|Paclitaxel|paclitaxel|mesh-list
1902724|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
1902725|NCT00436566|Doxorubicin|doxorubicin|mesh-list
1902726|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1902727|NCT00436566|Trastuzumab|trastuzumab|mesh-list
1902728|NCT00436566|Lapatinib|lapatinib|mesh-list
1902729|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1902730|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902731|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
1902732|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
1902733|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
1902734|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902735|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902736|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
1902737|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902738|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902739|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1902740|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
1902741|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1902742|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1902743|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1902744|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902745|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902746|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902747|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902748|NCT00436605|Dasatinib|dasatinib|mesh-list
1902749|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902750|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902751|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902752|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902753|NCT00436618|Everolimus|everolimus|mesh-list
1902754|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902755|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902756|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
1902906|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
1902757|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902758|NCT00436644|Topotecan|topotecan|mesh-list
1902759|NCT00436644|Lapatinib|lapatinib|mesh-list
1902760|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1902761|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902762|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902763|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902764|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902765|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902766|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
1902767|NCT00436748|Hematinics|hematinics|mesh-ancestor
1902779|NCT00436904|Rituximab|rituximab|mesh-list
1902780|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
1902781|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902782|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902783|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
1902784|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902785|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902786|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
1902787|NCT00436917|Letrozole|letrozole|mesh-list
1902788|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902789|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1902790|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1902791|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902792|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902793|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1902794|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
1902795|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902796|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902797|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1902798|NCT00436956|Prednisone|prednisone|mesh-list
1902799|NCT00436956|Cediranib|cediranib|mesh-list
1902800|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1902801|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
1902802|NCT00436956|Hormones|hormones|mesh-ancestor
1902803|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902804|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902805|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1902806|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902807|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902808|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902809|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902810|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
1902811|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1902812|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
1902813|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902814|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
1902815|NCT00436969|Protective Agents|protective agents|mesh-ancestor
1902816|NCT00437034|Aflibercept|aflibercept|mesh-list
1902817|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
1902818|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902819|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902820|NCT00437034|Growth Substances|growth substances|mesh-ancestor
1902821|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902822|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902823|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902824|NCT00437073|Capecitabine|capecitabine|mesh-list
1902825|NCT00437073|Topotecan|topotecan|mesh-list
1902826|NCT00437073|Lapatinib|lapatinib|mesh-list
1902827|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902828|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
1902829|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902830|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902831|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1902832|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902834|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1902835|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1902836|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1902837|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1902838|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902839|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902840|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1902841|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902842|NCT00437125|Analgesics|analgesics|mesh-ancestor
1902843|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
1902844|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902845|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
1902846|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902847|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
1902848|NCT00437203|Gemcitabine|gemcitabine|mesh-list
1902849|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902850|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
1902851|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902852|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902853|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
1902854|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902855|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902856|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902857|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
1902858|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902859|NCT00437268|Irinotecan|irinotecan|mesh-list
1902860|NCT00437268|Cetuximab|cetuximab|mesh-list
1902861|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1902862|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1902863|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902864|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902865|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902866|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902867|NCT00437281|Pregabalin|pregabalin|mesh-list
1902868|NCT00437281|Analgesics|analgesics|mesh-ancestor
1902869|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
1902870|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902871|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902872|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
1902873|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1902874|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902875|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902876|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1902877|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1902878|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1902879|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902880|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902881|NCT00437294|Capecitabine|capecitabine|mesh-list
1902882|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902883|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
1902884|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902885|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902886|NCT00437489|Insulin|insulin|mesh-list
1902887|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1902888|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1902889|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902890|NCT00437645|Amlodipine|amlodipine|mesh-list
1902891|NCT00437645|Valsartan|valsartan|mesh-list
1902892|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1902893|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1902894|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902895|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902896|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1902897|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902898|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
1902899|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1902900|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1902901|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1902902|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
1902903|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1902904|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1902905|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1902907|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1902908|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902909|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1902910|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1902911|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1902912|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1902913|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902914|NCT00438100|Capecitabine|capecitabine|mesh-list
1902915|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902916|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
1902917|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902918|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902919|NCT00438204|Gemcitabine|gemcitabine|mesh-list
1902920|NCT00438204|Bevacizumab|bevacizumab|mesh-list
1902921|NCT00438204|Pemetrexed|pemetrexed|mesh-list
1902922|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1902923|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902924|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1902925|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1902926|NCT00438204|Growth Substances|growth substances|mesh-ancestor
1902927|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902928|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
1902929|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902930|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
1902931|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902932|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
1902933|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902934|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902935|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902936|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
1902937|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1902938|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1902939|NCT00438256|Capecitabine|capecitabine|mesh-list
1902940|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1902941|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
1902942|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902943|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1902944|NCT00438360|Cyclosporine|cyclosporine|mesh-list
1902945|NCT00438360|Cyclosporins|cyclosporins|mesh-list
1902946|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902947|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902948|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1902949|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
1902950|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902951|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
1902952|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1902953|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
1902954|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1902955|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1902956|NCT00438451|Lamotrigine|lamotrigine|mesh-list
1902957|NCT00438451|Carbamazepine|carbamazepine|mesh-list
1902958|NCT00438451|Levetiracetam|levetiracetam|mesh-list
1902959|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
1902960|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
1902961|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1902962|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1902963|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902964|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1902965|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902966|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1902967|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1902968|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1902969|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1902970|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1902971|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
1902972|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1902973|NCT00438451|Analgesics|analgesics|mesh-ancestor
1902974|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
1902975|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902976|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1902977|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1902978|NCT00438464|Finasteride|finasteride|mesh-list
1902979|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1902980|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1902981|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1902982|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1902983|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
1902984|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1902985|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902986|NCT00438464|Urological Agents|urological agents|mesh-ancestor
1902987|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
1902988|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1902989|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
1902990|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1902991|NCT00438672|Dexamethasone|dexamethasone|mesh-list
1902992|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1902993|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
1902994|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
1902995|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1902996|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1902997|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1902998|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
1902999|NCT00438672|Hormones|hormones|mesh-ancestor
1903000|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903001|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903002|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903003|NCT00438802|Alefacept|alefacept|mesh-list
1903004|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903005|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
1903006|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903007|NCT00438815|Complement C1s|complement c1s|mesh-list
1903008|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1903009|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1903010|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
1903011|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903012|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1903013|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903014|NCT00438854|Dasatinib|dasatinib|mesh-list
1903015|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903016|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1903017|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903018|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903019|NCT00438880|Rituximab|rituximab|mesh-list
1903020|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1903021|NCT00438880|Antibodies|antibodies|mesh-list
1903022|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
1903023|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1903024|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
1903025|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903026|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903027|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903028|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1903029|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1903030|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1903031|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903032|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903033|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903034|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903035|NCT00438971|Analgesics|analgesics|mesh-ancestor
1903036|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
1903037|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903038|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
1903039|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903040|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
1903041|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
1903042|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1903043|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1903044|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1903045|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903046|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903047|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
1903048|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903049|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903050|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1903051|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903052|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1903053|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903054|NCT00439231|Lenalidomide|lenalidomide|mesh-list
1903055|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
1903056|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903057|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1903058|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1903059|NCT00439231|Growth Substances|growth substances|mesh-ancestor
1903060|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
1903061|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903062|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
1903063|NCT00439244|Teriparatide|teriparatide|mesh-list
1903064|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1903065|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903066|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1903067|NCT00439270|Docetaxel|docetaxel|mesh-list
1903068|NCT00439270|Dasatinib|dasatinib|mesh-list
1903069|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903070|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
1903071|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
1903072|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
1903073|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903074|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1903075|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903076|NCT00439296|Cytarabine|cytarabine|mesh-list
1903077|NCT00439296|Dexamethasone|dexamethasone|mesh-list
1903078|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
1903079|NCT00439296|Doxorubicin|doxorubicin|mesh-list
1903080|NCT00439296|Methotrexate|methotrexate|mesh-list
1903081|NCT00439296|Asparaginase|asparaginase|mesh-list
1903082|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
1903083|NCT00439296|Thioguanine|thioguanine|mesh-list
1903084|NCT00439296|Pegaspargase|pegaspargase|mesh-list
1903085|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903086|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
1903087|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903088|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903089|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1903090|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
1903091|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903092|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903093|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1903094|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903095|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
1903096|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
1903097|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903098|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903099|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
1903100|NCT00439296|Hormones|hormones|mesh-ancestor
1903101|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903102|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903103|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1903104|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1903105|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1903106|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903107|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1903108|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
1903109|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1903110|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1903111|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
1903112|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903113|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1903114|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903115|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
1903116|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903117|NCT00439309|Thrombin|thrombin|mesh-list
1903118|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1903119|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
1903120|NCT00439309|Coagulants|coagulants|mesh-ancestor
1903121|NCT00439335|Vaccines|vaccines|mesh-list
1903122|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
1903123|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903124|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1903125|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1903126|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1903127|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903128|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903129|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903130|NCT00439374|Progestins|progestins|mesh-ancestor
1903131|NCT00439374|Hormones|hormones|mesh-ancestor
1903132|NCT00439413|Selegiline|selegiline|mesh-list
1903133|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
1903134|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903135|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1903136|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1903137|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1903138|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903139|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903140|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1903141|NCT00439413|Protective Agents|protective agents|mesh-ancestor
1903142|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903143|NCT00439517|Cetuximab|cetuximab|mesh-list
1903144|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903145|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903146|NCT00439556|Cytarabine|cytarabine|mesh-list
1903147|NCT00439556|Rituximab|rituximab|mesh-list
1903148|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1903149|NCT00439556|Methotrexate|methotrexate|mesh-list
1903150|NCT00439556|Etoposide|etoposide|mesh-list
1903151|NCT00439556|Bortezomib|bortezomib|mesh-list
1903152|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
1903153|NCT00439556|Melphalan|melphalan|mesh-list
1903154|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
1903155|NCT00439556|Carmustine|carmustine|mesh-list
1903156|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
1903157|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1903158|NCT00439556|Antibodies|antibodies|mesh-list
1903159|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
1903160|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1903161|NCT00439556|Lenograstim|lenograstim|mesh-list
1903162|NCT00439556|Tacrolimus|tacrolimus|mesh-list
1903163|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
1903164|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1903165|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
1903166|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903167|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903168|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903169|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1903170|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
1903171|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1903172|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1903173|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
1903174|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903175|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903176|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903177|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1903178|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903179|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903180|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1903181|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1903182|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1903183|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1903184|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
1903185|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903186|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1903187|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1903188|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
1903189|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1903190|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
1903191|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
1903192|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
1903193|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
1903194|NCT00439608|Paclitaxel|paclitaxel|mesh-list
1903195|NCT00439608|Carboplatin|carboplatin|mesh-list
1903196|NCT00439608|Cetuximab|cetuximab|mesh-list
1903197|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1903198|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903199|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
1903200|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
1903201|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
1903202|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903203|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903204|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
1903205|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1903206|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903207|NCT00439673|Azacitidine|azacitidine|mesh-list
1903208|NCT00439673|Valproic Acid|valproic acid|mesh-list
1903209|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1903210|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
1903211|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903212|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903213|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903214|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
1903215|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
1903216|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903217|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903218|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
1903219|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1903220|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1903221|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903222|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
1903223|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1903224|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
1903225|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1903226|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903227|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903228|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903229|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
1903230|NCT00439738|Amlodipine|amlodipine|mesh-list
1903231|NCT00439738|Valsartan|valsartan|mesh-list
1903232|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1903233|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1903234|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1903235|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903236|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903237|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1903238|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903239|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
1903240|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1903241|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1903242|NCT00439738|Diuretics|diuretics|mesh-ancestor
1903243|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
1903244|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1903245|NCT00439777|Enoxaparin|enoxaparin|mesh-list
1903246|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
1903247|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1903248|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
1903249|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1903250|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903251|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903252|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903253|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
1903254|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1903255|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1903256|NCT00439946|Treprostinil|treprostinil|mesh-list
1903257|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1903258|NCT00440011|Bimatoprost|bimatoprost|mesh-list
1903259|NCT00440011|Travoprost|travoprost|mesh-list
1903260|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1903261|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1903262|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1903263|NCT00440115|Bupropion|bupropion|mesh-list
1903264|NCT00440115|Nicotine|nicotine|mesh-list
1903265|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1903266|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
1903267|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903268|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903269|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1903270|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1903271|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
1903272|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903273|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903274|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1903275|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
1903276|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903277|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1903278|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1903279|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903280|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
1903281|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1903282|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1903283|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903284|NCT00440180|Anastrozole|anastrozole|mesh-list
1903285|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903286|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903287|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1903288|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1903289|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903290|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903291|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1903292|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903293|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903294|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903295|NCT00440193|Enoxaparin|enoxaparin|mesh-list
1903296|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
1903297|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1903298|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
1903299|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1903300|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903301|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903302|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903303|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
1903304|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1903305|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1903306|NCT00440232|Frovatriptan|frovatriptan|mesh-list
1903307|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1903308|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
1903309|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903310|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903311|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903312|NCT00440310|Talaporfin|talaporfin|mesh-list
1903313|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903314|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1903315|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903316|NCT00440401|Thrombin|thrombin|mesh-list
1903317|NCT00440401|Hemostatics|hemostatics|mesh-list
1903318|NCT00440401|Coagulants|coagulants|mesh-ancestor
1903319|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
1903320|NCT00440466|Hematinics|hematinics|mesh-ancestor
1903321|NCT00440505|Nicotine|nicotine|mesh-list
1903322|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1903323|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
1903324|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903325|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903326|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1903327|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1903328|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
1903329|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903330|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903331|NCT00440518|Lacosamide|lacosamide|mesh-list
1903332|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
1903333|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1903334|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1903335|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903336|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903337|NCT00440531|Vaccines|vaccines|mesh-list
1903338|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
1903339|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903340|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
1903341|NCT00440557|Hematinics|hematinics|mesh-ancestor
1903342|NCT00440726|Cytarabine|cytarabine|mesh-list
1903343|NCT00440726|Dexamethasone|dexamethasone|mesh-list
1903344|NCT00440726|Doxorubicin|doxorubicin|mesh-list
1903345|NCT00440726|Methotrexate|methotrexate|mesh-list
1903346|NCT00440726|Vincristine|vincristine|mesh-list
1903347|NCT00440726|Bortezomib|bortezomib|mesh-list
1903348|NCT00440726|Asparaginase|asparaginase|mesh-list
1903349|NCT00440726|Pegaspargase|pegaspargase|mesh-list
1903350|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903351|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
1903352|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
1903353|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903354|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903355|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903356|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
1903357|NCT00440726|Hormones|hormones|mesh-ancestor
1903358|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903359|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903360|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903361|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1903362|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1903363|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1903364|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903365|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903366|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1903367|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
1903368|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1903369|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1903370|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
1903371|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903372|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1903373|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903374|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
1903375|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903376|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903377|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
1903378|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903379|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1903380|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
1903381|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
1903382|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
1903383|NCT00440830|Nicotine|nicotine|mesh-list
1903384|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1903385|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
1903386|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903387|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903388|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1903389|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1903390|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
1903391|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903392|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903393|NCT00440947|Ritonavir|ritonavir|mesh-list
1903394|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1903395|NCT00440947|Lamivudine|lamivudine|mesh-list
1903396|NCT00440947|Abacavir|abacavir|mesh-list
1903397|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
1903398|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1903399|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1903400|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903401|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903402|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903403|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1903404|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1903405|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
1903406|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903407|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1903408|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1903409|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1903410|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903411|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
1903412|NCT00440999|Artesunate|artesunate|mesh-list
1903413|NCT00440999|Chloroquine|chloroquine|mesh-list
1903414|NCT00440999|Pyronaridine|pyronaridine|mesh-list
1903415|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
1903416|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1903417|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1903418|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903419|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903420|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
1903421|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
1903422|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1903423|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
1903424|NCT00440999|Amebicides|amebicides|mesh-ancestor
1903425|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903426|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
1903427|NCT00441103|Interferon-beta|interferon-beta|mesh-list
1903428|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1903429|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
1903430|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903431|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903432|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
1903433|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903434|NCT00441116|Dutasteride|dutasteride|mesh-list
1903435|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1903436|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1903437|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903438|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903439|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903515|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1903440|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903441|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903442|NCT00441129|Insulin|insulin|mesh-list
1903443|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1903444|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903445|NCT00441142|Temozolomide|temozolomide|mesh-list
1903446|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1903447|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
1903448|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903449|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903450|NCT00441168|Dexamethasone|dexamethasone|mesh-list
1903451|NCT00441168|Vincristine|vincristine|mesh-list
1903452|NCT00441168|Doxorubicin|doxorubicin|mesh-list
1903453|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1903454|NCT00441168|Bortezomib|bortezomib|mesh-list
1903455|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903456|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
1903457|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
1903458|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903459|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903460|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903461|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
1903462|NCT00441168|Hormones|hormones|mesh-ancestor
1903463|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903464|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903465|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903466|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1903467|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
1903468|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
1903469|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
1903470|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903471|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1903472|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1903473|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1903474|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903475|NCT00441285|Albendazole|albendazole|mesh-list
1903476|NCT00441285|Praziquantel|praziquantel|mesh-list
1903477|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
1903478|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1903479|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903480|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
1903481|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1903482|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1903483|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
1903484|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
1903485|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
1903486|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903487|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903488|NCT00441337|Nivolumab|nivolumab|mesh-list
1903489|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903490|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903491|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1903492|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903493|NCT00441363|Bromocriptine|bromocriptine|mesh-list
1903494|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1903495|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1903496|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903497|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903498|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903499|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
1903500|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
1903501|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903502|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903503|NCT00441441|Fluticasone|fluticasone|mesh-list
1903504|NCT00441441|Xhance|xhance|mesh-list
1903505|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1903506|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903507|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1903508|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
1903509|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903510|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903511|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1903512|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
1903513|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903514|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1903516|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1903517|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1903518|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
1903519|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903520|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903521|NCT00441545|Sevelamer|sevelamer|mesh-list
1903522|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
1903523|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
1903524|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903525|NCT00441584|Ribavirin|ribavirin|mesh-list
1903526|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1903527|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
1903528|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
1903529|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903530|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
1903531|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903532|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
1903533|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903534|NCT00441727|Esomeprazole|esomeprazole|mesh-list
1903535|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1903536|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903537|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1903538|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903539|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903540|NCT00441792|Midazolam|midazolam|mesh-list
1903541|NCT00441792|Etomidate|etomidate|mesh-list
1903542|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1903543|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1903544|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1903545|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903546|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1903547|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1903548|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903549|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1903550|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
1903551|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
1903552|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
1903553|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
1903554|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903555|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903556|NCT00441883|Latanoprost|latanoprost|mesh-list
1903557|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1903558|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1903559|NCT00441974|Adefovir|adefovir|mesh-list
1903560|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1903561|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
1903562|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903563|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1903564|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903565|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903566|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903567|NCT00442013|Lansoprazole|lansoprazole|mesh-list
1903568|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
1903569|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1903570|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903571|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1903572|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903573|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903574|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
1903575|NCT00442117|Budesonide|budesonide|mesh-list
1903576|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903577|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1903578|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
1903579|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903580|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903581|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1903582|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
1903583|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
1903584|NCT00442117|Hormones|hormones|mesh-ancestor
1903585|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903586|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903587|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1903588|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1903589|NCT00442338|Aminophylline|aminophylline|mesh-list
1903590|NCT00442338|Theophylline|theophylline|mesh-list
1903591|NCT00442338|Montelukast|montelukast|mesh-list
1903592|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1903593|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
1903594|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1903595|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903596|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903597|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903598|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1903599|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1903600|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903601|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1903602|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
1903603|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903604|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1903605|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1903606|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903607|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1903608|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1903609|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
1903610|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903611|NCT00442338|Protective Agents|protective agents|mesh-ancestor
1903612|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
1903613|NCT00442364|Polidocanol|polidocanol|mesh-list
1903614|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1903615|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1903616|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
1903617|NCT00442416|Hematinics|hematinics|mesh-ancestor
1903618|NCT00442507|Bevacizumab|bevacizumab|mesh-list
1903619|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1903620|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903621|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903622|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1903623|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1903624|NCT00442507|Growth Substances|growth substances|mesh-ancestor
1903625|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903626|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
1903627|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1903628|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903629|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903644|NCT00442559|Montelukast|montelukast|mesh-list
1903645|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1903646|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
1903647|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1903648|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903649|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903650|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903651|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1903652|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1903653|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903654|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1903655|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
1903656|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903657|NCT00442611|Abatacept|abatacept|mesh-list
1903658|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1903659|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903660|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903661|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903662|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
1903663|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903664|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903665|NCT00442689|Flutamide|flutamide|mesh-list
1903666|NCT00442689|Drospirenone|drospirenone|mesh-list
1903667|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1903668|NCT00442689|Estradiol|estradiol|mesh-list
1903669|NCT00442689|Estrogens|estrogens|mesh-ancestor
1903670|NCT00442689|Hormones|hormones|mesh-ancestor
1903671|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903672|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903673|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1903674|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
1903675|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1903676|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1903677|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1903678|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1903679|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1903680|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
1903681|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1903682|NCT00442689|Diuretics|diuretics|mesh-ancestor
1903683|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
1903684|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
1903685|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903686|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903687|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
1903688|NCT00442702|Hematinics|hematinics|mesh-ancestor
1903689|NCT00442767|Insulin|insulin|mesh-list
1903690|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1903691|NCT00442767|Pramlintide|pramlintide|mesh-list
1903692|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
1903693|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1903694|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903695|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
1903696|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1903697|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
1903698|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903699|NCT00442897|Atorvastatin|atorvastatin|mesh-list
1903700|NCT00442897|Simvastatin|simvastatin|mesh-list
1903701|NCT00442897|Ezetimibe|ezetimibe|mesh-list
1903702|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1903703|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1903704|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
1903705|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903706|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1903707|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1903708|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903709|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
1903710|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
1903711|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1903712|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1903713|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
1903714|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903715|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903716|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903717|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903718|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1903719|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903720|NCT00442962|Tenofovir|tenofovir|mesh-list
1903721|NCT00442962|Emtricitabine|emtricitabine|mesh-list
1903722|NCT00442962|Efavirenz|efavirenz|mesh-list
1903723|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1903724|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
1903725|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903726|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1903727|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903728|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903729|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903730|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1903731|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1903732|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1903733|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1903734|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1903735|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1903736|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1903737|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1903738|NCT00443053|PENTA|penta|mesh-list
1903739|NCT00443053|Fondaparinux|fondaparinux|mesh-list
1903740|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1903741|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
1903742|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1903743|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903744|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903745|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903746|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
1903747|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1903748|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1903749|NCT00443209|Rizatriptan|rizatriptan|mesh-list
1903750|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1903751|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
1903752|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903753|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903754|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903755|NCT00443261|Azacitidine|azacitidine|mesh-list
1903756|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903757|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1903758|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
1903759|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903760|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903761|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1903762|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1903763|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1903764|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903765|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903766|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903767|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903768|NCT00443352|Analgesics|analgesics|mesh-ancestor
1903769|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
1903770|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903771|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
1903772|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903773|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
1903774|NCT00443430|Prednisone|prednisone|mesh-list
1903775|NCT00443430|Prednisolone|prednisolone|mesh-list
1903776|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1903777|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
1903778|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1903779|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
1903780|NCT00443430|Etanercept|etanercept|mesh-list
1903781|NCT00443430|Methotrexate|methotrexate|mesh-list
1903782|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1903783|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
1903784|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903785|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
1903786|NCT00443430|Hormones|hormones|mesh-ancestor
1903787|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903788|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903789|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1903790|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903791|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1903792|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
1903793|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1903794|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1903795|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
1903796|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903797|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
1903798|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903799|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1903800|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903801|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
1903802|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903803|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1903804|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
1903805|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
1903806|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903807|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903808|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1903809|NCT00443430|Protective Agents|protective agents|mesh-ancestor
1903810|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1903811|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1903812|NCT00443430|Analgesics|analgesics|mesh-ancestor
1903813|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
1903814|NCT00443456|Amlodipine|amlodipine|mesh-list
1903815|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1903816|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1903817|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1903818|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903819|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1903820|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903821|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
1903822|NCT00443534|Sunitinib|sunitinib|mesh-list
1903823|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903824|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1903825|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1903826|NCT00443534|Growth Substances|growth substances|mesh-ancestor
1903827|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903828|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
1903829|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1903830|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903831|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903832|NCT00443560|Fentanyl|fentanyl|mesh-list
1903833|NCT00443560|Bupivacaine|bupivacaine|mesh-list
1903834|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
1903835|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
1903836|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1903837|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903838|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
1903839|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1903840|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1903841|NCT00443560|Narcotics|narcotics|mesh-ancestor
1903842|NCT00443560|Analgesics|analgesics|mesh-ancestor
1903843|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1903844|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1903845|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
1903846|NCT00443599|Insulin|insulin|mesh-list
1903847|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1903848|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1903849|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903850|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1903851|NCT00443651|Rituximab|rituximab|mesh-list
1903852|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903853|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903854|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
1903855|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903856|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1903857|NCT00443703|Ritonavir|ritonavir|mesh-list
1903858|NCT00443703|Lopinavir|lopinavir|mesh-list
1903859|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
1903860|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1903861|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1903862|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903863|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903864|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903865|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1903866|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1903867|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
1903868|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903869|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1903870|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1903871|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1903872|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1903873|NCT00443729|Ritonavir|ritonavir|mesh-list
1903874|NCT00443729|Lopinavir|lopinavir|mesh-list
1903875|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
1903876|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1903877|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1903878|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
1903879|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903880|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903881|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1903882|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1903883|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
1903884|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903885|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1903886|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1903887|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1903888|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1903889|NCT00443755|Metformin|metformin|mesh-list
1903890|NCT00443755|Pioglitazone|pioglitazone|mesh-list
1903891|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1903892|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903893|NCT00443781|Anesthetics|anesthetics|mesh-list
1903894|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1903895|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903896|NCT00443820|Terbinafine|terbinafine|mesh-list
1903897|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
1903898|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903899|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903900|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903901|NCT00443872|Selegiline|selegiline|mesh-list
1903902|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
1903903|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903904|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1903905|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1903906|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1903907|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903908|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903909|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1903910|NCT00443872|Protective Agents|protective agents|mesh-ancestor
1903911|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903912|NCT00443898|Terbinafine|terbinafine|mesh-list
1903913|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
1903914|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903915|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903916|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903917|NCT00444028|Loxapine|loxapine|mesh-list
1903918|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1903919|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1903920|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1903921|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903922|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1903923|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1903924|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
1903925|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1903926|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903927|NCT00444106|Artesunate|artesunate|mesh-list
1903928|NCT00444106|Lumefantrine|lumefantrine|mesh-list
1903929|NCT00444106|Artemether|artemether|mesh-list
1903930|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1903931|NCT00444106|Mefloquine|mefloquine|mesh-list
1903932|NCT00444106|Atovaquone|atovaquone|mesh-list
1903933|NCT00444106|Proguanil|proguanil|mesh-list
1903934|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
1903935|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
1903936|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1903937|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1903938|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1903939|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903940|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
1903941|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
1903942|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1903943|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
1903944|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903945|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903946|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
1903947|NCT00444145|Lansoprazole|lansoprazole|mesh-list
1903948|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1903949|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903950|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1903951|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903952|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903953|NCT00444275|Esomeprazole|esomeprazole|mesh-list
1903954|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1903955|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1903956|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1903957|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903958|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903959|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1903960|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
1903961|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903962|NCT00444535|Bevacizumab|bevacizumab|mesh-list
1903963|NCT00444535|Lapatinib|lapatinib|mesh-list
1903964|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903965|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903966|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1903967|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1903968|NCT00444535|Growth Substances|growth substances|mesh-ancestor
1903969|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903970|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
1903971|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1903972|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903973|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903974|NCT00444587|Trastuzumab|trastuzumab|mesh-list
1903975|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903976|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903977|NCT00444600|Triamcinolone|triamcinolone|mesh-list
1903978|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1903979|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1903980|NCT00444600|Bevacizumab|bevacizumab|mesh-list
1903981|NCT00444600|Ranibizumab|ranibizumab|mesh-list
1903982|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1903983|NCT00444600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1903984|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1903985|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1903986|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1903987|NCT00444600|Growth Substances|growth substances|mesh-ancestor
1903988|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1903989|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
1903990|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1903991|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
1903992|NCT00444600|Hormones|hormones|mesh-ancestor
1903993|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1903994|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1903995|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
1903996|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1903997|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1903998|NCT00444626|Lidocaine|lidocaine|mesh-list
1903999|NCT00444626|Prilocaine|prilocaine|mesh-list
1904000|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
1904001|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
1904002|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
1904003|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
1904004|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1904005|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904006|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
1904007|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904008|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1904009|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1904010|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1904011|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904012|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904013|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1904014|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
1904015|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
1904016|NCT00444626|Protective Agents|protective agents|mesh-ancestor
1904017|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
1904018|NCT00444678|Capecitabine|capecitabine|mesh-list
1904019|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
1904020|NCT00444678|Cetuximab|cetuximab|mesh-list
1904021|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904022|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
1904023|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904024|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904025|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904026|NCT00444795|Sunitinib|sunitinib|mesh-list
1904027|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904028|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904029|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904030|NCT00444795|Growth Substances|growth substances|mesh-ancestor
1904031|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904032|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904033|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904034|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904035|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904036|NCT00444912|Plerixafor|plerixafor|mesh-list
1904037|NCT00444912|Rituximab|rituximab|mesh-list
1904038|NCT00444912|Lenograstim|lenograstim|mesh-list
1904039|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904191|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
1904040|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904041|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
1904042|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904043|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904044|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1904045|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1904046|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1904047|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
1904048|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904049|NCT00444925|Fesoterodine|fesoterodine|mesh-list
1904050|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1904051|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1904052|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1904053|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
1904054|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904055|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904056|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904057|NCT00444925|Urological Agents|urological agents|mesh-ancestor
1904058|NCT00444951|Vaccines|vaccines|mesh-list
1904059|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
1904060|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904061|NCT00444964|Hormones|hormones|mesh-list
1904062|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904063|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904064|NCT00445003|Triamcinolone|triamcinolone|mesh-list
1904065|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1904066|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1904067|NCT00445003|Ranibizumab|ranibizumab|mesh-list
1904068|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1904069|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904070|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904071|NCT00445003|Growth Substances|growth substances|mesh-ancestor
1904072|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904073|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904074|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904075|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904076|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
1904077|NCT00445003|Hormones|hormones|mesh-ancestor
1904078|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904079|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904080|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
1904081|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904082|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904083|NCT00445068|Panobinostat|panobinostat|mesh-list
1904084|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904085|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1904086|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904087|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904088|NCT00445146|Elvitegravir|elvitegravir|mesh-list
1904089|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1904090|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1904091|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
1904092|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904093|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1904094|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904095|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904096|NCT00445211|Heparin|heparin|mesh-list
1904097|NCT00445211|Calcium heparin|calcium heparin|mesh-list
1904098|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
1904099|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1904100|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1904101|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904102|NCT00445263|Tirofiban|tirofiban|mesh-list
1904103|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1904104|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1904105|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904106|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1904107|NCT00445302|Plerixafor|plerixafor|mesh-list
1904108|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1904109|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1904110|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
1904111|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904112|NCT00445328|Heparin|heparin|mesh-list
1904113|NCT00445328|Calcium heparin|calcium heparin|mesh-list
1904114|NCT00445328|Dalteparin|dalteparin|mesh-list
1904115|NCT00445328|Tinzaparin|tinzaparin|mesh-list
1904192|NCT00445692|Hormones|hormones|mesh-ancestor
1904116|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1904117|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
1904118|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1904119|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1904120|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904121|NCT00445341|Alvocidib|alvocidib|mesh-list
1904122|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904123|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904124|NCT00445341|Growth Substances|growth substances|mesh-ancestor
1904125|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904126|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904127|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904128|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904129|NCT00445432|Adalimumab|adalimumab|mesh-list
1904130|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904131|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904132|NCT00445458|Paclitaxel|paclitaxel|mesh-list
1904133|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1904134|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904135|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
1904136|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
1904137|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
1904138|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904139|NCT00445484|Lenalidomide|lenalidomide|mesh-list
1904140|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1904141|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
1904142|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904143|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904144|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904145|NCT00445484|Growth Substances|growth substances|mesh-ancestor
1904146|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904147|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904148|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1904149|NCT00445588|Sorafenib|sorafenib|mesh-list
1904150|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904151|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904152|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904153|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904154|NCT00445601|Gemcitabine|gemcitabine|mesh-list
1904155|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904156|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
1904157|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904158|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904159|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
1904160|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904161|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904162|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904163|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
1904164|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904165|NCT00445679|Paroxetine|paroxetine|mesh-list
1904166|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1904167|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1904168|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904169|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904170|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904171|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
1904172|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904173|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1904174|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
1904175|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1904176|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1904177|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1904178|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904179|NCT00445692|Clarithromycin|clarithromycin|mesh-list
1904180|NCT00445692|Dexamethasone|dexamethasone|mesh-list
1904181|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
1904182|NCT00445692|Lenalidomide|lenalidomide|mesh-list
1904183|NCT00445692|Ichthammol|ichthammol|mesh-list
1904184|NCT00445692|BB 1101|bb 1101|mesh-list
1904185|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904186|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
1904187|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
1904188|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904189|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904190|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1904193|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904194|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1904195|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904196|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
1904197|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904198|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904199|NCT00445692|Growth Substances|growth substances|mesh-ancestor
1904200|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904201|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1904202|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904203|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1904204|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904205|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904206|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1904207|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1904208|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
1904209|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904210|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
1904211|NCT00445744|Busulfan|busulfan|mesh-list
1904212|NCT00445744|Methotrexate|methotrexate|mesh-list
1904213|NCT00445744|Tacrolimus|tacrolimus|mesh-list
1904214|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904215|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
1904216|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904217|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904218|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1904219|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
1904220|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904221|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904222|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1904223|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1904224|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
1904225|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1904226|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904227|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
1904228|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904229|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904230|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1904231|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904232|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1904233|NCT00445770|Etanercept|etanercept|mesh-list
1904234|NCT00445770|Methotrexate|methotrexate|mesh-list
1904235|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1904236|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
1904237|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1904238|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904239|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904240|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
1904241|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904242|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904243|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904244|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904245|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1904246|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904247|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
1904248|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904249|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904250|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904251|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904252|NCT00445770|Analgesics|analgesics|mesh-ancestor
1904253|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
1904254|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904255|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904256|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1904257|NCT00445848|Bevacizumab|bevacizumab|mesh-list
1904258|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1904259|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904260|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904261|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904262|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904263|NCT00445848|Growth Substances|growth substances|mesh-ancestor
1904264|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904265|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904266|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904267|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904268|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904269|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
1904270|NCT00445887|Norgestrel|norgestrel|mesh-list
1904271|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1904272|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
1904273|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1904274|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904275|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1904276|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1904277|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1904278|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1904279|NCT00445939|Adalimumab|adalimumab|mesh-list
1904280|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904281|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904282|NCT00445978|Verapamil|verapamil|mesh-list
1904283|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1904284|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1904285|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904286|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904287|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1904288|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904289|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
1904290|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
1904291|NCT00446030|Bevacizumab|bevacizumab|mesh-list
1904292|NCT00446030|Carboplatin|carboplatin|mesh-list
1904293|NCT00446030|Docetaxel|docetaxel|mesh-list
1904294|NCT00446030|Doxorubicin|doxorubicin|mesh-list
1904295|NCT00446030|Trastuzumab|trastuzumab|mesh-list
1904296|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904297|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
1904298|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904299|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904300|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1904301|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
1904302|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904303|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904304|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1904305|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904306|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904307|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904308|NCT00446030|Growth Substances|growth substances|mesh-ancestor
1904309|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904310|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
1904311|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
1904312|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
1904313|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1904314|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1904315|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1904316|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904317|NCT00446134|Ribavirin|ribavirin|mesh-list
1904318|NCT00446134|Taribavirin|taribavirin|mesh-list
1904319|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
1904320|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904321|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
1904322|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904323|NCT00446147|Pyridoxine|pyridoxine|mesh-list
1904324|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
1904325|NCT00446147|Vitamins|vitamins|mesh-ancestor
1904326|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
1904327|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904328|NCT00446199|Drospirenone|drospirenone|mesh-list
1904329|NCT00446199|Estradiol|estradiol|mesh-list
1904330|NCT00446199|Estrogens|estrogens|mesh-ancestor
1904331|NCT00446199|Hormones|hormones|mesh-ancestor
1904332|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904333|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904334|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1904335|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
1904336|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1904337|NCT00446199|Diuretics|diuretics|mesh-ancestor
1904338|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
1904339|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
1904340|NCT00446251|Rituximab|rituximab|mesh-list
1904341|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904342|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904343|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
1904344|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904345|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904346|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1904347|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1904348|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
1904349|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1904350|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904351|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904352|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904353|NCT00446264|Sirolimus|sirolimus|mesh-list
1904354|NCT00446264|Tacrolimus|tacrolimus|mesh-list
1904355|NCT00446264|Daclizumab|daclizumab|mesh-list
1904356|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904357|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
1904358|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904359|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1904360|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904361|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904362|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1904363|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904364|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1904365|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904366|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
1904367|NCT00446290|Docetaxel|docetaxel|mesh-list
1904368|NCT00446290|Capecitabine|capecitabine|mesh-list
1904369|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
1904370|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904371|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
1904372|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
1904373|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
1904374|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904375|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904376|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
1904377|NCT00446446|Panitumumab|panitumumab|mesh-list
1904378|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904379|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904380|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
1904381|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1904382|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904383|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1904384|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
1904385|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1904386|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904387|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904388|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904389|NCT00446511|Valsartan|valsartan|mesh-list
1904390|NCT00446511|Enalapril|enalapril|mesh-list
1904391|NCT00446511|Enalaprilat|enalaprilat|mesh-list
1904392|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1904393|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1904394|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1904395|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904396|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1904397|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
1904398|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904399|NCT00446563|Losartan|losartan|mesh-list
1904400|NCT00446563|Amlodipine|amlodipine|mesh-list
1904401|NCT00446563|Valsartan|valsartan|mesh-list
1904402|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1904403|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1904404|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1904405|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904406|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904407|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1904408|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904409|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
1904410|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1904411|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1904412|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1904413|NCT00446563|Diuretics|diuretics|mesh-ancestor
1904414|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
1904415|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1904416|NCT00446641|Cilostazol|cilostazol|mesh-list
1904417|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1904418|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
1904419|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904420|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904421|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1904422|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
1904423|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1904424|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1904425|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904426|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1904427|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
1904428|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1904429|NCT00446641|Protective Agents|protective agents|mesh-ancestor
1904430|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1904431|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1904432|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904433|NCT00446797|Celecoxib|celecoxib|mesh-list
1904434|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904435|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904436|NCT00446797|Analgesics|analgesics|mesh-ancestor
1904437|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
1904438|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904439|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904440|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904441|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904442|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1904443|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1904444|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904445|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904446|NCT00446849|Mesalamine|mesalamine|mesh-list
1904447|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904448|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904449|NCT00446849|Analgesics|analgesics|mesh-ancestor
1904450|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
1904451|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904452|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904453|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904454|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904455|NCT00446992|Olanzapine|olanzapine|mesh-list
1904456|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
1904457|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
1904458|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904459|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904460|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1904461|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1904462|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1904463|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1904464|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1904465|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1904466|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1904467|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904468|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904469|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904470|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
1904471|NCT00447005|Axitinib|axitinib|mesh-list
1904472|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904473|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904474|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904475|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904476|NCT00447057|Pemetrexed|pemetrexed|mesh-list
1904477|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1904478|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904479|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904480|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904481|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1904482|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904483|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904484|NCT00447122|Gemcitabine|gemcitabine|mesh-list
1904485|NCT00447122|Lapatinib|lapatinib|mesh-list
1904486|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904487|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
1904488|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904489|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904490|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
1904491|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904492|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904493|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904494|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
1904495|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904496|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904497|NCT00447226|Lapatinib|lapatinib|mesh-list
1904498|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904499|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904500|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904501|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904502|NCT00447265|Etanercept|etanercept|mesh-list
1904503|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904504|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904505|NCT00447265|Analgesics|analgesics|mesh-ancestor
1904506|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
1904507|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904508|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904509|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904510|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904511|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1904512|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904513|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
1904514|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1904515|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1904516|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1904517|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904518|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904519|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
1904520|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904521|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904522|NCT00447330|Bevacizumab|bevacizumab|mesh-list
1904523|NCT00447330|Capecitabine|capecitabine|mesh-list
1904524|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
1904525|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904526|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904527|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904528|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904529|NCT00447330|Growth Substances|growth substances|mesh-ancestor
1904530|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904531|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904532|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904533|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
1904534|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904535|NCT00447382|Insulin|insulin|mesh-list
1904536|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1904537|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
1904538|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
1904539|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1904540|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904541|NCT00447499|Lanreotide|lanreotide|mesh-list
1904542|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904543|NCT00447694|Deferasirox|deferasirox|mesh-list
1904544|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1904545|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
1904546|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
1904547|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904548|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
1904549|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1904550|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1904551|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1904552|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904553|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904554|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
1904555|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904556|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904557|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1904558|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904559|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
1904560|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1904561|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1904562|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1904563|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904564|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904565|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
1904566|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904567|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904568|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1904569|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904570|NCT00447902|Ritonavir|ritonavir|mesh-list
1904571|NCT00447902|Tipranavir|tipranavir|mesh-list
1904572|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1904573|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1904574|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
1904575|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904576|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904577|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1904578|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1904579|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
1904580|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904581|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1904582|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1904583|NCT00448019|Vidarabine|vidarabine|mesh-list
1904584|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
1904585|NCT00448019|Bevacizumab|bevacizumab|mesh-list
1904586|NCT00448019|Rituximab|rituximab|mesh-list
1904587|NCT00448019|Fludarabine|fludarabine|mesh-list
1904588|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
1904589|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904590|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
1904591|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904592|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904593|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1904594|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
1904595|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904596|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904597|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1904598|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904599|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904600|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904601|NCT00448019|Growth Substances|growth substances|mesh-ancestor
1904602|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904603|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904604|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
1904605|NCT00448019|Antiviral Agents|antiviral agents|mesh-ancestor
1904606|NCT00448019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904607|NCT00448123|Tamsulosin|tamsulosin|mesh-list
1904608|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1904609|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1904610|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1904611|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
1904612|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904613|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904614|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904615|NCT00448123|Urological Agents|urological agents|mesh-ancestor
1904616|NCT00448136|Bevacizumab|bevacizumab|mesh-list
1904617|NCT00448136|Streptozocin|streptozocin|mesh-list
1904618|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904619|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904620|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904621|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904622|NCT00448136|Growth Substances|growth substances|mesh-ancestor
1904623|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904624|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904625|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1904626|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1904627|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1904628|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1904629|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
1904630|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904631|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904632|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904633|NCT00448175|Urological Agents|urological agents|mesh-ancestor
1904634|NCT00448201|Methotrexate|methotrexate|mesh-list
1904635|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
1904636|NCT00448201|Fludarabine|fludarabine|mesh-list
1904637|NCT00448201|Busulfan|busulfan|mesh-list
1904638|NCT00448201|Tacrolimus|tacrolimus|mesh-list
1904639|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1904640|NCT00448201|Sargramostim|sargramostim|mesh-list
1904641|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1904642|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
1904643|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1904644|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904645|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904646|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
1904647|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904648|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904649|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904650|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904651|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1904652|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904653|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
1904654|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904655|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904656|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1904657|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
1904658|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1904659|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1904660|NCT00448227|Famciclovir|famciclovir|mesh-list
1904661|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
1904662|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904663|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904664|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904665|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904666|NCT00448279|Trastuzumab|trastuzumab|mesh-list
1904667|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904668|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904669|NCT00448357|Methotrexate|methotrexate|mesh-list
1904670|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
1904671|NCT00448357|Fludarabine|fludarabine|mesh-list
1904672|NCT00448357|Busulfan|busulfan|mesh-list
1904673|NCT00448357|Tacrolimus|tacrolimus|mesh-list
1904674|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1904675|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
1904676|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1904677|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
1904678|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1904679|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904680|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904681|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
1904682|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904683|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904684|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904685|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904686|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1904687|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904688|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
1904689|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904690|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904691|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1904692|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
1904693|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1904694|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1904695|NCT00448435|Fluticasone|fluticasone|mesh-list
1904696|NCT00448435|Xhance|xhance|mesh-list
1904697|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1904698|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1904699|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904700|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1904701|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
1904702|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904703|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904704|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1904705|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
1904706|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904707|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1904708|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1904709|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1904710|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1904711|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
1904712|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904713|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904714|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
1904715|NCT00448435|Hormones|hormones|mesh-ancestor
1904716|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904717|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
1904718|NCT00448539|Rufinamide|rufinamide|mesh-list
1904719|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
1904720|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1904721|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1904722|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904723|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904724|NCT00448591|Bevacizumab|bevacizumab|mesh-list
1904725|NCT00448591|Taxane|taxane|mesh-list
1904726|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904727|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904728|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904729|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904730|NCT00448591|Growth Substances|growth substances|mesh-ancestor
1904731|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904732|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904733|NCT00448669|Tenofovir|tenofovir|mesh-list
1904734|NCT00448669|Emtricitabine|emtricitabine|mesh-list
1904735|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
1904736|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904737|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1904738|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1904739|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904740|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904741|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1904742|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1904743|NCT00448708|Paclitaxel|paclitaxel|mesh-list
1904744|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1904745|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1904746|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904747|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
1904748|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
1904749|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
1904750|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904751|NCT00448760|Leucovorin|leucovorin|mesh-list
1904752|NCT00448760|Docetaxel|docetaxel|mesh-list
1904753|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
1904754|NCT00448760|Floxuridine|floxuridine|mesh-list
1904755|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904756|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
1904757|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
1904758|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
1904759|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904760|NCT00448760|Antidotes|antidotes|mesh-ancestor
1904761|NCT00448760|Protective Agents|protective agents|mesh-ancestor
1904762|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904763|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
1904764|NCT00448760|Vitamins|vitamins|mesh-ancestor
1904765|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
1904766|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904767|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
1904768|NCT00448864|Ecallantide|ecallantide|mesh-list
1904769|NCT00448864|Analgesics|analgesics|mesh-ancestor
1904770|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
1904771|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904772|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904773|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904774|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904775|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904776|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904777|NCT00448916|Pregabalin|pregabalin|mesh-list
1904778|NCT00448916|Analgesics|analgesics|mesh-ancestor
1904779|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
1904780|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904781|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904782|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
1904783|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1904784|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904785|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904786|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1904787|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1904788|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1904789|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1904790|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1904791|NCT00449007|Bupropion|bupropion|mesh-list
1904792|NCT00449007|Fluoxetine|fluoxetine|mesh-list
1904793|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1904794|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
1904795|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1904796|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1904797|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1904798|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904799|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904800|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
1904801|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904802|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904803|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1904804|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1904805|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904806|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1904807|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
1904808|NCT00449033|Gemcitabine|gemcitabine|mesh-list
1904809|NCT00449033|Sorafenib|sorafenib|mesh-list
1904810|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904811|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904812|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
1904813|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904814|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
1904815|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904816|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904817|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904818|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
1904819|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904820|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1904821|NCT00449046|Fluticasone|fluticasone|mesh-list
1904822|NCT00449046|Xhance|xhance|mesh-list
1904823|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1904824|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904825|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1904826|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
1904827|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904828|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904829|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1904830|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
1904831|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904832|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1904833|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1904834|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1904835|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1904836|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
1904837|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904838|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904839|NCT00449072|Loratadine|loratadine|mesh-list
1904840|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
1904841|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
1904842|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1904843|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1904844|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1904845|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
1904846|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
1904847|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904848|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904849|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904850|NCT00449150|Cetrorelix|cetrorelix|mesh-list
1904851|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1904852|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
1904853|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1904854|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904855|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
1904856|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904857|NCT00449163|Leucovorin|leucovorin|mesh-list
1904858|NCT00449163|Bevacizumab|bevacizumab|mesh-list
1904859|NCT00449163|Irinotecan|irinotecan|mesh-list
1904860|NCT00449163|Floxuridine|floxuridine|mesh-list
1904861|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
1904862|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1904863|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904864|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904865|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904866|NCT00449163|Growth Substances|growth substances|mesh-ancestor
1904867|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904868|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
1904869|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1904870|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1904871|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904872|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904873|NCT00449163|Antidotes|antidotes|mesh-ancestor
1904874|NCT00449163|Protective Agents|protective agents|mesh-ancestor
1904875|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
1904876|NCT00449163|Vitamins|vitamins|mesh-ancestor
1904877|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
1904878|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1904879|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
1904880|NCT00449176|Oxycodone|oxycodone|mesh-list
1904881|NCT00449176|Tapentadol|tapentadol|mesh-list
1904882|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1904883|NCT00449176|Narcotics|narcotics|mesh-ancestor
1904884|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1904885|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904886|NCT00449176|Analgesics|analgesics|mesh-ancestor
1904887|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
1904888|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904889|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1904890|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1904891|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904892|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904893|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
1904894|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904895|NCT00449644|Bedaquiline|bedaquiline|mesh-list
1904896|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
1904897|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1904898|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1904899|NCT00449670|Vaccines|vaccines|mesh-list
1904900|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
1904901|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904902|NCT00449748|Everolimus|everolimus|mesh-list
1904903|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904904|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1904905|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
1904906|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904907|NCT00449761|Panobinostat|panobinostat|mesh-list
1904908|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1904909|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1904910|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904911|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904912|NCT00449787|Naproxen|naproxen|mesh-list
1904913|NCT00449787|Sumatriptan|sumatriptan|mesh-list
1904914|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904915|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904916|NCT00449787|Analgesics|analgesics|mesh-ancestor
1904917|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
1904918|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904919|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904920|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904921|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904922|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
1904923|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1904924|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904925|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904926|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1904927|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1904928|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1904929|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
1904930|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904931|NCT00449930|Metformin|metformin|mesh-list
1904932|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1904933|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1904934|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904935|NCT00449930|Incretins|incretins|mesh-ancestor
1904936|NCT00449930|Hormones|hormones|mesh-ancestor
1904937|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1904938|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1904939|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
1904940|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904941|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904942|NCT00449956|Timolol|timolol|mesh-list
1904943|NCT00449956|Dorzolamide|dorzolamide|mesh-list
1904944|NCT00449956|Maleic acid|maleic acid|mesh-list
1904945|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1904946|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1904947|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
1904948|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904949|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904950|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904951|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1904952|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1904953|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904954|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1904955|NCT00450073|Vitamin D|vitamin d|mesh-list
1904956|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
1904957|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
1904958|NCT00450073|Vitamins|vitamins|mesh-list
1904959|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
1904960|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904961|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1904962|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1904963|NCT00450216|Ibuprofen|ibuprofen|mesh-list
1904964|NCT00450216|Famotidine|famotidine|mesh-list
1904965|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1904966|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1904967|NCT00450216|Analgesics|analgesics|mesh-ancestor
1904968|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
1904969|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904970|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904971|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1904972|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1904973|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1904974|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1904975|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904976|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1904977|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1904978|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1904979|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
1904980|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
1904981|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1904982|NCT00450242|Lidocaine|lidocaine|mesh-list
1904983|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
1904984|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
1904985|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1904986|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1904987|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
1904988|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1904989|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1904990|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1904991|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1904992|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1904993|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1904994|NCT00450255|Aflibercept|aflibercept|mesh-list
1904995|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
1904996|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1904997|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1904998|NCT00450255|Growth Substances|growth substances|mesh-ancestor
1904999|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905000|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905001|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905002|NCT00450385|Prednisone|prednisone|mesh-list
1905003|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
1905004|NCT00450385|Rituximab|rituximab|mesh-list
1905005|NCT00450385|Doxorubicin|doxorubicin|mesh-list
1905006|NCT00450385|Vincristine|vincristine|mesh-list
1905007|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905008|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
1905009|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905010|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905011|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905012|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
1905013|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905014|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905015|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905016|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905017|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905018|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905019|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905020|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905021|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905022|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
1905023|NCT00450385|Hormones|hormones|mesh-ancestor
1905024|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905025|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905026|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905027|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905028|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905029|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905030|NCT00450450|Lenograstim|lenograstim|mesh-list
1905031|NCT00450450|Sargramostim|sargramostim|mesh-list
1905032|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1905033|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
1905034|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905035|NCT00450463|Metronidazole|metronidazole|mesh-list
1905036|NCT00450463|Molgramostim|molgramostim|mesh-list
1905037|NCT00450463|Flutamide|flutamide|mesh-list
1905038|NCT00450463|Sargramostim|sargramostim|mesh-list
1905039|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
1905040|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905041|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905042|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905043|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905044|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1905045|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1905046|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
1905047|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
1905048|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905049|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905050|NCT00450580|Ritonavir|ritonavir|mesh-list
1905051|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
1905052|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1905053|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1905054|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
1905055|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905056|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905057|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1905058|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1905059|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
1905060|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905061|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1905062|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1905063|NCT00450619|Metronidazole|metronidazole|mesh-list
1905064|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
1905065|NCT00450619|Vaccines|vaccines|mesh-list
1905066|NCT00450619|Sargramostim|sargramostim|mesh-list
1905067|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
1905068|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905069|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905070|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905071|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1905072|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1905073|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1905074|NCT00450619|Analgesics|analgesics|mesh-ancestor
1905075|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
1905076|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905077|NCT00450658|Ibuprofen|ibuprofen|mesh-list
1905078|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1905079|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1905080|NCT00450658|Analgesics|analgesics|mesh-ancestor
1905081|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
1905082|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905083|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905084|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905085|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905086|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1905087|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905088|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905089|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
1905090|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1905091|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905092|NCT00450749|Lycopene|lycopene|mesh-list
1905093|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905094|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
1905095|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905096|NCT00450749|Protective Agents|protective agents|mesh-ancestor
1905097|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905098|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1905099|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1905100|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905101|NCT00450801|Leucovorin|leucovorin|mesh-list
1905102|NCT00450801|Cytarabine|cytarabine|mesh-list
1905103|NCT00450801|Thalidomide|thalidomide|mesh-list
1905104|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
1905105|NCT00450801|Ifosfamide|ifosfamide|mesh-list
1905106|NCT00450801|Rituximab|rituximab|mesh-list
1905107|NCT00450801|Doxorubicin|doxorubicin|mesh-list
1905108|NCT00450801|Methotrexate|methotrexate|mesh-list
1905109|NCT00450801|Etoposide|etoposide|mesh-list
1905110|NCT00450801|Vincristine|vincristine|mesh-list
1905111|NCT00450801|Granisetron|granisetron|mesh-list
1905112|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905113|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
1905114|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905115|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905116|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905117|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
1905118|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905119|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905120|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905121|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905122|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905123|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905124|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905125|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905126|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1905127|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
1905128|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1905129|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905130|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
1905131|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905132|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1905133|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1905134|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905135|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
1905136|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905137|NCT00450801|Antidotes|antidotes|mesh-ancestor
1905138|NCT00450801|Protective Agents|protective agents|mesh-ancestor
1905139|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
1905140|NCT00450801|Vitamins|vitamins|mesh-ancestor
1905141|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
1905142|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905143|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905144|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905145|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
1905146|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
1905147|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905148|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1905149|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
1905150|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905151|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905152|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905153|NCT00450801|Growth Substances|growth substances|mesh-ancestor
1905154|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905155|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1905156|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
1905157|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905158|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
1905159|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905160|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
1905161|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905162|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905163|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905164|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
1905165|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905166|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905167|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905168|NCT00450866|Epothilones|epothilones|mesh-list
1905169|NCT00450866|Epothilone B|epothilone b|mesh-list
1905170|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905171|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905172|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905173|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905174|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905175|NCT00450983|Methotrexate|methotrexate|mesh-list
1905176|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
1905177|NCT00450983|Fludarabine|fludarabine|mesh-list
1905178|NCT00450983|Thiotepa|thiotepa|mesh-list
1905179|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
1905180|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1905181|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
1905182|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1905183|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905184|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905185|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
1905186|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905187|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905188|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905189|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905190|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1905191|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905192|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
1905193|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905194|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1905195|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905196|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
1905197|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905198|NCT00451035|Panobinostat|panobinostat|mesh-list
1905199|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905200|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1905201|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905202|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905203|NCT00451048|Sunitinib|sunitinib|mesh-list
1905204|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905205|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905206|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905207|NCT00451048|Growth Substances|growth substances|mesh-ancestor
1905208|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905209|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905210|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905211|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905212|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905213|NCT00451178|Prednisone|prednisone|mesh-list
1905214|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
1905215|NCT00451178|Rituximab|rituximab|mesh-list
1905216|NCT00451178|Doxorubicin|doxorubicin|mesh-list
1905217|NCT00451178|Vincristine|vincristine|mesh-list
1905218|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905219|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
1905220|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905221|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905222|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905223|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
1905224|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905225|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905226|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905227|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905228|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905229|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905230|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905231|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905232|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905233|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
1905234|NCT00451178|Hormones|hormones|mesh-ancestor
1905235|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905236|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905237|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905238|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905239|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905240|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905241|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
1905242|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1905243|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1905244|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1905320|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
1905245|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905246|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905247|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
1905248|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905249|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905250|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1905251|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905252|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
1905253|NCT00451204|Estrogens|estrogens|mesh-list
1905254|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
1905255|NCT00451204|Hormones|hormones|mesh-ancestor
1905256|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905257|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905258|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1905259|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
1905260|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905261|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905262|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
1905263|NCT00451217|Neostigmine|neostigmine|mesh-list
1905264|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1905265|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905266|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905267|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
1905268|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905269|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905270|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1905271|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
1905272|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905273|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1905274|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1905275|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1905276|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
1905277|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1905278|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
1905279|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905280|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905281|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
1905282|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905283|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1905284|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905285|NCT00451555|Fulvestrant|fulvestrant|mesh-list
1905286|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905287|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905288|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1905289|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1905290|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
1905291|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905292|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905293|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
1905294|NCT00451698|Hematinics|hematinics|mesh-ancestor
1905295|NCT00451906|Bevacizumab|bevacizumab|mesh-list
1905296|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905297|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905298|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905299|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905300|NCT00451906|Growth Substances|growth substances|mesh-ancestor
1905301|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905302|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905303|NCT00451958|Leuprolide|leuprolide|mesh-list
1905304|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1905305|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
1905306|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1905307|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905308|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905309|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905310|NCT00452335|Lubiprostone|lubiprostone|mesh-list
1905311|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1905312|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905313|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905314|NCT00452348|Fluticasone|fluticasone|mesh-list
1905315|NCT00452348|Xhance|xhance|mesh-list
1905316|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1905317|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1905318|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905319|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1905321|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905322|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905323|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1905324|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
1905325|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905326|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1905327|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1905328|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1905329|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1905330|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
1905331|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905332|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905333|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
1905334|NCT00452348|Hormones|hormones|mesh-ancestor
1905335|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905336|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
1905337|NCT00452374|Vidarabine|vidarabine|mesh-list
1905338|NCT00452374|Cytarabine|cytarabine|mesh-list
1905339|NCT00452374|Rituximab|rituximab|mesh-list
1905340|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
1905341|NCT00452374|Fludarabine|fludarabine|mesh-list
1905342|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
1905343|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905344|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905345|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
1905346|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905347|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905348|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905349|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
1905350|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905351|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905352|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
1905353|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905354|NCT00452387|Prednisone|prednisone|mesh-list
1905355|NCT00452387|Sorafenib|sorafenib|mesh-list
1905356|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
1905357|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905358|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
1905359|NCT00452387|Hormones|hormones|mesh-ancestor
1905360|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905361|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905362|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905363|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905364|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905365|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905366|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905367|NCT00452387|Analgesics|analgesics|mesh-ancestor
1905368|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
1905369|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905370|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905371|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905372|NCT00452400|Olodaterol|olodaterol|mesh-list
1905373|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1905374|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
1905375|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905376|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905377|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1905378|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
1905379|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1905380|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905381|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905382|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905383|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905384|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
1905385|NCT00452426|Narcotics|narcotics|mesh-ancestor
1905386|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1905387|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905388|NCT00452426|Analgesics|analgesics|mesh-ancestor
1905389|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
1905390|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905391|NCT00452439|Vitamin D|vitamin d|mesh-list
1905392|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
1905393|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
1905394|NCT00452439|Calcium|calcium|mesh-list
1905395|NCT00452439|Vitamins|vitamins|mesh-ancestor
1905396|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
1905397|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905398|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1905399|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1905400|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1905401|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905402|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905403|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1905404|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
1905405|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905406|NCT00452530|Enoxaparin|enoxaparin|mesh-list
1905407|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
1905408|NCT00452530|Apixaban|apixaban|mesh-list
1905409|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
1905410|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1905411|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1905412|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905413|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1905414|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
1905415|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1905416|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
1905417|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905418|NCT00452543|Acamprosate|acamprosate|mesh-list
1905419|NCT00452543|Dexetimide|dexetimide|mesh-list
1905420|NCT00452543|Citalopram|citalopram|mesh-list
1905421|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1905422|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1905423|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905424|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905425|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905426|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
1905427|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905428|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1905429|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
1905430|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1905431|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1905432|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1905433|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
1905434|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
1905435|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905436|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1905437|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1905438|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
1905439|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1905440|NCT00452673|Capecitabine|capecitabine|mesh-list
1905441|NCT00452673|Dasatinib|dasatinib|mesh-list
1905442|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905443|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
1905444|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905445|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905446|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905447|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905448|NCT00452699|Fluticasone|fluticasone|mesh-list
1905449|NCT00452699|Xhance|xhance|mesh-list
1905450|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1905451|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905452|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1905453|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
1905454|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905455|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905456|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1905457|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
1905458|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905459|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1905460|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1905461|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1905462|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1905463|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
1905464|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905465|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905466|NCT00452790|Vaccines|vaccines|mesh-list
1905467|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1905468|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
1905469|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905470|NCT00452868|Donepezil|donepezil|mesh-list
1905471|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1905472|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905473|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905474|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
1905475|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905476|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905477|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
1905478|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
1905479|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905480|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905481|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1905482|NCT00453102|Rituximab|rituximab|mesh-list
1905483|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905484|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905485|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
1905486|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905487|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905488|NCT00453154|Cisplatin|cisplatin|mesh-list
1905489|NCT00453154|Carboplatin|carboplatin|mesh-list
1905490|NCT00453154|Etoposide|etoposide|mesh-list
1905491|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
1905492|NCT00453154|Sunitinib|sunitinib|mesh-list
1905493|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
1905494|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905495|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905496|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905497|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905498|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905499|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905500|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905501|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905502|NCT00453154|Growth Substances|growth substances|mesh-ancestor
1905503|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905504|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905505|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905506|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
1905507|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905508|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905509|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905510|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905511|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
1905512|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1905513|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
1905514|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905515|NCT00453180|Expectorants|expectorants|mesh-ancestor
1905516|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
1905517|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1905518|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
1905519|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905520|NCT00453180|Protective Agents|protective agents|mesh-ancestor
1905521|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905522|NCT00453180|Antidotes|antidotes|mesh-ancestor
1905523|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
1905524|NCT00453193|Pentostatin|pentostatin|mesh-list
1905525|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905526|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905527|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1905528|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905529|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905530|NCT00453310|Sunitinib|sunitinib|mesh-list
1905531|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905532|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905533|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905534|NCT00453310|Growth Substances|growth substances|mesh-ancestor
1905535|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905536|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905537|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905538|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905539|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905540|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
1905541|NCT00453336|Trioxsalen|trioxsalen|mesh-list
1905542|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905543|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905544|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1905545|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
1905546|NCT00453349|Metronidazole|metronidazole|mesh-list
1905547|NCT00453349|Levofloxacin|levofloxacin|mesh-list
1905548|NCT00453349|Ofloxacin|ofloxacin|mesh-list
1905549|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1905550|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905551|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905552|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905553|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905554|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905555|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905556|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905557|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1905558|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
1905559|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1905560|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905561|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1905562|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1905563|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1905564|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1905565|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1905566|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1905567|NCT00453349|Renal Agents|renal agents|mesh-ancestor
1905568|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1905569|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1905570|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1905571|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905572|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905573|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905574|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905575|NCT00453388|Cyclosporine|cyclosporine|mesh-list
1905576|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
1905577|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
1905578|NCT00453388|Fludarabine|fludarabine|mesh-list
1905579|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
1905580|NCT00453388|Cyclosporins|cyclosporins|mesh-list
1905581|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905582|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
1905583|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905584|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905585|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905586|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
1905587|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905588|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905589|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905590|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905591|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
1905592|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905593|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
1905594|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905595|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905596|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1905597|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905598|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1905599|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
1905600|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905601|NCT00453895|Sunitinib|sunitinib|mesh-list
1905602|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905603|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905604|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905605|NCT00453895|Growth Substances|growth substances|mesh-ancestor
1905606|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905607|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905608|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905609|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905610|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905611|NCT00453921|Methylphenidate|methylphenidate|mesh-list
1905612|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1905613|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905614|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1905615|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1905616|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905617|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905618|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
1905619|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905620|NCT00453999|Oseltamivir|oseltamivir|mesh-list
1905621|NCT00453999|Peramivir|peramivir|mesh-list
1905622|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
1905623|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905624|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905625|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905626|NCT00454051|Omalizumab|omalizumab|mesh-list
1905627|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1905628|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1905629|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
1905630|NCT00454181|Interferons|interferons|mesh-list
1905631|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
1905632|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905633|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
1905634|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905635|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
1905636|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905637|NCT00454194|Pemetrexed|pemetrexed|mesh-list
1905638|NCT00454194|Sorafenib|sorafenib|mesh-list
1905639|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905640|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905641|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905642|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1905643|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1905644|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905645|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
1905646|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905647|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
1905648|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1905649|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1905650|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905651|NCT00454207|Urological Agents|urological agents|mesh-ancestor
1905652|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
1905653|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
1905654|NCT00454246|Hematinics|hematinics|mesh-ancestor
1905655|NCT00454324|Paclitaxel|paclitaxel|mesh-list
1905656|NCT00454324|Carboplatin|carboplatin|mesh-list
1905657|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1905658|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905659|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905660|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905661|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905662|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905663|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905664|NCT00454584|Etanercept|etanercept|mesh-list
1905665|NCT00454584|Ustekinumab|ustekinumab|mesh-list
1905666|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1905667|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1905668|NCT00454584|Analgesics|analgesics|mesh-ancestor
1905669|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
1905670|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905671|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905672|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905673|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905674|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1905675|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905676|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
1905677|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905678|NCT00454636|Cisplatin|cisplatin|mesh-list
1905679|NCT00454636|Docetaxel|docetaxel|mesh-list
1905680|NCT00454636|Capecitabine|capecitabine|mesh-list
1905681|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
1905682|NCT00454636|Epirubicin|epirubicin|mesh-list
1905683|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905684|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905685|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905686|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905687|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905688|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905689|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
1905690|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905691|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905692|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905693|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905694|NCT00454649|Gemcitabine|gemcitabine|mesh-list
1905695|NCT00454649|Paclitaxel|paclitaxel|mesh-list
1905696|NCT00454649|Docetaxel|docetaxel|mesh-list
1905697|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1905698|NCT00454649|Cisplatin|cisplatin|mesh-list
1905699|NCT00454649|Carboplatin|carboplatin|mesh-list
1905700|NCT00454649|Capecitabine|capecitabine|mesh-list
1905701|NCT00454649|Pemetrexed|pemetrexed|mesh-list
1905702|NCT00454649|Axitinib|axitinib|mesh-list
1905703|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905704|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905705|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905706|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905707|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905708|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905709|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905710|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
1905711|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
1905712|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905713|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905714|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905715|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
1905716|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905717|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1905718|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1905719|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905720|NCT00454779|Cisplatin|cisplatin|mesh-list
1905721|NCT00454779|Docetaxel|docetaxel|mesh-list
1905722|NCT00454779|Panitumumab|panitumumab|mesh-list
1905723|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905724|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905725|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905726|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905727|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905728|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905729|NCT00454805|Fulvestrant|fulvestrant|mesh-list
1905730|NCT00454805|Cediranib|cediranib|mesh-list
1905731|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905732|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905733|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1905734|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1905735|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
1905736|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905737|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905738|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1905739|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905740|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905741|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
1905742|NCT00455013|Sirolimus|sirolimus|mesh-list
1905743|NCT00455013|Abatacept|abatacept|mesh-list
1905744|NCT00455013|Tacrolimus|tacrolimus|mesh-list
1905745|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
1905746|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905747|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
1905748|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905749|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1905750|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905751|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905752|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905753|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905754|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1905755|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
1905756|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905757|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905758|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
1905759|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1905760|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905761|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
1905762|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
1905763|NCT00455312|Fludarabine|fludarabine|mesh-list
1905764|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
1905765|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
1905766|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1905767|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905768|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
1905769|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905770|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905771|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905772|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
1905773|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905774|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905775|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905776|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905777|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
1905778|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
1905779|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905780|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1905781|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
1905782|NCT00455312|Hormones|hormones|mesh-ancestor
1905783|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905784|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1905785|NCT00455312|Protective Agents|protective agents|mesh-ancestor
1905786|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905794|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1905795|NCT00455520|Tapentadol|tapentadol|mesh-list
1905796|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1905797|NCT00455520|Narcotics|narcotics|mesh-ancestor
1905798|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1905799|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905800|NCT00455520|Analgesics|analgesics|mesh-ancestor
1905801|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
1905802|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905803|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1905804|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1905805|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905806|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905807|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
1905808|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905809|NCT00455533|Paclitaxel|paclitaxel|mesh-list
1905810|NCT00455533|Epothilones|epothilones|mesh-list
1905811|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
1905812|NCT00455533|Doxorubicin|doxorubicin|mesh-list
1905813|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1905814|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905815|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
1905816|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
1905817|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
1905818|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905819|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905820|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
1905821|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905822|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905823|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1905824|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
1905825|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1905826|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1905827|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1905828|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1905829|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905830|NCT00455650|Mecamylamine|mecamylamine|mesh-list
1905831|NCT00455650|Varenicline|varenicline|mesh-list
1905832|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1905833|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1905834|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
1905835|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905836|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905837|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905838|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1905839|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1905840|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
1905841|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905842|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1905843|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1905844|NCT00455689|Leuprolide|leuprolide|mesh-list
1905845|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1905846|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
1905847|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1905848|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905849|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1905850|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905851|NCT00455702|Cycloserine|cycloserine|mesh-list
1905852|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1905853|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905854|NCT00455702|Renal Agents|renal agents|mesh-ancestor
1905855|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1905856|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
1905857|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1905858|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
1905859|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905860|NCT00455741|Estradiol|estradiol|mesh-list
1905861|NCT00455741|Progesterone|progesterone|mesh-list
1905862|NCT00455741|Estrogens|estrogens|mesh-ancestor
1905863|NCT00455741|Hormones|hormones|mesh-ancestor
1905864|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905865|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905866|NCT00455741|Progestins|progestins|mesh-ancestor
1905867|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
1905868|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1905869|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905870|NCT00455923|Fluticasone|fluticasone|mesh-list
1905871|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1905872|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1905873|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
1905874|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905875|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905876|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1905877|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
1905878|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
1905879|NCT00455923|Hormones|hormones|mesh-ancestor
1905880|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905881|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
1905882|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905883|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
1905884|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1905885|NCT00455962|Estradiol|estradiol|mesh-list
1905886|NCT00455962|Progesterone|progesterone|mesh-list
1905887|NCT00455962|Estrogens|estrogens|mesh-ancestor
1905888|NCT00455962|Hormones|hormones|mesh-ancestor
1905889|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905890|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905891|NCT00455962|Progestins|progestins|mesh-ancestor
1905892|NCT00455975|Bevacizumab|bevacizumab|mesh-list
1905893|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905894|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905895|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905896|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905897|NCT00455975|Growth Substances|growth substances|mesh-ancestor
1905898|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905899|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905900|NCT00456014|Citalopram|citalopram|mesh-list
1905901|NCT00456014|Desipramine|desipramine|mesh-list
1905902|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1905903|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1905904|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905905|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905906|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905907|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
1905908|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905909|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1905910|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
1905911|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1905912|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1905913|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905914|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1905915|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
1905916|NCT00456092|Apremilast|apremilast|mesh-list
1905917|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1905918|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1905919|NCT00456092|Analgesics|analgesics|mesh-ancestor
1905920|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
1905921|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905922|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905923|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905924|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905925|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1905926|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1905927|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905928|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905929|NCT00456261|Gemcitabine|gemcitabine|mesh-list
1905930|NCT00456261|Bevacizumab|bevacizumab|mesh-list
1905931|NCT00456261|Carboplatin|carboplatin|mesh-list
1905932|NCT00456261|Pemetrexed|pemetrexed|mesh-list
1905933|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1905934|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905935|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905936|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905937|NCT00456261|Growth Substances|growth substances|mesh-ancestor
1905938|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905939|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905940|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1905941|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
1905942|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905943|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
1905944|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1905945|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905946|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1905947|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
1905948|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1905949|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1905950|NCT00456300|Exenatide|exenatide|mesh-list
1905951|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1905952|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905953|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1905954|NCT00456300|Incretins|incretins|mesh-ancestor
1905955|NCT00456300|Hormones|hormones|mesh-ancestor
1905956|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1905957|NCT00456365|Pravastatin|pravastatin|mesh-list
1905958|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1905959|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1905960|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
1905961|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905962|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1905963|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1905964|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1905965|NCT00456495|Ranibizumab|ranibizumab|mesh-list
1905966|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1905967|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1905968|NCT00456495|Growth Substances|growth substances|mesh-ancestor
1905969|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905970|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
1905971|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1905972|NCT00456508|Ecallantide|ecallantide|mesh-list
1905973|NCT00456508|Analgesics|analgesics|mesh-ancestor
1905974|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
1905975|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905976|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905977|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1905978|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1905979|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1905980|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1905981|NCT00456521|Naltrexone|naltrexone|mesh-list
1905982|NCT00456521|Bupropion|bupropion|mesh-list
1905983|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1905984|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1905985|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1905986|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
1905987|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1905988|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1905989|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
1905990|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1905991|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1905992|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1905993|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1905994|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1905995|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
1905996|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1905997|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1905998|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1905999|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906000|NCT00456599|Gemcitabine|gemcitabine|mesh-list
1906001|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
1906002|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906003|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
1906004|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906005|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906006|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
1906007|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906008|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906009|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906010|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
1906011|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906012|NCT00456625|Vaccines|vaccines|mesh-list
1906013|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
1906014|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906015|NCT00456807|Vaccines|vaccines|mesh-list
1906016|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
1906017|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906018|NCT00456846|Paclitaxel|paclitaxel|mesh-list
1906019|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1906020|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1906021|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906022|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
1906023|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
1906024|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
1906025|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906026|NCT00456885|Exenatide|exenatide|mesh-list
1906027|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1906028|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906029|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1906030|NCT00456885|Incretins|incretins|mesh-ancestor
1906031|NCT00456885|Hormones|hormones|mesh-ancestor
1906032|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906033|NCT00457002|Enoxaparin|enoxaparin|mesh-list
1906034|NCT00457002|Apixaban|apixaban|mesh-list
1906035|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
1906036|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1906037|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1906038|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906039|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1906040|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
1906041|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1906042|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
1906043|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906044|NCT00457015|Ecallantide|ecallantide|mesh-list
1906045|NCT00457015|Analgesics|analgesics|mesh-ancestor
1906046|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
1906047|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906048|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906049|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1906050|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1906051|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906052|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906053|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1906054|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
1906055|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1906056|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1906057|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1906058|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906059|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906060|NCT00457366|Lorazepam|lorazepam|mesh-list
1906061|NCT00457366|Haloperidol|haloperidol|mesh-list
1906062|NCT00457366|Benztropine|benztropine|mesh-list
1906063|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1906064|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
1906065|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
1906066|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1906067|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1906068|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1906069|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906070|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906071|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
1906072|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
1906073|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906074|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906075|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1906076|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
1906077|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906078|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906079|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1906080|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
1906081|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1906082|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1906083|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
1906084|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
1906085|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1906086|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
1906087|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1906088|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1906089|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
1906090|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1906091|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1906092|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1906093|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1906094|NCT00457392|Sunitinib|sunitinib|mesh-list
1906095|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906096|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906097|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906098|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906099|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906100|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906101|NCT00457392|Growth Substances|growth substances|mesh-ancestor
1906102|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906103|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906104|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1906105|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
1906106|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906107|NCT00457626|Valsartan|valsartan|mesh-list
1906108|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1906109|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1906110|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1906111|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906112|NCT00457639|Cholic Acids|cholic acids|mesh-list
1906113|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906114|NCT00457665|Efavirenz|efavirenz|mesh-list
1906115|NCT00457665|Nelfinavir|nelfinavir|mesh-list
1906116|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1906117|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906118|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906119|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906120|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
1906121|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906122|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1906123|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1906124|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1906125|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1906126|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1906127|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1906128|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1906129|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1906130|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
1906131|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1906132|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1906133|NCT00457691|Leucovorin|leucovorin|mesh-list
1906134|NCT00457691|Fluorouracil|fluorouracil|mesh-list
1906135|NCT00457691|Irinotecan|irinotecan|mesh-list
1906136|NCT00457691|Sunitinib|sunitinib|mesh-list
1906137|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
1906138|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
1906139|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906140|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906141|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906142|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906143|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
1906144|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906145|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1906146|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1906147|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906148|NCT00457691|Antidotes|antidotes|mesh-ancestor
1906149|NCT00457691|Protective Agents|protective agents|mesh-ancestor
1906150|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
1906151|NCT00457691|Vitamins|vitamins|mesh-ancestor
1906152|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
1906153|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906154|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906155|NCT00457691|Growth Substances|growth substances|mesh-ancestor
1906156|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906157|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906158|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1906159|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1906160|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1906161|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1906162|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906163|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906164|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906165|NCT00457730|Analgesics|analgesics|mesh-ancestor
1906166|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
1906167|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906168|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
1906169|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1906170|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
1906171|NCT00457743|Sunitinib|sunitinib|mesh-list
1906172|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906173|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906174|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906175|NCT00457743|Growth Substances|growth substances|mesh-ancestor
1906176|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906177|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906178|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906179|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906180|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906181|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1906182|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1906183|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1906184|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1906185|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1906186|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
1906187|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906188|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906189|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906190|NCT00457821|Ivacaftor|ivacaftor|mesh-list
1906191|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1906192|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1906193|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906194|NCT00457977|Vaccines|vaccines|mesh-list
1906195|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1906196|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
1906197|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906198|NCT00458211|Ziprasidone|ziprasidone|mesh-list
1906199|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1906200|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
1906201|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906202|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906203|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906204|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1906205|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1906206|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906207|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1906208|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1906209|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
1906210|NCT00458237|Trastuzumab|trastuzumab|mesh-list
1906211|NCT00458237|Everolimus|everolimus|mesh-list
1906212|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906213|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906214|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906215|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
1906216|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906217|NCT00458302|Darunavir|darunavir|mesh-list
1906218|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1906219|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1906220|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
1906221|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906222|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906223|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1906224|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1906225|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
1906226|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906304|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1906227|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1906228|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1906229|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906230|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906231|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906232|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
1906233|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906234|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1906235|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1906241|NCT00458705|Thalidomide|thalidomide|mesh-list
1906242|NCT00458705|Dexamethasone|dexamethasone|mesh-list
1906243|NCT00458705|Doxorubicin|doxorubicin|mesh-list
1906244|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1906245|NCT00458705|Bortezomib|bortezomib|mesh-list
1906246|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906247|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
1906248|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
1906249|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906250|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906251|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906252|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
1906253|NCT00458705|Hormones|hormones|mesh-ancestor
1906254|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906255|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1906256|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906257|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1906258|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1906259|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1906260|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906261|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906262|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906263|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
1906264|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
1906265|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1906266|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906267|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906268|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906269|NCT00458705|Growth Substances|growth substances|mesh-ancestor
1906270|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906271|NCT00458822|Dexamethasone|dexamethasone|mesh-list
1906272|NCT00458822|Bortezomib|bortezomib|mesh-list
1906273|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906274|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
1906275|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
1906276|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906277|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906278|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906279|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
1906280|NCT00458822|Hormones|hormones|mesh-ancestor
1906281|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906282|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1906283|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906284|NCT00458848|Prednisone|prednisone|mesh-list
1906285|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
1906286|NCT00458848|Methotrexate|methotrexate|mesh-list
1906287|NCT00458848|Etoposide|etoposide|mesh-list
1906288|NCT00458848|Vincristine|vincristine|mesh-list
1906289|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
1906290|NCT00458848|Daunorubicin|daunorubicin|mesh-list
1906291|NCT00458848|Asparaginase|asparaginase|mesh-list
1906292|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
1906293|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
1906294|NCT00458848|Idarubicin|idarubicin|mesh-list
1906295|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906296|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
1906297|NCT00458848|Hormones|hormones|mesh-ancestor
1906298|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906299|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906300|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1906301|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906302|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1906303|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
1906305|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906306|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
1906307|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906308|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
1906309|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906310|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1906311|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906312|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
1906313|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906314|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906315|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1906316|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1906317|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1906318|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
1906319|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
1906320|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
1906321|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
1906322|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
1906323|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906324|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906325|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1906326|NCT00458848|Protective Agents|protective agents|mesh-ancestor
1906327|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906328|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1906329|NCT00458848|Analgesics|analgesics|mesh-ancestor
1906330|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
1906331|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
1906332|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906333|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906334|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906335|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1906336|NCT00459043|Docetaxel|docetaxel|mesh-list
1906337|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906338|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
1906339|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
1906340|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
1906341|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906342|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1906343|NCT00459056|Carvedilol|carvedilol|mesh-list
1906344|NCT00459056|Lisinopril|lisinopril|mesh-list
1906345|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1906346|NCT00459056|Diuretics|diuretics|mesh-ancestor
1906347|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
1906348|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906349|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1906350|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1906351|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906352|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1906353|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1906354|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
1906355|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906356|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
1906357|NCT00459056|Protective Agents|protective agents|mesh-ancestor
1906358|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1906359|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1906360|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
1906361|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1906362|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1906363|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1906364|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
1906365|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906366|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1906367|NCT00459108|Dasatinib|dasatinib|mesh-list
1906368|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906369|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906370|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906371|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906372|NCT00459186|Prednisone|prednisone|mesh-list
1906373|NCT00459186|Docetaxel|docetaxel|mesh-list
1906374|NCT00459186|Everolimus|everolimus|mesh-list
1906375|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906376|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
1906377|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
1906378|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
1906379|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906380|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906381|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
1906382|NCT00459186|Hormones|hormones|mesh-ancestor
1906383|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906384|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906385|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1906386|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906387|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
1906388|NCT00459290|Mifepristone|mifepristone|mesh-list
1906389|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1906390|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
1906391|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1906392|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906393|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1906394|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1906395|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1906396|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
1906397|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1906398|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1906399|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
1906400|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906401|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
1906402|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1906403|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1906404|NCT00459342|Dasatinib|dasatinib|mesh-list
1906405|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906406|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906407|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906408|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906409|NCT00459537|Terbinafine|terbinafine|mesh-list
1906410|NCT00459537|Amorolfine|amorolfine|mesh-list
1906411|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
1906412|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906413|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906414|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906415|NCT00459667|Interferons|interferons|mesh-list
1906416|NCT00459667|Interferon-beta|interferon-beta|mesh-list
1906417|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
1906418|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906419|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
1906420|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906421|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
1906422|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906423|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1906424|NCT00459706|Etanercept|etanercept|mesh-list
1906425|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1906426|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1906427|NCT00459706|Analgesics|analgesics|mesh-ancestor
1906428|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
1906429|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906430|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906431|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906432|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906433|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906434|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906435|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
1906436|NCT00459732|Zinc|zinc|mesh-list
1906437|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
1906438|NCT00459732|Trace Elements|trace elements|mesh-ancestor
1906439|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
1906440|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906441|NCT00459732|Astringents|astringents|mesh-ancestor
1906442|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
1906443|NCT00459810|Paclitaxel|paclitaxel|mesh-list
1906444|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
1906445|NCT00459810|Estradiol|estradiol|mesh-list
1906446|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1906447|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906448|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
1906449|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
1906450|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
1906451|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906452|NCT00459810|Estrogens|estrogens|mesh-ancestor
1906453|NCT00459810|Hormones|hormones|mesh-ancestor
1906454|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906830|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
1906455|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906456|NCT00459875|Sunitinib|sunitinib|mesh-list
1906457|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906458|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906459|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906460|NCT00459875|Growth Substances|growth substances|mesh-ancestor
1906461|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906462|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906463|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906464|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906465|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906466|NCT00459953|Nicotine|nicotine|mesh-list
1906467|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1906468|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
1906469|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906470|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906471|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1906472|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1906473|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
1906474|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906475|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906476|NCT00459979|Sunitinib|sunitinib|mesh-list
1906477|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906478|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906479|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906480|NCT00459979|Growth Substances|growth substances|mesh-ancestor
1906481|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906482|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906483|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906484|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906485|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906486|NCT00460031|Ketoconazole|ketoconazole|mesh-list
1906487|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
1906488|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1906489|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1906490|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1906491|NCT00460031|Lenalidomide|lenalidomide|mesh-list
1906492|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
1906493|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906494|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906495|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906496|NCT00460031|Growth Substances|growth substances|mesh-ancestor
1906497|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906498|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906499|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906500|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
1906501|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906502|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1906503|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1906504|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906505|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906506|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1906507|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
1906508|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906509|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1906510|NCT00460109|Rituximab|rituximab|mesh-list
1906511|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
1906512|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906513|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906514|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
1906515|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906516|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906517|NCT00460239|Morphine|morphine|mesh-list
1906518|NCT00460239|Buprenorphine|buprenorphine|mesh-list
1906519|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1906520|NCT00460239|Narcotics|narcotics|mesh-ancestor
1906521|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906522|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906523|NCT00460239|Analgesics|analgesics|mesh-ancestor
1906524|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
1906525|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906526|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1906527|NCT00460551|Zalutumumab|zalutumumab|mesh-list
1906528|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906529|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906530|NCT00460577|Bromides|bromides|mesh-list
1906531|NCT00460577|Fenoterol|fenoterol|mesh-list
1906532|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
1906533|NCT00460577|Ipratropium|ipratropium|mesh-list
1906534|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1906535|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
1906536|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906537|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906538|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1906539|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
1906540|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1906541|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1906542|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1906543|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
1906544|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906545|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906546|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
1906547|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1906548|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
1906549|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
1906550|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
1906551|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1906552|NCT00460603|Bevacizumab|bevacizumab|mesh-list
1906553|NCT00460603|Axitinib|axitinib|mesh-list
1906554|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906555|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906556|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906557|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906558|NCT00460603|Growth Substances|growth substances|mesh-ancestor
1906559|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906560|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906561|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906562|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906563|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906564|NCT00460746|Ritonavir|ritonavir|mesh-list
1906565|NCT00460746|Darunavir|darunavir|mesh-list
1906566|NCT00460746|Etravirine|etravirine|mesh-list
1906567|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1906568|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1906569|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
1906570|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906571|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906572|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1906573|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1906574|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
1906575|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906576|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1906577|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1906578|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1906579|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906580|NCT00460798|Sunitinib|sunitinib|mesh-list
1906581|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906582|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906583|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906584|NCT00460798|Growth Substances|growth substances|mesh-ancestor
1906585|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906586|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906587|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906588|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906589|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906590|NCT00460811|Linaclotide|linaclotide|mesh-list
1906591|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1906592|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
1906593|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906594|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906595|NCT00460993|Eszopiclone|eszopiclone|mesh-list
1906596|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1906597|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906598|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906599|NCT00461032|Montelukast|montelukast|mesh-list
1906600|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1906601|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
1906602|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1906603|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
1906604|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906605|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906606|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1906607|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1906608|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906609|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1906610|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
1906611|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1906612|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1906613|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906614|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906615|NCT00461123|Urological Agents|urological agents|mesh-ancestor
1906616|NCT00461253|Copper|copper|mesh-list
1906617|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
1906618|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1906619|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
1906620|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1906621|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906622|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1906623|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1906624|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1906625|NCT00461253|Trace Elements|trace elements|mesh-ancestor
1906626|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
1906627|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
1906628|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1906629|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1906630|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1906631|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1906632|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906633|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
1906634|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906635|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906636|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1906637|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906638|NCT00461305|Drospirenone|drospirenone|mesh-list
1906639|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1906640|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
1906641|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906642|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906643|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1906644|NCT00461305|Diuretics|diuretics|mesh-ancestor
1906645|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
1906646|NCT00461331|Insulin|insulin|mesh-list
1906647|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1906648|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
1906649|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
1906650|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1906651|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
1906652|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1906653|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906654|NCT00461500|Fluticasone|fluticasone|mesh-list
1906655|NCT00461500|Xhance|xhance|mesh-list
1906656|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1906657|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906658|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1906659|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
1906660|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906661|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906662|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1906663|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
1906664|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
1906665|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1906666|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1906667|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1906668|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1906669|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
1906670|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906671|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906672|NCT00461591|Apaziquone|apaziquone|mesh-list
1906673|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906674|NCT00461630|Niacin|niacin|mesh-list
1906675|NCT00461630|Simvastatin|simvastatin|mesh-list
1906676|NCT00461630|Ezetimibe|ezetimibe|mesh-list
1906677|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1906678|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1906679|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1906680|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
1906681|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906682|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1906683|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1906684|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906685|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
1906686|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
1906687|NCT00461630|Vitamins|vitamins|mesh-ancestor
1906688|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
1906689|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906690|NCT00461708|Gemcitabine|gemcitabine|mesh-list
1906691|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1906692|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906693|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
1906694|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906695|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906696|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
1906697|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906698|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906699|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906700|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
1906701|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906702|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906703|NCT00461773|Bevacizumab|bevacizumab|mesh-list
1906704|NCT00461773|Letrozole|letrozole|mesh-list
1906705|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906706|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906707|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906708|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906709|NCT00461773|Growth Substances|growth substances|mesh-ancestor
1906710|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906711|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906712|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1906713|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1906714|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906715|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906716|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1906717|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
1906718|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1906719|NCT00461786|Pemetrexed|pemetrexed|mesh-list
1906720|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906721|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906722|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906723|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1906724|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906725|NCT00461851|Gemcitabine|gemcitabine|mesh-list
1906726|NCT00461851|Carboplatin|carboplatin|mesh-list
1906727|NCT00461851|Sorafenib|sorafenib|mesh-list
1906728|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906729|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906730|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
1906731|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906732|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
1906733|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906734|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906735|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906736|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
1906737|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906738|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906739|NCT00461981|Vaccines|vaccines|mesh-list
1906740|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
1906741|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906742|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1906743|NCT00462020|Metronidazole|metronidazole|mesh-list
1906744|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
1906745|NCT00462020|Ampicillin|ampicillin|mesh-list
1906746|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
1906747|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
1906748|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1906749|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906750|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
1906751|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1906752|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1906753|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906754|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906755|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1906756|NCT00462072|Infliximab|infliximab|mesh-list
1906757|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
1906758|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1906759|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906760|NCT00462228|Memantine|memantine|mesh-list
1906761|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1906762|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1906763|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
1906764|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906765|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906766|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906767|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1906768|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1906769|NCT00462280|Lovastatin|lovastatin|mesh-list
1906770|NCT00462280|L 647318|l 647318|mesh-list
1906771|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
1906772|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1906773|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1906774|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
1906775|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906776|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1906777|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1906778|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906779|NCT00462332|Vidarabine|vidarabine|mesh-list
1906780|NCT00462332|Fludarabine|fludarabine|mesh-list
1906781|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
1906782|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
1906783|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906784|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906785|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
1906786|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906787|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906788|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
1906789|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906790|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
1906791|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906792|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906793|NCT00462345|Rituximab|rituximab|mesh-list
1906794|NCT00462345|Methotrexate|methotrexate|mesh-list
1906795|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906796|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906797|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
1906798|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906799|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906800|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1906801|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
1906802|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1906803|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906804|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
1906805|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906806|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
1906807|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906808|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1906809|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906810|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906811|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
1906812|NCT00462384|Hematinics|hematinics|mesh-ancestor
1906813|NCT00462423|Bevacizumab|bevacizumab|mesh-list
1906814|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1906815|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906816|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906817|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906818|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906819|NCT00462423|Growth Substances|growth substances|mesh-ancestor
1906820|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906821|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906822|NCT00462462|Ethanol|ethanol|mesh-list
1906823|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1906824|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906825|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906826|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906827|NCT00462501|Leucovorin|leucovorin|mesh-list
1906828|NCT00462501|Bevacizumab|bevacizumab|mesh-list
1906829|NCT00462501|Fluorouracil|fluorouracil|mesh-list
1906831|NCT00462501|Calcium|calcium|mesh-list
1906832|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
1906833|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906834|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906835|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906836|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906837|NCT00462501|Growth Substances|growth substances|mesh-ancestor
1906838|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906839|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906840|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1906841|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
1906842|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906843|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906844|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906845|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
1906846|NCT00462501|Antidotes|antidotes|mesh-ancestor
1906847|NCT00462501|Protective Agents|protective agents|mesh-ancestor
1906848|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
1906849|NCT00462501|Vitamins|vitamins|mesh-ancestor
1906850|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
1906851|NCT00462605|Entinostat|entinostat|mesh-list
1906852|NCT00462605|Sargramostim|sargramostim|mesh-list
1906853|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1906854|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
1906855|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906856|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906857|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906858|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906859|NCT00462644|Fentanyl|fentanyl|mesh-list
1906860|NCT00462644|Midazolam|midazolam|mesh-list
1906861|NCT00462644|Etomidate|etomidate|mesh-list
1906862|NCT00462644|Succinylcholine|succinylcholine|mesh-list
1906863|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1906864|NCT00462644|Narcotics|narcotics|mesh-ancestor
1906865|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906866|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906867|NCT00462644|Analgesics|analgesics|mesh-ancestor
1906868|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
1906869|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906870|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1906871|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1906872|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
1906873|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
1906874|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1906875|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1906876|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1906877|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1906878|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
1906879|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
1906880|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1906881|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906882|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1906883|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1906884|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1906885|NCT00462670|Tolvaptan|tolvaptan|mesh-list
1906886|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1906887|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906888|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
1906889|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906890|NCT00462709|Complement C1s|complement c1s|mesh-list
1906891|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1906892|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1906893|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
1906894|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906895|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1906896|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906897|NCT00462722|Ibuprofen|ibuprofen|mesh-list
1906898|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1906899|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1906900|NCT00462722|Analgesics|analgesics|mesh-ancestor
1906901|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
1906902|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906903|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906904|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1906905|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1906906|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1906907|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906908|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906909|NCT00462735|Fluorouracil|fluorouracil|mesh-list
1906910|NCT00462735|Cetuximab|cetuximab|mesh-list
1906911|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
1906912|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
1906913|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906914|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906915|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906916|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906917|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
1906918|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906919|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906920|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
1906921|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906922|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1906923|NCT00462748|Atorvastatin|atorvastatin|mesh-list
1906924|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1906925|NCT00462748|Simvastatin|simvastatin|mesh-list
1906926|NCT00462748|Ezetimibe|ezetimibe|mesh-list
1906927|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1906928|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1906929|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
1906930|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906931|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1906932|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1906933|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906934|NCT00462826|Aflibercept|aflibercept|mesh-list
1906935|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
1906936|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906937|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906938|NCT00462826|Growth Substances|growth substances|mesh-ancestor
1906939|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906940|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906941|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906942|NCT00462865|Gemcitabine|gemcitabine|mesh-list
1906943|NCT00462865|Bevacizumab|bevacizumab|mesh-list
1906944|NCT00462865|Capecitabine|capecitabine|mesh-list
1906945|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1906946|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906947|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906948|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906949|NCT00462865|Growth Substances|growth substances|mesh-ancestor
1906950|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906951|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906952|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1906953|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
1906954|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906955|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
1906956|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1906957|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906958|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1906959|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
1906966|NCT00462982|Sunitinib|sunitinib|mesh-list
1906967|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906968|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906969|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906970|NCT00462982|Growth Substances|growth substances|mesh-ancestor
1906971|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906972|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906973|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906974|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906975|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906976|NCT00463047|Fentanyl|fentanyl|mesh-list
1906977|NCT00463047|Oxycodone|oxycodone|mesh-list
1906978|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1906979|NCT00463047|Narcotics|narcotics|mesh-ancestor
1906980|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1906981|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906982|NCT00463047|Analgesics|analgesics|mesh-ancestor
1906983|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
1906984|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1906985|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1906986|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1906987|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
1906988|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
1906989|NCT00463060|Sunitinib|sunitinib|mesh-list
1906990|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1906991|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1906992|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1906993|NCT00463060|Growth Substances|growth substances|mesh-ancestor
1906994|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1906995|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
1906996|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1906997|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1906998|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1906999|NCT00463151|Rebamipide|rebamipide|mesh-list
1907000|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1907001|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907002|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
1907003|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907004|NCT00463151|Protective Agents|protective agents|mesh-ancestor
1907005|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907006|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907007|NCT00463346|Acamprosate|acamprosate|mesh-list
1907008|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1907009|NCT00463385|Thalidomide|thalidomide|mesh-list
1907010|NCT00463385|Prednisone|prednisone|mesh-list
1907011|NCT00463385|Pomalidomide|pomalidomide|mesh-list
1907012|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907013|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
1907014|NCT00463385|Hormones|hormones|mesh-ancestor
1907015|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907016|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907017|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1907018|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907019|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
1907020|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1907021|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1907022|NCT00463385|Growth Substances|growth substances|mesh-ancestor
1907023|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
1907024|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907025|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
1907026|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907027|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907028|NCT00463437|Vaccines|vaccines|mesh-list
1907029|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1907030|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
1907031|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907032|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
1907033|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
1907034|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1907035|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
1907036|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907037|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907038|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1907039|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
1907040|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1907041|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1907042|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1907043|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
1907044|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907045|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907046|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
1907047|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1907048|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
1907049|NCT00463580|Infliximab|infliximab|mesh-list
1907050|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
1907051|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907052|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907053|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
1907054|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1907055|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
1907056|NCT00463606|Calcium|calcium|mesh-list
1907057|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1907281|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907058|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907059|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1907060|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1907061|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1907062|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
1907063|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907064|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1907065|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1907066|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907067|NCT00463684|Vaccines|vaccines|mesh-list
1907068|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
1907069|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907070|NCT00463788|Cisplatin|cisplatin|mesh-list
1907071|NCT00463788|Cetuximab|cetuximab|mesh-list
1907072|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907073|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907074|NCT00463801|Daptomycin|daptomycin|mesh-list
1907075|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907076|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907077|NCT00463840|Fluorouracil|fluorouracil|mesh-list
1907078|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
1907079|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
1907080|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907081|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907082|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907083|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907084|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
1907085|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907086|NCT00463866|Budesonide|budesonide|mesh-list
1907087|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
1907088|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907089|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1907090|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
1907091|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907092|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907093|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1907094|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
1907095|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
1907096|NCT00463866|Hormones|hormones|mesh-ancestor
1907097|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907098|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1907099|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1907100|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1907101|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
1907102|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907103|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907104|NCT00464087|Heparin|heparin|mesh-list
1907105|NCT00464087|Calcium heparin|calcium heparin|mesh-list
1907106|NCT00464087|PENTA|penta|mesh-list
1907107|NCT00464087|Bivalirudin|bivalirudin|mesh-list
1907108|NCT00464087|Fondaparinux|fondaparinux|mesh-list
1907109|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
1907110|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1907111|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1907112|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907113|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
1907114|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1907115|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
1907116|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907117|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1907118|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
1907119|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
1907120|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
1907121|NCT00464269|Brivaracetam|brivaracetam|mesh-list
1907122|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
1907123|NCT00464308|Esomeprazole|esomeprazole|mesh-list
1907124|NCT00464308|Rabeprazole|rabeprazole|mesh-list
1907125|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1907126|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907127|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1907128|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907129|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907130|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
1907131|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
1907132|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1907133|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907134|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907135|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1907136|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1907137|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907138|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907139|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907140|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1907141|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
1907142|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1907143|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907144|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907145|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907146|NCT00464490|Analgesics|analgesics|mesh-ancestor
1907147|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
1907148|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907149|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1907150|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1907151|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1907152|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
1907153|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907154|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907155|NCT00464542|Metronidazole|metronidazole|mesh-list
1907156|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907157|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907158|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1907159|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1907160|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
1907161|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1907162|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1907163|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907164|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907165|NCT00464620|Dasatinib|dasatinib|mesh-list
1907166|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907167|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1907168|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907169|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907170|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
1907171|NCT00464646|Bevacizumab|bevacizumab|mesh-list
1907172|NCT00464646|Docetaxel|docetaxel|mesh-list
1907173|NCT00464646|Trastuzumab|trastuzumab|mesh-list
1907174|NCT00464646|Epirubicin|epirubicin|mesh-list
1907175|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907176|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
1907177|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907178|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907179|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907180|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
1907181|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907182|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907183|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1907184|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907185|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1907186|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1907187|NCT00464646|Growth Substances|growth substances|mesh-ancestor
1907188|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
1907189|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
1907190|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
1907191|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
1907192|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1907193|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1907194|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1907195|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907196|NCT00464672|Vaccines|vaccines|mesh-list
1907197|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
1907198|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907199|NCT00464685|Dexamethasone|dexamethasone|mesh-list
1907200|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907201|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
1907202|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
1907203|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907204|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907205|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907206|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
1907207|NCT00464685|Hormones|hormones|mesh-ancestor
1907357|NCT00466310|Aripiprazole|aripiprazole|mesh-list
1907208|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907209|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1907210|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907211|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1907212|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1907213|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1907214|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1907215|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907216|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907217|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907218|NCT00464698|Analgesics|analgesics|mesh-ancestor
1907219|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
1907220|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907221|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
1907222|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907223|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
1907224|NCT00464711|Citalopram|citalopram|mesh-list
1907225|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1907226|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1907227|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1907228|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907229|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907230|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
1907231|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907232|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1907233|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
1907234|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907235|NCT00464737|Rotigotine|rotigotine|mesh-list
1907236|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
1907237|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
1907238|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907239|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907240|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907241|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1907242|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
1907243|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907244|NCT00465088|Niacin|niacin|mesh-list
1907245|NCT00465088|Niacinamide|niacinamide|mesh-list
1907246|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
1907247|NCT00465088|Atorvastatin|atorvastatin|mesh-list
1907248|NCT00465088|Simvastatin|simvastatin|mesh-list
1907249|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1907250|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1907251|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
1907252|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907253|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1907254|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1907255|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907256|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
1907257|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
1907258|NCT00465088|Vitamins|vitamins|mesh-ancestor
1907259|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
1907260|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907261|NCT00465179|Sunitinib|sunitinib|mesh-list
1907262|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907263|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1907264|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1907265|NCT00465179|Growth Substances|growth substances|mesh-ancestor
1907266|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907267|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
1907268|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1907269|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907270|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907271|NCT00465530|Gentamicins|gentamicins|mesh-list
1907272|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907273|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907274|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1907275|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907276|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907277|NCT00465595|Psilocybin|psilocybin|mesh-list
1907278|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
1907279|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
1907280|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907282|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1907283|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
1907284|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907285|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907286|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1907287|NCT00465647|Hydromorphone|hydromorphone|mesh-list
1907288|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1907289|NCT00465647|Narcotics|narcotics|mesh-ancestor
1907290|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907291|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907292|NCT00465647|Analgesics|analgesics|mesh-ancestor
1907293|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
1907294|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907295|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
1907296|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1907297|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1907298|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1907299|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1907300|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1907301|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907302|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
1907303|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907304|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907305|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1907306|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907307|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1907308|NCT00465894|Estradiol|estradiol|mesh-list
1907309|NCT00465894|Estrogens|estrogens|mesh-ancestor
1907310|NCT00465894|Hormones|hormones|mesh-ancestor
1907311|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907312|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907313|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1907314|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1907315|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
1907316|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907317|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907318|NCT00465894|Urological Agents|urological agents|mesh-ancestor
1907319|NCT00465972|Doxepin|doxepin|mesh-list
1907320|NCT00465972|Temazepam|temazepam|mesh-list
1907321|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1907322|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1907323|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907324|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907325|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1907326|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
1907327|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907328|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
1907329|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
1907330|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907331|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907332|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1907333|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1907334|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
1907335|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
1907336|NCT00466167|Pramipexole|pramipexole|mesh-list
1907337|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
1907338|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907339|NCT00466167|Protective Agents|protective agents|mesh-ancestor
1907340|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907341|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1907342|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1907343|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
1907344|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
1907345|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907346|NCT00466193|Zolpidem|zolpidem|mesh-list
1907347|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1907348|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1907349|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907350|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907351|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1907352|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
1907353|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
1907354|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907355|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907356|NCT00466310|Risperidone|risperidone|mesh-list
1907358|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1907359|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
1907360|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907361|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907362|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907363|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1907364|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1907365|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907366|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907367|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1907368|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
1907369|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
1907370|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
1907371|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1907372|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1907373|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1907374|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1907375|NCT00466440|Prednisone|prednisone|mesh-list
1907376|NCT00466440|Docetaxel|docetaxel|mesh-list
1907377|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907378|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
1907379|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
1907380|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
1907381|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907382|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907383|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
1907384|NCT00466440|Hormones|hormones|mesh-ancestor
1907385|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907386|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907387|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1907388|NCT00466505|Celecoxib|celecoxib|mesh-list
1907389|NCT00466505|Cetuximab|cetuximab|mesh-list
1907390|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907391|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907392|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1907393|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907394|NCT00466505|Analgesics|analgesics|mesh-ancestor
1907395|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
1907396|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907397|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907398|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907399|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907400|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1907401|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1907402|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907403|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907404|NCT00466661|Acamprosate|acamprosate|mesh-list
1907405|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1907406|NCT00466687|Bevacizumab|bevacizumab|mesh-list
1907407|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1907408|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907409|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907410|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1907411|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1907412|NCT00466687|Growth Substances|growth substances|mesh-ancestor
1907413|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907414|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
1907415|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1907416|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907417|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907418|NCT00466726|Sargramostim|sargramostim|mesh-list
1907419|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
1907420|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907421|NCT00466752|Sorafenib|sorafenib|mesh-list
1907422|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907423|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1907424|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907425|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907426|NCT00466817|Valganciclovir|valganciclovir|mesh-list
1907427|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
1907428|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907429|NCT00466921|Lenalidomide|lenalidomide|mesh-list
1907430|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
1907431|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907432|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1907433|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1907434|NCT00466921|Growth Substances|growth substances|mesh-ancestor
1907435|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
1907436|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907437|NCT00466947|Vaccines|vaccines|mesh-list
1907438|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1907439|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
1907440|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907441|NCT00466960|Paclitaxel|paclitaxel|mesh-list
1907442|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1907443|NCT00466960|Sargramostim|sargramostim|mesh-list
1907444|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1907445|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907446|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
1907447|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
1907448|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
1907449|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907450|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
1907451|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907452|NCT00467051|Paclitaxel|paclitaxel|mesh-list
1907453|NCT00467051|Carboplatin|carboplatin|mesh-list
1907454|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1907455|NCT00467051|Ifosfamide|ifosfamide|mesh-list
1907456|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
1907457|NCT00467051|Lenograstim|lenograstim|mesh-list
1907458|NCT00467051|Sargramostim|sargramostim|mesh-list
1907459|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1907460|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907461|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
1907462|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
1907463|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
1907464|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907465|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1907466|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
1907467|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907468|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907469|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
1907470|NCT00467077|Interferons|interferons|mesh-list
1907471|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
1907472|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
1907473|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1907474|NCT00467077|Gefitinib|gefitinib|mesh-list
1907475|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907476|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
1907477|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907478|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
1907479|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907480|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1907481|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907482|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907483|NCT00467259|Testosterone|testosterone|mesh-list
1907484|NCT00467259|Androgens|androgens|mesh-ancestor
1907485|NCT00467259|Hormones|hormones|mesh-ancestor
1907486|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907487|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907488|NCT00467272|Daptomycin|daptomycin|mesh-list
1907489|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907490|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907491|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1907492|NCT00467350|Laxatives|laxatives|mesh-ancestor
1907493|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907494|NCT00467363|Aspirin|aspirin|mesh-list
1907495|NCT00467363|Folic Acid|folic acid|mesh-list
1907496|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1907497|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907498|NCT00467363|Analgesics|analgesics|mesh-ancestor
1907499|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
1907500|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907501|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907502|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907503|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907504|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1907505|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1907506|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907507|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1907586|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
1907508|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1907509|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907510|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
1907511|NCT00467363|Hematinics|hematinics|mesh-ancestor
1907512|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
1907513|NCT00467363|Vitamins|vitamins|mesh-ancestor
1907514|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
1907515|NCT00467389|Donepezil|donepezil|mesh-list
1907516|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1907517|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907518|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907519|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
1907520|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907521|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907522|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
1907523|NCT00467558|Naltrexone|naltrexone|mesh-list
1907524|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1907525|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1907526|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907527|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
1907528|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907529|NCT00467584|Aspirin|aspirin|mesh-list
1907530|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1907531|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907532|NCT00467584|Analgesics|analgesics|mesh-ancestor
1907533|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
1907534|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907535|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907536|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907537|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907538|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1907539|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1907540|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907541|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1907542|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1907543|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907544|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
1907545|NCT00467597|Levodopa|levodopa|mesh-list
1907546|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1907547|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1907548|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
1907549|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907550|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907551|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907552|NCT00467649|Insulin|insulin|mesh-list
1907553|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1907554|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
1907555|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
1907556|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
1907557|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
1907558|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
1907559|NCT00467649|Pramlintide|pramlintide|mesh-list
1907560|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
1907561|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1907562|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907563|NCT00467740|Olodaterol|olodaterol|mesh-list
1907564|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1907565|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
1907566|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907567|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907568|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1907569|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
1907570|NCT00467779|Midazolam|midazolam|mesh-list
1907571|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
1907572|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1907573|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1907574|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907575|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907576|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1907577|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1907578|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907579|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1907580|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
1907581|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
1907582|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
1907583|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
1907584|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907585|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907587|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
1907588|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1907589|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1907590|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
1907591|NCT00467831|Erythromycin|erythromycin|mesh-list
1907592|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
1907593|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1907594|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
1907595|NCT00467831|Zileuton|zileuton|mesh-list
1907596|NCT00467831|Losartan|losartan|mesh-list
1907597|NCT00467831|Pravastatin|pravastatin|mesh-list
1907598|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1907599|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1907600|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1907601|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1907602|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1907603|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907604|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
1907605|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907606|NCT00467831|Expectorants|expectorants|mesh-ancestor
1907607|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
1907608|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1907609|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
1907610|NCT00467831|Protective Agents|protective agents|mesh-ancestor
1907611|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907612|NCT00467831|Antidotes|antidotes|mesh-ancestor
1907613|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1907614|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1907615|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
1907616|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1907617|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1907618|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907619|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907620|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907621|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1907622|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1907623|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907624|NCT00467831|Analgesics|analgesics|mesh-ancestor
1907625|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
1907626|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907627|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907628|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907629|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1907630|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1907631|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
1907632|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907633|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
1907634|NCT00467870|Testosterone|testosterone|mesh-list
1907635|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
1907636|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
1907637|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1907638|NCT00467870|Androgens|androgens|mesh-ancestor
1907639|NCT00467870|Hormones|hormones|mesh-ancestor
1907640|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907641|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907642|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1907643|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907644|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
1907645|NCT00467896|Iloprost|iloprost|mesh-list
1907646|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1907647|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
1907648|NCT00468052|Fentanyl|fentanyl|mesh-list
1907649|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
1907650|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1907651|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907652|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907653|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907654|NCT00468052|Analgesics|analgesics|mesh-ancestor
1907655|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
1907656|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907657|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1907658|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1907659|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1907660|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
1907661|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907735|NCT00468546|Methotrexate|methotrexate|mesh-list
1907662|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907663|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1907664|NCT00468052|Narcotics|narcotics|mesh-ancestor
1907665|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1907666|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1907667|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
1907668|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
1907669|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1907670|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1907671|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1907672|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907673|NCT00468143|Adderall|adderall|mesh-list
1907674|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1907675|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907676|NCT00468169|Cetuximab|cetuximab|mesh-list
1907677|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
1907678|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907679|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907680|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
1907681|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907682|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907683|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1907684|NCT00468208|Abatacept|abatacept|mesh-list
1907685|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1907686|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907687|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907688|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907689|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
1907690|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907691|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907692|NCT00468299|Misoprostol|misoprostol|mesh-list
1907693|NCT00468299|Mifepristone|mifepristone|mesh-list
1907694|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1907695|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
1907696|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1907697|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907698|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1907699|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907700|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
1907701|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1907702|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1907703|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1907704|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1907705|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
1907706|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1907707|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1907708|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
1907709|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907710|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
1907711|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1907712|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1907713|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
1907714|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907715|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
1907716|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1907717|NCT00468481|Drospirenone|drospirenone|mesh-list
1907718|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1907719|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1907720|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1907721|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1907722|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1907723|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
1907724|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1907725|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907726|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1907727|NCT00468481|Estrogens|estrogens|mesh-ancestor
1907728|NCT00468481|Hormones|hormones|mesh-ancestor
1907729|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1907730|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1907731|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
1907732|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1907733|NCT00468481|Diuretics|diuretics|mesh-ancestor
1907734|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
1907736|NCT00468546|Rituximab|rituximab|mesh-list
1907737|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1907738|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
1907739|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1907740|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907741|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907742|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
1907743|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907744|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907745|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
1907746|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907747|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1907748|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907749|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
1907750|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907751|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1907752|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907753|NCT00468559|Esomeprazole|esomeprazole|mesh-list
1907754|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1907755|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1907756|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1907757|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907758|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907759|NCT00468585|Bevacizumab|bevacizumab|mesh-list
1907760|NCT00468585|Capecitabine|capecitabine|mesh-list
1907761|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1907762|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907763|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1907764|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1907765|NCT00468585|Growth Substances|growth substances|mesh-ancestor
1907766|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907767|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
1907768|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907769|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
1907770|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907771|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
1907772|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907773|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
1907774|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1907775|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1907776|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907777|NCT00468650|Urological Agents|urological agents|mesh-ancestor
1907778|NCT00468728|Vancomycin|vancomycin|mesh-list
1907779|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1907780|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907781|NCT00468845|Pregabalin|pregabalin|mesh-list
1907782|NCT00468845|Analgesics|analgesics|mesh-ancestor
1907783|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
1907784|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907785|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907786|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
1907787|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1907788|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1907789|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907790|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1907791|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1907792|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1907793|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1907794|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1907795|NCT00468910|Aspirin|aspirin|mesh-list
1907796|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1907797|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1907798|NCT00468910|Analgesics|analgesics|mesh-ancestor
1907799|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
1907800|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907801|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907802|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1907803|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907804|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1907805|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1907806|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907807|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1907808|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1907809|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907810|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
1907811|NCT00469014|Vidarabine|vidarabine|mesh-list
1907812|NCT00469014|Fludarabine|fludarabine|mesh-list
1907813|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
1907814|NCT00469014|Busulfan|busulfan|mesh-list
1907815|NCT00469014|Clofarabine|clofarabine|mesh-list
1907816|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
1907817|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1907818|NCT00469014|Lenograstim|lenograstim|mesh-list
1907819|NCT00469014|Sargramostim|sargramostim|mesh-list
1907820|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907821|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907822|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
1907823|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907824|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907825|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
1907826|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907827|NCT00469014|Antiviral Agents|antiviral agents|mesh-ancestor
1907828|NCT00469014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907829|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1907830|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
1907831|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907832|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1907833|NCT00469079|Nicotine|nicotine|mesh-list
1907834|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1907835|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
1907836|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1907837|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907838|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1907839|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1907840|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
1907841|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907842|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907843|NCT00469092|Insulin|insulin|mesh-list
1907844|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1907845|NCT00469092|Metformin|metformin|mesh-list
1907846|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
1907847|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
1907848|NCT00469092|Glimepiride|glimepiride|mesh-list
1907849|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
1907850|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1907851|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907852|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1907853|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907854|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
1907855|NCT00469144|Fludarabine|fludarabine|mesh-list
1907856|NCT00469144|Busulfan|busulfan|mesh-list
1907857|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907858|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907859|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907860|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
1907861|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907862|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
1907863|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907864|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1907865|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
1907866|NCT00469209|Bortezomib|bortezomib|mesh-list
1907867|NCT00469209|Melphalan|melphalan|mesh-list
1907868|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
1907869|NCT00469209|Vitamins|vitamins|mesh-ancestor
1907870|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
1907871|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907872|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907873|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907874|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
1907875|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907876|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1907877|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907878|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
1907879|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
1907880|NCT00469209|Protective Agents|protective agents|mesh-ancestor
1907881|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1907882|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1907883|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907884|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
1907885|NCT00469456|Memantine|memantine|mesh-list
1907886|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1907887|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1907888|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
1907889|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1907890|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907891|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907892|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1907893|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1907894|NCT00469508|Modafinil|modafinil|mesh-list
1907895|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1907896|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907897|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1907898|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1907899|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1907900|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907901|NCT00469833|Insulin|insulin|mesh-list
1907902|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1907903|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
1907904|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
1907905|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1907906|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907907|NCT00469859|Cytarabine|cytarabine|mesh-list
1907908|NCT00469859|Idarubicin|idarubicin|mesh-list
1907909|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907910|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
1907911|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907912|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907913|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
1907914|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907915|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907916|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
1907917|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907918|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1907919|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1907920|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1907921|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907922|NCT00469898|Carboplatin|carboplatin|mesh-list
1907923|NCT00469898|Irinotecan|irinotecan|mesh-list
1907924|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907925|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1907926|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1907927|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907928|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907929|NCT00470054|Dasatinib|dasatinib|mesh-list
1907930|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907931|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1907932|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907933|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907934|NCT00470093|Interferons|interferons|mesh-list
1907935|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907936|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
1907937|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907938|NCT00470158|Iron|iron|mesh-list
1907939|NCT00470158|Zinc|zinc|mesh-list
1907940|NCT00470158|Trace Elements|trace elements|mesh-ancestor
1907941|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
1907942|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907943|NCT00470184|Capecitabine|capecitabine|mesh-list
1907944|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
1907945|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907946|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
1907947|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907948|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907949|NCT00470262|Pioglitazone|pioglitazone|mesh-list
1907950|NCT00470262|Fenofibrate|fenofibrate|mesh-list
1907951|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1907952|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907953|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1907954|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
1907955|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907956|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1907957|NCT00470275|Cytarabine|cytarabine|mesh-list
1907958|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1907959|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
1907960|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907961|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907962|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
1907963|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1907964|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907965|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
1907966|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907967|NCT00470301|Paclitaxel|paclitaxel|mesh-list
1907968|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
1907969|NCT00470301|Doxorubicin|doxorubicin|mesh-list
1907970|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1907971|NCT00470301|Tipifarnib|tipifarnib|mesh-list
1907972|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1907973|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907974|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
1907975|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
1907976|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
1907977|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907978|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1907979|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
1907980|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1907981|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1907982|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907983|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
1907984|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1907985|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1907986|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1907987|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1907988|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1907989|NCT00470366|Paclitaxel|paclitaxel|mesh-list
1907990|NCT00470366|Ifosfamide|ifosfamide|mesh-list
1907991|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1907992|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1907993|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
1907994|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
1907995|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
1907996|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1907997|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1907998|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
1907999|NCT00470392|Clobetasol|clobetasol|mesh-list
1908000|NCT00470392|Imiquimod|imiquimod|mesh-list
1908001|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1908002|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
1908003|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908004|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908005|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
1908006|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908007|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
1908008|NCT00470392|Hormones|hormones|mesh-ancestor
1908009|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908010|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
1908011|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908012|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908013|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908014|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908015|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1908016|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908017|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908018|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908019|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908020|NCT00470548|Paclitaxel|paclitaxel|mesh-list
1908021|NCT00470548|Pemetrexed|pemetrexed|mesh-list
1908022|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1908023|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1908024|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908025|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
1908026|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
1908027|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
1908028|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908029|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908030|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1908031|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1908032|NCT00470600|Ibuprofen|ibuprofen|mesh-list
1908033|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1908034|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1908035|NCT00470600|Analgesics|analgesics|mesh-ancestor
1908036|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
1908037|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908038|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908039|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908040|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908041|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1908042|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908043|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908044|NCT00470834|Bicalutamide|bicalutamide|mesh-list
1908045|NCT00470834|Dutasteride|dutasteride|mesh-list
1908046|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
1908047|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
1908048|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908049|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908050|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908051|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1908052|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1908053|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908054|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908055|NCT00470847|Trastuzumab|trastuzumab|mesh-list
1908056|NCT00470847|Lapatinib|lapatinib|mesh-list
1908057|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908058|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908059|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908060|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908061|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908062|NCT00471068|Timolol|timolol|mesh-list
1908063|NCT00471068|Travoprost|travoprost|mesh-list
1908064|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1908065|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1908066|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
1908067|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908068|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908069|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908070|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1908071|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1908072|NCT00471146|Gemcitabine|gemcitabine|mesh-list
1908073|NCT00471146|Axitinib|axitinib|mesh-list
1908074|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1908075|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
1908076|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908077|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908078|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
1908079|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908080|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908081|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908082|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
1908083|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908084|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908085|NCT00471237|Alendronate|alendronate|mesh-list
1908086|NCT00471237|Teriparatide|teriparatide|mesh-list
1908087|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1908088|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908089|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1908090|NCT00471276|Sunitinib|sunitinib|mesh-list
1908091|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908092|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908093|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908094|NCT00471276|Growth Substances|growth substances|mesh-ancestor
1908095|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908096|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908097|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908098|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908099|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908100|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1908101|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1908102|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908103|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908104|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908105|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908106|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908107|NCT00471315|Analgesics|analgesics|mesh-ancestor
1908108|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
1908109|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908110|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
1908111|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908112|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
1908113|NCT00471328|Sunitinib|sunitinib|mesh-list
1908114|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
1908115|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908116|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908117|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908118|NCT00471328|Growth Substances|growth substances|mesh-ancestor
1908119|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908120|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908121|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908122|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908123|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908124|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1908125|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1908126|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908127|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908128|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908129|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
1908130|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908131|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908132|NCT00471380|Timolol|timolol|mesh-list
1908133|NCT00471380|Travoprost|travoprost|mesh-list
1908134|NCT00471380|Dorzolamide|dorzolamide|mesh-list
1908135|NCT00471380|Brinzolamide|brinzolamide|mesh-list
1908136|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1908137|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1908138|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
1908139|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908140|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908141|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908142|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1908143|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1908144|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1908145|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908146|NCT00471445|Ketamine|ketamine|mesh-list
1908147|NCT00471445|Amitriptyline|amitriptyline|mesh-list
1908148|NCT00471445|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1908149|NCT00471445|Analgesics|analgesics|mesh-ancestor
1908150|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
1908151|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908152|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908153|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1908154|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1908155|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
1908156|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
1908157|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908158|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1908159|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1908160|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908161|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908162|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1908163|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
1908164|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908165|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1908166|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1908167|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908168|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908169|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
1908170|NCT00471445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1908171|NCT00471445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1908172|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
1908173|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908174|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908175|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908176|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908177|NCT00471705|Miltefosine|miltefosine|mesh-list
1908178|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
1908179|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
1908180|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908181|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908182|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1908183|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1908184|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
1908185|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1908186|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
1908187|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908188|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908189|NCT00471887|Tremelimumab|tremelimumab|mesh-list
1908190|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908191|NCT00472030|Omalizumab|omalizumab|mesh-list
1908192|NCT00472030|Prednisone|prednisone|mesh-list
1908193|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908194|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
1908195|NCT00472030|Hormones|hormones|mesh-ancestor
1908196|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908197|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908198|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908199|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908200|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1908201|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1908202|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
1908203|NCT00472056|Cytarabine|cytarabine|mesh-list
1908204|NCT00472056|Rituximab|rituximab|mesh-list
1908205|NCT00472056|Etoposide|etoposide|mesh-list
1908206|NCT00472056|Melphalan|melphalan|mesh-list
1908207|NCT00472056|Carmustine|carmustine|mesh-list
1908208|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908209|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908210|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
1908211|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908212|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908213|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1908214|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1908215|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1908216|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908217|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908218|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1908219|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
1908220|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
1908221|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908222|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908223|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1908224|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
1908225|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1908226|NCT00472199|Pramipexole|pramipexole|mesh-list
1908227|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
1908228|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908229|NCT00472199|Protective Agents|protective agents|mesh-ancestor
1908230|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908231|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1908232|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1908233|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
1908234|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
1908235|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908236|NCT00472303|Morphine|morphine|mesh-list
1908237|NCT00472303|Tapentadol|tapentadol|mesh-list
1908238|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1908239|NCT00472303|Narcotics|narcotics|mesh-ancestor
1908240|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908241|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908242|NCT00472303|Analgesics|analgesics|mesh-ancestor
1908243|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
1908244|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908245|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1908246|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908247|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908248|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908249|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
1908250|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908251|NCT00472420|Rituximab|rituximab|mesh-list
1908252|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908253|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908254|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
1908255|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908256|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908257|NCT00472641|Ziprasidone|ziprasidone|mesh-list
1908258|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1908259|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
1908260|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908411|NCT00473746|Prednisolone|prednisolone|mesh-list
1908261|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908262|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908263|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1908264|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1908265|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908266|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908267|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1908268|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
1908269|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
1908270|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1908271|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
1908272|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908273|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908274|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
1908275|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908276|NCT00472849|Cytarabine|cytarabine|mesh-list
1908277|NCT00472849|Rituximab|rituximab|mesh-list
1908278|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
1908279|NCT00472849|Fludarabine|fludarabine|mesh-list
1908280|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908281|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908282|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
1908283|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908284|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908285|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1908286|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
1908287|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908288|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908289|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
1908290|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908291|NCT00473083|Minocycline|minocycline|mesh-list
1908292|NCT00473083|Clindamycin|clindamycin|mesh-list
1908293|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
1908294|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
1908295|NCT00473083|Triamcinolone|triamcinolone|mesh-list
1908296|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1908297|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1908298|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
1908299|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1908300|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908301|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908302|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908303|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
1908304|NCT00473083|Hormones|hormones|mesh-ancestor
1908305|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908306|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908307|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908308|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
1908309|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1908310|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908311|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1908312|NCT00473265|Teriparatide|teriparatide|mesh-list
1908313|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1908314|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908315|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1908316|NCT00473330|Ranibizumab|ranibizumab|mesh-list
1908317|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908318|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908319|NCT00473330|Growth Substances|growth substances|mesh-ancestor
1908320|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908321|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908322|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908323|NCT00473382|Ranibizumab|ranibizumab|mesh-list
1908324|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908325|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908326|NCT00473382|Growth Substances|growth substances|mesh-ancestor
1908327|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908328|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908329|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908330|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1908331|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1908332|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1908333|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908334|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908335|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908412|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
1908336|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1908337|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1908338|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
1908339|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908340|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908341|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1908342|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1908343|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
1908344|NCT00473512|Dexamethasone|dexamethasone|mesh-list
1908345|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
1908346|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908347|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
1908348|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
1908349|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908350|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908351|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908352|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
1908353|NCT00473512|Hormones|hormones|mesh-ancestor
1908354|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908355|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908356|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908357|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1908358|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908359|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908360|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
1908361|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1908362|NCT00473590|Bevacizumab|bevacizumab|mesh-list
1908363|NCT00473590|Bortezomib|bortezomib|mesh-list
1908364|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908365|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908366|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908367|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908368|NCT00473590|Growth Substances|growth substances|mesh-ancestor
1908369|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908370|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908371|NCT00473642|Ranibizumab|ranibizumab|mesh-list
1908372|NCT00473642|Verteporfin|verteporfin|mesh-list
1908373|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908374|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908375|NCT00473642|Growth Substances|growth substances|mesh-ancestor
1908376|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908377|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908378|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908379|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1908380|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
1908381|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1908382|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1908383|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1908384|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
1908385|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908386|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1908387|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1908388|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908389|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
1908390|NCT00473694|Rocuronium|rocuronium|mesh-list
1908391|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
1908392|NCT00473694|Neostigmine|neostigmine|mesh-list
1908393|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1908394|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1908395|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1908396|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908397|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908398|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1908399|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908400|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908401|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
1908402|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908403|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1908404|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
1908405|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1908406|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1908407|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1908408|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1908409|NCT00473746|Dexamethasone|dexamethasone|mesh-list
1908410|NCT00473746|Prednisone|prednisone|mesh-list
1908413|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908414|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
1908415|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
1908416|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908417|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908418|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908419|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
1908420|NCT00473746|Hormones|hormones|mesh-ancestor
1908421|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908422|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908423|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908424|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1908425|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908426|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908427|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
1908428|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1908429|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
1908430|NCT00473824|Antibodies|antibodies|mesh-list
1908431|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
1908432|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1908433|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1908434|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
1908435|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908436|NCT00473837|Chloroquine|chloroquine|mesh-list
1908437|NCT00473837|Amebicides|amebicides|mesh-ancestor
1908438|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1908439|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1908440|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908441|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
1908442|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908443|NCT00473876|Metformin|metformin|mesh-list
1908444|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1908445|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908446|NCT00473889|Paclitaxel|paclitaxel|mesh-list
1908447|NCT00473889|Carboplatin|carboplatin|mesh-list
1908448|NCT00473889|Vorinostat|vorinostat|mesh-list
1908449|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1908450|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908451|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
1908452|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
1908453|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
1908454|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908455|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1908456|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908457|NCT00474045|Insulin|insulin|mesh-list
1908458|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1908459|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
1908460|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
1908461|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
1908462|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
1908463|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
1908464|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1908465|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908466|NCT00474058|Rotigotine|rotigotine|mesh-list
1908467|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
1908468|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
1908469|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908470|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908471|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908472|NCT00474123|Simvastatin|simvastatin|mesh-list
1908473|NCT00474123|Ezetimibe|ezetimibe|mesh-list
1908474|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1908475|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1908476|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
1908477|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908478|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1908479|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1908480|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908481|NCT00474175|Benzocaine|benzocaine|mesh-list
1908482|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
1908483|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
1908484|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908485|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908486|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
1908487|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908488|NCT00474201|Ritonavir|ritonavir|mesh-list
1908489|NCT00474201|Lopinavir|lopinavir|mesh-list
1908490|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
1908491|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1908492|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1908493|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
1908494|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908495|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908496|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1908497|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1908498|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
1908499|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908500|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1908501|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1908502|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1908503|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
1908504|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1908505|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1908506|NCT00474240|Atorvastatin|atorvastatin|mesh-list
1908507|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1908508|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1908509|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
1908510|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908511|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1908512|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1908513|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908514|NCT00474253|Rocuronium|rocuronium|mesh-list
1908515|NCT00474253|Succinylcholine|succinylcholine|mesh-list
1908516|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1908517|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1908518|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1908519|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908520|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908521|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1908522|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
1908523|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
1908524|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908525|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1908526|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908527|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908528|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
1908529|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908530|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908531|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1908532|NCT00474383|Hormones|hormones|mesh-ancestor
1908533|NCT00474487|Vaccines|vaccines|mesh-list
1908534|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
1908535|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908536|NCT00474526|Vaccines|vaccines|mesh-list
1908537|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1908538|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
1908539|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908540|NCT00474539|Vaccines|vaccines|mesh-list
1908541|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1908542|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
1908543|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908544|NCT00474630|Naltrexone|naltrexone|mesh-list
1908545|NCT00474630|Bupropion|bupropion|mesh-list
1908546|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1908547|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1908548|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908549|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
1908550|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908551|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1908552|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
1908553|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908554|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1908555|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908556|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908557|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908558|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
1908559|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908560|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1908561|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1908562|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908563|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1908564|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1908565|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908566|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908567|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908568|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908569|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908570|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1908571|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
1908572|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908573|NCT00474786|Sirolimus|sirolimus|mesh-list
1908574|NCT00474786|Sorafenib|sorafenib|mesh-list
1908575|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908576|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908577|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908578|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908579|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1908580|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908581|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1908582|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
1908583|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908584|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
1908585|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908586|NCT00474812|Dasatinib|dasatinib|mesh-list
1908587|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908588|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908589|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908590|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908591|NCT00474851|Norethindrone|norethindrone|mesh-list
1908592|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
1908593|NCT00474851|Estrogens|estrogens|mesh-list
1908594|NCT00474851|Hormones|hormones|mesh-ancestor
1908595|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908596|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908597|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1908598|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1908599|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1908600|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
1908601|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1908602|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1908603|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1908604|NCT00474903|Aspirin|aspirin|mesh-list
1908605|NCT00474903|Esomeprazole|esomeprazole|mesh-list
1908606|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1908607|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908608|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1908609|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908610|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908611|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1908612|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1908613|NCT00474903|Analgesics|analgesics|mesh-ancestor
1908614|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
1908615|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908616|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908617|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908618|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908619|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1908620|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1908621|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1908622|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1908623|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
1908624|NCT00474929|Everolimus|everolimus|mesh-list
1908625|NCT00474929|Sorafenib|sorafenib|mesh-list
1908626|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908627|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908628|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
1908629|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908630|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908631|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908632|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908633|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1908634|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
1908635|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908636|NCT00474994|Sunitinib|sunitinib|mesh-list
1908637|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908638|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1908639|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1908640|NCT00474994|Growth Substances|growth substances|mesh-ancestor
1908641|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908642|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
1908643|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908644|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908645|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908646|NCT00475020|Vidarabine|vidarabine|mesh-list
1908647|NCT00475020|Fludarabine|fludarabine|mesh-list
1908648|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
1908649|NCT00475020|Busulfan|busulfan|mesh-list
1908650|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
1908651|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1908652|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908653|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1908654|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
1908655|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908656|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908657|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
1908658|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908659|NCT00475020|Antiviral Agents|antiviral agents|mesh-ancestor
1908660|NCT00475020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908661|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
1908662|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1908663|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1908664|NCT00475033|Vaccines|vaccines|mesh-list
1908665|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1908666|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
1908667|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908668|NCT00475085|Dexamethasone|dexamethasone|mesh-list
1908669|NCT00475085|Aprepitant|aprepitant|mesh-list
1908670|NCT00475085|Palonosetron|palonosetron|mesh-list
1908671|NCT00475085|Granisetron|granisetron|mesh-list
1908672|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
1908673|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908674|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
1908675|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
1908676|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908677|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908678|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908679|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
1908680|NCT00475085|Hormones|hormones|mesh-ancestor
1908681|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908682|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908683|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908684|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1908685|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908686|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908687|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1908688|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1908689|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
1908690|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1908691|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1908692|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908693|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908694|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1908695|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
1908696|NCT00475150|Cediranib|cediranib|mesh-list
1908697|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908698|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908699|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908700|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908701|NCT00475176|Ribavirin|ribavirin|mesh-list
1908702|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1908703|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
1908704|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908705|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
1908706|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908707|NCT00475215|Rocuronium|rocuronium|mesh-list
1908708|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1908709|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1908710|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1908711|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909310|NCT00478335|Urological Agents|urological agents|mesh-ancestor
1908712|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908713|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
1908714|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1908715|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
1908716|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1908717|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908718|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1908719|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1908720|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1908721|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
1908722|NCT00475306|Promethazine|promethazine|mesh-list
1908723|NCT00475306|Metoclopramide|metoclopramide|mesh-list
1908724|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1908725|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1908726|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908727|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908728|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
1908729|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
1908730|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
1908731|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908732|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
1908733|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
1908734|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908735|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1908736|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
1908737|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
1908738|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908739|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908740|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1908741|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
1908742|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
1908743|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1908744|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1908745|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
1908746|NCT00475319|Rebamipide|rebamipide|mesh-list
1908747|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1908748|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908749|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
1908750|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908751|NCT00475319|Protective Agents|protective agents|mesh-ancestor
1908752|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908753|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908754|NCT00475423|Rituximab|rituximab|mesh-list
1908755|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908756|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908757|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
1908758|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908759|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908760|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
1908761|NCT00475501|Finasteride|finasteride|mesh-list
1908762|NCT00475501|Testosterone|testosterone|mesh-list
1908763|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
1908764|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
1908765|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1908766|NCT00475501|Androgens|androgens|mesh-ancestor
1908767|NCT00475501|Hormones|hormones|mesh-ancestor
1908768|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908769|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908770|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908771|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908772|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
1908773|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1908774|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1908775|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908776|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908777|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
1908778|NCT00475501|Urological Agents|urological agents|mesh-ancestor
1908779|NCT00475670|Paclitaxel|paclitaxel|mesh-list
1908780|NCT00475670|Docetaxel|docetaxel|mesh-list
1908781|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1908782|NCT00475670|Trastuzumab|trastuzumab|mesh-list
1908783|NCT00475670|Taxane|taxane|mesh-list
1908784|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1908785|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908786|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
1908787|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
1908788|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
1908789|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908790|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908791|NCT00475735|Methylphenidate|methylphenidate|mesh-list
1908792|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1908793|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908794|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1908795|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908796|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908797|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908798|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
1908799|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908800|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1908801|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
1908802|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908803|NCT00475865|Teriflunomide|teriflunomide|mesh-list
1908804|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
1908805|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
1908806|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1908807|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
1908808|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908809|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908810|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908811|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1908812|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1908813|NCT00475865|Analgesics|analgesics|mesh-ancestor
1908814|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
1908815|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908816|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908817|NCT00475878|Citalopram|citalopram|mesh-list
1908818|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1908819|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908820|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908821|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908822|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908823|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
1908824|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908825|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1908826|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
1908827|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908828|NCT00475904|Gabapentin|gabapentin|mesh-list
1908829|NCT00475904|Analgesics|analgesics|mesh-ancestor
1908830|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
1908831|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908832|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908833|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
1908834|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1908835|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1908836|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908837|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908838|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1908839|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1908840|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908841|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908842|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
1908843|NCT00476008|Memantine|memantine|mesh-list
1908844|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1908845|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1908846|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
1908847|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908848|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908849|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908850|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1908851|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1908852|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
1908853|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1908854|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
1908855|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1908856|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908857|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1908858|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1908859|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1908860|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
1908861|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908862|NCT00476086|Gemcitabine|gemcitabine|mesh-list
1908863|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
1908864|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1908865|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
1908866|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908867|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908868|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
1908869|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908870|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908871|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908872|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
1908873|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908874|NCT00476151|Ketamine|ketamine|mesh-list
1908875|NCT00476151|Amitriptyline|amitriptyline|mesh-list
1908876|NCT00476151|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1908877|NCT00476151|Analgesics|analgesics|mesh-ancestor
1908878|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
1908879|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908880|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908881|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1908882|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1908883|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
1908884|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
1908885|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1908886|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1908887|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1908888|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908889|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908890|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1908891|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
1908892|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1908893|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1908894|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1908895|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1908896|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1908897|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
1908898|NCT00476151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1908899|NCT00476151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1908900|NCT00476229|Rituximab|rituximab|mesh-list
1908901|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
1908902|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1908903|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1908904|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908905|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
1908906|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908907|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908908|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908909|NCT00476242|Naltrexone|naltrexone|mesh-list
1908910|NCT00476242|Memantine|memantine|mesh-list
1908911|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1908912|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1908913|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
1908914|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1908915|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908916|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908917|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1908918|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1908919|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1908920|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1908921|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
1908922|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908923|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1908924|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908925|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1908926|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908927|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908928|NCT00476593|Dexamethasone|dexamethasone|mesh-list
1908929|NCT00476593|Diclofenac|diclofenac|mesh-list
1908930|NCT00476593|Lactitol|lactitol|mesh-list
1908931|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1908932|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1908933|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
1908934|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
1908935|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1908936|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908937|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1908938|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
1908939|NCT00476593|Hormones|hormones|mesh-ancestor
1908940|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908941|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908942|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908943|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1908944|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1908945|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1908946|NCT00476593|Analgesics|analgesics|mesh-ancestor
1908947|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
1908948|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908949|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1908950|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908951|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908952|NCT00476593|Cathartics|cathartics|mesh-ancestor
1908953|NCT00476645|Fulvestrant|fulvestrant|mesh-list
1908954|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1908955|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908956|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1908957|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1908958|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
1908959|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1908960|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908961|NCT00476788|Insulin|insulin|mesh-list
1908962|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1908963|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1908964|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908965|NCT00476957|Sirolimus|sirolimus|mesh-list
1908966|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1908967|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1908968|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1908969|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908970|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
1908971|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908972|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
1908973|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908974|NCT00476996|Methotrexate|methotrexate|mesh-list
1908975|NCT00476996|Leflunomide|leflunomide|mesh-list
1908976|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
1908977|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1908978|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
1908979|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1908980|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908981|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1908982|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
1908983|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1908984|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908985|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
1908986|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1908987|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1908988|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1908989|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
1908990|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1908991|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1908992|NCT00477087|Molgramostim|molgramostim|mesh-list
1908993|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
1908994|NCT00477087|Sargramostim|sargramostim|mesh-list
1908995|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
1908996|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1908997|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1908998|NCT00477087|Analgesics|analgesics|mesh-ancestor
1908999|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
1909000|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909001|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1909002|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1909003|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909004|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909005|NCT00477165|Citalopram|citalopram|mesh-list
1909006|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1909007|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1909008|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1909009|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909010|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909011|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
1909012|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909013|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1909014|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
1909015|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1909016|NCT00477191|Etanercept|etanercept|mesh-list
1909017|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1909018|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909019|NCT00477191|Analgesics|analgesics|mesh-ancestor
1909020|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
1909021|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909022|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909023|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909024|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909025|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909026|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909027|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
1909028|NCT00477204|Simvastatin|simvastatin|mesh-list
1909029|NCT00477204|Ezetimibe|ezetimibe|mesh-list
1909030|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1909031|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1909032|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1909033|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
1909034|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909035|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1909036|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1909037|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909038|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
1909039|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909040|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909041|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909042|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909043|NCT00477295|Carbamazepine|carbamazepine|mesh-list
1909044|NCT00477295|Zonisamide|zonisamide|mesh-list
1909045|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
1909046|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
1909047|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1909048|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909049|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909050|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1909051|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909052|NCT00477295|Analgesics|analgesics|mesh-ancestor
1909053|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
1909054|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909055|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1909056|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1909057|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909058|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1909059|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1909060|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1909061|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1909062|NCT00477334|Famciclovir|famciclovir|mesh-list
1909063|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
1909064|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909065|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1909066|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909067|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909068|NCT00477386|Decitabine|decitabine|mesh-list
1909069|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909070|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
1909071|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909072|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909073|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909074|NCT00477451|Alprazolam|alprazolam|mesh-list
1909075|NCT00477451|Doxapram|doxapram|mesh-list
1909076|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1909077|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909078|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909079|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1909080|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1909081|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1909082|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
1909083|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
1909084|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909085|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909086|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1909087|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
1909088|NCT00477464|Capecitabine|capecitabine|mesh-list
1909089|NCT00477464|Lapatinib|lapatinib|mesh-list
1909090|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909091|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
1909092|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909093|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909094|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909095|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909096|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1909097|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
1909098|NCT00477490|Coagulants|coagulants|mesh-ancestor
1909099|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1909100|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
1909101|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909102|NCT00477594|Mipomersen|mipomersen|mesh-list
1909103|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1909104|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1909105|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
1909106|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909107|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1909108|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
1909109|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
1909110|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909111|NCT00477607|Protective Agents|protective agents|mesh-ancestor
1909112|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909113|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
1909114|NCT00477607|Vitamins|vitamins|mesh-ancestor
1909115|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
1909116|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1909117|NCT00477633|Norethindrone|norethindrone|mesh-list
1909118|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
1909119|NCT00477633|Estradiol|estradiol|mesh-list
1909120|NCT00477633|Estrogens|estrogens|mesh-ancestor
1909121|NCT00477633|Hormones|hormones|mesh-ancestor
1909122|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909123|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909124|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1909125|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
1909126|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1909127|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1909128|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1909129|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1909130|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1909131|NCT00477659|Donepezil|donepezil|mesh-list
1909132|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1909133|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909134|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909135|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
1909136|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909137|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909138|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
1909139|NCT00477672|Pimavanserin|pimavanserin|mesh-list
1909140|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1909141|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1909142|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1909143|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1909144|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909145|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909146|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1909147|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1909148|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1909149|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
1909150|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909151|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909152|NCT00477750|Prednisone|prednisone|mesh-list
1909153|NCT00477750|Lenalidomide|lenalidomide|mesh-list
1909154|NCT00477750|Melphalan|melphalan|mesh-list
1909155|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909156|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
1909157|NCT00477750|Hormones|hormones|mesh-ancestor
1909158|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909159|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909160|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909161|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909162|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
1909163|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1909164|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1909165|NCT00477750|Growth Substances|growth substances|mesh-ancestor
1909166|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
1909167|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909168|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
1909169|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909170|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909171|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909172|NCT00477971|Dexamethasone|dexamethasone|mesh-list
1909173|NCT00477971|Melphalan|melphalan|mesh-list
1909174|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909175|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
1909176|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
1909177|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909178|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909179|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909180|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
1909181|NCT00477971|Hormones|hormones|mesh-ancestor
1909182|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909183|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909184|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909185|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
1909186|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909187|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
1909188|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909189|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909190|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909191|NCT00478023|Morphine|morphine|mesh-list
1909192|NCT00478023|Tapentadol|tapentadol|mesh-list
1909193|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1909194|NCT00478023|Narcotics|narcotics|mesh-ancestor
1909195|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909196|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909197|NCT00478023|Analgesics|analgesics|mesh-ancestor
1909198|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
1909199|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909200|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1909201|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1909202|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1909203|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909204|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
1909205|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909206|NCT00478036|Prednisolone|prednisolone|mesh-list
1909207|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
1909208|NCT00478036|Ketorolac|ketorolac|mesh-list
1909209|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1909210|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1909211|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909212|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
1909213|NCT00478036|Hormones|hormones|mesh-ancestor
1909214|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909215|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909216|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909217|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909218|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909219|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909220|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1909221|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909222|NCT00478036|Analgesics|analgesics|mesh-ancestor
1909223|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
1909224|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909225|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1909226|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909227|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909228|NCT00478036|Laxatives|laxatives|mesh-ancestor
1909229|NCT00478140|Trastuzumab|trastuzumab|mesh-list
1909230|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1909231|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909232|NCT00478192|Conivaptan|conivaptan|mesh-list
1909233|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1909234|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909235|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
1909236|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909237|NCT00478205|Donepezil|donepezil|mesh-list
1909238|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1909239|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909240|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909241|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
1909242|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909243|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909244|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
1909245|NCT00478218|Dexamethasone|dexamethasone|mesh-list
1909246|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
1909247|NCT00478218|Lenalidomide|lenalidomide|mesh-list
1909248|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909249|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
1909250|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909251|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909252|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909253|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
1909254|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909255|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909256|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909257|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909258|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
1909259|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
1909260|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909261|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909262|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
1909263|NCT00478218|Hormones|hormones|mesh-ancestor
1909264|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909265|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909266|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1909267|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1909268|NCT00478218|Growth Substances|growth substances|mesh-ancestor
1909269|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
1909270|NCT00478231|Maraviroc|maraviroc|mesh-list
1909271|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1909272|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1909273|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909274|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1909275|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1909276|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
1909277|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909278|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1909279|NCT00478244|Vidarabine|vidarabine|mesh-list
1909280|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
1909281|NCT00478244|Busulfan|busulfan|mesh-list
1909282|NCT00478244|Fludarabine|fludarabine|mesh-list
1909283|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
1909284|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909285|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
1909286|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909287|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909288|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909289|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
1909290|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909291|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909292|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909293|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909294|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
1909295|NCT00478244|Antiviral Agents|antiviral agents|mesh-ancestor
1909296|NCT00478244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909297|NCT00478335|Calcitonin|calcitonin|mesh-list
1909298|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
1909299|NCT00478335|Indomethacin|indomethacin|mesh-list
1909300|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1909301|NCT00478335|Amiloride|amiloride|mesh-list
1909302|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
1909303|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1909304|NCT00478335|Katacalcin|katacalcin|mesh-list
1909305|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
1909306|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1909307|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1909308|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909309|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909311|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1909312|NCT00478335|Diuretics|diuretics|mesh-ancestor
1909313|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
1909314|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909315|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1909316|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1909317|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1909318|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909319|NCT00478335|Analgesics|analgesics|mesh-ancestor
1909320|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
1909321|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909322|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909323|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909324|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
1909325|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
1909326|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1909327|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1909328|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
1909329|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1909330|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1909331|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1909332|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1909333|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1909334|NCT00478361|Gemcitabine|gemcitabine|mesh-list
1909335|NCT00478361|Paclitaxel|paclitaxel|mesh-list
1909336|NCT00478361|Doxorubicin|doxorubicin|mesh-list
1909337|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1909338|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909339|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909340|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909341|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909342|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909343|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909344|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909345|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
1909346|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
1909347|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909348|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909349|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909350|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
1909351|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909352|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1909353|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1909354|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1909355|NCT00478426|Sunitinib|sunitinib|mesh-list
1909356|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909357|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1909358|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1909359|NCT00478426|Growth Substances|growth substances|mesh-ancestor
1909360|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909361|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
1909362|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909363|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909364|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909365|NCT00478569|Hormones|hormones|mesh-list
1909366|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
1909367|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909368|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909369|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1909370|NCT00478608|Sirolimus|sirolimus|mesh-list
1909371|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1909372|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909373|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1909374|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909375|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
1909376|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909377|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
1909378|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909379|NCT00478777|Dexamethasone|dexamethasone|mesh-list
1909380|NCT00478777|Lenalidomide|lenalidomide|mesh-list
1909381|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909382|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
1909383|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
1909384|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909385|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909386|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909387|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
1909388|NCT00478777|Hormones|hormones|mesh-ancestor
1909389|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909390|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909391|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909392|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
1909393|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1909394|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1909395|NCT00478777|Growth Substances|growth substances|mesh-ancestor
1909396|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
1909397|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1909398|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
1909399|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1909400|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1909401|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909402|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909403|NCT00478881|Urological Agents|urological agents|mesh-ancestor
1909404|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
1909405|NCT00479037|Hormones|hormones|mesh-list
1909406|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
1909407|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909408|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909409|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1909410|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1909411|NCT00479089|Dexamethasone|dexamethasone|mesh-list
1909412|NCT00479089|Docetaxel|docetaxel|mesh-list
1909413|NCT00479089|Gefitinib|gefitinib|mesh-list
1909414|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909415|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
1909416|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
1909417|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909418|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909419|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909420|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
1909421|NCT00479089|Hormones|hormones|mesh-ancestor
1909422|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909423|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909424|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909425|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909426|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909427|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909428|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909429|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909430|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909431|NCT00479115|Plerixafor|plerixafor|mesh-list
1909432|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1909433|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1909434|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
1909435|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909436|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
1909437|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1909438|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1909439|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1909440|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1909441|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909442|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
1909443|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909444|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909445|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1909446|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909447|NCT00479232|Decitabine|decitabine|mesh-list
1909448|NCT00479232|Vorinostat|vorinostat|mesh-list
1909449|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909450|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
1909451|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909452|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909453|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909454|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1909455|NCT00479336|Tolvaptan|tolvaptan|mesh-list
1909456|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1909457|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909458|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
1909459|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909460|NCT00479388|Niacin|niacin|mesh-list
1909461|NCT00479388|Atorvastatin|atorvastatin|mesh-list
1909462|NCT00479388|Simvastatin|simvastatin|mesh-list
1909463|NCT00479388|Calcium|calcium|mesh-list
1909464|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1909465|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909466|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1909467|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1909468|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
1909469|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909470|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1909471|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1909472|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909473|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
1909474|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
1909475|NCT00479388|Vitamins|vitamins|mesh-ancestor
1909476|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
1909477|NCT00479401|Pramipexole|pramipexole|mesh-list
1909478|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
1909479|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909480|NCT00479401|Protective Agents|protective agents|mesh-ancestor
1909481|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909482|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1909483|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1909484|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
1909485|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
1909486|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909487|NCT00479466|Metformin|metformin|mesh-list
1909488|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1909489|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909490|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
1909491|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1909492|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
1909493|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909494|NCT00479674|Paclitaxel|paclitaxel|mesh-list
1909495|NCT00479674|Bevacizumab|bevacizumab|mesh-list
1909496|NCT00479674|Carboplatin|carboplatin|mesh-list
1909497|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1909498|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909499|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909500|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909501|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909502|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909503|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909504|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1909505|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1909506|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1909507|NCT00479674|Growth Substances|growth substances|mesh-ancestor
1909508|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909509|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
1909510|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
1909511|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1909512|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
1909513|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909514|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
1909515|NCT00479687|Protective Agents|protective agents|mesh-ancestor
1909516|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1909517|NCT00479713|Simvastatin|simvastatin|mesh-list
1909518|NCT00479713|Ezetimibe|ezetimibe|mesh-list
1909519|NCT00479713|Calcium|calcium|mesh-list
1909520|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1909521|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909522|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1909523|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1909524|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
1909525|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909526|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1909527|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1909528|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909529|NCT00479765|Paclitaxel|paclitaxel|mesh-list
1909530|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909531|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909532|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909533|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909534|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909762|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
1909535|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909536|NCT00479856|Paclitaxel|paclitaxel|mesh-list
1909537|NCT00479856|Docetaxel|docetaxel|mesh-list
1909538|NCT00479856|Capecitabine|capecitabine|mesh-list
1909539|NCT00479856|Lapatinib|lapatinib|mesh-list
1909540|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909541|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909542|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909543|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909544|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909545|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909546|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909547|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
1909548|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909549|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909550|NCT00479882|Simvastatin|simvastatin|mesh-list
1909551|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1909552|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1909553|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
1909554|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909555|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1909556|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1909557|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909558|NCT00480441|Dronabinol|dronabinol|mesh-list
1909559|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
1909560|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909561|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1909562|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909563|NCT00480441|Analgesics|analgesics|mesh-ancestor
1909564|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
1909565|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909566|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1909567|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1909568|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909569|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909570|NCT00480441|Hormones|hormones|mesh-ancestor
1909571|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909572|NCT00480532|Doxycycline|doxycycline|mesh-list
1909573|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
1909574|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1909575|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1909576|NCT00480532|Estradiol|estradiol|mesh-list
1909577|NCT00480532|Estrogens|estrogens|mesh-ancestor
1909578|NCT00480532|Hormones|hormones|mesh-ancestor
1909579|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909580|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909581|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1909582|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
1909583|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1909584|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1909585|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1909586|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909587|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
1909588|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1909589|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1909590|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1909591|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1909592|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1909593|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1909594|NCT00480636|Dalteparin|dalteparin|mesh-list
1909595|NCT00480636|Tinzaparin|tinzaparin|mesh-list
1909596|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1909597|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
1909598|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1909599|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1909600|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909601|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
1909602|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1909603|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909604|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909605|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909606|NCT00480740|Analgesics|analgesics|mesh-ancestor
1909607|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
1909608|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909916|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
1909609|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1909610|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1909611|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1909612|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
1909613|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909614|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909615|NCT00480857|Docetaxel|docetaxel|mesh-list
1909616|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909617|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909618|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909619|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909620|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909621|NCT00480987|Vidarabine|vidarabine|mesh-list
1909622|NCT00480987|Cytarabine|cytarabine|mesh-list
1909623|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
1909624|NCT00480987|Fludarabine|fludarabine|mesh-list
1909625|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
1909626|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909627|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909628|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
1909629|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909630|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909631|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
1909632|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909633|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
1909634|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909635|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
1909636|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1909637|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
1909638|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909639|NCT00481078|Paclitaxel|paclitaxel|mesh-list
1909640|NCT00481078|Carboplatin|carboplatin|mesh-list
1909641|NCT00481078|Vorinostat|vorinostat|mesh-list
1909642|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909643|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909644|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909645|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909646|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909647|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909648|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1909649|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909650|NCT00481195|Modafinil|modafinil|mesh-list
1909651|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1909652|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909653|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1909654|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1909655|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1909656|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909657|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
1909658|NCT00481247|Dasatinib|dasatinib|mesh-list
1909659|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909660|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909661|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909662|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909663|NCT00481351|Simvastatin|simvastatin|mesh-list
1909664|NCT00481351|Ezetimibe|ezetimibe|mesh-list
1909665|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1909666|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1909667|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
1909668|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909669|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1909670|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1909671|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909672|NCT00481676|Omalizumab|omalizumab|mesh-list
1909673|NCT00481676|Loratadine|loratadine|mesh-list
1909674|NCT00481676|Clemastine|clemastine|mesh-list
1909675|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1909676|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1909677|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1909678|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
1909679|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
1909680|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909681|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
1909682|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
1909683|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1909684|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1909685|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
1909686|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
1909687|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909688|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909689|NCT00481767|Vaccines|vaccines|mesh-list
1909690|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
1909691|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909692|NCT00481832|Cyclosporine|cyclosporine|mesh-list
1909693|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
1909694|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
1909695|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1909696|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1909697|NCT00481832|Prednisolone|prednisolone|mesh-list
1909698|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
1909699|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
1909700|NCT00481832|Carmustine|carmustine|mesh-list
1909701|NCT00481832|Rituximab|rituximab|mesh-list
1909702|NCT00481832|Etoposide|etoposide|mesh-list
1909703|NCT00481832|Cyclosporins|cyclosporins|mesh-list
1909704|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1909705|NCT00481832|Lenograstim|lenograstim|mesh-list
1909706|NCT00481832|Sargramostim|sargramostim|mesh-list
1909707|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1909708|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
1909709|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909710|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
1909711|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909712|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909713|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909714|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
1909715|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909716|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909717|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909718|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1909719|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909720|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1909721|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1909722|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909723|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1909724|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
1909725|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909726|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
1909727|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1909728|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1909729|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1909730|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
1909731|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1909732|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909733|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
1909734|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
1909735|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909736|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909737|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
1909738|NCT00481832|Hormones|hormones|mesh-ancestor
1909739|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909740|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1909741|NCT00481832|Protective Agents|protective agents|mesh-ancestor
1909742|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909743|NCT00481845|Anastrozole|anastrozole|mesh-list
1909744|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909745|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909746|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1909747|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1909748|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909749|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909750|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1909751|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
1909752|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909753|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909754|NCT00481871|Vitamins|vitamins|mesh-list
1909755|NCT00481871|Folic Acid|folic acid|mesh-list
1909756|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
1909757|NCT00481871|Hydroxocobalamin|hydroxocobalamin|mesh-list
1909758|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
1909759|NCT00481871|Gemcitabine|gemcitabine|mesh-list
1909760|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1909761|NCT00481871|Aminopterin|aminopterin|mesh-list
1909763|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909764|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909765|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
1909766|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909767|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909768|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
1909769|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909770|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909771|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909772|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
1909773|NCT00481871|Hematinics|hematinics|mesh-ancestor
1909774|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1909775|NCT00482001|Donepezil|donepezil|mesh-list
1909776|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1909777|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909778|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909779|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
1909780|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909781|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909782|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
1909783|NCT00482014|Carboplatin|carboplatin|mesh-list
1909784|NCT00482014|Pemetrexed|pemetrexed|mesh-list
1909785|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909786|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909787|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909788|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1909789|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1909790|NCT00482053|Acetaminophen|acetaminophen|mesh-list
1909791|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
1909792|NCT00482053|Promethazine|promethazine|mesh-list
1909793|NCT00482053|Cyclosporine|cyclosporine|mesh-list
1909794|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
1909795|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
1909796|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1909797|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
1909798|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
1909799|NCT00482053|Carmustine|carmustine|mesh-list
1909800|NCT00482053|Rituximab|rituximab|mesh-list
1909801|NCT00482053|Etoposide|etoposide|mesh-list
1909802|NCT00482053|Cyclosporins|cyclosporins|mesh-list
1909803|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1909804|NCT00482053|Lenograstim|lenograstim|mesh-list
1909805|NCT00482053|Sargramostim|sargramostim|mesh-list
1909806|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909807|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
1909808|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909809|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909810|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909811|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
1909812|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909813|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909814|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909815|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1909816|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909817|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1909818|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1909819|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909820|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1909821|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
1909822|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1909823|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
1909824|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1909825|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909826|NCT00482053|Analgesics|analgesics|mesh-ancestor
1909827|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
1909828|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909829|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
1909830|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1909831|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1909832|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
1909833|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1909834|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909835|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
1909836|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
1909837|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909838|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
1909839|NCT00482053|Hormones|hormones|mesh-ancestor
1909915|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1909840|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909841|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1909842|NCT00482053|Protective Agents|protective agents|mesh-ancestor
1909843|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909844|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1909845|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1909846|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909847|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
1909848|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
1909849|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1909850|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
1909851|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
1909852|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909853|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1909854|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
1909855|NCT00482170|Etanercept|etanercept|mesh-list
1909856|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1909857|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1909858|NCT00482170|Analgesics|analgesics|mesh-ancestor
1909859|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
1909860|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1909861|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909862|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1909863|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909864|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1909865|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909866|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
1909867|NCT00482274|Docetaxel|docetaxel|mesh-list
1909868|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909869|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909870|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909871|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909872|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909873|NCT00482391|Paclitaxel|paclitaxel|mesh-list
1909874|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
1909875|NCT00482391|Doxorubicin|doxorubicin|mesh-list
1909876|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1909877|NCT00482391|Trastuzumab|trastuzumab|mesh-list
1909878|NCT00482391|Lapatinib|lapatinib|mesh-list
1909879|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1909880|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909881|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
1909882|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
1909883|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
1909884|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909885|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909886|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
1909887|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909888|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909889|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909890|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
1909891|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909892|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1909893|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1909894|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1909895|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909896|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1909897|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909898|NCT00482612|Mirtazapine|mirtazapine|mesh-list
1909899|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
1909900|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1909901|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1909902|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
1909903|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
1909904|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909905|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909906|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909907|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1909908|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1909909|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1909910|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1909911|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1909912|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1909913|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
1909914|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1909917|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1909918|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1909919|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909920|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909921|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909922|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909923|NCT00482677|Temozolomide|temozolomide|mesh-list
1909924|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909925|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
1909926|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909927|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909928|NCT00482703|Dasatinib|dasatinib|mesh-list
1909929|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909930|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909931|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909932|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909933|NCT00482729|Metformin|metformin|mesh-list
1909934|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1909935|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1909936|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909937|NCT00482729|Incretins|incretins|mesh-ancestor
1909938|NCT00482729|Hormones|hormones|mesh-ancestor
1909939|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1909940|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1909941|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
1909942|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909943|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909944|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
1909945|NCT00482911|Lenalidomide|lenalidomide|mesh-list
1909946|NCT00482911|Sunitinib|sunitinib|mesh-list
1909947|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1909948|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
1909949|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909950|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1909951|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1909952|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
1909953|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909954|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909955|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1909956|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1909957|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1909958|NCT00482911|Growth Substances|growth substances|mesh-ancestor
1909959|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
1909960|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1909961|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1909962|NCT00483002|Varenicline|varenicline|mesh-list
1909963|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1909964|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1909965|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
1909966|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1909967|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909968|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909969|NCT00483223|Carboplatin|carboplatin|mesh-list
1909970|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909971|NCT00483262|Bortezomib|bortezomib|mesh-list
1909972|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909973|NCT00483327|Megestrol|megestrol|mesh-list
1909974|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
1909975|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1909976|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1909977|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1909978|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
1909979|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1909980|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1909981|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1909982|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1909983|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1909984|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909985|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
1909986|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1909987|NCT00483405|Capecitabine|capecitabine|mesh-list
1909988|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
1909989|NCT00483405|Cetuximab|cetuximab|mesh-list
1909990|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1909991|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
1909992|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1909993|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1909994|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1909995|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
1909996|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
1909997|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1909998|NCT00483496|Protective Agents|protective agents|mesh-ancestor
1909999|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910000|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
1910001|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1910002|NCT00483509|Doxorubicin|doxorubicin|mesh-list
1910003|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1910004|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910005|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1910006|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1910007|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910008|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910009|NCT00483548|Ziprasidone|ziprasidone|mesh-list
1910010|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1910011|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
1910012|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910013|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910014|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910015|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1910016|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1910017|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910018|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910019|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1910020|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
1910021|NCT00483561|Etoposide|etoposide|mesh-list
1910022|NCT00483561|Gefitinib|gefitinib|mesh-list
1910023|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1910024|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910025|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1910026|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1910027|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910028|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910029|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1910030|NCT00483574|Vaccines|vaccines|mesh-list
1910031|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
1910032|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910033|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
1910034|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1910035|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910036|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910037|NCT00483717|Ketorolac|ketorolac|mesh-list
1910038|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1910039|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1910040|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910041|NCT00483717|Analgesics|analgesics|mesh-ancestor
1910042|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
1910043|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910044|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910045|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910046|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910047|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1910048|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910049|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910050|NCT00483756|Cyclosporine|cyclosporine|mesh-list
1910051|NCT00483756|Cyclosporins|cyclosporins|mesh-list
1910052|NCT00483756|Tofacitinib|tofacitinib|mesh-list
1910053|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910054|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910055|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910056|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
1910057|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910058|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
1910059|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910060|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
1910061|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910062|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1910063|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1910064|NCT00483938|Interferons|interferons|mesh-list
1910065|NCT00483938|Ribavirin|ribavirin|mesh-list
1910066|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
1910067|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
1910068|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1910069|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910070|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
1910071|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910072|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
1910073|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910074|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
1910075|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910076|NCT00484094|Sirolimus|sirolimus|mesh-list
1910077|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1910078|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910079|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1910080|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910081|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
1910082|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910083|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
1910084|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910085|NCT00484159|Lidocaine|lidocaine|mesh-list
1910086|NCT00484159|Bupivacaine|bupivacaine|mesh-list
1910087|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
1910088|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
1910089|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910090|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910091|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
1910092|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910093|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1910094|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1910095|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1910096|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910097|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910098|NCT00484198|Pioglitazone|pioglitazone|mesh-list
1910099|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1910100|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910101|NCT00484289|Abatacept|abatacept|mesh-list
1910102|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1910103|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910104|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910105|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910106|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
1910107|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910108|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910109|NCT00484315|Paclitaxel|paclitaxel|mesh-list
1910110|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1910111|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1910112|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910113|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910114|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910115|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910116|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910117|NCT00484393|Tetracaine|tetracaine|mesh-list
1910118|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
1910119|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
1910120|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910121|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910122|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
1910123|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910124|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1910125|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
1910126|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1910127|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1910128|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910129|NCT00484419|Incretins|incretins|mesh-ancestor
1910130|NCT00484419|Hormones|hormones|mesh-ancestor
1910131|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910132|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1910133|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
1910134|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910135|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910136|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1910137|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1910138|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
1910139|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1910140|NCT00484679|Triamcinolone|triamcinolone|mesh-list
1910141|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1910142|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1910143|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1910144|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910145|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
1910146|NCT00484679|Hormones|hormones|mesh-ancestor
1910147|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910148|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910149|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910150|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
1910151|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910152|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910153|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
1910154|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910155|NCT00484939|Bevacizumab|bevacizumab|mesh-list
1910156|NCT00484939|Capecitabine|capecitabine|mesh-list
1910157|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1910158|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910159|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1910160|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1910161|NCT00484939|Growth Substances|growth substances|mesh-ancestor
1910162|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910163|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
1910164|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1910165|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
1910166|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910167|NCT00485069|Levodopa|levodopa|mesh-list
1910168|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1910169|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1910170|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
1910171|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910172|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910173|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910174|NCT00485134|Vaccines|vaccines|mesh-list
1910175|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
1910176|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910177|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
1910178|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1910179|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1910180|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
1910181|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910182|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1910183|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1910184|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910185|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910186|NCT00485303|Prednisone|prednisone|mesh-list
1910187|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
1910188|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910189|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
1910190|NCT00485303|Hormones|hormones|mesh-ancestor
1910191|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910192|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910193|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1910194|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910195|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1910196|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910197|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910198|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
1910199|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1910200|NCT00485433|Epinephrine|epinephrine|mesh-list
1910201|NCT00485433|Bupivacaine|bupivacaine|mesh-list
1910202|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
1910203|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
1910204|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910205|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910206|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
1910207|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910208|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1910209|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1910210|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
1910211|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910212|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910213|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1910214|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1910215|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
1910216|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1910217|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
1910218|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
1910219|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
1910220|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1910221|NCT00485472|Lacosamide|lacosamide|mesh-list
1910222|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
1910223|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1910224|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1910225|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910226|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910227|NCT00485485|Docetaxel|docetaxel|mesh-list
1910228|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
1910229|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910230|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910231|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910232|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910233|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910234|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1910235|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910236|NCT00485589|Methotrexate|methotrexate|mesh-list
1910237|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
1910238|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1910239|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
1910240|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1910241|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910242|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1910243|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
1910244|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910245|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910246|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
1910247|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910248|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1910249|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910250|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
1910251|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910252|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1910253|NCT00485693|Epinephrine|epinephrine|mesh-list
1910254|NCT00485693|Bupivacaine|bupivacaine|mesh-list
1910255|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
1910256|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
1910257|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910258|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910259|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
1910260|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910261|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1910262|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1910263|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
1910264|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910265|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910266|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1910267|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1910268|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
1910269|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1910270|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
1910271|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
1910272|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
1910273|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1910274|NCT00485732|Vaccines|vaccines|mesh-list
1910275|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
1910276|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910277|NCT00485758|Niacin|niacin|mesh-list
1910278|NCT00485758|Niacinamide|niacinamide|mesh-list
1910279|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
1910280|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1910281|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
1910282|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910283|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1910284|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
1910285|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
1910286|NCT00485758|Vitamins|vitamins|mesh-ancestor
1910287|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
1910288|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910289|NCT00485836|Ranibizumab|ranibizumab|mesh-list
1910290|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1910291|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1910292|NCT00485836|Growth Substances|growth substances|mesh-ancestor
1910293|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910294|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
1910295|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910296|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
1910297|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1910298|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910299|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910300|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1910301|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910302|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1910303|NCT00486018|Ranibizumab|ranibizumab|mesh-list
1910304|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1910305|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1910306|NCT00486018|Growth Substances|growth substances|mesh-ancestor
1910307|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910308|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
1910309|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910310|NCT00486031|Balsalazide|balsalazide|mesh-list
1910311|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1910312|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910313|NCT00486031|Analgesics|analgesics|mesh-ancestor
1910314|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
1910315|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910316|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910317|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910318|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910319|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1910320|NCT00486044|Simvastatin|simvastatin|mesh-list
1910321|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1910322|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1910323|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
1910324|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910325|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1910326|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1910327|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910328|NCT00486330|Ritonavir|ritonavir|mesh-list
1910329|NCT00486330|Tipranavir|tipranavir|mesh-list
1910330|NCT00486330|Buprenorphine|buprenorphine|mesh-list
1910331|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1910332|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1910333|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
1910334|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910335|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910336|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1910337|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1910338|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
1910339|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910340|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1910341|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1910342|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1910343|NCT00486330|Narcotics|narcotics|mesh-ancestor
1910344|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910345|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910346|NCT00486330|Analgesics|analgesics|mesh-ancestor
1910347|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
1910348|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910349|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1910350|NCT00486434|Calcitonin|calcitonin|mesh-list
1910351|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
1910352|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1910353|NCT00486434|Katacalcin|katacalcin|mesh-list
1910354|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1910355|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910356|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1910357|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
1910358|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
1910359|NCT00486603|Temozolomide|temozolomide|mesh-list
1910360|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1910361|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
1910362|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910363|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910364|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
1910365|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1910366|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1910367|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910368|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910369|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910370|NCT00486642|Bicalutamide|bicalutamide|mesh-list
1910371|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
1910372|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
1910373|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910374|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910375|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910376|NCT00486720|Vorinostat|vorinostat|mesh-list
1910377|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910378|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1910379|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910380|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910381|NCT00486759|Bevacizumab|bevacizumab|mesh-list
1910382|NCT00486759|Rituximab|rituximab|mesh-list
1910383|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1910384|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910385|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1910386|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1910387|NCT00486759|Growth Substances|growth substances|mesh-ancestor
1910388|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910389|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
1910390|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
1910391|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910392|NCT00486811|Oxycodone|oxycodone|mesh-list
1910393|NCT00486811|Tapentadol|tapentadol|mesh-list
1910394|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1910395|NCT00486811|Narcotics|narcotics|mesh-ancestor
1910396|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910397|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910398|NCT00486811|Analgesics|analgesics|mesh-ancestor
1910399|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
1910400|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910401|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1910402|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1910403|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910404|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910405|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
1910406|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910407|NCT00486824|Indomethacin|indomethacin|mesh-list
1910408|NCT00486824|Nifedipine|nifedipine|mesh-list
1910409|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1910410|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910411|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910412|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1910413|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910414|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
1910415|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
1910416|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1910417|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1910418|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910419|NCT00486824|Analgesics|analgesics|mesh-ancestor
1910420|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
1910421|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910422|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910423|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910424|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
1910425|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1910426|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910427|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
1910428|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1910429|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910430|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910431|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1910432|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1910433|NCT00486863|Praziquantel|praziquantel|mesh-list
1910434|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
1910435|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1910436|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910437|NCT00486902|Ketamine|ketamine|mesh-list
1910438|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
1910439|NCT00486902|Analgesics|analgesics|mesh-ancestor
1910440|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
1910441|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910442|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910443|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1910444|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1910445|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
1910446|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
1910447|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910448|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1910449|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1910450|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910451|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910452|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
1910453|NCT00486954|Paclitaxel|paclitaxel|mesh-list
1910454|NCT00486954|Lapatinib|lapatinib|mesh-list
1910455|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1910456|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910457|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910458|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910459|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910460|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910461|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1910462|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910463|NCT00487084|Lidocaine|lidocaine|mesh-list
1910464|NCT00487084|Morphine|morphine|mesh-list
1910465|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
1910466|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
1910467|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910468|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910469|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
1910470|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910471|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1910472|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1910473|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1910474|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910475|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910476|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1910477|NCT00487084|Narcotics|narcotics|mesh-ancestor
1910478|NCT00487084|Analgesics|analgesics|mesh-ancestor
1910479|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1910480|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
1910481|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
1910482|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910483|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1910484|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1910485|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910486|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1910487|NCT00487240|Insulin|insulin|mesh-list
1910488|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1910489|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
1910490|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
1910491|NCT00487240|Protamines|protamines|mesh-list
1910492|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1910493|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910494|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
1910495|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910496|NCT00487240|Coagulants|coagulants|mesh-ancestor
1910497|NCT00487435|Tapentadol|tapentadol|mesh-list
1910498|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1910499|NCT00487435|Narcotics|narcotics|mesh-ancestor
1910500|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910501|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910502|NCT00487435|Analgesics|analgesics|mesh-ancestor
1910503|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
1910504|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910505|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1910506|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1910507|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910508|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910509|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
1910510|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910511|NCT00487539|Golimumab|golimumab|mesh-list
1910512|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1910513|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1910514|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910515|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910516|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
1910517|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910518|NCT00487669|Paclitaxel|paclitaxel|mesh-list
1910519|NCT00487669|Pemetrexed|pemetrexed|mesh-list
1910520|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
1910521|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1910522|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910523|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910524|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910525|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910526|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910527|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910528|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1910529|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1910530|NCT00487721|Silymarin|silymarin|mesh-list
1910531|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
1910532|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910533|NCT00487721|Protective Agents|protective agents|mesh-ancestor
1910534|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910535|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1910536|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
1910537|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910538|NCT00487825|Methotrexate|methotrexate|mesh-list
1910539|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1910540|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
1910541|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1910542|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910543|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1910544|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
1910545|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910546|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910547|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
1910548|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910549|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1910550|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910551|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
1910552|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910553|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1910554|NCT00487942|Modafinil|modafinil|mesh-list
1910555|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1910556|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910557|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1910558|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1910559|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1910560|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910561|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
1910562|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
1910563|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
1910564|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1910565|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1910566|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910567|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1910568|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1910569|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
1910570|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910571|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910572|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1910573|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1910574|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1910575|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910576|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910577|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910578|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1910579|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1910580|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
1910581|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910582|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910583|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1910584|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1910585|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
1910586|NCT00488345|Tigecycline|tigecycline|mesh-list
1910587|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1910588|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910589|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1910590|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910591|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910592|NCT00488475|Etanercept|etanercept|mesh-list
1910593|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1910594|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910595|NCT00488475|Analgesics|analgesics|mesh-ancestor
1910596|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
1910597|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910598|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910599|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910600|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910601|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1910602|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910603|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
1910604|NCT00488488|Tigecycline|tigecycline|mesh-list
1910605|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1910606|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910607|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1910608|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910609|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910610|NCT00488514|Naproxen|naproxen|mesh-list
1910611|NCT00488514|Sumatriptan|sumatriptan|mesh-list
1910612|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1910613|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910614|NCT00488514|Analgesics|analgesics|mesh-ancestor
1910615|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
1910616|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910617|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910618|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910619|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910620|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
1910621|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1910622|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910623|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910624|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1910625|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1910626|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1910627|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
1910628|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910629|NCT00488592|Molgramostim|molgramostim|mesh-list
1910630|NCT00488592|Sargramostim|sargramostim|mesh-list
1910631|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
1910632|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910633|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910634|NCT00488618|Cariprazine|cariprazine|mesh-list
1910635|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1910636|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1910637|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910638|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910639|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910640|NCT00488631|Golimumab|golimumab|mesh-list
1910641|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1910642|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1910643|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910644|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910645|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
1910646|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910647|NCT00488683|Vaccines|vaccines|mesh-list
1910648|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
1910649|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910650|NCT00488774|Golimumab|golimumab|mesh-list
1910651|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1910652|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1910653|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910654|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910655|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
1910656|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910657|NCT00488826|Vaccines|vaccines|mesh-list
1910658|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1910659|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
1910660|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910661|NCT00488982|Docetaxel|docetaxel|mesh-list
1910662|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910663|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910664|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910665|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910666|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910667|NCT00489086|Tazarotene|tazarotene|mesh-list
1910668|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
1910669|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
1910670|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
1910671|NCT00489281|Sirolimus|sirolimus|mesh-list
1910672|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
1910673|NCT00489281|Fludarabine|fludarabine|mesh-list
1910674|NCT00489281|Levetiracetam|levetiracetam|mesh-list
1910675|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
1910676|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1910677|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910678|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
1910679|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910680|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910681|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1910682|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
1910683|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910684|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910685|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1910686|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1910687|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1910688|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
1910689|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1910690|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910691|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910692|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
1910693|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
1910694|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
1910695|NCT00489359|Carboplatin|carboplatin|mesh-list
1910696|NCT00489359|Pemetrexed|pemetrexed|mesh-list
1910697|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910698|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910699|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910700|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1910701|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1910702|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1910703|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1910704|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1910705|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910706|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910707|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910708|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910709|NCT00489411|Analgesics|analgesics|mesh-ancestor
1910710|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
1910711|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910712|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
1910713|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910714|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
1910715|NCT00489424|Acetaminophen|acetaminophen|mesh-list
1910716|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910717|NCT00489424|Analgesics|analgesics|mesh-ancestor
1910718|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
1910719|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910720|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910721|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
1910722|NCT00489476|Loxapine|loxapine|mesh-list
1910723|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1910724|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1910725|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910726|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910727|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910728|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1910729|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
1910730|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910731|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910732|NCT00489489|Interferons|interferons|mesh-list
1910733|NCT00489489|Interferon-beta|interferon-beta|mesh-list
1910734|NCT00489489|Teriflunomide|teriflunomide|mesh-list
1910735|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
1910736|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910737|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
1910738|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910739|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1910740|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
1910741|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910742|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1910743|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910744|NCT00489489|Analgesics|analgesics|mesh-ancestor
1910745|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
1910746|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910747|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910748|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910749|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910750|NCT00489541|Paclitaxel|paclitaxel|mesh-list
1910751|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1910752|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910753|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910754|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910755|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910756|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910757|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1910758|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
1910759|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910760|NCT00489736|Amiodarone|amiodarone|mesh-list
1910761|NCT00489736|Dronedarone|dronedarone|mesh-list
1910762|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1910763|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
1910764|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1910765|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1910766|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910767|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1910768|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1910769|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1910770|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910771|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1910772|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1910773|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1910774|NCT00489853|Budesonide|budesonide|mesh-list
1910775|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
1910776|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910777|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1910778|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
1910779|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910780|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910781|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1910782|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
1910783|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
1910784|NCT00489853|Hormones|hormones|mesh-ancestor
1910785|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910786|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1910787|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1910788|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1910789|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
1910790|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910791|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910792|NCT00489866|Aripiprazole|aripiprazole|mesh-list
1910793|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
1910794|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910795|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1910796|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1910797|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910798|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910799|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
1910800|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
1910801|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910802|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910803|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1910804|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1910805|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
1910806|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1910807|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1910808|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1910809|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1910810|NCT00489918|Teriparatide|teriparatide|mesh-list
1910811|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1910812|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910813|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1910814|NCT00490009|Acetaminophen|acetaminophen|mesh-list
1910815|NCT00490009|Iodine|iodine|mesh-list
1910816|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
1910817|NCT00490009|Promethazine|promethazine|mesh-list
1910818|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
1910819|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
1910820|NCT00490009|Lugol's solution|lugol's solution|mesh-list
1910821|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1910822|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910823|NCT00490009|Analgesics|analgesics|mesh-ancestor
1910824|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
1910825|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910826|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910827|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
1910828|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1910829|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910830|NCT00490009|Trace Elements|trace elements|mesh-ancestor
1910831|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
1910832|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1910833|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1910834|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910835|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
1910836|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
1910837|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
1910838|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
1910839|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1910840|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1910841|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
1910842|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
1910843|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910844|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910845|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1910846|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
1910847|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
1910848|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910849|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
1910850|NCT00490009|Coagulants|coagulants|mesh-ancestor
1910851|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
1910852|NCT00490022|Androgens|androgens|mesh-ancestor
1910853|NCT00490022|Hormones|hormones|mesh-ancestor
1910854|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910855|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910856|NCT00490035|Brivaracetam|brivaracetam|mesh-list
1910857|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
1910858|NCT00490061|Lapatinib|lapatinib|mesh-list
1910859|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910860|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1910861|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910862|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910863|NCT00490100|Mecasermin|mecasermin|mesh-list
1910864|NCT00490100|Growth Substances|growth substances|mesh-ancestor
1910865|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910866|NCT00490139|Trastuzumab|trastuzumab|mesh-list
1910867|NCT00490139|Lapatinib|lapatinib|mesh-list
1910868|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1910869|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910870|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1910871|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910872|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910873|NCT00490269|Dronabinol|dronabinol|mesh-list
1910874|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
1910875|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910876|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910877|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1910878|NCT00490269|Analgesics|analgesics|mesh-ancestor
1910879|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
1910880|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910881|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1910882|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1910883|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910884|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910885|NCT00490269|Hormones|hormones|mesh-ancestor
1910886|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910887|NCT00490477|Polymyxins|polymyxins|mesh-list
1910888|NCT00490477|Polymyxin B|polymyxin b|mesh-list
1910889|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1910890|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910891|NCT00490490|Iodine|iodine|mesh-list
1910892|NCT00490490|Lugol's solution|lugol's solution|mesh-list
1910893|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1910894|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1910895|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1910896|NCT00490490|Trace Elements|trace elements|mesh-ancestor
1910897|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
1910898|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910899|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
1910900|NCT00490490|Coagulants|coagulants|mesh-ancestor
1910901|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
1910902|NCT00490529|Rituximab|rituximab|mesh-list
1910903|NCT00490529|Vaccines|vaccines|mesh-list
1910904|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
1910905|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910906|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1910907|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1910908|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1910909|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
1910910|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910911|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910912|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1910913|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1910914|NCT00490542|Ziprasidone|ziprasidone|mesh-list
1910915|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1910916|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
1910917|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1910918|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910919|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910920|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1910921|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1910922|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910923|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1910924|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1910925|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
1910926|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
1910927|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1910928|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
1910929|NCT00490555|Testosterone|testosterone|mesh-list
1910930|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
1910931|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
1910932|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1910933|NCT00490555|Dutasteride|dutasteride|mesh-list
1910934|NCT00490555|Androgens|androgens|mesh-ancestor
1910935|NCT00490555|Hormones|hormones|mesh-ancestor
1910936|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910937|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910938|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1910939|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910940|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
1910941|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1910942|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1910943|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910944|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910945|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
1910946|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1910947|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1910948|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1910949|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
1910950|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1910951|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1910952|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1910953|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1910954|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
1910955|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1910956|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910957|NCT00490646|Docetaxel|docetaxel|mesh-list
1910958|NCT00490646|Trastuzumab|trastuzumab|mesh-list
1910959|NCT00490646|Epothilones|epothilones|mesh-list
1910960|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1910961|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
1910962|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
1910963|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
1910964|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910965|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1910966|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
1910967|NCT00490698|Atorvastatin|atorvastatin|mesh-list
1910968|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1910969|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1910970|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
1910971|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1910972|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1910973|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1910974|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1910975|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1910976|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910977|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1910978|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
1910979|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910980|NCT00490802|Oxytocin|oxytocin|mesh-list
1910981|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
1910982|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1910983|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910984|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1910985|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1910986|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
1910987|NCT00490815|Hormones|hormones|mesh-ancestor
1910988|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1910989|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910990|NCT00490919|Buprenorphine|buprenorphine|mesh-list
1910991|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1910992|NCT00490919|Narcotics|narcotics|mesh-ancestor
1910993|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1910994|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1910995|NCT00490919|Analgesics|analgesics|mesh-ancestor
1910996|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
1910997|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1910998|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1910999|NCT00490971|Olanzapine|olanzapine|mesh-list
1911000|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1911001|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
1911002|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
1911003|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911004|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911005|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1911006|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1911007|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1911008|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1911009|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1911010|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1911011|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1911012|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911013|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911014|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911015|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
1911016|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1911017|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1911018|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1911019|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1911020|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
1911021|NCT00491075|Gemcitabine|gemcitabine|mesh-list
1911022|NCT00491075|Pemetrexed|pemetrexed|mesh-list
1911023|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911024|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
1911025|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911026|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911027|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
1911028|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911029|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911030|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911031|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
1911032|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911033|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1911034|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1911035|NCT00491179|Interferons|interferons|mesh-list
1911036|NCT00491179|Ribavirin|ribavirin|mesh-list
1911037|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
1911038|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
1911039|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1911040|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911041|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
1911042|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911043|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
1911044|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911045|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
1911046|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911047|NCT00491244|Interferons|interferons|mesh-list
1911048|NCT00491244|Ribavirin|ribavirin|mesh-list
1911049|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
1911050|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
1911051|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1911052|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911053|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
1911054|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911055|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
1911056|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911057|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
1911058|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911059|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
1911060|NCT00491322|Vitamin D|vitamin d|mesh-list
1911061|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1911062|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911063|NCT00491322|Vitamins|vitamins|mesh-ancestor
1911064|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
1911065|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1911066|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
1911067|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911068|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
1911069|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1911070|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
1911071|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911072|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
1911073|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1911074|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
1911075|NCT00491530|Atorvastatin|atorvastatin|mesh-list
1911076|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1911077|NCT00491530|Simvastatin|simvastatin|mesh-list
1911078|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
1911079|NCT00491530|Calcium|calcium|mesh-list
1911080|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1911081|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911082|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1911083|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1911084|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1911085|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
1911086|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911087|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1911088|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1911089|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911090|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1911091|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
1911092|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911093|NCT00491738|Bevacizumab|bevacizumab|mesh-list
1911094|NCT00491738|Sunitinib|sunitinib|mesh-list
1911095|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911096|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911097|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1911098|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1911099|NCT00491738|Growth Substances|growth substances|mesh-ancestor
1911100|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911101|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
1911102|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911103|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911104|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911105|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
1911106|NCT00491751|Atorvastatin|atorvastatin|mesh-list
1911107|NCT00491751|Vitamins|vitamins|mesh-ancestor
1911108|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
1911109|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911110|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1911111|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1911112|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
1911113|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911114|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1911115|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1911116|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911117|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
1911118|NCT00491751|Protective Agents|protective agents|mesh-ancestor
1911119|NCT00491764|Posaconazole|posaconazole|mesh-list
1911120|NCT00491764|Terbinafine|terbinafine|mesh-list
1911121|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
1911122|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911123|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1911124|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1911125|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1911126|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1911127|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1911128|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911129|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911130|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1911131|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
1911132|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911133|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911134|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
1911135|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1911136|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1911137|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1911138|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
1911139|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911140|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911141|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911142|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
1911143|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1911144|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911145|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911146|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1911147|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1911148|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911149|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911150|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911151|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1911152|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
1911153|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1911154|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911155|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1911156|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1911157|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1911158|NCT00492063|Vaccines|vaccines|mesh-list
1911159|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
1911160|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911161|NCT00492089|Bevacizumab|bevacizumab|mesh-list
1911162|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1911163|NCT00492089|Antibodies|antibodies|mesh-list
1911164|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
1911165|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1911166|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911167|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1911168|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1911169|NCT00492089|Growth Substances|growth substances|mesh-ancestor
1911170|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911171|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
1911172|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
1911173|NCT00492206|Cetuximab|cetuximab|mesh-list
1911174|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911175|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911176|NCT00492232|Zolpidem|zolpidem|mesh-list
1911177|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1911178|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1911179|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1911180|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911181|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1911182|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
1911183|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
1911184|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911185|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911186|NCT00492284|Dexamethasone|dexamethasone|mesh-list
1911187|NCT00492284|Ranibizumab|ranibizumab|mesh-list
1911188|NCT00492284|Verteporfin|verteporfin|mesh-list
1911189|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911190|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
1911191|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
1911192|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911193|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911194|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1911195|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
1911196|NCT00492284|Hormones|hormones|mesh-ancestor
1911197|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911198|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1911199|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911200|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1911201|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1911202|NCT00492284|Growth Substances|growth substances|mesh-ancestor
1911203|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
1911204|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1911205|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
1911206|NCT00492297|Sorafenib|sorafenib|mesh-list
1911207|NCT00492297|Dacarbazine|dacarbazine|mesh-list
1911208|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911209|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911210|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911211|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911212|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1911213|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
1911214|NCT00492336|Rasagiline|rasagiline|mesh-list
1911215|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1911216|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911217|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911218|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1911219|NCT00492336|Protective Agents|protective agents|mesh-ancestor
1911220|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911228|NCT00492401|Decitabine|decitabine|mesh-list
1911229|NCT00492401|Azacitidine|azacitidine|mesh-list
1911230|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911231|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
1911232|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911233|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911234|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911235|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
1911236|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
1911237|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
1911238|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1911239|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911240|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911241|NCT00492531|Urological Agents|urological agents|mesh-ancestor
1911242|NCT00492544|Vaccines|vaccines|mesh-list
1911243|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
1911244|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911245|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1911246|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
1911247|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911248|NCT00492622|Omeprazole|omeprazole|mesh-list
1911249|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1911250|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1911251|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1911252|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911253|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911254|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
1911255|NCT00492726|Ertapenem|ertapenem|mesh-list
1911256|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1911257|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911258|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911259|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1911260|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1911261|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911262|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911263|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911264|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1911265|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
1911266|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1911267|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911268|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1911269|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1911270|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1911271|NCT00492752|Sorafenib|sorafenib|mesh-list
1911272|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911273|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911274|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911275|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911276|NCT00492856|Methotrexate|methotrexate|mesh-list
1911277|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
1911278|NCT00492856|Tretinoin|tretinoin|mesh-list
1911279|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1911280|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
1911281|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1911282|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911283|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911284|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
1911285|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911286|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911287|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
1911288|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911289|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1911290|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911291|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
1911292|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911293|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1911294|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
1911295|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
1911296|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911297|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
1911298|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911299|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911300|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1911301|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
1911302|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911303|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911304|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1911305|NCT00492973|Cefuroxime|cefuroxime|mesh-list
1911306|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
1911307|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1911308|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1911309|NCT00492973|Prednisolone|prednisolone|mesh-list
1911310|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
1911311|NCT00492973|Clonidine|clonidine|mesh-list
1911312|NCT00492973|Epinephrine|epinephrine|mesh-list
1911313|NCT00492973|Morphine|morphine|mesh-list
1911314|NCT00492973|Bupivacaine|bupivacaine|mesh-list
1911315|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1911316|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
1911317|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
1911318|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
1911319|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1911320|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911321|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
1911322|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911323|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1911324|NCT00492973|Narcotics|narcotics|mesh-ancestor
1911325|NCT00492973|Analgesics|analgesics|mesh-ancestor
1911326|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911327|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
1911328|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
1911329|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1911330|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
1911331|NCT00492973|Hormones|hormones|mesh-ancestor
1911332|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911333|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1911334|NCT00492973|Protective Agents|protective agents|mesh-ancestor
1911335|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1911336|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911337|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1911338|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1911339|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
1911340|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911341|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911342|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1911343|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1911344|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1911345|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
1911346|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
1911347|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
1911348|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1911349|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1911350|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
1911351|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1911352|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911353|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911354|NCT00493012|Vitamin D|vitamin d|mesh-list
1911355|NCT00493012|Vitamins|vitamins|mesh-ancestor
1911356|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
1911357|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911358|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1911359|NCT00493038|Amoxicillin|amoxicillin|mesh-list
1911360|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
1911361|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
1911362|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
1911363|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1911364|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1911365|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911366|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911367|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1911368|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1911369|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911370|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911371|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911372|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1911373|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
1911374|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1911375|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911376|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1911377|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1911378|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1911379|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1911380|NCT00493064|Niacin|niacin|mesh-list
1911381|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
1911382|NCT00493064|Niacinamide|niacinamide|mesh-list
1911383|NCT00493064|Prednisolone|prednisolone|mesh-list
1911384|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1911385|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
1911386|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1911387|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
1911388|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1911389|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
1911390|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911391|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
1911392|NCT00493064|Hormones|hormones|mesh-ancestor
1911393|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911394|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911395|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1911396|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911397|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
1911398|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
1911399|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911400|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1911401|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1911402|NCT00493064|Protective Agents|protective agents|mesh-ancestor
1911403|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1911404|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
1911405|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911406|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1911407|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
1911408|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
1911409|NCT00493064|Vitamins|vitamins|mesh-ancestor
1911410|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
1911411|NCT00493181|Oprelvekin|oprelvekin|mesh-list
1911412|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911413|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
1911414|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911415|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911416|NCT00493246|Acetaminophen|acetaminophen|mesh-list
1911417|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1911418|NCT00493246|Analgesics|analgesics|mesh-ancestor
1911419|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
1911420|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911421|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911422|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
1911423|NCT00493311|Acetaminophen|acetaminophen|mesh-list
1911424|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1911425|NCT00493311|Analgesics|analgesics|mesh-ancestor
1911426|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
1911427|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911428|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911429|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
1911430|NCT00493454|Rituximab|rituximab|mesh-list
1911431|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1911432|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911433|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911434|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
1911435|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911436|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911437|NCT00493467|Rituximab|rituximab|mesh-list
1911438|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911439|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911440|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
1911441|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911442|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911443|NCT00493636|Gemcitabine|gemcitabine|mesh-list
1911444|NCT00493636|Capecitabine|capecitabine|mesh-list
1911445|NCT00493636|Sorafenib|sorafenib|mesh-list
1911446|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911447|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
1911448|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911449|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911450|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
1911451|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911452|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911453|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911454|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
1911455|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911456|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911457|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
1911458|NCT00493649|Docetaxel|docetaxel|mesh-list
1911459|NCT00493649|Trastuzumab|trastuzumab|mesh-list
1911460|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911461|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
1911462|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911463|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911464|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1911465|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
1911466|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911467|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911468|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1911469|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
1911470|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
1911471|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
1911472|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911473|NCT00493805|Interferons|interferons|mesh-list
1911474|NCT00493805|Ribavirin|ribavirin|mesh-list
1911475|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
1911476|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
1911477|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1911478|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911479|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
1911480|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911481|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
1911482|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911483|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
1911484|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911485|NCT00493974|Zileuton|zileuton|mesh-list
1911486|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1911487|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1911488|NCT00493974|Analgesics|analgesics|mesh-ancestor
1911489|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
1911490|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911491|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911492|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911493|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911494|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1911495|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911496|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911497|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1911498|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
1911499|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911500|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
1911501|NCT00494013|Protamines|protamines|mesh-list
1911502|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1911503|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911504|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
1911505|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911506|NCT00494013|Coagulants|coagulants|mesh-ancestor
1911507|NCT00494026|Carboplatin|carboplatin|mesh-list
1911508|NCT00494026|Pemetrexed|pemetrexed|mesh-list
1911509|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911510|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911511|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911512|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1911513|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1911514|NCT00494091|Sirolimus|sirolimus|mesh-list
1911515|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911516|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911517|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1911518|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911519|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
1911520|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911521|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
1911522|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911523|NCT00494221|Leucovorin|leucovorin|mesh-list
1911524|NCT00494221|Fluorouracil|fluorouracil|mesh-list
1911525|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
1911526|NCT00494221|Cediranib|cediranib|mesh-list
1911527|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
1911528|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
1911529|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911530|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911531|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911532|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911533|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
1911534|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911535|NCT00494221|Antidotes|antidotes|mesh-ancestor
1911536|NCT00494221|Protective Agents|protective agents|mesh-ancestor
1911537|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
1911538|NCT00494221|Vitamins|vitamins|mesh-ancestor
1911539|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
1911540|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911541|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911542|NCT00494234|Olaparib|olaparib|mesh-list
1911543|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1911544|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911545|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911546|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911547|NCT00494299|Sorafenib|sorafenib|mesh-list
1911548|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911549|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911550|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911551|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911552|NCT00494442|Olaparib|olaparib|mesh-list
1911553|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1911554|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911555|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911556|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911557|NCT00494481|Docetaxel|docetaxel|mesh-list
1911558|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911559|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
1911560|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
1911561|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
1911562|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911563|NCT00494494|Nepafenac|nepafenac|mesh-list
1911564|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1911565|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1911566|NCT00494494|Analgesics|analgesics|mesh-ancestor
1911567|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
1911568|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911569|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911570|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911571|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911572|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
1911573|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1911574|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911575|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911576|NCT00494676|Methamphetamine|methamphetamine|mesh-list
1911577|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1911578|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911579|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
1911580|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
1911581|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911582|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
1911583|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911584|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911585|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
1911586|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1911587|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1911588|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911589|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1911590|NCT00494780|Prednisone|prednisone|mesh-list
1911591|NCT00494780|Prednisolone|prednisolone|mesh-list
1911592|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
1911593|NCT00494780|Doxorubicin|doxorubicin|mesh-list
1911594|NCT00494780|Vincristine|vincristine|mesh-list
1911595|NCT00494780|Ofatumumab|ofatumumab|mesh-list
1911596|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911597|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
1911598|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911599|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911600|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1911601|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
1911602|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911603|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911604|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1911605|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1911606|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1911607|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1911608|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911609|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911610|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
1911611|NCT00494780|Hormones|hormones|mesh-ancestor
1911612|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911613|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1911614|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1911615|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
1911616|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
1911617|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
1911618|NCT00494871|Warfarin|warfarin|mesh-list
1911619|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
1911620|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
1911621|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1911622|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
1911623|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1911624|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
1911625|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911626|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911627|NCT00495079|Vincristine|vincristine|mesh-list
1911628|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1911629|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911630|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
1911631|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
1911632|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
1911633|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911634|NCT00495131|Interferons|interferons|mesh-list
1911635|NCT00495131|Ribavirin|ribavirin|mesh-list
1911636|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
1911637|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
1911638|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1911639|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911640|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
1911641|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911642|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
1911643|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911644|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
1911645|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911646|NCT00495170|Paclitaxel|paclitaxel|mesh-list
1911647|NCT00495170|Carboplatin|carboplatin|mesh-list
1911648|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1911649|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911650|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
1911651|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
1911652|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
1911653|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911654|NCT00495391|Ribavirin|ribavirin|mesh-list
1911655|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1911656|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
1911657|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
1911658|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911659|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
1911660|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911661|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1911662|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
1911663|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
1911664|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911665|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911666|NCT00495586|Amoxicillin|amoxicillin|mesh-list
1911667|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
1911668|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
1911669|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1911670|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911671|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911672|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911673|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1911674|NCT00495612|Omalizumab|omalizumab|mesh-list
1911675|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1911676|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1911677|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
1911678|NCT00495625|Sunitinib|sunitinib|mesh-list
1911679|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911680|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1911681|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1911682|NCT00495625|Growth Substances|growth substances|mesh-ancestor
1911683|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911684|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
1911685|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911686|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911687|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911688|NCT00495677|PF 232798|pf 232798|mesh-list
1911689|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1911690|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911691|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1911692|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1911693|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
1911694|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911695|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
1911696|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911697|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911698|NCT00495820|Methylphenidate|methylphenidate|mesh-list
1911699|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1911700|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911701|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1911702|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1911703|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911704|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911705|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
1911706|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911707|NCT00496015|Acetaminophen|acetaminophen|mesh-list
1911708|NCT00496015|Vaccines|vaccines|mesh-list
1911709|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1911710|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
1911711|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911712|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1911713|NCT00496015|Analgesics|analgesics|mesh-ancestor
1911714|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
1911715|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911716|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
1911717|NCT00496054|Vaccines|vaccines|mesh-list
1911718|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
1911719|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911720|NCT00496197|Fluconazole|fluconazole|mesh-list
1911721|NCT00496197|Voriconazole|voriconazole|mesh-list
1911722|NCT00496197|Anidulafungin|anidulafungin|mesh-list
1911723|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
1911724|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911725|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1911726|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1911727|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911728|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911729|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1911730|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
1911731|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911732|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911733|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1911734|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1911735|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1911736|NCT00496340|Rituximab|rituximab|mesh-list
1911737|NCT00496340|Busulfan|busulfan|mesh-list
1911738|NCT00496340|Pentostatin|pentostatin|mesh-list
1911739|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911740|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911741|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
1911742|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911743|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911744|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
1911745|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911746|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911747|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1911748|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1911749|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1911750|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911751|NCT00496366|Capecitabine|capecitabine|mesh-list
1911752|NCT00496366|Lapatinib|lapatinib|mesh-list
1911753|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911754|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
1911755|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911756|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911757|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1911758|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911759|NCT00496379|Epothilones|epothilones|mesh-list
1911760|NCT00496379|Sagopilone|sagopilone|mesh-list
1911761|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
1911762|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
1911763|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
1911764|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911765|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911766|NCT00496470|Budesonide|budesonide|mesh-list
1911767|NCT00496470|Bromides|bromides|mesh-list
1911768|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
1911769|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
1911770|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1911771|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911772|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1911773|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
1911774|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911775|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911776|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1911777|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
1911778|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
1911779|NCT00496470|Hormones|hormones|mesh-ancestor
1911780|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1911781|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1911782|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1911783|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1911784|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
1911785|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911786|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911787|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
1911788|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1911789|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
1911790|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
1911791|NCT00496483|Tacrolimus|tacrolimus|mesh-list
1911792|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911793|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
1911794|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911795|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1911796|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911797|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911798|NCT00496587|Gemcitabine|gemcitabine|mesh-list
1911799|NCT00496587|Bevacizumab|bevacizumab|mesh-list
1911800|NCT00496587|Capecitabine|capecitabine|mesh-list
1911801|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911802|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911803|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1911804|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1911805|NCT00496587|Growth Substances|growth substances|mesh-ancestor
1911806|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911807|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
1911808|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1911809|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
1911810|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911811|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
1911812|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911813|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911814|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911815|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
1911816|NCT00496730|Atorvastatin|atorvastatin|mesh-list
1911817|NCT00496730|Simvastatin|simvastatin|mesh-list
1911818|NCT00496730|Ezetimibe|ezetimibe|mesh-list
1911819|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1911820|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1911821|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
1911822|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911823|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1911824|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1911825|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911826|NCT00496769|Aspirin|aspirin|mesh-list
1911827|NCT00496769|Apixaban|apixaban|mesh-list
1911828|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1911829|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1911830|NCT00496769|Analgesics|analgesics|mesh-ancestor
1911831|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
1911832|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911833|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911834|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1911835|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911836|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1911837|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1911838|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911839|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1911840|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1911841|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911842|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
1911843|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1911844|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
1911845|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1911846|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
1911847|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
1911848|NCT00496808|Trastuzumab|trastuzumab|mesh-list
1911849|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911850|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911851|NCT00496834|Losartan|losartan|mesh-list
1911852|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1911853|NCT00496834|Carvedilol|carvedilol|mesh-list
1911854|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1911855|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1911856|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1911857|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1911858|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911859|NCT00496834|Diuretics|diuretics|mesh-ancestor
1911860|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
1911861|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911862|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1911863|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911864|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1911865|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1911866|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
1911867|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911868|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
1911869|NCT00496834|Protective Agents|protective agents|mesh-ancestor
1911870|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1911871|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1911872|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
1911873|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1911874|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1911875|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
1911876|NCT00496873|Rituximab|rituximab|mesh-list
1911877|NCT00496873|Pentostatin|pentostatin|mesh-list
1911878|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1911879|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
1911880|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911881|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911882|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1911883|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
1911884|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911885|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911886|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1911887|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911888|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1911889|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911890|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
1911891|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1911892|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1911893|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1911894|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911895|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911896|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
1911897|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911898|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911899|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1911900|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1911901|NCT00497055|Aripiprazole|aripiprazole|mesh-list
1911902|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
1911903|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1911904|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1911905|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1911906|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1911907|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911908|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
1911909|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
1911910|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911911|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911912|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1911913|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1911914|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
1911915|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1911916|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1911917|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1911918|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1911919|NCT00497081|Mirtazapine|mirtazapine|mesh-list
1911920|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
1911921|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1911922|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1911923|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
1911924|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
1911925|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911926|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911927|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911928|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1911929|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1911930|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1911931|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1911932|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1911933|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1911934|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
1911935|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1911936|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1911937|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
1911938|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1911939|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
1911940|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1911941|NCT00497770|Pemetrexed|pemetrexed|mesh-list
1911942|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911943|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911944|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911945|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1911946|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1911947|NCT00497796|Ganciclovir|ganciclovir|mesh-list
1911948|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1911949|NCT00497796|Maribavir|maribavir|mesh-list
1911950|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
1911951|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1911952|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1911953|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1911954|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911955|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1911956|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1911957|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1911958|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911959|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911960|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
1911961|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911962|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911963|NCT00498186|Rotigotine|rotigotine|mesh-list
1911964|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
1911965|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
1911966|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1911967|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911968|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911969|NCT00498355|Ranibizumab|ranibizumab|mesh-list
1911970|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1911971|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1911972|NCT00498355|Growth Substances|growth substances|mesh-ancestor
1911973|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911974|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
1911975|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911976|NCT00498368|Rituximab|rituximab|mesh-list
1911977|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
1911978|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1911979|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1911980|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
1911981|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911982|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1911983|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1911984|NCT00498433|Amlodipine|amlodipine|mesh-list
1911985|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1911986|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1911987|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1911988|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1911989|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1911990|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911991|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
1911992|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
1911993|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1911994|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1911995|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
1911996|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
1911997|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1911998|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1911999|NCT00498550|Clozapine|clozapine|mesh-list
1912000|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1912001|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
1912002|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912003|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912004|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912005|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1912006|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1912007|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912008|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1912009|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
1912010|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
1912011|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
1912012|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1912013|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
1912014|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912015|NCT00498615|Fasudil|fasudil|mesh-list
1912016|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1912017|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912018|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912019|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1912020|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912021|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
1912022|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912023|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912024|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1912025|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
1912026|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1912027|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1912028|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1912029|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912030|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912031|NCT00498797|Prednisolone|prednisolone|mesh-list
1912032|NCT00498797|Docetaxel|docetaxel|mesh-list
1912033|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912034|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912035|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912036|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912037|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912038|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912039|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
1912040|NCT00498797|Hormones|hormones|mesh-ancestor
1912041|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1912042|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912043|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1912044|NCT00498927|Temozolomide|temozolomide|mesh-list
1912045|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912046|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
1912047|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912048|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912049|NCT00499031|Cetuximab|cetuximab|mesh-list
1912050|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912051|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912052|NCT00499083|Tamoxifen|tamoxifen|mesh-list
1912053|NCT00499083|Paclitaxel|paclitaxel|mesh-list
1912054|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
1912055|NCT00499083|Doxorubicin|doxorubicin|mesh-list
1912056|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1912057|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1912058|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912059|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912060|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912061|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912062|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912063|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912064|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912065|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
1912066|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912067|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912068|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912069|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
1912070|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912071|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1912072|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912073|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912074|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912075|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1912076|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
1912077|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1912078|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1912079|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1912080|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1912081|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1912082|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1912083|NCT00499109|Gemcitabine|gemcitabine|mesh-list
1912084|NCT00499109|Carboplatin|carboplatin|mesh-list
1912085|NCT00499109|Docetaxel|docetaxel|mesh-list
1912086|NCT00499109|Vinorelbine|vinorelbine|mesh-list
1912087|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
1912088|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912089|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
1912090|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912091|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
1912092|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912093|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912094|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912095|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
1912096|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912097|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912098|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912099|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912100|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912101|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
1912102|NCT00499122|Docetaxel|docetaxel|mesh-list
1912103|NCT00499122|Doxorubicin|doxorubicin|mesh-list
1912104|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912105|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
1912106|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912107|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912108|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912109|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
1912110|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912111|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912112|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912113|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912114|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912115|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912116|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1912117|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912118|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912119|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912120|NCT00499252|Paclitaxel|paclitaxel|mesh-list
1912121|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1912122|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912123|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912124|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912125|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912126|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912127|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912128|NCT00499343|Rituximab|rituximab|mesh-list
1912129|NCT00499343|Etoposide|etoposide|mesh-list
1912130|NCT00499343|Ifosfamide|ifosfamide|mesh-list
1912131|NCT00499343|Sargramostim|sargramostim|mesh-list
1912132|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912133|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912134|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
1912135|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912136|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912137|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912138|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912139|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912140|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912141|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912142|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912143|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
1912144|NCT00499369|Leucovorin|leucovorin|mesh-list
1912145|NCT00499369|Bevacizumab|bevacizumab|mesh-list
1912146|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1912147|NCT00499369|Cetuximab|cetuximab|mesh-list
1912148|NCT00499369|Fluorouracil|fluorouracil|mesh-list
1912149|NCT00499369|Irinotecan|irinotecan|mesh-list
1912150|NCT00499369|Antibodies|antibodies|mesh-list
1912151|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
1912152|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1912153|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
1912154|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912155|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912156|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1912157|NCT00499369|Growth Substances|growth substances|mesh-ancestor
1912158|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912159|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
1912160|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
1912161|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
1912162|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912163|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912164|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912165|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1912166|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912167|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912168|NCT00499369|Antidotes|antidotes|mesh-ancestor
1912169|NCT00499369|Protective Agents|protective agents|mesh-ancestor
1912170|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
1912171|NCT00499369|Vitamins|vitamins|mesh-ancestor
1912172|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
1912173|NCT00499408|Vitamin D|vitamin d|mesh-list
1912174|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
1912175|NCT00499408|Vitamins|vitamins|mesh-ancestor
1912176|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
1912177|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912178|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1912179|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1912180|NCT00499460|Oxycodone|oxycodone|mesh-list
1912181|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1912182|NCT00499460|Narcotics|narcotics|mesh-ancestor
1912183|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912184|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912185|NCT00499460|Analgesics|analgesics|mesh-ancestor
1912186|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
1912187|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912188|NCT00499473|Sunitinib|sunitinib|mesh-list
1912189|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912190|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912191|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1912192|NCT00499473|Growth Substances|growth substances|mesh-ancestor
1912193|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912194|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
1912195|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912196|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912197|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912198|NCT00499486|Sirolimus|sirolimus|mesh-list
1912199|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1912200|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912201|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1912202|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912203|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
1912204|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912205|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
1912206|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912207|NCT00499603|Paclitaxel|paclitaxel|mesh-list
1912208|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
1912209|NCT00499603|Fluorouracil|fluorouracil|mesh-list
1912210|NCT00499603|Epirubicin|epirubicin|mesh-list
1912211|NCT00499603|Everolimus|everolimus|mesh-list
1912212|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912213|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912214|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912215|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912216|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912217|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912218|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912219|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
1912220|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912221|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912222|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912223|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
1912224|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912225|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
1912226|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912227|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1912228|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912229|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912230|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912231|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
1912232|NCT00499616|Carboplatin|carboplatin|mesh-list
1912233|NCT00499616|Doxorubicin|doxorubicin|mesh-list
1912234|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1912235|NCT00499616|Etoposide|etoposide|mesh-list
1912236|NCT00499616|Topotecan|topotecan|mesh-list
1912237|NCT00499616|Isotretinoin|isotretinoin|mesh-list
1912238|NCT00499616|Lenograstim|lenograstim|mesh-list
1912239|NCT00499616|Sargramostim|sargramostim|mesh-list
1912240|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912241|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
1912242|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912243|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912244|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912245|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
1912246|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912247|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912248|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912249|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1912250|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912251|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912252|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912253|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912254|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1912255|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1912256|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
1912257|NCT00499655|Celecoxib|celecoxib|mesh-list
1912258|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1912259|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912260|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912261|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912262|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912263|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1912264|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1912265|NCT00499655|Analgesics|analgesics|mesh-ancestor
1912266|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
1912267|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912268|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912269|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912270|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912271|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1912272|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1912273|NCT00499681|Letrozole|letrozole|mesh-list
1912274|NCT00499681|Lapatinib|lapatinib|mesh-list
1912275|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912276|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1912277|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1912278|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912279|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912280|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1912281|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
1912282|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1912283|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912284|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912285|NCT00499694|Bevacizumab|bevacizumab|mesh-list
1912286|NCT00499694|Satraplatin|satraplatin|mesh-list
1912287|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912288|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912289|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912290|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1912291|NCT00499694|Growth Substances|growth substances|mesh-ancestor
1912292|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912293|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
1912294|NCT00499746|Tramadol|tramadol|mesh-list
1912295|NCT00499746|Hydromorphone|hydromorphone|mesh-list
1912296|NCT00499746|Methylphenidate|methylphenidate|mesh-list
1912297|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1912298|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912299|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1912300|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1912301|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912302|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912303|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
1912304|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912305|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1912306|NCT00499746|Narcotics|narcotics|mesh-ancestor
1912307|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912308|NCT00499746|Analgesics|analgesics|mesh-ancestor
1912309|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
1912310|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912311|NCT00499863|Methylphenidate|methylphenidate|mesh-list
1912312|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1912313|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912314|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1912315|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1912316|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912317|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912318|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
1912319|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912320|NCT00499889|Vidarabine|vidarabine|mesh-list
1912321|NCT00499889|Methotrexate|methotrexate|mesh-list
1912322|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
1912323|NCT00499889|Fludarabine|fludarabine|mesh-list
1912324|NCT00499889|Busulfan|busulfan|mesh-list
1912325|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
1912326|NCT00499889|Tacrolimus|tacrolimus|mesh-list
1912327|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
1912328|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1912329|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1912330|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
1912331|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1912332|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912333|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912334|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
1912335|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912336|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912337|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
1912338|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912339|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1912340|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912341|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
1912342|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912343|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1912344|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
1912345|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912346|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1912347|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
1912348|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912349|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912350|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912351|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1912352|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1912353|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912354|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1912355|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1912356|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912357|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912358|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
1912359|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912360|NCT00500110|Docetaxel|docetaxel|mesh-list
1912361|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
1912362|NCT00500110|Leuprolide|leuprolide|mesh-list
1912363|NCT00500110|Goserelin|goserelin|mesh-list
1912364|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912365|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912366|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912367|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912368|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912369|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912370|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912371|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1912372|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
1912373|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1912374|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912375|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1912376|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1912377|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1912378|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912379|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1912380|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1912381|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912382|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912383|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
1912384|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912385|NCT00500240|Insulin|insulin|mesh-list
1912386|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1912387|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
1912388|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
1912389|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1912390|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912391|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1912392|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
1912393|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912394|NCT00500292|Leucovorin|leucovorin|mesh-list
1912395|NCT00500292|Folic Acid|folic acid|mesh-list
1912396|NCT00500292|Fluorouracil|fluorouracil|mesh-list
1912397|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
1912398|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
1912399|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
1912400|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912401|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912402|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912403|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912404|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
1912405|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912406|NCT00500292|Antidotes|antidotes|mesh-ancestor
1912407|NCT00500292|Protective Agents|protective agents|mesh-ancestor
1912408|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
1912409|NCT00500292|Vitamins|vitamins|mesh-ancestor
1912410|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
1912411|NCT00500292|Hematinics|hematinics|mesh-ancestor
1912412|NCT00500318|Bromides|bromides|mesh-list
1912413|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
1912414|NCT00500331|Pioglitazone|pioglitazone|mesh-list
1912415|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1912416|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912417|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1912418|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
1912419|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912420|NCT00500370|Exenatide|exenatide|mesh-list
1912421|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1912422|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912423|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1912424|NCT00500370|Incretins|incretins|mesh-ancestor
1912425|NCT00500370|Hormones|hormones|mesh-ancestor
1912426|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1912427|NCT00500539|Omalizumab|omalizumab|mesh-list
1912428|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1912429|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1912430|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
1912431|NCT00500578|Ribavirin|ribavirin|mesh-list
1912432|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
1912433|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912434|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
1912435|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912436|NCT00500656|Icatibant|icatibant|mesh-list
1912437|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
1912438|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1912439|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1912440|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912441|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
1912442|NCT00500656|Coagulants|coagulants|mesh-ancestor
1912443|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1912444|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1912445|NCT00500656|Analgesics|analgesics|mesh-ancestor
1912446|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
1912447|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912448|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912449|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912450|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912451|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1912452|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1912453|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1912454|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912455|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
1912456|NCT00500760|Panitumumab|panitumumab|mesh-list
1912457|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912458|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912459|NCT00501059|Aspirin|aspirin|mesh-list
1912460|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1912461|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1912462|NCT00501059|Analgesics|analgesics|mesh-ancestor
1912463|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
1912464|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912465|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912466|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912467|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912468|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1912469|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1912470|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912471|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1912472|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1912473|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912474|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
1912475|NCT00501293|Methylphenidate|methylphenidate|mesh-list
1912476|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1912477|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912478|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1912479|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1912480|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912481|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912482|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
1912483|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912484|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
1912485|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
1912486|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1912487|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912488|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912489|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
1912490|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1912491|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912492|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912493|NCT00501631|Naltrexone|naltrexone|mesh-list
1912494|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1912495|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1912496|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912497|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
1912498|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912499|NCT00501644|Interferons|interferons|mesh-list
1912500|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
1912501|NCT00501644|Carboplatin|carboplatin|mesh-list
1912502|NCT00501644|Molgramostim|molgramostim|mesh-list
1912503|NCT00501644|Sargramostim|sargramostim|mesh-list
1912504|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912505|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
1912506|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912507|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
1912508|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912509|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
1912510|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
1912511|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1912512|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
1912513|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912514|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912515|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1912516|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
1912517|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
1912518|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1912519|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
1912520|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912521|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912522|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1912523|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1912524|NCT00501891|Bevacizumab|bevacizumab|mesh-list
1912525|NCT00501891|Temozolomide|temozolomide|mesh-list
1912526|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912527|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912528|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912529|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1912530|NCT00501891|Growth Substances|growth substances|mesh-ancestor
1912531|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912532|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
1912533|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912534|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
1912535|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912536|NCT00501943|Interferons|interferons|mesh-list
1912537|NCT00501943|Interferon-beta|interferon-beta|mesh-list
1912538|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
1912539|NCT00501943|Riluzole|riluzole|mesh-list
1912540|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912541|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
1912542|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912543|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
1912544|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912545|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1912546|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
1912547|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1912548|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1912549|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912550|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912551|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1912552|NCT00501943|Protective Agents|protective agents|mesh-ancestor
1912553|NCT00501969|Rotigotine|rotigotine|mesh-list
1912554|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
1912555|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
1912556|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912557|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912558|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912559|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
1912560|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912561|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
1912562|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912563|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912564|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912565|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
1912566|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912567|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912568|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912569|NCT00502203|Paclitaxel|paclitaxel|mesh-list
1912570|NCT00502203|Carboplatin|carboplatin|mesh-list
1912571|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912572|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912573|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912574|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912575|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912576|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912577|NCT00502216|Naltrexone|naltrexone|mesh-list
1912578|NCT00502216|Varenicline|varenicline|mesh-list
1912579|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1912580|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1912581|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912582|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
1912583|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912584|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1912585|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1912586|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
1912587|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912588|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912589|NCT00502242|Ramipril|ramipril|mesh-list
1912590|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1912591|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
1912592|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912593|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912594|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1912595|NCT00502671|Capecitabine|capecitabine|mesh-list
1912596|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912597|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
1912598|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912599|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912600|NCT00502775|Fluticasone|fluticasone|mesh-list
1912601|NCT00502775|Xhance|xhance|mesh-list
1912602|NCT00502775|Fexofenadine|fexofenadine|mesh-list
1912603|NCT00502775|Terfenadine|terfenadine|mesh-list
1912604|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912605|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1912606|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
1912607|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912608|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912609|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1912610|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
1912611|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
1912612|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1912613|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1912614|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1912615|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
1912616|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
1912617|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912618|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912619|NCT00502801|Doripenem|doripenem|mesh-list
1912620|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1912621|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912622|NCT00502840|Rituximab|rituximab|mesh-list
1912623|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912624|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912625|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
1912626|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912627|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912628|NCT00502853|Rituximab|rituximab|mesh-list
1912629|NCT00502853|Methotrexate|methotrexate|mesh-list
1912630|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912631|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912632|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
1912633|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912634|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912635|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1912636|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
1912637|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1912638|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912639|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
1912640|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912641|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
1912642|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912643|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1912644|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912645|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1912646|NCT00502905|Vidarabine|vidarabine|mesh-list
1912647|NCT00502905|Fludarabine|fludarabine|mesh-list
1912648|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
1912649|NCT00502905|Busulfan|busulfan|mesh-list
1912650|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912651|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912652|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
1912653|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912654|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912655|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
1912656|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912657|NCT00502905|Antiviral Agents|antiviral agents|mesh-ancestor
1912658|NCT00502905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912659|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
1912660|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912661|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1912662|NCT00502996|Rituximab|rituximab|mesh-list
1912663|NCT00502996|Methotrexate|methotrexate|mesh-list
1912664|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912665|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912666|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
1912667|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912668|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912669|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1912670|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
1912671|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1912672|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912673|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
1912674|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912675|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
1912676|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912677|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1912678|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912679|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1912680|NCT00503113|Alendronate|alendronate|mesh-list
1912681|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
1912682|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1912683|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912684|NCT00503139|Etanercept|etanercept|mesh-list
1912685|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1912686|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1912687|NCT00503139|Analgesics|analgesics|mesh-ancestor
1912688|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
1912689|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912690|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912691|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912692|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912693|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1912694|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912695|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
1912696|NCT00503399|Teriparatide|teriparatide|mesh-list
1912697|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
1912698|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1912699|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912853|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
1912700|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1912701|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1912702|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912703|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912704|NCT00503425|Rituximab|rituximab|mesh-list
1912705|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912706|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912707|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
1912708|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912709|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912710|NCT00503685|Cetuximab|cetuximab|mesh-list
1912711|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912712|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912713|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1912714|NCT00503750|Vinorelbine|vinorelbine|mesh-list
1912715|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912716|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912717|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912718|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912719|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912720|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912721|NCT00503776|Amifostine|amifostine|mesh-list
1912722|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1912723|NCT00503776|Protective Agents|protective agents|mesh-ancestor
1912724|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912725|NCT00503906|Gemcitabine|gemcitabine|mesh-list
1912726|NCT00503906|Paclitaxel|paclitaxel|mesh-list
1912727|NCT00503906|Bevacizumab|bevacizumab|mesh-list
1912728|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1912729|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912730|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912731|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912732|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912733|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912734|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912735|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912736|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912737|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1912738|NCT00503906|Growth Substances|growth substances|mesh-ancestor
1912739|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912740|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
1912741|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912742|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
1912743|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
1912744|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912745|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912746|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912747|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
1912748|NCT00503984|Prednisone|prednisone|mesh-list
1912749|NCT00503984|Docetaxel|docetaxel|mesh-list
1912750|NCT00503984|Azacitidine|azacitidine|mesh-list
1912751|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912752|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912753|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912754|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912755|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912756|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912757|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
1912758|NCT00503984|Hormones|hormones|mesh-ancestor
1912759|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1912760|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912761|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1912762|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912763|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
1912764|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912765|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
1912766|NCT00503997|Pemetrexed|pemetrexed|mesh-list
1912767|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912768|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912769|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912770|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1912771|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1912772|NCT00504023|Imiquimod|imiquimod|mesh-list
1912773|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1912774|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
1912775|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912776|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912777|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
1912778|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
1912779|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1912780|NCT00504075|Antibodies|antibodies|mesh-list
1912781|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
1912782|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1912783|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
1912784|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912785|NCT00504153|Dasatinib|dasatinib|mesh-list
1912786|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912787|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1912788|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912789|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912790|NCT00504166|Alendronate|alendronate|mesh-list
1912791|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1912792|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912793|NCT00504257|Bevacizumab|bevacizumab|mesh-list
1912794|NCT00504257|Docetaxel|docetaxel|mesh-list
1912795|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912796|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912797|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912798|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1912799|NCT00504257|Growth Substances|growth substances|mesh-ancestor
1912800|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912801|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
1912802|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912803|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912804|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912805|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912806|NCT00504348|Tacrolimus|tacrolimus|mesh-list
1912807|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912808|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
1912809|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912810|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1912811|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912812|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912813|NCT00504504|Rituximab|rituximab|mesh-list
1912814|NCT00504504|Doxorubicin|doxorubicin|mesh-list
1912815|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1912816|NCT00504504|Dacarbazine|dacarbazine|mesh-list
1912817|NCT00504504|Bleomycin|bleomycin|mesh-list
1912818|NCT00504504|Vinblastine|vinblastine|mesh-list
1912819|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912820|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912821|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
1912822|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912823|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912824|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1912825|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912826|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912827|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912828|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912829|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912830|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
1912831|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912832|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
1912833|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
1912834|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
1912835|NCT00504556|Warfarin|warfarin|mesh-list
1912836|NCT00504556|Edoxaban|edoxaban|mesh-list
1912837|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
1912838|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1912839|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
1912840|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1912841|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
1912842|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912843|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912844|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1912845|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
1912846|NCT00504582|Coagulants|coagulants|mesh-ancestor
1912847|NCT00504660|Celecoxib|celecoxib|mesh-list
1912848|NCT00504660|Capecitabine|capecitabine|mesh-list
1912849|NCT00504660|Thioguanine|thioguanine|mesh-list
1912850|NCT00504660|Temozolomide|temozolomide|mesh-list
1912851|NCT00504660|Lomustine|lomustine|mesh-list
1912852|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912854|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912855|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912856|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912857|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
1912858|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1912859|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1912860|NCT00504660|Analgesics|analgesics|mesh-ancestor
1912861|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
1912862|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912863|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912864|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912865|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912866|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1912867|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1912868|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912869|NCT00504725|Ketamine|ketamine|mesh-list
1912870|NCT00504725|Analgesics|analgesics|mesh-ancestor
1912871|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
1912872|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912873|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912874|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1912875|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1912876|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
1912877|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
1912878|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912879|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1912880|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1912881|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912882|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912883|NCT00504751|Dexamethasone|dexamethasone|mesh-list
1912884|NCT00504751|Rituximab|rituximab|mesh-list
1912885|NCT00504751|Etoposide|etoposide|mesh-list
1912886|NCT00504751|Bortezomib|bortezomib|mesh-list
1912887|NCT00504751|Ifosfamide|ifosfamide|mesh-list
1912888|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912889|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1912890|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
1912891|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
1912892|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912893|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912894|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1912895|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
1912896|NCT00504751|Hormones|hormones|mesh-ancestor
1912897|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1912898|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1912899|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912900|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
1912901|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912902|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1912903|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1912904|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1912905|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912906|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912907|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912908|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
1912909|NCT00504777|Rituximab|rituximab|mesh-list
1912910|NCT00504777|Methotrexate|methotrexate|mesh-list
1912911|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1912912|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912913|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
1912914|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912915|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912916|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1912917|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
1912918|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1912919|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1912920|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
1912921|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912922|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
1912923|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912924|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1912925|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912926|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1912927|NCT00504829|Atorvastatin|atorvastatin|mesh-list
1912928|NCT00504829|Fenofibrate|fenofibrate|mesh-list
1912929|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1912930|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1912931|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
1912932|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912933|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1912934|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1912935|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1912936|NCT00504881|Brivaracetam|brivaracetam|mesh-list
1912937|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
1912938|NCT00504894|Thiopental|thiopental|mesh-list
1912939|NCT00504894|Propofol|propofol|mesh-list
1912940|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1912941|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912942|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912943|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1912944|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
1912945|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
1912946|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
1912947|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
1912948|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
1912949|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912950|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912951|NCT00505375|Abatacept|abatacept|mesh-list
1912952|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1912953|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912954|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912955|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912956|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
1912957|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912958|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1912959|NCT00505414|Morphine|morphine|mesh-list
1912960|NCT00505414|Tapentadol|tapentadol|mesh-list
1912961|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1912962|NCT00505414|Narcotics|narcotics|mesh-ancestor
1912963|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1912964|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912965|NCT00505414|Analgesics|analgesics|mesh-ancestor
1912966|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
1912967|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912968|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1912969|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1912970|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1912971|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912972|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
1912973|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1912974|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
1912975|NCT00505635|Interferons|interferons|mesh-list
1912976|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
1912977|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
1912978|NCT00505635|Thalidomide|thalidomide|mesh-list
1912979|NCT00505635|Cisplatin|cisplatin|mesh-list
1912980|NCT00505635|Temozolomide|temozolomide|mesh-list
1912981|NCT00505635|Interleukin-2|interleukin-2|mesh-list
1912982|NCT00505635|Vinblastine|vinblastine|mesh-list
1912983|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1912984|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
1912985|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1912986|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1912987|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
1912988|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1912989|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
1912990|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1912991|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1912992|NCT00505635|Analgesics|analgesics|mesh-ancestor
1912993|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
1912994|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1912995|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1912996|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
1912997|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1912998|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1912999|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913000|NCT00505635|Growth Substances|growth substances|mesh-ancestor
1913001|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913002|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913003|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913004|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913005|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913006|NCT00505661|Letrozole|letrozole|mesh-list
1913007|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913008|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1913009|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1913010|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913011|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913012|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1913013|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
1913014|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913015|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913016|NCT00505687|Rotigotine|rotigotine|mesh-list
1913017|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
1913018|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
1913019|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913020|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913021|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913022|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1913023|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1913024|NCT00505752|Hormones|hormones|mesh-ancestor
1913025|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913026|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913027|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1913028|NCT00505778|Mesalamine|mesalamine|mesh-list
1913029|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1913030|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1913031|NCT00505778|Analgesics|analgesics|mesh-ancestor
1913032|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
1913033|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913034|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913035|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913036|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913037|NCT00505895|Vidarabine|vidarabine|mesh-list
1913038|NCT00505895|Rituximab|rituximab|mesh-list
1913039|NCT00505895|Fludarabine|fludarabine|mesh-list
1913040|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
1913041|NCT00505895|Melphalan|melphalan|mesh-list
1913042|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913043|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913044|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
1913045|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913046|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913047|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913048|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
1913049|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913050|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913051|NCT00505895|Antiviral Agents|antiviral agents|mesh-ancestor
1913052|NCT00505895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913053|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913054|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
1913055|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913056|NCT00505921|Cytarabine|cytarabine|mesh-list
1913057|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
1913058|NCT00505921|Melphalan|melphalan|mesh-list
1913059|NCT00505921|Carmustine|carmustine|mesh-list
1913060|NCT00505921|Fludarabine|fludarabine|mesh-list
1913061|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
1913062|NCT00505921|Etoposide|etoposide|mesh-list
1913063|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
1913064|NCT00505921|Molgramostim|molgramostim|mesh-list
1913065|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
1913066|NCT00505921|Lenograstim|lenograstim|mesh-list
1913067|NCT00505921|Sargramostim|sargramostim|mesh-list
1913068|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913069|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
1913070|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913071|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913072|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913073|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
1913074|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913075|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913076|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913077|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913078|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
1913079|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
1913080|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913156|NCT00506350|Vaccines|vaccines|mesh-list
1913081|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913082|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1913083|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1913084|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913085|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1913086|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913087|NCT00505934|Levetiracetam|levetiracetam|mesh-list
1913088|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
1913089|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
1913090|NCT00506129|Vidarabine|vidarabine|mesh-list
1913091|NCT00506129|Fludarabine|fludarabine|mesh-list
1913092|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
1913093|NCT00506129|Melphalan|melphalan|mesh-list
1913094|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
1913095|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1913096|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913097|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913098|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
1913099|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913100|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913101|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
1913102|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913103|NCT00506129|Antiviral Agents|antiviral agents|mesh-ancestor
1913104|NCT00506129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913105|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913106|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
1913107|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913108|NCT00506142|Vincristine|vincristine|mesh-list
1913109|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913110|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913111|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913112|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913113|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913114|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913115|NCT00506155|Bevacizumab|bevacizumab|mesh-list
1913116|NCT00506155|Cisplatin|cisplatin|mesh-list
1913117|NCT00506155|Doxorubicin|doxorubicin|mesh-list
1913118|NCT00506155|Methotrexate|methotrexate|mesh-list
1913119|NCT00506155|Vinblastine|vinblastine|mesh-list
1913120|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913121|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913122|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913123|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913124|NCT00506155|Growth Substances|growth substances|mesh-ancestor
1913125|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913126|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913127|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1913128|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1913129|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1913130|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913131|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913132|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1913133|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
1913134|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1913135|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913136|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
1913137|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
1913138|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1913139|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913140|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
1913141|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913142|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1913143|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913144|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913145|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913146|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913147|NCT00506285|Methylphenidate|methylphenidate|mesh-list
1913148|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1913149|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913150|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1913151|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913152|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913153|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913154|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
1913155|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913157|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
1913158|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913159|NCT00506389|Mirtazapine|mirtazapine|mesh-list
1913160|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
1913161|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1913162|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1913163|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
1913164|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
1913165|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913166|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913167|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913168|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1913169|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1913170|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1913171|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1913172|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1913173|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1913174|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
1913175|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1913176|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1913177|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
1913178|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1913179|NCT00506415|Rivastigmine|rivastigmine|mesh-list
1913180|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1913181|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913182|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913183|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913184|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913185|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913186|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1913187|NCT00506415|Protective Agents|protective agents|mesh-ancestor
1913188|NCT00506519|Antithrombins|antithrombins|mesh-list
1913189|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
1913190|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1913191|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
1913192|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913193|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913194|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
1913195|NCT00506597|Asparaginase|asparaginase|mesh-list
1913196|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913197|NCT00506662|Insulin|insulin|mesh-list
1913198|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1913199|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
1913200|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
1913201|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
1913202|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
1913203|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913204|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913205|NCT00506675|Atropine|atropine|mesh-list
1913206|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1913207|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1913208|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1913209|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
1913210|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913211|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913212|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1913213|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
1913214|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
1913215|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
1913216|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1913217|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1913218|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913219|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913220|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913221|NCT00506779|Paclitaxel|paclitaxel|mesh-list
1913222|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
1913223|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913224|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913225|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913226|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913227|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913228|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913229|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913230|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913231|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
1913232|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913233|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913234|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913235|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913236|NCT00506857|Vidarabine|vidarabine|mesh-list
1913237|NCT00506857|Fludarabine|fludarabine|mesh-list
1913238|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
1913239|NCT00506857|Busulfan|busulfan|mesh-list
1913240|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913241|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913242|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
1913243|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913244|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913245|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
1913246|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913247|NCT00506857|Antiviral Agents|antiviral agents|mesh-ancestor
1913248|NCT00506857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913249|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
1913250|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913251|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913252|NCT00506883|Colchicine|colchicine|mesh-list
1913253|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
1913254|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913255|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913256|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913257|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913258|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913259|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913260|NCT00506922|Methotrexate|methotrexate|mesh-list
1913261|NCT00506922|Pentostatin|pentostatin|mesh-list
1913262|NCT00506922|Tacrolimus|tacrolimus|mesh-list
1913263|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1913264|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
1913265|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1913266|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913267|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913268|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
1913269|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913270|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913271|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
1913272|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913273|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1913274|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913275|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
1913276|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913277|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1913278|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1913279|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1913280|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
1913281|NCT00506948|Sirolimus|sirolimus|mesh-list
1913282|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
1913283|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1913284|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1913285|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913286|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1913287|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
1913288|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1913289|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913290|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913291|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913292|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
1913293|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913294|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
1913295|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913296|NCT00507026|Diclofenac|diclofenac|mesh-list
1913297|NCT00507026|Ketorolac|ketorolac|mesh-list
1913298|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1913299|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1913300|NCT00507026|Analgesics|analgesics|mesh-ancestor
1913301|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
1913302|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913303|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913304|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913305|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913306|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1913307|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913308|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913309|NCT00507416|Thalidomide|thalidomide|mesh-list
1913310|NCT00507416|Dexamethasone|dexamethasone|mesh-list
1913311|NCT00507416|Prednisone|prednisone|mesh-list
1913312|NCT00507416|Bortezomib|bortezomib|mesh-list
1913313|NCT00507416|Melphalan|melphalan|mesh-list
1913314|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913315|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
1913316|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
1913317|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913318|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913319|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913320|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
1913321|NCT00507416|Hormones|hormones|mesh-ancestor
1913322|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913323|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1913324|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913325|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913326|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
1913327|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913328|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913329|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913330|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
1913331|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
1913332|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1913333|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913334|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913335|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913336|NCT00507416|Growth Substances|growth substances|mesh-ancestor
1913337|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913338|NCT00507429|Paclitaxel|paclitaxel|mesh-list
1913339|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
1913340|NCT00507429|Combretastatin|combretastatin|mesh-list
1913341|NCT00507429|Carboplatin|carboplatin|mesh-list
1913342|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913343|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913344|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913345|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913346|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913347|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913348|NCT00507442|Dexamethasone|dexamethasone|mesh-list
1913349|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
1913350|NCT00507442|Lenalidomide|lenalidomide|mesh-list
1913351|NCT00507442|Bortezomib|bortezomib|mesh-list
1913352|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913353|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
1913354|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913355|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913356|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913357|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
1913358|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913359|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913360|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913361|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913362|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
1913363|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
1913364|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913365|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913366|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
1913367|NCT00507442|Hormones|hormones|mesh-ancestor
1913368|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913369|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1913370|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913371|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913372|NCT00507442|Growth Substances|growth substances|mesh-ancestor
1913373|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913374|NCT00507455|Tamsulosin|tamsulosin|mesh-list
1913375|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
1913376|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1913377|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1913378|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1913379|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
1913380|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913381|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913382|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913383|NCT00507455|Urological Agents|urological agents|mesh-ancestor
1913384|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1913385|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1913386|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913387|NCT00507507|Tenofovir|tenofovir|mesh-list
1913388|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
1913389|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913390|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1913391|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1913392|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913393|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913394|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1913395|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1913396|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
1913397|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1913398|NCT00507689|Antibodies|antibodies|mesh-list
1913399|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
1913400|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913401|NCT00507728|Bupropion|bupropion|mesh-list
1913402|NCT00507728|Varenicline|varenicline|mesh-list
1913403|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1913404|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
1913405|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1913406|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1913407|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913408|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913409|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913410|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
1913411|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913412|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913413|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1913414|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1913415|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913416|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1913417|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1913418|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913419|NCT00507767|Dasatinib|dasatinib|mesh-list
1913420|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913421|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913422|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913423|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913424|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
1913425|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
1913426|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1913427|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1913428|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913429|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913430|NCT00507819|Urological Agents|urological agents|mesh-ancestor
1913431|NCT00508027|Simvastatin|simvastatin|mesh-list
1913432|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1913433|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1913434|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
1913435|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913436|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1913437|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1913438|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913439|NCT00508118|Nicardipine|nicardipine|mesh-list
1913440|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1913441|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1913442|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913443|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913444|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1913445|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913446|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
1913447|NCT00508144|Pemetrexed|pemetrexed|mesh-list
1913448|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913449|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913450|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913451|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1913452|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1913453|NCT00508157|Olanzapine|olanzapine|mesh-list
1913454|NCT00508157|Risperidone|risperidone|mesh-list
1913455|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1913456|NCT00508157|Aripiprazole|aripiprazole|mesh-list
1913457|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
1913458|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1913459|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
1913460|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913461|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913462|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913463|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1913464|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1913465|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1913466|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1913467|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
1913468|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
1913469|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
1913470|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913471|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913472|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1913473|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913474|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913475|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
1913476|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
1913477|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1913478|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1913479|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1913480|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1913481|NCT00508274|Capecitabine|capecitabine|mesh-list
1913482|NCT00508274|Lapatinib|lapatinib|mesh-list
1913483|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913484|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
1913485|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913486|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913487|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913488|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913489|NCT00508404|Panitumumab|panitumumab|mesh-list
1913490|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913491|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913492|NCT00508469|Timolol|timolol|mesh-list
1913493|NCT00508469|Travoprost|travoprost|mesh-list
1913494|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1913495|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1913496|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1913497|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1913498|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
1913499|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913500|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913501|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913502|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1913503|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1913504|NCT00508482|Lactulose|lactulose|mesh-list
1913505|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913506|NCT00508742|Vaccines|vaccines|mesh-list
1913507|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1913508|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
1913509|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913510|NCT00508924|Heparin|heparin|mesh-list
1913511|NCT00508924|Argatroban|argatroban|mesh-list
1913512|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
1913513|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1913514|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1913515|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913516|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
1913517|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1913518|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
1913519|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913520|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1913521|NCT00509002|Gefitinib|gefitinib|mesh-list
1913522|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913523|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913524|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913525|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913526|NCT00509028|Budesonide|budesonide|mesh-list
1913527|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913528|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1913529|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
1913530|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913531|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913532|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1913533|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
1913534|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
1913535|NCT00509028|Hormones|hormones|mesh-ancestor
1913536|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913537|NCT00509041|Dasatinib|dasatinib|mesh-list
1913538|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913539|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913540|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913541|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913542|NCT00509067|Olanzapine|olanzapine|mesh-list
1913543|NCT00509067|Risperidone|risperidone|mesh-list
1913544|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1913545|NCT00509067|Aripiprazole|aripiprazole|mesh-list
1913546|NCT00509067|Ziprasidone|ziprasidone|mesh-list
1913547|NCT00509067|Choline|choline|mesh-list
1913548|NCT00509067|Galantamine|galantamine|mesh-list
1913549|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1913550|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1913551|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
1913552|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913553|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913554|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913555|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1913556|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1913557|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1913558|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1913559|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1913560|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
1913561|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
1913562|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
1913563|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913564|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913565|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1913566|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913567|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913568|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
1913569|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
1913570|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1913571|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1913572|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1913573|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1913574|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
1913575|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1913576|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
1913577|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1913578|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
1913579|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1913580|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913581|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913582|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1913583|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
1913584|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913585|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913586|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913587|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913588|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
1913589|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1913590|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1913591|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913592|NCT00509197|Fluticasone|fluticasone|mesh-list
1913593|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913594|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1913595|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
1913596|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913597|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913598|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1913599|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
1913600|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
1913601|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1913602|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1913603|NCT00509236|Glipizide|glipizide|mesh-list
1913604|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913605|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913606|NCT00509236|Incretins|incretins|mesh-ancestor
1913607|NCT00509236|Hormones|hormones|mesh-ancestor
1913608|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913609|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1913610|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
1913611|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913612|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913613|NCT00509249|Aflibercept|aflibercept|mesh-list
1913614|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
1913615|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913616|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913617|NCT00509249|Growth Substances|growth substances|mesh-ancestor
1913618|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913619|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913620|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913621|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1913622|NCT00509262|Glipizide|glipizide|mesh-list
1913623|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913624|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913625|NCT00509262|Incretins|incretins|mesh-ancestor
1913626|NCT00509262|Hormones|hormones|mesh-ancestor
1913627|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913628|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1913629|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
1913630|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913631|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913632|NCT00509288|Aldesleukin|aldesleukin|mesh-list
1913633|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
1913634|NCT00509288|Fludarabine|fludarabine|mesh-list
1913635|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913636|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
1913637|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913638|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913639|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913640|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
1913641|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913642|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913643|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913644|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1913645|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1913646|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
1913647|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913648|NCT00509366|Gemcitabine|gemcitabine|mesh-list
1913649|NCT00509366|Cisplatin|cisplatin|mesh-list
1913650|NCT00509366|Docetaxel|docetaxel|mesh-list
1913651|NCT00509366|Pemetrexed|pemetrexed|mesh-list
1913652|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913653|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913654|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
1913655|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913656|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
1913657|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913658|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913659|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913660|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
1913661|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913662|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913663|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913664|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913665|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1913666|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1913667|NCT00509496|Aldesleukin|aldesleukin|mesh-list
1913668|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
1913669|NCT00509496|Fludarabine|fludarabine|mesh-list
1913670|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
1913671|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913672|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
1913673|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913674|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913675|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913676|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
1913677|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913678|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913679|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1913680|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913681|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
1913682|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1913683|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1913684|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
1913685|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913686|NCT00509665|Gemcitabine|gemcitabine|mesh-list
1913687|NCT00509665|Doxorubicin|doxorubicin|mesh-list
1913688|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1913689|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1913690|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
1913691|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913692|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913693|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
1913694|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913695|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913696|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913697|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
1913698|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913699|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1913700|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1913701|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1913702|NCT00509769|Trastuzumab|trastuzumab|mesh-list
1913703|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1913704|NCT00509769|Maytansine|maytansine|mesh-list
1913705|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913706|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913707|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913708|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913709|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913710|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913711|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913712|NCT00509795|Ranibizumab|ranibizumab|mesh-list
1913713|NCT00509795|Aflibercept|aflibercept|mesh-list
1913714|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913715|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913716|NCT00509795|Growth Substances|growth substances|mesh-ancestor
1913717|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913718|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913719|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913720|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
1913721|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1913722|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1913723|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1913724|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913725|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1913726|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1913727|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913728|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913729|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913730|NCT00509925|Insulin|insulin|mesh-list
1913731|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1913732|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
1913733|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
1913734|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
1913735|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
1913736|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
1913737|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913738|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913739|NCT00510068|Everolimus|everolimus|mesh-list
1913740|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913741|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1913742|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
1913743|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913744|NCT00510146|Olanzapine|olanzapine|mesh-list
1913745|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
1913746|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
1913747|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913748|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913749|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913750|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1913751|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1913752|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1913753|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1913754|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1913755|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913756|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913757|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913758|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913759|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
1913760|NCT00510224|Octreotide|octreotide|mesh-list
1913761|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913762|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1913763|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913764|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1913765|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1913766|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913767|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913768|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913769|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
1913770|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913771|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913772|NCT00510289|Sorafenib|sorafenib|mesh-list
1913773|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913774|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913775|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913776|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913777|NCT00510484|Pancrelipase|pancrelipase|mesh-list
1913778|NCT00510484|Pancreatin|pancreatin|mesh-list
1913779|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913780|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
1913781|NCT00510510|Bromides|bromides|mesh-list
1913782|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
1913783|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1913784|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1913785|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1913786|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913787|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913788|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913789|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913790|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
1913791|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913792|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1913793|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913794|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913795|NCT00510783|Phenytoin|phenytoin|mesh-list
1913796|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
1913797|NCT00510783|Levetiracetam|levetiracetam|mesh-list
1913798|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
1913799|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
1913800|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1913801|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1913802|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913803|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913804|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1913805|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1913806|NCT00510809|Ethanol|ethanol|mesh-list
1913807|NCT00510809|Policosanol|policosanol|mesh-list
1913808|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1913809|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1913810|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913811|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1913812|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913813|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1913814|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1913815|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
1913816|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913817|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913818|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1913819|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1913820|NCT00510887|Dexamethasone|dexamethasone|mesh-list
1913821|NCT00510887|Rituximab|rituximab|mesh-list
1913822|NCT00510887|Fludarabine|fludarabine|mesh-list
1913823|NCT00510887|Bortezomib|bortezomib|mesh-list
1913824|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
1913825|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913826|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
1913827|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
1913828|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913829|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913830|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913831|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
1913832|NCT00510887|Hormones|hormones|mesh-ancestor
1913833|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913834|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1913835|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913836|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913837|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
1913838|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1913839|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913840|NCT00510887|Analgesics|analgesics|mesh-ancestor
1913841|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
1913842|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1913843|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1913844|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913845|NCT00510952|Insulin|insulin|mesh-list
1913846|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1913847|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
1913848|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
1913849|NCT00510952|Protamines|protamines|mesh-list
1913850|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913851|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913852|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
1913853|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913854|NCT00510952|Coagulants|coagulants|mesh-ancestor
1913855|NCT00511004|Albendazole|albendazole|mesh-list
1913856|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
1913857|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
1913858|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1913859|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913860|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
1913861|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1913862|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1913863|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913864|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913865|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913866|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913867|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913868|NCT00511004|Filaricides|filaricides|mesh-ancestor
1913869|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
1913870|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1913871|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913872|NCT00511108|Pioglitazone|pioglitazone|mesh-list
1913873|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1913874|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913875|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913876|NCT00511108|Incretins|incretins|mesh-ancestor
1913877|NCT00511108|Hormones|hormones|mesh-ancestor
1913878|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913879|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1913880|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
1913881|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913882|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913883|NCT00511134|Eszopiclone|eszopiclone|mesh-list
1913884|NCT00511134|Bupropion|bupropion|mesh-list
1913885|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1913886|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
1913887|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1913888|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1913889|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1913890|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913891|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913892|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
1913893|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913894|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913895|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1913896|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1913897|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1913898|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1913899|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1913900|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
1913901|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1913902|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
1913903|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1913904|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
1913905|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913906|NCT00511173|Warfarin|warfarin|mesh-list
1913907|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
1913908|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
1913909|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1913910|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1913911|NCT00511355|Estradiol|estradiol|mesh-list
1913912|NCT00511355|Estrogens|estrogens|mesh-ancestor
1913913|NCT00511355|Hormones|hormones|mesh-ancestor
1913914|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913915|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913916|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1913917|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
1913918|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1913919|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1913920|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1913921|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1913922|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1913923|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1913924|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
1913925|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1913926|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913927|NCT00511706|Dexamethasone|dexamethasone|mesh-list
1913928|NCT00511706|Ranibizumab|ranibizumab|mesh-list
1913929|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1913930|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
1913931|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
1913932|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913933|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913934|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1913935|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
1913936|NCT00511706|Hormones|hormones|mesh-ancestor
1913937|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1913938|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1913939|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913940|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913941|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913942|NCT00511706|Growth Substances|growth substances|mesh-ancestor
1913943|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913944|NCT00511836|Naltrexone|naltrexone|mesh-list
1913945|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1913946|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1913947|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913948|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
1913949|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913950|NCT00511875|Doxycycline|doxycycline|mesh-list
1913951|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1913952|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1913953|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
1913954|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1913955|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1913956|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
1913957|NCT00511901|Hematinics|hematinics|mesh-ancestor
1913958|NCT00511992|Paclitaxel|paclitaxel|mesh-list
1913959|NCT00511992|Bevacizumab|bevacizumab|mesh-list
1913960|NCT00511992|Cisplatin|cisplatin|mesh-list
1913961|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913962|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913963|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913964|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913965|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913966|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913967|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1913968|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1913969|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1913970|NCT00511992|Growth Substances|growth substances|mesh-ancestor
1913971|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913972|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
1913973|NCT00512096|Paclitaxel|paclitaxel|mesh-list
1913974|NCT00512096|Cisplatin|cisplatin|mesh-list
1913975|NCT00512096|Ifosfamide|ifosfamide|mesh-list
1913976|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1913977|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1913978|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
1913979|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
1913980|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
1913981|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913982|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1913983|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
1913984|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
1913985|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1913986|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1913987|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1913988|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1913989|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1913990|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1913991|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
1913992|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1913993|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1913994|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1913995|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1913996|NCT00512252|Cytarabine|cytarabine|mesh-list
1913997|NCT00512252|Plerixafor|plerixafor|mesh-list
1913998|NCT00512252|Etoposide|etoposide|mesh-list
1913999|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
1914000|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914001|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914002|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1914003|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914004|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914005|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914006|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914007|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
1914008|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
1914009|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914010|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914011|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
1914012|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914013|NCT00512252|Analgesics|analgesics|mesh-ancestor
1914014|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
1914015|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914016|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1914017|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1914018|NCT00512278|Infliximab|infliximab|mesh-list
1914019|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914020|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1914021|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914022|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
1914023|NCT00512707|Testosterone|testosterone|mesh-list
1914024|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914025|NCT00512707|Androgens|androgens|mesh-ancestor
1914026|NCT00512707|Hormones|hormones|mesh-ancestor
1914027|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914028|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914029|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
1914030|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1914031|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1914032|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914033|NCT00512707|Urological Agents|urological agents|mesh-ancestor
1914034|NCT00512798|Temozolomide|temozolomide|mesh-list
1914035|NCT00512798|Bortezomib|bortezomib|mesh-list
1914036|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914037|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
1914038|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914039|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914040|NCT00512876|Bevacizumab|bevacizumab|mesh-list
1914041|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914042|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914043|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914044|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914045|NCT00512876|Growth Substances|growth substances|mesh-ancestor
1914046|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914047|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914048|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
1914049|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914050|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914051|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914052|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914053|NCT00513019|Lamotrigine|lamotrigine|mesh-list
1914054|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
1914055|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1914056|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914057|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914058|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1914059|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914060|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1914061|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914062|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914063|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914064|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1914065|NCT00513071|Saracatinib|saracatinib|mesh-list
1914066|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914067|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914068|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914069|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
1914070|NCT00513240|Hematinics|hematinics|mesh-ancestor
1914071|NCT00513292|Paclitaxel|paclitaxel|mesh-list
1914072|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
1914073|NCT00513292|Trastuzumab|trastuzumab|mesh-list
1914074|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1914075|NCT00513292|Epirubicin|epirubicin|mesh-list
1914076|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1914077|NCT00513292|Antibodies|antibodies|mesh-list
1914078|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
1914079|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1914080|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914081|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914082|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914083|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914084|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914085|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914086|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914087|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
1914088|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914089|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914090|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914091|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
1914092|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1914093|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1914094|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1914095|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914096|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914097|NCT00513305|Cytarabine|cytarabine|mesh-list
1914098|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
1914099|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914100|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
1914101|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914102|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914103|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
1914104|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914105|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914106|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
1914107|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914108|NCT00513357|Melatonin|melatonin|mesh-list
1914109|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
1914110|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914111|NCT00513357|Protective Agents|protective agents|mesh-ancestor
1914112|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914113|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914114|NCT00513370|Adalimumab|adalimumab|mesh-list
1914115|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914116|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914117|NCT00513435|Saracatinib|saracatinib|mesh-list
1914118|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914119|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914120|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914121|NCT00513474|Cyclosporine|cyclosporine|mesh-list
1914122|NCT00513474|Sirolimus|sirolimus|mesh-list
1914123|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
1914124|NCT00513474|Busulfan|busulfan|mesh-list
1914125|NCT00513474|Methotrexate|methotrexate|mesh-list
1914126|NCT00513474|Fludarabine|fludarabine|mesh-list
1914127|NCT00513474|Etoposide|etoposide|mesh-list
1914128|NCT00513474|Allopurinol|allopurinol|mesh-list
1914129|NCT00513474|Rasburicase|rasburicase|mesh-list
1914130|NCT00513474|Tacrolimus|tacrolimus|mesh-list
1914131|NCT00513474|Cyclosporins|cyclosporins|mesh-list
1914132|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914133|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
1914134|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914135|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914136|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914137|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
1914138|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914139|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914140|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1914141|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1914142|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
1914143|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1914144|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914145|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
1914146|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914147|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914148|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1914149|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1914150|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914151|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1914152|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914153|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1914154|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
1914155|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914156|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914157|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1914158|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
1914159|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1914160|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
1914161|NCT00513474|Protective Agents|protective agents|mesh-ancestor
1914162|NCT00513500|Amoxicillin|amoxicillin|mesh-list
1914163|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1914164|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914165|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914166|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
1914167|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1914168|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1914169|NCT00513526|Vaccines|vaccines|mesh-list
1914170|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
1914171|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914172|NCT00513604|Aldesleukin|aldesleukin|mesh-list
1914173|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
1914174|NCT00513604|Fludarabine|fludarabine|mesh-list
1914175|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
1914176|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914177|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
1914178|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914179|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914180|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914181|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
1914182|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914183|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914184|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1914185|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914186|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
1914187|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1914188|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1914189|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
1914190|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914191|NCT00513682|Pancrelipase|pancrelipase|mesh-list
1914192|NCT00513682|Pancreatin|pancreatin|mesh-list
1914193|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1914194|NCT00513695|Paclitaxel|paclitaxel|mesh-list
1914195|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
1914196|NCT00513695|Doxorubicin|doxorubicin|mesh-list
1914197|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1914198|NCT00513695|Sunitinib|sunitinib|mesh-list
1914199|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914200|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914201|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914202|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914203|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914204|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914205|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914206|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
1914207|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914208|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914209|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914210|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
1914211|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1914212|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1914213|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1914214|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914215|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914216|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914217|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914218|NCT00513695|Growth Substances|growth substances|mesh-ancestor
1914219|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914220|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914221|NCT00513747|Rituximab|rituximab|mesh-list
1914222|NCT00513747|Fludarabine|fludarabine|mesh-list
1914223|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
1914224|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914225|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914226|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
1914227|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914228|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914229|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914230|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
1914231|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914232|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914233|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
1914234|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1914235|NCT00513799|Mupirocin|mupirocin|mesh-list
1914236|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1914237|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914238|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
1914239|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914240|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914241|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1914242|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914243|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914244|NCT00514020|Leucovorin|leucovorin|mesh-list
1914245|NCT00514020|Fluorouracil|fluorouracil|mesh-list
1914246|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
1914247|NCT00514020|Calcium|calcium|mesh-list
1914248|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
1914249|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1914250|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914251|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
1914252|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914253|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914254|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914255|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914256|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
1914257|NCT00514020|Antidotes|antidotes|mesh-ancestor
1914258|NCT00514020|Protective Agents|protective agents|mesh-ancestor
1914259|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
1914260|NCT00514020|Vitamins|vitamins|mesh-ancestor
1914261|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
1914262|NCT00514137|Sunitinib|sunitinib|mesh-list
1914263|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914264|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914265|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914266|NCT00514137|Growth Substances|growth substances|mesh-ancestor
1914267|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914268|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914269|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914270|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914271|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914272|NCT00514215|Molgramostim|molgramostim|mesh-list
1914273|NCT00514215|Sargramostim|sargramostim|mesh-list
1914274|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
1914275|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914276|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914277|NCT00514449|Valacyclovir|valacyclovir|mesh-list
1914278|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
1914279|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914280|NCT00514514|Cyclosporine|cyclosporine|mesh-list
1914281|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
1914282|NCT00514514|Everolimus|everolimus|mesh-list
1914283|NCT00514514|Cyclosporins|cyclosporins|mesh-list
1914284|NCT00514514|Basiliximab|basiliximab|mesh-list
1914285|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914286|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914287|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914288|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
1914289|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914290|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
1914291|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914292|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914293|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914294|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1914295|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914296|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1914297|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1914298|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
1914299|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914300|NCT00514540|Carboplatin|carboplatin|mesh-list
1914301|NCT00514540|Docetaxel|docetaxel|mesh-list
1914302|NCT00514540|Etoposide|etoposide|mesh-list
1914303|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914304|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914305|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914306|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914307|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914308|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914309|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1914310|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914311|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914312|NCT00514683|Nintedanib|nintedanib|mesh-list
1914313|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914314|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914315|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914316|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914317|NCT00514709|Vaccines|vaccines|mesh-list
1914318|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
1914319|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914320|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1914321|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1914322|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
1914323|NCT00514852|Glycerol|glycerol|mesh-list
1914324|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1914325|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1914326|NCT00514852|Laxatives|laxatives|mesh-ancestor
1914327|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1914328|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1914329|NCT00514852|Protective Agents|protective agents|mesh-ancestor
1914330|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914331|NCT00514904|Vaccines|vaccines|mesh-list
1914332|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
1914333|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914334|NCT00514917|Docetaxel|docetaxel|mesh-list
1914335|NCT00514917|Leuprolide|leuprolide|mesh-list
1914336|NCT00514917|Bicalutamide|bicalutamide|mesh-list
1914337|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914338|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914339|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914340|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914341|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914342|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1914343|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
1914344|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1914345|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914346|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1914347|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
1914348|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
1914349|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914350|NCT00514943|Cetuximab|cetuximab|mesh-list
1914351|NCT00514943|Afatinib|afatinib|mesh-list
1914352|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914353|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914354|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914355|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914356|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914357|NCT00515021|Eplerenone|eplerenone|mesh-list
1914358|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1914359|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
1914360|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914361|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914362|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1914363|NCT00515021|Diuretics|diuretics|mesh-ancestor
1914364|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
1914365|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1914366|NCT00515034|Imipenem|imipenem|mesh-list
1914367|NCT00515034|Doripenem|doripenem|mesh-list
1914368|NCT00515034|Cilastatin|cilastatin|mesh-list
1914369|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914370|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914371|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
1914372|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914373|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914374|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
1914375|NCT00515073|Promethazine|promethazine|mesh-list
1914376|NCT00515073|Dexamethasone|dexamethasone|mesh-list
1914377|NCT00515073|Paclitaxel|paclitaxel|mesh-list
1914378|NCT00515073|Cimetidine|cimetidine|mesh-list
1914379|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914380|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914381|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914382|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914383|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914384|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914385|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914386|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
1914387|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
1914388|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914389|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914390|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1914391|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
1914392|NCT00515073|Hormones|hormones|mesh-ancestor
1914393|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914394|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1914395|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1914396|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1914397|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914398|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
1914399|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
1914400|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
1914401|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1914402|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
1914403|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
1914404|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914405|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1914406|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
1914407|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914408|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1914409|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1914410|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1914411|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1914412|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914413|NCT00515086|Everolimus|everolimus|mesh-list
1914414|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914415|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914416|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
1914417|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914418|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
1914419|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1914420|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
1914421|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914422|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914423|NCT00515177|Eszopiclone|eszopiclone|mesh-list
1914424|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1914425|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914426|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914427|NCT00515216|Leucovorin|leucovorin|mesh-list
1914428|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
1914429|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
1914430|NCT00515216|Fluorouracil|fluorouracil|mesh-list
1914431|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
1914432|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
1914433|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
1914434|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914435|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914436|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914437|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914438|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
1914439|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914440|NCT00515216|Antidotes|antidotes|mesh-ancestor
1914441|NCT00515216|Protective Agents|protective agents|mesh-ancestor
1914442|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
1914443|NCT00515216|Vitamins|vitamins|mesh-ancestor
1914444|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
1914445|NCT00515294|Caffeine|caffeine|mesh-list
1914446|NCT00515294|Methamphetamine|methamphetamine|mesh-list
1914447|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1914448|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914449|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1914450|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914451|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914452|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1914453|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1914454|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
1914455|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914456|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
1914457|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
1914458|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914459|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
1914460|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
1914461|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1914462|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1914463|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914464|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1914465|NCT00515411|Leucovorin|leucovorin|mesh-list
1914466|NCT00515411|Cisplatin|cisplatin|mesh-list
1914467|NCT00515411|Docetaxel|docetaxel|mesh-list
1914468|NCT00515411|Fluorouracil|fluorouracil|mesh-list
1914469|NCT00515411|Trastuzumab|trastuzumab|mesh-list
1914470|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914471|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914472|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914473|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914474|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914475|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
1914476|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914477|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914478|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
1914479|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914480|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914481|NCT00515411|Antidotes|antidotes|mesh-ancestor
1914482|NCT00515411|Protective Agents|protective agents|mesh-ancestor
1914483|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
1914484|NCT00515411|Vitamins|vitamins|mesh-ancestor
1914485|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
1914486|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
1914487|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
1914488|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1914489|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1914490|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1914491|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914492|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914493|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
1914494|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914495|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914496|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1914497|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914498|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1914499|NCT00515463|Denosumab|denosumab|mesh-list
1914500|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1914501|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914502|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
1914503|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1914504|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
1914505|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914506|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914507|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1914508|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
1914509|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
1914510|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1914511|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
1914512|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914513|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914514|NCT00515619|Lacosamide|lacosamide|mesh-list
1914515|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
1914516|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1914517|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1914518|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914519|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914520|NCT00515697|Ramucirumab|ramucirumab|mesh-list
1914521|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914522|NCT00515723|Olanzapine|olanzapine|mesh-list
1914523|NCT00515723|Risperidone|risperidone|mesh-list
1914524|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1914525|NCT00515723|Ziprasidone|ziprasidone|mesh-list
1914526|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1914527|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
1914528|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914529|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914530|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914531|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1914532|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914533|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914534|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914535|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1914536|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
1914537|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
1914538|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
1914539|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914540|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1914541|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1914542|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1914543|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914544|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
1914545|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
1914546|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1914547|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1914548|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
1914549|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914550|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1914551|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1914552|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914553|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914554|NCT00515879|Cycloserine|cycloserine|mesh-list
1914555|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1914556|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914557|NCT00515879|Renal Agents|renal agents|mesh-ancestor
1914558|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1914559|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
1914560|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914561|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
1914562|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914563|NCT00516048|Exenatide|exenatide|mesh-list
1914564|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1914565|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914566|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1914567|NCT00516048|Incretins|incretins|mesh-ancestor
1914568|NCT00516048|Hormones|hormones|mesh-ancestor
1914569|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914570|NCT00516074|Exenatide|exenatide|mesh-list
1914571|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1914572|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914573|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1914574|NCT00516074|Incretins|incretins|mesh-ancestor
1914575|NCT00516074|Hormones|hormones|mesh-ancestor
1914576|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914577|NCT00516139|Lamotrigine|lamotrigine|mesh-list
1914578|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
1914579|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1914580|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914581|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914582|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1914583|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914584|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1914585|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914586|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914587|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914588|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1914589|NCT00516165|Everolimus|everolimus|mesh-list
1914590|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914591|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914592|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
1914593|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914594|NCT00516217|Galiximab|galiximab|mesh-list
1914595|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914596|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914597|NCT00516269|Methylphenidate|methylphenidate|mesh-list
1914598|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1914599|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914600|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1914601|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1914602|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914603|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914604|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
1914605|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914606|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
1914607|NCT00516295|Bevacizumab|bevacizumab|mesh-list
1914608|NCT00516295|Vincristine|vincristine|mesh-list
1914609|NCT00516295|Topotecan|topotecan|mesh-list
1914610|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1914611|NCT00516295|Antibodies|antibodies|mesh-list
1914612|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
1914613|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1914614|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914615|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
1914616|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914617|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914618|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914619|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
1914620|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914621|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914622|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1914623|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914624|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914625|NCT00516295|Growth Substances|growth substances|mesh-ancestor
1914626|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914627|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914628|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914629|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914630|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914631|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1914632|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914633|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914634|NCT00516386|Mecasermin|mecasermin|mesh-list
1914635|NCT00516386|Growth Substances|growth substances|mesh-ancestor
1914636|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914637|NCT00516503|Ketamine|ketamine|mesh-list
1914638|NCT00516503|Amitriptyline|amitriptyline|mesh-list
1914639|NCT00516503|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1914640|NCT00516503|Baclofen|baclofen|mesh-list
1914641|NCT00516503|Analgesics|analgesics|mesh-ancestor
1914642|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
1914643|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914644|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914645|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1914646|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1914647|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
1914648|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
1914649|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914650|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1914651|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1914652|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914653|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914654|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1914655|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1914656|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1914657|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
1914658|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
1914659|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1914660|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
1914661|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914662|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1914663|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1914664|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1914665|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914666|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
1914667|NCT00516503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1914668|NCT00516503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914669|NCT00516737|Rizatriptan|rizatriptan|mesh-list
1914670|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1914671|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
1914672|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914673|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914674|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914675|NCT00516893|Natalizumab|natalizumab|mesh-list
1914676|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
1914677|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914678|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
1914679|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1914680|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1914681|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914682|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
1914683|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914684|NCT00516919|Orlistat|orlistat|mesh-list
1914685|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914686|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914687|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1914688|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1914689|NCT00517010|Ranibizumab|ranibizumab|mesh-list
1914690|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914691|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914692|NCT00517010|Growth Substances|growth substances|mesh-ancestor
1914693|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914694|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914695|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914696|NCT00517296|Adalimumab|adalimumab|mesh-list
1914697|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914698|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914699|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
1914700|NCT00517413|Hematinics|hematinics|mesh-ancestor
1914701|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
1914702|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914703|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914704|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
1914705|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
1914706|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1914707|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914708|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1914709|NCT00517595|Gemcitabine|gemcitabine|mesh-list
1914710|NCT00517595|Bevacizumab|bevacizumab|mesh-list
1914711|NCT00517595|Pemetrexed|pemetrexed|mesh-list
1914712|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914713|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914714|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914715|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914716|NCT00517595|Growth Substances|growth substances|mesh-ancestor
1914717|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914718|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914719|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914720|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
1914721|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914722|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
1914723|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914724|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914725|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914726|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
1914727|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1914728|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1914729|NCT00517829|Docetaxel|docetaxel|mesh-list
1914730|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
1914731|NCT00517829|Cetuximab|cetuximab|mesh-list
1914732|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914733|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914734|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914735|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914736|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914737|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914738|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
1914739|NCT00517881|Hematinics|hematinics|mesh-ancestor
1914740|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
1914741|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914742|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
1914743|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1914744|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1914745|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914746|NCT00517933|Urological Agents|urological agents|mesh-ancestor
1914747|NCT00518011|Gemcitabine|gemcitabine|mesh-list
1914748|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1914749|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914750|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
1914751|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914752|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914753|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
1914754|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914755|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914756|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914757|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
1914758|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914759|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914760|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
1914761|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1914762|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1914763|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1914764|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914765|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1914766|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1914767|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914768|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914769|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914770|NCT00518115|Exenatide|exenatide|mesh-list
1914771|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
1914772|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1914773|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914774|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1914775|NCT00518115|Incretins|incretins|mesh-ancestor
1914776|NCT00518115|Hormones|hormones|mesh-ancestor
1914777|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914778|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
1914779|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1914780|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914781|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914782|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
1914783|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914784|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914785|NCT00518180|Lactitol|lactitol|mesh-list
1914786|NCT00518180|Vaccines|vaccines|mesh-list
1914787|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
1914788|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914789|NCT00518180|Cathartics|cathartics|mesh-ancestor
1914790|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1914791|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
1914792|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914793|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
1914794|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914795|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914796|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1914797|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
1914798|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914799|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914800|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1914801|NCT00518284|Paclitaxel|paclitaxel|mesh-list
1914802|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1914803|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914804|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914805|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914806|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914807|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914808|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914809|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1914810|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1914811|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914812|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914813|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914814|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914815|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1914816|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1914817|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
1914818|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914819|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914820|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1914821|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1914822|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
1914823|NCT00518531|Denosumab|denosumab|mesh-list
1914824|NCT00518531|Alendronate|alendronate|mesh-list
1914825|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1914826|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914827|NCT00518687|Vaccines|vaccines|mesh-list
1914828|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
1914829|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914830|NCT00518713|Clobazam|clobazam|mesh-list
1914831|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
1914832|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1914833|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914834|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914835|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914836|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914837|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1914838|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
1914839|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
1914840|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914841|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914842|NCT00518882|Liraglutide|liraglutide|mesh-list
1914843|NCT00518882|Exenatide|exenatide|mesh-list
1914844|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1914845|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914846|NCT00518882|Incretins|incretins|mesh-ancestor
1914847|NCT00518882|Hormones|hormones|mesh-ancestor
1914848|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914849|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1914850|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1914851|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
1914852|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914853|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1914854|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1914855|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914856|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914857|NCT00518986|Modafinil|modafinil|mesh-list
1914858|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1914859|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914860|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1914861|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1914862|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1914863|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914864|NCT00519077|Gefitinib|gefitinib|mesh-list
1914865|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914866|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914867|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914868|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914869|NCT00519285|Prednisone|prednisone|mesh-list
1914870|NCT00519285|Prednisolone|prednisolone|mesh-list
1914871|NCT00519285|Docetaxel|docetaxel|mesh-list
1914872|NCT00519285|Aflibercept|aflibercept|mesh-list
1914873|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914874|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914875|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914876|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914877|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914878|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914879|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
1914880|NCT00519285|Hormones|hormones|mesh-ancestor
1914881|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1914882|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914883|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1914884|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914885|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914886|NCT00519285|Growth Substances|growth substances|mesh-ancestor
1914887|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914888|NCT00519428|Dexetimide|dexetimide|mesh-list
1914889|NCT00519428|Citalopram|citalopram|mesh-list
1914890|NCT00519428|Bupropion|bupropion|mesh-list
1914891|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1914892|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1914893|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1914894|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914895|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914896|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
1914897|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914898|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1914899|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
1914900|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1914901|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1914902|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1914903|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
1914904|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
1914905|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914906|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1914907|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1914908|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
1914909|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1914910|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
1914911|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1914912|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1914913|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914914|NCT00519532|Rotigotine|rotigotine|mesh-list
1914915|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
1914916|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
1914917|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1914918|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914919|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914920|NCT00519584|Bupivacaine|bupivacaine|mesh-list
1914921|NCT00519584|Ropivacaine|ropivacaine|mesh-list
1914922|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
1914923|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
1914924|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1914925|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914926|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
1914927|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914928|NCT00519623|Insulin|insulin|mesh-list
1914929|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1914930|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914931|NCT00519636|Fluticasone|fluticasone|mesh-list
1914932|NCT00519636|Xhance|xhance|mesh-list
1914933|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914934|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1914935|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
1914936|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1914937|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914938|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1914939|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
1914940|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914941|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1914942|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
1914943|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1914944|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1914945|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1914946|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1914947|NCT00519831|Cetuximab|cetuximab|mesh-list
1914948|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914949|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914950|NCT00519896|Sunitinib|sunitinib|mesh-list
1914951|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914952|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914953|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914954|NCT00519896|Growth Substances|growth substances|mesh-ancestor
1914955|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914956|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914957|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914958|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914959|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914960|NCT00520013|Paclitaxel|paclitaxel|mesh-list
1914961|NCT00520013|Bevacizumab|bevacizumab|mesh-list
1914962|NCT00520013|Carboplatin|carboplatin|mesh-list
1914963|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1914964|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1914965|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914966|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
1914967|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
1914968|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
1914969|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914970|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914971|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1914972|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1914973|NCT00520013|Growth Substances|growth substances|mesh-ancestor
1914974|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914975|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
1914976|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1914977|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914978|NCT00520130|Cytarabine|cytarabine|mesh-list
1914979|NCT00520130|Cyclosporine|cyclosporine|mesh-list
1914980|NCT00520130|Rituximab|rituximab|mesh-list
1914981|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
1914982|NCT00520130|Fludarabine|fludarabine|mesh-list
1914983|NCT00520130|Cyclosporins|cyclosporins|mesh-list
1914984|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1914985|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1914986|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
1914987|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1914988|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1914989|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1914990|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
1914991|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1914992|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1914993|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
1914994|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1914995|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1914996|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
1914997|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
1914998|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1914999|NCT00520234|Caspofungin|caspofungin|mesh-list
1915000|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
1915001|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915002|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915003|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915004|NCT00520286|Modafinil|modafinil|mesh-list
1915005|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1915006|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915007|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1915008|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1915009|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1915010|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915011|NCT00520403|Interferons|interferons|mesh-list
1915012|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
1915013|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
1915014|NCT00520403|Bevacizumab|bevacizumab|mesh-list
1915015|NCT00520403|Vinblastine|vinblastine|mesh-list
1915016|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915017|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915018|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915019|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915020|NCT00520403|Growth Substances|growth substances|mesh-ancestor
1915021|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915022|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915023|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
1915024|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915025|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
1915026|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1915027|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915028|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915029|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915030|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915031|NCT00520468|Cyclosporine|cyclosporine|mesh-list
1915032|NCT00520468|Prednisone|prednisone|mesh-list
1915033|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
1915034|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
1915035|NCT00520468|Cyclosporins|cyclosporins|mesh-list
1915036|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915037|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
1915038|NCT00520468|Hormones|hormones|mesh-ancestor
1915039|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915040|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915041|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1915042|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915043|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
1915044|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915045|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915046|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915047|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
1915048|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915049|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
1915050|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915051|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1915052|NCT00520468|Hematinics|hematinics|mesh-ancestor
1915053|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1915054|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
1915055|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915056|NCT00520533|Sunitinib|sunitinib|mesh-list
1915057|NCT00520533|Antibodies|antibodies|mesh-list
1915058|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1915059|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
1915060|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915061|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915062|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915063|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915064|NCT00520533|Growth Substances|growth substances|mesh-ancestor
1915065|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915066|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915067|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915068|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915069|NCT00520572|Etanercept|etanercept|mesh-list
1915070|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1915071|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1915072|NCT00520572|Analgesics|analgesics|mesh-ancestor
1915073|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
1915074|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915075|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915076|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915077|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915078|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915079|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915080|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
1915081|NCT00520676|Carboplatin|carboplatin|mesh-list
1915082|NCT00520676|Docetaxel|docetaxel|mesh-list
1915083|NCT00520676|Pemetrexed|pemetrexed|mesh-list
1915084|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915085|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915086|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915087|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915088|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915089|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915090|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1915091|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1915092|NCT00520741|Lacosamide|lacosamide|mesh-list
1915093|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
1915094|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1915095|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1915096|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915097|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915098|NCT00520767|Dexamethasone|dexamethasone|mesh-list
1915099|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
1915100|NCT00520767|Bortezomib|bortezomib|mesh-list
1915101|NCT00520767|Melphalan|melphalan|mesh-list
1915102|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1915103|NCT00520767|BB 1101|bb 1101|mesh-list
1915104|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915105|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
1915106|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
1915107|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915108|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915109|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915110|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
1915111|NCT00520767|Hormones|hormones|mesh-ancestor
1915112|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915113|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1915114|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915115|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
1915116|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915117|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915118|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915119|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
1915120|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1915121|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915122|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
1915123|NCT00520845|Celecoxib|celecoxib|mesh-list
1915124|NCT00520845|Docetaxel|docetaxel|mesh-list
1915125|NCT00520845|Pemetrexed|pemetrexed|mesh-list
1915126|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915127|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915128|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915129|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915130|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915131|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915132|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1915133|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1915134|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1915135|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1915136|NCT00520845|Analgesics|analgesics|mesh-ancestor
1915137|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
1915138|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915139|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915140|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915141|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915142|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1915143|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1915144|NCT00520936|Pemetrexed|pemetrexed|mesh-list
1915145|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915146|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915147|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915148|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1915149|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1915150|NCT00520975|Paclitaxel|paclitaxel|mesh-list
1915151|NCT00520975|Bevacizumab|bevacizumab|mesh-list
1915152|NCT00520975|Carboplatin|carboplatin|mesh-list
1915153|NCT00520975|Trastuzumab|trastuzumab|mesh-list
1915154|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1915155|NCT00520975|Antibodies|antibodies|mesh-list
1915156|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
1915157|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1915158|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1915159|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915160|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915161|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915162|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915163|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915164|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915165|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915166|NCT00520975|Growth Substances|growth substances|mesh-ancestor
1915167|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915168|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915169|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
1915170|NCT00521001|Everolimus|everolimus|mesh-list
1915171|NCT00521001|Temozolomide|temozolomide|mesh-list
1915172|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915173|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915174|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
1915175|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915176|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915177|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
1915178|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915179|NCT00521014|Cytarabine|cytarabine|mesh-list
1915180|NCT00521014|Rituximab|rituximab|mesh-list
1915181|NCT00521014|Etoposide|etoposide|mesh-list
1915182|NCT00521014|Melphalan|melphalan|mesh-list
1915183|NCT00521014|Carmustine|carmustine|mesh-list
1915184|NCT00521014|Sargramostim|sargramostim|mesh-list
1915185|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915186|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915187|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
1915188|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915189|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915190|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1915191|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1915192|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1915193|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915194|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915195|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915196|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
1915197|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
1915198|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915199|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915200|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915201|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
1915202|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1915203|NCT00521144|Topotecan|topotecan|mesh-list
1915204|NCT00521144|Obatoclax|obatoclax|mesh-list
1915205|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1915206|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1915207|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915208|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915209|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915210|NCT00521339|Apremilast|apremilast|mesh-list
1915211|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1915212|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1915213|NCT00521339|Analgesics|analgesics|mesh-ancestor
1915214|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
1915215|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915216|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915217|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915218|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915219|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1915220|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1915221|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915222|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915223|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1915224|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
1915225|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1915226|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1915227|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1915228|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1915229|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915230|NCT00521404|Gemcitabine|gemcitabine|mesh-list
1915231|NCT00521404|Antibodies|antibodies|mesh-list
1915232|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
1915233|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915234|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915235|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
1915236|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915237|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915238|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
1915239|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915240|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915241|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915242|NCT00521456|Ketorolac|ketorolac|mesh-list
1915243|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1915244|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1915245|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1915246|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1915247|NCT00521456|Analgesics|analgesics|mesh-ancestor
1915248|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
1915249|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915250|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915251|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915252|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915253|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1915254|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915255|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915256|NCT00521586|Vaccines|vaccines|mesh-list
1915257|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1915258|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
1915259|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915260|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
1915261|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915262|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
1915263|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1915264|NCT00521989|Prednisolone|prednisolone|mesh-list
1915265|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1915266|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
1915267|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1915268|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
1915269|NCT00521989|Dipyridamole|dipyridamole|mesh-list
1915270|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1915271|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
1915272|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915273|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
1915274|NCT00521989|Hormones|hormones|mesh-ancestor
1915275|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915276|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915277|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1915278|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915279|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
1915280|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
1915281|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915430|NCT00523848|Thalidomide|thalidomide|mesh-list
1915282|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915283|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1915284|NCT00521989|Protective Agents|protective agents|mesh-ancestor
1915285|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1915286|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915287|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915288|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1915289|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
1915290|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
1915291|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
1915292|NCT00522275|Lacosamide|lacosamide|mesh-list
1915293|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
1915294|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1915295|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1915296|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915297|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915298|NCT00522379|Rotigotine|rotigotine|mesh-list
1915299|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
1915300|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
1915301|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915302|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915303|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915304|NCT00522392|Dexamethasone|dexamethasone|mesh-list
1915305|NCT00522392|Lenalidomide|lenalidomide|mesh-list
1915306|NCT00522392|Bortezomib|bortezomib|mesh-list
1915307|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915308|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
1915309|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
1915310|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915311|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915312|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915313|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
1915314|NCT00522392|Hormones|hormones|mesh-ancestor
1915315|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915316|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1915317|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915318|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
1915319|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915320|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915321|NCT00522392|Growth Substances|growth substances|mesh-ancestor
1915322|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915323|NCT00522431|Testosterone|testosterone|mesh-list
1915324|NCT00522431|Androgens|androgens|mesh-ancestor
1915325|NCT00522431|Hormones|hormones|mesh-ancestor
1915326|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915327|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915328|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
1915329|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1915330|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915331|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1915332|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
1915333|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1915334|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915335|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915336|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915337|NCT00522795|Paclitaxel|paclitaxel|mesh-list
1915338|NCT00522795|Cisplatin|cisplatin|mesh-list
1915339|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
1915340|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1915341|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915342|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915343|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915344|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915345|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915346|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
1915347|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1915348|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1915349|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
1915350|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915351|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1915352|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1915353|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915354|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915355|NCT00523341|Denosumab|denosumab|mesh-list
1915356|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1915357|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915358|NCT00523419|Pemetrexed|pemetrexed|mesh-list
1915359|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915360|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915361|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915362|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1915363|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1915364|NCT00523549|Amlodipine|amlodipine|mesh-list
1915365|NCT00523549|Valsartan|valsartan|mesh-list
1915366|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1915367|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1915368|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915369|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915370|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1915371|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915372|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
1915373|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1915374|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1915375|NCT00523640|Gemcitabine|gemcitabine|mesh-list
1915376|NCT00523640|Bevacizumab|bevacizumab|mesh-list
1915377|NCT00523640|Capecitabine|capecitabine|mesh-list
1915378|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915379|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915380|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915381|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915382|NCT00523640|Growth Substances|growth substances|mesh-ancestor
1915383|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915384|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915385|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915386|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
1915387|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915388|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
1915389|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915390|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915391|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915392|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
1915393|NCT00523705|Citalopram|citalopram|mesh-list
1915394|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1915395|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1915396|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915397|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915398|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915399|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
1915400|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915401|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1915402|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
1915403|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1915404|NCT00523718|Riluzole|riluzole|mesh-list
1915405|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
1915406|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1915407|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1915408|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915409|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915410|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915411|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1915412|NCT00523718|Protective Agents|protective agents|mesh-ancestor
1915413|NCT00523744|Amlodipine|amlodipine|mesh-list
1915414|NCT00523744|Valsartan|valsartan|mesh-list
1915415|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1915416|NCT00523744|Olmesartan|olmesartan|mesh-list
1915417|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1915418|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1915419|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1915420|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915421|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915422|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1915423|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915424|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
1915425|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1915426|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1915427|NCT00523744|Diuretics|diuretics|mesh-ancestor
1915428|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
1915429|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1915431|NCT00523848|Doxorubicin|doxorubicin|mesh-list
1915432|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1915433|NCT00523848|Bortezomib|bortezomib|mesh-list
1915434|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1915435|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915436|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1915437|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1915438|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915439|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915440|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915441|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
1915442|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915443|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
1915444|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1915445|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915446|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915447|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915448|NCT00523848|Growth Substances|growth substances|mesh-ancestor
1915449|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915450|NCT00523978|Sotalol|sotalol|mesh-list
1915451|NCT00523978|Flecainide|flecainide|mesh-list
1915452|NCT00523978|Propafenone|propafenone|mesh-list
1915453|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1915454|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1915455|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
1915456|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915457|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915458|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915459|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1915460|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
1915461|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
1915462|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915463|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1915464|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1915465|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915466|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
1915467|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1915468|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
1915469|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915470|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915471|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1915472|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
1915473|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
1915474|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1915475|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
1915476|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915477|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915478|NCT00524017|Cetuximab|cetuximab|mesh-list
1915479|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915480|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915481|NCT00524030|Pregabalin|pregabalin|mesh-list
1915482|NCT00524030|Analgesics|analgesics|mesh-ancestor
1915483|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
1915484|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915485|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915486|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
1915487|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1915488|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915489|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915490|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1915491|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1915492|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1915493|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1915494|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1915495|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1915496|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1915497|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1915498|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1915499|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915500|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1915501|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1915502|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1915503|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
1915504|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915505|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915506|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1915507|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1915508|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
1915509|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1915510|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915511|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915512|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915513|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915514|NCT00524173|Tenofovir|tenofovir|mesh-list
1915515|NCT00524173|Emtricitabine|emtricitabine|mesh-list
1915516|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
1915517|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915518|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1915519|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1915520|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915521|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915522|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1915523|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1915524|NCT00524225|Oprelvekin|oprelvekin|mesh-list
1915525|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915526|NCT00524264|Ketorolac|ketorolac|mesh-list
1915527|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1915528|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1915529|NCT00524264|Analgesics|analgesics|mesh-ancestor
1915530|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
1915531|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915532|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915533|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915534|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915535|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1915536|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915537|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915538|NCT00524303|Paclitaxel|paclitaxel|mesh-list
1915539|NCT00524303|Trastuzumab|trastuzumab|mesh-list
1915540|NCT00524303|Lapatinib|lapatinib|mesh-list
1915541|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1915542|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915543|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915544|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915545|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915546|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915547|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915548|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915549|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915550|NCT00524316|Doxorubicin|doxorubicin|mesh-list
1915551|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1915552|NCT00524316|Sunitinib|sunitinib|mesh-list
1915553|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1915554|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915555|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1915556|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1915557|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915558|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915559|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915560|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915561|NCT00524316|Growth Substances|growth substances|mesh-ancestor
1915562|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915563|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915564|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915565|NCT00524342|Oprelvekin|oprelvekin|mesh-list
1915566|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915567|NCT00524368|Ritonavir|ritonavir|mesh-list
1915568|NCT00524368|Darunavir|darunavir|mesh-list
1915569|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1915570|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1915571|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
1915572|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915573|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915574|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1915575|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1915576|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
1915577|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915578|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1915579|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1915580|NCT00524472|Insulin|insulin|mesh-list
1915581|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1915582|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1915583|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915584|NCT00524576|Vaccines|vaccines|mesh-list
1915585|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
1915586|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915587|NCT00524589|Calcitriol|calcitriol|mesh-list
1915588|NCT00524589|Dexamethasone|dexamethasone|mesh-list
1915589|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915590|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
1915591|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
1915592|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915593|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915594|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915595|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
1915596|NCT00524589|Hormones|hormones|mesh-ancestor
1915597|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915598|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1915599|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915600|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1915601|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1915602|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915603|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915604|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1915605|NCT00524589|Vitamins|vitamins|mesh-ancestor
1915606|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
1915607|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1915608|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
1915609|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1915610|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915611|NCT00524680|Vitamins|vitamins|mesh-ancestor
1915612|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
1915613|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1915614|NCT00525031|Interferons|interferons|mesh-list
1915615|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
1915616|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
1915617|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1915618|NCT00525031|Temozolomide|temozolomide|mesh-list
1915619|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915620|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
1915621|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915622|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915623|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
1915624|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915625|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
1915626|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915627|NCT00525044|Ambroxol|ambroxol|mesh-list
1915628|NCT00525044|Expectorants|expectorants|mesh-ancestor
1915629|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
1915630|NCT00525057|Dalteparin|dalteparin|mesh-list
1915631|NCT00525057|Tinzaparin|tinzaparin|mesh-list
1915632|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1915633|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
1915634|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1915635|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1915636|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915637|NCT00525135|Valproic Acid|valproic acid|mesh-list
1915638|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
1915639|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915640|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915641|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
1915642|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915643|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915644|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
1915645|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1915646|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1915647|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1915648|NCT00525148|Afatinib|afatinib|mesh-list
1915649|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915650|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915651|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915652|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915653|NCT00525161|Sorafenib|sorafenib|mesh-list
1915654|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915655|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915656|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915657|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915658|NCT00525265|Tolvaptan|tolvaptan|mesh-list
1915659|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1915660|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915661|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
1915662|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915663|NCT00525421|Curcumin|curcumin|mesh-list
1915664|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1915665|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1915666|NCT00525421|Analgesics|analgesics|mesh-ancestor
1915667|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
1915668|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915669|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915670|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915671|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915672|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915673|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915674|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915675|NCT00525499|Androgens|androgens|mesh-list
1915676|NCT00525499|Hormones|hormones|mesh-ancestor
1915677|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915678|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915679|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
1915680|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1915681|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
1915682|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915683|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915684|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1915685|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
1915686|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
1915687|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1915688|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
1915689|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915690|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915691|NCT00525525|Bevacizumab|bevacizumab|mesh-list
1915692|NCT00525525|Temozolomide|temozolomide|mesh-list
1915693|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1915694|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915695|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915696|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915697|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915698|NCT00525525|Growth Substances|growth substances|mesh-ancestor
1915699|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915700|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915701|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915702|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
1915703|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915704|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915705|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915706|NCT00525590|Carmustine|carmustine|mesh-list
1915707|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915708|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
1915709|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915710|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915711|NCT00525603|Vidarabine|vidarabine|mesh-list
1915712|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
1915713|NCT00525603|Rituximab|rituximab|mesh-list
1915714|NCT00525603|Fludarabine|fludarabine|mesh-list
1915715|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
1915716|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
1915717|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915718|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
1915719|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915720|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915721|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915722|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
1915723|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915724|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915725|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1915726|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915727|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915728|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
1915729|NCT00525603|Antiviral Agents|antiviral agents|mesh-ancestor
1915730|NCT00525603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915731|NCT00525733|Ritonavir|ritonavir|mesh-list
1915732|NCT00525733|Darunavir|darunavir|mesh-list
1915733|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
1915734|NCT00525733|Maraviroc|maraviroc|mesh-list
1915735|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1915736|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1915737|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
1915738|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915739|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915740|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1915741|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1915742|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
1915743|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915744|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1915745|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1915746|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1915747|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1915748|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1915749|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1915750|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1915751|NCT00525785|Leucovorin|leucovorin|mesh-list
1915752|NCT00525785|Folic Acid|folic acid|mesh-list
1915753|NCT00525785|Fluorouracil|fluorouracil|mesh-list
1915754|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
1915755|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
1915756|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
1915757|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915758|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915759|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915760|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915761|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
1915762|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915763|NCT00525785|Antidotes|antidotes|mesh-ancestor
1915764|NCT00525785|Protective Agents|protective agents|mesh-ancestor
1915765|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
1915766|NCT00525785|Vitamins|vitamins|mesh-ancestor
1915767|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
1915768|NCT00525785|Hematinics|hematinics|mesh-ancestor
1915769|NCT00525798|Calcitonin|calcitonin|mesh-list
1915770|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
1915771|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1915772|NCT00525798|Katacalcin|katacalcin|mesh-list
1915773|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1915774|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915775|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1915776|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
1915777|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1915778|NCT00525824|Simvastatin|simvastatin|mesh-list
1915779|NCT00525824|Ezetimibe|ezetimibe|mesh-list
1915780|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1915781|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1915782|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
1915783|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915784|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1915785|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1915786|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915787|NCT00525837|Varenicline|varenicline|mesh-list
1915788|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1915789|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1915790|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
1915791|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915792|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915793|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915794|NCT00525876|Vidarabine|vidarabine|mesh-list
1915795|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
1915796|NCT00525876|Rituximab|rituximab|mesh-list
1915797|NCT00525876|Fludarabine|fludarabine|mesh-list
1915798|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
1915799|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
1915800|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915801|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
1915802|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915803|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915804|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915805|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
1915806|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915807|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915808|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1915809|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915810|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915811|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
1915812|NCT00525876|Antiviral Agents|antiviral agents|mesh-ancestor
1915813|NCT00525876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915814|NCT00525902|Adalimumab|adalimumab|mesh-list
1915815|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915816|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915817|NCT00525915|Fluorouracil|fluorouracil|mesh-list
1915818|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
1915819|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
1915820|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915821|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915822|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915823|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915824|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
1915825|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915826|NCT00526058|Clotrimazole|clotrimazole|mesh-list
1915827|NCT00526058|Miconazole|miconazole|mesh-list
1915828|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1915829|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915830|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
1915831|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1915832|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1915833|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915834|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915835|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1915836|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
1915837|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915838|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915839|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1915840|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1915841|NCT00526097|Bisacodyl|bisacodyl|mesh-list
1915842|NCT00526097|Cathartics|cathartics|mesh-ancestor
1915843|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915844|NCT00526097|Laxatives|laxatives|mesh-ancestor
1915845|NCT00526110|Docetaxel|docetaxel|mesh-list
1915846|NCT00526110|Fluorouracil|fluorouracil|mesh-list
1915847|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
1915848|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915849|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915850|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915851|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915852|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915853|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
1915854|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915855|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915856|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
1915857|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915858|NCT00526227|Clotrimazole|clotrimazole|mesh-list
1915859|NCT00526227|Miconazole|miconazole|mesh-list
1915860|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1915861|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1915862|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
1915863|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1915864|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1915865|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915866|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915867|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1915868|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
1915869|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915870|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915871|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1915872|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1915873|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
1915874|NCT00526292|Fludarabine|fludarabine|mesh-list
1915875|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915876|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
1915877|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915878|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915879|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1915880|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
1915881|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915882|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915883|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1915884|NCT00526474|Vorapaxar|vorapaxar|mesh-list
1915885|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1915886|NCT00526591|Everolimus|everolimus|mesh-list
1915887|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915888|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915889|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
1915890|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915891|NCT00526630|Methylphenidate|methylphenidate|mesh-list
1915892|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1915893|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915894|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1915895|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1915896|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1915897|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915898|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
1915899|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1915900|NCT00526656|Sunitinib|sunitinib|mesh-list
1915901|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915902|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915903|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915904|NCT00526656|Growth Substances|growth substances|mesh-ancestor
1915905|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915906|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915907|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915908|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915909|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915910|NCT00526669|Capecitabine|capecitabine|mesh-list
1915911|NCT00526669|Lapatinib|lapatinib|mesh-list
1915912|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915913|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
1915914|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915915|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915916|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915917|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915918|NCT00526799|Sorafenib|sorafenib|mesh-list
1915919|NCT00526799|Topotecan|topotecan|mesh-list
1915920|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915921|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915922|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915923|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915924|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1915925|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1915926|NCT00526890|Selenium|selenium|mesh-list
1915927|NCT00526890|Paclitaxel|paclitaxel|mesh-list
1915928|NCT00526890|Carboplatin|carboplatin|mesh-list
1915929|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1915930|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915931|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915932|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915933|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915934|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915935|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
1915936|NCT00526890|Protective Agents|protective agents|mesh-ancestor
1915937|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915938|NCT00526890|Trace Elements|trace elements|mesh-ancestor
1915939|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
1915940|NCT00527072|Infliximab|infliximab|mesh-list
1915941|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
1915942|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1915943|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1915944|NCT00527111|Fluorouracil|fluorouracil|mesh-list
1915945|NCT00527111|Cetuximab|cetuximab|mesh-list
1915946|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
1915947|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915948|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1915949|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915950|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1915951|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
1915952|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915953|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1915954|NCT00527124|Prednisone|prednisone|mesh-list
1915955|NCT00527124|Docetaxel|docetaxel|mesh-list
1915956|NCT00527124|Cediranib|cediranib|mesh-list
1915957|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915958|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
1915959|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
1915960|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
1915961|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1915962|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1915963|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
1915964|NCT00527124|Hormones|hormones|mesh-ancestor
1915965|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1915966|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915967|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1915968|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1915969|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1915970|NCT00527332|Fentanyl|fentanyl|mesh-list
1915971|NCT00527332|Morphine|morphine|mesh-list
1915972|NCT00527332|Bupivacaine|bupivacaine|mesh-list
1915973|NCT00527332|Propofol|propofol|mesh-list
1915974|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
1915975|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
1915976|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1915977|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915978|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
1915979|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1915980|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1915981|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1915982|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
1915983|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1915984|NCT00527332|Narcotics|narcotics|mesh-ancestor
1915985|NCT00527332|Analgesics|analgesics|mesh-ancestor
1915986|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1915987|NCT00527397|Insulin|insulin|mesh-list
1915988|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1915989|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915990|NCT00527423|Aflibercept|aflibercept|mesh-list
1915991|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1915992|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1915993|NCT00527423|Growth Substances|growth substances|mesh-ancestor
1915994|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1915995|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
1915996|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1915997|NCT00527475|Ranibizumab|ranibizumab|mesh-list
1915998|NCT00527475|Verteporfin|verteporfin|mesh-list
1915999|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916000|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916001|NCT00527475|Growth Substances|growth substances|mesh-ancestor
1916002|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916003|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916004|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916005|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1916006|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
1916007|NCT00527514|Amlodipine|amlodipine|mesh-list
1916008|NCT00527514|Olmesartan|olmesartan|mesh-list
1916009|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1916010|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1916011|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1916012|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916013|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916014|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1916015|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916016|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
1916017|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1916018|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1916019|NCT00527592|Travoprost|travoprost|mesh-list
1916020|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1916021|NCT00527592|Latanoprost|latanoprost|mesh-list
1916022|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1916023|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1916024|NCT00527605|Dutasteride|dutasteride|mesh-list
1916025|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1916026|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1916027|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916028|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916029|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
1916030|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916031|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916032|NCT00527618|Valacyclovir|valacyclovir|mesh-list
1916033|NCT00527618|Acyclovir|acyclovir|mesh-list
1916034|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
1916035|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916036|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1916037|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
1916038|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
1916039|NCT00527644|Hormones|hormones|mesh-ancestor
1916040|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916041|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916042|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916043|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916044|NCT00527735|Paclitaxel|paclitaxel|mesh-list
1916045|NCT00527735|Carboplatin|carboplatin|mesh-list
1916046|NCT00527735|Ipilimumab|ipilimumab|mesh-list
1916047|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1916048|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916049|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
1916050|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
1916051|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
1916052|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916053|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916054|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1916055|NCT00527787|Naproxen|naproxen|mesh-list
1916056|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1916057|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1916058|NCT00527787|Analgesics|analgesics|mesh-ancestor
1916059|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
1916060|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916061|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916062|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916063|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1916064|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
1916065|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1916066|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916067|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916068|NCT00527826|Fluticasone|fluticasone|mesh-list
1916069|NCT00527826|Xhance|xhance|mesh-list
1916070|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1916071|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916072|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1916073|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
1916074|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916075|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916076|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1916077|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
1916078|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
1916079|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1916080|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1916081|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1916082|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1916083|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916084|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916085|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916086|NCT00527878|Ranitidine|ranitidine|mesh-list
1916087|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1916088|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1916089|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916090|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1916091|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
1916092|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
1916093|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916094|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916095|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916096|NCT00527904|Naproxen|naproxen|mesh-list
1916097|NCT00527904|Esomeprazole|esomeprazole|mesh-list
1916098|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1916099|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916100|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1916101|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916102|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916103|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1916104|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1916105|NCT00527904|Analgesics|analgesics|mesh-ancestor
1916106|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
1916107|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916108|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916109|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916110|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1916111|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
1916112|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1916113|NCT00527943|Vorapaxar|vorapaxar|mesh-list
1916114|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1916115|NCT00528190|Itraconazole|itraconazole|mesh-list
1916116|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
1916117|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916118|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1916119|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916120|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916121|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916122|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1916123|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
1916124|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916125|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916126|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1916127|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1916128|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916129|NCT00528372|Metformin|metformin|mesh-list
1916130|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
1916131|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916132|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916133|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1916134|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916135|NCT00528398|Cytarabine|cytarabine|mesh-list
1916136|NCT00528398|Idarubicin|idarubicin|mesh-list
1916137|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1916138|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
1916139|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916140|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916141|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
1916142|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916143|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916144|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
1916145|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916146|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1916147|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1916148|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1916149|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916150|NCT00528411|Aspirin|aspirin|mesh-list
1916151|NCT00528411|Clopidogrel|clopidogrel|mesh-list
1916152|NCT00528411|Ticagrelor|ticagrelor|mesh-list
1916153|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1916154|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1916155|NCT00528411|Analgesics|analgesics|mesh-ancestor
1916156|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
1916157|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916158|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916159|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916160|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1916161|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1916162|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1916163|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916164|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1916165|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1916166|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916167|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
1916168|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1916169|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1916170|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1916171|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
1916172|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916173|NCT00528450|Idarubicin|idarubicin|mesh-list
1916174|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
1916175|NCT00528450|Tretinoin|tretinoin|mesh-list
1916176|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1916177|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916178|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1916179|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1916180|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916181|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916182|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
1916183|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
1916184|NCT00528528|Ribavirin|ribavirin|mesh-list
1916185|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
1916186|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
1916187|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
1916188|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1916189|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1916190|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
1916191|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916192|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
1916193|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916194|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
1916195|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916196|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916197|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
1916198|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1916199|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1916200|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1916201|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916202|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916203|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
1916204|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916205|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916206|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1916207|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916208|NCT00528567|Bevacizumab|bevacizumab|mesh-list
1916209|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916210|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916211|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916212|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916213|NCT00528567|Growth Substances|growth substances|mesh-ancestor
1916214|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916215|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916216|NCT00528580|Simvastatin|simvastatin|mesh-list
1916217|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1916218|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1916219|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
1916220|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916221|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1916222|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1916223|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916224|NCT00528645|Saracatinib|saracatinib|mesh-list
1916225|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916226|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916227|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916228|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
1916229|NCT00528788|Vitamins|vitamins|mesh-ancestor
1916230|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
1916231|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916232|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1916233|NCT00528866|Docetaxel|docetaxel|mesh-list
1916234|NCT00528866|Bicalutamide|bicalutamide|mesh-list
1916235|NCT00528866|Flutamide|flutamide|mesh-list
1916236|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916237|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
1916238|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
1916239|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
1916240|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916241|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
1916242|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
1916243|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916244|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916245|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1916246|NCT00528879|Metformin|metformin|mesh-list
1916247|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
1916248|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916249|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916250|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1916251|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916252|NCT00528957|Tenofovir|tenofovir|mesh-list
1916253|NCT00528957|Zidovudine|zidovudine|mesh-list
1916254|NCT00528957|Stavudine|stavudine|mesh-list
1916255|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
1916256|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916257|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1916258|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1916259|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916260|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916261|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1916262|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1916263|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
1916264|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
1916265|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1916266|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916267|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
1916268|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916269|NCT00528996|Bromides|bromides|mesh-list
1916270|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
1916271|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1916272|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
1916273|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916274|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916275|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1916276|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
1916277|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
1916278|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1916279|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
1916280|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916281|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916282|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
1916283|NCT00529035|Interleukin-2|interleukin-2|mesh-list
1916284|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916285|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1916286|NCT00529035|Analgesics|analgesics|mesh-ancestor
1916287|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
1916288|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916289|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916290|NCT00529087|Bromides|bromides|mesh-list
1916291|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
1916292|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
1916293|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1916294|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916295|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
1916296|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916297|NCT00529100|Cisplatin|cisplatin|mesh-list
1916298|NCT00529100|Pemetrexed|pemetrexed|mesh-list
1916299|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916300|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916301|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916302|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1916303|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1916304|NCT00529126|Epinephrine|epinephrine|mesh-list
1916305|NCT00529126|Bupivacaine|bupivacaine|mesh-list
1916306|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
1916307|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
1916308|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1916309|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916310|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
1916311|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916312|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1916313|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1916314|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916315|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916316|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916317|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1916318|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1916319|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
1916320|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1916321|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
1916322|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
1916323|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
1916324|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1916325|NCT00529152|Deferiprone|deferiprone|mesh-list
1916326|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1916327|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
1916328|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
1916329|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916330|NCT00529191|Atorvastatin|atorvastatin|mesh-list
1916331|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1916332|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1916333|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
1916334|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916335|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1916336|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1916337|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916338|NCT00529204|Exenatide|exenatide|mesh-list
1916339|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916340|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916341|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1916342|NCT00529204|Incretins|incretins|mesh-ancestor
1916343|NCT00529204|Hormones|hormones|mesh-ancestor
1916344|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916345|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
1916346|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1916347|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1916348|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
1916349|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916350|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1916351|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1916352|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916353|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916354|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
1916355|NCT00529373|Vitamin D|vitamin d|mesh-list
1916356|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
1916357|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
1916358|NCT00529373|Calcium|calcium|mesh-list
1916359|NCT00529373|Vitamins|vitamins|mesh-ancestor
1916360|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
1916361|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916362|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1916363|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1916364|NCT00529373|Antacids|antacids|mesh-ancestor
1916365|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916366|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916367|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1916368|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
1916369|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1916370|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
1916371|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916372|NCT00529399|Antacids|antacids|mesh-ancestor
1916373|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916374|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916375|NCT00529451|Ramipril|ramipril|mesh-list
1916376|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1916377|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
1916378|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916379|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916380|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1916381|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1916382|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1916383|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
1916384|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916385|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916386|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1916387|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
1916388|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1916389|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1916390|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1916391|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916392|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916393|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916394|NCT00529542|Atorvastatin|atorvastatin|mesh-list
1916395|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1916396|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1916397|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
1916398|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916399|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1916400|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1916401|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916402|NCT00529555|Minocycline|minocycline|mesh-list
1916403|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1916404|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916405|NCT00529633|Thalidomide|thalidomide|mesh-list
1916406|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916407|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
1916408|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916409|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
1916410|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1916411|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916412|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916413|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916414|NCT00529633|Growth Substances|growth substances|mesh-ancestor
1916415|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916416|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916422|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1916423|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1916424|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916425|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916426|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916427|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916428|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916429|NCT00529789|Analgesics|analgesics|mesh-ancestor
1916430|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
1916431|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916432|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
1916433|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916434|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
1916435|NCT00529802|Everolimus|everolimus|mesh-list
1916436|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916437|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916438|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
1916439|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916440|NCT00530023|Insulin|insulin|mesh-list
1916441|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916442|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916443|NCT00530075|Gusperimus|gusperimus|mesh-list
1916444|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1916445|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916446|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916447|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916448|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916449|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
1916450|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1916451|NCT00530075|Protective Agents|protective agents|mesh-ancestor
1916452|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
1916453|NCT00530088|Trioxsalen|trioxsalen|mesh-list
1916454|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916455|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
1916456|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1916457|NCT00530218|Ganciclovir|ganciclovir|mesh-list
1916458|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1916459|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
1916460|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916461|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1916462|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916463|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916464|NCT00530257|Methylphenidate|methylphenidate|mesh-list
1916465|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1916466|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916467|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1916468|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916469|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916470|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916471|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
1916472|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916473|NCT00530270|Dexamethasone|dexamethasone|mesh-list
1916474|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916475|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
1916476|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
1916477|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916478|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916479|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916480|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
1916481|NCT00530270|Hormones|hormones|mesh-ancestor
1916482|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916483|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1916484|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916485|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1916486|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1916487|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916488|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916489|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916490|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916491|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916492|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916493|NCT00530348|Interferons|interferons|mesh-list
1916494|NCT00530348|Interferon-beta|interferon-beta|mesh-list
1916495|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
1916496|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
1916497|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916498|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
1916499|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916500|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916501|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
1916502|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916503|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1916504|NCT00530621|Pemetrexed|pemetrexed|mesh-list
1916505|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916506|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916507|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916508|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1916509|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1916510|NCT00530634|Gemcitabine|gemcitabine|mesh-list
1916511|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916512|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1916513|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
1916514|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916515|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
1916516|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916517|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916518|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916519|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
1916520|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916521|NCT00530764|Nabiximols|nabiximols|mesh-list
1916522|NCT00530764|Dronabinol|dronabinol|mesh-list
1916523|NCT00530764|Cannabidiol|cannabidiol|mesh-list
1916524|NCT00530764|Analgesics|analgesics|mesh-ancestor
1916525|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
1916526|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916527|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916528|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
1916529|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
1916530|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916531|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1916532|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1916533|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1916534|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916535|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916536|NCT00530764|Hormones|hormones|mesh-ancestor
1916537|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916538|NCT00530777|Valacyclovir|valacyclovir|mesh-list
1916539|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
1916540|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916541|NCT00530790|Ropinirole|ropinirole|mesh-list
1916542|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1916543|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1916544|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
1916545|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
1916546|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916547|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916548|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916549|NCT00530803|Lidocaine|lidocaine|mesh-list
1916550|NCT00530803|Tetracaine|tetracaine|mesh-list
1916551|NCT00530803|Prilocaine|prilocaine|mesh-list
1916552|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
1916553|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
1916554|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
1916555|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1916556|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916557|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
1916558|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916559|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1916560|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1916561|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1916562|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916563|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916564|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
1916565|NCT00530842|Fluticasone|fluticasone|mesh-list
1916566|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
1916567|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1916568|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1916569|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916570|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1916571|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
1916572|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916573|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916574|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1916575|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
1916576|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
1916577|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1916578|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
1916579|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1916580|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
1916581|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916582|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916583|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1916584|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1916585|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1916586|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916587|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
1916588|NCT00530842|Hormones|hormones|mesh-ancestor
1916589|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916590|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
1916591|NCT00530855|Lacosamide|lacosamide|mesh-list
1916592|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
1916593|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1916594|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1916595|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916596|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916597|NCT00530920|Ritonavir|ritonavir|mesh-list
1916598|NCT00530920|Tipranavir|tipranavir|mesh-list
1916599|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1916600|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1916601|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
1916602|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916603|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916604|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1916605|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1916606|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
1916607|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916608|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1916609|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916610|NCT00530946|Amlodipine|amlodipine|mesh-list
1916611|NCT00530946|Atorvastatin|atorvastatin|mesh-list
1916612|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1916613|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1916614|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
1916615|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916616|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1916617|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1916618|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916619|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1916620|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1916621|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916622|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1916623|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916624|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
1916625|NCT00531011|Paclitaxel|paclitaxel|mesh-list
1916626|NCT00531011|Everolimus|everolimus|mesh-list
1916627|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1916628|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916629|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
1916630|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
1916631|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
1916632|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916633|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916634|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
1916635|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916636|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1916637|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1916638|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
1916639|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916640|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916641|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1916642|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
1916643|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1916644|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1916645|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1916646|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916647|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916648|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916649|NCT00531206|Ritonavir|ritonavir|mesh-list
1916650|NCT00531206|Tipranavir|tipranavir|mesh-list
1916651|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1916652|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1916653|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
1916654|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916655|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916656|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1916657|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1916658|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
1916659|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916660|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1916661|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916662|NCT00531232|Clofarabine|clofarabine|mesh-list
1916663|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1916664|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
1916665|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916666|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916667|NCT00531284|Dexamethasone|dexamethasone|mesh-list
1916668|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916669|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
1916670|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
1916671|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916672|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916673|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916674|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
1916675|NCT00531284|Hormones|hormones|mesh-ancestor
1916676|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916677|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1916678|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916679|NCT00531427|Buprenorphine|buprenorphine|mesh-list
1916680|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1916681|NCT00531427|Narcotics|narcotics|mesh-ancestor
1916682|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1916683|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916684|NCT00531427|Analgesics|analgesics|mesh-ancestor
1916685|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
1916686|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916687|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1916688|NCT00531453|Thalidomide|thalidomide|mesh-list
1916689|NCT00531453|Dexamethasone|dexamethasone|mesh-list
1916690|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
1916691|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
1916692|NCT00531453|Bortezomib|bortezomib|mesh-list
1916693|NCT00531453|BB 1101|bb 1101|mesh-list
1916694|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916695|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
1916696|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916697|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1916698|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1916699|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
1916700|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916701|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916702|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1916703|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916704|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
1916705|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
1916706|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916707|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916708|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
1916709|NCT00531453|Hormones|hormones|mesh-ancestor
1916710|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916711|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1916712|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
1916713|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916714|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
1916715|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1916716|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916717|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916718|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916719|NCT00531453|Growth Substances|growth substances|mesh-ancestor
1916720|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916721|NCT00531479|Voriconazole|voriconazole|mesh-list
1916722|NCT00531479|Anidulafungin|anidulafungin|mesh-list
1916723|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
1916724|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916725|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1916726|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916727|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916728|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916729|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1916730|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
1916731|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916732|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916733|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1916734|NCT00531518|Lamotrigine|lamotrigine|mesh-list
1916735|NCT00531518|Aripiprazole|aripiprazole|mesh-list
1916736|NCT00531518|Bupropion|bupropion|mesh-list
1916737|NCT00531518|Fluoxetine|fluoxetine|mesh-list
1916738|NCT00531518|Sertraline|sertraline|mesh-list
1916739|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1916740|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
1916741|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916742|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1916743|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916744|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916745|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916746|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
1916747|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916748|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916749|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1916750|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916751|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916752|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1916753|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1916754|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1916755|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
1916756|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1916757|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1916758|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
1916759|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1916760|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1916761|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1916762|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1916763|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1916764|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
1916765|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1916766|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1916767|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1916768|NCT00531843|PENTA|penta|mesh-list
1916769|NCT00531843|Fondaparinux|fondaparinux|mesh-list
1916770|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1916771|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
1916772|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1916773|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
1916774|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916775|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916776|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
1916777|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1916778|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1916779|NCT00531882|Pioglitazone|pioglitazone|mesh-list
1916780|NCT00531882|Ibuprofen|ibuprofen|mesh-list
1916781|NCT00531882|Simvastatin|simvastatin|mesh-list
1916782|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1916783|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1916784|NCT00531882|Analgesics|analgesics|mesh-ancestor
1916785|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
1916786|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916787|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916788|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916789|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1916790|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1916791|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916792|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916793|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1916794|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1916795|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
1916796|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1916797|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1916798|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916799|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1916800|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916801|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1916802|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916803|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916804|NCT00531947|Selegiline|selegiline|mesh-list
1916805|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
1916806|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916807|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1916808|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1916809|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1916810|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916811|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916812|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1916813|NCT00531947|Protective Agents|protective agents|mesh-ancestor
1916814|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916815|NCT00531960|Bevacizumab|bevacizumab|mesh-list
1916816|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1916817|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916818|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916819|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916820|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916821|NCT00531960|Growth Substances|growth substances|mesh-ancestor
1916822|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916823|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916824|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1916825|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916826|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916827|NCT00532129|Rituximab|rituximab|mesh-list
1916828|NCT00532129|Chlorambucil|chlorambucil|mesh-list
1916829|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916830|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916831|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
1916832|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916833|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1916834|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1916835|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
1916836|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916837|NCT00532155|Dexamethasone|dexamethasone|mesh-list
1916838|NCT00532155|Docetaxel|docetaxel|mesh-list
1916839|NCT00532155|Aflibercept|aflibercept|mesh-list
1916840|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1916841|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
1916842|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
1916843|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916844|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916845|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1916846|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
1916847|NCT00532155|Hormones|hormones|mesh-ancestor
1916848|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916849|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1916850|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916851|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
1916852|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
1916853|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
1916854|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916855|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916856|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916857|NCT00532155|Growth Substances|growth substances|mesh-ancestor
1916858|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916859|NCT00532259|Pidilizumab|pidilizumab|mesh-list
1916860|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916861|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916862|NCT00532298|Vaccines|vaccines|mesh-list
1916863|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
1916864|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916865|NCT00532441|Docetaxel|docetaxel|mesh-list
1916866|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1916867|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916868|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
1916869|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
1916870|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
1916871|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916872|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1916873|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916874|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1916875|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1916876|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916877|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916878|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916879|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916880|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916881|NCT00532480|Analgesics|analgesics|mesh-ancestor
1916882|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
1916883|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916884|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
1916885|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916886|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
1916887|NCT00532493|Prazosin|prazosin|mesh-list
1916888|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1916889|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1916890|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1916891|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1916892|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
1916893|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916894|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916895|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916896|NCT00532779|Naltrexone|naltrexone|mesh-list
1916897|NCT00532779|Bupropion|bupropion|mesh-list
1916898|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1916899|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1916900|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916901|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
1916902|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1916903|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1916904|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
1916905|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916906|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1916907|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916908|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916909|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916910|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
1916911|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916912|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1916913|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916914|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916915|NCT00532844|Vitamins|vitamins|mesh-list
1916916|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
1916917|NCT00532844|Verapamil|verapamil|mesh-list
1916918|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
1916919|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916920|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
1916921|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916922|NCT00532844|Protective Agents|protective agents|mesh-ancestor
1916923|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1916924|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1916925|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916926|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1916927|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
1916928|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
1916929|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916930|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
1916931|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916932|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916933|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1916934|NCT00532935|Metformin|metformin|mesh-list
1916935|NCT00532935|Pioglitazone|pioglitazone|mesh-list
1916936|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1916937|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1916938|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916939|NCT00532935|Incretins|incretins|mesh-ancestor
1916940|NCT00532935|Hormones|hormones|mesh-ancestor
1916941|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1916942|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1916943|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
1916944|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916945|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916946|NCT00532948|Capecitabine|capecitabine|mesh-list
1916947|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1916948|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
1916949|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916950|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916951|NCT00533117|Fluoxetine|fluoxetine|mesh-list
1916952|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1916953|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1916954|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1916955|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916956|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1916957|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
1916958|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916959|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1916960|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
1916961|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1916962|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1916963|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1916964|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916965|NCT00533429|Bevacizumab|bevacizumab|mesh-list
1916966|NCT00533429|Carboplatin|carboplatin|mesh-list
1916967|NCT00533429|Pemetrexed|pemetrexed|mesh-list
1916968|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1916969|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916970|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1916971|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1916972|NCT00533429|Growth Substances|growth substances|mesh-ancestor
1916973|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916974|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
1916975|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916976|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916977|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1916978|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1916979|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
1916980|NCT00533442|Sirolimus|sirolimus|mesh-list
1916981|NCT00533442|Tacrolimus|tacrolimus|mesh-list
1916982|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1916983|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
1916984|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916985|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1916986|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1916987|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1916988|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1916989|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1916990|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1916991|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
1916992|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1916993|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1916994|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
1916995|NCT00533507|Vaccines|vaccines|mesh-list
1916996|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1916997|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
1916998|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1916999|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
1917000|NCT00533546|Protein C|protein c|mesh-list
1917001|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
1917002|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1917003|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1917004|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917005|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917006|NCT00533702|Dacarbazine|dacarbazine|mesh-list
1917007|NCT00533702|Ramucirumab|ramucirumab|mesh-list
1917008|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1917009|NCT00533702|Imidazole|imidazole|mesh-list
1917010|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1917011|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
1917012|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917013|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917014|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
1917015|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917016|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917017|NCT00533845|Bupivacaine|bupivacaine|mesh-list
1917018|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
1917019|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
1917020|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917021|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917022|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
1917023|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917024|NCT00533897|Abatacept|abatacept|mesh-list
1917025|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1917026|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917027|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917028|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917029|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
1917030|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917031|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917032|NCT00533910|Rifaximin|rifaximin|mesh-list
1917033|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1917034|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917035|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1917036|NCT00533949|Paclitaxel|paclitaxel|mesh-list
1917037|NCT00533949|Carboplatin|carboplatin|mesh-list
1917038|NCT00533949|Cetuximab|cetuximab|mesh-list
1917039|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1917040|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917041|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
1917042|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
1917043|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
1917044|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917045|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917046|NCT00534001|Bupropion|bupropion|mesh-list
1917047|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1917048|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917049|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917050|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1917051|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1917052|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917053|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917054|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
1917055|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917056|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917057|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1917058|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1917059|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917060|NCT00534313|Abatacept|abatacept|mesh-list
1917061|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1917062|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917063|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917064|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917065|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
1917066|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917067|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917068|NCT00534352|Ritonavir|ritonavir|mesh-list
1917069|NCT00534352|Darunavir|darunavir|mesh-list
1917070|NCT00534352|Etravirine|etravirine|mesh-list
1917071|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1917072|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1917073|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
1917074|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917075|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917076|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1917077|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1917078|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
1917079|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917080|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1917081|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1917082|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1917083|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1917084|NCT00534404|Nicotine|nicotine|mesh-list
1917085|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1917086|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
1917087|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917088|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917089|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1917090|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1917091|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
1917092|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917093|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917094|NCT00534417|Capecitabine|capecitabine|mesh-list
1917095|NCT00534417|Fulvestrant|fulvestrant|mesh-list
1917096|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917097|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
1917098|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917099|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917100|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1917101|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1917102|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1917103|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
1917104|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917105|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917106|NCT00534495|Rilonacept|rilonacept|mesh-list
1917107|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917108|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1917109|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917110|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917111|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1917112|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917113|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917114|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917115|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1917116|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1917117|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1917118|NCT00534794|Analgesics|analgesics|mesh-ancestor
1917119|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
1917120|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917121|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917122|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917123|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917124|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1917125|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1917126|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1917127|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
1917128|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
1917129|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917130|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917131|NCT00534833|Vaccines|vaccines|mesh-list
1917132|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
1917133|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917134|NCT00534976|Montelukast|montelukast|mesh-list
1917135|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1917136|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
1917137|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1917138|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
1917139|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917140|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917141|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1917142|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1917143|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917144|NCT00535002|Yohimbine|yohimbine|mesh-list
1917145|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
1917146|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
1917147|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917148|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917149|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1917150|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1917151|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1917152|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
1917153|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917154|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917155|NCT00535002|Urological Agents|urological agents|mesh-ancestor
1917156|NCT00535132|Risperidone|risperidone|mesh-list
1917157|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1917158|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1917159|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
1917160|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917161|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917162|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917163|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1917164|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917165|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917166|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917167|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1917168|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
1917169|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1917170|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1917171|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1917172|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1917173|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917174|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917175|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917176|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917177|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1917178|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1917179|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
1917180|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917181|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917182|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1917183|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1917184|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
1917185|NCT00535288|Mirtazapine|mirtazapine|mesh-list
1917186|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917187|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917188|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917189|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1917190|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
1917191|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
1917192|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917193|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917194|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1917195|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917196|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917197|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1917198|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1917199|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1917200|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
1917201|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1917202|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1917203|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
1917204|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1917205|NCT00535392|Levetiracetam|levetiracetam|mesh-list
1917206|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
1917207|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
1917208|NCT00535405|Atorvastatin|atorvastatin|mesh-list
1917209|NCT00535405|Simvastatin|simvastatin|mesh-list
1917210|NCT00535405|Ezetimibe|ezetimibe|mesh-list
1917211|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1917212|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1917213|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
1917214|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917215|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1917216|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1917217|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917218|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
1917297|NCT00535925|Analgesics|analgesics|mesh-ancestor
1917219|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1917220|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917221|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917222|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
1917223|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917224|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917225|NCT00535613|Propofol|propofol|mesh-list
1917226|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1917227|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917228|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917229|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1917230|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
1917231|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
1917232|NCT00535652|Ertapenem|ertapenem|mesh-list
1917233|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1917234|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917235|NCT00535730|Vaccines|vaccines|mesh-list
1917236|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1917237|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
1917238|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917239|NCT00535743|Bromides|bromides|mesh-list
1917240|NCT00535743|Rocuronium|rocuronium|mesh-list
1917241|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
1917242|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1917243|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1917244|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1917245|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917246|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917247|NCT00535782|Methotrexate|methotrexate|mesh-list
1917248|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1917249|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
1917250|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1917251|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917252|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917253|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
1917254|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917255|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917256|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
1917257|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917258|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1917259|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917260|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
1917261|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917262|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1917263|NCT00535847|Interferons|interferons|mesh-list
1917264|NCT00535847|Ribavirin|ribavirin|mesh-list
1917265|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
1917266|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
1917267|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1917268|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917269|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
1917270|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917271|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
1917272|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917273|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
1917274|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917275|NCT00535873|Lenalidomide|lenalidomide|mesh-list
1917276|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
1917277|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917278|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917279|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917280|NCT00535873|Growth Substances|growth substances|mesh-ancestor
1917281|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917282|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917283|NCT00535925|Aspirin|aspirin|mesh-list
1917284|NCT00535925|Atenolol|atenolol|mesh-list
1917285|NCT00535925|Amlodipine|amlodipine|mesh-list
1917286|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1917287|NCT00535925|Clonidine|clonidine|mesh-list
1917288|NCT00535925|Ramipril|ramipril|mesh-list
1917289|NCT00535925|Irbesartan|irbesartan|mesh-list
1917290|NCT00535925|Doxazosin|doxazosin|mesh-list
1917291|NCT00535925|Furosemide|furosemide|mesh-list
1917292|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
1917293|NCT00535925|Simvastatin|simvastatin|mesh-list
1917294|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917295|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1917296|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1917298|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
1917299|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917300|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917301|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917302|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1917303|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1917304|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917305|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1917306|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1917307|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917308|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
1917309|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1917310|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1917311|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917312|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1917313|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
1917314|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1917315|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1917316|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
1917317|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1917318|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1917319|NCT00535925|Diuretics|diuretics|mesh-ancestor
1917320|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
1917321|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1917322|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1917323|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
1917324|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
1917325|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1917326|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1917327|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1917328|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
1917329|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917330|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1917331|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
1917332|NCT00535925|Hematinics|hematinics|mesh-ancestor
1917333|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1917334|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1917335|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1917336|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1917337|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1917338|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1917339|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1917340|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1917341|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
1917342|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1917343|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1917344|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1917345|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917346|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917347|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
1917348|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917349|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917350|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1917351|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917352|NCT00536107|Docetaxel|docetaxel|mesh-list
1917353|NCT00536107|Gefitinib|gefitinib|mesh-list
1917354|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917355|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
1917356|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
1917357|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
1917358|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917359|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1917360|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917361|NCT00536120|Natalizumab|natalizumab|mesh-list
1917362|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
1917363|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
1917364|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917365|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1917366|NCT00536172|Citalopram|citalopram|mesh-list
1917367|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1917368|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1917369|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917444|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1917370|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917371|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917372|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
1917373|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917374|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1917375|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917376|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917377|NCT00536198|Sertraline|sertraline|mesh-list
1917378|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917379|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917380|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1917381|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1917382|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917383|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917384|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917385|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
1917386|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917387|NCT00536263|Interferons|interferons|mesh-list
1917388|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
1917389|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
1917390|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1917391|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917392|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
1917393|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917394|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
1917395|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917396|NCT00536341|Rituximab|rituximab|mesh-list
1917397|NCT00536341|Fludarabine|fludarabine|mesh-list
1917398|NCT00536341|Lenalidomide|lenalidomide|mesh-list
1917399|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917400|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917401|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
1917402|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917403|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917404|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917405|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917406|NCT00536341|Growth Substances|growth substances|mesh-ancestor
1917407|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917408|NCT00536380|Loratadine|loratadine|mesh-list
1917409|NCT00536380|Desloratadine|desloratadine|mesh-list
1917410|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1917411|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
1917412|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917413|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917414|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917415|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1917416|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1917417|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
1917418|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
1917419|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
1917420|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
1917421|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1917422|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1917423|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1917424|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1917425|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917426|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917427|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917428|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917429|NCT00536471|Analgesics|analgesics|mesh-ancestor
1917430|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
1917431|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917432|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917433|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917434|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
1917435|NCT00536484|Fesoterodine|fesoterodine|mesh-list
1917436|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1917437|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1917438|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
1917439|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917440|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917441|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917442|NCT00536484|Urological Agents|urological agents|mesh-ancestor
1917443|NCT00536510|Niacin|niacin|mesh-list
1917445|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
1917446|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917447|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1917448|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
1917449|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
1917450|NCT00536510|Vitamins|vitamins|mesh-ancestor
1917451|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
1917452|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917453|NCT00536575|Bortezomib|bortezomib|mesh-list
1917454|NCT00536575|Sorafenib|sorafenib|mesh-list
1917455|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917456|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1917457|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917458|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917459|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
1917460|NCT00536601|Melphalan|melphalan|mesh-list
1917461|NCT00536601|Busulfan|busulfan|mesh-list
1917462|NCT00536601|Thiotepa|thiotepa|mesh-list
1917463|NCT00536601|Carmustine|carmustine|mesh-list
1917464|NCT00536601|Carboplatin|carboplatin|mesh-list
1917465|NCT00536601|Etoposide|etoposide|mesh-list
1917466|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
1917467|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917468|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
1917469|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917470|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917471|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1917472|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
1917473|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917474|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917475|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1917476|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1917477|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1917478|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1917479|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917480|NCT00536731|Budesonide|budesonide|mesh-list
1917481|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1917482|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1917483|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
1917484|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917485|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1917486|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
1917487|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917488|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917489|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
1917490|NCT00536731|Hormones|hormones|mesh-ancestor
1917491|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917492|NCT00536809|Capecitabine|capecitabine|mesh-list
1917493|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
1917494|NCT00536809|Lapatinib|lapatinib|mesh-list
1917495|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917496|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
1917497|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917498|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917499|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1917500|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917501|NCT00536874|Gemcitabine|gemcitabine|mesh-list
1917502|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
1917503|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917504|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
1917505|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917506|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917507|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
1917508|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917509|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917510|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917511|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
1917512|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917513|NCT00536913|Budesonide|budesonide|mesh-list
1917514|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
1917515|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1917516|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917517|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1917518|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
1917519|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917520|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917521|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1917522|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
1917523|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
1917524|NCT00536913|Hormones|hormones|mesh-ancestor
1917525|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917526|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1917527|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1917528|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1917529|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
1917530|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917531|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917532|NCT00536939|Paclitaxel|paclitaxel|mesh-list
1917533|NCT00536939|Bevacizumab|bevacizumab|mesh-list
1917534|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1917535|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917536|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
1917537|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
1917538|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
1917539|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917540|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917541|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917542|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917543|NCT00536939|Growth Substances|growth substances|mesh-ancestor
1917544|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917545|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917546|NCT00536991|Calcitriol|calcitriol|mesh-list
1917547|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
1917548|NCT00536991|Ketoconazole|ketoconazole|mesh-list
1917549|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
1917550|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1917551|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1917552|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1917553|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917554|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
1917555|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917556|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1917557|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1917558|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917559|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917560|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1917561|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
1917562|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917563|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917564|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1917565|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1917566|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1917567|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917568|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1917569|NCT00536991|Vitamins|vitamins|mesh-ancestor
1917570|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
1917571|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1917572|NCT00537017|Levodopa|levodopa|mesh-list
1917573|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1917574|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1917575|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
1917576|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917577|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917578|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917579|NCT00537030|Asparaginase|asparaginase|mesh-list
1917580|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917581|NCT00537056|Sunitinib|sunitinib|mesh-list
1917582|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1917583|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917584|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917585|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917586|NCT00537056|Growth Substances|growth substances|mesh-ancestor
1917587|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917588|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917589|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1917590|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917591|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917592|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1917593|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1917594|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1917595|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917596|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917597|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
1917598|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917599|NCT00537238|Pregabalin|pregabalin|mesh-list
1917600|NCT00537238|Levetiracetam|levetiracetam|mesh-list
1917601|NCT00537238|Analgesics|analgesics|mesh-ancestor
1917602|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
1917603|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917604|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917605|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
1917606|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1917607|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917608|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917609|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1917610|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1917611|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917612|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917613|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917614|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
1917615|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
1917616|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
1917617|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1917618|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1917619|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917620|NCT00537290|Rituximab|rituximab|mesh-list
1917621|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917622|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917623|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
1917624|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917625|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917626|NCT00537303|Insulin|insulin|mesh-list
1917627|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1917628|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
1917629|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
1917630|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1917631|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
1917632|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1917633|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917634|NCT00537316|Azathioprine|azathioprine|mesh-list
1917635|NCT00537316|Infliximab|infliximab|mesh-list
1917636|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
1917637|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1917638|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917639|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
1917640|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917641|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917642|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917643|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917644|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
1917645|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917646|NCT00537329|Anidulafungin|anidulafungin|mesh-list
1917647|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
1917648|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917649|NCT00537381|Prednisone|prednisone|mesh-list
1917650|NCT00537381|Docetaxel|docetaxel|mesh-list
1917651|NCT00537381|Intetumumab|intetumumab|mesh-list
1917652|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917653|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
1917654|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
1917655|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
1917656|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917657|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917658|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
1917659|NCT00537381|Hormones|hormones|mesh-ancestor
1917660|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917661|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917662|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1917663|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917664|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
1917665|NCT00537394|Maraviroc|maraviroc|mesh-list
1917666|NCT00537394|Darunavir|darunavir|mesh-list
1917667|NCT00537394|Tipranavir|tipranavir|mesh-list
1917668|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
1917669|NCT00537394|Etravirine|etravirine|mesh-list
1917670|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1917671|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1917672|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
1917673|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917674|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1917675|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1917676|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917677|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917678|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1917679|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1917680|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1917681|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1917682|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1917683|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
1917684|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1917685|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1917686|NCT00537407|Ribavirin|ribavirin|mesh-list
1917687|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1917688|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
1917689|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917690|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
1917691|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917692|NCT00537511|Etoposide|etoposide|mesh-list
1917693|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
1917694|NCT00537511|Pomalidomide|pomalidomide|mesh-list
1917695|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917696|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1917697|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1917698|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1917699|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917700|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917701|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
1917702|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917703|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917704|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917705|NCT00537511|Growth Substances|growth substances|mesh-ancestor
1917706|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917707|NCT00537680|Ubiquinone|ubiquinone|mesh-list
1917708|NCT00537680|Idebenone|idebenone|mesh-list
1917709|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
1917710|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917711|NCT00537680|Protective Agents|protective agents|mesh-ancestor
1917712|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917713|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
1917714|NCT00537745|Naltrexone|naltrexone|mesh-list
1917715|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1917716|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1917717|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917718|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
1917719|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917720|NCT00537771|Tamoxifen|tamoxifen|mesh-list
1917721|NCT00537771|Anastrozole|anastrozole|mesh-list
1917722|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1917723|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
1917724|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917725|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917726|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1917727|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917728|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1917729|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1917730|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1917731|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1917732|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1917733|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917734|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917735|NCT00537810|Sibutramine|sibutramine|mesh-list
1917736|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
1917737|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917738|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
1917739|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1917740|NCT00537823|Leucovorin|leucovorin|mesh-list
1917741|NCT00537823|Bevacizumab|bevacizumab|mesh-list
1917742|NCT00537823|Cetuximab|cetuximab|mesh-list
1917743|NCT00537823|Fluorouracil|fluorouracil|mesh-list
1917744|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
1917745|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917746|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917747|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917748|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917749|NCT00537823|Growth Substances|growth substances|mesh-ancestor
1917750|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917751|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917752|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
1917753|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917754|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917755|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917756|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
1917757|NCT00537823|Antidotes|antidotes|mesh-ancestor
1917758|NCT00537823|Protective Agents|protective agents|mesh-ancestor
1917759|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
1917760|NCT00537823|Vitamins|vitamins|mesh-ancestor
1917761|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
1917762|NCT00537940|Pregabalin|pregabalin|mesh-list
1917763|NCT00537940|Gabapentin|gabapentin|mesh-list
1917764|NCT00537940|Analgesics|analgesics|mesh-ancestor
1917765|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
1917766|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917767|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917768|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
1917769|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1917770|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917771|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917772|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1917773|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1917774|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917775|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917776|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917777|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1917778|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1917779|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917780|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
1917781|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
1917782|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1917783|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917784|NCT00537979|Vitamins|vitamins|mesh-ancestor
1917785|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
1917786|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1917787|NCT00538291|Capecitabine|capecitabine|mesh-list
1917788|NCT00538291|Cetuximab|cetuximab|mesh-list
1917789|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1917790|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
1917791|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917792|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917793|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1917794|NCT00538304|Bimatoprost|bimatoprost|mesh-list
1917795|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1917796|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1917797|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1917798|NCT00538434|Reslizumab|reslizumab|mesh-list
1917799|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1917800|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
1917801|NCT00538590|Mitomycins|mitomycins|mesh-list
1917802|NCT00538590|Mitomycin|mitomycin|mesh-list
1917803|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1917804|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917805|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
1917806|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917807|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1917808|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917809|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
1917810|NCT00538616|Propofol|propofol|mesh-list
1917811|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1917812|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917813|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917814|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1917815|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
1917816|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
1917817|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1917818|NCT00538616|Analgesics|analgesics|mesh-ancestor
1917819|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
1917820|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917821|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1917822|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1917823|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1917824|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
1917825|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917826|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917827|NCT00538642|Ziprasidone|ziprasidone|mesh-list
1917828|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1917829|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
1917830|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917831|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917832|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917833|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1917834|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1917835|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917836|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917837|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1917838|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
1917839|NCT00538681|Pemetrexed|pemetrexed|mesh-list
1917840|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917841|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917842|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917843|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1917844|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1917845|NCT00538733|Clarithromycin|clarithromycin|mesh-list
1917846|NCT00538733|Thalidomide|thalidomide|mesh-list
1917847|NCT00538733|Dexamethasone|dexamethasone|mesh-list
1917848|NCT00538733|Lenalidomide|lenalidomide|mesh-list
1917849|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917850|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
1917851|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
1917852|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917853|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917854|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1917855|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
1917856|NCT00538733|Hormones|hormones|mesh-ancestor
1917857|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917858|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1917859|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917860|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
1917861|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917862|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917863|NCT00538733|Growth Substances|growth substances|mesh-ancestor
1917864|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917865|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1917866|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917867|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1917868|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917869|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917870|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1917871|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1917872|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917873|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
1917874|NCT00538785|Palivizumab|palivizumab|mesh-list
1917875|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
1917876|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917877|NCT00538824|Thalidomide|thalidomide|mesh-list
1917878|NCT00538824|Dexamethasone|dexamethasone|mesh-list
1917879|NCT00538824|Lenalidomide|lenalidomide|mesh-list
1917880|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917881|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
1917882|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
1917883|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917884|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917885|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1917886|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
1917887|NCT00538824|Hormones|hormones|mesh-ancestor
1917888|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917889|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1917890|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917891|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
1917892|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1917893|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1917894|NCT00538824|Growth Substances|growth substances|mesh-ancestor
1917895|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
1917896|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1917897|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
1917898|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1917899|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917900|NCT00538850|Fentanyl|fentanyl|mesh-list
1917901|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1917902|NCT00538850|Narcotics|narcotics|mesh-ancestor
1917903|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917904|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917905|NCT00538850|Analgesics|analgesics|mesh-ancestor
1917906|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
1917907|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917908|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1917909|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1917910|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
1917911|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
1917912|NCT00538863|Fentanyl|fentanyl|mesh-list
1917913|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1917914|NCT00538863|Narcotics|narcotics|mesh-ancestor
1917915|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1917916|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917917|NCT00538863|Analgesics|analgesics|mesh-ancestor
1917918|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
1917919|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917920|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1917921|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1917922|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
1917923|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
1917924|NCT00538902|Adalimumab|adalimumab|mesh-list
1917925|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917926|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1917927|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
1917928|NCT00538915|Antibodies|antibodies|mesh-list
1917929|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
1917930|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1917931|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1917932|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
1917933|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917934|NCT00539006|Fluticasone|fluticasone|mesh-list
1917935|NCT00539006|Xhance|xhance|mesh-list
1917936|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1917937|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1917938|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
1917939|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1917940|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917941|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1917942|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
1917943|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
1917944|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1917945|NCT00539032|Vaccines|vaccines|mesh-list
1917946|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
1917947|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917948|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
1917949|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1917950|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
1917951|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1917952|NCT00539188|Expectorants|expectorants|mesh-ancestor
1917953|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
1917954|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1917955|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
1917956|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917957|NCT00539188|Protective Agents|protective agents|mesh-ancestor
1917958|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917959|NCT00539188|Antidotes|antidotes|mesh-ancestor
1917960|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
1917961|NCT00539240|Nortriptyline|nortriptyline|mesh-list
1917962|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
1917963|NCT00539240|Rabeprazole|rabeprazole|mesh-list
1917964|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1917965|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1917966|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1917967|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917968|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917969|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1917970|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1917971|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1917972|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1917973|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
1917974|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1917975|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917976|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
1917977|NCT00539305|Testosterone|testosterone|mesh-list
1917978|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
1917979|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
1917980|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1917981|NCT00539305|Androgens|androgens|mesh-ancestor
1917982|NCT00539305|Hormones|hormones|mesh-ancestor
1917983|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1917984|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1917985|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1917986|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917987|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
1917988|NCT00539500|Carboplatin|carboplatin|mesh-list
1917989|NCT00539500|Etoposide|etoposide|mesh-list
1917990|NCT00539500|Melphalan|melphalan|mesh-list
1917991|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1917992|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1917993|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1917994|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1917995|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1917996|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1917997|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1917998|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
1917999|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918000|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918001|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
1918002|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918003|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
1918004|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1918005|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
1918006|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918007|NCT00539513|Expectorants|expectorants|mesh-ancestor
1918008|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918009|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1918010|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
1918011|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918012|NCT00539513|Protective Agents|protective agents|mesh-ancestor
1918013|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918014|NCT00539513|Antidotes|antidotes|mesh-ancestor
1918015|NCT00539526|Bimatoprost|bimatoprost|mesh-list
1918016|NCT00539526|Travoprost|travoprost|mesh-list
1918017|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1918018|NCT00539526|Latanoprost|latanoprost|mesh-list
1918019|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1918020|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1918021|NCT00539591|Interferons|interferons|mesh-list
1918022|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
1918023|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
1918024|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1918025|NCT00539591|Temozolomide|temozolomide|mesh-list
1918026|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918027|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
1918028|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918029|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918030|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
1918031|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918032|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
1918033|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918034|NCT00539695|Aldesleukin|aldesleukin|mesh-list
1918035|NCT00539695|Interleukin-2|interleukin-2|mesh-list
1918036|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918037|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1918038|NCT00539695|Analgesics|analgesics|mesh-ancestor
1918039|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
1918040|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918041|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918042|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1918043|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1918044|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
1918045|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918046|NCT00539734|Ranibizumab|ranibizumab|mesh-list
1918047|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918048|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918049|NCT00539734|Growth Substances|growth substances|mesh-ancestor
1918050|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918051|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918353|NCT00541970|Vaccines|vaccines|mesh-list
1918052|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918053|NCT00539864|Vaccines|vaccines|mesh-list
1918054|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
1918055|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
1918056|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918057|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
1918058|NCT00539942|PENTA|penta|mesh-list
1918059|NCT00539942|Fondaparinux|fondaparinux|mesh-list
1918060|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1918061|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
1918062|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1918063|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918064|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918065|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918066|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
1918067|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1918068|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1918069|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
1918070|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
1918071|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918072|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
1918073|NCT00539994|Retapamulin|retapamulin|mesh-list
1918074|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1918075|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918076|NCT00540007|Lenalidomide|lenalidomide|mesh-list
1918077|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
1918078|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918079|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918080|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918081|NCT00540007|Growth Substances|growth substances|mesh-ancestor
1918082|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918083|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918084|NCT00540046|Copper|copper|mesh-list
1918085|NCT00540046|Trace Elements|trace elements|mesh-ancestor
1918086|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
1918087|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918088|NCT00540124|Tadalafil|tadalafil|mesh-list
1918089|NCT00540124|Tamsulosin|tamsulosin|mesh-list
1918090|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
1918091|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1918092|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1918093|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918094|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918095|NCT00540124|Urological Agents|urological agents|mesh-ancestor
1918096|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1918097|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1918098|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1918099|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
1918100|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918101|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918102|NCT00540293|Atorvastatin|atorvastatin|mesh-list
1918103|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1918104|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1918105|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
1918106|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918107|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1918108|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1918109|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918110|NCT00540436|Ambrisentan|ambrisentan|mesh-list
1918111|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1918112|NCT00540449|Efavirenz|efavirenz|mesh-list
1918113|NCT00540449|Rilpivirine|rilpivirine|mesh-list
1918114|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1918115|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1918116|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918117|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918118|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
1918119|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918120|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1918121|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1918122|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1918123|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1918124|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1918125|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1918126|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1918127|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1918128|NCT00540514|Paclitaxel|paclitaxel|mesh-list
1918129|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1918130|NCT00540514|Carboplatin|carboplatin|mesh-list
1918131|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918132|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918133|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918134|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918135|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918136|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918137|NCT00540579|Gemcitabine|gemcitabine|mesh-list
1918138|NCT00540579|Pomalidomide|pomalidomide|mesh-list
1918139|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1918140|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
1918141|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918142|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918143|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
1918144|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918145|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918146|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918147|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
1918148|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918149|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918150|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918151|NCT00540579|Growth Substances|growth substances|mesh-ancestor
1918152|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918153|NCT00540644|Prednisone|prednisone|mesh-list
1918154|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
1918155|NCT00540644|Lenalidomide|lenalidomide|mesh-list
1918156|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918157|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
1918158|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918159|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918160|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918161|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
1918162|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918163|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918164|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918165|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918166|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
1918167|NCT00540644|Hormones|hormones|mesh-ancestor
1918168|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918169|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1918170|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918171|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918172|NCT00540644|Growth Substances|growth substances|mesh-ancestor
1918173|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918174|NCT00540722|Acetic Acid|acetic acid|mesh-list
1918175|NCT00540722|Retinol acetate|retinol acetate|mesh-list
1918176|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
1918177|NCT00540722|Gossypol|gossypol|mesh-list
1918178|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1918179|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918180|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1918181|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
1918182|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918183|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1918184|NCT00540722|Protective Agents|protective agents|mesh-ancestor
1918185|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918186|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1918187|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
1918188|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1918189|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918190|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1918191|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1918192|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1918193|NCT00540982|Vinorelbine|vinorelbine|mesh-list
1918194|NCT00540982|Lidocaine|lidocaine|mesh-list
1918195|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
1918196|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
1918197|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1918198|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918199|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
1918200|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918201|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1918202|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1918203|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1918204|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1918205|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918206|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918207|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918208|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918209|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918210|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918211|NCT00540995|Etoposide|etoposide|mesh-list
1918212|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
1918213|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
1918214|NCT00540995|Busulfan|busulfan|mesh-list
1918215|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918216|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918217|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1918218|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1918219|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918220|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918221|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
1918222|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918223|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
1918224|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918225|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918226|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918227|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
1918228|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
1918229|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918230|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918231|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918232|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
1918233|NCT00541034|Rituximab|rituximab|mesh-list
1918234|NCT00541034|Pentostatin|pentostatin|mesh-list
1918235|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918236|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
1918237|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918238|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918239|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918240|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
1918241|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918242|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918243|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918244|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918245|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1918246|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918247|NCT00541099|Bevacizumab|bevacizumab|mesh-list
1918248|NCT00541099|Docetaxel|docetaxel|mesh-list
1918249|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918250|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918251|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918252|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918253|NCT00541099|Growth Substances|growth substances|mesh-ancestor
1918254|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918255|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918256|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918257|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918258|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918259|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918260|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1918261|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1918262|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918263|NCT00541229|Incretins|incretins|mesh-ancestor
1918264|NCT00541229|Hormones|hormones|mesh-ancestor
1918265|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918266|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1918267|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918268|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918269|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918270|NCT00541242|Bimatoprost|bimatoprost|mesh-list
1918271|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1918272|NCT00541242|Latanoprost|latanoprost|mesh-list
1918273|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1918274|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1918275|NCT00541307|Heparin|heparin|mesh-list
1918276|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
1918277|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1918278|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1918279|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918280|NCT00541346|Methylphenidate|methylphenidate|mesh-list
1918281|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1918282|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918283|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1918284|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1918285|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1918286|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918287|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
1918288|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918289|NCT00541385|Artesunate|artesunate|mesh-list
1918290|NCT00541385|Lumefantrine|lumefantrine|mesh-list
1918291|NCT00541385|Pyronaridine|pyronaridine|mesh-list
1918292|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
1918293|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1918294|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1918295|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918296|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918297|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
1918298|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
1918299|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1918300|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
1918301|NCT00541450|Metformin|metformin|mesh-list
1918302|NCT00541450|Pioglitazone|pioglitazone|mesh-list
1918303|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1918304|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1918305|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918306|NCT00541450|Incretins|incretins|mesh-ancestor
1918307|NCT00541450|Hormones|hormones|mesh-ancestor
1918308|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918309|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1918310|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918311|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918312|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918313|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
1918314|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
1918315|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1918316|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1918317|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918318|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1918319|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918320|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1918321|NCT00541671|Promethazine|promethazine|mesh-list
1918322|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
1918323|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
1918324|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1918325|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
1918326|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
1918327|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918328|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918329|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918330|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1918331|NCT00541775|Metformin|metformin|mesh-list
1918332|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1918333|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
1918334|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1918335|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918336|NCT00541775|Incretins|incretins|mesh-ancestor
1918337|NCT00541775|Hormones|hormones|mesh-ancestor
1918338|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918339|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1918340|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918341|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918342|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918343|NCT00541866|Cytarabine|cytarabine|mesh-list
1918344|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1918345|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
1918346|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918347|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918348|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
1918349|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918350|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918351|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
1918352|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918354|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
1918355|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918356|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1918357|NCT00542178|Simvastatin|simvastatin|mesh-list
1918358|NCT00542178|Fenofibrate|fenofibrate|mesh-list
1918359|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1918360|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1918361|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
1918362|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918363|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1918364|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1918365|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918366|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918367|NCT00542191|Paclitaxel|paclitaxel|mesh-list
1918368|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
1918369|NCT00542191|Carboplatin|carboplatin|mesh-list
1918370|NCT00542191|Doxorubicin|doxorubicin|mesh-list
1918371|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918372|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918373|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918374|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918375|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918376|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918377|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918378|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
1918379|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918380|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918381|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918382|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
1918383|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918384|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1918385|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1918386|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1918387|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918388|NCT00542269|Amlodipine|amlodipine|mesh-list
1918389|NCT00542269|Ramipril|ramipril|mesh-list
1918390|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1918391|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1918392|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1918393|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918394|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1918395|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918396|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
1918397|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1918398|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918399|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918400|NCT00542308|Zalutumumab|zalutumumab|mesh-list
1918401|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918402|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918403|NCT00542425|Teriparatide|teriparatide|mesh-list
1918404|NCT00542425|Abaloparatide|abaloparatide|mesh-list
1918405|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
1918406|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1918407|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918408|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1918409|NCT00542620|Insulin|insulin|mesh-list
1918410|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1918411|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
1918412|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
1918413|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1918414|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
1918415|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1918416|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918417|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
1918418|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1918419|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
1918420|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918421|NCT00542750|Expectorants|expectorants|mesh-ancestor
1918422|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918423|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1918424|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
1918425|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918426|NCT00542750|Protective Agents|protective agents|mesh-ancestor
1918427|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918428|NCT00542750|Antidotes|antidotes|mesh-ancestor
1918429|NCT00542789|Esomeprazole|esomeprazole|mesh-list
1918430|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1918431|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1918432|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1918433|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918434|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918435|NCT00542815|Sevelamer|sevelamer|mesh-list
1918436|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
1918437|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
1918438|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918439|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
1918440|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
1918441|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1918442|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
1918443|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918444|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918445|NCT00542880|Fluticasone|fluticasone|mesh-list
1918446|NCT00542880|Budesonide|budesonide|mesh-list
1918447|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
1918448|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1918449|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1918450|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1918451|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918452|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1918453|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
1918454|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918455|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918456|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1918457|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918458|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
1918459|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1918460|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
1918461|NCT00542880|Hormones|hormones|mesh-ancestor
1918462|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918463|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1918464|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1918465|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1918466|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
1918467|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918468|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918469|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
1918470|NCT00542971|Cytarabine|cytarabine|mesh-list
1918471|NCT00542971|Sorafenib|sorafenib|mesh-list
1918472|NCT00542971|Idarubicin|idarubicin|mesh-list
1918473|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1918474|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
1918475|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918476|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918477|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
1918478|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918479|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918480|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
1918481|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918482|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1918483|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918484|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1918485|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1918486|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1918487|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
1918488|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1918489|NCT00542997|Antibodies|antibodies|mesh-list
1918490|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
1918491|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918492|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
1918493|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
1918494|NCT00543062|Loxapine|loxapine|mesh-list
1918495|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1918496|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918497|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1918498|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1918499|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918500|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918501|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918502|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918503|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
1918504|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
1918505|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918506|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1918507|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1918508|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1918509|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1918510|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1918511|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1918512|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
1918513|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918514|NCT00543101|Darunavir|darunavir|mesh-list
1918515|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1918516|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1918517|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918518|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918519|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918520|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1918521|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1918522|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
1918523|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918524|NCT00543127|Fulvestrant|fulvestrant|mesh-list
1918525|NCT00543127|Anastrozole|anastrozole|mesh-list
1918526|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1918527|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918528|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1918529|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1918530|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
1918531|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918532|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918533|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1918534|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1918535|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918536|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918537|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1918538|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918539|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
1918540|NCT00543296|Hormones|hormones|mesh-ancestor
1918541|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918542|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918543|NCT00543309|Milrinone|milrinone|mesh-list
1918544|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1918545|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
1918546|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918547|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1918548|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1918549|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
1918550|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1918551|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1918552|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918553|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918554|NCT00543309|Protective Agents|protective agents|mesh-ancestor
1918555|NCT00543387|Docetaxel|docetaxel|mesh-list
1918556|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918557|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918558|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918559|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918560|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918561|NCT00543400|Heparin|heparin|mesh-list
1918562|NCT00543400|Calcium heparin|calcium heparin|mesh-list
1918563|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
1918564|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1918565|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1918566|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918567|NCT00543439|Factor VIII|factor viii|mesh-list
1918568|NCT00543439|Coagulants|coagulants|mesh-ancestor
1918569|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
1918570|NCT00543569|Alefacept|alefacept|mesh-list
1918571|NCT00543569|Tacrolimus|tacrolimus|mesh-list
1918572|NCT00543569|Basiliximab|basiliximab|mesh-list
1918573|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918574|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
1918575|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918576|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1918577|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918578|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918579|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1918580|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918581|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1918582|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
1918583|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1918584|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918585|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
1918586|NCT00543725|Efavirenz|efavirenz|mesh-list
1918587|NCT00543725|Rilpivirine|rilpivirine|mesh-list
1918588|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1918589|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1918590|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918591|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918592|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
1918593|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918594|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1918595|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1918596|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1918597|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1918598|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1918599|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1918600|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1918601|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1918602|NCT00543855|Donepezil|donepezil|mesh-list
1918603|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1918604|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918605|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918606|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
1918607|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918608|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918609|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
1918610|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
1918611|NCT00544076|Alprostadil|alprostadil|mesh-list
1918612|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918613|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
1918614|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1918615|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1918616|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918617|NCT00544076|Urological Agents|urological agents|mesh-ancestor
1918618|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1918619|NCT00544167|Paclitaxel|paclitaxel|mesh-list
1918620|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
1918621|NCT00544167|Doxorubicin|doxorubicin|mesh-list
1918622|NCT00544167|Sorafenib|sorafenib|mesh-list
1918623|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918624|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918625|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918626|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918627|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918628|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918629|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918630|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
1918631|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918632|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918633|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918634|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
1918635|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918636|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1918637|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1918638|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1918639|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918640|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1918641|NCT00544440|Prednisone|prednisone|mesh-list
1918642|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
1918643|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918644|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
1918645|NCT00544440|Hormones|hormones|mesh-ancestor
1918646|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918647|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918648|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1918649|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918650|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1918651|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918652|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918653|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
1918654|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1918655|NCT00544544|Riluzole|riluzole|mesh-list
1918656|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
1918657|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1918658|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1918659|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918660|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918661|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918662|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1918663|NCT00544544|Protective Agents|protective agents|mesh-ancestor
1918664|NCT00544557|Etanercept|etanercept|mesh-list
1918665|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1918666|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1918667|NCT00544557|Analgesics|analgesics|mesh-ancestor
1918668|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
1918669|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918670|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918671|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918672|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918673|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1918674|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918675|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
1918676|NCT00544648|Paclitaxel|paclitaxel|mesh-list
1918677|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1918678|NCT00544648|Carboplatin|carboplatin|mesh-list
1918679|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918680|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918681|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918682|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918683|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918684|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918685|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1918686|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
1918687|NCT00544713|Glycerol|glycerol|mesh-list
1918688|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1918689|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1918690|NCT00544713|Laxatives|laxatives|mesh-ancestor
1918691|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1918692|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1918693|NCT00544713|Protective Agents|protective agents|mesh-ancestor
1918694|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918695|NCT00544778|Doxorubicin|doxorubicin|mesh-list
1918696|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1918697|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
1918698|NCT00544778|Irinotecan|irinotecan|mesh-list
1918699|NCT00544778|Ifosfamide|ifosfamide|mesh-list
1918700|NCT00544778|Razoxane|razoxane|mesh-list
1918701|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1918702|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918703|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1918704|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1918705|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918706|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918707|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1918708|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918709|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918710|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
1918711|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1918712|NCT00544778|Protective Agents|protective agents|mesh-ancestor
1918713|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918714|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918715|NCT00544817|Temozolomide|temozolomide|mesh-list
1918716|NCT00544817|Sorafenib|sorafenib|mesh-list
1918717|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918718|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
1918719|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918720|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918721|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1918722|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918723|NCT00544869|Tolvaptan|tolvaptan|mesh-list
1918724|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1918725|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918726|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
1918727|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918728|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1918729|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1918730|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1918731|NCT00544882|Desogestrel|desogestrel|mesh-list
1918732|NCT00544882|Oviol|oviol|mesh-list
1918733|NCT00544882|Estradiol|estradiol|mesh-list
1918734|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1918735|NCT00544882|Estrogens|estrogens|mesh-ancestor
1918736|NCT00544882|Hormones|hormones|mesh-ancestor
1918737|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918738|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918739|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1918740|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
1918741|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1918742|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1918743|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1918744|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1918745|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1918746|NCT00544882|Progestins|progestins|mesh-ancestor
1918747|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1918748|NCT00544908|Dasatinib|dasatinib|mesh-list
1918749|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918750|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1918751|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918752|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918753|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
1918754|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1918755|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918756|NCT00545064|Timolol|timolol|mesh-list
1918757|NCT00545064|Dorzolamide|dorzolamide|mesh-list
1918758|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1918759|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1918760|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
1918761|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918762|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918763|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918764|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1918765|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1918766|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918767|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1918768|NCT00545077|Bevacizumab|bevacizumab|mesh-list
1918769|NCT00545077|Letrozole|letrozole|mesh-list
1918770|NCT00545077|Fulvestrant|fulvestrant|mesh-list
1918771|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918772|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918773|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918774|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918775|NCT00545077|Growth Substances|growth substances|mesh-ancestor
1918776|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918777|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918778|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1918779|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1918780|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918781|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918782|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1918783|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
1918784|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918785|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1918786|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1918787|NCT00545103|Mesalamine|mesalamine|mesh-list
1918788|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1918789|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1918790|NCT00545103|Analgesics|analgesics|mesh-ancestor
1918791|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
1918792|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918793|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918794|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918795|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918801|NCT00545168|Permethrin|permethrin|mesh-list
1918802|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918803|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918804|NCT00545181|Metronidazole|metronidazole|mesh-list
1918805|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918806|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1918807|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1918808|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1918809|NCT00545233|Pioglitazone|pioglitazone|mesh-list
1918810|NCT00545233|Ribavirin|ribavirin|mesh-list
1918811|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1918812|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
1918813|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918814|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
1918815|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918816|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1918817|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918818|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
1918819|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1918820|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
1918821|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918822|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918823|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1918824|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918825|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1918826|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1918827|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1918828|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
1918829|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918830|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918831|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
1918832|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1918833|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
1918834|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918835|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918836|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1918837|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918838|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1918839|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
1918840|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918841|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918842|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1918843|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
1918844|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
1918845|NCT00545298|Protective Agents|protective agents|mesh-ancestor
1918846|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
1918847|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1918848|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918849|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
1918850|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1918851|NCT00545402|Tacrolimus|tacrolimus|mesh-list
1918852|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918853|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
1918854|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918855|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1918856|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918857|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918858|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1918859|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918860|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1918861|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
1918862|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1918863|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918864|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918865|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
1918866|NCT00545402|Hormones|hormones|mesh-ancestor
1918867|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918868|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1918869|NCT00545402|Protective Agents|protective agents|mesh-ancestor
1918870|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1918871|NCT00545532|Oseltamivir|oseltamivir|mesh-list
1918872|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
1918873|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1918874|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918875|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918876|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
1918877|NCT00545571|Hematinics|hematinics|mesh-ancestor
1918878|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1918879|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1918880|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918881|NCT00545584|Incretins|incretins|mesh-ancestor
1918882|NCT00545584|Hormones|hormones|mesh-ancestor
1918883|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918884|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1918885|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
1918886|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918887|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918888|NCT00545662|Choline|choline|mesh-list
1918889|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1918890|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
1918891|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1918892|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
1918893|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918894|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1918895|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1918896|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
1918897|NCT00545688|Docetaxel|docetaxel|mesh-list
1918898|NCT00545688|Trastuzumab|trastuzumab|mesh-list
1918899|NCT00545688|Pertuzumab|pertuzumab|mesh-list
1918900|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918901|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918902|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918903|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918904|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918905|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918906|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
1918907|NCT00545714|Rituximab|rituximab|mesh-list
1918908|NCT00545714|Fludarabine|fludarabine|mesh-list
1918909|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1918910|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
1918911|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918912|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918913|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1918914|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
1918915|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918916|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918917|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1918918|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918919|NCT00545740|Mesalamine|mesalamine|mesh-list
1918920|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1918921|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1918922|NCT00545740|Analgesics|analgesics|mesh-ancestor
1918923|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
1918924|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918925|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918926|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918927|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1918928|NCT00545753|Permethrin|permethrin|mesh-list
1918929|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918930|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918931|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
1918932|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1918933|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918934|NCT00545792|Bevacizumab|bevacizumab|mesh-list
1918935|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1918936|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918937|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1918938|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1918939|NCT00545792|Growth Substances|growth substances|mesh-ancestor
1918940|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918941|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
1918942|NCT00545844|Montelukast|montelukast|mesh-list
1918943|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1918944|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918945|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1918946|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
1918947|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1918948|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918949|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1918950|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1918951|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918952|NCT00545948|Cisplatin|cisplatin|mesh-list
1918953|NCT00545948|Pemetrexed|pemetrexed|mesh-list
1918954|NCT00545948|Vinorelbine|vinorelbine|mesh-list
1918955|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1918956|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1918957|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918958|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1918959|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1918960|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1918961|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
1918962|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
1918963|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
1918964|NCT00545974|Memantine|memantine|mesh-list
1918965|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1918966|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1918967|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
1918968|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1918969|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918970|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918971|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1918972|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1918973|NCT00546000|Fluticasone|fluticasone|mesh-list
1918974|NCT00546000|Xhance|xhance|mesh-list
1918975|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1918976|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1918977|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
1918978|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1918979|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918980|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1918981|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
1918982|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
1918983|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1918984|NCT00546052|Losartan|losartan|mesh-list
1918985|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1918986|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1918987|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1918988|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1918989|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1918990|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1918991|NCT00546052|Diuretics|diuretics|mesh-ancestor
1918992|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
1918993|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918994|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1918995|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1918996|NCT00546078|Vaccines|vaccines|mesh-list
1918997|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
1918998|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1918999|NCT00546104|Dasatinib|dasatinib|mesh-list
1919000|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919001|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919002|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919003|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919004|NCT00546117|Lansoprazole|lansoprazole|mesh-list
1919005|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
1919006|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1919007|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1919008|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1919009|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919010|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919011|NCT00546156|Paclitaxel|paclitaxel|mesh-list
1919012|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
1919013|NCT00546156|Bevacizumab|bevacizumab|mesh-list
1919014|NCT00546156|Doxorubicin|doxorubicin|mesh-list
1919015|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1919016|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919017|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
1919018|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
1919019|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
1919020|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919021|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919022|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
1919023|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919024|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919025|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1919026|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
1919027|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1919028|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919029|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1919030|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1919031|NCT00546156|Growth Substances|growth substances|mesh-ancestor
1919032|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
1919033|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1919034|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1919035|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1919036|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919037|NCT00546273|Vaccines|vaccines|mesh-list
1919038|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
1919039|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919040|NCT00546351|Lacosamide|lacosamide|mesh-list
1919041|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
1919042|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1919043|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1919044|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919045|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919046|NCT00546364|Docetaxel|docetaxel|mesh-list
1919047|NCT00546364|Capecitabine|capecitabine|mesh-list
1919048|NCT00546364|Epothilones|epothilones|mesh-list
1919049|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919050|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
1919051|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
1919052|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
1919053|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919054|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919055|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
1919056|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
1919057|NCT00546377|Rituximab|rituximab|mesh-list
1919058|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
1919059|NCT00546377|Pentostatin|pentostatin|mesh-list
1919060|NCT00546377|Sargramostim|sargramostim|mesh-list
1919061|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919062|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
1919063|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919064|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919065|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1919066|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
1919067|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919068|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919069|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1919070|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919071|NCT00546377|Analgesics|analgesics|mesh-ancestor
1919072|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
1919073|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919074|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1919075|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1919076|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919077|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1919078|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
1919079|NCT00546481|Hematinics|hematinics|mesh-ancestor
1919080|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1919081|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
1919082|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919083|NCT00546637|Fesoterodine|fesoterodine|mesh-list
1919084|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1919085|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1919086|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
1919087|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919088|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919089|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919090|NCT00546637|Urological Agents|urological agents|mesh-ancestor
1919091|NCT00546728|Metformin|metformin|mesh-list
1919092|NCT00546728|Exenatide|exenatide|mesh-list
1919093|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1919094|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919095|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1919096|NCT00546728|Incretins|incretins|mesh-ancestor
1919097|NCT00546728|Hormones|hormones|mesh-ancestor
1919098|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919099|NCT00546754|Losartan|losartan|mesh-list
1919100|NCT00546754|Valsartan|valsartan|mesh-list
1919101|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1919102|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1919103|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1919104|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1919105|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919106|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1919107|NCT00546754|Diuretics|diuretics|mesh-ancestor
1919108|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
1919109|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919110|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1919111|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919112|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
1919113|NCT00546871|Antibodies|antibodies|mesh-list
1919114|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
1919115|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1919116|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1919117|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
1919118|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919119|NCT00546897|Lenalidomide|lenalidomide|mesh-list
1919120|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
1919121|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919122|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1919123|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1919124|NCT00546897|Growth Substances|growth substances|mesh-ancestor
1919125|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
1919126|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919127|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1919128|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1919129|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1919130|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919131|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919132|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
1919133|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919134|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919135|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1919136|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919137|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919138|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919139|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919140|NCT00547118|Rimonabant|rimonabant|mesh-list
1919141|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1919142|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
1919143|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1919144|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919145|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919146|NCT00547118|Hormones|hormones|mesh-ancestor
1919147|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919148|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919149|NCT00547157|Cisplatin|cisplatin|mesh-list
1919150|NCT00547157|Panitumumab|panitumumab|mesh-list
1919151|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919152|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919153|NCT00547248|Vaccines|vaccines|mesh-list
1919154|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1919155|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
1919156|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919157|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
1919158|NCT00547365|Antibodies|antibodies|mesh-list
1919159|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
1919160|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1919161|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1919162|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
1919163|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919164|NCT00547521|Methotrexate|methotrexate|mesh-list
1919165|NCT00547521|Abatacept|abatacept|mesh-list
1919166|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1919167|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
1919168|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1919169|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919170|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919171|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
1919172|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919173|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919174|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
1919175|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919176|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1919177|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919178|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
1919179|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919180|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1919181|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1919182|NCT00547534|Rituximab|rituximab|mesh-list
1919183|NCT00547534|Bortezomib|bortezomib|mesh-list
1919184|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1919185|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919186|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919187|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
1919188|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919189|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919190|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1919191|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
1919192|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919193|NCT00547586|Bromides|bromides|mesh-list
1919194|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
1919195|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
1919196|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1919197|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919198|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
1919199|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919200|NCT00547703|Nortriptyline|nortriptyline|mesh-list
1919201|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1919202|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
1919203|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919204|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1919205|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1919206|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919207|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919208|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
1919209|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919210|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919211|NCT00547911|Carbidopa|carbidopa|mesh-list
1919212|NCT00547911|Entacapone|entacapone|mesh-list
1919213|NCT00547911|Droxidopa|droxidopa|mesh-list
1919214|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1919215|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1919216|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
1919217|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919218|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919219|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919220|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1919221|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919222|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1919223|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
1919224|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1919225|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919226|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
1919227|NCT00548145|Ezetimibe|ezetimibe|mesh-list
1919228|NCT00548145|Pitavastatin|pitavastatin|mesh-list
1919229|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1919230|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1919231|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
1919232|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919233|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1919234|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1919235|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919236|NCT00548184|Trastuzumab|trastuzumab|mesh-list
1919237|NCT00548184|Lapatinib|lapatinib|mesh-list
1919238|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919239|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919240|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919241|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919242|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919243|NCT00548197|Bevacizumab|bevacizumab|mesh-list
1919244|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919245|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919246|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1919247|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1919248|NCT00548197|Growth Substances|growth substances|mesh-ancestor
1919249|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919250|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
1919251|NCT00548249|Iron|iron|mesh-list
1919252|NCT00548249|Trace Elements|trace elements|mesh-ancestor
1919253|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
1919254|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919255|NCT00548262|Voriconazole|voriconazole|mesh-list
1919256|NCT00548262|Anidulafungin|anidulafungin|mesh-list
1919257|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
1919258|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919259|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1919260|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1919261|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919262|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919263|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1919264|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
1919265|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919266|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919267|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1919268|NCT00548405|Interferons|interferons|mesh-list
1919269|NCT00548405|Interferon-beta|interferon-beta|mesh-list
1919270|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
1919271|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
1919272|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919273|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
1919274|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919275|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919276|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
1919277|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919278|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1919279|NCT00548418|Bevacizumab|bevacizumab|mesh-list
1919280|NCT00548418|Topotecan|topotecan|mesh-list
1919281|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919282|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919283|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1919284|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1919285|NCT00548418|Growth Substances|growth substances|mesh-ancestor
1919286|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919287|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
1919288|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1919289|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1919290|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919291|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919292|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
1919293|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
1919294|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919295|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919296|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919297|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919298|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
1919299|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919300|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1919301|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919302|NCT00548470|Varenicline|varenicline|mesh-list
1919303|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1919304|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1919305|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
1919306|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919307|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919308|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919309|NCT00548548|Bevacizumab|bevacizumab|mesh-list
1919310|NCT00548548|Fluorouracil|fluorouracil|mesh-list
1919311|NCT00548548|Capecitabine|capecitabine|mesh-list
1919312|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919313|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919314|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1919315|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1919316|NCT00548548|Growth Substances|growth substances|mesh-ancestor
1919317|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919318|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
1919319|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
1919320|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919321|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919322|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919323|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
1919324|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
1919325|NCT00548717|Sirolimus|sirolimus|mesh-list
1919326|NCT00548717|Bortezomib|bortezomib|mesh-list
1919327|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1919328|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919329|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1919330|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
1919331|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1919332|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919333|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919334|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919335|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
1919336|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919337|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
1919338|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919339|NCT00548808|Insulin|insulin|mesh-list
1919340|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1919341|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
1919342|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
1919343|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1919344|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919345|NCT00548847|Interferons|interferons|mesh-list
1919346|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
1919347|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
1919348|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1919349|NCT00548847|Molgramostim|molgramostim|mesh-list
1919350|NCT00548847|Sargramostim|sargramostim|mesh-list
1919351|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919352|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
1919353|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919354|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
1919355|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919356|NCT00549042|Hydromorphone|hydromorphone|mesh-list
1919357|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1919358|NCT00549042|Narcotics|narcotics|mesh-ancestor
1919359|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919360|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919361|NCT00549042|Analgesics|analgesics|mesh-ancestor
1919362|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
1919363|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919364|NCT00549198|Tenofovir|tenofovir|mesh-list
1919365|NCT00549198|Lamivudine|lamivudine|mesh-list
1919366|NCT00549198|Emtricitabine|emtricitabine|mesh-list
1919367|NCT00549198|Efavirenz|efavirenz|mesh-list
1919368|NCT00549198|Abacavir|abacavir|mesh-list
1919369|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
1919370|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919371|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1919372|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1919373|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919374|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919375|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1919376|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1919377|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1919378|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1919379|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1919380|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1919381|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1919382|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1919383|NCT00549302|Tadalafil|tadalafil|mesh-list
1919384|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
1919385|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1919386|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1919387|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919388|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919389|NCT00549302|Urological Agents|urological agents|mesh-ancestor
1919390|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
1919391|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1919392|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1919393|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919394|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
1919395|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
1919396|NCT00549445|Azithromycin|azithromycin|mesh-list
1919397|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1919398|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919399|NCT00549549|Celecoxib|celecoxib|mesh-list
1919400|NCT00549549|Indomethacin|indomethacin|mesh-list
1919401|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1919402|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1919403|NCT00549549|Analgesics|analgesics|mesh-ancestor
1919404|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
1919405|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919406|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919407|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919408|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919409|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1919410|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1919411|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919412|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919413|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
1919414|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
1919415|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1919416|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1919417|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1919418|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919419|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919420|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919421|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919422|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1919423|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1919424|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
1919425|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919426|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919427|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1919428|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1919429|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
1919430|NCT00549601|Rivastigmine|rivastigmine|mesh-list
1919431|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1919432|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919433|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919434|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
1919435|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919436|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919437|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1919438|NCT00549601|Protective Agents|protective agents|mesh-ancestor
1919439|NCT00549640|Methylphenidate|methylphenidate|mesh-list
1919440|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1919441|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919442|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1919443|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1919444|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919445|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919446|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
1919447|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919448|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1919449|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1919450|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919451|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919452|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919453|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919454|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1919455|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1919456|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1919457|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
1919458|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919459|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919460|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1919461|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1919462|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
1919463|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1919464|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1919465|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
1919466|NCT00549770|Valsartan|valsartan|mesh-list
1919467|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1919468|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1919469|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1919470|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1919471|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919472|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
1919473|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1919474|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1919475|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1919476|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919477|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919478|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
1919479|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919480|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919481|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1919482|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919483|NCT00549822|Letrozole|letrozole|mesh-list
1919484|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919485|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1919486|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1919487|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919488|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919489|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1919490|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
1919491|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919492|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919493|NCT00549900|Vaccines|vaccines|mesh-list
1919494|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
1919495|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919496|NCT00549939|Alfuzosin|alfuzosin|mesh-list
1919497|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1919498|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1919499|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1919500|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
1919501|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919502|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919503|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919504|NCT00549939|Urological Agents|urological agents|mesh-ancestor
1919505|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1919506|NCT00550147|Methylphenidate|methylphenidate|mesh-list
1919507|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1919508|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919509|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1919510|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1919511|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919512|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919513|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
1919514|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919515|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
1919516|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919517|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1919518|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919519|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919520|NCT00550173|Pemetrexed|pemetrexed|mesh-list
1919521|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1919522|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919523|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919524|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919525|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1919526|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1919527|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919528|NCT00550238|Pimavanserin|pimavanserin|mesh-list
1919529|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1919530|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1919531|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1919532|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919533|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919534|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919535|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919536|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1919537|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1919538|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
1919539|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919540|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919541|NCT00550277|Panobinostat|panobinostat|mesh-list
1919542|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919543|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1919544|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919545|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919546|NCT00550290|Cefazolin|cefazolin|mesh-list
1919547|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1919548|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919549|NCT00550394|Topiramate|topiramate|mesh-list
1919550|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1919551|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
1919552|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919553|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1919554|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919555|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919556|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919557|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
1919558|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1919559|NCT00550407|Lamotrigine|lamotrigine|mesh-list
1919560|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
1919561|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1919562|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919563|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919564|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1919565|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919566|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1919567|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919568|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919569|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919570|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1919571|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
1919572|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1919573|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919574|NCT00550446|Adalimumab|adalimumab|mesh-list
1919575|NCT00550446|Tofacitinib|tofacitinib|mesh-list
1919576|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919577|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919578|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919579|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919580|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919581|NCT00550459|Tolvaptan|tolvaptan|mesh-list
1919582|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1919583|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919584|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
1919585|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919586|NCT00550537|Paclitaxel|paclitaxel|mesh-list
1919587|NCT00550537|Bevacizumab|bevacizumab|mesh-list
1919588|NCT00550537|Carboplatin|carboplatin|mesh-list
1919589|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1919590|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1919591|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919592|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
1919593|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
1919594|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
1919595|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919596|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919597|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1919598|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1919599|NCT00550537|Growth Substances|growth substances|mesh-ancestor
1919600|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919601|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
1919602|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919603|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919604|NCT00550550|Fluticasone|fluticasone|mesh-list
1919605|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
1919606|NCT00550550|Loratadine|loratadine|mesh-list
1919607|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1919608|NCT00550550|Prednisone|prednisone|mesh-list
1919609|NCT00550550|Albuterol|albuterol|mesh-list
1919610|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919611|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
1919612|NCT00550550|Hormones|hormones|mesh-ancestor
1919613|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919614|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919615|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1919616|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919617|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1919618|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
1919619|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919620|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1919621|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
1919622|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
1919623|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1919624|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
1919625|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1919626|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1919627|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1919628|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1919629|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
1919630|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919631|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919632|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
1919633|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1919634|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1919635|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
1919636|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
1919637|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1919638|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1919639|NCT00550550|Analgesics|analgesics|mesh-ancestor
1919640|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
1919641|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919642|NCT00550589|Cidofovir|cidofovir|mesh-list
1919643|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
1919644|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919645|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919646|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919647|NCT00550615|Dasatinib|dasatinib|mesh-list
1919648|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919649|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919650|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919651|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919652|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
1919653|NCT00550680|Hematinics|hematinics|mesh-ancestor
1919654|NCT00550732|Posaconazole|posaconazole|mesh-list
1919655|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
1919656|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919657|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1919658|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1919659|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1919660|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1919661|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1919662|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919663|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919664|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1919665|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
1919666|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919667|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919668|NCT00550771|Paclitaxel|paclitaxel|mesh-list
1919669|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1919670|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
1919671|NCT00550771|Doxorubicin|doxorubicin|mesh-list
1919672|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1919673|NCT00550771|Trastuzumab|trastuzumab|mesh-list
1919674|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1919675|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919676|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
1919677|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
1919678|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
1919679|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919680|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919681|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
1919682|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919683|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919684|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1919685|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
1919686|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1919687|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1919688|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1919689|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1919690|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919691|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919692|NCT00550836|Gemcitabine|gemcitabine|mesh-list
1919693|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1919694|NCT00550836|Panitumumab|panitumumab|mesh-list
1919695|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919696|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
1919697|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919698|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919699|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
1919700|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919701|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919702|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919703|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
1919704|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919705|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1919706|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919707|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1919708|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1919709|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1919710|NCT00550953|Amlodipine|amlodipine|mesh-list
1919711|NCT00550953|Telmisartan|telmisartan|mesh-list
1919712|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1919713|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1919714|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1919715|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919716|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919717|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1919718|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919719|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
1919720|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1919721|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1919722|NCT00551031|Vaccines|vaccines|mesh-list
1919723|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
1919724|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919725|NCT00551135|Pregabalin|pregabalin|mesh-list
1919726|NCT00551135|Analgesics|analgesics|mesh-ancestor
1919727|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
1919728|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919729|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919730|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
1919731|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1919732|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919733|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919734|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1919735|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1919736|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1919737|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919738|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919739|NCT00551161|Memantine|memantine|mesh-list
1919740|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1919741|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1919742|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
1919743|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919744|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919745|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919746|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1919747|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1919748|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
1919749|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1919750|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919751|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1919752|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919753|NCT00551213|Capecitabine|capecitabine|mesh-list
1919754|NCT00551213|Irinotecan|irinotecan|mesh-list
1919755|NCT00551213|Cetuximab|cetuximab|mesh-list
1919756|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919757|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
1919758|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919759|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919760|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1919761|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1919762|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919763|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919764|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
1919765|NCT00551291|Prednisone|prednisone|mesh-list
1919766|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
1919767|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919768|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
1919769|NCT00551291|Hormones|hormones|mesh-ancestor
1919845|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1919770|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919771|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919772|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1919773|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919774|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1919775|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1919776|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
1919777|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1919778|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919779|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919780|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919781|NCT00551291|Hematinics|hematinics|mesh-ancestor
1919782|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1919783|NCT00551421|Cetuximab|cetuximab|mesh-list
1919784|NCT00551421|Pertuzumab|pertuzumab|mesh-list
1919785|NCT00551421|Irinotecan|irinotecan|mesh-list
1919786|NCT00551421|Antibodies|antibodies|mesh-list
1919787|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
1919788|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1919789|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
1919790|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919791|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919792|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1919793|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1919794|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919795|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919796|NCT00551460|Methotrexate|methotrexate|mesh-list
1919797|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
1919798|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
1919799|NCT00551460|Tretinoin|tretinoin|mesh-list
1919800|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
1919801|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1919802|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
1919803|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1919804|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919805|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919806|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
1919807|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919808|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919809|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
1919810|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919811|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1919812|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919813|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
1919814|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919815|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1919816|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
1919817|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919818|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
1919819|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1919820|NCT00551525|Analgesics|analgesics|mesh-ancestor
1919821|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
1919822|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919823|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919824|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
1919825|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1919826|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
1919827|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919828|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919829|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1919830|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
1919831|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1919832|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
1919833|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919834|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919835|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1919836|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
1919837|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
1919838|NCT00551642|Protective Agents|protective agents|mesh-ancestor
1919839|NCT00551707|Prednisolone|prednisolone|mesh-list
1919840|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1919841|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
1919842|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1919843|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
1919844|NCT00551707|Dipyridamole|dipyridamole|mesh-list
1919846|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
1919847|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919848|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
1919849|NCT00551707|Hormones|hormones|mesh-ancestor
1919850|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1919851|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919852|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1919853|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919854|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
1919855|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
1919856|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919857|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1919858|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1919859|NCT00551707|Protective Agents|protective agents|mesh-ancestor
1919860|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1919861|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919862|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919863|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1919864|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
1919865|NCT00551759|Docetaxel|docetaxel|mesh-list
1919866|NCT00551759|Fluorouracil|fluorouracil|mesh-list
1919867|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
1919868|NCT00551759|Cetuximab|cetuximab|mesh-list
1919869|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919870|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
1919871|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
1919872|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
1919873|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919874|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
1919875|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1919876|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919877|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
1919878|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919879|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1919880|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
1919881|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919882|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
1919883|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1919884|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
1919885|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919886|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
1919887|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919888|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919889|NCT00552071|Octreotide|octreotide|mesh-list
1919890|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1919891|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1919892|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1919893|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
1919894|NCT00552110|Phenylephrine|phenylephrine|mesh-list
1919895|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
1919896|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1919897|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
1919898|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1919899|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1919900|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1919901|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
1919902|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919903|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919904|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919905|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
1919906|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
1919907|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919908|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
1919909|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1919910|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
1919911|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1919912|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
1919913|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1919914|NCT00552110|Protective Agents|protective agents|mesh-ancestor
1919915|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1919916|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1919917|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1919918|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919919|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919920|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919921|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919922|NCT00552175|Analgesics|analgesics|mesh-ancestor
1919923|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
1919924|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919925|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
1919926|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1919927|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
1919928|NCT00552188|Atreleuton|atreleuton|mesh-list
1919929|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1919930|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919931|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919932|NCT00552240|Ritonavir|ritonavir|mesh-list
1919933|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1919934|NCT00552240|Tenofovir|tenofovir|mesh-list
1919935|NCT00552240|Emtricitabine|emtricitabine|mesh-list
1919936|NCT00552240|Nevirapine|nevirapine|mesh-list
1919937|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1919938|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1919939|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
1919940|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1919941|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919942|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1919943|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1919944|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
1919945|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1919946|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1919947|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1919948|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1919949|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1919950|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1919951|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1919952|NCT00552279|Vaccines|vaccines|mesh-list
1919953|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
1919954|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919955|NCT00552305|Lacosamide|lacosamide|mesh-list
1919956|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
1919957|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1919958|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1919959|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1919960|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919961|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
1919962|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1919963|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
1919964|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919965|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1919966|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
1919967|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1919968|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919969|NCT00552409|Vitamins|vitamins|mesh-ancestor
1919970|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
1919971|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1919972|NCT00552422|Domperidone|domperidone|mesh-list
1919973|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
1919974|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
1919975|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919976|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919977|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1919978|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1919979|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
1919980|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1919981|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1919982|NCT00552578|Buprenorphine|buprenorphine|mesh-list
1919983|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1919984|NCT00552578|Naloxone|naloxone|mesh-list
1919985|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1919986|NCT00552578|Narcotics|narcotics|mesh-ancestor
1919987|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1919988|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1919989|NCT00552578|Analgesics|analgesics|mesh-ancestor
1919990|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
1919991|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919992|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1919993|NCT00552617|Rocuronium|rocuronium|mesh-list
1919994|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
1919995|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1919996|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1919997|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1919998|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1919999|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920000|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1920001|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1920002|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
1920003|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920004|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920005|NCT00552669|Sirolimus|sirolimus|mesh-list
1920006|NCT00552669|Paclitaxel|paclitaxel|mesh-list
1920007|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920008|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920009|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920010|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920011|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920012|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920013|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920014|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920015|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1920016|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
1920017|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920018|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
1920019|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920020|NCT00552695|Lidocaine|lidocaine|mesh-list
1920021|NCT00552695|Tetracaine|tetracaine|mesh-list
1920022|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
1920023|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
1920024|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920025|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920026|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
1920027|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920028|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1920029|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1920030|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1920031|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920032|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920033|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
1920034|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1920035|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
1920036|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920037|NCT00552786|Expectorants|expectorants|mesh-ancestor
1920038|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920039|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1920040|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
1920041|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920042|NCT00552786|Protective Agents|protective agents|mesh-ancestor
1920043|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920044|NCT00552786|Antidotes|antidotes|mesh-ancestor
1920045|NCT00553059|Dexamethasone|dexamethasone|mesh-list
1920046|NCT00553059|Dronabinol|dronabinol|mesh-list
1920047|NCT00553059|Palonosetron|palonosetron|mesh-list
1920048|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920049|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
1920050|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
1920051|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920052|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920053|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1920054|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
1920055|NCT00553059|Hormones|hormones|mesh-ancestor
1920056|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920057|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1920058|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920059|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1920060|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1920061|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
1920062|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920063|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920064|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
1920065|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1920066|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1920067|NCT00553059|Analgesics|analgesics|mesh-ancestor
1920068|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
1920069|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1920070|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1920071|NCT00553098|Cyclosporine|cyclosporine|mesh-list
1920072|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
1920073|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1920074|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
1920075|NCT00553098|Fludarabine|fludarabine|mesh-list
1920076|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
1920077|NCT00553098|Antibodies|antibodies|mesh-list
1920078|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
1920079|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1920080|NCT00553098|Cyclosporins|cyclosporins|mesh-list
1920081|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
1920082|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920083|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920084|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920085|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
1920086|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920087|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920088|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920089|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
1920090|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920091|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920092|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920093|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1920094|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1920095|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1920096|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
1920097|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920098|NCT00553150|Everolimus|everolimus|mesh-list
1920099|NCT00553150|Temozolomide|temozolomide|mesh-list
1920100|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920101|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920102|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
1920103|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920104|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1920105|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
1920106|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920107|NCT00553202|Cyclosporine|cyclosporine|mesh-list
1920108|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
1920109|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1920110|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1920111|NCT00553202|Prednisolone|prednisolone|mesh-list
1920112|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
1920113|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
1920114|NCT00553202|Busulfan|busulfan|mesh-list
1920115|NCT00553202|Methotrexate|methotrexate|mesh-list
1920116|NCT00553202|Tacrolimus|tacrolimus|mesh-list
1920117|NCT00553202|Cyclosporins|cyclosporins|mesh-list
1920118|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
1920119|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1920120|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1920121|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
1920122|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920123|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
1920124|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920125|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920126|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1920127|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
1920128|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920129|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920130|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1920131|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1920132|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
1920133|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1920134|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920135|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
1920136|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920137|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920138|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1920139|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1920140|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1920141|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
1920142|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920143|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920144|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
1920145|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
1920146|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920147|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1920148|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
1920149|NCT00553202|Hormones|hormones|mesh-ancestor
1920150|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920151|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1920152|NCT00553202|Protective Agents|protective agents|mesh-ancestor
1920153|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1920154|NCT00553267|Amlodipine|amlodipine|mesh-list
1920155|NCT00553267|Telmisartan|telmisartan|mesh-list
1920156|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1920157|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1920158|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1920159|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920160|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920161|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1920162|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920163|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
1920164|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1920165|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1920166|NCT00553280|Pregabalin|pregabalin|mesh-list
1920167|NCT00553280|Analgesics|analgesics|mesh-ancestor
1920168|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
1920169|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920170|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920171|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
1920172|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1920173|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920174|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920175|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1920176|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1920177|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1920178|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920179|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1920180|NCT00553319|Amphetamine|amphetamine|mesh-list
1920181|NCT00553319|Adderall|adderall|mesh-list
1920182|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1920183|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920184|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
1920185|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
1920186|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920187|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
1920188|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920189|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920190|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920191|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1920192|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1920193|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920194|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1920195|NCT00553358|Paclitaxel|paclitaxel|mesh-list
1920196|NCT00553358|Trastuzumab|trastuzumab|mesh-list
1920197|NCT00553358|Lapatinib|lapatinib|mesh-list
1920198|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920199|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920200|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920201|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920202|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920203|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920204|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1920205|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920206|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920207|NCT00553410|Letrozole|letrozole|mesh-list
1920208|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920209|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1920210|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1920211|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920212|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920213|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1920214|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
1920215|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920216|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920217|NCT00553462|Paclitaxel|paclitaxel|mesh-list
1920218|NCT00553462|Carboplatin|carboplatin|mesh-list
1920219|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1920220|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1920221|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920222|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920223|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920224|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920225|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920226|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920227|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920228|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920229|NCT00553475|Pregabalin|pregabalin|mesh-list
1920230|NCT00553475|Analgesics|analgesics|mesh-ancestor
1920231|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
1920232|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920233|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920234|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
1920235|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1920236|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920237|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920238|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1920239|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1920240|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1920241|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920242|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1920243|NCT00553501|Rituximab|rituximab|mesh-list
1920244|NCT00553501|Epratuzumab|epratuzumab|mesh-list
1920245|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1920246|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920247|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
1920248|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920249|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920250|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1920251|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1920252|NCT00553514|Hormones|hormones|mesh-ancestor
1920253|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920254|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920255|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1920256|NCT00553605|Ketoprofen|ketoprofen|mesh-list
1920257|NCT00553605|Parecoxib|parecoxib|mesh-list
1920258|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1920259|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1920260|NCT00553605|Analgesics|analgesics|mesh-ancestor
1920261|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
1920262|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920263|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920264|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920265|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920266|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1920267|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920268|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920269|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1920270|NCT00553644|Lenalidomide|lenalidomide|mesh-list
1920271|NCT00553644|Bortezomib|bortezomib|mesh-list
1920272|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
1920273|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920274|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1920275|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1920276|NCT00553644|Growth Substances|growth substances|mesh-ancestor
1920277|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
1920278|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920279|NCT00553696|Sunitinib|sunitinib|mesh-list
1920280|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920281|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1920282|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1920283|NCT00553696|Growth Substances|growth substances|mesh-ancestor
1920284|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920285|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
1920286|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920287|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920288|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920289|NCT00553735|Cyclosporine|cyclosporine|mesh-list
1920290|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
1920291|NCT00553735|Cyclosporins|cyclosporins|mesh-list
1920292|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920293|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920294|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920295|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
1920296|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920297|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
1920298|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920299|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920300|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920301|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1920302|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1920303|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1920304|NCT00553839|Ketamine|ketamine|mesh-list
1920305|NCT00553839|Analgesics|analgesics|mesh-ancestor
1920306|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
1920307|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920308|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920309|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1920310|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1920311|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
1920312|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
1920313|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920314|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1920315|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1920316|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920317|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920318|NCT00553969|Carvedilol|carvedilol|mesh-list
1920319|NCT00553969|Lisinopril|lisinopril|mesh-list
1920320|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1920321|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1920322|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920323|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920324|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920325|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920326|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1920327|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
1920328|NCT00553969|Protective Agents|protective agents|mesh-ancestor
1920329|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1920330|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920331|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1920332|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
1920333|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1920334|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1920335|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1920336|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
1920337|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920338|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1920339|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1920340|NCT00554099|Mesalamine|mesalamine|mesh-list
1920341|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920342|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1920343|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1920344|NCT00554099|Analgesics|analgesics|mesh-ancestor
1920345|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
1920346|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920347|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920348|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920349|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920350|NCT00554216|Topiramate|topiramate|mesh-list
1920351|NCT00554216|Phentermine|phentermine|mesh-list
1920352|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
1920353|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1920354|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920355|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1920356|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
1920357|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1920358|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
1920359|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
1920360|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920361|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920362|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920363|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920364|NCT00554463|Etoposide|etoposide|mesh-list
1920365|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920366|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920367|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1920368|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1920369|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920447|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920370|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920371|NCT00554515|Aldesleukin|aldesleukin|mesh-list
1920372|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920373|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1920374|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1920375|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
1920376|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920377|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
1920378|NCT00554788|Thiotepa|thiotepa|mesh-list
1920379|NCT00554788|Cisplatin|cisplatin|mesh-list
1920380|NCT00554788|Carboplatin|carboplatin|mesh-list
1920381|NCT00554788|Etoposide|etoposide|mesh-list
1920382|NCT00554788|Vincristine|vincristine|mesh-list
1920383|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
1920384|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
1920385|NCT00554788|Lenograstim|lenograstim|mesh-list
1920386|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920387|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
1920388|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920389|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920390|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1920391|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
1920392|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920393|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920394|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1920395|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920396|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1920397|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1920398|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920399|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1920400|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920401|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920402|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920403|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
1920404|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920405|NCT00554840|Varenicline|varenicline|mesh-list
1920406|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1920407|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1920408|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
1920409|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920410|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920411|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920412|NCT00554853|Pioglitazone|pioglitazone|mesh-list
1920413|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
1920414|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1920415|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920416|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
1920417|NCT00554970|Budesonide|budesonide|mesh-list
1920418|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920419|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1920420|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
1920421|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920422|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920423|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1920424|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920425|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
1920426|NCT00554970|Hormones|hormones|mesh-ancestor
1920427|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920428|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
1920429|NCT00555048|Busulfan|busulfan|mesh-list
1920430|NCT00555048|Methotrexate|methotrexate|mesh-list
1920431|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
1920432|NCT00555048|Tacrolimus|tacrolimus|mesh-list
1920433|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920434|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
1920435|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920436|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920437|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1920438|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
1920439|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920440|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920441|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1920442|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1920443|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
1920444|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1920445|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920446|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
1920448|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920449|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1920450|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1920451|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1920452|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1920453|NCT00555061|Retapamulin|retapamulin|mesh-list
1920454|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920455|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920456|NCT00555152|Lapatinib|lapatinib|mesh-list
1920457|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920458|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920459|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920460|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920461|NCT00555217|Losartan|losartan|mesh-list
1920462|NCT00555217|Lisinopril|lisinopril|mesh-list
1920463|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1920464|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1920465|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1920466|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1920467|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920468|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1920469|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
1920470|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920471|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1920472|NCT00555217|Protective Agents|protective agents|mesh-ancestor
1920473|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920474|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
1920475|NCT00555321|Abatacept|abatacept|mesh-list
1920476|NCT00555321|Tacrolimus|tacrolimus|mesh-list
1920477|NCT00555321|Basiliximab|basiliximab|mesh-list
1920478|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920479|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
1920480|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920481|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1920482|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920483|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920484|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1920485|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920486|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1920487|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
1920488|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920489|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920490|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1920491|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920492|NCT00555425|Buprenorphine|buprenorphine|mesh-list
1920493|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1920494|NCT00555425|Naloxone|naloxone|mesh-list
1920495|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1920496|NCT00555425|Narcotics|narcotics|mesh-ancestor
1920497|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920498|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920499|NCT00555425|Analgesics|analgesics|mesh-ancestor
1920500|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
1920501|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920502|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1920503|NCT00555438|PENTA|penta|mesh-list
1920504|NCT00555438|Fondaparinux|fondaparinux|mesh-list
1920505|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1920506|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
1920507|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1920508|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
1920509|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920510|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920511|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
1920512|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1920513|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1920514|NCT00555464|Prednisone|prednisone|mesh-list
1920515|NCT00555464|Prednisolone|prednisolone|mesh-list
1920516|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1920517|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
1920518|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1920519|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
1920520|NCT00555464|Vincristine|vincristine|mesh-list
1920521|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1920522|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
1920523|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920524|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
1920525|NCT00555464|Hormones|hormones|mesh-ancestor
1920526|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920527|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920528|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1920529|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920530|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920531|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920532|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920533|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920534|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920535|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
1920536|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
1920537|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920538|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1920539|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1920540|NCT00555464|Protective Agents|protective agents|mesh-ancestor
1920541|NCT00555477|Anastrozole|anastrozole|mesh-list
1920542|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1920543|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920544|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1920545|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1920546|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920547|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920548|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1920549|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
1920550|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920551|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920552|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
1920553|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920554|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920555|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920556|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920557|NCT00555620|Capecitabine|capecitabine|mesh-list
1920558|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
1920559|NCT00555620|Sunitinib|sunitinib|mesh-list
1920560|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920561|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920562|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
1920563|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920564|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1920565|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1920566|NCT00555620|Growth Substances|growth substances|mesh-ancestor
1920567|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920568|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
1920569|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920570|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920571|NCT00555672|Fluorouracil|fluorouracil|mesh-list
1920572|NCT00555672|Sunitinib|sunitinib|mesh-list
1920573|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920574|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
1920575|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920576|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920577|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920578|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
1920579|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920580|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1920581|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1920582|NCT00555672|Growth Substances|growth substances|mesh-ancestor
1920583|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
1920584|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920585|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920586|NCT00555750|Eszopiclone|eszopiclone|mesh-list
1920587|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1920588|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920589|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920590|NCT00555880|Midodrine|midodrine|mesh-list
1920591|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
1920592|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
1920593|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920594|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920595|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1920596|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1920597|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1920598|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1920599|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920600|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920601|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920602|NCT00555893|Oseltamivir|oseltamivir|mesh-list
1920603|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
1920604|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920605|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920606|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920607|NCT00555906|Dexamethasone|dexamethasone|mesh-list
1920608|NCT00555906|Bortezomib|bortezomib|mesh-list
1920609|NCT00555906|Palbociclib|palbociclib|mesh-list
1920610|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920611|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
1920612|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
1920613|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920614|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920615|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1920616|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
1920617|NCT00555906|Hormones|hormones|mesh-ancestor
1920618|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920619|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1920620|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920621|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920622|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920623|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920624|NCT00555971|Omalizumab|omalizumab|mesh-list
1920625|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1920626|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1920627|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920628|NCT00555997|Ziprasidone|ziprasidone|mesh-list
1920629|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1920630|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
1920631|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920632|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920633|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920634|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1920635|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1920636|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920637|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1920638|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1920639|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
1920640|NCT00556049|Gemcitabine|gemcitabine|mesh-list
1920641|NCT00556049|Sunitinib|sunitinib|mesh-list
1920642|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920643|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
1920644|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920645|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920646|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
1920647|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920648|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920649|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920650|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
1920651|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920652|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1920653|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1920654|NCT00556049|Growth Substances|growth substances|mesh-ancestor
1920655|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
1920656|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920657|NCT00556140|Aripiprazole|aripiprazole|mesh-list
1920658|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
1920659|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1920660|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1920661|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1920662|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920663|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920664|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
1920665|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
1920666|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920667|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920668|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1920669|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1920670|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
1920671|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1920672|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1920673|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1920674|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1920675|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1920676|NCT00556322|Docetaxel|docetaxel|mesh-list
1920677|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920678|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920679|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920680|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920681|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920682|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920683|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920684|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
1920685|NCT00556374|Denosumab|denosumab|mesh-list
1920686|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1920687|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1920688|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920689|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1920690|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920691|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920692|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1920693|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
1920694|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920695|NCT00556439|Abatacept|abatacept|mesh-list
1920696|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1920697|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920698|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920699|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920700|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
1920701|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920702|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920703|NCT00556452|Busulfan|busulfan|mesh-list
1920704|NCT00556452|Clofarabine|clofarabine|mesh-list
1920705|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
1920706|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920707|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920708|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
1920709|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920710|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1920711|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920712|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1920713|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920714|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
1920715|NCT00556478|Lidocaine|lidocaine|mesh-list
1920716|NCT00556478|Prilocaine|prilocaine|mesh-list
1920717|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
1920718|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
1920719|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
1920720|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1920721|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920722|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
1920723|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920724|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1920725|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1920726|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1920727|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920728|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920729|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
1920730|NCT00556491|Minocycline|minocycline|mesh-list
1920731|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920732|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920733|NCT00556504|Ribavirin|ribavirin|mesh-list
1920734|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1920735|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1920736|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
1920737|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920738|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
1920739|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920740|NCT00556673|Fluticasone|fluticasone|mesh-list
1920741|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
1920742|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1920743|NCT00556673|Maleic acid|maleic acid|mesh-list
1920744|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920745|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1920746|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
1920747|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920748|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920749|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1920750|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920751|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920752|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1920753|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1920754|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1920755|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1920756|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920757|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920758|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920759|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920760|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1920761|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920762|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920763|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920764|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920765|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
1920766|NCT00556933|Sirolimus|sirolimus|mesh-list
1920767|NCT00556933|Tacrolimus|tacrolimus|mesh-list
1920768|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
1920769|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1920770|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920771|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
1920772|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920773|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1920774|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920775|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920776|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1920777|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920778|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1920779|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
1920780|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920781|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920782|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
1920783|NCT00556998|Voriconazole|voriconazole|mesh-list
1920784|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
1920785|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920786|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1920787|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1920788|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920789|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920790|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1920791|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
1920792|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920793|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920794|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1920795|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
1920796|NCT00557193|Leucovorin|leucovorin|mesh-list
1920797|NCT00557193|Folic Acid|folic acid|mesh-list
1920798|NCT00557193|Cytarabine|cytarabine|mesh-list
1920799|NCT00557193|Dexamethasone|dexamethasone|mesh-list
1920800|NCT00557193|Prednisone|prednisone|mesh-list
1920801|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
1920802|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1920803|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1920804|NCT00557193|Prednisolone|prednisolone|mesh-list
1920805|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
1920806|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
1920807|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1920808|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1920809|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1920810|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
1920811|NCT00557193|Cortisone|cortisone|mesh-list
1920812|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
1920813|NCT00557193|Methotrexate|methotrexate|mesh-list
1920814|NCT00557193|Etoposide|etoposide|mesh-list
1920815|NCT00557193|Vincristine|vincristine|mesh-list
1920816|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
1920817|NCT00557193|Daunorubicin|daunorubicin|mesh-list
1920818|NCT00557193|Asparaginase|asparaginase|mesh-list
1920819|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
1920820|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
1920821|NCT00557193|Pegaspargase|pegaspargase|mesh-list
1920822|NCT00557193|Lenograstim|lenograstim|mesh-list
1920823|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1920824|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
1920825|NCT00557193|Calcium|calcium|mesh-list
1920826|NCT00557193|BB 1101|bb 1101|mesh-list
1920827|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
1920828|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920829|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
1920830|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920831|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1920832|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1920833|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
1920834|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920835|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920836|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1920837|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920838|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
1920839|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
1920840|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920841|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1920842|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
1920843|NCT00557193|Hormones|hormones|mesh-ancestor
1920844|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920845|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1920846|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1920847|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1920848|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1920849|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
1920850|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1920851|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920852|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
1920853|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920854|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920855|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1920856|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1920857|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1920858|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1920859|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1920860|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1920861|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
1920862|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920863|NCT00557193|Antidotes|antidotes|mesh-ancestor
1920864|NCT00557193|Protective Agents|protective agents|mesh-ancestor
1920865|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
1920866|NCT00557193|Vitamins|vitamins|mesh-ancestor
1920867|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
1920868|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
1920869|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
1920870|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
1920871|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1920872|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1920873|NCT00557193|Hematinics|hematinics|mesh-ancestor
1920874|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
1920875|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
1920876|NCT00557245|Tenofovir|tenofovir|mesh-list
1920877|NCT00557245|Emtricitabine|emtricitabine|mesh-list
1920878|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1920879|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
1920880|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920881|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1920882|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1920883|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920884|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920885|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1920886|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1920887|NCT00557284|Montelukast|montelukast|mesh-list
1920888|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1920889|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920890|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1920891|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
1920892|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920893|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920894|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1920895|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1920896|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920897|NCT00557310|Teriparatide|teriparatide|mesh-list
1920898|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1921120|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920899|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920900|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1920901|NCT00557349|Omeprazole|omeprazole|mesh-list
1920902|NCT00557349|Famotidine|famotidine|mesh-list
1920903|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1920904|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1920905|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1920906|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920907|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920908|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1920909|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
1920910|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
1920911|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920912|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920913|NCT00557362|Voriconazole|voriconazole|mesh-list
1920914|NCT00557362|Natamycin|natamycin|mesh-list
1920915|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
1920916|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920917|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1920918|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1920919|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920920|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920921|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1920922|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
1920923|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920924|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920925|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1920926|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1920927|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1920928|NCT00557440|Fluticasone|fluticasone|mesh-list
1920929|NCT00557440|Xhance|xhance|mesh-list
1920930|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
1920931|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1920932|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1920933|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1920934|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1920935|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
1920936|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920937|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920938|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1920939|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920940|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
1920941|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1920942|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1920943|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1920944|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1920945|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920946|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920947|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920948|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
1920949|NCT00557440|Hormones|hormones|mesh-ancestor
1920950|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1920951|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
1920952|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
1920953|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1920954|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
1920955|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1920956|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920957|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1920958|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
1920959|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1920960|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1920961|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1920962|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
1920963|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920964|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920965|NCT00557492|Gemcitabine|gemcitabine|mesh-list
1920966|NCT00557492|Bevacizumab|bevacizumab|mesh-list
1920967|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1920968|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920969|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1920970|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1920971|NCT00557492|Growth Substances|growth substances|mesh-ancestor
1920972|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920973|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
1920974|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1920975|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
1920976|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920977|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
1920978|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1920979|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920980|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1920981|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
1920982|NCT00557622|Paroxetine|paroxetine|mesh-list
1920983|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1920984|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1920985|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1920986|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1920987|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1920988|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
1920989|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1920990|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1920991|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
1920992|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1920993|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1920994|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1920995|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1920996|NCT00557830|Sorafenib|sorafenib|mesh-list
1920997|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1920998|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1920999|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921000|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921001|NCT00558012|Vitamin D|vitamin d|mesh-list
1921002|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
1921003|NCT00558012|Calcium|calcium|mesh-list
1921004|NCT00558012|Vitamins|vitamins|mesh-ancestor
1921005|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
1921006|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921007|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1921008|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1921009|NCT00558025|Pramipexole|pramipexole|mesh-list
1921010|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
1921011|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921012|NCT00558025|Protective Agents|protective agents|mesh-ancestor
1921013|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921014|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1921015|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1921016|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
1921017|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
1921018|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921019|NCT00558064|Amlodipine|amlodipine|mesh-list
1921020|NCT00558064|Telmisartan|telmisartan|mesh-list
1921021|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1921022|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1921023|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1921024|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921025|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921026|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1921027|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921028|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
1921029|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1921030|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1921031|NCT00558103|Lapatinib|lapatinib|mesh-list
1921032|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921033|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1921034|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921035|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921036|NCT00558259|Dabigatran|dabigatran|mesh-list
1921037|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
1921038|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1921039|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
1921040|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921041|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921042|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
1921043|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
1921044|NCT00558272|Saracatinib|saracatinib|mesh-list
1921045|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1921046|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921047|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921048|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921049|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921050|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
1921051|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1921052|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1921053|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1921054|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
1921055|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921056|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921057|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921058|NCT00558363|Dutasteride|dutasteride|mesh-list
1921059|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1921060|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1921061|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921062|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921063|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
1921064|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921065|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921066|NCT00558428|Amlodipine|amlodipine|mesh-list
1921067|NCT00558428|Telmisartan|telmisartan|mesh-list
1921068|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1921069|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1921070|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1921071|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921072|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921073|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1921074|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921075|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
1921076|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1921077|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1921078|NCT00558467|Pramipexole|pramipexole|mesh-list
1921079|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
1921080|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921081|NCT00558467|Protective Agents|protective agents|mesh-ancestor
1921082|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921083|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1921084|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1921085|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
1921086|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
1921087|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921088|NCT00558519|Cytarabine|cytarabine|mesh-list
1921089|NCT00558519|Dexamethasone|dexamethasone|mesh-list
1921090|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
1921091|NCT00558519|Doxorubicin|doxorubicin|mesh-list
1921092|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1921093|NCT00558519|Methotrexate|methotrexate|mesh-list
1921094|NCT00558519|Vincristine|vincristine|mesh-list
1921095|NCT00558519|Daunorubicin|daunorubicin|mesh-list
1921096|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
1921097|NCT00558519|Pegaspargase|pegaspargase|mesh-list
1921098|NCT00558519|Thioguanine|thioguanine|mesh-list
1921099|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921100|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
1921101|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921102|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921103|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1921104|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
1921105|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921106|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921107|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1921108|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921109|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
1921110|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
1921111|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921112|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921113|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
1921114|NCT00558519|Hormones|hormones|mesh-ancestor
1921115|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921116|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921117|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1921118|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1921119|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921121|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1921122|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
1921123|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1921124|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1921125|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
1921126|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
1921127|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1921128|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1921129|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
1921130|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921131|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921132|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921133|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921134|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921135|NCT00558571|Empagliflozin|empagliflozin|mesh-list
1921136|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1921137|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921138|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1921139|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921140|NCT00558636|Paclitaxel|paclitaxel|mesh-list
1921141|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1921142|NCT00558636|Carboplatin|carboplatin|mesh-list
1921143|NCT00558636|Sorafenib|sorafenib|mesh-list
1921144|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921145|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921146|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921147|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921148|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921149|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921150|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1921151|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921152|NCT00558753|Pregabalin|pregabalin|mesh-list
1921153|NCT00558753|Analgesics|analgesics|mesh-ancestor
1921154|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
1921155|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921156|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921157|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
1921158|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1921159|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921160|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921161|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1921162|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1921163|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1921164|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921165|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921166|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1921167|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
1921168|NCT00558896|Dexamethasone|dexamethasone|mesh-list
1921169|NCT00558896|Pomalidomide|pomalidomide|mesh-list
1921170|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921171|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
1921172|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
1921173|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921174|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921175|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921176|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
1921177|NCT00558896|Hormones|hormones|mesh-ancestor
1921178|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921179|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921180|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921181|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
1921182|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921183|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921184|NCT00558896|Growth Substances|growth substances|mesh-ancestor
1921185|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921186|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
1921187|NCT00559104|Carmustine|carmustine|mesh-list
1921188|NCT00559104|Etoposide|etoposide|mesh-list
1921189|NCT00559104|Sargramostim|sargramostim|mesh-list
1921190|NCT00559104|Lenograstim|lenograstim|mesh-list
1921191|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921192|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
1921193|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921194|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921195|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1921196|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
1921197|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921198|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921199|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1921200|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921201|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1921202|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921203|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921204|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1921205|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
1921206|NCT00559273|Hematinics|hematinics|mesh-ancestor
1921207|NCT00559364|Omeprazole|omeprazole|mesh-list
1921208|NCT00559364|Pancrelipase|pancrelipase|mesh-list
1921209|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
1921210|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1921211|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921212|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921213|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921214|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1921215|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1921216|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921217|NCT00559468|Bromides|bromides|mesh-list
1921218|NCT00559468|Propofol|propofol|mesh-list
1921219|NCT00559468|Sevoflurane|sevoflurane|mesh-list
1921220|NCT00559468|Rocuronium|rocuronium|mesh-list
1921221|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1921222|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921223|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921224|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1921225|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
1921226|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
1921227|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1921228|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1921229|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
1921230|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1921231|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1921232|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1921233|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921234|NCT00559507|Saracatinib|saracatinib|mesh-list
1921235|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921236|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921237|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921238|NCT00559585|Abatacept|abatacept|mesh-list
1921239|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1921240|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921241|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921242|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921243|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
1921244|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921245|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921246|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
1921247|NCT00559637|Hematinics|hematinics|mesh-ancestor
1921248|NCT00559754|Bevacizumab|bevacizumab|mesh-list
1921249|NCT00559754|Docetaxel|docetaxel|mesh-list
1921250|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1921251|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921252|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921253|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921254|NCT00559754|Growth Substances|growth substances|mesh-ancestor
1921255|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921256|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921257|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921258|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921259|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921260|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921261|NCT00559845|Paclitaxel|paclitaxel|mesh-list
1921262|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
1921263|NCT00559845|Bevacizumab|bevacizumab|mesh-list
1921264|NCT00559845|Fluorouracil|fluorouracil|mesh-list
1921265|NCT00559845|Epirubicin|epirubicin|mesh-list
1921266|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921267|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921268|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921269|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921270|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921271|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921272|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921273|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
1921274|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921275|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921276|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1921277|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
1921278|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1921279|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1921280|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921281|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921282|NCT00559845|Growth Substances|growth substances|mesh-ancestor
1921283|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921284|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
1921285|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1921286|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1921287|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1921288|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921289|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921290|NCT00559936|Bevacizumab|bevacizumab|mesh-list
1921291|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1921292|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921293|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921294|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921295|NCT00559936|Growth Substances|growth substances|mesh-ancestor
1921296|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921297|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921298|NCT00559962|Atorvastatin|atorvastatin|mesh-list
1921299|NCT00559962|Ezetimibe|ezetimibe|mesh-list
1921300|NCT00559962|Fenofibrate|fenofibrate|mesh-list
1921301|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1921302|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1921303|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
1921304|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921305|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1921306|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1921307|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921308|NCT00560066|Vaccines|vaccines|mesh-list
1921309|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
1921310|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921311|NCT00560352|Dexamethasone|dexamethasone|mesh-list
1921312|NCT00560352|Bortezomib|bortezomib|mesh-list
1921313|NCT00560352|Dasatinib|dasatinib|mesh-list
1921314|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921315|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
1921316|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
1921317|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921318|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921319|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921320|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
1921321|NCT00560352|Hormones|hormones|mesh-ancestor
1921322|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921323|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921324|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921325|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1921326|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921327|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921328|NCT00560391|Dexamethasone|dexamethasone|mesh-list
1921329|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
1921330|NCT00560391|Lenalidomide|lenalidomide|mesh-list
1921331|NCT00560391|Dasatinib|dasatinib|mesh-list
1921332|NCT00560391|BB 1101|bb 1101|mesh-list
1921333|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921334|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
1921335|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
1921336|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921337|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921338|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921339|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
1921340|NCT00560391|Hormones|hormones|mesh-ancestor
1921341|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921342|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921343|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921344|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
1921345|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921346|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921347|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
1921348|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921349|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921350|NCT00560391|Growth Substances|growth substances|mesh-ancestor
1921351|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921352|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1921353|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
1921354|NCT00560404|Hematinics|hematinics|mesh-ancestor
1921355|NCT00560417|Insulin|insulin|mesh-list
1921356|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1921357|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
1921358|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
1921359|NCT00560417|Protamines|protamines|mesh-list
1921360|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1921361|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921362|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
1921363|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921364|NCT00560417|Coagulants|coagulants|mesh-ancestor
1921365|NCT00560508|Pramipexole|pramipexole|mesh-list
1921366|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
1921367|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921368|NCT00560508|Protective Agents|protective agents|mesh-ancestor
1921369|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921370|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1921371|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1921372|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
1921373|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
1921374|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921375|NCT00560573|Gemcitabine|gemcitabine|mesh-list
1921376|NCT00560573|Pemetrexed|pemetrexed|mesh-list
1921377|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921378|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1921379|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
1921380|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921381|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
1921382|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921383|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921384|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921385|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
1921386|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921387|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1921388|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1921389|NCT00560612|Paroxetine|paroxetine|mesh-list
1921390|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1921391|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1921392|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921393|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921394|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921395|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
1921396|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921397|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1921398|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
1921399|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921400|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1921401|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1921402|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921403|NCT00560703|Doxycycline|doxycycline|mesh-list
1921404|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1921405|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921406|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
1921407|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1921408|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1921409|NCT00560794|Blinatumomab|blinatumomab|mesh-list
1921410|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1921411|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921412|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
1921413|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921414|NCT00560833|Mirtazapine|mirtazapine|mesh-list
1921415|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921416|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
1921417|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921418|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1921419|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
1921420|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
1921421|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921422|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921423|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1921424|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1921425|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921426|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1921427|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1921428|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1921429|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921430|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1921431|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1921432|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
1921433|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1921434|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1921435|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
1921436|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921437|NCT00561002|Vaccines|vaccines|mesh-list
1921438|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
1921439|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921440|NCT00561015|Ribavirin|ribavirin|mesh-list
1921441|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
1921442|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1921443|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
1921444|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921445|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
1921446|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921447|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921448|NCT00561080|Vaccines|vaccines|mesh-list
1921449|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
1921450|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921451|NCT00561353|Ribavirin|ribavirin|mesh-list
1921452|NCT00561353|Simeprevir|simeprevir|mesh-list
1921453|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
1921454|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921455|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
1921456|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921457|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
1921458|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921459|NCT00561392|Rivastigmine|rivastigmine|mesh-list
1921460|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1921461|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921462|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921463|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
1921464|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921465|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921466|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1921467|NCT00561392|Protective Agents|protective agents|mesh-ancestor
1921468|NCT00561418|Vorinostat|vorinostat|mesh-list
1921469|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921470|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1921471|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921472|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921473|NCT00561470|Leucovorin|leucovorin|mesh-list
1921474|NCT00561470|Fluorouracil|fluorouracil|mesh-list
1921475|NCT00561470|Irinotecan|irinotecan|mesh-list
1921476|NCT00561470|Aflibercept|aflibercept|mesh-list
1921477|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
1921478|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
1921479|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921480|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1921481|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921482|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921483|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
1921484|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921485|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1921486|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921487|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921488|NCT00561470|Antidotes|antidotes|mesh-ancestor
1921489|NCT00561470|Protective Agents|protective agents|mesh-ancestor
1921490|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
1921491|NCT00561470|Vitamins|vitamins|mesh-ancestor
1921492|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
1921493|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921494|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921495|NCT00561470|Growth Substances|growth substances|mesh-ancestor
1921496|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921497|NCT00561574|Mirtazapine|mirtazapine|mesh-list
1921498|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
1921499|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921500|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1921501|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
1921502|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
1921503|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921504|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921505|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921506|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1921507|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1921508|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921509|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1921510|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1921511|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1921512|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921513|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1921514|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1921515|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
1921516|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1921517|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
1921518|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1921519|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921520|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921521|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921522|NCT00561678|Analgesics|analgesics|mesh-ancestor
1921523|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
1921524|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921525|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1921526|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1921527|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1921528|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921529|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921530|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921531|NCT00561730|Pantoprazole|pantoprazole|mesh-list
1921532|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1921533|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921534|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1921535|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921536|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921537|NCT00561821|Mirtazapine|mirtazapine|mesh-list
1921538|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
1921539|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921540|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1921541|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
1921542|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
1921543|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921544|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921545|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921546|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1921547|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1921548|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921549|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1921550|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1921551|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1921552|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921553|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1921554|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1921555|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
1921556|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1921557|NCT00561834|Ranibizumab|ranibizumab|mesh-list
1921558|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921559|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921560|NCT00561834|Growth Substances|growth substances|mesh-ancestor
1921561|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921562|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921563|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921564|NCT00561925|Nevirapine|nevirapine|mesh-list
1921565|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1921566|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1921567|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921568|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921569|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
1921570|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921571|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1921572|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1921573|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1921574|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1921575|NCT00561951|Fesoterodine|fesoterodine|mesh-list
1921576|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1921577|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1921578|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
1921579|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921580|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921581|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921582|NCT00561951|Urological Agents|urological agents|mesh-ancestor
1921583|NCT00562094|Pantoprazole|pantoprazole|mesh-list
1921584|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1921585|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921586|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1921587|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921588|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921589|NCT00562120|Fexofenadine|fexofenadine|mesh-list
1921590|NCT00562120|Terfenadine|terfenadine|mesh-list
1921591|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1921592|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1921593|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1921594|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
1921595|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
1921596|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921597|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921598|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921599|NCT00562159|Fluticasone|fluticasone|mesh-list
1921600|NCT00562159|Xhance|xhance|mesh-list
1921601|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
1921602|NCT00562159|Loratadine|loratadine|mesh-list
1921603|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1921604|NCT00562159|Prednisone|prednisone|mesh-list
1921605|NCT00562159|Albuterol|albuterol|mesh-list
1921606|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921607|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
1921608|NCT00562159|Hormones|hormones|mesh-ancestor
1921609|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921610|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921611|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921612|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921613|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1921614|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
1921615|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921616|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1921617|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
1921618|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
1921619|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1921620|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
1921621|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1921622|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1921623|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1921624|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1921625|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921626|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921627|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921628|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
1921629|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1921630|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1921631|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
1921632|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
1921633|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1921634|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921635|NCT00562159|Analgesics|analgesics|mesh-ancestor
1921636|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
1921637|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921638|NCT00562328|Rituximab|rituximab|mesh-list
1921639|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
1921640|NCT00562328|Sargramostim|sargramostim|mesh-list
1921641|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1921642|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921643|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
1921644|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921645|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921646|NCT00562588|Dipyridamole|dipyridamole|mesh-list
1921647|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
1921648|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1921649|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921650|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921651|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1921652|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
1921653|NCT00562627|Ketorolac|ketorolac|mesh-list
1921654|NCT00562627|Epinephrine|epinephrine|mesh-list
1921655|NCT00562627|Racepinephrine|racepinephrine|mesh-list
1921656|NCT00562627|Fentanyl|fentanyl|mesh-list
1921657|NCT00562627|Morphine|morphine|mesh-list
1921658|NCT00562627|Bupivacaine|bupivacaine|mesh-list
1921659|NCT00562627|Ropivacaine|ropivacaine|mesh-list
1921660|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
1921661|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
1921662|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
1921663|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921664|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921665|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
1921666|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921667|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1921668|NCT00562627|Narcotics|narcotics|mesh-ancestor
1921669|NCT00562627|Analgesics|analgesics|mesh-ancestor
1921670|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1921671|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1921672|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
1921673|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1921674|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1921675|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921676|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921677|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921678|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1921679|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1921680|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
1921681|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1921682|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
1921683|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
1921684|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
1921685|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1921686|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1921687|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921688|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921689|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921690|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1921691|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921692|NCT00562718|Capecitabine|capecitabine|mesh-list
1921693|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1921694|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
1921695|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921696|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921697|NCT00562861|Lamotrigine|lamotrigine|mesh-list
1921698|NCT00562861|Carbamazepine|carbamazepine|mesh-list
1921699|NCT00562861|Valproic Acid|valproic acid|mesh-list
1921700|NCT00562861|Citalopram|citalopram|mesh-list
1921701|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
1921702|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1921703|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921704|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921705|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1921706|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921707|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1921708|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1921709|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921710|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921711|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1921712|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1921713|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1921714|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921715|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
1921716|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1921717|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
1921718|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921719|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921720|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
1921721|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
1921722|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921723|NCT00562861|Analgesics|analgesics|mesh-ancestor
1921724|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
1921725|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1921802|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
1921726|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1921727|NCT00562965|Dexamethasone|dexamethasone|mesh-list
1921728|NCT00562965|Prednisone|prednisone|mesh-list
1921729|NCT00562965|Prednisolone|prednisolone|mesh-list
1921730|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
1921731|NCT00562965|Rituximab|rituximab|mesh-list
1921732|NCT00562965|Fludarabine|fludarabine|mesh-list
1921733|NCT00562965|Vincristine|vincristine|mesh-list
1921734|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
1921735|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1921736|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921737|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
1921738|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921739|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921740|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1921741|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
1921742|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921743|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921744|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1921745|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921746|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
1921747|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
1921748|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921749|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921750|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
1921751|NCT00562965|Hormones|hormones|mesh-ancestor
1921752|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921753|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921754|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1921755|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921756|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921757|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921758|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921759|NCT00562965|Analgesics|analgesics|mesh-ancestor
1921760|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
1921761|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1921762|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921763|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921764|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1921765|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
1921766|NCT00562978|Etoposide|etoposide|mesh-list
1921767|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921768|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
1921769|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921770|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921771|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1921772|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
1921773|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921774|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921775|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1921776|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921777|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1921778|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921779|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921780|NCT00563290|Dasatinib|dasatinib|mesh-list
1921781|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921782|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1921783|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921784|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921785|NCT00563316|Irinotecan|irinotecan|mesh-list
1921786|NCT00563316|Panitumumab|panitumumab|mesh-list
1921787|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1921788|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921789|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921790|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921791|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921792|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1921793|NCT00563368|Topiramate|topiramate|mesh-list
1921794|NCT00563368|Phentermine|phentermine|mesh-list
1921795|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
1921796|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1921797|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921798|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1921799|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
1921800|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1921801|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
1921803|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921804|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921805|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921806|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921807|NCT00563381|Bromides|bromides|mesh-list
1921808|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
1921809|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1921810|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1921811|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
1921812|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921813|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921814|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1921815|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
1921816|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
1921817|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1921818|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
1921819|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921820|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921821|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1921822|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1921823|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1921824|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
1921825|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
1921843|NCT00563706|Risperidone|risperidone|mesh-list
1921844|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1921845|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
1921846|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921847|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921848|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921849|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1921850|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1921851|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1921852|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921853|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1921854|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
1921855|NCT00563784|Paclitaxel|paclitaxel|mesh-list
1921856|NCT00563784|Carboplatin|carboplatin|mesh-list
1921857|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1921858|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921859|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921860|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921861|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921862|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921863|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921864|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1921865|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921866|NCT00563797|Mecamylamine|mecamylamine|mesh-list
1921867|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1921868|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1921869|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
1921870|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921871|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921872|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1921873|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1921874|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
1921875|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921876|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921877|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
1921878|NCT00564018|Protamines|protamines|mesh-list
1921879|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1921880|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921881|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
1921882|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921883|NCT00564018|Coagulants|coagulants|mesh-ancestor
1921884|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
1921885|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1921886|NCT00564395|Insulin|insulin|mesh-list
1921887|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1921888|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
1921889|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1921890|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921891|NCT00564447|Azithromycin|azithromycin|mesh-list
1921892|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
1921893|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1921894|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921895|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1921896|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1921897|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921898|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921899|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921900|NCT00564486|Acetaminophen|acetaminophen|mesh-list
1921901|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921902|NCT00564486|Analgesics|analgesics|mesh-ancestor
1921903|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
1921904|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921905|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921906|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
1921907|NCT00564629|Acetaminophen|acetaminophen|mesh-list
1921908|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921909|NCT00564629|Analgesics|analgesics|mesh-ancestor
1921910|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
1921911|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921912|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921913|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
1921914|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
1921915|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1921916|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1921917|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1921918|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921919|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921920|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
1921921|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921922|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921923|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1921924|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921925|NCT00564733|Gemcitabine|gemcitabine|mesh-list
1921926|NCT00564733|Paclitaxel|paclitaxel|mesh-list
1921927|NCT00564733|Docetaxel|docetaxel|mesh-list
1921928|NCT00564733|Carboplatin|carboplatin|mesh-list
1921929|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1921930|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1921931|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921932|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
1921933|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
1921934|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
1921935|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921936|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1921937|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
1921938|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
1921939|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1921940|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1921941|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921942|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
1921943|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921944|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1921945|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1921946|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
1921947|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1921948|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
1921949|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1921950|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921951|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1921952|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921953|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921954|NCT00564889|Dexamethasone|dexamethasone|mesh-list
1921955|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
1921956|NCT00564889|Lenalidomide|lenalidomide|mesh-list
1921957|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1921958|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
1921959|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921960|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921961|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1921962|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
1921963|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921964|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1921965|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1921966|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921967|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
1921968|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
1921969|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921970|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1921971|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
1921972|NCT00564889|Hormones|hormones|mesh-ancestor
1921973|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1921974|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1921975|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1921976|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1921977|NCT00564889|Growth Substances|growth substances|mesh-ancestor
1921978|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1921979|NCT00564954|Methylphenidate|methylphenidate|mesh-list
1921980|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1921981|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1921982|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921983|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1921984|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1921985|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1921986|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1921987|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
1921988|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1921989|NCT00565084|Ibuprofen|ibuprofen|mesh-list
1921990|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1921991|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1921992|NCT00565084|Analgesics|analgesics|mesh-ancestor
1921993|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
1921994|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1921995|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1921996|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1921997|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1921998|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1921999|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922000|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922001|NCT00565266|Beclomethasone|beclomethasone|mesh-list
1922002|NCT00565266|Bromides|bromides|mesh-list
1922003|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
1922004|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1922005|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922006|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
1922007|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922008|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922009|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922010|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922011|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
1922012|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1922013|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922014|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922015|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922016|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1922017|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1922018|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1922019|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
1922020|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
1922021|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1922022|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
1922023|NCT00565266|Hormones|hormones|mesh-ancestor
1922024|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922025|NCT00565370|Capecitabine|capecitabine|mesh-list
1922026|NCT00565370|Sorafenib|sorafenib|mesh-list
1922027|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922028|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922029|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
1922030|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922031|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922032|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922033|NCT00565409|Etanercept|etanercept|mesh-list
1922034|NCT00565409|Methotrexate|methotrexate|mesh-list
1922035|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1922036|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
1922037|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1922038|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922039|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922040|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
1922041|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922042|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922043|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
1922044|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922045|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1922046|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922047|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
1922048|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922049|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1922050|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1922051|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1922052|NCT00565409|Analgesics|analgesics|mesh-ancestor
1922053|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
1922054|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922055|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1922056|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1922057|NCT00565448|Docetaxel|docetaxel|mesh-list
1922058|NCT00565448|Fluorouracil|fluorouracil|mesh-list
1922059|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922060|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
1922061|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
1922062|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
1922063|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922064|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
1922065|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922066|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922067|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
1922068|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922072|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1922073|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
1922074|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1922075|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
1922076|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922077|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
1922078|NCT00565643|Protective Agents|protective agents|mesh-ancestor
1922079|NCT00565643|Laxatives|laxatives|mesh-ancestor
1922080|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1922081|NCT00565669|Cyclosporine|cyclosporine|mesh-list
1922082|NCT00565669|Cyclosporins|cyclosporins|mesh-list
1922083|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922084|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922085|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922086|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
1922087|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922088|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
1922089|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922090|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
1922091|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922092|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1922093|NCT00565773|Sirolimus|sirolimus|mesh-list
1922094|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
1922095|NCT00565773|Abatacept|abatacept|mesh-list
1922096|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922097|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922098|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1922099|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922100|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
1922101|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922102|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
1922103|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922104|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1922105|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1922106|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922107|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922138|NCT00565916|Estradiol|estradiol|mesh-list
1922139|NCT00565916|Estrogens|estrogens|mesh-list
1922140|NCT00565916|Progesterone|progesterone|mesh-list
1922141|NCT00565916|Hormones|hormones|mesh-ancestor
1922142|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922143|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922144|NCT00565916|Progestins|progestins|mesh-ancestor
1922145|NCT00566020|Lamotrigine|lamotrigine|mesh-list
1922146|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
1922147|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1922148|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922149|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922150|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1922151|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922152|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1922153|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1922154|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1922155|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1922156|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1922157|NCT00566098|Melphalan|melphalan|mesh-list
1922158|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1922159|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
1922160|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922161|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922162|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1922163|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922164|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
1922165|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922166|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
1922167|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922168|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922169|NCT00566150|Levetiracetam|levetiracetam|mesh-list
1922170|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
1922171|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
1922172|NCT00566254|Zonisamide|zonisamide|mesh-list
1922173|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
1922174|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1922175|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922176|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922177|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1922178|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922179|NCT00566501|Donepezil|donepezil|mesh-list
1922180|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1922181|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922182|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922183|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922184|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922185|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922186|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
1922187|NCT00566540|Paclitaxel|paclitaxel|mesh-list
1922188|NCT00566540|Cisplatin|cisplatin|mesh-list
1922189|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1922190|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922191|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
1922192|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
1922193|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
1922194|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922195|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1922196|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1922197|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1922198|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1922199|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922200|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1922201|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1922202|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1922203|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
1922204|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922205|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922206|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1922207|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1922208|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
1922209|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
1922210|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
1922211|NCT00566696|Melphalan|melphalan|mesh-list
1922212|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
1922213|NCT00566696|Thiotepa|thiotepa|mesh-list
1922214|NCT00566696|Rituximab|rituximab|mesh-list
1922215|NCT00566696|Fludarabine|fludarabine|mesh-list
1922216|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
1922217|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
1922218|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1922219|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
1922220|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922221|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
1922222|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922223|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922224|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1922225|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
1922226|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922227|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922228|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1922229|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1922230|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1922231|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1922232|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
1922233|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922234|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922235|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922236|NCT00566722|Adalimumab|adalimumab|mesh-list
1922237|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1922238|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922239|NCT00566735|Galantamine|galantamine|mesh-list
1922240|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1922241|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922242|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922243|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922244|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922245|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922246|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1922247|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
1922248|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922249|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
1922250|NCT00566813|Exenatide|exenatide|mesh-list
1922251|NCT00566813|Etanercept|etanercept|mesh-list
1922252|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1922253|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1922254|NCT00566813|Analgesics|analgesics|mesh-ancestor
1922255|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
1922331|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1922256|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922257|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922258|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1922259|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922260|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1922261|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922262|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
1922263|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1922264|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1922265|NCT00566813|Incretins|incretins|mesh-ancestor
1922266|NCT00566813|Hormones|hormones|mesh-ancestor
1922267|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922268|NCT00566852|Memantine|memantine|mesh-list
1922269|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1922270|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1922271|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
1922272|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922273|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922274|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922275|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1922276|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1922277|NCT00566969|Carvedilol|carvedilol|mesh-list
1922278|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1922279|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1922280|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
1922281|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922282|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922283|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922284|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1922285|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
1922286|NCT00566969|Protective Agents|protective agents|mesh-ancestor
1922287|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1922288|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922289|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1922290|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
1922291|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1922292|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1922293|NCT00567008|Varenicline|varenicline|mesh-list
1922294|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1922295|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1922296|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922297|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922298|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922299|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922300|NCT00567164|Drospirenone|drospirenone|mesh-list
1922301|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1922302|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
1922303|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922304|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922305|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1922306|NCT00567164|Diuretics|diuretics|mesh-ancestor
1922307|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
1922308|NCT00567190|Docetaxel|docetaxel|mesh-list
1922309|NCT00567190|Trastuzumab|trastuzumab|mesh-list
1922310|NCT00567190|Pertuzumab|pertuzumab|mesh-list
1922311|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922312|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
1922313|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
1922314|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
1922315|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922316|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1922317|NCT00567229|Rituximab|rituximab|mesh-list
1922318|NCT00567229|Lenalidomide|lenalidomide|mesh-list
1922319|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1922320|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922321|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
1922322|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922323|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922324|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1922325|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1922326|NCT00567229|Growth Substances|growth substances|mesh-ancestor
1922327|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
1922328|NCT00567255|Naltrexone|naltrexone|mesh-list
1922329|NCT00567255|Bupropion|bupropion|mesh-list
1922330|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1922332|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922333|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
1922334|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922335|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1922336|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
1922337|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1922338|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1922339|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1922340|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922341|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922342|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
1922343|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922344|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1922345|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1922346|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922347|NCT00567268|Gabapentin|gabapentin|mesh-list
1922348|NCT00567268|Analgesics|analgesics|mesh-ancestor
1922349|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
1922350|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922351|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922352|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
1922353|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1922354|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1922355|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1922356|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1922357|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1922358|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1922359|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922360|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922361|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
1922362|NCT00567320|Varenicline|varenicline|mesh-list
1922363|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1922364|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1922365|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922366|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922367|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922368|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922369|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1922370|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922371|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922372|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922373|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922374|NCT00567398|Icodextrin|icodextrin|mesh-list
1922375|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
1922376|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1922377|NCT00567476|Omalizumab|omalizumab|mesh-list
1922378|NCT00567476|Terbutaline|terbutaline|mesh-list
1922379|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
1922380|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
1922381|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922382|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
1922383|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922384|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922385|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922386|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922387|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
1922388|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1922389|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1922390|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1922391|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922392|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922393|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1922394|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
1922395|NCT00567489|Icodextrin|icodextrin|mesh-list
1922396|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
1922397|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1922458|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
1922459|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1922460|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922461|NCT00567879|Trastuzumab|trastuzumab|mesh-list
1922462|NCT00567879|Panobinostat|panobinostat|mesh-list
1922463|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1922464|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922465|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1922466|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922467|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922468|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1922469|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922470|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
1922471|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922472|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922473|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922474|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922475|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1922476|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1922477|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1922478|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
1922479|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922480|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922481|NCT00568022|Capecitabine|capecitabine|mesh-list
1922482|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922483|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
1922559|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
1922484|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922485|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922486|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
1922487|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922488|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
1922489|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922490|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922491|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922492|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922493|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1922494|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
1922495|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922496|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922497|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1922498|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
1922499|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
1922500|NCT00568061|Protective Agents|protective agents|mesh-ancestor
1922501|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
1922502|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1922503|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
1922504|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922505|NCT00568087|Expectorants|expectorants|mesh-ancestor
1922506|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922507|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1922508|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
1922509|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922510|NCT00568087|Protective Agents|protective agents|mesh-ancestor
1922511|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922512|NCT00568087|Antidotes|antidotes|mesh-ancestor
1922513|NCT00568178|Losartan|losartan|mesh-list
1922514|NCT00568178|Amlodipine|amlodipine|mesh-list
1922515|NCT00568178|Enalapril|enalapril|mesh-list
1922516|NCT00568178|Enalaprilat|enalaprilat|mesh-list
1922517|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1922518|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1922519|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922520|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922521|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1922522|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922523|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
1922524|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1922525|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1922526|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1922527|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922528|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1922529|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
1922530|NCT00568321|Tanezumab|tanezumab|mesh-list
1922531|NCT00568321|Analgesics|analgesics|mesh-ancestor
1922532|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
1922533|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922534|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922535|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1922536|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
1922537|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1922538|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
1922539|NCT00568399|Antidotes|antidotes|mesh-ancestor
1922540|NCT00568399|Protective Agents|protective agents|mesh-ancestor
1922541|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922542|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
1922543|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922544|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
1922545|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922546|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922547|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
1922548|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
1922549|NCT00568451|Paclitaxel|paclitaxel|mesh-list
1922550|NCT00568451|Carboplatin|carboplatin|mesh-list
1922551|NCT00568451|Temozolomide|temozolomide|mesh-list
1922552|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1922553|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922554|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
1922555|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
1922556|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
1922557|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922558|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1922560|NCT00568555|Naltrexone|naltrexone|mesh-list
1922561|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1922562|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1922563|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922564|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
1922565|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922566|NCT00568633|Cyclosporine|cyclosporine|mesh-list
1922567|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
1922568|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
1922569|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1922570|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1922571|NCT00568633|Prednisolone|prednisolone|mesh-list
1922572|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
1922573|NCT00568633|Cyclosporins|cyclosporins|mesh-list
1922574|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
1922575|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1922576|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1922577|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
1922578|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922579|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922580|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922581|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
1922582|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922583|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
1922584|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922585|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
1922586|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922587|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1922588|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1922589|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922590|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1922591|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
1922592|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922593|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1922594|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
1922595|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
1922596|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922597|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1922598|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
1922599|NCT00568633|Hormones|hormones|mesh-ancestor
1922600|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922601|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1922602|NCT00568633|Protective Agents|protective agents|mesh-ancestor
1922603|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1922604|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1922605|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1922606|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1922607|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922608|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922609|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
1922610|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922611|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922612|NCT00568776|Inositol|inositol|mesh-list
1922613|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
1922614|NCT00568776|Vitamins|vitamins|mesh-ancestor
1922615|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
1922616|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922617|NCT00568958|Naltrexone|naltrexone|mesh-list
1922618|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1922619|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1922620|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922621|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
1922622|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922623|NCT00569010|Cytarabine|cytarabine|mesh-list
1922624|NCT00569010|Azacitidine|azacitidine|mesh-list
1922625|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922626|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
1922627|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922628|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922629|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
1922630|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922631|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922632|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
1922633|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922634|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922635|NCT00569127|Interferons|interferons|mesh-list
1922636|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
1922637|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
1922638|NCT00569127|Bevacizumab|bevacizumab|mesh-list
1922639|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1922640|NCT00569127|Octreotide|octreotide|mesh-list
1922641|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
1922642|NCT00569127|Antibodies|antibodies|mesh-list
1922643|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
1922644|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1922645|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
1922646|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922647|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1922648|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1922649|NCT00569127|Growth Substances|growth substances|mesh-ancestor
1922650|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922651|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
1922652|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
1922653|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
1922654|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922655|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1922656|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1922657|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1922658|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
1922659|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922660|NCT00569374|Modafinil|modafinil|mesh-list
1922661|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1922662|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922663|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1922664|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1922665|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1922666|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922667|NCT00569530|Calfactant|calfactant|mesh-list
1922668|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
1922669|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922670|NCT00569582|Mifepristone|mifepristone|mesh-list
1922671|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1922672|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
1922673|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1922674|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922675|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1922676|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1922677|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1922678|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
1922679|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1922680|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1922681|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
1922682|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922683|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
1922684|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1922685|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1922686|NCT00569660|Azacitidine|azacitidine|mesh-list
1922687|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922688|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
1922689|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922690|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922691|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922692|NCT00569673|Docetaxel|docetaxel|mesh-list
1922693|NCT00569673|Trabectedin|trabectedin|mesh-list
1922694|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922695|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
1922696|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
1922697|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
1922698|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922699|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1922700|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
1922701|NCT00569777|Ketotifen|ketotifen|mesh-list
1922702|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
1922703|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
1922704|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1922705|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
1922706|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
1922707|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922708|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922709|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922710|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1922711|NCT00569803|Abatacept|abatacept|mesh-list
1922712|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1922713|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922714|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922715|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922716|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
1922717|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922718|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922719|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
1922720|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1922721|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1922722|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
1922723|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922724|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922725|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922726|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1922727|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
1922728|NCT00569946|Axitinib|axitinib|mesh-list
1922729|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922730|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922731|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922732|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922733|NCT00570089|Ranolazine|ranolazine|mesh-list
1922734|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1922735|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922736|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922737|NCT00570128|Donepezil|donepezil|mesh-list
1922738|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1922739|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922740|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922741|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922742|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922743|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922744|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
1922745|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1922746|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922747|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922748|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922749|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922750|NCT00570310|Pregabalin|pregabalin|mesh-list
1922751|NCT00570310|Analgesics|analgesics|mesh-ancestor
1922752|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
1922753|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922754|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922755|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
1922756|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1922757|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1922758|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922759|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1922760|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1922761|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1922762|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1922763|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1922764|NCT00570323|Fulvestrant|fulvestrant|mesh-list
1922765|NCT00570323|Anastrozole|anastrozole|mesh-list
1922766|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1922767|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922768|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1922769|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1922770|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
1922771|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922772|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922773|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1922774|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1922775|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922776|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922777|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
1922778|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922779|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
1922780|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922781|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922782|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922783|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922784|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1922785|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
1922786|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922787|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922788|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1922789|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
1922790|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
1922791|NCT00570349|Protective Agents|protective agents|mesh-ancestor
1922792|NCT00570401|Dasatinib|dasatinib|mesh-list
1922793|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922794|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922795|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922796|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922797|NCT00570492|Fluticasone|fluticasone|mesh-list
1922798|NCT00570492|Xhance|xhance|mesh-list
1922799|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1922800|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922801|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
1922802|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922803|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922804|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922805|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922806|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
1922807|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1922808|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1922809|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
1922810|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922811|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922812|NCT00570674|Paclitaxel|paclitaxel|mesh-list
1922813|NCT00570674|Carboplatin|carboplatin|mesh-list
1922814|NCT00570674|Cetuximab|cetuximab|mesh-list
1922815|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1922816|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1922817|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922818|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
1922819|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
1922820|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
1922821|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922822|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1922823|NCT00570687|Insulin|insulin|mesh-list
1922824|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1922825|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922826|NCT00570700|Dasatinib|dasatinib|mesh-list
1922827|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922828|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922829|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922830|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922831|NCT00570713|Gemcitabine|gemcitabine|mesh-list
1922832|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922833|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
1922834|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922835|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922836|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
1922837|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922838|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922839|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922840|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
1922841|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922842|NCT00570739|Metformin|metformin|mesh-list
1922843|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1922844|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1922845|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922846|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1922847|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1922848|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
1922849|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922850|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1922851|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
1922852|NCT00570765|Cathartics|cathartics|mesh-ancestor
1922853|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1922854|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
1922855|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1922856|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1922857|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1922858|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922859|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922860|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922861|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922862|NCT00570908|Capecitabine|capecitabine|mesh-list
1922863|NCT00570908|Sunitinib|sunitinib|mesh-list
1922864|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922865|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
1922866|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922867|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922868|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1922869|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1922870|NCT00570908|Growth Substances|growth substances|mesh-ancestor
1922871|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922872|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
1922873|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1922874|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922875|NCT00570921|Everolimus|everolimus|mesh-list
1922876|NCT00570921|Fulvestrant|fulvestrant|mesh-list
1922877|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922878|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922879|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
1922880|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922881|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1922882|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1922883|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1922884|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
1922885|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1922886|NCT00570960|Dextrans|dextrans|mesh-list
1922887|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
1922888|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
1922889|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
1922890|NCT00571064|Donepezil|donepezil|mesh-list
1922891|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1922892|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922893|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922894|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
1922895|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922896|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922897|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
1922898|NCT00571103|Acamprosate|acamprosate|mesh-list
1922899|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1922900|NCT00571259|Gentamicins|gentamicins|mesh-list
1922901|NCT00571259|Heparin|heparin|mesh-list
1922902|NCT00571259|Citric Acid|citric acid|mesh-list
1922903|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
1922904|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
1922905|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1922906|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
1922907|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
1922908|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922909|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1922910|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1922911|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922912|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922913|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1922914|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922915|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1922916|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
1922917|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1922918|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
1922919|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1922920|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922921|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1922922|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
1922923|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1922924|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1922925|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1922926|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
1922927|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922928|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922929|NCT00571493|Cytarabine|cytarabine|mesh-list
1922930|NCT00571493|Etoposide|etoposide|mesh-list
1922931|NCT00571493|Bortezomib|bortezomib|mesh-list
1922932|NCT00571493|Melphalan|melphalan|mesh-list
1922933|NCT00571493|Carmustine|carmustine|mesh-list
1922934|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1922935|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922936|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1922937|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1922938|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922939|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922940|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1922941|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
1922942|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
1922943|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922944|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922945|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
1922946|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922947|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1922948|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
1922949|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1922950|NCT00571519|Metformin|metformin|mesh-list
1922951|NCT00571519|Pioglitazone|pioglitazone|mesh-list
1922952|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1922953|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922954|NCT00571649|Enoxaparin|enoxaparin|mesh-list
1922955|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
1922956|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
1922957|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1922958|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
1922959|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1922960|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
1922961|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922962|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922963|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
1922964|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1922965|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1922966|NCT00571662|Cyclosporine|cyclosporine|mesh-list
1922967|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
1922968|NCT00571662|Pentostatin|pentostatin|mesh-list
1922969|NCT00571662|Cyclosporins|cyclosporins|mesh-list
1922970|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1922971|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922972|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1922973|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
1922974|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922975|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
1922976|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1922977|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
1922978|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1922979|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1922980|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1922981|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1922982|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1922983|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
1922984|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1922985|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1922986|NCT00571688|Risperidone|risperidone|mesh-list
1922987|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1922988|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
1922989|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1922990|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1922991|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1922992|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1922993|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1922994|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1922995|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1922996|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1922997|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
1922998|NCT00571701|Celecoxib|celecoxib|mesh-list
1922999|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1923000|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1923001|NCT00571701|Analgesics|analgesics|mesh-ancestor
1923002|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
1923003|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923004|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923005|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923006|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923007|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1923008|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1923009|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923010|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923011|NCT00571961|Ritonavir|ritonavir|mesh-list
1923012|NCT00571961|Lopinavir|lopinavir|mesh-list
1923013|NCT00571961|Buprenorphine|buprenorphine|mesh-list
1923014|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1923015|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1923016|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
1923017|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923018|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923019|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1923020|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1923021|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
1923022|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923023|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1923024|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1923025|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1923026|NCT00571961|Narcotics|narcotics|mesh-ancestor
1923027|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923028|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923029|NCT00571961|Analgesics|analgesics|mesh-ancestor
1923030|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
1923031|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923032|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1923033|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1923034|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1923035|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
1923036|NCT00572117|Topiramate|topiramate|mesh-list
1923037|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
1923038|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923039|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923040|NCT00572156|Mecasermin|mecasermin|mesh-list
1923041|NCT00572156|Growth Substances|growth substances|mesh-ancestor
1923042|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923043|NCT00572234|Bupropion|bupropion|mesh-list
1923044|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1923045|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
1923046|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1923047|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1923048|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1923049|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923050|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923051|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
1923052|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923053|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923054|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1923055|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1923056|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923057|NCT00572455|Latanoprost|latanoprost|mesh-list
1923058|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1923059|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1923060|NCT00572468|Simvastatin|simvastatin|mesh-list
1923061|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1923062|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1923063|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
1923064|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923065|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1923066|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1923067|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923068|NCT00572572|Aprepitant|aprepitant|mesh-list
1923069|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
1923070|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
1923071|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923072|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923073|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1923074|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1923075|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923076|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923077|NCT00572728|Alovudine|alovudine|mesh-list
1923078|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
1923079|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
1923080|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923081|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
1923082|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923083|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1923084|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1923085|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923086|NCT00572832|Vaccines|vaccines|mesh-list
1923087|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
1923088|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923089|NCT00572897|Fludarabine|fludarabine|mesh-list
1923090|NCT00572897|Melphalan|melphalan|mesh-list
1923091|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923092|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923093|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923094|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
1923095|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923096|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923097|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
1923098|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923099|NCT00572936|Timolol|timolol|mesh-list
1923100|NCT00572936|Dorzolamide|dorzolamide|mesh-list
1923101|NCT00572936|Latanoprost|latanoprost|mesh-list
1923102|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1923103|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1923104|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923105|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923106|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923107|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923108|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1923109|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1923110|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1923111|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1923112|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1923113|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923114|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
1923115|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1923116|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923117|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923118|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1923119|NCT00573066|Analgesics|analgesics|mesh-ancestor
1923120|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
1923121|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923122|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1923123|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1923124|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1923125|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923126|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923127|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923128|NCT00573131|Paclitaxel|paclitaxel|mesh-list
1923129|NCT00573131|Cisplatin|cisplatin|mesh-list
1923130|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1923131|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923132|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
1923133|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
1923134|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
1923135|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923136|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1923137|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
1923138|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923139|NCT00573248|Nicotine|nicotine|mesh-list
1923140|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1923141|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
1923142|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923143|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923144|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1923145|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1923146|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
1923147|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923148|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923149|NCT00573261|Pregabalin|pregabalin|mesh-list
1923150|NCT00573261|Analgesics|analgesics|mesh-ancestor
1923151|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
1923152|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923153|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923154|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
1923155|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1923156|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923157|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923158|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1923159|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1923160|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1923161|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923162|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1923163|NCT00573287|Risperidone|risperidone|mesh-list
1923164|NCT00573287|Clozapine|clozapine|mesh-list
1923165|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1923166|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
1923167|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923168|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923169|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923170|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1923171|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1923172|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923173|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1923174|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1923175|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
1923176|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
1923177|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
1923178|NCT00573430|Candesartan|candesartan|mesh-list
1923179|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
1923180|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1923181|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1923182|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1923183|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923184|NCT00573443|Quinidine|quinidine|mesh-list
1923185|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
1923186|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
1923187|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
1923188|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
1923189|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1923190|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1923191|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923192|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923193|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923194|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1923195|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1923196|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923197|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1923198|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
1923199|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1923200|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1923201|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923202|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923203|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1923204|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1923205|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
1923206|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1923207|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1923208|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923209|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1923210|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1923211|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
1923212|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1923213|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1923214|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
1923215|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923216|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923217|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923218|NCT00573508|Urological Agents|urological agents|mesh-ancestor
1923219|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1923220|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1923221|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923222|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1923223|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1923224|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923225|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923226|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
1923227|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923228|NCT00573755|Sorafenib|sorafenib|mesh-list
1923229|NCT00573755|Letrozole|letrozole|mesh-list
1923230|NCT00573755|Anastrozole|anastrozole|mesh-list
1923231|NCT00573755|Exemestane|exemestane|mesh-list
1923232|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923233|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923234|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923235|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923236|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1923237|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1923238|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1923239|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
1923240|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923241|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923242|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923243|NCT00573768|Diclofenac|diclofenac|mesh-list
1923244|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1923245|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1923246|NCT00573768|Analgesics|analgesics|mesh-ancestor
1923247|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
1923248|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923249|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923250|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923251|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923252|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1923253|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923254|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923255|NCT00573794|Adalimumab|adalimumab|mesh-list
1923256|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923257|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923258|NCT00573859|Methylphenidate|methylphenidate|mesh-list
1923259|NCT00573859|Amphetamine|amphetamine|mesh-list
1923260|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1923261|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
1923262|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1923263|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1923264|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923265|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1923266|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1923267|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923268|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923269|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
1923270|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923271|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1923272|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923273|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
1923274|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
1923275|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923276|NCT00573989|Pemetrexed|pemetrexed|mesh-list
1923277|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1923278|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923279|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923280|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923281|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1923282|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1923283|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923284|NCT00574067|Buprenorphine|buprenorphine|mesh-list
1923285|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1923286|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1923287|NCT00574067|Narcotics|narcotics|mesh-ancestor
1923288|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923289|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923290|NCT00574067|Analgesics|analgesics|mesh-ancestor
1923291|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
1923292|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923293|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1923294|NCT00574119|Spironolactone|spironolactone|mesh-list
1923295|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1923296|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
1923297|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923298|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923299|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1923300|NCT00574119|Diuretics|diuretics|mesh-ancestor
1923301|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
1923302|NCT00574171|Capecitabine|capecitabine|mesh-list
1923303|NCT00574171|Lapatinib|lapatinib|mesh-list
1923304|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1923305|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
1923306|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923307|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923308|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923309|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923310|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
1923311|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1923312|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923313|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1923314|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
1923315|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1923316|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923317|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923318|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923319|NCT00574236|Doxorubicin|doxorubicin|mesh-list
1923320|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1923321|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923322|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923323|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923324|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923325|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923326|NCT00574249|Adalimumab|adalimumab|mesh-list
1923327|NCT00574249|Betamethasone|betamethasone|mesh-list
1923328|NCT00574249|Calcipotriene|calcipotriene|mesh-list
1923329|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923330|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923331|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
1923332|NCT00574249|Hormones|hormones|mesh-ancestor
1923333|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923334|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923335|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1923336|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
1923337|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
1923338|NCT00574275|Gemcitabine|gemcitabine|mesh-list
1923339|NCT00574275|Aflibercept|aflibercept|mesh-list
1923340|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1923341|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
1923342|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923343|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923344|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
1923345|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923346|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923347|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923348|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
1923349|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923350|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1923351|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1923352|NCT00574275|Growth Substances|growth substances|mesh-ancestor
1923353|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
1923354|NCT00574288|Dexamethasone|dexamethasone|mesh-list
1923355|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
1923356|NCT00574288|Daratumumab|daratumumab|mesh-list
1923357|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1923358|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923359|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
1923360|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
1923361|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923362|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923363|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1923364|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
1923365|NCT00574288|Hormones|hormones|mesh-ancestor
1923366|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923367|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923368|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923369|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1923370|NCT00574288|Protective Agents|protective agents|mesh-ancestor
1923371|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
1923372|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1923373|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923374|NCT00574405|Insulin|insulin|mesh-list
1923375|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1923376|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
1923377|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
1923378|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
1923379|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
1923380|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
1923381|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923382|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923383|NCT00574548|Vaccines|vaccines|mesh-list
1923384|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1923385|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
1923386|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923387|NCT00574587|Paclitaxel|paclitaxel|mesh-list
1923388|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
1923389|NCT00574587|Doxorubicin|doxorubicin|mesh-list
1923390|NCT00574587|Trastuzumab|trastuzumab|mesh-list
1923391|NCT00574587|Vorinostat|vorinostat|mesh-list
1923392|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1923393|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923394|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
1923395|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
1923396|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
1923397|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923398|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923399|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
1923400|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923401|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923402|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923403|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
1923404|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923405|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1923406|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923407|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923408|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923409|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923410|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1923411|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1923412|NCT00574834|Ramipril|ramipril|mesh-list
1923413|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1923414|NCT00574834|Diuretics|diuretics|mesh-ancestor
1923415|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
1923416|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923417|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1923418|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923419|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923420|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1923421|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
1923422|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923423|NCT00574847|Citalopram|citalopram|mesh-list
1923424|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1923425|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1923426|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923427|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923428|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923429|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
1923430|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923431|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1923432|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
1923433|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1923434|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
1923435|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923436|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923437|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923438|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923439|NCT00574912|Insulin|insulin|mesh-list
1923440|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1923441|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
1923442|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923443|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923444|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
1923445|NCT00574951|Imetelstat|imetelstat|mesh-list
1923446|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923447|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923448|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923449|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
1923450|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1923451|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1923452|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1923453|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923454|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923455|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
1923456|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923457|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923458|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1923459|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923460|NCT00575029|Megestrol|megestrol|mesh-list
1923461|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
1923462|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1923463|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1923464|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1923465|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
1923466|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1923467|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923468|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1923469|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1923470|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923471|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923472|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
1923473|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1923474|NCT00575042|Fenofibrate|fenofibrate|mesh-list
1923475|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1923476|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
1923477|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923478|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1923479|NCT00575094|Tigecycline|tigecycline|mesh-list
1923480|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1923481|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923482|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1923483|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923484|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923485|NCT00575367|Azithromycin|azithromycin|mesh-list
1923486|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
1923487|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1923488|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1923489|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1923490|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1923491|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923492|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923493|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923494|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923495|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923496|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923497|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1923498|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
1923499|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1923500|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923501|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1923502|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1923503|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1923504|NCT00575380|Azithromycin|azithromycin|mesh-list
1923505|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
1923506|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1923507|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1923508|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1923509|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1923510|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923511|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923512|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923513|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923514|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923515|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923516|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1923517|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
1923518|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1923519|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923520|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1923521|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1923522|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1923523|NCT00575588|Metformin|metformin|mesh-list
1923524|NCT00575588|Saxagliptin|saxagliptin|mesh-list
1923525|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923526|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923527|NCT00575588|Incretins|incretins|mesh-ancestor
1923528|NCT00575588|Hormones|hormones|mesh-ancestor
1923529|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923530|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1923531|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
1923532|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923533|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923534|NCT00575666|Insulin|insulin|mesh-list
1923535|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923536|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923537|NCT00575887|Temozolomide|temozolomide|mesh-list
1923538|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923539|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
1923540|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923541|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923542|NCT00575965|Simvastatin|simvastatin|mesh-list
1923543|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1923544|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1923545|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
1923546|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923547|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1923548|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1923549|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923550|NCT00576056|Sorafenib|sorafenib|mesh-list
1923551|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923552|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923553|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923554|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923555|NCT00576199|Bevacizumab|bevacizumab|mesh-list
1923556|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923557|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923558|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1923559|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1923560|NCT00576199|Growth Substances|growth substances|mesh-ancestor
1923561|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923562|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
1923563|NCT00576251|Tobramycin|tobramycin|mesh-list
1923564|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
1923565|NCT00576251|Dexamethasone|dexamethasone|mesh-list
1923566|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923567|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
1923568|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
1923569|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923570|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923571|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1923572|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
1923573|NCT00576251|Hormones|hormones|mesh-ancestor
1923574|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923575|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923576|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923577|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1923578|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923579|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1923580|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1923581|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
1923582|NCT00576303|Hematinics|hematinics|mesh-ancestor
1923583|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1923584|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1923585|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
1923586|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
1923587|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1923588|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923589|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923590|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1923591|NCT00576381|Analgesics|analgesics|mesh-ancestor
1923592|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
1923593|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923594|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1923595|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1923596|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1923597|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923598|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923599|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923600|NCT00576472|Methylphenidate|methylphenidate|mesh-list
1923601|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1923602|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923603|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1923604|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1923605|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923606|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923607|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
1923608|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923609|NCT00576576|Atorvastatin|atorvastatin|mesh-list
1923610|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1923611|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1923612|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
1923613|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923614|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1923615|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1923616|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923617|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
1923618|NCT00576628|Hematinics|hematinics|mesh-ancestor
1923619|NCT00576680|Temozolomide|temozolomide|mesh-list
1923620|NCT00576680|Everolimus|everolimus|mesh-list
1923621|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923622|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
1923623|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923624|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923625|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923626|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
1923627|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923628|NCT00576732|Risperidone|risperidone|mesh-list
1923629|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1923630|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
1923631|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923632|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923633|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923634|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1923635|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1923636|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923637|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1923638|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1923639|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
1923640|NCT00576758|Rituximab|rituximab|mesh-list
1923641|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
1923642|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923643|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923644|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
1923645|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923646|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923647|NCT00576823|Alfuzosin|alfuzosin|mesh-list
1923648|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1923649|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1923650|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1923651|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923652|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923653|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923654|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923655|NCT00576823|Urological Agents|urological agents|mesh-ancestor
1923656|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
1923657|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1923658|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923659|NCT00576901|Bevacizumab|bevacizumab|mesh-list
1923660|NCT00576901|Docetaxel|docetaxel|mesh-list
1923661|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923662|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923663|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1923664|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1923665|NCT00576901|Growth Substances|growth substances|mesh-ancestor
1923666|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923667|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
1923668|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
1923669|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
1923670|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
1923671|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923672|NCT00577005|Levetiracetam|levetiracetam|mesh-list
1923673|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
1923674|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
1923675|NCT00577031|Bevacizumab|bevacizumab|mesh-list
1923676|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
1923677|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923678|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923679|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1923680|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1923681|NCT00577031|Growth Substances|growth substances|mesh-ancestor
1923682|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923683|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
1923684|NCT00577096|Thalidomide|thalidomide|mesh-list
1923685|NCT00577096|Dexamethasone|dexamethasone|mesh-list
1923686|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
1923687|NCT00577096|Melphalan|melphalan|mesh-list
1923688|NCT00577096|Cisplatin|cisplatin|mesh-list
1923689|NCT00577096|Doxorubicin|doxorubicin|mesh-list
1923690|NCT00577096|Etoposide|etoposide|mesh-list
1923691|NCT00577096|Vincristine|vincristine|mesh-list
1923692|NCT00577096|Heparin|heparin|mesh-list
1923693|NCT00577096|Calcium heparin|calcium heparin|mesh-list
1923694|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1923695|NCT00577096|Tinzaparin|tinzaparin|mesh-list
1923696|NCT00577096|Dalteparin|dalteparin|mesh-list
1923697|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
1923698|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923699|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
1923700|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923701|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923702|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923703|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
1923704|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923705|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923706|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923707|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923708|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
1923709|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
1923710|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923711|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1923712|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
1923713|NCT00577096|Hormones|hormones|mesh-ancestor
1923714|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923715|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923716|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923717|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1923718|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923719|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923720|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1923721|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
1923722|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
1923723|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
1923724|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
1923725|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1923726|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1923727|NCT00577096|Hematinics|hematinics|mesh-ancestor
1923728|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
1923729|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1923730|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923731|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1923732|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1923733|NCT00577096|Growth Substances|growth substances|mesh-ancestor
1923734|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
1923735|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
1923736|NCT00577122|Methotrexate|methotrexate|mesh-list
1923737|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1923738|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
1923739|NCT00577122|Progesterone|progesterone|mesh-list
1923740|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923741|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
1923742|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923743|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923744|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923745|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
1923746|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923747|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923748|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923749|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1923750|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
1923751|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1923752|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1923753|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
1923754|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
1923755|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923756|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1923757|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1923758|NCT00577122|Progestins|progestins|mesh-ancestor
1923759|NCT00577122|Hormones|hormones|mesh-ancestor
1923760|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923761|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1923762|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1923763|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1923764|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
1923765|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1923766|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1923767|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1923768|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923769|NCT00577135|Furosemide|furosemide|mesh-list
1923770|NCT00577135|Diuretics|diuretics|mesh-list
1923771|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
1923772|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
1923773|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923774|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923775|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923776|NCT00577382|Sunitinib|sunitinib|mesh-list
1923777|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923778|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1923779|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1923780|NCT00577382|Growth Substances|growth substances|mesh-ancestor
1923781|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923782|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
1923783|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923784|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923785|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923786|NCT00577408|Naltrexone|naltrexone|mesh-list
1923787|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1923788|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1923789|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923790|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
1923791|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923792|NCT00577460|Pramipexole|pramipexole|mesh-list
1923793|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
1923794|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923795|NCT00577460|Protective Agents|protective agents|mesh-ancestor
1923796|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923797|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1923798|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1923799|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
1923800|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
1923801|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923802|NCT00577473|Mesalamine|mesalamine|mesh-list
1923803|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1923804|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1923805|NCT00577473|Analgesics|analgesics|mesh-ancestor
1923806|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
1923807|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923808|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923809|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923810|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923811|NCT00577590|Metformin|metformin|mesh-list
1923812|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
1923813|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923814|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923815|NCT00577629|Cytarabine|cytarabine|mesh-list
1923816|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
1923817|NCT00577629|Rituximab|rituximab|mesh-list
1923818|NCT00577629|Doxorubicin|doxorubicin|mesh-list
1923819|NCT00577629|Etoposide|etoposide|mesh-list
1923820|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923821|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
1923822|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923823|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923824|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923825|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
1923826|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923827|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923828|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923829|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923830|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1923831|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923832|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923833|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923834|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1923835|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1923836|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
1923837|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
1923838|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923839|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
1923840|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1923841|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923842|NCT00577655|Albuterol|albuterol|mesh-list
1923843|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1923844|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
1923845|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923846|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923847|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1923848|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
1923849|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
1923850|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1923851|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1923852|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1923853|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1923854|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
1923855|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923856|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923857|NCT00577707|Pemetrexed|pemetrexed|mesh-list
1923858|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1923859|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923860|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923861|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923862|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1923863|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1923864|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1923865|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
1923866|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
1923867|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1923868|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1923869|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923870|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1923871|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923872|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1923873|NCT00577824|Exenatide|exenatide|mesh-list
1923874|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1923875|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923876|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1923877|NCT00577824|Incretins|incretins|mesh-ancestor
1923878|NCT00577824|Hormones|hormones|mesh-ancestor
1923879|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923880|NCT00577863|Teriparatide|teriparatide|mesh-list
1923881|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1923882|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923883|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1923884|NCT00577889|Gemcitabine|gemcitabine|mesh-list
1923885|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1923886|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
1923887|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923888|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923889|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
1923890|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923891|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923892|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923893|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
1923894|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923895|NCT00577993|Interferons|interferons|mesh-list
1923896|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
1923897|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
1923898|NCT00577993|Dexamethasone|dexamethasone|mesh-list
1923899|NCT00577993|Prednisone|prednisone|mesh-list
1923900|NCT00577993|Prednisolone|prednisolone|mesh-list
1923901|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1923902|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
1923903|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1923904|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
1923905|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
1923906|NCT00577993|Rituximab|rituximab|mesh-list
1923907|NCT00577993|Doxorubicin|doxorubicin|mesh-list
1923908|NCT00577993|Fludarabine|fludarabine|mesh-list
1923909|NCT00577993|Etoposide|etoposide|mesh-list
1923910|NCT00577993|Vincristine|vincristine|mesh-list
1923911|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
1923912|NCT00577993|Bleomycin|bleomycin|mesh-list
1923913|NCT00577993|Procarbazine|procarbazine|mesh-list
1923914|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1923915|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
1923916|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923917|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
1923918|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923919|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923920|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923921|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
1923922|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923923|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923924|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923925|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1923926|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
1923927|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
1923928|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923929|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1923930|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
1923931|NCT00577993|Hormones|hormones|mesh-ancestor
1923932|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1923933|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1923934|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1923935|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923936|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1923937|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1923938|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1923939|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1923940|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
1923941|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1923942|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
1923943|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
1923944|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
1923945|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1923946|NCT00577993|Protective Agents|protective agents|mesh-ancestor
1923947|NCT00577993|Analgesics|analgesics|mesh-ancestor
1923948|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
1923949|NCT00578071|Capecitabine|capecitabine|mesh-list
1923950|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
1923951|NCT00578071|Panitumumab|panitumumab|mesh-list
1923952|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1923953|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
1923954|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923955|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923956|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923957|NCT00578136|Bupivacaine|bupivacaine|mesh-list
1923958|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
1923959|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
1923960|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923961|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923962|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
1923963|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1923964|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1923965|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
1923966|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923967|NCT00578214|Midazolam|midazolam|mesh-list
1923968|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
1923969|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1923970|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923971|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1923972|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1923973|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1923974|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1923975|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1923976|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1923977|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
1923978|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
1923979|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
1923980|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1923981|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923982|NCT00578227|Vaccines|vaccines|mesh-list
1923983|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
1924208|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923984|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923985|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
1923986|NCT00578292|Busulfan|busulfan|mesh-list
1923987|NCT00578292|Fludarabine|fludarabine|mesh-list
1923988|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
1923989|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1923990|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
1923991|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1923992|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1923993|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1923994|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
1923995|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1923996|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1923997|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1923998|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1923999|NCT00578305|Folic Acid|folic acid|mesh-list
1924000|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
1924001|NCT00578305|Rituximab|rituximab|mesh-list
1924002|NCT00578305|Methotrexate|methotrexate|mesh-list
1924003|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924004|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924005|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
1924006|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924007|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924008|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1924009|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
1924010|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1924011|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924012|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
1924013|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924014|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
1924015|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924016|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1924017|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924018|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1924019|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924020|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
1924021|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
1924022|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924023|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924024|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
1924025|NCT00578305|Hormones|hormones|mesh-ancestor
1924026|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1924027|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1924028|NCT00578305|Protective Agents|protective agents|mesh-ancestor
1924029|NCT00578305|Hematinics|hematinics|mesh-ancestor
1924030|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
1924031|NCT00578305|Vitamins|vitamins|mesh-ancestor
1924032|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
1924033|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1924034|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924035|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924036|NCT00578331|Analgesics|analgesics|mesh-ancestor
1924037|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
1924038|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924039|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924040|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924041|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924042|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1924043|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1924044|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1924045|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
1924046|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
1924047|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924048|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924049|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
1924050|NCT00578344|Busulfan|busulfan|mesh-list
1924051|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
1924052|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924053|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
1924054|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924055|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924056|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924057|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
1924058|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924059|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924060|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924061|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924062|NCT00578448|Abatacept|abatacept|mesh-list
1924063|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1924064|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924065|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924066|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924067|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
1924068|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924069|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924070|NCT00578461|Cytarabine|cytarabine|mesh-list
1924071|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
1924072|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924073|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
1924074|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924075|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924076|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924077|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
1924078|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924079|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924080|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924081|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924082|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
1924083|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
1924084|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924085|NCT00578539|Cytarabine|cytarabine|mesh-list
1924086|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
1924087|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
1924088|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924089|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
1924090|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924091|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924092|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924093|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
1924094|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924095|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924096|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924097|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924098|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
1924099|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
1924100|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924101|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924102|NCT00578552|Gabapentin|gabapentin|mesh-list
1924103|NCT00578552|Analgesics|analgesics|mesh-ancestor
1924104|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
1924105|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924106|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924107|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
1924108|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1924109|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1924110|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1924111|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1924112|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1924113|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1924114|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924115|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924116|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
1924117|NCT00578565|Rituximab|rituximab|mesh-list
1924118|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924119|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924120|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
1924121|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924122|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924123|NCT00578617|Amiodarone|amiodarone|mesh-list
1924124|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924125|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1924126|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
1924127|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1924128|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1924129|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1924130|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1924131|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1924132|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924133|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1924134|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1924135|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1924136|NCT00578643|Cyclosporine|cyclosporine|mesh-list
1924137|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
1924138|NCT00578643|Busulfan|busulfan|mesh-list
1924139|NCT00578643|Fludarabine|fludarabine|mesh-list
1924140|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
1924141|NCT00578643|Cyclosporins|cyclosporins|mesh-list
1924142|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924143|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
1924144|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924145|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924146|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924147|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
1924148|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924149|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924150|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924151|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924152|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
1924153|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924154|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
1924155|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1924156|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924157|NCT00578669|Fluoxetine|fluoxetine|mesh-list
1924158|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1924159|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1924160|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1924161|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924162|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924163|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
1924164|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924165|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1924166|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
1924167|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1924168|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1924169|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1924170|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924171|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1924172|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
1924173|NCT00578786|Ambrisentan|ambrisentan|mesh-list
1924174|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1924175|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
1924176|NCT00578864|Doxorubicin|doxorubicin|mesh-list
1924177|NCT00578864|Etoposide|etoposide|mesh-list
1924178|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
1924179|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924180|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
1924181|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924182|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924183|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924184|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
1924185|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924186|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924187|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924188|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1924189|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1924190|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1924191|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924192|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1924193|NCT00578877|Nonoxynol|nonoxynol|mesh-list
1924194|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1924195|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1924196|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924197|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1924198|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
1924199|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1924200|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1924201|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
1924202|NCT00578903|Methotrexate|methotrexate|mesh-list
1924203|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
1924204|NCT00578903|Tacrolimus|tacrolimus|mesh-list
1924205|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924206|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
1924207|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924209|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924210|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
1924211|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924212|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924213|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924214|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1924215|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
1924216|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1924217|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924218|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
1924219|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
1924220|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924221|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1924222|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1924223|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1924224|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924225|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1924226|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924227|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924228|NCT00578929|Analgesics|analgesics|mesh-ancestor
1924229|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
1924230|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924231|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924232|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924233|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924234|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1924235|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1924236|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1924237|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
1924238|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
1924239|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924240|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924241|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
1924242|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924243|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924244|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
1924245|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1924246|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
1924247|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924248|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924249|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1924250|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
1924251|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
1924252|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1924253|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924254|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924255|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924256|NCT00579098|Atorvastatin|atorvastatin|mesh-list
1924257|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1924258|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1924259|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
1924260|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924261|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1924262|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1924263|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924264|NCT00579111|Fludarabine|fludarabine|mesh-list
1924265|NCT00579111|Busulfan|busulfan|mesh-list
1924266|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
1924267|NCT00579111|Tacrolimus|tacrolimus|mesh-list
1924268|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924269|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924270|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924271|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
1924272|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924273|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1924274|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924275|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
1924276|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924277|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924278|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924279|NCT00579137|Fludarabine|fludarabine|mesh-list
1924280|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
1924281|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924282|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924283|NCT00579280|Valproic Acid|valproic acid|mesh-list
1924284|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1924285|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
1924286|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1924287|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1924288|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1924289|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1924290|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924291|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
1924292|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924293|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924294|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
1924295|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924296|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
1924297|NCT00579345|Vaccines|vaccines|mesh-list
1924298|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
1924299|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924300|NCT00579501|Dexamethasone|dexamethasone|mesh-list
1924301|NCT00579501|Trabectedin|trabectedin|mesh-list
1924302|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924303|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
1924304|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
1924305|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924306|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924307|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924308|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
1924309|NCT00579501|Hormones|hormones|mesh-ancestor
1924310|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1924311|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1924312|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924313|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924314|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
1924315|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924316|NCT00579527|Cyclosporine|cyclosporine|mesh-list
1924317|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
1924318|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
1924319|NCT00579527|Prednisolone|prednisolone|mesh-list
1924320|NCT00579527|Tacrolimus|tacrolimus|mesh-list
1924321|NCT00579527|Cyclosporins|cyclosporins|mesh-list
1924322|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
1924323|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1924324|NCT00579527|Daclizumab|daclizumab|mesh-list
1924325|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
1924326|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924327|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
1924328|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924329|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1924330|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924331|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924332|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
1924333|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924334|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
1924335|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924336|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1924337|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924338|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1924339|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
1924340|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1924341|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924342|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
1924343|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
1924344|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924345|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924346|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
1924347|NCT00579527|Hormones|hormones|mesh-ancestor
1924348|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1924349|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1924350|NCT00579527|Protective Agents|protective agents|mesh-ancestor
1924351|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1924352|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1924353|NCT00579553|Progesterone|progesterone|mesh-list
1924354|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1924355|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1924356|NCT00579553|Progestins|progestins|mesh-ancestor
1924357|NCT00579553|Hormones|hormones|mesh-ancestor
1924432|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
1924358|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1924359|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924360|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1924361|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
1924362|NCT00579670|Ziprasidone|ziprasidone|mesh-list
1924363|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1924364|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
1924365|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924366|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924367|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924368|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1924369|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1924370|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1924371|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1924372|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1924373|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
1924374|NCT00579813|Pioglitazone|pioglitazone|mesh-list
1924375|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1924376|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924387|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
1924388|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
1924389|NCT00579878|Methotrexate|methotrexate|mesh-list
1924390|NCT00579878|Leflunomide|leflunomide|mesh-list
1924391|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1924392|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
1924393|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1924394|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924395|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924396|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
1924397|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924398|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924399|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
1924400|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924401|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1924402|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924403|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
1924404|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924405|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1924406|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
1924407|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1924408|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1924409|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924410|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924411|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924412|NCT00579878|Analgesics|analgesics|mesh-ancestor
1924413|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
1924414|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924415|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924416|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924417|NCT00579982|Lamotrigine|lamotrigine|mesh-list
1924418|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
1924419|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1924420|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1924421|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924422|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1924423|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924424|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1924425|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1924426|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1924427|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1924428|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1924429|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
1924430|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924431|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924433|NCT00580047|Vitamin D|vitamin d|mesh-list
1924434|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
1924435|NCT00580047|Alendronate|alendronate|mesh-list
1924436|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
1924437|NCT00580047|Calcium|calcium|mesh-list
1924438|NCT00580047|Vitamins|vitamins|mesh-ancestor
1924439|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
1924440|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924441|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1924442|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1924443|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924444|NCT00580047|Antacids|antacids|mesh-ancestor
1924445|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924446|NCT00580073|Leucovorin|leucovorin|mesh-list
1924447|NCT00580073|Fluorouracil|fluorouracil|mesh-list
1924448|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
1924449|NCT00580073|Cetuximab|cetuximab|mesh-list
1924450|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
1924451|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924452|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924453|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924454|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924455|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
1924456|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924457|NCT00580073|Antidotes|antidotes|mesh-ancestor
1924458|NCT00580073|Protective Agents|protective agents|mesh-ancestor
1924459|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
1924460|NCT00580073|Vitamins|vitamins|mesh-ancestor
1924461|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
1924462|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924463|NCT00580151|Clonidine|clonidine|mesh-list
1924464|NCT00580151|Analgesics|analgesics|mesh-ancestor
1924465|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
1924466|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924467|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924468|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1924469|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
1924470|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
1924471|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1924472|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1924473|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1924474|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
1924475|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924476|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924477|NCT00580229|Prednisone|prednisone|mesh-list
1924478|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924479|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
1924480|NCT00580229|Hormones|hormones|mesh-ancestor
1924481|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1924482|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924483|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1924484|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924485|NCT00580294|Oxymorphone|oxymorphone|mesh-list
1924486|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1924487|NCT00580294|Narcotics|narcotics|mesh-ancestor
1924488|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1924489|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924490|NCT00580294|Analgesics|analgesics|mesh-ancestor
1924491|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
1924492|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924493|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1924494|NCT00580333|Paclitaxel|paclitaxel|mesh-list
1924495|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
1924496|NCT00580333|Bevacizumab|bevacizumab|mesh-list
1924497|NCT00580333|Doxorubicin|doxorubicin|mesh-list
1924498|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1924499|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924500|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
1924501|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
1924502|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
1924503|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924504|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924505|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
1924506|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924507|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924508|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924509|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
1924510|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924511|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924512|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1924513|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1924514|NCT00580333|Growth Substances|growth substances|mesh-ancestor
1924515|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
1924516|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1924517|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1924518|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1924519|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924520|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
1924521|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924522|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
1924523|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924524|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924525|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924526|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
1924527|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924528|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924529|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924530|NCT00580398|Varenicline|varenicline|mesh-list
1924531|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1924532|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1924533|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924534|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924535|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924536|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924537|NCT00580606|Glycerol|glycerol|mesh-list
1924538|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1924539|NCT00580606|Protective Agents|protective agents|mesh-ancestor
1924540|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924541|NCT00580645|Varenicline|varenicline|mesh-list
1924542|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1924543|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1924544|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924545|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924546|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924547|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924548|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
1924549|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
1924550|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924551|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1924552|NCT00580801|Interferons|interferons|mesh-list
1924553|NCT00580801|Ribavirin|ribavirin|mesh-list
1924554|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
1924555|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
1924556|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1924557|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924558|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
1924559|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924560|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
1924561|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924562|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
1924563|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924564|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
1924565|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924566|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
1924567|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924568|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924569|NCT00580853|Bupropion|bupropion|mesh-list
1924570|NCT00580853|Varenicline|varenicline|mesh-list
1924571|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1924572|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
1924573|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1924574|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1924575|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1924576|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1924577|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924578|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
1924579|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924580|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924581|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1924582|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1924583|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924584|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1924585|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1924586|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924587|NCT00580957|Trimethaphan|trimethaphan|mesh-list
1924588|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1924589|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1924590|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1924591|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
1924592|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924593|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924594|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1924595|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1924596|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924597|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924598|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924599|NCT00580970|Lovastatin|lovastatin|mesh-list
1924600|NCT00580970|L 647318|l 647318|mesh-list
1924601|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
1924602|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1924603|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1924604|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
1924605|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924606|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1924607|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1924608|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924609|NCT00580983|Paclitaxel|paclitaxel|mesh-list
1924610|NCT00580983|Carboplatin|carboplatin|mesh-list
1924611|NCT00580983|Fluorouracil|fluorouracil|mesh-list
1924612|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1924613|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924614|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
1924615|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
1924616|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
1924617|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924618|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
1924619|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924620|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924621|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
1924622|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924623|NCT00581048|Vitamin E|vitamin e|mesh-list
1924624|NCT00581048|Tocopherols|tocopherols|mesh-list
1924625|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
1924626|NCT00581048|Vitamins|vitamins|mesh-ancestor
1924627|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
1924628|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924629|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
1924630|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924631|NCT00581048|Protective Agents|protective agents|mesh-ancestor
1924632|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
1924633|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1924634|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1924635|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924636|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924637|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924638|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924639|NCT00581061|Urological Agents|urological agents|mesh-ancestor
1924640|NCT00581100|Etanercept|etanercept|mesh-list
1924641|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924642|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924643|NCT00581100|Analgesics|analgesics|mesh-ancestor
1924644|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
1924645|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924646|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924647|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924648|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924649|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924650|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924651|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
1924652|NCT00581360|Doxorubicin|doxorubicin|mesh-list
1924653|NCT00581360|Bortezomib|bortezomib|mesh-list
1924654|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1924655|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924656|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1924657|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1924658|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924659|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924660|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
1924661|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1924662|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924663|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1924664|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1924665|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924666|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924667|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924668|NCT00581555|Etanercept|etanercept|mesh-list
1924669|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924670|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924671|NCT00581555|Analgesics|analgesics|mesh-ancestor
1924672|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
1924673|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924674|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924675|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924676|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924677|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924678|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924679|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
1924680|NCT00581776|Dexamethasone|dexamethasone|mesh-list
1924681|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
1924682|NCT00581776|Rituximab|rituximab|mesh-list
1924683|NCT00581776|Doxorubicin|doxorubicin|mesh-list
1924684|NCT00581776|Vincristine|vincristine|mesh-list
1924685|NCT00581776|Bortezomib|bortezomib|mesh-list
1924686|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924687|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
1924688|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924689|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924690|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924691|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
1924692|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924693|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924694|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924695|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924696|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
1924697|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
1924698|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924699|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924700|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
1924701|NCT00581776|Hormones|hormones|mesh-ancestor
1924702|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1924703|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1924704|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924705|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1924706|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1924707|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1924708|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924709|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1924710|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
1924711|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
1924712|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
1924713|NCT00581828|Vitamin D|vitamin d|mesh-list
1924714|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
1924715|NCT00581828|Vitamins|vitamins|mesh-list
1924716|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
1924717|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924718|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1924719|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1924720|NCT00581867|Insulin|insulin|mesh-list
1924721|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1924722|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
1924723|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1924724|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924725|NCT00581893|Phenytoin|phenytoin|mesh-list
1924726|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
1924727|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1924728|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1924729|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1924730|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924731|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1924732|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1924733|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
1924734|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924735|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
1924736|NCT00581919|Vitamins|vitamins|mesh-ancestor
1924737|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
1924738|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
1924739|NCT00581971|Celecoxib|celecoxib|mesh-list
1924740|NCT00581971|Paclitaxel|paclitaxel|mesh-list
1924741|NCT00581971|Carboplatin|carboplatin|mesh-list
1924742|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1924743|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924744|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
1924745|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
1924746|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
1924747|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924748|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924749|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924750|NCT00581971|Analgesics|analgesics|mesh-ancestor
1924751|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
1924752|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924753|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924754|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924755|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924756|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1924757|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1924758|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924759|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
1924760|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1924761|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
1924762|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924763|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924764|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1924765|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
1924766|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1924767|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
1924768|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924769|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924770|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1924771|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
1924772|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
1924773|NCT00582010|Protective Agents|protective agents|mesh-ancestor
1924774|NCT00582075|Temozolomide|temozolomide|mesh-list
1924775|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924776|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
1924777|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924778|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924779|NCT00582114|Atenolol|atenolol|mesh-list
1924780|NCT00582114|Lisinopril|lisinopril|mesh-list
1924781|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1924782|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
1924783|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924784|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924785|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1924786|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1924787|NCT00582114|Protective Agents|protective agents|mesh-ancestor
1924788|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924789|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1924790|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
1924791|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
1924792|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924793|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1924794|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1924795|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1924796|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
1924797|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924798|NCT00582166|Rituximab|rituximab|mesh-list
1924799|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1924800|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924801|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924802|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
1924803|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924804|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924805|NCT00582205|Paclitaxel|paclitaxel|mesh-list
1924806|NCT00582205|Cisplatin|cisplatin|mesh-list
1924807|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1924808|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924809|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
1924810|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
1924811|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
1924812|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924813|NCT00582309|Insulin|insulin|mesh-list
1924814|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1924815|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1924816|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924817|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
1924818|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924819|NCT00582426|Octreotide|octreotide|mesh-list
1924820|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924821|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1924822|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924823|NCT00582491|Modafinil|modafinil|mesh-list
1924824|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1924825|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924826|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1924827|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1924828|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1924829|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924830|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
1924831|NCT00582556|Leuprolide|leuprolide|mesh-list
1924832|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1924833|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924834|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1924835|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
1924836|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1924837|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1924838|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924839|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
1924840|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1924841|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924842|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924843|NCT00582660|Celecoxib|celecoxib|mesh-list
1924844|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924845|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924846|NCT00582660|Analgesics|analgesics|mesh-ancestor
1924847|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
1924848|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924849|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924850|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924851|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924852|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1924853|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1924854|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924855|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924856|NCT00582738|Everolimus|everolimus|mesh-list
1924857|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924858|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924859|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
1924860|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924861|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
1924862|NCT00582790|Interleukin-2|interleukin-2|mesh-list
1924863|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924864|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924865|NCT00582790|Analgesics|analgesics|mesh-ancestor
1924866|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
1924867|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924868|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924869|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1924870|NCT00582894|Fludarabine|fludarabine|mesh-list
1924871|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
1924872|NCT00582894|Busulfan|busulfan|mesh-list
1924873|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924874|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924875|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924876|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
1924877|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924878|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924879|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
1924880|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924881|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924882|NCT00582907|Rilonacept|rilonacept|mesh-list
1924883|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924884|NCT00582933|Vidarabine|vidarabine|mesh-list
1924885|NCT00582933|Fludarabine|fludarabine|mesh-list
1924886|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
1924887|NCT00582933|Melphalan|melphalan|mesh-list
1924888|NCT00582933|Busulfan|busulfan|mesh-list
1924889|NCT00582933|Lenograstim|lenograstim|mesh-list
1924890|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924891|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924892|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
1924893|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924894|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924895|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
1924896|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924897|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
1924898|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924899|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924900|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
1924901|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924902|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1924903|NCT00582972|Omeprazole|omeprazole|mesh-list
1924904|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1924905|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1924906|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1924907|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924908|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924909|NCT00583011|Anesthetics|anesthetics|mesh-list
1924910|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1924911|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924912|NCT00583102|Cytarabine|cytarabine|mesh-list
1924913|NCT00583102|Lovastatin|lovastatin|mesh-list
1924914|NCT00583102|L 647318|l 647318|mesh-list
1924915|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
1924916|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924917|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
1924918|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924919|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924920|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
1924921|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924922|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924923|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
1924924|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924925|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1924926|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1924927|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1924928|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1924929|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924930|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1924931|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1924932|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
1924933|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1924934|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1924935|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924936|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
1924937|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1924938|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924939|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1924940|NCT00583219|Protective Agents|protective agents|mesh-ancestor
1924941|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1924942|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
1924943|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1924944|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924945|NCT00583362|Belimumab|belimumab|mesh-list
1924946|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924947|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
1924948|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924949|NCT00583453|Celecoxib|celecoxib|mesh-list
1924950|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1924951|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1924952|NCT00583453|Analgesics|analgesics|mesh-ancestor
1924953|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
1924954|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1924955|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924956|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1924957|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1924958|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1924959|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1924960|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925112|NCT00585013|Protective Agents|protective agents|mesh-ancestor
1924961|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924962|NCT00583557|Belimumab|belimumab|mesh-list
1924963|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924964|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
1924965|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924966|NCT00583622|Gemcitabine|gemcitabine|mesh-list
1924967|NCT00583622|Bevacizumab|bevacizumab|mesh-list
1924968|NCT00583622|Carboplatin|carboplatin|mesh-list
1924969|NCT00583622|Docetaxel|docetaxel|mesh-list
1924970|NCT00583622|Melphalan|melphalan|mesh-list
1924971|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1924972|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1924973|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1924974|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1924975|NCT00583622|Growth Substances|growth substances|mesh-ancestor
1924976|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924977|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
1924978|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1924979|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
1924980|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924981|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
1924982|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1924983|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1924984|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1924985|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
1924986|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
1924987|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
1924988|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
1924989|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1924990|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
1924991|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1924992|NCT00583700|Vitamin E|vitamin e|mesh-list
1924993|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
1924994|NCT00583700|Vitamins|vitamins|mesh-ancestor
1924995|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
1924996|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1924997|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
1924998|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1924999|NCT00583700|Protective Agents|protective agents|mesh-ancestor
1925000|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1925001|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925002|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1925003|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1925004|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925005|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1925006|NCT00583947|Albuterol|albuterol|mesh-list
1925007|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
1925008|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1925009|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
1925010|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925011|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925012|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925013|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925014|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
1925015|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925016|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1925017|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1925018|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1925019|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925020|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925021|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925022|NCT00584701|Risperidone|risperidone|mesh-list
1925023|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1925024|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
1925025|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925026|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925027|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925028|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1925029|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1925030|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925031|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1925032|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1925033|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
1925034|NCT00584857|Paclitaxel|paclitaxel|mesh-list
1925035|NCT00584857|Carboplatin|carboplatin|mesh-list
1925036|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925037|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925038|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
1925039|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
1925040|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
1925041|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925042|NCT00584870|Naproxen|naproxen|mesh-list
1925043|NCT00584870|Tanezumab|tanezumab|mesh-list
1925044|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1925045|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1925046|NCT00584870|Analgesics|analgesics|mesh-ancestor
1925047|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
1925048|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925049|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925050|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925051|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925052|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
1925053|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1925054|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925055|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925056|NCT00584909|Paclitaxel|paclitaxel|mesh-list
1925057|NCT00584909|Carboplatin|carboplatin|mesh-list
1925058|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925059|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925060|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
1925061|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
1925062|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
1925063|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925064|NCT00584948|Memantine|memantine|mesh-list
1925065|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1925066|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1925067|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
1925068|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925069|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925070|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925071|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1925072|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1925073|NCT00584987|Fluticasone|fluticasone|mesh-list
1925074|NCT00584987|Xhance|xhance|mesh-list
1925075|NCT00584987|Phenylephrine|phenylephrine|mesh-list
1925076|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
1925077|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925078|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1925079|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
1925080|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925081|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925082|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925083|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925084|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
1925085|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1925086|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1925087|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1925088|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925089|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925090|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925091|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
1925092|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
1925093|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1925094|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1925095|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
1925096|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1925097|NCT00584987|Protective Agents|protective agents|mesh-ancestor
1925098|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
1925099|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1925100|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
1925101|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925102|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925103|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925104|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925105|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1925106|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
1925107|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925108|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925109|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1925110|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925111|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
1925113|NCT00585039|Albuterol|albuterol|mesh-list
1925114|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1925115|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
1925116|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925117|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925118|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925119|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925120|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
1925121|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925122|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1925123|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1925124|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1925125|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925126|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925127|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925128|NCT00585052|Paclitaxel|paclitaxel|mesh-list
1925129|NCT00585052|Lovastatin|lovastatin|mesh-list
1925130|NCT00585052|L 647318|l 647318|mesh-list
1925131|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
1925132|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925133|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925134|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
1925135|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
1925136|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
1925137|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925138|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1925139|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1925140|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
1925141|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1925142|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1925143|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925144|NCT00585078|Capecitabine|capecitabine|mesh-list
1925145|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
1925146|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925147|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
1925148|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925149|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925150|NCT00585104|Simendan|simendan|mesh-list
1925151|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1925152|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925153|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1925154|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1925155|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925156|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925157|NCT00585104|Protective Agents|protective agents|mesh-ancestor
1925158|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925159|NCT00585169|Memantine|memantine|mesh-list
1925160|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1925161|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1925162|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
1925163|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925164|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925165|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925166|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1925167|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1925168|NCT00585182|Enoxaparin|enoxaparin|mesh-list
1925169|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
1925170|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1925171|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1925172|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925173|NCT00585195|Itraconazole|itraconazole|mesh-list
1925174|NCT00585195|Rifampin|rifampin|mesh-list
1925175|NCT00585195|Crizotinib|crizotinib|mesh-list
1925176|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
1925177|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925178|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1925179|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1925180|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925181|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925182|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1925183|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
1925184|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925185|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925186|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1925187|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1925188|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
1925189|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1925190|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
1925191|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1925192|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1925193|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1925194|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1925195|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1925196|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1925197|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1925198|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925199|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925200|NCT00585247|Imiquimod|imiquimod|mesh-list
1925201|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1925202|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
1925203|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925204|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925205|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
1925206|NCT00585312|Celecoxib|celecoxib|mesh-list
1925207|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1925208|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1925209|NCT00585312|Analgesics|analgesics|mesh-ancestor
1925210|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
1925211|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925212|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925213|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925214|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925215|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1925216|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1925217|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925218|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925219|NCT00585325|Lidocaine|lidocaine|mesh-list
1925220|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
1925221|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
1925222|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925223|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925224|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
1925225|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925226|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1925227|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1925228|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1925229|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925230|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925231|NCT00585351|Ranitidine|ranitidine|mesh-list
1925232|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1925233|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1925234|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1925235|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1925236|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
1925237|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
1925238|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925239|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925240|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925241|NCT00585377|Bevacizumab|bevacizumab|mesh-list
1925242|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1925243|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925244|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925245|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1925246|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1925247|NCT00585377|Growth Substances|growth substances|mesh-ancestor
1925248|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925249|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
1925250|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925251|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925252|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925253|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
1925254|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1925255|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925256|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1925257|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
1925258|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1925259|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925260|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925261|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925262|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1925263|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925264|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925265|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925266|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925267|NCT00585546|Clenbuterol|clenbuterol|mesh-list
1925268|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1925269|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1925270|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925271|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925272|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925273|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925274|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1925275|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
1925276|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925277|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925278|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925279|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
1925280|NCT00585637|Vitamin D|vitamin d|mesh-list
1925281|NCT00585637|Vitamins|vitamins|mesh-ancestor
1925282|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
1925283|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925284|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1925285|NCT00585650|Etanercept|etanercept|mesh-list
1925286|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1925287|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1925288|NCT00585650|Analgesics|analgesics|mesh-ancestor
1925289|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
1925290|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925291|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925292|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925293|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925294|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1925295|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925296|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
1925297|NCT00585689|Gemcitabine|gemcitabine|mesh-list
1925298|NCT00585689|Carboplatin|carboplatin|mesh-list
1925299|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1925300|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925301|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925302|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
1925303|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925304|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
1925305|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925306|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925307|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925308|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
1925309|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925310|NCT00585780|Prazosin|prazosin|mesh-list
1925311|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1925312|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1925313|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1925314|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1925315|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925316|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925317|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925318|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925319|NCT00585910|Methylphenidate|methylphenidate|mesh-list
1925320|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1925321|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1925322|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925323|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1925324|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1925325|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925326|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925327|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
1925328|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925329|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1925330|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925331|NCT00585975|Bromfenac|bromfenac|mesh-list
1925332|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1925333|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1925334|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1925335|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1925336|NCT00585975|Analgesics|analgesics|mesh-ancestor
1925337|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
1925338|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925339|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925340|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925341|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925342|NCT00586066|Memantine|memantine|mesh-list
1925343|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1925344|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1925345|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
1925346|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925347|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925348|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925349|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1925350|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1925351|NCT00586105|Sorafenib|sorafenib|mesh-list
1925352|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925353|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925354|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925355|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925356|NCT00586157|Methylphenidate|methylphenidate|mesh-list
1925357|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1925358|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925359|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1925360|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1925361|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925362|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925363|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
1925364|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925365|NCT00586196|Donepezil|donepezil|mesh-list
1925366|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1925367|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925368|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925369|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
1925370|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925371|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925372|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
1925373|NCT00586261|Pioglitazone|pioglitazone|mesh-list
1925374|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
1925375|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1925376|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925377|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925378|NCT00586482|Nicotine|nicotine|mesh-list
1925379|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1925380|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
1925381|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925382|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925383|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1925384|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1925385|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
1925386|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925387|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925388|NCT00586495|Sorafenib|sorafenib|mesh-list
1925389|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925390|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925391|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925392|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925393|NCT00586508|Bevacizumab|bevacizumab|mesh-list
1925394|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
1925395|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925396|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925397|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1925398|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1925399|NCT00586508|Growth Substances|growth substances|mesh-ancestor
1925400|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925401|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
1925402|NCT00586521|Factor VIII|factor viii|mesh-list
1925403|NCT00586521|Coagulants|coagulants|mesh-ancestor
1925404|NCT00586573|Memantine|memantine|mesh-list
1925405|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1925406|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1925407|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
1925408|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925409|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925410|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925411|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1925412|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1925413|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1925414|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
1925415|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925416|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
1925417|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1925418|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
1925419|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1925420|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1925421|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1925422|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1925423|NCT00586690|Antibodies|antibodies|mesh-list
1925424|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
1925425|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1925426|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
1925427|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925428|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925429|NCT00586729|Mafenide|mafenide|mesh-list
1925430|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1925431|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925432|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1925433|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1925434|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925435|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925436|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
1925437|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1925438|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1925439|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925440|NCT00586846|Doxorubicin|doxorubicin|mesh-list
1925441|NCT00586846|Methotrexate|methotrexate|mesh-list
1925442|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925443|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1925444|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1925445|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1925446|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925447|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925448|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1925449|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
1925450|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925451|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925452|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925453|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
1925454|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
1925455|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1925456|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925457|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
1925458|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925459|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1925460|NCT00586898|Ketoconazole|ketoconazole|mesh-list
1925461|NCT00586898|Bicalutamide|bicalutamide|mesh-list
1925462|NCT00586898|Testosterone|testosterone|mesh-list
1925463|NCT00586898|Estrogens|estrogens|mesh-list
1925464|NCT00586898|Androgens|androgens|mesh-ancestor
1925465|NCT00586898|Hormones|hormones|mesh-ancestor
1925466|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925467|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925468|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925469|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
1925470|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925471|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1925472|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1925473|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925474|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925475|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1925476|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
1925477|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1925478|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
1925481|NCT00587067|Floxuridine|floxuridine|mesh-list
1925482|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925483|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
1925484|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925485|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925486|NCT00587132|Secretin|secretin|mesh-list
1925487|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1925488|NCT00587132|Hormones|hormones|mesh-ancestor
1925489|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925490|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925491|NCT00587288|Reslizumab|reslizumab|mesh-list
1925492|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925493|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925494|NCT00587431|Docetaxel|docetaxel|mesh-list
1925495|NCT00587431|Leuprolide|leuprolide|mesh-list
1925496|NCT00587431|Testosterone|testosterone|mesh-list
1925497|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925498|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
1925499|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
1925500|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
1925501|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925502|NCT00587431|Androgens|androgens|mesh-ancestor
1925503|NCT00587431|Hormones|hormones|mesh-ancestor
1925504|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925505|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925506|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1925507|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1925508|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
1925509|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925510|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
1925511|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925512|NCT00587483|Lidocaine|lidocaine|mesh-list
1925513|NCT00587483|Amiodarone|amiodarone|mesh-list
1925514|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
1925515|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
1925516|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925517|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925518|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
1925519|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925520|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1925521|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1925522|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1925523|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925524|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925525|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925526|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1925527|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1925528|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1925529|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925530|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1925531|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1925532|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1925533|NCT00587678|Simvastatin|simvastatin|mesh-list
1925534|NCT00587678|Ezetimibe|ezetimibe|mesh-list
1925535|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1925536|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1925537|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
1925538|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925539|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1925540|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1925541|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925542|NCT00587769|Bupropion|bupropion|mesh-list
1925543|NCT00587769|Varenicline|varenicline|mesh-list
1925544|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1925545|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
1925546|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1925547|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1925548|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1925549|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925550|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925551|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
1925552|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925553|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925554|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1925555|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1925556|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925557|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1925558|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1925559|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
1925560|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
1925561|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925562|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925563|NCT00588094|Rituximab|rituximab|mesh-list
1925564|NCT00588094|Carboplatin|carboplatin|mesh-list
1925565|NCT00588094|Etoposide|etoposide|mesh-list
1925566|NCT00588094|Ifosfamide|ifosfamide|mesh-list
1925567|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925568|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925569|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
1925570|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925571|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925572|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925573|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1925574|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1925575|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925576|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925577|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1925578|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
1925579|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
1925580|NCT00588159|Promethazine|promethazine|mesh-list
1925581|NCT00588159|Gabapentin|gabapentin|mesh-list
1925582|NCT00588159|Analgesics|analgesics|mesh-ancestor
1925583|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
1925584|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925585|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925586|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
1925587|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1925588|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1925589|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925590|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1925591|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1925592|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1925593|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925594|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925595|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
1925596|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1925597|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1925598|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
1925599|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
1925600|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
1925601|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
1925602|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1925603|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1925604|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
1925605|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
1925606|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1925607|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
1925608|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
1925609|NCT00588237|Paclitaxel|paclitaxel|mesh-list
1925610|NCT00588237|Bevacizumab|bevacizumab|mesh-list
1925611|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925612|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925613|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
1925614|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
1925615|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
1925616|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925617|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925618|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1925619|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1925620|NCT00588237|Growth Substances|growth substances|mesh-ancestor
1925621|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925622|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
1925623|NCT00588341|Temozolomide|temozolomide|mesh-list
1925624|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1925625|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
1925626|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925627|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925628|NCT00588354|Triamcinolone|triamcinolone|mesh-list
1925629|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1925630|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1925631|NCT00588354|Lidocaine|lidocaine|mesh-list
1925632|NCT00588354|Clonidine|clonidine|mesh-list
1925633|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1925634|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
1925635|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
1925636|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925637|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925638|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
1925639|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925640|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1925641|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1925642|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1925643|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925644|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925645|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925646|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
1925647|NCT00588354|Hormones|hormones|mesh-ancestor
1925648|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925649|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925650|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
1925651|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925652|NCT00588354|Analgesics|analgesics|mesh-ancestor
1925653|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1925654|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
1925655|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
1925656|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1925657|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1925658|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1925659|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925660|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925661|NCT00588406|Prednisone|prednisone|mesh-list
1925662|NCT00588406|Budesonide|budesonide|mesh-list
1925663|NCT00588406|Bromides|bromides|mesh-list
1925664|NCT00588406|Albuterol|albuterol|mesh-list
1925665|NCT00588406|Ipratropium|ipratropium|mesh-list
1925666|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925667|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
1925668|NCT00588406|Hormones|hormones|mesh-ancestor
1925669|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925670|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925671|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1925672|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925673|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1925674|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
1925675|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925676|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1925677|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925678|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
1925679|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
1925680|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925681|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1925682|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1925683|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1925684|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925685|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925686|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925687|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1925688|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
1925689|NCT00588445|Gefitinib|gefitinib|mesh-list
1925690|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925691|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925692|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925693|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925694|NCT00588536|Leucovorin|leucovorin|mesh-list
1925695|NCT00588536|Methotrexate|methotrexate|mesh-list
1925696|NCT00588536|Thioguanine|thioguanine|mesh-list
1925697|NCT00588536|Calcium|calcium|mesh-list
1925698|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
1925699|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1925700|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925701|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1925702|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
1925703|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925704|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925705|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
1925706|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925707|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925708|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
1925709|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925710|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1925711|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925712|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
1925713|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925714|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1925715|NCT00588536|Antidotes|antidotes|mesh-ancestor
1925716|NCT00588536|Protective Agents|protective agents|mesh-ancestor
1925717|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
1925718|NCT00588536|Vitamins|vitamins|mesh-ancestor
1925719|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
1925720|NCT00588640|Methadone|methadone|mesh-list
1925721|NCT00588640|D-methadone|d-methadone|mesh-list
1925722|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1925723|NCT00588640|Narcotics|narcotics|mesh-ancestor
1925724|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925725|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925726|NCT00588640|Analgesics|analgesics|mesh-ancestor
1925727|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
1925728|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925729|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
1925730|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
1925731|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1925732|NCT00588666|Gemcitabine|gemcitabine|mesh-list
1925733|NCT00588666|Bevacizumab|bevacizumab|mesh-list
1925734|NCT00588666|Carboplatin|carboplatin|mesh-list
1925735|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925736|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925737|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1925738|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1925739|NCT00588666|Growth Substances|growth substances|mesh-ancestor
1925740|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925741|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
1925742|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925743|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
1925744|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925745|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
1925746|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925747|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925748|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925749|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
1925750|NCT00588731|Cannabidiol|cannabidiol|mesh-list
1925751|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
1925777|NCT00588822|Rituximab|rituximab|mesh-list
1925778|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1925779|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925780|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
1925781|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925782|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925783|NCT00588900|Irinotecan|irinotecan|mesh-list
1925784|NCT00588900|Cediranib|cediranib|mesh-list
1925785|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1925786|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1925787|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925788|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925789|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925790|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925791|NCT00588952|Ketamine|ketamine|mesh-list
1925792|NCT00588952|Analgesics|analgesics|mesh-ancestor
1925793|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
1925794|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925795|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925796|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1925797|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1925798|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
1925799|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
1925800|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925801|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1925802|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1925803|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925804|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925805|NCT00588965|Propranolol|propranolol|mesh-list
1925806|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1925807|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1925808|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925809|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925810|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925811|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925812|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1925813|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1925814|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925815|NCT00589056|Nelfinavir|nelfinavir|mesh-list
1925816|NCT00589056|Etoposide|etoposide|mesh-list
1925817|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925818|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925819|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1925820|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1925821|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925822|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925823|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1925824|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1925825|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
1925826|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1925827|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1925828|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
1925829|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925830|NCT00589290|Belinostat|belinostat|mesh-list
1925831|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925832|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1925833|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925834|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925835|NCT00589303|Metoprolol|metoprolol|mesh-list
1925836|NCT00589303|Amiodarone|amiodarone|mesh-list
1925837|NCT00589303|Verapamil|verapamil|mesh-list
1925838|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1925839|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1925840|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
1925841|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
1925842|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925843|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925844|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1925845|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1925846|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1925847|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
1925848|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925849|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925850|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
1925851|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1925852|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925853|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1925854|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1925855|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1925856|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925857|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1925858|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1925859|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1925860|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1925861|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1925862|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1925863|NCT00589329|Metronidazole|metronidazole|mesh-list
1925864|NCT00589329|Erythromycin|erythromycin|mesh-list
1925865|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
1925866|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1925867|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
1925868|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925869|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1925870|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1925871|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1925872|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1925873|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925874|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925875|NCT00589472|Vorinostat|vorinostat|mesh-list
1925876|NCT00589472|Leuprolide|leuprolide|mesh-list
1925877|NCT00589472|Goserelin|goserelin|mesh-list
1925878|NCT00589472|Bicalutamide|bicalutamide|mesh-list
1925879|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925880|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1925881|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925882|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925883|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1925884|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
1925885|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925886|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925887|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1925888|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
1925889|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
1925890|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1925891|NCT00589563|Sirolimus|sirolimus|mesh-list
1925892|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
1925893|NCT00589563|Melphalan|melphalan|mesh-list
1925894|NCT00589563|Methotrexate|methotrexate|mesh-list
1925895|NCT00589563|Fludarabine|fludarabine|mesh-list
1925896|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
1925897|NCT00589563|Etoposide|etoposide|mesh-list
1925898|NCT00589563|Tacrolimus|tacrolimus|mesh-list
1925899|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1925900|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925901|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
1925902|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925903|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925904|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1925905|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
1925906|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925907|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925908|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1925909|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1925910|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
1925911|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1925912|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925913|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
1925914|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
1925915|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925916|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1925917|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1925918|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1925919|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1925920|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1925921|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1925922|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1925923|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925924|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1925925|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
1925926|NCT00589628|Infliximab|infliximab|mesh-list
1925927|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
1925928|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1925929|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1925930|NCT00589667|Gemcitabine|gemcitabine|mesh-list
1925931|NCT00589667|Pemetrexed|pemetrexed|mesh-list
1925932|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1925933|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
1925934|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925935|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925936|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
1925937|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925938|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925939|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1925940|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
1925941|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925942|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1925943|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1925944|NCT00589693|Imipenem|imipenem|mesh-list
1925945|NCT00589693|Doripenem|doripenem|mesh-list
1925946|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
1925947|NCT00589693|Cilastatin|cilastatin|mesh-list
1925948|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1925949|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1925950|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
1925951|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925952|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925953|NCT00589784|Sunitinib|sunitinib|mesh-list
1925954|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
1925955|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1925956|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1925957|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1925958|NCT00589784|Growth Substances|growth substances|mesh-ancestor
1925959|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925960|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
1925961|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1925962|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1925963|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925964|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1925965|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1925966|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1925967|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1925968|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1925969|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1925970|NCT00589914|Risperidone|risperidone|mesh-list
1925971|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1925972|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1925973|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925974|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925975|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1925976|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1925977|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1925978|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
1925979|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1925980|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925981|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1925982|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1925983|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
1925984|NCT00589979|Lidocaine|lidocaine|mesh-list
1925985|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
1925986|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
1925987|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1925988|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1925989|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
1925990|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1925991|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1925992|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1925993|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1925994|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1925995|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1925996|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
1925997|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1925998|NCT00590031|Irinotecan|irinotecan|mesh-list
1925999|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926000|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1926001|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1926002|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926003|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926004|NCT00590044|Insulin|insulin|mesh-list
1926005|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1926006|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
1926007|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
1926008|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1926009|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926010|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
1926011|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1926012|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926013|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926014|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1926015|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1926016|NCT00590161|Protective Agents|protective agents|mesh-ancestor
1926017|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926018|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
1926019|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1926020|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
1926021|NCT00590226|Insulin|insulin|mesh-list
1926022|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1926023|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
1926024|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
1926025|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
1926026|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
1926027|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1926028|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926029|NCT00590317|Ondansetron|ondansetron|mesh-list
1926030|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
1926031|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
1926032|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
1926033|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926034|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926035|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1926036|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
1926037|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
1926038|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1926039|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
1926040|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926041|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926042|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1926043|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926044|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926045|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926046|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1926047|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1926048|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
1926049|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1926050|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
1926051|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926052|NCT00590460|Fludarabine|fludarabine|mesh-list
1926053|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
1926054|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926055|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926056|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1926057|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1926058|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926059|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926060|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926061|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926062|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1926063|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1926064|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
1926065|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926066|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926067|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1926068|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1926069|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
1926070|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
1926071|NCT00590590|Promethazine|promethazine|mesh-list
1926072|NCT00590590|Lidocaine|lidocaine|mesh-list
1926073|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
1926074|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
1926075|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926076|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926077|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
1926078|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926079|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1926080|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1926081|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1926082|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926156|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
1926083|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926084|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1926085|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1926086|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
1926087|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
1926088|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1926089|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1926090|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
1926091|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
1926092|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926093|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1926094|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
1926095|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
1926096|NCT00590681|Bevacizumab|bevacizumab|mesh-list
1926097|NCT00590681|Temozolomide|temozolomide|mesh-list
1926098|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926099|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926100|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926101|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926102|NCT00590681|Growth Substances|growth substances|mesh-ancestor
1926103|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926104|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926105|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926106|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
1926107|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926108|NCT00590772|Montelukast|montelukast|mesh-list
1926109|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1926110|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
1926111|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1926112|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
1926113|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1926114|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926115|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1926116|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1926117|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926118|NCT00590824|Interleukin-2|interleukin-2|mesh-list
1926119|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926120|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1926121|NCT00590824|Analgesics|analgesics|mesh-ancestor
1926122|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
1926123|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926124|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926125|NCT00590863|Dexetimide|dexetimide|mesh-list
1926126|NCT00590863|Mirtazapine|mirtazapine|mesh-list
1926127|NCT00590863|Citalopram|citalopram|mesh-list
1926128|NCT00590863|Bupropion|bupropion|mesh-list
1926129|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1926130|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1926131|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1926132|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926133|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926134|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926135|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
1926136|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926137|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1926138|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
1926139|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926140|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1926141|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1926142|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
1926143|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
1926144|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926145|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1926146|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1926147|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
1926148|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1926149|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
1926150|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1926151|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1926152|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926153|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1926154|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1926155|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
1926157|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1926158|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926159|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926160|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1926161|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1926162|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1926163|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
1926164|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1926165|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1926166|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1926167|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1926168|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926169|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1926170|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926171|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926172|NCT00590967|Cisplatin|cisplatin|mesh-list
1926173|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926174|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
1926175|NCT00591006|Phenytoin|phenytoin|mesh-list
1926176|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1926177|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
1926178|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1926179|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1926180|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926181|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926182|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1926183|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1926184|NCT00591019|Modafinil|modafinil|mesh-list
1926185|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1926186|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926187|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1926188|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1926189|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1926190|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926191|NCT00591123|Leucovorin|leucovorin|mesh-list
1926192|NCT00591123|Fluorouracil|fluorouracil|mesh-list
1926193|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
1926194|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1926195|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
1926196|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926197|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
1926198|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926199|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1926200|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926201|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926202|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
1926203|NCT00591123|Antidotes|antidotes|mesh-ancestor
1926204|NCT00591123|Protective Agents|protective agents|mesh-ancestor
1926205|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
1926206|NCT00591123|Vitamins|vitamins|mesh-ancestor
1926207|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
1926208|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1926209|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926210|NCT00591149|Docetaxel|docetaxel|mesh-list
1926211|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
1926212|NCT00591149|Cetuximab|cetuximab|mesh-list
1926213|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926214|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
1926215|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
1926216|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
1926217|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926218|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926219|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
1926220|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1926221|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926222|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1926223|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1926224|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1926225|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926226|NCT00591266|Amlodipine|amlodipine|mesh-list
1926227|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1926228|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1926229|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1926230|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926231|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926232|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1926233|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926234|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
1926235|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1926236|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1926237|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
1926238|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1926239|NCT00591305|Protective Agents|protective agents|mesh-ancestor
1926240|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926241|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926242|NCT00591370|Temozolomide|temozolomide|mesh-list
1926243|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926244|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
1926245|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926246|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926247|NCT00591565|Acamprosate|acamprosate|mesh-list
1926248|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1926249|NCT00591578|Valsartan|valsartan|mesh-list
1926250|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1926251|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1926252|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1926253|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1926254|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926255|NCT00591630|Cytarabine|cytarabine|mesh-list
1926256|NCT00591630|Rituximab|rituximab|mesh-list
1926257|NCT00591630|Etoposide|etoposide|mesh-list
1926258|NCT00591630|Melphalan|melphalan|mesh-list
1926259|NCT00591630|Carmustine|carmustine|mesh-list
1926260|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926261|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926262|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
1926263|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926264|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926265|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1926266|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1926267|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1926268|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926269|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926270|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1926271|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
1926272|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
1926273|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926274|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926275|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926276|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
1926277|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1926278|NCT00591734|Bevacizumab|bevacizumab|mesh-list
1926279|NCT00591734|Everolimus|everolimus|mesh-list
1926280|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926281|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926282|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926283|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926284|NCT00591734|Growth Substances|growth substances|mesh-ancestor
1926285|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926286|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926287|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926288|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
1926289|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
1926290|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1926291|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1926292|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1926293|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926294|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1926295|NCT00591773|Diuretics|diuretics|mesh-ancestor
1926296|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
1926297|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926298|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1926299|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926300|NCT00591825|Cycloserine|cycloserine|mesh-list
1926301|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1926302|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926303|NCT00591825|Renal Agents|renal agents|mesh-ancestor
1926304|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1926305|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
1926306|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1926307|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
1926308|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926309|NCT00591851|Paclitaxel|paclitaxel|mesh-list
1926310|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
1926311|NCT00591851|Doxorubicin|doxorubicin|mesh-list
1926312|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1926313|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1926314|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926315|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
1926316|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
1926317|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
1926318|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926319|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926320|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
1926321|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926322|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926323|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926324|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
1926325|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1926326|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1926327|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1926328|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1926329|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926330|NCT00592072|Decanoic acid|decanoic acid|mesh-list
1926331|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
1926332|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926333|NCT00592124|Tenofovir|tenofovir|mesh-list
1926334|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
1926335|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926336|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1926337|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1926338|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926339|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926340|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1926341|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1926342|NCT00592176|Bevacizumab|bevacizumab|mesh-list
1926343|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926344|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926345|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926346|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926347|NCT00592176|Growth Substances|growth substances|mesh-ancestor
1926348|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926349|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926350|NCT00592319|Celecoxib|celecoxib|mesh-list
1926351|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1926352|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1926353|NCT00592319|Analgesics|analgesics|mesh-ancestor
1926354|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
1926355|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926356|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926357|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1926358|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926359|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1926360|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1926361|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926362|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926363|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1926364|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1926365|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926366|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926367|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926368|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926369|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1926370|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1926371|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
1926372|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926373|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926374|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1926375|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1926376|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
1926377|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1926449|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1926378|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1926379|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1926380|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926381|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926382|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926383|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926384|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1926385|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
1926386|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926387|NCT00592475|Conivaptan|conivaptan|mesh-list
1926388|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1926389|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926390|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
1926391|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926392|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
1926393|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
1926394|NCT00592488|Vitamins|vitamins|mesh-ancestor
1926395|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
1926396|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926397|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
1926398|NCT00592501|Fluorouracil|fluorouracil|mesh-list
1926399|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926400|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
1926401|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926402|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1926403|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926404|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
1926405|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926406|NCT00592683|Aripiprazole|aripiprazole|mesh-list
1926407|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
1926408|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926409|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1926410|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926411|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926412|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926413|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
1926414|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
1926415|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926416|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926417|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1926418|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1926419|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
1926420|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1926421|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1926422|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1926423|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1926424|NCT00592839|Estrogens|estrogens|mesh-list
1926425|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1926426|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
1926427|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
1926428|NCT00592839|Hormones|hormones|mesh-ancestor
1926429|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1926430|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926431|NCT00592852|Fluoxetine|fluoxetine|mesh-list
1926432|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1926433|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1926434|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926435|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926436|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926437|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
1926438|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926439|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1926440|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
1926441|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926442|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1926443|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1926444|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926445|NCT00592943|Modafinil|modafinil|mesh-list
1926446|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1926447|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926448|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1926450|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1926451|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926452|NCT00593112|Methylphenidate|methylphenidate|mesh-list
1926453|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1926454|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926455|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1926456|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1926457|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926458|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926459|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
1926460|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926461|NCT00593450|Bevacizumab|bevacizumab|mesh-list
1926462|NCT00593450|Ranibizumab|ranibizumab|mesh-list
1926463|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926464|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926465|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926466|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926467|NCT00593450|Growth Substances|growth substances|mesh-ancestor
1926468|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926469|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926470|NCT00593489|Insulin|insulin|mesh-list
1926471|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1926472|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926473|NCT00593554|Fludarabine|fludarabine|mesh-list
1926474|NCT00593554|Thiotepa|thiotepa|mesh-list
1926475|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
1926476|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1926477|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926478|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926479|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926480|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
1926481|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926482|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926483|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
1926484|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1926485|NCT00593606|Rotigotine|rotigotine|mesh-list
1926486|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
1926487|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
1926488|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926489|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926490|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926491|NCT00593645|Cytarabine|cytarabine|mesh-list
1926492|NCT00593645|Clofarabine|clofarabine|mesh-list
1926493|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
1926494|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1926495|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1926496|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
1926497|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926498|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926499|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
1926500|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926501|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926502|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
1926503|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926504|NCT00593827|Epothilones|epothilones|mesh-list
1926505|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
1926506|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
1926507|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
1926508|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926509|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926510|NCT00593866|Gemcitabine|gemcitabine|mesh-list
1926511|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1926512|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
1926513|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926514|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926515|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
1926516|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926517|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926518|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926519|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
1926520|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926521|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
1926522|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
1926523|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
1926599|NCT00594516|Analgesics|analgesics|mesh-ancestor
1926524|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1926525|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1926526|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926527|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926528|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926529|NCT00594165|Rotigotine|rotigotine|mesh-list
1926530|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
1926531|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
1926532|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926533|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926534|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926535|NCT00594204|Varenicline|varenicline|mesh-list
1926536|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1926537|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1926538|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
1926539|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926540|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926541|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926542|NCT00594230|Panobinostat|panobinostat|mesh-list
1926543|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926544|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1926545|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926546|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926547|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
1926548|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1926549|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1926550|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
1926551|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
1926552|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926553|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926554|NCT00594308|Cyclosporine|cyclosporine|mesh-list
1926555|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
1926556|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
1926557|NCT00594308|Fludarabine|fludarabine|mesh-list
1926558|NCT00594308|Cyclosporins|cyclosporins|mesh-list
1926559|NCT00594308|Basiliximab|basiliximab|mesh-list
1926560|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926561|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
1926562|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926563|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926564|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926565|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
1926566|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926567|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926568|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1926569|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926570|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
1926571|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926572|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
1926573|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1926574|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1926575|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1926576|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
1926577|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1926578|NCT00594386|Rotigotine|rotigotine|mesh-list
1926579|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
1926580|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
1926581|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926582|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926583|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926584|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1926585|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
1926586|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1926587|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
1926588|NCT00594464|Rotigotine|rotigotine|mesh-list
1926589|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
1926590|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
1926591|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926592|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926593|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926594|NCT00594516|Tapentadol|tapentadol|mesh-list
1926595|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1926596|NCT00594516|Narcotics|narcotics|mesh-ancestor
1926597|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926598|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926600|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
1926601|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926602|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1926603|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1926604|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926605|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926606|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
1926607|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926608|NCT00594646|Tenofovir|tenofovir|mesh-list
1926609|NCT00594646|Emtricitabine|emtricitabine|mesh-list
1926610|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
1926611|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1926612|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
1926613|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926614|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1926615|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1926616|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926617|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926618|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1926619|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1926620|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1926621|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1926622|NCT00594815|Leucovorin|leucovorin|mesh-list
1926623|NCT00594815|Cytarabine|cytarabine|mesh-list
1926624|NCT00594815|Rituximab|rituximab|mesh-list
1926625|NCT00594815|Methotrexate|methotrexate|mesh-list
1926626|NCT00594815|Vincristine|vincristine|mesh-list
1926627|NCT00594815|Procarbazine|procarbazine|mesh-list
1926628|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926629|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926630|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
1926631|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926632|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926633|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1926634|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
1926635|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1926636|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1926637|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
1926638|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926639|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
1926640|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926641|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1926642|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926643|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1926644|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
1926645|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926646|NCT00594815|Antidotes|antidotes|mesh-ancestor
1926647|NCT00594815|Protective Agents|protective agents|mesh-ancestor
1926648|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
1926649|NCT00594815|Vitamins|vitamins|mesh-ancestor
1926650|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
1926651|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1926652|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
1926653|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
1926654|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
1926655|NCT00594854|Diclofenac|diclofenac|mesh-list
1926656|NCT00594854|Arthrotec|arthrotec|mesh-list
1926657|NCT00594854|Misoprostol|misoprostol|mesh-list
1926658|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1926659|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
1926660|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1926661|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926662|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1926663|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1926664|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
1926665|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1926666|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1926667|NCT00594854|Analgesics|analgesics|mesh-ancestor
1926668|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
1926669|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926670|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1926671|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926672|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1926673|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926674|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926675|NCT00594880|Interferons|interferons|mesh-list
1926676|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
1926677|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
1926678|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1926679|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926680|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
1926681|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926682|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
1926683|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926684|NCT00594906|Teriparatide|teriparatide|mesh-list
1926685|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1926686|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926687|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1926688|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
1926689|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1926690|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926691|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1926692|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
1926693|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1926694|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926695|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926696|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926697|NCT00594945|Clonazepam|clonazepam|mesh-list
1926698|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
1926699|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
1926700|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
1926701|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926702|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926703|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926704|NCT00594958|Vaccines|vaccines|mesh-list
1926705|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
1926706|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926707|NCT00595101|Latanoprost|latanoprost|mesh-list
1926708|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1926709|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1926710|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
1926711|NCT00595127|Fludarabine|fludarabine|mesh-list
1926712|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926713|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
1926714|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926715|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926716|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926717|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
1926718|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926719|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926720|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1926721|NCT00595153|Budesonide|budesonide|mesh-list
1926722|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1926723|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1926724|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
1926725|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926726|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926727|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1926728|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
1926729|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
1926730|NCT00595153|Hormones|hormones|mesh-ancestor
1926731|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1926732|NCT00595231|Rufinamide|rufinamide|mesh-list
1926733|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
1926734|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1926735|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1926736|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926737|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926738|NCT00595270|Vaccines|vaccines|mesh-list
1926739|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
1926740|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926741|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
1926742|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1926743|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1926744|NCT00595335|Prednisolone|prednisolone|mesh-list
1926745|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
1926746|NCT00595335|Rituximab|rituximab|mesh-list
1926747|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1926748|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
1926749|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926750|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926751|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
1926752|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926753|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926754|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1926755|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
1926756|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
1926757|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926758|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1926759|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
1926760|NCT00595335|Hormones|hormones|mesh-ancestor
1926761|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1926762|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1926763|NCT00595335|Protective Agents|protective agents|mesh-ancestor
1926764|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1926765|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1926766|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1926767|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
1926768|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926769|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926770|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1926771|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
1926772|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1926773|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1926774|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1926775|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
1926776|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926777|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926778|NCT00595413|Adalimumab|adalimumab|mesh-list
1926779|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1926780|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926781|NCT00595517|Esomeprazole|esomeprazole|mesh-list
1926782|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1926783|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1926784|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1926785|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926786|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926787|NCT00595530|Ketamine|ketamine|mesh-list
1926788|NCT00595530|Analgesics|analgesics|mesh-ancestor
1926789|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
1926790|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926791|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926792|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1926793|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1926794|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
1926795|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
1926796|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926797|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1926798|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1926799|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926800|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926801|NCT00595556|Zonisamide|zonisamide|mesh-list
1926802|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
1926803|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1926804|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926805|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926806|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1926807|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926808|NCT00595790|Vaccines|vaccines|mesh-list
1926809|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
1926810|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926811|NCT00595868|Varenicline|varenicline|mesh-list
1926812|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1926813|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1926814|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
1926815|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926816|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926817|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926818|NCT00595946|Lubiprostone|lubiprostone|mesh-list
1926819|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1926820|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926821|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926822|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1926823|NCT00596167|Vancomycin|vancomycin|mesh-list
1926824|NCT00596167|Levofloxacin|levofloxacin|mesh-list
1926825|NCT00596167|Gentamicins|gentamicins|mesh-list
1926826|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926827|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1926828|NCT00596167|Renal Agents|renal agents|mesh-ancestor
1926829|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1926830|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1926831|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926832|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926833|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926834|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1926835|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1926836|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1926837|NCT00596271|Vaccines|vaccines|mesh-list
1926838|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
1926839|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926840|NCT00596362|Bevacizumab|bevacizumab|mesh-list
1926841|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926842|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926843|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926844|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926845|NCT00596362|Growth Substances|growth substances|mesh-ancestor
1926846|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926847|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926848|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1926849|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1926850|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1926851|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
1926852|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926853|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1926854|NCT00596440|Nicotine|nicotine|mesh-list
1926855|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1926856|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
1926857|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926858|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926859|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1926860|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1926861|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
1926862|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926863|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926864|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
1926865|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1926866|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1926867|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1926868|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1926869|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926870|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926871|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926872|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1926873|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1926874|NCT00596466|Pregabalin|pregabalin|mesh-list
1926875|NCT00596466|Analgesics|analgesics|mesh-ancestor
1926876|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
1926877|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1926878|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926879|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
1926880|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1926881|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926882|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926883|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1926884|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1926885|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926886|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926887|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926888|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
1926889|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
1926890|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926891|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926892|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926893|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
1926894|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926895|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926896|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926897|NCT00596687|Insulin|insulin|mesh-list
1926898|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1926899|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
1926900|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
1926901|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1926902|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926903|NCT00596752|Alprostadil|alprostadil|mesh-list
1926904|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1926905|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
1926906|NCT00596752|Urological Agents|urological agents|mesh-ancestor
1926907|NCT00596817|Vortioxetine|vortioxetine|mesh-list
1926908|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
1926909|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1926910|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1926911|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1926912|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1926913|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926914|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1926915|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1926916|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926917|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926918|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1926919|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
1926920|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1926921|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1926922|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1926923|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1926924|NCT00596830|Paclitaxel|paclitaxel|mesh-list
1926925|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1926926|NCT00596830|Carboplatin|carboplatin|mesh-list
1926927|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1926928|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926929|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
1926930|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
1926931|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
1926932|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926933|NCT00597038|Dasatinib|dasatinib|mesh-list
1926934|NCT00597038|Dacarbazine|dacarbazine|mesh-list
1926935|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926936|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1926937|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926938|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926939|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926940|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
1926941|NCT00597116|Vinorelbine|vinorelbine|mesh-list
1926942|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1926943|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926944|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
1926945|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
1926946|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
1926947|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926948|NCT00597402|Bevacizumab|bevacizumab|mesh-list
1926949|NCT00597402|Irinotecan|irinotecan|mesh-list
1926950|NCT00597402|Temozolomide|temozolomide|mesh-list
1926951|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926952|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926953|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926954|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926955|NCT00597402|Growth Substances|growth substances|mesh-ancestor
1926956|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926957|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926958|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1926959|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1926960|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926961|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926962|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926963|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
1926964|NCT00597428|Lubiprostone|lubiprostone|mesh-list
1926965|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1926966|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1926967|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926968|NCT00597493|Temozolomide|temozolomide|mesh-list
1926969|NCT00597493|Sorafenib|sorafenib|mesh-list
1926970|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926971|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
1927048|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
1926972|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926973|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926974|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1926975|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1926976|NCT00597506|Bevacizumab|bevacizumab|mesh-list
1926977|NCT00597506|Everolimus|everolimus|mesh-list
1926978|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1926979|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926980|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1926981|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1926982|NCT00597506|Growth Substances|growth substances|mesh-ancestor
1926983|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926984|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
1926985|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926986|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
1926987|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
1926988|NCT00597519|Fludarabine|fludarabine|mesh-list
1926989|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1926990|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
1926991|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1926992|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1926993|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1926994|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
1926995|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1926996|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1926997|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1926998|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
1926999|NCT00597584|Hematinics|hematinics|mesh-ancestor
1927000|NCT00597701|Lorazepam|lorazepam|mesh-list
1927001|NCT00597701|Baclofen|baclofen|mesh-list
1927002|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1927003|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927004|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1927005|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927006|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1927007|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
1927008|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
1927009|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927010|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927011|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
1927012|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
1927013|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
1927014|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1927015|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1927016|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927017|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1927018|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927019|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927020|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
1927021|NCT00597727|Glycerol|glycerol|mesh-list
1927022|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1927023|NCT00597727|Protective Agents|protective agents|mesh-ancestor
1927024|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927025|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
1927026|NCT00597753|Hematinics|hematinics|mesh-ancestor
1927027|NCT00597766|Triamcinolone|triamcinolone|mesh-list
1927028|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1927029|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1927030|NCT00597766|Lidocaine|lidocaine|mesh-list
1927031|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1927032|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
1927033|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
1927034|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927035|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927036|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
1927037|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927038|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1927039|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1927040|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1927041|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927042|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927043|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927044|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
1927045|NCT00597766|Hormones|hormones|mesh-ancestor
1927046|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927047|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927049|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927050|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1927051|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1927052|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927053|NCT00597818|Analgesics|analgesics|mesh-ancestor
1927054|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
1927055|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927056|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927057|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927058|NCT00597896|Pramipexole|pramipexole|mesh-list
1927059|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
1927060|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927061|NCT00597896|Protective Agents|protective agents|mesh-ancestor
1927062|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927063|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1927064|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1927065|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
1927066|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
1927067|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927068|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
1927069|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1927070|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1927071|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
1927072|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
1927073|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927074|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927075|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
1927076|NCT00598273|Hematinics|hematinics|mesh-ancestor
1927077|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
1927078|NCT00598442|Hematinics|hematinics|mesh-ancestor
1927079|NCT00598481|Busulfan|busulfan|mesh-list
1927080|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
1927081|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927082|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927083|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
1927084|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927085|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1927086|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927087|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1927088|NCT00598507|Sagopilone|sagopilone|mesh-list
1927089|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927090|NCT00598559|Acetaminophen|acetaminophen|mesh-list
1927091|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927092|NCT00598559|Analgesics|analgesics|mesh-ancestor
1927093|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
1927094|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927095|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927096|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
1927097|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
1927098|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
1927099|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1927100|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1927101|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927102|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927103|NCT00598585|Urological Agents|urological agents|mesh-ancestor
1927104|NCT00598650|Donepezil|donepezil|mesh-list
1927105|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1927106|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927107|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927108|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
1927109|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927110|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927111|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
1927112|NCT00598663|Insulin|insulin|mesh-list
1927113|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1927114|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1927115|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927116|NCT00598702|Acetaminophen|acetaminophen|mesh-list
1927117|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927118|NCT00598702|Analgesics|analgesics|mesh-ancestor
1927119|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
1927120|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927121|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927122|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
1927123|NCT00598806|Apaziquone|apaziquone|mesh-list
1927124|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927125|NCT00598832|Adapalene|adapalene|mesh-list
1927126|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1927127|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927128|NCT00598832|Analgesics|analgesics|mesh-ancestor
1927129|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
1927130|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927131|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927132|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927133|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927134|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
1927135|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1927136|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1927137|NCT00598975|Irinotecan|irinotecan|mesh-list
1927138|NCT00598975|Cetuximab|cetuximab|mesh-list
1927139|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
1927140|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1927141|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1927142|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927143|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927144|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927145|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927146|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1927147|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
1927148|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927149|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
1927150|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1927151|NCT00599053|Azithromycin|azithromycin|mesh-list
1927152|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1927153|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927154|NCT00599196|Rotigotine|rotigotine|mesh-list
1927155|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
1927156|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
1927157|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927158|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927159|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927160|NCT00599313|Sunitinib|sunitinib|mesh-list
1927161|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927162|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927163|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927164|NCT00599313|Growth Substances|growth substances|mesh-ancestor
1927165|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927166|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927167|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1927168|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927169|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927170|NCT00599326|Deferasirox|deferasirox|mesh-list
1927171|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1927172|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
1927173|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
1927174|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927175|NCT00599521|Adapalene|adapalene|mesh-list
1927176|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1927177|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927178|NCT00599521|Analgesics|analgesics|mesh-ancestor
1927179|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
1927180|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927181|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927182|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927183|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927184|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
1927185|NCT00599638|Pregabalin|pregabalin|mesh-list
1927186|NCT00599638|Analgesics|analgesics|mesh-ancestor
1927187|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
1927188|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927189|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927190|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
1927191|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1927192|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927193|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927194|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1927195|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1927196|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927197|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927198|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927199|NCT00599755|Gemcitabine|gemcitabine|mesh-list
1927200|NCT00599755|Carboplatin|carboplatin|mesh-list
1927201|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927202|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927203|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
1927204|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927205|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
1927206|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927207|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927208|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927209|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
1927210|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927211|NCT00599924|Leucovorin|leucovorin|mesh-list
1927212|NCT00599924|Sunitinib|sunitinib|mesh-list
1927213|NCT00599924|Fluorouracil|fluorouracil|mesh-list
1927214|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
1927215|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927216|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927217|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927218|NCT00599924|Growth Substances|growth substances|mesh-ancestor
1927219|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927220|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927221|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1927222|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927223|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927224|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
1927225|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927226|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927227|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
1927228|NCT00599924|Antidotes|antidotes|mesh-ancestor
1927229|NCT00599924|Protective Agents|protective agents|mesh-ancestor
1927230|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
1927231|NCT00599924|Vitamins|vitamins|mesh-ancestor
1927232|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
1927233|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1927234|NCT00600015|Sorafenib|sorafenib|mesh-list
1927235|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927236|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1927237|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927238|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927239|NCT00600028|Thalidomide|thalidomide|mesh-list
1927240|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927241|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
1927242|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927243|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
1927244|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1927245|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927246|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927247|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927248|NCT00600028|Growth Substances|growth substances|mesh-ancestor
1927249|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927250|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927251|NCT00600067|Topiramate|topiramate|mesh-list
1927252|NCT00600067|Phentermine|phentermine|mesh-list
1927253|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
1927254|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1927255|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927256|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1927257|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
1927258|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1927259|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
1927260|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
1927261|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927262|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
1927263|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927264|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927265|NCT00600119|Naloxegol|naloxegol|mesh-list
1927266|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1927267|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927268|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
1927269|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927270|NCT00600340|Paclitaxel|paclitaxel|mesh-list
1927271|NCT00600340|Bevacizumab|bevacizumab|mesh-list
1927272|NCT00600340|Capecitabine|capecitabine|mesh-list
1927273|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927274|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927275|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
1927276|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
1927277|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
1927278|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927279|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927280|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927281|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927282|NCT00600340|Growth Substances|growth substances|mesh-ancestor
1927283|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927284|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927285|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927286|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
1927287|NCT00600353|Dexamethasone|dexamethasone|mesh-list
1927288|NCT00600353|Aprepitant|aprepitant|mesh-list
1927289|NCT00600353|Palonosetron|palonosetron|mesh-list
1927290|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927291|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
1927292|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
1927293|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927294|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927295|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1927296|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
1927297|NCT00600353|Hormones|hormones|mesh-ancestor
1927298|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927299|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1927300|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927301|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1927302|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927303|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927304|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1927305|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1927306|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
1927307|NCT00600756|Risperidone|risperidone|mesh-list
1927308|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1927309|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1927310|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
1927311|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927312|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927313|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927314|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1927315|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927316|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927317|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927318|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1927319|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
1927320|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927321|NCT00600821|Paclitaxel|paclitaxel|mesh-list
1927322|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1927323|NCT00600821|Bevacizumab|bevacizumab|mesh-list
1927324|NCT00600821|Carboplatin|carboplatin|mesh-list
1927325|NCT00600821|Axitinib|axitinib|mesh-list
1927326|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927327|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927328|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
1927329|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
1927330|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
1927331|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927332|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927333|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927334|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927335|NCT00600821|Growth Substances|growth substances|mesh-ancestor
1927336|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927337|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927338|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1927339|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927340|NCT00600886|Octreotide|octreotide|mesh-list
1927341|NCT00600886|Pasireotide|pasireotide|mesh-list
1927342|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1927343|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1927344|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927345|NCT00600886|Hormones|hormones|mesh-ancestor
1927346|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927347|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927348|NCT00600925|Gentamicins|gentamicins|mesh-list
1927349|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1927350|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927351|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1927352|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927353|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927354|NCT00600938|Deferasirox|deferasirox|mesh-list
1927355|NCT00600938|Deferoxamine|deferoxamine|mesh-list
1927356|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1927357|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
1927358|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
1927359|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927360|NCT00600938|Siderophores|siderophores|mesh-ancestor
1927361|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
1927362|NCT00601107|Vitamins|vitamins|mesh-ancestor
1927363|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
1927364|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927365|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1927366|NCT00601172|Dexamethasone|dexamethasone|mesh-list
1927367|NCT00601172|Ondansetron|ondansetron|mesh-list
1927368|NCT00601172|Casopitant|casopitant|mesh-list
1927369|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927370|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
1927371|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
1927372|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927373|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927374|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1927375|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
1927376|NCT00601172|Hormones|hormones|mesh-ancestor
1927377|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927378|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1927379|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927380|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
1927381|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
1927382|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1927383|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
1927384|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927385|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927386|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1927387|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927388|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927389|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927390|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1927391|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1927392|NCT00601250|Linagliptin|linagliptin|mesh-list
1927393|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1927394|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927395|NCT00601250|Incretins|incretins|mesh-ancestor
1927396|NCT00601250|Hormones|hormones|mesh-ancestor
1927397|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927398|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1927399|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
1927400|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927401|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927402|NCT00601354|Orlistat|orlistat|mesh-list
1927403|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927404|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927405|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1927406|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1927407|NCT00601458|Naproxen|naproxen|mesh-list
1927408|NCT00601458|Pregabalin|pregabalin|mesh-list
1927409|NCT00601458|Analgesics|analgesics|mesh-ancestor
1927410|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
1927411|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927412|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927413|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
1927414|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1927415|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927416|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927417|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1927418|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1927419|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927420|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927421|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927422|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1927423|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927424|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927425|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927426|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
1927427|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1927428|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927429|NCT00601484|Tanezumab|tanezumab|mesh-list
1927430|NCT00601484|Analgesics|analgesics|mesh-ancestor
1927431|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
1927432|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927433|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927434|NCT00601523|Pramipexole|pramipexole|mesh-list
1927435|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
1927436|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927437|NCT00601523|Protective Agents|protective agents|mesh-ancestor
1927438|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927439|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1927440|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1927441|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
1927442|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
1927443|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927444|NCT00601627|Gemcitabine|gemcitabine|mesh-list
1927445|NCT00601627|Fluorouracil|fluorouracil|mesh-list
1927446|NCT00601627|Capecitabine|capecitabine|mesh-list
1927447|NCT00601627|Panitumumab|panitumumab|mesh-list
1927448|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927449|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
1927450|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927451|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927452|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
1927453|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927454|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927455|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927456|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
1927457|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927458|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927459|NCT00601640|Eflornithine|eflornithine|mesh-list
1927460|NCT00601640|Diclofenac|diclofenac|mesh-list
1927461|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1927462|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927463|NCT00601640|Analgesics|analgesics|mesh-ancestor
1927464|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
1927465|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927466|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927467|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927468|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927469|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1927470|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927471|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927472|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927473|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1927474|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1927475|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1927476|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927477|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1927478|NCT00601705|Fluorouracil|fluorouracil|mesh-list
1927479|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
1927480|NCT00601705|Epirubicin|epirubicin|mesh-list
1927481|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927482|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
1927483|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927484|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927485|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927486|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
1927487|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927488|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1927489|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1927490|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1927491|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927492|NCT00601718|Rituximab|rituximab|mesh-list
1927493|NCT00601718|Carboplatin|carboplatin|mesh-list
1927494|NCT00601718|Etoposide|etoposide|mesh-list
1927495|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
1927496|NCT00601718|Ifosfamide|ifosfamide|mesh-list
1927497|NCT00601718|Vorinostat|vorinostat|mesh-list
1927498|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927499|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927500|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
1927501|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927502|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927503|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927504|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1927505|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1927506|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927507|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927508|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1927509|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
1927510|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1927511|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
1927512|NCT00601796|Tretinoin|tretinoin|mesh-list
1927513|NCT00601796|Vaccines|vaccines|mesh-list
1927514|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
1927515|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927516|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927517|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927518|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1927519|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
1927520|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927521|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927522|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1927523|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
1927524|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
1927525|NCT00601835|Vaccines|vaccines|mesh-list
1927526|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
1927527|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927555|NCT00601926|Bevacizumab|bevacizumab|mesh-list
1927556|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927557|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927558|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927559|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927560|NCT00601926|Growth Substances|growth substances|mesh-ancestor
1927561|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927562|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927563|NCT00601965|Citalopram|citalopram|mesh-list
1927564|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1927565|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1927566|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927567|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927568|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927569|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
1927570|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927571|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1927572|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927573|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927574|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1927575|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1927576|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927577|NCT00602225|Cytarabine|cytarabine|mesh-list
1927578|NCT00602225|Clofarabine|clofarabine|mesh-list
1927579|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
1927580|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927581|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927582|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
1927583|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927584|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927585|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
1927586|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927587|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927588|NCT00602290|Methylphenidate|methylphenidate|mesh-list
1927589|NCT00602290|Citalopram|citalopram|mesh-list
1927590|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1927591|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927592|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1927593|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1927594|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927595|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927596|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
1927597|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927598|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1927599|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
1927600|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1927601|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927602|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927603|NCT00602355|Sertraline|sertraline|mesh-list
1927604|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927605|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927606|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1927607|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1927608|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927609|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927610|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927611|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
1927612|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927613|NCT00602420|Naproxen|naproxen|mesh-list
1927614|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1927615|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927616|NCT00602420|Analgesics|analgesics|mesh-ancestor
1927617|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
1927618|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927619|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927620|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927621|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927622|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
1927623|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1927624|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927625|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927626|NCT00602446|Deferasirox|deferasirox|mesh-list
1927627|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1927628|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
1927629|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
1927630|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927631|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
1927632|NCT00602459|Rituximab|rituximab|mesh-list
1927633|NCT00602459|Fludarabine|fludarabine|mesh-list
1927634|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
1927635|NCT00602459|Lenalidomide|lenalidomide|mesh-list
1927636|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1927637|NCT00602459|Antibodies|antibodies|mesh-list
1927638|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
1927639|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1927640|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927641|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
1927642|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927643|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927644|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1927645|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
1927646|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927647|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927648|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1927649|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927650|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
1927651|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927652|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927653|NCT00602459|Growth Substances|growth substances|mesh-ancestor
1927654|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927655|NCT00602472|Linagliptin|linagliptin|mesh-list
1927656|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1927657|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927658|NCT00602472|Incretins|incretins|mesh-ancestor
1927659|NCT00602472|Hormones|hormones|mesh-ancestor
1927660|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927661|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1927662|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
1927663|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927664|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927665|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
1927666|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1927667|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927668|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927669|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927670|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927671|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
1927672|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927673|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927674|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927675|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1927676|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1927677|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927678|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927679|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1927743|NCT00602771|Etoposide|etoposide|mesh-list
1927744|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
1927745|NCT00602771|Tipifarnib|tipifarnib|mesh-list
1927746|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927747|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927748|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1927749|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1927750|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927751|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927752|NCT00602797|Paclitaxel|paclitaxel|mesh-list
1927753|NCT00602797|Vinorelbine|vinorelbine|mesh-list
1927754|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1927755|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927756|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927757|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
1927758|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
1927759|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
1927760|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927761|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
1927762|NCT00602836|Rituximab|rituximab|mesh-list
1927763|NCT00602836|Lenalidomide|lenalidomide|mesh-list
1927764|NCT00602836|Pentostatin|pentostatin|mesh-list
1927765|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927766|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
1927767|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927768|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927769|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1927770|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
1927771|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927772|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927773|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1927774|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1927775|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927776|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927777|NCT00602836|Growth Substances|growth substances|mesh-ancestor
1927778|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927779|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1927780|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927781|NCT00602927|Varenicline|varenicline|mesh-list
1927782|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1927783|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1927784|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
1927785|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927786|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927787|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927788|NCT00603018|Fluoxetine|fluoxetine|mesh-list
1927789|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1927790|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1927791|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927792|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927793|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927794|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
1927795|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927796|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1927797|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927798|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927799|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1927800|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1927801|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927802|NCT00603044|Fluticasone|fluticasone|mesh-list
1927803|NCT00603044|Xhance|xhance|mesh-list
1927804|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927805|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1927806|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
1927807|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927808|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927809|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1927810|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
1927811|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
1927812|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1927813|NCT00603187|Acyline|acyline|mesh-list
1927814|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
1927815|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927816|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927817|NCT00603239|Exenatide|exenatide|mesh-list
1927818|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1927819|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927820|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1927821|NCT00603239|Incretins|incretins|mesh-ancestor
1927822|NCT00603239|Hormones|hormones|mesh-ancestor
1927823|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927824|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1927825|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1927826|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1927827|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1927828|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927829|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927830|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927831|NCT00603265|Analgesics|analgesics|mesh-ancestor
1927832|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
1927833|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927834|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
1927835|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927836|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
1927837|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
1927838|NCT00603304|Urological Agents|urological agents|mesh-ancestor
1927839|NCT00603408|Cisplatin|cisplatin|mesh-list
1927840|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927841|NCT00603447|Dexamethasone|dexamethasone|mesh-list
1927842|NCT00603447|Lenalidomide|lenalidomide|mesh-list
1927843|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927844|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
1927845|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
1927846|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927847|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927848|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1927849|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
1927850|NCT00603447|Hormones|hormones|mesh-ancestor
1927851|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1927852|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1927853|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927854|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
1927855|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1927856|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1927857|NCT00603447|Growth Substances|growth substances|mesh-ancestor
1927858|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
1927859|NCT00603473|Gabapentin|gabapentin|mesh-list
1927860|NCT00603473|Analgesics|analgesics|mesh-ancestor
1927861|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
1927862|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927863|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927864|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
1927865|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1927866|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927867|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927868|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927869|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1927870|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1927871|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927872|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927873|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
1927874|NCT00603512|Tofacitinib|tofacitinib|mesh-list
1927875|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1927876|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927877|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927878|NCT00603525|Ofatumumab|ofatumumab|mesh-list
1927879|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927880|NCT00603538|Paclitaxel|paclitaxel|mesh-list
1927881|NCT00603538|Carboplatin|carboplatin|mesh-list
1927882|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927883|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927884|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
1927885|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
1927886|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
1927887|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927888|NCT00603720|Phenylephrine|phenylephrine|mesh-list
1927889|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
1927890|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
1927891|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1927892|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
1927893|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
1927894|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927895|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927896|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
1927897|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1927898|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
1927899|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
1927900|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1927901|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1927902|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1927903|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
1927904|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927905|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927906|NCT00603720|Protective Agents|protective agents|mesh-ancestor
1927907|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927908|NCT00603733|Mesalamine|mesalamine|mesh-list
1927909|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1927910|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1927911|NCT00603733|Analgesics|analgesics|mesh-ancestor
1927912|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
1927913|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927914|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927915|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927916|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927917|NCT00603798|Imiquimod|imiquimod|mesh-list
1927918|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1927919|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
1927920|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927921|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927922|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
1927923|NCT00603915|Gemcitabine|gemcitabine|mesh-list
1927924|NCT00603915|Carboplatin|carboplatin|mesh-list
1927925|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1927926|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927927|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1927928|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
1927929|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927930|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
1927931|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927932|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1927933|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1927934|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
1927935|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927936|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1927937|NCT00603941|Paclitaxel|paclitaxel|mesh-list
1927938|NCT00603941|Efatutazone|efatutazone|mesh-list
1927939|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1927940|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1927941|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
1927942|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
1927943|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
1927944|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927945|NCT00603980|Alprazolam|alprazolam|mesh-list
1927946|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1927947|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927948|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927949|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1927950|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927951|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927952|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
1927953|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
1927954|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927955|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927956|NCT00603993|Adalimumab|adalimumab|mesh-list
1927957|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1927958|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1927959|NCT00604019|Dopamine|dopamine|mesh-list
1927960|NCT00604019|Norepinephrine|norepinephrine|mesh-list
1927961|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1927962|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1927963|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
1927964|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927965|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927966|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927967|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
1927968|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
1927969|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927970|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1927971|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1927972|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
1927973|NCT00604019|Protective Agents|protective agents|mesh-ancestor
1927974|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1927975|NCT00604188|Buprenorphine|buprenorphine|mesh-list
1927976|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1927977|NCT00604188|Narcotics|narcotics|mesh-ancestor
1927978|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927979|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927980|NCT00604188|Analgesics|analgesics|mesh-ancestor
1927981|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
1927982|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1927983|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1927984|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
1927985|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1927986|NCT00604279|Risperidone|risperidone|mesh-list
1927987|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1927988|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1927989|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
1927990|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1927991|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1927992|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1927993|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1927994|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1927995|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1927996|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1927997|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1927998|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
1927999|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928000|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1928001|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
1928002|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928003|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928004|NCT00604461|Bevacizumab|bevacizumab|mesh-list
1928005|NCT00604461|Carboplatin|carboplatin|mesh-list
1928006|NCT00604461|Pemetrexed|pemetrexed|mesh-list
1928007|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1928008|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928009|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928010|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928011|NCT00604461|Growth Substances|growth substances|mesh-ancestor
1928012|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928013|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928014|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928015|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928016|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1928017|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928018|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
1928019|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
1928020|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1928021|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
1928022|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928023|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928024|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1928025|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
1928026|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1928027|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1928028|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1928029|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
1928030|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928031|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928032|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928033|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
1928034|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1928035|NCT00604695|Tenecteplase|tenecteplase|mesh-list
1928036|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1928037|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1928038|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928039|NCT00604708|Vaccines|vaccines|mesh-list
1928040|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
1928041|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928042|NCT00604786|Omalizumab|omalizumab|mesh-list
1928043|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1928044|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1928045|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
1928046|NCT00604812|Rizatriptan|rizatriptan|mesh-list
1928047|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1928048|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
1928049|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928050|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928051|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928052|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1928053|NCT00604825|Estrogens|estrogens|mesh-ancestor
1928054|NCT00604825|Hormones|hormones|mesh-ancestor
1928055|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928056|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928057|NCT00604968|Doxorubicin|doxorubicin|mesh-list
1928058|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1928059|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1928060|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928061|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1928062|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1928063|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928064|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928065|NCT00605033|Buprenorphine|buprenorphine|mesh-list
1928066|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1928067|NCT00605033|Naloxone|naloxone|mesh-list
1928068|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1928069|NCT00605033|Narcotics|narcotics|mesh-ancestor
1928070|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928071|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928072|NCT00605033|Analgesics|analgesics|mesh-ancestor
1928073|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
1928074|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928075|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1928076|NCT00605072|Metoprolol|metoprolol|mesh-list
1928077|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1928078|NCT00605072|Candesartan|candesartan|mesh-list
1928079|NCT00605072|Lisinopril|lisinopril|mesh-list
1928080|NCT00605072|Nifedipine|nifedipine|mesh-list
1928081|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1928082|NCT00605072|Diuretics|diuretics|mesh-ancestor
1928083|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
1928084|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928085|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1928086|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928087|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928088|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1928089|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
1928090|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
1928091|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928092|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1928093|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1928094|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1928095|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
1928096|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928097|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1928098|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1928099|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1928100|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1928101|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
1928102|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
1928103|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1928104|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1928105|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
1928106|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928107|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1928108|NCT00605072|Protective Agents|protective agents|mesh-ancestor
1928109|NCT00605176|Imiquimod|imiquimod|mesh-list
1928110|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1928111|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
1928112|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928113|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928114|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
1928115|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1928116|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1928117|NCT00605202|Diuretics|diuretics|mesh-ancestor
1928118|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
1928119|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928120|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1928121|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928122|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928123|NCT00605267|Tamoxifen|tamoxifen|mesh-list
1928124|NCT00605267|Goserelin|goserelin|mesh-list
1928125|NCT00605267|Anastrozole|anastrozole|mesh-list
1928126|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1928127|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
1928128|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928129|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928130|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1928131|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928132|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1928133|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1928134|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1928135|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1928136|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1928137|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928138|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928139|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
1928140|NCT00605293|Hematinics|hematinics|mesh-ancestor
1928141|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
1928142|NCT00605306|Maleic acid|maleic acid|mesh-list
1928143|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928144|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928145|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928146|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
1928147|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1928148|NCT00605319|Fesoterodine|fesoterodine|mesh-list
1928149|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1928150|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1928151|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
1928152|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928153|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928154|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928155|NCT00605319|Urological Agents|urological agents|mesh-ancestor
1928156|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
1928157|NCT00605345|Hematinics|hematinics|mesh-ancestor
1928158|NCT00605384|Tenofovir|tenofovir|mesh-list
1928159|NCT00605384|Lamivudine|lamivudine|mesh-list
1928160|NCT00605384|Entecavir|entecavir|mesh-list
1928161|NCT00605384|Adefovir|adefovir|mesh-list
1928162|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
1928163|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928164|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1928165|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928166|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928167|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928168|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1928169|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1928170|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1928171|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928172|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
1928173|NCT00605423|Hormones|hormones|mesh-ancestor
1928174|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928175|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928176|NCT00605475|Metformin|metformin|mesh-list
1928177|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1928252|NCT00605917|Sertraline|sertraline|mesh-list
1928178|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928179|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
1928180|NCT00605566|Sorafenib|sorafenib|mesh-list
1928181|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928182|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
1928183|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928184|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928185|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1928186|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
1928187|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928188|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928189|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1928190|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928191|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928192|NCT00605657|Valproic Acid|valproic acid|mesh-list
1928193|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
1928194|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928195|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928196|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
1928197|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928198|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928199|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
1928200|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928201|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928202|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928203|NCT00605696|Insulin|insulin|mesh-list
1928204|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1928205|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928206|NCT00605722|Bevacizumab|bevacizumab|mesh-list
1928207|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1928208|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1928209|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928210|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928211|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928212|NCT00605722|Growth Substances|growth substances|mesh-ancestor
1928213|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928214|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928215|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928216|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928217|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928218|NCT00605813|Sertraline|sertraline|mesh-list
1928219|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928220|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928221|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1928222|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1928223|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928224|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928225|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928226|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
1928227|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928228|NCT00605865|Sertraline|sertraline|mesh-list
1928229|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928230|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928231|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1928232|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1928233|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928234|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928235|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928236|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
1928237|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928238|NCT00605904|Acamprosate|acamprosate|mesh-list
1928239|NCT00605904|Yohimbine|yohimbine|mesh-list
1928240|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1928241|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
1928242|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
1928243|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928244|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928245|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1928246|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1928247|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1928248|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
1928249|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928250|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928251|NCT00605904|Urological Agents|urological agents|mesh-ancestor
1928253|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928254|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928255|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1928256|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1928257|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928258|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928259|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928260|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
1928261|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928262|NCT00606008|Sunitinib|sunitinib|mesh-list
1928263|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928264|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928265|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928266|NCT00606008|Growth Substances|growth substances|mesh-ancestor
1928267|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928268|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928269|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928270|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928271|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928272|NCT00606021|Pemetrexed|pemetrexed|mesh-list
1928273|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928274|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928275|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928276|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1928277|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928278|NCT00606034|Insulin|insulin|mesh-list
1928279|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1928280|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928281|NCT00606086|Interferons|interferons|mesh-list
1928282|NCT00606086|Ribavirin|ribavirin|mesh-list
1928283|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1928284|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
1928285|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928286|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
1928287|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928288|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
1928289|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928290|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
1928291|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928292|NCT00606138|Ranibizumab|ranibizumab|mesh-list
1928293|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928294|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928295|NCT00606138|Growth Substances|growth substances|mesh-ancestor
1928296|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928297|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928298|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928299|NCT00606177|Aripiprazole|aripiprazole|mesh-list
1928300|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928301|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928302|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1928303|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928304|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928305|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928306|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
1928307|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
1928308|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928309|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928310|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1928311|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1928312|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
1928313|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928314|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1928315|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1928316|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1928317|NCT00606229|Aripiprazole|aripiprazole|mesh-list
1928318|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928319|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928320|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1928321|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928322|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928323|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928324|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
1928325|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
1928326|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928327|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928328|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1928329|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1928330|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
1928331|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928332|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1928333|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1928334|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1928335|NCT00606281|Aripiprazole|aripiprazole|mesh-list
1928336|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928337|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928338|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1928339|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928340|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928341|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928342|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
1928343|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
1928344|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928345|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928346|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1928347|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1928348|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
1928349|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928350|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1928351|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1928352|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1928353|NCT00606294|Misonidazole|misonidazole|mesh-list
1928354|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928355|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1928356|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1928357|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928358|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
1928359|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1928360|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928361|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928362|NCT00606320|Aripiprazole|aripiprazole|mesh-list
1928363|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928364|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928365|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1928366|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928367|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928368|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928369|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
1928370|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
1928371|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928372|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928373|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1928374|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1928375|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
1928376|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928377|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1928378|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1928379|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1928380|NCT00606489|Ibuprofen|ibuprofen|mesh-list
1928381|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1928382|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1928383|NCT00606489|Analgesics|analgesics|mesh-ancestor
1928384|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
1928385|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928386|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928387|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928388|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928389|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1928390|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928391|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928392|NCT00606502|Vitamins|vitamins|mesh-list
1928393|NCT00606502|Folic Acid|folic acid|mesh-list
1928394|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
1928395|NCT00606502|Hydroxocobalamin|hydroxocobalamin|mesh-list
1928396|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
1928397|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1928398|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1928399|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
1928400|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928401|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928402|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928403|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928404|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928405|NCT00606502|Hematinics|hematinics|mesh-ancestor
1928406|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1928407|NCT00606580|Paromomycin|paromomycin|mesh-list
1928408|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1928409|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928410|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1928411|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1928412|NCT00606801|Galantamine|galantamine|mesh-list
1928413|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1928414|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928415|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928416|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
1928417|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928418|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928419|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1928420|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
1928421|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928422|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
1928423|NCT00606892|Nicotine|nicotine|mesh-list
1928424|NCT00606892|Varenicline|varenicline|mesh-list
1928425|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1928426|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
1928427|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928428|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928429|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1928430|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1928431|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
1928432|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928433|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928434|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
1928435|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
1928436|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1928437|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1928438|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
1928439|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928440|NCT00607048|Paclitaxel|paclitaxel|mesh-list
1928441|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1928442|NCT00607048|Carboplatin|carboplatin|mesh-list
1928443|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1928444|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1928445|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928446|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
1928447|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
1928448|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
1928449|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928450|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
1928451|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928452|NCT00607087|Insulin|insulin|mesh-list
1928453|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1928454|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
1928455|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
1928456|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
1928457|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1928458|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928459|NCT00607113|Bevacizumab|bevacizumab|mesh-list
1928460|NCT00607113|Everolimus|everolimus|mesh-list
1928461|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1928462|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928463|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928464|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928465|NCT00607113|Growth Substances|growth substances|mesh-ancestor
1928466|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928467|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928468|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928469|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
1928470|NCT00607373|Mipomersen|mipomersen|mesh-list
1928471|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1928472|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1928473|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
1928474|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928475|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1928476|NCT00607594|Saracatinib|saracatinib|mesh-list
1928477|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928478|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928479|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928480|NCT00607672|Candesartan|candesartan|mesh-list
1928481|NCT00607672|Ramipril|ramipril|mesh-list
1928482|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1928483|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1928484|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1928485|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928486|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1928487|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
1928488|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928489|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1928490|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1928491|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1928492|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928493|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928494|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928495|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928496|NCT00607789|Analgesics|analgesics|mesh-ancestor
1928497|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
1928498|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928499|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928500|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928501|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
1928502|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1928503|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1928504|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1928505|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928506|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928507|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
1928508|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928509|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928510|NCT00608023|Tesamorelin|tesamorelin|mesh-list
1928511|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
1928512|NCT00608023|Growth Substances|growth substances|mesh-ancestor
1928513|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928514|NCT00608023|Hormones|hormones|mesh-ancestor
1928515|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928516|NCT00608062|Estradiol|estradiol|mesh-list
1928517|NCT00608062|Ganirelix|ganirelix|mesh-list
1928518|NCT00608062|Estrogens|estrogens|mesh-ancestor
1928519|NCT00608062|Hormones|hormones|mesh-ancestor
1928520|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928521|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928522|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
1928523|NCT00608205|Fluorouracil|fluorouracil|mesh-list
1928524|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928525|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
1928526|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928527|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1928528|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928529|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
1928530|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928531|NCT00608244|Tacrolimus|tacrolimus|mesh-list
1928532|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928533|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
1928534|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928535|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1928536|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928537|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928538|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
1928539|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1928540|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
1928541|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928542|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928543|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1928544|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
1928545|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1928546|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
1928547|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928548|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928624|NCT00608868|Gefitinib|gefitinib|mesh-list
1928549|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1928550|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
1928551|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
1928552|NCT00608322|Protective Agents|protective agents|mesh-ancestor
1928553|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
1928554|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
1928555|NCT00608517|Fludarabine|fludarabine|mesh-list
1928556|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
1928557|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1928558|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928559|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
1928560|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928561|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928562|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1928563|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
1928564|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928565|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928566|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1928567|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1928568|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
1928569|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928570|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
1928571|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
1928572|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928573|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928574|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
1928575|NCT00608517|Hormones|hormones|mesh-ancestor
1928576|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928577|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1928578|NCT00608517|Protective Agents|protective agents|mesh-ancestor
1928579|NCT00608543|Aripiprazole|aripiprazole|mesh-list
1928580|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928581|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928582|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1928583|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928584|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928585|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928586|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
1928587|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
1928588|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928589|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928590|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1928591|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1928592|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
1928593|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928594|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1928595|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1928596|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1928597|NCT00608569|Ritonavir|ritonavir|mesh-list
1928598|NCT00608569|Lopinavir|lopinavir|mesh-list
1928599|NCT00608569|Tenofovir|tenofovir|mesh-list
1928600|NCT00608569|Zidovudine|zidovudine|mesh-list
1928601|NCT00608569|Emtricitabine|emtricitabine|mesh-list
1928602|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1928603|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1928604|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1928605|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
1928606|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928607|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928608|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1928609|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1928610|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
1928611|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928612|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1928613|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1928614|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1928615|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928616|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
1928617|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
1928618|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928619|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928620|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928621|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
1928622|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1928623|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928625|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928626|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928627|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928628|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928629|NCT00608881|Ubiquinone|ubiquinone|mesh-list
1928630|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
1928631|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
1928632|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928633|NCT00608881|Vitamins|vitamins|mesh-ancestor
1928634|NCT00608894|Prednisone|prednisone|mesh-list
1928635|NCT00608894|Azathioprine|azathioprine|mesh-list
1928636|NCT00608894|Tacrolimus|tacrolimus|mesh-list
1928637|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928638|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
1928639|NCT00608894|Hormones|hormones|mesh-ancestor
1928640|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928641|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928642|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1928643|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928644|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928645|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
1928646|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1928647|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928648|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928649|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
1928650|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1928651|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928652|NCT00608907|Rifampin|rifampin|mesh-list
1928653|NCT00608907|Dexamethasone|dexamethasone|mesh-list
1928654|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
1928655|NCT00608907|Bortezomib|bortezomib|mesh-list
1928656|NCT00608907|BB 1101|bb 1101|mesh-list
1928657|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928658|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
1928659|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
1928660|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928661|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928662|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928663|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
1928664|NCT00608907|Hormones|hormones|mesh-ancestor
1928665|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928666|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1928667|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928668|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
1928669|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928670|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928671|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1928672|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
1928673|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1928674|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928675|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
1928676|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928677|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1928678|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1928679|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1928680|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1928681|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1928682|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1928683|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
1928684|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1928685|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928686|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
1928687|NCT00608985|Zolpidem|zolpidem|mesh-list
1928688|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1928689|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1928690|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928691|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928692|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1928693|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
1928694|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
1928695|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928696|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928697|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1928698|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1928699|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1928700|NCT00609128|Analgesics|analgesics|mesh-ancestor
1928701|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
1928702|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928703|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928704|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928705|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928706|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1928707|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1928708|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1928709|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
1928710|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
1928711|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928712|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928713|NCT00609167|Dexamethasone|dexamethasone|mesh-list
1928714|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
1928715|NCT00609167|Bortezomib|bortezomib|mesh-list
1928716|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928717|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
1928718|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928719|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928720|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1928721|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
1928722|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928723|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928724|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1928725|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928726|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
1928727|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
1928728|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928729|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928730|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
1928731|NCT00609167|Hormones|hormones|mesh-ancestor
1928732|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928733|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1928734|NCT00609245|Valproic Acid|valproic acid|mesh-list
1928735|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
1928736|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928737|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928738|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
1928739|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928740|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928741|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
1928742|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928743|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928744|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928745|NCT00609336|Gemcitabine|gemcitabine|mesh-list
1928746|NCT00609336|Capecitabine|capecitabine|mesh-list
1928747|NCT00609336|Docetaxel|docetaxel|mesh-list
1928748|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
1928749|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1928750|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
1928751|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928752|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928753|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
1928754|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928755|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928756|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928757|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
1928758|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928759|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
1928760|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
1928761|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
1928762|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
1928763|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1928764|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928765|NCT00609466|Morphine|morphine|mesh-list
1928766|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1928767|NCT00609466|Narcotics|narcotics|mesh-ancestor
1928768|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928769|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928770|NCT00609466|Analgesics|analgesics|mesh-ancestor
1928771|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
1928772|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928773|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1928774|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
1928775|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928776|NCT00609518|Folic Acid|folic acid|mesh-list
1928777|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
1928778|NCT00609518|Hydroxocobalamin|hydroxocobalamin|mesh-list
1928779|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
1928780|NCT00609518|Dexamethasone|dexamethasone|mesh-list
1928781|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
1928782|NCT00609518|Pemetrexed|pemetrexed|mesh-list
1928783|NCT00609518|BB 1101|bb 1101|mesh-list
1928784|NCT00609518|Vitamins|vitamins|mesh-ancestor
1928785|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
1928786|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928787|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928788|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
1928789|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
1928790|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928791|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928792|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
1928793|NCT00609518|Hormones|hormones|mesh-ancestor
1928794|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928795|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1928796|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928797|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
1928798|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928799|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928800|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1928801|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928802|NCT00609518|Hematinics|hematinics|mesh-ancestor
1928803|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
1928804|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1928805|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1928806|NCT00609609|Prednisolone|prednisolone|mesh-list
1928807|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
1928808|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1928809|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
1928810|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928811|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
1928812|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
1928813|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928814|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928815|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928816|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
1928817|NCT00609609|Hormones|hormones|mesh-ancestor
1928818|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928819|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1928820|NCT00609609|Protective Agents|protective agents|mesh-ancestor
1928821|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1928822|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928823|NCT00609622|Bevacizumab|bevacizumab|mesh-list
1928824|NCT00609622|Sunitinib|sunitinib|mesh-list
1928825|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1928826|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928827|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928828|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928829|NCT00609622|Growth Substances|growth substances|mesh-ancestor
1928830|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928831|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928832|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928833|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928834|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928835|NCT00609674|Fluticasone|fluticasone|mesh-list
1928836|NCT00609674|Xhance|xhance|mesh-list
1928837|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928838|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1928839|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
1928840|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928841|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928842|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1928843|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
1928844|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
1928845|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1928846|NCT00609739|Cytarabine|cytarabine|mesh-list
1928847|NCT00609739|Cyclosporine|cyclosporine|mesh-list
1928848|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
1928849|NCT00609739|Methotrexate|methotrexate|mesh-list
1928850|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
1928851|NCT00609739|Tretinoin|tretinoin|mesh-list
1928852|NCT00609739|Isotretinoin|isotretinoin|mesh-list
1928853|NCT00609739|Cyclosporins|cyclosporins|mesh-list
1928854|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1928855|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
1928856|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1928857|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928858|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1928859|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
1928860|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928861|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928862|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
1928863|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928864|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1928865|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928866|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
1928867|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928868|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1928869|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
1928870|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928871|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
1928872|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1928873|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928874|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
1928875|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
1928876|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928877|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928878|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
1928879|NCT00609739|Hormones|hormones|mesh-ancestor
1928880|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1928881|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1928882|NCT00609739|Protective Agents|protective agents|mesh-ancestor
1928883|NCT00609739|Analgesics|analgesics|mesh-ancestor
1928884|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
1928885|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1928886|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1928887|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
1928888|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1928889|NCT00609804|Sorafenib|sorafenib|mesh-list
1928890|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928891|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1928892|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928893|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928894|NCT00609869|Rituximab|rituximab|mesh-list
1928895|NCT00609869|Lenalidomide|lenalidomide|mesh-list
1928896|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1928897|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928898|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
1928899|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928900|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928901|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1928902|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1928903|NCT00609869|Growth Substances|growth substances|mesh-ancestor
1928904|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
1928905|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
1928906|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1928907|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928908|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1928909|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1928910|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1928911|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928912|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928913|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1928914|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1928915|NCT00609986|Insulin|insulin|mesh-list
1928916|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1928917|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
1928918|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
1928919|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
1928920|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
1928921|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1928922|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928923|NCT00610155|Pregabalin|pregabalin|mesh-list
1928924|NCT00610155|Tramadol|tramadol|mesh-list
1928925|NCT00610155|Analgesics|analgesics|mesh-ancestor
1928926|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
1928927|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928928|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928929|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
1928930|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1928931|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1928932|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928933|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1928934|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1928935|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928936|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928937|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928938|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1928939|NCT00610155|Narcotics|narcotics|mesh-ancestor
1928940|NCT00610168|Vaccines|vaccines|mesh-list
1928941|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
1928942|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928943|NCT00610311|Aldesleukin|aldesleukin|mesh-list
1928944|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
1928945|NCT00610311|Fludarabine|fludarabine|mesh-list
1928946|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
1928947|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1928948|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
1928949|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928950|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1928951|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1928952|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
1928953|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928954|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1928955|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1928956|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1928957|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
1928958|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1928959|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1928960|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
1928961|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1928962|NCT00610363|Rilonacept|rilonacept|mesh-list
1928963|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1928964|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
1928965|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
1928966|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
1928967|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1928968|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928969|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1928970|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1928971|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928972|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928973|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928974|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1928975|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
1928976|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928977|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928978|NCT00610675|Mirtazapine|mirtazapine|mesh-list
1928979|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
1928980|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1928981|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1928982|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
1928983|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
1928984|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1928985|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1928986|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1928987|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1928988|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1928989|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1928990|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1928991|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1928992|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1928993|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
1928994|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1928995|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1928996|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
1928997|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1928998|NCT00610688|Vitamin D|vitamin d|mesh-list
1928999|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
1929000|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
1929001|NCT00610688|Vitamins|vitamins|mesh-list
1929002|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
1929003|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929004|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1929005|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1929006|NCT00610714|Paclitaxel|paclitaxel|mesh-list
1929007|NCT00610714|Carboplatin|carboplatin|mesh-list
1929008|NCT00610714|Saracatinib|saracatinib|mesh-list
1929009|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1929010|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929011|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
1929012|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
1929013|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
1929014|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929015|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929016|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
1929017|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
1929018|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
1929019|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929020|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929021|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1929022|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1929023|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1929024|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929025|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929026|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1929027|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
1929028|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929029|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929030|NCT00610740|Gemcitabine|gemcitabine|mesh-list
1929031|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929032|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
1929033|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929034|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929035|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
1929036|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929037|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929038|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929039|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
1929040|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929041|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1929042|NCT00610857|Antibodies|antibodies|mesh-list
1929043|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
1929044|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1929045|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
1929046|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929047|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929048|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
1929049|NCT00610883|Methotrexate|methotrexate|mesh-list
1929050|NCT00610883|Asparaginase|asparaginase|mesh-list
1929051|NCT00610883|Daunorubicin|daunorubicin|mesh-list
1929052|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929053|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
1929054|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929055|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929056|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929057|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
1929058|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929059|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929060|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1929061|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1929062|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
1929063|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1929064|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929065|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
1929066|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
1929067|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929068|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1929069|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1929070|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1929071|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1929072|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929073|NCT00610935|Peramivir|peramivir|mesh-list
1929074|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
1929075|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929076|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929077|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929078|NCT00610987|Cefazolin|cefazolin|mesh-list
1929079|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1929080|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929081|NCT00611026|Fesoterodine|fesoterodine|mesh-list
1929082|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1929083|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1929084|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1929085|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
1929086|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929087|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929088|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929089|NCT00611026|Urological Agents|urological agents|mesh-ancestor
1929090|NCT00611130|Vigabatrin|vigabatrin|mesh-list
1929091|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
1929092|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929093|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929094|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
1929095|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929096|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929097|NCT00611247|Temozolomide|temozolomide|mesh-list
1929098|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929099|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
1929100|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929101|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929102|NCT00611325|Bevacizumab|bevacizumab|mesh-list
1929103|NCT00611325|Bortezomib|bortezomib|mesh-list
1929104|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929105|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929106|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929107|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929108|NCT00611325|Growth Substances|growth substances|mesh-ancestor
1929109|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929110|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929111|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
1929112|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
1929113|NCT00611351|Busulfan|busulfan|mesh-list
1929114|NCT00611351|Tacrolimus|tacrolimus|mesh-list
1929115|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1929116|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929117|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
1929118|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929119|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929120|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929121|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
1929122|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929123|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929124|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1929125|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1929126|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929127|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1929128|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1929129|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
1929130|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1929131|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929132|NCT00611403|Cyclosporine|cyclosporine|mesh-list
1929133|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
1929134|NCT00611403|Cyclosporins|cyclosporins|mesh-list
1929135|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929136|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929137|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929138|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
1929139|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929140|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
1929141|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929142|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
1929143|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929144|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1929145|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1929146|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1929147|NCT00611442|Lubiprostone|lubiprostone|mesh-list
1929148|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1929149|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929150|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929151|NCT00611455|Ofatumumab|ofatumumab|mesh-list
1929152|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929153|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1929154|NCT00611468|Topotecan|topotecan|mesh-list
1929155|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929156|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929157|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929158|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929159|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1929160|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929161|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1929162|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1929163|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1929164|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929165|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929166|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
1929167|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929168|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929169|NCT00611559|PENTA|penta|mesh-list
1929170|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
1929171|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1929172|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1929173|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929174|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1929175|NCT00611715|Letrozole|letrozole|mesh-list
1929176|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929177|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929178|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929179|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929180|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1929181|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1929182|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1929183|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
1929184|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929185|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929186|NCT00611767|Thiopental|thiopental|mesh-list
1929187|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
1929188|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1929189|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929190|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929191|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1929192|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
1929193|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
1929194|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
1929195|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
1929196|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929197|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929198|NCT00611806|Folic Acid|folic acid|mesh-list
1929199|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
1929200|NCT00611806|Hematinics|hematinics|mesh-ancestor
1929201|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
1929202|NCT00611806|Vitamins|vitamins|mesh-ancestor
1929203|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
1929204|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929205|NCT00611858|Fluorouracil|fluorouracil|mesh-list
1929206|NCT00611858|Cetuximab|cetuximab|mesh-list
1929207|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
1929208|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929209|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929210|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929211|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929212|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
1929213|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929214|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929215|NCT00611884|Insulin|insulin|mesh-list
1929216|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1929217|NCT00611884|Metformin|metformin|mesh-list
1929218|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
1929219|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
1929220|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929221|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929222|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
1929223|NCT00611897|Ketamine|ketamine|mesh-list
1929224|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1929225|NCT00611897|Analgesics|analgesics|mesh-ancestor
1929226|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
1929227|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929228|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929229|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1929230|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1929231|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
1929232|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
1929233|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929234|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1929235|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1929236|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929237|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929238|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
1929239|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929240|NCT00611897|Expectorants|expectorants|mesh-ancestor
1929241|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
1929242|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1929243|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
1929244|NCT00611897|Protective Agents|protective agents|mesh-ancestor
1929245|NCT00611897|Antidotes|antidotes|mesh-ancestor
1929246|NCT00611923|Flutamide|flutamide|mesh-list
1929247|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
1929248|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
1929249|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929250|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929251|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1929252|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929253|NCT00611975|Bupropion|bupropion|mesh-list
1929254|NCT00611975|Fluoxetine|fluoxetine|mesh-list
1929255|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1929256|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
1929257|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929258|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1929259|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1929260|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929261|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929262|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
1929263|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929264|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929265|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1929266|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1929267|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929268|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1929269|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
1929270|NCT00612040|Insulin|insulin|mesh-list
1929271|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1929272|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
1929273|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
1929274|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
1929275|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929276|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929277|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
1929278|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929279|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929280|NCT00612105|Ezogabine|ezogabine|mesh-list
1929281|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
1929282|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929283|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929284|NCT00612222|Aldesleukin|aldesleukin|mesh-list
1929285|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
1929286|NCT00612222|Fludarabine|fludarabine|mesh-list
1929287|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
1929288|NCT00612222|Interleukin-2|interleukin-2|mesh-list
1929289|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929290|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
1929291|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929292|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929293|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929294|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
1929295|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929296|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929297|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1929298|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929299|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
1929300|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1929301|NCT00612222|Analgesics|analgesics|mesh-ancestor
1929302|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
1929303|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929304|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1929305|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1929306|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
1929307|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929308|NCT00612235|Lamotrigine|lamotrigine|mesh-list
1929309|NCT00612235|Carbamazepine|carbamazepine|mesh-list
1929310|NCT00612235|Levetiracetam|levetiracetam|mesh-list
1929311|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
1929312|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
1929313|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1929314|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929315|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929316|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1929317|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929318|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1929319|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1929320|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929321|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929322|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1929323|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
1929324|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1929325|NCT00612235|Analgesics|analgesics|mesh-ancestor
1929326|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
1929327|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929328|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1929329|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1929330|NCT00612313|Fluoxetine|fluoxetine|mesh-list
1929331|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1929332|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1929333|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929334|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929335|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929336|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
1929337|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929338|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1929339|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
1929340|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929341|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1929342|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1929343|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929344|NCT00612339|Bevacizumab|bevacizumab|mesh-list
1929345|NCT00612339|Temozolomide|temozolomide|mesh-list
1929346|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929347|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929348|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929349|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929350|NCT00612339|Growth Substances|growth substances|mesh-ancestor
1929351|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929352|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929353|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929354|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
1929355|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929356|NCT00612352|Ethanol|ethanol|mesh-list
1929357|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1929358|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929359|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929360|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929361|NCT00612430|Bevacizumab|bevacizumab|mesh-list
1929362|NCT00612430|Etoposide|etoposide|mesh-list
1929363|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
1929364|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929365|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929366|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929367|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929368|NCT00612430|Growth Substances|growth substances|mesh-ancestor
1929369|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929370|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929371|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1929372|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1929373|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929374|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929375|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929376|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1929377|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1929378|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1929379|NCT00612508|Etonogestrel|etonogestrel|mesh-list
1929380|NCT00612508|Desogestrel|desogestrel|mesh-list
1929381|NCT00612508|NuvaRing|nuvaring|mesh-list
1929382|NCT00612508|Estradiol|estradiol|mesh-list
1929683|NCT00614380|Amlodipine|amlodipine|mesh-list
1929383|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1929384|NCT00612508|Estrogens|estrogens|mesh-ancestor
1929385|NCT00612508|Hormones|hormones|mesh-ancestor
1929386|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929387|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929388|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1929389|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
1929390|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1929391|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1929392|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1929393|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1929394|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1929395|NCT00612508|Progestins|progestins|mesh-ancestor
1929396|NCT00612534|Sufentanil|sufentanil|mesh-list
1929397|NCT00612534|Dsuvia|dsuvia|mesh-list
1929398|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1929399|NCT00612534|Narcotics|narcotics|mesh-ancestor
1929400|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929401|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929402|NCT00612534|Analgesics|analgesics|mesh-ancestor
1929403|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
1929404|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929405|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1929406|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1929407|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
1929408|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
1929409|NCT00612560|Anastrozole|anastrozole|mesh-list
1929410|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1929411|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929412|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1929413|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1929414|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929415|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929416|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1929417|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
1929418|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929419|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929420|NCT00612573|Doxycycline|doxycycline|mesh-list
1929421|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1929422|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929423|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
1929424|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1929425|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1929426|NCT00612586|Leucovorin|leucovorin|mesh-list
1929427|NCT00612586|Bevacizumab|bevacizumab|mesh-list
1929428|NCT00612586|Fluorouracil|fluorouracil|mesh-list
1929429|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929430|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929431|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929432|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929433|NCT00612586|Growth Substances|growth substances|mesh-ancestor
1929434|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929435|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929436|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
1929437|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929438|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929439|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929440|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
1929441|NCT00612586|Antidotes|antidotes|mesh-ancestor
1929442|NCT00612586|Protective Agents|protective agents|mesh-ancestor
1929443|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
1929444|NCT00612586|Vitamins|vitamins|mesh-ancestor
1929445|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
1929446|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
1929447|NCT00612716|Busulfan|busulfan|mesh-list
1929448|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929449|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
1929450|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929451|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929452|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929453|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
1929454|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929455|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929456|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1929457|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
1929458|NCT00612807|Bupropion|bupropion|mesh-list
1929459|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1929460|NCT00612807|Sertraline|sertraline|mesh-list
1929461|NCT00612807|Nortriptyline|nortriptyline|mesh-list
1929462|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1929463|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
1929464|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929465|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1929466|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1929467|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929468|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929469|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
1929470|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929471|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929472|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1929473|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1929474|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929475|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1929476|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
1929477|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1929478|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929479|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1929480|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1929481|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1929482|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
1929483|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1929484|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1929485|NCT00613015|Guanfacine|guanfacine|mesh-list
1929486|NCT00613015|Modafinil|modafinil|mesh-list
1929487|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1929488|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929489|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1929490|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1929491|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1929492|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929493|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1929494|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1929495|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1929496|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1929497|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
1929498|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929499|NCT00613028|Bevacizumab|bevacizumab|mesh-list
1929500|NCT00613028|Etoposide|etoposide|mesh-list
1929501|NCT00613028|Temozolomide|temozolomide|mesh-list
1929502|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929503|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929504|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929505|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929506|NCT00613028|Growth Substances|growth substances|mesh-ancestor
1929507|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929508|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929509|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1929510|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1929511|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929512|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929513|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929514|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929515|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
1929516|NCT00613080|Leucovorin|leucovorin|mesh-list
1929517|NCT00613080|Fluorouracil|fluorouracil|mesh-list
1929518|NCT00613080|Capecitabine|capecitabine|mesh-list
1929519|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
1929520|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
1929521|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929522|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929523|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929524|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929525|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
1929526|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929527|NCT00613080|Antidotes|antidotes|mesh-ancestor
1929528|NCT00613080|Protective Agents|protective agents|mesh-ancestor
1929529|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
1929530|NCT00613080|Vitamins|vitamins|mesh-ancestor
1929531|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
1929532|NCT00613106|Ibuprofen|ibuprofen|mesh-list
1929533|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1929534|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1929535|NCT00613106|Analgesics|analgesics|mesh-ancestor
1929536|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
1929537|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929538|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929539|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1929540|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929541|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1929542|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929543|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929544|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
1929545|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929546|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929547|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929548|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929549|NCT00613327|Oxybutynin|oxybutynin|mesh-list
1929550|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
1929551|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
1929552|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929553|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929554|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1929555|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1929556|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
1929557|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929558|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929559|NCT00613327|Urological Agents|urological agents|mesh-ancestor
1929560|NCT00613366|Misoprostol|misoprostol|mesh-list
1929561|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
1929562|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1929563|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
1929564|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1929565|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929566|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1929567|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1929568|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
1929569|NCT00613366|Antacids|antacids|mesh-ancestor
1929570|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929571|NCT00613379|Leronlimab|leronlimab|mesh-list
1929572|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
1929573|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1929574|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1929575|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929576|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1929577|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1929578|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
1929579|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929580|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
1929581|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929582|NCT00613509|Interferons|interferons|mesh-list
1929583|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
1929584|NCT00613509|Vaccines|vaccines|mesh-list
1929585|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929586|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
1929587|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929588|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
1929589|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929590|NCT00613574|Bromides|bromides|mesh-list
1929591|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
1929592|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1929593|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
1929594|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929595|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929596|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1929597|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
1929598|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
1929599|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1929600|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
1929601|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929602|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929603|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
1929604|NCT00613626|Etoposide|etoposide|mesh-list
1929605|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929606|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1929607|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1929608|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929609|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929610|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929611|NCT00613821|Lidocaine|lidocaine|mesh-list
1929612|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
1929613|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
1929614|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929615|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929616|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
1929617|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929618|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1929619|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1929620|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1929621|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929622|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929623|NCT00613834|Lidocaine|lidocaine|mesh-list
1929624|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
1929625|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
1929626|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929627|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929628|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
1929629|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929630|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1929631|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1929632|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1929633|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929634|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929635|NCT00613938|Oxycodone|oxycodone|mesh-list
1929636|NCT00613938|Tapentadol|tapentadol|mesh-list
1929637|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1929638|NCT00613938|Narcotics|narcotics|mesh-ancestor
1929639|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929640|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929641|NCT00613938|Analgesics|analgesics|mesh-ancestor
1929642|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
1929643|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929644|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1929645|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1929646|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929647|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929648|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
1929649|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929650|NCT00613951|Insulin|insulin|mesh-list
1929651|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1929652|NCT00613951|Metformin|metformin|mesh-list
1929653|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
1929654|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
1929655|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1929656|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
1929657|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929658|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929659|NCT00614055|Insulin|insulin|mesh-list
1929660|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1929661|NCT00614055|Metformin|metformin|mesh-list
1929662|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
1929663|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
1929664|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
1929665|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1929666|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929667|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929668|NCT00614120|Metformin|metformin|mesh-list
1929669|NCT00614120|Liraglutide|liraglutide|mesh-list
1929670|NCT00614120|Glimepiride|glimepiride|mesh-list
1929671|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929672|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929673|NCT00614120|Incretins|incretins|mesh-ancestor
1929674|NCT00614120|Hormones|hormones|mesh-ancestor
1929675|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929676|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1929677|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929678|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
1929679|NCT00614198|Caseins|caseins|mesh-list
1929680|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
1929681|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
1929682|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929684|NCT00614380|Telmisartan|telmisartan|mesh-list
1929685|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1929686|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1929687|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1929688|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929689|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929690|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1929691|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929692|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
1929693|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1929694|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1929695|NCT00614393|Irinotecan|irinotecan|mesh-list
1929696|NCT00614393|Cetuximab|cetuximab|mesh-list
1929697|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1929698|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1929699|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929700|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929701|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929702|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929703|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929704|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
1929705|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929706|NCT00614406|Celecoxib|celecoxib|mesh-list
1929707|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1929708|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1929709|NCT00614406|Analgesics|analgesics|mesh-ancestor
1929710|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
1929711|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929712|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929713|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1929714|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929715|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1929716|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1929717|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929718|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929719|NCT00614445|Pyridoxine|pyridoxine|mesh-list
1929720|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
1929721|NCT00614445|Doxylamine|doxylamine|mesh-list
1929722|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
1929723|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
1929724|NCT00614445|Vitamins|vitamins|mesh-ancestor
1929725|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
1929726|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929727|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1929728|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
1929729|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
1929730|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929731|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929732|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
1929733|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
1929734|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929735|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1929736|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
1929737|NCT00614458|Valproic Acid|valproic acid|mesh-list
1929738|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1929739|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1929740|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
1929741|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929742|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1929743|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1929744|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929745|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929746|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
1929747|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
1929748|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929749|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929750|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
1929751|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1929752|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929753|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929754|NCT00614484|Paclitaxel|paclitaxel|mesh-list
1929755|NCT00614484|Carboplatin|carboplatin|mesh-list
1929756|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1929757|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929758|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
1929759|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
1929760|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
1929761|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929762|NCT00614614|Vaccines|vaccines|mesh-list
1929763|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
1929764|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929765|NCT00614822|Bevacizumab|bevacizumab|mesh-list
1929766|NCT00614822|Carboplatin|carboplatin|mesh-list
1929767|NCT00614822|Pemetrexed|pemetrexed|mesh-list
1929768|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929769|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929770|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929771|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929772|NCT00614822|Growth Substances|growth substances|mesh-ancestor
1929773|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929774|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929775|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929776|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929777|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1929778|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1929779|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
1929780|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929781|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929782|NCT00614926|Modafinil|modafinil|mesh-list
1929783|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1929784|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929785|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1929786|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1929787|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1929788|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929789|NCT00614939|Saxagliptin|saxagliptin|mesh-list
1929790|NCT00614939|Incretins|incretins|mesh-ancestor
1929791|NCT00614939|Hormones|hormones|mesh-ancestor
1929792|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929793|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929794|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1929795|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
1929796|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929797|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929798|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1929799|NCT00614991|Ritonavir|ritonavir|mesh-list
1929800|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
1929801|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
1929802|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1929803|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1929804|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
1929805|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929806|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929807|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1929808|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1929809|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
1929810|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929811|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1929812|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1929813|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1929814|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1929815|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1929816|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1929817|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
1929818|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929819|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929820|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1929821|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
1929822|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1929823|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1929824|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1929825|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
1929826|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929827|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929828|NCT00615056|Leucovorin|leucovorin|mesh-list
1929829|NCT00615056|Bevacizumab|bevacizumab|mesh-list
1929830|NCT00615056|Fluorouracil|fluorouracil|mesh-list
1929831|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
1929832|NCT00615056|Irinotecan|irinotecan|mesh-list
1929833|NCT00615056|Axitinib|axitinib|mesh-list
1929834|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
1929835|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1929836|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929837|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929838|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929839|NCT00615056|Growth Substances|growth substances|mesh-ancestor
1929840|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929841|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929842|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
1929843|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929844|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929845|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929846|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
1929847|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1929848|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1929849|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929850|NCT00615056|Antidotes|antidotes|mesh-ancestor
1929851|NCT00615056|Protective Agents|protective agents|mesh-ancestor
1929852|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
1929853|NCT00615056|Vitamins|vitamins|mesh-ancestor
1929854|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
1929855|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929856|NCT00615199|Tofacitinib|tofacitinib|mesh-list
1929857|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929858|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929859|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929860|NCT00615290|Tipranavir|tipranavir|mesh-list
1929861|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1929862|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1929863|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
1929864|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1929865|NCT00615433|Olanzapine|olanzapine|mesh-list
1929866|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1929867|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
1929868|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
1929869|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929870|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929871|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1929872|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1929873|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1929874|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929875|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1929876|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1929877|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1929878|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1929879|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929880|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929881|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
1929882|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1929883|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1929884|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1929885|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
1929886|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1929887|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1929888|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1929889|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1929890|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
1929891|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
1929892|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1929893|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
1929894|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929895|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929896|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1929897|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
1929898|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
1929899|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1929900|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
1929901|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929902|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929903|NCT00615472|Remifentanil|remifentanil|mesh-list
1929904|NCT00615472|Propofol|propofol|mesh-list
1929905|NCT00615472|Isoflurane|isoflurane|mesh-list
1929906|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1929907|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1929908|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929909|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1929910|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
1929911|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
1929912|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1929913|NCT00615472|Narcotics|narcotics|mesh-ancestor
1929914|NCT00615472|Analgesics|analgesics|mesh-ancestor
1929915|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
1929916|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929917|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1929918|NCT00615550|Progesterone|progesterone|mesh-list
1929919|NCT00615550|Progestins|progestins|mesh-ancestor
1929920|NCT00615550|Hormones|hormones|mesh-ancestor
1929921|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1929922|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929923|NCT00615589|Fludarabine|fludarabine|mesh-list
1929924|NCT00615589|Busulfan|busulfan|mesh-list
1929925|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929926|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929927|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929928|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
1929929|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929930|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
1929931|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929932|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1929933|NCT00615784|Bexarotene|bexarotene|mesh-list
1929934|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929935|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1929936|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
1929937|NCT00615836|Coagulants|coagulants|mesh-ancestor
1929938|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1929939|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
1929940|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929941|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
1929942|NCT00615901|Fluorouracil|fluorouracil|mesh-list
1929943|NCT00615901|Methotrexate|methotrexate|mesh-list
1929944|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1929945|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
1929946|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929947|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1929948|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1929949|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
1929950|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929951|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929952|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1929953|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
1929954|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1929955|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1929956|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
1929957|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1929958|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
1929959|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929960|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1929961|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1929962|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
1929963|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
1929964|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929965|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929966|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929967|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929968|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
1929969|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1929970|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
1929971|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1929972|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
1929973|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929974|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929975|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1929976|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
1929977|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
1929978|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1929979|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
1929980|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1929981|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929982|NCT00616018|Acetaminophen|acetaminophen|mesh-list
1929983|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1929984|NCT00616018|Analgesics|analgesics|mesh-ancestor
1929985|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
1929986|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1929987|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929988|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
1929989|NCT00616109|Sunitinib|sunitinib|mesh-list
1929990|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1929991|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1929992|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1929993|NCT00616109|Growth Substances|growth substances|mesh-ancestor
1929994|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1929995|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
1929996|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1929997|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1929998|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1929999|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
1930000|NCT00616122|Methotrexate|methotrexate|mesh-list
1930001|NCT00616122|Sunitinib|sunitinib|mesh-list
1930002|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930003|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
1930004|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930005|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930006|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1930007|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
1930008|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930009|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930010|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1930011|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1930012|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
1930013|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1930014|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930015|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
1930016|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930017|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930018|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1930019|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1930020|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1930021|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1930022|NCT00616122|Growth Substances|growth substances|mesh-ancestor
1930023|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
1930024|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1930025|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
1930026|NCT00616239|Salicylates|salicylates|mesh-list
1930027|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930028|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
1930029|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
1930030|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930031|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1930032|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1930033|NCT00616239|Analgesics|analgesics|mesh-ancestor
1930034|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
1930035|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930036|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930037|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930038|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930039|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1930040|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930041|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930042|NCT00616434|Interferons|interferons|mesh-list
1930043|NCT00616434|Interferon-beta|interferon-beta|mesh-list
1930044|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
1930045|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930046|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
1930047|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930048|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
1930049|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930050|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1930051|NCT00616655|Eszopiclone|eszopiclone|mesh-list
1930052|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1930053|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930054|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930055|NCT00616772|Choline|choline|mesh-list
1930056|NCT00616772|Atorvastatin|atorvastatin|mesh-list
1930057|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
1930058|NCT00616772|Fenofibrate|fenofibrate|mesh-list
1930059|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1930060|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1930061|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
1930062|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930063|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1930064|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1930065|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930066|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
1930067|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930068|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
1930069|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
1930070|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1930071|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930072|NCT00616902|Vitamins|vitamins|mesh-ancestor
1930073|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
1930074|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1930075|NCT00616941|Poly ICLC|poly iclc|mesh-list
1930076|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
1930077|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
1930078|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930079|NCT00616967|Paclitaxel|paclitaxel|mesh-list
1930080|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1930081|NCT00616967|Carboplatin|carboplatin|mesh-list
1930082|NCT00616967|Vorinostat|vorinostat|mesh-list
1930083|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1930084|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930085|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930086|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930087|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930088|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930089|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1930090|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930091|NCT00617058|Metformin|metformin|mesh-list
1930092|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1930093|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930094|NCT00617084|Everolimus|everolimus|mesh-list
1930095|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930096|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930097|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
1930098|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930099|NCT00617097|Ketorolac|ketorolac|mesh-list
1930100|NCT00617097|Lidocaine|lidocaine|mesh-list
1930101|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
1930102|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
1930103|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930104|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930105|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
1930106|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930107|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1930108|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1930109|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1930110|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930111|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930112|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1930113|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1930114|NCT00617097|Analgesics|analgesics|mesh-ancestor
1930115|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930116|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930117|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1930118|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930119|NCT00617123|Vorapaxar|vorapaxar|mesh-list
1930120|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1930121|NCT00617188|Fulvestrant|fulvestrant|mesh-list
1930122|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1930123|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930124|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1930125|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1930126|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
1930127|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930128|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930129|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1930130|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1930131|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930132|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930133|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930134|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
1930135|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930136|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930137|NCT00617240|Metformin|metformin|mesh-list
1930138|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1930139|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930140|NCT00617305|Ambrisentan|ambrisentan|mesh-list
1930141|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
1930142|NCT00617305|Tadalafil|tadalafil|mesh-list
1930143|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930144|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1930145|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1930146|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930147|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930148|NCT00617305|Urological Agents|urological agents|mesh-ancestor
1930149|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1930150|NCT00617344|Vaccines|vaccines|mesh-list
1930151|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
1930152|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930153|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1930154|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930155|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930156|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1930157|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930158|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930159|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930160|NCT00617409|Paclitaxel|paclitaxel|mesh-list
1930161|NCT00617409|Tretinoin|tretinoin|mesh-list
1930162|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1930163|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930164|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930165|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930166|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930167|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930168|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
1930169|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930170|NCT00617461|Gabapentin|gabapentin|mesh-list
1930171|NCT00617461|Analgesics|analgesics|mesh-ancestor
1930172|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
1930173|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930174|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930175|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
1930176|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1930177|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930178|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930179|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930180|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1930181|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1930182|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930183|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930184|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
1930185|NCT00617539|Irinotecan|irinotecan|mesh-list
1930186|NCT00617539|Temozolomide|temozolomide|mesh-list
1930187|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1930188|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1930189|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930190|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930191|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930192|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1930193|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
1930194|NCT00617591|Dexamethasone|dexamethasone|mesh-list
1930195|NCT00617591|Doxorubicin|doxorubicin|mesh-list
1930196|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1930197|NCT00617591|Lenalidomide|lenalidomide|mesh-list
1930198|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930199|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
1930200|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
1930201|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930202|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930203|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930204|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
1930205|NCT00617591|Hormones|hormones|mesh-ancestor
1930206|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930207|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1930208|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930209|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1930210|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1930211|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1930212|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930213|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930214|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
1930215|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1930216|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1930217|NCT00617591|Growth Substances|growth substances|mesh-ancestor
1930218|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
1930219|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
1930220|NCT00617604|Alefacept|alefacept|mesh-list
1930221|NCT00617604|Tacrolimus|tacrolimus|mesh-list
1930222|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930223|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
1930224|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930225|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1930226|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930227|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930228|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1930229|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930230|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1930231|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
1930232|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930233|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930234|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930235|NCT00617669|Docetaxel|docetaxel|mesh-list
1930236|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930237|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930238|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930239|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930240|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930241|NCT00617708|Gemcitabine|gemcitabine|mesh-list
1930242|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1930243|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1930244|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930245|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
1930246|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930247|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930248|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
1930249|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930250|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930251|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930252|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
1930253|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930254|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1930255|NCT00617734|Cetuximab|cetuximab|mesh-list
1930256|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1930257|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1930258|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930259|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
1930260|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930261|NCT00617851|Vaccines|vaccines|mesh-list
1930262|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
1930263|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930264|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1930265|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
1930266|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930267|NCT00617903|Azelaic acid|azelaic acid|mesh-list
1930268|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930269|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930270|NCT00617929|Rituximab|rituximab|mesh-list
1930271|NCT00617929|Clofarabine|clofarabine|mesh-list
1930272|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
1930273|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1930274|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1930275|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930276|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
1930277|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930278|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930279|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930280|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930281|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
1930282|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930283|NCT00617942|Paclitaxel|paclitaxel|mesh-list
1930284|NCT00617942|Carboplatin|carboplatin|mesh-list
1930285|NCT00617942|Trastuzumab|trastuzumab|mesh-list
1930286|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1930287|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930288|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930289|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930290|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930291|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930292|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1930293|NCT00618072|Metformin|metformin|mesh-list
1930294|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
1930295|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1930296|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930297|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
1930298|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930299|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930300|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1930301|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
1930302|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1930303|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1930304|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
1930305|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930306|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1930307|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1930308|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930309|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930310|NCT00618436|Phenytoin|phenytoin|mesh-list
1930311|NCT00618436|Levetiracetam|levetiracetam|mesh-list
1930312|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
1930313|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
1930314|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1930315|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1930316|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930317|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930318|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1930319|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1930320|NCT00618449|Azithromycin|azithromycin|mesh-list
1930321|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930322|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930323|NCT00618540|Fludarabine|fludarabine|mesh-list
1930324|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
1930325|NCT00618540|Melphalan|melphalan|mesh-list
1930326|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
1930327|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930328|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930329|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
1930330|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930331|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930332|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
1930333|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930334|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1930335|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
1930336|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1930337|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1930338|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
1930339|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1930340|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930341|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
1930342|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1930343|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930344|NCT00618748|Olanzapine|olanzapine|mesh-list
1930345|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
1930346|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
1930347|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930348|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930349|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930350|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1930351|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930352|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930353|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930354|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1930355|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930356|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930357|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930358|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930359|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
1930360|NCT00618774|Amlodipine|amlodipine|mesh-list
1930361|NCT00618774|Telmisartan|telmisartan|mesh-list
1930362|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1930363|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1930364|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930365|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930366|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1930367|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930368|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930369|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1930370|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1930371|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
1930372|NCT00618813|Ifosfamide|ifosfamide|mesh-list
1930373|NCT00618813|Doxorubicin|doxorubicin|mesh-list
1930374|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1930375|NCT00618813|Etoposide|etoposide|mesh-list
1930376|NCT00618813|Vincristine|vincristine|mesh-list
1930377|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
1930378|NCT00618813|Topotecan|topotecan|mesh-list
1930379|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930380|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
1930381|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930382|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930383|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1930384|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
1930385|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930386|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930387|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1930388|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1930389|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1930390|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1930391|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930392|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1930393|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930394|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930395|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930396|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1930397|NCT00618826|Gemcitabine|gemcitabine|mesh-list
1930398|NCT00618826|Paclitaxel|paclitaxel|mesh-list
1930399|NCT00618826|Bevacizumab|bevacizumab|mesh-list
1930400|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1930401|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930402|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930403|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930404|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930405|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930406|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930407|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
1930408|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
1930409|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930410|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930411|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930412|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
1930413|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930414|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1930415|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1930416|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1930417|NCT00618826|Growth Substances|growth substances|mesh-ancestor
1930418|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
1930419|NCT00618917|Manganese|manganese|mesh-list
1930420|NCT00618917|Paclitaxel|paclitaxel|mesh-list
1930421|NCT00618917|Carboplatin|carboplatin|mesh-list
1930422|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
1930423|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1930424|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930425|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930426|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930427|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930428|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930429|NCT00618917|Trace Elements|trace elements|mesh-ancestor
1930430|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
1930431|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930432|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1930433|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
1930434|NCT00618917|Protective Agents|protective agents|mesh-ancestor
1930435|NCT00618956|Milnacipran|milnacipran|mesh-list
1930436|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
1930437|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1930513|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1930438|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930439|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930440|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930441|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930442|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930443|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1930444|NCT00618956|Analgesics|analgesics|mesh-ancestor
1930445|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
1930446|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930447|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930448|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930449|NCT00618982|Sorafenib|sorafenib|mesh-list
1930450|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930451|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1930452|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930453|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930454|NCT00618995|Niacin|niacin|mesh-list
1930455|NCT00618995|Niacinamide|niacinamide|mesh-list
1930456|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
1930457|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1930458|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
1930459|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930460|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1930461|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930462|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
1930463|NCT00618995|Vitamins|vitamins|mesh-ancestor
1930464|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
1930465|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930466|NCT00619060|Niacin|niacin|mesh-list
1930467|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
1930468|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1930469|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
1930470|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930471|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1930472|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930473|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
1930474|NCT00619060|Vitamins|vitamins|mesh-ancestor
1930475|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
1930476|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930477|NCT00619073|Aspirin|aspirin|mesh-list
1930478|NCT00619073|Clopidogrel|clopidogrel|mesh-list
1930479|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1930480|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1930481|NCT00619073|Analgesics|analgesics|mesh-ancestor
1930482|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
1930483|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930484|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930485|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930486|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930487|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1930488|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1930489|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930490|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1930491|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1930492|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930493|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
1930494|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1930495|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1930496|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1930497|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
1930498|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930499|NCT00619099|Decitabine|decitabine|mesh-list
1930500|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930501|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
1930502|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930503|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930504|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930505|NCT00619112|Temozolomide|temozolomide|mesh-list
1930506|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1930507|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
1930508|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930509|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930510|NCT00619190|Aripiprazole|aripiprazole|mesh-list
1930511|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930512|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930514|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930515|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930516|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930517|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
1930518|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
1930519|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930520|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930521|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1930522|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1930523|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
1930524|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1930525|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1930526|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1930527|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1930528|NCT00619229|Alprostadil|alprostadil|mesh-list
1930529|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1930530|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930531|NCT00619229|Urological Agents|urological agents|mesh-ancestor
1930532|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
1930533|NCT00619307|Ibuprofen|ibuprofen|mesh-list
1930534|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1930535|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1930536|NCT00619307|Analgesics|analgesics|mesh-ancestor
1930537|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
1930538|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930539|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930540|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930541|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930542|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1930543|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930544|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930545|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1930546|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
1930547|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930548|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
1930549|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930550|NCT00619359|Dexamethasone|dexamethasone|mesh-list
1930551|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
1930552|NCT00619359|Ondansetron|ondansetron|mesh-list
1930553|NCT00619359|Aprepitant|aprepitant|mesh-list
1930554|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
1930555|NCT00619359|BB 1101|bb 1101|mesh-list
1930556|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930557|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
1930558|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
1930559|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930560|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930561|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930562|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
1930563|NCT00619359|Hormones|hormones|mesh-ancestor
1930564|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930565|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1930566|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930567|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
1930568|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930569|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930570|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
1930571|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930572|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1930573|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
1930574|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930575|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1930576|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930577|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930578|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930579|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1930580|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1930581|NCT00619476|Gabapentin|gabapentin|mesh-list
1930582|NCT00619476|Analgesics|analgesics|mesh-ancestor
1930583|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
1930584|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930585|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930586|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
1930587|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1930588|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930589|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930590|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930591|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1930592|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1930593|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930594|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930595|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
1930596|NCT00619489|Vedolizumab|vedolizumab|mesh-list
1930597|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930598|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1930599|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1930600|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930601|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930602|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930603|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930604|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930605|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930606|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930607|NCT00619645|Cyclosporine|cyclosporine|mesh-list
1930608|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
1930609|NCT00619645|Fludarabine|fludarabine|mesh-list
1930610|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
1930611|NCT00619645|Busulfan|busulfan|mesh-list
1930612|NCT00619645|Cyclosporins|cyclosporins|mesh-list
1930613|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930614|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930615|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
1930616|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930617|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930618|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
1930619|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930620|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930621|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
1930622|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930623|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
1930624|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930625|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1930626|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1930627|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1930628|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
1930629|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930630|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
1930631|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1930632|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1930633|NCT00619684|Lenalidomide|lenalidomide|mesh-list
1930634|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
1930635|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930636|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1930637|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1930638|NCT00619684|Growth Substances|growth substances|mesh-ancestor
1930639|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
1930640|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930641|NCT00619723|Choline|choline|mesh-list
1930642|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1930643|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
1930644|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1930645|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
1930646|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930647|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930648|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1930649|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
1930650|NCT00619801|Levocetirizine|levocetirizine|mesh-list
1930651|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1930652|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1930653|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
1930654|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
1930655|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930656|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930657|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930658|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1930659|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930660|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930661|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1930662|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930663|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930664|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930665|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
1930666|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1930667|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930668|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930669|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1930670|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930671|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1930672|NCT00619970|Rifaximin|rifaximin|mesh-list
1930673|NCT00619970|Lactulose|lactulose|mesh-list
1930674|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930675|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930676|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930677|NCT00619983|Gabapentin|gabapentin|mesh-list
1930678|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1930679|NCT00619983|Donepezil|donepezil|mesh-list
1930680|NCT00619983|Analgesics|analgesics|mesh-ancestor
1930681|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
1930682|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930683|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930684|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
1930685|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1930686|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930687|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930688|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930689|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1930690|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1930691|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930692|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930693|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
1930694|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1930695|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930696|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930697|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930698|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
1930699|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1930700|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930701|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
1930702|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
1930703|NCT00620035|Etonogestrel|etonogestrel|mesh-list
1930704|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1930705|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
1930706|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1930707|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930708|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1930709|NCT00620061|Lubiprostone|lubiprostone|mesh-list
1930710|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1930711|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930712|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930713|NCT00620074|Voriconazole|voriconazole|mesh-list
1930714|NCT00620074|Anidulafungin|anidulafungin|mesh-list
1930715|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
1930716|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930717|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1930718|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1930719|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930720|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930721|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1930722|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
1930723|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930724|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930725|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1930726|NCT00620113|Vitamin D|vitamin d|mesh-list
1930727|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
1930728|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
1930729|NCT00620113|Calcium|calcium|mesh-list
1930730|NCT00620113|Vitamins|vitamins|mesh-ancestor
1930731|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
1930732|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930733|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1930734|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1930735|NCT00620113|Antacids|antacids|mesh-ancestor
1930736|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930737|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1930738|NCT00620191|Metformin|metformin|mesh-list
1930739|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1930740|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930741|NCT00620282|Liraglutide|liraglutide|mesh-list
1930742|NCT00620282|Glimepiride|glimepiride|mesh-list
1930743|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1930744|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930745|NCT00620282|Incretins|incretins|mesh-ancestor
1930746|NCT00620282|Hormones|hormones|mesh-ancestor
1930747|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930748|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1930749|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930750|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
1930751|NCT00620321|Cytarabine|cytarabine|mesh-list
1930752|NCT00620321|Idarubicin|idarubicin|mesh-list
1930753|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930754|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
1930755|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930756|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930757|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
1930758|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930759|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1930760|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
1930761|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930762|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1930763|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1930764|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1930765|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930766|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
1930767|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1930768|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930769|NCT00620425|Sumatriptan|sumatriptan|mesh-list
1930770|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1930771|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1930772|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1930773|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
1930774|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930775|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930776|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930777|NCT00620464|Etonogestrel|etonogestrel|mesh-list
1930778|NCT00620464|Desogestrel|desogestrel|mesh-list
1930779|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1930780|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
1930781|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1930782|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930783|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1930784|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1930785|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1930786|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1930787|NCT00620464|Progestins|progestins|mesh-ancestor
1930788|NCT00620464|Hormones|hormones|mesh-ancestor
1930789|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930790|NCT00620542|Atorvastatin|atorvastatin|mesh-list
1930791|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1930792|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1930793|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1930794|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
1930795|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930796|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1930797|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1930798|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930799|NCT00620555|Gabapentin|gabapentin|mesh-list
1930800|NCT00620555|Analgesics|analgesics|mesh-ancestor
1930801|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
1930802|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930803|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930804|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
1930805|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1930806|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1930807|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1930808|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930809|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1930810|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1930885|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
1930811|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930812|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930813|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
1930814|NCT00620659|Modafinil|modafinil|mesh-list
1930815|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1930816|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930817|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1930818|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1930819|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1930820|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930821|NCT00620750|Naltrexone|naltrexone|mesh-list
1930822|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1930823|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1930824|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930825|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
1930826|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930827|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1930828|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1930829|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930830|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930831|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930832|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930833|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930834|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1930835|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930836|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930837|NCT00620815|Vaccines|vaccines|mesh-list
1930838|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
1930839|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
1930840|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930841|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1930842|NCT00620854|Calcitonin|calcitonin|mesh-list
1930843|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
1930844|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1930845|NCT00620854|Katacalcin|katacalcin|mesh-list
1930846|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1930847|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930848|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1930849|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930850|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
1930851|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1930852|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1930853|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
1930854|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930855|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930856|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930857|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1930858|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
1930859|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
1930860|NCT00621023|Decitabine|decitabine|mesh-list
1930861|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
1930862|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1930863|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
1930864|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930865|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930866|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930867|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
1930868|NCT00621023|Protective Agents|protective agents|mesh-ancestor
1930869|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930870|NCT00621023|Vitamins|vitamins|mesh-ancestor
1930871|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
1930872|NCT00621049|Bevacizumab|bevacizumab|mesh-list
1930873|NCT00621049|Carboplatin|carboplatin|mesh-list
1930874|NCT00621049|Docetaxel|docetaxel|mesh-list
1930875|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1930876|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1930877|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930878|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1930879|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1930880|NCT00621049|Growth Substances|growth substances|mesh-ancestor
1930881|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930882|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
1930883|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
1930884|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
1930886|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930887|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1930888|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930889|NCT00621140|Linagliptin|linagliptin|mesh-list
1930890|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1930891|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930892|NCT00621140|Incretins|incretins|mesh-ancestor
1930893|NCT00621140|Hormones|hormones|mesh-ancestor
1930894|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1930895|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1930896|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
1930897|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930898|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930899|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1930900|NCT00621153|Candesartan|candesartan|mesh-list
1930901|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
1930902|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1930903|NCT00621153|Diuretics|diuretics|mesh-ancestor
1930904|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
1930905|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930906|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1930907|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930908|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930909|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1930910|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1930911|NCT00621179|Leuprolide|leuprolide|mesh-list
1930912|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1930913|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
1930914|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1930915|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930916|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1930917|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930918|NCT00621192|Meropenem|meropenem|mesh-list
1930919|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930920|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930921|NCT00621244|Panobinostat|panobinostat|mesh-list
1930922|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930923|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1930924|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930925|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930926|NCT00621257|Vitamin D|vitamin d|mesh-list
1930927|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
1930928|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
1930929|NCT00621257|Vitamins|vitamins|mesh-list
1930930|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
1930931|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930932|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1930933|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1930934|NCT00621309|Rifampin|rifampin|mesh-list
1930935|NCT00621309|Rifamycins|rifamycins|mesh-list
1930936|NCT00621309|Sulforaphane|sulforaphane|mesh-list
1930937|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1930938|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
1930939|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930940|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930941|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
1930942|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1930943|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930944|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930945|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1930946|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1930947|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1930948|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1930949|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1930950|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1930951|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1930952|NCT00621309|Protective Agents|protective agents|mesh-ancestor
1930953|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930954|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1930955|NCT00621322|Vaccines|vaccines|mesh-list
1930956|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
1930957|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930958|NCT00621504|Clarithromycin|clarithromycin|mesh-list
1930959|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
1930960|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1930961|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1930962|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1930963|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1930964|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930965|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930966|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1930967|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1930968|NCT00621517|Bupropion|bupropion|mesh-list
1930969|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1930970|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
1930971|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1930972|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1930973|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1930974|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1930975|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930976|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
1930977|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1930978|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930979|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1930980|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1930981|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930982|NCT00621530|Ketorolac|ketorolac|mesh-list
1930983|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1930984|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1930985|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1930986|NCT00621530|Analgesics|analgesics|mesh-ancestor
1930987|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
1930988|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1930989|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1930990|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1930991|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1930992|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1930993|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1930994|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1930995|NCT00621543|Copper|copper|mesh-list
1930996|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
1930997|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1930998|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
1930999|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1931000|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931001|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1931002|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1931003|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1931004|NCT00621543|Trace Elements|trace elements|mesh-ancestor
1931005|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
1931006|NCT00621686|Bevacizumab|bevacizumab|mesh-list
1931007|NCT00621686|Sorafenib|sorafenib|mesh-list
1931008|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931009|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931010|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931011|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931012|NCT00621686|Growth Substances|growth substances|mesh-ancestor
1931013|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931014|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931015|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1931016|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931017|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931018|NCT00621751|Carbamazepine|carbamazepine|mesh-list
1931019|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
1931020|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
1931021|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1931022|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931023|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931024|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931025|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931026|NCT00621751|Analgesics|analgesics|mesh-ancestor
1931027|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
1931028|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931029|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1931030|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931031|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931032|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1931033|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1931034|NCT00621764|Vaccines|vaccines|mesh-list
1931035|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
1931036|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931037|NCT00621777|Varenicline|varenicline|mesh-list
1931038|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1931039|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1931040|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
1931041|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931042|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931043|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931044|NCT00621842|Lamotrigine|lamotrigine|mesh-list
1931045|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
1931046|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1931047|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931048|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931049|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1931050|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931051|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1931052|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1931053|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931054|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931055|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1931056|NCT00621855|Dabigatran|dabigatran|mesh-list
1931057|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
1931058|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1931059|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
1931060|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931061|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931062|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
1931063|NCT00621946|Dexetimide|dexetimide|mesh-list
1931064|NCT00621946|Citalopram|citalopram|mesh-list
1931065|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1931066|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1931067|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931068|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931069|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931070|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
1931071|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931072|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1931073|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
1931074|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931075|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1931076|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1931077|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
1931078|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
1931079|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931080|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1931081|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1931082|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
1931083|NCT00621959|Levocetirizine|levocetirizine|mesh-list
1931084|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1931085|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1931086|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
1931087|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
1931088|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931089|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931090|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931091|NCT00621985|Dexamethasone|dexamethasone|mesh-list
1931092|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
1931093|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931094|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
1931095|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
1931096|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931097|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931098|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1931099|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
1931100|NCT00621985|Hormones|hormones|mesh-ancestor
1931101|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931102|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1931103|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931104|NCT00622284|Glimepiride|glimepiride|mesh-list
1931105|NCT00622284|Linagliptin|linagliptin|mesh-list
1931106|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1931107|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1931108|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931109|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931110|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
1931111|NCT00622284|Incretins|incretins|mesh-ancestor
1931112|NCT00622284|Hormones|hormones|mesh-ancestor
1931113|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931114|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1931115|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
1931116|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931117|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931118|NCT00622336|Lenalidomide|lenalidomide|mesh-list
1931119|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
1931120|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931121|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931122|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931123|NCT00622336|Growth Substances|growth substances|mesh-ancestor
1931124|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931125|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931126|NCT00622388|Ofatumumab|ofatumumab|mesh-list
1931127|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931128|NCT00622401|Interleukin-12|interleukin-12|mesh-list
1931129|NCT00622401|Vaccines|vaccines|mesh-list
1931130|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
1931131|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931132|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1931133|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931134|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931135|NCT00622401|Growth Substances|growth substances|mesh-ancestor
1931136|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931137|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931138|NCT00622466|Paclitaxel|paclitaxel|mesh-list
1931139|NCT00622466|Sorafenib|sorafenib|mesh-list
1931140|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1931141|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931142|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
1931143|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
1931144|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
1931145|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931146|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1931147|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931148|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
1931149|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1931150|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931151|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1931152|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931153|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
1931154|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931155|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931156|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931157|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931158|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1931159|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1931160|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1931161|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
1931162|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931163|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931164|NCT00622700|Teriflunomide|teriflunomide|mesh-list
1931165|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1931166|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931167|NCT00622700|Analgesics|analgesics|mesh-ancestor
1931168|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
1931169|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931170|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931171|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931172|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931173|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931174|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
1931175|NCT00622713|Rivastigmine|rivastigmine|mesh-list
1931176|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1931177|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931178|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931179|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
1931180|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931181|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931182|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1931183|NCT00622713|Protective Agents|protective agents|mesh-ancestor
1931184|NCT00622726|Bevacizumab|bevacizumab|mesh-list
1931185|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931186|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931187|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931188|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931189|NCT00622726|Growth Substances|growth substances|mesh-ancestor
1931190|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931191|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931192|NCT00622739|Ziprasidone|ziprasidone|mesh-list
1931193|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1931194|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
1931195|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931196|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931197|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931198|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1931199|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1931200|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931201|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931202|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1931203|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
1931204|NCT00622869|Everolimus|everolimus|mesh-list
1931205|NCT00622869|Tacrolimus|tacrolimus|mesh-list
1931206|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931207|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
1931208|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931209|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1931210|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931211|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931212|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931213|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
1931214|NCT00622895|Fludarabine|fludarabine|mesh-list
1931215|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
1931216|NCT00622895|Tacrolimus|tacrolimus|mesh-list
1931217|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931218|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931219|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
1931220|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931221|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931222|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
1931223|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931224|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1931225|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931226|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1931227|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1931228|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
1931229|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1931230|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931231|NCT00622908|Besifloxacin|besifloxacin|mesh-list
1931232|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1931233|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931234|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1931235|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1931236|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931237|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931238|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931239|NCT00623012|Sirolimus|sirolimus|mesh-list
1931240|NCT00623012|Tacrolimus|tacrolimus|mesh-list
1931241|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931242|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
1931243|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931244|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1931245|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931246|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931247|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1931248|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931249|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1931250|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931251|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
1931252|NCT00623103|Rivastigmine|rivastigmine|mesh-list
1931253|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1931254|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931255|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931256|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
1931257|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931258|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931259|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1931260|NCT00623103|Protective Agents|protective agents|mesh-ancestor
1931261|NCT00623181|Vaccines|vaccines|mesh-list
1931262|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
1931263|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931264|NCT00623194|Insulin|insulin|mesh-list
1931265|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1931266|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
1931267|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
1931268|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1931269|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931270|NCT00623233|Gemcitabine|gemcitabine|mesh-list
1931271|NCT00623233|Bevacizumab|bevacizumab|mesh-list
1931272|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931273|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931274|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931275|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931276|NCT00623233|Growth Substances|growth substances|mesh-ancestor
1931277|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931278|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931279|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931280|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
1931281|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931282|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
1931283|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931284|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931285|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931286|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
1931287|NCT00623363|Piclozotan|piclozotan|mesh-list
1931288|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1931289|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1931290|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
1931291|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931292|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931293|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931294|NCT00623428|Ribavirin|ribavirin|mesh-list
1931295|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1931296|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
1931297|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931298|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
1931299|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931300|NCT00623480|Factor VIII|factor viii|mesh-list
1931301|NCT00623480|Coagulants|coagulants|mesh-ancestor
1931302|NCT00623545|Exenatide|exenatide|mesh-list
1931303|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1931304|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931305|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1931306|NCT00623545|Incretins|incretins|mesh-ancestor
1931307|NCT00623545|Hormones|hormones|mesh-ancestor
1931308|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931309|NCT00623597|Ritonavir|ritonavir|mesh-list
1931310|NCT00623597|Saquinavir|saquinavir|mesh-list
1931311|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1931312|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1931313|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
1931314|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931315|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931316|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1931317|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1931318|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
1931319|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931320|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1931321|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1931322|NCT00623623|Enoxaparin|enoxaparin|mesh-list
1931323|NCT00623623|Tenecteplase|tenecteplase|mesh-list
1931324|NCT00623623|Clopidogrel|clopidogrel|mesh-list
1931325|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1931326|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1931327|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1931328|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1931329|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
1931330|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931331|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931332|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931333|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
1931334|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1931335|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1931336|NCT00623714|Fluticasone|fluticasone|mesh-list
1931337|NCT00623714|Xhance|xhance|mesh-list
1931338|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931339|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931340|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
1931341|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931342|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931343|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931344|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931345|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
1931346|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1931347|NCT00623727|Factor VIII|factor viii|mesh-list
1931348|NCT00623727|Coagulants|coagulants|mesh-ancestor
1931349|NCT00623766|Dexamethasone|dexamethasone|mesh-list
1931350|NCT00623766|Prednisone|prednisone|mesh-list
1931351|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
1931352|NCT00623766|Prednisolone|prednisolone|mesh-list
1931353|NCT00623766|Triamcinolone|triamcinolone|mesh-list
1931354|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
1931355|NCT00623766|Betamethasone|betamethasone|mesh-list
1931356|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
1931357|NCT00623766|Ipilimumab|ipilimumab|mesh-list
1931358|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931359|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
1931360|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
1931361|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931362|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931363|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1931364|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
1931365|NCT00623766|Hormones|hormones|mesh-ancestor
1931366|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931367|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1931368|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931369|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931370|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1931371|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931372|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1931373|NCT00623766|Protective Agents|protective agents|mesh-ancestor
1931374|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931375|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931376|NCT00623779|Aspirin|aspirin|mesh-list
1931377|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1931378|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931379|NCT00623779|Analgesics|analgesics|mesh-ancestor
1931380|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
1931381|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931382|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931383|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931384|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931385|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1931386|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1931387|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931388|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1931389|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1931390|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931391|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
1931392|NCT00623805|Bevacizumab|bevacizumab|mesh-list
1931393|NCT00623805|Capecitabine|capecitabine|mesh-list
1931394|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
1931395|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931396|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931397|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931398|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931399|NCT00623805|Growth Substances|growth substances|mesh-ancestor
1931400|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931401|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931402|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931403|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
1931404|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931405|NCT00623935|Fludarabine|fludarabine|mesh-list
1931406|NCT00623935|Busulfan|busulfan|mesh-list
1931407|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931408|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931409|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931410|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
1931411|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931412|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
1931413|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1931414|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1931415|NCT00624013|Sertraline|sertraline|mesh-list
1931416|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
1931417|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931418|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1931419|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1931420|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931421|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931422|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931423|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
1931424|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931425|NCT00624052|Amlodipine|amlodipine|mesh-list
1931426|NCT00624052|Telmisartan|telmisartan|mesh-list
1931427|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1931428|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1931429|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931430|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931431|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1931432|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931433|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
1931434|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1931435|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1931436|NCT00624065|Carvedilol|carvedilol|mesh-list
1931437|NCT00624065|Lisinopril|lisinopril|mesh-list
1931438|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1931439|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1931440|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
1931441|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931442|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931443|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931444|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1931445|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
1931446|NCT00624065|Protective Agents|protective agents|mesh-ancestor
1931447|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1931448|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931449|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1931450|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
1931451|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1931452|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1931453|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1931454|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
1931455|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931456|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1931457|NCT00624195|Etravirine|etravirine|mesh-list
1931458|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1931459|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1931460|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1931461|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931462|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931463|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
1931464|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931465|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
1931466|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931467|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
1931468|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931469|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931470|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931471|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931472|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
1931473|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1931474|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
1931475|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931476|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931477|NCT00624416|Prednisolone|prednisolone|mesh-list
1931478|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1931479|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
1931480|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1931481|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
1931482|NCT00624416|Cortisone|cortisone|mesh-list
1931483|NCT00624416|Isoproterenol|isoproterenol|mesh-list
1931484|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1931485|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
1931486|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931487|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
1931488|NCT00624416|Hormones|hormones|mesh-ancestor
1931489|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931490|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931491|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1931492|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931493|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
1931494|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
1931495|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931496|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1931497|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1931498|NCT00624416|Protective Agents|protective agents|mesh-ancestor
1931499|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1931500|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1931501|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
1931502|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931503|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931504|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931505|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931506|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931507|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1931508|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
1931509|NCT00624559|Celecoxib|celecoxib|mesh-list
1931510|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1931511|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931512|NCT00624559|Analgesics|analgesics|mesh-ancestor
1931513|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
1931514|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931515|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931516|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931517|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931518|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1931519|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1931520|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931521|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931522|NCT00624585|Dasatinib|dasatinib|mesh-list
1931523|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931524|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1931525|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931526|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931527|NCT00624780|Pregabalin|pregabalin|mesh-list
1931528|NCT00624780|Lorazepam|lorazepam|mesh-list
1931529|NCT00624780|Analgesics|analgesics|mesh-ancestor
1931530|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
1931531|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931532|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931533|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
1931534|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1931535|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931536|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931537|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1931538|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1931539|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1931540|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931541|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931542|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
1931543|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
1931544|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1931545|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1931546|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
1931547|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
1931548|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931549|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1931550|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
1931551|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931552|NCT00624832|Omalizumab|omalizumab|mesh-list
1931553|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1931554|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931555|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931556|NCT00624910|Bupivacaine|bupivacaine|mesh-list
1931557|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
1931558|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
1931559|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931560|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931561|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
1931562|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931563|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1931564|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
1931565|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1931566|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931567|NCT00624923|Analgesics|analgesics|mesh-ancestor
1931568|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
1931569|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931570|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931571|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931572|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931573|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1931574|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931575|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931576|NCT00625131|Bupropion|bupropion|mesh-list
1931577|NCT00625131|Nicotine|nicotine|mesh-list
1931578|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1931579|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
1931580|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931581|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931582|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1931583|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1931584|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
1931585|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931586|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931587|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1931588|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
1931589|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931590|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1931591|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1931592|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931593|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
1931594|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1931595|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1931596|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931597|NCT00625183|Selenium|selenium|mesh-list
1931598|NCT00625183|Capecitabine|capecitabine|mesh-list
1931599|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
1931600|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931601|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
1931602|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931603|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931604|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
1931605|NCT00625183|Protective Agents|protective agents|mesh-ancestor
1931606|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931607|NCT00625183|Trace Elements|trace elements|mesh-ancestor
1931608|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
1931609|NCT00625404|Tenofovir|tenofovir|mesh-list
1931610|NCT00625404|Emtricitabine|emtricitabine|mesh-list
1931611|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1931612|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
1931613|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931614|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1931615|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1931616|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931617|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931618|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1931619|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1931620|NCT00625729|Aldesleukin|aldesleukin|mesh-list
1931621|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
1931622|NCT00625729|Rituximab|rituximab|mesh-list
1931623|NCT00625729|Fludarabine|fludarabine|mesh-list
1931624|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
1931625|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931626|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
1931627|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931628|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931629|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1931630|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
1931631|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931632|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931633|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1931634|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931635|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931636|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
1931637|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1931638|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1931639|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
1931640|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931641|NCT00625820|Ascorbic Acid|ascorbic acid|mesh-list
1931642|NCT00625820|Vitamins|vitamins|mesh-ancestor
1931643|NCT00625820|Micronutrients|micronutrients|mesh-ancestor
1931644|NCT00625820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931645|NCT00625820|Antioxidants|antioxidants|mesh-ancestor
1931646|NCT00625820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931647|NCT00625820|Protective Agents|protective agents|mesh-ancestor
1931648|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
1931649|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931650|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
1931651|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931652|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931653|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931654|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931655|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1931656|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
1931657|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931658|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931659|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1931660|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
1931661|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
1931662|NCT00626028|Protective Agents|protective agents|mesh-ancestor
1931663|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
1931664|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
1931665|NCT00626197|Azathioprine|azathioprine|mesh-list
1931666|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
1931667|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931668|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
1931669|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931670|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931671|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1931672|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
1931673|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931674|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931675|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1931676|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1931677|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1931678|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
1931679|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1931680|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931681|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931682|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
1931683|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931684|NCT00626210|Modafinil|modafinil|mesh-list
1931685|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1931686|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931687|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1931688|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1931689|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1931690|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931691|NCT00626275|Naproxen|naproxen|mesh-list
1931692|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1931693|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931694|NCT00626275|Analgesics|analgesics|mesh-ancestor
1931695|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
1931696|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931697|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931698|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931699|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931700|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
1931701|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1931702|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931703|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931704|NCT00626340|Fluoxetine|fluoxetine|mesh-list
1931705|NCT00626340|Estrogens|estrogens|mesh-list
1931706|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1931707|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1931708|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931709|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931710|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931711|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
1931712|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931713|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1931714|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
1931715|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1931716|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1931717|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1931718|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931719|NCT00626340|Hormones|hormones|mesh-ancestor
1931720|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931721|NCT00626392|Aspirin|aspirin|mesh-list
1931722|NCT00626392|Niacin|niacin|mesh-list
1931723|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1931724|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1931725|NCT00626392|Analgesics|analgesics|mesh-ancestor
1931726|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
1931727|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931728|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931729|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931730|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931731|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1931732|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1931733|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931734|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1931735|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1931736|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931737|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
1931738|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1931739|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
1931740|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1931741|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
1931742|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
1931743|NCT00626392|Vitamins|vitamins|mesh-ancestor
1931744|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
1931745|NCT00626405|Paclitaxel|paclitaxel|mesh-list
1931746|NCT00626405|Bevacizumab|bevacizumab|mesh-list
1931747|NCT00626405|Carboplatin|carboplatin|mesh-list
1931748|NCT00626405|Temozolomide|temozolomide|mesh-list
1931749|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1931750|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1931751|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931752|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
1931753|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
1931754|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
1931755|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931756|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931757|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931758|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931759|NCT00626405|Growth Substances|growth substances|mesh-ancestor
1931760|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931761|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931762|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1931763|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
1931764|NCT00626431|Leuprolide|leuprolide|mesh-list
1931765|NCT00626431|Hormones|hormones|mesh-list
1931766|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1931767|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931768|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931769|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1931770|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
1931771|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1931772|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1931773|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931774|NCT00626522|Bromides|bromides|mesh-list
1931775|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
1931776|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931777|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
1931778|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931779|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931780|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931781|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931782|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1931783|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1931784|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1931785|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
1931786|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931787|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931788|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
1931789|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
1931790|NCT00626574|Hematinics|hematinics|mesh-ancestor
1931791|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
1931792|NCT00626626|Clofarabine|clofarabine|mesh-list
1931793|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
1931794|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1931795|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931796|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1931797|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
1931798|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931799|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1931800|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
1931801|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931802|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1931803|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1931804|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
1931805|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1931806|NCT00626639|Cisplatin|cisplatin|mesh-list
1931807|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931808|NCT00626743|Amlodipine|amlodipine|mesh-list
1931809|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1931810|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1931811|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931812|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931813|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1931814|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931815|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
1931816|NCT00626782|Ranibizumab|ranibizumab|mesh-list
1931817|NCT00626782|Mitomycins|mitomycins|mesh-list
1931818|NCT00626782|Mitomycin|mitomycin|mesh-list
1931819|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1931820|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1931821|NCT00626782|Growth Substances|growth substances|mesh-ancestor
1931822|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931823|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
1931824|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931825|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1931826|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
1931827|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931828|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1931829|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931830|NCT00626795|Mupirocin|mupirocin|mesh-list
1931831|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1931832|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931833|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1931834|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931835|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931836|NCT00626886|Bupivacaine|bupivacaine|mesh-list
1931837|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
1931838|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
1931839|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931840|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931841|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
1931842|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931843|NCT00626925|Topiramate|topiramate|mesh-list
1931844|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
1931845|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1931846|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931847|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
1931848|NCT00627016|Lansoprazole|lansoprazole|mesh-list
1931849|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1931850|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1931851|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1931852|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931853|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931854|NCT00627042|Ramucirumab|ramucirumab|mesh-list
1931855|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1931856|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931857|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
1931858|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931859|NCT00627367|Hydromorphone|hydromorphone|mesh-list
1931860|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1931861|NCT00627367|Narcotics|narcotics|mesh-ancestor
1931862|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931863|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931864|NCT00627367|Analgesics|analgesics|mesh-ancestor
1931865|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
1931866|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931867|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
1931868|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1931869|NCT00627393|Dexamethasone|dexamethasone|mesh-list
1931870|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931871|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
1931872|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
1931873|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931874|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931875|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1931876|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
1931877|NCT00627393|Hormones|hormones|mesh-ancestor
1931878|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931879|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1931880|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931881|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1931882|NCT00627406|Buserelin|buserelin|mesh-list
1931883|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1931884|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931885|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1931886|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
1931887|NCT00627445|Insulin|insulin|mesh-list
1931888|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1931889|NCT00627445|Metformin|metformin|mesh-list
1931890|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
1931891|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
1931892|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1931893|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
1931894|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1931895|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1931896|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931897|NCT00627458|Vaccines|vaccines|mesh-list
1931898|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
1931899|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931900|NCT00627679|Budesonide|budesonide|mesh-list
1931901|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1931902|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1931903|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
1931904|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931905|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931906|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1931907|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931908|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
1931909|NCT00627679|Hormones|hormones|mesh-ancestor
1931910|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1931911|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
1931912|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1931913|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
1931914|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931915|NCT00627705|Expectorants|expectorants|mesh-ancestor
1931916|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931917|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1931918|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
1931919|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931920|NCT00627705|Protective Agents|protective agents|mesh-ancestor
1931921|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931922|NCT00627705|Antidotes|antidotes|mesh-ancestor
1931923|NCT00627861|Metoprolol|metoprolol|mesh-list
1931924|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1931925|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1931926|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
1931927|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
1931928|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931929|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931930|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1931931|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1931932|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1931933|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
1931934|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931935|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931936|NCT00627926|Interferons|interferons|mesh-list
1931937|NCT00627926|Ribavirin|ribavirin|mesh-list
1931938|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
1931939|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
1931940|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1931941|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931942|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
1931943|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1931944|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
1931945|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931946|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
1931947|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931948|NCT00628108|Levocetirizine|levocetirizine|mesh-list
1931949|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1931950|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1931951|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
1931952|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
1931953|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931954|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931955|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931956|NCT00628134|Calfactant|calfactant|mesh-list
1931957|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
1931958|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
1931959|NCT00628251|Doxorubicin|doxorubicin|mesh-list
1931960|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1931961|NCT00628251|Olaparib|olaparib|mesh-list
1931962|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1931963|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1931964|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1931965|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1931966|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1931967|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931968|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1931969|NCT00628355|Lidocaine|lidocaine|mesh-list
1931970|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
1931971|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
1931972|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931973|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931974|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
1931975|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1931976|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1931977|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1931978|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1931979|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931980|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931981|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1931982|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1931983|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1931984|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1931985|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931986|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
1931987|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1931988|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931989|NCT00628498|Defibrotide|defibrotide|mesh-list
1931990|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1931991|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1931992|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1931993|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1931994|NCT00628589|Loxapine|loxapine|mesh-list
1931995|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1931996|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1931997|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1931998|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1931999|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932000|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1932001|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
1932002|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932003|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932004|NCT00628628|Rasburicase|rasburicase|mesh-list
1932005|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
1932006|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932007|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1932008|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
1932009|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1932010|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1932011|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
1932012|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1932013|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
1932014|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932015|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932016|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1932017|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1932018|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1932019|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
1932020|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932021|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932022|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
1932023|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1932024|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
1932025|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932026|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932027|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1932028|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
1932029|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1932030|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1932031|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1932032|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
1932033|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932034|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932035|NCT00629122|Clotrimazole|clotrimazole|mesh-list
1932036|NCT00629122|Miconazole|miconazole|mesh-list
1932037|NCT00629122|Nystatin|nystatin|mesh-list
1932038|NCT00629122|Tacrolimus|tacrolimus|mesh-list
1932039|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932040|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
1932041|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932042|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1932043|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932044|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932045|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1932046|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932047|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
1932048|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1932049|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1932050|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1932051|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
1932052|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932053|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1932054|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1932055|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932056|NCT00629122|Ionophores|ionophores|mesh-ancestor
1932057|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1932058|NCT00629499|Paclitaxel|paclitaxel|mesh-list
1932059|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
1932060|NCT00629499|Trastuzumab|trastuzumab|mesh-list
1932061|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1932062|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932063|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
1932064|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
1932065|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
1932066|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932067|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932068|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
1932069|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932070|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932071|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1932072|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
1932073|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1932074|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932075|NCT00629525|Everolimus|everolimus|mesh-list
1932076|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932077|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932078|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
1932079|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932080|NCT00629772|Infliximab|infliximab|mesh-list
1932081|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
1932082|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1932083|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932084|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
1932085|NCT00630032|Docetaxel|docetaxel|mesh-list
1932086|NCT00630032|Fluorouracil|fluorouracil|mesh-list
1932087|NCT00630032|Epirubicin|epirubicin|mesh-list
1932088|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932089|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
1932090|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932091|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932092|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1932093|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
1932094|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932095|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932096|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1932097|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
1932098|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
1932099|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
1932100|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
1932101|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932102|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932103|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1932104|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1932105|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932106|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
1932107|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
1932108|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
1932109|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1932110|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
1932111|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932112|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
1932113|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932114|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932115|NCT00630253|Cyclosporine|cyclosporine|mesh-list
1932116|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
1932117|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
1932118|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
1932119|NCT00630253|Fludarabine|fludarabine|mesh-list
1932120|NCT00630253|Cyclosporins|cyclosporins|mesh-list
1932121|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1932122|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932123|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
1932124|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932125|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932126|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1932127|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
1932128|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932129|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932130|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1932131|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932132|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
1932133|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932134|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
1932135|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1932136|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932137|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1932138|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
1932139|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932140|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932141|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
1932142|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
1932143|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932144|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1932145|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
1932146|NCT00630253|Hormones|hormones|mesh-ancestor
1932147|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932148|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1932149|NCT00630253|Protective Agents|protective agents|mesh-ancestor
1932150|NCT00630331|Vaccines|vaccines|mesh-list
1932151|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
1932152|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932153|NCT00630344|Everolimus|everolimus|mesh-list
1932154|NCT00630344|Bicalutamide|bicalutamide|mesh-list
1932155|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932156|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932157|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
1932158|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932159|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
1932160|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
1932161|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932162|NCT00630396|Minocycline|minocycline|mesh-list
1932163|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932164|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932165|NCT00630409|Gemcitabine|gemcitabine|mesh-list
1932166|NCT00630409|Doxorubicin|doxorubicin|mesh-list
1932167|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932168|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
1932169|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932170|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932171|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
1932172|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932173|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932174|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932175|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
1932176|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932177|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932178|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1932179|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1932180|NCT00630539|Tamoxifen|tamoxifen|mesh-list
1932181|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1932182|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
1932183|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932184|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932185|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1932186|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932187|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1932188|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1932189|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1932190|NCT00630734|Ritonavir|ritonavir|mesh-list
1932191|NCT00630734|Darunavir|darunavir|mesh-list
1932192|NCT00630734|Pravastatin|pravastatin|mesh-list
1932193|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1932194|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1932195|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
1932196|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932197|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932198|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1932199|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1932200|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
1932201|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932202|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1932203|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1932204|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1932205|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1932206|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
1932207|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1932208|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1932209|NCT00630786|Panitumumab|panitumumab|mesh-list
1932210|NCT00630786|Conatumumab|conatumumab|mesh-list
1932211|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932212|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932213|NCT00630812|Mannitol|mannitol|mesh-list
1932214|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1932215|NCT00630812|Diuretics|diuretics|mesh-ancestor
1932216|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
1932217|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932218|NCT00630825|Dulaglutide|dulaglutide|mesh-list
1932219|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1932220|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932221|NCT00630877|Aspirin|aspirin|mesh-list
1932222|NCT00630877|Niacin|niacin|mesh-list
1932223|NCT00630877|Niacinamide|niacinamide|mesh-list
1932224|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
1932225|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1932226|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1932227|NCT00630877|Analgesics|analgesics|mesh-ancestor
1932228|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
1932229|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932230|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932231|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932232|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932233|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1932234|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1932235|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932236|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1932237|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1932238|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932239|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
1932240|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1932241|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
1932242|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1932243|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
1932244|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
1932245|NCT00630877|Vitamins|vitamins|mesh-ancestor
1932246|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
1932247|NCT00630955|Memantine|memantine|mesh-list
1932248|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1932249|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1932250|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
1932251|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932252|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932253|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932254|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1932255|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1932256|NCT00630994|Decitabine|decitabine|mesh-list
1932257|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932258|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
1932259|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932260|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932261|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932262|NCT00631007|Pioglitazone|pioglitazone|mesh-list
1932263|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1932264|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932265|NCT00631163|Deferasirox|deferasirox|mesh-list
1932266|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1932267|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
1932268|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
1932269|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932270|NCT00631189|Atorvastatin|atorvastatin|mesh-list
1932271|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1932272|NCT00631189|Pravastatin|pravastatin|mesh-list
1932273|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1932274|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1932275|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
1932276|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932277|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1932278|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1932279|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932280|NCT00631319|Hydromorphone|hydromorphone|mesh-list
1932281|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1932282|NCT00631319|Narcotics|narcotics|mesh-ancestor
1932283|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932284|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932285|NCT00631319|Analgesics|analgesics|mesh-ancestor
1932286|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
1932287|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932288|NCT00631358|Dexamethasone|dexamethasone|mesh-list
1932289|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932290|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
1932291|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
1932292|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932293|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932294|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1932295|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
1932296|NCT00631358|Hormones|hormones|mesh-ancestor
1932297|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932298|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1932299|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932300|NCT00631371|Interferons|interferons|mesh-list
1932301|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
1932302|NCT00631371|Sirolimus|sirolimus|mesh-list
1932303|NCT00631371|Bevacizumab|bevacizumab|mesh-list
1932304|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932305|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932306|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1932307|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1932308|NCT00631371|Growth Substances|growth substances|mesh-ancestor
1932309|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932310|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932311|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
1932312|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932313|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
1932314|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932315|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932316|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
1932317|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932318|NCT00631410|Sunitinib|sunitinib|mesh-list
1932319|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932320|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1932321|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1932322|NCT00631410|Growth Substances|growth substances|mesh-ancestor
1932323|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932324|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932325|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932326|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932327|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932328|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
1932329|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1932330|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1932331|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
1932332|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932333|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1932334|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1932335|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932336|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932337|NCT00631475|Bosentan|bosentan|mesh-list
1932338|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1932339|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1932340|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932341|NCT00631488|Metformin|metformin|mesh-list
1932342|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1932343|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1932344|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932345|NCT00631488|Incretins|incretins|mesh-ancestor
1932346|NCT00631488|Hormones|hormones|mesh-ancestor
1932347|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932348|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1932349|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
1932350|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932351|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932352|NCT00631566|Mupirocin|mupirocin|mesh-list
1932353|NCT00631566|Triclosan|triclosan|mesh-list
1932354|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
1932355|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932356|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932357|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1932358|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932359|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932360|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1932361|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1932362|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1932363|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
1932364|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1932365|NCT00631657|Mirtazapine|mirtazapine|mesh-list
1932366|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
1932367|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932368|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1932369|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
1932370|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
1932371|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932372|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932373|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932374|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1932375|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1932376|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932377|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1932378|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1932379|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1932380|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
1932381|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1932382|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1932383|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
1932384|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1932385|NCT00631696|Pregabalin|pregabalin|mesh-list
1932386|NCT00631696|Analgesics|analgesics|mesh-ancestor
1932387|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
1932388|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932389|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932390|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
1932391|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1932392|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1932393|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932394|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1932395|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1932396|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1932397|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932398|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932399|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1932400|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
1932401|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932402|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1932403|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1932404|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932405|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932406|NCT00631917|Ramipril|ramipril|mesh-list
1932407|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1932408|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
1932409|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932410|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932411|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1932412|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1932413|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
1932414|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1932415|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1932416|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932417|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932418|NCT00631969|Urological Agents|urological agents|mesh-ancestor
1932419|NCT00632099|Progesterone|progesterone|mesh-list
1932420|NCT00632099|Progestins|progestins|mesh-ancestor
1932421|NCT00632099|Hormones|hormones|mesh-ancestor
1932422|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932423|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932424|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
1932425|NCT00632125|Hematinics|hematinics|mesh-ancestor
1932426|NCT00632203|Temozolomide|temozolomide|mesh-list
1932427|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1932428|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
1932429|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932430|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932431|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1932432|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1932433|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1932434|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932435|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932436|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932437|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1932438|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1932439|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
1932440|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932441|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932442|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1932443|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1932444|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
1932445|NCT00632359|Lenalidomide|lenalidomide|mesh-list
1932446|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
1932447|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932448|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1932449|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1932450|NCT00632359|Growth Substances|growth substances|mesh-ancestor
1932451|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932452|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932453|NCT00632411|Nicotine|nicotine|mesh-list
1932454|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1932455|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
1932456|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932457|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932458|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1932459|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1932460|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
1932461|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932462|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932463|NCT00632489|Capecitabine|capecitabine|mesh-list
1932464|NCT00632489|Lapatinib|lapatinib|mesh-list
1932465|NCT00632489|Panobinostat|panobinostat|mesh-list
1932466|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932467|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
1932468|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932469|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932470|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932471|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932472|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1932473|NCT00632541|Bevacizumab|bevacizumab|mesh-list
1932474|NCT00632541|Sorafenib|sorafenib|mesh-list
1932475|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932476|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932477|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1932478|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1932479|NCT00632541|Growth Substances|growth substances|mesh-ancestor
1932480|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932481|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932482|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932483|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932484|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932485|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
1932486|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932487|NCT00632632|Cycloserine|cycloserine|mesh-list
1932488|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1932489|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932490|NCT00632632|Renal Agents|renal agents|mesh-ancestor
1932491|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1932492|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
1932493|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932494|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
1932495|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932496|NCT00632736|Ropinirole|ropinirole|mesh-list
1932497|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1932498|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1932499|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
1932500|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
1932501|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932502|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932503|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932504|NCT00632749|Cytarabine|cytarabine|mesh-list
1932505|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932506|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
1932507|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932508|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932509|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
1932510|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932511|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932512|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
1932513|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932514|NCT00632814|Factor VIII|factor viii|mesh-list
1932515|NCT00632814|Coagulants|coagulants|mesh-ancestor
1932516|NCT00632827|Leucovorin|leucovorin|mesh-list
1932517|NCT00632827|Gemcitabine|gemcitabine|mesh-list
1932518|NCT00632827|Cytarabine|cytarabine|mesh-list
1932519|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
1932520|NCT00632827|Carmustine|carmustine|mesh-list
1932521|NCT00632827|Doxorubicin|doxorubicin|mesh-list
1932522|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1932523|NCT00632827|Methotrexate|methotrexate|mesh-list
1932524|NCT00632827|Etoposide|etoposide|mesh-list
1932525|NCT00632827|Vincristine|vincristine|mesh-list
1932526|NCT00632827|Vinorelbine|vinorelbine|mesh-list
1932527|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
1932528|NCT00632827|Lenograstim|lenograstim|mesh-list
1932529|NCT00632827|Sargramostim|sargramostim|mesh-list
1932530|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932531|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
1932532|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932533|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932534|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1932535|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
1932536|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932537|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932538|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1932539|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932540|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
1932541|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
1932542|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932543|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932544|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932545|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1932546|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1932547|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1932548|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
1932549|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1932550|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
1932551|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1932552|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1932553|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1932554|NCT00632827|Antidotes|antidotes|mesh-ancestor
1932555|NCT00632827|Protective Agents|protective agents|mesh-ancestor
1932556|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
1932557|NCT00632827|Vitamins|vitamins|mesh-ancestor
1932558|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
1932559|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
1932560|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
1932561|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
1932562|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1932563|NCT00632931|Vorinostat|vorinostat|mesh-list
1932564|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932565|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1932566|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932567|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932568|NCT00632970|Ritonavir|ritonavir|mesh-list
1932569|NCT00632970|Lopinavir|lopinavir|mesh-list
1932570|NCT00632970|Tenofovir|tenofovir|mesh-list
1932571|NCT00632970|Emtricitabine|emtricitabine|mesh-list
1932572|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
1932573|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1932574|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1932575|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1932576|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
1932577|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932578|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932579|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1932580|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1932581|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
1932582|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932583|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1932584|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1932585|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1932586|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1932587|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1932588|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1932589|NCT00633074|Vaccines|vaccines|mesh-list
1932590|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
1932591|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932592|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1932593|NCT00633126|Cephalosporins|cephalosporins|mesh-list
1932594|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932595|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932596|NCT00633152|Linezolid|linezolid|mesh-list
1932597|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1932598|NCT00633152|Cephalosporins|cephalosporins|mesh-list
1932599|NCT00633152|Aztreonam|aztreonam|mesh-list
1932600|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932601|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932602|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1932603|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932604|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932605|NCT00633217|Fluticasone|fluticasone|mesh-list
1932606|NCT00633217|Xhance|xhance|mesh-list
1932607|NCT00633217|Norflurane|norflurane|mesh-list
1932608|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1932609|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1932610|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932611|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1932612|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
1932613|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932614|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932615|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1932616|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
1932617|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
1932618|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1932619|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1932620|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1932621|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1932622|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
1932623|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932624|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932625|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
1932626|NCT00633217|Hormones|hormones|mesh-ancestor
1932627|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932628|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
1932629|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
1932630|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932631|NCT00633256|Isoniazid|isoniazid|mesh-list
1932632|NCT00633256|Cycloserine|cycloserine|mesh-list
1932633|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
1932634|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932635|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932636|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1932637|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1932638|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
1932639|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932640|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1932641|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1932642|NCT00633256|Renal Agents|renal agents|mesh-ancestor
1932643|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1932644|NCT00633360|Drospirenone|drospirenone|mesh-list
1932645|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1932646|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1932647|NCT00633360|Estradiol|estradiol|mesh-list
1932648|NCT00633360|Estrogens|estrogens|mesh-ancestor
1932649|NCT00633360|Hormones|hormones|mesh-ancestor
1932650|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932651|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932652|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1932653|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
1932654|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1932655|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1932656|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1932657|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1932658|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1932659|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
1932660|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1932661|NCT00633360|Diuretics|diuretics|mesh-ancestor
1932662|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
1932663|NCT00633399|Ziprasidone|ziprasidone|mesh-list
1932664|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1932665|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
1932666|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932667|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932668|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932669|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1932670|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1932671|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932672|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932673|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1932674|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
1932675|NCT00633464|Cetuximab|cetuximab|mesh-list
1932676|NCT00633464|Epothilones|epothilones|mesh-list
1932677|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932678|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932679|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
1932680|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
1932681|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
1932682|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932683|NCT00633594|Rituximab|rituximab|mesh-list
1932684|NCT00633594|Lenalidomide|lenalidomide|mesh-list
1932685|NCT00633594|Bortezomib|bortezomib|mesh-list
1932686|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932687|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932688|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
1932689|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932690|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932691|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1932692|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1932693|NCT00633594|Growth Substances|growth substances|mesh-ancestor
1932694|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932695|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1932696|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932697|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932698|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932699|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932700|NCT00633880|Droxidopa|droxidopa|mesh-list
1932701|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1932702|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1932703|NCT00633893|Apixaban|apixaban|mesh-list
1932704|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1932705|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
1932706|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1932707|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
1932708|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932709|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932710|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
1932711|NCT00633919|Prednisone|prednisone|mesh-list
1932712|NCT00633919|Budesonide|budesonide|mesh-list
1932713|NCT00633919|Albuterol|albuterol|mesh-list
1932714|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
1932715|NCT00633919|Desloratadine|desloratadine|mesh-list
1932716|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932717|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
1932718|NCT00633919|Hormones|hormones|mesh-ancestor
1932719|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932720|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932721|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1932722|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932723|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1932724|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
1932725|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932726|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1932727|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
1932728|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1932729|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1932730|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1932731|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
1932732|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932733|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932734|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
1932735|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1932736|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1932737|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
1932738|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1932739|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1932740|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
1932741|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
1932742|NCT00633932|Esomeprazole|esomeprazole|mesh-list
1932743|NCT00633932|Omeprazole|omeprazole|mesh-list
1932744|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1932745|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1932746|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1932747|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932748|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932749|NCT00633945|Lenalidomide|lenalidomide|mesh-list
1932750|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
1932751|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932752|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1932753|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1932754|NCT00633945|Growth Substances|growth substances|mesh-ancestor
1932755|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932756|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932757|NCT00633984|Cycloserine|cycloserine|mesh-list
1932758|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1932759|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932760|NCT00633984|Renal Agents|renal agents|mesh-ancestor
1932761|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1932762|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
1932763|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932764|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
1932765|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932766|NCT00634036|Pioglitazone|pioglitazone|mesh-list
1932767|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1932768|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932769|NCT00634049|Isavuconazole|isavuconazole|mesh-list
1932770|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
1932771|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932772|NCT00634088|Capecitabine|capecitabine|mesh-list
1932773|NCT00634088|Lapatinib|lapatinib|mesh-list
1932774|NCT00634088|Epothilones|epothilones|mesh-list
1932775|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932776|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
1932777|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932778|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932779|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932780|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932781|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
1932782|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
1932783|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
1932784|NCT00634114|Esomeprazole|esomeprazole|mesh-list
1932785|NCT00634114|Omeprazole|omeprazole|mesh-list
1932786|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1932787|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1932788|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1932789|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932790|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932791|NCT00634166|Vancomycin|vancomycin|mesh-list
1932792|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1932793|NCT00634166|Cefazolin|cefazolin|mesh-list
1932794|NCT00634166|Tazobactam|tazobactam|mesh-list
1932795|NCT00634166|Piperacillin|piperacillin|mesh-list
1932796|NCT00634166|Amphotericin B|amphotericin b|mesh-list
1932797|NCT00634166|Nystatin|nystatin|mesh-list
1932798|NCT00634166|Bacitracin|bacitracin|mesh-list
1932799|NCT00634166|Sulfadiazine|sulfadiazine|mesh-list
1932800|NCT00634166|Mafenide|mafenide|mesh-list
1932801|NCT00634166|Fluconazole|fluconazole|mesh-list
1932802|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
1932803|NCT00634166|Clotrimazole|clotrimazole|mesh-list
1932804|NCT00634166|Miconazole|miconazole|mesh-list
1932805|NCT00634166|Silver Sulfadiazine|silver sulfadiazine|mesh-list
1932806|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
1932807|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1932808|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1932809|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932810|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932811|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1932812|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
1932813|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932814|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932815|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1932816|NCT00634166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1932817|NCT00634166|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1932818|NCT00634166|Amebicides|amebicides|mesh-ancestor
1932819|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1932820|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1932821|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1932822|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1932823|NCT00634166|Ionophores|ionophores|mesh-ancestor
1932824|NCT00634166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1932825|NCT00634166|Coccidiostats|coccidiostats|mesh-ancestor
1932826|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1932827|NCT00634179|Prednisone|prednisone|mesh-list
1932828|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
1932829|NCT00634179|Rituximab|rituximab|mesh-list
1932830|NCT00634179|Doxorubicin|doxorubicin|mesh-list
1932831|NCT00634179|Vincristine|vincristine|mesh-list
1932832|NCT00634179|Bortezomib|bortezomib|mesh-list
1932833|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932834|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
1932835|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932836|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932837|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1932838|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
1932839|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932840|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932841|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1932842|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1932843|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932844|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1932845|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1932846|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932847|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932848|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
1932849|NCT00634179|Hormones|hormones|mesh-ancestor
1932850|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932851|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1932852|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1932853|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
1932854|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
1932855|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
1932856|NCT00634244|Cytarabine|cytarabine|mesh-list
1932857|NCT00634244|Sirolimus|sirolimus|mesh-list
1932858|NCT00634244|Carboplatin|carboplatin|mesh-list
1932859|NCT00634244|Etoposide|etoposide|mesh-list
1932860|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
1932861|NCT00634244|Topotecan|topotecan|mesh-list
1932862|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
1932863|NCT00634244|Alvocidib|alvocidib|mesh-list
1932864|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932865|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1932866|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1932867|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1932868|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932869|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932870|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932871|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
1932872|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
1932873|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932874|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932875|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
1932876|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932877|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932878|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932879|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
1932880|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1932881|NCT00634244|Analgesics|analgesics|mesh-ancestor
1932882|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
1932883|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932884|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
1932885|NCT00634244|Growth Substances|growth substances|mesh-ancestor
1932886|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932887|NCT00634270|Sirolimus|sirolimus|mesh-list
1932888|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1932889|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1932890|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1932891|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932892|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
1932893|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932894|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
1932895|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932896|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1932897|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1932898|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1932899|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1932900|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932901|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932902|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932903|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1932904|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
1932905|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932906|NCT00634504|Leucovorin|leucovorin|mesh-list
1932907|NCT00634504|Methotrexate|methotrexate|mesh-list
1932908|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
1932909|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1932910|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
1932911|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1932912|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932913|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932914|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
1932915|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932916|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932917|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
1932918|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932919|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1932920|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932921|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
1932922|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1932923|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1932924|NCT00634504|Antidotes|antidotes|mesh-ancestor
1932925|NCT00634504|Protective Agents|protective agents|mesh-ancestor
1932926|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
1932927|NCT00634504|Vitamins|vitamins|mesh-ancestor
1932928|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
1932929|NCT00634543|Acetaminophen|acetaminophen|mesh-list
1932930|NCT00634543|Gabapentin|gabapentin|mesh-list
1932931|NCT00634543|Tramadol|tramadol|mesh-list
1932932|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1932933|NCT00634543|Analgesics|analgesics|mesh-ancestor
1932934|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
1932935|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932936|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932937|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
1932938|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
1932939|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1932940|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1932941|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932942|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1932943|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1932944|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1932945|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1932946|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932947|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
1932948|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1932949|NCT00634543|Narcotics|narcotics|mesh-ancestor
1932950|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
1932951|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1932952|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1932953|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
1932954|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932955|NCT00634647|Prednisone|prednisone|mesh-list
1932956|NCT00634647|Satraplatin|satraplatin|mesh-list
1932957|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1932958|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
1932959|NCT00634647|Hormones|hormones|mesh-ancestor
1932960|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1932961|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932962|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1932963|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932964|NCT00634751|Capecitabine|capecitabine|mesh-list
1932965|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
1932966|NCT00634751|Sorafenib|sorafenib|mesh-list
1932967|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1932968|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
1932969|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932970|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1932971|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1932972|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932973|NCT00634803|Buprenorphine|buprenorphine|mesh-list
1932974|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1932975|NCT00634803|Narcotics|narcotics|mesh-ancestor
1932976|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1932977|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932978|NCT00634803|Analgesics|analgesics|mesh-ancestor
1932979|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
1932980|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1932981|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1932982|NCT00634842|Insulin|insulin|mesh-list
1932983|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1932984|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
1932985|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1932986|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1932987|NCT00634907|Warfarin|warfarin|mesh-list
1932988|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
1932989|NCT00634920|Cyclosporine|cyclosporine|mesh-list
1932990|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
1932991|NCT00634920|Prednisolone|prednisolone|mesh-list
1932992|NCT00634920|Everolimus|everolimus|mesh-list
1932993|NCT00634920|Cyclosporins|cyclosporins|mesh-list
1932994|NCT00634920|Basiliximab|basiliximab|mesh-list
1932995|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1932996|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1932997|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1932998|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
1932999|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933000|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
1933001|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933002|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
1933003|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933004|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1933005|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933006|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1933007|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1933008|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
1933009|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1933010|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933011|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
1933012|NCT00634920|Hormones|hormones|mesh-ancestor
1933013|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933014|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933015|NCT00634933|Prednisone|prednisone|mesh-list
1933016|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
1933017|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1933018|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1933019|NCT00634933|Prednisolone|prednisolone|mesh-list
1933020|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
1933021|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1933022|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
1933023|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933024|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
1933025|NCT00634933|Hormones|hormones|mesh-ancestor
1933026|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933027|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933028|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933029|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933030|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
1933031|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
1933032|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933033|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933034|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1933035|NCT00634933|Protective Agents|protective agents|mesh-ancestor
1933036|NCT00635024|Melphalan|melphalan|mesh-list
1933037|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1933038|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933039|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
1933040|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933041|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933042|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1933043|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933044|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
1933045|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933046|NCT00635050|Paclitaxel|paclitaxel|mesh-list
1933047|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
1933048|NCT00635050|Bevacizumab|bevacizumab|mesh-list
1933049|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1933050|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933051|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
1933052|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
1933053|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
1933054|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933055|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933056|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
1933057|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933058|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933059|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933060|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
1933061|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1933062|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1933063|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1933064|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1933065|NCT00635050|Growth Substances|growth substances|mesh-ancestor
1933066|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
1933067|NCT00635089|Reslizumab|reslizumab|mesh-list
1933068|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1933069|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
1933070|NCT00635102|Cycloserine|cycloserine|mesh-list
1933071|NCT00635102|Glycine|glycine|mesh-list
1933072|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1933073|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933074|NCT00635102|Renal Agents|renal agents|mesh-ancestor
1933075|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1933076|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
1933077|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1933078|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
1933079|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933080|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
1933081|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933082|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933083|NCT00635154|Dexamethasone|dexamethasone|mesh-list
1933084|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
1933085|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1933086|NCT00635154|BB 1101|bb 1101|mesh-list
1933087|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933088|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
1933089|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
1933090|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933091|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933092|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933093|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
1933094|NCT00635154|Hormones|hormones|mesh-ancestor
1933095|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933096|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933097|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933098|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933099|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
1933100|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933101|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933102|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1933103|NCT00635219|Vortioxetine|vortioxetine|mesh-list
1933104|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1933105|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1933106|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933107|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933108|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933109|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933110|NCT00635219|Analgesics|analgesics|mesh-ancestor
1933111|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
1933112|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933113|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
1933114|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933115|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
1933116|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1933117|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933118|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933119|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1933120|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
1933121|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1933122|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1933123|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1933124|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1933125|NCT00635232|Irbesartan|irbesartan|mesh-list
1933126|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1933127|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1933128|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1933129|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933130|NCT00635349|Acetaminophen|acetaminophen|mesh-list
1933131|NCT00635349|Meloxicam|meloxicam|mesh-list
1933132|NCT00635349|Aceclofenac|aceclofenac|mesh-list
1933133|NCT00635349|Tramadol|tramadol|mesh-list
1933134|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933135|NCT00635349|Analgesics|analgesics|mesh-ancestor
1933136|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
1933137|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933138|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933139|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
1933140|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1933141|NCT00635349|Narcotics|narcotics|mesh-ancestor
1933142|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933143|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1933144|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933145|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933146|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1933147|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1933148|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933149|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933150|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
1933151|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1933152|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
1933153|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1933154|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933155|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1933156|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1933157|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1933158|NCT00635492|Insulin|insulin|mesh-list
1933159|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1933160|NCT00635492|Exenatide|exenatide|mesh-list
1933161|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933162|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933163|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1933164|NCT00635492|Incretins|incretins|mesh-ancestor
1933165|NCT00635492|Hormones|hormones|mesh-ancestor
1933166|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933167|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
1933168|NCT00635570|NuvaRing|nuvaring|mesh-list
1933169|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1933170|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1933171|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
1933172|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1933173|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933174|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1933175|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1933176|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1933177|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1933178|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933179|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1933180|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1933181|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933182|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933183|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933184|NCT00635609|Doxycycline|doxycycline|mesh-list
1933185|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1933186|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933187|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
1933188|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1933189|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1933190|NCT00635648|Caspofungin|caspofungin|mesh-list
1933191|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
1933192|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933193|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933194|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933195|NCT00635700|Ziprasidone|ziprasidone|mesh-list
1933196|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1933197|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
1933198|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933199|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933200|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933201|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1933202|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933203|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933204|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933205|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1933206|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
1933207|NCT00635817|Leuprolide|leuprolide|mesh-list
1933208|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1933209|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
1933210|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1933211|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933212|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933213|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933214|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
1933215|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
1933216|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1933217|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
1933218|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933219|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933220|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1933221|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
1933222|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1933223|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1933224|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1933225|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
1933226|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933227|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933228|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933229|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
1933230|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1933231|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
1933232|NCT00636155|Rituximab|rituximab|mesh-list
1933233|NCT00636155|Fludarabine|fludarabine|mesh-list
1933234|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933235|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
1933236|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933237|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933238|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933239|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
1933240|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933241|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933242|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1933243|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1933244|NCT00636168|Ipilimumab|ipilimumab|mesh-list
1933245|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1933246|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933247|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1933248|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933249|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1933250|NCT00636207|Montelukast|montelukast|mesh-list
1933251|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1933252|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
1933253|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1933254|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
1933255|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933256|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933257|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1933258|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1933259|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933260|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1933261|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
1933262|NCT00636441|Docetaxel|docetaxel|mesh-list
1933263|NCT00636441|Doxorubicin|doxorubicin|mesh-list
1933264|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1933265|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933266|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
1933267|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933268|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933269|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933270|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
1933271|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933272|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933273|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1933274|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
1933275|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
1933276|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
1933277|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1933278|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1933279|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1933280|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933281|NCT00636610|Bevacizumab|bevacizumab|mesh-list
1933282|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1933283|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933284|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1933285|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1933286|NCT00636610|Growth Substances|growth substances|mesh-ancestor
1933287|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933288|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
1933289|NCT00636636|Gabapentin|gabapentin|mesh-list
1933290|NCT00636636|Analgesics|analgesics|mesh-ancestor
1933291|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
1933292|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933293|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933294|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
1933295|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1933296|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933297|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933298|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933299|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1933300|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1933301|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933302|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933303|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
1933304|NCT00636649|Citalopram|citalopram|mesh-list
1933305|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1933306|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1933307|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933308|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933309|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933310|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
1933311|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933312|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1933313|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
1933314|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933315|NCT00636792|Rituximab|rituximab|mesh-list
1933316|NCT00636792|Bortezomib|bortezomib|mesh-list
1933317|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1933318|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1933319|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933320|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
1933321|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933322|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933323|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933324|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
1933325|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933326|NCT00636805|Dexamethasone|dexamethasone|mesh-list
1933327|NCT00636805|Palonosetron|palonosetron|mesh-list
1933328|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933329|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
1933330|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
1933331|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933332|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933333|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933334|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
1933335|NCT00636805|Hormones|hormones|mesh-ancestor
1933336|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933337|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933338|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933339|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1933340|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1933341|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
1933342|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933343|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933344|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1933345|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1933346|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1933347|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933348|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933349|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
1933350|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933351|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933352|NCT00637000|Buprenorphine|buprenorphine|mesh-list
1933353|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1933354|NCT00637000|Naloxone|naloxone|mesh-list
1933355|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1933356|NCT00637000|Narcotics|narcotics|mesh-ancestor
1933357|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933358|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933359|NCT00637000|Analgesics|analgesics|mesh-ancestor
1933360|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
1933361|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933362|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1933363|NCT00637195|Vaccines|vaccines|mesh-list
1933364|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
1933365|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933366|NCT00637247|Gemcitabine|gemcitabine|mesh-list
1933367|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1933368|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
1933369|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933370|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933371|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
1933372|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933373|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933374|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933375|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
1933376|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933377|NCT00637273|Pioglitazone|pioglitazone|mesh-list
1933378|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1933379|NCT00637273|Exenatide|exenatide|mesh-list
1933380|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933381|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933382|NCT00637273|Incretins|incretins|mesh-ancestor
1933383|NCT00637273|Hormones|hormones|mesh-ancestor
1933384|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933385|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1933386|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
1933387|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933388|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933389|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1933390|NCT00637377|Ranibizumab|ranibizumab|mesh-list
1933391|NCT00637377|Aflibercept|aflibercept|mesh-list
1933392|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1933393|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1933394|NCT00637377|Growth Substances|growth substances|mesh-ancestor
1933395|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933396|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
1933397|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933398|NCT00637494|Mifepristone|mifepristone|mesh-list
1933399|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1933400|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
1933401|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1933402|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933403|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1933404|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1933405|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1933406|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
1933407|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1933408|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1933409|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
1933410|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933411|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
1933412|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1933413|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1933414|NCT00637572|Megestrol|megestrol|mesh-list
1933415|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
1933416|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1933417|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1933418|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1933419|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
1933420|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1933421|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933422|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1933423|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1933424|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933425|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933426|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
1933427|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1933428|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
1933429|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933430|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1933431|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933432|NCT00637780|Analgesics|analgesics|mesh-ancestor
1933433|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
1933434|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933435|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933436|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933437|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933438|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933439|NCT00637923|Ribavirin|ribavirin|mesh-list
1933440|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1933441|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
1933442|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
1933443|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933444|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
1933445|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933446|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1933447|NCT00638027|Memantine|memantine|mesh-list
1933448|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1933449|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1933450|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
1933451|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933452|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933453|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933454|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1933455|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1933456|NCT00638157|Gentamicins|gentamicins|mesh-list
1933457|NCT00638157|Daptomycin|daptomycin|mesh-list
1933458|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1933459|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933460|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1933461|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933462|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933463|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
1933464|NCT00638443|Promethazine|promethazine|mesh-list
1933465|NCT00638443|Pregabalin|pregabalin|mesh-list
1933466|NCT00638443|Analgesics|analgesics|mesh-ancestor
1933467|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
1933468|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933469|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933470|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
1933471|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1933472|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933473|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933474|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1933475|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1933476|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933477|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933478|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933479|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1933480|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1933481|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
1933482|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
1933483|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
1933484|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
1933485|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933486|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1933487|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
1933488|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
1933489|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933490|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1933491|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
1933492|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
1933493|NCT00638456|Budesonide|budesonide|mesh-list
1933494|NCT00638456|Lansoprazole|lansoprazole|mesh-list
1933495|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
1933496|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933497|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1933498|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
1933499|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933500|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933501|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1933502|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
1933503|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
1933504|NCT00638456|Hormones|hormones|mesh-ancestor
1933505|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933506|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1933507|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933508|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1933509|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933510|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933511|NCT00638508|Ketorolac|ketorolac|mesh-list
1933512|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1933513|NCT00638508|Ropivacaine|ropivacaine|mesh-list
1933514|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
1933515|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
1933516|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933517|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933518|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
1933519|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933520|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1933521|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933522|NCT00638508|Analgesics|analgesics|mesh-ancestor
1933523|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933524|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933525|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1933526|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933527|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933528|NCT00638651|Imiquimod|imiquimod|mesh-list
1933529|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1933530|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
1933531|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933532|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933533|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
1933534|NCT00638690|Prednisone|prednisone|mesh-list
1933535|NCT00638690|Prednisolone|prednisolone|mesh-list
1933536|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
1933537|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933538|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
1933539|NCT00638690|Hormones|hormones|mesh-ancestor
1933540|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933541|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933542|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933543|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933544|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1933545|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933546|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933547|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
1933548|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1933549|NCT00638820|Busulfan|busulfan|mesh-list
1933550|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
1933551|NCT00638820|Clofarabine|clofarabine|mesh-list
1933552|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
1933553|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933554|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933555|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
1933556|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933557|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933558|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933559|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1933560|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1933561|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1933562|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
1933563|NCT00638937|Saracatinib|saracatinib|mesh-list
1933564|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933565|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933566|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933567|NCT00638963|Temozolomide|temozolomide|mesh-list
1933568|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1933569|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
1933570|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933571|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933572|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1933573|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
1933574|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933575|NCT00639002|Dexamethasone|dexamethasone|mesh-list
1933576|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933577|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
1933578|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
1933579|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933580|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933581|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933582|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
1933583|NCT00639002|Hormones|hormones|mesh-ancestor
1933584|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933585|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933586|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933587|NCT00639158|Choline|choline|mesh-list
1933588|NCT00639158|Atorvastatin|atorvastatin|mesh-list
1933589|NCT00639158|Ezetimibe|ezetimibe|mesh-list
1933590|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
1933591|NCT00639158|Fenofibrate|fenofibrate|mesh-list
1933592|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1933593|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1933594|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
1933595|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933596|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1933597|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1933598|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933599|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
1933600|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933601|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
1933602|NCT00639223|Pravastatin|pravastatin|mesh-list
1933603|NCT00639223|Red yeast rice|red yeast rice|mesh-list
1933604|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1933605|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1933606|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
1933607|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933608|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1933609|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1933610|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933611|NCT00639418|Vaccines|vaccines|mesh-list
1933612|NCT00639418|Immunologic Factors|immunologic factors|mesh-ancestor
1933613|NCT00639418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933614|NCT00639457|Pioglitazone|pioglitazone|mesh-list
1933615|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933616|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933617|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1933618|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
1933619|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933620|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1933621|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
1933622|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933623|NCT00639717|Etanercept|etanercept|mesh-list
1933624|NCT00639717|Methoxsalen|methoxsalen|mesh-list
1933625|NCT00639717|Tacrolimus|tacrolimus|mesh-list
1933626|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933627|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
1933628|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933629|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1933630|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933631|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933632|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1933633|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933634|NCT00639717|Analgesics|analgesics|mesh-ancestor
1933635|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
1933636|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933637|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933638|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933639|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933640|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1933641|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
1933642|NCT00639769|Cisplatin|cisplatin|mesh-list
1933643|NCT00639769|Irinotecan|irinotecan|mesh-list
1933644|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933645|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1933646|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1933647|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933648|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933649|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1933650|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
1933651|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933652|NCT00640042|Morphine|morphine|mesh-list
1933653|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1933654|NCT00640042|Narcotics|narcotics|mesh-ancestor
1933655|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933656|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933657|NCT00640042|Analgesics|analgesics|mesh-ancestor
1933658|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
1933659|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933660|NCT00640146|Bromides|bromides|mesh-list
1933661|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
1933662|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
1933663|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1933664|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933665|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
1933666|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933667|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
1933668|NCT00640224|Drospirenone|drospirenone|mesh-list
1933669|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1933670|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1933671|NCT00640224|Estradiol|estradiol|mesh-list
1933672|NCT00640224|Estrogens|estrogens|mesh-ancestor
1933673|NCT00640224|Hormones|hormones|mesh-ancestor
1933674|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933675|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933676|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1933677|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
1933678|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1933679|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1933680|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933681|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1933682|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1933683|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1933684|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
1933685|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1933686|NCT00640224|Diuretics|diuretics|mesh-ancestor
1933687|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
1933688|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
1933689|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1933690|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1933691|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933692|NCT00640315|Riociguat|riociguat|mesh-list
1933693|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
1933694|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933695|NCT00640328|Ofatumumab|ofatumumab|mesh-list
1933696|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1933697|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933698|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
1933699|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933700|NCT00640393|Etanercept|etanercept|mesh-list
1933701|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1933702|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933703|NCT00640393|Analgesics|analgesics|mesh-ancestor
1933704|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
1933705|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933706|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933707|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933708|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933709|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933710|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933711|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
1933712|NCT00640510|Olanzapine|olanzapine|mesh-list
1933713|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
1933714|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
1933715|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933716|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933717|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933718|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1933719|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933720|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933721|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933722|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1933723|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1933724|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933725|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933726|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933727|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
1933728|NCT00640562|Risperidone|risperidone|mesh-list
1933729|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1933730|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1933731|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
1933732|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933733|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933734|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933735|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1933736|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933737|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933738|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933739|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1933740|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
1933741|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
1933742|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1933743|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
1933744|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933745|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1933746|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933747|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933748|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933749|NCT00640822|Calcitriol|calcitriol|mesh-list
1933750|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
1933751|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1933752|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1933753|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1933754|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
1933755|NCT00640822|Calcipotriene|calcipotriene|mesh-list
1933756|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933757|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
1933758|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1933759|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933760|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1933761|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933762|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933763|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1933764|NCT00640822|Vitamins|vitamins|mesh-ancestor
1933765|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
1933766|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1933767|NCT00640835|Buprenorphine|buprenorphine|mesh-list
1933768|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1933769|NCT00640835|Naloxone|naloxone|mesh-list
1933770|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1933771|NCT00640835|Narcotics|narcotics|mesh-ancestor
1933772|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933773|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933774|NCT00640835|Analgesics|analgesics|mesh-ancestor
1933775|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
1933776|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933777|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1933778|NCT00640926|Radezolid|radezolid|mesh-list
1933779|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
1933780|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1933781|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933782|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1933783|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933784|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933785|NCT00640978|Everolimus|everolimus|mesh-list
1933786|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1933787|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933788|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1933789|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
1933790|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933791|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1933792|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933793|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933794|NCT00641043|Pioglitazone|pioglitazone|mesh-list
1933795|NCT00641043|Linagliptin|linagliptin|mesh-list
1933796|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933797|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933798|NCT00641043|Incretins|incretins|mesh-ancestor
1933799|NCT00641043|Hormones|hormones|mesh-ancestor
1933800|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933801|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1933802|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
1933803|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933804|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933805|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
1933806|NCT00641056|Exenatide|exenatide|mesh-list
1933807|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933808|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933809|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1933810|NCT00641056|Incretins|incretins|mesh-ancestor
1933811|NCT00641056|Hormones|hormones|mesh-ancestor
1933812|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933813|NCT00641147|Curcumin|curcumin|mesh-list
1933814|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1933815|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933816|NCT00641147|Analgesics|analgesics|mesh-ancestor
1933817|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
1933818|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933819|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933820|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933821|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1933822|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933823|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933824|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933830|NCT00641563|Midazolam|midazolam|mesh-list
1933831|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
1933832|NCT00641563|Remifentanil|remifentanil|mesh-list
1933833|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1933834|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933835|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933836|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1933837|NCT00641563|Analgesics|analgesics|mesh-ancestor
1933838|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
1933839|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933840|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1933841|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1933842|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1933843|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
1933844|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933845|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933846|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1933847|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1933848|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933849|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933850|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1933851|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
1933852|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
1933853|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
1933854|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
1933855|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1933856|NCT00641563|Narcotics|narcotics|mesh-ancestor
1933857|NCT00641641|Tenofovir|tenofovir|mesh-list
1933858|NCT00641641|Emtricitabine|emtricitabine|mesh-list
1933859|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
1933860|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
1933861|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1933862|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1933863|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1933864|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933865|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933866|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1933867|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1933868|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1933869|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1933870|NCT00641667|Fentanyl|fentanyl|mesh-list
1933871|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1933872|NCT00641667|Narcotics|narcotics|mesh-ancestor
1933873|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933874|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933875|NCT00641667|Analgesics|analgesics|mesh-ancestor
1933876|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
1933877|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933878|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1933879|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1933880|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
1933881|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
1933882|NCT00641706|Bortezomib|bortezomib|mesh-list
1933883|NCT00641706|Vorinostat|vorinostat|mesh-list
1933884|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933885|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1933886|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933887|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933888|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1933889|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1933890|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1933891|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1933892|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933893|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933894|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933895|NCT00641719|Analgesics|analgesics|mesh-ancestor
1933896|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
1933897|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933898|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
1933899|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933900|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
1933901|NCT00641745|Risperidone|risperidone|mesh-list
1933902|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1933903|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1933904|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
1933905|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933906|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933907|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933908|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1933909|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933910|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933911|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933912|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1933913|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
1933914|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1933915|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1933916|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1933917|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
1933918|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1933919|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1933920|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
1933921|NCT00641797|Promethazine|promethazine|mesh-list
1933922|NCT00641797|Meclizine|meclizine|mesh-list
1933923|NCT00641797|Lorazepam|lorazepam|mesh-list
1933924|NCT00641797|Ondansetron|ondansetron|mesh-list
1933925|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
1933926|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
1933927|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1933928|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933929|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1933930|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
1933931|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
1933932|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1933933|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
1933934|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933935|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933936|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1933937|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1933938|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1933939|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1933940|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1933941|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1933942|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1933943|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
1933944|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
1933945|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
1933946|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1933947|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
1933948|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
1933949|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1933950|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
1933951|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
1933952|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
1933953|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
1933954|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
1933955|NCT00641862|Vitamins|vitamins|mesh-ancestor
1933956|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
1933957|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933958|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
1933959|NCT00641862|Hematinics|hematinics|mesh-ancestor
1933960|NCT00642018|Prednisone|prednisone|mesh-list
1933961|NCT00642018|Docetaxel|docetaxel|mesh-list
1933962|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1933963|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
1933964|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
1933965|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
1933966|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933967|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1933968|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
1933969|NCT00642018|Hormones|hormones|mesh-ancestor
1933970|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933971|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933972|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1933973|NCT00642174|Clopidogrel|clopidogrel|mesh-list
1933974|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1933975|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1933976|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1933977|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1933978|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1933979|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
1933980|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1933981|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933982|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933983|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1933984|NCT00642278|Canagliflozin|canagliflozin|mesh-list
1933985|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1933986|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1933987|NCT00642278|Incretins|incretins|mesh-ancestor
1933988|NCT00642278|Hormones|hormones|mesh-ancestor
1933989|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1933990|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1933991|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
1933992|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1933993|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1933994|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1933995|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
1933996|NCT00642304|Hematinics|hematinics|mesh-ancestor
1933997|NCT00642356|Levodopa|levodopa|mesh-list
1933998|NCT00642356|Carbidopa|carbidopa|mesh-list
1933999|NCT00642356|Entacapone|entacapone|mesh-list
1934000|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1934001|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1934002|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934003|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
1934004|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934005|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934006|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934007|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1934008|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934009|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1934010|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1934011|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
1934012|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
1934013|NCT00642369|Haloperidol|haloperidol|mesh-list
1934014|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1934015|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
1934016|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
1934017|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934018|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1934019|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934020|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934021|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934022|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
1934023|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
1934024|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934025|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1934026|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1934027|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
1934028|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934029|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934030|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934031|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1934032|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1934033|NCT00642460|Methotrexate|methotrexate|mesh-list
1934034|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1934035|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
1934036|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1934037|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934038|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934039|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
1934040|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934041|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934042|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934043|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934044|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1934045|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934046|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
1934047|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934048|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1934049|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934050|NCT00642460|Analgesics|analgesics|mesh-ancestor
1934051|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
1934052|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934053|NCT00642473|Metronidazole|metronidazole|mesh-list
1934054|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1934055|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934056|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1934057|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934058|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934059|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934060|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1934061|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1934062|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1934063|NCT00642616|Insulin|insulin|mesh-list
1934064|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1934065|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934066|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
1934067|NCT00642668|Hematinics|hematinics|mesh-ancestor
1934068|NCT00642694|Dexetimide|dexetimide|mesh-list
1934069|NCT00642694|Citalopram|citalopram|mesh-list
1934070|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1934071|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1934072|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934073|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934074|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934075|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
1934076|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934077|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1934078|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
1934079|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934080|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1934081|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934082|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
1934083|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
1934084|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934085|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1934086|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1934087|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
1934088|NCT00642707|Leronlimab|leronlimab|mesh-list
1934089|NCT00642707|Antibodies|antibodies|mesh-list
1934090|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1934091|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
1934092|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934093|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1934094|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1934095|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934096|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1934097|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1934098|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
1934099|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934100|NCT00642746|Leucovorin|leucovorin|mesh-list
1934101|NCT00642746|Fluorouracil|fluorouracil|mesh-list
1934102|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
1934103|NCT00642746|Irinotecan|irinotecan|mesh-list
1934104|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1934105|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
1934106|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934107|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934108|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934109|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934110|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
1934111|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934112|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1934113|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1934114|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934115|NCT00642746|Antidotes|antidotes|mesh-ancestor
1934116|NCT00642746|Protective Agents|protective agents|mesh-ancestor
1934117|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
1934118|NCT00642746|Vitamins|vitamins|mesh-ancestor
1934119|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
1934120|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1934121|NCT00642759|Paclitaxel|paclitaxel|mesh-list
1934122|NCT00642759|Bevacizumab|bevacizumab|mesh-list
1934123|NCT00642759|Carboplatin|carboplatin|mesh-list
1934124|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1934125|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934126|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
1934127|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
1934128|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
1934129|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934130|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1934131|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1934132|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1934133|NCT00642759|Growth Substances|growth substances|mesh-ancestor
1934134|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934135|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
1934136|NCT00642811|Aspirin|aspirin|mesh-list
1934137|NCT00642811|Clopidogrel|clopidogrel|mesh-list
1934138|NCT00642811|Ticagrelor|ticagrelor|mesh-list
1934139|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1934140|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934141|NCT00642811|Analgesics|analgesics|mesh-ancestor
1934142|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
1934143|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934144|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934145|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934146|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934147|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1934148|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1934149|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934150|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1934151|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1934152|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934153|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
1934154|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1934155|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1934156|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1934157|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
1934158|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934159|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
1934160|NCT00642850|Hematinics|hematinics|mesh-ancestor
1934161|NCT00642954|Dexamethasone|dexamethasone|mesh-list
1934162|NCT00642954|Lenalidomide|lenalidomide|mesh-list
1934163|NCT00642954|Vorinostat|vorinostat|mesh-list
1934164|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934165|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
1934166|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
1934167|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934168|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934169|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1934170|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
1934171|NCT00642954|Hormones|hormones|mesh-ancestor
1934172|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934173|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1934174|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934175|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
1934176|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1934177|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1934178|NCT00642954|Growth Substances|growth substances|mesh-ancestor
1934179|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
1934180|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1934181|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934182|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934183|NCT00643097|Temozolomide|temozolomide|mesh-list
1934184|NCT00643097|Sargramostim|sargramostim|mesh-list
1934185|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1934186|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
1934187|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934188|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934189|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
1934190|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934191|NCT00643123|Allopurinol|allopurinol|mesh-list
1934192|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
1934193|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934194|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934195|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
1934196|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934197|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1934198|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
1934199|NCT00643123|Protective Agents|protective agents|mesh-ancestor
1934200|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934201|NCT00643162|Citalopram|citalopram|mesh-list
1934202|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1934203|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1934204|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934205|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934206|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934207|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
1934208|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934209|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1934210|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
1934211|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934212|NCT00643201|Enoxaparin|enoxaparin|mesh-list
1934213|NCT00643201|Warfarin|warfarin|mesh-list
1934214|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
1934215|NCT00643201|Apixaban|apixaban|mesh-list
1934216|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
1934217|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1934218|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1934219|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934220|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1934221|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
1934222|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1934223|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
1934224|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934225|NCT00643565|Bevacizumab|bevacizumab|mesh-list
1934226|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1934227|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934228|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1934229|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1934230|NCT00643565|Growth Substances|growth substances|mesh-ancestor
1934231|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934232|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
1934233|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
1934234|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1934235|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
1934236|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934237|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934238|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1934239|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
1934240|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1934241|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1934242|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1934243|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
1934244|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934245|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934246|NCT00643604|Treprostinil|treprostinil|mesh-list
1934247|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1934248|NCT00643760|Pregabalin|pregabalin|mesh-list
1934249|NCT00643760|Gabapentin|gabapentin|mesh-list
1934250|NCT00643760|Analgesics|analgesics|mesh-ancestor
1934251|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
1934252|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934253|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934254|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
1934255|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1934256|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934257|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934258|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1934259|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1934260|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934261|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934262|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934263|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1934264|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1934265|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934266|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
1934267|NCT00643851|Metformin|metformin|mesh-list
1934268|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
1934269|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1934270|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934271|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1934272|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934273|NCT00644059|Vaccines|vaccines|mesh-list
1934274|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
1934275|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934276|NCT00644189|Clofarabine|clofarabine|mesh-list
1934277|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934278|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
1934279|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934280|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934281|NCT00644228|Dexamethasone|dexamethasone|mesh-list
1934282|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
1934283|NCT00644228|Lenalidomide|lenalidomide|mesh-list
1934284|NCT00644228|Bortezomib|bortezomib|mesh-list
1934285|NCT00644228|Ichthammol|ichthammol|mesh-list
1934286|NCT00644228|BB 1101|bb 1101|mesh-list
1934287|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934288|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
1934289|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
1934290|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934291|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934292|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1934293|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
1934294|NCT00644228|Hormones|hormones|mesh-ancestor
1934295|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934296|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1934297|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934298|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
1934299|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934300|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934301|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
1934302|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1934303|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1934304|NCT00644228|Growth Substances|growth substances|mesh-ancestor
1934305|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
1934306|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934307|NCT00644280|Ranibizumab|ranibizumab|mesh-list
1934308|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1934309|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1934310|NCT00644280|Growth Substances|growth substances|mesh-ancestor
1934311|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934312|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
1934313|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934314|NCT00644332|Ranolazine|ranolazine|mesh-list
1934315|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1934316|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934317|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934318|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
1934319|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
1934320|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934321|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1934322|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1934323|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934324|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934325|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934326|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
1934327|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934328|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1934329|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1934330|NCT00644592|Fenofibrate|fenofibrate|mesh-list
1934331|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1934332|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
1934333|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934334|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1934335|NCT00644657|Clopidogrel|clopidogrel|mesh-list
1934336|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1934337|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1934338|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1934339|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1934340|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
1934341|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934417|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
1934342|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934343|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934344|NCT00644787|Fentanyl|fentanyl|mesh-list
1934345|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1934346|NCT00644787|Narcotics|narcotics|mesh-ancestor
1934347|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934348|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934349|NCT00644787|Analgesics|analgesics|mesh-ancestor
1934350|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
1934351|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934352|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1934353|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1934354|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
1934355|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
1934356|NCT00644969|Varenicline|varenicline|mesh-list
1934357|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1934358|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1934359|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
1934360|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934361|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934362|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934363|NCT00645099|Olanzapine|olanzapine|mesh-list
1934364|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1934365|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
1934366|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
1934367|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934368|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934369|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1934370|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1934371|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934372|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934373|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934374|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1934375|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1934376|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934377|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934378|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934379|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
1934380|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1934381|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1934382|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1934383|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1934384|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
1934385|NCT00645333|Docetaxel|docetaxel|mesh-list
1934386|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934387|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
1934388|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
1934389|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
1934390|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934391|NCT00645411|Vaccines|vaccines|mesh-list
1934392|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
1934393|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934394|NCT00645450|Propranolol|propranolol|mesh-list
1934395|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1934396|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1934397|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
1934398|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934399|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934400|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934401|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1934402|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1934403|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
1934404|NCT00645528|Insulin|insulin|mesh-list
1934405|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1934406|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934407|NCT00645593|Gemcitabine|gemcitabine|mesh-list
1934408|NCT00645593|Cetuximab|cetuximab|mesh-list
1934409|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934410|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934411|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
1934412|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934413|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
1934414|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934415|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934416|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934418|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934419|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1934420|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1934421|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1934422|NCT00645710|Gemcitabine|gemcitabine|mesh-list
1934423|NCT00645710|Floxuridine|floxuridine|mesh-list
1934424|NCT00645710|Antibodies|antibodies|mesh-list
1934425|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1934426|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
1934427|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934428|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934429|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
1934430|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934431|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934432|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
1934433|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934434|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934435|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934436|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
1934437|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1934438|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934439|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1934440|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1934441|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934442|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934443|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934444|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1934445|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1934446|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1934447|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934448|NCT00645853|Warfarin|warfarin|mesh-list
1934449|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
1934450|NCT00645944|Eszopiclone|eszopiclone|mesh-list
1934451|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1934452|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934453|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934454|NCT00646451|Pregabalin|pregabalin|mesh-list
1934455|NCT00646451|Analgesics|analgesics|mesh-ancestor
1934456|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
1934457|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934458|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934459|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
1934460|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1934461|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934462|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934463|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1934464|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1934465|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934466|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934467|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934468|NCT00646581|Insulin|insulin|mesh-list
1934469|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1934470|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1934471|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934472|NCT00646646|Midazolam|midazolam|mesh-list
1934473|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
1934474|NCT00646646|Propofol|propofol|mesh-list
1934475|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1934476|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934477|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934478|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1934479|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
1934480|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
1934481|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934482|NCT00646646|Analgesics|analgesics|mesh-ancestor
1934483|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
1934484|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934485|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1934486|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1934487|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1934488|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
1934489|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934490|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934491|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1934492|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1934493|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934494|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934495|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
1934496|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
1934497|NCT00646763|Lenograstim|lenograstim|mesh-list
1934498|NCT00646763|Sargramostim|sargramostim|mesh-list
1934499|NCT00646763|Mitogens|mitogens|mesh-list
1934500|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1934501|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
1934502|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934503|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
1934504|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934505|NCT00646776|Ritonavir|ritonavir|mesh-list
1934506|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1934507|NCT00646776|Rifabutin|rifabutin|mesh-list
1934508|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1934509|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1934510|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
1934511|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934512|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934513|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1934514|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1934515|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
1934516|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934517|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1934518|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1934519|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1934520|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1934521|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
1934522|NCT00646906|Aspirin|aspirin|mesh-list
1934523|NCT00646906|Acetaminophen|acetaminophen|mesh-list
1934524|NCT00646906|Ibuprofen|ibuprofen|mesh-list
1934525|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1934526|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934527|NCT00646906|Analgesics|analgesics|mesh-ancestor
1934528|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
1934529|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934530|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934531|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934532|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934533|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1934534|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1934535|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934536|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1934537|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1934538|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934539|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
1934540|NCT00646958|Linezolid|linezolid|mesh-list
1934541|NCT00646958|Radezolid|radezolid|mesh-list
1934542|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
1934543|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1934544|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934545|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1934546|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934547|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934548|NCT00647270|Adalimumab|adalimumab|mesh-list
1934549|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934550|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934551|NCT00647296|Pramipexole|pramipexole|mesh-list
1934552|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
1934553|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934554|NCT00647296|Protective Agents|protective agents|mesh-ancestor
1934555|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934556|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1934557|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934558|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
1934559|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
1934560|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934561|NCT00647348|Simvastatin|simvastatin|mesh-list
1934562|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1934563|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1934564|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
1934565|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934566|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1934567|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1934568|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934569|NCT00647400|Adalimumab|adalimumab|mesh-list
1934570|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934571|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934572|NCT00647556|Adapalene|adapalene|mesh-list
1934573|NCT00647556|Tretinoin|tretinoin|mesh-list
1934574|NCT00647556|Emollients|emollients|mesh-list
1934575|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1934576|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934577|NCT00647556|Analgesics|analgesics|mesh-ancestor
1934578|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
1934579|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934580|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934581|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934582|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934583|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934584|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934585|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
1934586|NCT00647699|Riboflavin|riboflavin|mesh-list
1934587|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1934588|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1934589|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
1934590|NCT00647699|Vitamins|vitamins|mesh-ancestor
1934591|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
1934592|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934593|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1934594|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934595|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
1934596|NCT00647998|Hematinics|hematinics|mesh-ancestor
1934597|NCT00648037|Rituximab|rituximab|mesh-list
1934598|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1934599|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934600|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
1934601|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934602|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934603|NCT00648375|Propranolol|propranolol|mesh-list
1934604|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1934605|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1934606|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
1934607|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934608|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934609|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934610|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1934611|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1934612|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
1934613|NCT00648648|Gemcitabine|gemcitabine|mesh-list
1934614|NCT00648648|Carboplatin|carboplatin|mesh-list
1934615|NCT00648648|Adavosertib|adavosertib|mesh-list
1934616|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934617|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934618|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
1934619|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934620|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
1934621|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934622|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934623|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934624|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
1934625|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934626|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
1934627|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1934628|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934629|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934630|NCT00649220|Memantine|memantine|mesh-list
1934631|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1934632|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934633|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
1934634|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934635|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934636|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934637|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1934638|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1934639|NCT00649389|Amlodipine|amlodipine|mesh-list
1934640|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1934641|NCT00649389|Olmesartan|olmesartan|mesh-list
1934642|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1934643|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1934644|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1934645|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934646|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934647|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1934648|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934649|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
1934650|NCT00649389|Diuretics|diuretics|mesh-ancestor
1934651|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
1934652|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1934653|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1934654|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1934655|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
1934656|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1934657|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934658|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934659|NCT00649961|Melatonin|melatonin|mesh-list
1934660|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
1934661|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934662|NCT00649961|Protective Agents|protective agents|mesh-ancestor
1934663|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934664|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934665|NCT00650078|Prednisone|prednisone|mesh-list
1934666|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934667|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
1934668|NCT00650078|Hormones|hormones|mesh-ancestor
1934669|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934670|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934671|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1934672|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934673|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
1934674|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1934675|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
1934676|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934677|NCT00650091|Expectorants|expectorants|mesh-ancestor
1934678|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
1934679|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1934680|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
1934681|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934682|NCT00650091|Protective Agents|protective agents|mesh-ancestor
1934683|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934684|NCT00650091|Antidotes|antidotes|mesh-ancestor
1934685|NCT00650104|Ropinirole|ropinirole|mesh-list
1934686|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1934687|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934688|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
1934689|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
1934690|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934691|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934692|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934693|NCT00650546|Exenatide|exenatide|mesh-list
1934694|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1934695|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934696|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1934697|NCT00650546|Incretins|incretins|mesh-ancestor
1934698|NCT00650546|Hormones|hormones|mesh-ancestor
1934699|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934700|NCT00650806|Canagliflozin|canagliflozin|mesh-list
1934701|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1934702|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934703|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1934704|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934705|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
1934706|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
1934707|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
1934708|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934709|NCT00650858|Plasminogen|plasminogen|mesh-list
1934710|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1934711|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
1934712|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1934713|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934714|NCT00651040|Prednisone|prednisone|mesh-list
1934715|NCT00651040|Prednisolone|prednisolone|mesh-list
1934716|NCT00651040|Methotrexate|methotrexate|mesh-list
1934717|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934718|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
1934719|NCT00651040|Hormones|hormones|mesh-ancestor
1934948|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934720|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934721|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934722|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1934723|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934724|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1934725|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
1934726|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1934727|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934728|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
1934729|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934730|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934731|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934732|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1934733|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934734|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
1934735|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934736|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1934737|NCT00651118|Fluticasone|fluticasone|mesh-list
1934738|NCT00651118|Xhance|xhance|mesh-list
1934739|NCT00651118|Azelastine|azelastine|mesh-list
1934740|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934741|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1934742|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
1934743|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934744|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934745|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1934746|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
1934747|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934748|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1934749|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1934750|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934751|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934752|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1934753|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1934754|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
1934755|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
1934756|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934757|NCT00651183|Pramipexole|pramipexole|mesh-list
1934758|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
1934759|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934760|NCT00651183|Protective Agents|protective agents|mesh-ancestor
1934761|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934762|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1934763|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1934764|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
1934765|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
1934766|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934767|NCT00651261|Cytarabine|cytarabine|mesh-list
1934768|NCT00651261|Dexamethasone|dexamethasone|mesh-list
1934769|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
1934770|NCT00651261|Daunorubicin|daunorubicin|mesh-list
1934771|NCT00651261|Midostaurin|midostaurin|mesh-list
1934772|NCT00651261|BB 1101|bb 1101|mesh-list
1934773|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934774|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
1934775|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
1934776|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934777|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934778|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1934779|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
1934780|NCT00651261|Hormones|hormones|mesh-ancestor
1934781|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934782|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1934783|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934784|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934785|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
1934786|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934787|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
1934788|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934789|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934790|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
1934791|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1934792|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1934793|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1934794|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934795|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1934796|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
1934797|NCT00651313|Lidocaine|lidocaine|mesh-list
1934798|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
1934799|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
1934800|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934801|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934802|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
1934803|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934804|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1934805|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1934806|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1934807|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1934808|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934809|NCT00651482|Bevacizumab|bevacizumab|mesh-list
1934810|NCT00651482|Everolimus|everolimus|mesh-list
1934811|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1934812|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934813|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1934814|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1934815|NCT00651482|Growth Substances|growth substances|mesh-ancestor
1934816|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934817|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
1934818|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934819|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
1934820|NCT00651755|Prednisone|prednisone|mesh-list
1934821|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
1934822|NCT00651755|Rituximab|rituximab|mesh-list
1934823|NCT00651755|Doxorubicin|doxorubicin|mesh-list
1934824|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1934825|NCT00651755|Vincristine|vincristine|mesh-list
1934826|NCT00651755|Ondansetron|ondansetron|mesh-list
1934827|NCT00651755|Aprepitant|aprepitant|mesh-list
1934828|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934829|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
1934830|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934831|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934832|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1934833|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
1934834|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934835|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934836|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1934837|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1934838|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1934839|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1934840|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1934841|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934842|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934843|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
1934844|NCT00651755|Hormones|hormones|mesh-ancestor
1934845|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1934846|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1934847|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1934848|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
1934849|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
1934850|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
1934851|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
1934852|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
1934853|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934854|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1934855|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
1934856|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
1934857|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1934858|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
1934859|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934860|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1934861|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934862|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934863|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934864|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1934865|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1934866|NCT00651937|Melphalan|melphalan|mesh-list
1934867|NCT00651937|Sargramostim|sargramostim|mesh-list
1934868|NCT00651937|Lenograstim|lenograstim|mesh-list
1934869|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1934870|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
1934871|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934872|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934873|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1934874|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934875|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
1934876|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934877|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1934878|NCT00652028|Fentanyl|fentanyl|mesh-list
1934879|NCT00652028|Midazolam|midazolam|mesh-list
1934880|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
1934881|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1934882|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934883|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934884|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934885|NCT00652028|Analgesics|analgesics|mesh-ancestor
1934886|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
1934887|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934888|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1934889|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1934890|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1934891|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
1934892|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1934893|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934894|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1934895|NCT00652028|Narcotics|narcotics|mesh-ancestor
1934896|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1934897|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1934898|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
1934899|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
1934900|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1934901|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1934902|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1934903|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
1934904|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
1934905|NCT00652093|Acetaminophen|acetaminophen|mesh-list
1934906|NCT00652093|Oxymorphone|oxymorphone|mesh-list
1934907|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
1934908|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
1934909|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
1934910|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934911|NCT00652093|Analgesics|analgesics|mesh-ancestor
1934912|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
1934913|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934914|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934915|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
1934916|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1934917|NCT00652093|Narcotics|narcotics|mesh-ancestor
1934918|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1934919|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1934920|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
1934921|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
1934922|NCT00652145|Mesalamine|mesalamine|mesh-list
1934923|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1934924|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934925|NCT00652145|Analgesics|analgesics|mesh-ancestor
1934926|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
1934927|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1934928|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934929|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1934930|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934931|NCT00652314|Thrombin|thrombin|mesh-list
1934932|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
1934933|NCT00652314|Coagulants|coagulants|mesh-ancestor
1934934|NCT00652327|Atorvastatin|atorvastatin|mesh-list
1934935|NCT00652327|Simvastatin|simvastatin|mesh-list
1934936|NCT00652327|Ezetimibe|ezetimibe|mesh-list
1934937|NCT00652327|Pravastatin|pravastatin|mesh-list
1934938|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1934939|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1934940|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1934941|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
1934942|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934943|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1934944|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934945|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1934946|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934947|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1934949|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934950|NCT00652366|Gemcitabine|gemcitabine|mesh-list
1934951|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1934952|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934953|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
1934954|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934955|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934956|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
1934957|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934958|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934959|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934960|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
1934961|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934962|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1934963|NCT00652626|Azacitidine|azacitidine|mesh-list
1934964|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934965|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
1934966|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934967|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934968|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934969|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
1934970|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1934971|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934972|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1934973|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
1934974|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1934975|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934976|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1934977|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934978|NCT00652899|Vidarabine|vidarabine|mesh-list
1934979|NCT00652899|Aldesleukin|aldesleukin|mesh-list
1934980|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
1934981|NCT00652899|Fludarabine|fludarabine|mesh-list
1934982|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
1934983|NCT00652899|Interleukin-2|interleukin-2|mesh-list
1934984|NCT00652899|Allopurinol|allopurinol|mesh-list
1934985|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1934986|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
1934987|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1934988|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1934989|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1934990|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
1934991|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1934992|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1934993|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1934994|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1934995|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
1934996|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
1934997|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1934998|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1934999|NCT00652899|Analgesics|analgesics|mesh-ancestor
1935000|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
1935001|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935002|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1935003|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1935004|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935005|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
1935006|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1935007|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
1935008|NCT00652899|Protective Agents|protective agents|mesh-ancestor
1935009|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1935010|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
1935011|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935012|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
1935013|NCT00653068|Leucovorin|leucovorin|mesh-list
1935014|NCT00653068|Folic Acid|folic acid|mesh-list
1935015|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
1935016|NCT00653068|Thiotepa|thiotepa|mesh-list
1935017|NCT00653068|Cisplatin|cisplatin|mesh-list
1935018|NCT00653068|Carboplatin|carboplatin|mesh-list
1935019|NCT00653068|Methotrexate|methotrexate|mesh-list
1935020|NCT00653068|Etoposide|etoposide|mesh-list
1935021|NCT00653068|Vincristine|vincristine|mesh-list
1935022|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
1935023|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
1935024|NCT00653068|Lenograstim|lenograstim|mesh-list
1935025|NCT00653068|Calcium|calcium|mesh-list
1935026|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
1935027|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935028|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
1935029|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935030|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935031|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1935032|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
1935033|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935034|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935035|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1935036|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1935037|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1935038|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1935039|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
1935040|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1935041|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1935042|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
1935043|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935044|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935045|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1935046|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1935047|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1935048|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1935049|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935050|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1935051|NCT00653068|Antidotes|antidotes|mesh-ancestor
1935052|NCT00653068|Protective Agents|protective agents|mesh-ancestor
1935053|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
1935054|NCT00653068|Vitamins|vitamins|mesh-ancestor
1935055|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
1935056|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935057|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935058|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935059|NCT00653068|Hematinics|hematinics|mesh-ancestor
1935060|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
1935061|NCT00653159|Copper|copper|mesh-list
1935062|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
1935063|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1935064|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
1935065|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1935066|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935067|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1935068|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1935069|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1935070|NCT00653159|Trace Elements|trace elements|mesh-ancestor
1935071|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
1935072|NCT00653224|Levocetirizine|levocetirizine|mesh-list
1935073|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1935074|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1935075|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
1935076|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
1935077|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935078|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935079|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935080|NCT00653328|Doxorubicin|doxorubicin|mesh-list
1935081|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1935082|NCT00653328|Atrasentan|atrasentan|mesh-list
1935083|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1935084|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935085|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1935086|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935087|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935088|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935089|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1935090|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1935091|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
1935092|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1935093|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
1935094|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935095|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
1935096|NCT00653432|Protective Agents|protective agents|mesh-ancestor
1935097|NCT00653523|Simvastatin|simvastatin|mesh-list
1935098|NCT00653523|Ezetimibe|ezetimibe|mesh-list
1935099|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935100|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935101|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
1935102|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935103|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935104|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1935105|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935106|NCT00653861|Lidocaine|lidocaine|mesh-list
1935107|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
1935108|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
1935109|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935110|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935111|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
1935112|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935113|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1935114|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1935115|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1935116|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935117|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935118|NCT00653939|Paclitaxel|paclitaxel|mesh-list
1935119|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
1935120|NCT00653939|Combretastatin|combretastatin|mesh-list
1935121|NCT00653939|Bevacizumab|bevacizumab|mesh-list
1935122|NCT00653939|Carboplatin|carboplatin|mesh-list
1935123|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1935124|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935125|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935126|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935127|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935128|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935129|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935130|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935131|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935132|NCT00653939|Growth Substances|growth substances|mesh-ancestor
1935133|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935134|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935135|NCT00654030|Vaccines|vaccines|mesh-list
1935136|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
1935137|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935138|NCT00654069|Niacin|niacin|mesh-list
1935139|NCT00654069|Niacinamide|niacinamide|mesh-list
1935140|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
1935141|NCT00654069|Oxycodone|oxycodone|mesh-list
1935142|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1935143|NCT00654069|Narcotics|narcotics|mesh-ancestor
1935144|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935145|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935146|NCT00654069|Analgesics|analgesics|mesh-ancestor
1935147|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
1935148|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935149|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935150|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
1935151|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935152|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935153|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
1935154|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
1935155|NCT00654069|Vitamins|vitamins|mesh-ancestor
1935156|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
1935157|NCT00654095|Atorvastatin|atorvastatin|mesh-list
1935158|NCT00654095|Ezetimibe|ezetimibe|mesh-list
1935159|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935160|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935161|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
1935162|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935163|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935164|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1935165|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935166|NCT00654147|Ritonavir|ritonavir|mesh-list
1935167|NCT00654147|Lopinavir|lopinavir|mesh-list
1935168|NCT00654147|Tenofovir|tenofovir|mesh-list
1935169|NCT00654147|Emtricitabine|emtricitabine|mesh-list
1935170|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
1935171|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1935172|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1935173|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
1935174|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935175|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935176|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1935177|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1935178|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
1935179|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935180|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1935181|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1935182|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1935183|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1935184|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1935185|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1935186|NCT00654186|Lenalidomide|lenalidomide|mesh-list
1935187|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
1935188|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935189|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935190|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935191|NCT00654186|Growth Substances|growth substances|mesh-ancestor
1935192|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935193|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935194|NCT00654238|Sorafenib|sorafenib|mesh-list
1935195|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935196|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1935197|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935198|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935199|NCT00654329|Fentanyl|fentanyl|mesh-list
1935200|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
1935201|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1935202|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935203|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935204|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1935205|NCT00654329|Analgesics|analgesics|mesh-ancestor
1935206|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
1935207|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935208|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1935209|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1935210|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1935211|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
1935212|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935213|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935214|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1935215|NCT00654329|Narcotics|narcotics|mesh-ancestor
1935216|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1935217|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1935218|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
1935219|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
1935220|NCT00654355|Tacrolimus|tacrolimus|mesh-list
1935221|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935222|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
1935223|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935224|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1935225|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935226|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935227|NCT00654368|Etanercept|etanercept|mesh-list
1935228|NCT00654368|Methotrexate|methotrexate|mesh-list
1935229|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1935230|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
1935231|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1935232|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935233|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1935234|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
1935235|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935236|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935237|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935238|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935239|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1935240|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935241|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
1935242|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935243|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1935244|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1935245|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1935246|NCT00654368|Analgesics|analgesics|mesh-ancestor
1935247|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
1935248|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935249|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1935250|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935251|NCT00654381|Inositol|inositol|mesh-list
1935252|NCT00654381|Linagliptin|linagliptin|mesh-list
1935253|NCT00654381|Voglibose|voglibose|mesh-list
1935254|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1935255|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935256|NCT00654381|Incretins|incretins|mesh-ancestor
1935257|NCT00654381|Hormones|hormones|mesh-ancestor
1935258|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935259|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1935260|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
1935261|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935262|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935263|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1935264|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
1935265|NCT00654381|Vitamins|vitamins|mesh-ancestor
1935266|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
1935267|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1935268|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935269|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1935270|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935271|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935272|NCT00654498|Pramipexole|pramipexole|mesh-list
1935273|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
1935274|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935275|NCT00654498|Protective Agents|protective agents|mesh-ancestor
1935276|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935277|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1935278|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1935279|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
1935280|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
1935281|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935282|NCT00654511|Fentanyl|fentanyl|mesh-list
1935283|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
1935284|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1935285|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935286|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935287|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1935288|NCT00654511|Analgesics|analgesics|mesh-ancestor
1935289|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
1935290|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935291|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1935292|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1935293|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1935294|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
1935295|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935296|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935297|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1935298|NCT00654511|Narcotics|narcotics|mesh-ancestor
1935299|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1935300|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1935301|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
1935302|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
1935303|NCT00654628|Simvastatin|simvastatin|mesh-list
1935304|NCT00654628|Ezetimibe|ezetimibe|mesh-list
1935305|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935306|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935307|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
1935308|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935309|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935310|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1935311|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935312|NCT00654732|Rituximab|rituximab|mesh-list
1935313|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1935314|NCT00654732|Doxorubicin|doxorubicin|mesh-list
1935315|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1935316|NCT00654732|Dacarbazine|dacarbazine|mesh-list
1935317|NCT00654732|Bleomycin|bleomycin|mesh-list
1935318|NCT00654732|Vinblastine|vinblastine|mesh-list
1935319|NCT00654732|Antibodies|antibodies|mesh-list
1935320|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
1935321|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1935322|NCT00654732|Imidazole|imidazole|mesh-list
1935323|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
1935324|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935325|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935326|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935327|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1935328|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1935329|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935330|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935479|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1935331|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935332|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1935333|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
1935334|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1935335|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935336|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935337|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935338|NCT00654745|Amlodipine|amlodipine|mesh-list
1935339|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1935340|NCT00654745|Olmesartan|olmesartan|mesh-list
1935341|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1935342|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1935343|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1935344|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935345|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935346|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1935347|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935348|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
1935349|NCT00654745|Diuretics|diuretics|mesh-ancestor
1935350|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
1935351|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1935352|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1935353|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1935354|NCT00654784|Idebenone|idebenone|mesh-list
1935355|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
1935356|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935357|NCT00654784|Protective Agents|protective agents|mesh-ancestor
1935358|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935359|NCT00654836|Bevacizumab|bevacizumab|mesh-list
1935360|NCT00654836|Carboplatin|carboplatin|mesh-list
1935361|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1935362|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935363|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935364|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935365|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935366|NCT00654836|Growth Substances|growth substances|mesh-ancestor
1935367|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935368|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935369|NCT00654901|Vaccines|vaccines|mesh-list
1935370|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
1935371|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935372|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
1935373|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1935374|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935375|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935376|NCT00654940|Pregabalin|pregabalin|mesh-list
1935377|NCT00654940|Analgesics|analgesics|mesh-ancestor
1935378|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
1935379|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935380|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935381|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
1935382|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1935383|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935384|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935385|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1935386|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1935387|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1935388|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935389|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1935390|NCT00654953|Gabapentin|gabapentin|mesh-list
1935391|NCT00654953|Sertraline|sertraline|mesh-list
1935392|NCT00654953|Analgesics|analgesics|mesh-ancestor
1935393|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
1935394|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935395|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935396|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
1935397|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1935398|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1935399|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935400|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1935401|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1935402|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1935403|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935557|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935404|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935405|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
1935406|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
1935407|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1935408|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1935409|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935410|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
1935411|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
1935412|NCT00654992|Hematinics|hematinics|mesh-ancestor
1935413|NCT00655083|MEN 11420|men 11420|mesh-list
1935414|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1935415|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
1935416|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935417|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935418|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1935419|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
1935420|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
1935421|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935422|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935423|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
1935424|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935425|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935426|NCT00655486|Lacosamide|lacosamide|mesh-list
1935427|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
1935428|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1935429|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1935430|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935431|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935432|NCT00655499|Irinotecan|irinotecan|mesh-list
1935433|NCT00655499|Panitumumab|panitumumab|mesh-list
1935434|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1935435|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935436|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935437|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935438|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935439|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935440|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
1935441|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935442|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935443|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
1935444|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935445|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935446|NCT00655551|Lacosamide|lacosamide|mesh-list
1935447|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
1935448|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1935449|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1935450|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935451|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935452|NCT00655564|Alefacept|alefacept|mesh-list
1935453|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935454|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
1935455|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935456|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1935457|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
1935458|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1935459|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1935460|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935461|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935462|NCT00655629|Urological Agents|urological agents|mesh-ancestor
1935463|NCT00655642|Promethazine|promethazine|mesh-list
1935464|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
1935465|NCT00655642|Ondansetron|ondansetron|mesh-list
1935466|NCT00655642|Metoclopramide|metoclopramide|mesh-list
1935467|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
1935468|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
1935469|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935470|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935471|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935472|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
1935473|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935474|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1935475|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
1935476|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935477|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935478|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1935480|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935481|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1935482|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1935483|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1935484|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1935485|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
1935486|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1935487|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
1935488|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
1935489|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1935490|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1935491|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1935492|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
1935493|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
1935494|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
1935495|NCT00655668|Lenalidomide|lenalidomide|mesh-list
1935496|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
1935497|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935498|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935499|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935500|NCT00655668|Growth Substances|growth substances|mesh-ancestor
1935501|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935502|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935503|NCT00655746|Dasatinib|dasatinib|mesh-list
1935504|NCT00655746|Omeprazole|omeprazole|mesh-list
1935505|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1935506|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935507|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1935508|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935509|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935510|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935511|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1935512|NCT00655811|Capsaicin|capsaicin|mesh-list
1935513|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
1935514|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935515|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
1935516|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935517|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935520|NCT00655850|Gemcitabine|gemcitabine|mesh-list
1935521|NCT00655850|Paclitaxel|paclitaxel|mesh-list
1935522|NCT00655850|Bevacizumab|bevacizumab|mesh-list
1935523|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1935524|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935525|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935526|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935527|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935528|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935529|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1935530|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
1935531|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
1935532|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935533|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935534|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935535|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
1935536|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935537|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935538|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935539|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935540|NCT00655850|Growth Substances|growth substances|mesh-ancestor
1935541|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935542|NCT00655863|Pioglitazone|pioglitazone|mesh-list
1935543|NCT00655863|Alogliptin|alogliptin|mesh-list
1935544|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1935545|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935546|NCT00655863|Incretins|incretins|mesh-ancestor
1935547|NCT00655863|Hormones|hormones|mesh-ancestor
1935548|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935549|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1935550|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
1935551|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935552|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935553|NCT00655876|Paclitaxel|paclitaxel|mesh-list
1935554|NCT00655876|Cetuximab|cetuximab|mesh-list
1935555|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1935556|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935558|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935559|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935560|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935561|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935562|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
1935563|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1935564|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
1935565|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935566|NCT00655928|Expectorants|expectorants|mesh-ancestor
1935567|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
1935568|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1935569|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
1935570|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935571|NCT00655928|Protective Agents|protective agents|mesh-ancestor
1935572|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935573|NCT00655928|Antidotes|antidotes|mesh-ancestor
1935574|NCT00655980|Folic Acid|folic acid|mesh-list
1935575|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
1935576|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
1935577|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
1935578|NCT00655980|Vitamins|vitamins|mesh-ancestor
1935579|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
1935580|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935581|NCT00655980|Hematinics|hematinics|mesh-ancestor
1935582|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
1935583|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1935584|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
1935585|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
1935586|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935587|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1935588|NCT00655980|Analgesics|analgesics|mesh-ancestor
1935589|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
1935590|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935591|NCT00656019|Vitamin D|vitamin d|mesh-list
1935592|NCT00656019|Calcipotriene|calcipotriene|mesh-list
1935593|NCT00656019|Vitamins|vitamins|mesh-ancestor
1935594|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
1935595|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935596|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1935597|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935598|NCT00656058|Montelukast|montelukast|mesh-list
1935599|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1935600|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
1935601|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1935602|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
1935603|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935604|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935605|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1935606|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1935607|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935608|NCT00656084|Gemcitabine|gemcitabine|mesh-list
1935609|NCT00656084|Rituximab|rituximab|mesh-list
1935610|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
1935611|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935612|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935613|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
1935614|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935615|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935616|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1935617|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
1935618|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935619|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
1935620|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935621|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935622|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935623|NCT00656084|Analgesics|analgesics|mesh-ancestor
1935624|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
1935625|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935626|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1935627|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935628|NCT00656136|Afatinib|afatinib|mesh-list
1935629|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935630|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1935631|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935632|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935633|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
1935634|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1935635|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1935636|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
1935637|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935638|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1935639|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1935640|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935641|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935642|NCT00656201|Progesterone|progesterone|mesh-list
1935643|NCT00656201|Progestins|progestins|mesh-ancestor
1935644|NCT00656201|Hormones|hormones|mesh-ancestor
1935645|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935646|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935647|NCT00656292|Simvastatin|simvastatin|mesh-list
1935648|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935649|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935650|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
1935651|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935652|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935653|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1935654|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935655|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
1935656|NCT00656448|Hematinics|hematinics|mesh-ancestor
1935657|NCT00656487|Rimonabant|rimonabant|mesh-list
1935658|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1935659|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
1935660|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1935661|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935662|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935663|NCT00656487|Hormones|hormones|mesh-ancestor
1935664|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935665|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935666|NCT00656513|Pilocarpine|pilocarpine|mesh-list
1935667|NCT00656513|Miotics|miotics|mesh-ancestor
1935668|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
1935669|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935670|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935671|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1935672|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1935673|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
1935674|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935675|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935676|NCT00656617|Cytarabine|cytarabine|mesh-list
1935677|NCT00656617|Vorinostat|vorinostat|mesh-list
1935678|NCT00656617|Idarubicin|idarubicin|mesh-list
1935679|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1935680|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
1935681|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935682|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935683|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
1935684|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935685|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935686|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
1935687|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935688|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1935689|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935690|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1935691|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1935692|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935693|NCT00656630|Naltrexone|naltrexone|mesh-list
1935694|NCT00656630|Acamprosate|acamprosate|mesh-list
1935695|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1935696|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1935697|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935698|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
1935699|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935700|NCT00656656|Dexamethasone|dexamethasone|mesh-list
1935701|NCT00656656|Rituximab|rituximab|mesh-list
1935702|NCT00656656|Azathioprine|azathioprine|mesh-list
1935703|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1935704|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
1935705|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
1935706|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935707|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935708|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935709|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
1935710|NCT00656656|Hormones|hormones|mesh-ancestor
1935711|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935712|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1935713|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935714|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935715|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
1935716|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935717|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
1935718|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935719|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1935720|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935721|NCT00656669|Paclitaxel|paclitaxel|mesh-list
1935722|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
1935723|NCT00656669|Doxorubicin|doxorubicin|mesh-list
1935724|NCT00656669|Sunitinib|sunitinib|mesh-list
1935725|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1935726|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935727|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935728|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935729|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935730|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935731|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935732|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
1935733|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935734|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935735|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1935736|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
1935737|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1935738|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1935739|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1935740|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1935741|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935742|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935743|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935744|NCT00656669|Growth Substances|growth substances|mesh-ancestor
1935745|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935746|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1935747|NCT00656799|Bromides|bromides|mesh-list
1935748|NCT00656799|Rocuronium|rocuronium|mesh-list
1935749|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
1935750|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1935751|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1935752|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1935753|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935754|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935755|NCT00656851|Pioglitazone|pioglitazone|mesh-list
1935756|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1935757|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935758|NCT00656968|Esomeprazole|esomeprazole|mesh-list
1935759|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1935760|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935761|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1935762|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935763|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935764|NCT00657020|Nicotine|nicotine|mesh-list
1935765|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1935766|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
1935767|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935768|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935769|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1935770|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1935771|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
1935772|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935773|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935774|NCT00657046|Droxidopa|droxidopa|mesh-list
1935775|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1935776|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1935777|NCT00657150|Enoxaparin|enoxaparin|mesh-list
1935778|NCT00657150|Dabigatran|dabigatran|mesh-list
1935779|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
1935780|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1935781|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1935782|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935783|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
1935784|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1935785|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
1935786|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935787|NCT00657267|Temozolomide|temozolomide|mesh-list
1935788|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1935789|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
1935790|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935791|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935792|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1935793|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1935794|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935795|NCT00657280|Incretins|incretins|mesh-ancestor
1935796|NCT00657280|Hormones|hormones|mesh-ancestor
1935797|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935798|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1935799|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
1935800|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935801|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935802|NCT00657358|Lidocaine|lidocaine|mesh-list
1935803|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
1935804|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
1935805|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935806|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935807|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
1935808|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935809|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1935810|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1935811|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1935812|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1935813|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935814|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
1935815|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1935816|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1935817|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935818|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
1935819|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1935820|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
1935821|NCT00657709|Vaccines|vaccines|mesh-list
1935822|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1935823|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
1935824|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935825|NCT00657917|Gentamicins|gentamicins|mesh-list
1935826|NCT00657917|Paromomycin|paromomycin|mesh-list
1935827|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1935828|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935829|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1935830|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935831|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935832|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1935833|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1935834|NCT00658021|Exenatide|exenatide|mesh-list
1935835|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1935836|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935837|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1935838|NCT00658021|Incretins|incretins|mesh-ancestor
1935839|NCT00658021|Hormones|hormones|mesh-ancestor
1935840|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935841|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1935842|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935843|NCT00658320|Cyclosporine|cyclosporine|mesh-list
1935844|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
1935845|NCT00658320|Everolimus|everolimus|mesh-list
1935846|NCT00658320|Cyclosporins|cyclosporins|mesh-list
1935847|NCT00658320|Basiliximab|basiliximab|mesh-list
1935848|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935849|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935850|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935851|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
1935852|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935853|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
1935854|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935855|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935856|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935857|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1935858|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935859|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1935860|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1935861|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
1935862|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1935863|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
1935864|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1935865|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935866|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1935867|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
1935868|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1935869|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935870|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935871|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935872|NCT00658359|Cyclosporine|cyclosporine|mesh-list
1935873|NCT00658359|Cyclosporins|cyclosporins|mesh-list
1935874|NCT00658359|Tofacitinib|tofacitinib|mesh-list
1935875|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935876|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935877|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1935878|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
1935879|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935880|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
1935881|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1935882|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935883|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1935884|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1935885|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1935886|NCT00658411|Deferoxamine|deferoxamine|mesh-list
1935887|NCT00658411|Siderophores|siderophores|mesh-ancestor
1935888|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1935889|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
1935890|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
1935891|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935892|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
1935893|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1935894|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1935895|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
1935896|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935897|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1935898|NCT00658528|Esomeprazole|esomeprazole|mesh-list
1935899|NCT00658528|Rabeprazole|rabeprazole|mesh-list
1935900|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1935901|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935902|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1935903|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935904|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935905|NCT00658541|Zolpidem|zolpidem|mesh-list
1935906|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1935907|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1935908|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935909|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935910|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1935911|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
1935912|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
1935913|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935914|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935915|NCT00658567|Pimavanserin|pimavanserin|mesh-list
1935916|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1935917|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1935918|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1935919|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1935920|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935921|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935922|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1935923|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1935924|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1935925|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
1935926|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935927|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935928|NCT00658606|Alefacept|alefacept|mesh-list
1935929|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
1935930|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
1935931|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935932|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1935933|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1935934|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1935935|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1935936|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1935937|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
1935938|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935939|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935940|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935941|NCT00658632|Esomeprazole|esomeprazole|mesh-list
1935942|NCT00658632|Rabeprazole|rabeprazole|mesh-list
1935943|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1935944|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935945|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1935946|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935947|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935948|NCT00658658|Panitumumab|panitumumab|mesh-list
1935949|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935950|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935951|NCT00658684|Fesoterodine|fesoterodine|mesh-list
1935952|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1935953|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1935954|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
1935955|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1935956|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935957|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935958|NCT00658684|Urological Agents|urological agents|mesh-ancestor
1935959|NCT00658697|Bevacizumab|bevacizumab|mesh-list
1935960|NCT00658697|Docetaxel|docetaxel|mesh-list
1935961|NCT00658697|Bicalutamide|bicalutamide|mesh-list
1935962|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1935963|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1935964|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1935965|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1935966|NCT00658697|Growth Substances|growth substances|mesh-ancestor
1935967|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935968|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
1935969|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
1935970|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
1935971|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
1935972|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935973|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
1935974|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
1935975|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935976|NCT00658736|Triamcinolone|triamcinolone|mesh-list
1935977|NCT00658736|Bupivacaine|bupivacaine|mesh-list
1935978|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
1935979|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
1935980|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1935981|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935982|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
1935983|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1935984|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1935985|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
1935986|NCT00658736|Hormones|hormones|mesh-ancestor
1935987|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1935988|NCT00658775|Esomeprazole|esomeprazole|mesh-list
1935989|NCT00658775|Rabeprazole|rabeprazole|mesh-list
1935990|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1935991|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1935992|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1935993|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1935994|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1935995|NCT00658788|Calcitriol|calcitriol|mesh-list
1935996|NCT00658788|Clobetasol|clobetasol|mesh-list
1935997|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1935998|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1935999|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1936000|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936001|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936002|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1936003|NCT00658788|Vitamins|vitamins|mesh-ancestor
1936004|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
1936005|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1936006|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936007|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
1936008|NCT00658788|Hormones|hormones|mesh-ancestor
1936009|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936010|NCT00658814|Azacitidine|azacitidine|mesh-list
1936011|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
1936012|NCT00658814|Calicheamicins|calicheamicins|mesh-list
1936013|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936014|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
1936015|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936016|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936017|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936018|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936019|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1936020|NCT00659061|Micronutrients|micronutrients|mesh-list
1936021|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936022|NCT00659165|Insulin|insulin|mesh-list
1936023|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1936024|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
1936025|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
1936026|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936027|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936028|NCT00659230|Dopamine|dopamine|mesh-list
1936029|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1936030|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
1936031|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
1936032|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936033|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936034|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
1936035|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936036|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936037|NCT00659230|Protective Agents|protective agents|mesh-ancestor
1936038|NCT00659269|Vitamins|vitamins|mesh-list
1936039|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
1936040|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
1936041|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
1936042|NCT00659269|Pyridoxal|pyridoxal|mesh-list
1936043|NCT00659269|Pyridoxine|pyridoxine|mesh-list
1936044|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
1936045|NCT00659269|Paclitaxel|paclitaxel|mesh-list
1936046|NCT00659269|Vincristine|vincristine|mesh-list
1936047|NCT00659269|Vinorelbine|vinorelbine|mesh-list
1936048|NCT00659269|Docetaxel|docetaxel|mesh-list
1936049|NCT00659269|Cisplatin|cisplatin|mesh-list
1936050|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
1936051|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1936052|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936053|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936054|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936055|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936056|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936057|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
1936058|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936059|NCT00659269|Hematinics|hematinics|mesh-ancestor
1936060|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
1936061|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936062|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936063|NCT00659360|Saracatinib|saracatinib|mesh-list
1936064|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936065|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936066|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936067|NCT00659373|Tamoxifen|tamoxifen|mesh-list
1936068|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1936069|NCT00659373|Exemestane|exemestane|mesh-list
1936070|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1936071|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
1936072|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936073|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936074|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1936075|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936076|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1936077|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1936078|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1936079|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1936080|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1936081|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936082|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936083|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
1936084|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1936085|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
1936086|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1936087|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1936088|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
1936089|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936090|NCT00659438|Bicalutamide|bicalutamide|mesh-list
1936091|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
1936092|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
1936093|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936094|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936095|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936096|NCT00659490|Naproxen|naproxen|mesh-list
1936097|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1936098|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936099|NCT00659490|Analgesics|analgesics|mesh-ancestor
1936100|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
1936101|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936102|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936103|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936104|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936105|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
1936106|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1936107|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936108|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936109|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
1936110|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
1936111|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1936112|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1936113|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936114|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936115|NCT00659529|Urological Agents|urological agents|mesh-ancestor
1936116|NCT00659581|Telmisartan|telmisartan|mesh-list
1936117|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1936118|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1936119|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1936120|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936121|NCT00659633|Lidocaine|lidocaine|mesh-list
1936122|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
1936123|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
1936124|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936125|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936126|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
1936127|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936128|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1936129|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1936130|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1936131|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936132|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936148|NCT00659737|Scopolamine|scopolamine|mesh-list
1936149|NCT00659737|Aprepitant|aprepitant|mesh-list
1936150|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
1936151|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1936152|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
1936153|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
1936154|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936155|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936156|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936157|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1936158|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936159|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936160|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1936161|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
1936162|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1936163|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
1936164|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1936165|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
1936166|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1936167|NCT00659945|Ondansetron|ondansetron|mesh-list
1936168|NCT00659945|Aprepitant|aprepitant|mesh-list
1936169|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
1936170|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
1936171|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936172|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936173|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936174|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
1936175|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
1936176|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1936177|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
1936178|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936179|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936180|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1936181|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1936182|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936183|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1936184|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1936185|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1936186|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
1936187|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936188|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936189|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936190|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1936191|NCT00660010|Leuprolide|leuprolide|mesh-list
1936192|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1936193|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
1936194|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1936195|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936196|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1936197|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936198|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
1936199|NCT00660023|Hematinics|hematinics|mesh-ancestor
1936200|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1936201|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936202|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936203|NCT00660075|Incretins|incretins|mesh-ancestor
1936204|NCT00660075|Hormones|hormones|mesh-ancestor
1936205|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936206|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1936207|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
1936208|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936209|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936210|NCT00660179|Macitentan|macitentan|mesh-list
1936211|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1936212|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1936213|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936214|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1936215|NCT00660309|Irbesartan|irbesartan|mesh-list
1936216|NCT00660309|Captopril|captopril|mesh-list
1936217|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1936218|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1936219|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1936220|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936221|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1936222|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
1936223|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936224|NCT00660387|Levodopa|levodopa|mesh-list
1936225|NCT00660387|Carbidopa|carbidopa|mesh-list
1936226|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1936227|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1936228|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1936229|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
1936230|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936231|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936232|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936233|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1936234|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936235|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1936236|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
1936237|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
1936238|NCT00660400|Azacitidine|azacitidine|mesh-list
1936239|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936240|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
1936241|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936242|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936243|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936244|NCT00660504|Etoposide|etoposide|mesh-list
1936245|NCT00660504|Amrubicin|amrubicin|mesh-list
1936246|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936247|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1936248|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1936249|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1936250|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936251|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936252|NCT00660517|Fluticasone|fluticasone|mesh-list
1936253|NCT00660517|Xhance|xhance|mesh-list
1936254|NCT00660517|Azelastine|azelastine|mesh-list
1936255|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936256|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1936257|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
1936258|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936259|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936260|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1936261|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
1936262|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
1936263|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1936264|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1936265|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936266|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936267|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1936268|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1936269|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
1936270|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
1936271|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936272|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1936273|NCT00660543|Hematinics|hematinics|mesh-ancestor
1936274|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1936275|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1936276|NCT00660660|Esomeprazole|esomeprazole|mesh-list
1936277|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1936278|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936279|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1936280|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936281|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936282|NCT00660699|Gemcitabine|gemcitabine|mesh-list
1936283|NCT00660699|Docetaxel|docetaxel|mesh-list
1936284|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936285|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
1936286|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936287|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936288|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
1936289|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936290|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936291|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936292|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
1936293|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936294|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936295|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936296|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936297|NCT00660816|Docetaxel|docetaxel|mesh-list
1936298|NCT00660816|Pemetrexed|pemetrexed|mesh-list
1936299|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1936300|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936301|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936302|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936303|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936304|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936305|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936306|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1936307|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1936308|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1936309|NCT00660829|Azelastine|azelastine|mesh-list
1936310|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1936311|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
1936312|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936313|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936314|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1936315|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
1936316|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1936317|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936318|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936319|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1936320|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1936321|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1936322|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
1936323|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
1936324|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936325|NCT00660907|Metformin|metformin|mesh-list
1936326|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
1936327|NCT00660907|Glipizide|glipizide|mesh-list
1936328|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936329|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936330|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1936331|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936332|NCT00660985|Adapalene|adapalene|mesh-list
1936333|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1936334|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936335|NCT00660985|Analgesics|analgesics|mesh-ancestor
1936336|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
1936337|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936338|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936339|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936340|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936341|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
1936342|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
1936343|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1936344|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1936345|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1936346|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936347|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936348|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
1936349|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936350|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936351|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1936352|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936353|NCT00661141|Ethanol|ethanol|mesh-list
1936354|NCT00661141|Fomepizole|fomepizole|mesh-list
1936355|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1936356|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936357|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936358|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936359|NCT00661141|Antidotes|antidotes|mesh-ancestor
1936360|NCT00661141|Protective Agents|protective agents|mesh-ancestor
1936361|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936362|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936363|NCT00661193|Paclitaxel|paclitaxel|mesh-list
1936364|NCT00661193|Carboplatin|carboplatin|mesh-list
1936365|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1936366|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1936367|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936368|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936369|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936370|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936371|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936372|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1936373|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936374|NCT00661362|Metformin|metformin|mesh-list
1936375|NCT00661362|Saxagliptin|saxagliptin|mesh-list
1936376|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936377|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936378|NCT00661362|Incretins|incretins|mesh-ancestor
1936379|NCT00661362|Hormones|hormones|mesh-ancestor
1936380|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936381|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1936382|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
1936383|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936384|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936385|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
1936386|NCT00661388|Hematinics|hematinics|mesh-ancestor
1936387|NCT00661427|Cetuximab|cetuximab|mesh-list
1936388|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936389|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936390|NCT00661453|Valproic Acid|valproic acid|mesh-list
1936391|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
1936392|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936393|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936394|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
1936395|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936396|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936397|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
1936398|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1936399|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936400|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1936401|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1936402|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1936403|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1936404|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1936405|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1936406|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
1936407|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936408|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936409|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936410|NCT00661492|Cetuximab|cetuximab|mesh-list
1936411|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
1936412|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936413|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936414|NCT00661492|Analgesics|analgesics|mesh-ancestor
1936415|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
1936416|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936417|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936418|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1936419|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1936420|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936421|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936422|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
1936423|NCT00661505|Hematinics|hematinics|mesh-ancestor
1936424|NCT00661531|Anastrozole|anastrozole|mesh-list
1936425|NCT00661531|Estradiol|estradiol|mesh-list
1936426|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1936427|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936428|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1936429|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1936430|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936431|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936432|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1936433|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
1936434|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936435|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936436|NCT00661531|Estrogens|estrogens|mesh-ancestor
1936437|NCT00661531|Hormones|hormones|mesh-ancestor
1936438|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
1936439|NCT00661544|Melphalan|melphalan|mesh-list
1936440|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
1936441|NCT00661544|Vitamins|vitamins|mesh-ancestor
1936442|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
1936443|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936444|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1936445|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
1936446|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936447|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936448|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1936449|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936450|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
1936451|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
1936452|NCT00661544|Protective Agents|protective agents|mesh-ancestor
1936453|NCT00661583|Ranibizumab|ranibizumab|mesh-list
1936454|NCT00661583|Mitomycins|mitomycins|mesh-list
1936455|NCT00661583|Mitomycin|mitomycin|mesh-list
1936456|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1936457|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1936458|NCT00661583|Growth Substances|growth substances|mesh-ancestor
1936459|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936460|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
1936461|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936462|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1936463|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
1936464|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936465|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1936466|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936467|NCT00661622|Molgramostim|molgramostim|mesh-list
1936468|NCT00661622|Sargramostim|sargramostim|mesh-list
1936469|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
1936470|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936471|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936472|NCT00661661|Tofacitinib|tofacitinib|mesh-list
1936473|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1936474|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936475|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936476|NCT00661674|Palonosetron|palonosetron|mesh-list
1936477|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
1936478|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
1936479|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
1936480|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936481|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936482|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936483|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1936484|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1936485|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
1936486|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936487|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936488|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
1936489|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
1936490|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1936491|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
1936492|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
1936493|NCT00661713|Vaccines|vaccines|mesh-list
1936494|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
1936495|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936496|NCT00661726|Decitabine|decitabine|mesh-list
1936497|NCT00661726|Azacitidine|azacitidine|mesh-list
1936498|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936499|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
1936500|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936501|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936502|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936503|NCT00661778|Bevacizumab|bevacizumab|mesh-list
1936504|NCT00661778|Docetaxel|docetaxel|mesh-list
1936505|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936506|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936507|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1936508|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1936509|NCT00661778|Growth Substances|growth substances|mesh-ancestor
1936510|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936511|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
1936512|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936513|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936514|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936515|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936516|NCT00661830|Gemcitabine|gemcitabine|mesh-list
1936517|NCT00661830|Sorafenib|sorafenib|mesh-list
1936518|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936519|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
1936520|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936521|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936522|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
1936523|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936524|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936525|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936526|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
1936527|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936528|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1936529|NCT00661895|Metoprolol|metoprolol|mesh-list
1936530|NCT00661895|Atenolol|atenolol|mesh-list
1936531|NCT00661895|Amlodipine|amlodipine|mesh-list
1936532|NCT00661895|Valsartan|valsartan|mesh-list
1936533|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1936534|NCT00661895|Clonidine|clonidine|mesh-list
1936535|NCT00661895|Lisinopril|lisinopril|mesh-list
1936536|NCT00661895|Doxazosin|doxazosin|mesh-list
1936537|NCT00661895|Hydralazine|hydralazine|mesh-list
1936538|NCT00661895|Nifedipine|nifedipine|mesh-list
1936539|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1936540|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1936541|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936542|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936543|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1936544|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936545|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
1936546|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1936547|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1936548|NCT00661895|Diuretics|diuretics|mesh-ancestor
1936549|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
1936550|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1936551|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1936552|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
1936553|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
1936554|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936555|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1936556|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1936557|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1936558|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
1936559|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936560|NCT00661895|Analgesics|analgesics|mesh-ancestor
1936561|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
1936562|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1936563|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1936564|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1936565|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
1936566|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1936567|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1936568|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
1936569|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936570|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1936571|NCT00661895|Protective Agents|protective agents|mesh-ancestor
1936572|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1936573|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1936574|NCT00661960|Efavirenz|efavirenz|mesh-list
1936575|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
1936576|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1936577|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1936578|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936579|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936580|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
1936581|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936582|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1936583|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1936584|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1936585|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1936586|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1936587|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1936588|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1936589|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1936590|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1936591|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1936592|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
1936593|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
1936594|NCT00661999|Hematinics|hematinics|mesh-ancestor
1936595|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
1936596|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1936597|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1936598|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936599|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
1936600|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1936601|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
1936602|NCT00662025|Capecitabine|capecitabine|mesh-list
1936603|NCT00662025|Sunitinib|sunitinib|mesh-list
1936604|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936605|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
1936606|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936607|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936608|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1936609|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1936610|NCT00662025|Growth Substances|growth substances|mesh-ancestor
1936611|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936612|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
1936613|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1936614|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936615|NCT00662038|Pirfenidone|pirfenidone|mesh-list
1936616|NCT00662038|Analgesics|analgesics|mesh-ancestor
1936617|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
1936618|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936619|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936620|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1936621|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936622|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936623|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936624|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936625|NCT00662129|Gemcitabine|gemcitabine|mesh-list
1936626|NCT00662129|Paclitaxel|paclitaxel|mesh-list
1936627|NCT00662129|Bevacizumab|bevacizumab|mesh-list
1936628|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1936629|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1936630|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936631|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936632|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936633|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936634|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936635|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936636|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1936637|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1936638|NCT00662129|Growth Substances|growth substances|mesh-ancestor
1936639|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936640|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
1936641|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936642|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
1936643|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
1936644|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936645|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936646|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936647|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
1936648|NCT00662155|Zolpidem|zolpidem|mesh-list
1936649|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1936650|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1936651|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936652|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936653|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1936654|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
1936655|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
1936656|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936657|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936658|NCT00662259|Alprazolam|alprazolam|mesh-list
1936659|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1936660|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936661|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936662|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1936663|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1936664|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1936665|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
1936666|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
1936667|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936668|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936669|NCT00662298|Prednisolone|prednisolone|mesh-list
1936670|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936671|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
1936672|NCT00662298|Hormones|hormones|mesh-ancestor
1936673|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936674|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936675|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1936676|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936677|NCT00662311|Paclitaxel|paclitaxel|mesh-list
1936678|NCT00662311|Vorinostat|vorinostat|mesh-list
1936679|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1936680|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936681|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936682|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936683|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936684|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936685|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1936686|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936687|NCT00662363|Lubiprostone|lubiprostone|mesh-list
1936688|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1936689|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936690|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936691|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1936692|NCT00662532|Minocycline|minocycline|mesh-list
1936693|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936694|NCT00662545|Tenofovir|tenofovir|mesh-list
1936695|NCT00662545|Lamivudine|lamivudine|mesh-list
1936696|NCT00662545|Emtricitabine|emtricitabine|mesh-list
1936697|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1936698|NCT00662545|Entecavir|entecavir|mesh-list
1936699|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1936700|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
1936701|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936702|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1936703|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1936704|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936705|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936706|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1936707|NCT00662558|Celecoxib|celecoxib|mesh-list
1936708|NCT00662558|Tramadol|tramadol|mesh-list
1936709|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1936710|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936711|NCT00662558|Analgesics|analgesics|mesh-ancestor
1936712|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
1936713|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936714|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936715|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936716|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936717|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1936718|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1936719|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936720|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936721|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1936722|NCT00662558|Narcotics|narcotics|mesh-ancestor
1936723|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936724|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1936725|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1936726|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936727|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936728|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
1936729|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936730|NCT00662675|Pancrelipase|pancrelipase|mesh-list
1936731|NCT00662675|Pancreatin|pancreatin|mesh-list
1936732|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936733|NCT00662818|Acetaminophen|acetaminophen|mesh-list
1936734|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936735|NCT00662818|Analgesics|analgesics|mesh-ancestor
1936736|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
1936737|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936738|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936739|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
1936740|NCT00662831|Dalteparin|dalteparin|mesh-list
1936741|NCT00662831|Tinzaparin|tinzaparin|mesh-list
1936742|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1936743|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
1936744|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1936745|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1936746|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936747|NCT00662857|Insulin|insulin|mesh-list
1936748|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1936749|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936750|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936751|NCT00662909|Mirabegron|mirabegron|mesh-list
1936752|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1936753|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1936754|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1936755|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
1936756|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936757|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936758|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936759|NCT00662909|Urological Agents|urological agents|mesh-ancestor
1936760|NCT00663039|Oxytocin|oxytocin|mesh-list
1936761|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
1936762|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1936838|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
1936763|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936776|NCT00663117|Naltrexone|naltrexone|mesh-list
1936777|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1936778|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1936779|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936780|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
1936781|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936782|NCT00663169|Dexamethasone|dexamethasone|mesh-list
1936783|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
1936784|NCT00663169|BB 1101|bb 1101|mesh-list
1936785|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1936786|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936787|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
1936788|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
1936789|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936790|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936791|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936792|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
1936793|NCT00663169|Hormones|hormones|mesh-ancestor
1936794|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936795|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1936796|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936797|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
1936798|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936799|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936800|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
1936801|NCT00663234|Atorvastatin|atorvastatin|mesh-list
1936802|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1936803|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1936804|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
1936805|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936806|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1936807|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1936808|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936809|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
1936810|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1936811|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936812|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936813|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936814|NCT00663403|Daptomycin|daptomycin|mesh-list
1936815|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1936816|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936817|NCT00663702|Abatacept|abatacept|mesh-list
1936818|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1936819|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936820|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936821|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936822|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
1936823|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936824|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936825|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
1936826|NCT00663793|Finasteride|finasteride|mesh-list
1936827|NCT00663793|Testosterone|testosterone|mesh-list
1936828|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
1936829|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
1936830|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1936831|NCT00663793|Acyline|acyline|mesh-list
1936832|NCT00663793|Androgens|androgens|mesh-ancestor
1936833|NCT00663793|Hormones|hormones|mesh-ancestor
1936834|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936835|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936836|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1936837|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936839|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1936840|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1936841|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936842|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936843|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
1936844|NCT00663793|Urological Agents|urological agents|mesh-ancestor
1936845|NCT00663858|Cetrorelix|cetrorelix|mesh-list
1936846|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1936847|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
1936848|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1936849|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936850|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
1936851|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1936852|NCT00663962|Pregabalin|pregabalin|mesh-list
1936853|NCT00663962|Analgesics|analgesics|mesh-ancestor
1936854|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
1936855|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936856|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936857|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
1936858|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1936859|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936860|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936861|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1936862|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1936863|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1936864|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936865|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1936866|NCT00664105|Carboplatin|carboplatin|mesh-list
1936867|NCT00664105|Docetaxel|docetaxel|mesh-list
1936868|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936869|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936870|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936871|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936872|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936873|NCT00664209|Amoxicillin|amoxicillin|mesh-list
1936874|NCT00664209|Omeprazole|omeprazole|mesh-list
1936875|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1936876|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936877|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1936878|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936879|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1936880|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936881|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936882|NCT00664430|Calcitriol|calcitriol|mesh-list
1936883|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1936884|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936885|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1936886|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1936887|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936888|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1936889|NCT00664430|Vitamins|vitamins|mesh-ancestor
1936890|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
1936891|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1936892|NCT00664521|Rituximab|rituximab|mesh-list
1936893|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936894|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936895|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
1936896|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936897|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936898|NCT00664534|Insulin|insulin|mesh-list
1936899|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1936900|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
1936901|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
1936902|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936903|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936904|NCT00664560|Celecoxib|celecoxib|mesh-list
1936905|NCT00664560|Antacids|antacids|mesh-list
1936906|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1936907|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936908|NCT00664560|Analgesics|analgesics|mesh-ancestor
1936909|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
1936910|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936911|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936912|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936913|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936914|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1936915|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1936916|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936917|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936918|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1936919|NCT00664755|Nicotine|nicotine|mesh-list
1936920|NCT00664755|Varenicline|varenicline|mesh-list
1936921|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1936922|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
1936923|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936924|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936925|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1936926|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1936927|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
1936928|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936929|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936930|NCT00664859|Atorvastatin|atorvastatin|mesh-list
1936931|NCT00664859|Fenofibrate|fenofibrate|mesh-list
1936932|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1936933|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1936934|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
1936935|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936936|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1936937|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1936938|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936939|NCT00665002|Sargramostim|sargramostim|mesh-list
1936940|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
1936941|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936942|NCT00665353|Pioglitazone|pioglitazone|mesh-list
1936943|NCT00665353|Ribavirin|ribavirin|mesh-list
1936944|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
1936945|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936946|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
1936947|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1936948|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1936949|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936950|NCT00665366|Valproic Acid|valproic acid|mesh-list
1936951|NCT00665366|Aripiprazole|aripiprazole|mesh-list
1936952|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
1936953|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1936954|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1936955|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1936956|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1936957|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936958|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
1936959|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
1936960|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1936961|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936962|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1936963|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1936964|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
1936965|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1936966|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1936967|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1936968|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1936969|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1936970|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
1936971|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
1936972|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
1936973|NCT00665392|Docetaxel|docetaxel|mesh-list
1936974|NCT00665392|Fluorouracil|fluorouracil|mesh-list
1936975|NCT00665392|Cetuximab|cetuximab|mesh-list
1936976|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1936977|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
1936978|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
1936979|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
1936980|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1936981|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
1936982|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1936983|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1936984|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
1936985|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936986|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1936987|NCT00665431|Celecoxib|celecoxib|mesh-list
1936988|NCT00665431|Antacids|antacids|mesh-list
1936989|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1936990|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1936991|NCT00665431|Analgesics|analgesics|mesh-ancestor
1936992|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
1936993|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1936994|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1936995|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1936996|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1936997|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1936998|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1936999|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937000|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937001|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1937002|NCT00665457|Celecoxib|celecoxib|mesh-list
1937003|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
1937004|NCT00665457|Docetaxel|docetaxel|mesh-list
1937005|NCT00665457|Doxorubicin|doxorubicin|mesh-list
1937006|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1937007|NCT00665457|Capecitabine|capecitabine|mesh-list
1937008|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937009|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
1937010|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937011|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937012|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937013|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
1937014|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937015|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937016|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1937017|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
1937018|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
1937019|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
1937020|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1937021|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1937022|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937023|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937024|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1937025|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
1937026|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1937027|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1937028|NCT00665457|Analgesics|analgesics|mesh-ancestor
1937029|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
1937030|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937031|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937032|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1937033|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1937034|NCT00665470|Aldesleukin|aldesleukin|mesh-list
1937035|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937036|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1937037|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1937038|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
1937039|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937040|NCT00665561|Maraviroc|maraviroc|mesh-list
1937041|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1937042|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1937043|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1937044|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937045|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1937046|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
1937047|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937048|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1937049|NCT00665652|Lenalidomide|lenalidomide|mesh-list
1937050|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
1937051|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937052|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937053|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937054|NCT00665652|Growth Substances|growth substances|mesh-ancestor
1937055|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937056|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937057|NCT00665847|Etravirine|etravirine|mesh-list
1937058|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1937059|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1937060|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937061|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937062|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
1937063|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937064|NCT00666029|Atorvastatin|atorvastatin|mesh-list
1937065|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1937066|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1937067|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
1937068|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937069|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1937070|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1937071|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937072|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
1937073|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
1937074|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1937075|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1937076|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937077|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937078|NCT00666198|Urological Agents|urological agents|mesh-ancestor
1937079|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
1937080|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
1937081|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1937082|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
1937083|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937084|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937085|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937086|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1937087|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
1937088|NCT00666263|Antibodies|antibodies|mesh-list
1937089|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
1937090|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1937091|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1937092|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
1937093|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937094|NCT00666276|Linezolid|linezolid|mesh-list
1937095|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1937096|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937097|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1937098|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937099|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937100|NCT00666328|Clevidipine|clevidipine|mesh-list
1937101|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1937102|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937103|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937104|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1937105|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937106|NCT00666406|Factor VIII|factor viii|mesh-list
1937107|NCT00666406|Coagulants|coagulants|mesh-ancestor
1937108|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1937109|NCT00666458|Saxagliptin|saxagliptin|mesh-list
1937110|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937111|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937112|NCT00666458|Incretins|incretins|mesh-ancestor
1937113|NCT00666458|Hormones|hormones|mesh-ancestor
1937114|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937115|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1937116|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
1937117|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937118|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937119|NCT00666536|Amlodipine|amlodipine|mesh-list
1937120|NCT00666536|Valsartan|valsartan|mesh-list
1937121|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
1937122|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1937123|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1937124|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937125|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937126|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1937127|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937128|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
1937129|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1937130|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1937131|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
1937132|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
1937133|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937134|NCT00666562|Protective Agents|protective agents|mesh-ancestor
1937135|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937136|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1937137|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1937138|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937139|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1937140|NCT00666588|Cytarabine|cytarabine|mesh-list
1937141|NCT00666588|Etoposide|etoposide|mesh-list
1937142|NCT00666588|Idarubicin|idarubicin|mesh-list
1937143|NCT00666588|Bortezomib|bortezomib|mesh-list
1937144|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
1937145|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937146|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937147|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1937148|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937149|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937150|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937151|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1937152|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
1937153|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
1937154|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937155|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937156|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
1937157|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937158|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1937159|NCT00666666|Acetic Acid|acetic acid|mesh-list
1937160|NCT00666666|Bicalutamide|bicalutamide|mesh-list
1937161|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
1937162|NCT00666666|Gossypol|gossypol|mesh-list
1937163|NCT00666666|Hormones|hormones|mesh-list
1937164|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937165|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937166|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
1937167|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
1937168|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937169|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1937170|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937171|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937172|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1937173|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
1937174|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937175|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1937176|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1937177|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1937178|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
1937179|NCT00666679|Montelukast|montelukast|mesh-list
1937180|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937181|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937182|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1937183|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
1937184|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937185|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937186|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1937187|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1937188|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937189|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937190|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937191|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1937192|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
1937193|NCT00666705|Maraviroc|maraviroc|mesh-list
1937194|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1937195|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1937196|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
1937197|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937198|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1937199|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1937200|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937201|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937202|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1937203|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1937204|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1937205|NCT00666718|Insulin|insulin|mesh-list
1937206|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1937207|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
1937208|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
1937209|NCT00666718|Protamines|protamines|mesh-list
1937210|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937211|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937212|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
1937213|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937214|NCT00666718|Coagulants|coagulants|mesh-ancestor
1937215|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1937216|NCT00666757|Sertraline|sertraline|mesh-list
1937217|NCT00666757|Fluoxetine|fluoxetine|mesh-list
1937218|NCT00666757|Paroxetine|paroxetine|mesh-list
1937219|NCT00666757|Citalopram|citalopram|mesh-list
1937220|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1937221|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1937222|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937223|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937224|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937225|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937226|NCT00666757|Analgesics|analgesics|mesh-ancestor
1937227|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
1937228|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937229|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
1937230|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937231|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
1937232|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1937233|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
1937234|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1937235|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1937236|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1937237|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937238|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
1937239|NCT00666835|Hematinics|hematinics|mesh-ancestor
1937240|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1937241|NCT00666848|Enalapril|enalapril|mesh-list
1937242|NCT00666848|Enalaprilat|enalaprilat|mesh-list
1937243|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937244|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937245|NCT00666848|Incretins|incretins|mesh-ancestor
1937246|NCT00666848|Hormones|hormones|mesh-ancestor
1937247|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937248|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1937249|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
1937250|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937251|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937252|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1937253|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1937254|NCT00666965|Rotigotine|rotigotine|mesh-list
1937255|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
1937256|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
1937257|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937258|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937259|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937260|NCT00666978|Bupropion|bupropion|mesh-list
1937261|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1937262|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
1937263|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937264|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1937265|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1937266|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937267|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937268|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
1937269|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937270|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937271|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1937272|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1937273|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937274|NCT00667004|Ecabet|ecabet|mesh-list
1937275|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1937276|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1937277|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937278|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1937279|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1937280|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
1937281|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937282|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937283|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1937284|NCT00667004|Protective Agents|protective agents|mesh-ancestor
1937285|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937286|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937287|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1937288|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
1937289|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1937290|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937291|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937292|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1937293|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937294|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937295|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
1937296|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937297|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1937298|NCT00667095|Protective Agents|protective agents|mesh-ancestor
1937299|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1937300|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
1937301|NCT00667225|Cantharidin|cantharidin|mesh-list
1937302|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937303|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937304|NCT00667251|Paclitaxel|paclitaxel|mesh-list
1937305|NCT00667251|Docetaxel|docetaxel|mesh-list
1937306|NCT00667251|Trastuzumab|trastuzumab|mesh-list
1937307|NCT00667251|Lapatinib|lapatinib|mesh-list
1937308|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937309|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937310|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
1937311|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
1937312|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
1937313|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937314|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937315|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1937316|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937317|NCT00667277|Bevacizumab|bevacizumab|mesh-list
1937318|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937319|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937320|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937321|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937322|NCT00667277|Growth Substances|growth substances|mesh-ancestor
1937323|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937324|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937325|NCT00667342|Bevacizumab|bevacizumab|mesh-list
1937326|NCT00667342|Doxorubicin|doxorubicin|mesh-list
1937327|NCT00667342|Methotrexate|methotrexate|mesh-list
1937328|NCT00667342|Etoposide|etoposide|mesh-list
1937329|NCT00667342|Ifosfamide|ifosfamide|mesh-list
1937330|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937331|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937332|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937333|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937334|NCT00667342|Growth Substances|growth substances|mesh-ancestor
1937335|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937336|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937337|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1937338|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1937339|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937340|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937341|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937342|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1937343|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
1937344|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937345|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1937346|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
1937347|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937348|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1937349|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937350|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
1937351|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937352|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1937353|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937354|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937355|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
1937356|NCT00667355|Adalimumab|adalimumab|mesh-list
1937357|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937358|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937359|NCT00667368|Metronidazole|metronidazole|mesh-list
1937360|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937361|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1937362|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1937363|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1937364|NCT00667394|Bevacizumab|bevacizumab|mesh-list
1937365|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937366|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937367|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937368|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937369|NCT00667394|Growth Substances|growth substances|mesh-ancestor
1937370|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937371|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937372|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
1937373|NCT00667420|Epirubicin|epirubicin|mesh-list
1937374|NCT00667420|Panitumumab|panitumumab|mesh-list
1937375|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937376|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937377|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1937378|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1937379|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937380|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937381|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937382|NCT00667446|Leuprolide|leuprolide|mesh-list
1937383|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1937384|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
1937385|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937386|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937387|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1937388|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937389|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
1937390|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937391|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937392|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1937393|NCT00667576|Protective Agents|protective agents|mesh-ancestor
1937394|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937395|NCT00667589|Fluocinonide|fluocinonide|mesh-list
1937396|NCT00667589|Tazarotene|tazarotene|mesh-list
1937397|NCT00667589|Emollients|emollients|mesh-list
1937398|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937399|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
1937400|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937401|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
1937402|NCT00667589|Hormones|hormones|mesh-ancestor
1937403|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937404|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937405|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1937406|NCT00667615|Prednisone|prednisone|mesh-list
1937407|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
1937408|NCT00667615|Rituximab|rituximab|mesh-list
1937409|NCT00667615|Etoposide|etoposide|mesh-list
1937410|NCT00667615|Vorinostat|vorinostat|mesh-list
1937411|NCT00667615|Lenograstim|lenograstim|mesh-list
1937412|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937413|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
1937414|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937415|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937416|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937417|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
1937418|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937419|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937420|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1937421|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937422|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937423|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
1937424|NCT00667615|Hormones|hormones|mesh-ancestor
1937425|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937426|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1937427|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937428|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1937429|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937430|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937431|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1937432|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1937433|NCT00667719|Amlodipine|amlodipine|mesh-list
1937434|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1937435|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1937436|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1937437|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937438|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937439|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1937440|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937441|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
1937442|NCT00667719|Diuretics|diuretics|mesh-ancestor
1937443|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
1937444|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1937445|NCT00667732|Exenatide|exenatide|mesh-list
1937446|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937447|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937448|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1937449|NCT00667732|Incretins|incretins|mesh-ancestor
1937450|NCT00667732|Hormones|hormones|mesh-ancestor
1937451|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937452|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
1937453|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
1937454|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937455|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937456|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937457|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
1937458|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1937459|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1937460|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937461|NCT00667862|Panobinostat|panobinostat|mesh-list
1937462|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937463|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1937464|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937465|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937466|NCT00667875|Naltrexone|naltrexone|mesh-list
1937467|NCT00667875|Aripiprazole|aripiprazole|mesh-list
1937468|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1937469|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1937470|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937471|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
1937472|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937473|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
1937474|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937475|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1937476|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1937477|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1937478|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
1937479|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
1937480|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937481|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937482|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1937483|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1937484|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
1937485|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1937486|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1937487|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1937488|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1937489|NCT00667992|Budesonide|budesonide|mesh-list
1937490|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937491|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1937492|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
1937493|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937494|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937495|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937496|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937497|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
1937498|NCT00667992|Hormones|hormones|mesh-ancestor
1937499|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937500|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1937501|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
1937502|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937503|NCT00668200|Vitamin D|vitamin d|mesh-list
1937504|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
1937505|NCT00668200|Calcium|calcium|mesh-list
1937506|NCT00668200|Vitamins|vitamins|mesh-ancestor
1937507|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
1937508|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937509|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1937510|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1937511|NCT00668317|Omeprazole|omeprazole|mesh-list
1937512|NCT00668317|Ranitidine|ranitidine|mesh-list
1937513|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1937514|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1937515|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1937516|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1937517|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937518|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937519|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1937520|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
1937521|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
1937522|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937523|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937524|NCT00668395|Efavirenz|efavirenz|mesh-list
1937525|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1937526|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1937527|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937528|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937529|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
1937530|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937531|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1937532|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1937533|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1937534|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1937535|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1937536|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1937537|NCT00668434|Prednisone|prednisone|mesh-list
1937538|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937539|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
1937540|NCT00668434|Hormones|hormones|mesh-ancestor
1937541|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937542|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937543|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1937544|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937545|NCT00668525|Dexetimide|dexetimide|mesh-list
1937546|NCT00668525|Citalopram|citalopram|mesh-list
1937547|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1937548|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1937549|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937550|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937551|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937552|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
1937553|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937554|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1937555|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
1937556|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937557|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1937558|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1937559|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
1937560|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
1937561|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937562|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1937563|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1937564|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
1937565|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
1937566|NCT00668564|Busulfan|busulfan|mesh-list
1937567|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
1937568|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937569|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
1937570|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937571|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937572|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937573|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
1937574|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937575|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937576|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1937577|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937578|NCT00668707|Melatonin|melatonin|mesh-list
1937579|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
1937580|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937581|NCT00668707|Protective Agents|protective agents|mesh-ancestor
1937582|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937583|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1937584|NCT00668746|Minocycline|minocycline|mesh-list
1937585|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1937586|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937587|NCT00668811|Sunitinib|sunitinib|mesh-list
1937588|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937589|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937590|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937591|NCT00668811|Growth Substances|growth substances|mesh-ancestor
1937592|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937593|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937594|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1937595|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937596|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937597|NCT00668863|Leucovorin|leucovorin|mesh-list
1937598|NCT00668863|Fluorouracil|fluorouracil|mesh-list
1937599|NCT00668863|Irinotecan|irinotecan|mesh-list
1937600|NCT00668863|Sunitinib|sunitinib|mesh-list
1937601|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
1937602|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
1937603|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937604|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1937605|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937606|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937607|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
1937608|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937609|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1937610|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937611|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937612|NCT00668863|Antidotes|antidotes|mesh-ancestor
1937613|NCT00668863|Protective Agents|protective agents|mesh-ancestor
1937614|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
1937615|NCT00668863|Vitamins|vitamins|mesh-ancestor
1937616|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
1937617|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937618|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937619|NCT00668863|Growth Substances|growth substances|mesh-ancestor
1937620|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937621|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1937622|NCT00668902|Pantoprazole|pantoprazole|mesh-list
1937623|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1937624|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1937625|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1937626|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937627|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937628|NCT00669019|Saracatinib|saracatinib|mesh-list
1937629|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937630|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937631|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937632|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
1937633|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1937634|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
1937635|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937636|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
1937637|NCT00669032|Protective Agents|protective agents|mesh-ancestor
1937638|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1937639|NCT00669071|Tretinoin|tretinoin|mesh-list
1937640|NCT00669071|Hydroquinone|hydroquinone|mesh-list
1937641|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937642|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
1937643|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937644|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937645|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
1937646|NCT00669071|Hormones|hormones|mesh-ancestor
1937647|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937648|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937649|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
1937650|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937651|NCT00669071|Protective Agents|protective agents|mesh-ancestor
1937652|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1937653|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1937654|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1937655|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1937656|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937657|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937658|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937659|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937660|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
1937661|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937662|NCT00669162|Docetaxel|docetaxel|mesh-list
1937663|NCT00669162|Leuprolide|leuprolide|mesh-list
1937664|NCT00669162|Goserelin|goserelin|mesh-list
1937665|NCT00669162|Bicalutamide|bicalutamide|mesh-list
1937666|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937667|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
1937668|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
1937669|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
1937670|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937671|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1937672|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
1937673|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937674|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937675|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1937676|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
1937677|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
1937678|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937679|NCT00669240|Varenicline|varenicline|mesh-list
1937680|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1937681|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1937682|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
1937683|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937684|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937685|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937686|NCT00669279|Atenolol|atenolol|mesh-list
1937687|NCT00669279|Carvedilol|carvedilol|mesh-list
1937688|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1937689|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1937690|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
1937691|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937692|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937693|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937694|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1937695|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
1937696|NCT00669279|Protective Agents|protective agents|mesh-ancestor
1937697|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1937698|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937699|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1937700|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
1937701|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1937702|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1937703|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1937704|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
1937705|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
1937706|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937707|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1937708|NCT00669318|Rituximab|rituximab|mesh-list
1937709|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
1937710|NCT00669318|Pentostatin|pentostatin|mesh-list
1937711|NCT00669318|Sargramostim|sargramostim|mesh-list
1937712|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937713|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937714|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
1937715|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937716|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937717|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1937718|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937719|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937720|NCT00669331|Mannitol|mannitol|mesh-list
1937721|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1937722|NCT00669331|Diuretics|diuretics|mesh-ancestor
1937723|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
1937724|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937725|NCT00669383|Betamethasone|betamethasone|mesh-list
1937726|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937727|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
1937728|NCT00669383|Hormones|hormones|mesh-ancestor
1937729|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937730|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937731|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937732|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937733|NCT00669396|Copper|copper|mesh-list
1937734|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
1937735|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1937736|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
1937737|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937738|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937739|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1937740|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1937741|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1937742|NCT00669396|Trace Elements|trace elements|mesh-ancestor
1937743|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
1937744|NCT00669409|Tanezumab|tanezumab|mesh-list
1937745|NCT00669409|Analgesics|analgesics|mesh-ancestor
1937746|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
1937747|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937748|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937749|NCT00669578|Pomalidomide|pomalidomide|mesh-list
1937750|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
1937751|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937752|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937753|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937754|NCT00669578|Growth Substances|growth substances|mesh-ancestor
1937755|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937756|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937757|NCT00669617|Fluticasone|fluticasone|mesh-list
1937758|NCT00669617|Xhance|xhance|mesh-list
1937759|NCT00669617|Albuterol|albuterol|mesh-list
1937760|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1937761|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937762|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1937763|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
1937764|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937765|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937766|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937767|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937768|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937769|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1937770|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1937771|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1937772|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1937773|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
1937774|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937775|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937776|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
1937777|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937778|NCT00669669|Plerixafor|plerixafor|mesh-list
1937779|NCT00669669|Temozolomide|temozolomide|mesh-list
1937780|NCT00669669|Carmustine|carmustine|mesh-list
1937781|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
1937782|NCT00669669|Lenograstim|lenograstim|mesh-list
1937783|NCT00669669|Sargramostim|sargramostim|mesh-list
1937784|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1937785|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
1937786|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937787|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937788|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
1937789|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937790|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937791|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1937792|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1937793|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
1937794|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937795|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937796|NCT00669864|Metformin|metformin|mesh-list
1937797|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
1937798|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
1937799|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1937800|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937801|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937802|NCT00669877|Cytarabine|cytarabine|mesh-list
1937803|NCT00669877|Dexamethasone|dexamethasone|mesh-list
1937804|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
1937805|NCT00669877|Rituximab|rituximab|mesh-list
1937806|NCT00669877|Doxorubicin|doxorubicin|mesh-list
1937807|NCT00669877|Methotrexate|methotrexate|mesh-list
1937808|NCT00669877|Vincristine|vincristine|mesh-list
1937809|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937810|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
1937811|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937812|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937813|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937814|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
1937815|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937816|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937817|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1937818|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937819|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
1937820|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
1937821|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937822|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1937823|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
1937824|NCT00669877|Hormones|hormones|mesh-ancestor
1937825|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937826|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1937827|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937828|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1937829|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1937830|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1937831|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937832|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1937833|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
1937834|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937835|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1937836|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
1937837|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937838|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1937839|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1937840|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
1937841|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937842|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937843|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
1937844|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
1937845|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
1937846|NCT00669955|Amoxicillin|amoxicillin|mesh-list
1937847|NCT00669955|Metronidazole|metronidazole|mesh-list
1937848|NCT00669955|Clarithromycin|clarithromycin|mesh-list
1937849|NCT00669955|Tetracycline|tetracycline|mesh-list
1937850|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
1937851|NCT00669955|Omeprazole|omeprazole|mesh-list
1937852|NCT00669955|Bismuth|bismuth|mesh-list
1937853|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1937854|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937855|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1937856|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1937857|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1937858|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1937859|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1937860|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937861|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937862|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1937863|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1937864|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1937865|NCT00669955|Antacids|antacids|mesh-ancestor
1937866|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
1937867|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1937868|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937869|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937870|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1937871|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1937872|NCT00670046|Valproic Acid|valproic acid|mesh-list
1937873|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
1937874|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937875|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937876|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
1937877|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937878|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937879|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
1937880|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1937881|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1937882|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1937883|NCT00670202|Fasudil|fasudil|mesh-list
1937884|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1937885|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1937886|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937887|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1937888|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937889|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
1937890|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1937891|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1937892|NCT00670228|Insulin|insulin|mesh-list
1937893|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1937894|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
1937895|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
1937896|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937897|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937898|NCT00670241|Betamethasone|betamethasone|mesh-list
1937899|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
1937900|NCT00670241|Calcipotriene|calcipotriene|mesh-list
1937901|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937902|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
1937903|NCT00670241|Hormones|hormones|mesh-ancestor
1937904|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937905|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937906|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937907|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937908|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
1937909|NCT00670267|Nadolol|nadolol|mesh-list
1937910|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1937911|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1937912|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
1937913|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1937914|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937915|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937916|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1937917|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1937918|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
1937919|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
1937920|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1937921|NCT00670306|Cetrorelix|cetrorelix|mesh-list
1937922|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1937923|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
1937924|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1937925|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937926|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
1937927|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937928|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1937929|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1937930|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937931|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937932|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
1937933|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937934|NCT00670748|Aldesleukin|aldesleukin|mesh-list
1937935|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
1937936|NCT00670748|Fludarabine|fludarabine|mesh-list
1937937|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
1937938|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937939|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
1937940|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937941|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1937942|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1937943|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
1937944|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937945|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937946|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1937947|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1937948|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
1937949|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1937950|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1937951|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
1937952|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1937953|NCT00670774|Eculizumab|eculizumab|mesh-list
1937954|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1937955|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1937956|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
1937957|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937958|NCT00670800|Metformin|metformin|mesh-list
1937959|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1937960|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937961|NCT00670930|Omalizumab|omalizumab|mesh-list
1937962|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1937963|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937964|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937965|NCT00670956|Betamethasone|betamethasone|mesh-list
1937966|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1937967|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
1937968|NCT00670956|Hormones|hormones|mesh-ancestor
1937969|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1937970|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937971|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1937972|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
1937973|NCT00670982|Bevacizumab|bevacizumab|mesh-list
1937974|NCT00670982|Trastuzumab|trastuzumab|mesh-list
1937975|NCT00670982|Vinorelbine|vinorelbine|mesh-list
1937976|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1937977|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1937978|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1937979|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1937980|NCT00670982|Growth Substances|growth substances|mesh-ancestor
1937981|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1937982|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
1937983|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1937984|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
1937985|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
1937986|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
1937987|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1937988|NCT00671034|Cytarabine|cytarabine|mesh-list
1937989|NCT00671034|Dexamethasone|dexamethasone|mesh-list
1937990|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
1937991|NCT00671034|Prednisone|prednisone|mesh-list
1937992|NCT00671034|Cortisone|cortisone|mesh-list
1937993|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
1937994|NCT00671034|Doxorubicin|doxorubicin|mesh-list
1937995|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1937996|NCT00671034|Methotrexate|methotrexate|mesh-list
1937997|NCT00671034|Vincristine|vincristine|mesh-list
1937998|NCT00671034|Daunorubicin|daunorubicin|mesh-list
1937999|NCT00671034|Asparaginase|asparaginase|mesh-list
1938000|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
1938001|NCT00671034|Pegaspargase|pegaspargase|mesh-list
1938002|NCT00671034|Thioguanine|thioguanine|mesh-list
1938003|NCT00671034|BB 1101|bb 1101|mesh-list
1938004|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
1938005|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938006|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
1938007|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938008|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938009|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1938010|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
1938011|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938012|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938013|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1938014|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938015|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
1938016|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
1938017|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938018|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1938019|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
1938020|NCT00671034|Hormones|hormones|mesh-ancestor
1938021|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938022|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1938023|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
1938024|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938025|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1938026|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1938027|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1938028|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1938029|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
1938030|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1938031|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1938032|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
1938033|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938034|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1938035|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1938036|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
1938037|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938038|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1938039|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
1938040|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
1938041|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
1938042|NCT00671060|Misoprostol|misoprostol|mesh-list
1938043|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1938044|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
1938045|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1938046|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938047|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1938048|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1938049|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
1938050|NCT00671437|Cetuximab|cetuximab|mesh-list
1938051|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938052|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938053|NCT00671502|Carisoprodol|carisoprodol|mesh-list
1938054|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1938055|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938056|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1938057|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938058|NCT00671515|Pioglitazone|pioglitazone|mesh-list
1938059|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1938060|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938061|NCT00671528|Gentamicins|gentamicins|mesh-list
1938062|NCT00671528|Clotrimazole|clotrimazole|mesh-list
1938063|NCT00671528|Miconazole|miconazole|mesh-list
1938064|NCT00671528|Betamethasone|betamethasone|mesh-list
1938065|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
1938066|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1938067|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
1938068|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1938069|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938070|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
1938071|NCT00671528|Hormones|hormones|mesh-ancestor
1938072|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938073|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938074|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1938075|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
1938076|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938077|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938078|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1938079|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938080|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938081|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1938082|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
1938083|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1938084|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1938085|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1938086|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
1938087|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1938088|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1938089|NCT00671658|Cytarabine|cytarabine|mesh-list
1938090|NCT00671658|Dexamethasone|dexamethasone|mesh-list
1938091|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
1938092|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1938093|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1938094|NCT00671658|Prednisolone|prednisolone|mesh-list
1938095|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
1938096|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
1938097|NCT00671658|Rituximab|rituximab|mesh-list
1938098|NCT00671658|Doxorubicin|doxorubicin|mesh-list
1938099|NCT00671658|Methotrexate|methotrexate|mesh-list
1938100|NCT00671658|Vincristine|vincristine|mesh-list
1938101|NCT00671658|Asparaginase|asparaginase|mesh-list
1938102|NCT00671658|Pegaspargase|pegaspargase|mesh-list
1938103|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1938104|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
1938105|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938106|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
1938107|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938108|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938109|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1938110|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
1938111|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938112|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938113|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1938114|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938115|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
1938116|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
1938117|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938118|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1938119|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
1938120|NCT00671658|Hormones|hormones|mesh-ancestor
1938121|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938345|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
1938122|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1938123|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938124|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1938125|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1938126|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1938127|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938128|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1938129|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
1938130|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1938131|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1938132|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
1938133|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938134|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1938135|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1938136|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
1938137|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938138|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1938139|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
1938140|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
1938141|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
1938142|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1938143|NCT00671658|Protective Agents|protective agents|mesh-ancestor
1938144|NCT00671749|Clindamycin|clindamycin|mesh-list
1938145|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
1938146|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
1938147|NCT00671749|Adapalene|adapalene|mesh-list
1938148|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1938149|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938150|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938151|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1938152|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938153|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938154|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938155|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1938156|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1938157|NCT00671749|Analgesics|analgesics|mesh-ancestor
1938158|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
1938159|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938160|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938161|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938162|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938163|NCT00671788|Dasatinib|dasatinib|mesh-list
1938164|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938165|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938166|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938167|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938168|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1938169|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938170|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938171|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1938172|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938173|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938174|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938175|NCT00671879|Carisoprodol|carisoprodol|mesh-list
1938176|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1938177|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938178|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1938179|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938180|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
1938181|NCT00671931|Propofol|propofol|mesh-list
1938182|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1938183|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938184|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938185|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1938186|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
1938187|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
1938188|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1938189|NCT00671931|Analgesics|analgesics|mesh-ancestor
1938190|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
1938191|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938192|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1938193|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1938194|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1938195|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
1938196|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938197|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938198|NCT00671970|Bevacizumab|bevacizumab|mesh-list
1938199|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1938200|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938201|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938202|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938203|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938204|NCT00671970|Growth Substances|growth substances|mesh-ancestor
1938205|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938206|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938207|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938208|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938209|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938210|NCT00672100|Ropivacaine|ropivacaine|mesh-list
1938211|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
1938212|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
1938213|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938214|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938215|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
1938216|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938217|NCT00672139|Bromides|bromides|mesh-list
1938218|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
1938219|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
1938220|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1938221|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938222|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
1938223|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938224|NCT00672204|Sirolimus|sirolimus|mesh-list
1938225|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
1938226|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1938227|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938228|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938229|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1938230|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938231|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
1938232|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938233|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
1938234|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938235|NCT00672243|Sirolimus|sirolimus|mesh-list
1938236|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1938237|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938238|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938239|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938240|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938241|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938242|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938243|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1938244|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
1938245|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938246|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
1938247|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938248|NCT00672438|Alfentanil|alfentanil|mesh-list
1938249|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1938250|NCT00672438|Narcotics|narcotics|mesh-ancestor
1938251|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938252|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938253|NCT00672438|Analgesics|analgesics|mesh-ancestor
1938254|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
1938255|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938256|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1938257|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
1938258|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
1938259|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
1938260|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1938261|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938262|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
1938263|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938264|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1938265|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938266|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938267|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1938268|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938269|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938270|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938271|NCT00672594|Sunitinib|sunitinib|mesh-list
1938272|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938273|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938274|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938275|NCT00672594|Growth Substances|growth substances|mesh-ancestor
1938276|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938277|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938278|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938279|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938280|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938281|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1938282|NCT00672620|Vortioxetine|vortioxetine|mesh-list
1938283|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1938284|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1938285|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938286|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938287|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938288|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938289|NCT00672620|Analgesics|analgesics|mesh-ancestor
1938290|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
1938291|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938292|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938293|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938294|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
1938295|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1938296|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938297|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938298|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1938299|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
1938300|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1938301|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1938302|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1938303|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1938304|NCT00672646|Naproxen|naproxen|mesh-list
1938305|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1938306|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1938307|NCT00672646|Analgesics|analgesics|mesh-ancestor
1938308|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
1938309|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938310|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938311|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938312|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938313|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
1938314|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1938315|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938316|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938317|NCT00672737|Remifentanil|remifentanil|mesh-list
1938318|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1938319|NCT00672737|Narcotics|narcotics|mesh-ancestor
1938320|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938321|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938322|NCT00672737|Analgesics|analgesics|mesh-ancestor
1938323|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
1938324|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938325|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
1938326|NCT00672841|Clotrimazole|clotrimazole|mesh-list
1938327|NCT00672841|Miconazole|miconazole|mesh-list
1938328|NCT00672841|Anidulafungin|anidulafungin|mesh-list
1938329|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938330|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1938331|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1938332|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1938333|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938334|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938335|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1938336|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
1938337|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938338|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938339|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1938340|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1938341|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1938342|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1938343|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1938344|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1938346|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1938347|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1938348|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
1938349|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938350|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1938351|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1938352|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938353|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938354|NCT00672958|Vortioxetine|vortioxetine|mesh-list
1938355|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938356|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938357|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1938358|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938359|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938360|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938361|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1938362|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1938363|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938364|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938365|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938366|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
1938367|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1938368|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1938369|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1938370|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1938371|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
1938372|NCT00672984|Guanfacine|guanfacine|mesh-list
1938373|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938374|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938375|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1938376|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1938377|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938378|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938379|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938380|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938381|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1938382|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1938383|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1938384|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1938385|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
1938386|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938387|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1938388|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938389|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938390|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938391|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938392|NCT00673075|Carvedilol|carvedilol|mesh-list
1938393|NCT00673075|Nebivolol|nebivolol|mesh-list
1938394|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1938395|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1938396|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
1938397|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938398|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938399|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938400|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1938401|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
1938402|NCT00673075|Protective Agents|protective agents|mesh-ancestor
1938403|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1938404|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938405|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1938406|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
1938407|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1938408|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1938409|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1938410|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1938411|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1938412|NCT00673127|Ketoconazole|ketoconazole|mesh-list
1938413|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
1938414|NCT00673127|Dutasteride|dutasteride|mesh-list
1938415|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938416|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
1938417|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938418|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1938419|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1938420|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938421|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938422|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1938423|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
1938424|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938425|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938426|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1938427|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1938428|NCT00673153|Vorinostat|vorinostat|mesh-list
1938429|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
1938430|NCT00673153|Calicheamicins|calicheamicins|mesh-list
1938431|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938432|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1938433|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938434|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938435|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938436|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1938437|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
1938438|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1938439|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938440|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1938441|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938442|NCT00673244|Furosemide|furosemide|mesh-list
1938443|NCT00673244|Diuretics|diuretics|mesh-ancestor
1938444|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
1938445|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938446|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1938447|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938448|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938449|NCT00673387|Pramlintide|pramlintide|mesh-list
1938450|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
1938451|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1938452|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938453|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
1938454|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1938455|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
1938456|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938457|NCT00673439|PENTA|penta|mesh-list
1938458|NCT00673439|Warfarin|warfarin|mesh-list
1938459|NCT00673439|Fondaparinux|fondaparinux|mesh-list
1938460|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
1938461|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1938462|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
1938463|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1938464|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
1938465|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938466|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938467|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1938468|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1938469|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1938470|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1938471|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1938472|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938473|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938474|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938475|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938476|NCT00673452|Analgesics|analgesics|mesh-ancestor
1938477|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
1938478|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938479|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938480|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938481|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
1938482|NCT00673465|Metformin|metformin|mesh-list
1938483|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1938484|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938485|NCT00673673|Bevacizumab|bevacizumab|mesh-list
1938486|NCT00673673|Fluorouracil|fluorouracil|mesh-list
1938487|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938488|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938489|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938490|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938491|NCT00673673|Growth Substances|growth substances|mesh-ancestor
1938492|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938493|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938494|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
1938495|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938496|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1938497|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938498|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
1938499|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
1938500|NCT00673712|Narcotics|narcotics|mesh-ancestor
1938501|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938502|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938503|NCT00673712|Analgesics|analgesics|mesh-ancestor
1938504|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
1938505|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938506|NCT00673738|Docetaxel|docetaxel|mesh-list
1938507|NCT00673738|Cetuximab|cetuximab|mesh-list
1938508|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938509|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
1938510|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
1938511|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
1938512|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938513|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938514|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1938515|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
1938516|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1938517|NCT00673790|Losartan|losartan|mesh-list
1938518|NCT00673790|Lisinopril|lisinopril|mesh-list
1938519|NCT00673790|Nebivolol|nebivolol|mesh-list
1938520|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1938521|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1938522|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1938523|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1938524|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938525|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1938526|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
1938527|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938528|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1938529|NCT00673790|Protective Agents|protective agents|mesh-ancestor
1938530|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938531|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
1938532|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1938533|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1938534|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1938535|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
1938536|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938537|NCT00673816|Sunitinib|sunitinib|mesh-list
1938538|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938539|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938540|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938541|NCT00673816|Growth Substances|growth substances|mesh-ancestor
1938542|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938543|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938544|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938545|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938546|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938547|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1938548|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
1938549|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1938550|NCT00673881|Choline|choline|mesh-list
1938551|NCT00673881|Fenofibrate|fenofibrate|mesh-list
1938552|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1938553|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
1938554|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938555|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1938556|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
1938557|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1938558|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
1938559|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1938560|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1938561|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938562|NCT00673894|Incretins|incretins|mesh-ancestor
1938563|NCT00673894|Hormones|hormones|mesh-ancestor
1938564|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938565|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1938566|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
1938567|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938568|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938569|NCT00673920|Methotrexate|methotrexate|mesh-list
1938570|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
1938571|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1938572|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
1938573|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1938574|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938575|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1938576|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
1938577|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938578|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938579|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938580|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938581|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1938582|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938583|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
1938584|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938585|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1938586|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1938587|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
1938588|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1938589|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938590|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1938591|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
1938592|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1938593|NCT00674115|Omeprazole|omeprazole|mesh-list
1938594|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1938595|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1938596|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1938597|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938598|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938599|NCT00674154|Vitamin D|vitamin d|mesh-list
1938600|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
1938601|NCT00674154|Vitamins|vitamins|mesh-ancestor
1938602|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
1938603|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938604|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1938605|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1938606|NCT00674206|Gemcitabine|gemcitabine|mesh-list
1938607|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
1938608|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1938609|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
1938610|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938611|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938612|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
1938613|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938614|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938615|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938616|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
1938617|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938618|NCT00674219|Memantine|memantine|mesh-list
1938619|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1938620|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1938621|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
1938622|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938623|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938624|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938625|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1938626|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1938627|NCT00674323|Ranibizumab|ranibizumab|mesh-list
1938628|NCT00674323|Verteporfin|verteporfin|mesh-list
1938629|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938630|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938631|NCT00674323|Growth Substances|growth substances|mesh-ancestor
1938632|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938633|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938634|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938635|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1938636|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938637|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
1938638|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938639|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
1938640|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938641|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938642|NCT00674570|Cycloserine|cycloserine|mesh-list
1938643|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
1938644|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938645|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1938646|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938647|NCT00674570|Renal Agents|renal agents|mesh-ancestor
1938648|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1938649|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
1938650|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938651|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
1938652|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938653|NCT00674583|Vaccines|vaccines|mesh-list
1938654|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
1938655|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938656|NCT00674609|Nabiximols|nabiximols|mesh-list
1938657|NCT00674609|Analgesics|analgesics|mesh-ancestor
1938658|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
1938659|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938660|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938661|NCT00674661|Riboflavin|riboflavin|mesh-list
1938662|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1938663|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1938664|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
1938665|NCT00674661|Vitamins|vitamins|mesh-ancestor
1938666|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
1938667|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938668|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1938669|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
1938670|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
1938671|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938672|NCT00674739|Imiquimod|imiquimod|mesh-list
1938673|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1938674|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
1938675|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938676|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938677|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
1938678|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1938679|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938680|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938681|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1938682|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938683|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938684|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938685|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1938686|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938687|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938688|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938689|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938690|NCT00675025|Donepezil|donepezil|mesh-list
1938691|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1938692|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938693|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938694|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
1938695|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938696|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938697|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
1938698|NCT00675259|Paclitaxel|paclitaxel|mesh-list
1938699|NCT00675259|Bevacizumab|bevacizumab|mesh-list
1938700|NCT00675259|Carboplatin|carboplatin|mesh-list
1938701|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1938702|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938703|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
1938704|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
1938705|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
1938706|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938707|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938708|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938709|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938710|NCT00675259|Growth Substances|growth substances|mesh-ancestor
1938711|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938712|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938713|NCT00675428|Natalizumab|natalizumab|mesh-list
1938714|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
1938715|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938716|NCT00675441|Lenalidomide|lenalidomide|mesh-list
1938717|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
1938718|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938719|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938720|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938721|NCT00675441|Growth Substances|growth substances|mesh-ancestor
1938722|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938723|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938724|NCT00675506|Hormones|hormones|mesh-list
1938725|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
1938726|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938727|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938728|NCT00675584|Budesonide|budesonide|mesh-list
1938729|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938730|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1938731|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
1938732|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938733|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938734|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1938735|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
1938736|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
1938737|NCT00675584|Hormones|hormones|mesh-ancestor
1938738|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938739|NCT00675597|Bevacizumab|bevacizumab|mesh-list
1938740|NCT00675597|Docetaxel|docetaxel|mesh-list
1938741|NCT00675597|Vinorelbine|vinorelbine|mesh-list
1938742|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938743|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938744|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938745|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938746|NCT00675597|Growth Substances|growth substances|mesh-ancestor
1938747|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938748|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938749|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
1938750|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
1938751|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
1938752|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938753|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1938754|NCT00675792|Bromides|bromides|mesh-list
1938755|NCT00675792|Rocuronium|rocuronium|mesh-list
1938756|NCT00675792|Neostigmine|neostigmine|mesh-list
1938757|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
1938758|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1938759|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1938760|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1938761|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938762|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938763|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1938764|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938765|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938766|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
1938767|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938768|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1938769|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
1938770|NCT00675909|Midazolam|midazolam|mesh-list
1938771|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1938772|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1938773|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938774|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938775|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1938776|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938777|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938778|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1938779|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
1938780|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
1938781|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
1938782|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
1938783|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938784|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938785|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
1938786|NCT00675922|Mafenide|mafenide|mesh-list
1938787|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1938788|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938789|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938790|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1938791|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938792|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938793|NCT00675948|Nabiximols|nabiximols|mesh-list
1938794|NCT00675948|Analgesics|analgesics|mesh-ancestor
1938795|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
1938796|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938797|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938798|NCT00675987|Losartan|losartan|mesh-list
1938799|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1938800|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1938801|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1938802|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1938803|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938804|NCT00676091|Vaccines|vaccines|mesh-list
1938805|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1938806|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
1938807|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938808|NCT00676130|Trimethoprim|trimethoprim|mesh-list
1938809|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1938810|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
1938811|NCT00676130|Cephalexin|cephalexin|mesh-list
1938812|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1938813|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938814|NCT00676130|Renal Agents|renal agents|mesh-ancestor
1938815|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
1938816|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1938817|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1938818|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1938819|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938820|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938821|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1938822|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1938823|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1938824|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938825|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
1938826|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1938827|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
1938828|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938829|NCT00676195|Expectorants|expectorants|mesh-ancestor
1938830|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
1938831|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1938832|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
1938833|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938834|NCT00676195|Protective Agents|protective agents|mesh-ancestor
1938835|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938836|NCT00676195|Antidotes|antidotes|mesh-ancestor
1938837|NCT00676338|Metformin|metformin|mesh-list
1938838|NCT00676338|Pioglitazone|pioglitazone|mesh-list
1938839|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1938840|NCT00676338|Exenatide|exenatide|mesh-list
1938841|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1938842|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938843|NCT00676338|Incretins|incretins|mesh-ancestor
1938844|NCT00676338|Hormones|hormones|mesh-ancestor
1938845|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938846|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1938847|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
1938848|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938849|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938850|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1938851|NCT00676364|Lidocaine|lidocaine|mesh-list
1938852|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
1938853|NCT00676364|Anesthetics|anesthetics|mesh-list
1938854|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938855|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938856|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
1938857|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938858|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1938859|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1938860|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1938861|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938862|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938863|NCT00676403|Pregabalin|pregabalin|mesh-list
1938864|NCT00676403|Analgesics|analgesics|mesh-ancestor
1938865|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
1938866|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1938867|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938868|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
1938869|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1938870|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938871|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938872|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1938873|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1938874|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1938875|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1938876|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938877|NCT00676520|Everolimus|everolimus|mesh-list
1938878|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938879|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938880|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
1938881|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938882|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
1938883|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938884|NCT00676650|Prednisone|prednisone|mesh-list
1938885|NCT00676650|Sunitinib|sunitinib|mesh-list
1938886|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1938887|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
1938888|NCT00676650|Hormones|hormones|mesh-ancestor
1938889|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938890|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938891|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1938892|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938893|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1938894|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1938895|NCT00676650|Growth Substances|growth substances|mesh-ancestor
1938896|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
1938897|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938898|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938899|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938900|NCT00676663|Exemestane|exemestane|mesh-list
1938901|NCT00676663|Entinostat|entinostat|mesh-list
1938902|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938903|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1938904|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1938905|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938906|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938907|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1938908|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
1938909|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938910|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938911|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1938912|NCT00676676|Testosterone|testosterone|mesh-list
1938913|NCT00676676|Androgens|androgens|mesh-ancestor
1938914|NCT00676676|Hormones|hormones|mesh-ancestor
1938915|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1938916|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938925|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
1938926|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1938927|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
1938928|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938929|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938930|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1938931|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
1938932|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938933|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938934|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1938935|NCT00676897|Simvastatin|simvastatin|mesh-list
1938936|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1938937|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1938938|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
1938939|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938940|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1938941|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1938942|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938943|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
1938944|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938945|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1938946|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938947|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938948|NCT00677352|Sertraline|sertraline|mesh-list
1938949|NCT00677352|Paroxetine|paroxetine|mesh-list
1938950|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
1938951|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1938952|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1938953|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1938954|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1938955|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938956|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1938957|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
1938958|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938959|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1938960|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1938961|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1938962|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938963|NCT00677365|Levofloxacin|levofloxacin|mesh-list
1938964|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1938965|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938966|NCT00677365|Renal Agents|renal agents|mesh-ancestor
1938967|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938968|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1938969|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1938970|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1938971|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1938972|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938973|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1938974|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1938975|NCT00677534|Vitamin D|vitamin d|mesh-list
1938976|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
1938977|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
1938978|NCT00677534|Vitamins|vitamins|mesh-ancestor
1938979|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
1938980|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1938981|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1938982|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1938983|NCT00677833|Azithromycin|azithromycin|mesh-list
1938984|NCT00677833|Chloroquine|chloroquine|mesh-list
1938985|NCT00677833|Lumefantrine|lumefantrine|mesh-list
1938986|NCT00677833|Artemether|artemether|mesh-list
1938987|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1938988|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1938989|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1938990|NCT00677833|Amebicides|amebicides|mesh-ancestor
1938991|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1938992|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1938993|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
1938994|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1938995|NCT00677924|Zalutumumab|zalutumumab|mesh-list
1938996|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1938997|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1938998|NCT00678015|Masoprocol|masoprocol|mesh-list
1938999|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
1939000|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939001|NCT00678015|Protective Agents|protective agents|mesh-ancestor
1939002|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939003|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1939004|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939005|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1939006|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1939007|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1939008|NCT00678015|Analgesics|analgesics|mesh-ancestor
1939009|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
1939010|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939011|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939012|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939013|NCT00678080|Metformin|metformin|mesh-list
1939014|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939015|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939016|NCT00678210|Tofacitinib|tofacitinib|mesh-list
1939246|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
1939017|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939018|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939019|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939020|NCT00678301|Vaccines|vaccines|mesh-list
1939021|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
1939022|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939023|NCT00678379|Lidocaine|lidocaine|mesh-list
1939024|NCT00678379|Clonidine|clonidine|mesh-list
1939025|NCT00678379|Bupivacaine|bupivacaine|mesh-list
1939026|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
1939027|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
1939028|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939029|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939030|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
1939031|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939032|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1939033|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1939034|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1939035|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1939036|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939037|NCT00678379|Analgesics|analgesics|mesh-ancestor
1939038|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1939039|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
1939040|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
1939041|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1939042|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1939043|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1939044|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
1939045|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939046|NCT00678392|Sorafenib|sorafenib|mesh-list
1939047|NCT00678392|Axitinib|axitinib|mesh-list
1939048|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939049|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939050|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939051|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939052|NCT00678418|Naltrexone|naltrexone|mesh-list
1939053|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1939054|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1939055|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939056|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
1939057|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939058|NCT00678470|Alefacept|alefacept|mesh-list
1939059|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
1939060|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
1939061|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939062|NCT00678535|Capecitabine|capecitabine|mesh-list
1939063|NCT00678535|Cetuximab|cetuximab|mesh-list
1939064|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939065|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1939066|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
1939067|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939068|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1939069|NCT00678561|Tofacitinib|tofacitinib|mesh-list
1939070|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939071|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939072|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939073|NCT00678652|Vaccines|vaccines|mesh-list
1939074|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
1939075|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939076|NCT00678691|Modafinil|modafinil|mesh-list
1939077|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1939078|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939079|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1939080|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1939081|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1939082|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939083|NCT00678795|Nabiximols|nabiximols|mesh-list
1939084|NCT00678795|Analgesics|analgesics|mesh-ancestor
1939085|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
1939086|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939087|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939088|NCT00678834|Tocopherols|tocopherols|mesh-list
1939089|NCT00678834|Vitamin E|vitamin e|mesh-list
1939090|NCT00678834|Tocotrienols|tocotrienols|mesh-list
1939091|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
1939092|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
1939093|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939094|NCT00678834|Protective Agents|protective agents|mesh-ancestor
1939095|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939096|NCT00678834|Vitamins|vitamins|mesh-ancestor
1939097|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
1939098|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
1939099|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
1939100|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939101|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939102|NCT00679029|Gemcitabine|gemcitabine|mesh-list
1939103|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
1939104|NCT00679029|Bevacizumab|bevacizumab|mesh-list
1939105|NCT00679029|Doxorubicin|doxorubicin|mesh-list
1939106|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1939107|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1939108|NCT00679029|Antibodies|antibodies|mesh-list
1939109|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
1939110|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1939111|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939112|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939113|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939114|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
1939115|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939116|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939117|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1939118|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
1939119|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1939120|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939121|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939122|NCT00679029|Growth Substances|growth substances|mesh-ancestor
1939123|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939124|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1939125|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
1939126|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
1939127|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939128|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939129|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1939130|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1939131|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1939132|NCT00679042|Exenatide|exenatide|mesh-list
1939133|NCT00679042|Sirolimus|sirolimus|mesh-list
1939134|NCT00679042|Etanercept|etanercept|mesh-list
1939135|NCT00679042|Tacrolimus|tacrolimus|mesh-list
1939136|NCT00679042|Basiliximab|basiliximab|mesh-list
1939137|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939138|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
1939139|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939140|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1939141|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939142|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939143|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1939144|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939145|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1939146|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939147|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
1939148|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1939149|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1939150|NCT00679042|Analgesics|analgesics|mesh-ancestor
1939151|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
1939152|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939153|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939154|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939155|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939156|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939157|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1939158|NCT00679042|Incretins|incretins|mesh-ancestor
1939159|NCT00679042|Hormones|hormones|mesh-ancestor
1939160|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939161|NCT00679211|Trastuzumab|trastuzumab|mesh-list
1939162|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1939163|NCT00679211|Maytansine|maytansine|mesh-list
1939164|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1939165|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939166|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1939167|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
1939168|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
1939169|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
1939170|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939171|NCT00679289|Interferons|interferons|mesh-list
1939172|NCT00679289|Ecromeximab|ecromeximab|mesh-list
1939173|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939174|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
1939175|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939176|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1939177|NCT00679302|Trimethoprim|trimethoprim|mesh-list
1939178|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1939179|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
1939180|NCT00679302|Simethicone|simethicone|mesh-list
1939181|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1939182|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939183|NCT00679302|Renal Agents|renal agents|mesh-ancestor
1939184|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
1939185|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1939186|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1939187|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1939188|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939189|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939190|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1939191|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1939192|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1939193|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
1939194|NCT00679302|Emollients|emollients|mesh-ancestor
1939195|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
1939196|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1939197|NCT00679341|Docetaxel|docetaxel|mesh-list
1939198|NCT00679341|Trastuzumab|trastuzumab|mesh-list
1939199|NCT00679341|Maytansine|maytansine|mesh-list
1939200|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1939201|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939202|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
1939203|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
1939204|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
1939205|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939206|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1939207|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1939208|NCT00679367|Dexamethasone|dexamethasone|mesh-list
1939209|NCT00679367|Lenalidomide|lenalidomide|mesh-list
1939210|NCT00679367|Melphalan|melphalan|mesh-list
1939211|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939212|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
1939213|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
1939214|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939215|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939216|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939217|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
1939218|NCT00679367|Hormones|hormones|mesh-ancestor
1939219|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939220|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1939221|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939222|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
1939223|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939224|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939225|NCT00679367|Growth Substances|growth substances|mesh-ancestor
1939226|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939227|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1939228|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
1939229|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939230|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1939231|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939232|NCT00679380|Budesonide|budesonide|mesh-list
1939233|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939234|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1939235|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
1939236|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939237|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939238|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1939239|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
1939240|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
1939241|NCT00679380|Hormones|hormones|mesh-ancestor
1939242|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939243|NCT00679432|Budesonide|budesonide|mesh-list
1939244|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939245|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1939247|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939248|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939249|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1939250|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
1939251|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
1939252|NCT00679432|Hormones|hormones|mesh-ancestor
1939253|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939254|NCT00679627|Galantamine|galantamine|mesh-list
1939255|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1939256|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939257|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939258|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
1939259|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939260|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939261|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1939262|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
1939263|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939264|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
1939265|NCT00679783|Olaparib|olaparib|mesh-list
1939266|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1939267|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939268|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939269|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939270|NCT00679939|Metformin|metformin|mesh-list
1939271|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
1939272|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939273|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939274|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1939275|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
1939276|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1939277|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1939278|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
1939279|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939280|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1939281|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1939282|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939283|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
1939284|NCT00680043|Hematinics|hematinics|mesh-ancestor
1939285|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
1939286|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
1939287|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1939288|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
1939289|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939290|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939291|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1939292|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
1939293|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1939294|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1939295|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1939296|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
1939297|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939298|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939299|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
1939300|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1939301|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
1939302|NCT00680121|Benphothiamine|benphothiamine|mesh-list
1939303|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1939304|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
1939305|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939306|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
1939307|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
1939308|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939309|NCT00680186|Warfarin|warfarin|mesh-list
1939310|NCT00680186|Dabigatran|dabigatran|mesh-list
1939311|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
1939312|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
1939313|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1939314|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
1939315|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939316|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939317|NCT00680225|Ranibizumab|ranibizumab|mesh-list
1939318|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939319|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939320|NCT00680225|Growth Substances|growth substances|mesh-ancestor
1939321|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939322|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939323|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939324|NCT00680407|Silymarin|silymarin|mesh-list
1939325|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
1939326|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939327|NCT00680407|Protective Agents|protective agents|mesh-ancestor
1939328|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939329|NCT00680459|Ethanol|ethanol|mesh-list
1939330|NCT00680459|Heparin|heparin|mesh-list
1939331|NCT00680459|Anticoagulants|anticoagulants|mesh-list
1939332|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1939333|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1939334|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939335|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1939336|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939337|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939338|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939339|NCT00680628|Enoxaparin|enoxaparin|mesh-list
1939340|NCT00680628|Tenecteplase|tenecteplase|mesh-list
1939341|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
1939342|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
1939343|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1939344|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1939345|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939346|NCT00680706|Thiamine|thiamine|mesh-list
1939347|NCT00680706|Vitamins|vitamins|mesh-ancestor
1939348|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
1939349|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939350|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
1939351|NCT00680745|Metformin|metformin|mesh-list
1939352|NCT00680745|Pioglitazone|pioglitazone|mesh-list
1939353|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
1939354|NCT00680745|Glimepiride|glimepiride|mesh-list
1939355|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
1939356|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939357|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939358|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1939359|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939360|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1939361|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939362|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
1939363|NCT00680797|Testosterone|testosterone|mesh-list
1939364|NCT00680797|Estrogens|estrogens|mesh-list
1939365|NCT00680797|Androgens|androgens|mesh-ancestor
1939366|NCT00680797|Hormones|hormones|mesh-ancestor
1939367|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939368|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939369|NCT00680823|Ropivacaine|ropivacaine|mesh-list
1939370|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
1939371|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
1939372|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939373|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939374|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
1939375|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939376|NCT00680836|Rifaximin|rifaximin|mesh-list
1939377|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1939378|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939379|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939380|NCT00680901|Capecitabine|capecitabine|mesh-list
1939381|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
1939382|NCT00680901|Lapatinib|lapatinib|mesh-list
1939383|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1939384|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
1939385|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939386|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939387|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939388|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939389|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1939390|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
1939391|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939392|NCT00680953|Denosumab|denosumab|mesh-list
1939393|NCT00680953|Alendronate|alendronate|mesh-list
1939394|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1939395|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939396|NCT00680992|Denosumab|denosumab|mesh-list
1939397|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
1939398|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
1939399|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
1939400|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939401|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1939402|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1939403|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
1939404|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939405|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1939406|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1939407|NCT00681187|Lanreotide|lanreotide|mesh-list
1939408|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939409|NCT00681265|Glycerol|glycerol|mesh-list
1939410|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1939411|NCT00681265|Protective Agents|protective agents|mesh-ancestor
1939412|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939413|NCT00681538|Nabiximols|nabiximols|mesh-list
1939414|NCT00681538|Analgesics|analgesics|mesh-ancestor
1939415|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
1939416|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939417|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939418|NCT00681590|Vitamin D|vitamin d|mesh-list
1939419|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
1939420|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
1939421|NCT00681590|Vitamins|vitamins|mesh-list
1939422|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
1939423|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939424|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1939425|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1939426|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1939427|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
1939428|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1939429|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1939430|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1939431|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939432|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939433|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1939434|NCT00681824|Thrombin|thrombin|mesh-list
1939435|NCT00681824|Aprotinin|aprotinin|mesh-list
1939436|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
1939437|NCT00681824|Coagulants|coagulants|mesh-ancestor
1939438|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1939439|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1939440|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
1939441|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939442|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939443|NCT00681863|Pramipexole|pramipexole|mesh-list
1939444|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
1939445|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939446|NCT00681863|Protective Agents|protective agents|mesh-ancestor
1939447|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939448|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1939449|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1939450|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
1939451|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
1939452|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939453|NCT00681889|Ranibizumab|ranibizumab|mesh-list
1939454|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939455|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939456|NCT00681889|Growth Substances|growth substances|mesh-ancestor
1939457|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939458|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939459|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939460|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
1939461|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1939462|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1939463|NCT00682357|Prednisolone|prednisolone|mesh-list
1939464|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
1939465|NCT00682357|Lidocaine|lidocaine|mesh-list
1939466|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1939467|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
1939468|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
1939469|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
1939470|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939471|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939472|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
1939473|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939474|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1939475|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1939476|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1939477|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1939478|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939479|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939480|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
1939481|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
1939482|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939483|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
1939484|NCT00682357|Hormones|hormones|mesh-ancestor
1939485|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939486|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1939487|NCT00682357|Protective Agents|protective agents|mesh-ancestor
1939488|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1939489|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939490|NCT00682435|Hydromorphone|hydromorphone|mesh-list
1939491|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1939492|NCT00682435|Narcotics|narcotics|mesh-ancestor
1939493|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939494|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939495|NCT00682435|Analgesics|analgesics|mesh-ancestor
1939496|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
1939497|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939498|NCT00682448|Metformin|metformin|mesh-list
1939499|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939500|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939501|NCT00682461|Nicotine|nicotine|mesh-list
1939502|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1939503|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
1939504|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939505|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939506|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1939507|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1939508|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
1939509|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939510|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939511|NCT00682539|Triamcinolone|triamcinolone|mesh-list
1939512|NCT00682539|Bevacizumab|bevacizumab|mesh-list
1939513|NCT00682539|Ranibizumab|ranibizumab|mesh-list
1939514|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1939515|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939516|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939517|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939518|NCT00682539|Growth Substances|growth substances|mesh-ancestor
1939519|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939520|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939521|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939522|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
1939523|NCT00682539|Hormones|hormones|mesh-ancestor
1939524|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939525|NCT00682643|Fluticasone|fluticasone|mesh-list
1939526|NCT00682643|Xhance|xhance|mesh-list
1939527|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939528|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1939529|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
1939530|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939531|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939532|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1939533|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
1939534|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
1939535|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1939536|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
1939537|NCT00682734|Promethazine|promethazine|mesh-list
1939538|NCT00682734|Metoclopramide|metoclopramide|mesh-list
1939539|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1939540|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1939541|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939542|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939543|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
1939544|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
1939545|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
1939546|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939547|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
1939548|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
1939549|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939550|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1939551|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
1939552|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
1939553|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939554|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939555|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1939556|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
1939557|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
1939558|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1939559|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1939560|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
1939561|NCT00682786|Fluorouracil|fluorouracil|mesh-list
1939562|NCT00682786|Irinotecan|irinotecan|mesh-list
1939563|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
1939564|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939565|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1939566|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939567|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939568|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
1939569|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939570|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1939571|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1939572|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939573|NCT00682890|Metformin|metformin|mesh-list
1939574|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939575|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939576|NCT00682929|Dronabinol|dronabinol|mesh-list
1939577|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
1939578|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939579|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1939580|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1939581|NCT00682929|Analgesics|analgesics|mesh-ancestor
1939582|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
1939583|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939584|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1939585|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1939586|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939587|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939588|NCT00682929|Hormones|hormones|mesh-ancestor
1939589|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939590|NCT00683046|Fludarabine|fludarabine|mesh-list
1939591|NCT00683046|Melphalan|melphalan|mesh-list
1939592|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
1939593|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939594|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939595|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939596|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
1939597|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939598|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1939599|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
1939600|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1939601|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1939602|NCT00683085|Vaccines|vaccines|mesh-list
1939603|NCT00683085|Immunologic Factors|immunologic factors|mesh-ancestor
1939604|NCT00683085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939605|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
1939606|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
1939607|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1939608|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939609|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1939610|NCT00683332|Tigecycline|tigecycline|mesh-list
1939611|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1939612|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939613|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1939614|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939615|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939616|NCT00683384|Etanercept|etanercept|mesh-list
1939617|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1939618|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1939619|NCT00683384|Analgesics|analgesics|mesh-ancestor
1939620|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
1939621|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939622|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939623|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939624|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939625|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939626|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939627|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
1939628|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1939629|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
1939630|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939631|NCT00683475|Prednisone|prednisone|mesh-list
1939632|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
1939633|NCT00683475|Ramucirumab|ramucirumab|mesh-list
1939634|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1939635|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939636|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
1939637|NCT00683475|Hormones|hormones|mesh-ancestor
1939638|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939639|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939640|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1939641|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939642|NCT00683475|Analgesics|analgesics|mesh-ancestor
1939643|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
1939644|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939645|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1939646|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1939647|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939648|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939649|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
1939650|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
1939651|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
1939652|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1939653|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1939654|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1939655|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1939656|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939657|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939658|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
1939659|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939660|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1939661|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1939662|NCT00683618|Atorvastatin|atorvastatin|mesh-list
1939663|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1939664|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1939665|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1939666|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
1939667|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939668|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1939669|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1939670|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939671|NCT00683644|Zinc|zinc|mesh-list
1939672|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
1939673|NCT00683644|Trace Elements|trace elements|mesh-ancestor
1939674|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
1939675|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939676|NCT00683644|Astringents|astringents|mesh-ancestor
1939677|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
1939678|NCT00683657|Saxagliptin|saxagliptin|mesh-list
1939679|NCT00683657|Incretins|incretins|mesh-ancestor
1939680|NCT00683657|Hormones|hormones|mesh-ancestor
1939681|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1939682|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939683|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1939684|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
1939685|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939686|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939687|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939688|NCT00683774|Diazoxide|diazoxide|mesh-list
1939689|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1939690|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
1939691|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1939692|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1939693|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1939694|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1939695|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939696|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939697|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939698|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
1939699|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1939700|NCT00683852|Aripiprazole|aripiprazole|mesh-list
1939701|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
1939702|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1939703|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1939704|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1939705|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939706|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939707|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
1939708|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
1939709|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939710|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939711|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1939712|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1939713|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
1939714|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1939715|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1939716|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1939717|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1939718|NCT00683878|Pioglitazone|pioglitazone|mesh-list
1939719|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
1939720|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
1939721|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939722|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939723|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1939724|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939725|NCT00683904|Carboplatin|carboplatin|mesh-list
1939726|NCT00683904|Epothilones|epothilones|mesh-list
1939727|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939728|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
1939729|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
1939730|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
1939731|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939732|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
1939733|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1939734|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939735|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1939736|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
1939737|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1939738|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939739|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939740|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939741|NCT00684073|Buprenorphine|buprenorphine|mesh-list
1939742|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1939743|NCT00684073|Naloxone|naloxone|mesh-list
1939744|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1939745|NCT00684073|Narcotics|narcotics|mesh-ancestor
1939746|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939747|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939748|NCT00684073|Analgesics|analgesics|mesh-ancestor
1939749|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
1939750|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939751|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1939752|NCT00684177|Retapamulin|retapamulin|mesh-list
1939753|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1939754|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939755|NCT00684203|Aspirin|aspirin|mesh-list
1939756|NCT00684203|Clopidogrel|clopidogrel|mesh-list
1939757|NCT00684203|Vorapaxar|vorapaxar|mesh-list
1939758|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1939759|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1939760|NCT00684203|Analgesics|analgesics|mesh-ancestor
1939761|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
1939762|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939763|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939764|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939765|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939766|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1939767|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1939768|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939769|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1939770|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1939771|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939772|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
1939773|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1939774|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1939775|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1939776|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
1939777|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939778|NCT00684242|Lenalidomide|lenalidomide|mesh-list
1939779|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
1939780|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939781|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939782|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939783|NCT00684242|Growth Substances|growth substances|mesh-ancestor
1939784|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939785|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939786|NCT00684307|Vitamin K|vitamin k|mesh-list
1939787|NCT00684307|Warfarin|warfarin|mesh-list
1939788|NCT00684307|Vitamins|vitamins|mesh-ancestor
1939789|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
1939790|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939791|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
1939792|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1939793|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1939794|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939795|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
1939796|NCT00684307|Coagulants|coagulants|mesh-ancestor
1939797|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
1939798|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939799|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939800|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939801|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939802|NCT00684515|Aspirin|aspirin|mesh-list
1939803|NCT00684515|Vorapaxar|vorapaxar|mesh-list
1939804|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1939805|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1939806|NCT00684515|Analgesics|analgesics|mesh-ancestor
1939807|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
1939808|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939809|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939810|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1939811|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1939812|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1939813|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1939814|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939815|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1939816|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1939817|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939818|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
1939819|NCT00684554|Buprenorphine|buprenorphine|mesh-list
1939820|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1939821|NCT00684554|Narcotics|narcotics|mesh-ancestor
1939822|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939823|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939824|NCT00684554|Analgesics|analgesics|mesh-ancestor
1939825|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
1939826|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939827|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1939828|NCT00684567|Temozolomide|temozolomide|mesh-list
1939829|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1939830|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
1939831|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939832|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939833|NCT00684645|Sunitinib|sunitinib|mesh-list
1939834|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939835|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939836|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939837|NCT00684645|Growth Substances|growth substances|mesh-ancestor
1939838|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939839|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939840|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939841|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939842|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939843|NCT00684723|Lovastatin|lovastatin|mesh-list
1939844|NCT00684723|L 647318|l 647318|mesh-list
1939845|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
1939846|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1939847|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1939848|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
1939849|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939850|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1939851|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1939852|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939853|NCT00684762|Cilostazol|cilostazol|mesh-list
1939854|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1939855|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
1939856|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939857|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939858|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1939859|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
1939860|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1939861|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1939862|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939863|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1939864|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
1939865|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1939866|NCT00684762|Protective Agents|protective agents|mesh-ancestor
1939867|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1939868|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1939869|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939870|NCT00684775|Naltrexone|naltrexone|mesh-list
1939871|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1939872|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1939873|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939874|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
1939875|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939876|NCT00684814|Zolpidem|zolpidem|mesh-list
1939877|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1939878|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1939879|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939880|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939881|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1939882|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
1939883|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
1939884|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939885|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939886|NCT00684983|Capecitabine|capecitabine|mesh-list
1939887|NCT00684983|Lapatinib|lapatinib|mesh-list
1939888|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1939889|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1939890|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
1939891|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939892|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939893|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1939894|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939895|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
1939896|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939897|NCT00684996|Bevacizumab|bevacizumab|mesh-list
1939898|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1939899|NCT00684996|Antibodies|antibodies|mesh-list
1939900|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
1939901|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1939902|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939903|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1939904|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1939905|NCT00684996|Growth Substances|growth substances|mesh-ancestor
1939906|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939907|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
1939908|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
1939909|NCT00685139|Zonisamide|zonisamide|mesh-list
1939910|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
1939911|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1939912|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1939913|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939914|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1939915|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939916|NCT00685165|Primidone|primidone|mesh-list
1939917|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
1939918|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
1939919|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
1939920|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939921|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939922|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939923|NCT00685178|Topiramate|topiramate|mesh-list
1939924|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
1939925|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1939926|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939927|NCT00685295|Fentanyl|fentanyl|mesh-list
1939928|NCT00685295|Oxycodone|oxycodone|mesh-list
1939929|NCT00685295|Lansoprazole|lansoprazole|mesh-list
1939930|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
1939931|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1939932|NCT00685295|Narcotics|narcotics|mesh-ancestor
1939933|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939934|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939935|NCT00685295|Analgesics|analgesics|mesh-ancestor
1939936|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
1939937|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939938|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1939939|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1939940|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
1939941|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
1939942|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1939943|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939944|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1939945|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939946|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939947|NCT00685334|Olanzapine|olanzapine|mesh-list
1939948|NCT00685334|Aripiprazole|aripiprazole|mesh-list
1939949|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
1939950|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
1939951|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1939952|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939953|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1939954|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1939955|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1939956|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1939957|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1939958|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1939959|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1939960|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1939961|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939962|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1939963|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
1939964|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
1939965|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
1939966|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
1939967|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1939968|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1939969|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1939970|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1939971|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1939972|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1939973|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1939974|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
1939975|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939976|NCT00685685|Lovastatin|lovastatin|mesh-list
1939977|NCT00685685|L 647318|l 647318|mesh-list
1939978|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
1939979|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1939980|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1939981|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
1939982|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939983|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1939984|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1939985|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939986|NCT00685763|Gemcitabine|gemcitabine|mesh-list
1939987|NCT00685763|Capecitabine|capecitabine|mesh-list
1939988|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1939989|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
1939990|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1939991|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1939992|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
1939993|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1939994|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1939995|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1939996|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
1939997|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1939998|NCT00685802|Cilostazol|cilostazol|mesh-list
1939999|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1940000|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
1940001|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940002|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940003|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1940004|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
1940005|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1940006|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1940007|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940008|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1940009|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
1940010|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1940011|NCT00685802|Protective Agents|protective agents|mesh-ancestor
1940012|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1940013|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1940014|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940024|NCT00685945|Isosorbide|isosorbide|mesh-list
1940025|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
1940026|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
1940027|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
1940028|NCT00685945|Bradykinin|bradykinin|mesh-list
1940029|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
1940030|NCT00685945|Kininogens|kininogens|mesh-list
1940031|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
1940032|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1940033|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1940034|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940035|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940036|NCT00685945|Urological Agents|urological agents|mesh-ancestor
1940037|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1940038|NCT00685945|Diuretics|diuretics|mesh-ancestor
1940039|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
1940040|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940041|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1940042|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1940043|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
1940044|NCT00686127|Lidocaine|lidocaine|mesh-list
1940045|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
1940046|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
1940047|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1940048|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940049|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
1940050|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940051|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1940052|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1940053|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1940054|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940055|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940056|NCT00686166|Capecitabine|capecitabine|mesh-list
1940057|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
1940058|NCT00686166|Cetuximab|cetuximab|mesh-list
1940059|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1940060|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
1940061|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940062|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940063|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1940064|NCT00686231|Lidocaine|lidocaine|mesh-list
1940065|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
1940066|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
1940067|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
1940068|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1940069|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940070|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
1940071|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940072|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1940073|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1940074|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1940075|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940076|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940077|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
1940078|NCT00686335|Prednisone|prednisone|mesh-list
1940079|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940080|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
1940081|NCT00686335|Hormones|hormones|mesh-ancestor
1940082|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940083|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940084|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940085|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940089|NCT00686517|Interferons|interferons|mesh-list
1940090|NCT00686517|Ribavirin|ribavirin|mesh-list
1940091|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
1940092|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
1940093|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940094|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940095|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
1940096|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940097|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
1940098|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940099|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
1940100|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940101|NCT00686543|Posaconazole|posaconazole|mesh-list
1940102|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
1940103|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940104|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1940105|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1940106|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1940107|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1940108|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1940109|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940110|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940111|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1940112|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
1940113|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940114|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940115|NCT00686595|Infliximab|infliximab|mesh-list
1940116|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940117|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940118|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940119|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1940120|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1940121|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940122|NCT00686634|Incretins|incretins|mesh-ancestor
1940123|NCT00686634|Hormones|hormones|mesh-ancestor
1940124|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940125|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1940126|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
1940127|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940128|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940129|NCT00686686|Infliximab|infliximab|mesh-list
1940130|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940131|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940132|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940133|NCT00686712|Insulin|insulin|mesh-list
1940134|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1940135|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
1940136|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
1940137|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
1940138|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
1940139|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1940140|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940141|NCT00686725|Temozolomide|temozolomide|mesh-list
1940142|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940143|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
1940144|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940145|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940146|NCT00686777|Interferons|interferons|mesh-list
1940147|NCT00686777|Ribavirin|ribavirin|mesh-list
1940148|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
1940149|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
1940150|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940151|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940152|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
1940153|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940154|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
1940155|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940156|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
1940157|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940158|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940159|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
1940160|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
1940161|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940162|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
1940163|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940164|NCT00686829|Maleic acid|maleic acid|mesh-list
1940165|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940166|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940167|NCT00686855|Dexamethasone|dexamethasone|mesh-list
1940168|NCT00686855|Tacrolimus|tacrolimus|mesh-list
1940169|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940170|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
1940171|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
1940172|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940173|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940174|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940175|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
1940176|NCT00686855|Hormones|hormones|mesh-ancestor
1940177|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940178|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940179|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940180|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940181|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
1940182|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1940183|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940184|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940185|NCT00686881|Interferons|interferons|mesh-list
1940186|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
1940187|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
1940188|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940189|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940190|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
1940191|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940192|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
1940193|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940194|NCT00686894|Infliximab|infliximab|mesh-list
1940195|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940196|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940197|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940198|NCT00686920|Rifaximin|rifaximin|mesh-list
1940199|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1940200|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940201|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940202|NCT00686959|Paclitaxel|paclitaxel|mesh-list
1940203|NCT00686959|Etoposide|etoposide|mesh-list
1940204|NCT00686959|Vinorelbine|vinorelbine|mesh-list
1940205|NCT00686959|Carboplatin|carboplatin|mesh-list
1940206|NCT00686959|Pemetrexed|pemetrexed|mesh-list
1940207|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1940208|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940209|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
1940210|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
1940211|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
1940212|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940213|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1940214|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1940215|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940216|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1940217|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1940218|NCT00686998|Olanzapine|olanzapine|mesh-list
1940219|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
1940220|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
1940221|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940222|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940223|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940224|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1940225|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1940226|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1940227|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1940228|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1940379|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
1940229|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1940230|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940231|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940232|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940233|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
1940234|NCT00687076|Aspirin|aspirin|mesh-list
1940235|NCT00687076|Niacin|niacin|mesh-list
1940236|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
1940237|NCT00687076|Clopidogrel|clopidogrel|mesh-list
1940238|NCT00687076|Ezetimibe|ezetimibe|mesh-list
1940239|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940240|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940241|NCT00687076|Analgesics|analgesics|mesh-ancestor
1940242|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
1940243|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940244|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940245|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940246|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940247|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1940248|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1940249|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940250|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1940251|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1940252|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940253|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
1940254|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1940255|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1940256|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1940257|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
1940258|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940259|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1940260|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1940261|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
1940262|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1940263|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
1940264|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
1940265|NCT00687076|Vitamins|vitamins|mesh-ancestor
1940266|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
1940267|NCT00687102|Tamoxifen|tamoxifen|mesh-list
1940268|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1940269|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1940270|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
1940271|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940272|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940273|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940274|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940275|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1940276|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1940277|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1940278|NCT00687167|Zonisamide|zonisamide|mesh-list
1940279|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
1940280|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1940281|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940282|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940283|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1940284|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940285|NCT00687193|Tofacitinib|tofacitinib|mesh-list
1940286|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1940287|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940288|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940289|NCT00687219|Ribavirin|ribavirin|mesh-list
1940290|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940291|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
1940292|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940293|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
1940294|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940295|NCT00687271|Atorvastatin|atorvastatin|mesh-list
1940296|NCT00687271|Calcium|calcium|mesh-list
1940297|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1940298|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940299|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1940300|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1940301|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
1940302|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940303|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1940304|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1940305|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940306|NCT00687297|Carboplatin|carboplatin|mesh-list
1940307|NCT00687297|Docetaxel|docetaxel|mesh-list
1940308|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940309|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
1940310|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
1940311|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
1940312|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940313|NCT00687323|Temozolomide|temozolomide|mesh-list
1940314|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940315|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
1940316|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940317|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940318|NCT00687362|Infliximab|infliximab|mesh-list
1940319|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940320|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940321|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940322|NCT00687401|Infliximab|infliximab|mesh-list
1940323|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940324|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940325|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940326|NCT00687440|Docetaxel|docetaxel|mesh-list
1940327|NCT00687440|Doxorubicin|doxorubicin|mesh-list
1940328|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1940329|NCT00687440|Trastuzumab|trastuzumab|mesh-list
1940330|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940331|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
1940332|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
1940333|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
1940334|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940335|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1940336|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1940337|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1940338|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940339|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1940340|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
1940341|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1940342|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940343|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
1940344|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940345|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940346|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1940347|NCT00687544|Ribavirin|ribavirin|mesh-list
1940348|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940349|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
1940350|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940351|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
1940352|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940353|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1940354|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1940355|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1940356|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940357|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940358|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
1940359|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940360|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940361|NCT00687674|Dexamethasone|dexamethasone|mesh-list
1940362|NCT00687674|Lenalidomide|lenalidomide|mesh-list
1940363|NCT00687674|Sorafenib|sorafenib|mesh-list
1940364|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940365|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
1940366|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
1940367|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940368|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940369|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940370|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
1940371|NCT00687674|Hormones|hormones|mesh-ancestor
1940372|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940373|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940374|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940375|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
1940376|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1940377|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1940378|NCT00687674|Growth Substances|growth substances|mesh-ancestor
1940380|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1940381|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940382|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940383|NCT00687713|Bupropion|bupropion|mesh-list
1940384|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1940385|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
1940386|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1940387|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1940388|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1940389|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940390|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940391|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
1940392|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940393|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940394|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1940395|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1940396|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940397|NCT00687739|Leuprolide|leuprolide|mesh-list
1940398|NCT00687739|Estradiol|estradiol|mesh-list
1940399|NCT00687739|Estrogens|estrogens|mesh-ancestor
1940400|NCT00687739|Hormones|hormones|mesh-ancestor
1940401|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940402|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940403|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1940404|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1940405|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
1940406|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940407|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940408|NCT00687804|Ranibizumab|ranibizumab|mesh-list
1940409|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1940410|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1940411|NCT00687804|Growth Substances|growth substances|mesh-ancestor
1940412|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940413|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
1940414|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940415|NCT00687908|Adapalene|adapalene|mesh-list
1940416|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1940417|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940418|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940419|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940420|NCT00687908|Analgesics|analgesics|mesh-ancestor
1940421|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
1940422|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940423|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940424|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940425|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940426|NCT00687973|Atenolol|atenolol|mesh-list
1940427|NCT00687973|Amlodipine|amlodipine|mesh-list
1940428|NCT00687973|Valsartan|valsartan|mesh-list
1940429|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1940430|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1940431|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940432|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940433|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1940434|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940435|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
1940436|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1940437|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1940438|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1940439|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
1940440|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
1940441|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940442|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1940443|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1940444|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1940445|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
1940446|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940447|NCT00688064|Doxycycline|doxycycline|mesh-list
1940448|NCT00688064|Adapalene|adapalene|mesh-list
1940449|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1940450|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940451|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
1940452|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1940453|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1940454|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940455|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940456|NCT00688064|Analgesics|analgesics|mesh-ancestor
1940457|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
1940458|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940459|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940460|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940461|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940462|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940463|NCT00688103|Etanercept|etanercept|mesh-list
1940464|NCT00688103|Methotrexate|methotrexate|mesh-list
1940465|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1940466|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
1940467|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1940468|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940469|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1940470|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
1940471|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940472|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940473|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940474|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940475|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1940476|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940477|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
1940478|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940479|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1940480|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940481|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940482|NCT00688103|Analgesics|analgesics|mesh-ancestor
1940483|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
1940484|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940485|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940486|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940487|NCT00688324|Acamprosate|acamprosate|mesh-list
1940488|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1940497|NCT00688545|Celecoxib|celecoxib|mesh-list
1940498|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940499|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940500|NCT00688545|Analgesics|analgesics|mesh-ancestor
1940501|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
1940502|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940503|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940504|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940505|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940506|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1940507|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1940508|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940509|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940510|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
1940511|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
1940512|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940513|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940514|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940515|NCT00688623|Everolimus|everolimus|mesh-list
1940516|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940517|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940518|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
1940519|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940520|NCT00688636|Infliximab|infliximab|mesh-list
1940521|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940522|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940523|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940524|NCT00688688|Mirabegron|mirabegron|mesh-list
1940525|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1940526|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1940527|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1940528|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1940529|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
1940530|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940531|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940532|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940533|NCT00688688|Urological Agents|urological agents|mesh-ancestor
1940534|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1940535|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1940536|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
1940537|NCT00688701|Lixisenatide|lixisenatide|mesh-list
1940538|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1940539|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940540|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
1940541|NCT00688740|Docetaxel|docetaxel|mesh-list
1940542|NCT00688740|Doxorubicin|doxorubicin|mesh-list
1940543|NCT00688740|Fluorouracil|fluorouracil|mesh-list
1940544|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940545|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
1940546|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940547|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940548|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940549|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
1940550|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940551|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940552|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1940553|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
1940554|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
1940555|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
1940556|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1940557|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1940558|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1940559|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940560|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
1940561|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1940562|NCT00688753|Everolimus|everolimus|mesh-list
1940563|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940564|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940565|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
1940566|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940567|NCT00688870|Vaccines|vaccines|mesh-list
1940568|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1940569|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
1940570|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940571|NCT00688909|Letrozole|letrozole|mesh-list
1940572|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940573|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1940574|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1940575|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940576|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940577|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1940578|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
1940579|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940580|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940581|NCT00689026|Lubiprostone|lubiprostone|mesh-list
1940582|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1940583|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940584|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940585|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1940586|NCT00689078|Prednisolone|prednisolone|mesh-list
1940587|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1940588|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
1940589|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1940590|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
1940591|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
1940592|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1940593|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
1940594|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940595|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
1940596|NCT00689078|Hormones|hormones|mesh-ancestor
1940597|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940598|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940599|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940600|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940601|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
1940602|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
1940603|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940604|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940605|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1940606|NCT00689078|Protective Agents|protective agents|mesh-ancestor
1940607|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1940608|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1940609|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1940610|NCT00689104|Mirabegron|mirabegron|mesh-list
1940611|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1940612|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1940613|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1940614|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1940615|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
1940616|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940617|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940618|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940619|NCT00689104|Urological Agents|urological agents|mesh-ancestor
1940620|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1940621|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1940622|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
1940623|NCT00689117|Clindamycin|clindamycin|mesh-list
1940624|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
1940625|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
1940626|NCT00689117|Tretinoin|tretinoin|mesh-list
1940627|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1940628|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940629|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1940630|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940631|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940632|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940633|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
1940634|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940635|NCT00689221|Temozolomide|temozolomide|mesh-list
1940636|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940637|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
1940638|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940639|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940640|NCT00689338|Fluconazole|fluconazole|mesh-list
1940641|NCT00689338|Voriconazole|voriconazole|mesh-list
1940642|NCT00689338|Anidulafungin|anidulafungin|mesh-list
1940643|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
1940644|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940645|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1940646|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1940647|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940648|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940649|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1940650|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
1940651|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940652|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940653|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1940654|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1940655|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1940656|NCT00689351|Vaccines|vaccines|mesh-list
1940657|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1940658|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
1940659|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940660|NCT00689390|Ribavirin|ribavirin|mesh-list
1940661|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1940662|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
1940663|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940664|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
1940665|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940666|NCT00689572|Ondansetron|ondansetron|mesh-list
1940667|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
1940668|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
1940669|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940670|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940671|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940672|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
1940673|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940674|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1940675|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
1940676|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940677|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940678|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1940679|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1940680|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1940681|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1940682|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1940683|NCT00689611|Bupropion|bupropion|mesh-list
1940684|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1940685|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
1940686|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1940687|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1940688|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1940689|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940690|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940691|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
1940692|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940693|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940694|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1940695|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1940696|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940697|NCT00689793|Iron|iron|mesh-list
1940698|NCT00689793|Trace Elements|trace elements|mesh-ancestor
1940699|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
1940700|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940701|NCT00689936|Thalidomide|thalidomide|mesh-list
1940702|NCT00689936|Dexamethasone|dexamethasone|mesh-list
1940703|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
1940704|NCT00689936|Prednisone|prednisone|mesh-list
1940705|NCT00689936|Lenalidomide|lenalidomide|mesh-list
1940706|NCT00689936|Melphalan|melphalan|mesh-list
1940707|NCT00689936|BB 1101|bb 1101|mesh-list
1940708|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940709|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
1940710|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
1940711|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940712|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940713|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940714|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
1940715|NCT00689936|Hormones|hormones|mesh-ancestor
1940716|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940717|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940718|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940719|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
1940720|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940721|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940722|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
1940723|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1940724|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1940725|NCT00689936|Growth Substances|growth substances|mesh-ancestor
1940726|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
1940727|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940728|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
1940729|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1940730|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940731|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
1940732|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1940733|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940734|NCT00690235|Pramlintide|pramlintide|mesh-list
1940735|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1940736|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940737|NCT00690378|Imipenem|imipenem|mesh-list
1940738|NCT00690378|Ceftazidime|ceftazidime|mesh-list
1940739|NCT00690378|Avibactam|avibactam|mesh-list
1940740|NCT00690378|Cilastatin|cilastatin|mesh-list
1940741|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1940742|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940743|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
1940744|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940745|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940746|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1940747|NCT00690430|Octreotide|octreotide|mesh-list
1940748|NCT00690430|Pasireotide|pasireotide|mesh-list
1940749|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940750|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940751|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940752|NCT00690430|Hormones|hormones|mesh-ancestor
1940753|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940832|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940754|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940755|NCT00690443|Atorvastatin|atorvastatin|mesh-list
1940756|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1940757|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1940758|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
1940759|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940760|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1940761|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1940762|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940763|NCT00690495|Propofol|propofol|mesh-list
1940764|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1940765|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1940766|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940767|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1940768|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
1940769|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
1940770|NCT00690573|Adalimumab|adalimumab|mesh-list
1940771|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940772|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940773|NCT00690612|Candesartan|candesartan|mesh-list
1940774|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
1940775|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1940776|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1940777|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1940778|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940779|NCT00690794|Travoprost|travoprost|mesh-list
1940780|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1940781|NCT00690794|Latanoprost|latanoprost|mesh-list
1940782|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1940783|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1940784|NCT00690820|Pancrelipase|pancrelipase|mesh-list
1940785|NCT00690820|Pancreatin|pancreatin|mesh-list
1940786|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940787|NCT00690833|Desonide|desonide|mesh-list
1940788|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940789|NCT00690898|Lanreotide|lanreotide|mesh-list
1940790|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940791|NCT00690924|Calcitriol|calcitriol|mesh-list
1940792|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1940793|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940794|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1940795|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940796|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940797|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1940798|NCT00690924|Vitamins|vitamins|mesh-ancestor
1940799|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
1940800|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1940801|NCT00691002|Calcitriol|calcitriol|mesh-list
1940802|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
1940803|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1940804|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1940805|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1940806|NCT00691002|Calcipotriene|calcipotriene|mesh-list
1940807|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940808|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940809|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1940810|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940811|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1940812|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1940813|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940814|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1940815|NCT00691002|Vitamins|vitamins|mesh-ancestor
1940816|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
1940817|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1940818|NCT00691015|Cytarabine|cytarabine|mesh-list
1940819|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
1940820|NCT00691015|Melphalan|melphalan|mesh-list
1940821|NCT00691015|Busulfan|busulfan|mesh-list
1940822|NCT00691015|Carmustine|carmustine|mesh-list
1940823|NCT00691015|Rituximab|rituximab|mesh-list
1940824|NCT00691015|Fludarabine|fludarabine|mesh-list
1940825|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
1940826|NCT00691015|Etoposide|etoposide|mesh-list
1940827|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
1940828|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1940829|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940830|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
1940831|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940833|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940834|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
1940835|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940836|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940837|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1940838|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1940839|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1940840|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
1940841|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1940842|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1940843|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1940844|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940845|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
1940846|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940847|NCT00691028|Infliximab|infliximab|mesh-list
1940848|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940849|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940850|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940851|NCT00691054|Paclitaxel|paclitaxel|mesh-list
1940852|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1940853|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1940854|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940855|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
1940856|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
1940857|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
1940858|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940859|NCT00691093|Fesoterodine|fesoterodine|mesh-list
1940860|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1940861|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1940862|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
1940863|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940864|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940865|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940866|NCT00691093|Urological Agents|urological agents|mesh-ancestor
1940867|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
1940868|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940869|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940870|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1940871|NCT00691132|Protective Agents|protective agents|mesh-ancestor
1940872|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940873|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940874|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1940875|NCT00691197|Glycerol|glycerol|mesh-list
1940876|NCT00691197|Laxatives|laxatives|mesh-ancestor
1940877|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940878|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1940879|NCT00691197|Protective Agents|protective agents|mesh-ancestor
1940880|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940881|NCT00691210|Niacinamide|niacinamide|mesh-list
1940882|NCT00691210|Niacin|niacin|mesh-list
1940883|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
1940884|NCT00691210|Etoposide|etoposide|mesh-list
1940885|NCT00691210|Vorinostat|vorinostat|mesh-list
1940886|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1940887|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940888|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1940889|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1940890|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940891|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940892|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1940893|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
1940894|NCT00691210|Vitamins|vitamins|mesh-ancestor
1940895|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
1940896|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940897|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1940898|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
1940899|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1940900|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
1940901|NCT00691301|Pemetrexed|pemetrexed|mesh-list
1940902|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940903|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940904|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940905|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1940906|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1940907|NCT00691483|Varenicline|varenicline|mesh-list
1940908|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1940909|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1940910|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
1940911|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940912|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940913|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940914|NCT00691600|Trimethoprim|trimethoprim|mesh-list
1940915|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
1940916|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1940917|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1940918|NCT00691600|Renal Agents|renal agents|mesh-ancestor
1940919|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
1940920|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1940921|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1940922|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1940923|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940924|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940925|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1940926|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1940927|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1940928|NCT00691665|Fluticasone|fluticasone|mesh-list
1940929|NCT00691665|Xhance|xhance|mesh-list
1940930|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1940931|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940932|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1940933|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
1940934|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940935|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940936|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1940937|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
1940938|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
1940939|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1940940|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940941|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940942|NCT00691665|Analgesics|analgesics|mesh-ancestor
1940943|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
1940944|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940945|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1940946|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1940947|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
1940948|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
1940949|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1940950|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940951|NCT00691704|Aspirin|aspirin|mesh-list
1940952|NCT00691704|Prednisone|prednisone|mesh-list
1940953|NCT00691704|Lenalidomide|lenalidomide|mesh-list
1940954|NCT00691704|Bortezomib|bortezomib|mesh-list
1940955|NCT00691704|Melphalan|melphalan|mesh-list
1940956|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1940957|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
1940958|NCT00691704|Hormones|hormones|mesh-ancestor
1940959|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1940960|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940961|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1940962|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940963|NCT00691704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1940964|NCT00691704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1940965|NCT00691704|Analgesics|analgesics|mesh-ancestor
1940966|NCT00691704|Sensory System Agents|sensory system agents|mesh-ancestor
1940967|NCT00691704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940968|NCT00691704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1940969|NCT00691704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1940970|NCT00691704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1940971|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940972|NCT00691704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1940973|NCT00691704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1940974|NCT00691704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940975|NCT00691704|Antipyretics|antipyretics|mesh-ancestor
1940976|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
1940977|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1940978|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1940979|NCT00691704|Growth Substances|growth substances|mesh-ancestor
1940980|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
1940981|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1940982|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
1940983|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1940984|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1940985|NCT00691938|Decitabine|decitabine|mesh-list
1940986|NCT00691938|Panobinostat|panobinostat|mesh-list
1940987|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1940988|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
1940989|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1940990|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1940991|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1940992|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1940993|NCT00692185|Olanzapine|olanzapine|mesh-list
1940994|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
1940995|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
1940996|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1940997|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1940998|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1940999|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1941000|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941001|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941002|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941003|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1941004|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1941005|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941006|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941007|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941008|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
1941009|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
1941010|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
1941011|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1941012|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1941013|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941014|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941015|NCT00692237|Urological Agents|urological agents|mesh-ancestor
1941016|NCT00692341|Axitinib|axitinib|mesh-list
1941017|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941018|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941019|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941020|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941021|NCT00692770|Sorafenib|sorafenib|mesh-list
1941022|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941023|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941024|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941025|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941026|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
1941027|NCT00692913|Alendronate|alendronate|mesh-list
1941028|NCT00692913|Calcium|calcium|mesh-list
1941029|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1941030|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941031|NCT00692913|Vitamins|vitamins|mesh-ancestor
1941032|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
1941033|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1941034|NCT00692978|Fluticasone|fluticasone|mesh-list
1941035|NCT00692978|Xhance|xhance|mesh-list
1941036|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941037|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1941038|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
1941039|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941040|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941041|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1941042|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
1941043|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
1941044|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1941045|NCT00693160|Ketorolac|ketorolac|mesh-list
1941046|NCT00693160|Remifentanil|remifentanil|mesh-list
1941047|NCT00693160|Capsaicin|capsaicin|mesh-list
1941048|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1941049|NCT00693160|Narcotics|narcotics|mesh-ancestor
1941050|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941051|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941052|NCT00693160|Analgesics|analgesics|mesh-ancestor
1941053|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
1941054|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941055|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1941056|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1941057|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941058|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941059|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1941060|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941061|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941062|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
1941063|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
1941064|NCT00693225|Omeprazole|omeprazole|mesh-list
1941065|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1941066|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1941067|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1941068|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941069|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941070|NCT00693420|Bimatoprost|bimatoprost|mesh-list
1941071|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1941072|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941073|NCT00693472|Propranolol|propranolol|mesh-list
1941074|NCT00693472|Haloperidol|haloperidol|mesh-list
1941075|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
1941076|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
1941077|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
1941078|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
1941079|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941080|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941081|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1941082|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1941083|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941084|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941085|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941086|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1941087|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
1941088|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941089|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941090|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1941091|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
1941092|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1941093|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1941094|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941095|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1941096|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941097|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
1941098|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1941099|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941100|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1941101|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1941102|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1941103|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941104|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941105|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941106|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941107|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
1941108|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1941109|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1941110|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1941111|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
1941112|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941113|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
1941114|NCT00693719|Irinotecan|irinotecan|mesh-list
1941115|NCT00693719|Etoposide|etoposide|mesh-list
1941116|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1941117|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1941118|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941119|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941120|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941121|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1941122|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1941123|NCT00693992|Sunitinib|sunitinib|mesh-list
1941124|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941125|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941126|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941127|NCT00693992|Growth Substances|growth substances|mesh-ancestor
1941128|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941129|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941130|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941131|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941132|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941133|NCT00694096|Sunitinib|sunitinib|mesh-list
1941134|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941135|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941136|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941137|NCT00694096|Growth Substances|growth substances|mesh-ancestor
1941138|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941139|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941140|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941141|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941142|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941143|NCT00694109|Mipomersen|mipomersen|mesh-list
1941144|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1941145|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1941146|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
1941147|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941148|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1941149|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
1941150|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1941151|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941152|NCT00694304|Vortioxetine|vortioxetine|mesh-list
1941153|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
1941154|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941155|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1941156|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941157|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941158|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941159|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1941160|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1941161|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941162|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941163|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941164|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
1941165|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1941166|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1941167|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1941168|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1941169|NCT00694369|Acetaminophen|acetaminophen|mesh-list
1941170|NCT00694369|Ibuprofen|ibuprofen|mesh-list
1941171|NCT00694369|Etoricoxib|etoricoxib|mesh-list
1941172|NCT00694369|Codeine|codeine|mesh-list
1941173|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1941174|NCT00694369|Analgesics|analgesics|mesh-ancestor
1941175|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
1941176|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941177|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941178|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
1941179|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1941180|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941181|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941182|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1941183|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941184|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941185|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1941186|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1941187|NCT00694369|Narcotics|narcotics|mesh-ancestor
1941188|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941189|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
1941190|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
1941191|NCT00694551|Poly I-C|poly i-c|mesh-list
1941192|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1941193|NCT00694551|Vaccines|vaccines|mesh-list
1941194|NCT00694551|Poly ICLC|poly iclc|mesh-list
1941195|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
1941196|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941197|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
1941198|NCT00694551|Laxatives|laxatives|mesh-ancestor
1941199|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1941200|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
1941201|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941202|NCT00694603|Cetuximab|cetuximab|mesh-list
1941203|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941204|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941205|NCT00694707|Risperidone|risperidone|mesh-list
1941206|NCT00694707|Cariprazine|cariprazine|mesh-list
1941207|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1941208|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
1941209|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941210|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941211|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941212|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1941213|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941214|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941215|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941216|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1941217|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
1941218|NCT00695019|Interferons|interferons|mesh-list
1941219|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
1941220|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
1941221|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
1941222|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941223|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
1941224|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941225|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
1941226|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941227|NCT00695097|Rituximab|rituximab|mesh-list
1941228|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941229|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941230|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
1941231|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941232|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941233|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
1941234|NCT00695110|Testosterone|testosterone|mesh-list
1941235|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
1941236|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
1941237|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1941238|NCT00695110|Androgens|androgens|mesh-ancestor
1941239|NCT00695110|Hormones|hormones|mesh-ancestor
1941240|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941241|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941242|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1941243|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941244|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
1941245|NCT00695136|Donepezil|donepezil|mesh-list
1941246|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1941247|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941248|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941249|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
1941250|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941251|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941252|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
1941253|NCT00695188|Methotrexate|methotrexate|mesh-list
1941254|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1941255|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
1941256|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1941257|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941258|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1941259|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
1941260|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941261|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941262|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
1941263|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941264|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1941265|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1941266|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
1941267|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941268|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1941269|NCT00695292|Carboplatin|carboplatin|mesh-list
1941270|NCT00695292|Irinotecan|irinotecan|mesh-list
1941271|NCT00695292|Sunitinib|sunitinib|mesh-list
1941272|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941273|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1941274|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1941275|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941276|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941277|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941278|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941279|NCT00695292|Growth Substances|growth substances|mesh-ancestor
1941280|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941281|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941282|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941283|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1941284|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941285|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
1941286|NCT00695318|Hormones|hormones|mesh-ancestor
1941287|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941288|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941289|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
1941290|NCT00695396|Hematinics|hematinics|mesh-ancestor
1941291|NCT00695409|Cytarabine|cytarabine|mesh-list
1941292|NCT00695409|Rituximab|rituximab|mesh-list
1941293|NCT00695409|Etoposide|etoposide|mesh-list
1941294|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
1941295|NCT00695409|Melphalan|melphalan|mesh-list
1941296|NCT00695409|Carmustine|carmustine|mesh-list
1941297|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1941298|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941299|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941300|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
1941301|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941302|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941303|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1941304|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1941305|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1941306|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941307|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941308|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1941309|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
1941310|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
1941311|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941312|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1941313|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1941314|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
1941315|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1941316|NCT00695435|Tobramycin|tobramycin|mesh-list
1941317|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
1941318|NCT00695435|Dexamethasone|dexamethasone|mesh-list
1941319|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1941320|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941321|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
1941322|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
1941323|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941324|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941325|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1941326|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
1941327|NCT00695435|Hormones|hormones|mesh-ancestor
1941328|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941329|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1941330|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941331|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1941332|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1941333|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941334|NCT00695500|Varenicline|varenicline|mesh-list
1941335|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1941336|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1941337|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
1941338|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941339|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941340|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941341|NCT00695565|Clonidine|clonidine|mesh-list
1941342|NCT00695565|Analgesics|analgesics|mesh-ancestor
1941343|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
1941344|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941345|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941346|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941347|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
1941348|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
1941349|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1941350|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1941351|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1941352|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941353|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941354|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941355|NCT00695578|Bacitracin|bacitracin|mesh-list
1941356|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1941357|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941358|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1941359|NCT00695786|Rituximab|rituximab|mesh-list
1941360|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1941361|NCT00695786|Lenalidomide|lenalidomide|mesh-list
1941362|NCT00695786|Antibodies|antibodies|mesh-list
1941363|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
1941364|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1941365|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
1941366|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941367|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941368|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941369|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941370|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941371|NCT00695786|Growth Substances|growth substances|mesh-ancestor
1941372|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941373|NCT00695864|Ondansetron|ondansetron|mesh-list
1941374|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
1941375|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
1941376|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941377|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941378|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1941379|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
1941380|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
1941381|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1941382|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
1941383|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941384|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941385|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1941386|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941387|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941388|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941389|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1941390|NCT00695903|Vancomycin|vancomycin|mesh-list
1941391|NCT00695903|Daptomycin|daptomycin|mesh-list
1941392|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1941393|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941394|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1941395|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
1941396|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1941397|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941398|NCT00695955|Diuretics|diuretics|mesh-ancestor
1941399|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
1941400|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941401|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1941402|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941403|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941404|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941405|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941406|NCT00696020|Bromides|bromides|mesh-list
1941407|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
1941408|NCT00696020|Olodaterol|olodaterol|mesh-list
1941409|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1941410|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
1941411|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941412|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941413|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1941414|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
1941415|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
1941416|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1941417|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
1941418|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941419|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941420|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
1941421|NCT00696072|Letrozole|letrozole|mesh-list
1941422|NCT00696072|Dasatinib|dasatinib|mesh-list
1941423|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941424|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1941425|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1941426|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941427|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941428|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1941429|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
1941430|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941431|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941432|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941433|NCT00696137|Fentanyl|fentanyl|mesh-list
1941434|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1941435|NCT00696137|Narcotics|narcotics|mesh-ancestor
1941436|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941437|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941438|NCT00696137|Analgesics|analgesics|mesh-ancestor
1941439|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
1941440|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941441|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1941442|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1941443|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
1941444|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
1941445|NCT00696241|Olmesartan|olmesartan|mesh-list
1941446|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1941447|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1941448|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941449|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941450|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941451|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941452|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1941453|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1941454|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1941455|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941456|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941457|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941458|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941459|NCT00696293|Analgesics|analgesics|mesh-ancestor
1941460|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
1941461|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941462|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
1941463|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941464|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
1941465|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
1941466|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
1941467|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1941468|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941469|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941470|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941471|NCT00696384|Diuretics|diuretics|mesh-ancestor
1941472|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
1941473|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941474|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1941475|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941476|NCT00696410|Zinc|zinc|mesh-list
1941477|NCT00696410|Trace Elements|trace elements|mesh-ancestor
1941478|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
1941479|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941480|NCT00696436|Valsartan|valsartan|mesh-list
1941481|NCT00696436|Olmesartan|olmesartan|mesh-list
1941482|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1941483|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941484|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941485|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941486|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941487|NCT00696449|Adapalene|adapalene|mesh-list
1941488|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1941489|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1941490|NCT00696449|Analgesics|analgesics|mesh-ancestor
1941491|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
1941492|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941493|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941494|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941495|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941496|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
1941497|NCT00696488|Fluorouracil|fluorouracil|mesh-list
1941498|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
1941499|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941500|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1941501|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941502|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1941503|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
1941504|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941505|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
1941506|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1941507|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1941508|NCT00696657|Liraglutide|liraglutide|mesh-list
1941509|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1941510|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941511|NCT00696657|Incretins|incretins|mesh-ancestor
1941512|NCT00696657|Hormones|hormones|mesh-ancestor
1941513|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941514|NCT00696696|Gemcitabine|gemcitabine|mesh-list
1941515|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1941516|NCT00696696|Sorafenib|sorafenib|mesh-list
1941517|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1941518|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
1941519|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941520|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941521|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
1941522|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941523|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941524|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1941525|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
1941526|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941527|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941528|NCT00696761|Alfuzosin|alfuzosin|mesh-list
1941529|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1941530|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1941531|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1941532|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941533|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941534|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941535|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941536|NCT00696761|Urological Agents|urological agents|mesh-ancestor
1941537|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1941538|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1941539|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1941540|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941541|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941542|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941543|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941544|NCT00696774|Analgesics|analgesics|mesh-ancestor
1941545|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
1941546|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941547|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
1941548|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941549|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
1941550|NCT00696787|Pregabalin|pregabalin|mesh-list
1941551|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1941552|NCT00696787|Analgesics|analgesics|mesh-ancestor
1941553|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
1941554|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941555|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941556|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
1941557|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1941558|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941559|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941560|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1941561|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1941562|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941563|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941564|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941565|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1941566|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1941567|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941568|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
1941569|NCT00696800|Progesterone|progesterone|mesh-list
1941570|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1941571|NCT00696800|Ganirelix|ganirelix|mesh-list
1941572|NCT00696800|Progestins|progestins|mesh-ancestor
1941573|NCT00696800|Hormones|hormones|mesh-ancestor
1941574|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941575|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941576|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
1941577|NCT00696878|Progesterone|progesterone|mesh-list
1941578|NCT00696878|Progestins|progestins|mesh-ancestor
1941579|NCT00696878|Hormones|hormones|mesh-ancestor
1941580|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941581|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941582|NCT00697073|Idebenone|idebenone|mesh-list
1941583|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
1941584|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941585|NCT00697073|Protective Agents|protective agents|mesh-ancestor
1941586|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941587|NCT00697112|Sirolimus|sirolimus|mesh-list
1941588|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1941589|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941590|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1941591|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941592|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
1941593|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1941594|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
1941595|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941596|NCT00697203|Pravastatin|pravastatin|mesh-list
1941597|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
1941598|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1941599|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1941600|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
1941601|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941602|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1941603|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1941604|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941605|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1941606|NCT00697255|Hormones|hormones|mesh-list
1941607|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1941608|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941609|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941610|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1941611|NCT00697463|Teriparatide|teriparatide|mesh-list
1941612|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1941613|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941614|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1941615|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1941616|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1941617|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1941618|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941619|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1941620|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1941621|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1941622|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941623|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941624|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941625|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941626|NCT00697593|Antibodies|antibodies|mesh-list
1941627|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1941628|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
1941629|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941630|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
1941631|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1941632|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941633|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
1941634|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1941635|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941636|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941637|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1941638|NCT00697788|Analgesics|analgesics|mesh-ancestor
1941639|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
1941640|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941641|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1941642|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1941643|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1941644|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941645|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941646|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941647|NCT00698022|Risperidone|risperidone|mesh-list
1941648|NCT00698022|Mifepristone|mifepristone|mesh-list
1941649|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1941650|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
1941651|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941652|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941653|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941654|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1941655|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1941656|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941657|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1941658|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1941659|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
1941660|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1941661|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
1941662|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1941663|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1941664|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1941665|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1941666|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
1941667|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1941668|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1941669|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
1941670|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941671|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
1941672|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1941673|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1941674|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
1941675|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1941676|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1941677|NCT00698035|Testosterone|testosterone|mesh-list
1941678|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
1941679|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
1941680|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1941681|NCT00698035|Estradiol|estradiol|mesh-list
1941682|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1941683|NCT00698035|Androgens|androgens|mesh-ancestor
1941684|NCT00698035|Hormones|hormones|mesh-ancestor
1941685|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941686|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941687|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1941688|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941689|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
1941690|NCT00698035|Estrogens|estrogens|mesh-ancestor
1941691|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1941692|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
1941693|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1941694|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1941695|NCT00698204|Celecoxib|celecoxib|mesh-list
1941696|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1941697|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1941698|NCT00698204|Analgesics|analgesics|mesh-ancestor
1941699|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
1941700|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941701|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941702|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941703|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941704|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1941705|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1941706|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941707|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941708|NCT00698451|Bevacizumab|bevacizumab|mesh-list
1941709|NCT00698451|Carboplatin|carboplatin|mesh-list
1941710|NCT00698451|Doxorubicin|doxorubicin|mesh-list
1941711|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1941712|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941713|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941714|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941715|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941716|NCT00698451|Growth Substances|growth substances|mesh-ancestor
1941717|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941718|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941719|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1941720|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1941721|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1941722|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941723|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941724|NCT00698516|Bevacizumab|bevacizumab|mesh-list
1941725|NCT00698516|Topotecan|topotecan|mesh-list
1941726|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941727|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941728|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941729|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941730|NCT00698516|Growth Substances|growth substances|mesh-ancestor
1941731|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941732|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941733|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1941734|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1941735|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941736|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941737|NCT00698581|Brivaracetam|brivaracetam|mesh-list
1941738|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
1941739|NCT00698646|Valsartan|valsartan|mesh-list
1941740|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1941741|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941742|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941743|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941744|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941745|NCT00698646|Diuretics|diuretics|mesh-ancestor
1941746|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
1941747|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941748|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1941749|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941750|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
1941751|NCT00698685|Pentostatin|pentostatin|mesh-list
1941752|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941753|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941754|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1941755|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941756|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941757|NCT00698815|Pemetrexed|pemetrexed|mesh-list
1941758|NCT00698815|Sunitinib|sunitinib|mesh-list
1941759|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941760|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941761|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941762|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1941763|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1941764|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941765|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941766|NCT00698815|Growth Substances|growth substances|mesh-ancestor
1941767|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941768|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941769|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941770|NCT00698841|Cetuximab|cetuximab|mesh-list
1941771|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941772|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941773|NCT00698932|Saxagliptin|saxagliptin|mesh-list
1941774|NCT00698932|Incretins|incretins|mesh-ancestor
1941775|NCT00698932|Hormones|hormones|mesh-ancestor
1941776|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941777|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941778|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1941779|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
1941780|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941781|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941782|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1941783|NCT00699010|Oxycodone|oxycodone|mesh-list
1941784|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1941785|NCT00699010|Narcotics|narcotics|mesh-ancestor
1941786|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941787|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941788|NCT00699010|Analgesics|analgesics|mesh-ancestor
1941789|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
1941790|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941791|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1941792|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1941793|NCT00699192|Amlodipine|amlodipine|mesh-list
1941794|NCT00699192|Valsartan|valsartan|mesh-list
1941795|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941796|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1941797|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941798|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941799|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1941800|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941801|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
1941802|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941803|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941804|NCT00699283|Brivaracetam|brivaracetam|mesh-list
1941805|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
1941806|NCT00699335|Fentanyl|fentanyl|mesh-list
1941807|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1941808|NCT00699335|Narcotics|narcotics|mesh-ancestor
1941809|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941810|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941811|NCT00699335|Analgesics|analgesics|mesh-ancestor
1941812|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
1941813|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941814|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1941815|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1941816|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
1941817|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
1941818|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
1941819|NCT00699348|Hematinics|hematinics|mesh-ancestor
1941820|NCT00699374|Sorafenib|sorafenib|mesh-list
1941821|NCT00699374|Sunitinib|sunitinib|mesh-list
1941822|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941823|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1941824|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941825|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941826|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941827|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941828|NCT00699374|Growth Substances|growth substances|mesh-ancestor
1941829|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941830|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941831|NCT00699491|Sirolimus|sirolimus|mesh-list
1941832|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1941833|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1941834|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941835|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1941836|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941837|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
1941838|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1941839|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
1941840|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941841|NCT00699556|Nicotine|nicotine|mesh-list
1941842|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1941843|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
1941844|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941845|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941846|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1941847|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1941848|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
1941849|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941850|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941851|NCT00699608|Zopiclone|zopiclone|mesh-list
1941852|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1941853|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1941854|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941855|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
1941856|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941857|NCT00699803|Prednisone|prednisone|mesh-list
1941858|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
1941859|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1941860|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
1941861|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1941862|NCT00699803|Prednisolone|prednisolone|mesh-list
1941863|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1941864|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
1941865|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941866|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
1941867|NCT00699803|Hormones|hormones|mesh-ancestor
1941868|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941869|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941870|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1941871|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941872|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
1941873|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
1941874|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941875|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1941876|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1941877|NCT00699803|Protective Agents|protective agents|mesh-ancestor
1941878|NCT00699907|Flutamide|flutamide|mesh-list
1941879|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
1941880|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
1941881|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1941882|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941883|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1941884|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941885|NCT00699998|Aspirin|aspirin|mesh-list
1941886|NCT00699998|Clopidogrel|clopidogrel|mesh-list
1941887|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1941888|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1941889|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1941890|NCT00699998|Analgesics|analgesics|mesh-ancestor
1941891|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
1941892|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1941893|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941894|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1941895|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1941896|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1941897|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1941898|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941899|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1941900|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1941901|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941902|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
1941903|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1941904|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1941905|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1941906|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
1941907|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941908|NCT00700011|Clofarabine|clofarabine|mesh-list
1941909|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1941910|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
1941911|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941912|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941913|NCT00700102|Bevacizumab|bevacizumab|mesh-list
1941914|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941915|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941916|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941917|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941918|NCT00700102|Growth Substances|growth substances|mesh-ancestor
1941919|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941920|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941921|NCT00700115|Ritonavir|ritonavir|mesh-list
1941922|NCT00700115|Lopinavir|lopinavir|mesh-list
1941923|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
1941924|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1941925|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1941926|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1941927|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
1941928|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941929|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941930|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1941931|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
1941932|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941933|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1941934|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1941935|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1941936|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1941937|NCT00700180|Bevacizumab|bevacizumab|mesh-list
1941938|NCT00700180|Carboplatin|carboplatin|mesh-list
1941939|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941940|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941941|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941942|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941943|NCT00700180|Growth Substances|growth substances|mesh-ancestor
1941944|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941945|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941946|NCT00700271|Amlodipine|amlodipine|mesh-list
1941947|NCT00700271|Valsartan|valsartan|mesh-list
1941948|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1941949|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1941950|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941951|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941952|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1941953|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941954|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
1941955|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1941956|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1941957|NCT00700336|Cisplatin|cisplatin|mesh-list
1941958|NCT00700336|Pemetrexed|pemetrexed|mesh-list
1941959|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941960|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1941961|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941962|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1941963|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1941964|NCT00700401|Ribavirin|ribavirin|mesh-list
1941965|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1941966|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
1941967|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941968|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
1941969|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1941970|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1941971|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1941972|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1941973|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1941974|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941975|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
1941976|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1941977|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941978|NCT00700440|Cetuximab|cetuximab|mesh-list
1941979|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941980|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941981|NCT00700570|Bevacizumab|bevacizumab|mesh-list
1941982|NCT00700570|Capecitabine|capecitabine|mesh-list
1941983|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
1941984|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1941985|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1941986|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1941987|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1941988|NCT00700570|Growth Substances|growth substances|mesh-ancestor
1941989|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1941990|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
1941991|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1941992|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
1941993|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1941994|NCT00700622|Insulin|insulin|mesh-list
1941995|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1941996|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
1941997|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
1941998|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1941999|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942000|NCT00700817|Metformin|metformin|mesh-list
1942001|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1942002|NCT00700817|Liraglutide|liraglutide|mesh-list
1942003|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1942004|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942005|NCT00700817|Incretins|incretins|mesh-ancestor
1942006|NCT00700817|Hormones|hormones|mesh-ancestor
1942007|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942008|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1942009|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
1942010|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942011|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942012|NCT00700882|Dasatinib|dasatinib|mesh-list
1942013|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942014|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942015|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942016|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942017|NCT00700999|Paroxetine|paroxetine|mesh-list
1942018|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1942019|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1942020|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942021|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942022|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942023|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
1942024|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942025|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1942026|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942027|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942028|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1942029|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1942030|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942031|NCT00701090|Metformin|metformin|mesh-list
1942032|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1942033|NCT00701090|Glimepiride|glimepiride|mesh-list
1942034|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1942035|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942036|NCT00701090|Incretins|incretins|mesh-ancestor
1942037|NCT00701090|Hormones|hormones|mesh-ancestor
1942038|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942039|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1942040|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
1942041|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942042|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942043|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1942044|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942045|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
1942046|NCT00701129|Rituximab|rituximab|mesh-list
1942047|NCT00701129|Methotrexate|methotrexate|mesh-list
1942048|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1942049|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942050|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
1942051|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942052|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942053|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1942054|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
1942055|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1942056|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1942057|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
1942058|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942059|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942060|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942061|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1942062|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942063|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1942064|NCT00701311|Apremilast|apremilast|mesh-list
1942065|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1942066|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1942067|NCT00701311|Analgesics|analgesics|mesh-ancestor
1942068|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
1942069|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942070|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942071|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942072|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942073|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1942074|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1942075|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942076|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942077|NCT00701363|Lanreotide|lanreotide|mesh-list
1942078|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942079|NCT00701376|Liver Extracts|liver extracts|mesh-list
1942080|NCT00701376|Hematinics|hematinics|mesh-ancestor
1942081|NCT00701389|Sumatriptan|sumatriptan|mesh-list
1942082|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1942083|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1942084|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1942085|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
1942086|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942087|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942088|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942089|NCT00701558|Gemcitabine|gemcitabine|mesh-list
1942090|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1942091|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1942092|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
1942093|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942094|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942095|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
1942096|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942097|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942098|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942099|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
1942100|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942101|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942102|NCT00701636|Daptomycin|daptomycin|mesh-list
1942103|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1942104|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942105|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
1942106|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
1942107|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942108|NCT00701675|Sertraline|sertraline|mesh-list
1942109|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942110|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942111|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1942112|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1942113|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942114|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942115|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942116|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
1942117|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942118|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
1942119|NCT00701714|Hematinics|hematinics|mesh-ancestor
1942120|NCT00701727|Ezetimibe|ezetimibe|mesh-list
1942121|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1942122|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1942123|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
1942124|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942125|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1942126|NCT00701779|Tamsulosin|tamsulosin|mesh-list
1942127|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1942128|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1942129|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1942130|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
1942131|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942132|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942133|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942134|NCT00701779|Urological Agents|urological agents|mesh-ancestor
1942135|NCT00701896|Nicotine|nicotine|mesh-list
1942136|NCT00701896|Varenicline|varenicline|mesh-list
1942137|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1942138|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
1942139|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942140|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942141|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1942142|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1942143|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
1942144|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942145|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942146|NCT00701935|Exenatide|exenatide|mesh-list
1942147|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1942148|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942149|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1942150|NCT00701935|Incretins|incretins|mesh-ancestor
1942151|NCT00701935|Hormones|hormones|mesh-ancestor
1942152|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942153|NCT00702052|Everolimus|everolimus|mesh-list
1942154|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942155|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942156|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
1942157|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942158|NCT00702221|Vaccines|vaccines|mesh-list
1942159|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
1942160|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942161|NCT00702234|Progesterone|progesterone|mesh-list
1942162|NCT00702234|Progestins|progestins|mesh-ancestor
1942163|NCT00702234|Hormones|hormones|mesh-ancestor
1942164|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942165|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942166|NCT00702273|Progesterone|progesterone|mesh-list
1942167|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942168|NCT00702273|Ganirelix|ganirelix|mesh-list
1942169|NCT00702273|Progestins|progestins|mesh-ancestor
1942170|NCT00702273|Hormones|hormones|mesh-ancestor
1942171|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942172|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942173|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942174|NCT00702299|Paclitaxel|paclitaxel|mesh-list
1942175|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1942176|NCT00702299|Cisplatin|cisplatin|mesh-list
1942177|NCT00702299|Pemetrexed|pemetrexed|mesh-list
1942178|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1942179|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942180|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
1942181|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
1942182|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
1942183|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942184|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942185|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1942186|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1942187|NCT00702325|Budesonide|budesonide|mesh-list
1942188|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
1942189|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1942190|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942191|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1942192|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
1942193|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942194|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942195|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1942196|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
1942197|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
1942198|NCT00702325|Hormones|hormones|mesh-ancestor
1942199|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942200|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1942201|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1942202|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1942203|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
1942204|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942205|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942206|NCT00702338|Hormones|hormones|mesh-list
1942207|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942208|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942209|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942210|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1942211|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1942212|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1942213|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942214|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942215|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
1942216|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942217|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942218|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
1942219|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942220|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942221|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942222|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942223|NCT00702468|Nabiximols|nabiximols|mesh-list
1942224|NCT00702468|Analgesics|analgesics|mesh-ancestor
1942225|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
1942226|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942227|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942228|NCT00702507|Miconazole|miconazole|mesh-list
1942229|NCT00702507|Clotrimazole|clotrimazole|mesh-list
1942230|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
1942231|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942232|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1942233|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1942234|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942235|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942236|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1942237|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942238|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942239|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942240|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1942241|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1942242|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1942243|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1942244|NCT00702520|Hormones|hormones|mesh-list
1942245|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942246|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942247|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942248|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
1942249|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1942250|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
1942251|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1942252|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1942253|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1942254|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942255|NCT00702546|Hormones|hormones|mesh-list
1942256|NCT00702546|Progesterone|progesterone|mesh-list
1942257|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942258|NCT00702546|Ganirelix|ganirelix|mesh-list
1942259|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942260|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942261|NCT00702546|Progestins|progestins|mesh-ancestor
1942262|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942263|NCT00702624|Hormones|hormones|mesh-list
1942264|NCT00702624|Progesterone|progesterone|mesh-list
1942265|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942266|NCT00702624|Ganirelix|ganirelix|mesh-list
1942267|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942268|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942269|NCT00702624|Progestins|progestins|mesh-ancestor
1942270|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942271|NCT00702650|Testosterone|testosterone|mesh-list
1942272|NCT00702650|Androgens|androgens|mesh-ancestor
1942273|NCT00702650|Hormones|hormones|mesh-ancestor
1942274|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942275|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942276|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
1942277|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942278|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942279|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942280|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942281|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
1942282|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
1942283|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1942284|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1942285|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1942286|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942287|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942288|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
1942289|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942290|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942291|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1942292|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942293|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1942294|NCT00702780|Citalopram|citalopram|mesh-list
1942295|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1942296|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1942297|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942298|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942299|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942300|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
1942301|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942302|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1942303|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942304|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942305|NCT00702845|Hormones|hormones|mesh-list
1942306|NCT00702845|Progesterone|progesterone|mesh-list
1942307|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942308|NCT00702845|Ganirelix|ganirelix|mesh-list
1942309|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942310|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942311|NCT00702845|Progestins|progestins|mesh-ancestor
1942312|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942313|NCT00702884|Sunitinib|sunitinib|mesh-list
1942314|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942315|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1942316|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1942317|NCT00702884|Growth Substances|growth substances|mesh-ancestor
1942318|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942319|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
1942320|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942321|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942322|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942323|NCT00702923|Tremelimumab|tremelimumab|mesh-list
1942324|NCT00702923|Bicalutamide|bicalutamide|mesh-list
1942325|NCT00702923|Ipilimumab|ipilimumab|mesh-list
1942326|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1942327|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942328|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
1942329|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942330|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
1942331|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942332|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942333|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1942334|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1942335|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942336|NCT00702949|Pregabalin|pregabalin|mesh-list
1942337|NCT00702949|Analgesics|analgesics|mesh-ancestor
1942338|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
1942339|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942340|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942341|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
1942342|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1942343|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942344|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942345|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1942346|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1942347|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942348|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942349|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942350|NCT00703014|Progesterone|progesterone|mesh-list
1942351|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1942352|NCT00703014|Ganirelix|ganirelix|mesh-list
1942353|NCT00703014|Progestins|progestins|mesh-ancestor
1942354|NCT00703014|Hormones|hormones|mesh-ancestor
1942355|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942356|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942357|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942358|NCT00703118|Ribavirin|ribavirin|mesh-list
1942359|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
1942360|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1942361|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
1942362|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942363|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
1942364|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942365|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942366|NCT00703261|Atorvastatin|atorvastatin|mesh-list
1942367|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1942368|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1942369|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
1942370|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942371|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1942372|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1942373|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942381|NCT00703508|Metformin|metformin|mesh-list
1942382|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1942383|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942384|NCT00703664|Bortezomib|bortezomib|mesh-list
1942385|NCT00703664|Vorinostat|vorinostat|mesh-list
1942386|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942387|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1942388|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942389|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942390|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
1942391|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942392|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942393|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942394|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942395|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
1942396|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942397|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942398|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942399|NCT00703781|Bromfenac|bromfenac|mesh-list
1942400|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1942401|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1942402|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1942403|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1942404|NCT00703781|Analgesics|analgesics|mesh-ancestor
1942405|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
1942406|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942407|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942408|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942409|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942410|NCT00703820|Cytarabine|cytarabine|mesh-list
1942411|NCT00703820|Etoposide|etoposide|mesh-list
1942412|NCT00703820|Daunorubicin|daunorubicin|mesh-list
1942413|NCT00703820|Clofarabine|clofarabine|mesh-list
1942414|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1942415|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942416|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1942417|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1942418|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942419|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942420|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1942421|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
1942422|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
1942423|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942424|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942425|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
1942426|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942427|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1942428|NCT00703846|Ketoconazole|ketoconazole|mesh-list
1942429|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
1942430|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942431|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1942432|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1942433|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942434|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942435|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1942436|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942437|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942438|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942439|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1942440|NCT00703924|Paromomycin|paromomycin|mesh-list
1942441|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1942442|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942443|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1942444|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1942445|NCT00703976|Bevacizumab|bevacizumab|mesh-list
1942446|NCT00703976|Cetuximab|cetuximab|mesh-list
1942447|NCT00703976|Pemetrexed|pemetrexed|mesh-list
1942448|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1942449|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942450|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1942451|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1942452|NCT00703976|Growth Substances|growth substances|mesh-ancestor
1942453|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942454|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
1942455|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942456|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942457|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1942458|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1942459|NCT00704028|Dextrans|dextrans|mesh-list
1942460|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
1942461|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
1942462|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
1942463|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
1942464|NCT00704028|Hematinics|hematinics|mesh-ancestor
1942465|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1942466|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1942467|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942468|NCT00704132|Incretins|incretins|mesh-ancestor
1942469|NCT00704132|Hormones|hormones|mesh-ancestor
1942470|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942471|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1942472|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
1942473|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942474|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942475|NCT00704184|Interferons|interferons|mesh-list
1942476|NCT00704184|Ribavirin|ribavirin|mesh-list
1942477|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942478|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
1942479|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942480|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
1942481|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942482|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
1942483|NCT00704262|Calcipotriene|calcipotriene|mesh-list
1942484|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942485|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942486|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
1942487|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
1942488|NCT00704353|Hematinics|hematinics|mesh-ancestor
1942489|NCT00704379|Sertraline|sertraline|mesh-list
1942490|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942491|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942492|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1942493|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1942494|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942495|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942496|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942497|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
1942498|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942499|NCT00704405|Interferons|interferons|mesh-list
1942500|NCT00704405|Ribavirin|ribavirin|mesh-list
1942501|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942502|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
1942503|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942504|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
1942505|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942506|NCT00704418|Bromfenac|bromfenac|mesh-list
1942507|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1942508|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1942509|NCT00704418|Analgesics|analgesics|mesh-ancestor
1942510|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
1942511|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942512|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942513|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942514|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942515|NCT00704522|Ribavirin|ribavirin|mesh-list
1942516|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942517|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
1942518|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942519|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
1942520|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942521|NCT00704535|Ezetimibe|ezetimibe|mesh-list
1942522|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1942523|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1942524|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
1942525|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942526|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1942527|NCT00704717|Ribavirin|ribavirin|mesh-list
1942528|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942529|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
1942530|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
1942531|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942532|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
1942533|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942534|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
1942535|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942536|NCT00704769|Desloratadine|desloratadine|mesh-list
1942537|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1942538|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
1942539|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942540|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942541|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942542|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1942543|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1942544|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
1942545|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
1942546|NCT00704808|Temozolomide|temozolomide|mesh-list
1942547|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1942548|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
1942549|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942550|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942551|NCT00704847|Calcitonin|calcitonin|mesh-list
1942552|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
1942553|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1942554|NCT00704847|Katacalcin|katacalcin|mesh-list
1942555|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1942556|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942557|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1942558|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
1942559|NCT00704912|Orlistat|orlistat|mesh-list
1942560|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
1942561|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
1942562|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
1942563|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1942564|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942565|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1942566|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942567|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942568|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1942569|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1942570|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1942571|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1942572|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1942573|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
1942574|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1942575|NCT00704938|Aldesleukin|aldesleukin|mesh-list
1942576|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
1942577|NCT00704938|Fludarabine|fludarabine|mesh-list
1942578|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
1942579|NCT00704938|Sargramostim|sargramostim|mesh-list
1942580|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942581|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
1942582|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942583|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942584|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1942585|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
1942586|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942587|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942588|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1942589|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1942590|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
1942591|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1942592|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1942593|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
1942594|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942595|NCT00704964|Ribavirin|ribavirin|mesh-list
1942596|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942597|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
1942598|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
1942599|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942600|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
1942601|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942602|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
1942603|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942604|NCT00705003|Melatonin|melatonin|mesh-list
1942605|NCT00705003|Buspirone|buspirone|mesh-list
1942606|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
1942607|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942608|NCT00705003|Protective Agents|protective agents|mesh-ancestor
1942609|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942610|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942611|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1942612|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942613|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942614|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1942615|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
1942616|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942617|NCT00705016|Fluorouracil|fluorouracil|mesh-list
1942618|NCT00705016|Cetuximab|cetuximab|mesh-list
1942619|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942620|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
1942621|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942622|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1942623|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942624|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
1942625|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942626|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1942627|NCT00705081|Ezetimibe|ezetimibe|mesh-list
1942628|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1942629|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1942630|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
1942631|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942632|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1942633|NCT00705107|Ribavirin|ribavirin|mesh-list
1942634|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942635|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
1942636|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
1942637|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942638|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
1942639|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942640|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
1942641|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942642|NCT00705133|Treprostinil|treprostinil|mesh-list
1942643|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1942644|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1942645|NCT00705159|Tobramycin|tobramycin|mesh-list
1942646|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1942647|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942648|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1942649|NCT00705224|Interferons|interferons|mesh-list
1942650|NCT00705224|Ribavirin|ribavirin|mesh-list
1942651|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942652|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
1942653|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942654|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
1942655|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942656|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1942657|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1942658|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
1942659|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942660|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942661|NCT00705263|Ribavirin|ribavirin|mesh-list
1942662|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942663|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
1942664|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942665|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
1942666|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942667|NCT00705289|Infliximab|infliximab|mesh-list
1942668|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942669|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1942670|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942671|NCT00705341|Fluticasone|fluticasone|mesh-list
1942672|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942673|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1942674|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
1942675|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942676|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942677|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1942678|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
1942679|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942680|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1942681|NCT00705367|Abatacept|abatacept|mesh-list
1942682|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1942683|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942684|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942685|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942686|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
1942687|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942688|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942689|NCT00705406|Peramivir|peramivir|mesh-list
1942690|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
1942691|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942692|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942693|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942694|NCT00705432|Ribavirin|ribavirin|mesh-list
1942695|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942696|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
1942697|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942698|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
1942699|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942700|NCT00705484|Infliximab|infliximab|mesh-list
1942701|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942702|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1942703|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942704|NCT00705523|Varenicline|varenicline|mesh-list
1942705|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1942706|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1942707|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
1942708|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942709|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942710|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942711|NCT00705536|Insulin|insulin|mesh-list
1942712|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1942713|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
1942714|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1942715|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942716|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1942717|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1942718|NCT00705575|Diuretics|diuretics|mesh-ancestor
1942719|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
1942720|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942721|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1942722|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942723|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942724|NCT00705614|Infliximab|infliximab|mesh-list
1942725|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942726|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1942727|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1942728|NCT00705666|Ribavirin|ribavirin|mesh-list
1942729|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1942730|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
1942731|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942732|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
1942733|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942734|NCT00705679|Tenofovir|tenofovir|mesh-list
1942735|NCT00705679|Emtricitabine|emtricitabine|mesh-list
1942736|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1942737|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
1942738|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942739|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1942740|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1942741|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942742|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942743|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1942744|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1942745|NCT00705757|Bimatoprost|bimatoprost|mesh-list
1942746|NCT00705757|Travoprost|travoprost|mesh-list
1942747|NCT00705757|Latanoprost|latanoprost|mesh-list
1942748|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1942749|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1942750|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1942751|NCT00705783|Aripiprazole|aripiprazole|mesh-list
1942752|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942753|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942754|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1942755|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942756|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942757|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942758|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
1942759|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
1942760|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942761|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942762|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1942763|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1942764|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
1942765|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1942766|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1942767|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1942768|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1942769|NCT00705874|Leucovorin|leucovorin|mesh-list
1942770|NCT00705874|Gemcitabine|gemcitabine|mesh-list
1942771|NCT00705874|Bevacizumab|bevacizumab|mesh-list
1942772|NCT00705874|Sunitinib|sunitinib|mesh-list
1942773|NCT00705874|Docetaxel|docetaxel|mesh-list
1942774|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1942775|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1942776|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942777|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1942778|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1942779|NCT00705874|Growth Substances|growth substances|mesh-ancestor
1942780|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942781|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
1942782|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1942783|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
1942784|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942785|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
1942786|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1942787|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942788|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1942789|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
1942790|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
1942791|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
1942792|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
1942793|NCT00705874|Antidotes|antidotes|mesh-ancestor
1942794|NCT00705874|Protective Agents|protective agents|mesh-ancestor
1942795|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
1942796|NCT00705874|Vitamins|vitamins|mesh-ancestor
1942797|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
1942798|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942799|NCT00706004|Lubiprostone|lubiprostone|mesh-list
1942800|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1942801|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942802|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942803|NCT00706030|Vinorelbine|vinorelbine|mesh-list
1942804|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1942805|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942806|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
1942807|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
1942808|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
1942809|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942810|NCT00706121|Vitamins|vitamins|mesh-list
1942811|NCT00706121|Vitamin E|vitamin e|mesh-list
1942812|NCT00706121|Tocopherols|tocopherols|mesh-list
1942813|NCT00706121|Tocotrienols|tocotrienols|mesh-list
1942814|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
1942815|NCT00706121|Selenium|selenium|mesh-list
1942816|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
1942817|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942818|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
1942819|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942820|NCT00706121|Protective Agents|protective agents|mesh-ancestor
1942821|NCT00706121|Trace Elements|trace elements|mesh-ancestor
1942822|NCT00706264|Silicon|silicon|mesh-list
1942823|NCT00706264|Trace Elements|trace elements|mesh-ancestor
1942824|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
1942825|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942826|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1942827|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1942828|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1942829|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1942830|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1942831|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942832|NCT00706446|Fluticasone|fluticasone|mesh-list
1942833|NCT00706446|Xhance|xhance|mesh-list
1942834|NCT00706446|Budesonide|budesonide|mesh-list
1942835|NCT00706446|Bromides|bromides|mesh-list
1942836|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
1942837|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
1942838|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1942839|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1942840|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1942841|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
1942842|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942843|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942844|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1942845|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
1942846|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
1942847|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1942848|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
1942849|NCT00706446|Hormones|hormones|mesh-ancestor
1942850|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942851|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1942852|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1942853|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1942854|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
1942855|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942856|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942857|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
1942858|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1942859|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
1942860|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
1942861|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1942862|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
1942863|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942864|NCT00706589|Aripiprazole|aripiprazole|mesh-list
1942865|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942866|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942867|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1942868|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942869|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942870|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942871|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
1942872|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
1942873|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942874|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942875|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1942876|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1942877|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
1942878|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1942879|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1942880|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1942881|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1942882|NCT00706628|Nintedanib|nintedanib|mesh-list
1942883|NCT00706628|Afatinib|afatinib|mesh-list
1942884|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942885|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942886|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942887|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942888|NCT00706641|Dasatinib|dasatinib|mesh-list
1942889|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942890|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942891|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942892|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942893|NCT00706654|Aripiprazole|aripiprazole|mesh-list
1942894|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
1942895|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942896|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1942897|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942898|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942899|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942900|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
1942901|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
1942902|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942903|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942904|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1942905|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1942906|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
1942907|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1942908|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1942909|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1942910|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1942911|NCT00706706|Sunitinib|sunitinib|mesh-list
1942912|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942913|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1942914|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1942915|NCT00706706|Growth Substances|growth substances|mesh-ancestor
1942916|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942917|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
1942918|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1942919|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942920|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942921|NCT00706719|Enclomiphene|enclomiphene|mesh-list
1942922|NCT00706719|Clomiphene|clomiphene|mesh-list
1942923|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
1942924|NCT00706719|Testosterone|testosterone|mesh-list
1942925|NCT00706719|Androgens|androgens|mesh-ancestor
1942926|NCT00706719|Hormones|hormones|mesh-ancestor
1942927|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942928|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942929|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1942930|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942931|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1942932|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
1943006|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1942933|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1942934|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1942935|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1942936|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
1942937|NCT00706810|Verapamil|verapamil|mesh-list
1942938|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1942939|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
1942940|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942941|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942942|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1942943|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1942944|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1942945|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942946|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1942947|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942948|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
1942949|NCT00706836|Pregabalin|pregabalin|mesh-list
1942950|NCT00706836|Analgesics|analgesics|mesh-ancestor
1942951|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
1942952|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942953|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942954|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
1942955|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1942956|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1942957|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942958|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1942959|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1942960|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1942961|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1942962|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1942963|NCT00706849|Mipomersen|mipomersen|mesh-list
1942964|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1942965|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1942966|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
1942967|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942968|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1942969|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
1942970|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1942971|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
1942972|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942973|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942974|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1942975|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
1942976|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1942977|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1942978|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1942979|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
1942980|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942981|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942982|NCT00706966|Dutasteride|dutasteride|mesh-list
1942983|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1942984|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1942985|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1942986|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1942987|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
1942988|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1942989|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942990|NCT00706979|Nicotine|nicotine|mesh-list
1942991|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1942992|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
1942993|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1942994|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1942995|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1942996|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1942997|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
1942998|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1942999|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943000|NCT00706992|Aldesleukin|aldesleukin|mesh-list
1943001|NCT00706992|Vaccines|vaccines|mesh-list
1943002|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
1943003|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
1943004|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943005|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943007|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1943008|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
1943009|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943010|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1943011|NCT00707031|Metformin|metformin|mesh-list
1943012|NCT00707031|Exenatide|exenatide|mesh-list
1943013|NCT00707031|Lixisenatide|lixisenatide|mesh-list
1943014|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943015|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943016|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1943017|NCT00707031|Incretins|incretins|mesh-ancestor
1943018|NCT00707031|Hormones|hormones|mesh-ancestor
1943019|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943020|NCT00707057|Ibuprofen|ibuprofen|mesh-list
1943021|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1943022|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1943023|NCT00707057|Analgesics|analgesics|mesh-ancestor
1943024|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
1943025|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943026|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943027|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943028|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943029|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1943030|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943031|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943032|NCT00707174|Imiquimod|imiquimod|mesh-list
1943033|NCT00707174|Tazarotene|tazarotene|mesh-list
1943034|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1943035|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
1943036|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943037|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943038|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
1943039|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943040|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
1943041|NCT00707239|Imipenem|imipenem|mesh-list
1943042|NCT00707239|Tigecycline|tigecycline|mesh-list
1943043|NCT00707239|Cilastatin|cilastatin|mesh-list
1943044|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943045|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943046|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1943047|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943048|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943049|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
1943050|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1943051|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
1943052|NCT00707486|Coagulants|coagulants|mesh-ancestor
1943053|NCT00707655|Zalutumumab|zalutumumab|mesh-list
1943054|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1943055|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943056|NCT00707746|Mipomersen|mipomersen|mesh-list
1943057|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1943058|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1943059|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
1943060|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943061|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1943062|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
1943063|NCT00707759|Prednisone|prednisone|mesh-list
1943064|NCT00707759|Prednisolone|prednisolone|mesh-list
1943065|NCT00707759|Tacrolimus|tacrolimus|mesh-list
1943066|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943067|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
1943068|NCT00707759|Hormones|hormones|mesh-ancestor
1943069|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943070|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943071|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1943072|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943073|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943074|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
1943075|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1943076|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943077|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943078|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943079|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1943080|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
1943081|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943082|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943083|NCT00707863|Citalopram|citalopram|mesh-list
1943084|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1943085|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1943086|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1943087|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943088|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943089|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
1943090|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943091|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1943092|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
1943093|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943094|NCT00707967|Vaccines|vaccines|mesh-list
1943095|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
1943096|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943097|NCT00707980|Vortioxetine|vortioxetine|mesh-list
1943098|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
1943099|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943100|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1943101|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1943102|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943103|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943104|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1943105|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1943106|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1943107|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943108|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943109|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
1943110|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1943111|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1943112|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1943113|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1943114|NCT00707993|Alogliptin|alogliptin|mesh-list
1943115|NCT00707993|Glipizide|glipizide|mesh-list
1943116|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943117|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943118|NCT00707993|Incretins|incretins|mesh-ancestor
1943119|NCT00707993|Hormones|hormones|mesh-ancestor
1943120|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943121|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1943122|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
1943123|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943124|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943125|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1943126|NCT00708071|Thrombin|thrombin|mesh-list
1943127|NCT00708071|Aprotinin|aprotinin|mesh-list
1943128|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
1943129|NCT00708071|Coagulants|coagulants|mesh-ancestor
1943130|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1943131|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1943132|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
1943133|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943134|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943135|NCT00708097|Fluorides|fluorides|mesh-list
1943136|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
1943137|NCT00708097|Protective Agents|protective agents|mesh-ancestor
1943138|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943139|NCT00708110|Dolutegravir|dolutegravir|mesh-list
1943140|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1943141|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1943142|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943143|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943144|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1943145|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1943146|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
1943147|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943148|NCT00708123|Listerine|listerine|mesh-list
1943149|NCT00708123|Fluorides|fluorides|mesh-list
1943150|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
1943151|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
1943152|NCT00708123|Protective Agents|protective agents|mesh-ancestor
1943153|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943154|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1943155|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943156|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
1943157|NCT00708162|Elvitegravir|elvitegravir|mesh-list
1943158|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1943159|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1943160|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
1943161|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943162|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1943163|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1943164|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943165|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943166|NCT00708175|Pioglitazone|pioglitazone|mesh-list
1943167|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943168|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943169|NCT00708201|Alvimopan|alvimopan|mesh-list
1943170|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943171|NCT00708214|Letrozole|letrozole|mesh-list
1943172|NCT00708214|Afatinib|afatinib|mesh-list
1943173|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943174|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1943175|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1943176|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943177|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943178|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1943179|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
1943180|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943181|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943182|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943183|NCT00708305|Listerine|listerine|mesh-list
1943184|NCT00708305|Fluorides|fluorides|mesh-list
1943185|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
1943186|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
1943187|NCT00708305|Protective Agents|protective agents|mesh-ancestor
1943188|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943189|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1943190|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943191|NCT00708422|Travoprost|travoprost|mesh-list
1943192|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1943193|NCT00708422|Latanoprost|latanoprost|mesh-list
1943194|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1943195|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1943196|NCT00708435|Protein C|protein c|mesh-list
1943197|NCT00708435|Protein S|protein s|mesh-list
1943198|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
1943199|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1943200|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1943201|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943202|NCT00708500|Interferons|interferons|mesh-list
1943203|NCT00708500|Ribavirin|ribavirin|mesh-list
1943204|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
1943205|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
1943206|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1943207|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943208|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
1943209|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943210|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
1943211|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943212|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
1943213|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943214|NCT00708526|Anesthetics|anesthetics|mesh-list
1943215|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943216|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943217|NCT00708552|Donepezil|donepezil|mesh-list
1943218|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1943219|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943220|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943221|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
1943222|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943223|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943224|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
1943225|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1943226|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
1943227|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943228|NCT00708708|Etanercept|etanercept|mesh-list
1943229|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1943230|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1943231|NCT00708708|Analgesics|analgesics|mesh-ancestor
1943232|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
1943233|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943234|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943235|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943236|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943237|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943238|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943239|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
1943240|NCT00708721|Clofarabine|clofarabine|mesh-list
1943241|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1943242|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
1943243|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943244|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943245|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1943246|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1943247|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943248|NCT00709059|Ribavirin|ribavirin|mesh-list
1943249|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1943250|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
1943251|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
1943252|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943253|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
1943254|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943255|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
1943256|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943257|NCT00709098|Iloprost|iloprost|mesh-list
1943258|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1943259|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
1943260|NCT00709111|Maraviroc|maraviroc|mesh-list
1943261|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1943262|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1943263|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943264|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1943265|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1943266|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
1943267|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943268|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1943269|NCT00709202|Betahistine|betahistine|mesh-list
1943270|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
1943271|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
1943272|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
1943273|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943274|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943275|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943276|NCT00709228|Ribavirin|ribavirin|mesh-list
1943277|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1943278|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
1943279|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943280|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
1943281|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943282|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
1943283|NCT00709592|Tacrolimus|tacrolimus|mesh-list
1943284|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
1943285|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1943286|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943287|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
1943288|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943289|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1943290|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943291|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943292|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943293|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943294|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1943295|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
1943296|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943297|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943298|NCT00709618|Vinorelbine|vinorelbine|mesh-list
1943299|NCT00709618|Lapatinib|lapatinib|mesh-list
1943300|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1943301|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943302|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
1943303|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
1943304|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
1943305|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943306|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943307|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943308|NCT00709696|Varenicline|varenicline|mesh-list
1943309|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1943310|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1943311|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
1943312|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943313|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943314|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943315|NCT00709722|Gusperimus|gusperimus|mesh-list
1943316|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943317|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943318|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943319|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943320|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943321|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
1943322|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1943323|NCT00709722|Protective Agents|protective agents|mesh-ancestor
1943324|NCT00709735|Propranolol|propranolol|mesh-list
1943325|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1943326|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1943327|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
1943328|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943329|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943330|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943331|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1943332|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1943333|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
1943334|NCT00709761|Paclitaxel|paclitaxel|mesh-list
1943335|NCT00709761|Lapatinib|lapatinib|mesh-list
1943336|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1943337|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943338|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
1943339|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
1943340|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
1943341|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943342|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943343|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943344|NCT00709826|Gemcitabine|gemcitabine|mesh-list
1943345|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1943346|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1943347|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
1943348|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943349|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943350|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
1943351|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943352|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943353|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943354|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
1943355|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943356|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943357|NCT00709956|Iloprost|iloprost|mesh-list
1943358|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1943359|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
1943360|NCT00709995|Sunitinib|sunitinib|mesh-list
1943361|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943362|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1943363|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1943364|NCT00709995|Growth Substances|growth substances|mesh-ancestor
1943365|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943366|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
1943367|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943368|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943369|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943370|NCT00710021|Vitamin D|vitamin d|mesh-list
1943371|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
1943372|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
1943373|NCT00710021|Vitamins|vitamins|mesh-list
1943374|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
1943375|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943376|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1943377|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1943378|NCT00710034|Nicotine|nicotine|mesh-list
1943379|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1943380|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
1943381|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943382|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943383|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1943384|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1943385|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
1943386|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943387|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943388|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1943389|NCT00710385|Buprenorphine|buprenorphine|mesh-list
1943390|NCT00710385|Heroin|heroin|mesh-list
1943391|NCT00710385|Naloxone|naloxone|mesh-list
1943392|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1943393|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943394|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
1943395|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943396|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1943397|NCT00710385|Narcotics|narcotics|mesh-ancestor
1943398|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943399|NCT00710385|Analgesics|analgesics|mesh-ancestor
1943400|NCT00710424|Nabiximols|nabiximols|mesh-list
1943401|NCT00710424|Analgesics|analgesics|mesh-ancestor
1943402|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
1943403|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943404|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943405|NCT00710554|Nabiximols|nabiximols|mesh-list
1943406|NCT00710554|Analgesics|analgesics|mesh-ancestor
1943407|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
1943408|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943409|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943410|NCT00710606|NuvaRing|nuvaring|mesh-list
1943411|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1943412|NCT00710606|Desogestrel|desogestrel|mesh-list
1943413|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1943414|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
1943415|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1943416|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943417|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1943418|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1943419|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1943420|NCT00710606|Estrogens|estrogens|mesh-ancestor
1943421|NCT00710606|Hormones|hormones|mesh-ancestor
1943422|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943423|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1943424|NCT00710606|Progestins|progestins|mesh-ancestor
1943425|NCT00710684|Donepezil|donepezil|mesh-list
1943426|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1943427|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943428|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943429|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
1943430|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943431|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943432|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
1943433|NCT00710762|Nintedanib|nintedanib|mesh-list
1943434|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943435|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943436|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943437|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943449|NCT00711009|Ritonavir|ritonavir|mesh-list
1943450|NCT00711009|Lopinavir|lopinavir|mesh-list
1943451|NCT00711009|Tenofovir|tenofovir|mesh-list
1943452|NCT00711009|Emtricitabine|emtricitabine|mesh-list
1943453|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
1943454|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1943455|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1943456|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1943457|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
1943458|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943459|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943460|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1943461|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1943462|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
1943463|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943464|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1943465|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1943466|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1943467|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1943468|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1943469|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1943470|NCT00711191|Antibodies|antibodies|mesh-list
1943471|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1943472|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
1943473|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943474|NCT00711243|Docetaxel|docetaxel|mesh-list
1943475|NCT00711243|Fluorouracil|fluorouracil|mesh-list
1943476|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
1943477|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943478|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
1943479|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
1943480|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
1943481|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943482|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
1943483|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1943484|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943485|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
1943486|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943487|NCT00711269|Risperidone|risperidone|mesh-list
1943488|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1943489|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1943490|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
1943491|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943492|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943493|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943494|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1943495|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1943496|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943497|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943498|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1943499|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
1943500|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1943501|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1943502|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1943503|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
1943504|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1943505|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1943506|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
1943507|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1943508|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
1943509|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943510|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
1943511|NCT00711347|Protective Agents|protective agents|mesh-ancestor
1943512|NCT00711412|Capecitabine|capecitabine|mesh-list
1943513|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
1943514|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1943515|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
1943516|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943517|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943518|NCT00711464|Modafinil|modafinil|mesh-list
1943519|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1943520|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943521|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1943522|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1943523|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1943524|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943525|NCT00711477|Naltrexone|naltrexone|mesh-list
1943526|NCT00711477|Bupropion|bupropion|mesh-list
1943527|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1943528|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1943529|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943530|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
1943531|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943532|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1943533|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
1943534|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943535|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1943536|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1943537|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1943612|NCT00711802|Cloxacillin|cloxacillin|mesh-list
1943538|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943539|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
1943540|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943541|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1943542|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1943543|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943544|NCT00711490|Sirolimus|sirolimus|mesh-list
1943545|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943546|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943547|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943548|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943549|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
1943550|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943551|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
1943552|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943553|NCT00711516|Modafinil|modafinil|mesh-list
1943554|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1943555|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943556|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1943557|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1943558|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1943559|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943560|NCT00711529|Gabapentin|gabapentin|mesh-list
1943561|NCT00711529|Analgesics|analgesics|mesh-ancestor
1943562|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
1943563|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943564|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943565|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
1943566|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1943567|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1943568|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943569|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943570|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1943571|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1943572|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943573|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943574|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
1943575|NCT00711555|Dexamethasone|dexamethasone|mesh-list
1943576|NCT00711555|Ondansetron|ondansetron|mesh-list
1943577|NCT00711555|Aprepitant|aprepitant|mesh-list
1943578|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943579|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
1943580|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
1943581|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943582|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943583|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943584|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
1943585|NCT00711555|Hormones|hormones|mesh-ancestor
1943586|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943587|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1943588|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943589|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
1943590|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943591|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1943592|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
1943593|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943594|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943595|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1943596|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1943597|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943598|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943599|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1943600|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1943601|NCT00711594|Afatinib|afatinib|mesh-list
1943602|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943603|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943604|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943605|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943606|NCT00711646|Nabiximols|nabiximols|mesh-list
1943607|NCT00711646|Analgesics|analgesics|mesh-ancestor
1943608|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
1943609|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943610|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943611|NCT00711802|Daptomycin|daptomycin|mesh-list
1943613|NCT00711802|Oxacillin|oxacillin|mesh-list
1943614|NCT00711802|Nafcillin|nafcillin|mesh-list
1943615|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943616|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943617|NCT00711828|Dexamethasone|dexamethasone|mesh-list
1943618|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
1943619|NCT00711828|Rituximab|rituximab|mesh-list
1943620|NCT00711828|Bortezomib|bortezomib|mesh-list
1943621|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943622|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
1943623|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943624|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943625|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1943626|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
1943627|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943628|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943629|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1943630|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943631|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
1943632|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
1943633|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943634|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943635|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
1943636|NCT00711828|Hormones|hormones|mesh-ancestor
1943637|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943638|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1943639|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1943640|NCT00711880|Nabiximols|nabiximols|mesh-list
1943641|NCT00711880|Analgesics|analgesics|mesh-ancestor
1943642|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
1943643|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943644|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943645|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1943646|NCT00712010|Caseins|caseins|mesh-list
1943647|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
1943648|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
1943649|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943650|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
1943651|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1943652|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
1943653|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943654|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
1943655|NCT00712244|Protective Agents|protective agents|mesh-ancestor
1943656|NCT00712270|Risperidone|risperidone|mesh-list
1943657|NCT00712270|Aripiprazole|aripiprazole|mesh-list
1943658|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1943659|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
1943660|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943661|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943662|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943663|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1943664|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1943665|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943666|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1943667|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1943668|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
1943669|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
1943670|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
1943671|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1943672|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1943673|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1943674|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1943675|NCT00712335|Fluticasone|fluticasone|mesh-list
1943676|NCT00712335|Xhance|xhance|mesh-list
1943677|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1943678|NCT00712335|Montelukast|montelukast|mesh-list
1943679|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
1943680|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943681|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1943682|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
1943683|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943684|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943685|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1943686|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
1943687|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943688|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1943689|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1943690|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1943691|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1943692|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
1943693|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943694|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943695|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
1943696|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943697|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1943698|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1943699|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1943700|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
1943701|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943702|NCT00712543|Lactulose|lactulose|mesh-list
1943703|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943704|NCT00712673|Metformin|metformin|mesh-list
1943705|NCT00712673|Lixisenatide|lixisenatide|mesh-list
1943706|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943707|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943708|NCT00712712|Acetaminophen|acetaminophen|mesh-list
1943709|NCT00712712|Morphine|morphine|mesh-list
1943710|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1943711|NCT00712712|Narcotics|narcotics|mesh-ancestor
1943712|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1943713|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943714|NCT00712712|Analgesics|analgesics|mesh-ancestor
1943715|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
1943716|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943717|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1943718|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
1943719|NCT00712920|Azelastine|azelastine|mesh-list
1943720|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1943721|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
1943722|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943723|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943724|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1943725|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
1943726|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1943727|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943728|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943729|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1943730|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1943731|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1943732|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
1943733|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
1943734|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943739|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
1943740|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1943741|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943742|NCT00713219|Docetaxel|docetaxel|mesh-list
1943743|NCT00713219|Cetuximab|cetuximab|mesh-list
1943744|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943745|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
1943746|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
1943747|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
1943748|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943749|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1943750|NCT00713284|Sirolimus|sirolimus|mesh-list
1943751|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943752|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943753|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943754|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943755|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
1943756|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943757|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
1943758|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943759|NCT00713310|Mesalamine|mesalamine|mesh-list
1943760|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1943761|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1943762|NCT00713310|Analgesics|analgesics|mesh-ancestor
1943763|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
1943764|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943765|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943766|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943767|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943768|NCT00713323|Nabiximols|nabiximols|mesh-list
1943769|NCT00713323|Analgesics|analgesics|mesh-ancestor
1943770|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
1943771|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943772|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943773|NCT00713479|Varenicline|varenicline|mesh-list
1943774|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1943775|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1943776|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
1943777|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943778|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943779|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943780|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
1943781|NCT00713544|Etanercept|etanercept|mesh-list
1943782|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1943783|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1943784|NCT00713544|Analgesics|analgesics|mesh-ancestor
1943785|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
1943786|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943787|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943788|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943789|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943790|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943791|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943792|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
1943793|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1943794|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943795|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1943796|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1943797|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
1943798|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943799|NCT00713583|Levodopa|levodopa|mesh-list
1943800|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1943801|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1943802|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
1943803|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943804|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943805|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943806|NCT00713609|Clindamycin|clindamycin|mesh-list
1943807|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
1943808|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
1943809|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1943810|NCT00713609|Tazarotene|tazarotene|mesh-list
1943811|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943812|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943813|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1943814|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943815|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943816|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943817|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
1943818|NCT00713817|Nabiximols|nabiximols|mesh-list
1943819|NCT00713817|Analgesics|analgesics|mesh-ancestor
1943820|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
1943821|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943822|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943823|NCT00713830|Metformin|metformin|mesh-list
1943824|NCT00713830|Lixisenatide|lixisenatide|mesh-list
1943825|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943826|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943827|NCT00714233|Metformin|metformin|mesh-list
1943828|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
1943829|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
1943830|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1943831|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1943832|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943833|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943834|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1943835|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1943836|NCT00714259|Fludarabine|fludarabine|mesh-list
1943837|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943838|NCT00714285|Vaccines|vaccines|mesh-list
1943839|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
1943840|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943841|NCT00714493|Infliximab|infliximab|mesh-list
1943842|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943843|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1943844|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943845|NCT00714688|Methylphenidate|methylphenidate|mesh-list
1943846|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1943847|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943848|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1943849|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1943850|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1943851|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943852|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
1943853|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943854|NCT00714714|Adapalene|adapalene|mesh-list
1943855|NCT00714714|Tretinoin|tretinoin|mesh-list
1943856|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1943857|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1943858|NCT00714714|Analgesics|analgesics|mesh-ancestor
1943859|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
1943860|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943861|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943862|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943863|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943864|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
1943865|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943866|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
1943867|NCT00715117|Naltrexone|naltrexone|mesh-list
1943868|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1943869|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1943870|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943871|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
1943872|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943873|NCT00715208|Prednisone|prednisone|mesh-list
1943874|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
1943875|NCT00715208|Rituximab|rituximab|mesh-list
1943876|NCT00715208|Doxorubicin|doxorubicin|mesh-list
1943877|NCT00715208|Bortezomib|bortezomib|mesh-list
1943878|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943879|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
1943880|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943881|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1943882|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1943883|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
1943884|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943885|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943886|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1943887|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1943888|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943889|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1943890|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1943891|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943892|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1943893|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
1943894|NCT00715208|Hormones|hormones|mesh-ancestor
1943895|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1943896|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1943897|NCT00715403|Nintedanib|nintedanib|mesh-list
1943898|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943899|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1943900|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943901|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943902|NCT00715429|Vitamin D|vitamin d|mesh-list
1943903|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
1943904|NCT00715429|Vitamins|vitamins|mesh-ancestor
1943905|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
1943906|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943907|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1943908|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1943909|NCT00715520|Levodopa|levodopa|mesh-list
1943910|NCT00715520|Carbidopa|carbidopa|mesh-list
1943911|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1943912|NCT00715520|Methylphenidate|methylphenidate|mesh-list
1943913|NCT00715520|Amphetamine|amphetamine|mesh-list
1943914|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1943915|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943916|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1943917|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1943918|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1943919|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943920|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
1943921|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943922|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1943923|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1943924|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1943925|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943926|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
1943927|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
1943928|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943929|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
1943930|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1943931|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1943932|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
1943933|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
1943934|NCT00715559|Cysteamine|cysteamine|mesh-list
1943935|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1943936|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943937|NCT00715624|Metformin|metformin|mesh-list
1943938|NCT00715624|Lixisenatide|lixisenatide|mesh-list
1943939|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1943940|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943941|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
1943942|NCT00715676|Vitamins|vitamins|mesh-ancestor
1943943|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
1943944|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943945|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1943946|NCT00715793|Temozolomide|temozolomide|mesh-list
1943947|NCT00715793|Decitabine|decitabine|mesh-list
1943948|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1943949|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
1943950|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943951|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943952|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1943953|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
1943954|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1943955|NCT00715884|Sirolimus|sirolimus|mesh-list
1943956|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1943957|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1943958|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1943959|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1943960|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
1943961|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1943962|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
1943963|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943964|NCT00715910|Vaccines|vaccines|mesh-list
1943965|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
1943966|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943967|NCT00716079|Metoprolol|metoprolol|mesh-list
1943968|NCT00716079|Clonidine|clonidine|mesh-list
1943969|NCT00716079|Hydralazine|hydralazine|mesh-list
1943970|NCT00716079|Labetalol|labetalol|mesh-list
1943971|NCT00716079|Nicardipine|nicardipine|mesh-list
1943972|NCT00716079|Phentolamine|phentolamine|mesh-list
1943973|NCT00716079|Urapidil|urapidil|mesh-list
1943974|NCT00716079|Enalaprilat|enalaprilat|mesh-list
1943975|NCT00716079|Esmolol|esmolol|mesh-list
1943976|NCT00716079|Glycerol|glycerol|mesh-list
1943977|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1943978|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1943979|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
1943980|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
1943981|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1943982|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1943983|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1943984|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1943985|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1943986|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
1943987|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1943988|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1943989|NCT00716079|Analgesics|analgesics|mesh-ancestor
1943990|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
1943991|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1943992|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1943993|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1943994|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1943995|NCT00716079|Protective Agents|protective agents|mesh-ancestor
1943996|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
1943997|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
1943998|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1943999|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1944000|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1944001|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1944002|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1944003|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1944004|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
1944005|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1944006|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
1944007|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944008|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1944009|NCT00716092|Linagliptin|linagliptin|mesh-list
1944010|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1944011|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944012|NCT00716092|Incretins|incretins|mesh-ancestor
1944013|NCT00716092|Hormones|hormones|mesh-ancestor
1944014|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944015|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1944016|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
1944017|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944018|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944019|NCT00716144|R 115866|r 115866|mesh-list
1944020|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1944021|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944022|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944023|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1944024|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1944025|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1944026|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1944027|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944028|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
1944029|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944030|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944031|NCT00716417|Afatinib|afatinib|mesh-list
1944032|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944033|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944034|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944035|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944036|NCT00716443|Lidocaine|lidocaine|mesh-list
1944037|NCT00716443|Tetracaine|tetracaine|mesh-list
1944038|NCT00716443|Benzocaine|benzocaine|mesh-list
1944039|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
1944040|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
1944041|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944042|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944043|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
1944044|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944045|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1944046|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1944047|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1944048|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1944049|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944050|NCT00716456|Cetuximab|cetuximab|mesh-list
1944051|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1944052|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944053|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944054|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944055|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944056|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944057|NCT00716586|Dorzolamide|dorzolamide|mesh-list
1944058|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1944059|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1944060|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944061|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944062|NCT00716625|Sunitinib|sunitinib|mesh-list
1944063|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944064|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944065|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944066|NCT00716625|Growth Substances|growth substances|mesh-ancestor
1944067|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944068|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944069|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944070|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944071|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944072|NCT00716742|Bimatoprost|bimatoprost|mesh-list
1944073|NCT00716742|Travoprost|travoprost|mesh-list
1944074|NCT00716742|Latanoprost|latanoprost|mesh-list
1944075|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1944076|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1944077|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1944078|NCT00716820|Sunitinib|sunitinib|mesh-list
1944079|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944080|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944081|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944082|NCT00716820|Growth Substances|growth substances|mesh-ancestor
1944083|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944084|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944085|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944086|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944087|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944088|NCT00716859|Timolol|timolol|mesh-list
1944089|NCT00716859|Latanoprost|latanoprost|mesh-list
1944090|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1944091|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1944092|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
1944093|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944094|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944095|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944096|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1944097|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1944098|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1944099|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1944100|NCT00716963|Fluticasone|fluticasone|mesh-list
1944101|NCT00716963|Xhance|xhance|mesh-list
1944102|NCT00716963|Budesonide|budesonide|mesh-list
1944103|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944104|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1944105|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
1944106|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944107|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944108|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1944109|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
1944110|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944111|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1944112|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
1944113|NCT00716963|Hormones|hormones|mesh-ancestor
1944114|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944115|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
1944116|NCT00716976|Antidotes|antidotes|mesh-ancestor
1944117|NCT00716976|Protective Agents|protective agents|mesh-ancestor
1944118|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944119|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
1944120|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944121|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
1944122|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1944123|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944124|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
1944125|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
1944126|NCT00717054|Scopolamine|scopolamine|mesh-list
1944127|NCT00717054|Aprepitant|aprepitant|mesh-list
1944128|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1944129|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
1944130|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
1944131|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944132|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944133|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1944134|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1944135|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944136|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944137|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1944138|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
1944139|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1944140|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
1944141|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1944142|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
1944143|NCT00717067|Ritonavir|ritonavir|mesh-list
1944144|NCT00717067|Saquinavir|saquinavir|mesh-list
1944145|NCT00717067|Maraviroc|maraviroc|mesh-list
1944146|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1944147|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1944148|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
1944149|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944150|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944151|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1944152|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1944153|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
1944154|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944155|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1944156|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1944157|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1944158|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1944159|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1944160|NCT00717093|Varenicline|varenicline|mesh-list
1944161|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1944162|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1944163|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
1944164|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944165|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944166|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944167|NCT00717197|Capecitabine|capecitabine|mesh-list
1944168|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944169|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
1944170|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944171|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944172|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
1944173|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944174|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
1944175|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944176|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944177|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
1944178|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1944179|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944180|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
1944181|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1944182|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944183|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1944184|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
1944185|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1944186|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944187|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944188|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944189|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
1944190|NCT00717366|Hematinics|hematinics|mesh-ancestor
1944191|NCT00717405|Bevacizumab|bevacizumab|mesh-list
1944192|NCT00717405|Trastuzumab|trastuzumab|mesh-list
1944193|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944194|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944195|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944196|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944197|NCT00717405|Growth Substances|growth substances|mesh-ancestor
1944198|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944199|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944200|NCT00717418|Cyclosporine|cyclosporine|mesh-list
1944201|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
1944202|NCT00717418|Cyclosporins|cyclosporins|mesh-list
1944203|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944204|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944205|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944206|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
1944207|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944208|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
1944209|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944210|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944211|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944212|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1944213|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1944214|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1944215|NCT00717522|Pomalidomide|pomalidomide|mesh-list
1944216|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
1944217|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944218|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944219|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944220|NCT00717522|Growth Substances|growth substances|mesh-ancestor
1944221|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944222|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944223|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
1944224|NCT00717574|Propofol|propofol|mesh-list
1944225|NCT00717574|Sevoflurane|sevoflurane|mesh-list
1944226|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1944227|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944228|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944229|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1944230|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
1944231|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
1944232|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1944233|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1944234|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1944235|NCT00717574|Analgesics|analgesics|mesh-ancestor
1944236|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
1944237|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944238|NCT00717626|Factor VIII|factor viii|mesh-list
1944239|NCT00717626|Coagulants|coagulants|mesh-ancestor
1944240|NCT00717756|Lenalidomide|lenalidomide|mesh-list
1944241|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
1944242|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944243|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944244|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944245|NCT00717756|Growth Substances|growth substances|mesh-ancestor
1944246|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944247|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944248|NCT00717860|Caspofungin|caspofungin|mesh-list
1944249|NCT00717860|Micafungin|micafungin|mesh-list
1944250|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
1944251|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944252|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944253|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944254|NCT00718081|Sufentanil|sufentanil|mesh-list
1944255|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1944256|NCT00718081|Narcotics|narcotics|mesh-ancestor
1944257|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944258|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944259|NCT00718081|Analgesics|analgesics|mesh-ancestor
1944260|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
1944261|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944262|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1944263|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1944264|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
1944265|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
